<SEC-DOCUMENT>0001193125-21-085777.txt : 20210318
<SEC-HEADER>0001193125-21-085777.hdr.sgml : 20210318
<ACCEPTANCE-DATETIME>20210318160230
ACCESSION NUMBER:		0001193125-21-085777
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		122
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210318
DATE AS OF CHANGE:		20210318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Foghorn Therapeutics Inc.
		CENTRAL INDEX KEY:			0001822462
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39634
		FILM NUMBER:		21754332

	BUSINESS ADDRESS:	
		STREET 1:		500 TECHNOLOGY SQUARE
		STREET 2:		SUITE 700
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		617-586-3100

	MAIL ADDRESS:	
		STREET 1:		500 TECHNOLOGY SQUARE
		STREET 2:		SUITE 700
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>d105868d10k.htm
<DESCRIPTION>10-K
<TEXT>
<HTML><HEAD>
<TITLE>10-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">10-K</FONT> </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>(Mark One) </B></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9746;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For the fiscal year ended December&nbsp;31, 2020 </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>OR </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
</B></P></TD></TR></TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For the transition period from
<U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U> to
<U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U> </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Commission file number: 001-39634 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>Foghorn
Therapeutics Inc. </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">47-5271393</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>500 Technology Square, Ste 700</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Cambridge, Massachusetts</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>02139</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">617-586-3100</FONT></FONT> </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities registered pursuant to Section&nbsp;12(b) of the Act: </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Title&nbsp;of&nbsp;each&nbsp;class</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Trading</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Symbol(s)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Name&nbsp;of&nbsp;each&nbsp;exchange
on&nbsp;which&nbsp;registered</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Common&nbsp;Stock,&nbsp;$0.0001&nbsp;Par&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FHTX</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>The Nasdaq Global&nbsp;Market</B></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities registered pursuant to Section&nbsp;12(g) of the Act: </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>None </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Indicate by check
mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9746; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Indicate by check mark if the registrant is not required to file reports pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the
Act.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the
registrant (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and
(2)&nbsp;has been subject to such filing requirements for the past 90&nbsp;days.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-T</FONT> (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such
files).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148;
&#147;accelerated filer,&#148; &#147;smaller reporting company,&#148; and &#147;emerging growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated</FONT> filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#146;s assessment of the effectiveness of
its internal control over financial reporting under Section&nbsp;404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a shell company (as defined in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the
Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">As of June&nbsp;30, 2020, the
last business day of the registrant&#146;s most recently completed second fiscal quarter, there was no established public market for the registrant&#146;s Common Stock.&nbsp;The registrant&#146;s Common Stock began trading on the NASDAQ Global
Market on October&nbsp;23, 2020. The aggregate market value of Common Stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> of the registrant computed by reference to the price of the registrant&#146;s Common Stock as of
October&nbsp;23, 2020 (based on the last reported sale price on the NASDAQ Global Market as of such date) was $291.7&nbsp;million. </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">As of
January&nbsp;31, 2021 there were 36,816,714 shares of the registrant&#146;s Common Stock, $0.0001 par value per share, outstanding. </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>DOCUMENTS INCORPORATED BY REFERENCE </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Portions of the registrant&#146;s Proxy Statement for its 2021 Annual Meeting of Stockholders, which the registrant intends to file with the
Securities and Exchange Commission not later than 120 days after the registrant&#146;s fiscal year ended December&nbsp;31, 2020, are incorporated by reference into Part III of this Annual Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;10-K.</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Foghorn Therapeutics Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>Index </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A HREF="#tx105868_1"><U>PART I</U> </A></B></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_2">Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;1A.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_3">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;1B.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_4">Unresolved Staff Comments</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_5">Properties</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;3.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_6">Legal Proceedings</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;4.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_7">Mine Safety Disclosures</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A HREF="#tx105868_8"><U>PART II</U>
</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;5.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_9">Market for Registrant&#146;s Common Equity, Related Stockholder Matters and Issuer
 Purchases of Equity Securities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;6.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_10">Selected Financial Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;7.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_11">Management&#146;s Discussion and Analysis of Financial Condition and Results of
 Operations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;7A.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_12">Quantitative and Qualitative Disclosures About Market Risk</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;8.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_13">Consolidated Financial Statements and Supplementary Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;9.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_14">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;9A.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_15">Controls and Procedures</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;9B.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_16">Other Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A HREF="#tx105868_17"><U>PART III</U>
</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;10.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_18">Directors, Executive Officers and Corporate Governance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;11.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_19">Executive Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;12.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_20">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
 Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;13.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_21">Certain Relationships and Related Transactions, and Director
Independence</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;14.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_22">Principal Accounting Fees and Services</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A HREF="#tx105868_23"><U>PART&nbsp;IV</U>
</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;15.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_24">Exhibits, Financial Statement Schedules</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;16.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_25">Form 10-K Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><A HREF="#tx105868_26">Signatures </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> contains forward-looking statements that are based on management&#146;s beliefs and
assumptions and on information currently available to management. All statements other than statements of historical facts contained in this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> are forward-looking statements. In some
cases, you can identify forward-looking statements by terms such as &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;expect,&#148; &#147;plan,&#148; &#147;anticipate,&#148; &#147;could,&#148; &#147;intend,&#148; &#147;target,&#148;
&#147;project,&#148; &#147;contemplate,&#148; &#147;believe,&#148; &#147;estimate,&#148; &#147;predict,&#148; &#147;potential&#148; or &#147;continue&#148; or the negative of these terms or other similar expressions, although not all forward-looking
statements contain these words. Forward-looking statements include, but are not limited to, statements concerning: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the initiation, timing, progress and results of our research and development programs, preclinical and clinical
studies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to advance any product candidates that we may develop and successfully complete preclinical and
clinical studies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to leverage our initial programs to develop additional product candidates using our Gene Traffic
Control platform; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on our and our collaborators&#146;
business operations, including our research and development programs and preclinical and clinical studies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments related to our competitors and our industry; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to expand the target populations of our programs and the availability of patients for clinical
testing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain regulatory approval for <FONT STYLE="white-space:nowrap">FHD-286,</FONT> <FONT
STYLE="white-space:nowrap">FHD-609</FONT> and any future product candidates from the U.S. Food and Drug Administration, or FDA, and other regulatory authorities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to identify and enter into future license agreements and collaborations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to continue to rely on our contract development and manufacturing organizations, or CDMOs, and
contract research organizations, or CROs, for our manufacturing and research needs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory developments in the United States and foreign countries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract and retain key scientific and management personnel; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope of protection we are able to establish, maintain and enforce for intellectual property rights covering <FONT
STYLE="white-space:nowrap">FHD-286,</FONT> <FONT STYLE="white-space:nowrap">FHD-609,</FONT> our future products and our Gene Traffic Control platform. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The forward-looking statements in this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> are only predictions and are based largely on our
current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> and are subject to a number of known and unknown risks, uncertainties and assumptions, including those described under the section entitled &#147;Item 1A. Risk&nbsp;Factors&#148; in this Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should
not rely on these forward-looking statements as predictions of future events. Moreover, we operate in an evolving environment. New risks and uncertainties may emerge from time to time, and it is not possible for management to predict all risks and
uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUMMARY OF RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Below is a summary of the principal factors that make an investment in our common stock speculative or risky. This summary does not address all of the
risks that we face. Additional discussion of the risks summarized in this risk factor summary and other risks that we face can be found below under the heading &#147;Item 1A. Risk Factors&#148; and should be carefully considered, together with other
information in this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and our other filings with the SEC, before making an investment decision regarding our common stock. </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have a limited operating history and have no products approved for commercial sale, which may make it
difficult for you to evaluate our current business and predict our future success and viability. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have incurred significant losses since inception. We expect to incur losses for the foreseeable future and may
never achieve or maintain profitability. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We will need substantial additional funding. If we are unable to raise capital when needed, we would be forced to
delay, reduce, or eliminate our research and product development programs or future commercialization efforts. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We are heavily dependent on the success of our product candidates, which are in preclinical and Phase&nbsp;1
clinical development. We may not be successful in our efforts to identify and develop potential product candidates. If these efforts are unsuccessful, or if we experience significant delays, we may never become a commercial stage company or generate
any revenues, and our business will be materially harmed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">There is substantial competition in our field, which may result in others developing or commercializing products
before we do. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our product candidates utilize novel mechanisms of action, which may result in greater research and development
expenses, regulatory issues that could delay or prevent approval, or discovery of unknown or unanticipated adverse effects. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we are unable to adequately protect our proprietary technology and platform or obtain and maintain patent
protection for our technology and products or if the scope of the patent protection obtained is not sufficiently broad or if we are unable to maintain the confidentiality of our trade secrets, our competitors could develop and commercialize
technology and products similar or identical to ours, and our ability to successfully develop and commercialize our technology and products may be impaired. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The continuing outbreak of <FONT STYLE="white-space:nowrap">COVID-19</FONT> in the United States and other
countries may adversely affect our business and the market price of our common stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If any of the product candidates we may develop or the delivery modalities we rely on cause serious adverse
events, undesirable side effects or unexpected characteristics, such events, side effects or characteristics could delay or prevent regulatory approval of the product candidates, limit the commercial potential, or result in significant negative
consequences following any potential marketing approval. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_1"></A>PART I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Unless the context otherwise requires, the terms &#147;Foghorn,&#148; &#147;Foghorn Therapeutics,&#148; the &#147;Company,&#148; &#147;we,&#148;
&#147;us&#148; and &#147;our&#148; relate to Foghorn Therapeutics Inc., together with its consolidated subsidiary. </I></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_2"></A>ITEM&nbsp;1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>BUSINESS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The chromatin regulatory system orchestrates
gene expression&#150;the turning on and off of genes&#150;which is fundamental to how all our cells function. Breakdowns in this system lead to a wide range of diseases impacting millions of patients. Understanding the mechanism of how this system
works could lead to an entirely new class of therapeutics. To our knowledge, we are the only company with the ability to study the chromatin regulatory system at scale, in context, and in an integrated way. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory
system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to
identify, validate and potentially drug targets within the system. Breakdowns in the chromatin regulatory system are associated with over 50&nbsp;percent of all cancers. Addressing these breakdowns could potentially provide therapies for over
2.5&nbsp;million patients. Consequently, we are initially focused in oncology. We are developing <FONT STYLE="white-space:nowrap">FHD-286,</FONT> a selective, allosteric ATPase inhibitor and are currently initiating separate Phase 1 studies in
metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia, or AML. The investigational new drug applications for metastatic uveal melanoma and relapsed and/or refractory AML were accepted by the FDA in late December and early
January, respectively. We are developing <FONT STYLE="white-space:nowrap">FHD-609,</FONT> a targeted protein degrader, to treat synovial sarcoma, for which we plan to submit an investigational new drug application, or IND, in the second quarter of
2021. Our vision is to use our Gene Traffic Control platform to discover and develop drugs in oncology and other therapeutic areas, including virology, autoimmune disease and neurology. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>How the Chromatin Regulatory System Orchestrates Gene Expression </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order for DNA to fit in the nucleus of each human cell, DNA is densely packed into what is called chromatin, which needs to be unpacked as a necessary first
step to allow for gene expression. Cells have evolved a system known as the chromatin regulatory system that can locate and unpack particular regions of chromatin, thereby enabling and orchestrating gene expression. Two of the major components of
the chromatin regulatory system are chromatin remodeling complexes and transcription factors, and these components work in concert to orchestrate gene expression. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Gene Traffic Control Platform </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have built
our proprietary Gene Traffic Control platform to give us an integrated and mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the
system. We are initially using our Gene Traffic Control platform in oncology. In cancer, the mutations that are in or impinge on the chromatin regulatory system create genetically determined dependencies, on which the cancer cells rely for survival.
These genetic dependencies result in diseased cell vulnerabilities, creating potential opportunities to selectively drug and kill diseased cells while minimizing impact to healthy cells. With our platform, we are able to produce components of the
chromatin regulatory system at scale, thereby allowing us to identify these genetic dependencies, understand their mechanism and target their vulnerabilities. We combine our genomic and <FONT STYLE="white-space:nowrap">epi-genomic</FONT> tools, our
proprietary high throughput screening technology and our expertise in medicinal chemistry to develop enzymatic inhibitors, protein degraders and transcription factor disruptors that target the chromatin regulatory system. While initially focused in
oncology, we believe our platform is broadly applicable across other disease areas. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Gene Traffic Control platform encompasses the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Target Identification and Validation&#151;</B>We use genomic screens, and a suite of <FONT
STYLE="white-space:nowrap">epi-genome</FONT> sequencing and computational tools, including aspects of AI and machine learning, to characterize, identify, and validate targets within the chromatin regulatory system. Our
<FONT STYLE="white-space:nowrap">epi-genome</FONT> sequencing tools allow us to understand the mechanisms of how our drugs are modifying the chromatin structure. Our platform allows for the identification of genetically determined dependencies
associated with the chromatin regulatory system. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Production of Chromatin Regulatory System Components at Scale and Proprietary Assays&#151;</B>We have built
unique capabilities to purify and synthesize chromatin remodeling complexes and transcription factors. These capabilities allow us to study the chromatin regulatory system at scale and in a context that, to our knowledge, is unavailable to others,
and yields unique insights that are critical to systematically drugging this system. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Discovery and Optimization of Chemical Matter</B>&#151;We perform proprietary high throughput screens that
leverage our ability to produce the chromatin regulatory system components at scale. For example, we are able to screen for inhibitors of chromatin remodeling complex activity, for binders that we can turn into degraders, and for disruptors of
transcription factor-chromatin remodeling complex interactions. Once we find hits from our screens, we use our unique suite of assays involving the relevant component of the chromatin regulatory system to characterize, validate, and optimize our
chemical matter. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Targeted Protein Degradation</B>&#151;In cases where our drugging efforts are directed at targets that have no
enzymatic activity, we seek to degrade the protein of interest. We have built extensive protein degrader capabilities encompassing linkers and E3 ligase binders, assays to measure protein degradation and guide optimization, and ternary complex
modeling. After completing screens and finding small molecule binders to the target of interest, we use our protein degradation <FONT STYLE="white-space:nowrap">know-how</FONT> to convert binders into selective protein degraders.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Translation to Clinic and Identification of Biomarkers</B>&#151;Early in the drug discovery process, we use
various genome and <FONT STYLE="white-space:nowrap">epi-genome</FONT> analyses to understand the mechanism of the genetic dependency of the disease on the chromatin regulatory system. Our understanding of the mechanism of the dependency enables us
to identify biomarkers for patient identification and treatment. We seek to enrich our clinical studies with the genetically relevant patient populations that are most likely to benefit from treatment. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Using our proprietary Gene Traffic Control platform, we are developing a broad pipeline of
product candidates that target genetically determined dependencies within the chromatin regulatory system. Our current pipeline of product candidates and discovery programs is focused on oncology and is shown below, along with anticipated
milestones. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g66l79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Within the chromatin regulatory system, we have initially focused our development efforts on the BAF chromatin remodeling
complex, or the BAF complex, the most mutated amongst a family of chromatin remodeling complexes, and its interactions with transcription factors. Our precision approach consists of designing novel small molecules to inhibit the ATPase activity of
BAF complexes, to selectively degrade mutated or dependent subunits, or to disrupt the interaction between the BAF complex and associated transcription factors. We believe our platform is broadly applicable to other chromatin remodeling complexes
and transcription factors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our first product candidate, <FONT STYLE="white-space:nowrap">FHD-286,</FONT> is a highly potent, selective, allosteric and
orally available, small-molecule, enzymatic inhibitor of BRG1 and BRM, that we are initially developing for the potential treatment of AML and uveal melanoma. BRG1 and BRM are two highly similar proteins that are the ATPases, or the catalytic
engines, across all forms of BAF. In our preclinical studies, we have observed in both AML and uveal melanoma animal xenograft models anti-tumor effects at tolerated doses. We are currently initiating Phase 1 studies for metastatic uveal melanoma
and relapsed and/or refractory AML. As <FONT STYLE="white-space:nowrap">FHD-286</FONT> progresses through clinical testing, our intention is to expand into other indications beyond AML and uveal melanoma. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our second product candidate, <FONT STYLE="white-space:nowrap">FHD-609,</FONT> is a highly potent, selective and intravenous, small molecule protein degrader
of BRD9, a component of a form of the BAF complex. Nearly all synovial sarcoma cancers contain a translocation, a type of mutation, between a BAF subunit gene, SS18, and another set of genes, SSX1, SSX2 and SSX4. These mutations render the cancer
genetically dependent upon BRD9. <FONT STYLE="white-space:nowrap">FHD-609</FONT> has two domains: one that binds with high potency and selectivity to BRD9 and the other that binds to a receptor on the E3 ligase complex that directs proteins for
destruction. In our preclinical studies in synovial sarcoma animal xenograft models, we have observed anti-tumor effects that we believe support submitting an IND and progressing <FONT STYLE="white-space:nowrap">FHD-609</FONT> into clinical studies.
We have successfully completed our GLP toxicology studies for <FONT STYLE="white-space:nowrap">FHD-609.</FONT> We plan to submit an IND for <FONT STYLE="white-space:nowrap">FHD-609</FONT> in the second quarter of 2021 and, if cleared, expect to
initiate a clinical study in synovial sarcoma shortly thereafter. As <FONT STYLE="white-space:nowrap">FHD-609</FONT> progresses through clinical testing, our intention is to expand into other indications beyond synovial sarcoma. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have used our Gene Traffic Control platform to generate additional programs targeting both large and
small patient populations. Examples of programs targeting large populations include selective BRM and selective ARID1B modulators, which have potential implications in over 100,000 cancer patients and 175,000 cancer patients that harbor BRG1 and
ARID1A mutations respectively. We are pursuing other programs with genetically determined dependencies on other chromatin remodeling complexes beyond the BAF complex. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we are developing compounds that disrupt the interactions between the transcription factors and BAF complexes. We believe that there are more
than 100 transcription factors that could be amenable to our approach, one that disrupts the interaction of the transcription factor with the BAF complex. Preclinical activities of these early programs are underway. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our approach to disrupting the interactions between transcription factors and the BAF complex is the basis of a collaboration signed with Merck
Sharp&nbsp;&amp; Dohme Corp., or Merck, in July 2020. In this collaboration, we intend to apply our Gene Traffic Control platform to identify disruptors of a single predetermined transcription factor. As part of the collaboration, we received an
upfront payment of $15.0&nbsp;million, and are also eligible to receive up to $245.0&nbsp;million upon achievement of specified research, development and regulatory milestones by any product candidate generated by the collaboration, and up to
$165.0&nbsp;million upon achievement of specified sales-based milestones. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Team </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have assembled a team with deep scientific, clinical, manufacturing, business, and leadership expertise in biotechnology, platform research, drug discovery,
and development. Our management team has extensive experience discovering, developing, and commercializing drugs to treat patients with serious diseases. Adrian Gottschalk, our President and Chief Executive Officer, has more than 15 years of
experience as a biopharmaceutical executive. Prior to joining Foghorn, Mr.&nbsp;Gottschalk served in various roles at Biogen, Inc., where he was most recently Senior Vice President and Neurodegeneration Therapeutic Area Head. In this role, he was
responsible for late-stage development and commercialization of drugs to treat Alzheimer&#146;s disease, Parkinson&#146;s disease, and amyotrophic lateral sclerosis. Our Chief Medical Officer, Samuel Agresta, M.D., M.P.H.&nbsp;&amp; T.M., previously
served as Chief Medical Officer at Infinity Pharmaceuticals and led the development of the marketed oncology drugs TIBSOVO<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and IDHIFA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>
at Agios. Carl P. Decicco, Ph.D., our Chief Scientific Officer previously served as Senior Vice President, Head of Discovery at Bristol-Myers Squibb and has been involved in over 200 drug candidates transitioning into the clinic. Our research
efforts are also guided by world-class scientists and physicians on our Scientific Advisory Board, including David Schenkein, M.D., formerly the chief executive officer of Agios and presently a general partner and
<FONT STYLE="white-space:nowrap">co-leader</FONT> of Google Ventures life science team, Tony Kouzarides, Ph.D., F.Med.Sci., FRS, professor of cancer biology at the University of Cambridge and deputy director of the Gurdon Institute, United Kingdom,
Gerald Crabtree, M.D., founder of Ariad Pharmaceuticals, a Howard Hughes Medical Institute investigator and professor at Stanford University, and Charles Sawyers, M.D., chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering
Cancer center, a Howard Hughes Medical Institute investigator, and past president of the American Association for Cancer Research, or AACR. We have assembled an exceptional team of 95 employees as of December&nbsp;31, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Beginnings: Foghorn Therapeutics and Flagship Pioneering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Foghorn Therapeutics was founded in 2015 by Flagship Pioneering, working together with academic <FONT STYLE="white-space:nowrap">co-founders</FONT>
Dr.&nbsp;Cigall Kadoch (Dana Farber Cancer Institute, Harvard, Broad Institute) and Dr.&nbsp;Gerald Crabtree (Stanford, Howard Hughes Medical Institute) to develop and commercialize a new category of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">first-in-class</FONT></FONT> therapeutics to treat patients with cancer and other serious diseases.&nbsp;Our platform was inspired by work in the academic <FONT STYLE="white-space:nowrap">co-founders&#146;</FONT>
laboratories at the Dana Farber Cancer Institute and Stanford.&nbsp;This seminal work made it possible to understand how mutations cause disease by disrupting the machinery&#151;the chromatin regulatory system&#151;that orchestrates how cells turn
genes on and off. Such mutations are associated with up to 50&nbsp;percent of cancer and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
play roles in many other diseases. A Flagship Labs innovation team at Flagship Pioneering, led by Flagship Managing Partner, Dr.&nbsp;Douglas Cole, and, subsequently, Foghorn&#146;s research and
development team, established a fully integrated drug discovery platform based on this seminal work, which we call our Gene Traffic Control platform. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our mission is to leverage our unique
insights into the chromatin regulatory system to pioneer the discovery, development and commercialization of a new class of therapies that transform the lives of patients suffering from a wide spectrum of diseases with high unmet need. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our approach is to identify and drug genetically determined dependencies within the chromatin regulatory system. Our initial focus is in cancer with a
precision oncology approach. Every program we pursue is based on a genetic dependency on the chromatin regulatory system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To achieve our mission, we are
executing a strategy with the following key elements: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Advance our lead precision oncology product candidates, <FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT
STYLE="white-space:nowrap">FHD-609,</FONT> through clinical development in patients with select solid tumors and hematological cancers.</B> <FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT STYLE="white-space:nowrap">FHD-609</FONT> are a
highly selective and potent enzymatic inhibitor and protein degrader, respectively, that target two different components of a chromatin remodeling complex. We believe our lead product candidates have the potential to address significant unmet
medical needs across multiple oncology indications. We are currently initiating separate Phase 1 studies for metastatic uveal melanoma and relapsed and/or refractory AML and expect preliminary clinical <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> data for <FONT STYLE="white-space:nowrap">FHD-286</FONT> as early as the fourth quarter of 2021. We also plan to submit an IND for <FONT STYLE="white-space:nowrap">FHD-609</FONT> in the
second quarter of 2021 for the treatment of synovial sarcoma and, if cleared, expect to initiate a Phase 1 clinical trial shortly thereafter. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Expand our precision oncology pipeline by developing proprietary enzymatic inhibitors, degraders and
disruptors that target genetically defined dependencies within the chromatin regulatory system. </B>Based on our unique insights and understanding of the chromatin regulatory system, we continue to develop proprietary selective inhibitors, protein
degraders and disruptors that modulate both chromatin remodeling complexes and transcription factors, two key components of the chromatin regulatory system. For example, using our proprietary platform, we are pursuing two distinct targets BRM and
ARID1B that have genetically determined dependencies within the chromatin regulatory system with combined potential impact in over 275,000 cancer patients. We plan to begin <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies for a selective
BRM modulator in the second half of 2021. We plan to continue our preclinical efforts of our selective ARID1B program. We intend to utilize our platform to consistently develop novel product candidates to further deepen our precision oncology
pipeline.<B> </B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Harness our platform to develop novel product candidates to address therapeutic areas beyond oncology.</B> As
the orchestrator of gene expression, the chromatin regulatory system has implications in a large array of diseases. Based on academic literature and our research efforts, we believe our platform has significant potential across multiple therapeutic
areas. We are committed to applying our Gene Traffic Control platform to additional therapeutic areas including virology, autoimmune diseases and neurology. We believe our platform will allow us to continue to build a long-term pipeline of novel
product candidates to address areas of high unmet medical need. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Continue to enhance our platform to extend our leading position in developing novel therapeutics targeting the
chromatin regulatory system.</B> Our platform and unique understanding of the chromatin regulatory system is built upon the groundbreaking work of our academic <FONT STYLE="white-space:nowrap">co-founders</FONT> and has been further developed by our
experienced team. We are committed to continuously integrating new insights, tools, technologies and capabilities to enhance our platform. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Selectively enter into additional strategic partnerships to maximize the potential of our pipeline and our
platform. </B>Given the breadth of opportunities that are implicated by the chromatin regulatory system and the versatility of our platform, we may opportunistically enter into strategic collaborations intended to advance and accelerate our
development programs, expand into new therapeutic areas and enhance the capabilities of our platform. In July 2020, we entered into a collaboration with Merck to discover and develop novel oncology therapeutics against a transcription factor target.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Chromatin Regulatory System: An Untapped Opportunity for Therapeutic Intervention </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The chromatin regulatory system orchestrates gene expression. In order for DNA to fit in the nucleus of each human cell, it is densely packed into what is
called chromatin. This packing of DNA occurs by winding it around a core of proteins called histones to form what is known as a nucleosome, having the appearance of thread (the DNA) wrapped around a spool (the histones). Multiple nucleosomes cluster
further to form more densely packed chromatin. Before DNA can be transcribed to RNA and then translated into protein, chromatin needs to be &#147;unpacked&#148; to allow access for the cellular machinery responsible for DNA transcription. Cells have
therefore evolved a system known as the chromatin regulatory system that can locate and unpack particular regions of the chromatin to orchestrate and allow for gene expression. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g74u24.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 1: Chromatin Regulatory System Biology: Chromatin remodeling complexes and transcription factors work in concert
to unpack chromatin to enable gene expression. The left portion of the figure shows &#147;packed&#148; or closed chromatin and the right portion of the figure shows &#147;unpacked&#148; or open chromatin with DNA highlighted in green. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Two of the major components of the chromatin regulatory system are chromatin remodeling complexes and transcription factors. Transcription factors specify the
locations of genes to be transcribed by binding to specific locations on DNA. Chromatin remodeling complexes, guided by transcription factors, unpack the chromatin to expose DNA for transcription. These two components work in concert in both healthy
and diseased cells. While chromatin remodeling complexes have been known in the scientific community for decades, disease relevance was not initially recognized, and consequently chromatin remodeling complexes were underappreciated as a set of
relevant drug targets. Transcription factors, on the other hand, while linked decades ago to cancer and understood as relevant targets, have led to few approved oncology drugs, as companies seeking to drug these targets have lacked a systematic
approach to doing so. Recently, ground-breaking work by our academic <FONT STYLE="white-space:nowrap">co-founders</FONT> has revealed that alterations in chromatin remodeling complexes as well as their interactions with transcription factors are
strongly associated with various cancers. Broad cancer sequencing initiatives have shown that mutations in the chromatin regulatory system are found in over 50&nbsp;percent of all cancers, potentially impacting over 2.5&nbsp;million cancer patients
across the United States, Europe and Japan. Further work in the field by our founders and others has highlighted the association of this system in other therapeutic areas, including virology, autoimmune disease and neurology, implying even greater
potential for therapeutic intervention. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Vulnerabilities in Cancer Created by Genetic Dependencies on the Chromatin Regulatory System </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cancer cells often contain many different mutations that lead to their abnormal growth and proliferation. Within cancer cells, these mutations give rise to
genetically determined dependencies, upon which the cancer cells rely for their survival. The creation of these dependencies can be directly related to the mutation or to other cellular biology, thereby creating vulnerabilities for cancer cells and
the opportunity for therapeutic intervention. In contrast, healthy cells, which lack these mutations and therefore these dependencies, are less susceptible to a therapeutic that targets these genetically determined dependencies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are three primary mechanisms by which genetically determined dependencies on the chromatin regulatory system arise. They are: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mutations in chromatin remodeling complexes </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mutations or overexpression of transcription factors </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mutations elsewhere in the cell that impinge on chromatin remodeling complexes and/or transcription factors
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our platform enables us to identify these genetic dependencies and thereby discover the cancer cells&#146; vulnerability within the
chromatin regulatory system. We believe these vulnerabilities create opportunities to selectively drug and kill cancer cells while minimizing impact to healthy cells.&nbsp;These genetically determined dependencies enable us to select specific
patient populations and enrich our clinical trials using a precision approach. Every program we pursue is based on a genetically determined dependency on the chromatin regulatory system. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our Initial Focus&#151;BAF Complexes and Associated Transcription Factors </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are 28 types of chromatin remodeling complexes. All types of chromatin remodeling complexes use ATP as an energy source for opening and closing
chromatin. These remodeling complexes contain a catalytic subunit that is capable of breaking down ATP, known as the ATPase. The ATPase serves as the catalytic engine that drives the function of each chromatin remodeling complex. The breakdown or
hydrolysis of each ATP molecule by the ATPase creates energy that, in turn, drives chromatin remodeling. These chromatin remodeling complexes are mutated in approximately 25&nbsp;percent of cancers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BAF, which stands for <FONT STYLE="white-space:nowrap">BRG1/BRM-associated</FONT> factors, one type of chromatin remodeling complex, is mutated in
approximately 20&nbsp;percent of cancers, thus being the most mutated in the family of ATPase chromatin remodelers and among the most mutated targets in cancer. Given the breadth of mutations in cancer, the BAF complex is our initial focus among the
ATPase dependent chromatin remodeling complexes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The BAF complex is a multicomponent protein structure containing twelve to fifteen protein subunits
taken from a larger set of a possible 29 subunits. Three common forms of BAF are known as canonical BAF, or cBAF; <FONT STYLE="white-space:nowrap">non-canonical</FONT> BAF, or ncBAF; and polybromo BAF, or PBAF. While the exact compositions of these
forms of BAF are different, each form contains a number of common subunits, one such being the ATPase catalytic subunit. Each BAF complex contains one of two possible ATPases, either ATPase known as BRM, also known as SMARCA2, or ATPase known as
BRG1, also known as SMARCA4. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Different cell types and tissues contain different forms of BAF. This cell and tissue specificity gives rise
to the possibility of additional pharmacological selectivity when drugging potential targets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g79y27.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 2. Schematic depicting biochemical subunit compositions of mammalian BAF, ncBAF and PBAF complexes. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g00g23.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 3. Genetic alterations are commonly found in subunits of the BAF complex in tumors. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The BAF complex, when aggregating mutations across all of its subunits, is the second most mutated target to the well-known cancer target TP53. Genetic
alterations of various subunits of the BAF complex have been observed in a wide range of cancers. These include but are not limited to the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">More than 90&nbsp;percent of ovarian cancer patients; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">34&nbsp;percent of uterine endometrial patients; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">34&nbsp;percent of stomach cancer patients; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">29&nbsp;percent of bladder cancer patients; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">28&nbsp;percent of <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer, or NSCLC, patients; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">27&nbsp;percent of skin cancer patients. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following mechanistic insights provide strategies to target the BAF complex in cancer: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Dependency exists between BAF complex subunits; </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">One example is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In some cancer cells, the gene encoding BRG1, a catalytic subunit of the BAF complex, is mutated causing a loss
of function in BRG1 </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Often this loss of function leads to a dependency on BRM, a similar protein to BRG1 that is the other catalytic
subunit of the BAF complex </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">This loss of BRG1 and subsequent dependency on BRM creates a vulnerability by rendering these cancer cells highly
sensitive to targeting BRM </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mutations elsewhere in the cell confer a dependency on the BAF complex; </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">One example is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mutations in <FONT STYLE="white-space:nowrap">G-protein</FONT> coupled receptors (GNAQ/GNA11) are found in
85&nbsp;percent to 95&nbsp;percent of uveal melanoma, a cancer of the eye </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In uveal melanoma cell lines with these mutations, we have established a dependency on two transcription factors,
MITF and SOX10. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">These two transcriptions interact with the BAF complex </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Targeting the BAF complex then inhibits MITF and SOX10 mediated transcription </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transcription factors, the proteins that guide the chromatin remodeling complexes, help determine which genes are expressed and have long been desirable but
elusive targets for drug discovery efforts. Work by our academic <FONT STYLE="white-space:nowrap">co-founder</FONT> Cigall Kadoch, as well as others in the field, revealed that transcription factors work in concert with chromatin remodeling
complexes, BAF as one example, to orchestrate gene expression. A transcription factor recognizes specific guidepost-like sequences, or locations, on DNA. The transcription factor binds to the chromatin remodeling complex and in doing so directs the
remodeling complex to the appropriate location on chromatin. Once recruited to the appropriate location, the chromatin remodeling complex unpacks the chromatin, exposing the DNA and allowing transcription machinery to transcribe the corresponding
gene. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some transcription factors, such as the estrogen receptor, or ER, have long been the targets of approved and efficacious drugs for the treatment of
cancers such as breast cancer. However, the majority of transcription factors have not been amenable to traditional small molecule drug inhibition. While directly blocking the DNA binding site on transcription factors would be an effective way of
inhibiting their activity, it is usually not possible to find small molecules that can bind to these sites with the potency and selectivity needed to advance as therapeutics. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Different healthy cell types, such as heart, brain, or muscle cells, use different types of transcription factors. In cancer cells, mutated and/or abnormal
levels of specific transcription factors are found. Because many transcription factors are cell and tissue specific, there is the possibility of additional pharmacological selectivity when drugging potential transcription factor-chromatin remodeling
complex interactions. We believe that there are more than 100 transcription factors that could be amenable to our approach of disrupting the interactions of transcription factors with the BAF complex. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Approach to Drugging the Chromatin Regulatory System </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are focused on developing small molecule product candidates that target the chromatin regulatory system through the use of enzyme inhibitors, protein
degraders and transcription factor disruptors. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Enzyme inhibitors</B>. These candidates have the potential to act on targets such as the ATPases BRG1 and BRM
of the BAF complex. Our screening capabilities enable us to find allosteric inhibitors which afford additional selectivity over orthosteric, or direct, inhibitors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Protein degraders</B>. These candidates are bifunctional degraders in which one portion of the molecule
specifically recognizes the target while the other portion is able to direct the destruction of the target by the cell&#146;s protein degradation system. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Transcription factor disruptors</B>. These candidates will be direct small-molecule disruptors of the
protein-protein interactions between transcription factors and chromatin remodeling complexes. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We leverage the appropriate mechanism
based on the target in the chromatin regulatory system. In some cases, we may take multiple approaches and remain modality agnostic in order to ensure we achieve the best approach and most appropriate molecule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The two main approaches that we are taking to drugging chromatin remodeling complexes are inhibiting its ATPase activity and degrading mutated or dependent
subunits within the chromatin remodeling complex. We are taking a different approach to modulating the activity of transcription factors than previously attempted by the field. We believe this approach can be applied across the broad set of
chromatin remodeling complexes and transcription factors with which they interact, as illustrated by the BAF complex. Because transcription factors require collaboration with the BAF complex, disrupting the interaction between the two shuts down the
ability of the transcription factor to drive transcription. Our approach is to find small molecule disruptors that bind to either the transcription factor or the BAF complex in order to break the interaction between the two. In order to understand
whether it is possible to selectively drug these interactions, there are two important aspects that need to be understood. One is where specifically the transcription factor binds to the BAF complex and the second is how tightly it binds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on our work, we have observed that individual transcription factors bind to the BAF complex at specific sites rather than all binding to a single site,
implying that it should be possible to specifically interfere with the binding of one transcription factor to the BAF complex without affecting the binding of every other transcription factor. This is a critical success factor for the specificity of
drug candidates binding to the BAF complex. We have also observed that the potencies of these interactions are roughly equivalent to those observed in other protein-protein interactions that have been successfully disrupted by small molecule
drugs.<B> </B>Because many transcription factors are cell and tissue specific, there is the possibility of additional pharmacological selectivity when drugging potential transcription factor-chromatin remodeling complex interactions. We believe
these findings provide the opportunity to systematically discover and develop a novel class of product candidates that are specific, selective and that will be designed to disrupt the interaction between transcription factors and the BAF complex.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g95v85.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 4. We are disrupting transcription factor activity by blocking interactions with the BAF complex. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Gene Traffic Control Platform </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The chromatin
regulatory system has remained an untapped opportunity for therapeutic intervention due to the inability to systematically characterize and study the chromatin remodeling complexes and associated transcription factors. Building upon the
groundbreaking discoveries of our academic <FONT STYLE="white-space:nowrap">co-founders,</FONT> we have developed our proprietary Gene Traffic Control platform which allows us to identify and validate targets within the chromatin regulatory system.
We have unique capabilities to isolate, synthesize, characterize, and interrogate the BAF complex at a level of scale, precision, and efficiency, that to our knowledge, no others have achieved. We have unique capabilities to understand how
transcription factors interact with the BAF complex and have generated unique insights into where and how transcription factors bind. We believe our platform is broadly applicable to other chromatin remodeling complexes and transcription factors.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our capabilities and insights have allowed for the development of a suite of unique biochemical, biophysical, structural, and functional assays. We use
these assays to discover and optimize novel small molecule chemical matter which include enzymatic inhibitors, protein degraders, and transcription factor disruptors to various targets within the chromatin regulatory system. To our knowledge, we are
the only company that has the ability to study the chromatin regulatory system at scale, in context, and in an integrated way. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Gene Traffic Control
platform encompasses the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Target Identification and Validation </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Production of Chromatin Regulatory System Components at Scale&nbsp;and Proprietary Assays </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Discovery and Optimization of Chemical Matter </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Targeted Protein Degradation </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Translation to Clinic and Identification of Biomarkers </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The key features and capabilities of our platform are described below: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Target Identification and Validation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We use genomic
screens and a suite of <FONT STYLE="white-space:nowrap">epi-genome</FONT> sequencing and computational tools to characterize, identify and validate targets within the chromatin regulatory system. Our
<FONT STYLE="white-space:nowrap">epi-genome</FONT> sequencing tools allow us to understand the mechanisms of how our drugs are modifying the chromatin structure. Our platform allows for the identification of genetically determined dependencies
associated with the chromatin regulatory system. Specifically, we: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Conduct and leverage genomic screens to identify dependencies and relationships. </B>We utilize both broad and
specific genomic screens to identify dependencies and relationships associated with the chromatin regulatory system. We use a mix of internal and external data sets that apply CRISPR and shRNA technology to understand relationships across and within
a range of cancer cell lines. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Perform broad <FONT STYLE="white-space:nowrap">epi-genome</FONT> sequencing to validate dependencies
</B><B><I>in vitro</I></B><B>. </B>We apply cutting edge <FONT STYLE="white-space:nowrap">epi-genome</FONT> sequencing tools in combination with proprietary tool compounds to further validate targets and enhance our understanding of the impact of
drugging the chromatin regulatory system. These tools allow us to rapidly understand the gene expression profiles of specific cancer cell lines, the open / closed state of chromatin, and give us mechanistic understanding of how components of the
system work together. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Apply machine learning</B><B></B><B>&nbsp;and artificial intelligence to enhance discovery efforts.</B> We
have built tools that allow us to mine and interpret external and internal datasets that aid in our discovery efforts yielding unbiased and unsupervised computer analyses to identify targets and genetic dependencies on the chromatin regulatory
system and to further understand mechanism of action. Examples of external data sets include data from The Cancer Genome Atlas (TCGA) and the Broad Institute. Internal data sets include data from cell lines, data from xenograft models and <FONT
STYLE="white-space:nowrap">epi-genomic</FONT> information <FONT STYLE="white-space:nowrap">(RNA-seq,</FONT> <FONT STYLE="white-space:nowrap">ATAC-seq,</FONT> <FONT STYLE="white-space:nowrap">CHiP-seq,</FONT>
<FONT STYLE="white-space:nowrap">SNAP-seq).</FONT> We also use these tools in the preclinical stage to evaluate cancer cell lines&nbsp;&amp; patient samples to identify biomarkers for patient stratification and patient population identification.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Validate dependencies</B><B><I> in vivo</I></B><B>. </B>Where possible, we endeavor to validate targets in
various animal models with implanted cancer cells relevant to the disease we are aiming to treat. Specifically, we use mouse xenograft models with inducible CRISPR / shRNA to validate that knockdown of our target of interest results in tumor growth
inhibition. We also apply <FONT STYLE="white-space:nowrap">epi-genome</FONT> sequencing tools in the animal model setting to identify potential biomarkers. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Production of Chromatin Regulatory System Components at Scale&nbsp;and Proprietary Assays </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have built unique capabilities to purify and synthesize the BAF complex and transcription factors. These capabilities allow us to study the chromatin
regulatory system at scale and in context that, to our knowledge, is unavailable to others, and yields insights that are critical to systematically drugging this system. Specifically, we: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Purify and synthesize chromatin remodeling complexes and transcription factors at scale. </B>Our platform has
the unique ability to purify and synthesize the BAF complex with potential applications to other chromatin remodeling complexes. Importantly, we are able to purify disease relevant and mutated forms of BAF directly from the cancer cell lines of
interest. To our knowledge, we are the only company that has developed the ability to purify and manipulate BAF, <FONT STYLE="white-space:nowrap">sub-complexes</FONT> of BAF, as well as its host of subunits, in quantities that enable us both to
generate structural data to identify potential binding sites for drug candidates and to conduct high throughput screens of small molecule drug candidates against these sites. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Study chromatin remodeling complexes in context leading to relevant insights into the impact of drug
intervention.</B> We have found that the properties of subunits of BAF, such as BRG1 or BRM, are </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
different when they are incorporated into the BAF complex than when we test them in isolation. For example, the catalytic activity of these subunits using nucleosomes was increased by over <FONT
STYLE="white-space:nowrap">15-fold</FONT> when they were incorporated into the BAF complex compared to their activities in isolation (see Figure 5 below). This is the biologically relevant activity of the complex. Additionally, the ability to screen
the full complex greatly improves the potential of finding allosteric modulators which may afford additional pharmacological selectivity. These examples underscore the importance of assaying and screening the full complex. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Utilize advanced analytical methods to develop and understand critical insights into how transcription factors
interact with chromatin remodeling complexes.</B> We integrate multiple technologies and methodologies, including high-throughput-screening, biophysics, affinity screening, and surface mapping to gain unparalleled insights into the chromatin
regulatory system and how its primary two components, transcription factors and chromatin remodeling complexes, interact. Based on our protein-protein interaction mapping technology, we have determined precisely the binding sites of multiple
transcription factors to the BAF complex, providing us with critical insights into how these factors bind to the BAF complex, and details on how these binding interactions can be disrupted using small, drug-like molecules. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that our unique capabilities as applied to the BAF complex and associated transcription factors can be applied to other chromatin remodeling
complexes and transcription factors. It is our intention to further leverage our capabilities on other chromatin remodeling complex targets. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ATPase activity using nucleosome substrate </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g54l66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 5. ATPase activity of full BAF complex underscores the importance of assaying in the appropriate biological
context. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Discovery and Optimization of Chemical Matter </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We perform proprietary high throughput screens that leverage our ability to produce the chromatin regulatory system components at scale. An example screen is
the use of the fully assembled BAF complex which is specific to its mutated or disease relevant form (e.g., screening the BRM form of BAF which corresponds to BRG1 mutated cancer). Furthermore, we are able to screen the BAF complex when bound to a
relevant transcription factor. We utilize both proprietary and publicly available chemical libraries in our screens. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once we find hits from our screens,
we use our unique suite of assays involving the relevant component of the chromatin regulatory system to characterize, validate, and optimize our chemical matter. These assays provide us with biologically relevant insights that guide our medicinal
chemistry efforts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Targeted Protein Degradation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In cases where our drugging efforts are directed at targets that have no enzymatic activity, we seek to degrade the protein of interest through targeted
protein degraders. Protein degraders are bifunctional small molecules in which one portion of the molecule specifically recognizes the target while the other portion directs the destruction of the target by harnessing the cell&#146;s
proteasome-based degradation system. The two chemical functionalities of the molecule are connected by a variable linker. This approach affords a general method of degrading protein targets of interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After completing screens, as described above, and finding small molecule binders to the target of interest, we use our protein degradation <FONT
STYLE="white-space:nowrap">know-how</FONT> to convert binders into selective protein degraders. This <FONT STYLE="white-space:nowrap">know-how</FONT> and capabilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proprietary library of linkers and E3 ligase binders </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Biochemical, biophysical, and cellular assays that measure protein degradation and guide optimization, including
protein synthesis and degradation kinetics </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ternary complex modeling and characterization </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Genome wide proteomic analysis of degradation to measure selectivity </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Translation to Clinic and Identification of Biomarkers </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We seek to enrich our clinical studies with the genetically relevant patient populations that are most likely to benefit from treatment. Early in the drug
discovery process, we use various genome and <FONT STYLE="white-space:nowrap">epi-genome</FONT> analyses to understand the genetic dependency of the cancer on the chromatin regulatory system. Our intent is to have clear genetic markers for patients
whom we seek to potentially treat. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As we progress a drug candidate, we analyze tumor models and where available direct patient samples to understand
biomarkers of response (e.g., change in expression level of a particular gene or set of genes, change in protein level of a component of the chromatin regulatory system). We intend to use these biomarkers in our clinical studies to understand tumor
response to our drug candidates. Additionally, we will retrospectively analyze our clinical studies for any other biomarkers that will further enhance patient stratification and response. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Product Candidates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are developing a broad pipeline of product candidates that target genetically determined dependencies within the chromatin regulatory system. Our programs
consist of enzyme inhibitors, protein degraders and transcription factor disruptors. For <FONT STYLE="white-space:nowrap">FHD-286,</FONT> we are currently initiating separate Phase 1 studies for metastatic uveal melanoma and relapsed and/or
refractory AML. For our second product candidate, <FONT STYLE="white-space:nowrap">FHD-609,</FONT> we intend to submit an IND in the second quarter of 2021. Our pipeline is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g66l79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">FHD-286</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are currently advancing our lead
product candidate, <FONT STYLE="white-space:nowrap">FHD-286,</FONT> a highly potent, selective, allosteric and orally available, small-molecule, enzymatic inhibitor of BRG1 and BRM, for the potential treatment of AML and uveal melanoma. BRG1 and BRM
are two highly similar proteins that each serves as the ATPases, or the catalytic engines, across all forms of BAF. We are currently initiating Phase 1 studies for metastatic uveal melanoma and relapsed and/or refractory AML. The IND&#146;s for
metastatic uveal melanoma and relapsed and/or refractory AML were accepted by the FDA in late December and early January, respectively. Our preclinical data in both AML and uveal melanoma animal xenograft models have demonstrated anti-tumor effects
that we believe support progressing <FONT STYLE="white-space:nowrap">FHD-286</FONT> into clinical studies. These multi-center Phase 1 studies will primarily assess the safety and tolerability of <FONT STYLE="white-space:nowrap">FHD-286</FONT> in
adults with AML and uveal melanoma. Secondary endpoints are expected to include the pharmacokinetic and pharmacodynamic properties of <FONT STYLE="white-space:nowrap">FHD-286</FONT> as well as clinical activity. Proof of mechanism will be based on
indicators of target engagement in association with <FONT STYLE="white-space:nowrap">FHD-286</FONT> treatment. As we further understand the therapeutic potential of <FONT STYLE="white-space:nowrap">FHD-286</FONT> in the course of these initial
clinical studies, we may pursue additional clinical studies in these and other indications as a single agent and/or in combination with novel or standard of care agents. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>AML Disease Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acute myeloid leukemia, or
AML, is a heterogeneous group of hematologic cancers characterized by a proliferation of myeloid precursors, commonly known as blasts, with limited ability to differentiate into more mature myeloid cells. These blasts replace normal hematopoietic
tissue in the bone marrow, resulting in decreased hematologic cell numbers, or pancytopenia, and the morbidities associated with the cancer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AML is the second most common subtype of leukemia in adults. In major markets (United States, EU4, UK and
Japan) AML has an incidence of approximately 35,000 cases annually and is generally a disease of elderly people, with more than 60&nbsp;percent of diagnosed patients being older than 60 years. The average five-year survival rate for patients with
AML is 20&nbsp;percent, and there are significant differences in prognosis depending on several factors, including the age of the patient and <FONT STYLE="white-space:nowrap">co-morbidities</FONT> at diagnosis. For patients under the age of 60, the
five-year survival rate is approximately 33&nbsp;percent, while for those over the age of 60 it is less than 15&nbsp;percent. There are likely multiple reasons for this discrepancy, including the ability of younger patients to tolerate more
aggressive therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Current first-line treatments for patients with AML typically involve aggressive combination chemotherapy regimens with or without
hematopoietic stem cell transplantation (HSCT). Older patients or patients who cannot tolerate HSCT, typically those with comorbidities, are often treated with cytarabine and daunorubicin induction followed by high-dose cytarabine consolidation.
Patients who cannot tolerate combination chemotherapy receive low dose cytarabine, azacitidine, Venclexta<SUP STYLE="font-size:85%; vertical-align:top"> </SUP><SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> , and/or enroll in clinical
trials. There is a single biologic, gemtuzumab ozogamicin or Mylotarg<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, approved by the FDA for newly diagnosed and relapsed-refractory AML. Other, more recently approved therapeutics for AML
target subsets of patients with tumors containing specific mutations such as midostaurin marketed as Rydapt<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> by Novartis for those with FLT3 mutations, enasidenib marketed as Idhifa<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> by Celgene for those with mutations in IDH2, and ivosidenib, marketed as Tibsovo<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> by Agios for those with mutations in IDH1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Despite these advances, patients who do achieve remission, five-year disease-free survival is only <FONT STYLE="white-space:nowrap">30-40&nbsp;percent</FONT>
because the majority of patients relapse. Patients in the elderly population have a relapse rate of <FONT STYLE="white-space:nowrap">80-90&nbsp;percent.</FONT> Younger patients have a relapse rate of between
<FONT STYLE="white-space:nowrap">60-80&nbsp;percent.</FONT> There remains a significant need for safe, durable and broadly effective AML treatments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Uveal Melanoma Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Uveal melanoma is the
most frequent type of ocular cancer with approximately 5,000 cases each year in the major markets (United States, EU4, UK and Japan), typically presenting upon a routine eye exam in patients without specific symptoms. Local treatment, primarily with
radiation therapy, is effective in preventing local recurrence in over 95&nbsp;percent of cases. Due to the asymptomatic nature of uveal melanoma, at the time of the diagnosis, a considerable portion of these patients already have metastatic
disease, typically in the liver. Roughly half of all patients will eventually develop metastases. For those diagnosed with metastatic disease, the <FONT STYLE="white-space:nowrap">one-year</FONT> survival is only 15&nbsp;percent. The poor prognosis
associated with metastatic disease and the lack of any effective therapy highlights the need for novel therapeutic approaches that specifically target metastatic uveal melanoma. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Between 85&nbsp;percent and 95&nbsp;percent of uveal melanoma tumors contain mutations in one of two <FONT STYLE="white-space:nowrap">G-protein-coupled</FONT>
receptor subunits: GNAQ or GNA11. We have established through uveal melanoma cell lines with the GNAQ/GNA11 mutations that there is a dependency of these cell lines on two over expressed transcription factors, MITF and SOX10. In uveal melanoma,
these two transcription factors abnormally interact with the BAF complex. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Solution: <FONT STYLE="white-space:nowrap">FHD-286</FONT>
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">FHD-286</FONT> is a highly potent, selective, allosteric and orally available, small molecule inhibitor of the
enzymatic activity of both BRG1 and BRM. In established AML cell line-derived xenograft, or CDX, models <FONT STYLE="white-space:nowrap">MV4-11</FONT> and <FONT STYLE="white-space:nowrap">OCI-AML2,</FONT> we observed robust tumor growth inhibition.
In established uveal melanoma CDX models, specifically <FONT STYLE="white-space:nowrap">MP-46</FONT> and <FONT STYLE="white-space:nowrap">92-1,</FONT> we observed significant tumor growth inhibition and tumor regression, respectively. We are
currently initiating separate Phase 1 studies for metastatic uveal melanoma and relapsed and/or refractory AML. The IND&#146;s for metastatic uveal melanoma and relapsed and/or refractory AML were accepted by the FDA in late December and early
January, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Either BRG1 or BRM can serve as the primary ATPase, or catalytic engine, of the BAF complex. BAF complexes
will contain only BRG1 or BRM, as they are mutually exclusive subunits, as shown in the figure below. BRG1 or BRM are two proteins which are 76&nbsp;percent identical at the amino acid level over their entire length and over 90&nbsp;percent
identical in the catalytic region. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g28m19.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 6. The enzymatic activity of the BAF complex is provided by the BRM or BRG1 subunits. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When we conducted compound screening against a panel of tumor cell lines, a number of these tumor cell lines were shown to be highly sensitive to BRG1 or BRM
inhibition over a <FONT STYLE="white-space:nowrap">three-day</FONT> period. These cell lines include nineteen of <FONT STYLE="white-space:nowrap">twenty-one</FONT> of the hematopoietic malignancy cell lines tested, all four of the uveal melanoma
cell lines, three out of four prostate tumor cell lines, and three out of seven breast tumor cell lines. We observed additional sensitivity in other tumor cell lines tested over a <FONT STYLE="white-space:nowrap">seven-day</FONT> period.<B> </B>
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g08g84.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 7. Certain cell lines, including those derived from uveal melanoma, hematological cancers, prostate cancer, and
breast cancer were highly sensitive to BRG1/BRM inhibition. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Preclinical Data for AML </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Genetic studies have identified a critical role of BRG1 in the maintenance of the undifferentiated state of AML cells. Knockdown of the expression of BRG1 was
found both to inhibit the expression of genes associated with high proliferation and to induce the expression of genes associated with mature myeloid cells. In a mouse model of AML, partial genetic inactivation of BRG1 led to a greater than <FONT
STYLE="white-space:nowrap">two-fold</FONT> increase in overall survival. These data suggest that pharmacological inhibition of BRG1 may provide a therapeutic benefit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have generated <I>in vivo</I> proof of concept data that demonstrated antitumor activity of <FONT STYLE="white-space:nowrap">FHD-286</FONT> in AML patient
samples as well as multiple AML CDX models. Using tumor cells isolated from AML patients, we demonstrated that treatment with <FONT STYLE="white-space:nowrap">FHD-286</FONT> allowed for appropriate differentiation of AML cells. We treated these
tumor cells with a single dose of <FONT STYLE="white-space:nowrap">FHD-286</FONT> at increasing exposures and assessed the effects on both myeloid cellular differentiation and cell death. We observed myeloid cellular differentiation at a lower
nanomolar exposure relative to where we observed cell death. The data support that pharmacologic inhibition of BRG1 can release the differentiation block associated with BRG1 overexpression in AML. Ongoing research has revealed that transcription
factors interacting with over-expressed BRG1 containing BAF complexes are implicated in AML. Targeted treatment that releases a differentiation block has been observed to be clinically meaningful with ATRA treatment in acute promyelocytic leukemia
as well as IDH1 and IDH2 inhibition in <FONT STYLE="white-space:nowrap">IDH-mutated</FONT> AML. The cell killing observed was comparable to the effect of standard of care combinations: cytarabine plus daunorubicin and azacytidine plus venetoclax.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>taratartPatient #1 Sample</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">BM-de</FONT> novo AML</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Patient #2 Sample</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">BM-secondary</FONT> AML</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Patient #3 Sample</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">BM-secondary</FONT> AML</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g105868g62s71.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g105868g52h11.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g105868g05j33.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 8. Treatment of patient-derived AML tumor samples with <FONT STYLE="white-space:nowrap">FHD-286</FONT> stimulated
differentiation and cell death. Dose-dependent reduction of blast counts in samples from three patients. The blast count was normalized and plotted as relative to the level in vehicle DMSO-treated samples. The level of blast count reduction achieved
by standards of care (Aza + venetoclax and &#147;7+3&#148;) are indicated by the dashed lines. BM = Bone Marrow. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Total Blasts</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Differentiation-like Blasts</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Immature Blasts</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g105868g86q07.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g105868g72z06.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g105868g59b86.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 9: Evidence of a dose-dependent differentiation effect in patient #1 sample. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have confirmed the sensitivity observed in our <FONT STYLE="white-space:nowrap">three-day</FONT> cell
line panel in CDX models created using <FONT STYLE="white-space:nowrap">OCI-AML2</FONT> and <FONT STYLE="white-space:nowrap">MV4-11,</FONT> two AML cell lines with different underlying genetic mutations. In addition, we have observed robust dose
response in further evaluation of <FONT STYLE="white-space:nowrap">FHD-286</FONT> in <FONT STYLE="white-space:nowrap">MV4-11</FONT> CDX models. We have also observed synergy of <FONT STYLE="white-space:nowrap">FHD-286</FONT> in combination with
cytarabine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">MV4-11</FONT> AML CDX Model </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLT3 ITD, <FONT STYLE="white-space:nowrap">MLL-AF4</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g77m50.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">OCI-AML-2</FONT></FONT> AML CDX Model
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">MII-AF6,</FONT> DNMTa3 mut. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g87w79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 10. <FONT STYLE="white-space:nowrap">FHD-286,</FONT> dosed as monotherapy, led to tumor growth inhibition in two
AML xenograft models <FONT STYLE="white-space:nowrap">MV4-11</FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">OCI-AML-2.</FONT></FONT> </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Preclinical Data for Uveal Melanoma </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In uveal
melanoma cell lines that contain GNAQ/GNA11 mutations, genetic studies have revealed that these cells overexpressed two transcription factors, MITF and SOX10.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>Our data showed that the MITF and
SOX10 transcription factors abnormally over-interacted with the BAF complex in uveal melanoma cell lines. By inhibiting the ATPase activity, both BRG1 and BRM, of the BAF complex, we observed anti-tumor effects in several CDX and patient-derived
xenograft, or PDX, uveal melanoma models. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We established the genetic dependency of uveal melanoma cell lines on MITF and SOX10 by analyzing data from
the Project Achilles, a functional genomics screen conducted by the Broad Institute. We found that established uveal melanoma cell lines such as <FONT STYLE="white-space:nowrap">92-1</FONT> and OMM1 were highly dependent on MITF or SOX10. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g73f73.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 11. Uveal melanoma cell lines, such as <FONT STYLE="white-space:nowrap">92-1</FONT> and OMM1, were highly
dependent on MITF or SOX10. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We found that inhibition of BRG1 and BRM led to suppression of gene expression from several MITF and
SOX10-dependent genes. A broader measure of the effect of dual inhibition of BRG1 and BRM on transcription of MITF and SOX10-dependent genes was obtained using a technique known as chromatin immunoprecipitation sequencing, or <FONT
STYLE="white-space:nowrap">ChIP-seq.</FONT> <FONT STYLE="white-space:nowrap">ChIP-seq</FONT> allows us to find where particular proteins, in this case transcription factors, are binding to chromatin. Treatment of uveal melanoma cells with a research
compound with similar properties to that of <FONT STYLE="white-space:nowrap">FHD-286</FONT> resulted in decreased binding of both MITF and SOX10 transcription factors to their respective chromatin binding sites. These results validate the mechanism
of action of <FONT STYLE="white-space:nowrap">FHD-286</FONT> in uveal melanoma cells. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g53c77.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 12. BRG1/BRM inhibitor blocked the ability of MITF and SOX10 to bind to their target sequences as determined by <FONT
STYLE="white-space:nowrap">ChIP-seq.</FONT> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have generated <I>in vivo</I> proof of concept data that demonstrated antitumor activity of <FONT
STYLE="white-space:nowrap">FHD-286</FONT> in multiple uveal melanoma CDX and PDX models. In two uveal melanoma models, <FONT STYLE="white-space:nowrap">92-1</FONT> and <FONT STYLE="white-space:nowrap">MP-46,</FONT> oral dosing of <FONT
STYLE="white-space:nowrap">FHD-286</FONT> at 1.5 mg/kg as monotherapy resulted in tumor growth regression and inhibition, respectively. Importantly, doses of <FONT STYLE="white-space:nowrap">FHD-286</FONT> of up to 1.5 mg/kg were well-tolerated in
that <FONT STYLE="white-space:nowrap">FHD-286</FONT> at these doses did not lead to changes in body weight considered to be clinically meaningful compared to controls (e.g., changes greater than 10&nbsp;percent of body weight), a commonly used
measure of safety. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">92-1</FONT> Uveal Melanoma Model </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g03r21.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">MP-46</FONT> Uveal Melanoma Model </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g78v37.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 13. <FONT STYLE="white-space:nowrap">FHD-286</FONT> led to dose-dependent tumor growth inhibition in two uveal
melanoma xenograft models <FONT STYLE="white-space:nowrap">92-1</FONT> and <FONT STYLE="white-space:nowrap">MP-46.</FONT> </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical Plans for <FONT
STYLE="white-space:nowrap">FHD-286</FONT> in AML and Uveal Melanoma </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We submitted two separate INDs <FONT STYLE="white-space:nowrap">FHD-286</FONT>
for metastatic uveal melanoma and relapsed and/or refractory AML in December 2020 and received IND acceptance in late December 2020 and early January 2021, respectively. We are currently initiating separate Phase 1 studies for metastatic uveal
melanoma and relapsed and/or refractory AML. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> phase I
study in AML is an accelerated titration design with two parts. Part one is the dose escalation phase that will enroll a single patient per dose (n=1) until certain criteria are met. The trial will convert to a 3+3 design once relevant
pharmacokinetics/pharmacodynamics, or PK/PD, safety and or clinical activity are observed. The dose escalation portion will evaluate once daily oral, multiple ascending doses of <FONT STYLE="white-space:nowrap">FHD-286,</FONT> with a starting dose
determined by our GLP toxicology studies. Dose escalation will include patients with relapsed and/or refractory AML. The second part of the study is an expansion phase. This phase may include multiple distinct cohorts of patients with AML, informed
by findings from the dose escalation phase. Initially, biomarkers, such as the association of clinical activity and BRG1 expression levels, will be evaluated retrospectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The primary objective of this
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> study will be the evaluation of safety and tolerability, and the identification of the maximum tolerated dose and the recommended Phase 2 dose. The
secondary objectives are expected to include an evaluation of preliminary clinical activity and pharmacokinetics. Biomarkers will be evaluated in an exploratory fashion, evaluating markers associated with response. Prospective enrollment based on
biomarker findings may be included in the expansion phase of the study. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> Phase 1 study in uveal melanoma is an accelerated titration design with two parts. Part one is the dose escalation phase that will enroll a single patient
per dose (n=1) until certain criteria are met. The trial will convert to a 3+3 design once relevant PK/PD, safety and or clinical activity are observed. The dose escalation portion will evaluate once daily oral, multiple ascending doses of <FONT
STYLE="white-space:nowrap">FHD-286,</FONT> with a starting dose determined by our GLP toxicology studies. Dose escalation will include patients with metastatic uveal melanoma. The second part of the study is an expansion phase, which will be
informed by findings from the dose escalation phase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The primary objective will be the evaluation of safety and tolerability and identification of the
maximum tolerated dose and/or recommended Phase 2 dose. The secondary objectives are expected to include an evaluation of pharmacokinetics and preliminary clinical activity. Biomarkers will be evaluated in an exploratory fashion, evaluating target
engagement as well as markers associated with response. Prospective enrollment based on biomarker findings may be included in the expansion phase of the study. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As shown in the graphic below, these two Phase 1 studies will be conducted in parallel. We intend to explore the potential value of multiple biomarkers to
further understand and accelerate drug development. Biomarkers will include assessment of various tumor mutations, as well as expression levels of BRG1 and BRM. These biomarkers may be used for future patient selection, measurements of target
engagement and biochemical and cellular measures associated with efficacy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A recent data publication highlighted neuroendocrine prostate cancer as being
dependent on BAF. We are evaluating multiple tumor types preclinically to determine our indication expansion strategy for <FONT STYLE="white-space:nowrap">FHD-286.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g48e61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">FHD-609</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are currently advancing <FONT
STYLE="white-space:nowrap">FHD-609,</FONT> a highly potent, selective and intravenous, small molecule protein degrader of BRD9, a subunit of a form of the BAF complex. Nearly all synovial sarcoma cancers harbor
<FONT STYLE="white-space:nowrap">SS18-SSX</FONT> mutations. These mutations render the cancer genetically dependent upon BRD9. <FONT STYLE="white-space:nowrap">FHD-609</FONT> has two domains: one that binds with high potency and selectivity to BRD9
and the other that binds to a receptor on the E3 ligase complex that directs proteins for destruction. Our preclinical data in synovial sarcoma animal xenograft models demonstrate anti-tumor effects that we believe support filing an IND and
progressing <FONT STYLE="white-space:nowrap">FHD-609</FONT> into </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
clinical studies. We have completed the GLP toxicology studies for <FONT STYLE="white-space:nowrap">FHD-609.</FONT> We plan to submit an IND for <FONT STYLE="white-space:nowrap">FHD-609</FONT> in
the second quarter of 2021 and, if cleared, expect to initiate a clinical study in synovial sarcoma shortly thereafter. This multi-center Phase 1 study will primarily assess the safety and tolerability of
<FONT STYLE="white-space:nowrap">FHD-609</FONT> in patients with synovial sarcoma. Secondary endpoints are expected to include the PK/PD properties of <FONT STYLE="white-space:nowrap">FHD-609</FONT> as well as clinical activity. Proof of mechanism
will be based on indicators of target engagement in association with <FONT STYLE="white-space:nowrap">FHD-609</FONT> treatment. As we further understand the therapeutic potential of <FONT STYLE="white-space:nowrap">FHD-609</FONT> in the course of
the initial clinical studies, we may pursue additional clinical studies in synovial sarcoma, as a single agent and/or in combination with novel or standard of care agents. In parallel, and as early as Phase 1 expansion studies, we plan to evaluate <FONT
STYLE="white-space:nowrap">FHD-609</FONT> in other indications, including SMARCB1-deleted cancers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Synovial Sarcoma Overview </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Synovial sarcoma is a cancer of the connective tissue and most commonly originates in the arms or legs. Synovial sarcoma occurs most frequently in adolescents
and young adults. There is an incidence over 1,800 new cases of synovial sarcoma in the United States, EU4, UK and Japan. Approximately 30&nbsp;percent of synovial sarcomas occur in patients under 20 years of age with 84&nbsp;percent of cases
occurring in patients under 50 years of age. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Delay in diagnosis and treatment of synovial sarcoma is common because it is recognized simply by a lump
that gradually grows over time. The primary treatment for synovial sarcoma is surgical excision of the tumor and surrounding normal tissue with the goal of sparing the limb if possible. Failure to adequately excise a sufficient area of tissue
surrounding the tumor leads to recurrence rates of over 70&nbsp;percent. Surgical resection is then followed by adjuvant chemotherapy or radiation therapy or both. However, there appears to be minimal benefit of these post-surgical treatments other
than for palliative reasons. Radiation and chemotherapy are used in the neoadjuvant setting, or before surgery, to improve the chances of a successful limb sparing surgery. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approximately ten percent of cases originally present as metastatic disease, and half of all cases eventually develop into metastatic disease. Eighty percent
of metastases are localized in the lungs. Five-year survival rates for younger patients with early-stage disease are approximately 76&nbsp;percent; however, this decreases to approximately 20&nbsp;percent in patients over age 30 with advanced
disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no therapies specifically approved by the FDA for synovial sarcoma patients with metastatic disease. Pazopanib, marketed as Votrient<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> by Novartis has been approved by the FDA for treatment of soft tissue sarcoma in patients who had received prior chemotherapy. In a Phase 3 soft tissue sarcoma trial that included a total of 369
patients, the progression-free survival time for the subset of patients with synovial sarcoma was 4.1 months (N=25) compared to 0.9 months for those who received placebo (N=13). Other chemotherapeutic agents that may be used for palliative purposes
include ifosfamide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Synovial sarcomas are characterized by a chromosomal translocation that results in the fusion of the SS18 gene to one of three genes:
SSX1, SSX2 and SSX4, creating <FONT STYLE="white-space:nowrap">SS18-SSX</FONT> gene fusions. These gene fusions are unique in synovial sarcoma and create a protein not found in healthy patients that fuels the growth and proliferation of the cancer
cells. In the scientific literature, the process has been described as the gene fusion &#147;hijacking&#148; the BAF complex, altering its function and causing it to unpack chromatin at wrong locations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SS18 is a component of the BAF complex. The <FONT STYLE="white-space:nowrap">SS18-SSX</FONT> fusion protein can also be incorporated into the BAF complex,
leading to synovial sarcoma. Genomic screening in synovial sarcoma cells has identified a genetic dependency between synovial sarcoma cells containing <FONT STYLE="white-space:nowrap">SS18-SSX</FONT> fusions and BRD9, a subunit of the ncBAF complex.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g05d92.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 14. Synovial sarcoma cell lines were highly dependent on BRD9. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Solution: <FONT STYLE="white-space:nowrap">FHD-609</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">FHD-609</FONT> is a highly potent, selective and intravenous, small molecule protein degrader of BRD9. Unlike many traditional
intracellular drug targets, BRD9 is not an enzyme and does not exhibit enzymatic activity. We therefore designed <FONT STYLE="white-space:nowrap">FHD-609</FONT> as a protein degrader, a molecule with two binding domains connected by a linker that
drives the removal of targeted proteins by the cell&#146;s protein degradation system. In cells, these protein degrader molecules bring their target into proximity of the E3 ligase which marks these target proteins for destruction by the cell&#146;s
proteasome system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One domain of <FONT STYLE="white-space:nowrap">FHD-609</FONT> is a potent and selective binder of BRD9. This is chemically linked to a
domain that binds to a receptor on the E3 ligase complex. <FONT STYLE="white-space:nowrap">FHD-609</FONT> led to the specific degradation of BRD9 in multiple synovial sarcoma tumor cell lines, with a DC50 of less than 1 (one) nM. This resulted in
the elimination of detectable BRD9 protein and the concomitant inhibition of proliferation of these synovial sarcoma cell lines. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Preclinical
Data for Synovial Sarcoma </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have generated <I>in vivo</I> proof of concept data that demonstrated antitumor activity of <FONT
STYLE="white-space:nowrap">FHD-609</FONT> in synovial sarcoma CDX models. In the synovial sarcoma SYO1 CDX model containing the SS18-SSX2 mutation, dosing with <FONT STYLE="white-space:nowrap">FHD-609</FONT> led to potent inhibition of tumor growth.
Intraperitoneal doses of <FONT STYLE="white-space:nowrap">FHD-609</FONT> yielded similar antitumor activity whether dosing was delivered as a once-weekly (every 7 days for three weeks) or an equivalent drug amount delivered daily over seven days for
three weeks (3.5 mg/kg delivered every week versus 0.5 mg/kg delivered daily over 7 days). This suggests that sustained tumor regression can occur with a less frequent dosing regimen, which will be explored in clinical development. In the model,
tumor growth inhibition levels were associated with levels of BRD9 degradation as indicated below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">SYO-1</FONT> Synovial Sarcoma CDX Model </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g88t46.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 15. <FONT STYLE="white-space:nowrap">FHD-609</FONT> led to dose-dependent tumor growth inhibition of synovial
sarcoma tumors equivalently at a once weekly or daily treatment schedule. On the right, the western blot shows dose-dependent BRD9 degradation correlating with the anti-tumor activity. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the synovial sarcoma ASKA CDX model containing the SS18-SSX1 mutation, the antitumor activity of <FONT STYLE="white-space:nowrap">FHD-609</FONT> was
comparable and superior to that observed for other systemic therapeutic agents. In this model <FONT STYLE="white-space:nowrap">FHD-609</FONT> was dosed intravenously twice per week, ifosfamide as a monotherapy intravenously on days one through three
every three weeks, and pazopanib orally once daily. <FONT STYLE="white-space:nowrap">FHD-609</FONT> led to robust tumor suppression, with meaningful suppression observed through 40 days at the highest studied dose of 2 mg/kg. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASKA Synovial Sarcoma CDX Model </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g77c24.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 16. <FONT STYLE="white-space:nowrap">FHD-609</FONT> resulted in tumor regression in the ASKA synovial sarcoma
xenograft model. <FONT STYLE="white-space:nowrap">FHD-609</FONT> demonstrated significant tumor growth inhibition compared to either ifosfamide or pazopanib. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Importantly, after discontinuation of <FONT STYLE="white-space:nowrap">FHD-609,</FONT> treatment with <FONT STYLE="white-space:nowrap">FHD-609</FONT> was
associated with sustained tumor growth inhibition. Following discontinuance of <FONT STYLE="white-space:nowrap">FHD-609</FONT> treatment at 2 mg/kg, at approximately day&nbsp;21 tumor regrowth was not detectable for at least another 15 days. We
believe these results support the targeted degradation of BRD9 and its importance in synovial sarcoma. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASKA Synovial Sarcoma CDX Model </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g41v33.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 17. <FONT STYLE="white-space:nowrap">FHD-609</FONT> treatment was associated with sustained tumor suppression
after treatment withdrawal. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clinical Plans for <FONT STYLE="white-space:nowrap">FHD-609</FONT> in Synovial Sarcoma </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> study in synovial sarcoma will include a standard dose
escalation and expansion phase. The dose escalation portion is a Phase 1 design with a starting dose determined by the GLP toxicology studies. Dose escalation may include <FONT STYLE="white-space:nowrap">treatment-na&iuml;ve</FONT> or
treatment-experienced patients with metastatic synovial sarcoma. The expansion phase may include multiple distinct cohorts of synovial sarcoma patients, informed by findings from the dose escalation phase. Initially, biomarkers such as the
association of clinical activity and <FONT STYLE="white-space:nowrap">SS18-SSX</FONT> mutational status will be evaluated retrospectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The primary
endpoints of this <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> study will be safety, the identification of any dose-limiting toxicities, the maximum tolerated dose, the recommended Phase 2 dose, and
the evaluation of pharmacokinetics and pharmacodynamics. The secondary endpoints are expected to include an evaluation of clinical activity: overall response rate, duration of response and additional time to event analyses. Biomarkers will be
evaluated in an exploratory fashion, evaluating target engagement as well as markers associated with response and/or resistance. Prospective enrollment based on biomarker findings may be included in the expansion phase of the study. As we further
understand the therapeutic potential of <FONT STYLE="white-space:nowrap">FHD-609</FONT> in the course of the initial clinical studies, we may pursue additional clinical studies in synovial sarcoma, as a single agent and/or in combination with novel
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or standard of care agents. In parallel, and as early as Phase 1 expansion studies, we plan to evaluate <FONT STYLE="white-space:nowrap">FHD-609</FONT> in other indications, including
SMARCB1-deleted cancers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g97b09.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">BRM-Selective</FONT> Modulators </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Broad cancer sequencing initiatives have
shown that BRG1 is one of the most highly mutated subunits of the BAF complex. BRG1 was found to be mutated in approximately five percent of tumors sequenced as part of the Memorial Sloan Kettering Cancer Center
<FONT STYLE="white-space:nowrap">MSK-IMPACT</FONT> study, and in up to ten percent of NSCLC tumors. Beyond NSCLC, the <FONT STYLE="white-space:nowrap">MSK-IMPACT</FONT> study highlighted BRG1 mutations in over thirty different types of tumors. In
many cases, these mutations lead to a loss of enzymatic activity in the BRG1 subunit, creating a genetically determined dependency on BRM. This loss of BRG1 and subsequent dependency on BRM leads to a drugging opportunity. We are currently
developing selective modulators of BRM to target this genetic dependency in BRG1 mutated cancers. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>12 Tumor Types with Highest
Prevalence of <FONT STYLE="white-space:nowrap">BRG-1</FONT> Mutations </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g02s39.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 18. The above chart highlights the cancers with the highest prevalence of BRG1 mutations from the <FONT
STYLE="white-space:nowrap">MSK-IMPACT</FONT> study. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Small</FONT> Cell Lung Cancer (NSCLC) Overview
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lung cancer is the leading cause of cancer-related death, accounting for approximately 18&nbsp;percent of all cancer deaths globally or an
estimated 1.8&nbsp;million deaths per year. There are an estimated 228,000 new cases of lung </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cancer diagnosed and 135,000 deaths in the United States annually. NSCLC accounts for 80 to 85&nbsp;percent of lung cancer cases. Genetic profiling of tumors has identified a number of genes that
are altered in NSCLC. The standard of care for NSCLC has included conventional chemotherapy with or without a checkpoint inhibitor. Targeted therapies developed for the proteins encoded by some of these genes such as the epidermal growth factor
receptor, or EGFR, and anaplastic lymphoma kinase gene, or ALK, have been approved and are now part of the standard of care of patents with NSCLC. However, less than 30&nbsp;percent of NSCLC patients have alterations in these two genes. Up to two
thirds of NSCLC patients who are ineligible for or resistant to treatment with EGFR or ALK targeted therapies have tumors that express <FONT STYLE="white-space:nowrap">PD-L1</FONT> and are candidates for checkpoint inhibitor therapies, which lead to
significant improvements in progression free survival and overall survival compared to standard chemotherapy. Despite the availability of both targeted and conventional therapies, the prognosis in NSCLC remains poor, with an overall five-year
survival for all patients diagnosed with NSCLC of 19&nbsp;percent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An analysis of genomic data in NSCLC cancer patients, collected as part of <FONT
STYLE="white-space:nowrap">MSK-IMPACT,</FONT> revealed that gene alterations in BRG1 were found in ten percent of NSCLC samples. In a retrospective analysis conducted by MSKCC it was observed that among patients with BRG1-deficient NSCLC who
received first-line platinum doublet chemotherapy or chemotherapy plus immunotherapy, median progression-free survival was 38 days and 35 days, respectively. Prognosis is poor in patients with BRG1-deficient NSCLC, highlighting the importance of
developing novel therapeutics that address this unmet need. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">MSK-IMPACT:</FONT> <FONT
STYLE="white-space:nowrap">BRG-1</FONT> Mutated in 10% of NSCLC </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g46u77.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 19. BRG1 gene alterations are found in 10&nbsp;percent of NSCLC tumors and have minimal overlap with other
actionable mutations present in NSCLC, such as EGFR and ALK. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Genomic screening of over 400 cancer cell lines that remove BRM via CRISPR revealed a genetic dependency of
certain BRG1-mutated cancers on BRM. This finding suggests that selective inhibition of BRM has the potential to be therapeutically meaningful in certain cancers with BRG1 mutations. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g17c48.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 20. In a screen of over 400 cancer cell lines, inactivation of the BRM gene resulted in selective inhibition of
cell lines containing mutations in BRG1. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Solution: Selective BRM Modulators </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are advancing two classes of molecules, an enzymatic inhibitor and a protein degrader, as selective modulators of BRM. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One class consists of selective, allosteric inhibitors of the ATPase activity of BRM. We are designing these inhibitors to be more selective for BRM than the
very similar ATPase BRG1. Through our proprietary methods of isolating and screening BAF complexes that contain either BRG1 or BRM, we have identified small molecule inhibitors that are over 10 times more selective for BRM than BRG1. We have shown
that this selectivity was </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
also observed in cellular assays. Pharmacokinetic profiles of these molecules have been consistent with the ability to potently inhibit BRM while having minimal inhibitory activity against BRG1.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Enzyme assay using BRG1 and BRM subunits</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Enzyme assay using BRG1 and BRM&nbsp;containing&nbsp;full&nbsp;BAF complexes</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Cellular assays for BRG1 and BRM</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g105868g75b52.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g105868g85n13.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g105868g80r02.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 21. This panel showed biochemical (percent of ATPase activity) and cellular selectivity of a 20X selective inhibitor
of BRG1 versus BRM. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our other approach to selective BRM modulation consists of protein degrader molecules that activate the cell&#146;s protein
degradation system to selectively destroy BRM. One domain of the BRM degrader molecule is a potent and selective binder of BRM. This is chemically linked to a domain that binds to a receptor on the E3 ligase complex. In cells, these protein degrader
molecules bring their target into proximity of the E3 ligase which marks these target proteins for destruction by the cell&#146;s protein degradation system. We have shown that it is possible to identify protein degraders that lead to the
destruction of BRM while leaving BRG1 untouched. We anticipate nominating a drug candidate in 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Selective Degradation of BRM
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g23f27.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 22. Selective BRM degrading molecules led to the degradation of over 75&nbsp;percent of BRM while leaving the
levels of BRG1 virtually unchanged. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ARID1B Selective Modulators and Other Opportunities in the Chromatin Regulatory System </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ARID1A subunit is the most mutated subunit within the BAF complex.&nbsp;Mutations in ARID1A confer a dependency on the ARID1B subunit of the BAF complex.
ARID1A mutations are implicated in ovarian, endometrial, colorectal, bladder, and gastric cancers.&nbsp;Data suggest that there are over 175,000 patients with ARID1A mutations that would potentially benefit from a therapy selectively targeting
ARID1B. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g14e02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 23. In a screen of over 400 cancer cell lines, inactivation of the ARID1B gene resulted in selective growth
inhibition of cell lines containing mutations in ARID1A, establishing the dependency on ARID1B in these cell lines. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since ARID1B is not an enzyme,
our strategy is to selectively degrade ARID1B.&nbsp;Our platform allows us to generate full BAF complexes containing only ARID1A or ARID1B.&nbsp;Using our platform, we have conducted high throughput screens and have discovered binders to the ARID1B
protein that we will seek to optimize as protein degrader product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given the significance of mutations within the chromatin regulatory system,
we are using our platform to discover and validate additional dependencies. We have several additional early programs underway. We continue to evaluate new target opportunities and intend to further expand our pipeline in oncology as well as other
therapeutic areas. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Targeting Transcription Factors: Disrupting Transcription Factor Binding to Chromatin Remodeling Complexes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transcription factors work in concert with chromatin remodeling complexes, BAF as one example, to orchestrate gene expression. In tumor cells, genes encoding
transcription factors are often amplified, deleted, rearranged via chromosomal translocation or subjected to point mutations that result in a gain or loss of function. We have developed a set of tools to visualize and study the interactions between
transcription factors and chromatin remodeling complexes. To our knowledge, we are the only company with these capabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are using these
capabilities to drive our drug discovery efforts across multiple transcription factor programs for a variety of cancer indications. Our strategy is to disrupt the interaction between transcription factors and chromatin remodeling complexes. Our
initial focus is on disrupting transcription factor interactions with the BAF complex. We believe that there are over 100 transcription factors in oncology that would be amenable to this new approach. Based on these insights, we are developing small
molecule disruptors that block the interaction between transcription factors and the BAF complex. In addition to applications in cancer, we believe that such disruptors could be applied in other therapeutic areas. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our approach to disrupting the interactions between transcription factors and the BAF complex is the basis
of a collaboration signed with Merck in July 2020. In this collaboration, we intend to apply our Gene Traffic Control platform to identify disruptors of a single predetermined transcription factor. As part of the collaboration, we received an
upfront payment of $15.0&nbsp;million, and are also eligible to receive up to $245.0&nbsp;million upon achievement of specified research, development and regulatory milestones by any product candidate generated by the collaboration, and up to
$165.0&nbsp;million upon achievement of specified sales-based milestones. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A prototypical example of a chromatin remodeling complex&#150;transcription
factor interaction is exemplified by the ERG transcription factor and BAF. In approximately half of all prostate cancers, the gene encoding ERG is fused to the TMPRRS2 promotor, resulting in the overexpression of ERG and the upregulation of a broad
set of additional genes. Furthermore, genetic suppression of ERG expression in cells containing the <FONT STYLE="white-space:nowrap">TMPRRS2-ERG</FONT> gene fusion has been shown to inhibit cell proliferation. These results support our approach that
disrupting the interaction of over expressed transcription factors, such as ERG, with a chromatin remodeling complex has the potential to be therapeutically beneficial to patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Similar to ERG, the ability of individual transcription factors to interact with the BAF complex has previously been reported in the literature, but to our
knowledge, there have not previously been systematic studies quantifying and describing these binding interactions. We used our Gene Traffic Control platform to produce and purify BAF complexes and multiple transcription factors to study the
structural details as well as the biochemical and biophysical properties of their interactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We observed that different transcription factors bind to
different sites on the surface of the BAF complex. This suggests that there is specificity in these interactions. Therefore, it may be possible to block the interaction of a specific transcription factor with the BAF complex without blocking the
interactions of other transcription factors. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g83b78.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 24. Illustrative locations of the binding sites of multiple transcription factors to the BAF complex. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also observed that the binding affinities that describe how tightly transcription factors bind to the BAF complex were roughly comparable to those observed
for other protein-protein interactions for which small </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
molecule disruptors have been developed. We found that the interactions between multiple transcription factors and the BAF complex had a
K<SUB STYLE="font-size:85%; vertical-align:bottom">d</SUB>, a measure of binding affinity, in the range of 20 to 350 nM. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g105868g60p32.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 25. Interactions between transcription factors and the BAF complex had K<SUB
STYLE="font-size:85%; vertical-align:bottom">d</SUB>s in the range of 20 to 350 nM. Smaller numbers reflected higher affinity binding. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Using the
insights of where and how tightly transcription factors bind, we have developed as part of our Gene Traffic Control platform the ability to conduct high throughput screens on chromatin remodeling complex&#150;transcription factor interactions. We
have already validated eight <FONT STYLE="white-space:nowrap">BAF-transcription</FONT> factor interactions for targets of interest in various cancers. We are applying our <FONT STYLE="white-space:nowrap">know-how</FONT> to screen several of these <FONT
STYLE="white-space:nowrap">BAF-transcription</FONT> factor interactions to discover and develop transcription factor disruptors. We intend to use our platform to validate and drug additional transcription factors that interact with BAF and other
chromatin remodeling complexes both in oncology and other therapeutic areas. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The biotechnology and pharmaceutical industries are characterized by the rapid evolution of technologies and understanding of disease etiology, intense
competition and a strong emphasis on intellectual property. We believe that our approach, strategy, scientific capabilities, <FONT STYLE="white-space:nowrap">know-how</FONT> and experience provide us with competitive advantages, including, to our
knowledge, our being the only company with the ability to study the chromatin regulatory system at scale, in context, and in an integrated way. However, we expect substantial competition from multiple sources, including major pharmaceutical,
specialty pharmaceutical, and existing or emerging biotechnology companies, academic research institutions and governmental agencies and public and private research institutions worldwide. Many of our competitors, either alone or through
collaborations, have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we do.
Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These companies may be or may become interested in the chromatin regulatory system
and rapidly develop programs that may compete with ours by studying the chromatin regulatory system at scale, in context and in an integrated way. Even if they do not advance programs with the same mechanism of action as ours, these companies could
develop products or product candidates that are competitive with ours or that have a superior product profile and may do so at a rapid pace. These competitors also compete with us in recruiting and retaining qualified scientific and management
personnel and establishing clinical trial sites and patient enrollment in clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. As a result, our competitors may discover, develop, license or
commercialize products before or more successfully than we do. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We face competition from segments of the pharmaceutical, biotechnology and other related
markets that pursue the development of therapies that target broad genetic expression mechanisms, including the chromatin regulatory system.<B> </B>In addition, we may face competition from companies developing product candidates that utilize
protein degradation approaches, including Arvinas, Inc., Kymera Therapeutics, Inc., Nurix Therapeutics, Inc., C4 Therapeutics, Inc., and Vividion Therapeutics, Inc. Further, several large pharmaceutical companies have disclosed preclinical
investments in this field. Our competitors will also include companies that are or will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be developing other targeted therapies, including small molecule, antibody, or protein degraders for the same indications that we are targeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We could see a reduction or elimination in our commercial opportunity if our competitors develop and commercialize drugs that are safer, more effective, have
fewer or less severe side effects, are more convenient to administer, are less expensive or with more favorable labeling than our product candidates, regardless of whether they target the chromatin regulatory system as a mechanism of action. Our
competitors also may obtain FDA or other regulatory approval for their drugs more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. The
key competitive factors affecting the success of all of our product candidates, if approved, are likely to be their efficacy, safety, convenience, price, the level of generic competition and the availability of reimbursement from government and
other third-party payors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
seek to protect the intellectual property and proprietary technology that we consider important to our business, including by pursuing patent applications that cover our product candidates and methods of using the same, as well as other relevant
inventions and improvements that we believe to be commercially important to the development of our business. We also rely on trade secrets, <FONT STYLE="white-space:nowrap">know-how</FONT> and continuing technological innovation to develop and
maintain our proprietary and intellectual property position. Our commercial success depends, in part, on our ability to obtain, maintain, enforce and protect our intellectual property and other proprietary rights for the technology, inventions and
improvements we consider important to our business, and to defend any patents we may own or <FONT STYLE="white-space:nowrap">in-license</FONT> in the future, prevent others from infringing any patents we may own or
<FONT STYLE="white-space:nowrap">in-license</FONT> in the future, preserve the confidentiality of our trade secrets, and operate without infringing, misappropriating or otherwise violating the valid and enforceable patents and proprietary rights of
third parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As with other biotechnology and pharmaceutical companies, our ability to maintain and solidify our proprietary and intellectual property
position for our product candidates and technologies will depend on our success in obtaining effective patent claims and enforcing those claims if granted. However, our pending provisional and PCT patent applications, and any patent applications
that we may in the future file or license from third parties, may not result in the issuance of patents and any issued patents we may obtain do not guarantee us the right to practice our technology or commercialize our product candidates. We also
cannot predict the breadth of claims that may be allowed or enforced in any patents we may own or <FONT STYLE="white-space:nowrap">in-license</FONT> in the future. Any issued patents that we may own or
<FONT STYLE="white-space:nowrap">in-license</FONT> in the future may be challenged, invalidated, circumvented or have the scope of their claims narrowed. In addition, because of the extensive time required for clinical development and regulatory
review of a product candidate we may develop, it is possible that, before any of our product candidates can be commercialized, any related patent may expire or remain in force for only a short period following commercialization, thereby limiting the
protection such patent would afford the respective product and any competitive advantage such patent may provide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The term of individual patents depends
upon the date of filing of the patent application, the date of patent issuance and the legal term of patents in the countries in which they are obtained. In most countries, including the United States, the patent term is 20&nbsp;years from the
earliest filing date of a <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application. In the United States, a patent&#146;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by
the USPTO in examining and granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier filed patent. The term of a patent claiming a new drug product may also be eligible for a limited patent term extension when FDA
approval is granted, provided statutory and regulatory requirements are met. The restoration period granted on a patent covering a product is typically <FONT STYLE="white-space:nowrap">one-half</FONT> the time between the effective date of a
clinical investigation involving human beings is begun and the submission date of an application, plus the time between the submission date of an application and the ultimate approval date. The restoration period cannot be longer than five years and
the total patent term, including the restoration period, must not exceed 14 years following FDA approval. Only one patent applicable to an approved product is eligible </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for the extension, and only those claims covering the approved product, a method for using it, or a method for manufacturing it may be extended. Additionally, the application for the extension
must be submitted prior to the expiration of the patent in question. A patent that covers multiple products for which approval is sought can only be extended in connection with one of the approvals. The United States Patent and Trademark Office
reviews and approves the application for any patent term extension or restoration in consultation with the FDA. In the future, if our product candidates receive approval by the FDA, we expect to apply for patent term extensions on any issued patents
covering those products, depending upon the length of the clinical studies for each product and other factors. There can be no assurance that patents will issue from our current or future pending patent applications, or that we will benefit from any
patent term extension or favorable adjustments to the terms of any patents we may own or <FONT STYLE="white-space:nowrap">in-license</FONT> in the future. In addition, the actual protection afforded by a patent varies on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> basis, from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-to-country,</FONT></FONT> and depends upon many factors, including the
type of patent, the scope of its coverage, the availability of regulatory-related extensions, the availability of legal remedies in a particular country and the validity and enforceability of the patent. Patent term may be inadequate to protect our
competitive position on our products for an adequate amount of time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of February&nbsp;28, 2021, we owned 10 pending U.S. provisional patent
applications, eight pending U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications, and 19 pending PCT applications, and ten pending <FONT STYLE="white-space:nowrap">ex-U.S.</FONT> patent applications. We currently do not
own or <FONT STYLE="white-space:nowrap">in-license</FONT> any issued patents with respect to any of our product candidates, including <FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT STYLE="white-space:nowrap">FHD-609,</FONT> or our
platform technology, and our intellectual property portfolio is in its very early stages. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">FHD-286</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of February&nbsp;28, 2021, we owned three pending U.S. provisional patent applications, two pending U.S.
<FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications, four pending Patent Cooperation Treaty, or PCT, patent applications, and five pending <FONT STYLE="white-space:nowrap">ex-U.S.</FONT> patent applications that relate to <FONT
STYLE="white-space:nowrap">FHD-286,</FONT> including its composition and various methods of use. Any U.S. or <FONT STYLE="white-space:nowrap">ex-U.S.</FONT> patent that may issue from these patent applications would be scheduled to expire between
2039-2041, excluding any additional term for patent term adjustment or patent term extension, if applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">FHD-609</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of
February&nbsp;28, 2021, we owned one pending U.S. provisional patent applications, two pending U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications, and three pending Patent Cooperation Treaty, or PCT, patent
applications, and five pending <FONT STYLE="white-space:nowrap">ex-U.S.</FONT> patent applications that relate to <FONT STYLE="white-space:nowrap">FHD-609,</FONT> including its composition and various methods of use. Any U.S. or <FONT
STYLE="white-space:nowrap">ex-U.S.</FONT> patent that may issue from a <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application claiming priority to these applications would be scheduled to expire between 2039-2041, excluding any
additional term for patent term adjustment or patent term extension, if applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prosecution of most of our PCT patent applications and our
provisional patent applications has not commenced and will not commence unless and until they are timely converted into U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> or national stage applications. Prosecution is a lengthy process,
during which the scope of the claims initially submitted for examination by the USPTO or other foreign jurisdiction are often significantly narrowed by the time they issue, if they issue at all. Any of our pending PCT patent applications are not
eligible to become issued patents until, among other things, we file national stage patent applications within 30 months in the countries in which we seek patent protection. If we do not timely file any national stage patent applications, we may
lose our priority date with respect to our PCT patent applications and any patent protection on the inventions disclosed in such PCT patent applications. Our provisional patent applications may never result in issued patents and are not eligible to
become issued patents until, among other things, we file a <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application within 12 months of filing the related provisional patent application. If we do not timely file <FONT
STYLE="white-space:nowrap">non-provisional</FONT> patent applications, we may lose our priority date with respect to our provisional patent applications and any patent protection on the inventions disclosed in our provisional patent applications.
While we intend to timely file <FONT STYLE="white-space:nowrap">non-provisional</FONT> and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
national stage patent applications relating to our provisional and PCT patent applications, we cannot predict whether any of our current or future patent applications related to <FONT
STYLE="white-space:nowrap">FHD-286,</FONT> <FONT STYLE="white-space:nowrap">FHD-609,</FONT> or any of our other product candidates, will issue as patents. If we do not successfully obtain patent protection, or, even if we do obtain patent
protection, if the scope of the patent protection we obtain with respect to <FONT STYLE="white-space:nowrap">FHD-286,</FONT> <FONT STYLE="white-space:nowrap">FHD-609,</FONT> or our other product candidates or technology is not sufficiently broad, we
will be unable to prevent others from using our technology or from developing or commercializing technology and products similar or identical to ours or other competing products and technologies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to patent applications, we rely on unpatented trade secrets, <FONT STYLE="white-space:nowrap">know-how</FONT> and continuing technological
innovation to develop and maintain our competitive position. However, trade secrets and confidential <FONT STYLE="white-space:nowrap">know-how</FONT> are difficult to protect. In particular, we consider various aspects of our Gene Traffic Control
platform to constitute our trade secrets and <FONT STYLE="white-space:nowrap">know-how.</FONT> We seek to protect our proprietary information, in part, by executing confidentiality agreements with our collaborators and scientific advisors and <FONT
STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation,</FONT> confidentiality and invention assignment agreements with our employees and consultants. We cannot guarantee that we will have executed such
agreements with all applicable employees and contractors, or that these agreements will afford us adequate protection of our intellectual property and proprietary information rights. In addition, our trade secrets and/or confidential <FONT
STYLE="white-space:nowrap">know-how</FONT> may become known or be independently developed by a third party or misused by any person to whom we disclose such information. These agreements may also be breached, and we may not have an adequate remedy
for any such breach. Despite any measures taken to protect our intellectual property, unauthorized parties may attempt to copy aspects of our products or to obtain or use information that we regard as proprietary. Although we take steps to protect
our proprietary information, third parties may independently develop the same or similar proprietary information or may otherwise gain access to our proprietary information. As a result, we may be unable to meaningfully protect our trade secrets and
proprietary information. For more information regarding the risks related to our intellectual property, please see &#147;Risk Factors&#151;Risks Related to our Intellectual Property.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>License Agreement with Merck </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2020, we entered
into a Research Collaboration and Exclusive License Agreement, or the Merck Collaboration Agreement, with Merck to apply our Gene Traffic Control platform to discover and develop novel therapeutics based on disruptors of a specified transcription
factor target. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the Merck Collaboration Agreement, we are responsible for certain preclinical research activities under a mutually
agreed research plan, such as the use of our high throughput screening and compound optimization technology to identify and validate disruptors directed to this transcription factor target, up until our delivery to Merck of a hit package that
identifies validated disruptors directed to the transcription factor target. Merck will be responsible for further preclinical research under the Merck Collaboration Agreement and for the clinical development and commercialization of therapeutics
arising from the agreement. Merck will have a limited right to substitute the transcription factor target that is the subject of the collaboration for other transcription factors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the Merck Collaboration Agreement, we have granted Merck an exclusive, worldwide, sublicensable license under certain patent rights and <FONT
STYLE="white-space:nowrap">know-how</FONT> to make, have made, use, import, offer to sell and sell therapeutics arising from the collaboration that disrupt the specified transcription factor target. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have received an upfront payment of $15.0&nbsp;million from Merck, and are eligible to receive up to $245.0&nbsp;million upon achievement of specified
research, development and regulatory milestones by any product candidate generated by the collaboration, and up to $165.0&nbsp;million upon achievement of specified sales-based milestones per approved product from the collaboration, if any. We will
be eligible to receive tiered royalties, calculated on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> basis, on net sales of approved products from the collaboration, if any, at royalty rates
ranging from the <FONT STYLE="white-space:nowrap">mid-single</FONT> digits to low tens, depending on whether the products are covered by patent rights we license to Merck. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Merck Collaboration Agreement will expire upon expiration of all of Merck&#146;s royalty obligations
under the agreement. Merck may terminate the Merck Collaboration Agreement for convenience, and either party may terminate the Merck Collaboration Agreement in the event the other party&#146;s uncured material breach or such party&#146;s bankruptcy
or insolvency. If Merck terminates the Merck Collaboration Agreement as a result of our breach, the licenses and other rights granted to Merck under the agreement will remain in effect and become perpetual. If the term of the agreement expires, then
such licenses and other rights will become fully <FONT STYLE="white-space:nowrap">paid-up.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufacturing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have any manufacturing facilities or personnel. We currently rely, and expect to continue to rely, on third parties for the manufacture of our
product candidates undergoing preclinical testing, as well as for clinical testing and commercial manufacture if our product candidates receive marketing approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of our drug candidates are small molecules and are manufactured in synthetic processes from available starting materials. The chemistry appears amenable
to scale up and does not currently require unusual equipment in the manufacturing process. We expect to continue to develop product candidates that can be produced cost-effectively at contract manufacturing facilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We generally expect to rely on third parties for the manufacture of companion diagnostics for our products, which are assays or tests to identify an
appropriate patient population. Depending on the technology solutions we choose, we may rely on multiple third parties to manufacture and sell a single test. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commercialization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to receiving marketing
approvals, we expect to commence commercialization activities by building a focused sales and marketing organization in the United States to sell our products. We believe that such an organization will be able to address the community of oncologists
who are the key specialists in treating the patient populations for which our product candidates are being developed. Outside the United States, we expect to enter into distribution and other marketing arrangements with third parties for any of our
product candidates that obtain marketing approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also plan to build a marketing and sales management organization to create and implement marketing
strategies for any products that we market through our own sales organization and to oversee and support our sales force. The responsibilities of the marketing organization would include developing educational initiatives with respect to approved
products and establishing relationships with researchers and practitioners in relevant fields of medicine. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Government Regulation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA and other regulatory authorities at federal, state and local levels, as well as in <FONT STYLE="white-space:nowrap">ex-United</FONT> States countries,
extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, recordkeeping, approval, advertising, promotion,
marketing, post-approval monitoring and post-approval reporting of drugs. We, along with our vendors, contract research organizations and contract manufacturers, will be required to navigate the various preclinical, clinical, manufacturing and
commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval of our product candidates. The process of obtaining regulatory approvals of drugs and ensuring subsequent
compliance with appropriate federal, state, local and <FONT STYLE="white-space:nowrap">ex-United</FONT> States statutes and regulations requires the expenditure of substantial time and financial resources. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States, where we are initially focusing our drug development, the FDA regulates drug products under the Federal Food, Drug, and Cosmetic Act, or
FD&amp;C Act, as amended, its implementing regulations and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other laws. If we fail to comply with applicable FDA or other requirements at any time with respect to product development, clinical testing, approval or any other legal requirements relating to
product manufacture, processing, handling, storage, quality control, safety, marketing, advertising, promotion, packaging, labeling, export, import, distribution, or sale, we may become subject to administrative or judicial sanctions or other legal
consequences. These sanctions or consequences could include, among other things, the FDA&#146;s refusal to approve pending applications, issuance of clinical holds for ongoing studies, suspension or revocation of approved applications, warning or
untitled letters, product withdrawals or recalls, product seizures, relabeling or repackaging, total or partial suspensions of manufacturing or distribution, injunctions, fines, civil penalties or criminal prosecution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The process required by the FDA before our product candidates are approved as drugs for therapeutic indications and may be marketed in the United States
generally involves the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">completion of extensive preclinical studies in accordance with applicable regulations, including studies
conducted in accordance with good laboratory practice, or GLP, requirements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">completion of the manufacture, under cGMP conditions, of the drug substance and drug product that the sponsor
intends to use in human clinical trials along with required analytical and stability testing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submission to the FDA of an IND, which must become effective before clinical trials may begin;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval by an institutional review board, or IRB, or independent ethics committee at each clinical trial site
before each trial may be initiated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">performance of adequate and well-controlled clinical trials in accordance with applicable IND regulations, good
clinical practice, or GCP, requirements and other clinical trial-related regulations to establish the safety and efficacy of the investigational product for each proposed indication; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submission to the FDA of a New Drug Application, or NDA; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a determination by the FDA within 60 days of its receipt of an NDA, to accept the filing for review;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">satisfactory completion of one or more FDA <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspections of
the manufacturing facility or facilities where the drug will be produced to assess compliance with cGMP requirements to assure that the facilities, methods and controls are adequate to preserve the drug&#146;s identity, strength, quality and purity;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potentially, satisfactory completion of FDA audit of the clinical trial sites that generated the data in support
of the NDA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">payment of user fees for FDA review of the NDA; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">FDA review and approval of the NDA, including consideration of the views of any FDA advisory committee, prior to
any commercial marketing or sale of the drug in the United States. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical Studies and Clinical Trials for Drugs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before testing any drug in humans, the product candidate must undergo rigorous preclinical testing. Preclinical studies include laboratory evaluations of drug
chemistry, formulation and stability, as well as <I>in vitro</I> and animal studies to assess safety and in some cases to establish the rationale for therapeutic use. The conduct of preclinical studies is subject to United States federal and state
regulation, including GLP requirements for safety/toxicology studies. The results of the preclinical studies, together with manufacturing information and analytical data, must be submitted to the FDA as part of an IND. An IND is a request for
authorization from the FDA to administer an investigational product to humans and must become effective before clinical trials may begin. Some long-term preclinical testing may continue after the IND is submitted. The IND automatically becomes
effective 30 days after receipt by the FDA, unless the FDA, within the <FONT STYLE="white-space:nowrap">30-day</FONT> time period, raises concerns or questions about the conduct of the clinical trial, including concerns that human research subjects
will be exposed to unreasonable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
health risks, and imposes a full or partial clinical hold. FDA must notify the sponsor of the grounds for the hold and any identified deficiencies must be resolved before the clinical trial can
begin. Submission of an IND may result in the FDA not allowing clinical trials to commence or not allowing clinical trials to commence on the terms originally specified in the IND. A clinical hold can also be imposed once a trial has already begun,
thereby halting the trial until the deficiencies articulated by FDA are corrected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The clinical stage of development involves the administration of the
product candidate to healthy volunteers or patients under the supervision of qualified investigators, who generally are physicians not employed by or under the trial sponsor&#146;s control, in accordance with GCP requirements, which include the
requirements that all research subjects provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing
procedures, subject selection and exclusion criteria and the parameters and criteria to be used in monitoring safety and evaluating effectiveness. Each protocol, and any subsequent amendments to the protocol, must be submitted to the FDA as part of
the IND. Furthermore, each clinical trial must be reviewed and approved by an IRB for each institution at which the clinical trial will be conducted to ensure that the risks to individuals participating in the clinical trials are minimized and are
reasonable compared to the anticipated benefits. The IRB also approves the informed consent form that must be provided to each clinical trial subject or his or her legal representative and must monitor the clinical trial until completed. Regulatory
authorities, the IRB or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. Some
studies also include oversight by an independent group of qualified experts organized by the clinical study sponsor, known as a data safety monitoring board, which provides authorization for whether or not a study may move forward at designated
check points based on access to certain data from the study and may halt the clinical trial if it determines that there is an unacceptable safety risk for subject or other grounds, such as a lack of observed efficacy. There also are requirements
governing the reporting of ongoing clinical trials and completed clinical trials to public registries. Information about clinical trials, including results for clinical trials other than Phase 1 investigations, must be submitted within specific
timeframes for publication on www.ClinicalTrials.gov, a clinical trials database maintained by the National Institutes of Health. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A sponsor who wishes to
conduct a clinical trial outside of the United States may, but need not, obtain FDA authorization to conduct the clinical trial under an IND. If a foreign clinical trial is not conducted under an IND, FDA will nevertheless accept the results of the
study in support of an NDA if the study was conducted in accordance with GCP requirements, and the FDA is able to validate the data through an onsite inspection if deemed necessary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clinical trials to evaluate therapeutic indications to support NDAs for marketing approval are typically conducted in three sequential phases, which may
overlap. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase 1</I>&#151;Phase 1 clinical trials involve initial introduction of the investigational product into
healthy human volunteers or patients with the target disease or condition. These studies are typically designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans, excretion the
side effects associated with increasing doses, and, if possible, to gain early evidence of effectiveness. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase 2</I>&#151;Phase 2 clinical trials typically involve administration of the investigational product to a
limited patient population with a specified disease or condition to evaluate the drug&#146;s potential efficacy, to determine the optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase 3</I>&#151;Phase 3 clinical trials typically involve administration of the investigational product to an
expanded patient population to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are
intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval and physician labeling. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Post-approval trials, sometimes referred to as Phase 4 clinical trials or post-marketing studies, may be
conducted after initial marketing approval. These trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication and are commonly intended to generate additional safety data regarding use of the
product in a clinical setting. In certain instances, the FDA may mandate the performance of Phase 4 clinical trials as a condition of NDA approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Progress reports detailing the results of the clinical trials, among other information, must be submitted at least annually to the FDA. Written IND safety
reports must be submitted to the FDA and the investigators fifteen days after the trial sponsor determines the information qualifies for reporting for serious and unexpected suspected adverse events, findings from other studies or animal or <I>in
vitro</I> testing that suggest a significant risk for human volunteers and any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor must also notify
the FDA of any unexpected fatal or life-threatening suspected adverse reaction as soon as possible but in no case later than seven calendar days after the sponsor&#146;s initial receipt of the information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the development of a new drug, sponsors are given opportunities to meet with the FDA at certain points. These points may be prior to submission of an
IND, at the end of Phase 2, and before an NDA is submitted. Meetings at other times may be requested. These meetings can provide an opportunity for the sponsor to share information about the data gathered to date, for the FDA to provide advice, and
for the sponsor and the FDA to reach agreement on the next phase of development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Concurrent with clinical trials, companies usually complete additional
animal studies and must also develop additional information about the chemistry and physical characteristics of the product candidate and finalize a process for manufacturing the drug product in commercial quantities in accordance with cGMP
requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and manufacturers must develop, among other things, methods for testing the identity, strength, quality and purity of the
final drug product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>U.S. Marketing Approval for Drugs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Assuming
successful completion of the required clinical testing, the results of the preclinical studies and clinical trials, together with detailed information relating to the product&#146;s chemistry, manufacture, controls and proposed labeling, among other
things, are submitted to the FDA as part of an NDA package requesting approval to market the product for one or more indications. An NDA is a request for approval to market a new drug for one or more specified indications and must contain proof of
the drug&#146;s safety and efficacy for the requested indications. The marketing application is required to include both negative and ambiguous results of preclinical studies and clinical trials, as well as positive findings. Data may come from
company-sponsored clinical trials intended to test the safety and efficacy of a product&#146;s use or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be
sufficient in quality and quantity to establish the safety and efficacy of the investigational product to the satisfaction of the FDA. FDA must approve an NDA before a drug may be marketed in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA reviews all submitted NDAs before it accepts them for filing and may request additional information rather than accepting the NDA for filing. The FDA
must make a decision on accepting an NDA for filing within 60 days of receipt, and such decision could include a refusal to file by the FDA. Once the submission is accepted for filing, the FDA begins an
<FONT STYLE="white-space:nowrap">in-depth</FONT> substantive review of the NDA. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective for the indications sought and whether the facility in which it is
manufactured, processed, packaged or held meets standards designed to assure the product&#146;s continued safety, quality and purity. Under the goals and polices agreed to by the FDA under the Prescription Drug User Fee Act, or PDUFA, the FDA
targets ten months, from the filing date, in which to complete its initial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
review of a new molecular entity NDA and respond to the applicant, and six months from the filing date of a new molecular entity NDA for priority review. The FDA does not always meet its PDUFA
goal dates for standard or priority NDAs, and the review process is often extended by FDA requests for additional information or clarification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further,
under PDUFA, as amended, each NDA must be accompanied by a substantial user fee. The FDA adjusts the PDUFA user fees on an annual basis. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for
the first application filed by a small business. Additionally, no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a <FONT STYLE="white-space:nowrap">non-orphan</FONT> indication. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA also may require submission of a Risk Evaluation and Mitigation Strategy, or REMS, if it believes that a risk evaluation and mitigation strategy is
necessary to ensure that the benefits of the drug outweigh its risks. A REMS can include use of risk evaluation and mitigation strategies like medication guides, physician communication plans, assessment plans, and/or elements to assure safe use,
such as restricted distribution methods, patient registries, or other risk-minimization tools. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA may refer an application for a novel drug to an
advisory committee. An advisory committee is a panel of independent experts, including clinicians and other scientific experts, which reviews, evaluates and provides a recommendation as to whether the application should be approved and under what
conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before approving an NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application
unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and are adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA, the
FDA may inspect one or more clinical trial sites to assure compliance with GCP and other requirements and the integrity of the clinical data submitted to the FDA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After evaluating the NDA and all related information, including the advisory committee recommendation, if any, and inspection reports regarding the
manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a complete response letter. A complete response letter generally contains a statement of specific conditions that must be met in order to
secure final approval of the NDA and may require additional clinical or preclinical testing in order for the FDA to reconsider the application. Even with submission of this additional information, the FDA ultimately may decide that the application
does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#146;s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with
specific prescribing information for specific indications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if the FDA approves a product, depending on the specific risk(s) to be addressed it may
limit the approved indications for use of the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase 4 clinical trials, be conducted to further assess
a drug&#146;s safety after approval, require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a REMS,
which can materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of
changes to the approved product, such as adding new indications, manufacturing changes, and additional labeling claims, are subject to further testing requirements and FDA review and approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Orphan Drug Designation and Exclusivity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug intended to treat a rare disease or condition, which is a disease or condition that
affects fewer than 200,000 individuals in the United States, or if it affects more than 200,000 individuals in the United States, there is no reasonable expectation that the cost of developing and making the product available in the United States
for the disease or condition will be recovered from sales of the product. Orphan designation must be requested before submitting an NDA. Orphan designation does not convey any advantage in or shorten the duration of the regulatory review and
approval process, though companies developing orphan products are eligible for certain incentives, including tax credits for qualified clinical testing and waiver of application fees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a product that has orphan designation subsequently receives the first FDA approval for the disease or condition for which it has such designation, the
product is entitled to a seven-year period of marketing exclusivity during which the FDA may not approve any other applications to market the same therapeutic agent for the same indication, except in limited circumstances, such as a subsequent
product&#146;s showing of clinical superiority over the product with orphan exclusivity or where the original applicant cannot produce sufficient quantities of product. Competitors, however, may receive approval of different therapeutic agents for
the indication for which the orphan product has exclusivity or obtain approval for the same therapeutic agent for a different indication than that for which the orphan product has exclusivity. Orphan product exclusivity could block the approval of
one of our products for seven years if a competitor obtains approval for the same therapeutic agent for the same indication before we do, unless we are able to demonstrate that our product is clinically superior. If an orphan designated product
receives marketing approval for an indication broader than what is designated, it may not be entitled to orphan exclusivity. Further, orphan drug exclusive marketing rights in the United States may be lost if the FDA later determines that the
request for designation was materially defective or the manufacturer of the approved product is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Expedited Development and Review Programs for Drugs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA maintains several programs intended to facilitate and expedite development and review of new drugs to address unmet medical needs in the treatment of
serious or life-threatening diseases or conditions. These programs include Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval, and the purpose of these programs is to either expedite the development or
review of important new drugs to get them to patients more quickly than standard FDA review timelines typically permit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A new drug is eligible for Fast
Track designation if it is intended to treat a serious or life-threatening disease or condition and demonstrates the potential to address unmet medical needs for such disease or condition. Fast Track designation provides increased opportunities for
sponsor interactions with the FDA during preclinical and clinical development, in addition to the potential for rolling review once a marketing application is filed. Rolling review means that the agency may review portions of the marketing
application before the sponsor submits the complete application. In addition, a new drug may be eligible for Breakthrough Therapy designation if it is intended to treat a serious or life-threatening disease or condition and preliminary clinical
evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Breakthrough Therapy
designation provides all the features of Fast Track designation in addition to intensive guidance on an efficient drug development program beginning as early as Phase 1, and FDA organizational commitment to expedited development, including
involvement of senior managers and experienced review staff in a cross-disciplinary review, where appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any product submitted to the FDA for
approval, including a product with Fast Track or Breakthrough Therapy designation, may also be eligible for additional FDA programs intended to expedite the review and approval process, including Priority Review designation and Accelerated Approval.
A product is eligible for Priority </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Review, once an NDA or BLA is submitted, if the drug that is the subject of the marketing application has the potential to provide a significant improvement in safety or effectiveness in the
treatment, diagnosis or prevention of a serious disease or condition. Under priority review, the FDA&#146;s goal date to take action on the marketing application is six months compared to ten months for a standard review. Products are eligible for
Accelerated Approval if they can be shown to have an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or an effect on a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or
mortality, which is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative
treatments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accelerated Approval is usually contingent on a sponsor&#146;s agreement to conduct additional post-approval studies to verify and describe
the product&#146;s clinical benefit. The FDA may withdraw approval of a drug or an indication approved under Accelerated Approval if, for example, the confirmatory trial fails to verify the predicted clinical benefit of the product. In addition, the
FDA generally requires, as a condition for Accelerated Approval, that all advertising and promotional materials intended for dissemination or publication within 120 days of marketing approval be submitted to the agency for review during the <FONT
STYLE="white-space:nowrap">pre-approval</FONT> review period. After the <FONT STYLE="white-space:nowrap">120-day</FONT> period has passed, all advertising and promotional materials must be submitted at least 30 days prior to the intended time of
initial dissemination or publication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer
meets the conditions for qualification or the time period for FDA review or approval may not be shortened. Furthermore, Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval do not change the scientific
or medical standards for approval or the quality of evidence necessary to support approval, though they may expedite the development or review process. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Pediatric Information and Pediatric Exclusivity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Pediatric Research Equity Act, or PREA, requires a sponsor to conduct pediatric clinical trials for most drugs, for a new active ingredient, new
indication, new dosage form, new dosing regimen or new route of administration. Under PREA, as amended, certain NDAs and NDA supplements must contain data that can be used to assess the safety and efficacy of the drug for the claimed indications in
all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may grant deferrals for submission of pediatric data or full or partial waivers. The
FD&amp;C Act requires that a sponsor who is planning to submit a marketing application for a drug that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration submit an initial Pediatric
Study Plan, or PSP, within 60 days of an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-of-Phase</FONT></FONT> 2 meeting or, if there is no such meeting, as early as practicable before the initiation of the Phase 3 or Phase
2/3 study. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not
including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach
an agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials and/or other
clinical development programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A drug can also obtain pediatric market exclusivity in the United States. Pediatric exclusivity, if granted, adds six
months to existing exclusivity periods and patent terms. This <FONT STYLE="white-space:nowrap">six-month</FONT> exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of
a pediatric study in accordance with an <FONT STYLE="white-space:nowrap">FDA-issued</FONT> &#147;Written Request&#148; for such a study. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>United States. Post-Approval Requirements for Drugs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Drugs manufactured or distributed pursuant to FDA approvals are subject to continuing regulation by the FDA, including, among other things, requirements
relating to recordkeeping, periodic reporting, product sampling and distribution, reporting of adverse experiences with the product, complying with promotion and advertising requirements, which include restrictions on promoting products for
unapproved uses or patient populations (known as <FONT STYLE="white-space:nowrap">&#147;off-label</FONT> use&#148;) and limitations on industry-sponsored scientific and educational activities. Although physicians may prescribe legally available
products for <FONT STYLE="white-space:nowrap">off-label</FONT> uses, manufacturers may not market or promote such uses. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of
<FONT STYLE="white-space:nowrap">off-label</FONT> uses, and a company that is found to have improperly promoted <FONT STYLE="white-space:nowrap">off-label</FONT> uses may be subject to significant liability, including investigation by federal and
state authorities. Prescription drug promotional materials must be submitted to the FDA in conjunction with their first use or first publication. Further, if there are any modifications to the drug, including changes in indications, labeling or
manufacturing processes or facilities, the applicant may be required to submit and obtain FDA approval of a new NDA or NDA supplement, which may require the generation of additional data or the conduct of additional preclinical studies and clinical
trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-market
testing, including Phase 4 clinical trials, and surveillance to further assess and monitor the product&#146;s safety and effectiveness after commercialization. In addition, drug manufacturers and their subcontractors involved in the manufacture and
distribution of approved drugs are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with ongoing regulatory
requirements, including cGMPs, which impose certain procedural and documentation requirements. Failure to comply with statutory and regulatory requirements may subject a manufacturer to legal or regulatory action, such as warning letters, suspension
of manufacturing, product seizures, injunctions, civil penalties or criminal prosecution. There is also a continuing, annual prescription drug product program user fee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing
processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, requirements for post-market studies or clinical trials to assess new safety risks, or imposition of
distribution or other restrictions under a REMS. Other potential consequences include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market
or product recalls; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance of safety alerts, Dear Healthcare Provider letters, press releases or other communications
containing warnings or other safety information about the product; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, warning letters or holds on post-approval clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal of the FDA to approve applications or supplements to approved applications, or suspension or revocation
of product approvals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product seizure or detention, or refusal to permit the import or export of products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injunctions or the imposition of civil or criminal penalties; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs; or
mandated modification of promotional materials and labeling and issuance of corrective information. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Companion diagnostics are designed
to identify patients who are most likely to benefit from a particular therapeutic product; identify patients likely to be at increased risk for serious side effects as a result of treatment with a particular therapeutic product; or monitor response
to treatment with a particular therapeutic product for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the purpose of adjusting treatment to achieve improved safety or effectiveness. Companion diagnostics are regulated as medical devices by the FDA. In the United States, the FD&amp;C Act, and its
implementing regulations, and other federal and state statutes and regulations govern, among other things, medical device design and development, preclinical and clinical testing, premarket clearance or approval, registration and listing,
manufacturing, labeling, storage, advertising and promotion, sales and distribution, export and import, and post-market surveillance. Unless an exemption or FDA exercise of enforcement discretion applies, diagnostic tests generally require marketing
clearance or approval from the FDA prior to commercialization. The two primary types of FDA marketing authorization applicable to a medical device are clearance of a premarket notification, or 510(k), and approval of a premarket approval
application, or PMA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To obtain 510(k) clearance for a medical device, or for certain modifications to devices that have received 510(k) clearance, a
manufacturer must submit a premarket notification demonstrating that the proposed device is substantially equivalent to a previously cleared 510(k) device or to a <FONT STYLE="white-space:nowrap">pre-amendment</FONT> device that was in commercial
distribution before May&nbsp;28, 1976, or a predicate device, for which the FDA has not yet called for the submission of a PMA. In making a determination that the device is substantially equivalent to a predicate device, the FDA compares the
proposed device to the predicate device and assesses whether the subject device is comparable to the predicate device with respect to intended use, technology, design and other features which could affect safety and effectiveness. If the FDA
determines that the subject device is substantially equivalent to the predicate device, the subject device may be cleared for marketing. The 510(k) premarket notification pathway generally takes from three to twelve months from the date the
application is completed, but can take significantly longer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A PMA must be supported by valid scientific evidence, which typically requires extensive
data, including technical, preclinical, clinical and manufacturing data, to demonstrate to the FDA&#146;s satisfaction the safety and effectiveness of the device. The process for developing a PMA, including the gathering of clinical and preclinical
data and submission to FDA can take several years or longer. For diagnostic tests, a PMA typically includes data regarding analytical and clinical validation studies. As part of its review of the PMA, the FDA will conduct a <FONT
STYLE="white-space:nowrap">pre-approval</FONT> inspection of the manufacturing facility or facilities to ensure compliance with the quality system regulation, or QSR, which requires manufacturers to follow design, testing, control, documentation and
other quality assurance procedures. The FDA&#146;s review of an initial PMA is required by statute to take between six to ten months, although the process typically takes longer, and may require several years to complete, and PMA approval is not
guaranteed. If the FDA evaluations of both the PMA and the manufacturing facilities are favorable, the FDA will either issue an approval letter or an approvable letter, which usually contains a number of conditions that must be met in order to
secure the final approval of the PMA. If the FDA&#146;s evaluation of the PMA or manufacturing facilities is not favorable, the FDA will deny the approval of the PMA or issue a not approvable letter. A not approvable letter will outline the
deficiencies in the application and, where practical, will identify what is necessary to make the PMA approvable. Once granted, PMA approval may be withdrawn by the FDA if compliance with post-approval requirements, conditions of approval or other
regulatory standards is not maintained or problems are identified following initial marketing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;31, 2014, the FDA issued a final guidance
document addressing the development and approval process for &#147;<I>In Vitro</I> Companion Diagnostic Devices.&#148; According to the guidance document, for novel therapeutic products that depend on the use of a diagnostic test and where the
diagnostic device could be essential for the safe and effective use of the corresponding therapeutic product, the companion diagnostic device should be developed and approved or cleared contemporaneously with the therapeutic, although the FDA
recognizes that there may be cases when contemporaneous development may not be possible. However, in cases where a drug cannot be used safely or effectively without the companion diagnostic, the FDA&#146;s guidance indicates it will generally not
approve the drug without the approval or clearance of the diagnostic device. The FDA also issued a draft guidance in July 2016 setting forth the principles for <FONT STYLE="white-space:nowrap">co-development</FONT> of an <I>in vitro</I> companion
diagnostic device with a therapeutic product. The draft guidance describes principles to guide the development and contemporaneous marketing authorization for the therapeutic product and its corresponding <I>in vitro</I> companion diagnostic. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once cleared or approved, the companion diagnostic device must adhere to post-marketing requirements
including the requirements of the FDA&#146;s QSR, which cover the methods and documentation of the design, testing, production, processes, controls, quality assurance, labeling, packaging, and shipping of all medical devices, as well as adverse
event reporting, recalls and corrections along with product marketing requirements and limitations. Medical devices, including companion diagnostics, may be marketed only for the uses and indications for which they are cleared or approved. Device
manufacturers must also establish registration and device listings with the FDA. Like drug makers, companion diagnostic makers are subject to unannounced FDA inspections at any time during which the FDA will conduct an audit of the product(s) and
the company&#146;s facilities, facility records, and manufacturing processes for compliance with its authorities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Marketing Exclusivity
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Market exclusivity provisions authorized under the FD&amp;C Act can delay the submission or the approval of certain marketing applications. The
FD&amp;C Act provides a five-year period of <FONT STYLE="white-space:nowrap">non-patent</FONT> marketing exclusivity within the United States to the first applicant to obtain approval of an NDA for a new chemical entity. A drug is a new chemical
entity if the FDA has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not approve or even accept
for review an abbreviated new drug application, or ANDA, or an NDA submitted under Section&nbsp;505(b)(2), or 505(b)(2) NDA, submitted by another company for another drug based on the same active moiety, regardless of whether the drug is intended
for the same indication as the original innovative drug or for another indication, where the applicant does not own or have a legal right of reference to all the data required for approval. However, an application may be submitted after four years
if it contains a certification of patent invalidity or <FONT STYLE="white-space:nowrap">non-infringement</FONT> to one of the patents listed with the FDA by the innovator NDA holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FD&amp;C Act alternatively provides three years of marketing exclusivity for an NDA, or supplement to an existing NDA if new clinical investigations,
other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example new indications, dosages or strengths of an existing drug. This three-year
exclusivity covers only the modification for which the drug received approval on the basis of the new clinical investigations and does not prohibit the FDA from approving ANDAs or 505(b)(2) NDAs for drugs containing the active agent for the original
indication or condition of use. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to any preclinical
studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pediatric exclusivity is another type of
marketing exclusivity available in the United States. Pediatric exclusivity provides for an additional six months of marketing exclusivity attached to another period of exclusivity if a sponsor conducts clinical trials in children in response to a
written request from the FDA. The issuance of a written request does not require the sponsor to undertake the described clinical trials. In addition, orphan drug exclusivity, as described above, may offer a seven-year period of marketing
exclusivity, except in certain circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Regulatory Matters </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Manufacturing, sales, promotion and other activities of product candidates following product approval, where applicable, or commercialization are also subject
to regulation by numerous regulatory authorities in the United States in addition to the FDA, which may include the Centers for Medicare&nbsp;&amp; Medicaid Services, or CMS, other divisions of the U.S. Department of Health and Human Services, the
Department of Justice, the Drug Enforcement Administration, the Consumer Product Safety Commission, the Federal Trade Commission, the Occupational Safety&nbsp;&amp; Health Administration, the Environmental Protection Agency and state and local
governments and governmental agencies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Healthcare Laws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Healthcare providers, physicians, and third-party payors will play a primary role in the recommendation and prescription of any products for which we obtain
marketing approval. Our business operations and any current or future arrangements with third-party payors, healthcare providers and physicians may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may
constrain the business or financial arrangements and relationships through which we develop, market, sell and distribute any drugs for which we obtain marketing approval. In the United States, these laws include, without limitation, state and
federal anti-kickback, false claims, physician transparency, and patient data privacy and security laws and regulations, including but not limited to those described below. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The federal Anti-Kickback Statute prohibits, among other things, persons and entities from knowingly and
willfully soliciting, offering, paying, receiving or providing any remuneration (including any kickback, bribe, or certain rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the
referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare and Medicaid; a person or entity need not have
actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it in order to have committed a violation. Violations are subject to civil and criminal fines and penalties for each violation, plus up to three times the
remuneration involved, imprisonment, and exclusion from government healthcare programs. In addition, the government may assert that a claim that includes items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a
false or fraudulent claim for purposes of the civil False Claims Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The federal civil and criminal false claims laws, including the civil False Claims Act, or FCA, prohibit
individuals or entities from, among other things, knowingly presenting, or causing to be presented, to the federal government, claims for payment or approval that are false, fictitious or fraudulent; knowingly making, using, or causing to be made or
used, a false statement or record material to a false or fraudulent claim or obligation to pay or transmit money or property to the federal government; or knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay
money to the federal government. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#147;cause&#148; the submission of false or fraudulent claims. The FCA also
permits a private individual acting as a &#147;whistleblower&#148; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery. When an entity is determined to have violated the federal
civil False Claims Act, the government may impose civil fines and penalties for each false claim, plus treble damages, and exclude the entity from participation in Medicare, Medicaid and other federal healthcare programs. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The federal civil monetary penalties laws impose civil fines for, among other things, the offering or transfer or
remuneration to a Medicare or state healthcare program beneficiary, if the person knows or should know it is likely to influence the beneficiary&#146;s selection of a particular provider, practitioner, or supplier of services reimbursable by
Medicare or a state health care program, unless an exception applies. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Health Insurance Portability and Accountability Act of 1996, or HIPAA, imposes criminal and civil liability
for knowingly and willfully executing a scheme, or attempting to execute a scheme, to defraud any healthcare benefit program, including private payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully
obstructing a criminal investigation of a healthcare offense, or falsifying, concealing or covering up a material fact or making any materially false statements in connection with the delivery of or payment for healthcare benefits, items or
services. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH,
and their respective implementing regulations, impose, among other things, specified requirements on covered entities and their business associates relating to the privacy and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
security of individually identifiable health information including mandatory contractual terms and required implementation of technical safeguards of such information. HITECH also created new
tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates in some cases, and gave state attorneys general new authority to file civil actions for damages or injunctions in
federal courts to enforce the federal HIPAA laws and seek attorneys&#146; fees and costs associated with pursuing federal civil actions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Physician Payments Sunshine Act, which imposes annual reporting requirements for certain manufacturers of
drugs, devices, biologics, and medical supplies for which payment is available under Medicare, Medicaid, or the Children&#146;s Health Insurance Program, for certain payments and &#147;transfers of value&#148; provided to physicians (currently
defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Effective January&nbsp;1, 2022, these
reporting obligations will extend to include transfers of value made in the previous year to certain <FONT STYLE="white-space:nowrap">non-physician</FONT> providers such as physician assistants and nurse practitioners. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Federal consumer protection and unfair competition laws broadly regulate marketplace activities and activities
that potentially harm consumers. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Analogous state and foreign laws and regulations may be broader in scope than the provisions described above and
may apply regardless of payor. Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#146;s voluntary compliance guidelines and relevant federal government compliance guidance; require drug manufacturers to
report information related to payments and other transfers of value to physicians and other healthcare providers; restrict marketing practices or require disclosure of marketing expenditures and pricing information. State and foreign laws may govern
the privacy and security of health information in some circumstances. These data privacy and security laws may differ from each other in significant ways and often are not <FONT STYLE="white-space:nowrap">pre-empted</FONT> by HIPAA, which may
complicate compliance efforts. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current
environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of interactions between healthcare companies and healthcare
providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. It is possible that governmental authorities will conclude that our business practices do not comply with current or future
statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other related governmental regulations that may apply to us,
we may be subject to significant civil, criminal and administrative penalties, damages, fines, imprisonment, disgorgement, exclusion from government funded healthcare programs, such as Medicare and Medicaid, reputational harm, additional oversight
and reporting obligations if we become subject to a corporate integrity agreement or similar settlement to resolve allegations of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these laws and the curtailment or restructuring of our
operations. If any of the physicians or other healthcare providers or entities with whom we expect to do business is found not to be in compliance with applicable laws, they may be subject to similar actions, penalties and sanctions. Ensuring
business arrangements comply with applicable healthcare laws, as well as responding to possible investigations by government authorities, can be time- and resource-consuming and can divert a company&#146;s attention from its business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Coverage and Reimbursement by Third-Party Payors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States and markets in other countries, patients who are prescribed treatments for their conditions and providers performing the prescribed
services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Thus, even if a product candidate is approved, sales of the product will depend, in part, on the extent to which third-party payors, including
government health programs in the United States such as Medicare and Medicaid, commercial health insurers and managed care organizations, provide coverage, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
establish adequate reimbursement levels for, the product. In the United States, the Medicare and Medicaid programs are increasingly used as models for how private and other governmental payors
develop their coverage and reimbursement policies for drugs. No uniform policy of coverage and reimbursement for drug products exists, however, among third-party payors. Therefore, coverage and reimbursement for drug products can differ
significantly from payor to payor. The process for determining whether a third-party payor will provide coverage for a product may be separate from the process for setting the price or reimbursement rate that the payor will pay for the product once
coverage is approved. Third-party payors are increasingly challenging the prices charged, examining the medical necessity, reviewing the cost-effectiveness of medical products and services and imposing controls to manage costs. Third-party payors
may limit coverage to specific products on an approved list, also known as a formulary, which might not include all of the approved products for a particular indication. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to secure coverage and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic
studies in order to demonstrate the medical necessity and cost-effectiveness of the product, which will require additional expenditure above and beyond the costs required to obtain FDA or other comparable regulatory approvals. Additionally,
companies may also need to provide discounts to purchasers, private health plans or government healthcare programs. Nonetheless, product candidates may not be considered medically necessary or cost effective. A decision by a third-party payor not to
cover a product could reduce physician utilization once the product is approved and have a material adverse effect on sales, our operations and financial condition. Additionally, a third-party payor&#146;s decision to provide coverage for a product
does not imply that an adequate reimbursement rate will be approved. Further, one payor&#146;s determination to provide coverage for a product does not assure that other payors will also provide coverage and reimbursement for the product, and the
level of coverage and reimbursement can differ significantly from payor to payor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The containment of healthcare costs has become a priority of federal,
state and foreign governments, and the prices of products have been a focus in this effort. Governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement and
requirements for substitution of generic products. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company&#146;s revenue
generated from the sale of any approved products. Coverage policies and third-party payor reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which a company or its
collaborators receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Current and
Future Healthcare Reform Legislation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States and some foreign jurisdictions, there have been, and likely will continue to be, a
number of legislative and regulatory changes and proposed changes regarding the healthcare system directed at broadening the availability of healthcare, improving the quality of healthcare, and containing or lowering the cost of healthcare. For
example, in March 2010, the United States Congress enacted the Affordable Care Act, which, among other things, includes changes to the coverage and payment for products under government health care programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since its enactment, there have been numerous judicial, administrative, executive, and legislative challenges to certain aspects of the Affordable Care Act,
and we expect there will be additional challenges and amendments to the Affordable Care Act in the future. For example, various portions of the Affordable Care Act are currently facing legal and constitutional challenges in the Fifth Circuit Court
of Appeals and the United States Supreme Court. Additionally, the current administration has issued various Executive Orders which eliminated cost sharing subsidies and various provisions that would impose a fiscal burden on states or a cost, fee,
tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices, and Congress has introduced several pieces of legislation aimed at significantly revising or repealing
the Affordable Care Act. It is unclear whether the Affordable Care Act will be overturned, repealed, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
replaced, or further amended. We cannot predict what effect further changes to the Affordable Care Act would have on our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other legislative changes have been proposed and adopted in the United States since the Affordable Care Act was enacted. In August 2011, the Budget Control
Act of 2011, among other things, included aggregate reductions of Medicare payments to providers of 2% per fiscal year, which went into effect in April 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through
2030, with a temporary suspension from May&nbsp;1, 2020 through December&nbsp;31, 2020, unless additional Congressional action is taken. In addition, in January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other
things, further reduced Medicare payments to several providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to
five years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, CMS may develop
new payment and delivery models, including bundled payment models. In addition, recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their commercial products, which has resulted in several
Congressional inquiries and proposed and enacted state and federal legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform
government program reimbursement methodologies for pharmaceutical products. Although a number of these measures may require additional authorization to become effective, Congress and the current administration have each indicated that it will
continue to seek new legislative and/or administrative measures to control drug costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;24, 2020, President Trump announced a number of
executive orders related to prescription drug pricing that attempt to implement several of the Administration&#146;s proposals, including a policy that would tie Medicare Part B drug prices to international drug prices; one that directs HHS to
finalize the Canadian drug importation proposed rule previously issued by HHS and makes other changes allowing for personal importation of drugs from Canada; and one that directs HHS to finalize the rulemaking process on modifying the anti-kickback
law safe harbors for plans, pharmacies, and pharmaceutical benefit managers after HHS confirms that the action is not projected to increase federal spending, Medicare beneficiary premiums, or patients&#146; total <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs. The probability of success of these newly announced policies and their impact on the U.S. prescription drug marketplace is unknown. There are likely to be political and legal challenges
associated with implementing these reforms as they are currently envisioned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Individual states in the United States have also increasingly passed
legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency
measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Outside the United States, ensuring coverage
and adequate payment for a product also involves challenges. Pricing of prescription pharmaceuticals is subject to government control in many countries. Pricing negotiations with government authorities can extend well beyond the receipt of
regulatory approval for a product and may require a clinical trial that compares the cost-effectiveness of a product to other available therapies. The conduct of such a clinical trial could be expensive and result in delays in commercialization.
There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any products, if approved in those countries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other U.S. Environmental, Health and Safety Laws and Regulations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may be subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use,
storage, treatment and disposal of hazardous materials and wastes. From time to time and in the future, our operations may involve the use of hazardous and flammable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
materials, including chemicals and biological materials, and may also produce hazardous waste products. Even if we contract with third parties for the disposal of these materials and waste
products, we cannot completely eliminate the risk of contamination or injury resulting from these materials. In the event of contamination or injury resulting from the use or disposal of our hazardous materials, we could be held liable for any
resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain workers&#146; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees, but this insurance may not
provide adequate coverage against potential liabilities. However, we do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. Current or future
environmental laws and regulations may impair our research, development or production efforts. In addition, failure to comply with these laws and regulations may result in substantial fines, penalties or other sanctions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Government Regulation of Drugs Outside of the United States </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To market any product outside of the United States, we would need to comply with numerous and varying regulatory requirements of other countries and
jurisdictions regarding quality, safety and efficacy and governing, among other things, clinical trials, marketing authorization, commercial sales and distribution of drug products. Whether or not we obtain FDA approval for a product, we would need
to obtain the necessary approvals by the comparable foreign regulatory authorities before we can commence clinical trials or marketing of the product in those countries or jurisdictions. The approval process ultimately varies between countries and
jurisdictions and can involve additional product testing and additional administrative review periods. The time required to obtain approval in other countries and jurisdictions might differ from and be longer than that required to obtain FDA
approval. Regulatory approval in one country or jurisdiction does not ensure regulatory approval in another, but a failure or delay in obtaining regulatory approval in one country or jurisdiction may negatively impact the regulatory process in
others. As in the United States, post-approval regulatory requirements, such as those regarding product manufacture, marketing, or distribution would apply to any product that is approved outside the United States. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employees </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, we had 95
full-time employees. 53 of our employees have M.D. or Ph.D. degrees. Within our workforce, 79 employees are engaged in research and development and 16 are engaged in business development, finance, legal, and general management and administration.
None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Corporate Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were formed as a Delaware
corporation in October 2015 under the name Foghorn Therapeutics Inc. Our principal executive office is located at 500&nbsp;Technology Square, Suite&nbsp;700, Cambridge, Massachusetts, 02139, and our phone number is <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">617-586-3100.</FONT></FONT> Our website address is https://foghorntx.com. Our website and the information contained on, or that can be accessed through, the website will not be deemed to be incorporated by reference in,
and are not considered part of, this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company&#148; as
defined in the Jumpstart Our Business Startups Act of 2012. We will remain an emerging growth company until the earlier of: (i)&nbsp;the last day of the fiscal year (a)&nbsp;following the fifth anniversary of the completion of the IPO, (b)&nbsp;in
which we have total annual gross revenue of at least $1.07&nbsp;billion, or (c)&nbsp;in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by
<FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700.0&nbsp;million as of the prior June&nbsp;30th, and (ii)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT>
debt during the prior three-year period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are also a &#147;smaller reporting company&#148; as defined in the Securities and Exchange Act of 1934,
as amended, or the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies until the
fiscal year following the determination that our voting and <FONT STYLE="white-space:nowrap">non-voting</FONT> common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is more than $250&nbsp;million measured on the last business
day of our second fiscal quarter, or our annual revenues are more than $100&nbsp;million during the most recently completed fiscal year and our voting and <FONT STYLE="white-space:nowrap">non-voting</FONT> common stock held by <FONT
STYLE="white-space:nowrap">non-affiliates</FONT> is more than $700&nbsp;million measured on the last business day of our second fiscal quarter. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Available Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Internet address is
https://foghorntx.com. Our Annual Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT> Quarterly Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q,</FONT> Current Reports on
<FONT STYLE="white-space:nowrap">Form&nbsp;8-K,</FONT> including exhibits, proxy and information statements and amendments to those reports filed or furnished pursuant to Sections&nbsp;13(a) and 15(d) of the Exchange Act are available through the
&#147;Investors&#148; portion of our website free of charge as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Information on our website is not part of this Annual Report on <FONT
STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> or any of our other securities filings unless specifically incorporated herein by reference. In addition, our filings with the SEC may be accessed through the SEC&#146;s Electronic Data Gathering,
Analysis and Retrieval system at <I>http://www.sec.gov</I>. All statements made in any of our securities filings, including all forward-looking statements or information, are made as of the date of the document in which the statement is included,
and we do not assume or undertake any obligation to update any of those statements or documents unless we are required to do so by law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_3"></A>ITEM&nbsp;1A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RISK FACTORS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below together with all of
the other information contained in this Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT> including our consolidated financial statements and related notes, before deciding to invest in our common stock. Some of the following
risks and uncertainties are, and will be, exacerbated by the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic (including any resurgences thereof) and any worsening of the global business and economic environment as a result. If any of the
events or developments described below were to occur, our business, prospects, operating results and financial condition could suffer materially, the trading price of our common stock could decline and you could lose all or part of your investment.
The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Financial Position and Need for Additional Capital </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have a limited operating history and have no products approved for commercial sale, which may make it difficult for you to evaluate our current
business and predict our future success and viability. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a clinical-stage biopharmaceutical company with a limited operating history. We were
incorporated in October 2015, and our operations to date have been focused on building our proprietary Gene Traffic Control platform, organizing and staffing our company, business planning, raising capital, conducting discovery and research
activities, protecting our trade secrets, filing patent applications, identifying potential product candidates, undertaking preclinical studies and establishing arrangements with third parties for the manufacture of initial quantities of our product
candidates and component materials. We are currently initiating Phase 1 clinical trials for <FONT STYLE="white-space:nowrap">FHD-286,</FONT> and all of our other product candidates are in preclinical development. We have not yet demonstrated an
ability to successfully conduct or complete any clinical trials, obtain marketing approvals, manufacture a commercial-scale product or arrange for a third party to do so on our behalf, or conduct sales, marketing and distribution activities
necessary for successful product commercialization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, as a young business, we may encounter unforeseen expenses, difficulties, complications,
delays and other known and unknown factors. We will need to transition at some point from a company with a research and development focus to a company capable of supporting commercial activities. We may not be successful in such a transition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect our financial condition and results of operations to continue to fluctuate significantly from quarter to quarter and year to year due to a variety
of factors, many of which are beyond our control. Accordingly, you should not rely upon the results of any quarterly or annual periods as indications of future operating performance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have incurred significant losses since inception. We expect to incur losses for the foreseeable future and may never achieve or maintain
profitability. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since inception, we have incurred significant operating losses. As of December&nbsp;31, 2020, we had an accumulated deficit of
$162.9&nbsp;million. We have financed our operations primarily through private placements of our preferred stock and our initial public offering, as well as through a loan with Oxford Finance LLC, or Oxford Finance, and our collaboration agreement
with Merck Sharp&nbsp;&amp; Dohme Corp., or Merck. See &#147;Business&#151;License Agreement with Merck.&#148; We have devoted all of our efforts to research and development. We expect to continue to incur significant expenses and increasing
operating losses for the foreseeable future. The net losses we incur may fluctuate significantly from quarter to quarter. We anticipate that our expenses will increase substantially if and as we: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance our <FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT STYLE="white-space:nowrap">FHD-609</FONT>
product candidates and continue our preclinical development of product candidates from our current research programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identify additional research programs and additional product candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">initiate preclinical testing for any new product candidates we identify and develop; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain, maintain, expand, enforce, defend and protect our trade secrets and intellectual property portfolio and
provide reimbursement of third-party expenses related to our patent portfolio; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hire additional research and development personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add operational, legal, compliance, financial and management information systems and personnel to support our
research, product development and operations as a public company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expand the capabilities of our platform; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> product candidates, intellectual property and
technologies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">operate as a public company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seek marketing approvals for any of our product candidates that successfully complete clinical trials; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ultimately establish a sales, marketing, and distribution infrastructure to commercialize any products for which
we may obtain marketing approval. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have one product candidate in Phase 1 clinical development and have not initiated clinical
development of any other product candidate and expect that it will be many years, if ever, before we have a product candidate ready for commercialization. To become and remain profitable, we must develop and, either directly or through
collaborators, eventually commercialize a medicine or medicines with significant market potential. This will require us to be successful in a range of challenging activities, including identifying product candidates, completing preclinical testing
and clinical trials of product candidates, obtaining marketing approval for these product candidates, manufacturing, marketing, and selling those medicines for which we may obtain marketing approval, and satisfying any post-marketing requirements.
We may never succeed in these activities and, even if we do, may never generate revenues that are significant or large enough to achieve profitability. We are unable to predict the extent of any future losses or when we will become profitable, if at
all. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will need
substantial additional funding. If we are unable to raise capital when needed, we would be forced to delay, reduce, or eliminate our research and product development programs or future commercialization efforts. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect our expenses to increase in connection with our ongoing activities, particularly as we identify, continue the research and development of, initiate
clinical trials of, and seek marketing approval for, our product candidates. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on
attractive terms, we would be forced to delay, reduce, or eliminate our research and product development programs or future commercialization efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As
of December&nbsp;31, 2020, our cash, cash equivalents and marketable securities were $185.8&nbsp;million. The net proceeds of our initial public offering were $107.9&nbsp;million, after deducting underwriting discounts and commissions and other
offering expenses. On November&nbsp;19, 2020, we received additional net proceeds of $14.2&nbsp;million in connection with the underwriters&#146; partial exercise of their option to purchase additional shares of common stock in our initial public
offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional fundraising efforts, when needed, may divert our management&#146;s attention from their <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities, which may adversely affect our ability to advance our product candidates or develop new product candidates. We cannot be certain that additional funding will be available on acceptable
terms, or at all. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue the development or commercialization of our product candidates or other
research and development initiatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we are unable to obtain funding on a reasonable and timely basis, we may be required to significantly
curtail, delay or discontinue one or more of our research or development programs, clinical research, or the commercialization of any product candidate. We may be unable to expand our operations or otherwise capitalize on our business opportunities,
as desired, which could materially affect our business, financial condition and results of operations. Any of the above events could significantly harm our business, prospects, financial condition and results of operations and cause the price of our
common stock to decline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have never generated revenue from product sales and may never be profitable. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are currently in the Phase 1 clinical development stage for our most advanced product candidate, <FONT STYLE="white-space:nowrap">FHD-286,</FONT> and in the
preclinical development stage for our other lead research programs. In addition, we expect to submit an IND to the FDA for <FONT STYLE="white-space:nowrap">FHD-609</FONT> in the second quarter of 2021. We expect that it will be many years, if ever,
before we have a product candidate ready for commercialization. To become and remain profitable, we must succeed in developing, obtaining marketing approval for and commercializing products that generate significant revenue. This will require us to
be successful in a range of challenging activities, including completing preclinical testing and clinical trials of our current or future product candidates, establishing and maintaining arrangements with third parties for the manufacture of
clinical supplies of our product candidates, obtaining marketing approval for our product candidates and manufacturing, marketing, selling and obtaining reimbursement for any products for which we may obtain marketing approval. We may never succeed
in these activities and, even if we do, may never generate revenues that are significant enough to achieve profitability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Loan Agreement with
Oxford Finance contains certain covenants that could adversely affect our operations and, if an event of default were to occur, we could be forced to repay the outstanding indebtedness sooner than planned and possibly at a time when we do not have
sufficient capital to meet this obligation. The occurrence of any of these events could cause a significant adverse impact on our business, prospects and share price. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to our secured loan agreement with Oxford Finance we have agreed to certain affirmative and negative covenants that, among other things, restrict our
ability to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">dispose of any property; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">consolidate or merge; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur additional indebtedness; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">encumber any of our property; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make distributions, including dividends; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make certain investments or acquisitions; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">repay any subordinated debt. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These covenants could prevent us from taking certain actions without the consent of our lender, which may limit our flexibility in operating our business and
our ability to take actions that might be advantageous to us. The Oxford Finance agreement also includes events of default, including, among other things, payment defaults; breaches of certain covenants or agreements; certain bankruptcy or
insolvency events; the occurrence of certain events that could reasonably be expected to have a &#147;material adverse effect;&#148; and defaults in respect of certain other indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an event of default were to occur and Oxford Finance declared all outstanding obligations immediately due and payable, we would be required to repay the
outstanding indebtedness. If we are unable to repay this debt, Oxford Finance would be able to take remedies permitted under the agreement. Even if we are able to repay the indebtedness on an event of default, the repayment of these sums may
significantly reduce our working capital and impair our ability to operate as planned. The occurrence of any of these events could cause a significant adverse impact on our business, prospects and share price. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>U.S. federal income tax reform could adversely affect our business and financial condition.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The rules dealing with U.S. federal, state, and local income taxation are constantly under review by persons involved in the legislative process
and by the Internal Revenue Service and the U.S. Treasury Department. Changes to&nbsp;tax&nbsp;laws (which changes may have retroactive application) could adversely affect us or holders of our common stock. In recent years, many such changes have
been made and changes are likely to continue to occur in the future. For example, on March&nbsp;27, 2020, President Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act, which included certain changes in&nbsp;tax&nbsp;law
intended to stimulate the U.S. economy in light of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> coronavirus outbreak, including temporary beneficial changes to the treatment of net operating losses, interest deductibility limitations and
payroll tax matters. Additionally, on December&nbsp;22, 2017, President Trump signed into law the Tax Cuts and&nbsp;Jobs Act, or the TCJA, which significantly reformed the Internal Revenue Code of 1986, as amended, or the Code. The TCJA included
significant changes to corporate and individual taxation, some of which could adversely impact an investment in our common stock. Future changes in tax laws could have a material adverse effect on our business, cash flow, financial condition or
results of operations. We urge investors to consult with their legal and tax advisers regarding the implications of potential changes in tax laws on an investment in our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our future ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have incurred substantial losses during our history and we may never achieve profitability. To the extent that we continue to generate taxable losses,
unused losses will carry forward to offset a portion of future taxable income, if any, subject to expiration in the case of carryforwards generated prior to January&nbsp;1, 2018. Additionally, we continue to generate business tax credits, including
research and development tax credits, which generally may be carried forward to offset a portion of future taxable income, if any, subject to expiration of such credit carryforwards. Under Sections 382 and 383 of the Code, if a corporation undergoes
an &#147;ownership change,&#148; generally defined as a greater than 50 percentage point change (by value) in its equity ownership over a three-year period, the corporation&#146;s ability to use its <FONT STYLE="white-space:nowrap">pre-change</FONT>
net operating loss carryforwards, or NOLs, and other <FONT STYLE="white-space:nowrap">pre-change</FONT> tax attributes (such as research and development tax credits) to offset its post-change income or taxes may be limited. Our prior equity
offerings and other changes in our stock ownership may have resulted in such ownership changes. We may also experience ownership changes in the future or subsequent shifts in our stock ownership, some of which are outside of our control. As a
result, if we earn net taxable income, our ability to use our <FONT STYLE="white-space:nowrap">pre-change</FONT> NOLs or other <FONT STYLE="white-space:nowrap">pre-change</FONT> tax attributes to offset U.S. federal taxable income may be subject to
limitations, which could potentially result in increased future tax liability to us. Additionally, for taxable years beginning after December&nbsp;31, 2021, the deductibility of such U.S. federal NOLs is limited to 80% of our taxable income in any
future taxable year. There is a risk that under existing tax laws, changes thereto, regulatory changes, or other unforeseen reasons, our existing NOLs or business tax credits could expire or otherwise be unavailable to offset future income tax
liabilities. At the state level, there may also be periods during which the use of NOLs or business tax credits is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. For these reasons, we may not be able
to realize a tax benefit from the use of our NOLs or tax credits, even if we attain profitability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Discovery and Development </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are heavily dependent on the success of our product candidates, which are in preclinical and Phase 1 clinical development. We may not be successful in
our efforts to identify and develop potential product candidates. If these efforts are unsuccessful, or if we experience significant delays, we may never become a commercial stage company or generate any revenues, and our business will be materially
harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The success of our business depends primarily upon our ability to identify, develop, and commercialize product candidates based on our
platform. All of our product development programs are still in the research or preclinical or Phase 1 clinical stage of development. Our research programs may fail to identify potential product candidates for clinical development for a number of
reasons. Our research methodology may be unsuccessful in identifying </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
potential product candidates, our potential product candidates may be shown to have harmful side effects in preclinical <I>in</I><I></I><I>&nbsp;vitro</I> experiments or animal model studies,
they may not show promising signals of therapeutic effect in such experiments or studies or they may have other characteristics that may make the product candidates impractical to administer or market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any of these events occur, we may be forced to abandon our research or development efforts for a program or programs, which would have a material adverse
effect on our business, financial condition, results of operations, and prospects. Research programs to identify new product candidates require substantial technical, financial, and human resources. We may focus our efforts and resources on
potential programs or product candidates that ultimately prove to be unsuccessful, which would be costly and time-consuming. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The success of our product
candidates will depend on several factors, including but not limited to the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">successful completion of preclinical studies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">successful submission of INDs and initiation of clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing an acceptable safety profile of the products and maintaining such a profile following approval;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">achieving desirable therapeutic properties for our product candidates&#146; intended indications;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">making arrangements with third-party manufacturers, or establishing manufacturing capabilities, both for clinical
and commercial supplies of our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">receipt and related terms of marketing approvals from applicable regulatory authorities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtaining and maintaining patent and trade secret protection and regulatory exclusivity of our product
candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing sales, marketing and distribution capabilities and launching commercial sales of our products; if
and when approved, whether alone or in collaboration with others; acceptance of our products, if and when approved, by patients, the medical community and third-party payors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtaining and maintaining third-party coverage and adequate reimbursement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">effectively competing with other therapies; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sufficiency of our financial and other resources. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we do not successfully achieve one or more of these factors in a timely manner, or at all, we could experience significant delays or an inability to
successfully commercialize our product candidates, which could materially harm our business. Moreover, if we do not receive regulatory approvals, we may not be able to continue our operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to file INDs or IND amendments to commence clinical trials of our product candidates on the timelines we expect, and even if we are
able to, the FDA may not permit us to proceed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to commence a clinical trial in the United States, we are required to seek FDA acceptance
of an IND for each of our product candidates. We cannot be sure any IND we submit to the FDA, or any similar clinical trial application we submit in other countries, will be accepted. We may also be required to conduct additional preclinical testing
prior to filing or acceptance of an IND for any of our product candidates, and the results of any such additional preclinical testing may not be positive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, we may experience manufacturing delays or other delays with <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies. Moreover, we cannot be sure
that even once clinical trials have begun, issues will not arise that suspend or terminate clinical trials. Additionally, even if the FDA agrees with the design and implementation of the clinical trials set forth in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an IND, we cannot guarantee that the FDA will not change its requirements in the future. These considerations also apply to new clinical trials we may submit as amendments to existing INDs or to
a new IND. Any failure to file INDs on the timelines we expect or to obtain regulatory authorizations for our trials to proceed may prevent us from completing our clinical trials or commercializing our product candidates on a timely basis, if at
all. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There is substantial competition in our field, which may result in others developing or commercializing products before we do. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The biotechnology and pharmaceutical industries utilize rapidly advancing technologies and are characterized by intense competition. While we believe that our
scientific knowledge and platform development expertise provide us with competitive advantages, we face potential competition from many different sources, including major pharmaceuticals, specialty pharmaceuticals and biotechnology companies,
academic institutions and government agencies, and public and private research institutes that conduct research, development, manufacturing and commercialization. Many of our competitors have significantly greater financial resources and expertise
in research and development, manufacturing, preclinical testing, enrolling and conducting clinical trials, and seeking regulatory approvals and product marketing than we do, and have potential to advance products competitive with our product
candidates or other programs addressing the chromatin regulatory system at a rapid pace. In addition, our competitors may compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites
and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Our competitors may advance competing product candidates that have a more attractive product profile than our
product candidates, make progress examining the chromatin regulatory system or bring a product to market before we can. Any of these developments could put us at a significant competitive disadvantage and have a material adverse effect on the
prospects of our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Product candidates that we and our collaborators successfully develop and commercialize will compete with existing therapies
and new therapies that may become available in the future. While we are not aware of other companies addressing the chromatin regulatory system at scale, in context and in an integrated way, we are aware of efforts to bring products to market that
could be competitive with ours if our programs are successful. Specifically, we expect that our product candidates will compete against approved drugs, including Idhifa<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> by Celgene
Corporation, Tibsovo<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> by Agios Pharmaceuticals, and Rydapt<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> by Novartis International AG . If our drug candidates are approved for the
indications for which we are currently planning clinical trials, they will likely compete with the competitor drugs mentioned above and with other drugs that are currently in development. Key product features that would affect our ability to
effectively compete with other therapeutics include the efficacy, safety and convenience of our products. Our competitors may obtain patent protection or other intellectual property rights that limit our ability to develop or commercialize our
product candidates. Our competitors may also obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able
to enter the market. For additional information regarding our competition, see &#147;Business&#151;Competition.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Product development is a
lengthy and expensive process with an uncertain outcome. We may incur unexpected costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of our product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have one product in Phase 1 clinical development and all of our other product candidates are in preclinical development and their risk of failure is high.
We are unable to predict when or if any of our product candidates will prove effective or safe in humans or will receive marketing approval. Before obtaining marketing approval from regulatory authorities for the sale of any product candidate, we
must conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidates in humans. Before we can commence clinical trials for a product candidate, we must complete extensive preclinical testing and studies that
support our planned INDs in the United States or similar applications in other jurisdictions. We cannot be certain of the timely completion or outcome of our preclinical testing and studies and cannot predict if the FDA or similar regulatory
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
authorities outside the United States will accept our proposed clinical programs or if the outcome of our preclinical testing and studies ultimately will support the further development of our
programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clinical testing is expensive, difficult to design and implement, can take many years to complete and is uncertain as to the outcome. A failure
of one or more clinical trials can occur at any stage of testing. We cannot guarantee that any of our ongoing and planned clinical trials will be conducted as planned or completed on schedule, if at all. Moreover, we may experience numerous
unforeseen events during, or as a result of, clinical trials, that could delay or prevent our ability to receive marketing approval or commercialize our product candidates, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in discussions with or obtaining alignment with regulators regarding trial design; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the supply or quality of our product candidates or other materials necessary to conduct clinical trials of our
product candidates may be insufficient or inadequate, including as a result of delays in the testing, validation, manufacturing and delivery of product candidates to the clinical sites by us or by third parties with whom we have contracted to
perform certain of those functions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may experience delays in reaching, or may fail to reach, agreement on acceptable clinical trial contracts or
clinical trial protocols with prospective trial sites; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may experience delays in enrolling patients or may compete with other trials to enroll patients, including due
to our targeted disease having small patient populations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulators or institutional review boards may not authorize us or our investigators to commence a clinical trial
or conduct a clinical trial at a prospective trial site; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may experience difficulty in designing clinical trials and in selecting endpoints for diseases that have not
been well-studied and for which the natural history and course of the disease is poorly understood; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the selection of certain clinical endpoints may require prolonged periods of clinical observation or analysis of
the resulting data; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of patients required for clinical trials of our product candidates may be larger than we anticipate,
enrollment in these clinical trials may be slower than we anticipate or participants may drop out of these clinical trials at a higher rate than we anticipate; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may fail to perform clinical trials in accordance with the FDA&#146;s or any other regulatory authority&#146;s
good clinical practices, or GCP, requirements, or regulatory guidelines in other countries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our product candidates may have undesirable side effects or other unexpected characteristics, or adverse events
associated with the product candidate may occur which are viewed to outweigh its potential benefits, causing us or our investigators, regulators or institutional review boards to suspend or terminate the trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may have to suspend or terminate clinical trials of our product candidates for various reasons, including a
finding that the participants are being exposed to unacceptable health risks; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations
to us in a timely manner, or at all; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulators or institutional review boards may require that we or our investigators suspend or terminate clinical
trials for various reasons, including noncompliance with regulatory requirements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinical trials of our product candidates may produce negative or inconclusive results, and we may decide, or
regulators may require us, to conduct additional clinical trials or abandon product development programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of clinical trials of our product candidates may be greater than we anticipate; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disruptions caused by <FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;pandemic</FONT> may increase the
likelihood that we encounter such difficulties or delays in initiating, enrolling, conducting, or completing our planned and ongoing clinical trials; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we could be required to conduct additional clinical trials or testing of our product candidates beyond those that
we currently contemplate, which may result in a delay in our market approval, limitation of approval for patient populations, distribution limitations, or not obtaining marketing approval at all. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We could also encounter delays if a clinical trial is suspended or terminated by us, the IRBs of the institutions in which such trials are being conducted, or
the FDA or comparable foreign regulatory authorities, or recommended for suspension or termination by the data monitoring committee for such trial. A suspension or termination may be imposed due to a number of factors, including failure to conduct
the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or comparable foreign regulatory authorities resulting in the imposition of a clinical
hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a product or treatment, failure to establish or achieve clinically meaningful trial endpoints, changes in governmental regulations or administrative
actions or lack of adequate funding to continue the clinical trial. Many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product
candidates. Further, the FDA or comparable foreign regulatory authorities may disagree with our clinical trial design and our interpretation of data from clinical trials, or may change the requirements for approval even after they have reviewed and
commented on the design for our clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our product development costs also will increase if we experience delays in preclinical studies or
clinical trials or in obtaining marketing approvals. We do not know whether any of our preclinical studies or clinical trials will begin as planned, will need to be restructured or will be completed on schedule, or at all. Significant preclinical
study or clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize our product candidates, or could allow our competitors to bring products to market before we do and impair our ability to
successfully commercialize our product candidates, which may harm our business, results of operations, financial condition and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we
experience delays or difficulties in the enrollment and dosing of patients in our clinical trials, our receipt of necessary regulatory approvals for our product candidates could be delayed or prevented. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Identifying and qualifying patients to participate in clinical trials of <FONT STYLE="white-space:nowrap">FHD-286,</FONT>
<FONT STYLE="white-space:nowrap">FHD-609</FONT> or any other product candidates is critical to our success. The timing of our clinical trials depends on our ability to recruit patients to participate in our studies as well as the dosing of such
patients and completion of required <FONT STYLE="white-space:nowrap">follow-up</FONT> periods. Our competitors may compete for the same limited patient populations. If we or our collaborators are unable to locate and enroll a sufficient number of
eligible patients to participate in these trials as required by the FDA or other analogous regulatory authorities outside the United States, or as needed to provide appropriate statistical power for a given trial, we may not be able to initiate or
continue clinical trials for our current and future product candidates. Additionally, we may face similar challenges or delays in our other or potential future clinical trials. If patients are unwilling to participate in our studies because of
negative publicity from adverse events related to the biotechnology field, competitive clinical trials for similar patient populations or for other reasons, the timeline for recruiting patients, conducting studies and obtaining regulatory approval
of <FONT STYLE="white-space:nowrap">FHD-286</FONT> or any other product candidates may be delayed. These delays could result in increased costs, delays in advancing our product candidates, delays in testing the effectiveness of our product
candidates or termination of the clinical trials altogether. Furthermore, our ability to enroll patients may be significantly delayed by the evolving <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and we do not know the extent and scope
of such delays at this point. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Patient enrollment is also affected by other factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">severity of the disease under investigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">size of the patient population and process for identifying patients; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">design of the trial protocol; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">availability and efficacy of approved medications for the disease under investigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">convenience and ease of administration compared to approved medications for the disease under investigation and
the willingness of patients to undergo the surgical procedures necessary to administer our product candidates, such as biopsy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ability to obtain and maintain patient informed consent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risk that enrolled patients will drop out before completion of the trial; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">eligibility and exclusion criteria for the trial in question; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">perceived risks and benefits of the product candidate under trial; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">efforts to facilitate timely enrollment in clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">patient referral practices of physicians; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ability to monitor patients adequately during and after treatment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">proximity and availability of clinical trial sites for prospective patients; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">factors we may not be able to control, such as current or potential pandemics that may limit patients, principal
investigators or staff or clinical site availability (for example, outbreak of <FONT STYLE="white-space:nowrap">COVID-19).</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Enrollment delays in our clinical trials may result in increased development costs for <FONT STYLE="white-space:nowrap">FHD-286</FONT> or any other product
candidates, which would cause the value of our company to decline and limit our ability to obtain additional financing. If we have difficulty enrolling a sufficient number of patients to conduct our clinical trials as planned, we may need to delay,
limit, or terminate clinical trials for <FONT STYLE="white-space:nowrap">FHD-286</FONT> or our other product candidates, or expand to additional jurisdictions, which could impose additional challenges on our company and expose us to risks. If we are
not successful in conducting our clinical trials as planned, it would have an adverse effect on our business, financial condition, results of operations, and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Any favorable preclinical results may not be predictive of results that may be observed in clinical trials. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Data obtained from preclinical activities are subject to varying interpretations and analyses, which may delay, limit or prevent regulatory approval. Many
companies that have believed their product candidates performed satisfactorily in preclinical studies have nonetheless failed to demonstrate results in clinical studies. As we generate preclinical results, such results will not ensure that later
preclinical studies or clinical trials will demonstrate similar results. There is a high failure rate for drugs and biologics proceeding through clinical trials. Even if <FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT
STYLE="white-space:nowrap">FHD-609</FONT> reach the clinical trial stage, these product candidates may fail to show the desired safety and efficacy in later stage of clinical development. A number of companies in the pharmaceutical and biotechnology
industries have suffered significant setbacks in later-stage clinical trials even after achieving promising results in the preclinical and early stage clinical trials. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our product candidates utilize novel mechanisms of action, which may result in greater research and development expenses, regulatory issues that could
delay or prevent approval, or discovery of unknown or unanticipated adverse effects. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our lead product candidates utilize novel mechanisms of
action, which may result in greater research and development expenses, regulatory issues that could delay or prevent approval, or discovery of unknown or unanticipated adverse effects. For example, <FONT STYLE="white-space:nowrap">FHD-609</FONT> is
a protein degrader. Currently there are no approved medicines using this mechanism of action. Because <FONT STYLE="white-space:nowrap">FHD-609</FONT> in particular utilizes a novel mechanism of action that has not been the subject of extensive study
compared to more well-known product candidates, there is also an increased risk that we may discover previously unknown or unanticipated adverse effects during our preclinical studies and clinical trials. Any such events could adversely impact our
business prospects, financial condition and results of operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, a novel mechanism of action may lengthen the regulatory review process, require us to conduct
additional studies or clinical trials, increase our development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of our product candidates or lead to significant post-approval
limitations or restrictions. The novel mechanism of action also means that fewer people are trained in or experienced with product candidates of this type, which may make it more difficult to find, hire and retain personnel for research, development
and manufacturing positions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our approach to the discovery of product candidates is unproven, and we may not be successful in our efforts to use
and expand our platform to build a pipeline of product candidates with commercial value. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A key element of our strategy is to use and expand our
Gene Traffic Control platform to build a pipeline of product candidates and progress these product candidates through clinical development for the treatment of various cancers and other therapeutic areas. Although our research and development
efforts to date have resulted in our discovery and preclinical development of <FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT STYLE="white-space:nowrap">FHD-609</FONT> for the treatment of cancer,
<FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT STYLE="white-space:nowrap">FHD-609</FONT> may not be safe or effective as cancer treatments, and we may not be able to develop any other product candidates. We may not be successful in
identifying further targets in the chromatin regulatory system that are relevant in cancer, or other diseases, and which can be &#147;basketed&#148; into a group that is large enough to present a sufficient commercial opportunity or that is
druggable with one chemical compound. Even if we are successful in building our pipeline of product candidates, the potential product candidates that we identify may not be suitable for clinical development or generate acceptable clinical data,
including as a result of being shown to have unacceptable toxicity or other characteristics that indicate that they are unlikely to be products that will receive marketing approval from the FDA or other regulatory authorities or achieve market
acceptance. If we do not successfully develop and commercialize product candidates, we will not be able to generate product revenue in the future, which likely would result in significant harm to our financial position and adversely affect our stock
price. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our clinical trials may fail to demonstrate substantial evidence of the safety and efficacy of our product candidates, which would delay or
prevent regulatory approval of the product candidates, limit the commercial potential, or result in significant negative consequences following any potential marketing approval. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To obtain the requisite regulatory approvals to market and sell any of our product candidates, we must demonstrate through extensive preclinical studies and
clinical trials that such product candidates are safe and effective for use in each targeted indication. Failure can occur at any time during the clinical development process. Most product candidates that begin clinical trials are never approved by
regulatory authorities for commercialization. We have not evaluated any product candidates in human clinical trials. Moreover, we are not aware of any clinical trials involving products that interact with BAF complexes to affect the chromatin
regulatory system in a similar manner to our products. It is impossible to predict when or if any product candidates we may develop will prove safe in humans. Our clinical trials may fail to demonstrate with substantial evidence from adequate and
well-controlled trials, and to the satisfaction of the FDA or comparable foreign regulatory authorities, that such product candidates are safe and effective for their intended uses. There can be no assurance that our clinical trials will not cause
undesirable side effects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any product candidates we develop are associated with or cause serious adverse events, undesirable side effects, or
unexpected characteristics, we may need to abandon their development or limit development to certain uses or subpopulations in which the serious adverse events, undesirable side effects or other characteristics are less prevalent, less severe, or
more acceptable from a risk-benefit perspective, any of which would have a material adverse effect on our business, financial condition, results of operations, and prospects. Many product candidates that initially showed promise in early stage
testing for treating cancer or other diseases have later been found to cause side effects that prevented further clinical development of the product candidates. Additionally, any safety concerns observed in any one of our clinical trials in our
targeted indications could limit the prospects for regulatory approval of our product candidates in those and other indications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, if our product candidates are associated with undesirable side effects in preclinical studies or
clinical trials or have characteristics that are unexpected, we may elect to abandon their development or limit their development to more narrow uses or subpopulations in which the undesirable side effects or other characteristics are less
prevalent, less severe or more acceptable from a risk-benefit perspective, which may limit the commercial expectations for the product candidate if approved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, adverse developments in clinical trials of pharmaceutical and biopharmaceutical products conducted by others may cause the FDA or other
regulatory oversight bodies to suspend or terminate our clinical trials or to change the requirements for approval of any of our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any
of these events could prevent us from achieving or maintaining market acceptance of any product candidates we may identify and develop and could have a material adverse effect on our business, financial condition, results of operations, and
prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if our clinical trials are successfully completed, clinical data are often subject to varying interpretations and analyses, and we cannot
guarantee that the FDA or comparable foreign regulatory authorities will interpret the results as we do. Results acceptable to support approval in one jurisdiction may be deemed inadequate by another regulatory authority to support regulatory
approval in that other jurisdiction. Even if regulatory is secured for a product candidate, the terms of such approval may also limit its commercial potential. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties to manufacture our preclinical and clinical product supplies, to produce and process clinical quantities of our product
candidates and to assist with clinical trials </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently rely on third parties to manufacture preclinical and clinical product supplies and to
manufacture clinical supplies of our product candidates. We need to negotiate and maintain contractual arrangements with these outside vendors for the supply of our product candidates and we may not be able to do so on favorable terms. We have not
yet caused any product candidates to be manufactured on a commercial scale and may not be able to do so for any of our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The facilities
used by our contract manufacturers to manufacture our product candidates must be approved by the FDA or other foreign regulatory authorities following inspections that will be conducted after we submit an application to the FDA or other foreign
regulatory authorities. We will be completely dependent on our contract manufacturing partners for compliance with cGMP and any other regulatory requirements of the FDA or other regulatory authorities for the manufacture of our product candidates.
Beyond periodic audits, we have no control over the ability of our contract manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the FDA or a comparable foreign regulatory authority does not approve these
facilities for the manufacture of our product candidates, if it withdraws any approval in the future, or if it otherwise identifies noncompliance with cGMPs at these facilities, we may need to find alternative manufacturing facilities, which would
require the incurrence of significant additional costs and significantly impact our ability to develop, obtain regulatory approval for or market our product candidates, if approved. Similarly, if any third-party manufacturers on which we will rely
fail to manufacture quantities of our product candidates at quality levels necessary to meet regulatory requirements and at a scale sufficient to meet anticipated demand at a cost that allows us to achieve profitability, our business, financial
condition, results of operations, and prospects could be materially and adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we will rely on third-party clinical
investigators, contract research organizations, or CROs, and consultants. Relying on third-party clinical investigators, CROs and consultants may force us to encounter delays that are outside of our control. We may be unable to identify and contract
with a sufficient number of investigators, CROs and consultants on a timely basis or at all. There can be no assurance that we will be able to negotiate and enter into any additional master services agreement with other CROs, as necessary, on terms
that are acceptable to us on a timely basis or at all. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Disruptions at the FDA and other government agencies caused by funding shortages or global health
concerns could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, approved or commercialized in a timely manner or at all, which could negatively
impact our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government
budget and funding levels, statutory, regulatory, and policy changes, the FDA&#146;s ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise affect the FDA&#146;s ability to perform routine
functions. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is
inherently fluid and unpredictable. Disruptions at the FDA and other agencies may also slow the time necessary for new drugs or modifications to approved drugs to be reviewed and/or approved by necessary government agencies, which would adversely
affect our business. For example, over the last several years, including for 35 days beginning on December&nbsp;22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical
FDA employees and stop critical activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Separately, in response to the global <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, on
March&nbsp;10, 2020 the FDA announced its intention to postpone most foreign inspections of manufacturing facilities and products, and subsequently, on March&nbsp;18, 2020, the FDA announced its intention to temporarily postpone routine surveillance
inspections of domestic manufacturing facilities. Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. If a prolonged
government shutdown occurs, or if global health concerns continue to prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the
FDA or other regulatory authorities to timely review and process our regulatory submissions, which could have a material adverse effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Employee Matters, Managing Growth and Information Technology </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are highly dependent on our key personnel. If we are not successful in attracting and retaining highly qualified personnel, we may not be able to
successfully implement our business strategy. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are highly dependent on Adrian Gottschalk, our Chief Executive Officer. In addition, the loss of
the services of any of our executive officers, other key employees and other scientific and medical advisors, and an inability to find suitable replacements could result in delays in product development and harm our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Despite our efforts to retain Mr.&nbsp;Gottschalk and other valuable employees, members of our management, scientific and development teams may terminate
their employment with us on short notice. Although we have employment agreements with our key employees, these employment agreements provide for <FONT STYLE="white-space:nowrap">at-will</FONT> employment, which means that any of our employees could
leave our employment at any time, with or without notice. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will need to grow the size of our organization, and we may experience difficulties in
managing this growth. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, we had 95 full-time employees. We intend to hire new employees to assume activities and
responsibilities within the company, including conducting our research and performing development activities in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ability to compete in the
highly competitive biotechnology and pharmaceutical industries depends upon our ability to attract and retain highly qualified managerial, scientific and medical personnel. We conduct our operations at our facilities in Cambridge, Massachusetts. The
Massachusetts region is headquarters to many other biopharmaceutical companies and many academic and research institutions. Competition for skilled personnel in our market is intense and may limit our ability to hire and retain highly qualified
personnel on acceptable terms or at all. Changes to U.S. immigration and work authorization laws and regulations, including those that restrain </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the flow of scientific and professional talent, can be significantly affected by political forces and levels of economic activity. Our business may be materially adversely affected if legislative
or administrative changes to immigration or visa laws and regulations impair our hiring processes and goals or projects involving personnel who are not U.S. citizens. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any delay or disruption in hiring such new employees could result in delays in our research and development activities and would harm our business. As our
development and commercialization plans and strategies develop, and as we transition into operating as a public company, we expect to need additional managerial, operational, sales, marketing, financial and other personnel, as well as additional
facilities to expand our operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we are not able to effectively expand our organization by hiring new employees and expanding our groups of
consultants and contractors, or we are not able to effectively build out new facilities to accommodate this expansion, we may not be able to successfully implement the tasks necessary to further develop and commercialize our product candidates and,
accordingly, may not achieve our research, development and commercialization goals. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our internal computer systems, or those used by our third-party
CROs or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of the development programs of our product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Despite the implementation of security measures, our internal computer systems and those of our current and future CROs and other contractors and consultants
are vulnerable to damage from computer viruses, unauthorized access, natural disasters, and telecommunication and electrical failures. While we have not experienced any such material system failure or security breach to date, if such an event were
to occur and cause interruptions in our operations, it could result in a material disruption of our development programs and our business operations. For example, the loss of data from completed or future preclinical studies and clinical trials
could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we rely on third parties for the manufacture of our product candidates and to conduct clinical trials, and
similar events relating to their computer systems could also have a material adverse effect on our business. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate
disclosure of confidential or proprietary information, we could incur liability and the further development and commercialization of our product candidates could be delayed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We rely on multiple CROs to mitigate potential impacts that may affect any one of our CROs. However, CDMOs and other contractors and consultants, could be
subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, pandemics and other natural or <FONT STYLE="white-space:nowrap">man-made</FONT> disasters or
business interruptions, for which we are predominantly self-insured. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses. We rely on third-party
manufacturers to produce our product candidates. Our ability to obtain clinical supplies of our product candidates could be disrupted if the operations of these suppliers are affected by a <FONT STYLE="white-space:nowrap">man-made</FONT> or natural
disaster or other business interruption. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Disruptions at the FDA and other government agencies caused by funding shortages or global health concerns
could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, approved or commercialized in a timely manner or at all, which could negatively impact our
business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and
funding levels, statutory, regulatory, and policy changes, the FDA&#146;s ability to hire and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
retain key personnel and accept the payment of user fees, and other events that may otherwise affect the FDA&#146;s ability to perform routine functions. Average review times at the agency have
fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable. Disruptions at the
FDA and other agencies may also slow the time necessary for new drugs or modifications to approved drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several
years, including for 35 days beginning on December&nbsp;22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Separately, in response to the global pandemic of <FONT STYLE="white-space:nowrap">COVID-19,</FONT> on March&nbsp;10, 2020 the FDA announced its intention to
postpone most foreign inspections of manufacturing facilities and products, and subsequently, on March&nbsp;18, 2020, the FDA announced its intention to temporarily postpone routine surveillance inspections of domestic manufacturing facilities.
Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. If a prolonged government shutdown occurs, or if global health
concerns continue to prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA or other regulatory authorities to timely
review and process our regulatory submissions, which could have a material adverse effect on our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The continuing outbreak <FONT
STYLE="white-space:nowrap">of&nbsp;COVID-19&nbsp;in</FONT> the United States and other countries may adversely affect our business and the market price of our common stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The recent global pandemic <FONT STYLE="white-space:nowrap">of&nbsp;COVID-19&nbsp;is</FONT> impacting worldwide economic activity, particularly economic
activity in the United States, and poses the risk that we or our employees, contractors, suppliers, or other partners may be prevented or delayed from conducting business activities for an indefinite period of time, including due to shutdowns that
may be requested or mandated by governmental authorities. The continued prevalence <FONT STYLE="white-space:nowrap">of&nbsp;COVID-19&nbsp;and</FONT> the measures taken by the governments of countries affected could disrupt the supply chain and the
manufacture or shipment of both drug substance and finished drug product for our product candidates for preclinical testing or clinical trials, cause diversion of healthcare resources away from the conduct of preclinical and clinical trial matters
to focus on pandemic concerns, limit travel in a manner that interrupts key trial activities, such as trial site initiations and monitoring, delay regulatory filings with regulatory agencies in affected areas or adversely affect our ability to
obtain regulatory approvals. These disruptions could also affect other facets of our business, including but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to recruit employees from outside of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of our CROs to conduct preclinical studies and clinical trials in countries outside of the United
States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to important materials from outside of the United States; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to export materials to our CROs and other third-parties located outside of the United States.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">The&nbsp;COVID-19&nbsp;outbreak</FONT> and mitigation measures also may have an adverse impact on
global economic conditions, which could adversely impact our business, financial condition or results of operations. Additionally, <FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;outbreak</FONT> has resulted in significant financial market
volatility and uncertainty. A continuation or worsening of the levels of market disruption and volatility seen in the recent past as a result of <FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;outbreak</FONT> could have an adverse effect on
our ability to access capital and on the market price of our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to adequately protect our proprietary technology and platform or obtain and maintain patent protection for our technology and products
or if the scope of the patent protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and products similar or identical to ours, and our ability to successfully develop and commercialize our
technology and products may be impaired. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our commercial success will depend in part on our ability and the ability of our licensors to obtain and
maintain proprietary or intellectual property protection in the United States and other countries for our product candidates, and our core technologies, including aspects of our Gene Traffic Control platform. We rely on trade secrets, <FONT
STYLE="white-space:nowrap">know-how</FONT> and continuing technological innovation to develop and maintain our proprietary and intellectual property position. In particular, our Gene Traffic Control platform is not the subject of patent
applications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We seek to protect our proprietary product candidates by filing patent applications in the United States and abroad related to our product
candidates that are important to our business. If we or our licensors are unable to obtain or maintain patent protection with respect to our current and future product candidates, competitors and other third parties could develop and commercialize
products similar or identical to ours, and our ability to successfully commercialize our product candidates and other product candidates that we may pursue may be impaired. As a result, our business, financial condition, results of operations and
prospects could be materially harmed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Currently, our patent portfolio, including our portfolio related to our product candidates <FONT
STYLE="white-space:nowrap">FHD-286</FONT> and <FONT STYLE="white-space:nowrap">FHD-609,</FONT> is in its earliest stages, primarily consisting of provisional patent applications, which do not themselves issue as patents, and patent applications
filed pursuant to the Patent Cooperation Treaty, or PCT. We have no issued patents related to <FONT STYLE="white-space:nowrap">FHD-286</FONT> or <FONT STYLE="white-space:nowrap">FHD-609.</FONT> In order to continue to pursue protection based on
provisional patent applications, we will need to file PCT, foreign applications and/or U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications prior to applicable deadlines. In order to continue to pursue protection based on
PCT applications, we will need to file national phase applications in the U.S. and <FONT STYLE="white-space:nowrap">ex-U.S.</FONT> jurisdictions prior to applicable deadlines. Even then, patents may never issue from our patent applications, or the
scope of any patent may not be sufficient to provide a competitive advantage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The degree of patent protection we require to successfully commercialize
our product candidates may be unavailable or severely limited in some cases and may not adequately protect our rights or permit us to gain or keep any competitive advantage. We cannot provide any assurances that any of our pending patent
applications will issue, or that any of our pending patent applications that mature into issued patents will include claims with a scope sufficient to protect <FONT STYLE="white-space:nowrap">FHD-286</FONT> or
<FONT STYLE="white-space:nowrap">FHD-609</FONT> or our other current or future product candidates. In addition, the laws of foreign countries may not protect our rights to the same extent as the laws of the United States. Furthermore, patents have a
limited lifespan. In the United States, the natural expiration of a patent is generally twenty years after it is filed. Various extensions may be available; however, the life of a patent, and the protection it affords, is limited. Given the amount
of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent
portfolio may not provide us with adequate and continuing patent protection sufficient to exclude others from commercializing products similar or identical to our product candidates, including generic versions of such products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other parties have developed technologies that may be related or competitive to our own, and such parties may have filed or may file patent applications, or
may have received or may receive patents, claiming inventions that may overlap or conflict with those claimed in our own patent applications, in either case that they may rely upon to dominate our patent position in the market. Publications of
discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Therefore,
we cannot know with certainty whether we were the first to make the inventions claimed in our owned or licensed pending patent applications, or that we were the first to file for patent protection of such inventions. As a result, the issuance,
scope, validity, enforceability and commercial value of our patent rights cannot be predicted with any certainty. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the patent prosecution process is expensive and time-consuming, and we may not be able to file
and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. Further, with respect to most of the pending patent applications covering our product candidates, prosecution has yet to commence. Patent
prosecution is a lengthy process, during which the scope of the claims initially submitted for examination by the U.S. Patent and Trademark Office, or USPTO, have been significantly narrowed by the time they issue, if at all. It is also possible
that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if we
acquire patent protection that we expect should enable us to maintain such competitive advantage, third parties may challenge the validity, enforceability or scope thereof, which may result in such patents being narrowed, invalidated or held
unenforceable. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our owned and licensed patents may be challenged in the courts or patent offices in the United States and abroad. For example,
we may be subject to a third-party submission of prior art to the USPTO challenging the priority of an invention claimed within one of our patents, which submissions may also be made prior to a patent&#146;s issuance, precluding the granting of any
of our pending patent applications. We may become involved in opposition, derivation, reexamination, <I>inter partes</I> review, post-grant review or interference proceedings challenging our patent rights or the patent rights of others from whom we
have obtained licenses to such rights. Competitors may claim that they invented the inventions claimed in our issued patents or patent applications prior to us, or may file patent applications before we do. Competitors may also claim that we are
infringing on their patents and that we therefore cannot practice our technology as claimed under our patents, if issued. Competitors may also contest our patents, if issued, by showing the patent examiner that the invention was not original, was
not novel or was obvious. In litigation, a competitor could claim that our patents, if issued, are not valid for a number of reasons. If a court agrees, we would lose our rights to those challenged patents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we may in the future be subject to claims by our former employees or consultants asserting an ownership right in our patent applications or
technologies, as a result of the work they performed on our behalf. Although we generally require all of our employees, consultants and advisors and any other third parties who have access to our proprietary
<FONT STYLE="white-space:nowrap">know-how,</FONT> information or technology to assign or grant similar rights to their inventions to us, we cannot be certain that we have executed such agreements with all parties who may have contributed to our
intellectual property, nor can we be certain that our agreements with such parties will be upheld in the face of a potential challenge, or that they will not be breached, for which we may not have an adequate remedy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An adverse determination in any such submission or proceeding may result in loss of exclusivity or freedom to operate or in patent claims being narrowed,
invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical technology and products, without payment to us, or could limit the duration of the patent
protection covering our technology and product candidates. Such challenges may also result in our inability to manufacture or commercialize our product candidates without infringing third party patent rights. In addition, if the breadth or strength
of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if our patent portfolio is unchallenged, it may not provide us with any meaningful protection or prevent competitors from designing around our patent
claims to circumvent our owned or licensed patents by developing similar or alternative technologies or products in a <FONT STYLE="white-space:nowrap">non-infringing</FONT> manner. For example, a third party may develop a competitive product that
provides benefits similar to one or more of our product candidates but that has a different composition that falls outside the scope of our patent protection. If the patent protection provided by the patents and patent applications we hold or pursue
with respect to our product candidates is not sufficiently broad to impede such competition, our ability to successfully commercialize our product candidates could be negatively affected, which would harm our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to protect the confidentiality of our trade secrets, our business and competitive
position may be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the protection afforded by patents, we rely upon unpatented trade secret protection, unpatented <FONT
STYLE="white-space:nowrap">know-how</FONT> and continuing technological innovation to develop and maintain our competitive position. With respect to the various aspects of our Gene Traffic Control platform, including our proprietary libraries, we
consider trade secrets and <FONT STYLE="white-space:nowrap">know-how</FONT> to be our primary intellectual property. We seek to protect our proprietary technology and processes, in part, by entering into confidentiality agreements with our
collaborators, scientific advisors, employees and consultants, and invention assignment agreements with our consultants and employees. We may not be able to prevent the unauthorized disclosure or use of our technical
<FONT STYLE="white-space:nowrap">know-how</FONT> or other trade secrets by the parties to these agreements, however, despite the existence generally of confidentiality agreements and other contractual restrictions. Monitoring unauthorized uses and
disclosures is difficult, and we do not know whether the steps we have taken to protect our proprietary technologies will be effective. If any of the collaborators, scientific advisors, employees and consultants who are parties to these agreements
breaches or violates the terms of any of these agreements, we may not have adequate remedies for any such breach or violation, and we could lose our trade secrets as a result. We also seek to preserve the integrity and confidentiality of our
confidential proprietary information by maintaining physical security on our premises, and physical and electronic security of our information technology systems, but it is possible that these security measures could be breached. Enforcing a claim
that a third party illegally obtained and is using our trade secrets, like patent litigation, is expensive and time consuming, and the outcome is unpredictable. In addition, courts outside the United States are sometimes less willing to protect
trade secrets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our trade secrets could otherwise become known or be independently discovered by our competitors. Competitors could purchase our product
candidates and attempt to replicate some or all of the competitive advantages we derive from our development efforts, willfully infringe our intellectual property rights, design around our protected technology or develop their own competitive
technologies that fall outside of our intellectual property rights. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate it,
from using that technology or information to compete with us. If our trade secrets are not adequately protected so as to protect our market against competitors&#146; products, our competitive position could be adversely affected, as could our
business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other
requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these requirements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar
provisions during the patent application process. In addition, periodic maintenance fees on issued patents often must be paid to the USPTO and foreign patent agencies over the lifetime of the patent. While an unintentional lapse can in many cases be
cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of
patent rights in the relevant jurisdiction. <FONT STYLE="white-space:nowrap">Non-compliance</FONT> events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official
actions within prescribed time limits, <FONT STYLE="white-space:nowrap">non-payment</FONT> of fees and failure to properly legalize and submit formal documents. If we fail to maintain the patents and patent applications covering our products or
procedures, we may not be able to stop a competitor from marketing products that are the same as or similar to our product candidates, which would have a material adverse effect on our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The intellectual property landscape around our technology, including our Gene Traffic Control
platform, is highly dynamic, and third parties may obtain intellectual property rights that could affect our ability to use our platform or otherwise develop and commercialize product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The field of protein modeling, especially in the area of targeting transcription factors, is still in its infancy. Due to the intense research and development
that is taking place by several companies, including us and our competitors, in this field, the intellectual property landscape is evolving and in flux, and it may remain uncertain for the coming years. There may be significant intellectual property
related litigation and proceedings relating to our owned and <FONT STYLE="white-space:nowrap">in-licensed,</FONT> and other third party, intellectual property and proprietary rights in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our commercial success depends upon our ability and the ability of our collaborators and licensors to develop, manufacture, market, and sell any product
candidates that we may develop and use our proprietary technologies without infringing, misappropriating, or otherwise violating the intellectual property and proprietary rights of third parties. As the biotechnology and pharmaceutical industries
expand and more patents are issued, the risk increases that our Gene Traffic Control platform and related technology and product candidates may give rise to claims of infringement of the patent rights of others. Moreover, it is not always clear to
industry participants, including us, which patents cover various types of therapies, products or their methods of use or manufacture. There may be third-party patents of which we are currently unaware with claims to technologies, methods of
manufacture or methods for treatment related to the use or manufacture of our product candidates. Because patent applications can take many years to issue, there may be currently pending patent applications that may later result in issued patents
that our product candidates may infringe. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. We may be unable to obtain a license to such patents held by third-parties on
commercially reasonable terms or at all. In the event that we are unable to obtain licenses to such patents, our ability to develop and commercialize one or more product candidates may become severely limited. Even if we were able to obtain such a
license, it could be granted on <FONT STYLE="white-space:nowrap">non-exclusive</FONT> terms, thereby providing our competitors and other third parties access to the same technologies licensed to us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may initiate or become involved in legal proceedings involving allegations that we are infringing a third party&#146;s intellectual property rights,
the outcome of which would be uncertain and could have a material adverse effect on the success of our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our commercial success depends in
part upon our ability and the ability of our collaborators to develop, manufacture and sell our product candidates and use our proprietary technologies without infringing the propriety rights and intellectual property of third parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The biotechnology and pharmaceutical industries are characterized by extensive and frequent litigation regarding patents and other intellectual property
rights. We may in the future become party to, or threatened with, adversarial proceedings or litigation regarding intellectual property rights with respect to our product candidates and technology. Our competitors or other third parties may assert
infringement claims against us, alleging that our products or technologies are covered by their patents. Given the vast number of patents in our field of technology, we cannot be certain that we do not infringe existing patents or that we will not
infringe patents that may be granted in the future. If a patent holder believes our product or product candidate infringes on its patent, the patent holder may sue us even if we have received patent protection for our technology. Moreover, we may
face patent infringement claims from <FONT STYLE="white-space:nowrap">non-practicing</FONT> entities that have no relevant product revenue and against whom our own patent portfolio may thus have no deterrent effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we are found to infringe a third party&#146;s intellectual property rights, we could be required to obtain a license from such third party to continue
developing and marketing our product candidates and technology. We may choose to obtain a license, even in the absence of an action or finding of infringement. In either case, we may not be able to obtain any required license on commercially
reasonable terms or at all. Even if we were able to obtain such a license, it could be granted on <FONT STYLE="white-space:nowrap">non-exclusive</FONT> terms, thereby providing our competitors and other third
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
parties access to the same technologies licensed to us. Without such a license, we could be forced, including by court order, to cease developing and commercializing the infringing technology or
product candidates. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#146; fees if we are found to have willfully infringed such third-party patent rights. A finding of infringement could prevent us
from commercializing our product candidates or force us to cease some of our business operations, which could materially harm our business. If we lose a foreign patent lawsuit, alleging our infringement of a competitor&#146;s patents, we could be
prevented from marketing our products in one or more foreign countries, which would have a materially adverse effect on our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be
subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of our competitors or are in breach of <FONT STYLE="white-space:nowrap">non-competition</FONT> or <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> agreements with our competitors. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We could in the future also be subject to claims that we or
our employees have inadvertently or otherwise used or disclosed alleged trade secrets or other proprietary information of former employers or competitors. Although we try to ensure that our employees and consultants do not use the intellectual
property, proprietary information, <FONT STYLE="white-space:nowrap">know-how</FONT> or trade secrets of others in their work for us, we may in the future be subject to claims that we caused an employee to breach the terms of his or her <FONT
STYLE="white-space:nowrap">non-competition</FONT> or <FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreement, or that we or these individuals have, inadvertently or otherwise, used or disclosed the alleged trade secrets or other
proprietary information of a former employer or competitor. Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and could be a
distraction to management. If our defenses to these claims fail, in addition to requiring us to pay monetary damages, a court could prohibit us from using technologies or features that are essential to our product candidates, if such technologies or
features are found to incorporate or be derived from the trade secrets or other proprietary information of the former employers. An inability to incorporate such technologies or features would have a material adverse effect on our business and may
prevent us from successfully commercializing our product candidates. In addition, we may lose valuable intellectual property rights or personnel as a result of such claims. Moreover, any such litigation or the threat thereof may adversely affect our
ability to hire employees or contract with independent sales representatives. A loss of key personnel or their work product could hamper or prevent our ability to commercialize our product candidates, which would have an adverse effect on our
business, results of operations and financial condition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may become involved in lawsuits to protect or enforce our patents and other
intellectual property rights, which could be expensive, time consuming and unsuccessful. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Competitors and other third parties may infringe,
misappropriate or otherwise violate our patents, if obtained, and other intellectual property rights. To counter infringement or unauthorized use, we may be required to file infringement claims. A court may disagree with our allegations, however,
and may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the third-party technology in question. Further, such third parties could counterclaim that we infringe their intellectual
property or that a patent we have asserted against them is invalid or unenforceable. In patent litigation in the United States, defendant counterclaims challenging the validity, enforceability or scope of asserted patents are commonplace. In
addition, third parties may initiate legal proceedings against us to assert such challenges to our intellectual property rights. The outcome of any such proceeding is generally unpredictable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An adverse result in any litigation proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly. If a defendant were
to prevail on a legal assertion of invalidity or unenforceability of our patents covering one of our product candidates, we would lose at least part, and perhaps all, of the patent protection covering such product candidate. Competing products may
also be sold in other countries in which our patent coverage might not exist or be as strong. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intellectual property litigation could cause us to spend substantial resources and distract our
personnel from their normal responsibilities. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Litigation or other legal proceedings relating to intellectual property claims, with or without
merit, is unpredictable and generally expensive and time consuming and is likely to divert significant resources from our core business, including distracting our technical and management personnel from their normal responsibilities. Furthermore,
because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition,
there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the
price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain
the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Accordingly, despite our efforts, we may not be able to prevent
third parties from infringing upon or misappropriating or from successfully challenging our intellectual property rights, or we may be unable to successfully defend ourselves from allegations of infringement or misappropriation. Uncertainties
resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to effectively enforce our intellectual property rights throughout the world. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing, prosecuting and defending patents on our product candidates in all countries throughout the world would be prohibitively expensive. The requirements
for patentability may differ in certain countries, particularly in developing countries. Moreover, our ability to protect and enforce our intellectual property rights may be adversely affected by unforeseen changes in foreign intellectual property
laws. Additionally, the patent laws of some foreign countries do not afford intellectual property protection to the same extent as the laws of the United States. Many companies have encountered significant problems in protecting and defending
intellectual property rights in certain foreign jurisdictions. The legal systems of some countries, particularly developing countries, do not favor the enforcement of patents and other intellectual property rights. This could make it difficult for
us to stop the infringement of our patents or the misappropriation of our other intellectual property rights. For example, many foreign countries have compulsory licensing laws under which a patent owner must grant licenses to third parties.
Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their
own products and, further, may export otherwise infringing products to territories where we have patent protection, if our ability to enforce our patents to stop infringing activities is inadequate. These products may compete with our product
candidates, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proceedings to
enforce our patent rights in foreign jurisdictions, whether or not successful, could result in substantial costs and divert our efforts and resources from other aspects of our business. Furthermore, while we intend to protect our intellectual
property rights in the major markets for our product candidates, we cannot ensure that we will be able to initiate or maintain similar efforts in all jurisdictions in which we may wish to market our product candidates. Accordingly, our efforts to
protect our intellectual property rights in such countries may be inadequate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be subject to claims challenging the inventorship or ownership
of any intellectual property, including any patents we may own <FONT STYLE="white-space:nowrap">or&nbsp;in-license&nbsp;in</FONT> the future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
may be subject to claims that former employees, collaborators or other third parties have an interest in any patents we may own <FONT STYLE="white-space:nowrap">or&nbsp;in-license&nbsp;in</FONT> the future, trade secrets, or other intellectual
property as an inventor </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">or&nbsp;co-inventor.&nbsp;We</FONT> may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in
developing our product candidates or other technologies. We generally enter into confidentiality and intellectual property assignment agreements with our employees, consultants, and contractors. These agreements generally provide that inventions
conceived by the party in the course of rendering services to us will be our exclusive property. However, those agreements may not be honored and may not effectively assign intellectual property rights to us. Moreover, there may be some
circumstances where we are unable to negotiate for such ownership rights. Disputes regarding ownership or inventorship of intellectual property can also arise in other contexts, such as collaborations and sponsored research. If we are subject to an
inventorship dispute, such dispute may lead to litigation which could be expensive and time consuming. If we are unsuccessful, in addition to paying monetary damages, we could lose valuable rights in intellectual property that we regard as our own,
such as exclusive ownership of, or right to use, intellectual property that is important to our product candidates and our Gene Traffic Control platform. Even if we are successful in defending against such claims, litigation could result in
substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we do not obtain patent term extension and data exclusivity for any product candidates we may develop, our business may be materially harmed.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depending upon the timing, duration and specifics of any FDA marketing approval of any product candidates we may develop, one or more of our U.S.
patents, if obtained, may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Action of 1984, or Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent extension term of up to five
years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent may be extended
and only those claims covering the approved drug, a method for using it or a method for manufacturing it may be extended. However, we may not be granted an extension because of, for example, failing to exercise due diligence during the testing phase
or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent
protection afforded could be less than we request. If we are unable to obtain patent term extension or the term of any such extension is less than we request, our business, financial condition, results of operations and prospects could be materially
harmed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intellectual property rights do not necessarily address all potential threats. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not
adequately protect our business or permit us to maintain our competitive advantage. For example: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">aspects of our Gene Traffic Control platform are protected by trade secrets, which may be inadequate to safeguard
our competitive advantage, and some aspects of our platform may not be protectable by intellectual property rights at all; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may be able to make products that are similar to our product candidates or utilize similar technology but
that are not covered by the claims of any patents that may issue to us, our licensors or our collaborator; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or our licensors or collaborators, might not have been the first to make the inventions covered by our pending
patent applications, or any patents that may issue in the future; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or our licensors or collaborators, might not have been the first to file patent applications covering certain
of our or their inventions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may independently develop similar or alternative technologies or duplicate any of our technologies without
infringing or misappropriating our intellectual property rights; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that our present or future pending patent applications will not lead to issued patents;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal
challenges by our competitors or other third parties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our competitors or other third parties might conduct research and development activities in countries where we do
not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes to the patent law in the United States and other jurisdictions could diminish the value of patents in
general, thereby impairing our ability to protect our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patents of others may harm our business; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may choose not to file a patent application in order to maintain certain trade secrets or <FONT
STYLE="white-space:nowrap">know-how,</FONT> and a third party may subsequently file a patent covering such intellectual property. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Should any of these events occur, they could have a material adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Changes to the patent law in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to
protect our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property,
particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involve both technological and legal complexity and is therefore costly, time consuming and inherently uncertain. Recent patent reform legislation in the United
States and other countries, including the Leahy-Smith America Invents Act, or Leahy-Smith Act, signed into law on September&nbsp;16, 2011, could increase those uncertainties and costs. The Leahy-Smith Act includes a number of significant changes to
U.S. patent law. These include provisions that affect the way patent applications are prosecuted, redefine prior art and provide more efficient and cost-effective avenues for competitors to challenge the validity of patents. In addition, the
Leahy-Smith Act has transformed the U.S. patent system into a &#147;first to file&#148; system. The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-to-file</FONT></FONT> provisions, however, only became effective on
March&nbsp;16, 2013. Accordingly, it is not yet clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. However, the Leahy-Smith Act and its implementation could make it more difficult to obtain patent protection
for our inventions and increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could harm our business, results of operations and financial
condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain
circumstances or weakening the rights of patent owners in certain situations. Additionally, there have been recent proposals for additional changes to the patent laws of the United States and other countries that, if adopted, could impact our
ability to obtain patent protection for our proprietary technology or our ability to enforce rights in our proprietary technology. Depending on future actions by the U.S. Congress, the U.S. courts, the USPTO and the relevant <FONT
STYLE="white-space:nowrap">law-making</FONT> bodies in other countries, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce any patents that we may obtain in
the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Reliance on Third Parties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely, and expect to continue to rely, on third parties, including independent clinical investigators, CROs, and CDMOs to conduct certain aspects of
our discovery and preclinical studies and development, and clinical trials. If these third parties do not successfully carry out their contractual duties, comply with applicable regulatory requirements or meet expected deadlines, we may not be able
to obtain regulatory approval for or commercialize our product candidates and our business could be substantially harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have relied upon and
plan to continue to rely upon third parties, including independent clinical investigators and third-party CROs and CDMOs, as well as potential collaboration partners to conduct certain aspects of our
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discovery, preclinical studies and development and clinical trials and to monitor and manage data for our ongoing preclinical and clinical programs. We rely on these parties for execution of our
preclinical studies and planned clinical trials, and control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of our studies and trials is conducted in accordance with the applicable protocol, legal,
regulatory and scientific standards, and our reliance on these third parties does not relieve us of our regulatory responsibilities. We and our third-party contractors, CROs and CDMOs are required to comply with GCP requirements, which are
regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities for all of our product candidates in clinical development. Regulatory authorities enforce these GCPs through periodic inspections of trial sponsors,
principal investigators and trial sites. If we or any of these third parties, our CROs or our CDMOs fail to comply with applicable GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign
regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. Moreover, our business may be adversely affected if any of these third parties violates federal or state fraud and abuse or
false claims laws and regulations or healthcare privacy and security laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, these investigators, CROs and CDMOs are not our employees and we will
not be able to control, other than by contract, the amount of resources, including time, which they devote to our product candidates and clinical trials. These third parties may also have relationships with other commercial entities, including our
competitors, for whom they may also be conducting clinical trials or other product development activities, which could affect their performance on our behalf. If independent investigators, CROs and CDMOs fail to devote sufficient resources to the
development of our product candidates, or if CROs do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain is
compromised due to the failure to adhere to our clinical protocols, regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated and we may not be able to obtain regulatory approval for or successfully
commercialize our product candidates. As a result, our results of operations and the commercial prospects for our product candidates would be harmed, our costs could increase and our ability to generate revenues could be delayed or precluded
entirely. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any of our relationships with these third-party CROs terminate, we may not be able to enter into arrangements with alternative CROs or to do
so on commercially reasonable terms. Switching or adding additional CROs involves additional cost and requires management time and focus. In addition, there is a natural transition period when a new CRO commences work. As a result, delays occur,
which can materially impact our ability to meet our desired clinical development timelines. Additionally, CROs may lack the capacity to absorb higher workloads or take on additional capacity to support our needs. Though we carefully manage our
relationships with our CROs, there can be no assurance that we will not encounter similar challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, financial condition and
prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We currently rely and expect to rely in the future on the use of manufacturing suites in third-party facilities or third parties to
manufacture our product candidates. Our business could be harmed if we are unable to use third-party manufacturing suites or if the third-party manufacturers fail to provide us with sufficient quantities of our product candidates or fail to do so at
acceptable quality levels or prices. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not currently own any facility that may be used as our clinical-scale manufacturing and processing
facility and must currently rely on outside vendors to manufacture our product candidates in clinical quantities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our reliance on third parties for
clinical quantities exposes us to a number of risks, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our third-party manufacturers might be unable to timely manufacture our product candidates or produce the
quantity and quality required to meet our clinical and commercial needs, if any; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">contract manufacturers may not be able to execute our manufacturing procedures and other logistical support
requirements appropriately and incompliance with cGMP; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our third-party manufacturers could breach or terminate their agreements with us. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of these risks could delay or prevent the completion of our clinical trials or the approval of any of
our product candidates by the FDA or result in higher costs. In addition, we will rely on third parties to perform certain specification tests on our product candidates prior to delivery to patients. If these tests are not appropriately done and
test data are not reliable, patients could be put at risk of serious harm and the FDA could place significant restrictions on our company until deficiencies are remedied. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If our third-party manufacturers use hazardous and biological materials in a manner that causes injury or violates applicable law, we may be liable for
damages. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our research and development activities involve the controlled use of potentially hazardous substances, including chemical and biological
materials, by our third-party manufacturers. Our manufacturers are subject to numerous environmental, health and safety laws and regulations, including those governing the use, manufacture, storage, handling and disposal of medical and hazardous
materials. Although we believe that our manufacturers&#146; procedures for using, handling, storing and disposing of these materials comply with legally prescribed standards, we cannot completely eliminate the risk of contamination or injury
resulting from medical or hazardous materials. As a result of any such contamination or injury, we may incur liability or local, city, state or federal authorities may curtail the use of these materials and interrupt our business operations. In the
event of an accident, we could be held liable for damages or penalized with fines, and the liability could exceed our resources. We do not have any insurance for liabilities arising from medical or hazardous materials. Compliance with applicable
environmental laws and regulations is expensive, and current or future environmental regulations may impair our research, development and production efforts, which could harm our business, prospects, financial condition or results of operations.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Regulatory and Other Legal Compliance Matters </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our clinical trials may fail to demonstrate adequately the safety and efficacy of any of our product candidates, which would delay or prevent further
clinical development of those candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To obtain the requisite regulatory approvals to market and sell any of our product candidates, including
<FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT STYLE="white-space:nowrap">FHD-609,</FONT> and any other future product candidates, we must demonstrate through extensive preclinical studies and clinical trials that our products are safe
and effective in humans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clinical trials that we conduct may not demonstrate the efficacy and safety necessary to obtain regulatory approval to market
our product candidates. In some instances, there can be significant variability in safety or efficacy results between different clinical trials of the same product candidate due to numerous factors, including changes in trial procedures set forth in
protocols, differences in the size and type of the patient populations, changes in and adherence to the clinical trial protocols and the rate of dropout among clinical trial participants. If the results of our ongoing or future clinical trials are
inconclusive with respect to the efficacy of our product candidates, if we do not meet the clinical endpoints with statistical and clinically meaningful significance, or if there are safety concerns associated with our product candidates, we may be
delayed in obtaining marketing approval, if at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if the trials are successfully completed, clinical data are often susceptible to varying
interpretations and analyses, and we cannot guarantee that the FDA or other comparable foreign regulatory authorities will interpret the results as we do, and more trials could be required before we submit our product candidates for approval. We
cannot guarantee that the FDA or other comparable foreign regulatory authorities will view our product candidates as having sufficient efficacy to support the indication studied in the clinical trial even if positive results are observed in early
clinical trials. To the extent that the results of the trials are not satisfactory to the FDA or other comparable foreign regulatory authorities for support of a marketing application, approval of our product candidates may be significantly delayed,
or we may be required to expend significant additional resources, which may not be available to us, to conduct additional trials in support of potential approval of our product candidates. Additionally, any safety or efficacy concerns observed in
any tumor-specific subgroup of our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
clinical trials could limit the prospects for regulatory approval of our product candidates for a tumor-agnostic indication, which could have a material adverse effect on our business, financial
condition and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may in the future seek orphan drug status for <FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT
STYLE="white-space:nowrap">FHD-609</FONT> and some of our other future product candidates, but we may be unable to obtain such designations or to maintain the benefits associated with orphan drug status, including market exclusivity, which may cause
our future revenue, if any, to be reduced. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat
a rare disease or condition, defined as a disease or condition with a patient population of fewer than 200,000 in the United States, or a patient population greater than 200,000 in the United States when there is no reasonable expectation that the
cost of developing and making available the drug or biologic in the United States will be recovered from sales in the United States for that drug or biologic. Orphan drug designation must be requested before submitting an NDA. In the United States,
orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and <FONT STYLE="white-space:nowrap">user-fee</FONT> waivers. After the FDA grants orphan drug
designation, the generic identity of the drug and its potential orphan use are disclosed publicly by the FDA. Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a product that has orphan drug designation subsequently receives the first FDA approval for a particular active ingredient for the disease for which it has
such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications, including an NDA, to market the same drug for the same indication for seven years, except in limited
circumstances such as a showing of clinical superiority to the product with orphan drug exclusivity or if the FDA finds that the holder of the orphan drug exclusivity has not shown that it can assure the availability of sufficient quantities of the
orphan drug to meet the needs of patients with the disease or condition for which the drug was designated. As a result, even if one of our product candidates receives orphan exclusivity, the FDA can still approve other drugs that have a different
active ingredient for use in treating the same indication or disease. Furthermore, the FDA can waive orphan exclusivity if we are unable to manufacture sufficient supply of our product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may seek orphan drug designation for some or all of our other future product candidates, where applicable, in addition to orphan indications in which there
is a medically plausible basis for the use of these products. Even when we obtain orphan drug designation, exclusive marketing rights in the United States may be limited if we seek approval for an indication broader than the orphan designated
indication and may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or
condition. In addition, although we intend to seek orphan drug designation for other product candidates, we may never receive such designations. For example, the FDA has expressed concerns regarding the regulatory considerations for orphan drug
designation as applied to tissue agnostic therapies, and the FDA may interpret the federal Food, Drug and Cosmetic Act, as amended, or the FD&amp;C Act, and regulations promulgated thereunder in a way that limits or blocks our ability to obtain
orphan drug designation or orphan drug exclusivity, if our product candidates are approved, for our targeted indications. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>A Breakthrough Therapy
designation by the FDA, even if granted for any of our product candidates, may not lead to a faster development or regulatory review or approval process and it does not increase the likelihood that our product candidates will receive marketing
approval. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may seek Breakthrough Therapy designation from the FDA for <FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT
STYLE="white-space:nowrap">FHD-609,</FONT> and for some or all of our future product candidates. A breakthrough therapy is defined as a drug or biologic that is intended, alone or in combination with one or more other drugs or biologics, to treat a
serious or life- threatening disease or condition and preliminary clinical evidence indicates that the drug or biologic may demonstrate substantial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For product candidates that have
been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective
control regimens. Drugs designated as breakthrough therapies by the FDA may also be eligible for other expedited approval programs, including accelerated approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Designation as a breakthrough therapy is within the discretion of the FDA. Accordingly, even if we believe one of our product candidates meets the criteria
for designation as a breakthrough therapy, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a Breakthrough Therapy designation for a product candidate may not result in a faster development
process, review or approval compared to candidate products considered for approval under <FONT STYLE="white-space:nowrap">non-expedited</FONT> FDA review procedures and does not assure ultimate approval by the FDA. In addition, even if one or more
of our product candidates qualify as breakthrough therapies, the FDA may later decide that the product no longer meets the conditions for qualification. Thus, even though we intend to seek Breakthrough Therapy designation for some or all of our
future product candidates for the treatment of various cancers, there can be no assurance that we will receive breakthrough therapy designation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our relationships with healthcare providers, physicians, and third-party payors will be subject to applicable anti-kickback, fraud and abuse,
anti-bribery, physician payment transparency and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm, and diminished profits and future earnings. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our future arrangements with third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations
that may constrain the business or financial arrangements and relationships through which we research, market, sell, and distribute our medicines for which we obtain marketing approval. Restrictions under applicable federal and state healthcare laws
and regulations include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">federal Anti-Kickback Statute, which prohibits, among other things, persons from offering, soliciting, receiving
or providing remuneration, directly or indirectly, to induce either the referral of an individual, or the purchasing or ordering of, a good or service for which payment may be made under federal healthcare programs such as Medicare and Medicaid;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">federal false claims, false statements and civil monetary penalties laws prohibiting, among other things, any
person from knowingly presenting, or causing to be presented, a false claim for payment of government funds or knowingly making, or causing to be made, a false statement material to a false claim; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which, in addition to privacy
protections applicable to healthcare providers and other entities, prohibits executing a scheme to defraud any healthcare benefit program and making false statements relating to healthcare matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Physician Payments Sunshine Act, which requires pharmaceutical and medical device companies to report
information related to certain payments and transfers of value to certain healthcare providers to the Center for Medicare&nbsp;&amp; Medicaid Services, as well as ownership and investment interests held by physicians and their immediate family
members; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">analogous state and foreign laws and regulations, such as state anti-kickback, anti-bribery and false claims
laws, which may apply to healthcare items or services that are reimbursed by <FONT STYLE="white-space:nowrap">non-governmental</FONT> third-party payors, including private insurers, as well as other state laws that require companies to comply with
specific compliance standards, restrict financial interactions between companies and healthcare providers and require companies to report information related to payments to health care providers or marketing expenditures. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare
laws and regulations will involve substantial costs. Given the breadth of the laws and regulations, limited guidance for certain laws and regulations and evolving government interpretations of the laws and regulations, governmental authorities may
possibly conclude that our business practices may not comply with healthcare laws and regulations, including, without limitation, certain of our advisory board agreements with physicians who receive stock or stock options as compensation for
services provided to us. If our operations are found to be in violation of any of the laws described above or any other government regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, damages, fines,
exclusion from participation in government health care programs, such as Medicare and Medicaid, imprisonment, and the curtailment or restructuring of our operations, any of which could adversely affect our business, financial condition, results of
operations, and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Healthcare legislative reform measures may have a material adverse effect on our business and results of operations.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The U.S. and many foreign jurisdictions have enacted or proposed legislative and regulatory changes affecting the healthcare system that could
prevent or delay marketing approval of our current or future product candidates or any future product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell a product for which we obtain marketing
approval. In particular, in the U.S., there have been and continue to be a number of legislative initiatives at the federal and state level to contain healthcare costs. For example, in March 2010, the Patient Protection and Affordable Care Act, as
amended by the Health Care and Education Reconciliation Act, of collectively, the ACA, was enacted, which substantially changed the way healthcare is financed by both government and private payors. Since its enactment, there have been judicial and
Congressional challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. It is unclear how any efforts to challenge, repeal, or replace the ACA will impact the ACA or our
business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in regulations, statutes or the interpretation of existing regulations could impact our business in the future by requiring, for
example: (i)&nbsp;changes to our manufacturing arrangements, (ii)&nbsp;additions or modifications to product labeling, (iii)&nbsp;the recall or discontinuation of our products or (iv)&nbsp;additional record-keeping requirements. Further, healthcare
reform may result in changes to payment methodologies, the implementation of pharmaceutical and biological product price controls, and reductions in Medicare and other healthcare funding. If any such changes were to be imposed, they could adversely
affect the operation of our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The successful commercialization of our product candidates will depend in part on the extent to which
third-party payors establish coverage, adequate reimbursement levels and pricing policies. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ability to obtain coverage and adequate
reimbursement for our product candidates by governmental healthcare programs, private health insurers, and other third-party payors will have an effect on our ability to successfully commercialize our product candidates. We cannot be sure that
coverage and reimbursement will be available for our product candidates or any product that we may develop, and any reimbursement that may become available may not be adequate or may be decreased or eliminated in the future. No uniform policy for
coverage and reimbursement for products exists among third-party payors in the United States. Therefore, coverage and reimbursement for products can differ significantly from payor to payor. As a result, the coverage determination process is often a
time-consuming and costly process that will require us to provide scientific and clinical support for the use of our product candidates to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently
or obtained in the first instance. If reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize our product candidates and may not be able to obtain a satisfactory financial return on our
product candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are subject to U.S. and international restrictive regulations governing the use, processing and
cross-border transfer of data and personal information. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conduct of our clinical trials may be subject to privacy restrictions based on U.S.
and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> regulations. For example, we may be subject to the California Consumer Privacy Act, or CCPA. As currently written, the CCPA may impact our business activities and exemplifies the vulnerability of
our business to the evolving regulatory environment related to personal data and protected health information. Additionally, the collection, use, storage, disclosure, transfer, or other processing of personal data regarding individuals in the EU,
including personal health data, is subject to the EU General Data Protection Regulation, or GDPR. See &#147;Business&#151;Government Regulation.&#148; Compliance with the GDPR will be a rigorous and time-intensive process that may increase our cost
of doing business or require us to change our business practices, and despite those efforts, there is a risk that we may be subject to fines and penalties, litigation, and reputational harm in connection with our European activities. Further, the
United Kingdom&#146;s vote in favor of exiting the EU, often referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom. In particular, it is unclear how data transfers to and from the United
Kingdom will be regulated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compliance with U.S. and international data protection laws and regulations could require us to take on more onerous
obligations in our contracts, restrict our ability to collect, use and disclose data, or in some cases, impact our ability to operate in certain jurisdictions. Failure to comply with U.S. and international data protection laws and regulations could
result in government enforcement actions (which could include civil or criminal penalties), private litigation or adverse publicity and could negatively affect our operating results and business. Moreover, clinical trial subjects about whom we or
our potential collaborators obtain information, as well as the providers who share this information with us, may contractually limit our ability to use and disclose the information. Claims that we have violated individuals&#146; privacy rights,
failed to comply with data protection laws, or breached our contractual obligations, even if we are not found liable, could be expensive and time consuming to defend and could result in adverse publicity that could harm our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Risk Factors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The market price of our
common stock may be volatile, which could result in substantial losses for our stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our stock price has been and may continue to be
volatile. Since our initial public offering in October 2020, the price of our common stock as reported on the Nasdaq Global Market has ranged from a low of $12.38 on March&nbsp;10, 2021 to a high of $25.88 on December&nbsp;18, 2020. Some of the
factors that may cause the market price of our common stock to fluctuate include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success of existing or new competitive product candidates or technologies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and results of preclinical studies and clinical trials for any product candidates that we may develop;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure or discontinuation of any of our product development and research programs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">results of preclinical studies, clinical trials, or regulatory approvals of product candidates of our
competitors, or announcements about new research programs or product candidates of our competitors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commencement or termination of collaborations for our product development and research programs;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory or legal developments in the United States and other countries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments or disputes concerning patent applications, issued patents, or other proprietary rights;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the recruitment or departure of key personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the level of expenses related to any of our research programs or product candidates that we may develop;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the results of our efforts to develop additional product candidates or products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">actual or anticipated changes in estimates as to financial results, development timelines, or recommendations by
securities analysts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">announcement or expectation of additional financing efforts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales of our common stock by us, our insiders or other stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expiration of market <FONT STYLE="white-space:nowrap">stand-off</FONT> or
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">effects of public health crises, pandemics and epidemics, such as
<FONT STYLE="white-space:nowrap">COVID-19;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variations in our financial results or those of companies that are perceived to be similar to us;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in estimates or recommendations by securities analysts, if any, that cover our stock;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the structure of healthcare payment systems; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">market conditions in the pharmaceutical and biotechnology sectors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general economic, industry, and market conditions; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the other factors described in this &#147;Risk Factors&#148; section. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In recent years, the stock market in general, and the market for pharmaceutical and biotechnology companies in particular, has experienced extreme price and
volume fluctuations that have often been unrelated or disproportionate to changes in the operating performance of the companies whose stock is experiencing those price and volume fluctuations. Broad market and industry factors may seriously affect
the market price of our common stock, regardless of our actual operating performance. Following periods of such volatility in the market price of a company&#146;s securities, securities class action litigation has often been brought against that
company. Because of the potential volatility of our stock price, we may become the target of securities litigation in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities litigation
could result in substantial costs and divert management&#146;s attention and resources from our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If securities analysts do not publish
research or reports about our business or if they publish negative evaluations of our stock, the price of our stock could decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The trading
market for our common stock relies in part on the research and reports that industry or financial analysts publish about us or our business. We do not currently have and may never obtain research coverage by industry or financial analysts. If no or
few analysts commence coverage of us, the trading price of our stock would likely decrease. Even if we do obtain analyst coverage, if one or more of the analysts covering our business downgrade their evaluations of our stock, the price of our stock
could decline. If one or more of these analysts cease to cover our stock, we could lose visibility in the market for our stock, which in turn could cause our stock price to decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>A significant portion of our total outstanding shares is eligible to be sold into the market in the near future, which could cause the market price of
our common stock to drop significantly, even if our business is doing well. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales of a substantial number of shares of our common stock in the
public market, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our common stock. Certain holders of shares of our common stock have rights, subject to specified
conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders, until such shares can otherwise be sold without restriction
under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Securities Act Rule 144 or until the rights terminate pursuant to the terms of the investors&#146; rights agreement between us and such holders. If additional shares are sold, or if it is
perceived that they will be sold, in the public market, the market price of our common stock could decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Insiders have substantial influence
over us, which could limit your ability to affect the outcome of key transactions, including a change of control. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our directors and executive
officers and their affiliates beneficially own shares representing approximately 56% of our outstanding common stock. As a result, these stockholders, if they act together, will be able to influence our management and affairs and all matters
requiring stockholder approval, including the election of directors and approval of significant corporate transactions. This concentration of ownership may have the effect of delaying or preventing a change in control of our company and might affect
the market price of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are an &#147;emerging growth company,&#148; and the reduced disclosure requirements applicable to emerging
growth companies may make our common stock less attractive to investors. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company,&#148; as defined in the
Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and may remain an emerging growth company for up to five years. For so long as we remain an emerging growth company, we are permitted and plan to rely on exemptions from certain
disclosure requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley
Act of 2002, or SOX Section&nbsp;404, not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#146;s report
providing additional information about the audit and the financial statements, reduced disclosure obligations regarding executive compensation, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved. As a result, the information we provide stockholders will be different than the information that is available with respect to other public companies. In this annual
report, we have not included all of the executive compensation related information that would be required if we were not an emerging growth company. We cannot predict whether investors will find our common stock less attractive if we rely on these
exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised
accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected not to &#147;opt out&#148; of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we will adopt the new or revised standard at the time private companies adopt the new or revised
standard and will do so until such time that we either (i)&nbsp;irrevocably elect to &#147;opt out&#148; of such extended transition period or (ii)&nbsp;no longer qualify as an emerging growth company. Therefore, the reported results of operations
contained in our consolidated financial statements may not be directly comparable to those of other public companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We incur costs as a result of
operating as a public company, and our management will be required to devote substantial time to compliance initiatives and corporate governance practices. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2020, we completed our initial public offering. As a public company, and particularly after we are no longer an &#147;emerging growth company,&#148;
we incur significant legal, accounting, and other expenses that we did not incur as a private company. The Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of the Nasdaq Global
Market, and other applicable securities rules and regulations impose various requirements on public companies, including establishment and maintenance of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effective disclosure and financial controls and corporate governance practices. We expect that we will need to hire additional accounting, finance, and other personnel in connection with our
becoming, and our efforts to comply with the requirements of being, a public company, and our management and other personnel will need to devote a substantial amount of time towards maintaining compliance with these requirements. These requirements
will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect that the rules and regulations applicable to us as a public company may make it more difficult and more
expensive for us to obtain director and officer liability insurance, which could make it more difficult for us to attract and retain qualified members of our board of directors. We are currently evaluating these rules and regulations and cannot
predict or estimate the amount of additional costs we may incur or the timing of such costs. These rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their
application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure
and governance practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to SOX Section&nbsp;404, we will be required to furnish a report by our management on our internal control over
financial reporting beginning with our second filing of an Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> with the SEC after we become a public company. However, while we remain an emerging growth company, we will not be required
to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with SOX Section&nbsp;404 within the prescribed period, we will be engaged in a process
to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants, adopt a detailed work plan
to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented, and implement a continuous reporting
and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that we will not be able to conclude, within the prescribed timeframe or at all, that our internal control over financial reporting is
effective as required by SOX Section&nbsp;404. If we identify one or more material weaknesses, it could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Unfavorable global economic conditions could adversely affect our business, financial condition or results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets. A severe or prolonged
economic downturn, or additional global financial crises, could result in a variety of risks to our business, including weakened demand for our product candidates, if approved, or our ability to raise additional capital when needed on acceptable
terms, if at all. For example, the global financial crisis caused extreme volatility and disruptions in the capital and credit markets. Similarly, the recent significant volatility associated with
<FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;outbreak</FONT> has caused significant instability and disruptions in the capital and credit markets. A weak or declining economy could also strain our suppliers, possibly resulting in supply
disruption. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Provisions in our amended and restated certificate of incorporation, our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> and
Delaware law may have anti-takeover effects that could discourage an acquisition of us by others, even if an acquisition would be beneficial to our stockholders and may prevent attempts by our stockholders to replace or remove our current
management. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation, amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> and
Delaware law contain provisions that may have the effect of discouraging, delaying or preventing a change in control of us or changes in our management that stockholders may consider favorable, including transactions in which you might
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise receive a premium for your shares. Our amended and restated certificate of incorporation and <FONT STYLE="white-space:nowrap">by-laws</FONT> include provisions that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">authorize &#147;blank check&#148; preferred stock, which could be issued by our board of directors without
stockholder approval and may contain voting, liquidation, dividend and other rights superior to our common stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">create a classified board of directors whose members serve staggered three-year terms; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">specify that special meetings of our stockholders can be called only by our board of directors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibit stockholder action by written consent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our
stockholders, including proposed nominations of persons for election to our board of directors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide that vacancies on our board of directors may be filled only by a majority of directors then in office,
even though less than a quorum; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide that our directors may be removed only for cause; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">specify that no stockholder is permitted to cumulate votes at any election of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expressly authorize our board of directors to modify, alter or repeal our amended and restated <FONT
STYLE="white-space:nowrap">by-laws;</FONT> and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">require supermajority votes of the holders of our common stock to amend specified provisions of our amended and
restated certificate of incorporation and amended and restated <FONT STYLE="white-space:nowrap">by-laws.</FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These provisions, alone
or together, could delay or prevent hostile takeovers and changes in control or changes in our management. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, thereby
depressing the market price of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, because we are incorporated in the State of Delaware, we are governed by the provisions of
Section&nbsp;203 of the General Corporation Law of the State of Delaware, or the DGCL, which prohibits a person who owns in excess of 15% of our outstanding voting stock from merging or combining with us for a period of three years after the date of
the transaction in which the person acquired in excess of 15% of our outstanding voting stock, unless the merger or combination is approved in a prescribed manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any provision of our amended and restated certificate of incorporation, amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> or Delaware law
that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for
our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our amended and restated certificate of incorporation designates the state or federal courts within the State of Delaware as the
exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#146; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or
employees. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that, subject to limited exceptions, the state or federal courts (as
appropriate) within the State of Delaware will be exclusive forums for (1)&nbsp;any derivative action or proceeding brought on our behalf, (2)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or
other employees to us or our stockholders, (3)&nbsp;any action asserting a claim against us arising pursuant to any provision of the DGCL, our amended and restated certificate of incorporation or our amended and restated <FONT
STYLE="white-space:nowrap">by-laws,</FONT> (4)&nbsp;action against us or any of our directors or officers involving a claim or defense arising pursuant to the Exchange Act or the Securities Act or (5)&nbsp;any other action asserting a claim
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
against us that is governed by the internal affairs doctrine. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed to have notice of
and to have consented to the provisions of our amended and restated certificate of incorporation described above. This choice of forum provision may limit a stockholder&#146;s ability to bring a claim in a judicial forum that it finds favorable for
disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and employees. Alternatively, if a court were to find these provisions of our amended and restated certificate
of incorporation inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect
our business and financial condition. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_4"></A>ITEM&nbsp;1B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>UNRESOLVED STAFF COMMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_5"></A>ITEM&nbsp;2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PROPERTIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our corporate headquarters is located at 500 Technology Square, Suite 700, Cambridge, MA 02139, where we lease and occupy approximately 81,441 square feet of
office and laboratory space. The current term of our 500&nbsp;Technology Square lease expires in September 2028, with an option to extend the term five additional years with 12&nbsp;months&#146; notice at an agreed upon market rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe our existing facilities are sufficient for our needs for the foreseeable future. To meet the future needs of our business, we may lease additional
or alternate space, and we believe suitable additional or alternative space will be available in the future on commercially reasonable terms. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_6"></A>ITEM&nbsp;3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>LEGAL PROCEEDINGS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time, we may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that,
in the opinion of our management, are probable to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on our business, financial condition, results of operations and prospects because of
defense and settlement costs, diversion of management resources and other factors. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_7"></A>ITEM&nbsp;4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MINE SAFETY DISCLOSURES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_8"></A>PART II </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_4"></A><A NAME="tx105868_9"></A>ITEM&nbsp;5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MARKET FOR REGISTRANT&#146;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY
SECURITIES </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Information Regarding the Trading of Our Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock trades under the symbol &#147;FHTX&#148; on the Nasdaq Global Market and has been publicly traded since October&nbsp;23, 2020. Prior to this
time, there was no public market for our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Holders of Our Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of January&nbsp;31, 2021, there were approximately 90 holders of record of shares of our common stock. This number does not include stockholders for whom
shares are held in &#147;nominee&#148; or &#147;street&#148; name. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Securities Authorized for Issuance Under Equity Compensation Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information required by Item 5 of Form <FONT STYLE="white-space:nowrap">10-K</FONT> regarding equity compensation plans is incorporated herein by reference
to Item 12 of Part III of this Annual Report. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Sales of Unregistered Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Proceeds from Initial Public Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&nbsp;27, 2020, we closed our initial public offering, or IPO, of our common stock pursuant to which we issued and sold 7,500,000 shares of our
common stock at a price to the public of $16.00 per share for aggregate gross proceeds of $120.0&nbsp;million, before deducting underwriting discounts and commissions and other offering expenses. On November&nbsp;19, 2020, we sold an additional
951,837 shares of our common stock pursuant to the underwriters&#146; option to purchase additional shares in the IPO at the public offering price for an additional $15.2&nbsp;million in gross proceeds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of the shares issued and sold in the IPO were registered under the Securities Act pursuant to the Registration Statement,&nbsp;which was declared
effective by the SEC on October&nbsp;22, 2020. Goldman Sachs&nbsp;&amp; Co. LLC, Morgan Stanley&nbsp;&amp; Co. LLC and Cowen and Company, LLC acted as joint book-running managers and Wedbush Securities Inc. acted as lead manager of our IPO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We received aggregate net proceeds of approximately $122.1&nbsp;million after deducting underwriting discounts and commissions and other offering expenses.
None of the underwriting discounts and commissions or offering expenses were incurred or paid to directors or officers of ours or their associates or to persons owning 10&nbsp;percent or more of our common stock or to any of our affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have used approximately $12.1&nbsp;million of the net proceeds from the IPO as of&nbsp;December&nbsp;31, 2020 to advance
<FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT STYLE="white-space:nowrap">FHD-609</FONT> towards the clinic, to further invest in our pipeline and platform targeting the chromatin regulatory system and for working capital and other
general corporate purposes. There has been no material change in our planned use of the net proceeds from the offering as described in our Registration Statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Issuer Purchases of Equity Securities by the Issuer and Affiliated Purchasers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_10"></A>ITEM&nbsp;6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SELECTED FINANCIAL DATA </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a smaller reporting company, as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2&nbsp;under</FONT> the Securities Exchange Act of 1934, as
amended, for this reporting period and are not required to provide the information required under this item. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_11"></A>ITEM&nbsp;7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our
consolidated financial statements and the related notes to those statements included elsewhere in this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> In addition to historical financial information, the following discussion and
analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Some of the numbers included herein have been rounded for the convenience of presentation. Our actual results may differ materially from those
anticipated in these forward-looking statements as a result of many factors, including those discussed under &#147;Risk Factors&#148; and elsewhere in this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are pioneering the discovery and development
of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control platform gives us an integrated, mechanistic
understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system. Breakdowns in the chromatin regulatory system are associated with over
50&nbsp;percent of all cancers. Addressing these breakdowns could potentially provide therapies for over 2.5&nbsp;million patients. Consequently, we are initially focused in oncology. We are developing
<FONT STYLE="white-space:nowrap">FHD-286,</FONT> a selective, allosteric ATPase inhibitor and are currently initiating separate Phase 1 studies in metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia, or AML. The
investigational new drug applications for metastatic uveal melanoma and relapsed and/or refractory AML were accepted by the FDA in late December and early January, respectively. We are developing <FONT STYLE="white-space:nowrap">FHD-609,</FONT> a
targeted protein degrader, to treat synovial sarcoma, for which we plan to submit an investigational new drug application, or IND, in the second quarter of 2021. Our vision is to use our Gene Traffic Control platform to discover and develop drugs in
oncology and other therapeutic areas, including virology, autoimmune disease and neurology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our inception in October 2015, we have focused
substantially all of our resources on building our Gene Traffic Control&nbsp;platform, organizing and staffing our company, business planning, raising capital, conducting discovery and research activities, protecting our trade secrets, filing patent
applications, identifying potential product candidates, undertaking preclinical studies and clinical trial <FONT STYLE="white-space:nowrap">start-up</FONT> activities, establishing arrangements with third parties for the manufacture of initial
quantities of our product candidates and component materials. We do not have any products approved for sale and have not generated any revenue from product sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&nbsp;27, 2020, we completed our initial public offering, or IPO, pursuant to which we issued and sold 7,500,000 shares of our common stock at a
public offering price of $16.00 per share, resulting in net proceeds of $107.9&nbsp;million, after deducting underwriting discounts and commissions and other offering expenses. On November&nbsp;19, 2020, we issued and sold an additional 951,837
shares of common stock at the IPO price of $16.00&nbsp;per share pursuant to the underwriters&#146; partial exercise of their option to purchase additional shares of common stock, resulting in additional net proceeds of $14.2&nbsp;million after
deducting underwriting discounts and commissions. Prior to our IPO, we have funded our operations with proceeds from sales of preferred stock, term loans and an upfront payment of $15.0&nbsp;million we received in July 2020 under our collaboration
agreement with Merck Sharp&nbsp;&amp; Dohme Corp., or Merck. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have incurred significant operating losses since our inception. For the years ended
December&nbsp;31, 2020 and 2019, we reported net losses of $68.8&nbsp;million and $51.1&nbsp;million, respectively. As of December&nbsp;31, 2020, we had an accumulated deficit of $162.9&nbsp;million. We expect to continue to incur significant
expenses and increasing operating losses for at least the next several years. Our ability to generate any product revenue or product revenue sufficient to achieve profitability will depend on the successful development and eventual commercialization
of one or more product candidates we may develop. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect that our expenses and capital requirements will increase substantially in connection with our
ongoing activities, particularly if and as we: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance our <FONT STYLE="white-space:nowrap">FHD-286</FONT> and <FONT STYLE="white-space:nowrap">FHD-609</FONT>
product candidates and continue our preclinical development of product candidates from our current research programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identify additional research programs and additional product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">initiate preclinical testing for any new product candidates we identify and develop; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain, maintain, expand, enforce, defend and protect our trade secrets and intellectual property portfolio and
provide reimbursement of third-party expenses related to our patent portfolio; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hire additional research and development personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add operational, legal, compliance, financial and management information systems and personnel to support our
research, product development and operations as a public company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expand the capabilities of our platform; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> product candidates, intellectual property and
technologies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">operate as a public company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seek marketing approvals for any product candidates that successfully complete clinical trials; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ultimately establish a sales, marketing and distribution infrastructure to commercialize any products for which
we may obtain marketing approval. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will not generate revenue from product sales unless and until we successfully commercialize one of
our product candidates, after completing clinical development and obtaining regulatory approval. If we obtain regulatory approval for any of our product candidates, we expect to incur significant expenses related to developing our commercialization
capability to support product sales, marketing, and distribution. Further, we expect to incur additional costs associated with operating as a public company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until such time as we can
generate significant revenue from product sales, if ever, we expect to finance our operations through our collaboration agreement with Merck and a combination of equity offerings, debt financings and collaborations or licensing arrangements. We may
be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as, and when, needed, we may have to significantly delay,
scale back our development or commercialization plans for one or more of our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because of the numerous risks and uncertainties
associated with pharmaceutical product development, we are unable to accurately predict the timing or amount of increased expenses or when, or if, we will be able to achieve or maintain profitability. Even if we are able to generate product sales,
we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">COVID-19</FONT> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
March <FONT STYLE="white-space:nowrap">2020,&nbsp;COVID-19&nbsp;was</FONT> declared a global pandemic by the World Health Organization, and to date <FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;pandemic</FONT> continues to present a
substantial public health and economic challenge around the world.&nbsp;The length of time and full extent to which <FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;pandemic</FONT> will directly or indirectly impact our business, results of
operations and financial condition will depend on future developments that are highly uncertain, subject to change and are difficult to predict.&nbsp;While we continue to conduct our research and development activities, <FONT
STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;pandemic</FONT> may cause disruptions that affect our ability to initiate and complete preclinical studies, ongoing and future clinical trials or to procure items that are essential for our research
and development activities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We plan to continue to closely monitor the ongoing impact of
<FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;pandemic</FONT> on our employees and our business operations.&nbsp;In an effort to provide a safe work environment for our employees, we have, among other things, increased the cadence of
sanitization of our office and lab facilities, implemented various social distancing measures in our office and labs including replacing <FONT STYLE="white-space:nowrap">in-person&nbsp;meetings</FONT> with virtual interactions, and are providing
personal protective equipment for our employees present in our office and lab facilities.&nbsp;We expect to continue to take actions as may be required or recommended by government authorities or as we determine are in the best interests of our
employees and other business partners in light of the pandemic. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of Our Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Collaboration Revenue </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To date, we have not
generated any revenue from product sales and do not expect to generate any revenue from the sale of products in the near future. If our development efforts for our product candidates are successful and result in regulatory approval or licenses with
third parties, we may generate revenue in the future from product sales, milestone payments under our existing collaboration agreement or payments from other license agreements that we may enter into with third parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2020, we entered into a strategic research collaboration and license agreement, or the Collaboration Agreement, with Merck, pursuant to which we will
apply our proprietary Gene Traffic Control platform to discover and develop novel therapeutics. Under the Collaboration Agreement, we granted Merck exclusive global rights to develop and commercialize drugs that target dysregulation of a single
transcription factor. Under the terms of the Collaboration Agreement, we received a nonrefundable upfront payment of $15.0&nbsp;million from Merck, and are eligible to receive up to $245.0&nbsp;million upon achievement of specified research,
development and regulatory milestones by any product candidate generated by the collaboration, and up to $165.0&nbsp;million upon achievement of specified sales-based milestones per approved product from the collaboration, if any, as well as
royalties on sales of any approved product from the collaboration. We cannot provide assurance as to the timing of future milestone or royalty payments or that we will receive any of these payments at all. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We record revenue over the research term as we satisfy our performance obligation under the Collaboration Agreement. Accordingly, the upfront payment of
$15.0&nbsp;million is being recognized as revenue using the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> method, which we believe best depicts the transfer of control to the customer over time. Under
the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> method, the extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs expected upon
satisfying the identified single performance obligation. We expect revenue to fluctuate as the achievement of milestones becomes probable and as our efforts to satisfy our performance obligation vary from period to period. In estimating the total
costs to satisfy our performance obligation pursuant to the Collaboration Agreement, we are required to make significant estimates including an estimate of the number of transcription factor substitutions and the expected time and expected costs to
fulfill the performance obligation. The cumulative effect of revisions to the total estimated costs to complete our performance obligation will be recorded in the period in which the changes are identified, and amounts can be reasonably estimated.
While such revisions will have no impact on our cash flows, a significant change in these assumptions and estimates could have a material impact on the timing and amount of revenue recognized in future periods. As of December&nbsp;31, 2020, we
recorded $14.6&nbsp;million of the upfront payment as deferred revenue and recognized $0.4&nbsp;million of revenue under the Collaboration Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Operating Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our operating expenses are
comprised of research and development expenses and general and administrative expenses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development expenses consist primarily of costs incurred for our research activities, including our discovery efforts, and progressing our
programs, which include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">personnel-related costs, including salaries, benefits and stock-based compensation expense, for employees engaged
in research and development functions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenses incurred in connection with our research programs and preclinical and clinical development of our
product candidates, including under agreements with third parties, such as consultants and contractors and contract research organizations, or CROs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of manufacturing drug substance and drug product for use in our research and preclinical studies and
clinical trials under agreements with third parties, such as consultants and contractors and contract development and manufacturing organizations, or CDMOs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">laboratory supplies and research materials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">facilities, depreciation and amortization and other expenses, which include direct and allocated expenses for
rent and maintenance of facilities and insurance; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">payments made under third-party licensing agreements. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We track our direct external research and development expenses on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">program-by-program</FONT></FONT> basis. These consist of costs that include fees, reimbursed materials, and other costs paid to consultants, contractors, CDMOs, and CROs in connection
with our preclinical, clinical and manufacturing activities. We do not allocate employee costs, costs associated with our discovery efforts, laboratory supplies, and facilities expenses, including depreciation or other indirect costs, to specific
product development programs because these costs are deployed across multiple programs and our platform and, as such, are not separately classified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
expect that our research and development expenses will increase substantially as we advance our programs into clinical development and expand our discovery, research and preclinical activities in the near term and in the future. At this time, we
cannot accurately estimate or know the nature, timing and costs of the efforts that will be necessary to complete the preclinical and clinical development of any product candidates we may develop.&nbsp;A change in the outcome of any number of
variables with respect to product candidates we may develop could significantly change the costs and timing associated with the development of that product candidate. We may never succeed in obtaining regulatory approval for any product candidates
we may develop. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">General and administrative expenses consist primarily of personnel-related costs, including salaries, benefits and stock-based compensation, for employees
engaged in executive, legal, finance and accounting and other administrative functions. General and administrative expenses also include professional fees for legal, patent, consulting, investor and public relations and accounting and audit services
as well as direct and allocated facility-related costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We anticipate that our general and administrative expenses will increase in the future as we
increase our headcount to support our continued research activities and development of our programs and platform. We also anticipate that we will continue to incur increased accounting, audit, legal, regulatory, compliance, director and officer
insurance costs and investor and public relations expenses associated with operating as a public company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Income (Expense) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Interest Expense </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest expense consists of interest
expense associated with outstanding borrowings under our loan agreements as well as the amortization of debt discount associated with such agreements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Interest Income and Other Income (Expense), Net </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest income consists of interest earned on our invested cash balances. Other income (expense) consists of sublease income and miscellaneous expense
unrelated to our core operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Income Taxes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our inception, we have not recorded any income tax benefits for the net losses we have incurred or for the research and development tax credits earned in
each period, as we believe, based upon the weight of available evidence, that it is more likely than not that all of our net operating loss carryforwards and tax credit carryforwards will not be realized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, we had federal and state net operating loss carryforwards of $147.3&nbsp;million and $132.3&nbsp;million, respectively, which
may be available to offset future taxable income. The federal net operating loss carryforwards include $12.5&nbsp;million&nbsp;which expire at various dates beginning in&nbsp;2035&nbsp;and&nbsp;$134.8&nbsp;million which carryforward indefinitely but
in some circumstances may be limited to offset 80% of annual taxable income. The state net operating loss carryforwards expire at various dates beginning in&nbsp;2036. As of December&nbsp;31, 2020, we also had federal and state research and
development tax credit carryforwards of $3.4&nbsp;million and $2.0&nbsp;million, respectively, which may be available to reduce future tax liabilities and expire at various dates beginning in 2036 and 2031, respectively. Due to our history of
cumulative net losses since inception and uncertainties surrounding our ability to generate future taxable income, we have recorded a full valuation allowance against our net deferred tax assets at each balance sheet date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies and Significant Judgments and Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States, or GAAP. The preparation
of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, costs and expenses and the disclosure of contingent assets and liabilities
in our consolidated financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different
assumptions or conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While our significant accounting policies are described in more detail in Note&nbsp;2 to our consolidated financial statements
appearing elsewhere in this Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT> we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated
financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Revenue Recognition </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
account for our one collaboration arrangement, entered into in July 2020, under ASC Topic&nbsp;606,<I></I><I>&nbsp;Revenue From Contracts With Customers</I>&nbsp;(ASC&nbsp;606). Under ASC&nbsp;606, an entity recognizes revenue when its customer
obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements within the scope of ASC 606, the
entity performs the following five steps: (i)&nbsp;identify the contract(s) with a customer; (ii)&nbsp;identify the performance obligations in the contract; (iii)&nbsp;determine the transaction price, including variable consideration, if any;
(iv)&nbsp;allocate the transaction price to the performance obligations in the contract; and (v)&nbsp;recognize revenue when (or as) the entity satisfies a performance obligation. We only apply the five-step model to contracts when it is probable
that we will collect the consideration to which we are entitled in exchange for the goods or services we transfer to the customer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We assess the goods or services promised within each contract and determine those that are performance
obligations. The promised goods or services in our arrangements would likely consist of licenses, rights to our intellectual property, research and development services and related supporting activities. Arrangements that include rights to
additional goods or services that are exercisable at a customer&#146;s discretion are generally considered options. We assess if these options provide a material right to the customer and if so, they are considered performance obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We assess whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment
involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are
considered distinct provided that: (i)&nbsp;the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct)
and (ii)&nbsp;the entity&#146;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the
contract). In assessing whether a promised good or service is distinct, we consider factors such as the research, development, manufacturing and commercialization capabilities of the customer and the availability of the associated expertise in the
general marketplace. We also consider the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is
required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
transaction price is then determined and allocated to the identified performance obligations in proportion to their standalone selling prices (&#147;SSP&#148;) on a relative SSP basis. SSP is determined at contract inception and is not updated to
reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In developing the SSP for a performance obligation, we consider applicable
market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs. We validate the SSP for performance obligations by evaluating whether changes in the
key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the consideration promised in a contract includes a variable amount, we estimate the amount of consideration to which we will be entitled to in exchange
for transferring the promised goods or services to a customer. We determine the amount of variable consideration by using the expected value method or the most likely amount method. We include the unconstrained amount of estimated variable
consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent
reporting period, <FONT STYLE="white-space:nowrap">we&nbsp;re-evaluate&nbsp;the</FONT> estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjust our estimate of the overall transaction
price. Any such adjustments are recorded on a <FONT STYLE="white-space:nowrap">cumulative&nbsp;catch-up&nbsp;basis</FONT> in the period of adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If
an arrangement includes development and regulatory milestone payments, we evaluate whether the milestones are considered probable of being reached and estimate the amount to be included in the transaction price using the most likely amount method.
If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within our control such as regulatory approvals, are generally not considered
probable of being achieved until those approvals are received. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For arrangements with licenses of intellectual property that include sales-based
royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, we recognize royalty revenue and sales-based milestones at the later of (i)&nbsp;when the
related sales occur, or (ii)&nbsp;when the performance obligation to which the royalty has been allocated has been satisfied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We record amounts as accounts receivable when the right to consideration is deemed unconditional. When
consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded for deferred revenue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In determining the transaction price, we adjust consideration for the effects of the time value of money if the timing of payments provides us with a
significant benefit of financing. We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between the transfer of the promised goods or services to the customer and
the payment by the customer will be one year or less. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a
point in time or over time, and if over time, recognition is based on the use of an output or input method. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Under&nbsp;the&nbsp;cost-to-cost&nbsp;method,&nbsp;the</FONT></FONT> extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs expected upon satisfying the
identified single performance obligation. In estimating the total costs to satisfy our performance obligation, we are required to make significant estimates including an estimate of the expected time and expected costs to fulfill the performance
obligation.&nbsp;The cumulative effect of revisions to the total estimated costs to complete our performance obligation will be recorded in the period in which the changes are identified, and amounts can be reasonably estimated. While such revisions
will have no impact on our cash flows, a significant change in these assumptions and estimates could have a material impact on the timing and amount of revenue recognized in future periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Accrued Research and Development Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part
of the process of preparing our consolidated financial statements, we are required to estimate certain accrued research and development expenses. This process involves estimating the level of service performed and the associated cost incurred for
the service when we have not yet been invoiced or otherwise notified of actual costs. We make estimates of our accrued expenses as of each balance sheet date in our consolidated financial statements based on facts and circumstances known to us at
that time. We periodically confirm the accuracy of the estimates with the service providers and make adjustments if necessary. Examples of estimated accrued research and development expenses include those related to fees paid to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">vendors in connection with discovery, preclinical and clinical development activities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">CROs in connection with preclinical studies and testing and clinical trials; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">CDMOs in connection with the process development and scale up activities and the production and manufacturing of
materials. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We base the expense recorded related to contract research and manufacturing on our estimates of the services received and
efforts expended pursuant to quotes and contracts with multiple CROs and CDMOs that conduct services and produce and supply materials. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result
in uneven payment flows. In accruing service fees, we estimate the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort
varies from the estimate, we adjust the accrual accordingly. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual
status and timing of services performed may vary and may result in reporting amounts that are too high or too low in any particular period. While the majority of our service providers invoice us in arrears for services performed, on a <FONT
STYLE="white-space:nowrap">pre-determined</FONT> schedule or when contractual milestones are met; some require advance payments. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a
prepayment of the expense. We record these as prepaid expenses on our consolidated balance sheet. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-based Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We measure all stock-based awards granted to <FONT STYLE="white-space:nowrap">employees,&nbsp;non-employees&nbsp;and</FONT> directors based on their fair value
on the date of the grant using the Black-Scholes option-pricing model for options or the difference between the purchase price, if any, and the fair value of our common stock for restricted stock awards. Compensation expense for awards with
service-based vesting is generally recognized over the vesting period of the award using the straight-line method to record the expense. We use the graded-vesting method to record the expense of awards with both service-based and performance-based
vesting conditions, commencing once achievement of the performance condition becomes probable. The Black-Scholes option-pricing model uses as inputs the fair value of our common stock and assumptions we make for the expected volatility of our common
stock, the expected term of stock options, the risk-free interest rate for a period that approximates the expected term of our common stock options and our expected dividend yield. We account for forfeitures of share-based awards as they occur. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Years
Ended December&nbsp;31, 2020 and 2019 </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our results of operations for the years ended December&nbsp;31, 2020 and
2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">430</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">430</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,362</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,877</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,531</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,084</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(17,447</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(540</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(439</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income and other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">506</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of preferred stock warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(69</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(70</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on debt extinguishment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(222</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(222</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(269</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(44</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,128</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(17,672</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Collaboration Revenue </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Collaboration revenue recognized during the year ended December&nbsp;31, 2020 of $0.4&nbsp;million was related to our Collaboration Agreement. The upfront
payment of $15.0&nbsp;million was initially recorded as deferred revenue and is being recognized as revenue under <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">the&nbsp;cost-to-cost&nbsp;method.</FONT></FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our research and development expenses for the years ended December&nbsp;31, 2020 and 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development program expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">FHD-286</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">FHD-609</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,871</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Platform, research and discovery, and unallocated expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Platform and other early stage research external costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,522</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Personnel related (including stock-based compensation)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,822</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Facility related and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,362</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development expenses were $57.7&nbsp;million for the year ended December&nbsp;31, 2020, compared to
$44.4&nbsp;million for the year ended December&nbsp;31, 2019. The increase in our <FONT STYLE="white-space:nowrap">FHD-286</FONT> program costs of $0.1&nbsp;million was due to an increase in preclinical, manufacturing, and clinical trial <FONT
STYLE="white-space:nowrap">start-up</FONT> costs, partially offset by a decrease in research costs as we progressed towards an IND submission in December 2020. The increase in our <FONT STYLE="white-space:nowrap">FHD-609</FONT> program costs of
$1.9&nbsp;million was due to an increase in preclinical and manufacturing costs, partially offset by a decrease in research costs as we progressed our program candidate into <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies. Platform and
other early-stage research external costs, which include our selective BRM and selective ARID1B early-stage programs, increased by $0.2&nbsp;million, primarily as a result of an increase in selective BRM costs as a result of our ongoing <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">hit-to-lead</FONT></FONT> efforts. Personnel-related costs increased by $4.6&nbsp;million due primarily to increased headcount in our research and development function. The increase in
facility-related expenses and other of $6.5&nbsp;million was due to the increased costs of supporting a larger group of research and development personnel and their research efforts, including increased rent expense related to our new facility
lease, which commenced in January 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our general and administrative expenses for the years ended December&nbsp;31, 2020 and 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Personnel related (including stock-based compensation)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,732</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional and consultant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,153</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Facility related and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total general and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">General and administrative expenses were $11.2&nbsp;million for the year ended December&nbsp;31, 2020, compared to
$6.7&nbsp;million for the year ended December&nbsp;31, 2019. The increase in personnel-related costs of $2.3&nbsp;million was a result of an increase in headcount in our general and administrative function to support our business. The increase in
professional and consultant fees of $1.2&nbsp;million was primarily due to higher costs associated with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
operating as a public company. The increase in facility-related expenses and other of $1.1&nbsp;million was due to the increased rent expense related to our new facility lease, which commenced in
January 2020 as well as an increase due to directors and officers insurance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Income (Expense) </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest expense was $1.0&nbsp;million for the year ended December&nbsp;31, 2020, compared to $0.5&nbsp;million for the year ended December&nbsp;31, 2019. The
increase was due primarily to increased borrowings under our loan facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest income and other income (expense), net was $1.0&nbsp;million for the
year ended December&nbsp;31, 2020 and consisted primarily of sublease income of $1.0&nbsp;million related to the sublease that began in July 2020 and $0.1&nbsp;million of interest income. Interest income and other income (expense), net of
$0.5&nbsp;million for the year ended December&nbsp;31, 2019 consisted primarily of $0.5&nbsp;million of interest income. Interest income decreased from the year ended December&nbsp;31, 2019 to the same period in 2020 primarily due to lower interest
rates on invested balances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We recorded a loss on debt extinguishment of $0.2&nbsp;million for the year ended December&nbsp;31, 2020. We used proceeds
from a new loan and security agreement entered into in November 2020 to repay the balance of our prior loan outstanding at the time including a final payment fee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our inception in
October 2015, we have incurred significant operating losses. We expect to incur significant expenses and operating losses for the foreseeable future as we support our continued research activities and development of our programs and platform.
Through December&nbsp;31, 2020, we have funded our operations with proceeds from our IPO in October 2020, sales of preferred stock, term loans and an upfront payment of $15.0&nbsp;million we received in July 2020 under our Collaboration Agreement.
As of December&nbsp;31, 2020, we had cash, cash equivalents and marketable securities of $185.8&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our sources and uses of cash for each of the periods presented: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(31,286</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(46,335</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(108,914</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(964</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">217,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase (decrease) in cash, cash equivalents and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(23,330</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Operating Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2020, operating activities used $31.3&nbsp;million of cash, resulting from our net loss of $68.8&nbsp;million,
partially offset by net <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $8.8&nbsp;million and net cash provided by changes in our operating assets and liabilities of $28.7&nbsp;million. Net cash provided by changes in our operating
assets and liabilities for the year ended December&nbsp;31, 2020 consisted primarily of a $15.1&nbsp;million increase in operating lease liabilities resulting from our landlord incentives received, a $14.6&nbsp;million increase in deferred revenue
resulting from the upfront payment received in connection with our Collaboration Agreement and an increase of $3.7&nbsp;million in accounts payable and accrued expenses and other current liabilities, partially offset by an increase of
$4.7&nbsp;million in prepaid expenses and other assets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, operating activities used $46.3&nbsp;million of cash,
resulting from our net loss of $51.1&nbsp;million, partially offset by <FONT STYLE="white-space:nowrap">net&nbsp;non-cash&nbsp;charges</FONT> of $3.6&nbsp;million and net cash provided by changes in our operating assets and liabilities of
$1.2&nbsp;million. Net cash provided by changes in our operating assets and liabilities for the year ended December&nbsp;31, 2019 consisted primarily of a $3.3&nbsp;million increase in accounts payable and accrued expenses and other current
liabilities, partially offset by a $1.2&nbsp;million decrease in operating lease liabilities and a $1.0&nbsp;million increase in prepaid expenses and other assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in accounts payable, accrued expenses and other current liabilities and prepaid expenses and other assets in all periods were generally due to growth
in our business, the advancement of our research programs and the timing of vendor invoicing and payments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Investing Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2020, net cash used in investing activities was $108.9&nbsp;million primarily due to the purchases of marketable
securities of $93.0&nbsp;million and the acquisition of property and equipment of $16.2&nbsp;million. Property and equipment purchases for the year ended December&nbsp;31, 2020 were primarily related to leasehold improvements for our new facility in
Cambridge, Massachusetts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, net cash used by investing activities was $1.0&nbsp;million due to the
acquisition of property and equipment during the year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Financing Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2020, net cash provided by financing activities was $217.5&nbsp;million, consisting primarily of proceeds from our IPO,
net of underwriting discounts and commissions and other offering expenses of $122.1&nbsp;million, net proceeds from the sale of our Series B preferred stock of $89.9&nbsp;million, net borrowings of $4.3&nbsp;million and proceeds from the exercise of
common stock options of $1.2&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, net cash provided by financing activities was
$24.0&nbsp;million, consisting of proceeds from the sale of our Series B preferred stock of $15.3&nbsp;million, proceeds from borrowings under our loan and security agreement of $8.0&nbsp;million and proceeds from the exercise of common stock
options of $0.7&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Loan and Security Agreement with Oxford </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;19, 2020, we entered into a new loan and security agreement, or the Oxford Loan, with Oxford Finance LLC, or Oxford, for an aggregate
principal amount of $20.0&nbsp;million (Oxford Term Loan A) and up to an additional $5.0&nbsp;million (Oxford Term Loan B). The Term Loan bears interest at a floating per annum rate equal to the greater of (i) 8.0% and (ii)&nbsp;the sum of <FONT
STYLE="white-space:nowrap">(a)&nbsp;thirty-day</FONT> U.S. DOLLAR LIBOR rate reported in The Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue, plus (b) 7.84%. In
addition, upon loan maturity or prepayment, we are reqired to make a final payment fee equal to 5.0% of the aggregate principal amount borrowed. We are required to make monthly interest only payments under the Oxford Loan on the first calendar day
of each month beginning on January&nbsp;1, 2021. Beginning on December&nbsp;1, 2023, we are required to make consecutive equal monthly payments of principal, together with applicable interest, in arrears, based upon a repayment schedule equal to 24
months, with a final maturity date of November&nbsp;1, 2025. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our obligations under the Oxford Loan Agreement are secured by a security interest in all of
our assets, other than our intellectual property. We are also subject to certain affirmative and negative covenants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;19, 2020, we used
the proceeds from the Oxford Loan Agreement to pay in full the outstanding amounts under the Loan and Security Agreement with Comerica. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Funding Requirements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we advance the preclinical activities and initiate
clinical trials for our product candidates in development. We believe that the net proceeds from our IPO in October 2020, together with our existing cash, cash equivalents and marketable securities, will enable us to fund our operating expenses,
capital expenditure requirements and debt service payments into the third quarter of 2022. We have based these estimates as to how long we expect we will be able to fund our operations on assumptions that may prove to be inaccurate. We could use our
available capital resources sooner than we currently expect, in which case we would be required to obtain additional financing sooner than planned, which may not be available to us on acceptable terms, or at all. Our failure to raise capital as and
when needed would have a negative impact on our financial condition and our ability to pursue our business strategy. We will be required to obtain further funding through public or private equity offerings, debt financings, collaborations and
licensing arrangements or other sources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we are unable to raise sufficient capital as and when needed, we may be required to significantly curtail,
delay or discontinue one or more of our research or development programs or the commercialization of any product candidate we may develop, or be unable to expand our operations or otherwise capitalize on our business opportunities. If we raise
additional funds through collaborations or licensing arrangements with third parties, we may have to relinquish valuable rights to future revenue streams or product candidates or grant licenses on terms that may not be favorable to us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Off-balance&nbsp;Sheet</FONT> Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We did not have during the periods presented, and we do not currently have, <FONT STYLE="white-space:nowrap">any&nbsp;off-balance&nbsp;sheet</FONT>
arrangements, as defined in the rules and regulations of the Securities and Exchange Commission. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recently Issued Accounting Pronouncements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in
Note&nbsp;2 to our consolidated financial statements appearing elsewhere in this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_12"></A>ITEM&nbsp;7A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a smaller reporting company, as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2&nbsp;under</FONT> the Securities Exchange Act of 1934, as
amended, for this reporting period and are not required to provide the information required under this item. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx105868_13"></A>ITEM&nbsp;8. CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOGHORN THERAPEUTICS INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_100"></A>Index to Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_50">Report of Independent Registered Public Accounting Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_51">Consolidated Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_52">Consolidated Statements of Operations and Comprehensive
Loss</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_53">Consolidated Statements of Convertible Preferred Stock and Stockholders&#146;
 Equity (Deficit)</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_54">Consolidated Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx105868_55">Notes to Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_50"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders and the Board of Directors of Foghorn Therapeutics Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion on the Financial Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the
accompanying consolidated balance sheets of Foghorn Therapeutics Inc. and its subsidiary (the &#147;Company&#148;), as of December&nbsp;31, 2020 and 2019, the related consolidated statements of operations and comprehensive loss, convertible
preferred stock and stockholders&#146; equity (deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the &#147;financial statements&#148;). In our opinion, the financial statements present fairly, in
all material respects, the financial position of the Company as of December&nbsp;31, 2020 and 2019, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the
United States of America. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for Opinion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These
financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on the Company&#146;s financial statements based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange
Commission and the PCAOB. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over
financial reporting. Accordingly, we express no such opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our audits included performing procedures to assess the risks of material misstatement of
the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our
audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our
opinion. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Deloitte&nbsp;&amp; Touche LLP </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston,
Massachusetts </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;18, 2021 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as the
Company&#146;s auditor since 2018. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Foghorn Therapeutics Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_51"></A>Consolidated Balance Sheets </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except share and per share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">541</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">190,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,528</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,683</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">255,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities, Convertible Preferred Stock and Stockholders&#146; Equity (Deficit)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,680</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notes payable, net of discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,846</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,652</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notes payable, net of discount and current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities, net of current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue, net of current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109,407</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commitments and contingencies (Note 13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock (Series <FONT STYLE="white-space:nowrap">A-1,</FONT> <FONT
STYLE="white-space:nowrap">A-2</FONT> and B), $0.0001 par value; no shares and 28,629,622 shares authorized at December&nbsp;31, 2020 and 2019, respectively; no shares and 28,615,546 shares issued and outstanding at December&nbsp;31, 2020 and 2019,
respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; equity (deficit):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, $0.0001 par value; 25,000,000 shares authorized as of December&nbsp;31, 2020; no
shares issued or outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.0001 par value; 175,000,000 and 46,600,000 shares authorized at December&nbsp;31,
2020 and 2019, respectively; 36,790,946 shares issued and outstanding at December&nbsp;31, 2020 and 5,762,745 shares issued and 4,870,851 shares outstanding at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">309,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(162,936</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(94,136</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">146,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(88,016</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities, convertible preferred stock and stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">255,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Foghorn Therapeutics Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_52"></A>Consolidated Statements of Operations and Comprehensive Loss </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except share and per share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">430</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,362</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,531</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,084</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(979</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(540</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income and other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of preferred stock warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(69</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on debt extinguishment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(222</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(269</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(44</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,128</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share attributable to common stockholders&#151;basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6.23</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(12.20</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average common shares outstanding&#151;basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,046,802</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,191,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,128</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive loss:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized losses on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,807</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,128</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Foghorn Therapeutics Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_53"></A>Consolidated Statements of Convertible Preferred Stock and Stockholders&#146; Equity (Deficit) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series <FONT STYLE="white-space:nowrap">A-1,</FONT> <FONT STYLE="white-space:nowrap">A-2</FONT> and B<BR>Convertible<BR>Preferred&nbsp;Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common&nbsp;Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR><FONT STYLE="white-space:nowrap">Paid-in</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive</B><br><B>Loss</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholders&#146;<BR>Equity</B><br><B>(Deficit)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Balances at December&nbsp;31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,575,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71,250</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,475,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(43,008</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(39,273</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of Series B convertible preferred stock, net of issuance costs of $6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,040,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,294</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of common stock upon exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">503,808</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Vesting of restricted stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">891,891</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,694</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,694</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,128</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,128</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Balances at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,615,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86,544</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,870,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(94,136</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(88,016</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of Series B convertible preferred stock, net of issuance costs of $198</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,007,867</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89,861</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Conversion of preferred stock to common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(40,623,413</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(176,405</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,958,588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">176,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">176,405</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of common stock upon initial public offering net of underwriting discounts, commissions
and offering costs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,451,837</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Conversion of warrant liability to equity upon closing of initial public offering</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of common stock in connection with the cashless exercise of warrants</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of common stock upon exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">611,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of warrants in connection with notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Vesting of restricted stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">891,894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Unrealized losses on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Balances at December&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36,790,946</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">309,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(162,936</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">146,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Foghorn Therapeutics Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_54"></A>Consolidated Statements of Cash Flows </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from operating activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,128</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,694</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Gain) loss on disposal of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(206</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on debt extinguishment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of preferred stock warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Noncash lease expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Noncash interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion of discount on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,670</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(991</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">474</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,160</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(31,286</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(46,335</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from investing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16,183</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(968</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from sale of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(92,981</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(108,914</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(964</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from initial public offering, net of underwriting discounts, commissions and offering
costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of convertible preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of common stock upon exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of notes payable, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayments of notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(15,530</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">217,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net increase (decrease) in cash, cash equivalents and restricted cash</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(23,330</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and restricted cash at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40,585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and restricted cash at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94,528</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental cash flow information:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental disclosure of noncash investing and financing information:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property and equipment included in accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion of redeemable convertible preferred stock to common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">176,405</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion of warrant liability to equity upon closing of initial public offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of warrants in connection with notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Reconciliation of cash, cash equivalents and restricted cash:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash (current and <FONT STYLE="white-space:nowrap">non-current)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cash, cash equivalents and restricted cash shown in the statement of cash flows</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94,528</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Foghorn Therapeutics Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_55"></A>Notes to Consolidated Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Nature of Business and Basis of Presentation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Foghorn
Therapeutics&nbsp;Inc. (the &#147;Company&#148;) is a clinical-stage biopharmaceutical company discovering and developing a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. The Company uses
its proprietary Gene Traffic Control platform to identify, validate and potentially drug targets within the system. The Company was founded in October 2015 as a Delaware corporation. The Company is headquartered in Cambridge, Massachusetts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is subject to risks similar to those of other early-stage companies in the biopharmaceutical industry, including dependence on key individuals,
the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and the need to obtain adequate
additional financing to fund the development of its products. There can be no assurance that the Company&#146;s research and development will be successfully completed, that adequate protection for the Company&#146;s intellectual property will be
maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#146;s development efforts are successful, it is uncertain when, if ever, the Company
will generate significant revenue from the sale of its products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2020, the World Health Organization declared the global novel coronavirus
disease 2019 <FONT STYLE="white-space:nowrap">(&#147;COVID-19&#148;)&nbsp;outbreak</FONT> a pandemic. The Company&#146;s operations have not been significantly impacted by <FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;pandemic.</FONT>
However, the Company cannot at this time predict the specific extent, duration, or full impact that <FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;pandemic</FONT> will have on its financial condition and operations, including ongoing and
planned clinical trials. The impact of <FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;outbreak</FONT> on the Company&#146;s financial performance will depend on future developments, including the duration and spread of the pandemic and
related governmental advisories and restrictions. These developments and the impact <FONT STYLE="white-space:nowrap">of&nbsp;COVID-19&nbsp;on</FONT> the financial markets and the overall economy are highly uncertain and cannot be predicted. If the
financial markets and/or the overall economy are impacted for an extended period, the Company&#146;s results may be materially adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
October&nbsp;27, 2020, the Company completed its initial public offering (&#147;IPO&#148;) pursuant to which it issued and sold 7,500,000 shares of its common stock at a public offering price of $16.00 per share, resulting in net proceeds of
$107.9&nbsp;million, after deducting underwriting discounts and commissions and other offering expenses. On November&nbsp;19, 2020, the Company issued and sold an additional 951,837 shares of common stock at the IPO price of $16.00 per share
pursuant to the underwriters&#146; partial exercise of their option to purchase additional shares of common stock, resulting in additional net proceeds of $14.2&nbsp;million after deducting underwriting discounts and commissions. Upon the closing of
the IPO, all of the Company&#146;s outstanding convertible preferred stock automatically converted into shares of common stock and the Company&#146;s outstanding warrants to purchase Series&nbsp;A Preferred Stock automatically became warrants to
purchase an aggregate of 7,608 shares of common stock (see Note 7). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared on the basis of
continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. Since inception, the Company has funded its operations primarily with proceeds from sales of preferred stock,
debt financing and an upfront payment of $15.0&nbsp;million the Company received in July 2020 under a collaboration agreement with Merck Sharp&nbsp;&amp; Dohme Corp. (see Note 10), and most recently, with proceeds from the sale of common stock in
the IPO completed in October 2020. The Company has incurred recurring losses, including net losses of $68.8&nbsp;million and $51.1&nbsp;million for the years ended December&nbsp;31, 2020 and 2019, respectively. As of December&nbsp;31, 2020, the
Company had an accumulated deficit of $162.9&nbsp;million. The Company expects to continue to generate operating losses in the foreseeable future. As of the issuance date of these consolidated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
financial statements the Company expects that its cash, cash equivalents and marketable securities will be sufficient to fund its operating expenses and capital expenditure requirements for at
least 12 months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will need to obtain additional funding through public or private equity offerings, debt financings, collaborations,
strategic alliances and/or licensing arrangements. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborative or strategic alliances or licensing arrangements. The
terms of any financing may adversely affect the holdings or the rights of the Company&#146;s stockholders. Arrangements with collaborators or others may require the Company to relinquish rights to certain of its technologies or programs. If the
Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate some or all of its research and development programs, pipeline expansion or commercialization efforts, which could adversely affect its business
prospects. Although management will continue to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations when needed or at all.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis of presentation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s
consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#147;GAAP&#148;). The accompanying consolidated financial statements include the accounts of the
Company and its wholly owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting
Standards Codification (&#147;ASC&#148;) and Accounting Standards Update (&#147;ASU&#148;) of the Financial Accounting Standards Board (&#147;FASB&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Summary of Significant Accounting Policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Use
of estimates </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions
reflected in these consolidated financial statements include, but are not limited to, revenue recognition, the valuation of stock-based awards and the accrual of research and development expenses. The Company bases its estimates on historical
experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and
experience. Actual results may differ from those estimates or assumptions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Concentrations of credit risk and of significant suppliers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents and marketable
securities. As of December&nbsp;31, 2020, the Company maintained cash, cash equivalents and marketable securities at financial institutions in excess of federally insured limits. The Company does not believe that it is subject to unusual credit risk
beyond the normal credit risk associated with commercial banking relationships. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company relies, and expects to continue to rely, on a small number of
vendors to provide services, supplies and materials for certain activities related to its programs. These programs could be adversely affected by a significant interruption in these services or the availability of materials. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash equivalents </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers all highly
liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Marketable Securities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s marketable securities are classified
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">as&nbsp;available-for-sale&nbsp;and</FONT></FONT> are carried at fair value with the unrealized gains and losses reported as a component of accumulated other comprehensive loss in
stockholders&#146; equity (deficit). Realized gains and losses and declines in value judged to be other than temporary are included as a component of interest income and other income (expense), net based on the specific identification method. The
Company classifies its marketable securities with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities are available for current operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted cash </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amounts included in restricted
cash represent amounts pledged as collateral for letters of credit required for security deposits on the Company&#146;s leased facilities and credit cards. These amounts are classified as restricted cash (current and
<FONT STYLE="white-space:nowrap">non-current)</FONT> in the Company&#146;s consolidated balance sheets. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Property and equipment </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense is recognized using the
straight-line method over the estimated useful life of each asset as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Estimated&nbsp;Useful&nbsp;Life</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Laboratory equipment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">5 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Furniture and fixtures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">5 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Computer equipment and software</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">3 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Leasehold improvements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Shorter&nbsp;of&nbsp;useful&nbsp;life&nbsp;or&nbsp;remaining&nbsp;term&nbsp;of&nbsp;lease</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Costs for capital assets not yet placed into service are depreciated once placed into service. Upon retirement or sale, the
cost of assets disposed of and the related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is included in loss from operations. Expenditures for repairs and maintenance are charged to expense as
incurred. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Impairment of long-lived assets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company evaluates its long-lived assets, which consist primarily of property and equipment and operating lease <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is
measured by a comparison of the carrying amount of an asset to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by
which the carrying amount of the asset exceeds the fair value of the asset. The Company did not record any impairment losses on long-lived assets during the years ended December&nbsp;31, 2020 or 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fair value measurements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain assets and
liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability
in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities
carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level&nbsp;1&#151;Quoted prices in active markets for identical assets or liabilities. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level&nbsp;2&#151;Observable inputs (other than Level&nbsp;1 quoted prices), such as quoted prices in active
markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level&nbsp;3&#151;Unobservable inputs that are supported by little or no market activity and that are significant
to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s cash equivalents and marketable securities are carried at fair value, determined according to the fair value hierarchy described above (see
Note&nbsp;3). The carrying values of the Company&#146;s accounts payable and accrued expenses approximate their fair values due to the short-term nature of these liabilities. The carrying value of the Company&#146;s long-term debt approximates its
fair value (a level 2 measurement) due to its variable interest rate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Revenue recognition </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for its one collaboration arrangement, entered into in July 2020, under ASC Topic&nbsp;606,<I></I><I>&nbsp;Revenue From Contracts With
Customers</I>&nbsp;(ASC 606). For additional information on the Company&#146;s collaboration agreement, see Note 10,&nbsp;Collaboration&nbsp;Agreement, to these consolidated financial statements. Under ASC 606, an entity recognizes revenue when its
customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements within the scope of ASC
606, the entity performs the following five steps: (i)&nbsp;identify the contract(s) with a customer; (ii)&nbsp;identify the performance obligations in the contract; (iii)&nbsp;determine the transaction price, including variable consideration, if
any; (iv)&nbsp;allocate the transaction price to the performance obligations in the contract; and (v)&nbsp;recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when
it is probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company assesses the goods or services promised within each contract and determines those that are performance obligations. The promised goods or services
in the Company&#146;s arrangements would likely consist of licenses, rights to the Company&#146;s intellectual property, research and development services and related supporting activities. Arrangements that include rights to additional goods or
services that are exercisable at a customer&#146;s discretion are generally considered options. The Company assesses if these options provide a material right to the customer and if so, they are considered performance obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This
assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and
services are considered distinct provided that: (i)&nbsp;the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of
being distinct) and (ii)&nbsp;the entity&#146;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the
context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the research, development, manufacturing and commercialization capabilities of the customer and the availability of the
associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or
service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction price is then determined and allocated to the identified performance obligations in proportion to their standalone selling prices
(&#147;SSP&#148;) on a relative SSP basis. SSP is determined at contract inception and is not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
updated to reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In
developing the SSP for a performance obligation, the Company considers applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs.
The Company validates the SSP for performance obligations by evaluating whether changes in the key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance
obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will
be entitled in exchange for transferring the promised goods or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The Company includes the
unconstrained amount of estimated variable consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will
not occur. At the end of each subsequent reporting period, the <FONT STYLE="white-space:nowrap">Company&nbsp;re-evaluates&nbsp;the</FONT> estimated variable consideration included in the transaction price and any related constraint, and if
necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a <FONT STYLE="white-space:nowrap">cumulative&nbsp;catch-up&nbsp;basis</FONT> in the period of adjustment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being
reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price.
Milestone payments that are not within the Company&#146;s control such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For arrangements with licenses of intellectual property that include sales-based royalties, including milestone payments based on the level of sales, and the
license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestones at the later of (i)&nbsp;when the related sales occur, or (ii)&nbsp;when the performance obligation to
which the royalty has been allocated has been satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company records amounts as accounts receivable when the right to consideration is deemed
unconditional. When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded for deferred
revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments
provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between the transfer of the promised
goods or services to the customer and the payment by the customer will be one year or less. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each
performance obligation is satisfied, either at a point in time or over time, and if over time, recognition is based on the use of an output or input method. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Classification of convertible preferred stock </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company classified its convertible preferred stock outstanding prior to the IPO outside of stockholders&#146; equity (deficit) on the consolidated balance sheet because the holders of such shares had redemption rights in the event of a deemed
liquidation that, in certain situations, is not solely within the control of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and development costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development expenses consist of costs incurred in performing research and development activities, including salaries and bonuses, stock-based
compensation, employee benefits, facilities costs, laboratory </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
supplies, depreciation, and external costs of vendors engaged to conduct research, preclinical and clinical development activities as well as the cost of licensing technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upfront payments and milestone payments made for the licensing of technology are expensed as research and development over the period to which they relate.
Costs for research and development activities are expensed in the period in which they are incurred. Payments for such activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred, and are
reflected in the consolidated financial statements as prepaid expense or accrued research and development expense. Determining the prepaid and accrued balances at the end of any reporting period incorporate certain judgments and estimates by
management that are based on information available to the Company including information provided by vendors regarding the progress to completion of specific tasks or costs incurred. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Patent costs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All patent-related costs incurred in
connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Leases </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with
ASC&nbsp;842,<I></I><I>&nbsp;Leases</I>, the Company accounts for a contract as a lease when it has the right to control the asset for a period of time while obtaining substantially all of the asset&#146;s economic benefits. The Company determines
if an arrangement is a lease or contains an embedded lease at inception. For arrangements that meet the definition of a lease, the Company determines the initial classification and measurement of its <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset and lease liability at the lease commencement date and thereafter if modified. The lease term includes any renewal options that the Company is reasonably assured to exercise. The present
value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, the Company uses its estimated secured incremental borrowing rate for that lease term. The Company&#146;s policy
is to not record leases with an original term of twelve months or less on its consolidated balance sheets and recognizes those lease payments in the income statement on a straight-line basis over the lease term. The Company&#146;s existing leases
are for office and laboratory space and an equipment lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to rent, the leases may require the Company to pay additional costs, such as
utilities, maintenance and other operating costs, which are generally referred to as <FONT STYLE="white-space:nowrap">non-lease</FONT> components. The Company has&nbsp;elected to not separate lease and
<FONT STYLE="white-space:nowrap">non-lease</FONT> components. Only the fixed costs for lease components and their associated <FONT STYLE="white-space:nowrap">non-lease</FONT> components are accounted for as a single lease component and recognized as
part of a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset and liability. Rent expense for operating leases is recognized on a straight-line basis over the reasonably assured lease term based on the
total lease payments and is included in operating expense in the consolidated statements of operations and comprehensive loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-based
compensation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company measures stock options with service-based vesting or performance-based vesting granted to employees, <FONT
STYLE="white-space:nowrap">non-employees</FONT> and directors based on the fair value on the date of grant using the Black-Scholes option-pricing model. The Company measures restricted common stock awards using the difference between the purchase
price per share of the award, if any, and the fair value of the Company&#146;s common stock at the date of grant. Compensation expense for the awards is recognized over the requisite service period for employees and directors and as services are
delivered for <FONT STYLE="white-space:nowrap">non-employees,</FONT> both of which are generally the vesting period of the respective award. The Company uses the straight-line method to record the expense of awards with only service-based vesting
conditions. The Company uses the graded-vesting method to record the expense of awards with both service-based and performance-based vesting conditions, commencing once achievement of the performance condition becomes probable. The
Company&nbsp;accounts for forfeitures of share-based awards as they occur. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company classifies stock-based compensation expense in its consolidated statements of operations and
comprehensive loss in the same manner in which the award recipient&#146;s payroll costs are classified or in which the award recipient&#146;s service payments are classified. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net loss per share </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2020, upon the
closing of the IPO, all outstanding shares of the Company&#146;s convertible preferred stock automatically converted into 21,958,588 shares of the Company&#146;s common stock. Prior to this conversion,&nbsp;the Company followed <FONT
STYLE="white-space:nowrap">the&nbsp;two-class&nbsp;method</FONT> when computing net income (loss) per share as the Company had issued shares that meet the definition of participating securities.
<FONT STYLE="white-space:nowrap">The&nbsp;two-class&nbsp;method</FONT> determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in
undistributed earnings. <FONT STYLE="white-space:nowrap">The&nbsp;two-class&nbsp;method</FONT> requires income (loss) available to common stockholders for the period to be allocated between common stock and participating securities based upon their
respective rights to share in the earnings as if all income (loss) for the period had been distributed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Basic net income (loss) per share attributable to
common stockholders is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) per share attributable to common stockholders is
computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is
computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s participating securities contractually entitled the holders of such shares to participate in dividends but did not contractually require
the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reported a net loss, such losses were not allocated to such participating securities. In periods in which the Company reported a net
loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if
their effect is anti-dilutive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company reported a net loss attributable to common stockholders for the years ended December&nbsp;31, 2020 and 2019.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following common stock equivalents presented based on amounts outstanding at each period end, have been excluded from the calculation of diluted net
loss per share because including them would have had an anti-dilutive impact: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options to purchase common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,016,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,886,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants to purchase common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock (as converted to common stock)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,467,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested restricted common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">891,894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants to purchase convertible preferred stock (as converted to common stock)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,034,905</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,253,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Segments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Operating segments are defined as components of an entity for which separate discrete financial information is made available and that is regularly evaluated
by the chief operating decision maker (&#147;CODM&#148;) in making decisions regarding resource allocation and assessing performance. The Company&#146;s CODM is its chief executive officer and the Company manages its operations as a single segment
for the purposes of assessing performance and making operating decisions. The Company is focused on pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory
system. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comprehensive loss </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Comprehensive
loss includes net loss as well as other changes in stockholders&#146; equity (deficit) that result from transactions and economic events other than those with stockholders. For the year ended December&nbsp;31, 2020, the Company&#146;s only element
of other comprehensive loss was unrealized losses on available for sale debt securities. For the year ended December&nbsp;31, 2019, there was no difference between net loss and comprehensive loss. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Income taxes </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for income
taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the
Company&#146;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the
differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to
the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to the provision for
income taxes. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a
<FONT STYLE="white-space:nowrap">two-step</FONT> process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing
authorities. If the tax position is deemed <FONT STYLE="white-space:nowrap">more-likely-than-not</FONT> to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The
amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. Any resulting unrecognized tax benefits are recorded within the provision for income taxes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Recently issued accounting pronouncements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From
time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an &#147;emerging growth company&#148; as defined in the
Jumpstart Our Business Startups Act of 2012 and has elected not to &#147;opt out&#148; of the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has
different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either
(i)&nbsp;irrevocably elects to &#147;opt out&#148; of such extended transition period or (ii)&nbsp;no longer qualifies as an emerging growth company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
June 2016, the FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-13,</FONT> <I>Financial Instruments &#150; Credit Losses (Topic 326)</I>.&nbsp;The new standard adjusts the accounting for assets held at amortized costs basis, including
marketable securities accounted for as available for sale.&nbsp;The standard eliminates the probable initial recognition threshold and requires </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an entity to reflect its current estimate of all expected credit losses.&nbsp;The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the
financial assets to present the net amount expected to be collected. For public entities, the guidance was effective for annual reporting periods beginning after December&nbsp;15, 2019 and for interim periods within those fiscal years. For nonpublic
entities and emerging growth companies that choose to take advantage of the extended transition period, the guidance is effective for annual reporting periods beginning after December&nbsp;15, 2020. Early adoption is permitted for all entities. In
November 2019, the FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2019-10,</FONT> which deferred the effective date for nonpublic entities to annual reporting periods beginning after December&nbsp;15, 2022, including interim periods
within those fiscal years. The Company is evaluating when to adopt this standard and the effect the adoption will have on its consolidated financial statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Marketable Securities and Fair Value Measurements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As
of December&nbsp;31, 2020, available for sale marketable securities by security type consisted of (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Gross</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Gross</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Estimated</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Amortized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Unrealized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Unrealized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Fair</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. treasury notes (due within one year)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company had no marketable securities as of December&nbsp;31, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following tables present the Company&#146;s fair value hierarchy for its assets and liabilities, which are measured at fair value on a recurring basis (in
thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value Measurements at<BR>December&nbsp;31, 2020 Using:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash equivalents:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. treasury notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Marketable securities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. treasury notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">135,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">184,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value Measurements at<BR>December&nbsp;31, 2019 Using:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash equivalents:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preferred stock warrant liability as of December&nbsp;31, 2019 consisted of the fair value of warrants to purchase 14,076
shares of <FONT STYLE="white-space:nowrap">Series&nbsp;A-1</FONT> convertible preferred stock at $1.00 per share and was based on significant inputs not observable in the market, which represented a Level&nbsp;3 measurement within the fair value
hierarchy. The Company&#146;s valuation of the preferred stock warrants utilized the Black-Scholes option-pricing model, which incorporated assumptions and estimates to value the preferred stock warrants. The Company assessed these
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assumptions and estimates at the end of each reporting period. Changes in the fair value of the preferred stock warrants were recognized within other income (expense) in the consolidated
statements of operations and comprehensive loss and were not material during the years ended December&nbsp;31, 2020 and 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2020, upon
closing of the IPO, the warrants to purchase 14,076 shares of Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock automatically became warrants to purchase an aggregate of 7,608 shares of common stock. The Company
remeasured the warrants as of the IPO date and reclassified the carrying value of the warrants from a <FONT STYLE="white-space:nowrap">non-current</FONT> liability to additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital in its
consolidated balance sheet. During the year ended December&nbsp;31, 2020, these warrants were exercised in full. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Property and Equipment, Net
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property and equipment, net consisted of the following (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">337</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment and software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets not yet placed in service</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,103</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,292</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,528</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,683</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense was $1.3&nbsp;million and $0.7&nbsp;million for the years ended December&nbsp;31, 2020
and 2019, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Accrued Expenses </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accrued
expenses consisted of the following (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued employee compensation and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,867</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued construction in progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued external research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Notes Payable </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Long-term debt consisted of the following (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Principal amount of long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Current portion of long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt, net of current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Final payment fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt discount, net of accretion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,346</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(418</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt, net of discount and current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Loan and Security Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, the Company had outstanding loans under its amended loan and security agreement with Comerica Bank (the &#147;Loan&#148;) of
$7.0&nbsp;million (&#147;Term Loan A&#148;) and $8.0&nbsp;million (&#147;Term Loan B&#148;). Borrowings under both Term Loan A and Term Loan B were repayable in monthly payments of interest-only through February 2020, to be followed by monthly
payments of equal principal plus interest until the loan maturity date of February&nbsp;1, 2023. In April 2020, the Company amended the Loan to extend the interest only period through May&nbsp;31, 2020 and in June 2020 the Loan was further amended
to extend the interest-only period through August&nbsp;31, 2020. Interest for Term Loan A was the greater of 1) Comerica&#146;s Prime Rate or 2) LIBOR plus 2.5%, and for Term Loan B, 1.0% plus the greater of 1) Comerica&#146;s Prime Rate or 2) LIBOR
plus 2.5%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A final payment fee of 3.0% of the aggregate amounts drawn under Term Loan A and 4.0% under Term Loan B was due upon the earlier of the
maturity date, the repayment date if paid early, whether voluntary or upon acceleration due to default, the sale of substantially all of the Company&#146;s assets, or the Company&#146;s IPO. The Company may repay the Loan at any time by paying the
outstanding principal balance in full, along with any unpaid accrued interest and the final payment fee. The final payment fee of $0.5&nbsp;million was being amortized to interest expense over the term of the debt using the effective interest
method. Upon closing of the Company&#146;s IPO in October 2020, the final payment fee became due. In November 2020, the Company used a portion of the proceeds from its new loan and security agreement described below to repay the outstanding
principal balance under Term Loan A and Term Loan B plus unpaid accrued interest and the final payment fee. The Company recorded a loss on debt extinguishment of $0.2&nbsp;million related to this repayment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;19, 2020, the Company entered into a new loan and security agreement, or the Oxford Loan, with Oxford Finance LLC, or Oxford, for an
aggregate principal amount of $20.0&nbsp;million (Oxford Term Loan A) and up to an additional $5.0&nbsp;million (Oxford Term Loan B). On November&nbsp;19, 2020, the Company borrowed $20.0&nbsp;million under the Oxford Term Loan A. The Term Loan
bears interest at a floating per annum rate equal to the greater of (i) 8.0% and (ii)&nbsp;the sum of <FONT STYLE="white-space:nowrap">(a)&nbsp;thirty-day</FONT> LIBOR rate plus (b) 7.84%. In addition, upon loan maturity or prepayment, the Company
is reqired to make a final payment fee equal to 5.0% of the aggregate principal amount borrowed which is being amortized to interest expense over the term of the debt using the effective interest method. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is required to make monthly interest only payments under the Oxford Loan each month beginning on January&nbsp;1, 2021. Beginning on
December&nbsp;1, 2023, the Company is required to make consecutive equal monthly payments of principal, together with applicable interest, in arrears, based upon a repayment schedule equal to 24 months, with a final maturity date of November&nbsp;1,
2025 (the &#147;Maturity Date&#148;). At the Company&#146;s option, the Company may elect to prepay the loans subject to a prepayment fee equal to the following percentage of the principal amount being prepaid:&nbsp;2% if an advance is prepaid
during the first 12 months following the applicable advance date,&nbsp;1% if an advance is prepaid after 12 months but prior to 24 months following the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable advance date, and&nbsp;0.5% if an advance is prepaid any time after 24 months following the applicable advance date but prior to the Maturity Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s obligations under the Oxford Loan Agreement are secured by a security interest in all of its assets, other than its intellectual property.
The Company is also subject to certain affirmative and negative covenants including limitations on dispositions, mergers or acquisitions; encumbering its intellectual property; incurring indebtedness or liens; paying dividends; making certain
investments; and engaging in certain other business transactions. The obligations under the Loan are subject to acceleration upon the occurrence of specified events of default, including a material adverse change in the Company&#146;s business,
operations or financial or other condition. Upon the occurrence of an event of default and until such event of default is no longer continuing, the annual interest rate will be 5.0% above the otherwise applicable rate. As of December&nbsp;31, 2020,
the Company believes an event of default would be remote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in connection with the Oxford Loan Agreement, the Company granted warrants to
purchase 18,445 shares of the Company&#146;s common stock at $16.26 per share. The issued warrants are exerciseable for 10 years. The Company valued the warrants using the Black-Scholes option pricing model and determined the fair value of the
warrants to be $0.2&nbsp;million. The Company determined the warrants met the criteria for equity classification, and, as such, the fair value of the warrants were recorded as additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital and as
a discount to the debt which is being amortized to interest expense over the term of the Oxford Loan of five years. In addition, the Company incurred debt issuance costs of $0.2&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, the interest rate applicable to outstanding borrowings under the Oxford Loan was 8.0%. During the years ended December&nbsp;31,
2020 and 2019, the weighted average effective interest rate on outstanding borrowings was approximately 6.4% and 6.9%, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of
December&nbsp;31, 2020, future principal payments due are as follows (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,167</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Convertible Preferred Stock and Preferred Stock Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Convertible Preferred Stock </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company <FONT
STYLE="white-space:nowrap">issued&nbsp;Series&nbsp;A-1&nbsp;convertible</FONT> preferred stock
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(the&nbsp;&#147;Series&nbsp;A-1&#148;),&nbsp;Series&nbsp;A-2&nbsp;convertible</FONT></FONT> preferred stock (the
<FONT STYLE="white-space:nowrap">&#147;Series&nbsp;A-2&#148;)&nbsp;and</FONT> Series&nbsp;B convertible preferred stock (the &#147;Series&nbsp;B&#148;). <FONT STYLE="white-space:nowrap">The&nbsp;Series&nbsp;A-1&nbsp;and</FONT> <FONT
STYLE="white-space:nowrap">Series&nbsp;A-2&nbsp;are</FONT> collectively referred to as the &#147;Series A&#148; and the Series A and Series&nbsp;B are collectively referred to as the &#147;Preferred Stock.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July and August 2020, in two separate closings, the Company sold 5,600,000 shares of Series B preferred stock at a purchase price of $7.50 per share
resulting in gross proceeds to the Company of $42.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2020, in two separate closings, the Company sold 6,407,867 shares of Series B
preferred stock at a purchase price of $7.50 per share resulting in gross proceeds to the Company of $48.1&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, Preferred Stock consisted of the following (in thousands, except share
amounts): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred&nbsp;Stock<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred&nbsp;Stock<BR>Issued and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Liquidation<BR>Preference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common&nbsp;Stock<BR>Issuable Upon<BR>Conversion</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">A-1</FONT> Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,707,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,693,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,694</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,239,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">A-2</FONT> Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,804,165</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,804,165</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,840,089</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,117,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,117,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,387,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,629,622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,615,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,467,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the closing of the IPO in October 2020, the Company&#146;s Preferred Stock automatically converted into 21,958,588 shares
of common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Warrants to Purchase Preferred Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the issuance of notes payable, the Company issued warrants to purchase 14,076 shares of Series <FONT STYLE="white-space:nowrap">A-1</FONT>
preferred stock at an exercise price of $1.00 per share. In October 2020, upon closing of the IPO, the warrants automatically became warrants to purchase an aggregate of 7,608 shares of common stock and were then cashless exercised in full for 6,728
shares of common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
October&nbsp;27, 2020, the Company completed its initial public offering (&#147;IPO&#148;) pursuant to which it issued and sold 7,500,000 shares of its common stock at a public offering price of $16.00 per share, resulting in net proceeds of
$107.9&nbsp;million, after deducting underwriting discounts and commissions and other offering expenses. On November&nbsp;19, 2020, the Company issued and sold an additional 951,837 shares of common stock at the IPO price of $16.00 per share
pursuant to the underwriters&#146; partial exercise of their option to purchase additional shares of common stock, resulting in additional net proceeds of $14.2&nbsp;million after deducting underwriting discounts and commissions. Upon the closing of
the IPO, all of the Company&#146;s outstanding convertible preferred stock automatically converted into shares of common stock (see Note 7). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each share
of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#146;s stockholders. Common stockholders are not entitled to receive dividends, unless declared by the board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Stock-Based Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2016 Stock incentive
plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s 2016 Stock Incentive Plan, (the &#147;2016 Plan&#148;) provided for the Company to grant incentive stock options or
nonqualified stock options and other equity awards to employees, directors and consultants of the Company. Upon the effectiveness of the 2020 Equity Incentive Plan (the &#147;2020 Plan&#148;) in October 2020, the Company ceased granting additional
awards under the 2016 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2020 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&nbsp;21, 2020, the Company&#146;s board of directors adopted and its stockholders approved the 2020 Plan, which became effective on October&nbsp;21,
2020. The 2020 Plan provides for the grant of incentive stock <FONT STYLE="white-space:nowrap">options,&nbsp;non-qualified&nbsp;options,</FONT> stock appreciation rights, restricted stock awards, restricted stock units and other&nbsp;stock-based
awards. The number of shares initially reserved for issuance under the 2020 Plan was (i) 2,200,000 shares (the &#147;share pool&#148;), plus (ii)&nbsp;the number of shares of common stock available for issuance under the 2016 Plan as of the
effective date of the 2020 Plan, plus the number of shares of common stock underlying </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
awards under the 2016 Plan that on or after the date of adoption expire or become unexercisable without delivery of shares, are forfeited to, or repurchased for cash, are settled in cash, or
otherwise become available again for grant under the 2016 Plan, in each case, in accordance with its terms (up to an aggregate of 5,078,295 shares). As of December&nbsp;31, 2020, 2,213,094 shares remained available for future grants under the 2020
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The share pool will automatically increase on January&nbsp;1 of each year from 2021 to 2030 by the lesser of (i)&nbsp;four percent of the number of
shares of our common stock outstanding as of the close of business on the immediately preceding December&nbsp;31 and (ii)&nbsp;the number of shares determined by the board of directors on or prior to such date for such year.&nbsp;The number of
shares reserved for issuance under the 2020 Plan was increased by 1,471,576 shares effective January&nbsp;1, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020 Plan and 2016 Plan are
administered by the board of directors or, at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors, or its
committee if so delegated. Stock options granted with service-based vesting conditions generally vest over four years and expire after ten years. The exercise price for stock options granted is not less than the fair value of common stock on the
date of grant. The Company bases fair value of common stock on the quoted market price. Prior to the IPO, the board of directors determined the value the Company&#146;s common stock, taking into consideration its most recently available valuation of
common stock performed by third parties as well as additional relevant factors which may have changed since the date of the most recent contemporaneous valuation through the date of grant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2020 Employee Stock Purchase Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
October&nbsp;21, 2020, the Company&#146;s board of directors adopted and its stockholders approved the 2020 Employee Stock Purchase Plan (the &#147;ESPP&#148;), which became effective on October&nbsp;21, 2020. The aggregate number of shares of
common stock available for purchase pursuant to the exercise of options under the ESPP is 360,000 shares, plus an automatic annual increase, as of January&nbsp;1 of each year from 2021 to 2030, equal to the lesser of (i)&nbsp;one percent of the
number of shares of common stock outstanding as of the close of business on the immediately preceding December&nbsp;31 and (ii)&nbsp;the number of shares determined by the board of directors on or prior to such date for such year (up to a maximum of
3,220,520 shares). The number of shares reserved for issuance under the ESPP was increased by 367,894 shares effective January&nbsp;1, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of
December&nbsp;31, 2020, no offering periods have commenced under the ESPP. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock option valuation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of stock option grants is estimated using the Black-Scholes option-pricing model. Prior to the IPO, the Company was a private company and lacks
company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies. The expected term of the Company&#146;s stock
options has been determined utilizing the &#147;simplified&#148; method for awards that qualify as &#147;plain-vanilla&#148; options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of
grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable
future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the
grant-date fair value of stock options granted in 2020 and 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the Company&#146;s option activity during the year ended December&nbsp;31,
2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>Average<BR>Exercise<BR>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>Average<BR>Contractual<BR>Term</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>Intrinsic<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(in years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,886,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,922,377</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(611,048</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(181,358</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of December&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,016,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested and expected to vest as of December&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,016,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options exercisable as of December&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,508,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,683</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options
and the fair value of the Company&#146;s common stock for those stock options that had exercise prices lower than the fair value of the Company&#146;s common stock. The aggregate intrinsic value of stock options exercised during the years ended
December&nbsp;31, 2020 and 2019 was $3.5&nbsp;million and $1.2&nbsp;million, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted average grant-date fair value of stock options
granted during the years ended December&nbsp;31, 2020 and 2019 was $6.01 per share and $2.54 per share, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted common stock
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2015, the Company issued and sold 4,459,459 shares of restricted common stock at par value to the scientific founders of the Company. The
shares were subject to vesting over a period of five years and began vesting upon the closing of the Series <FONT STYLE="white-space:nowrap">A-1</FONT> Preferred Stock in April 2016 and were fully vested as of December&nbsp;31, 2020. The following
table summarizes the Company&#146;s restricted common stock activity during the year ended December&nbsp;31, 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested restricted common stock as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">891,894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(891,894</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested restricted common stock as of December&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aggregate fair value of restricted stock that vested during the years ended December 2020 and 2019 was $4.8&nbsp;million
and $3.3&nbsp;million, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-based compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recorded stock-based compensation expense related to common stock options and restricted common stock in the following expense categories of its
consolidated statements of operations and comprehensive loss (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">554</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">$2,961</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">$1,694</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, total unrecognized compensation cost was $13.5&nbsp;million, which is expected
to be recognized over a weighted average period of 3.6&nbsp;years. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Collaboration Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2020, the Company entered into a research collaboration and license agreement (the &#147;Collaboration Agreement&#148;) with Merck Sharp&nbsp;&amp;
Dohme Corp. (&#147;Merck&#148;). The Company and Merck will apply Foghorn&#146;s proprietary Gene Traffic Control platform to discover and develop novel therapeutics. Under the Collaboration Agreement, the Company granted Merck exclusive global
rights to develop and commercialize drugs that target dysregulation of a single transcription factor. Under the terms of the Collaboration Agreement, the Company and Merck are each responsible to perform certain research activities in accordance
with a mutually agreed upon research plan. Merck may substitute the selected transcription factor during certain stages of the research program, subject to certain limitations. Following completion of the research program, Merck is responsible for
the development and commercialization of the compounds developed pursuant to the research program and any product containing such compounds. Pursuant to the Collaboration Agreement, the Company will also participate on a joint steering
committee.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement, Foghorn received a nonrefundable upfront payment of $15.0&nbsp;million from Merck, and is eligible to receive
up to $245.0&nbsp;million upon achievement of specified research, development and regulatory milestones by any product candidate generated by the collaboration, and up to $165.0&nbsp;million upon achievement of specified sales-based milestones per
approved product from the collaboration, if any. The Company will be eligible to receive tiered royalties, calculated on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, on net sales of approved products from the collaboration, if any, at royalty rates ranging from the
<FONT STYLE="white-space:nowrap">mid-single</FONT> digits to low tens, depending on whether the products are covered by patent rights it licenses to Merck. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless terminated earlier, the Collaboration Agreement will continue in full force and effect until one or more products has received marketing authorization
and, thereafter, until expiration of all royalty obligations under the Collaboration Agreement. The Company or Merck may terminate the Collaboration Agreement upon an uncured material breach by the other party or insolvency of the other party. Merck
may also terminate the Merck Collaboration Agreement for any reason upon certain notice to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company determined that the
(1)&nbsp;research, development, manufacture and commercialization licenses, (2)&nbsp;the research activities performed by the Company and (3)&nbsp;service on the joint committees represent a single performance obligation under the Collaboration
Agreement. The Company determined that Merck cannot benefit from licenses separately from the research activities and participation on the joint steering committee as these services are specialized and rely on the Company&#146;s expertise such that
these activities are highly interrelated and therefore not distinct. Accordingly, the promised goods and services represent one combined performance obligation and the entire transaction price was allocated to that single combined performance
obligation. The performance obligation will be satisfied over the research term as the Company performs the research activities and participates in a joint steering committee to oversee research activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The upfront payment of $15.0&nbsp;million was initially recorded as deferred revenue and is being recognized as revenue as the performance obligation is
satisfied. The Company recognizes revenue <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">using&nbsp;the&nbsp;cost-to-cost&nbsp;method,&nbsp;which</FONT></FONT> it believes best depicts the transfer of control to the customer over
time. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Under&nbsp;the&nbsp;cost-to-cost&nbsp;method,&nbsp;the</FONT></FONT> extent of progress towards completion is measured based on the ratio of actual costs incurred to the total
estimated costs expected upon satisfying the identified performance obligation. Under this method, revenue is recorded as a percentage of the estimated transaction price based on the extent of progress towards completion. As of December&nbsp;31,
2020, the potential research, development and regulatory milestone payments that the Company is eligible to receive were excluded from the transaction price as they were fully constrained by uncertain events. The Company will reevaluate the
transaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur, and if necessary, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company will adjust its estimate of the transaction price. Any additions to the transaction price would be reflected in the period as a cumulative
<FONT STYLE="white-space:nowrap">revenue&nbsp;catch-up</FONT> based on the ratio of costs incurred to the total estimated costs expected applied to the revised transaction price.&nbsp;Sales-based royalties and milestone payments, which predominantly
relate to the license, will be recognized if and&nbsp;when the related sales occur. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, the aggregate amount of the transaction
price related to the unsatisfied portion of the performance obligation is $14.6&nbsp;million, which is expected to be recognized as revenue through 2028. The Company does not expect collaboration revenue to be recognized evenly over this period as
it will be recognized on a percentage of completion basis (using <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-to-cost</FONT></FONT> method) as the Company performs the research activities and participates on the joint
steering committee, which will likely vary from period to period. In estimating the total costs to satisfy its single performance obligation pursuant to the Collaboration Agreement, the Company is required to make significant estimates including an
estimate of the number of transcription factor substitutions and the expected time and expected costs to fulfill the performance obligation.&nbsp;The cumulative effect of revisions to the total estimated costs to complete the Company&#146;s single
performance obligation will be recorded in the period in which the changes are identified, and amounts can be reasonably estimated. While such revisions will have no impact on the Company&#146;s cash flows, a significant change in these assumptions
and estimates could have a material impact on the timing and amount of revenue recognized in future periods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company assessed the Collaboration
Agreement to determine whether a significant financing component exists and concluded that a significant financing component does not exist. Through December&nbsp;31, 2020, the Company had recorded $0.4&nbsp;million of revenue under the
Collaboration Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Income Taxes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During
the years ended December&nbsp;31, 2020 and 2019, the Company recorded no income tax benefits for the net deferred tax assets comprised primarily of net operating losses incurred and research and development tax credits generated in each year, due to
its uncertainty of realizing a benefit from these items. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of the Company&#146;s operating losses since inception have been generated in the United
States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reconciliation of the U.S. federal statutory income tax rate to the Company&#146;s effective income tax rate is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal statutory income tax rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(21.0</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(21.0</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State taxes, net of federal benefit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal and state research and development tax credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3.7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2.2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in deferred tax asset valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective income tax rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net deferred tax assets consisted of the following (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating loss carryforwards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development tax credit carryforwards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,955</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capitalized <FONT STYLE="white-space:nowrap">start-up</FONT> costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">522</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">436</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">414</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,896</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,819</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(482</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,694</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(281</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(14,513</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(763</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(48,383</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(26,621</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020, the Company had U.S. federal and state net operating loss carryforwards of $147.3&nbsp;million
and $132.3&nbsp;million, respectively, which may be available to offset future taxable income. The federal net operating loss carryforwards include&nbsp;$12.5 million&nbsp;which expire at various dates beginning
in&nbsp;2035&nbsp;and&nbsp;$134.8&nbsp;million&nbsp;which carryforward indefinitely but in some circumstances may be limited to offset 80% of annual taxable income. The state net operating loss carryforwards expire at various dates beginning
in&nbsp;2036.&nbsp;As of December&nbsp;31, 2020, the Company also had U.S. federal and state research and development tax credit carryforwards of $3.4&nbsp;million and $2.0&nbsp;million, respectively, which may be available to offset future tax
liabilities and expire at various dates beginning in 2036 and 2031, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Utilization of the U.S. federal and state net operating loss
carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Sections&nbsp;382 and 383 of the Internal Revenue Code of 1986, and corresponding provisions of state law, due to ownership
changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income or tax liabilities. In general, an ownership change,
as defined by Section&nbsp;382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not conducted a study to assess
whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined
by Section&nbsp;382, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section&nbsp;382. Any limitation may result in
expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization. Further, until a study is completed by the Company and any limitation is known, no amounts are being recorded as
an uncertain tax position. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets.
Management has considered the Company&#146;s history of cumulative net losses incurred since inception and its lack of commercialization of any products that would generate revenue from product sales and has concluded that it is more likely than not
that the Company will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets as of December&nbsp;31, 2020 and 2019. Management reevaluates the positive
and negative evidence at each reporting period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">126 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The valuation allowance increased by $21.8&nbsp;million and $15.3&nbsp;million during the years ended
December&nbsp;31, 2020 and 2019, respectively, primarily as a result of the increase in net operating loss carryforwards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2020
and 2019, the Company had not recorded any amounts for unrecognized tax benefits. The Company files income tax returns in the U.S. and Massachusetts, as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of
business, the Company is subject to examination by federal and state jurisdictions, where applicable. There are currently no pending tax examinations. Since the Company is in a loss carryforward position, it is generally subject to examination by
the U.S. federal, state, and local income tax authorities for all tax years in which a loss carryforward is available. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Leases </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2019, the Company entered into a lease for 81,441 square feet of office and laboratory space in Cambridge, Massachusetts, commencing in January 2020
(the &#147;New Lease&#148;). The initial term of the New Lease was eight years with a five-year option to extend at fair-market rent at the time of the extension. The base rent payments escalate annually over the eight-year lease term and totaled
approximately $60.3&nbsp;million. In connection with the New Lease, the landlord agreed to fund up to $3.0&nbsp;million in tenant improvements to the leased facility as well as up to an additional $16.3&nbsp;million, which resulted in additional
rent payments to the landlord over the lease term. During the year ended December&nbsp;31, 2020, $15.4&nbsp;million of leasehold improvements were reimbursed by the landlord, which resulted in an increase to operating lease liabilities. The Company
is obligated to pay its portion of real estate taxes and costs related to the premises, including costs of operations and management of the leased premises. The Company is required to maintain a cash balance of $1.7&nbsp;million to secure a letter
of credit associated with the lease. This amount was classified as restricted cash <FONT STYLE="white-space:nowrap">(non-current)</FONT> on the consolidated balance sheet as of December&nbsp;31, 2020 and 2019. On January&nbsp;1, 2020, the lease
commencement date, the Company recorded an operating lease asset of $38.6&nbsp;million and corresponding lease liability of $38.3&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June
2020, the Company amended the New Lease to defer payment of a portion of the base rent and operating expenses and to extend the lease term by nine months to September 2028. The amendment was accounted for as a lease modification and the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset and lease liability were remeasured at the modification date of June&nbsp;29, 2020 resulting in an increase of $7.4&nbsp;million to both the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset and lease liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company had a lease for office
and laboratory facilities in Cambridge, Massachusetts under a noncancelable operating lease that began in August 2017 and expired in March 2025. In April 2020, this lease was assigned and assumed by a related party which became effective in October
2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The components of lease expense were as follows (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term lease cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Variable lease cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">127 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Supplemental disclosure of cash flow information related to leases was as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for amounts included in the measurement of operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities arising from obtaining <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">271</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in operating lease liabilities and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets due to lease remeasurement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted-average remaining lease term and discount rate were as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average remaining lease term&#151;operating leases (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average discount rate&#151;operating leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.35</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.53</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Future annual minimum lease payments under operating leases as of December&nbsp;31, 2020 were as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total future minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,379</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: imputed interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(15,104</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: estimated lease incentives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,933</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt"><B>Included in the consolidated balance sheet (in thousands):</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,981</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities, net of current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sublease agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2020, the Company entered into a <FONT STYLE="white-space:nowrap">two-year</FONT> sublease of approximately 16,843 square feet of office space under
the New Lease, as amended, which began in July 2020. As of December&nbsp;31, 2020, the remaining base rent payments due to the Company under the subleases was $2.5&nbsp;million. The Company recorded other income of $1.0&nbsp;million during the year
ended December&nbsp;31, 2020 related to this sublease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Commitments and Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Leases </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s commitments under its
leases are described in Note&nbsp;12. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">128 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>License agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dana-Farber Cancer Institute </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2016, the Company entered
into a license agreement with the Dana-Farber Cancer Institute, Inc. (&#147;Dana Farber&#148;) for an exclusive license for certain biological materials as well as patent rights to methods of identifying compounds to treat prostate cancer. In
consideration for the right to develop, manufacture, and commercialize products based on certain of Dana Farber&#146;s intellectual property, the Company is obligated to reimburse Dana Farber for patent expenses and pay low single-digit sales-based
royalties upon the occurrence of specific events as outlined in the license agreement. Unless terminated earlier, in accordance with the provisions of the agreement, the agreement will terminate on the expiration date of the last to expire of the
applicable Dana Farber patents. None of the Company&#146;s product candidates utilize technology covered by this license. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stanford </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2017, the Company entered into a license agreement with the Board of Trustees of the Leland Stanford Junior University (&#147;Stanford&#148;) for a <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> license for patent rights to certain diseases associated with chromatin remodeling. In consideration for the right to develop, manufacture, and commercialize products based on certain of
Stanford&#146;s intellectual property, the Company paid a <FONT STYLE="white-space:nowrap">one-time,</FONT> <FONT STYLE="white-space:nowrap">non-refundable</FONT> license fee of less than $0.1&nbsp;million and reimbursed Stanford for
$0.1&nbsp;million of costs incurred related to the patented technology. The Company also issued 42,781 shares of the Company&#146;s common stock upon execution of a share purchase agreement. In addition to annual license maintenance fees of less
than $0.1&nbsp;million, the Company will reimburse Stanford for patent expenses, pay low single-digit sales-based royalties, and pay up to $1.1&nbsp;million in regulatory milestones on each licensed product upon the occurrence of specific events as
outlined in the license agreement. None of the Company&#146;s product candidates utilize technology covered by this license. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Indemnification
agreements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, contract
research organizations, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In
addition, the Company has entered into indemnification agreements with members of its board of directors and its executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by
reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. The Company has not incurred any
material costs as a result of such indemnifications and is not currently aware of any indemnification claims. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Legal Proceedings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time, the Company may become involved in litigation or other legal proceedings. The Company is not currently a party to any material litigation or
legal proceedings. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Defined Contribution Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has a 401(k) defined contribution plan (the &#147;401(k) Plan&#148;) for its employees. Eligible employees may make pretax contributions to the
401(k) Plan up to statutory limits. There was no discretionary match made under the 401(k) Plan as of December&nbsp;31, 2020 and 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Related
Parties </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2015, the Company entered into a five-year service agreement with Flagship Pioneering (&#147;Flagship&#148;), an affiliate of one
of its stockholders, to provide general and administrative services to the Company, including </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">129 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
certain consulting services and the provision of employee health and dental benefit plans for the Company&#146;s employees. The Company made cash payments for services received under this
agreement of $1.2&nbsp;million and $0.9&nbsp;million during the years ended December&nbsp;31, 2020 and 2019, respectively. As of December&nbsp;31, 2020 and 2019, the Company had no accounts payable to Flagship for costs related to the service
agreement. This agreement expired in 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2015, the Company entered into a five-year consulting agreement with a scientific founder of the
Company who is also a board member and a shareholder. In October 2020, this agreement was extended to January&nbsp;1, 2022, with an option to renew. During the years ended December&nbsp;31, 2020 and 2019, the Company paid the scientific founder
$0.2&nbsp;million and $0.2&nbsp;million, respectively. As of December&nbsp;31, 2020 the Company had less than $0.1&nbsp;million in accounts payable to this scientific founder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">130 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_14"></A>ITEM&nbsp;9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_15"></A>ITEM&nbsp;9A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CONTROLS AND PROCEDURES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Evaluation of Disclosure Controls and Procedures </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
management, under the supervision and with the participation of our Principal Executive Officer (our Chief Executive Officer) and Principal Financial and Accounting Officer (our Chief Financial Officer), has evaluated the effectiveness of our
disclosure controls and procedures as of period end. The term &#147;disclosure controls and procedures,&#148; as defined in
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Rules&nbsp;13a-15(e)&nbsp;and&nbsp;15d-15(e)&nbsp;under</FONT></FONT> the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a
company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the
SEC&#146;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange
Act is accumulated and communicated to the company&#146;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any
disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of
possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December&nbsp;31, 2020, our Principal Executive Officer and Principal Financial Officer concluded that, as of such date, our disclosure
controls and procedures were effective at the reasonable assurance level. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Internal Control Over Financial Reporting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Management&#146;s Report on Internal Control Over Financial Reporting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This annual report does not include a report of management&#146;s assessment regarding internal control over financial reporting or an attestation report of
the company&#146;s independent registered public accounting firm due to a transition period established by rules of the Securities and Exchange Commission for newly public companies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Changes in Internal Control Over Financial Reporting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No change in our internal control over financial reporting (as defined in
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Rules&nbsp;13a-15(f)&nbsp;and&nbsp;15d-15(f)&nbsp;under</FONT></FONT> the Exchange Act) occurred during the three months ended December&nbsp;31, 2020 that has materially affected, or
is reasonably likely to materially affect, our internal control over financial reporting. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_16"></A>ITEM&nbsp;9B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>OTHER INFORMATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_17"></A>PART III
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_18"></A>ITEM&nbsp;10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information required by this Item&nbsp;10 will be included in our definitive proxy statement to be filed with the SEC with respect to our 2021 Annual
Meeting of Stockholders and is incorporated herein by reference. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">131 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_19"></A>ITEM&nbsp;11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EXECUTIVE COMPENSATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information required by this Item&nbsp;11 will be included in our definitive proxy statement to be filed with the SEC with respect to our 2021 Annual
Meeting of Stockholders and is incorporated herein by reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_20"></A>ITEM&nbsp;12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information required by this Item&nbsp;12 will be included in our definitive proxy statement to be filed with the SEC with
respect to our 2021 Annual Meeting of Stockholders and is incorporated herein by reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_21"></A>ITEM&nbsp;13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information required by this Item&nbsp;13 will be included in our definitive proxy statement to be filed with the SEC with respect to our 2021 Annual
Meeting of Stockholders and is incorporated herein by reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_22"></A>ITEM&nbsp;14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PRINCIPAL ACCOUNTING FEES AND SERVICES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information required by this Item&nbsp;14 will be included in our definitive proxy statement to be filed with the SEC with respect to our 2021 Annual
Meeting of Stockholders and is incorporated herein by reference. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_23"></A>PART IV </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_24"></A>ITEM&nbsp;15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EXHIBITS, FINANCIAL STATEMENT SCHEDULES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>1. Financial Statements </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For a list of the financial
statements included herein, see <A HREF="#tx105868_100">Index to the Consolidated Financial Statements</A> on page&nbsp;103 of this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> incorporated into this Item by reference. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>2. Financial Statement Schedules </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial statement
schedules have been omitted because they are either not required or not applicable or the information is included in the consolidated financial statements or the notes thereto. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>3. Exhibits </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exhibits required by Item&nbsp;601 of
Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> and Item&nbsp;15(b) of this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> are listed in the Exhibit Index immediately preceding the signature page of this Annual Report on <FONT
STYLE="white-space:nowrap">Form&nbsp;10-K.&nbsp;The</FONT> exhibits listed in the Exhibit Index are incorporated by reference herein. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><A NAME="tx105868_25"></A>ITEM&nbsp;16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FORM <FONT STYLE="white-space:nowrap">10-K</FONT> SUMMARY </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">132 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exhibit Index </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="89%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description of document</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520278568/d71549dex31.htm">Third Amended and Restated Certificate of Incorporation of Foghorn Therapeutics Inc.(Incorporated by reference to Exhibit&nbsp;
3.1 to the Registrant&#146;s Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-39634),</FONT> filed on October&nbsp;27, 2020). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520278568/d71549dex32.htm">Amended and Restated <FONT STYLE="white-space:nowrap">By-laws</FONT> of Foghorn Therapeutics Inc. (Incorporated by reference to Exhibit&nbsp;
3.2 to the Registrant&#146;s Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-39634),</FONT> filed on October&nbsp;27, 2020). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex41.htm">Specimen stock certificate evidencing shares of common stock (Incorporated by reference to Exhibit&nbsp;
4.1 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;19, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex42.htm">Amended and Restated Investors&#146; Rights Agreement, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of December
<U></U>&nbsp;18, 2018 (Incorporated by reference to Exhibit&nbsp;4.2 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT>
as amended, filed on October<U></U>&nbsp;19, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520262469/d12441dex43.htm">Amendment to the Investors&#146; Rights Agreement and the Voting Agreement, dated December<U></U>&nbsp;
18, 2018, by and among Foghorn Therapeutics Inc. and the investors party thereto, dated as of April<U></U>&nbsp;17, 2020 (Incorporated by reference to Exhibit&nbsp;
4.3 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;2, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520262469/d12441dex44.htm">Form of Warrant to Purchase <FONT STYLE="white-space:nowrap">Series&nbsp;
A-2</FONT> Preferred Stock of the Registrant issued to Silicon Valley Bank, dated November<U></U>&nbsp;29, 2016 (Incorporated by reference to Exhibit&nbsp;
4.4 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;2, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520303604/d10278dex41.htm">Form of Warrant to Purchase Common Stock of the Registrant issued to Oxford Finance LLC (Incorporated by reference to Exhibit&nbsp;
4.1 to the Registrant&#146;s Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-39634),</FONT> filed on November&nbsp;25, 2020. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.6*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d105868dex46.htm">Description of Registrant&#146;s Securities</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520262469/d12441dex102.htm">Lease Agreement by and between <FONT STYLE="white-space:nowrap">ARE-Tech</FONT> Square, LLC and Foghorn Therapeutics Inc., dated October<U></U>&nbsp;23,
 2019 (Incorporated by reference to Exhibit&nbsp;10.2 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended,
filed on October<U></U>&nbsp;2, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.2++</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520262469/d12441dex103.htm">Exclusive Collaboration and License Agreement, by and between Merck Sharp<U></U>&nbsp;
&amp; Dohme Corp. and Foghorn Therapeutics Inc., dated as of July<U></U>&nbsp;2, 2020 (Incorporated by reference to Exhibit 10.3 to the Registrant&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> (File No.<U></U><FONT
STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;2, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.3&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520262469/d12441dex104.htm">Foghorn Therapeutics Inc. 2016 Stock Incentive Plan, as amended (Incorporated by reference to Exhibit&nbsp;
10.4 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;2, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.4&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520262469/d12441dex105.htm">Form of Stock Restriction Agreement under the Foghorn Therapeutics Inc. 2016 Stock Incentive Plan (Incorporated by reference to Exhibit&nbsp;10.5
 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;2, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.5&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520262469/d12441dex106.htm">Form of Incentive Stock Option Grant Notice under the Foghorn Therapeutics Inc. 2016 Stock Incentive Plan (Incorporated by reference to Exhibit&nbsp;10.6
 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264)</FONT> filed on October<U></U>&nbsp;2, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.6&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520262469/d12441dex107.htm">Form of <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option Grant Notice under the Foghorn Therapeutics Inc. 2016 Stock Incentive
 Plan (Incorporated by reference to Exhibit&nbsp;10.7 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended,
filed on October<U></U>&nbsp;2, 2020).</A></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">133 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description of document</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520262469/d12441dex108.htm">Form of Indemnification Agreement between Foghorn Therapeutics Inc. and its directors and officers (Incorporated by reference to Exhibit&nbsp;10.8
 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;2, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.8&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex109.htm">Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Adrian Gottschalk, dated October<U></U>&nbsp;
14, 2020 (Incorporated by reference to Exhibit&nbsp;10.9 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;
333-249264),</FONT> as amended, filed on October<U></U>&nbsp;19, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.9&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex1010.htm">Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Samuel Agresta, M.D., M.P.H. &amp; T.M., dated October&nbsp;
14, 2020 (Incorporated by reference to Exhibit&nbsp;10.10 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;
333-249264),</FONT> as amended, filed on October<U></U>&nbsp;19, 2020). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.10&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex1011.htm">Amended and Restated Letter Agreement between Foghorn Therapeutics Inc. and Carl P. Decicco, Ph.D., dated October<U></U>&nbsp;
14, 2020 (Incorporated by reference to Exhibit&nbsp;10.11 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;
333-249264),</FONT> as amended, filed on October<U></U>&nbsp;19, 2020). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.11&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex1012.htm">Foghorn Therapeutics Inc. 2020 Equity Incentive Plan (Incorporated by reference to Exhibit&nbsp;
10.12 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;19,
2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.12&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex1013.htm">Form of Incentive Stock Option Agreement under the Foghorn Therapeutics Inc. 2020 Equity Incentive Plan (Incorporated by reference to Exhibit&nbsp;10.13
 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;19, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.13&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex1014.htm">Form of <FONT STYLE="white-space:nowrap">Non-Statutory</FONT> Stock Option Agreement (Employees) under the Foghorn Therapeutics Inc. 2020 Equity
 Incentive Plan (Incorporated by reference to Exhibit&nbsp;10.14 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as
amended, filed on October<U></U>&nbsp;19, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.14&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex1015.htm">Form of <FONT STYLE="white-space:nowrap">Non-Statutory</FONT> Stock Option Agreement <FONT STYLE="white-space:nowrap">(Non-Employee</FONT> Directors)
under the Foghorn Therapeutics Inc. 2020 Equity Incentive Plan (Incorporated by reference to Exhibit&nbsp;10.15 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT
STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;19, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.15&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex1016.htm">Foghorn Therapeutics Inc. 2020 Employee Stock Purchase Plan (Incorporated by reference to Exhibit&nbsp;
10.16 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;19,
2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.16&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex1017.htm">Foghorn Therapeutics Inc. 2020 Cash Incentive Plan (Incorporated by reference to Exhibit&nbsp;
10.17 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;19,
2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.17&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520271564/d12441dex1018.htm">Consulting Agreement between Foghorn Therapeutics Inc. and Cigall Kadoch, dated October<U></U>&nbsp;
1, 2015 (Incorporated by reference to Exhibit&nbsp;10.18 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;
333-249264),</FONT> as amended, filed on October<U></U>&nbsp;19, 2020).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.18*&#094;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d105868dex1018.htm">Amendment to Consulting Agreement between Foghorn Therapeutics Inc. and Cigall Kadoch dated October&nbsp;29, 2020</A>.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520303604/d10278dex101.htm">Loan and Security Agreement dated as of November&nbsp;
19, 2020, among Oxford Finance LLC, and the Registrant (Incorporated by reference to Exhibit&nbsp;10.1 to the Registrant&#146;s Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;
001-39634),</FONT> filed on November&nbsp;25, 2020). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;21.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1822462/000119312520262469/d12441dex211.htm">List of Subsidiaries of Foghorn Therapeutics Inc. (Incorporated by reference to Exhibit&nbsp;
21.1 to the Registrant&#146;s Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File No.<U></U><FONT STYLE="white-space:nowrap">&nbsp;333-249264),</FONT> as amended, filed on October<U></U>&nbsp;2,
2020).</A></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">134 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="90%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description of document</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;23.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d105868dex231.htm">Consent of Deloitte<U></U>&nbsp;&amp; Touche LLP </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;31.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d105868dex311.htm">Rule<U></U>&nbsp;13a&#151;14(a)<U></U>&nbsp;/ 15d&#151;14(a)<U></U>&nbsp;Certification&#151;Principal Executive Officer. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;31.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d105868dex312.htm">Rule<U></U>&nbsp;13a&#151;14(a)<U></U>&nbsp;/ 15d&#151;14(a)<U></U>&nbsp;Certification&#151;Principal Financial Officer. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;32.1**</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d105868dex321.htm">Section<U></U>&nbsp;1350 Certification&#151;Principal Executive Officer. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;32.2**</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d105868dex322.htm">Section&nbsp;1350 Certification&#151;Principal Financial Officer. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Financial statements from the Annual Report on Form 10-K of the Company as of and for the period ended December 31, 2020, formatted in
Extensible Business Reporting Language (XBRL): (i)&nbsp;Balance Sheets; (ii)&nbsp;Statements of Operations; (iii)&nbsp;Statements of Changes in Redeemable Preferred Stock and Stockholders&#146; Equity; (iv)&nbsp;Statements of Cash Flows; and
(v)&nbsp;Notes to Financial Statements.</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Filed herewith </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Furnished herewith </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#094;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indicates management contract or compensatory plan, contract or arrangement. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">++</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Portions of this exhibit (indicated by asterisks) have been omitted because the Registrant has determined they
are not material and would likely cause competitive harm to the Registrant if publicly disclosed. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">135 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx105868_26"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>FOGHORN THERAPEUTICS INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: March&nbsp;18, 2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Allan Reine</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Allan Reine</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal
Accounting and Financial Officer)</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">136 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each person whose individual signature appears below hereby authorizes and appoints Adrian Gottschalk and Allan Reine, and each of them, with
full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> and agent to act in his or her
name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and to file
the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and
agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents or
any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements
of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adrian Gottschalk</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Adrian Gottschalk</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President,&nbsp;Chief&nbsp;Executive&nbsp;Officer&nbsp;and&nbsp;Director</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Principal Executive Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;18, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Allan Reine</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Allan Reine, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Principal Accounting and Financial Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;18, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jos&eacute; Baselga</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Jos&eacute; Baselga, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;18, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Scott Biller</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Scott Biller, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;18, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Douglas Cole</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Douglas Cole, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;18, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Simba Gill</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Simba Gill, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;18, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Cigall Kadoch</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Cigall Kadoch, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;18, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Koppel</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Adam Koppel, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;18, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Mendelsohn</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Michael Mendelsohn, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">March&nbsp;18, 2021</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">137 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>2
<FILENAME>d105868dex46.htm
<DESCRIPTION>EX-4.6
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.6</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.6 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DESCRIPTION OF THE REGISTRANT&#146;S SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summary describes all material provisions of the common stock, par value $0.0001 per share, of Foghorn Therapeutics Inc. The description of our
common stock is qualified by reference to our certificate of incorporation, bylaws, and investor rights agreement, which are included as exhibits to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> of which this Exhibit 4.6 is
a part. The summary below is also qualified by provisions of applicable law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our authorized capital stock consists of 175,000,000 shares of common stock, par value $0.0001 per share, and 25,000,000 shares of preferred stock, par value
$0.0001 per share. Our common stock is registered under Section&nbsp;12 of the Securities Exchange Act of 1934, as amended, and is listed on The Nasdaq Global Market under the symbol &#147;FHTX.&#148; <B> </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of our common stock are entitled to
one vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative voting rights. An election of directors by our stockholders shall be determined by a plurality of the votes cast by the stockholders entitled
to vote on the election. Holders of common stock are entitled to receive proportionately any dividends as may be declared by our board of directors, subject to any preferential dividend rights of any series of preferred stock that we may designate
and issue in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of our liquidation or dissolution, the holders of common stock are entitled to receive proportionately our net
assets available for distribution to stockholders after the payment of all debts and other liabilities and subject to the prior rights of any outstanding preferred stock. Holders of common stock have no preemptive, subscription, redemption or
conversion rights. Our outstanding shares of common stock are validly issued, fully paid and nonassessable. The rights, preferences and privileges of holders of common stock are subject to and may be adversely affected by the rights of the holders
of shares of any series of preferred stock that we may designate and issue in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of our amended and restated certificate of incorporation, our board of directors is authorized to direct us to issue shares of preferred stock
in one or more series without stockholder approval. Our board of directors has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and
liquidation preferences, of each series of preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of authorizing our board of directors to issue preferred stock and determine its
rights and preferences is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions, future financings and other corporate
purposes, could have the effect of making it more difficult for a third-party to acquire, or could discourage a third-party from seeking to acquire, a majority of our outstanding voting stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of our Certificate of Incorporation and <FONT STYLE="white-space:nowrap">our&nbsp;By-Laws</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation <FONT STYLE="white-space:nowrap">and&nbsp;by-laws&nbsp;contains</FONT> certain provisions that are intended to enhance the
likelihood of continuity and stability in the composition of our board of directors but which may have the effect of delaying, deferring or preventing a future takeover or change in control of us unless such takeover or change in control is approved
by our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These provisions include: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Classified board.</I>&nbsp;Our certificate of incorporation provides that our board of directors will be divided into three classes of directors, with the
classes as nearly equal in number as possible. As a result, <FONT STYLE="white-space:nowrap">approximately&nbsp;one-third&nbsp;of</FONT> our board of directors are elected each year. The classification of directors has the effect of making it more
difficult for stockholders to change the composition of our board. Our certificate of incorporation also provides that, subject to any rights of holders of preferred stock to elect additional directors under specified circumstances, the number of
directors will be fixed exclusively pursuant to a resolution adopted by our board of directors. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Action by written consent; special meetings of stockholders.</I>&nbsp;Our certificate of incorporation
provides that stockholder action can be taken only at an annual or special meeting of stockholders and cannot be taken by written consent in lieu of a meeting. Our certificate of incorporation and
<FONT STYLE="white-space:nowrap">the&nbsp;by-laws</FONT> also provides that, except as otherwise required by law, special meetings of the stockholders can only be called pursuant to a resolution adopted by a majority of our board of directors.
Except as described above, stockholders are not permitted to call a special meeting or to require our board of directors to call a special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Removal of directors.</I>&nbsp;Our certificate of incorporation provides that our directors may be removed only for cause by the affirmative vote of at
least 75% of the voting power of our outstanding shares of capital stock, voting together as a single class. This requirement of a supermajority vote to remove directors could enable a minority of our stockholders to prevent a change in the
composition of our board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Advance notice procedures.</I><FONT STYLE="white-space:nowrap">&nbsp;Our&nbsp;by-laws&nbsp;establish</FONT> an advance
notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to the board of directors. Stockholders at an annual meeting are only able to consider
proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of our board of directors or by a stockholder who was a stockholder of record on the record date for the meeting, who is entitled to
vote at the meeting and who has given our Secretary timely written notice, in proper form, of the stockholder&#146;s intention to bring that business before the meeting. Although the <FONT STYLE="white-space:nowrap">by-laws</FONT> do not give our
board of directors the power to approve or disapprove stockholder nominations of candidates or proposals regarding other business to be conducted at a special or annual meeting, <FONT STYLE="white-space:nowrap">the&nbsp;by-laws&nbsp;may</FONT> have
the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed or may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect its own slate of directors or
otherwise attempting to obtain control of us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Supermajority approval requirements.</I>&nbsp;The DGCL generally provides that the affirmative vote of a
majority of the shares entitled to vote on any matter is required to amend a corporation&#146;s certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws,</FONT> unless either a corporation&#146;s certificate of incorporation <FONT
STYLE="white-space:nowrap">or&nbsp;by-laws&nbsp;requires</FONT> a greater percentage. Our certificate of incorporation and <FONT STYLE="white-space:nowrap">by-laws</FONT> provide that the affirmative vote of holders of at least 75% of the total
votes eligible to be cast in the election of directors is required to amend, alter, change or repeal specified provisions. This requirement of a supermajority vote to approve amendments to our certificate of incorporation and <FONT
STYLE="white-space:nowrap">by-laws</FONT> could enable a minority of our stockholders to exercise veto power over any such amendments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Authorized but
unissued shares.</I>&nbsp;Our authorized but unissued shares of common stock and preferred stock are available for future issuance without stockholder approval. These additional shares may be utilized for a variety of corporate purposes, including
future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. The existence of authorized but unissued shares of common stock and preferred stock could render more difficult or discourage an attempt to
obtain control of a majority of our common stock by means of a proxy contest, tender offer, merger or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exclusive forum.</I>&nbsp;Our
certificate of incorporation requires, to the fullest extent permitted by law, that derivative actions brought in the name of the Company, actions against directors, officers and employees for breach of a fiduciary duty and other similar actions may
be brought only in specified courts in the State of Delaware. Although we believe this provision benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, the provision may have
the effect of discouraging lawsuits against our directors and officers. See &#147;Risk Factors&#151;Our amended and restated certificate of incorporation designates the state or federal courts within the State of Delaware as the exclusive forum for
certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#146; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Section&nbsp;203 of the DGCL </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to
the provisions of Section&nbsp;203 of the DGCL. In general, Section&nbsp;203 prohibits a publicly-held Delaware corporation from engaging in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for a three-year period
following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. A &#147;business combination&#148; includes, among other things, a merger, asset or stock sale or other
transaction resulting in a financial benefit to the interested stockholder. An &#147;interested stockholder&#148; is a person who, together with affiliates and associates, owns, or did own within three years prior to the determination of interested
stockholder status, 15% or more of the corporation&#146;s voting stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;203, a business combination between a corporation and an interested stockholder is
prohibited unless it satisfies one of the following conditions: before the stockholder became interested, our board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested
stockholder; upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction
commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans, in some instances; or at or after the time the stockholder became interested, the
business combination was approved by our board of directors of the corporation and authorized at an annual or special meeting of the stockholders by the affirmative vote of at <FONT STYLE="white-space:nowrap">least&nbsp;two-thirds&nbsp;of</FONT> the
outstanding voting stock which is not owned by the interested stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A Delaware corporation may &#147;opt out&#148; of these provisions with an
express provision in its original certificate of incorporation or an express provision in its certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws</FONT> resulting from a stockholders&#146; amendment approved by at least a
majority of the outstanding voting shares. We have not opted out of these provisions. As a result, mergers or other takeover or change in control attempts of us may be discouraged or prevented. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transfer agent and
registrar for our common stock is Computershare Trust Company, N.A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>3
<FILENAME>d105868dex1018.htm
<DESCRIPTION>EX-10.18
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.18</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.18 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g105868g33c86.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B><I>Execution Version</I></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;29, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cigall
Kadoch, Ph.D. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By Email Delivery </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Dr.&nbsp;Kadoch: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reference is made to that certain letter agreement dated October&nbsp;1, 2015, by and between you and Foghorn Therapeutics Inc. (the
&#147;<U>Company</U>&#148;), as amended by that certain fee increase letter dated January&nbsp;22, 2019 (such agreement, as so amended, the &#147;<U>Consulting Agreement</U>&#148;). The purpose of this letter (this &#147;<U>Amendment</U>&#148;) is
to amend certain terms of the Consulting Agreement, as described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A.&nbsp;&nbsp;&nbsp;&nbsp;<U>Term of Consulting Agreement</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;6(a) of the Consulting Agreement is hereby amended and replaced in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; margin-right:13%; font-size:10pt; font-family:Times New Roman">The &#147;<U>Term</U>&#148; shall commence on the Effective Date and shall continue until January&nbsp;1, 2022, unless
earlier terminated in accordance with this Section&nbsp;6. Notwithstanding the foregoing, from and after January&nbsp;1, 2022, the Term shall be extended automatically for each successive <FONT STYLE="white-space:nowrap">one-</FONT> (1)&nbsp;year
period unless the Company provides you written notice no later than the immediately preceding December&nbsp;1 of its intention not to renew the Term. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">B.&nbsp;&nbsp;&nbsp;&nbsp;<U>Compensation</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;8(b)
of the Consulting Agreement is hereby amended and replaced in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; margin-right:13%; font-size:10pt; font-family:Times New Roman">Effective as of October&nbsp;1,
2020, and continuing until the expiration or termination of this Agreement, the Company will pay you consulting fees, payable monthly in arrears, in a monthly amount as set forth below. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Month</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Monthly<BR>Consulting&nbsp;Fee</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May 2021 and thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">C.&nbsp;&nbsp;&nbsp;&nbsp;<U>Confidentiality</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;3(c) of the Consulting Agreement is hereby amended to include the following at the end of the Section: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; margin-right:13%; font-size:10pt; font-family:Times New Roman">Further, (i)&nbsp;nothing contained in this Agreement limits, restricts or in any other way affects your communicating with
any governmental agency or entity, or communicating with any official or staff person of a governmental agency or entity, concerning matters relevant to such governmental agency or entity; and (ii)&nbsp;you will not be held criminally or civilly
liable under any federal or state trade secret law for disclosing a trade secret (A)&nbsp;in confidence to a federal, state or local government official, directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating
a suspected violation of law, or (B)&nbsp;in a complaint or other document filed under seal in a lawsuit or other proceeding, <I>provided</I>, <I>however</I>, that notwithstanding this immunity from liability, you may be held liable if you
unlawfully access trade secrets by unauthorized means. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">D.&nbsp;&nbsp;&nbsp;&nbsp;<U>Limits on Competition</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;5(a)(i) is hereby deleted from the Consulting Agreement (with the defined term &#147;<U>Restricted Territory</U>&#148; surviving). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to protect the Company&#146;s legitimate business interests, you agree, as a condition of the extension of the Term as provided herein and in
exchange for the compensation and benefits provided hereunder, to which you are not otherwise entitled, to enter into the <FONT STYLE="white-space:nowrap">Non-Competition,</FONT> <FONT STYLE="white-space:nowrap">Non-Solicitation,</FONT>
Confidentiality and Assignment of Inventions Agreement (the &#147;<U>Confidentiality Agreement</U>&#148;) attached as <U>Exhibit</U><U></U><U>&nbsp;A</U> hereto. You must sign and return the Confidentiality Agreement in connection with the execution
of this Amendment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You acknowledge and agree that references to employment or termination of employment included in the Confidentiality Agreement will be
deemed to refer, respectively, to your services to the Company, under the Consulting Agreement or otherwise, or the termination thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding
anything to the contrary in the Confidentiality Agreement, the restrictions set forth in Sections&nbsp;8 <FONT STYLE="white-space:nowrap">(Non-Competition)</FONT> and 9 <FONT STYLE="white-space:nowrap">(Non-Solicitation)</FONT> of the
Confidentiality Agreement will not apply to activities conducted on behalf of DFCI (as defined in the Consulting Agreement) or any other academic, hospital, governmental or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> institution or entity that employs you or for which you consult or otherwise provide services, now or in the future, including the Broad Institute,
Harvard University, Stanford University and the Howard Hughes </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Medical Institute (collectively, &#147;<U>Institutions</U>&#148;), or to any seminars, talks or other educational activities you may undertake in your capacity as an employee or consultant of an
Institution, <I>provided</I> that you comply with the other terms of the Consulting Agreement and the Confidentiality Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">E.&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as
expressly amended by this Amendment, the Consulting Agreement will remain in full force and effect in accordance with its terms. This Amendment will be governed by and construed and enforced in accordance with the laws of the Commonwealth of
Massachusetts, without giving effect to the conflict of law principles of any jurisdiction. This Amendment may be executed in one or more counterparts (and may be delivered by email or other electronic means), each of which will be deemed an
original but all of which together will constitute one and the same instrument. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of Page Intentionally Left Blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please sign below to acknowledge your acceptance of the terms of this letter. Keep one copy for your files
and return one executed copy to the Company. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours,</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>FOGHORN THERAPEUTICS INC.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Adrian Gottschalk</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Adrian Gottschalk</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and CEO</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Accepted and agreed:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Cigall Kadoch</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Cigall Kadoch</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Signature Page to Letter Agreement</I>]<I> </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit&nbsp;A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">NON-COMPETITION,</FONT> <FONT STYLE="white-space:nowrap">NON-SOLICITATION,</FONT> CONFIDENTIALITY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND ASSIGNMENT OF INVENTIONS AGREEMENT </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(attached) </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>d105868dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the incorporation by reference in Registration Statement <FONT STYLE="white-space:nowrap">No.&nbsp;333-252119</FONT> on Form <FONT
STYLE="white-space:nowrap">S-8</FONT> of our report dated March&nbsp;18, 2021, relating to the consolidated financial statements of Foghorn Therapeutics Inc. appearing in this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for
the year ended December&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Deloitte&nbsp;&amp; Touche LLP </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston, Massachusetts </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;18, 2021 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>d105868dex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-31.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 31.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RULES <FONT STYLE="white-space:nowrap">13a-14(a)</FONT> AND <FONT STYLE="white-space:nowrap">15d-14(a)</FONT> UNDER THE SECURITIES EXCHANGE
ACT OF 1934, </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, Adrian Gottschalk, certify that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I have reviewed this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> of Foghorn Therapeutics
Inc.; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on my knowledge, the financial statements, and other financial information included in this report,
fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The registrant&#146;s other certifying officer(s) and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e))</FONT> for the registrant and have: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(Paragraph omitted pursuant to SEC Release Nos.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">33-8238/34-47986</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">33-8392/34-49313);</FONT></FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that
occurred during the registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal
control over financial reporting; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The registrant&#146;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions): </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any fraud, whether or not material, that involves management or other employees who have a significant role in
the registrant&#146;s internal control over financial reporting. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;18, 2021 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adrian Gottschalk</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Adrian Gottschalk </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President,&nbsp;Chief&nbsp;Executive&nbsp;Officer&nbsp;and&nbsp;Director </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Principal Executive Officer) </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>d105868dex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-31.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 31.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RULES <FONT STYLE="white-space:nowrap">13a-14(a)</FONT> AND <FONT STYLE="white-space:nowrap">15d-14(a)</FONT> UNDER THE SECURITIES EXCHANGE
ACT OF 1934, </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, Allan Reine, certify that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">I have reviewed this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> of Foghorn Therapeutics
Inc.; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on my knowledge, the financial statements, and other financial information included in this report,
fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The registrant&#146;s other certifying officer(s) and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e))</FONT> for the registrant and have: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(Paragraph omitted pursuant to SEC Release Nos.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">33-8238/34-47986</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">33-8392/34-49313);</FONT></FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that
occurred during the registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal
control over financial reporting; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The registrant&#146;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions): </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any fraud, whether or not material, that involves management or other employees who have a significant role in
the registrant&#146;s internal control over financial reporting. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;18, 2021 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Allan Reine <BR></P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Allan Reine, M.D. <BR>Chief Financial Officer</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Principal Accounting and Financial Officer) </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>d105868dex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-32.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 32.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Annual Report of Foghorn Therapeutics Inc. (the &#147;Company&#148;) on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#147;Report&#148;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted
pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of
1934; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information contained in the Report fairly presents, in all material respects, the financial condition and
result of operations of the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;18, 2021 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adrian Gottschalk</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Adrian Gottschalk </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President,&nbsp;Chief&nbsp;Executive&nbsp;Officer&nbsp;and&nbsp;Director </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Principal Executive Officer) </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>d105868dex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-32.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 32.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Annual Report of Foghorn Therapeutics Inc. (the &#147;Company&#148;) on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#147;Report&#148;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted
pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of
1934; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information contained in the Report fairly presents, in all material respects, the financial condition and
result of operations of the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;18, 2021 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Allan Reine </P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Allan Reine, M.D. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief
Financial Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Principal Accounting and Financial Officer) </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>9
<FILENAME>fhtx-20201231.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 18-March-2021 [12:26:36] {AM}-->
<xbrli:xbrl xmlns:fhtx="http://www.foghorntx.com/20201231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2020-01-31">
<link:schemaRef xlink:type="simple" xlink:href="fhtx-20201231.xsd" />
<xbrli:context id="P01_01_2020To12_31_2020">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn10_23_2020">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-10-23</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P07_01_2020To07_31_2020">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-07-01</xbrli:startDate>
<xbrli:endDate>2020-07-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn01_31_2021">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2021-01-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_MaximumMembersrtRangeAxis_ScientificFounderMemberFHTXAgreementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fhtx:AgreementsAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_FlagshipPioneeringMemberFHTXAgreementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fhtx:AgreementsAxis">fhtx:FlagshipPioneeringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_BaseRateMemberusgaapVariableRateAxis_TermLoanBMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanBMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_TermLoanAAndBMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanAAndBMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AdditionalRateInEventOfDefaultMemberusgaapShortTermDebtTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fhtx:AdditionalRateInEventOfDefaultMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_TermLoanBMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanBMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_TermLoanAMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanAMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ExpirableMemberusgaapTaxPeriodAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">fhtx:ExpirableMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_NonExpirableMemberusgaapTaxPeriodAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">fhtx:NonExpirableMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ResearchMemberusgaapTaxCreditCarryforwardAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ResearchMemberusgaapTaxCreditCarryforwardAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_USTreasuryNotesSecuritiesMemberusgaapInvestmentTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_ComputerEquipmentAndSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_LeaseholdsAndLeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AssetsNotYetPlacedInServiceMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:AssetsNotYetPlacedInServiceMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_LetterOfCreditMemberusgaapShortTermDebtTypeAxis_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">fhtx:NewLeaseAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_PreferredStockWarrantLiabilityMemberusgaapFinancialInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:PreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PreferredStockWarrantLiabilityMemberusgaapFinancialInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:PreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_FlagshipPioneeringMemberFHTXAgreementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fhtx:AgreementsAxis">fhtx:FlagshipPioneeringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_TermLoanAMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanAMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_TermLoanBMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanBMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_ComputerEquipmentAndSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_LeaseholdsAndLeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_AssetsNotYetPlacedInServiceMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:AssetsNotYetPlacedInServiceMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_SeriesAOnePreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fhtx:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_SeriesATwoPreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fhtx:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_RestrictedStockMemberusgaapAwardTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_IssuanceOfNotesPayableMemberusgaapSubsidiarySaleOfStockAxis_SeriesAOnePreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fhtx:IssuanceOfNotesPayableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fhtx:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ConversionOfRedeemableConvertibleStockMemberusgaapConversionOfStockByUniqueDescriptionAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">fhtx:ConversionOfRedeemableConvertibleStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ConversionOfWarrantLiabilityToEquityMemberusgaapConversionOfStockByUniqueDescriptionAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">fhtx:ConversionOfWarrantLiabilityToEquityMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_IPOMemberusgaapSubsidiarySaleOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_SoftwareAndSoftwareDevelopmentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_MaximumMembersrtRangeAxis_SalesMemberusgaapIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_MaximumMembersrtRangeAxis_ResearchDevelopmentAndRegulatoryMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:ResearchDevelopmentAndRegulatoryMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">fhtx:NewLeaseAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_WarrentsToPurchaseCommonStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fhtx:WarrentsToPurchaseCommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_EmployeeStockOptionMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AdditionalOverBaseRateMemberusgaapShortTermDebtTypeAxis_MinimumMembersrtRangeAxis_TermLoanBMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanBMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">fhtx:AdditionalOverBaseRateMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_MinimumMembersrtRangeAxis_TermLoanAMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanAMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_MerckCollaborationAgreementMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:MerckCollaborationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_SeriesBRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fhtx:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_FlagshipPioneeringMemberFHTXAgreementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fhtx:AgreementsAxis">fhtx:FlagshipPioneeringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ScientificFounderMemberFHTXAgreementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fhtx:AgreementsAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_MAsrtStatementGeographicalAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis_PropertyUnderOperatingLeaseSubleasedMemberusgaapLeaseContractualTermAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">fhtx:PropertyUnderOperatingLeaseSubleasedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_RestrictedStockMemberusgaapAwardTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ConversionOfNotesPayableInToWarrantsMemberusgaapConversionOfStockByUniqueDescriptionAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">fhtx:ConversionOfNotesPayableInToWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ResearchMemberusgaapTaxCreditCarryforwardAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ResearchMemberusgaapTaxCreditCarryforwardAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ExpirableMemberusgaapTaxPeriodAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">fhtx:ExpirableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_NonExpirableMemberusgaapTaxPeriodAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">fhtx:NonExpirableMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_ServiceBasedVestingMemberusgaapAwardTypeAxis_TwoThousandTwentyAndSixteenStockIncentivePlanMemberusgaapPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fhtx:ServiceBasedVestingMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyAndSixteenStockIncentivePlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_PrepaymentWithInFirstTwelveMonthsMemberFHTXPrepaymentPeriodAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fhtx:PrepaymentPeriodAxis">fhtx:PrepaymentWithInFirstTwelveMonthsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_PrepaymentAfter12MonthsButPriorTo24MonthsMemberFHTXPrepaymentPeriodAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fhtx:PrepaymentPeriodAxis">fhtx:PrepaymentAfter12MonthsButPriorTo24MonthsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_PrepaymentAfter24MonthsMemberFHTXPrepaymentPeriodAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fhtx:PrepaymentPeriodAxis">fhtx:PrepaymentAfter24MonthsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2020-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_WarrantMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_RestrictedStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_EmployeeStockOptionMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_PreferredStockWarrantLiabilityMemberusgaapFinancialInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:PreferredStockWarrantLiabilityMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_SeriesBRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fhtx:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_FlagshipPioneeringMemberFHTXAgreementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fhtx:AgreementsAxis">fhtx:FlagshipPioneeringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_ScientificFounderMemberFHTXAgreementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fhtx:AgreementsAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_CommonStockMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2019To12_31_2019_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-01-01</xbrli:startDate>
<xbrli:endDate>2019-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P10_27_2020To10_27_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-10-27</xbrli:startDate>
<xbrli:endDate>2020-10-27</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P10_27_2020To10_27_2020_IPOMemberusgaapSubsidiarySaleOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-10-27</xbrli:startDate>
<xbrli:endDate>2020-10-27</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn10_27_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-10-27</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn10_27_2020_IPOMemberusgaapSubsidiarySaleOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-10-27</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P11_19_2020To11_19_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-11-19</xbrli:startDate>
<xbrli:endDate>2020-11-19</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P11_19_2020To11_19_2020_MinimumMembersrtRangeAxis_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-11-19</xbrli:startDate>
<xbrli:endDate>2020-11-19</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P11_19_2020To11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-11-19</xbrli:startDate>
<xbrli:endDate>2020-11-19</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P11_19_2020To11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_TermLoanAMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanAMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-11-19</xbrli:startDate>
<xbrli:endDate>2020-11-19</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn11_19_2020_MaximumMembersrtRangeAxis_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_TermLoanBMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanBMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-11-19</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_TermLoanAMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanAMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-11-19</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn11_19_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-11-19</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn11_19_2020_MinimumMembersrtRangeAxis_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-11-19</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fhtx:OxfordFinanceLlcMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-11-19</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P04_30_2020To04_30_2020_MAsrtStatementGeographicalAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis_PropertyUnderOperatingLeaseSubleasedMemberusgaapLeaseContractualTermAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">fhtx:PropertyUnderOperatingLeaseSubleasedMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-04-30</xbrli:startDate>
<xbrli:endDate>2020-04-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn10_31_2019_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">fhtx:NewLeaseAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-10-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn10_31_2019_MAsrtStatementGeographicalAxis_MaximumMembersrtRangeAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">fhtx:NewLeaseAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-10-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn01_01_2020_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">fhtx:NewLeaseAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-01-01</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2020To12_31_2027_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis_ScenarioForecastMembersrtStatementScenarioAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">fhtx:NewLeaseAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-01-01</xbrli:startDate>
<xbrli:endDate>2027-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P06_29_2020To06_29_2020_MAsrtStatementGeographicalAxis_ModifiedNewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">fhtx:ModifiedNewLeaseAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-06-29</xbrli:startDate>
<xbrli:endDate>2020-06-29</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn04_30_2020_MAsrtStatementGeographicalAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis_PropertyUnderOperatingLeaseSubleasedMemberusgaapLeaseContractualTermAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">fhtx:PropertyUnderOperatingLeaseSubleasedMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-04-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn04_30_2020_SeriesBMemberusgaapAuctionMarketPreferredSecuritiesStockSeriesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-04-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P07_31_2017To07_31_2017_MaximumMemberusgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_StanfordLicenseAgreementMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">srt:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:StanfordLicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2017-07-31</xbrli:startDate>
<xbrli:endDate>2017-07-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P07_31_2017To07_31_2017_StanfordLicenseAgreementMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:StanfordLicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2017-07-31</xbrli:startDate>
<xbrli:endDate>2017-07-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn07_31_2017_StanfordLicenseAgreementMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:StanfordLicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-07-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P10_01_2015To10_31_2015_FlagshipPioneeringMemberFHTXAgreementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fhtx:AgreementsAxis">fhtx:FlagshipPioneeringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2015-10-01</xbrli:startDate>
<xbrli:endDate>2015-10-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P10_01_2015To10_31_2015_ScientificFounderMemberFHTXAgreementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fhtx:AgreementsAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2015-10-01</xbrli:startDate>
<xbrli:endDate>2015-10-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn08_31_2020_SeriesBMemberusgaapAuctionMarketPreferredSecuritiesStockSeriesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-08-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P10_31_2020To10_31_2020_IPOMemberusgaapSubsidiarySaleOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-10-31</xbrli:startDate>
<xbrli:endDate>2020-10-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P10_31_2019To10_31_2019_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">fhtx:NewLeaseAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2019-10-31</xbrli:startDate>
<xbrli:endDate>2019-10-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn10_21_2020_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMemberusgaapSubsidiarySaleOfStockAxis_MaximumMembersrtRangeAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fhtx:InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-10-21</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn10_21_2020_InitialAggregateMemberusgaapSubsidiarySaleOfStockAxis_TwoThousandTwentyEmployeeStockPurchasePlanMemberusgaapPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fhtx:InitialAggregateMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-10-21</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn10_21_2020_InitialAmountMemberusgaapSubsidiarySaleOfStockAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fhtx:InitialAmountMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-10-21</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn10_21_2020_TwoThousandTwentyEmployeeStockPurchasePlanMemberusgaapPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-10-21</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P11_01_2020To11_30_2020_TermLoanAAndBMemberusgaapDebtInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fhtx:TermLoanAAndBMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-11-01</xbrli:startDate>
<xbrli:endDate>2020-11-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn10_26_2020_BeforeIPOMemberusgaapSubsidiarySaleOfStockAxis_SeriesAOnePreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fhtx:BeforeIPOMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fhtx:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-10-26</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P07_01_2020To08_31_2020_SeriesBMemberusgaapAuctionMarketPreferredSecuritiesStockSeriesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-07-01</xbrli:startDate>
<xbrli:endDate>2020-08-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P04_01_2020To04_30_2020_SeriesBMemberusgaapAuctionMarketPreferredSecuritiesStockSeriesAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-04-01</xbrli:startDate>
<xbrli:endDate>2020-04-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P10_01_2020To10_21_2020_TwoThousandsTwentyToTwoThousandsThirtyMemberusgaapSubsidiarySaleOfStockAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fhtx:TwoThousandsTwentyToTwoThousandsThirtyMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-10-01</xbrli:startDate>
<xbrli:endDate>2020-10-21</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P10_01_2020To10_21_2020_TwoThousandsTwentyToTwoThousandsThirtyMemberusgaapSubsidiarySaleOfStockAxis_TwoThousandTwentyEmployeeStockPurchasePlanMemberusgaapPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fhtx:TwoThousandsTwentyToTwoThousandsThirtyMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2020-10-01</xbrli:startDate>
<xbrli:endDate>2020-10-21</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2015To12_31_2015_CommonStockMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2015-01-01</xbrli:startDate>
<xbrli:endDate>2015-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P04_01_2016To04_30_2016_CommonStockMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2016-04-01</xbrli:startDate>
<xbrli:endDate>2016-04-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2021To01_01_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2021-01-01</xbrli:startDate>
<xbrli:endDate>2021-01-01</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2021To01_01_2021_TwoThousandTwentyEmployeeStockPurchasePlanMemberusgaapPlanNameAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2021-01-01</xbrli:startDate>
<xbrli:endDate>2021-01-01</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2020-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2018_CommonStockMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2019_CommonStockMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2019-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<fhtx:InterestRateOutstandingBorrowingsLoan id="Factid_19065268" contextRef="PAsOn12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="3">0.080</fhtx:InterestRateOutstandingBorrowingsLoan>
<us-gaap:LongTermDebtWeightedAverageInterestRateOverTime id="Factid_19065269" contextRef="P01_01_2020To12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="3">0.064</us-gaap:LongTermDebtWeightedAverageInterestRateOverTime>
<us-gaap:LongTermDebtWeightedAverageInterestRateOverTime id="Factid_19065270" contextRef="P01_01_2019To12_31_2019_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="3">0.069</us-gaap:LongTermDebtWeightedAverageInterestRateOverTime>
<us-gaap:DebtInstrumentInterestRateEffectivePercentage id="Factid_19065271" contextRef="PAsOn12_31_2020_AdditionalRateInEventOfDefaultMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_pure" decimals="3">0.050</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
<fhtx:TemporaryEquityStockIssuedDuringPeriodShareNewIssues id="Factid_19065272" contextRef="P07_01_2020To08_31_2020_SeriesBMemberusgaapAuctionMarketPreferredSecuritiesStockSeriesAxis" unitRef="Unit_shares" decimals="INF">5600000</fhtx:TemporaryEquityStockIssuedDuringPeriodShareNewIssues>
<us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock id="Factid_19065273" contextRef="P07_01_2020To08_31_2020_SeriesBMemberusgaapAuctionMarketPreferredSecuritiesStockSeriesAxis" unitRef="Unit_USD" decimals="-5">42000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
<fhtx:TemporaryEquityStockIssuedDuringPeriodShareNewIssues id="Factid_19065274" contextRef="P04_01_2020To04_30_2020_SeriesBMemberusgaapAuctionMarketPreferredSecuritiesStockSeriesAxis" unitRef="Unit_shares" decimals="INF">6407867</fhtx:TemporaryEquityStockIssuedDuringPeriodShareNewIssues>
<us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock id="Factid_19065275" contextRef="P04_01_2020To04_30_2020_SeriesBMemberusgaapAuctionMarketPreferredSecuritiesStockSeriesAxis" unitRef="Unit_USD" decimals="-5">48100000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
<us-gaap:ShareBasedCompensation id="Factid_19065280" contextRef="P01_01_2019To12_31_2019_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3">554000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation id="Factid_19065281" contextRef="P01_01_2020To12_31_2020_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3">1237000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation id="Factid_19065282" contextRef="P01_01_2019To12_31_2019_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3">1140000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation id="Factid_19065283" contextRef="P01_01_2020To12_31_2020_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3">1724000</us-gaap:ShareBasedCompensation>
<fhtx:MilestoneReceivableUponAchievement id="Factid_19065284" contextRef="P01_01_2020To12_31_2020_MaximumMembersrtRangeAxis_SalesMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-5">165000000</fhtx:MilestoneReceivableUponAchievement>
<fhtx:MilestoneReceivableUponAchievement id="Factid_19065285" contextRef="P01_01_2020To12_31_2020_MaximumMembersrtRangeAxis_ResearchDevelopmentAndRegulatoryMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" unitRef="Unit_USD" decimals="-5">245000000</fhtx:MilestoneReceivableUponAchievement>
<fhtx:ProceedsFromUpfrontPayment id="Factid_19065286" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-5">15000000</fhtx:ProceedsFromUpfrontPayment>
<us-gaap:ContractWithCustomerLiability id="Factid_19065287" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-5">15000000</us-gaap:ContractWithCustomerLiability>
<us-gaap:RevenueRemainingPerformanceObligation id="Factid_19065288" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-5">14600000</us-gaap:RevenueRemainingPerformanceObligation>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Factid_19065289" contextRef="P01_01_2020To12_31_2020_MerckCollaborationAgreementMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" unitRef="Unit_USD" decimals="-5">400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:AreaOfRealEstateProperty id="Factid_19065290" contextRef="PAsOn10_31_2019_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis" unitRef="Unit_sqft" decimals="INF">81441</us-gaap:AreaOfRealEstateProperty>
<us-gaap:OperatingLeaseExpense id="Factid_19065291" contextRef="P01_01_2020To12_31_2027_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis_ScenarioForecastMembersrtStatementScenarioAxis" unitRef="Unit_USD" decimals="-5">60300000</us-gaap:OperatingLeaseExpense>
<fhtx:LeaseholdImprovementsLandlordAllowance id="Factid_19065292" contextRef="PAsOn10_31_2019_MAsrtStatementGeographicalAxis_MaximumMembersrtRangeAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis" unitRef="Unit_USD" decimals="-5">3000000</fhtx:LeaseholdImprovementsLandlordAllowance>
<fhtx:LeaseholdImprovementsLandlordAllowanceToBeRepaid id="Factid_19065293" contextRef="PAsOn10_31_2019_MAsrtStatementGeographicalAxis_MaximumMembersrtRangeAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis" unitRef="Unit_USD" decimals="-5">16300000</fhtx:LeaseholdImprovementsLandlordAllowanceToBeRepaid>
<us-gaap:PaymentsForProceedsFromTenantAllowance id="Factid_19065294" contextRef="P01_01_2020To12_31_2020_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis" unitRef="Unit_USD" decimals="-5">-15400000</us-gaap:PaymentsForProceedsFromTenantAllowance>
<us-gaap:OperatingLeaseRightOfUseAsset id="Factid_19065295" contextRef="PAsOn01_01_2020_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis" unitRef="Unit_USD" decimals="-5">38600000</us-gaap:OperatingLeaseRightOfUseAsset>
<us-gaap:OperatingLeaseLiability id="Factid_19065296" contextRef="PAsOn01_01_2020_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis" unitRef="Unit_USD" decimals="-5">38300000</us-gaap:OperatingLeaseLiability>
<fhtx:ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement id="Factid_19065297" contextRef="P06_29_2020To06_29_2020_MAsrtStatementGeographicalAxis_ModifiedNewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis" unitRef="Unit_USD" decimals="-5">7400000</fhtx:ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement>
<us-gaap:OperatingLeaseCost id="Factid_19065298" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">7032000</us-gaap:OperatingLeaseCost>
<us-gaap:OperatingLeaseCost id="Factid_19065299" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">1671000</us-gaap:OperatingLeaseCost>
<us-gaap:ShortTermLeaseCost id="Factid_19065300" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">61000</us-gaap:ShortTermLeaseCost>
<us-gaap:DebtInstrumentUnamortizedDiscount id="Factid_19065303" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">418000</us-gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:DebtInstrumentUnamortizedDiscount id="Factid_19065304" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">1346000</us-gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid id="Factid_19065305" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">530000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
<us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid id="Factid_19065306" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">1000000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
<fhtx:LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments id="Factid_19065307" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">10848000</fhtx:LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments>
<fhtx:LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments id="Factid_19065308" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">20000000</fhtx:LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments>
<us-gaap:LongTermDebtCurrent id="Factid_19065309" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">4152000</us-gaap:LongTermDebtCurrent>
<us-gaap:DebtInstrumentCarryingAmount id="Factid_19065311" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">15000000</us-gaap:DebtInstrumentCarryingAmount>
<us-gaap:DebtInstrumentCarryingAmount id="Factid_19065312" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">20000000</us-gaap:DebtInstrumentCarryingAmount>
<us-gaap:OtherAccruedLiabilitiesCurrent id="Factid_19065315" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">57000</us-gaap:OtherAccruedLiabilitiesCurrent>
<us-gaap:OtherAccruedLiabilitiesCurrent id="Factid_19065316" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">138000</us-gaap:OtherAccruedLiabilitiesCurrent>
<fhtx:AccruedResearchAndDevelopmentExpenses id="Factid_19065317" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">1384000</fhtx:AccruedResearchAndDevelopmentExpenses>
<fhtx:AccruedResearchAndDevelopmentExpenses id="Factid_19065318" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">2146000</fhtx:AccruedResearchAndDevelopmentExpenses>
<us-gaap:ConstructionPayableCurrent id="Factid_19065319" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">119000</us-gaap:ConstructionPayableCurrent>
<us-gaap:ConstructionPayableCurrent id="Factid_19065320" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">2385000</us-gaap:ConstructionPayableCurrent>
<us-gaap:EmployeeRelatedLiabilitiesCurrent id="Factid_19065321" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">1867000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
<us-gaap:EmployeeRelatedLiabilitiesCurrent id="Factid_19065322" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">3513000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
<us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Factid_19065323" contextRef="PAsOn12_31_2020_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3">48770000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
<us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Factid_19065324" contextRef="PAsOn12_31_2020_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3">48770000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
<us-gaap:FinancialLiabilitiesFairValueDisclosure id="Factid_19065325" contextRef="PAsOn12_31_2019_PreferredStockWarrantLiabilityMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3">45000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
<us-gaap:FinancialLiabilitiesFairValueDisclosure id="Factid_19065326" contextRef="PAsOn12_31_2019_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PreferredStockWarrantLiabilityMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3">45000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
<us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Factid_19065327" contextRef="PAsOn12_31_2019_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3">14951000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
<us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Factid_19065328" contextRef="PAsOn12_31_2019_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3">14951000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
<fhtx:WarrantIssuePrice id="Factid_19065329" contextRef="P01_01_2019To12_31_2019_PreferredStockWarrantLiabilityMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD_per_Share" decimals="2">1.00</fhtx:WarrantIssuePrice>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Factid_19065330" contextRef="PAsOn12_31_2019_PreferredStockWarrantLiabilityMemberusgaapFinancialInstrumentAxis" unitRef="Unit_shares" decimals="INF">14076</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<fhtx:ProceedsFromUpfrontPayment id="Factid_19065331" contextRef="P07_01_2020To07_31_2020" unitRef="Unit_USD" decimals="-5">15000000</fhtx:ProceedsFromUpfrontPayment>
<us-gaap:SaleOfStockConsiderationReceivedOnTransaction id="Factid_19065335" contextRef="P11_19_2020To11_19_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5">14200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
<us-gaap:SaleOfStockPricePerShare id="Factid_19065336" contextRef="PAsOn11_19_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF">16.00</us-gaap:SaleOfStockPricePerShare>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Factid_19065337" contextRef="P11_19_2020To11_19_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="INF">951837</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:SaleOfStockConsiderationReceivedOnTransaction id="Factid_19065338" contextRef="P10_27_2020To10_27_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5">107900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
<us-gaap:SaleOfStockPricePerShare id="Factid_19065339" contextRef="PAsOn10_27_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF">16.00</us-gaap:SaleOfStockPricePerShare>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Factid_19065340" contextRef="P10_27_2020To10_27_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="INF">7500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:CapitalExpendituresIncurredButNotYetPaid id="Factid_19065341" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">367000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
<us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="Factid_19065342" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">250000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
<us-gaap:FairValueAdjustmentOfWarrants id="Factid_19065344" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-1000</us-gaap:FairValueAdjustmentOfWarrants>
<us-gaap:CapitalExpendituresIncurredButNotYetPaid id="Factid_19065352" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">2400000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
<us-gaap:InterestPaidNet id="Factid_19065353" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">420000</us-gaap:InterestPaidNet>
<us-gaap:InterestPaidNet id="Factid_19065354" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">660000</us-gaap:InterestPaidNet>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Factid_19065356" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">94528000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Factid_19065357" contextRef="PAsOn12_31_2018" unitRef="Unit_USD" decimals="-3">40585000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents id="Factid_19065358" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">17255000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect id="Factid_19065359" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-23330000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect id="Factid_19065360" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">77273000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:NetCashProvidedByUsedInFinancingActivities id="Factid_19065361" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">23969000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities id="Factid_19065362" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">217473000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:ProceedsFromStockOptionsExercised id="Factid_19065363" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">691000</us-gaap:ProceedsFromStockOptionsExercised>
<us-gaap:ProceedsFromStockOptionsExercised id="Factid_19065364" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">1221000</us-gaap:ProceedsFromStockOptionsExercised>
<us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock id="Factid_19065365" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">15294000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
<us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock id="Factid_19065366" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">89861000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
<us-gaap:NetCashProvidedByUsedInInvestingActivities id="Factid_19065367" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-964000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities id="Factid_19065368" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-108914000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="Factid_19065369" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">4000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Factid_19065370" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">968000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Factid_19065371" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">16183000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:NetCashProvidedByUsedInOperatingActivities id="Factid_19065372" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-46335000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities id="Factid_19065373" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-31286000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:IncreaseDecreaseInContractWithCustomerLiability id="Factid_19065374" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">14570000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
<fhtx:IncreaseDecreaseInOperatingLeaseLiabilities id="Factid_19065375" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-1160000</fhtx:IncreaseDecreaseInOperatingLeaseLiabilities>
<fhtx:IncreaseDecreaseInOperatingLeaseLiabilities id="Factid_19065376" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">15135000</fhtx:IncreaseDecreaseInOperatingLeaseLiabilities>
<us-gaap:IncreaseDecreaseInAccruedLiabilities id="Factid_19065377" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">2137000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccruedLiabilities id="Factid_19065378" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">3194000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayable id="Factid_19065379" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">1211000</us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:IncreaseDecreaseInAccountsPayable id="Factid_19065380" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">474000</us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Factid_19065381" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">991000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Factid_19065382" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">4670000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:PaidInKindInterest id="Factid_19065383" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">99000</us-gaap:PaidInKindInterest>
<us-gaap:PaidInKindInterest id="Factid_19065384" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">238000</us-gaap:PaidInKindInterest>
<fhtx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset id="Factid_19065385" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">1100000</fhtx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
<fhtx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset id="Factid_19065386" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">4201000</fhtx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
<us-gaap:FairValueAdjustmentOfWarrants id="Factid_19065387" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">69000</us-gaap:FairValueAdjustmentOfWarrants>
<us-gaap:DepreciationDepletionAndAmortization id="Factid_19065389" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">693000</us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization id="Factid_19065390" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">1327000</us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:ShareBasedCompensation id="Factid_19065391" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">1694000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation id="Factid_19065392" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">2961000</us-gaap:ShareBasedCompensation>
<us-gaap:ProfitLoss id="Factid_19065393" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-51128000</us-gaap:ProfitLoss>
<us-gaap:ProfitLoss id="Factid_19065394" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-68800000</us-gaap:ProfitLoss>
<us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues id="Factid_19065399" contextRef="P01_01_2020To12_31_2020_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">89861000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
<fhtx:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues id="Factid_19065400" contextRef="P01_01_2020To12_31_2020_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF">12007867</fhtx:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
<us-gaap:TemporaryEquitySharesOutstanding id="Factid_19065402" contextRef="PAsOn12_31_2018_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF">26575544</us-gaap:TemporaryEquitySharesOutstanding>
<us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests id="Factid_19065403" contextRef="PAsOn12_31_2018_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">71250000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
<us-gaap:CommonStockSharesOutstanding id="Factid_19065404" contextRef="PAsOn12_31_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF">3475152</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity id="Factid_19065406" contextRef="PAsOn12_31_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">3735000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_19065407" contextRef="PAsOn12_31_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">-43008000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_19065408" contextRef="PAsOn12_31_2018" unitRef="Unit_USD" decimals="-3">-39273000</us-gaap:StockholdersEquity>
<fhtx:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues id="Factid_19065409" contextRef="P01_01_2019To12_31_2019_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF">2040002</fhtx:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
<us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues id="Factid_19065410" contextRef="P01_01_2019To12_31_2019_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">15294000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
<us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests id="Factid_19065412" contextRef="PAsOn12_31_2019_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">86544000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
<us-gaap:CommonStockSharesOutstanding id="Factid_19065413" contextRef="PAsOn12_31_2019_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF">4870851</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity id="Factid_19065415" contextRef="PAsOn12_31_2019_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">6120000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_19065416" contextRef="PAsOn12_31_2019_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">-94136000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_19065418" contextRef="PAsOn12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">-162936000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_19065419" contextRef="PAsOn12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">309126000</us-gaap:StockholdersEquity>
<us-gaap:CommonStockSharesOutstanding id="Factid_19065420" contextRef="PAsOn12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF">36790946</us-gaap:CommonStockSharesOutstanding>
<us-gaap:NetIncomeLoss id="Factid_19065424" contextRef="P01_01_2020To12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">-68800000</us-gaap:NetIncomeLoss>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Factid_19065425" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">2961000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Factid_19065426" contextRef="P01_01_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">2961000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures id="Factid_19065427" contextRef="P01_01_2020To12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF">891894</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Factid_19065428" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">1221000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Factid_19065429" contextRef="P01_01_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">1221000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:NetIncomeLoss id="Factid_19065433" contextRef="P01_01_2019To12_31_2019_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">-51128000</us-gaap:NetIncomeLoss>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Factid_19065434" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">1694000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Factid_19065435" contextRef="P01_01_2019To12_31_2019_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">1694000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures id="Factid_19065436" contextRef="P01_01_2019To12_31_2019_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF">891891</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Factid_19065437" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">691000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Factid_19065438" contextRef="P01_01_2019To12_31_2019_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">691000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Factid_19065439" contextRef="P01_01_2019To12_31_2019_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF">503808</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Factid_19065440" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_shares" decimals="INF">4191793</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Factid_19065441" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_shares" decimals="INF">11046802</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted id="Factid_19065442" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD_per_Share" decimals="INF">-12.20</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted id="Factid_19065443" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD_per_Share" decimals="INF">-6.23</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:NonoperatingIncomeExpense id="Factid_19065446" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-44000</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense id="Factid_19065447" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-269000</us-gaap:NonoperatingIncomeExpense>
<us-gaap:FairValueAdjustmentOfWarrants id="Factid_19065448" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-1000</us-gaap:FairValueAdjustmentOfWarrants>
<us-gaap:FairValueAdjustmentOfWarrants id="Factid_19065449" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">69000</us-gaap:FairValueAdjustmentOfWarrants>
<fhtx:InterestIncomeAndOtherIncomeExpense id="Factid_19065450" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">495000</fhtx:InterestIncomeAndOtherIncomeExpense>
<fhtx:InterestIncomeAndOtherIncomeExpense id="Factid_19065451" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">1001000</fhtx:InterestIncomeAndOtherIncomeExpense>
<us-gaap:InterestExpense id="Factid_19065452" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">540000</us-gaap:InterestExpense>
<us-gaap:InterestExpense id="Factid_19065453" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">979000</us-gaap:InterestExpense>
<us-gaap:OperatingIncomeLoss id="Factid_19065454" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-51084000</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss id="Factid_19065455" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-68531000</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingExpenses id="Factid_19065456" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">51084000</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses id="Factid_19065457" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">68961000</us-gaap:OperatingExpenses>
<us-gaap:GeneralAndAdministrativeExpense id="Factid_19065458" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">6722000</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense id="Factid_19065459" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">11246000</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:ResearchAndDevelopmentExpense id="Factid_19065460" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">44362000</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense id="Factid_19065461" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">57715000</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax id="Factid_19065463" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">430000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
<us-gaap:LiabilitiesAndStockholdersEquity id="Factid_19065464" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">22342000</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity id="Factid_19065465" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">255594000</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_19065466" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">-88016000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_19065467" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">146187000</us-gaap:StockholdersEquity>
<us-gaap:RetainedEarningsAccumulatedDeficit id="Factid_19065468" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">-94136000</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit id="Factid_19065469" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">-162936000</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:AdditionalPaidInCapital id="Factid_19065470" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">6120000</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital id="Factid_19065471" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">309126000</us-gaap:AdditionalPaidInCapital>
<us-gaap:CommonStockValue id="Factid_19065472" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">4000</us-gaap:CommonStockValue>
<us-gaap:TemporaryEquityCarryingAmountAttributableToParent id="Factid_19065473" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">86544000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
<us-gaap:CommitmentsAndContingencies id="Factid_19065475" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" xsi:nil="true" />
<us-gaap:CommitmentsAndContingencies id="Factid_19065476" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" xsi:nil="true" />
<us-gaap:Liabilities id="Factid_19065477" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">23814000</us-gaap:Liabilities>
<us-gaap:Liabilities id="Factid_19065478" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">109407000</us-gaap:Liabilities>
<fhtx:PreferredStockWarrantsLiability id="Factid_19065479" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">45000</fhtx:PreferredStockWarrantsLiability>
<us-gaap:ContractWithCustomerLiabilityNoncurrent id="Factid_19065481" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">12546000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
<us-gaap:OperatingLeaseLiabilityNoncurrent id="Factid_19065482" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">157000</us-gaap:OperatingLeaseLiabilityNoncurrent>
<us-gaap:OperatingLeaseLiabilityNoncurrent id="Factid_19065483" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">58361000</us-gaap:OperatingLeaseLiabilityNoncurrent>
<us-gaap:LongTermDebtNoncurrent id="Factid_19065484" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">10960000</us-gaap:LongTermDebtNoncurrent>
<us-gaap:LongTermDebtNoncurrent id="Factid_19065485" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">19654000</us-gaap:LongTermDebtNoncurrent>
<us-gaap:LiabilitiesCurrent id="Factid_19065486" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">12652000</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent id="Factid_19065487" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">18846000</us-gaap:LiabilitiesCurrent>
<us-gaap:ContractWithCustomerLiabilityCurrent id="Factid_19065488" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">2024000</us-gaap:ContractWithCustomerLiabilityCurrent>
<us-gaap:LongTermDebtCurrent id="Factid_19065489" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">4152000</us-gaap:LongTermDebtCurrent>
<us-gaap:OperatingLeaseLiabilityCurrent id="Factid_19065491" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">1360000</us-gaap:OperatingLeaseLiabilityCurrent>
<us-gaap:OperatingLeaseLiabilityCurrent id="Factid_19065492" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">3981000</us-gaap:OperatingLeaseLiabilityCurrent>
<us-gaap:AccruedLiabilitiesCurrent id="Factid_19065493" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">3701000</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:AccruedLiabilitiesCurrent id="Factid_19065494" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">9161000</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:AccountsPayableCurrent id="Factid_19065495" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">3439000</us-gaap:AccountsPayableCurrent>
<us-gaap:AccountsPayableCurrent id="Factid_19065496" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">3680000</us-gaap:AccountsPayableCurrent>
<us-gaap:Assets id="Factid_19065497" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">22342000</us-gaap:Assets>
<us-gaap:Assets id="Factid_19065498" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">255594000</us-gaap:Assets>
<us-gaap:OperatingLeaseRightOfUseAsset id="Factid_19065499" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">1030000</us-gaap:OperatingLeaseRightOfUseAsset>
<us-gaap:OperatingLeaseRightOfUseAsset id="Factid_19065500" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">42804000</us-gaap:OperatingLeaseRightOfUseAsset>
<us-gaap:OtherAssetsNoncurrent id="Factid_19065501" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">11000</us-gaap:OtherAssetsNoncurrent>
<us-gaap:OtherAssetsNoncurrent id="Factid_19065502" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">842000</us-gaap:OtherAssetsNoncurrent>
<us-gaap:RestrictedCashNoncurrent id="Factid_19065503" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">1733000</us-gaap:RestrictedCashNoncurrent>
<us-gaap:RestrictedCashNoncurrent id="Factid_19065504" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">1733000</us-gaap:RestrictedCashNoncurrent>
<us-gaap:PropertyPlantAndEquipmentNet id="Factid_19065505" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">2683000</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:PropertyPlantAndEquipmentNet id="Factid_19065506" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">19528000</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:AssetsCurrent id="Factid_19065507" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">16885000</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent id="Factid_19065508" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">190687000</us-gaap:AssetsCurrent>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Factid_19065509" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">1363000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Factid_19065510" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">4917000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:RestrictedCashCurrent id="Factid_19065511" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">541000</us-gaap:RestrictedCashCurrent>
<us-gaap:CashAndCashEquivalentsAtCarryingValue id="Factid_19065513" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">14981000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue id="Factid_19065514" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">92795000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:ShortTermLeaseCost id="Factid_19065515" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">60000</us-gaap:ShortTermLeaseCost>
<us-gaap:VariableLeaseCost id="Factid_19065516" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">1217000</us-gaap:VariableLeaseCost>
<us-gaap:VariableLeaseCost id="Factid_19065517" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">547000</us-gaap:VariableLeaseCost>
<us-gaap:LeaseCost id="Factid_19065518" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">8310000</us-gaap:LeaseCost>
<us-gaap:LeaseCost id="Factid_19065519" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">2278000</us-gaap:LeaseCost>
<us-gaap:OperatingLeasePayments id="Factid_19065520" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">3086000</us-gaap:OperatingLeasePayments>
<us-gaap:OperatingLeasePayments id="Factid_19065521" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">1731000</us-gaap:OperatingLeasePayments>
<us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability id="Factid_19065522" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">38306000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
<us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability id="Factid_19065523" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">271000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
<fhtx:ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement id="Factid_19065524" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">7384000</fhtx:ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement>
<fhtx:ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement id="Factid_19065525" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">6513000</fhtx:ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement>
<us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 id="Factid_19065526" contextRef="PAsOn12_31_2020">P7Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
<us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 id="Factid_19065527" contextRef="PAsOn12_31_2019">P1Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
<us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent id="Factid_19065528" contextRef="PAsOn12_31_2020" unitRef="Unit_pure" decimals="4">0.0535</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
<us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent id="Factid_19065529" contextRef="PAsOn12_31_2019" unitRef="Unit_pure" decimals="4">0.0753</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
<us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount id="Factid_19065537" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">15104000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
<fhtx:LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives id="Factid_19065538" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">3933000</fhtx:LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives>
<us-gaap:AreaOfRealEstateProperty id="Factid_19065543" contextRef="PAsOn04_30_2020_MAsrtStatementGeographicalAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis_PropertyUnderOperatingLeaseSubleasedMemberusgaapLeaseContractualTermAxis" unitRef="Unit_sqft" decimals="INF">16843</us-gaap:AreaOfRealEstateProperty>
<us-gaap:OtherIncome id="Factid_19065544" contextRef="P01_01_2020To12_31_2020_MAsrtStatementGeographicalAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis_PropertyUnderOperatingLeaseSubleasedMemberusgaapLeaseContractualTermAxis" unitRef="Unit_USD" decimals="-5">1000000</us-gaap:OtherIncome>
<fhtx:NonRefundableLicenseFee id="Factid_19065545" contextRef="P07_31_2017To07_31_2017_MaximumMemberusgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_StanfordLicenseAgreementMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" unitRef="Unit_USD" decimals="-5">100000</fhtx:NonRefundableLicenseFee>
<fhtx:ReimbursedPatentCosts id="Factid_19065546" contextRef="P07_31_2017To07_31_2017_StanfordLicenseAgreementMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" unitRef="Unit_USD" decimals="-5">100000</fhtx:ReimbursedPatentCosts>
<us-gaap:CommonStockSharesIssued id="Factid_19065547" contextRef="PAsOn07_31_2017_StanfordLicenseAgreementMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" unitRef="Unit_shares" decimals="INF">42781</us-gaap:CommonStockSharesIssued>
<fhtx:AnnualLicenseMaintenanceFees id="Factid_19065548" contextRef="P07_31_2017To07_31_2017_MaximumMemberusgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_StanfordLicenseAgreementMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" unitRef="Unit_USD" decimals="-5">100000</fhtx:AnnualLicenseMaintenanceFees>
<fhtx:MilestonesPayableUponEvent id="Factid_19065549" contextRef="P07_31_2017To07_31_2017_MaximumMemberusgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_StanfordLicenseAgreementMemberusgaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" unitRef="Unit_USD" decimals="-5">1100000</fhtx:MilestonesPayableUponEvent>
<fhtx:CashPaymentsRelatedParty id="Factid_19065550" contextRef="P01_01_2020To12_31_2020_FlagshipPioneeringMemberFHTXAgreementsAxis" unitRef="Unit_USD" decimals="-5">1200000</fhtx:CashPaymentsRelatedParty>
<fhtx:CashPaymentsRelatedParty id="Factid_19065551" contextRef="P01_01_2019To12_31_2019_FlagshipPioneeringMemberFHTXAgreementsAxis" unitRef="Unit_USD" decimals="-5">900000</fhtx:CashPaymentsRelatedParty>
<fhtx:CashPaymentsRelatedParty id="Factid_19065552" contextRef="P01_01_2020To12_31_2020_ScientificFounderMemberFHTXAgreementsAxis" unitRef="Unit_USD" decimals="-5">200000</fhtx:CashPaymentsRelatedParty>
<fhtx:CashPaymentsRelatedParty id="Factid_19065553" contextRef="P01_01_2019To12_31_2019_ScientificFounderMemberFHTXAgreementsAxis" unitRef="Unit_USD" decimals="-5">200000</fhtx:CashPaymentsRelatedParty>
<us-gaap:AccountsPayableCurrent id="Factid_19065554" contextRef="PAsOn12_31_2020_MaximumMembersrtRangeAxis_ScientificFounderMemberFHTXAgreementsAxis" unitRef="Unit_USD" decimals="-5">100000</us-gaap:AccountsPayableCurrent>
<us-gaap:TemporaryEquityParOrStatedValuePerShare id="Factid_19065555" contextRef="PAsOn12_31_2020_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
<us-gaap:TemporaryEquityParOrStatedValuePerShare id="Factid_19065556" contextRef="PAsOn12_31_2019_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
<us-gaap:TemporaryEquitySharesAuthorized id="Factid_19065557" contextRef="PAsOn12_31_2019_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF">28629622</us-gaap:TemporaryEquitySharesAuthorized>
<us-gaap:TemporaryEquitySharesAuthorized id="Factid_19065558" contextRef="PAsOn12_31_2020_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF">0</us-gaap:TemporaryEquitySharesAuthorized>
<us-gaap:TemporaryEquitySharesIssued id="Factid_19065559" contextRef="PAsOn12_31_2020_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF">0</us-gaap:TemporaryEquitySharesIssued>
<us-gaap:TemporaryEquitySharesOutstanding id="Factid_19065560" contextRef="PAsOn12_31_2020_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF">0</us-gaap:TemporaryEquitySharesOutstanding>
<us-gaap:TemporaryEquitySharesIssued id="Factid_19065561" contextRef="PAsOn12_31_2019_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF">28615546</us-gaap:TemporaryEquitySharesIssued>
<us-gaap:TemporaryEquitySharesOutstanding id="Factid_19065562" contextRef="PAsOn12_31_2019_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF">28615546</us-gaap:TemporaryEquitySharesOutstanding>
<us-gaap:PreferredStockParOrStatedValuePerShare id="Factid_19065563" contextRef="PAsOn12_31_2020" unitRef="Unit_USD_per_Share" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesAuthorized id="Factid_19065564" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF">25000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesIssued id="Factid_19065565" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding id="Factid_19065566" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:CommonStockParOrStatedValuePerShare id="Factid_19065567" contextRef="PAsOn12_31_2020" unitRef="Unit_USD_per_Share" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesOutstanding id="Factid_19065572" contextRef="PAsOn12_31_2019" unitRef="Unit_shares" decimals="INF">4870851</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockParOrStatedValuePerShare id="Factid_19065573" contextRef="PAsOn12_31_2019" unitRef="Unit_USD_per_Share" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesOutstanding id="Factid_19065574" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF">36790946</us-gaap:CommonStockSharesOutstanding>
<us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock id="Factid_19065576" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5. Accrued Expenses &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued expenses consisted of the following (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 76%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 78%;"&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width: 5%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Accrued &lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;employee compensation and benefits&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;3,513&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;1,867&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;construction in progress&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;2,385&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;119&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Accrued external research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;2,146&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;1,384&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued professional fee&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;s&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;"&gt;&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;979&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;"&gt;&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;274&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 78%; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;138&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;57&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 78%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(255, 255, 255); width: 78%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;9,161&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;3,701&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 78%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock id="Factid_19065577" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15. Related Parties &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In October 2015, the Company entered into a five-year service agreement with Flagship Pioneering (&amp;#8220;Flagship&amp;#8221;), &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;an affiliate of one of its stockholders, to provide general and administrative services&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; to the Company, including certain consulting services and the provision of employee health and dental benefit plans for the Company&amp;#8217;s employees. The Company made cash payments for services received under this agreement of $1.2&amp;#160;million and $0.9&amp;#160;million during the years ended December&amp;#160;31, 2020 and 2019, respectively. As of December&amp;#160;31, 2020 and 2019, the Company had no accounts payable to Flagship for costs related to the service agreement.&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;This agreement expired in 2020.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In October 2015, the Company entered into a five-year consulting agreement with a scientific founder of the Company who is also a board member and a &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;shareholder. In October 2020, this agreement was extended to January 1, 2022, with an option to renew. During&lt;/div&gt; the years ended December&amp;#160;31, 2020 and 2019, the Company paid the scientific founder $0.2&amp;#160;million and $0.2&amp;#160;million, respectively. As of December&amp;#160;31, 2020 the Company had less than $0.1&amp;#160;million in accounts payable to this scientific founder. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock id="Factid_19065578" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued expenses consisted of the following (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 76%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 78%;"&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width: 5%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Accrued &lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;employee compensation and benefits&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;3,513&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;1,867&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;construction in progress&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;2,385&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;119&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Accrued external research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;2,146&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;1,384&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 78%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued professional fee&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;s&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;"&gt;&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;979&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;"&gt;&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;274&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 78%; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;138&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;57&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 78%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(255, 255, 255); width: 78%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;9,161&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;3,701&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 78%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
<fhtx:ServiceAgreementTerm id="Factid_19065579" contextRef="P10_01_2015To10_31_2015_FlagshipPioneeringMemberFHTXAgreementsAxis">P5Y</fhtx:ServiceAgreementTerm>
<fhtx:ServiceAgreementTerm id="Factid_19065580" contextRef="P10_01_2015To10_31_2015_ScientificFounderMemberFHTXAgreementsAxis">P5Y</fhtx:ServiceAgreementTerm>
<us-gaap:DebtDisclosureTextBlock id="Factid_19065581" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6. Notes Payable &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Long-term debt consisted of the following (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 74%;"&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width: 5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Principal amount of long-term debt&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;15,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Less: Current portion of long-term debt&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(4,152&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Long-term debt, net of current portion&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10,848&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Final payment fee&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;530&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Debt discount, net of accretion&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,346&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(418&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Long-term debt, net of discount and current portion&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 5%;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;19,654&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,960&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Loan and Security Agreements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December 31, 2019, the Company had outstanding loans under its amended loan and security agreement with Comerica Bank (the &amp;#8220;Loan&amp;#8221;) of&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;$7.0&amp;#160;million (&amp;#8220;Term Loan A&amp;#8221;) and $8.0&amp;#160;million (&amp;#8220;Term Loan B&amp;#8221;). Borrowings under both Term Loan A and Term Loan B were repayable in monthly payments of interest-only through February 2020, to be followed by monthly payments of equal principal plus interest until the loan maturity date of February&amp;#160;1, 2023. In April 2020, the Company amended the Loan to extend the interest only period through May&amp;#160;31, 2020 and in June 2020 the Loan was further amended to extend the interest-only period through August&amp;#160;31, 2020. Interest for Term Loan A was the greater of 1) Comerica&amp;#8217;s Prime Rate or 2) LIBOR plus 2.5%, and for Term Loan B, 1.0% plus the greater of 1) Comerica&amp;#8217;s Prime Rate or 2) LIBOR plus 2.5%. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A final payment fee of 3.0% of the aggregate amounts drawn under Term Loan A and 4.0% under Term Loan B was due upon the earlier of the maturity date, the repayment date if paid early, whether voluntary or upon acceleration due to default, the sale of substantially all of the Company&amp;#8217;s assets, or the Company&amp;#8217;s IPO. The Company may repay the Loan at any time by paying the outstanding principal balance in full, along with any unpaid accrued interest and the final payment fee. The final payment fee of $0.5&amp;#160;million was being amortized to interest expense over the term of the debt using the effective interest method. Upon closing of the Company&amp;#8217;s IPO in October 2020, the final payment fee became due. In November 2020, the Company used a portion of the proceeds from its new loan and security agreement described below to repay the outstanding principal balance under Term Loan A and Term Loan B plus unpaid accrued interest and the final payment fee. &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;The Company recorded a loss&amp;#160;&lt;/div&gt; on debt extinguishment of $0.2&amp;#160;million related to this repayment. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;On November&amp;#160;19, 2020, the Company entered into a new loan and security agreement, or the Oxford Loan, with Oxford Finance LLC, or Oxford, for an aggregate principal amount of $20.0&amp;#160;million (Oxford Term Loan A) and up to an additional $5.0&amp;#160;million (Oxford Term Loan B). &lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On November&amp;#160;19, 2020, the Company borrowed $20.0&amp;#160;million under the Oxford Term Loan A.&lt;/div&gt; The Term Loan bears interest at a floating per annum rate equal to the greater of (i) 8.0% and (ii)&amp;#160;the sum of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(a)&amp;#160;thirty-day&lt;/div&gt; LIBOR rate plus (b) 7.84%. In addition, upon loan maturity or prepayment, the Company is reqired to make a final payment fee equal to 5.0% of the aggregate principal amount borrowed which is being amortized to interest expense over the term of the debt using the effective interest method. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company is required to make monthly interest only payments under the Oxford Loan each month beginning on January&amp;#160;1, 2021. Beginning on December&amp;#160;1, 2023, the Company is required to make consecutive equal monthly payments of principal, together with applicable interest, in arrears, based upon a repayment schedule equal to 24 months, with a final maturity date of November&amp;#160;1, 2025 (the &amp;#8220;Maturity Date&amp;#8221;).&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;At the Company&amp;#8217;s option, the Company may elect to prepay the loans subject to a prepayment fee equal to the following percentage of the principal amount being prepaid:&amp;#160;2% if an advance is prepaid during the first 12 months following the applicable advance date,&amp;#160;1% if an advance is prepaid after 12 months but prior to 24 months following the applicable advance date, and&amp;#160;0.5% if an advance is prepaid any time after 24 months following the applicable advance date but prior to the Maturity Date. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s obligations under the Oxford Loan Agreement are secured by a security interest in all of its assets, other than its intellectual property. The Company is also subject to certain affirmative and negative covenants&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;including&amp;#160;&lt;/div&gt;&lt;/div&gt;limitations on dispositions, mergers or acquisitions; encumbering its intellectual property; incurring indebtedness or liens; paying dividends; making certain investments; and engaging in certain other business transactions. The obligations under the Loan are subject to acceleration upon the occurrence of specified events of default, including a material adverse change in the Company&amp;#8217;s business, operations or financial or other condition. Upon the occurrence of an event of default and until such event of default is no longer continuing, the annual interest rate will be 5.0% above the otherwise applicable rate. As of December&amp;#160;31, 2020, the Company believes an event of default would be remote. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;In &lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;addition, in&lt;/div&gt; connection with the Oxford Loan Agreement, the Company granted warrants to purchase 18,445 shares of the Company&amp;#8217;s common stock at $16.26 per share. The issued warrants are exerciseable for 10 years. The Company valued the warrants using the Black-Scholes option pricing model and determined the fair value of the warrants to be $0.2&amp;#160;million. The Company determined the warrants met the criteria for equity classification, and, as such, the fair value of the warrants were recorded as additional &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;paid-in&lt;/div&gt; capital and as a discount to the &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;debt which is being amortized to interest expense over the term of the Oxford Loan of five years. In addition, the Company incurred debt issuance costs of&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; $0.2&amp;#160;million.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December 31, 2020, the interest rate applicable to outstanding borrowings under the Oxford Loan was&amp;#160;&lt;/div&gt;8.0%. During the years ended December&amp;#160;31, 2020 and 2019, the weighted average effective interest rate on outstanding borrowings was approximately 6.4% and 6.9%, respectively. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, future principal payments due are as follows (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 85%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 85%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;833&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 85%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9,167&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 85%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 85%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;20,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 85%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DebtDisclosureTextBlock>
<us-gaap:ScheduleOfDebtInstrumentsTextBlock id="Factid_19065582" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Long-term debt consisted of the following (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 74%;"&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width: 5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Principal amount of long-term debt&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;15,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Less: Current portion of long-term debt&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(4,152&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Long-term debt, net of current portion&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;20,000&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10,848&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Final payment fee&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;530&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Debt discount, net of accretion&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,346&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(418&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Long-term debt, net of discount and current portion&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 5%;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;19,654&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,960&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:5%;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
<us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock id="Factid_19065583" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, future principal payments due are as follows (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 85%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 85%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;833&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 85%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9,167&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 85%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 85%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;20,000&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 85%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths id="Factid_19065584" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo id="Factid_19065585" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree id="Factid_19065586" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">833000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
<us-gaap:AccountsPayableCurrent id="Factid_19065588" contextRef="PAsOn12_31_2020_FlagshipPioneeringMemberFHTXAgreementsAxis" unitRef="Unit_USD" decimals="-6">0</us-gaap:AccountsPayableCurrent>
<us-gaap:AccountsPayableCurrent id="Factid_19065589" contextRef="PAsOn12_31_2019_FlagshipPioneeringMemberFHTXAgreementsAxis" unitRef="Unit_USD" decimals="-6">0</us-gaap:AccountsPayableCurrent>
<us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock id="Factid_19065592" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;14. Defined Contribution Plan &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company has a 401(k) defined contribution plan (the &amp;#8220;401(k) Plan&amp;#8221;) for its employees. Eligible employees may make pretax contributions to the 401(k) Plan up to statutory limits. There was no discretionary match made under the 401(k) Plan as of December&amp;#160;31, 20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt;&amp;#160;and 2019. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="Factid_19065593" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;13. Commitments and Contingencies &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Leases &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s commitments under its leases are described in Note&amp;#160;1&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2&lt;/div&gt;. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;License agreements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Dana-Farber Cancer Institute &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In 2016, the Company entered into a license agreement with the Dana-Farber Cancer Institute, Inc. (&amp;#8220;Dana Farber&amp;#8221;) for an exclusive license for certain biological materials as well as patent rights to methods of identifying compounds to treat prostate cancer. In consideration for the right to develop, manufacture, and commercialize products based on certain of Dana Farber&amp;#8217;s intellectual property, the Company is obligated to reimburse Dana Farber for patent expenses and pay low single-digit sales-based royalties upon the occurrence of specific events as outlined in the license agreement. Unless terminated earlier, in accordance with the provisions of the agreement, the agreement will terminate on the expiration date of the last to expire of the applicable Dana Farber patents. None of the Company&amp;#8217;s product candidates utilize technology covered by this license. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stanford &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In July 2017, the Company entered into a license agreement with the Board of Trustees of the Leland Stanford Junior University (&amp;#8220;Stanford&amp;#8221;) for a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-exclusive&lt;/div&gt; license for patent rights to certain diseases associated with chromatin remodeling. In consideration for the right to develop, manufacture, and commercialize products based on certain of Stanford&amp;#8217;s intellectual property, the Company paid a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-time,&lt;/div&gt; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-refundable&lt;/div&gt; license fee of less than $0.1&amp;#160;million and reimbursed Stanford for $0.1&amp;#160;million of costs incurred related to the patented technology. The Company also issued 42,781 shares of the Company&amp;#8217;s common stock upon execution of a share purchase agreement. In addition to annual license maintenance fees of less than $0.1&amp;#160;million, the Company will reimburse Stanford for patent expenses, pay low single-digit sales-based royalties, and pay up to $1.1&amp;#160;million in regulatory milestones on each licensed product upon the occurrence of specific events as outlined in the license agreement. None of the Company&amp;#8217;s product candidates utilize technology covered by this license. &lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Indemnification agreements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, contract research organizations, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its board of directors and its executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. The Company has not incurred any material costs as a result of such indemnifications and is not currently aware of any indemnification claims. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Legal Proceedings &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;From time to time, the Company may become involved in litigation or other legal proceedings. The Company is not currently a party to any material litigation or legal proceedings. &lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
<us-gaap:SharesIssuedPricePerShare id="Factid_19065596" contextRef="PAsOn08_31_2020_SeriesBMemberusgaapAuctionMarketPreferredSecuritiesStockSeriesAxis" unitRef="Unit_USD_per_Share" decimals="INF">7.50</us-gaap:SharesIssuedPricePerShare>
<us-gaap:SharesIssuedPricePerShare id="Factid_19065597" contextRef="PAsOn04_30_2020_SeriesBMemberusgaapAuctionMarketPreferredSecuritiesStockSeriesAxis" unitRef="Unit_USD_per_Share" decimals="INF">7.50</us-gaap:SharesIssuedPricePerShare>
<us-gaap:ConversionOfStockSharesIssued1 id="Factid_19065598" contextRef="P10_27_2020To10_27_2020_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="0">21958588</us-gaap:ConversionOfStockSharesIssued1>
<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized id="Factid_19065601" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-5">13500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="Factid_19065602" contextRef="P01_01_2020To12_31_2020">P3Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
<fhtx:OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals id="Factid_19065603" contextRef="P01_01_2020To12_31_2020_MAsrtStatementGeographicalAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis_PropertyUnderOperatingLeaseSubleasedMemberusgaapLeaseContractualTermAxis" unitRef="Unit_USD" decimals="-5">2500000</fhtx:OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals>
<fhtx:LeaseTermCommencementDate id="Factid_19065604" contextRef="P10_31_2019To10_31_2019_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis">2020-01-01</fhtx:LeaseTermCommencementDate>
<us-gaap:CollaborativeArrangementDisclosureTextBlock id="Factid_19065605" contextRef="P01_01_2020To12_31_2020">&lt;div style="margin-block: 0em; margin-bottom: 0px; margin-top: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10. Collaboration Agreement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In July 2020, the Company entered into a research collaboration and license agreement (the &amp;#8220;Collaboration Agreement&amp;#8221;) with Merck Sharp&amp;#160;&amp;amp; Dohme Corp. (&amp;#8220;Merck&amp;#8221;). The Company and Merck will apply Foghorn&amp;#8217;s proprietary Gene Traffic Control platform to discover and develop novel therapeutics. Under the Collaboration Agreement, the Company granted Merck exclusive global rights to develop and commercialize drugs that target dysregulation of a single transcription factor. Under the terms of the Collaboration Agreement, the Company and Merck are each responsible to perform certain research activities in accordance with a mutually agreed upon research plan. Merck may substitute the selected transcription factor during certain stages of the research program, subject to certain limitations. Following completion of the research program, Merck is responsible for the development and commercialization of the compounds developed pursuant to the research program and any product containing such compounds. Pursuant to the Collaboration Agreement, the Company will also participate on a joint steering committee.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;Under the terms of the agreement, Foghorn received a nonrefundable upfront payment of $15.0&amp;#160;million from Merck, and is eligible to receive up to $245.0&amp;#160;million upon&amp;#160;achievement of specified research, development and regulatory milestones by any product candidate generated by the collaboration, and up to $165.0&amp;#160;&lt;div style="display:inline;"&gt;million upon achievement of specified sales-based milestones per approved product from the collaboration, if any. The Company will be eligible to receive tiered royalties, calculated on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;product-by-product&lt;/div&gt;&lt;/div&gt; and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;country-by-country&lt;/div&gt;&lt;/div&gt; basis, on net sales of approved products from the collaboration, if any, at royalty rates ranging from the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;mid-single&lt;/div&gt; digits to low tens, depending on whether the products are covered by patent rights it licenses to Merck. &lt;/div&gt; &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unless terminated earlier, the Collaboration Agreement will continue in full force and effect until one or more products has received marketing authorization and, thereafter, until expiration of all royalty obligations under the Collaboration Agreement. The Company or Merck may terminate the Collaboration Agreement upon an uncured material breach by the other party or insolvency of the other party. Merck may also terminate the Merck Collaboration Agreement for any reason upon certain notice to the Company. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company determined that the (1)&amp;#160;research, development, manufacture and commercialization licenses, (2)&amp;#160;the research activities performed by the Company and (3)&amp;#160;service on the joint committees represent a single performance obligation under the Collaboration Agreement. The Company determined that Merck cannot benefit from licenses separately from the research activities and participation on the joint steering committee as these services are specialized and rely on the Company&amp;#8217;s expertise such that these activities are highly interrelated and therefore not distinct. Accordingly, the promised goods and services represent one combined performance obligation and the entire transaction price was allocated to that single combined performance obligation. The performance obligation will be satisfied over the research term as the Company performs the research activities and participates in a joint steering committee to oversee research activities.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The upfront payment of &lt;/div&gt;&lt;/div&gt;&amp;#160;$15.0&amp;#160;million was initially recorded as deferred revenue and is being recognized as revenue as the performance obligation is satisfied. The Company recognizes revenue &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;using&amp;#160;the&amp;#160;cost-to-cost&amp;#160;method,&amp;#160;which&lt;/div&gt;&lt;/div&gt; it believes best depicts the transfer of control to the customer over time. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Under&amp;#160;the&amp;#160;cost-to-cost&amp;#160;method,&amp;#160;the&lt;/div&gt;&lt;/div&gt; extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs expected upon satisfying the identified performance obligation. Under this method, revenue is recorded as a percentage of the estimated transaction price based on the extent of progress towards completion. As of December&amp;#160;31, 2020, the potential research, development and regulatory milestone payments that the Company is eligible to receive were excluded from the transaction price as they were fully constrained by uncertain events. The Company will reevaluate the transaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur, and if necessary, the Company will adjust its estimate of the transaction price. Any additions to the transaction price would be reflected in the period as a cumulative &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;revenue&amp;#160;catch-up&lt;/div&gt; based on the ratio of costs incurred to the total estimated costs expected applied to the revised transaction price.&amp;#160;Sales-based royalties and milestone payments, which predominantly relate to the license, will be recognized if and&amp;#160;when the related sales occur. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;As of December&amp;#160;31, 2020, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation is $14.6&amp;#160;million, which is expected to be recognized as revenue through 2028. The Company does not expect collaboration revenue to be recognized evenly over this period as it will be recognized on a percentage of completion basis (using &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cost-to-cost&lt;/div&gt;&lt;/div&gt; method) as the Company performs the research activities and participates on the joint steering committee, which will likely vary from period to period. In estimating the total costs to satisfy its single performance obligation pursuant to the Collaboration Agreement, the Company is required to make significant estimates including an estimate of the number of transcription factor substitutions and the expected time and expected costs to fulfill the performance obligation.&amp;#160;The cumulative effect of revisions to the total estimated costs to complete the Company&amp;#8217;s single performance obligation will be recorded in the period in which the changes are identified, and amounts can be reasonably estimated. While such revisions will have no impact on the Company&amp;#8217;s cash flows, a significant change in these assumptions and estimates could have a material impact on the timing and amount of revenue recognized in future periods. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company assessed the Collaboration Agreement to determine whether a significant financing component exists and concluded that a significant financing component does not exist. Through December&amp;#160;31, 2020, the Company had recorded $0.4&amp;#160;million of revenue under the Collaboration Agreement. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
<us-gaap:LesseeOperatingLeaseTermOfContract id="Factid_19065606" contextRef="PAsOn10_31_2019_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis">P8Y</us-gaap:LesseeOperatingLeaseTermOfContract>
<us-gaap:LesseeOperatingLeaseRenewalTerm id="Factid_19065607" contextRef="PAsOn10_31_2019_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
<fhtx:TermOfPropertySubleasedUnderOperatingLease id="Factid_19065608" contextRef="P04_30_2020To04_30_2020_MAsrtStatementGeographicalAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis_PropertyUnderOperatingLeaseSubleasedMemberusgaapLeaseContractualTermAxis">P2Y</fhtx:TermOfPropertySubleasedUnderOperatingLease>
<us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock id="Factid_19065610" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following tables present the Company&amp;#8217;s fair value hierarchy for its assets and liabilities, which are measured at fair value on a recurring basis (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 61%;"&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value Measurements at&lt;br/&gt; December&amp;#160;31, 2020 Using:&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;1&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;2&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;3&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Assets:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cash equivalents:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Money market funds&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;48,770&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;48,770&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;U&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.S&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&lt;/div&gt; treasury notes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; text-align: right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212; &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;42,997&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; text-align: right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212; &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;42,997&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Marketable securities:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;U&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;S&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&amp;#160;treasury notes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,975&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,975&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;48,770&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;135,972&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;184,742&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:;;height:16;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="16" style="font-family: &amp;quot;times new roman&amp;quot;;;width:;;height:16;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value Measurements at&lt;br/&gt; December&amp;#160;31, 2019 Using:&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;1&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;2&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;3&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Assets:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cash equivalents:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Money market funds&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;14,951&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;14,951&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Preferred stock warrant liability&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;45&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;45&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
<dei:AmendmentFlag id="Factid_19065612" contextRef="P01_01_2020To12_31_2020">false</dei:AmendmentFlag>
<dei:DocumentFiscalYearFocus id="Factid_19065614" contextRef="P01_01_2020To12_31_2020">2020</dei:DocumentFiscalYearFocus>
<dei:DocumentFiscalPeriodFocus id="Factid_19065615" contextRef="P01_01_2020To12_31_2020">FY</dei:DocumentFiscalPeriodFocus>
<dei:EntityCentralIndexKey id="Factid_19065617" contextRef="P01_01_2020To12_31_2020">0001822462</dei:EntityCentralIndexKey>
<dei:CurrentFiscalYearEndDate id="Factid_19065618" contextRef="P01_01_2020To12_31_2020">--12-31</dei:CurrentFiscalYearEndDate>
<dei:DocumentAnnualReport id="Factid_19065619" contextRef="P01_01_2020To12_31_2020">true</dei:DocumentAnnualReport>
<dei:DocumentTransitionReport id="Factid_19065620" contextRef="P01_01_2020To12_31_2020">false</dei:DocumentTransitionReport>
<dei:EntityIncorporationStateCountryCode id="Factid_19065621" contextRef="P01_01_2020To12_31_2020">DE</dei:EntityIncorporationStateCountryCode>
<dei:EntityAddressStateOrProvince id="Factid_19065622" contextRef="P01_01_2020To12_31_2020">MA</dei:EntityAddressStateOrProvince>
<dei:EntityFilerCategory id="Factid_19065623" contextRef="P01_01_2020To12_31_2020">Non-accelerated Filer</dei:EntityFilerCategory>
<dei:EntitySmallBusiness id="Factid_19065624" contextRef="P01_01_2020To12_31_2020">true</dei:EntitySmallBusiness>
<dei:EntityEmergingGrowthCompany id="Factid_19065625" contextRef="P01_01_2020To12_31_2020">true</dei:EntityEmergingGrowthCompany>
<us-gaap:GainLossOnDispositionOfAssets id="Factid_19065626" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">206000</us-gaap:GainLossOnDispositionOfAssets>
<us-gaap:GainLossOnDispositionOfAssets id="Factid_19065627" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-11000</us-gaap:GainLossOnDispositionOfAssets>
<us-gaap:RepaymentsOfNotesPayable id="Factid_19065628" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">15530000</us-gaap:RepaymentsOfNotesPayable>
<dei:EntityExTransitionPeriod id="Factid_19065629" contextRef="P01_01_2020To12_31_2020">false</dei:EntityExTransitionPeriod>
<dei:EntityShellCompany id="Factid_19065632" contextRef="P01_01_2020To12_31_2020">false</dei:EntityShellCompany>
<us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock id="Factid_19065637" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1. Nature of Business and Basis of Presentation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Foghorn Therapeutics&amp;#160;Inc. (the &amp;#8220;Company&amp;#8221;) is a clinical-stage biopharmaceutical company discovering and developing a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. The Company uses its proprietary Gene Traffic Control platform to identify, validate and potentially drug targets within the system. The Company was founded in &lt;/div&gt;October 2015&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; as a Delaware corporation. The Company is headquartered in Cambridge, Massachusetts.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company is subject to risks similar to those of other early-stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; pandemic and the need to obtain adequate additional financing to fund the development of its products. There can be no assurance that the Company&amp;#8217;s research and development will be successfully completed, that adequate protection for the Company&amp;#8217;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&amp;#8217;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;In March 2020, the World Health Organization declared the global novel coronavirus disease 2019 &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(&amp;#8220;COVID-19&amp;#8221;)&amp;#160;outbreak&lt;/div&gt; a pandemic. The Company&amp;#8217;s operations have not been significantly impacted by &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the&amp;#160;COVID-19&amp;#160;pandemic.&lt;/div&gt; However, the Company cannot at this time predict the specific extent, duration, or full impact that &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the&amp;#160;COVID-19&amp;#160;pandemic&lt;/div&gt; will have on its financial condition and operations, including ongoing and planned clinical trials. The impact of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the&amp;#160;COVID-19&amp;#160;outbreak&lt;/div&gt; on the Company&amp;#8217;s financial performance will depend on future developments, including the duration and spread of the pandemic and related governmental advisories and restrictions. These developments and the impact &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;of&amp;#160;COVID-19&amp;#160;on&lt;/div&gt; the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company&amp;#8217;s results may be materially adversely affected. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On October&amp;#160;&lt;/div&gt;27&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;, &lt;/div&gt;2020&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;, the Company completed its initial public offering (&amp;#8220;IPO&amp;#8221;) pursuant to which it issued and sold &lt;/div&gt;7,500,000&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; shares of its common stock at a public offering price of $&lt;/div&gt;16.00&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; per share, resulting in net proceeds of $&lt;/div&gt;107.9&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;million, after deducting underwriting discounts and commissions and other offering expenses. On November&amp;#160;&lt;/div&gt;19&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;, &lt;/div&gt;2020&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;, the Company issued and sold an additional &lt;/div&gt;951,837&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; shares of common stock at the IPO price of $&lt;/div&gt;16.00&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; per share pursuant to the underwriters&amp;#8217; partial exercise of their option to purchase additional shares of common stock, resulting in additional net proceeds of $&lt;/div&gt;14.2&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;million after deducting underwriting discounts and commissions. Upon the closing of the IPO, all of the Company&amp;#8217;s outstanding convertible preferred stock automatically converted into shares of &lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;common stock and the Company&amp;#8217;s outstanding &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; warrants to purchase Series&amp;#160;A Preferred Stock automatically became warrants to purchase an aggregate of &lt;/div&gt;7,608&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;shares of common stock (see Note 7).&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The accompanying consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. Since inception, the Company has funded its operations primarily with proceeds from sales of preferred stock, debt financing and an upfront payment of $15.0&amp;#160;million the Company received in July 2020 under a collaboration agreement with Merck Sharp&amp;#160;&amp;amp; &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dohme Corp. (see Note 10), and most recently, &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;with proceeds from the sale of common stock in the IPO completed in October 2020. The Company has incurred recurring losses, including net losses of $68.8&amp;#160;million and $51.1&amp;#160;million for the years ended December&amp;#160;31, 2020 and 2019, respectively. As of December&amp;#160;31, 2020, the Company had an accumulated deficit of $162.9&amp;#160;million. The Company expects to continue to generate operating losses in the foreseeable future. As of the issuance date of these&amp;#160;consolidated financial statements the Company expects that&amp;#160;its cash&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;,&lt;/div&gt;&amp;#160;cash equivalents &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;and marketable securities&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;will be sufficient to fund its operating expenses and capital expenditure requirements for at least 12 months. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company will need to obtain additional funding through public or private equity offerings, debt financings, collaborations, strategic alliances and/or licensing arrangements. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborative or strategic alliances or licensing arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company&amp;#8217;s stockholders. Arrangements with collaborators or others may require the Company to relinquish rights to certain of its technologies or programs. If the Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate some or all of its research and development programs, pipeline expansion or commercialization efforts, which could adversely affect its business prospects. Although management will continue to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations when needed or at all.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px;;font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Basis of presentation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221;). The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) and Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) of the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;). &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
<fhtx:StockIssuanceCosts id="Factid_19065639" contextRef="P01_01_2019To12_31_2019_SeriesBRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">6000</fhtx:StockIssuanceCosts>
<fhtx:StockIssuanceCosts id="Factid_19065640" contextRef="P01_01_2020To12_31_2020_SeriesBRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">198000</fhtx:StockIssuanceCosts>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Factid_19065642" contextRef="PAsOn10_27_2020_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="INF">7608</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:CashAndCashEquivalentsPolicyTextBlock id="Factid_19065643" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Cash equivalents &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company considers all highly liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
<us-gaap:CompensationRelatedCostsPolicyTextBlock id="Factid_19065645" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Stock-based compensation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;The Company measures stock options with service-based vesting or performance-based vesting granted to employees, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-employees&lt;/div&gt; and directors based on the fair value on the date of grant using the Black-Scholes option-pricing model. The Company measures restricted common stock awards using the difference between the purchase price per share of the award, if any, and the fair value of the Company&amp;#8217;s common stock at the date of grant. Compensation expense for the awards is recognized over the requisite service period for employees and directors and as services are delivered for &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-employees,&lt;/div&gt; both of which are generally the vesting period of the respective award. The Company uses the straight-line method to record the expense of awards with only service-based vesting conditions. The Company uses the graded-vesting method to record the expense of awards with both service-based and performance-based vesting conditions, commencing once achievement of the performance condition becomes probable. The Company&amp;#160;accounts for forfeitures of share-based awards as they occur. &lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company classifies stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient&amp;#8217;s payroll costs are classified or in which the award recipient&amp;#8217;s service payments are classified. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
<us-gaap:IncomeTaxPolicyTextBlock id="Factid_19065646" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Income taxes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&amp;#8217;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to the provision for income taxes. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;two-step&lt;/div&gt; process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;more-likely-than-not&lt;/div&gt; to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. Any resulting unrecognized tax benefits are recorded within the provision for income taxes. &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IncomeTaxPolicyTextBlock>
<us-gaap:ImpairmentOfLongLivedAssetsHeldForUse id="Factid_19065649" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-6">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
<us-gaap:OperatingLossCarryforwards id="Factid_19065650" contextRef="PAsOn12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5">147300000</us-gaap:OperatingLossCarryforwards>
<us-gaap:OperatingLossCarryforwards id="Factid_19065651" contextRef="PAsOn12_31_2020_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5">132300000</us-gaap:OperatingLossCarryforwards>
<us-gaap:OperatingLossCarryforwards id="Factid_19065652" contextRef="PAsOn12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ExpirableMemberusgaapTaxPeriodAxis" unitRef="Unit_USD" decimals="-5">12500000</us-gaap:OperatingLossCarryforwards>
<us-gaap:OperatingLossCarryforwards id="Factid_19065653" contextRef="PAsOn12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_NonExpirableMemberusgaapTaxPeriodAxis" unitRef="Unit_USD" decimals="-5">134800000</us-gaap:OperatingLossCarryforwards>
<us-gaap:TaxCreditCarryforwardAmount id="Factid_19065654" contextRef="PAsOn12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ResearchMemberusgaapTaxCreditCarryforwardAxis" unitRef="Unit_USD" decimals="-5">3400000</us-gaap:TaxCreditCarryforwardAmount>
<us-gaap:TaxCreditCarryforwardAmount id="Factid_19065655" contextRef="PAsOn12_31_2020_ResearchMemberusgaapTaxCreditCarryforwardAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5">2000000</us-gaap:TaxCreditCarryforwardAmount>
<us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock id="Factid_19065656" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, available for sale marketable securities by security type consisted of (in thousands): &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 56%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:5%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:5%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Gross&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Gross&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimated&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amortized&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cost &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Gains&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Losses&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 56%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;U&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;S&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&lt;/div&gt; treasury notes (due within one year)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,982&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:5%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(7&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,975&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 56%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:5%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 56%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,982&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(7&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,975&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 56%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:5%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065657" contextRef="PAsOn12_31_2020_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3">3740000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065658" contextRef="PAsOn12_31_2019_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3">3202000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065659" contextRef="PAsOn12_31_2020_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3">815000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065660" contextRef="PAsOn12_31_2019_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3">337000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065661" contextRef="PAsOn12_31_2020_ComputerEquipmentAndSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3">100000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065662" contextRef="PAsOn12_31_2019_ComputerEquipmentAndSoftwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3">81000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065663" contextRef="PAsOn12_31_2020_LeaseholdsAndLeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3">16961000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065664" contextRef="PAsOn12_31_2019_LeaseholdsAndLeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3">75000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065665" contextRef="PAsOn12_31_2020_AssetsNotYetPlacedInServiceMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3">15000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065666" contextRef="PAsOn12_31_2019_AssetsNotYetPlacedInServiceMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3">280000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065667" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">21631000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross id="Factid_19065668" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">3975000</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="Factid_19065669" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">2103000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="Factid_19065670" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">1292000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-gaap:DebtInstrumentPaymentTerms id="Factid_19065674" contextRef="P11_19_2020To11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">The Company is required to make monthly interest only payments under the Oxford Loan each month beginning on January 1, 2021.</us-gaap:DebtInstrumentPaymentTerms>
<us-gaap:DebtInstrumentFrequencyOfPeriodicPayment id="Factid_19065675" contextRef="P11_19_2020To11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
<us-gaap:DebtInstrumentMaturityDate id="Factid_19065676" contextRef="P11_19_2020To11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">2025-11-01</us-gaap:DebtInstrumentMaturityDate>
<us-gaap:DebtInstrumentRestrictiveCovenants id="Factid_19065677" contextRef="P11_19_2020To11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">The Company&amp;#8217;s obligations under the Oxford Loan Agreement are secured by a security interest in all of its assets, other than its intellectual property. The Company is also subject to certain affirmative and negative covenants</us-gaap:DebtInstrumentRestrictiveCovenants>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Factid_19065679" contextRef="PAsOn12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_shares" decimals="0">18445</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<fhtx:WarrantsIssuePricePerShare id="Factid_19065680" contextRef="PAsOn12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD_per_Share" decimals="2">16.26</fhtx:WarrantsIssuePricePerShare>
<us-gaap:WarrantsAndRightsOutstandingTerm id="Factid_19065681" contextRef="PAsOn12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
<us-gaap:WarrantsNotSettleableInCashFairValueDisclosure id="Factid_19065682" contextRef="PAsOn11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="-5">200000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
<us-gaap:DebtInstrumentCarryingAmount id="Factid_19065683" contextRef="PAsOn12_31_2019_TermLoanAMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5">7000000</us-gaap:DebtInstrumentCarryingAmount>
<us-gaap:DebtInstrumentCarryingAmount id="Factid_19065684" contextRef="PAsOn12_31_2019_TermLoanBMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5">8000000</us-gaap:DebtInstrumentCarryingAmount>
<us-gaap:ProceedsFromIssuanceOfDebt id="Factid_19065685" contextRef="P11_19_2020To11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_TermLoanAMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5">20000000</us-gaap:ProceedsFromIssuanceOfDebt>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="Factid_19065686" contextRef="PAsOn10_21_2020_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMemberusgaapSubsidiarySaleOfStockAxis_MaximumMembersrtRangeAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0">5078295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="Factid_19065687" contextRef="PAsOn12_31_2020_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0">2213094</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="Factid_19065688" contextRef="PAsOn10_21_2020_InitialAggregateMemberusgaapSubsidiarySaleOfStockAxis_TwoThousandTwentyEmployeeStockPurchasePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0">360000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized id="Factid_19065689" contextRef="P01_01_2021To01_01_2021_TwoThousandTwentyEmployeeStockPurchasePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0">367894</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Factid_19065690" contextRef="PAsOn12_31_2019" unitRef="Unit_shares" decimals="0">3886489</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ConversionOfStockSharesConverted1 id="Factid_19065698" contextRef="P01_01_2020To12_31_2020_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">-40623413</us-gaap:ConversionOfStockSharesConverted1>
<us-gaap:ConversionOfStockAmountConverted1 id="Factid_19065699" contextRef="P01_01_2020To12_31_2020_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">-176405000</us-gaap:ConversionOfStockAmountConverted1>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities id="Factid_19065700" contextRef="P01_01_2020To12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0">21958588</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="Factid_19065701" contextRef="P01_01_2020To12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">3000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="Factid_19065702" contextRef="P01_01_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">176402000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="Factid_19065703" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">176405000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Factid_19065704" contextRef="P01_01_2020To12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="0">8451837</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues id="Factid_19065705" contextRef="P01_01_2020To12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-3">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues id="Factid_19065706" contextRef="P01_01_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-3">122120000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues id="Factid_19065707" contextRef="P01_01_2020To12_31_2020_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-3">122121000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="Factid_19065708" contextRef="P01_01_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">114000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<fhtx:StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants id="Factid_19065709" contextRef="P01_01_2020To12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0">6728</fhtx:StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants>
<us-gaap:DebtConversionConvertedInstrumentAmount1 id="Factid_19065710" contextRef="P01_01_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">188000</us-gaap:DebtConversionConvertedInstrumentAmount1>
<us-gaap:DebtConversionConvertedInstrumentAmount1 id="Factid_19065711" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">188000</us-gaap:DebtConversionConvertedInstrumentAmount1>
<us-gaap:MarketableSecuritiesUnrealizedGainLoss id="Factid_19065713" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-7000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
<us-gaap:GainsLossesOnExtinguishmentOfDebt id="Factid_19065714" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-222000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
<us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments id="Factid_19065715" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">1000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Factid_19065716" contextRef="PAsOn10_26_2020_BeforeIPOMemberusgaapSubsidiarySaleOfStockAxis_SeriesAOnePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF">14076</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Factid_19065717" contextRef="PAsOn10_27_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="INF">7608</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:MarketableSecurities id="Factid_19065718" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">0</us-gaap:MarketableSecurities>
<us-gaap:PaymentsToAcquireMarketableSecurities id="Factid_19065719" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">92981000</us-gaap:PaymentsToAcquireMarketableSecurities>
<us-gaap:ProceedsFromIssuanceInitialPublicOffering id="Factid_19065720" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">122121000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
<us-gaap:ProceedsFromNotesPayable id="Factid_19065721" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">19800000</us-gaap:ProceedsFromNotesPayable>
<us-gaap:ProceedsFromNotesPayable id="Factid_19065722" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">7984000</us-gaap:ProceedsFromNotesPayable>
<us-gaap:ConversionOfStockAmountConverted1 id="Factid_19065723" contextRef="P01_01_2020To12_31_2020_ConversionOfRedeemableConvertibleStockMemberusgaapConversionOfStockByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3">176405000</us-gaap:ConversionOfStockAmountConverted1>
<us-gaap:PaymentsOfDebtIssuanceCosts id="Factid_19065724" contextRef="P01_01_2020To12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="-5">200000</us-gaap:PaymentsOfDebtIssuanceCosts>
<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive id="Factid_19065725" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">9167000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour id="Factid_19065726" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">10000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
<us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock id="Factid_19065727" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 87%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shares&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 87%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Unvested restricted common stock as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;891,894&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 87%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Issued&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 87%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(891,894&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 87%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 87%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unvested restricted common stock as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 87%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock id="Factid_19065728" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table summarizes the Company&amp;#8217;s option activity during the year ended December&amp;#160;31, 2020: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;br/&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 61%;"&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number of&lt;br/&gt; Shares&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Contractual&lt;br/&gt; Term&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Aggregate&lt;br/&gt; Intrinsic&lt;br/&gt; Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&amp;#160;thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Outstanding as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;3,886,489&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.39&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Granted&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,922,377&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;8.87&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercised&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(611,048&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.99&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Forfeited&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(181,358&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.10&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Outstanding as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;5,016,460&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.93&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;8.5&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;76,941&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Vested and expected to vest as of&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;5,016,460&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.93&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;8.5&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;76,941&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Options exercisable as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,508,122&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.91&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;7.4&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;27,683&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
<us-gaap:AssetsFairValueDisclosure id="Factid_19065730" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">184742000</us-gaap:AssetsFairValueDisclosure>
<us-gaap:AssetsFairValueDisclosure id="Factid_19065731" contextRef="PAsOn12_31_2020_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3">135972000</us-gaap:AssetsFairValueDisclosure>
<us-gaap:AssetsFairValueDisclosure id="Factid_19065732" contextRef="PAsOn12_31_2020_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3">48770000</us-gaap:AssetsFairValueDisclosure>
<us-gaap:DepreciationAndAmortization id="Factid_19065737" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-5">700000</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization id="Factid_19065738" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-5">1300000</us-gaap:DepreciationAndAmortization>
<us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Factid_19065742" contextRef="PAsOn12_31_2020_USTreasuryNotesSecuritiesMemberusgaapInvestmentTypeAxis" unitRef="Unit_USD" decimals="-3">92975000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
<us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="Factid_19065743" contextRef="PAsOn12_31_2020_USTreasuryNotesSecuritiesMemberusgaapInvestmentTypeAxis" unitRef="Unit_USD" decimals="-3">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
<us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis id="Factid_19065744" contextRef="PAsOn12_31_2020_USTreasuryNotesSecuritiesMemberusgaapInvestmentTypeAxis" unitRef="Unit_USD" decimals="-3">92982000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="Factid_19065746" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4. Property and Equipment, Net &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;   &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment, net consisted of the following (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 74%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Laboratory equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,740&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,202&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Furniture and fixtures&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;815&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;337&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Computer equipment and software&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;100&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;81&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Leasehold improvements&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,961&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;75&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Assets not yet placed in service&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;15&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;280&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;21,631&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;3,975&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Less: Accumulated depreciation and amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,103&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,292&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;19,528&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,683&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Depreciation and amortization expense was $1.3&amp;#160;million and $0.7&amp;#160;million for the years ended December&amp;#160;31, 2020 and 2019, respectively. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
<us-gaap:DeferredTaxAssetsValuationAllowance id="Factid_19065747" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">26621000</us-gaap:DeferredTaxAssetsValuationAllowance>
<us-gaap:DeferredTaxAssetsValuationAllowance id="Factid_19065748" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">48383000</us-gaap:DeferredTaxAssetsValuationAllowance>
<us-gaap:DeferredIncomeTaxLiabilities id="Factid_19065749" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">763000</us-gaap:DeferredIncomeTaxLiabilities>
<us-gaap:DeferredIncomeTaxLiabilities id="Factid_19065750" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">14513000</us-gaap:DeferredIncomeTaxLiabilities>
<fhtx:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets id="Factid_19065751" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">281000</fhtx:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets>
<fhtx:DeferredTaxLiabilitiesDepreciation id="Factid_19065752" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">482000</fhtx:DeferredTaxLiabilitiesDepreciation>
<fhtx:DeferredTaxLiabilitiesDepreciation id="Factid_19065753" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">2819000</fhtx:DeferredTaxLiabilitiesDepreciation>
<us-gaap:DeferredTaxAssetsGross id="Factid_19065754" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">27384000</us-gaap:DeferredTaxAssetsGross>
<us-gaap:DeferredTaxAssetsGross id="Factid_19065755" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">62896000</us-gaap:DeferredTaxAssetsGross>
<fhtx:DeferredTaxAssetsOperatingLeaseLiabilities id="Factid_19065756" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">414000</fhtx:DeferredTaxAssetsOperatingLeaseLiabilities>
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities id="Factid_19065757" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">522000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities id="Factid_19065758" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">1010000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
<fhtx:DeferredTaxAssetsCapitalizedStartUpCosts id="Factid_19065759" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">190000</fhtx:DeferredTaxAssetsCapitalizedStartUpCosts>
<fhtx:DeferredTaxAssetsCapitalizedStartUpCosts id="Factid_19065760" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">174000</fhtx:DeferredTaxAssetsCapitalizedStartUpCosts>
<us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch id="Factid_19065761" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">2415000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
<us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch id="Factid_19065762" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">4955000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards id="Factid_19065763" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">23769000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards id="Factid_19065764" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">39289000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
<us-gaap:EffectiveIncomeTaxRateContinuingOperations id="Factid_19065765" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_pure" decimals="3">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
<us-gaap:EffectiveIncomeTaxRateContinuingOperations id="Factid_19065766" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="3">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
<us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance id="Factid_19065767" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_pure" decimals="3">0.299</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
<us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance id="Factid_19065768" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="3">0.316</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
<us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent id="Factid_19065769" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_pure" decimals="3">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
<us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent id="Factid_19065770" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="3">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
<us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch id="Factid_19065771" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_pure" decimals="3">-0.022</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
<us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch id="Factid_19065772" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="3">-0.037</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
<us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes id="Factid_19065773" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_pure" decimals="3">-0.071</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
<us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes id="Factid_19065774" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="3">-0.064</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Factid_19065775" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_pure" decimals="3">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Factid_19065776" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="3">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
<us-gaap:UnrecognizedTaxBenefits id="Factid_19065777" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-6">0</us-gaap:UnrecognizedTaxBenefits>
<us-gaap:UnrecognizedTaxBenefits id="Factid_19065778" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-6">0</us-gaap:UnrecognizedTaxBenefits>
<us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount id="Factid_19065779" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-5">15300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
<us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount id="Factid_19065780" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-5">21800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
<us-gaap:TaxCreditCarryforwardLimitationsOnUse id="Factid_19065781" contextRef="P01_01_2020To12_31_2020">Utilization of the U.S. federal and state net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, and corresponding provisions of state law, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income or tax liabilities. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period.</us-gaap:TaxCreditCarryforwardLimitationsOnUse>
<us-gaap:ImpairmentOfLongLivedAssetsHeldForUse id="Factid_19065782" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-6">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
<us-gaap:ConversionOfStockSharesIssued1 id="Factid_19065783" contextRef="P10_31_2020To10_31_2020_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="INF">21958588</us-gaap:ConversionOfStockSharesIssued1>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Factid_19065784" contextRef="P01_01_2020To12_31_2020_WarrentsToPurchaseCommonStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">18445</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:ComprehensiveIncomePolicyPolicyTextBlock id="Factid_19065785" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Comprehensive loss &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Comprehensive loss includes net loss as well as other changes in stockholders&amp;#8217; equity (deficit) that result from transactions and economic events other than those with stockholders. For the year ended December&amp;#160;31, 2020, the Company&amp;#8217;s only element of other comprehensive loss was unrealized losses on available for sale debt securities. For the year ended December&amp;#160;31, 2019, there was no difference between net loss and comprehensive loss. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
<us-gaap:SegmentReportingPolicyPolicyTextBlock id="Factid_19065786" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Segments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating segments are defined as components of an entity for which separate discrete financial information is made available and that is regularly evaluated by the chief operating decision maker (&amp;#8220;CODM&amp;#8221;) in making decisions regarding resource allocation and assessing performance. The Company&amp;#8217;s CODM is its chief executive officer and the Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company is focused on pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
<us-gaap:LesseeLeasesPolicyTextBlock id="Factid_19065787" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Leases &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In accordance with ASC 842, &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Leases,&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;the Company accounts for a contract as a lease when it has the right to control the asset for a period of time while obtaining substantially all of the asset&amp;#8217;s economic benefits. The Company determines if an arrangement is a lease or contains an embedded lease at inception. For arrangements that meet the definition of a lease, the Company determines the initial classification and measurement of its &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset and lease liability at the lease commencement date and thereafter if modified. The lease term includes any renewal options that the Company is reasonably assured to exercise. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, the Company uses its estimated secured incremental borrowing rate for that lease term. The Company&amp;#8217;s policy is to not record leases with an original term of twelve months or less on its consolidated balance sheets and recognizes those lease payments in the income statement on a straight-line basis over the lease term. The Company&amp;#8217;s existing leases are for office and laboratory space and an equipment lease. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;In addition to rent, the leases may require the Company to pay additional costs, such as utilities, maintenance and other operating costs, which are generally referred to as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-lease&lt;/div&gt; components. The Company has&amp;#160;elected to not separate lease and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-lease&lt;/div&gt; components. Only the fixed costs for lease components and their associated &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-lease&lt;/div&gt; components are accounted for as a single lease component and recognized as part of a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset and liability. Rent expense for operating leases is recognized on a straight-line basis over the reasonably assured lease term based on the total lease payments and is included in operating expense in the consolidated statements of operations and comprehensive loss. &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
<us-gaap:CapitalizationOfInternalCostsPolicy id="Factid_19065788" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Patent costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CapitalizationOfInternalCostsPolicy>
<us-gaap:ResearchAndDevelopmentExpensePolicy id="Factid_19065789" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Research and development costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research and development expenses consist of costs incurred in performing research and development activities, including salaries and bonuses, stock-based compensation, employee benefits, facilities costs, laboratory supplies, depreciation, and external costs of vendors engaged to conduct research, preclinical and clinical development activities as well as the cost of licensing technology.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Upfront payments and milestone payments made for the licensing of technology are expensed as research and development over the period to which they relate. Costs for research and development activities are expensed in the period in which they are incurred. Payments for such activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred, and are reflected in the consolidated financial statements as prepaid expense or accrued research and development expense. Determining the prepaid and accrued balances at the end of any reporting period incorporate certain judgments and estimates by management that are based on information available to the Company including information provided by vendors regarding the progress to completion of specific tasks or costs incurred. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
<us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy id="Factid_19065790" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Classification of convertible preferred stock &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company classified its convertible preferred stock outstanding prior to the IPO outside of stockholders&amp;#8217; equity (deficit) on the consolidated balance sheet because the holders of such shares had redemption rights in the event of a deemed liquidation that, in certain situations, is not solely within the control of the Company. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy>
<us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock id="Factid_19065791" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Impairment of long-lived assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;The Company evaluates its long-lived assets, which consist primarily of property and equipment and operating lease &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. The Company did not record any impairment losses on long-lived assets during the years ended December&amp;#160;31, 2020 or 2019. &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
<us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy id="Factid_19065792" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Restricted cash &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;Amounts included in restricted cash represent amounts pledged as collateral for letters of credit required for security deposits on the Company&amp;#8217;s leased facilities and credit cards. These amounts are classified as restricted cash (current and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current)&lt;/div&gt; in the Company&amp;#8217;s consolidated balance sheets. &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
<us-gaap:MarketableSecuritiesPolicy id="Factid_19065794" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Marketable Securities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s marketable securities are classified as available-for-sale and are carried at fair value with the unrealized gains and losses reported as a component of accumulated other comprehensive loss in stockholders&amp;#8217; equity (deficit). Realized gains and losses and declines in value judged to be other than temporary are included as a component of interest income and other income (expense), net based on the specific identification method. The Company classifies its marketable securities with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities are available for current operations.&amp;#160;&lt;/div&gt; &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:MarketableSecuritiesPolicy>
<us-gaap:ComprehensiveIncomeNetOfTax id="Factid_19065795" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-51128000</us-gaap:ComprehensiveIncomeNetOfTax>
<us-gaap:ComprehensiveIncomeNetOfTax id="Factid_19065796" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-68807000</us-gaap:ComprehensiveIncomeNetOfTax>
<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent id="Factid_19065797" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-7000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax id="Factid_19065798" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-7000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
<us-gaap:GainsLossesOnExtinguishmentOfDebt id="Factid_19065801" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-222000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="Factid_19065802" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">-7000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
<us-gaap:MarketableSecurities id="Factid_19065803" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">92975000</us-gaap:MarketableSecurities>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Factid_19065804" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_shares" decimals="0">20253854</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Factid_19065805" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_shares" decimals="0">5034905</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Factid_19065806" contextRef="P01_01_2019To12_31_2019_WarrantMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">7608</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Factid_19065807" contextRef="P01_01_2019To12_31_2019_RestrictedStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">891894</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Factid_19065808" contextRef="P01_01_2019To12_31_2019_ConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">15467863</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Factid_19065809" contextRef="P01_01_2019To12_31_2019_EmployeeStockOptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">3886489</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Factid_19065810" contextRef="P01_01_2020To12_31_2020_EmployeeStockOptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">5016460</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives id="Factid_19065811" contextRef="P01_01_2020To12_31_2020_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">Shorter of useful life or remaining term of lease</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
<us-gaap:PropertyPlantAndEquipmentUsefulLife id="Factid_19065812" contextRef="P01_01_2020To12_31_2020_SoftwareAndSoftwareDevelopmentCostsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife id="Factid_19065813" contextRef="P01_01_2020To12_31_2020_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife id="Factid_19065814" contextRef="P01_01_2020To12_31_2020_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:BasisOfAccountingPolicyPolicyTextBlock id="Factid_19065815" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221;). The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) and Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) of the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;). &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
<us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock id="Factid_19065816" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following common stock equivalents presented based on amounts outstanding at each period end, have been excluded from the calculation of diluted net loss per share because including them would have had an anti-dilutive impact: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 69%;"&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Stock options to purchase common stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,016,460&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,886,489&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Warrants to purchase common stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;18,445&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;15,467,863&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unvested restricted common stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;891,894&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Warrants to purchase convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;7,608&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; padding: 0px; width: 69%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; padding: 0px; width: 69%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5,034,905&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;20,253,854&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; padding: 0px; width: 69%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
<fhtx:SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock id="Factid_19065817" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense is recognized using the straight-line method over the estimated useful life of each asset as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 90%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 51%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 2%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 47%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt; width: 51%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; border-bottom: 0.75pt solid black; width: 47%;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; display: table-cell; line-height: normal;;text-align:center;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimated&amp;#160;Useful&amp;#160;Life&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Laboratory equipment&lt;/td&gt;&lt;td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;5 years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt; width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;5 years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Computer equipment and software&lt;/td&gt;&lt;td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;3 years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;Shorter&amp;#160;of&amp;#160;useful&amp;#160;life&amp;#160;or&amp;#160;remaining&amp;#160;term&amp;#160;of&amp;#160;lease&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fhtx:SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock>
<us-gaap:RevenueFromContractWithCustomerPolicyTextBlock id="Factid_19065818" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Revenue recognition &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company accounts for its one collaboration arrangement, entered into in July 2020, under ASC Topic&amp;#160;606,&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;&amp;#160;Revenue From Contracts With Customers&lt;/div&gt;&amp;#160;(ASC 606). For additional information on the Company&amp;#8217;s collaboration agreement, see Note 10,&amp;#160;Collaboration&amp;#160;Agreement, to these consolidated financial statements. Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements within the scope of ASC 606, the entity performs the following five steps: (i)&amp;#160;identify the contract(s) with a customer; (ii)&amp;#160;identify the performance obligations in the contract; (iii)&amp;#160;determine the transaction price, including variable consideration, if any; (iv)&amp;#160;allocate the transaction price to the performance obligations in the contract; and (v)&amp;#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company assesses the goods or services promised within each contract and determines those that are performance obligations. The promised goods or services in the Company&amp;#8217;s arrangements would likely consist of licenses, rights to the Company&amp;#8217;s intellectual property, research and development services and related supporting activities. Arrangements that include rights to additional goods or services that are exercisable at a customer&amp;#8217;s discretion are generally considered options. The Company assesses if these options provide a material right to the customer and if so, they are considered performance obligations. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i)&amp;#160;the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii)&amp;#160;the entity&amp;#8217;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the research, development, manufacturing and commercialization capabilities of the customer and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The transaction price is then determined and allocated to the identified performance obligations in proportion to their standalone selling prices (&amp;#8220;SSP&amp;#8221;) on a relative SSP basis. SSP is determined at contract inception and is not updated to reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In developing the SSP for a performance obligation, the Company considers applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs. The Company validates the SSP for performance obligations by evaluating whether changes in the key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance obligations. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;If the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The Company includes the unconstrained amount of estimated variable consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Company&amp;#160;re-evaluates&amp;#160;the&lt;/div&gt; estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cumulative&amp;#160;catch-up&amp;#160;basis&lt;/div&gt; in the period of adjustment. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&amp;#8217;s control such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For arrangements with licenses of intellectual property that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestones at the later of (i)&amp;#160;when the related sales occur, or (ii)&amp;#160;when the performance obligation to which the royalty has been allocated has been satisfied. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded for deferred revenue. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between the transfer of the promised goods or services to the customer and the payment by the customer will be one year or less. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time, and if over time, recognition is based on the use of an output or input method. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
<us-gaap:FairValueMeasurementPolicyPolicyTextBlock id="Factid_19065819" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Fair value measurements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:2%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align:top;;width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;1&amp;#8212;Quoted prices in active markets for identical assets or liabilities. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:2%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align:top;;width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;2&amp;#8212;Observable inputs (other than Level&amp;#160;1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:2%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align:top;;width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;3&amp;#8212;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s cash equivalents and marketable securities are carried at fair value, determined according to the fair value hierarchy described above (see Note&amp;#160;3). The carrying values of the Company&amp;#8217;s accounts payable and accrued expenses approximate their fair values due to the short-term nature of these liabilities. The carrying value of the Company&amp;#8217;s long-term debt approximates its fair value (a level 2 measurement) due to its variable interest rate. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="Factid_19065820" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Property and equipment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense is recognized using the straight-line method over the estimated useful life of each asset as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 90%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 51%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 2%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 47%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt; width: 51%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; border-bottom: 0.75pt solid black; width: 47%;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; display: table-cell; line-height: normal;;text-align:center;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimated&amp;#160;Useful&amp;#160;Life&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Laboratory equipment&lt;/td&gt;&lt;td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;5 years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt; width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;5 years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Computer equipment and software&lt;/td&gt;&lt;td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;3 years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;Shorter&amp;#160;of&amp;#160;useful&amp;#160;life&amp;#160;or&amp;#160;remaining&amp;#160;term&amp;#160;of&amp;#160;lease&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Costs for capital assets not yet placed into service are depreciated once placed into service. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is included in loss from operations. Expenditures for repairs and maintenance are charged to expense as incurred.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
<us-gaap:ConcentrationRiskCreditRisk id="Factid_19065821" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Concentrations of credit risk and of significant suppliers &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. As of December&amp;#160;31, 2020, the Company maintained cash, cash equivalents and marketable securities at financial institutions in excess of federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company relies, and expects to continue to rely, on a small number of vendors to provide services, supplies and materials for certain activities related to its programs. These programs could be adversely affected by a significant interruption in these services or the availability of materials. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ConcentrationRiskCreditRisk>
<us-gaap:UseOfEstimates id="Factid_19065822" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Use of estimates &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, revenue recognition, the valuation of stock-based awards and the accrual of research and development expenses. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:UseOfEstimates>
<us-gaap:EarningsPerSharePolicyTextBlock id="Factid_19065823" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Net loss per share &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In October 2020, upon the closing of the IPO, all outstanding shares of the Company&amp;#8217;s convertible preferred stock automatically converted into 21,958,588 shares of the Company&amp;#8217;s common stock. Prior to this conversion,&amp;#160;the Company followed &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the&amp;#160;two-class&amp;#160;method&lt;/div&gt; when computing net income (loss) per share as the Company had issued shares that meet the definition of participating securities. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The&amp;#160;two-class&amp;#160;method&lt;/div&gt; determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The&amp;#160;two-class&amp;#160;method&lt;/div&gt; requires income (loss) available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to share in the earnings as if all income (loss) for the period had been distributed. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basic net income (loss) per share attributable to common stockholders is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) per share attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common shares. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s participating securities contractually entitled the holders of such shares to participate in dividends but did not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reported a net loss, such losses were not allocated to such participating securities. In periods in which the Company reported a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company reported a net loss attributable to common stockholders for the years ended December&amp;#160;31, 2020 and 2019. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following common stock equivalents presented based on amounts outstanding at each period end, have been excluded from the calculation of diluted net loss per share because including them would have had an anti-dilutive impact: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 69%;"&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Stock options to purchase common stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,016,460&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,886,489&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Warrants to purchase common stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;18,445&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;15,467,863&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unvested restricted common stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;891,894&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Warrants to purchase convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;7,608&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; padding: 0px; width: 69%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; padding: 0px; width: 69%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5,034,905&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;20,253,854&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; padding: 0px; width: 69%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="Factid_19065824" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Recently issued accounting pronouncements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an &amp;#8220;emerging growth company&amp;#8221; as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to &amp;#8220;opt out&amp;#8221; of the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i)&amp;#160;irrevocably elects to &amp;#8220;opt out&amp;#8221; of such extended transition period or (ii)&amp;#160;no longer qualifies as an emerging growth company. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;In June 2016, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No.&amp;#160;2016-13,&lt;/div&gt; &lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Financial Instruments &amp;#8211; Credit Losses (Topic 326)&lt;/div&gt;.&amp;#160;The new standard adjusts the accounting for assets held at amortized costs basis, including marketable securities accounted for as available for sale.&amp;#160;The standard eliminates the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses.&amp;#160;The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For public entities, the guidance was effective for annual reporting periods beginning after December&amp;#160;15, 2019 and for interim periods within those fiscal years. For nonpublic entities and emerging growth companies that choose to take advantage of the extended transition period, the guidance is effective for annual reporting periods beginning after December&amp;#160;15, 2020. Early adoption is permitted for all entities. In November 2019, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No.&amp;#160;2019-10,&lt;/div&gt; which deferred the effective date for nonpublic entities to annual reporting periods beginning after December&amp;#160;15, 2022, including interim periods within those fiscal years. The Company is evaluating when to adopt this standard and the effect the adoption will have on its consolidated financial statements. &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="Factid_19065836" contextRef="PAsOn12_31_2019" unitRef="Unit_shares" decimals="0">15467863</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
<us-gaap:PreferredStockLiquidationPreferenceValue id="Factid_19065837" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">86782000</us-gaap:PreferredStockLiquidationPreferenceValue>
<us-gaap:PreferredStockValueOutstanding id="Factid_19065838" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">86544000</us-gaap:PreferredStockValueOutstanding>
<us-gaap:PreferredStockSharesIssued id="Factid_19065839" contextRef="PAsOn12_31_2019" unitRef="Unit_shares" decimals="INF">28615546</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesAuthorized id="Factid_19065840" contextRef="PAsOn12_31_2019" unitRef="Unit_shares" decimals="0">28629622</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="Factid_19065841" contextRef="PAsOn12_31_2019_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">4387909</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
<us-gaap:PreferredStockLiquidationPreferenceValue id="Factid_19065842" contextRef="PAsOn12_31_2019_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">60882000</us-gaap:PreferredStockLiquidationPreferenceValue>
<us-gaap:PreferredStockValueOutstanding id="Factid_19065843" contextRef="PAsOn12_31_2019_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">60756000</us-gaap:PreferredStockValueOutstanding>
<us-gaap:PreferredStockSharesIssued id="Factid_19065844" contextRef="PAsOn12_31_2019_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">8117631</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesAuthorized id="Factid_19065845" contextRef="PAsOn12_31_2019_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">8117631</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="Factid_19065846" contextRef="PAsOn12_31_2019_SeriesATwoPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">5840089</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
<us-gaap:PreferredStockLiquidationPreferenceValue id="Factid_19065847" contextRef="PAsOn12_31_2019_SeriesATwoPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">16206000</us-gaap:PreferredStockLiquidationPreferenceValue>
<us-gaap:PreferredStockValueOutstanding id="Factid_19065848" contextRef="PAsOn12_31_2019_SeriesATwoPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">16179000</us-gaap:PreferredStockValueOutstanding>
<us-gaap:PreferredStockSharesIssued id="Factid_19065849" contextRef="PAsOn12_31_2019_SeriesATwoPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">10804165</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesAuthorized id="Factid_19065850" contextRef="PAsOn12_31_2019_SeriesATwoPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">10804165</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="Factid_19065851" contextRef="PAsOn12_31_2019_SeriesAOnePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">5239865</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
<us-gaap:PreferredStockLiquidationPreferenceValue id="Factid_19065852" contextRef="PAsOn12_31_2019_SeriesAOnePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">9694000</us-gaap:PreferredStockLiquidationPreferenceValue>
<us-gaap:PreferredStockValueOutstanding id="Factid_19065853" contextRef="PAsOn12_31_2019_SeriesAOnePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3">9609000</us-gaap:PreferredStockValueOutstanding>
<us-gaap:PreferredStockSharesIssued id="Factid_19065854" contextRef="PAsOn12_31_2019_SeriesAOnePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">9693750</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesAuthorized id="Factid_19065855" contextRef="PAsOn12_31_2019_SeriesAOnePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0">9707826</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 id="Factid_19065866" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">27683000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 id="Factid_19065867" contextRef="P01_01_2020To12_31_2020">P7Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice id="Factid_19065868" contextRef="PAsOn12_31_2020" unitRef="Unit_USD_per_Share" decimals="2">1.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="Factid_19065869" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="0">1508122</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue id="Factid_19065870" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">76941000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 id="Factid_19065871" contextRef="P01_01_2020To12_31_2020">P8Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice id="Factid_19065872" contextRef="PAsOn12_31_2020" unitRef="Unit_USD_per_Share" decimals="2">4.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber id="Factid_19065873" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="0">5016460</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="Factid_19065874" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">76941000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Factid_19065875" contextRef="P01_01_2020To12_31_2020">P8Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Factid_19065876" contextRef="PAsOn12_31_2020" unitRef="Unit_USD_per_Share" decimals="2">4.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Factid_19065877" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="0">5016460</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice id="Factid_19065878" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD_per_Share" decimals="2">2.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod id="Factid_19065879" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_shares" decimals="0">181358</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="Factid_19065880" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD_per_Share" decimals="2">1.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Factid_19065881" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_shares" decimals="0">611048</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="Factid_19065882" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD_per_Share" decimals="2">8.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod id="Factid_19065883" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_shares" decimals="0">1922377</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Factid_19065884" contextRef="PAsOn12_31_2019" unitRef="Unit_USD_per_Share" decimals="2">2.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="Factid_19065886" contextRef="P01_01_2019To12_31_2019">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="Factid_19065887" contextRef="P01_01_2020To12_31_2020">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="Factid_19065888" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_pure" decimals="3">0.782</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="Factid_19065889" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="3">0.785</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="Factid_19065890" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_pure" decimals="3">0.022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="Factid_19065891" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="3">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
<fhtx:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage id="Factid_19065892" contextRef="PAsOn12_31_2020_TermLoanBMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="INF">0.040</fhtx:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage>
<fhtx:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage id="Factid_19065893" contextRef="PAsOn12_31_2020_TermLoanAMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="INF">0.030</fhtx:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage>
<fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares id="Factid_19065895" contextRef="PAsOn10_21_2020_TwoThousandTwentyEmployeeStockPurchasePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF">3220520</fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares>
<us-gaap:DebtInstrumentInterestRateTerms id="Factid_19065897" contextRef="P11_19_2020To11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">The Term Loan bears interest at a floating per annum rate equal to the greater of (i) 8.0% and (ii) the sum of (a) thirty-day LIBOR rate plus (b) 7.84%.</us-gaap:DebtInstrumentInterestRateTerms>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="Factid_19065898" contextRef="PAsOn10_21_2020_InitialAmountMemberusgaapSubsidiarySaleOfStockAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0">2200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
<us-gaap:DebtInstrumentCarryingAmount id="Factid_19065899" contextRef="PAsOn11_19_2020_MaximumMembersrtRangeAxis_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_TermLoanBMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5">5000000</us-gaap:DebtInstrumentCarryingAmount>
<us-gaap:DebtInstrumentCarryingAmount id="Factid_19065900" contextRef="PAsOn11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_TermLoanAMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5">20000000</us-gaap:DebtInstrumentCarryingAmount>
<fhtx:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage id="Factid_19065901" contextRef="PAsOn11_19_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="INF">0.050</fhtx:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage>
<us-gaap:DebtInstrumentInterestRateStatedPercentage id="Factid_19065902" contextRef="PAsOn11_19_2020_MinimumMembersrtRangeAxis_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="3">0.080</us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Factid_19065903" contextRef="P11_19_2020To11_19_2020_MinimumMembersrtRangeAxis_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="4">0.0784</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
<us-gaap:ConversionOfStockAmountConverted1 id="Factid_19065904" contextRef="P01_01_2020To12_31_2020_ConversionOfWarrantLiabilityToEquityMemberusgaapConversionOfStockByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3">114000</us-gaap:ConversionOfStockAmountConverted1>
<us-gaap:DebtConversionConvertedInstrumentAmount1 id="Factid_19065905" contextRef="P01_01_2020To12_31_2020_ConversionOfNotesPayableInToWarrantsMemberusgaapConversionOfStockByUniqueDescriptionAxis" unitRef="Unit_USD" decimals="-3">188000</us-gaap:DebtConversionConvertedInstrumentAmount1>
<us-gaap:GainsLossesOnExtinguishmentOfDebt id="Factid_19065906" contextRef="P11_01_2020To11_30_2020_TermLoanAAndBMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5">200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
<us-gaap:DebtInstrumentDescriptionOfVariableRateBasis id="Factid_19065907" contextRef="P01_01_2020To12_31_2020_AdditionalOverBaseRateMemberusgaapShortTermDebtTypeAxis_MinimumMembersrtRangeAxis_TermLoanBMemberusgaapDebtInstrumentAxis">LIBOR</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
<us-gaap:DebtInstrumentDescriptionOfVariableRateBasis id="Factid_19065908" contextRef="P01_01_2020To12_31_2020_MinimumMembersrtRangeAxis_TermLoanAMemberusgaapDebtInstrumentAxis">LIBOR</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Factid_19065909" contextRef="P01_01_2020To12_31_2020_AdditionalOverBaseRateMemberusgaapShortTermDebtTypeAxis_MinimumMembersrtRangeAxis_TermLoanBMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3">0.025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Factid_19065910" contextRef="P01_01_2020To12_31_2020_MinimumMembersrtRangeAxis_TermLoanAMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3">0.025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
<us-gaap:DebtInstrumentInterestRateStatedPercentage id="Factid_19065911" contextRef="PAsOn12_31_2020_BaseRateMemberusgaapVariableRateAxis_TermLoanBMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="3">0.010</us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid id="Factid_19065912" contextRef="PAsOn12_31_2020_TermLoanAAndBMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5">500000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
<us-gaap:PreferredStockValue id="Factid_19065913" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" xsi:nil="true" />
<us-gaap:PreferredStockValue id="Factid_19065914" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" xsi:nil="true" />
<us-gaap:CommonStockSharesIssued id="Factid_19065915" contextRef="PAsOn12_31_2019" unitRef="Unit_shares" decimals="INF">5762745</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued id="Factid_19065916" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF">36790946</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesAuthorized id="Factid_19065917" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF">175000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized id="Factid_19065918" contextRef="PAsOn12_31_2019" unitRef="Unit_shares" decimals="INF">46600000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue id="Factid_19065925" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-5">4800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue id="Factid_19065926" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-5">3300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
<us-gaap:DebtInstrumentDescriptionOfVariableRateBasis id="Factid_19065927" contextRef="P11_19_2020To11_19_2020_MinimumMembersrtRangeAxis_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">LIBOR</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
<fhtx:TaxCreditCarryForwardsExpirationStartYear id="Factid_19065931" contextRef="P01_01_2020To12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ResearchMemberusgaapTaxCreditCarryforwardAxis">2036</fhtx:TaxCreditCarryForwardsExpirationStartYear>
<fhtx:OperatingLossCarryforwardLimitPercentage id="Factid_19065933" contextRef="P01_01_2020To12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_NonExpirableMemberusgaapTaxPeriodAxis" unitRef="Unit_pure" decimals="2">0.80</fhtx:OperatingLossCarryforwardLimitPercentage>
<fhtx:OperatingLossCarryForwardsExpirationStartYear id="Factid_19065934" contextRef="P01_01_2020To12_31_2020_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">2036</fhtx:OperatingLossCarryForwardsExpirationStartYear>
<fhtx:TaxCreditCarryForwardsExpirationStartYear id="Factid_19065935" contextRef="P01_01_2020To12_31_2020_ResearchMemberusgaapTaxCreditCarryforwardAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">2031</fhtx:TaxCreditCarryForwardsExpirationStartYear>
<us-gaap:IncomeTaxExpenseBenefit id="Factid_19065937" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-6">0</us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit id="Factid_19065938" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-6">0</us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:DeferredTaxAssetsNet id="Factid_19065939" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">0</us-gaap:DeferredTaxAssetsNet>
<us-gaap:DeferredTaxAssetsNet id="Factid_19065940" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">0</us-gaap:DeferredTaxAssetsNet>
<us-gaap:LeaseExpirationDate1 id="Factid_19065941" contextRef="P06_29_2020To06_29_2020_MAsrtStatementGeographicalAxis_ModifiedNewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis">2028-09-30</us-gaap:LeaseExpirationDate1>
<us-gaap:RestrictedCashNoncurrent id="Factid_19065942" contextRef="PAsOn12_31_2020_LetterOfCreditMemberusgaapShortTermDebtTypeAxis_MAsrtStatementGeographicalAxis_NewLeaseAgreementMemberusgaapLeaseContractualTermAxis_OfficeBuildingMemberusgaapPropertySubjectToOrAvailableForOperatingLeaseAxis" unitRef="Unit_USD" decimals="-5">1700000</us-gaap:RestrictedCashNoncurrent>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized id="Factid_19065946" contextRef="P01_01_2021To01_01_2021_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="0">1471576</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 id="Factid_19065949" contextRef="P01_01_2020To12_31_2020_ServiceBasedVestingMemberusgaapAwardTypeAxis_TwoThousandTwentyAndSixteenStockIncentivePlanMemberusgaapPlanNameAxis">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod id="Factid_19065950" contextRef="P01_01_2020To12_31_2020_ServiceBasedVestingMemberusgaapAwardTypeAxis_TwoThousandTwentyAndSixteenStockIncentivePlanMemberusgaapPlanNameAxis">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 id="Factid_19065951" contextRef="P04_01_2016To04_30_2016_CommonStockMemberusgaapStatementEquityComponentsAxis">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<fhtx:OperatingLossCarryForwardsExpirationStartYear id="Factid_19065954" contextRef="P01_01_2020To12_31_2020_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ExpirableMemberusgaapTaxPeriodAxis">2035</fhtx:OperatingLossCarryForwardsExpirationStartYear>
<fhtx:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock id="Factid_19065957" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Supplemental disclosure of cash flow information related to leases was as follows (in thousands): &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:81%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 70%;"&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;Ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,086&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,731&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Operating lease liabilities arising from obtaining &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;38,306&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;271&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Increase in operating lease liabilities and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets due to lease remeasurement&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;7,384&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6,513&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fhtx:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
<us-gaap:PropertyPlantAndEquipmentTextBlock id="Factid_19065958" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment, net consisted of the following (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 74%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Laboratory equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,740&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,202&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Furniture and fixtures&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;815&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;337&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Computer equipment and software&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;100&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;81&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Leasehold improvements&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,961&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;75&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Assets not yet placed in service&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;15&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;280&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;21,631&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;3,975&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Less: Accumulated depreciation and amortization&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2,103&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(1,292&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;19,528&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,683&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 74%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
<us-gaap:StockholdersEquity id="Factid_19065959" contextRef="PAsOn12_31_2020_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">-7000</us-gaap:StockholdersEquity>
<us-gaap:MarketableSecuritiesUnrealizedGainLoss id="Factid_19065960" contextRef="P01_01_2020To12_31_2020_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">-7000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="Factid_19065961" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">114000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue id="Factid_19065962" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">81379000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive id="Factid_19065963" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">30500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive id="Factid_19065964" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">10595000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour id="Factid_19065965" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">10347000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree id="Factid_19065966" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">10107000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo id="Factid_19065967" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">10016000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
<us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths id="Factid_19065968" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">9814000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
<us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Factid_19065970" contextRef="PAsOn12_31_2020_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3">92975000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
<us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Factid_19065971" contextRef="PAsOn12_31_2020_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3">92975000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
<us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Factid_19065972" contextRef="PAsOn12_31_2020_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3">42997000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
<us-gaap:CashAndCashEquivalentsFairValueDisclosure id="Factid_19065973" contextRef="PAsOn12_31_2020_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3">42997000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
<us-gaap:AvailableForSaleSecuritiesDebtSecurities id="Factid_19065974" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">92975000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
<us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="Factid_19065975" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
<us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis id="Factid_19065976" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">92982000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
<us-gaap:RestrictedCash id="Factid_19065979" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">2274000</us-gaap:RestrictedCash>
<us-gaap:RestrictedCash id="Factid_19065980" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">1733000</us-gaap:RestrictedCash>
<us-gaap:NetIncomeLoss id="Factid_19065983" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-3">-51128000</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss id="Factid_19065984" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-3">-68800000</us-gaap:NetIncomeLoss>
<dei:SecurityExchangeName id="Factid_19065985" contextRef="P01_01_2020To12_31_2020">NASDAQ</dei:SecurityExchangeName>
<dei:IcfrAuditorAttestationFlag id="Factid_19065988" contextRef="P01_01_2020To12_31_2020">false</dei:IcfrAuditorAttestationFlag>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Factid_19065989" contextRef="P01_01_2020To12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF">611048</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<dei:EntityVoluntaryFilers id="Factid_19065991" contextRef="P01_01_2020To12_31_2020">No</dei:EntityVoluntaryFilers>
<dei:EntityWellKnownSeasonedIssuer id="Factid_19065992" contextRef="P01_01_2020To12_31_2020">No</dei:EntityWellKnownSeasonedIssuer>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Factid_19065993" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD_per_Share" decimals="2">2.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Factid_19065994" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD_per_Share" decimals="2">6.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="Factid_19065995" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_USD" decimals="-5">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="Factid_19065996" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_USD" decimals="-5">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
<us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross id="Factid_19066001" contextRef="P01_01_2015To12_31_2015_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="0">4459459</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
<us-gaap:OperatingLeaseLiability id="Factid_19066003" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">62342000</us-gaap:OperatingLeaseLiability>
<us-gaap:StockholdersEquity id="Factid_19066008" contextRef="PAsOn12_31_2020_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3">4000</us-gaap:StockholdersEquity>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="Factid_19066009" contextRef="P01_01_2020To12_31_2020_RestrictedStockMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="0">891894</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="Factid_19066010" contextRef="PAsOn12_31_2019_RestrictedStockMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="0">891894</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
<fhtx:MarketableSecuritiesAndFairValueMeasurementsTextBlock id="Factid_19112668" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Marketable Securities and Fair Value Measurements &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, available for sale marketable securities by security type consisted of (in thousands): &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 56%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:5%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:5%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Gross&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Gross&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimated&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Amortized&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cost &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Gains&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Losses&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 56%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;U&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;S&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&lt;/div&gt; treasury notes (due within one year)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,982&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:5%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(7&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,975&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 56%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:5%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 56%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,982&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(7&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,975&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 56%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:5%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company had no marketable securities as of December&amp;#160;31, 2019. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following tables present the Company&amp;#8217;s fair value hierarchy for its assets and liabilities, which are measured at fair value on a recurring basis (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 61%;"&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value Measurements at&lt;br/&gt; December&amp;#160;31, 2020 Using:&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;1&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;2&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;3&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Assets:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cash equivalents:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Money market funds&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;48,770&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;48,770&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;U&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.S&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&lt;/div&gt; treasury notes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; text-align: right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212; &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;42,997&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; text-align: right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8212; &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;42,997&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Marketable securities:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;U&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;S&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&amp;#160;treasury notes&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,975&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;92,975&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;48,770&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;135,972&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;184,742&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:;;height:16;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="16" style="font-family: &amp;quot;times new roman&amp;quot;;;width:;;height:16;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value Measurements at&lt;br/&gt; December&amp;#160;31, 2019 Using:&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;1&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;2&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&amp;#160;3&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Assets:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cash equivalents:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Money market funds&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;14,951&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;14,951&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Preferred stock warrant liability&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;45&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;45&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The preferred stock warrant liability as of December&amp;#160;31, 2019 consisted of the fair value of warrants to purchase 14,076 shares of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Series&amp;#160;A-1&lt;/div&gt; convertible preferred stock at $1.00 &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;per share and was based on significant inputs not observable in the market, which represented a Level&amp;#160;3 measurement within the fair value hierarchy. The Company&amp;#8217;s valuation of the preferred stock warrants utilized the Black-Scholes option-pricing model, which incorporated assumptions and estimates to value the preferred stock warrants. The Company assessed these assumptions and estimates at the end of each reporting period. Changes in the fair value of the preferred stock warrants were recognized within other income (expense) in the consolidated statements of operations and comprehensive loss and were not material during the years ended December&amp;#160;31, 2020 and 2019.&lt;/div&gt;&lt;/div&gt; &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;In October 2020, upon closing of the IPO, the warrants to purchase 14,076 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt; convertible preferred stock automatically became warrants to purchase an aggregate of 7,608 &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;shares of common stock. The Company remeasured the warrants as of the IPO date and reclassified the carrying value of the warrants from a non-current liability to additional paid-in capital in its consolidated balance sheet. During the year ended December 31, 2020, these warrants were exercised in full.&amp;#160;&lt;/div&gt; &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fhtx:MarketableSecuritiesAndFairValueMeasurementsTextBlock>
<us-gaap:AccruedProfessionalFeesCurrent id="Factid_19112885" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">979000</us-gaap:AccruedProfessionalFeesCurrent>
<us-gaap:AccruedProfessionalFeesCurrent id="Factid_19112886" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">274000</us-gaap:AccruedProfessionalFeesCurrent>
<fhtx:DebtInstrumentPrePaymentTerms id="Factid_19113281" contextRef="P01_01_2020To12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">At the Company&amp;#8217;s option, the Company may elect to prepay the loans subject to a prepayment fee equal to the following percentage of the principal amount being prepaid: 2% if an advance is prepaid during the first 12 months following the applicable advance date, 1% if an advance is prepaid after 12 months but prior to 24 months following the applicable advance date, and 0.5% if an advance is prepaid any time after 24 months following the applicable advance date but prior to the Maturity Date.</fhtx:DebtInstrumentPrePaymentTerms>
<fhtx:PercentageOfPrepaymentFee id="Factid_19113286" contextRef="P01_01_2020To12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_PrepaymentWithInFirstTwelveMonthsMemberFHTXPrepaymentPeriodAxis" unitRef="Unit_pure" decimals="2">0.02</fhtx:PercentageOfPrepaymentFee>
<fhtx:PercentageOfPrepaymentFee id="Factid_19113287" contextRef="P01_01_2020To12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_PrepaymentAfter12MonthsButPriorTo24MonthsMemberFHTXPrepaymentPeriodAxis" unitRef="Unit_pure" decimals="2">0.01</fhtx:PercentageOfPrepaymentFee>
<fhtx:PercentageOfPrepaymentFee id="Factid_19113288" contextRef="P01_01_2020To12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_PrepaymentAfter24MonthsMemberFHTXPrepaymentPeriodAxis" unitRef="Unit_pure" decimals="3">0.005</fhtx:PercentageOfPrepaymentFee>
<us-gaap:DebtInstrumentTerm id="Factid_19114502" contextRef="P01_01_2020To12_31_2020_OxfordFinanceLlcMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">P5Y</us-gaap:DebtInstrumentTerm>
<us-gaap:PreferredStockTextBlock id="Factid_19114594" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="text-align:left;;vertical-align:top;;width:4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7.&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Convertible Preferred Stock and Preferred Stock Warrants &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Convertible Preferred Stock &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;issued&amp;#160;Series&amp;#160;A-1&amp;#160;convertible&lt;/div&gt; preferred stock &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(the&amp;#160;&amp;#8220;Series&amp;#160;A-1&amp;#8221;),&amp;#160;Series&amp;#160;A-2&amp;#160;convertible&lt;/div&gt;&lt;/div&gt; preferred stock (the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#8220;Series&amp;#160;A-2&amp;#8221;)&amp;#160;and&lt;/div&gt; Series&amp;#160;B convertible preferred stock (the &amp;#8220;Series&amp;#160;B&amp;#8221;). &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The&amp;#160;Series&amp;#160;A-1&amp;#160;and&lt;/div&gt; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Series&amp;#160;A-2&amp;#160;are&lt;/div&gt; collectively referred to as the &amp;#8220;Series A&amp;#8221; and the Series A and Series&amp;#160;B are collectively referred to as the &amp;#8220;Preferred Stock.&amp;#8221; &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In July and August 2020, in two separate closings, the Company sold 5,600,000 shares of Series B preferred stock at a purchase price of $7.50 per share resulting in gross proceeds to the Company of $42.0&amp;#160;million. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In April 2020, in two separate closings, the Company sold 6,407,867 shares of Series B preferred stock at a purchase price of $7.50 per share resulting in gross proceeds to the Company of $48.1&amp;#160;million. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December 31, 2019,&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;Preferred Stock consisted of the following (in thousands, except share amounts):&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:51%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Preferred&amp;#160;Stock&lt;br/&gt; Authorized&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Preferred&amp;#160;Stock&lt;br/&gt; Issued and&lt;br/&gt; Outstanding&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&amp;#160;Value&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liquidation&lt;br/&gt; Preference&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Common&amp;#160;Stock&lt;br/&gt; Issuable Upon&lt;br/&gt; Conversion&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;A-1&lt;/div&gt; Preferred Stock&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9,707,826&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9,693,750&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9,609&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9,694&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,239,865&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-2&lt;/div&gt; Preferred Stock&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,804,165&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,804,165&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,179&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,206&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5,840,089&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Series B Preferred Stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;8,117,631&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;8,117,631&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;60,756&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;60,882&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;4,387,909&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;28,629,622&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;28,615,546&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;86,544&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;86,782&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15,467,863&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Upon the closing of the IPO in October 2020, the Company&amp;#8217;s Preferred Stock automatically converted into 21,958,588 shares of common stock. &lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Warrants to Purchase Preferred Stock&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="display:inline;"&gt;I&lt;/div&gt;n connection with the issuance of notes payable, the Company issued warrants to purchase 14,076 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt; preferred stock at an exercise price of $1.00 per share. In October 2020, upon closing of the IPO, the warrants automatically became warrants to purchase an aggregate of 7,608 shares of common stock and were then cashless exercised in full for 6,728 shares of common stock. &lt;/div&gt;</us-gaap:PreferredStockTextBlock>
<us-gaap:ScheduleOfStockByClassTextBlock id="Factid_19114612" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December 31, 2019,&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;Preferred Stock consisted of the following (in thousands, except share amounts):&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:51%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:3%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Preferred&amp;#160;Stock&lt;br/&gt; Authorized&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Preferred&amp;#160;Stock&lt;br/&gt; Issued and&lt;br/&gt; Outstanding&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&amp;#160;Value&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liquidation&lt;br/&gt; Preference&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Common&amp;#160;Stock&lt;br/&gt; Issuable Upon&lt;br/&gt; Conversion&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;A-1&lt;/div&gt; Preferred Stock&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9,707,826&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9,693,750&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9,609&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9,694&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,239,865&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-2&lt;/div&gt; Preferred Stock&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,804,165&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,804,165&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,179&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;16,206&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5,840,089&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Series B Preferred Stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;8,117,631&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;8,117,631&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;60,756&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;60,882&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;4,387,909&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;28,629,622&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;28,615,546&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;86,544&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;86,782&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;15,467,863&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Factid_19114779" contextRef="PAsOn12_31_2019_IssuanceOfNotesPayableMemberusgaapSubsidiarySaleOfStockAxis_SeriesAOnePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF">14076</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 id="Factid_19114785" contextRef="PAsOn12_31_2019_IssuanceOfNotesPayableMemberusgaapSubsidiarySaleOfStockAxis_SeriesAOnePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
<fhtx:StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants id="Factid_19114787" contextRef="P10_27_2020To10_27_2020_CommonStockMemberusgaapStatementEquityComponentsAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="INF">6728</fhtx:StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants>
<fhtx:DeferredTaxAssetsOperatingLeaseLiabilities id="Factid_19114940" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">17032000</fhtx:DeferredTaxAssetsOperatingLeaseLiabilities>
<fhtx:CommonStockTextBlock id="Factid_19115363" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8. Common Stock &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On October&amp;#160;27, 2020, the Company completed its initial public offering (&amp;#8220;IPO&amp;#8221;) pursuant to which it issued and sold 7,500,000 shares of its common stock at a public offering price of $16.00 per share, resulting in net proceeds of $107.9&amp;#160;million, after deducting underwriting discounts and commissions and other offering expenses. On November&amp;#160;19, 2020, the Company issued and sold an additional 951,837 shares of common stock at the IPO price of $16.00 per share pursuant to the underwriters&amp;#8217; partial exercise of their option to purchase additional shares of common stock, resulting in additional net proceeds of $14.2&amp;#160;million after deducting underwriting discounts and commissions. Upon the closing of the IPO, all of the Company&amp;#8217;s outstanding convertible preferred stock automatically converted into shares of common stock (see Note 7). &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&amp;#8217;s stockholders. Common stockholders are not entitled to receive dividends, unless declared by the board of directors. &lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fhtx:CommonStockTextBlock>
<fhtx:ServiceAgreementExtendedDate id="Factid_19115384" contextRef="P01_01_2020To12_31_2020_ScientificFounderMemberFHTXAgreementsAxis">2022-01-01</fhtx:ServiceAgreementExtendedDate>
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost id="Factid_19115394" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">436000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost id="Factid_19115395" contextRef="PAsOn12_31_2019" unitRef="Unit_USD" decimals="-3">74000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
<fhtx:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets id="Factid_19115508" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="-3">11694000</fhtx:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets>
<us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock id="Factid_19127687" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted in 2020 and 2019: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 71%;"&gt;&lt;/td&gt;&lt;td style="width: 11%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;Ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 71%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk-free interest rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 11%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.4&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2.2&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 71%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expected volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 11%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;78.5&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;78.2&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 71%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Expected dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 11%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 71%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expected term (in years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 11%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6.1&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
<us-gaap:LeaseCostTableTextBlock id="Factid_19130800" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The components of lease expense were as follows (in thousands):&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 70%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;Ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Operating lease cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;7,032&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,671&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Short-term lease cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;61&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;60&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Variable lease cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,217&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;547&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 70%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 70%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8,310&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,278&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 70%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
<us-gaap:PreferredStockSharesOutstanding id="Factid_19213979" contextRef="PAsOn12_31_2019" unitRef="Unit_shares" decimals="INF">28615546</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:CommonStockVotingRights id="Factid_19214244" contextRef="P01_01_2020To12_31_2020">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&amp;#8217;s stockholders. Common stockholders are not entitled to receive dividends, unless declared by the board of directors.</us-gaap:CommonStockVotingRights>
<fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage id="Factid_19214585" contextRef="P10_01_2020To10_21_2020_TwoThousandsTwentyToTwoThousandsThirtyMemberusgaapSubsidiarySaleOfStockAxis_TwoThousandTwentyEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_pure" decimals="2">0.04</fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage>
<fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage id="Factid_19214638" contextRef="P10_01_2020To10_21_2020_TwoThousandsTwentyToTwoThousandsThirtyMemberusgaapSubsidiarySaleOfStockAxis_TwoThousandTwentyEmployeeStockPurchasePlanMemberusgaapPlanNameAxis" unitRef="Unit_pure" decimals="2">0.01</fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage>
<fhtx:ServiceAgreementExpirationYear id="Factid_19215329" contextRef="P01_01_2020To12_31_2020_FlagshipPioneeringMemberFHTXAgreementsAxis">2020</fhtx:ServiceAgreementExpirationYear>
<dei:DocumentType id="Factid_19405462" contextRef="P01_01_2020To12_31_2020">10-K</dei:DocumentType>
<dei:DocumentPeriodEndDate id="Factid_19405463" contextRef="P01_01_2020To12_31_2020">2020-12-31</dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName id="Factid_19405464" contextRef="P01_01_2020To12_31_2020">Foghorn Therapeutics Inc.</dei:EntityRegistrantName>
<dei:Security12bTitle id="Factid_19405466" contextRef="P01_01_2020To12_31_2020">Common Stock, $0.0001 Par Value</dei:Security12bTitle>
<dei:TradingSymbol id="Factid_19405467" contextRef="P01_01_2020To12_31_2020">FHTX</dei:TradingSymbol>
<dei:EntityCurrentReportingStatus id="Factid_19405469" contextRef="P01_01_2020To12_31_2020">Yes</dei:EntityCurrentReportingStatus>
<dei:EntityInteractiveDataCurrent id="Factid_19405470" contextRef="P01_01_2020To12_31_2020">Yes</dei:EntityInteractiveDataCurrent>
<dei:EntityCommonStockSharesOutstanding id="Factid_19405471" contextRef="PAsOn01_31_2021" unitRef="Unit_shares" decimals="INF">36816714</dei:EntityCommonStockSharesOutstanding>
<dei:EntityPublicFloat id="Factid_19405485" contextRef="PAsOn10_23_2020" unitRef="Unit_USD" decimals="-5">291700000</dei:EntityPublicFloat>
<us-gaap:SignificantAccountingPoliciesTextBlock id="Factid_19405493" contextRef="P01_01_2020To12_31_2020">&lt;div style="margin-block: 0em; margin-bottom: 0px; margin-top: 18pt; line-height: 12pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2. Summary of Significant Accounting Policies &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Use of estimates &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, revenue recognition, the valuation of stock-based awards and the accrual of research and development expenses. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Concentrations of credit risk and of significant suppliers &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. As of December&amp;#160;31, 2020, the Company maintained cash, cash equivalents and marketable securities at financial institutions in excess of federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company relies, and expects to continue to rely, on a small number of vendors to provide services, supplies and materials for certain activities related to its programs. These programs could be adversely affected by a significant interruption in these services or the availability of materials. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Cash equivalents &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company considers all highly liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Marketable Securities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s marketable securities are classified as available-for-sale and are carried at fair value with the unrealized gains and losses reported as a component of accumulated other comprehensive loss in stockholders&amp;#8217; equity (deficit). Realized gains and losses and declines in value judged to be other than temporary are included as a component of interest income and other income (expense), net based on the specific identification method. The Company classifies its marketable securities with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities are available for current operations.&amp;#160;&lt;/div&gt; &lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Restricted cash &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;Amounts included in restricted cash represent amounts pledged as collateral for letters of credit required for security deposits on the Company&amp;#8217;s leased facilities and credit cards. These amounts are classified as restricted cash (current and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current)&lt;/div&gt; in the Company&amp;#8217;s consolidated balance sheets. &lt;/div&gt;  &lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Property and equipment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense is recognized using the straight-line method over the estimated useful life of each asset as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 90%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 51%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 2%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 47%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt; width: 51%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; width: 2%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; border-bottom: 0.75pt solid black; width: 47%;;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; display: table-cell; line-height: normal;;text-align:center;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimated&amp;#160;Useful&amp;#160;Life&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Laboratory equipment&lt;/td&gt;&lt;td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;5 years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.75pt; width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="padding-bottom: 0.75pt; width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;5 years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Computer equipment and software&lt;/td&gt;&lt;td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;3 years&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;"&gt;Shorter&amp;#160;of&amp;#160;useful&amp;#160;life&amp;#160;or&amp;#160;remaining&amp;#160;term&amp;#160;of&amp;#160;lease&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Costs for capital assets not yet placed into service are depreciated once placed into service. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is included in loss from operations. Expenditures for repairs and maintenance are charged to expense as incurred.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Impairment of long-lived assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;The Company evaluates its long-lived assets, which consist primarily of property and equipment and operating lease &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. The Company did not record any impairment losses on long-lived assets during the years ended December&amp;#160;31, 2020 or 2019. &lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Fair value measurements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:2%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align:top;;width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;1&amp;#8212;Quoted prices in active markets for identical assets or liabilities. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:2%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align:top;;width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;2&amp;#8212;Observable inputs (other than Level&amp;#160;1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"&gt;&lt;tr style="page-break-inside: avoid;"&gt;&lt;td style="width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;;width:2%;"&gt;&amp;#8226;&lt;/td&gt;&lt;td style="vertical-align:top;;width:1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:left;;vertical-align:top;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&amp;#160;3&amp;#8212;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s cash equivalents and marketable securities are carried at fair value, determined according to the fair value hierarchy described above (see Note&amp;#160;3). The carrying values of the Company&amp;#8217;s accounts payable and accrued expenses approximate their fair values due to the short-term nature of these liabilities. The carrying value of the Company&amp;#8217;s long-term debt approximates its fair value (a level 2 measurement) due to its variable interest rate. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Revenue recognition &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company accounts for its one collaboration arrangement, entered into in July 2020, under ASC Topic&amp;#160;606,&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;&amp;#160;Revenue From Contracts With Customers&lt;/div&gt;&amp;#160;(ASC 606). For additional information on the Company&amp;#8217;s collaboration agreement, see Note 10,&amp;#160;Collaboration&amp;#160;Agreement, to these consolidated financial statements. Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements within the scope of ASC 606, the entity performs the following five steps: (i)&amp;#160;identify the contract(s) with a customer; (ii)&amp;#160;identify the performance obligations in the contract; (iii)&amp;#160;determine the transaction price, including variable consideration, if any; (iv)&amp;#160;allocate the transaction price to the performance obligations in the contract; and (v)&amp;#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company assesses the goods or services promised within each contract and determines those that are performance obligations. The promised goods or services in the Company&amp;#8217;s arrangements would likely consist of licenses, rights to the Company&amp;#8217;s intellectual property, research and development services and related supporting activities. Arrangements that include rights to additional goods or services that are exercisable at a customer&amp;#8217;s discretion are generally considered options. The Company assesses if these options provide a material right to the customer and if so, they are considered performance obligations. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i)&amp;#160;the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii)&amp;#160;the entity&amp;#8217;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the research, development, manufacturing and commercialization capabilities of the customer and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The transaction price is then determined and allocated to the identified performance obligations in proportion to their standalone selling prices (&amp;#8220;SSP&amp;#8221;) on a relative SSP basis. SSP is determined at contract inception and is not updated to reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In developing the SSP for a performance obligation, the Company considers applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs. The Company validates the SSP for performance obligations by evaluating whether changes in the key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance obligations. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;If the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The Company includes the unconstrained amount of estimated variable consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Company&amp;#160;re-evaluates&amp;#160;the&lt;/div&gt; estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;cumulative&amp;#160;catch-up&amp;#160;basis&lt;/div&gt; in the period of adjustment. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&amp;#8217;s control such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For arrangements with licenses of intellectual property that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestones at the later of (i)&amp;#160;when the related sales occur, or (ii)&amp;#160;when the performance obligation to which the royalty has been allocated has been satisfied. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded for deferred revenue. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between the transfer of the promised goods or services to the customer and the payment by the customer will be one year or less. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time, and if over time, recognition is based on the use of an output or input method. &lt;/div&gt;&lt;/div&gt;   &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Classification of convertible preferred stock &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company classified its convertible preferred stock outstanding prior to the IPO outside of stockholders&amp;#8217; equity (deficit) on the consolidated balance sheet because the holders of such shares had redemption rights in the event of a deemed liquidation that, in certain situations, is not solely within the control of the Company. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Research and development costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Research and development expenses consist of costs incurred in performing research and development activities, including salaries and bonuses, stock-based compensation, employee benefits, facilities costs, laboratory supplies, depreciation, and external costs of vendors engaged to conduct research, preclinical and clinical development activities as well as the cost of licensing technology.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Upfront payments and milestone payments made for the licensing of technology are expensed as research and development over the period to which they relate. Costs for research and development activities are expensed in the period in which they are incurred. Payments for such activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred, and are reflected in the consolidated financial statements as prepaid expense or accrued research and development expense. Determining the prepaid and accrued balances at the end of any reporting period incorporate certain judgments and estimates by management that are based on information available to the Company including information provided by vendors regarding the progress to completion of specific tasks or costs incurred. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Patent costs &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Leases &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In accordance with ASC 842, &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Leases,&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;the Company accounts for a contract as a lease when it has the right to control the asset for a period of time while obtaining substantially all of the asset&amp;#8217;s economic benefits. The Company determines if an arrangement is a lease or contains an embedded lease at inception. For arrangements that meet the definition of a lease, the Company determines the initial classification and measurement of its &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset and lease liability at the lease commencement date and thereafter if modified. The lease term includes any renewal options that the Company is reasonably assured to exercise. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, the Company uses its estimated secured incremental borrowing rate for that lease term. The Company&amp;#8217;s policy is to not record leases with an original term of twelve months or less on its consolidated balance sheets and recognizes those lease payments in the income statement on a straight-line basis over the lease term. The Company&amp;#8217;s existing leases are for office and laboratory space and an equipment lease. &lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;In addition to rent, the leases may require the Company to pay additional costs, such as utilities, maintenance and other operating costs, which are generally referred to as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-lease&lt;/div&gt; components. The Company has&amp;#160;elected to not separate lease and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-lease&lt;/div&gt; components. Only the fixed costs for lease components and their associated &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-lease&lt;/div&gt; components are accounted for as a single lease component and recognized as part of a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset and liability. Rent expense for operating leases is recognized on a straight-line basis over the reasonably assured lease term based on the total lease payments and is included in operating expense in the consolidated statements of operations and comprehensive loss. &lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Stock-based compensation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;The Company measures stock options with service-based vesting or performance-based vesting granted to employees, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-employees&lt;/div&gt; and directors based on the fair value on the date of grant using the Black-Scholes option-pricing model. The Company measures restricted common stock awards using the difference between the purchase price per share of the award, if any, and the fair value of the Company&amp;#8217;s common stock at the date of grant. Compensation expense for the awards is recognized over the requisite service period for employees and directors and as services are delivered for &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-employees,&lt;/div&gt; both of which are generally the vesting period of the respective award. The Company uses the straight-line method to record the expense of awards with only service-based vesting conditions. The Company uses the graded-vesting method to record the expense of awards with both service-based and performance-based vesting conditions, commencing once achievement of the performance condition becomes probable. The Company&amp;#160;accounts for forfeitures of share-based awards as they occur. &lt;/div&gt;&lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company classifies stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient&amp;#8217;s payroll costs are classified or in which the award recipient&amp;#8217;s service payments are classified. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Net loss per share &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In October 2020, upon the closing of the IPO, all outstanding shares of the Company&amp;#8217;s convertible preferred stock automatically converted into 21,958,588 shares of the Company&amp;#8217;s common stock. Prior to this conversion,&amp;#160;the Company followed &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the&amp;#160;two-class&amp;#160;method&lt;/div&gt; when computing net income (loss) per share as the Company had issued shares that meet the definition of participating securities. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The&amp;#160;two-class&amp;#160;method&lt;/div&gt; determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The&amp;#160;two-class&amp;#160;method&lt;/div&gt; requires income (loss) available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to share in the earnings as if all income (loss) for the period had been distributed. &lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basic net income (loss) per share attributable to common stockholders is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) per share attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common shares. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s participating securities contractually entitled the holders of such shares to participate in dividends but did not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reported a net loss, such losses were not allocated to such participating securities. In periods in which the Company reported a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company reported a net loss attributable to common stockholders for the years ended December&amp;#160;31, 2020 and 2019. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following common stock equivalents presented based on amounts outstanding at each period end, have been excluded from the calculation of diluted net loss per share because including them would have had an anti-dilutive impact: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 69%;"&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Stock options to purchase common stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;5,016,460&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,886,489&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Warrants to purchase common stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;18,445&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;15,467,863&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unvested restricted common stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;891,894&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Warrants to purchase convertible preferred stock (as converted to common stock)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;7,608&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; padding: 0px; width: 69%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; padding: 0px; width: 69%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5,034,905&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;20,253,854&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; padding: 0px; width: 69%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 3%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Segments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating segments are defined as components of an entity for which separate discrete financial information is made available and that is regularly evaluated by the chief operating decision maker (&amp;#8220;CODM&amp;#8221;) in making decisions regarding resource allocation and assessing performance. The Company&amp;#8217;s CODM is its chief executive officer and the Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company is focused on pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Comprehensive loss &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Comprehensive loss includes net loss as well as other changes in stockholders&amp;#8217; equity (deficit) that result from transactions and economic events other than those with stockholders. For the year ended December&amp;#160;31, 2020, the Company&amp;#8217;s only element of other comprehensive loss was unrealized losses on available for sale debt securities. For the year ended December&amp;#160;31, 2019, there was no difference between net loss and comprehensive loss. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Income taxes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&amp;#8217;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to the provision for income taxes. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;two-step&lt;/div&gt; process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;more-likely-than-not&lt;/div&gt; to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. Any resulting unrecognized tax benefits are recorded within the provision for income taxes. &lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Recently issued accounting pronouncements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an &amp;#8220;emerging growth company&amp;#8221; as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to &amp;#8220;opt out&amp;#8221; of the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i)&amp;#160;irrevocably elects to &amp;#8220;opt out&amp;#8221; of such extended transition period or (ii)&amp;#160;no longer qualifies as an emerging growth company. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;In June 2016, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No.&amp;#160;2016-13,&lt;/div&gt; &lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Financial Instruments &amp;#8211; Credit Losses (Topic 326)&lt;/div&gt;.&amp;#160;The new standard adjusts the accounting for assets held at amortized costs basis, including marketable securities accounted for as available for sale.&amp;#160;The standard eliminates the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses.&amp;#160;The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For public entities, the guidance was effective for annual reporting periods beginning after December&amp;#160;15, 2019 and for interim periods within those fiscal years. For nonpublic entities and emerging growth companies that choose to take advantage of the extended transition period, the guidance is effective for annual reporting periods beginning after December&amp;#160;15, 2020. Early adoption is permitted for all entities. In November 2019, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No.&amp;#160;2019-10,&lt;/div&gt; which deferred the effective date for nonpublic entities to annual reporting periods beginning after December&amp;#160;15, 2022, including interim periods within those fiscal years. The Company is evaluating when to adopt this standard and the effect the adoption will have on its consolidated financial statements. &lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock id="Factid_19405539" contextRef="P01_01_2020To12_31_2020">&lt;div style="margin-block: 0em; margin-bottom: 0px; margin-top: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9. Stock-Based Compensation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;2016 Stock incentive plan &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s 2016 Stock Incentive Plan, (the &amp;#8220;2016 Plan&amp;#8221;) provided for the Company to grant incentive stock options or nonqualified stock options and other equity awards to employees, directors and consultants of the Company. Upon the effectiveness of the 2020 Equity Incentive Plan (the &amp;#8220;2020 Plan&amp;#8221;) in October 2020, the Company ceased granting additional awards under the 2016 Plan. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;2020 Equity Incentive Plan &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On October&amp;#160;21, 2020, the Company&amp;#8217;s board of directors adopted and its stockholders approved the 2020 Plan, which became effective on October&amp;#160;21, 2020. The 2020 Plan provides for the grant of incentive stock &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;options,&amp;#160;non-qualified&amp;#160;options,&lt;/div&gt; stock appreciation rights, restricted &lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;stock awards, restricted stock units and other&amp;#160;stock-based awards&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; The number of shares initially reserved for issuance under the 2020 Plan &lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;wa&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;s (i) &lt;/div&gt;2,200,000&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; shares (the &amp;#8220;share pool&amp;#8221;), plus (ii)&amp;#160;the number of shares of common stock available for issuance under the 2016 Plan as of the effective date of the 2020 Plan, plus the number of shares of common stock underlying awards under the 2016 Plan that on or after the date of adoption expire or become unexercisable without delivery of shares, are forfeited to, or repurchased for cash, are settled in cash, or otherwise become available again for grant under the 2016 Plan, in each case, in accordance with its terms (up to an aggregate of &lt;/div&gt;5,078,295&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; shares). As of December&amp;#160;31, 2020, &lt;/div&gt;2,213,094&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; shares remained available for future grants under the 2020 Plan.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The share pool will automatically increase on January&amp;#160;1 of each year from 2021 to 2030 by the lesser of (i)&amp;#160;four percent of the number of shares of our common stock outstanding as of the close of business on the immediately preceding December&amp;#160;31 and (ii)&amp;#160;the number of shares determined by the board of directors on or prior to such date for such year.&amp;#160;The number of shares reserved for issuance under the 2020 Plan was increased &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;by 1,471,576 shares effective January&amp;#160;1, 2021. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The 2020 Plan and 2016 Plan are administered by the board of directors or, at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors, or its committee if so delegated. Stock options granted with service-based vesting conditions generally vest over &lt;/div&gt;four&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; years and expire after &lt;/div&gt;ten&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; years. The exercise price for stock options granted is not less than the fair value of common stock on the date of grant. The Company bases fair value of common stock on the quoted market price. Prior to the IPO, the board of directors determined the value the Company&amp;#8217;s common stock, taking into consideration its most recently available valuation of common stock performed by third parties as well as additional relevant factors which may have changed since the date of the most recent contemporaneous valuation through the date of grant.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;2020 Employee Stock Purchase Plan &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On October&amp;#160;21, 2020, the Company&amp;#8217;s board of directors adopted and its stockholders approved the 2020 Employee Stock Purchase Plan (the &amp;#8220;ESPP&amp;#8221;), which became effective on October&amp;#160;21, 2020. The aggregate number of shares of common stock available for purchase pursuant to the exercise of options under the ESPP is 360,000 shares, plus an automatic annual increase, as of January&amp;#160;1 of each year from 2021 to 2030, equal to the lesser of (i)&amp;#160;one percent of the number of shares of common stock outstanding as of the close of business on the immediately preceding December&amp;#160;31 and (ii)&amp;#160;the number of shares determined by the board of directors on or prior to such date for such year (up to a maximum of 3,220,520 shares). The number of shares reserved for issuance under the ESPP was increased by 367,894 shares effective January&amp;#160;1, 2021.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, no offering periods have commenced under the ESPP. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Stock option valuation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value of stock option grants is estimated using the Black-Scholes option-pricing model. Prior to the IPO, the Company was a private company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies. The expected term of the Company&amp;#8217;s stock options has been determined utilizing the &amp;#8220;simplified&amp;#8221; method for awards that qualify as &amp;#8220;plain-vanilla&amp;#8221; options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted in 2020 and 2019: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 71%;"&gt;&lt;/td&gt;&lt;td style="width: 11%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;Ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 71%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Risk-free interest rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 11%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;0.4&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;2.2&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 71%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expected volatility&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 11%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;78.5&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;78.2&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 71%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Expected dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 11%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 71%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expected term (in years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 11%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6.1&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;6.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table summarizes the Company&amp;#8217;s option activity during the year ended December&amp;#160;31, 2020:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;br/&gt; &lt;br/&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 61%;"&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number of&lt;br/&gt; Shares&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Contractual&lt;br/&gt; Term&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Aggregate&lt;br/&gt; Intrinsic&lt;br/&gt; Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(in&amp;#160;thousands)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Outstanding as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;3,886,489&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.39&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Granted&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,922,377&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;8.87&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Exercised&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(611,048&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.99&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Forfeited&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(181,358&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.10&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Outstanding as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;5,016,460&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.93&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;8.5&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;76,941&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="width: 61%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Vested and expected to vest as of&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;5,016,460&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.93&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;8.5&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;76,941&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Options exercisable as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,508,122&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.91&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;7.4&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;27,683&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:times new roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company&amp;#8217;s common stock for those stock options that had exercise prices lower than the fair value of the Company&amp;#8217;s common stock. The aggregate intrinsic value of stock options exercised during the years ended December&amp;#160;31, 2020 and 2019 was $3.5&amp;#160;million and $1.2&amp;#160;million, respectively. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:times new roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The weighted average grant-date fair value of stock options granted during the years ended December&amp;#160;31, 2020 and 2019 was $6.01 per share and $2.54 per share, respectively.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Restricted common stock &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;During 2015, the Company issued and sold 4,459,459 shares of restricted common stock at par value to the scientific founders of the Company. The shares were subject to vesting over a period of five years and began vesting upon the closing of the Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A-1&lt;/div&gt; Preferred Stock in April 2016&amp;#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;and were fully vested as of December&amp;#160;31, 2020.&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table summarizes the Company&amp;#8217;s restricted common stock activity during the year ended December&amp;#160;31, 2020:&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 87%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Shares&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 87%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Unvested restricted common stock as of December&amp;#160;31, 2019&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;891,894&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 87%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Issued&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 87%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Vested&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(891,894&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 87%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 87%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unvested restricted common stock as of December&amp;#160;31, 2020&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 87%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The aggregate fair value of restricted stock that vested during the years ended December 2020 and 2019 was $4.8&amp;#160;million and $3.3&amp;#160;million, respectively. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Stock-based compensation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company recorded stock-based compensation expense related to common stock options and restricted common stock in the following expense categories of its consolidated statements of operations and comprehensive loss (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 72%;"&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;Ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,724&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,140&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,237&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;554&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255); padding: 0px;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255); text-align: center;;vertical-align:bottom;"&gt;$2,961&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255); text-align: center;;vertical-align:bottom;"&gt;$1,694&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;   &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 2020, total unrecognized compensation cost was &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;$13.5&amp;#160;million, which is expected to be recognized over a weighted average period of 3.6&amp;#160;years. &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
<us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock id="Factid_19405541" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company recorded stock-based compensation expense related to common stock options and restricted common stock in the following expense categories of its consolidated statements of operations and comprehensive loss (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 72%;"&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;Ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Research and development expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,724&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,140&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;General and administrative expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;1,237&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;554&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255); padding: 0px;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255); text-align: center;;vertical-align:bottom;"&gt;$2,961&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255); text-align: center;;vertical-align:bottom;"&gt;$1,694&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
<us-gaap:IncomeTaxDisclosureTextBlock id="Factid_19405558" contextRef="P01_01_2020To12_31_2020">&lt;div style="margin-block: 0em; margin-bottom: 0px; margin-top: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11. Income Taxes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;During the years ended December&amp;#160;31, 20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt;&amp;#160;and 2019, the Company recorded no&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;income tax benefits for the net deferred tax assets comprised primarily of net operating losses incurred and research and development tax credits generated in each year, due to its uncertainty of realizing a benefit from these items.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;All of the Company&amp;#8217;s operating losses since inception have been generated in the United States. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&amp;#160;&lt;/div&gt;  &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A reconciliation of the U.S. federal statutory income tax rate to the Company&amp;#8217;s effective income tax rate is as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 84%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 75%;"&gt;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:7%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;Ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Federal statutory income tax rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(21.0&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(21.0&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;State taxes, net of federal benefit&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(6.4&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(7.1&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Federal and state research and development tax credits&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(3.7&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2.2&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(0.5&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.4&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Change in deferred tax asset valuation allowance&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;31.6&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;29.9&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 75%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Effective income tax rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 75%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;    &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net deferred tax assets consisted of the following (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 76%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 72%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:3%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Deferred tax assets:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net operating loss carryforwards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:3%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;39,289&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;23,769&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Research and development tax credit carryforwards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;4,955&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;2,415&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Capitalized &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;start-up&lt;/div&gt; costs&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;174&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;190&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Accrued expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;1,010&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;522&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Stock-based compensation&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;"&gt;&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;436&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;"&gt;&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;74&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;17,032&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;414&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total deferred tax assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;62,896&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;27,384&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred tax liabilities:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Depreciation&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(2,819&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(482&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Operating lease &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(11,694&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(281&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total deferred tax liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(14,513&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(763&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Valuation allowance&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(48,383&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(26,621&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net deferred tax assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;   &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt;, the Company had U.S. federal and state net operating loss carryforwards of $147.3&amp;#160;million and $132.3&amp;#160;million, respectively, which may be available to offset future taxable income. The federal net operating loss carryforwards include&amp;#160;$12.5 million&amp;#160;which expire at various dates beginning in&amp;#160;2035&amp;#160;and&amp;#160;$134.8 million&amp;#160;which carryforward indefinitely but in some circumstances may be limited to offset 80% of annual taxable income. The state net operating loss carryforwards expire at various dates beginning in&amp;#160;2036.&amp;#160;As of December&amp;#160;31, 20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt;, the Company also had U.S. federal and state research and development tax credit carryforwards of $3.4&amp;#160;million and $2.0&amp;#160;million, respectively, which may be available to offset future tax liabilities and expire at various dates beginning in 2036 and 2031, respectively. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Utilization of the U.S. federal and state net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Sections&amp;#160;382 and 383 of the Internal Revenue Code of 1986, and corresponding provisions of state law, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income or tax liabilities. In general, an ownership change, as defined by Section&amp;#160;382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section&amp;#160;382, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section&amp;#160;382. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization. Further, until a study is completed by the Company and any limitation is known, no amounts are &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;being recorded as an uncertain tax position.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets. Management has considered the Company&amp;#8217;s history of cumulative net losses incurred since inception and its lack of commercialization of any products that would generate revenue from product sales and has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets as of December&amp;#160;31, 20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt; and 2019. Management reevaluates the positive and negative evidence at each reporting period. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The valuation allowance increased by $21.8&amp;#160;million and $15.3&amp;#160;million during the years ended December&amp;#160;31, 20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt; and 2019, respectively, primarily as a result of the increase in net operating loss carryforwards. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&amp;#160;31, 20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt; and 2019, the Company had not &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;recorded any amounts for unrecognized tax benefits. The Company files income tax returns in the U.S. and Massachusetts, as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal and state jurisdictions, where applicable. There are currently no pending tax examinations. Since the Company is in a loss carryforward position, it is generally subject to examination by the U.S. federal, state, and local income tax authorities for all tax years in which a loss carryforward is available.&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
<us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock id="Factid_19405563" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A reconciliation of the U.S. federal statutory income tax rate to the Company&amp;#8217;s effective income tax rate is as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 84%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 75%;"&gt;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:7%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;Ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Federal statutory income tax rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(21.0&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)%&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(21.0&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;State taxes, net of federal benefit&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(6.4&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(7.1&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Federal and state research and development tax credits&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(3.7&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(2.2&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(0.5&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.4&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Change in deferred tax asset valuation allowance&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;31.6&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;29.9&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 75%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 75%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Effective income tax rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:7%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;0.0&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 75%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:7%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
<us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock id="Factid_19405566" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net deferred tax assets consisted of the following (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 76%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 72%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:3%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Deferred tax assets:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net operating loss carryforwards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:3%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;39,289&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;23,769&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Research and development tax credit carryforwards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;4,955&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;2,415&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Capitalized &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;start-up&lt;/div&gt; costs&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;174&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;190&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Accrued expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;1,010&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;522&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Stock-based compensation&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;"&gt;&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;436&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;"&gt;&amp;#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;74&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;17,032&lt;/div&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;414&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total deferred tax assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;62,896&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;27,384&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred tax liabilities:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Depreciation&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(2,819&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(482&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Operating lease &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(11,694&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(281&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total deferred tax liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(14,513&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(763&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Valuation allowance&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(48,383&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(26,621&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net deferred tax assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-family: &amp;quot;times new roman&amp;quot;; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255);;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
<fhtx:ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock id="Factid_19405578" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The weighted-average remaining lease term and discount rate were as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 83%;"&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Weighted-average remaining lease term&amp;#8212;operating leases (in years)&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;7.7&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.1&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Weighted-average discount rate&amp;#8212;operating leases&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5.35&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7.53&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fhtx:ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock>
<us-gaap:LesseeOperatingLeasesTextBlock id="Factid_19405584" contextRef="P01_01_2020To12_31_2020">&lt;div style="margin-block: 0em; margin-bottom: 0px; margin-top: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12. Leases &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In October 2019, the Company entered into a lease for 81,441 square feet of office and laboratory space in Cambridge, Massachusetts, commencing in January 2020 (the &amp;#8220;New Lease&amp;#8221;). The initial term of the New Lease was eight years with a five-year option to extend at fair-market rent at the time of the extension. The base rent payments escalate annually over the eight-year lease term and totaled approximately $60.3&amp;#160;million. In connection with the New Lease, the landlord agreed to fund up to $3.0&amp;#160;million in tenant improvements to the leased facility as well as up to an additional $16.3&amp;#160;million, which resulted in additional rent payments to the landlord over the lease term. During the year ended December&amp;#160;31, 2020, $15.4&amp;#160;million of leasehold improvements were reimbursed by the landlord, which resulted in an increase to operating lease liabilities. The Company is obligated to pay its portion of real estate taxes and costs related to the premises, including costs of operations and management of the leased premises. The Company is required to maintain a cash balance of $1.7&amp;#160;million to secure a letter of credit associated with the lease. This amount was classified as restricted cash &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;(non-current)&lt;/div&gt; on the consolidated balance sheet as of December&amp;#160;31, 2020 and 2019. On January&amp;#160;1, 2020, the lease commencement date, the Company recorded an operating lease asset of $38.6&amp;#160;million and corresponding lease liability of $38.3&amp;#160;million. &lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;In June 2020, the Company amended the New Lease to defer payment of a portion of the base rent and operating expenses and to extend the lease term by nine months to September 2028. The amendment was accounted for as a lease modification and the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset and lease liability were remeasured at the modification date of June&amp;#160;29, 2020 resulting in an increase of $7.4&amp;#160;million to both the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; asset and lease liabilities. &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company had a lease for office and laboratory facilities in Cambridge, Massachusetts under a noncancelable operating lease that began in August 2017 and expired in March 2025. In April 2020, this lease was assigned and assumed by a related party which became effective in October 2020.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&amp;#160;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The components of lease expense were as follows (in thousands):&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 70%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;Ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Operating lease cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;7,032&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,671&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Short-term lease cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;61&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;60&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Variable lease cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,217&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;547&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 70%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 70%;;vertical-align:top;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;8,310&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;2,278&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 70%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"&gt;&lt;div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Supplemental disclosure of cash flow information related to leases was as follows (in thousands): &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&amp;#160;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width:81%;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:4%;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px; background: none;"&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 70%;"&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&amp;#160;Ended&amp;#160;December&amp;#160;31,&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,086&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1,731&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Operating lease liabilities arising from obtaining &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;38,306&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;271&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Increase in operating lease liabilities and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets due to lease remeasurement&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;7,384&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;6,513&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;   &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The weighted-average remaining lease term and discount rate were as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 83%;"&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Weighted-average remaining lease term&amp;#8212;operating leases (in years)&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;7.7&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;1.1&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Weighted-average discount rate&amp;#8212;operating leases&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 5%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;5.35&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;td style="width: 4%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;7.53&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;%&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Future annual minimum lease payments under operating leases as of December&amp;#160;31, 20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;20&lt;/div&gt;&amp;#160;were as follows (in thousands): &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt; &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 76%;;margin : 0px auto;;text-align:left;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 77%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 15%;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:0%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:0%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:0%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 77%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;9,814&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 77%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;10,016&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 77%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;10,107&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 77%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;10,347&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 77%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;10,595&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 77%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Thereafter&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;30,500&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 77%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 77%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Total future minimum lease payments&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;81,379&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 77%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Less: imputed interest&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(15,104&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 77%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Less: estimated lease incentives&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"&gt;(3,933&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 77%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="width: 77%;;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total operating lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"&gt;62,342&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;; width: 77%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15%;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;;width:0%;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="width:0%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="width: 77%; padding: 0cm;"&gt;&lt;/td&gt;&lt;td style="width: 15%; padding: 0cm;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="padding:0cm 0cm 0cm 0cm"&gt;&lt;/td&gt;&lt;td style="padding:0cm 0cm 0cm 0cm"&gt;&lt;/td&gt;&lt;td style="padding:0cm 0cm 0cm 0cm"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding:0cm 0cm 0cm 0cm;vertical-align:bottom;;width:;"&gt;&lt;div style="margin: 0cm 0cm 0.0001pt; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin: 0cm 0cm 0.0001pt; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0cm; font-size: 8pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-right: none; border-left: none; border-image: initial; padding: 0cm;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin: 0cm 0cm 0.0001pt; text-align: center; line-height: normal; font-family: &amp;quot;times new roman&amp;quot;, serif; font-size: 8pt;"&gt;&lt;div style="font-weight:bold;display:inline;width:100%;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0cm; border-bottom: 1pt solid white;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding:0cm 0cm 0cm 0cm;vertical-align:bottom;;width:;"&gt;&lt;div style="margin: 0cm 0cm 0.0001pt; font-family: calibri, sans-serif; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px; line-height: 10pt;;display:inline;"&gt;&lt;div style="line-height: 10pt; font-size: 10pt;;font-weight:bold;display:inline;"&gt;Included in the consolidated balance sheet (in thousands):&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0cm; font-size: 8pt;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border:none; border-bottom:solid black 1.0pt; padding:0cm 0cm 0cm 0cm;vertical-align:bottom;;width:;"&gt;&lt;div style="margin:0cm 0cm 0.0001pt; text-align:center; line-height:normal; font-family:calibri,sans-serif"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-size: 8pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;December&amp;#160;31,&amp;#160;2020&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0cm; border-bottom: 1pt solid white;;vertical-align:bottom;;width:;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0cm; font-size: 10pt; width: 77%;;vertical-align:top;"&gt;&lt;div style="margin-top:0cm; margin-right:0cm; margin-bottom:.0001pt; margin-left:12.0pt; text-indent:-12.0pt; line-height:normal; font-family:calibri,sans-serif"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Current operating lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0cm; font-size: 10pt; width: 15%;;vertical-align:bottom;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap; font-size: 10pt;;vertical-align:bottom;"&gt;&lt;div style="margin:0cm 0cm 0.0001pt; line-height:normal; font-family:calibri,sans-serif"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap; font-size: 10pt;;vertical-align:bottom;"&gt;&lt;div style="margin:0cm 0cm 0.0001pt; text-align:right; line-height:normal; font-family:calibri,sans-serif"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;3,981&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding: 0cm; font-size: 10pt; width: 77%;;vertical-align:top;"&gt;&lt;div style="margin-top:0cm; margin-right:0cm; margin-bottom:.0001pt; margin-left:12.0pt; text-indent:-12.0pt; line-height:normal; font-family:calibri,sans-serif"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease liabilities, net of current portion&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0cm; font-size: 10pt; width: 15%;;vertical-align:bottom;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0cm; white-space: nowrap; border-bottom: 0.75pt solid black;;vertical-align:bottom;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0cm; white-space: nowrap; font-size: 10pt; border-bottom: 0.75pt solid black;;vertical-align:bottom;"&gt;&lt;div style="margin:0cm 0cm 0.0001pt; text-align:right; line-height:normal; font-family:calibri,sans-serif"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;58,361&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0cm; white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0cm; font-size: 10pt; width: 77%;;vertical-align:top;"&gt;&lt;div style="margin-top:0cm; margin-right:0cm; margin-bottom:.0001pt; margin-left:36.0pt; text-indent:-12.0pt; line-height:normal; font-family:calibri,sans-serif"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total operating lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0cm; font-size: 10pt; width: 15%;;vertical-align:bottom;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap; font-size: 10pt;;vertical-align:bottom;"&gt;&lt;div style="margin:0cm 0cm 0.0001pt; line-height:normal; font-family:calibri,sans-serif"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap; font-size: 10pt;;vertical-align:bottom;"&gt;&lt;div style="margin:0cm 0cm 0.0001pt; text-align:right; line-height:normal; font-family:calibri,sans-serif"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"&gt;62,342&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap;;vertical-align:bottom;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding: 0cm; width: 77%;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0cm; font-size: 1pt; width: 15%;;vertical-align:bottom;"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:0cm 0cm 0cm 0cm;vertical-align:bottom;"&gt;&lt;div style="border-top:double black 2.25pt; padding:0cm 0cm 0cm 0cm"&gt;&lt;div style="border: none; margin: 0px 0cm; line-height: normal; padding: 0cm; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:0cm 0cm 0cm 0cm;vertical-align:bottom;"&gt;&lt;div style="border-top:double black 2.25pt; padding:0cm 0cm 0cm 0cm"&gt;&lt;div style="border: none; margin: 0px 0cm; line-height: normal; padding: 0cm; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:0cm 0cm 0cm 0cm"&gt;&lt;div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;;font-style:italic;display:inline;"&gt;Sublease agreement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;In April 2020, the Company entered into a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;two-year&lt;/div&gt; sublease of approximately 16,843 square feet of office space under the New Lease, as amended, which began in July 2020. As of December&amp;#160;31, 2020, the remaining base rent payments due to the Company under the subleases was $2.5&amp;#160;million. The Company recorded other income of $1.0&amp;#160;million during the year ended December&amp;#160;31, 2020 related to this sublease. &lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
<fhtx:OperatingLeaseLiabilityTableTextBlock id="Factid_19405789" contextRef="P01_01_2020To12_31_2020">&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 1pt;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;height:16;"&gt;&lt;/td&gt;&lt;td colspan="4" style="font-family: &amp;quot;times new roman&amp;quot;;;height:16;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 8pt;"&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Included in the consolidated balance sheet (in thousands):&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&amp;#160;31,&amp;#160;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 0.7pt;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Current operating lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;3,981&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease liabilities, net of current portion&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;58,361&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Total operating lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;62,342&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</fhtx:OperatingLeaseLiabilityTableTextBlock>
<us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock id="Factid_19405790" contextRef="P01_01_2020To12_31_2020">&lt;div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Future annual minimum lease payments under operating leases as of December&amp;#160;31, 2020 were as follows (in thousands): &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"&gt;&lt;tr style="font-size: 0px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;width:77%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;;width:15%;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;9,814&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,016&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10,107&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;10,347&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;10,595&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Thereafter&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;30,500&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Total future minimum lease payments&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;81,379&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Less: imputed interest&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;(15,104&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"&gt;Less: estimated lease incentives&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;"&gt;(3,933&lt;/td&gt;&lt;td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;"&gt;)&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total operating lease liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;$&lt;/td&gt;&lt;td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;"&gt;62,342&lt;/td&gt;&lt;td style="white-space: nowrap;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="font-size: 1px;"&gt;&lt;td style="font-family: &amp;quot;times new roman&amp;quot;;;vertical-align:bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="Factid_19424375" contextRef="P01_01_2020To12_31_2020" unitRef="Unit_pure" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="Factid_19424376" contextRef="P01_01_2019To12_31_2019" unitRef="Unit_pure" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<xbrli:unit id="Unit_USD">
<xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="Unit_shares">
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="Unit_pure">
<xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="Unit_sqft">
<xbrli:measure>utr:sqft</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="Unit_USD_per_Share">
<xbrli:divide>
<xbrli:unitNumerator>
<xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unitNumerator>
<xbrli:unitDenominator>
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unitDenominator>
</xbrli:divide>
</xbrli:unit>
<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended" />
</xbrli:xbrl>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>fhtx-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 18-March-2021 [12:26:36] {AM}-->
<schema targetNamespace="http://www.foghorntx.com/20201231" elementFormDefault="qualified" xmlns:fhtx="http://www.foghorntx.com/20201231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.foghorntx.com/role/CoverPage" id="CoverPage">
<link:definition>1001 - Document - Cover Page</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
<link:definition>1002 - Statement - Consolidated Balance Sheets</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
<link:definition>1003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="ConsolidatedStatementsOfOperationsAndComprehensiveLoss">
<link:definition>1004 - Statement - Consolidated Statements Of Operations And Comprehensive Loss</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit" id="ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit">
<link:definition>1005 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" id="ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
<link:definition>1006 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
<link:definition>1007 - Statement - Consolidated Statements of Cash Flows</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" id="ConsolidatedStatementsOfCashFlowsParenthetical">
<link:definition>1008 - Statement - Consolidated Statements of Cash Flows (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/NatureOfBusinessAndBasisOfPresentation" id="NatureOfBusinessAndBasisOfPresentation">
<link:definition>1009 - Disclosure - Nature of Business and Basis of Presentation</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition>1010 - Disclosure - Summary of Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurements" id="MarketableSecuritiesAndFairValueMeasurements">
<link:definition>1011 - Disclosure - Marketable Securities and Fair Value Measurements</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
<link:definition>1012 - Disclosure - Property and Equipment, Net</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/AccruedExpenses" id="AccruedExpenses">
<link:definition>1013 - Disclosure - Accrued Expenses</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/NotesPayable" id="NotesPayable">
<link:definition>1014 - Disclosure - Notes Payable</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrants" id="ConvertiblePreferredStockAndPreferredStockWarrants">
<link:definition>1015 - Disclosure - Convertible Preferred Stock and Preferred Stock Warrants</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/CommonStock" id="CommonStock">
<link:definition>1016 - Disclosure - Common Stock</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/StockBasedCompensation" id="StockBasedCompensation">
<link:definition>1017 - Disclosure - Stock-Based Compensation</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/CollaborationAgreement" id="CollaborationAgreement">
<link:definition>1018 - Disclosure - Collaboration Agreement</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/IncomeTaxes" id="IncomeTaxes">
<link:definition>1019 - Disclosure - Income Taxes</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/Leases" id="Leases">
<link:definition>1020 - Disclosure - Leases</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition>1021 - Disclosure - Commitments and Contingencies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/DefinedContributionPlan" id="DefinedContributionPlan">
<link:definition>1022 - Disclosure - Defined Contribution Plan</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/RelatedParties" id="RelatedParties">
<link:definition>1023 - Disclosure - Related Parties</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition>1024 - Disclosure - 	 Summary of Significant Accounting Policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
<link:definition>1025 - Disclosure - 	 Summary of Significant Accounting Policies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsTables" id="MarketableSecuritiesAndFairValueMeasurementsTables">
<link:definition>1026 - Disclosure - Marketable Securities and Fair Value Measurements (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
<link:definition>1027 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/AccruedExpensesTable" id="AccruedExpensesTable">
<link:definition>1028 - Disclosure - Accrued Expenses (Table)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/NotesPayableTables" id="NotesPayableTables">
<link:definition>1029 - Disclosure - Notes Payable (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsTables" id="ConvertiblePreferredStockAndPreferredStockWarrantsTables">
<link:definition>1030 - Disclosure - Convertible Preferred Stock and Preferred Stock Warrants (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/StockBasedCompensationTables" id="StockBasedCompensationTables">
<link:definition>1031 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
<link:definition>1032 - Disclosure - Income Taxes (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/LeasesTables" id="LeasesTables">
<link:definition>1033 - Disclosure - Leases (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/NatureOfBusinessAndBasisOfPresentationAdditionalInformationDetail" id="NatureOfBusinessAndBasisOfPresentationAdditionalInformationDetail">
<link:definition>1034 - Disclosure - Nature of Business and Basis of Presentation - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
<link:definition>1035 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfPropertyAndEquipmentAreStatedAtCostLessAccumulatedDepreciationAndAmortizationDetail" id="SummaryOfSignificantAccountingPoliciesSummaryOfPropertyAndEquipmentAreStatedAtCostLessAccumulatedDepreciationAndAmortizationDetail">
<link:definition>1036 - Disclosure - Summary of Significant Accounting Policies - Summary of Property and Equipment are Stated at Cost Less Accumulated Depreciation and Amortization (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareDilutedAntiDilutiveImpactDetail" id="SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareDilutedAntiDilutiveImpactDetail">
<link:definition>1037 - Disclosure - Summary of Significant Accounting Policies - Summary of Earnings Per Share Diluted Anti Dilutive Impact (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfAvailableForSaleMarkatableSecurtiesBySecurityTypeDetail" id="MarketableSecuritiesAndFairValueMeasurementsSummaryOfAvailableForSaleMarkatableSecurtiesBySecurityTypeDetail">
<link:definition>1038 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Available for Sale Markatable Securties By Security Type (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" id="MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail">
<link:definition>1039 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetail" id="MarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetail">
<link:definition>1040 - Disclosure - Marketable Securities and Fair Value Measurements - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail" id="PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail">
<link:definition>1041 - Disclosure - Property and Equipment, Net -  Sumary of Property and Equipment Net (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetParentheticalDetail" id="PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetParentheticalDetail">
<link:definition>1042 - Disclosure - Property and Equipment, Net -  Sumary of Property and Equipment Net (Parenthetical) (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/AccruedExpensesDetail" id="AccruedExpensesDetail">
<link:definition>1043 - Disclosure - Accrued Expenses (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/NotesPayableSummaryOfLongTermDebtDetail" id="NotesPayableSummaryOfLongTermDebtDetail">
<link:definition>1044 - Disclosure - Notes Payable - Summary of Long Term Debt (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/NotesPayableSummaryOfFuturePrincipalPaymentsDueDetail" id="NotesPayableSummaryOfFuturePrincipalPaymentsDueDetail">
<link:definition>1045 - Disclosure - Notes Payable - Summary of Future Principal Payments Due (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/NotesPayableAdditionalInformationDetail" id="NotesPayableAdditionalInformationDetail">
<link:definition>1046 - Disclosure - Notes Payable - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsAdditionalInformationDetail" id="ConvertiblePreferredStockAndPreferredStockWarrantsAdditionalInformationDetail">
<link:definition>1047 - Disclosure - Convertible Preferred Stock and Preferred Stock Warrants  - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsScheduleOfStockByClassDetail" id="ConvertiblePreferredStockAndPreferredStockWarrantsScheduleOfStockByClassDetail">
<link:definition>1048 - Disclosure - Convertible Preferred Stock and Preferred Stock Warrants  - Schedule of stock by class (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/CommonStockAdditionalInformationDetail" id="CommonStockAdditionalInformationDetail">
<link:definition>1049 - Disclosure - Common Stock - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetail" id="StockBasedCompensationAdditionalInformationDetail">
<link:definition>1050 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/StockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsAndRestrictedStockAwardsUsingBlackScholesOptionPricingModelDetail" id="StockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsAndRestrictedStockAwardsUsingBlackScholesOptionPricingModelDetail">
<link:definition>1051 - Disclosure - Stock-Based Compensation - Schedule of Weighted Average Assumptions Used to Estimate Fair Value of Stock Options and Restricted Stock Awards using Black-Scholes Option Pricing Model (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/StockBasedCompensationScheduleOfShareOptionActivityDetail" id="StockBasedCompensationScheduleOfShareOptionActivityDetail">
<link:definition>1052 - Disclosure - Stock-Based Compensation - Schedule of Share Option  Activity (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/StockBasedCompensationSummaryOfRestrictedCommonStockDetail" id="StockBasedCompensationSummaryOfRestrictedCommonStockDetail">
<link:definition>1053 - Disclosure - Stock-Based Compensation - Summary of Restricted Common Stock (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" id="StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail">
<link:definition>1054 - Disclosure - Stock-Based Compensation - Summary of Stock-based compensation expense (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/CollaborationAgreementAdditionalInformationDetail" id="CollaborationAgreementAdditionalInformationDetail">
<link:definition>1055 - Disclosure - Collaboration Agreement - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/IncomeTaxesAdditionalInformationDetail" id="IncomeTaxesAdditionalInformationDetail">
<link:definition>1056 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/IncomeTaxesSummaryOfReconciliationOfTheUSFederalStatutoryIncomeTaxRateToTheCompanySEffectiveIncomeTaxRateDetail" id="IncomeTaxesSummaryOfReconciliationOfTheUSFederalStatutoryIncomeTaxRateToTheCompanySEffectiveIncomeTaxRateDetail">
<link:definition>1057 - Disclosure - Income Taxes - Summary of Reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail" id="IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail">
<link:definition>1058 - Disclosure - Income Taxes - Summary of Net Deferred Tax Assets (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/LeasesAdditionalInformationDetail" id="LeasesAdditionalInformationDetail">
<link:definition>1059 - Disclosure - Leases - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/LeasesSummaryOfLeaseCostDetail" id="LeasesSummaryOfLeaseCostDetail">
<link:definition>1060 - Disclosure - Leases - Summary of Lease Cost (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/LeasesSummaryOfSupplementalCashFlowInformationRelatedToLeasesDetail" id="LeasesSummaryOfSupplementalCashFlowInformationRelatedToLeasesDetail">
<link:definition>1061 - Disclosure - Leases - Summary of Supplemental Cash Flow Information Related to Leases (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/LeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateLeasesDetail" id="LeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateLeasesDetail">
<link:definition>1062 - Disclosure - Leases - Summary of  Weighted-Average Remaining Lease Term and Discount Rate Leases (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/LeasesSummaryOfMinimumLeasePaymentDetail" id="LeasesSummaryOfMinimumLeasePaymentDetail">
<link:definition>1063 - Disclosure - Leases - Summary of Minimum Lease Payment (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/LeasesSummaryOfOperatingLeaseLiabilitiesDetail" id="LeasesSummaryOfOperatingLeaseLiabilitiesDetail">
<link:definition>1064 - Disclosure - Leases - Summary of Operating  Lease Liabilities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" id="CommitmentsAndContingenciesAdditionalInformationDetail">
<link:definition>1065 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/RelatedPartiesAdditionalInformationDetail" id="RelatedPartiesAdditionalInformationDetail">
<link:definition>1066 - Disclosure - Related Parties - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.foghorntx.com/role/LeasesSummaryOfMinimumLeasePaymentDetailAlternate1" id="LeasesSummaryOfMinimumLeasePaymentDetailAlternate1">
<link:definition>1067 - Statement - Leases - Summary of Minimum Lease Payment (Detail) Alternate 1</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="fhtx-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="fhtx-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="fhtx-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="fhtx-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
<import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
<import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
<import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
<element name="PreferredStockWarrantsLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_PreferredStockWarrantsLiability" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="InterestIncomeAndOtherIncomeExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_InterestIncomeAndOtherIncomeExpense" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" substitutionGroup="xbrli:item" />
<element name="StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" substitutionGroup="xbrli:item" />
<element name="SeriesBRedeemableConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_SeriesBRedeemableConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="StockIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_StockIssuanceCosts" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ConversionOfRedeemableConvertibleStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_ConversionOfRedeemableConvertibleStockMember" substitutionGroup="xbrli:item" />
<element name="ConversionOfWarrantLiabilityToEquityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_ConversionOfWarrantLiabilityToEquityMember" substitutionGroup="xbrli:item" />
<element name="ConversionOfNotesPayableInToWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_ConversionOfNotesPayableInToWarrantsMember" substitutionGroup="xbrli:item" />
<element name="IncreaseDecreaseInOperatingLeaseRightOfUseAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IncreaseDecreaseInOperatingLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_IncreaseDecreaseInOperatingLeaseLiabilities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="MarketableSecuritiesAndFairValueMeasurementsTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" substitutionGroup="xbrli:item" />
<element name="CommonStockTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_CommonStockTextBlock" substitutionGroup="xbrli:item" />
<element name="SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" substitutionGroup="xbrli:item" />
<element name="ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock" substitutionGroup="xbrli:item" />
<element name="ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" substitutionGroup="xbrli:item" />
<element name="OperatingLeaseLiabilityTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_OperatingLeaseLiabilityTableTextBlock" substitutionGroup="xbrli:item" />
<element name="OrganizationConsolidationAndPresentationOfFinancialStatementsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" substitutionGroup="xbrli:item" />
<element name="ProceedsFromUpfrontPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_ProceedsFromUpfrontPayment" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="EarningsPerShareDilutedAntiDilutiveImpactAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_EarningsPerShareDilutedAntiDilutiveImpactAbstract" substitutionGroup="xbrli:item" />
<element name="WarrentsToPurchaseCommonStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_WarrentsToPurchaseCommonStockMember" substitutionGroup="xbrli:item" />
<element name="PreferredStockWarrantLiabilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_PreferredStockWarrantLiabilityMember" substitutionGroup="xbrli:item" />
<element name="WarrantIssuePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_WarrantIssuePrice" substitutionGroup="xbrli:item" />
<element name="BeforeIPOMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_BeforeIPOMember" substitutionGroup="xbrli:item" />
<element name="SeriesAOnePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_SeriesAOnePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="ComputerEquipmentAndSoftwareMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_ComputerEquipmentAndSoftwareMember" substitutionGroup="xbrli:item" />
<element name="AssetsNotYetPlacedInServiceMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_AssetsNotYetPlacedInServiceMember" substitutionGroup="xbrli:item" />
<element name="AccruedResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_AccruedResearchAndDevelopmentExpenses" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TermLoanAMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_TermLoanAMember" substitutionGroup="xbrli:item" />
<element name="TermLoanBMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_TermLoanBMember" substitutionGroup="xbrli:item" />
<element name="TermLoanAAndBMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_TermLoanAAndBMember" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage" substitutionGroup="xbrli:item" />
<element name="InterestRateOutstandingBorrowingsLoan" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_InterestRateOutstandingBorrowingsLoan" substitutionGroup="xbrli:item" />
<element name="WarrantsIssuePricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_WarrantsIssuePricePerShare" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentPrePaymentTerms" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_DebtInstrumentPrePaymentTerms" substitutionGroup="xbrli:item" />
<element name="PercentageOfPrepaymentFee" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_PercentageOfPrepaymentFee" substitutionGroup="xbrli:item" />
<element name="AdditionalRateInEventOfDefaultMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_AdditionalRateInEventOfDefaultMember" substitutionGroup="xbrli:item" />
<element name="AdditionalOverBaseRateMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_AdditionalOverBaseRateMember" substitutionGroup="xbrli:item" />
<element name="OxfordFinanceLlcMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_OxfordFinanceLlcMember" substitutionGroup="xbrli:item" />
<element name="PrepaymentPeriodAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_PrepaymentPeriodAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="PrepaymentPeriodDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_PrepaymentPeriodDomain" substitutionGroup="xbrli:item" />
<element name="PrepaymentWithInFirstTwelveMonthsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_PrepaymentWithInFirstTwelveMonthsMember" substitutionGroup="xbrli:item" />
<element name="PrepaymentAfter12MonthsButPriorTo24MonthsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember" substitutionGroup="xbrli:item" />
<element name="PrepaymentAfter24MonthsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_PrepaymentAfter24MonthsMember" substitutionGroup="xbrli:item" />
<element name="TemporaryEquityStockIssuedDuringPeriodShareNewIssues" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" substitutionGroup="xbrli:item" />
<element name="IssuanceOfNotesPayableMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_IssuanceOfNotesPayableMember" substitutionGroup="xbrli:item" />
<element name="SeriesATwoPreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_SeriesATwoPreferredStockMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandTwentyEquityIncentivePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_TwoThousandTwentyEquityIncentivePlanMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandTwentyEmployeeStockPurchasePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandTwentyAndSixteenStockIncentivePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember" substitutionGroup="xbrli:item" />
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" substitutionGroup="xbrli:item" />
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage" substitutionGroup="xbrli:item" />
<element name="InitialAmountMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_InitialAmountMember" substitutionGroup="xbrli:item" />
<element name="InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember" substitutionGroup="xbrli:item" />
<element name="InitialAggregateMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_InitialAggregateMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandsTwentyToTwoThousandsThirtyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember" substitutionGroup="xbrli:item" />
<element name="ServiceBasedVestingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_ServiceBasedVestingMember" substitutionGroup="xbrli:item" />
<element name="CollaborationAgreementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_CollaborationAgreementAbstract" substitutionGroup="xbrli:item" />
<element name="MilestoneReceivableUponAchievement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_MilestoneReceivableUponAchievement" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="MerckCollaborationAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_MerckCollaborationAgreementMember" substitutionGroup="xbrli:item" />
<element name="ResearchDevelopmentAndRegulatoryMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_ResearchDevelopmentAndRegulatoryMember" substitutionGroup="xbrli:item" />
<element name="ExpirableMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_ExpirableMember" substitutionGroup="xbrli:item" />
<element name="NonExpirableMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_NonExpirableMember" substitutionGroup="xbrli:item" />
<element name="TaxCreditCarryForwardsExpirationStartYear" type="xbrli:gYearItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_TaxCreditCarryForwardsExpirationStartYear" substitutionGroup="xbrli:item" />
<element name="OperatingLossCarryForwardsExpirationStartYear" type="xbrli:gYearItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_OperatingLossCarryForwardsExpirationStartYear" substitutionGroup="xbrli:item" />
<element name="OperatingLossCarryforwardLimitPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_OperatingLossCarryforwardLimitPercentage" substitutionGroup="xbrli:item" />
<element name="DeferredTaxAssetsOperatingLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_DeferredTaxAssetsOperatingLeaseLiabilities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredTaxAssetsCapitalizedStartUpCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_DeferredTaxAssetsCapitalizedStartUpCosts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DeferredTaxLiabilitiesDepreciation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_DeferredTaxLiabilitiesDepreciation" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NewLeaseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_NewLeaseAgreementMember" substitutionGroup="xbrli:item" />
<element name="ModifiedNewLeaseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_ModifiedNewLeaseAgreementMember" substitutionGroup="xbrli:item" />
<element name="PropertyUnderOperatingLeaseSubleasedMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_PropertyUnderOperatingLeaseSubleasedMember" substitutionGroup="xbrli:item" />
<element name="LeaseholdImprovementsLandlordAllowance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_LeaseholdImprovementsLandlordAllowance" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TermOfPropertySubleasedUnderOperatingLease" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_TermOfPropertySubleasedUnderOperatingLease" substitutionGroup="xbrli:item" />
<element name="LeaseTermCommencementDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_LeaseTermCommencementDate" substitutionGroup="xbrli:item" />
<element name="LeaseholdImprovementsLandlordAllowanceToBeRepaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract" substitutionGroup="xbrli:item" />
<element name="LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NonRefundableLicenseFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_NonRefundableLicenseFee" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ReimbursedPatentCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_ReimbursedPatentCosts" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="MilestonesPayableUponEvent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_MilestonesPayableUponEvent" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="AnnualLicenseMaintenanceFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_AnnualLicenseMaintenanceFees" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="StanfordLicenseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_StanfordLicenseAgreementMember" substitutionGroup="xbrli:item" />
<element name="ServiceAgreementTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_ServiceAgreementTerm" substitutionGroup="xbrli:item" />
<element name="CashPaymentsRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_CashPaymentsRelatedParty" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ServiceAgreementExpirationYear" type="xbrli:gYearItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_ServiceAgreementExpirationYear" substitutionGroup="xbrli:item" />
<element name="ServiceAgreementExtendedDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="fhtx_ServiceAgreementExtendedDate" substitutionGroup="xbrli:item" />
<element name="AgreementsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_AgreementsAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="AgreementsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_AgreementsDomain" substitutionGroup="xbrli:item" />
<element name="FlagshipPioneeringMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_FlagshipPioneeringMember" substitutionGroup="xbrli:item" />
<element name="ScientificFounderMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="fhtx_ScientificFounderMember" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>fhtx-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 18-March-2021 [12:26:36] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedBalanceSheets" roleURI="http://www.foghorntx.com/role/ConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfOperationsAndComprehensiveLoss" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail" roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#AccruedExpensesDetail" roleURI="http://www.foghorntx.com/role/AccruedExpensesDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NotesPayableSummaryOfFuturePrincipalPaymentsDueDetail" roleURI="http://www.foghorntx.com/role/NotesPayableSummaryOfFuturePrincipalPaymentsDueDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail" roleURI="http://www.foghorntx.com/role/IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfLeaseCostDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfLeaseCostDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfMinimumLeasePaymentDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfMinimumLeasePaymentDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfOperatingLeaseLiabilitiesDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfOperatingLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfMinimumLeasePaymentDetailAlternate1" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfMinimumLeasePaymentDetailAlternate1" />
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_RestrictedCashNoncurrent" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_RestrictedCashCurrent" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="loc_us-gaap_MarketableSecurities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_MarketableSecurities" use="optional" order="9" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_Liabilities" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LongTermDebtNoncurrent" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PreferredStockWarrantsLiability" xlink:label="loc_FHTX_PreferredStockWarrantsLiability" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_FHTX_PreferredStockWarrantsLiability" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LiabilitiesCurrent" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableCurrent" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_LongTermDebtCurrent" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent" use="optional" order="21" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquity" use="optional" order="22" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_CommonStockValue" use="optional" order="23" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AdditionalPaidInCapital" use="optional" order="24" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" order="25" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" order="26" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_PreferredStockValue" use="optional" order="27" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaap_NetIncomeLoss" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_OperatingIncomeLoss" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_OperatingExpenses" use="optional" order="5" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_NonoperatingIncomeExpense" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_InterestExpense" use="optional" order="10" weight="-1" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_InterestIncomeAndOtherIncomeExpense" xlink:label="loc_FHTX_InterestIncomeAndOtherIncomeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_FHTX_InterestIncomeAndOtherIncomeExpense" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants" use="optional" order="12" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" use="optional" order="13" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" order="2" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities" use="optional" order="4" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromNotesPayable" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable" use="optional" order="10" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" order="12" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="loc_FHTX_IncreaseDecreaseInOperatingLeaseLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FHTX_IncreaseDecreaseInOperatingLeaseLiabilities" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets" use="optional" order="18" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:label="loc_FHTX_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FHTX_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="loc_us-gaap_PaidInKindInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_PaidInKindInterest" use="optional" order="21" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ShareBasedCompensation" use="optional" order="22" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" use="optional" order="23" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" use="optional" order="24" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ProfitLoss" use="optional" order="25" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesSummaryOfLeaseCostDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost" xlink:to="loc_us-gaap_OperatingLeaseCost" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost" xlink:to="loc_us-gaap_VariableLeaseCost" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost" xlink:to="loc_us-gaap_ShortTermLeaseCost" use="optional" order="3" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesSummaryOfMinimumLeasePaymentDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" use="optional" order="6" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesSummaryOfMinimumLeasePaymentDetailAlternate1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_OperatingLeaseLiability" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" xlink:label="loc_FHTX_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_FHTX_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" use="optional" order="9" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" use="optional" order="2" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" use="optional" order="3" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/NotesPayableSummaryOfFuturePrincipalPaymentsDueDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" use="optional" order="5" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" order="1" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesSummaryOfOperatingLeaseLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:label="loc_FHTX_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="loc_FHTX_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_FHTX_DeferredTaxLiabilitiesDepreciation" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="loc_FHTX_DeferredTaxLiabilitiesDepreciation" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxAssetsCapitalizedStartUpCosts" xlink:label="loc_FHTX_DeferredTaxAssetsCapitalizedStartUpCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="loc_FHTX_DeferredTaxAssetsCapitalizedStartUpCosts" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:label="loc_FHTX_DeferredTaxAssetsOperatingLeaseLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="loc_FHTX_DeferredTaxAssetsOperatingLeaseLiabilities" use="optional" order="8" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/AccruedExpensesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionPayableCurrent" xlink:label="loc_us-gaap_ConstructionPayableCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_ConstructionPayableCurrent" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AccruedResearchAndDevelopmentExpenses" xlink:label="loc_FHTX_AccruedResearchAndDevelopmentExpenses" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="loc_FHTX_AccruedResearchAndDevelopmentExpenses" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent" use="optional" order="5" weight="1" />
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>fhtx-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 18-March-2021 [12:26:36] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.foghorntx.com/role/ConsolidatedBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NatureOfBusinessAndBasisOfPresentationAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/NatureOfBusinessAndBasisOfPresentationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfPropertyAndEquipmentAreStatedAtCostLessAccumulatedDepreciationAndAmortizationDetail" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfPropertyAndEquipmentAreStatedAtCostLessAccumulatedDepreciationAndAmortizationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareDilutedAntiDilutiveImpactDetail" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareDilutedAntiDilutiveImpactDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#MarketableSecuritiesAndFairValueMeasurementsSummaryOfAvailableForSaleMarkatableSecurtiesBySecurityTypeDetail" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfAvailableForSaleMarkatableSecurtiesBySecurityTypeDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#MarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail" roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetParentheticalDetail" roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NotesPayableAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/NotesPayableAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConvertiblePreferredStockAndPreferredStockWarrantsAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConvertiblePreferredStockAndPreferredStockWarrantsScheduleOfStockByClassDetail" roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsScheduleOfStockByClassDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CommonStockAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/CommonStockAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationScheduleOfShareOptionActivityDetail" roleURI="http://www.foghorntx.com/role/StockBasedCompensationScheduleOfShareOptionActivityDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationSummaryOfRestrictedCommonStockDetail" roleURI="http://www.foghorntx.com/role/StockBasedCompensationSummaryOfRestrictedCommonStockDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" roleURI="http://www.foghorntx.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CollaborationAgreementAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/CollaborationAgreementAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#IncomeTaxesAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/IncomeTaxesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/LeasesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#RelatedPartiesAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/RelatedPartiesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfOperationsAndComprehensiveLoss" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedBalanceSheets" roleURI="http://www.foghorntx.com/role/ConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NatureOfBusinessAndBasisOfPresentation" roleURI="http://www.foghorntx.com/role/NatureOfBusinessAndBasisOfPresentation" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#MarketableSecuritiesAndFairValueMeasurementsTables" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#RelatedParties" roleURI="http://www.foghorntx.com/role/RelatedParties" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensation" roleURI="http://www.foghorntx.com/role/StockBasedCompensation" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationTables" roleURI="http://www.foghorntx.com/role/StockBasedCompensationTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#DefinedContributionPlan" roleURI="http://www.foghorntx.com/role/DefinedContributionPlan" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NotesPayable" roleURI="http://www.foghorntx.com/role/NotesPayable" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CollaborationAgreement" roleURI="http://www.foghorntx.com/role/CollaborationAgreement" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#AccruedExpensesTable" roleURI="http://www.foghorntx.com/role/AccruedExpensesTable" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#AccruedExpensesDetail" roleURI="http://www.foghorntx.com/role/AccruedExpensesDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConvertiblePreferredStockAndPreferredStockWarrants" roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrants" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NotesPayableTables" roleURI="http://www.foghorntx.com/role/NotesPayableTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NotesPayableSummaryOfLongTermDebtDetail" roleURI="http://www.foghorntx.com/role/NotesPayableSummaryOfLongTermDebtDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#Leases" roleURI="http://www.foghorntx.com/role/Leases" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CommitmentsAndContingencies" roleURI="http://www.foghorntx.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesTables" roleURI="http://www.foghorntx.com/role/LeasesTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfLeaseCostDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfLeaseCostDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfSupplementalCashFlowInformationRelatedToLeasesDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfSupplementalCashFlowInformationRelatedToLeasesDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateLeasesDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateLeasesDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfMinimumLeasePaymentDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfMinimumLeasePaymentDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfOperatingLeaseLiabilitiesDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfOperatingLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CoverPage" roleURI="http://www.foghorntx.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NotesPayableSummaryOfFuturePrincipalPaymentsDueDetail" roleURI="http://www.foghorntx.com/role/NotesPayableSummaryOfFuturePrincipalPaymentsDueDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfCashFlowsParenthetical" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#AccruedExpenses" roleURI="http://www.foghorntx.com/role/AccruedExpenses" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#IncomeTaxes" roleURI="http://www.foghorntx.com/role/IncomeTaxes" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#IncomeTaxesTables" roleURI="http://www.foghorntx.com/role/IncomeTaxesTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#IncomeTaxesSummaryOfReconciliationOfTheUSFederalStatutoryIncomeTaxRateToTheCompanySEffectiveIncomeTaxRateDetail" roleURI="http://www.foghorntx.com/role/IncomeTaxesSummaryOfReconciliationOfTheUSFederalStatutoryIncomeTaxRateToTheCompanySEffectiveIncomeTaxRateDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail" roleURI="http://www.foghorntx.com/role/IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#PropertyAndEquipmentNet" roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNet" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#PropertyAndEquipmentNetTables" roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNetTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsAndRestrictedStockAwardsUsingBlackScholesOptionPricingModelDetail" roleURI="http://www.foghorntx.com/role/StockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsAndRestrictedStockAwardsUsingBlackScholesOptionPricingModelDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConvertiblePreferredStockAndPreferredStockWarrantsTables" roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CommonStock" roleURI="http://www.foghorntx.com/role/CommonStock" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#MarketableSecuritiesAndFairValueMeasurements" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurements" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_845124" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_775213" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_775213" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_775215" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_775215" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_775216" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_775216" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_775217" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_775217" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_775201" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_StatementTable_775201" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_845102" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_775201" xlink:to="loc_us-gaap_StatementClassOfStockAxis_845102" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_845114" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_845102" xlink:to="loc_us-gaap_ClassOfStockDomain_845114" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_845114_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_845102" xlink:to="loc_us-gaap_ClassOfStockDomain_845114_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_776884" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_845114" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_776884" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_775230" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_775230" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_775232" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_CommonStockSharesIssued_775232" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_775234" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_775234" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_775229" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_775229" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_845054" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_845054" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_845057" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_845057" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_845063" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_845063" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_845066" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_PreferredStockSharesIssued_845066" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_775169" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_775166" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StatementTable_775166" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_775167" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_775166" xlink:to="loc_us-gaap_StatementClassOfStockAxis_775167" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_775168" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_775167" xlink:to="loc_us-gaap_ClassOfStockDomain_775168" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_775168_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_775167" xlink:to="loc_us-gaap_ClassOfStockDomain_775168_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_775364" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_775168" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_775364" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_775174" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_775166" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_775174" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_775175" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_775174" xlink:to="loc_us-gaap_EquityComponentDomain_775175" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_775175_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_775174" xlink:to="loc_us-gaap_EquityComponentDomain_775175_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_775176" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_775175" xlink:to="loc_us-gaap_CommonStockMember_775176" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_775177" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_775175" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_775177" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_775178" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_775175" xlink:to="loc_us-gaap_RetainedEarningsMember_775178" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_845714" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_775175" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_845714" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_844251" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_775166" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_844251" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844252" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_844251" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844252" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844252_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_844251" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844252_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_844253" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844252" xlink:to="loc_us-gaap_IPOMember_844253" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_775179" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_775179" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_775184" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_775184" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_775185" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockholdersEquity_775185" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_775181" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_775181" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_775183" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_775183" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_775273" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_775273" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_775282" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_775282" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_775187" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_775187" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_775190" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_775190" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_775192" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_775192" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_775195" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_NetIncomeLoss_775195" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_844263" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_844263" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_844255" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_844255" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_844256" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_844256" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_844260" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_844260" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:label="loc_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants_844261" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants_844261" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_844262" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_844262" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_855046" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_855046" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_855047" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_855047" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_855040" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_855040" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_855041" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_855041" use="optional" order="37" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_775315" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_775312" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_775315" xlink:to="loc_us-gaap_StatementTable_775312" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_775313" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_775312" xlink:to="loc_us-gaap_StatementClassOfStockAxis_775313" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_775314" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_775313" xlink:to="loc_us-gaap_ClassOfStockDomain_775314" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_775314_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_775313" xlink:to="loc_us-gaap_ClassOfStockDomain_775314_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="loc_fhtx_SeriesBRedeemableConvertiblePreferredStockMember_775319" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_775314" xlink:to="loc_fhtx_SeriesBRedeemableConvertiblePreferredStockMember_775319" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_StockIssuanceCosts" xlink:label="loc_fhtx_StockIssuanceCosts_778683" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775315" xlink:to="loc_fhtx_StockIssuanceCosts_778683" use="optional" order="6" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_845240" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_775084" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" xlink:to="loc_us-gaap_ProfitLoss_775084" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_775087" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_775087" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_775088" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_775088" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_775098" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_ShareBasedCompensation_775098" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_775090" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_775090" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="loc_us-gaap_PaidInKindInterest_775093" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_PaidInKindInterest_775093" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:label="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_775091" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_775091" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_844283" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_844283" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_844284" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_844284" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_775102" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_775102" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_775103" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_775103" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_775105" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_775105" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="loc_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities_775107" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" xlink:to="loc_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities_775107" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_776067" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_776067" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_775113" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_775113" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_775119" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_775119" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_775120" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_775120" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_775122" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_775122" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_776069" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_776069" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_844293" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_844293" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_844290" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_844290" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_775115" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_775115" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_775116" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_775116" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_776068" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_776068" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_844287" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_844287" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_775139" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_775139" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_775140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_775140" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_775144" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_775144" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_775145" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_775144" xlink:to="loc_us-gaap_InterestPaidNet_775145" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_775148" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_775148" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_775149" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_775148" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_775149" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_844295" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_775148" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_844295" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_844296" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_775148" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_844296" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_844302" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_StatementTable_844302" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_844303" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_844302" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_844303" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_844304" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_844303" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_844304" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_844304_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_844303" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_844304_default" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ConversionOfRedeemableConvertibleStockMember" xlink:label="loc_fhtx_ConversionOfRedeemableConvertibleStockMember_844313" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_844304" xlink:to="loc_fhtx_ConversionOfRedeemableConvertibleStockMember_844313" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ConversionOfWarrantLiabilityToEquityMember" xlink:label="loc_fhtx_ConversionOfWarrantLiabilityToEquityMember_844319" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_844304" xlink:to="loc_fhtx_ConversionOfWarrantLiabilityToEquityMember_844319" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ConversionOfNotesPayableInToWarrantsMember" xlink:label="loc_fhtx_ConversionOfNotesPayableInToWarrantsMember_844323" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_844304" xlink:to="loc_fhtx_ConversionOfNotesPayableInToWarrantsMember_844323" use="optional" order="45" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/NatureOfBusinessAndBasisOfPresentationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_776159" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_776159" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_776162" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_776159" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_776162" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_776163" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_776162" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_776163" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_776163_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_776162" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_776163_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_776164" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_776163" xlink:to="loc_us-gaap_IPOMember_776164" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_783843" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_776163" xlink:to="loc_us-gaap_OverAllotmentOptionMember_783843" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_780547" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_776159" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_780547" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_780548" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_780547" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_780548" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_780548_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_780547" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_780548_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_863435" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_776159" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_863435" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_863436" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_863435" xlink:to="loc_us-gaap_EquityComponentDomain_863436" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_863436_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_863435" xlink:to="loc_us-gaap_EquityComponentDomain_863436_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_863437" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_863436" xlink:to="loc_us-gaap_CommonStockMember_863437" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_776165" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_776165" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_776166" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_776166" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_776167" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_776167" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_776168" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_NetIncomeLoss_776168" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_776169" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_776169" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ProceedsFromUpfrontPayment" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment_781960" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_fhtx_ProceedsFromUpfrontPayment_781960" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_843451" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_843451" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_845287" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_843642" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845287" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_843642" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_843643" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_845287" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_843643" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_843638" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_845287" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_843638" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_843639" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_843638" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_843639" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843640" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_843639" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843640" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843640_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_843639" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843640_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_843641" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843640" xlink:to="loc_us-gaap_IPOMember_843641" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfPropertyAndEquipmentAreStatedAtCostLessAccumulatedDepreciationAndAmortizationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_775297" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_775296" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_775297" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_775296" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_776587" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_775296" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_776587" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_776587" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_776587" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_776590" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_776590" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_776612" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_776612" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_776616" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" xlink:to="loc_us-gaap_EquipmentMember_776616" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_776625" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_776625" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_775329" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_775297" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_775329" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_776576" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_775297" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_776576" use="optional" order="10" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareDilutedAntiDilutiveImpactDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_778749" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_776181" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_778749" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_776181" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_778746" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_778749" xlink:to="loc_us-gaap_StatementTable_778746" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_778747" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_778746" xlink:to="loc_us-gaap_StatementClassOfStockAxis_778747" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_778748" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_778747" xlink:to="loc_us-gaap_ClassOfStockDomain_778748" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_778748_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_778747" xlink:to="loc_us-gaap_ClassOfStockDomain_778748_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_778750" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_778748" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_778750" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_778751" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_778748" xlink:to="loc_us-gaap_WarrantMember_778751" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_778753" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_778748" xlink:to="loc_us-gaap_RestrictedStockMember_778753" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_778755" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_778748" xlink:to="loc_us-gaap_EmployeeStockOptionMember_778755" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_WarrentsToPurchaseCommonStockMember" xlink:label="loc_fhtx_WarrentsToPurchaseCommonStockMember_843600" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_778748" xlink:to="loc_fhtx_WarrentsToPurchaseCommonStockMember_843600" use="optional" order="10" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfAvailableForSaleMarkatableSecurtiesBySecurityTypeDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_855072" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_843746" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_855072" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_843746" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_843747" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_855072" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_843747" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_843749" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_855072" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_843749" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_855070" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_855072" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_855070" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_855076" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_855070" xlink:to="loc_us-gaap_InvestmentTypeAxis_855076" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_855077" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_855076" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_855077" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_855077_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_855076" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_855077_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryNotesSecuritiesMember" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember_855079" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_855077" xlink:to="loc_us-gaap_USTreasuryNotesSecuritiesMember_855079" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_776650" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_776650" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_776651" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_776650" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_776651" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_776651_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_776650" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_776651_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_776652" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_776651" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_776652" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_776653" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_776653" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_776654" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_776653" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_776654" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_776654_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_776653" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_776654_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_776655" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_776654" xlink:to="loc_us-gaap_MoneyMarketFundsMember_776655" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_843779" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_776654" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_843779" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_776657" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" xlink:to="loc_us-gaap_FinancialInstrumentAxis_776657" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776658" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_776657" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776658" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776658_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_776657" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776658_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PreferredStockWarrantLiabilityMember" xlink:label="loc_fhtx_PreferredStockWarrantLiabilityMember_776659" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776658" xlink:to="loc_fhtx_PreferredStockWarrantLiabilityMember_776659" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_776645" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_776645" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_776645" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_776645" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_776647" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_776647" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_776648" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_776648" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_776649" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_776649" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_775263" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_775263" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_775269" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_775269" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_843773" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_843773" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_845474" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_845474" use="optional" order="24" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_775290" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_775287" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_775290" xlink:to="loc_us-gaap_StatementTable_775287" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_776620" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_775287" xlink:to="loc_us-gaap_FinancialInstrumentAxis_776620" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776622" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_776620" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776622" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776622_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_776620" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776622_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PreferredStockWarrantLiabilityMember" xlink:label="loc_fhtx_PreferredStockWarrantLiabilityMember_776623" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776622" xlink:to="loc_fhtx_PreferredStockWarrantLiabilityMember_776623" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_844306" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_775287" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_844306" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844307" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_844306" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844307" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844307_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_844306" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844307_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_844308" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844307" xlink:to="loc_us-gaap_IPOMember_844308" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_BeforeIPOMember" xlink:label="loc_fhtx_BeforeIPOMember_855212" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844307" xlink:to="loc_fhtx_BeforeIPOMember_855212" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_844312" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_775287" xlink:to="loc_us-gaap_StatementClassOfStockAxis_844312" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_844316" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_844312" xlink:to="loc_us-gaap_ClassOfStockDomain_844316" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_844316_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_844312" xlink:to="loc_us-gaap_ClassOfStockDomain_844316_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_SeriesAOnePreferredStockMember" xlink:label="loc_fhtx_SeriesAOnePreferredStockMember_844320" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_844316" xlink:to="loc_fhtx_SeriesAOnePreferredStockMember_844320" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_855113" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_775287" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_855113" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_855114" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_855113" xlink:to="loc_us-gaap_EquityComponentDomain_855114" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_855114_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_855113" xlink:to="loc_us-gaap_EquityComponentDomain_855114_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_855115" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_855114" xlink:to="loc_us-gaap_CommonStockMember_855115" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_WarrantIssuePrice" xlink:label="loc_fhtx_WarrantIssuePrice_775293" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775290" xlink:to="loc_fhtx_WarrantIssuePrice_775293" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_776624" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775290" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_776624" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="loc_us-gaap_MarketableSecurities_844322" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775290" xlink:to="loc_us-gaap_MarketableSecurities_844322" use="optional" order="21" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843758" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843740" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843758" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843740" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_843741" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843740" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_843741" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_843741" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_843741" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_843743" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" xlink:to="loc_us-gaap_EquipmentMember_843743" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_843744" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_843744" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_843753" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_843753" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ComputerEquipmentAndSoftwareMember" xlink:label="loc_fhtx_ComputerEquipmentAndSoftwareMember_843751" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" xlink:to="loc_fhtx_ComputerEquipmentAndSoftwareMember_843751" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AssetsNotYetPlacedInServiceMember" xlink:label="loc_fhtx_AssetsNotYetPlacedInServiceMember_843755" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" xlink:to="loc_fhtx_AssetsNotYetPlacedInServiceMember_843755" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_843763" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843758" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_843763" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_843765" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843758" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_843765" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_843766" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843758" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_843766" use="optional" order="12" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetParentheticalDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843784" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843783" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843784" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843783" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_843785" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843784" xlink:to="loc_us-gaap_DepreciationAndAmortization_843785" use="optional" order="2" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/NotesPayableAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaap_ShortTermDebtLineItems_776699" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_776694" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_us-gaap_DebtInstrumentAxis_776694" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_776695" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_776694" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_776695" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_776695_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_776694" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_776695_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TermLoanAMember" xlink:label="loc_fhtx_TermLoanAMember_776696" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_776695" xlink:to="loc_fhtx_TermLoanAMember_776696" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TermLoanBMember" xlink:label="loc_fhtx_TermLoanBMember_776698" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_776695" xlink:to="loc_fhtx_TermLoanBMember_776698" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TermLoanAAndBMember" xlink:label="loc_fhtx_TermLoanAAndBMember_855245" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_776695" xlink:to="loc_fhtx_TermLoanAAndBMember_855245" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_779131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_779131" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_779132" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_779131" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_779132" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_779132_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_779131" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_779132_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AdditionalRateInEventOfDefaultMember" xlink:label="loc_fhtx_AdditionalRateInEventOfDefaultMember_779133" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_779132" xlink:to="loc_fhtx_AdditionalRateInEventOfDefaultMember_779133" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AdditionalOverBaseRateMember" xlink:label="loc_fhtx_AdditionalOverBaseRateMember_779134" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_779132" xlink:to="loc_fhtx_AdditionalOverBaseRateMember_779134" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_779136" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_srt_RangeAxis_779136" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_779137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_779136" xlink:to="loc_srt_RangeMember_779137" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_779137_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_779136" xlink:to="loc_srt_RangeMember_779137_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_779139" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_779137" xlink:to="loc_srt_MinimumMember_779139" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_779138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_779137" xlink:to="loc_srt_MaximumMember_779138" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_780553" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_780553" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_780554" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_780553" xlink:to="loc_us-gaap_RelatedPartyDomain_780554" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_780554_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_780553" xlink:to="loc_us-gaap_RelatedPartyDomain_780554_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OxfordFinanceLlcMember" xlink:label="loc_fhtx_OxfordFinanceLlcMember_780555" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_780554" xlink:to="loc_fhtx_OxfordFinanceLlcMember_780555" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_780556" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_780556" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_780557" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_780556" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_780557" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_780557_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_780556" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_780557_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_855272" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_us-gaap_VariableRateAxis_855272" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_855274" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_855272" xlink:to="loc_us-gaap_VariableRateDomain_855274" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_855274_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_855272" xlink:to="loc_us-gaap_VariableRateDomain_855274_default" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_855275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_855274" xlink:to="loc_us-gaap_BaseRateMember_855275" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentPeriodAxis" xlink:label="loc_fhtx_PrepaymentPeriodAxis_861282" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_fhtx_PrepaymentPeriodAxis_861282" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentPeriodDomain" xlink:label="loc_fhtx_PrepaymentPeriodDomain_861284" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_fhtx_PrepaymentPeriodAxis_861282" xlink:to="loc_fhtx_PrepaymentPeriodDomain_861284" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentPeriodDomain" xlink:label="loc_fhtx_PrepaymentPeriodDomain_861284_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_fhtx_PrepaymentPeriodAxis_861282" xlink:to="loc_fhtx_PrepaymentPeriodDomain_861284_default" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentWithInFirstTwelveMonthsMember" xlink:label="loc_fhtx_PrepaymentWithInFirstTwelveMonthsMember_861285" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_PrepaymentPeriodDomain_861284" xlink:to="loc_fhtx_PrepaymentWithInFirstTwelveMonthsMember_861285" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember" xlink:label="loc_fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember_861287" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_PrepaymentPeriodDomain_861284" xlink:to="loc_fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember_861287" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentAfter24MonthsMember" xlink:label="loc_fhtx_PrepaymentAfter24MonthsMember_861289" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_PrepaymentPeriodDomain_861284" xlink:to="loc_fhtx_PrepaymentAfter24MonthsMember_861289" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_775439" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_775439" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_776702" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_776702" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_776703" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_776703" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_776704" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_776704" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_776707" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_776707" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_776706" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_776706" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:label="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_780183" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_780183" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage" xlink:label="loc_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage_780184" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage_780184" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_InterestRateOutstandingBorrowingsLoan" xlink:label="loc_fhtx_InterestRateOutstandingBorrowingsLoan_779032" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_fhtx_InterestRateOutstandingBorrowingsLoan_779032" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="loc_us-gaap_DebtInstrumentInterestRateTerms_843899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentInterestRateTerms_843899" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="loc_us-gaap_DebtInstrumentPaymentTerms_843909" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentPaymentTerms_843909" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_843913" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_843913" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_843922" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_843922" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRestrictiveCovenants" xlink:label="loc_us-gaap_DebtInstrumentRestrictiveCovenants_843916" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentRestrictiveCovenants_843916" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_843935" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_843935" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_WarrantsIssuePricePerShare" xlink:label="loc_fhtx_WarrantsIssuePricePerShare_843940" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_fhtx_WarrantsIssuePricePerShare_843940" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_843942" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_843942" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_843994" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_843994" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DebtInstrumentPrePaymentTerms" xlink:label="loc_fhtx_DebtInstrumentPrePaymentTerms_844013" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_fhtx_DebtInstrumentPrePaymentTerms_844013" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_844062" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_844062" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_844021" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_844021" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_844716" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_844716" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PercentageOfPrepaymentFee" xlink:label="loc_fhtx_PercentageOfPrepaymentFee_861281" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_fhtx_PercentageOfPrepaymentFee_861281" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_861311" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentTerm_861311" use="optional" order="58" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_779123" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_776233" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_776233" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_776235" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_776235" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_780185" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_780185" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_779120" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_us-gaap_StatementTable_779120" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_779121" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_779120" xlink:to="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_779121" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_779122" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_779121" xlink:to="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_779122" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_779122_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_779121" xlink:to="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_779122_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBMember" xlink:label="loc_us-gaap_SeriesBMember_779128" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_779122" xlink:to="loc_us-gaap_SeriesBMember_779128" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_844212" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_779120" xlink:to="loc_us-gaap_StatementClassOfStockAxis_844212" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_844213" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_844212" xlink:to="loc_us-gaap_ClassOfStockDomain_844213" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_844213_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_844212" xlink:to="loc_us-gaap_ClassOfStockDomain_844213_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_SeriesAOnePreferredStockMember" xlink:label="loc_fhtx_SeriesAOnePreferredStockMember_844217" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_844213" xlink:to="loc_fhtx_SeriesAOnePreferredStockMember_844217" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_855278" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_779120" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_855278" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_855279" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_855278" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_855279" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_855279_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_855278" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_855279_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_855280" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_855279" xlink:to="loc_us-gaap_IPOMember_855280" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_IssuanceOfNotesPayableMember" xlink:label="loc_fhtx_IssuanceOfNotesPayableMember_861373" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_855279" xlink:to="loc_fhtx_IssuanceOfNotesPayableMember_861373" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_861374" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_779120" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_861374" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_861375" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_861374" xlink:to="loc_us-gaap_EquityComponentDomain_861375" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_861375_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_861374" xlink:to="loc_us-gaap_EquityComponentDomain_861375_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_861377" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_861375" xlink:to="loc_us-gaap_CommonStockMember_861377" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:label="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues_855283" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues_855283" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_861372" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_861372" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_861379" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_861379" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:label="loc_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants_861380" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants_861380" use="optional" order="25" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsScheduleOfStockByClassDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_844125" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_844121" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_844125" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_844121" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_844122" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_844121" xlink:to="loc_us-gaap_StatementClassOfStockAxis_844122" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_844123" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_844122" xlink:to="loc_us-gaap_ClassOfStockDomain_844123" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_844123_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_844122" xlink:to="loc_us-gaap_ClassOfStockDomain_844123_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_SeriesAOnePreferredStockMember" xlink:label="loc_fhtx_SeriesAOnePreferredStockMember_844126" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_844123" xlink:to="loc_fhtx_SeriesAOnePreferredStockMember_844126" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_SeriesATwoPreferredStockMember" xlink:label="loc_fhtx_SeriesATwoPreferredStockMember_844127" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_844123" xlink:to="loc_fhtx_SeriesATwoPreferredStockMember_844127" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_844128" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_844123" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_844128" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_844130" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_844125" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_844130" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_844141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_844125" xlink:to="loc_us-gaap_PreferredStockSharesIssued_844141" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_844143" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_844125" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_844143" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_844144" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_844125" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_844144" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_844146" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_844125" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_844146" use="optional" order="12" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/CommonStockAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_844203" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_844202" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_844203" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_844202" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_861458" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_844202" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_861458" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_861460" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_861458" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_861460" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_861460_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_861458" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_861460_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_861462" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_844202" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_861462" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_861463" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_861462" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_861463" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_861463_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_861462" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_861463_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_861464" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_861463" xlink:to="loc_us-gaap_IPOMember_861464" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_861471" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_861463" xlink:to="loc_us-gaap_OverAllotmentOptionMember_861471" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_863334" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_844202" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_863334" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_863335" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_863334" xlink:to="loc_us-gaap_EquityComponentDomain_863335" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_863335_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_863334" xlink:to="loc_us-gaap_EquityComponentDomain_863335_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_863336" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_863335" xlink:to="loc_us-gaap_CommonStockMember_863336" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaap_CommonStockVotingRights_855294" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_844203" xlink:to="loc_us-gaap_CommonStockVotingRights_855294" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_861466" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_844203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_861466" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_861467" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_844203" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_861467" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_861468" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_844203" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_861468" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_778990" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_778990" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_778991" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_778991" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_778992" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_778992" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_778993" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_778993" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_780208" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_PlanNameAxis_780208" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_780209" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_780208" xlink:to="loc_us-gaap_PlanNameDomain_780209" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_780209_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_780208" xlink:to="loc_us-gaap_PlanNameDomain_780209_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember_843900" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_780209" xlink:to="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember_843900" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:label="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember_843901" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_780209" xlink:to="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember_843901" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember" xlink:label="loc_fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember_863354" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_780209" xlink:to="loc_fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember_863354" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_843918" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_843918" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_843918" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_843918" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_InitialAmountMember" xlink:label="loc_fhtx_InitialAmountMember_843931" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" xlink:to="loc_fhtx_InitialAmountMember_843931" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember" xlink:label="loc_fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember_843933" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" xlink:to="loc_fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember_843933" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_InitialAggregateMember" xlink:label="loc_fhtx_InitialAggregateMember_860554" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" xlink:to="loc_fhtx_InitialAggregateMember_860554" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember" xlink:label="loc_fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember_863350" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" xlink:to="loc_fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember_863350" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_844057" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_844057" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_844058" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_844057" xlink:to="loc_us-gaap_RelatedPartyDomain_844058" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_844058_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_844057" xlink:to="loc_us-gaap_RelatedPartyDomain_844058_default" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_844049" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_DebtInstrumentAxis_844049" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_844051" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_844049" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_844051" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_844051_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_844049" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_844051_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_844044" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_srt_RangeAxis_844044" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_844045" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_844044" xlink:to="loc_srt_RangeMember_844045" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_844045_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_844044" xlink:to="loc_srt_RangeMember_844045_default" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_844046" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_844045" xlink:to="loc_srt_MaximumMember_844046" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_855295" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_855295" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_855296" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_855295" xlink:to="loc_us-gaap_EquityComponentDomain_855296" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_855296_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_855295" xlink:to="loc_us-gaap_EquityComponentDomain_855296_default" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_855297" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_855296" xlink:to="loc_us-gaap_CommonStockMember_855297" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_860545" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_AwardTypeAxis_860545" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_860546" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_860545" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_860546" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_860546_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_860545" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_860546_default" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ServiceBasedVestingMember" xlink:label="loc_fhtx_ServiceBasedVestingMember_860547" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_860546" xlink:to="loc_fhtx_ServiceBasedVestingMember_860547" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_845975" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_845975" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_845973" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_845973" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_845974" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_845974" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_845978" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_845978" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_855389" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_855389" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_860548" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_860548" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_860552" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_860552" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares_860556" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares_860556" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage_863340" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage_863340" use="optional" order="45" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/StockBasedCompensationScheduleOfShareOptionActivityDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844103" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844103" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_844106" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_844106" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_844107" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_844107" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_844110" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_844110" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_844112" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_844112" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_844116" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_844116" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_844118" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_844118" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_844129" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_844129" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_844131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_844131" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_844133" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_844133" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_844134" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_844134" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_844138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_844138" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_844140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_844140" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_844136" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_844136" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_844137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_844137" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_844148" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_844148" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_844145" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_844145" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_844147" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_844147" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_844150" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_844150" use="optional" order="19" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/StockBasedCompensationSummaryOfRestrictedCommonStockDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844168" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_844169" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_844169" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_844170" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_844170" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844164" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844168" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844164" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_844165" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844164" xlink:to="loc_us-gaap_AwardTypeAxis_844165" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_844166" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_844165" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_844166" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_844166_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_844165" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_844166_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_844167" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_844166" xlink:to="loc_us-gaap_RestrictedStockMember_844167" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_776673" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_776670" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_776673" xlink:to="loc_us-gaap_StatementTable_776670" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_776679" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_776670" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_776679" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_776681" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_776679" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_776681" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_776681_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_776679" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_776681_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_776682" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_776681" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_776682" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_776683" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_776681" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_776683" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_776676" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_776673" xlink:to="loc_us-gaap_ShareBasedCompensation_776676" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/CollaborationAgreementAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_776638" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_775398" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_776638" xlink:to="loc_us-gaap_ContractWithCustomerLiability_775398" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_776635" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_776638" xlink:to="loc_us-gaap_StatementTable_776635" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_780191" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_776635" xlink:to="loc_srt_RangeAxis_780191" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_780192" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_780191" xlink:to="loc_srt_RangeMember_780192" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_780192_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_780191" xlink:to="loc_srt_RangeMember_780192_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_780193" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_780192" xlink:to="loc_srt_MaximumMember_780193" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776639" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_776635" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776639" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776640" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776639" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776640" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776640_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776639" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776640_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_MerckCollaborationAgreementMember" xlink:label="loc_fhtx_MerckCollaborationAgreementMember_781734" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776640" xlink:to="loc_fhtx_MerckCollaborationAgreementMember_781734" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:label="loc_fhtx_ResearchDevelopmentAndRegulatoryMember_776641" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776640" xlink:to="loc_fhtx_ResearchDevelopmentAndRegulatoryMember_776641" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_780194" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_776635" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_780194" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_780195" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_780194" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_780195" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_780195_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_780194" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_780195_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember_780196" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_780195" xlink:to="loc_us-gaap_SalesMember_780196" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ProceedsFromUpfrontPayment" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment_776859" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_776638" xlink:to="loc_fhtx_ProceedsFromUpfrontPayment_776859" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_MilestoneReceivableUponAchievement" xlink:label="loc_fhtx_MilestoneReceivableUponAchievement_776860" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_776638" xlink:to="loc_fhtx_MilestoneReceivableUponAchievement_776860" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_776633" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_776638" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_776633" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_780571" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_776638" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_780571" use="optional" order="19" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/IncomeTaxesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_843653" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_843570" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_843570" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_843593" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_843570" xlink:to="loc_us-gaap_TaxPeriodAxis_843593" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_843594" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_843593" xlink:to="loc_us-gaap_TaxPeriodDomain_843594" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_843594_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_843593" xlink:to="loc_us-gaap_TaxPeriodDomain_843594_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ExpirableMember" xlink:label="loc_fhtx_ExpirableMember_855303" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_843594" xlink:to="loc_fhtx_ExpirableMember_855303" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_NonExpirableMember" xlink:label="loc_fhtx_NonExpirableMember_855307" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_843594" xlink:to="loc_fhtx_NonExpirableMember_855307" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_843588" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_843570" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_843588" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_843590" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_843588" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_843590" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_843590_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_843588" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_843590_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_843592" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_843590" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_843592" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_843591" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_843590" xlink:to="loc_us-gaap_DomesticCountryMember_843591" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_843648" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_843570" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_843648" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_843649" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_843648" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_843649" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_843649_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_843648" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_843649_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember" xlink:label="loc_us-gaap_ResearchMember_843652" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_843649" xlink:to="loc_us-gaap_ResearchMember_843652" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_855326" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_843570" xlink:to="loc_srt_RangeAxis_855326" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_855328" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_855326" xlink:to="loc_srt_RangeMember_855328" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_855328_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_855326" xlink:to="loc_srt_RangeMember_855328_default" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_843656" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_OperatingLossCarryforwards_843656" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_843657" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_843657" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:label="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse_843658" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse_843658" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_843659" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_843659" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_843660" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_843660" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TaxCreditCarryForwardsExpirationStartYear" xlink:label="loc_fhtx_TaxCreditCarryForwardsExpirationStartYear_855298" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_fhtx_TaxCreditCarryForwardsExpirationStartYear_855298" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OperatingLossCarryForwardsExpirationStartYear" xlink:label="loc_fhtx_OperatingLossCarryForwardsExpirationStartYear_855300" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_fhtx_OperatingLossCarryForwardsExpirationStartYear_855300" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OperatingLossCarryforwardLimitPercentage" xlink:label="loc_fhtx_OperatingLossCarryforwardLimitPercentage_855308" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_fhtx_OperatingLossCarryforwardLimitPercentage_855308" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_855320" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_855320" use="optional" order="27" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_776124" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="loc_us-gaap_LeaseContractualTermAxis_776125" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_us-gaap_LeaseContractualTermAxis_776125" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="loc_us-gaap_LeaseContractualTermDomain_776126" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_776125" xlink:to="loc_us-gaap_LeaseContractualTermDomain_776126" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="loc_us-gaap_LeaseContractualTermDomain_776126_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_776125" xlink:to="loc_us-gaap_LeaseContractualTermDomain_776126_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_NewLeaseAgreementMember" xlink:label="loc_fhtx_NewLeaseAgreementMember_776127" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_776126" xlink:to="loc_fhtx_NewLeaseAgreementMember_776127" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ModifiedNewLeaseAgreementMember" xlink:label="loc_fhtx_ModifiedNewLeaseAgreementMember_776134" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_776126" xlink:to="loc_fhtx_ModifiedNewLeaseAgreementMember_776134" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PropertyUnderOperatingLeaseSubleasedMember" xlink:label="loc_fhtx_PropertyUnderOperatingLeaseSubleasedMember_776135" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_776126" xlink:to="loc_fhtx_PropertyUnderOperatingLeaseSubleasedMember_776135" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_776128" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_srt_StatementGeographicalAxis_776128" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_776129" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_776128" xlink:to="loc_srt_SegmentGeographicalDomain_776129" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_776129_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_776128" xlink:to="loc_srt_SegmentGeographicalDomain_776129_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MA" xlink:label="loc_stpr_MA_776130" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_776129" xlink:to="loc_stpr_MA_776130" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_776131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_776131" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_776132" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_776131" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_776132" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_776132_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_776131" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_776132_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficeBuildingMember" xlink:label="loc_srt_OfficeBuildingMember_776133" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_776132" xlink:to="loc_srt_OfficeBuildingMember_776133" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_778973" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_srt_StatementScenarioAxis_778973" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_778974" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_778973" xlink:to="loc_srt_ScenarioUnspecifiedDomain_778974" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_778974_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_778973" xlink:to="loc_srt_ScenarioUnspecifiedDomain_778974_default" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_778975" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_778974" xlink:to="loc_srt_ScenarioForecastMember_778975" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_778981" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_srt_RangeAxis_778981" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_778982" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_778981" xlink:to="loc_srt_RangeMember_778982" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_778982_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_778981" xlink:to="loc_srt_RangeMember_778982_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_778983" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_778982" xlink:to="loc_srt_MaximumMember_778983" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_860575" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_860575" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_860576" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_860575" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_860576" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_860576_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_860575" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_860576_default" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_860577" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_860576" xlink:to="loc_us-gaap_LetterOfCreditMember_860577" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_776145" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_776145" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_776146" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_OperatingLeaseLiability_776146" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_776137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_776137" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_776138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_776138" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_776139" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_776139" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaap_OperatingLeaseExpense_776141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_OperatingLeaseExpense_776141" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_LeaseholdImprovementsLandlordAllowance" xlink:label="loc_fhtx_LeaseholdImprovementsLandlordAllowance_776142" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_LeaseholdImprovementsLandlordAllowance_776142" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TermOfPropertySubleasedUnderOperatingLease" xlink:label="loc_fhtx_TermOfPropertySubleasedUnderOperatingLease_776148" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_TermOfPropertySubleasedUnderOperatingLease_776148" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_LeaseTermCommencementDate" xlink:label="loc_fhtx_LeaseTermCommencementDate_780204" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_LeaseTermCommencementDate_780204" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaap_OtherIncome_779097" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_OtherIncome_779097" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid" xlink:label="loc_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid_776843" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid_776843" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:label="loc_us-gaap_PaymentsForProceedsFromTenantAllowance_776844" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_PaymentsForProceedsFromTenantAllowance_776844" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" xlink:label="loc_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement_778986" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement_778986" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals" xlink:label="loc_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals_776150" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals_776150" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_855361" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_LeaseExpirationDate1_855361" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_863363" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_863363" use="optional" order="43" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_776566" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_776563" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_776566" xlink:to="loc_us-gaap_StatementTable_776563" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_776564" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_776563" xlink:to="loc_us-gaap_StatementClassOfStockAxis_776564" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_776565" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_776564" xlink:to="loc_us-gaap_ClassOfStockDomain_776565" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_776565_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_776564" xlink:to="loc_us-gaap_ClassOfStockDomain_776565_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776568" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_776563" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776568" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776569" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776568" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776569" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776569_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776568" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776569_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_StanfordLicenseAgreementMember" xlink:label="loc_fhtx_StanfordLicenseAgreementMember_776570" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776569" xlink:to="loc_fhtx_StanfordLicenseAgreementMember_776570" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_776571" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_776563" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_776571" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_776572" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_776571" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_776572" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_776572_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_776571" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_776572_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_776573" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_776572" xlink:to="loc_srt_MaximumMember_776573" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_NonRefundableLicenseFee" xlink:label="loc_fhtx_NonRefundableLicenseFee_776596" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_776566" xlink:to="loc_fhtx_NonRefundableLicenseFee_776596" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_776599" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_776566" xlink:to="loc_us-gaap_CommonStockSharesIssued_776599" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ReimbursedPatentCosts" xlink:label="loc_fhtx_ReimbursedPatentCosts_776598" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_776566" xlink:to="loc_fhtx_ReimbursedPatentCosts_776598" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_MilestonesPayableUponEvent" xlink:label="loc_fhtx_MilestonesPayableUponEvent_776601" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_776566" xlink:to="loc_fhtx_MilestonesPayableUponEvent_776601" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AnnualLicenseMaintenanceFees" xlink:label="loc_fhtx_AnnualLicenseMaintenanceFees_776600" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_776566" xlink:to="loc_fhtx_AnnualLicenseMaintenanceFees_776600" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/RelatedPartiesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_778954" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ServiceAgreementTerm" xlink:label="loc_fhtx_ServiceAgreementTerm_778949" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_778954" xlink:to="loc_fhtx_ServiceAgreementTerm_778949" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_CashPaymentsRelatedParty" xlink:label="loc_fhtx_CashPaymentsRelatedParty_775325" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_778954" xlink:to="loc_fhtx_CashPaymentsRelatedParty_775325" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_775333" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_778954" xlink:to="loc_us-gaap_AccountsPayableCurrent_775333" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_778953" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_778954" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_778953" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AgreementsAxis" xlink:label="loc_fhtx_AgreementsAxis_778955" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_778953" xlink:to="loc_fhtx_AgreementsAxis_778955" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AgreementsDomain" xlink:label="loc_fhtx_AgreementsDomain_778956" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_fhtx_AgreementsAxis_778955" xlink:to="loc_fhtx_AgreementsDomain_778956" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AgreementsDomain" xlink:label="loc_fhtx_AgreementsDomain_778956_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_fhtx_AgreementsAxis_778955" xlink:to="loc_fhtx_AgreementsDomain_778956_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_FlagshipPioneeringMember" xlink:label="loc_fhtx_FlagshipPioneeringMember_778957" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_AgreementsDomain_778956" xlink:to="loc_fhtx_FlagshipPioneeringMember_778957" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ScientificFounderMember" xlink:label="loc_fhtx_ScientificFounderMember_778958" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_AgreementsDomain_778956" xlink:to="loc_fhtx_ScientificFounderMember_778958" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_779091" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_778953" xlink:to="loc_srt_RangeAxis_779091" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_779092" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_779091" xlink:to="loc_srt_RangeMember_779092" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_779092_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_779091" xlink:to="loc_srt_RangeMember_779092_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_779093" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_779092" xlink:to="loc_srt_MaximumMember_779093" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ServiceAgreementExpirationYear" xlink:label="loc_fhtx_ServiceAgreementExpirationYear_861436" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_778954" xlink:to="loc_fhtx_ServiceAgreementExpirationYear_861436" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ServiceAgreementExtendedDate" xlink:label="loc_fhtx_ServiceAgreementExtendedDate_861439" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_778954" xlink:to="loc_fhtx_ServiceAgreementExtendedDate_861439" use="optional" order="15" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>fhtx-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no" ?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 18-March-2021 [12:26:36] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract" xlink:type="locator"/>
    <label xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</label>
    <label xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</label>
    <label xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" xlink:type="locator"/>
    <label xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</label>
    <label xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</label>
    <label xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:type="locator"/>
    <label xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</label>
    <label xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <label xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</label>
    <label xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</label>
    <label xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</label>
    <label xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol" xlink:type="locator"/>
    <label xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</label>
    <label xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle" xlink:type="locator"/>
    <label xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</label>
    <label xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName" xlink:type="locator"/>
    <label xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</label>
    <label xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport" xlink:type="locator"/>
    <label xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat" xlink:type="locator"/>
    <label xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:type="locator"/>
    <label xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <label xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <label xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</label>
    <label xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</label>
    <label xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</label>
    <label xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current operating lease liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</label>
    <label xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Current Maturities</label>
    <label xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable, net of discount</label>
    <label xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Current portion of long-term debt</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</label>
    <label xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</label>
    <label xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable, net of discount and current portion</label>
    <label xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, net of discount and current portion</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, net of current portion</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_PreferredStockWarrantsLiability" xlink:label="loc_fhtx_PreferredStockWarrantsLiability" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_PreferredStockWarrantsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock Warrants Liability</label>
    <label xlink:label="lab_fhtx_PreferredStockWarrantsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock warrant liability</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_PreferredStockWarrantsLiability" xlink:to="lab_fhtx_PreferredStockWarrantsLiability" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_PreferredStockWarrantsLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The carrying value as of the balance sheet date of obligations related to preferred stock warrants.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</label>
    <label xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</label>
    <label xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 13)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</label>
    <label xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities, convertible preferred stock and stockholders' equity (deficit)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</label>
    <label xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock (Series A-1, A-2 and B), $0.0001 par value; no shares and 28,629,622 shares authorized at December 31, 2020 and 2019, respectively; no shares and 28,615,546 shares issued and outstanding at December 31, 2020 and 2019, respectively</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</label>
    <label xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue, net of current portion</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</label>
    <label xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' deficit:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</label>
    <label xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional&#xA0;paid-in&#xA0;capital</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <label xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Retained earnings accumulated deficit</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
    <label xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity (deficit)</label>
    <label xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</label>
    <label xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</label>
    <label xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.0001 par value; 175,000,000 and 46,600,000 shares authorized at December 31, 2020 and 2019, respectively; 36,790,946 shares issued and outstanding at December 31, 2020 and 5,762,745 shares issued and 4,870,851 shares outstanding at December 31, 2019</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</label>
    <label xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</label>
    <label xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.0001 par value; 25,000,000 shares authorized as of December&#xA0;31, 2020; no shares issued or outstanding</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</label>
    <label xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</label>
    <label xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</label>
    <label xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non Current Restricted Cash</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</label>
    <label xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease&#xA0;right-of-use&#xA0;assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</label>
    <label xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</label>
    <label xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</label>
    <label xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
    <label xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Current</label>
    <label xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <label xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="loc_us-gaap_MarketableSecurities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities</label>
    <label xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</label>
    <label xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</label>
    <label xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</label>
    <label xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock, Par Value Per Share</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares Authorized</label>
    <label xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock, Shares Authorized</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares Issued</label>
    <label xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock, Shares Issued</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares Outstanding</label>
    <label xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock, Shares Outstanding</label>
    <label xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (Shares)</label>
    <label xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (Shares)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <label xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <label xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <label xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issued under agreement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <label xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <label xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (Shares)</label>
    <label xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (Shares)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <label xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, Par Value Per Share</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <label xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par Value Per Share</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <label xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock Authorized</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <label xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proferred Stock, Shares, Outstanding</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <label xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares, Issued</label>
    <label xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock Issued and Outstanding</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</label>
    <label xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</label>
    <label xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <label xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</label>
    <label xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <label xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</label>
    <label xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</label>
    <label xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</label>
    <label xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>
    <label xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense):</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</label>
    <label xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_InterestIncomeAndOtherIncomeExpense" xlink:label="loc_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income And Other Income Expense</label>
    <label xlink:label="lab_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income and other income (expense), net</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:to="lab_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of interest income and income (expense) related to nonoperating activities, classified as other.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
    <label xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of preferred stock warrant liability</label>
    <label xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of preferred stock warrant liability</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <label xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other expense, net</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</label>
    <label xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Condensed Consolidated Statements Of Operations And Comprehensive Loss</label>
    <label xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on debt extinguishment</label>
    <label xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Loss on Extinguishment of Debt</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <label xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</label>
    <label xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</label>
    <label xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</label>
    <label xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic and Diluted</label>
    <label xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share attributable to common stockholders&#x2014;basic and diluted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</label>
    <label xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding&#x2014;basic and diluted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</label>
    <label xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Collaboration revenue</label>
    <label xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</label>
    <label xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</label>
    <label xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive loss:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</label>
    <label xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized losses on marketable securities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</label>
    <label xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive loss</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <label xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive loss</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</label>
    <label xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</label>
    <label xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity Stock Issued During Period Shares New Issues</label>
    <label xlink:label="lab_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of Series B convertible preferred stock, net of issuance costs, shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of shares of new stock classified as temporary equity issued during the period.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</label>
    <label xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of Series B convertible preferred stock, net of issuance costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of stock options , shares</label>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Number of shares, Exercised</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</label>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting of restricted stock, shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of stock options</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</label>
    <label xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Unrealized Gain (Loss)</label>
    <label xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized loss on marketable securities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon initial public offering net of underwriting discounts, commissions and offering costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon initial public offering net of underwriting discounts, commissions and offering costs, shares</label>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued during the period shares new issues shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</label>
    <label xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of warrant liability to equity upon closing of initial public offering</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:label="loc_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period Shares in Connection with the Cashless Exercise of Warrants</label>
    <label xlink:label="lab_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in connection with the cashless exercise of warrants</label>
    <label xlink:label="lab_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of stock options , shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:to="lab_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of shares issued during the period in connection with a cashless exercise of warrants.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</label>
    <label xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of warrants in connection with notes payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Shares Converted</label>
    <label xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of preferred stock to common stock, shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:to="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of preferred stock to common stock, shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</label>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of preferred stock to common stock</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Amount Converted</label>
    <label xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Conversion of preferred stock to common stock</label>
    <label xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of redeemable convertible preferred stock to common stock</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</label>
    <label xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <label xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</label>
    <label xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
    <label xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss [member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</label>
    <label xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</label>
    <label xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IPO [Member]</label>
    <label xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="loc_fhtx_SeriesBRedeemableConvertiblePreferredStockMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_SeriesBRedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series B Redeemable Convertible Preferred Stock [Member]</label>
    <label xlink:label="lab_fhtx_SeriesBRedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series B Convertible Preferred Stock [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_SeriesBRedeemableConvertiblePreferredStockMember" xlink:to="lab_fhtx_SeriesBRedeemableConvertiblePreferredStockMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_StockIssuanceCosts" xlink:label="loc_fhtx_StockIssuanceCosts" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_StockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issuance Costs</label>
    <label xlink:label="lab_fhtx_StockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issuance Costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_StockIssuanceCosts" xlink:to="lab_fhtx_StockIssuanceCosts" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_StockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Costs incurred directly with the issuance of an equity or temporary equity security.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <label xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</label>
    <label xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</label>
    <label xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ConversionOfRedeemableConvertibleStockMember" xlink:label="loc_fhtx_ConversionOfRedeemableConvertibleStockMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ConversionOfRedeemableConvertibleStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Redeemable Convertible stock [Member]</label>
    <label xlink:label="lab_fhtx_ConversionOfRedeemableConvertibleStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Redeemable Convertible stock [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ConversionOfRedeemableConvertibleStockMember" xlink:to="lab_fhtx_ConversionOfRedeemableConvertibleStockMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ConversionOfRedeemableConvertibleStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion of redeemable convertible stock.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ConversionOfWarrantLiabilityToEquityMember" xlink:label="loc_fhtx_ConversionOfWarrantLiabilityToEquityMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ConversionOfWarrantLiabilityToEquityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Warrant Liability to Equity [Member]</label>
    <label xlink:label="lab_fhtx_ConversionOfWarrantLiabilityToEquityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Warrant Liability to Equity [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ConversionOfWarrantLiabilityToEquityMember" xlink:to="lab_fhtx_ConversionOfWarrantLiabilityToEquityMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ConversionOfWarrantLiabilityToEquityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion of warrant liability to equity.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ConversionOfNotesPayableInToWarrantsMember" xlink:label="loc_fhtx_ConversionOfNotesPayableInToWarrantsMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ConversionOfNotesPayableInToWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Notes Payable in to Warrants [Member]</label>
    <label xlink:label="lab_fhtx_ConversionOfNotesPayableInToWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Notes Payable in to Warrants [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ConversionOfNotesPayableInToWarrantsMember" xlink:to="lab_fhtx_ConversionOfNotesPayableInToWarrantsMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ConversionOfNotesPayableInToWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion of notes payable in to warrants.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <label xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <label xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</label>
    <label xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">(Gain) loss&#xA0;on disposal of property and equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="loc_us-gaap_PaidInKindInterest" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Paid-in-Kind Interest</label>
    <label xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncash interest expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaidInKindInterest" xlink:to="lab_us-gaap_PaidInKindInterest" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:label="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease In Operating Lease Right Of Use Asset</label>
    <label xlink:label="lab_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncash lease expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:to="lab_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of increase (decrease) in right-of-use assets under an operating lease.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</label>
    <label xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accretion of discount on marketable securities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <label xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <label xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <label xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</label>
    <label xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="loc_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease In Operating Lease Liabilities</label>
    <label xlink:label="lab_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The increase (decrease) in operating lease liabilities during the reporting period.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</label>
    <label xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Redeemable Convertible Preferred Stock</label>
    <label xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of convertible preferred stock, net of issuance costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <label xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of stock options</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Notes Payable</label>
    <label xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayment of notes payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Notes Payable</label>
    <label xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance&#xA0;of notes payable, net of&#xA0;issuance costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <label xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from initial public offering, net of underwriting discounts, commissions and offering costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</label>
    <label xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of property and equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Marketable Securities</label>
    <label xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of marketable securities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <label xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</label>
    <label xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</label>
    <label xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
    <label xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Supplemental cash flow information:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
    <label xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for interest</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
    <label xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of noncash investing and financing information:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</label>
    <label xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment included in accounts payable and accrued expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</label>
    <label xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash</label>
    <label xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash (current and&#xA0;non-current)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</label>
    <label xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Business and Basis of Presentation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <label xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
    <label xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract] (Deprecated 2018-01-31)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:label="loc_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities and Fair Value Measurements [Text Block]</label>
    <label xlink:label="lab_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities and&#xA0;Fair Value Measurements</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:to="lab_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The entire disclosure for marketable securities and fair value measurements.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment, Net</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</label>
    <label xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
    <label xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</label>
    <label xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
    <label xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="loc_us-gaap_PreferredStockTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock [Text Block]</label>
    <label xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock&#xA0;and Preferred Stock Warrants</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockTextBlock" xlink:to="lab_us-gaap_PreferredStockTextBlock" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_CommonStockTextBlock" xlink:label="loc_fhtx_CommonStockTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_CommonStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Text Block]</label>
    <label xlink:label="lab_fhtx_CommonStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_CommonStockTextBlock" xlink:to="lab_fhtx_CommonStockTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_CommonStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The entire disclosure for common stock, including, but not limited to voting rights, dividends, and stock splits.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</label>
    <label xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="loc_us-gaap_DisclosureTextBlockAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DisclosureTextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Text Block [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureTextBlockAbstract" xlink:to="lab_us-gaap_DisclosureTextBlockAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</label>
    <label xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaboration Agreement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <label xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</label>
    <label xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <label xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Text Block]</label>
    <label xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <label xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <label xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Parties</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of presentation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentrations of credit risk and of significant suppliers</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently issued accounting pronouncements</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognition</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value measurements</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of estimates</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:label="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classification of convertible preferred stock</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:to="lab_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizationOfInternalCostsPolicy" xlink:label="loc_us-gaap_CapitalizationOfInternalCostsPolicy" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CapitalizationOfInternalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalization of Internal Costs, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_CapitalizationOfInternalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patent costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizationOfInternalCostsPolicy" xlink:to="lab_us-gaap_CapitalizationOfInternalCostsPolicy" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of long-lived assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <label xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Earnings Per Share Diluted Anti Dilutive Impact</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:label="loc_fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary Of Estimated Useful Lives Of Property Plant And Equipment [Table Text Block]</label>
    <label xlink:label="lab_fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Property and Equipment are Stated at Cost Less Accumulated Depreciation and Amortization</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:to="lab_fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of the estimated useful lives of property, plant and equipment.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Available for Sale Marketable Securities By Security Type</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sumary of Property and Equipment Net</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="loc_us-gaap_LongTermDebtAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Unclassified [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAbstract" xlink:to="lab_us-gaap_LongTermDebtAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Long Term Debt</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Future Long Term Loan Principal Payments Due</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of stock by class</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Stock-Based Compensation Expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options and Restricted Stock Awards using Black-Scholes Option Pricing Model</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share Option Activity</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Restricted common stock</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Net Deferred Tax Assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:label="loc_fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of WeightedAverage Remaining Lease Term And Discount Rate [Table Text Block]</label>
    <label xlink:label="lab_fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Weighted-Average Remaining Lease Term and Discount Rate Leases</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:to="lab_fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of the weighted average remaining lease term and weighted average discount rate related to leases.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Minimum Lease Payments</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</label>
    <label xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Lease Cost</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="loc_fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Supplemental Cash Flow Information Related To Leases [Table Text Block]</label>
    <label xlink:label="lab_fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Supplemental Cash Flow Information Related to Leases</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="lab_fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of supplemental information for the statement of cash flows related to leases.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_OperatingLeaseLiabilityTableTextBlock" xlink:label="loc_fhtx_OperatingLeaseLiabilityTableTextBlock" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_OperatingLeaseLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease Liability [Table Text Block]</label>
    <label xlink:label="lab_fhtx_OperatingLeaseLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Operating Lease Liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_OperatingLeaseLiabilityTableTextBlock" xlink:to="lab_fhtx_OperatingLeaseLiabilityTableTextBlock" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_OperatingLeaseLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of operating lease liabilities included in the consolidated balance sheet.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements [Table]</label>
    <label xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Organization consolidation and presentation of financial statements.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements [Line Items]</label>
    <label xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Organization consolidation and presentation of financial statements.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <label xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock issue price per share</label>
    <label xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock issue price per share</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</label>
    <label xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock consideration received on the transaction</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ProceedsFromUpfrontPayment" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ProceedsFromUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Upfront Payment</label>
    <label xlink:label="lab_fhtx_ProceedsFromUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upfront payment received from Merck</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ProceedsFromUpfrontPayment" xlink:to="lab_fhtx_ProceedsFromUpfrontPayment" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ProceedsFromUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds from upfront payment</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <label xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Warrants granted to purchase common stock</label>
    <label xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of warrant or right, number of securities called by warrants or rights</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <label xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <label xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <label xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Shares Issued</label>
    <label xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of preferred stock, common shares issued</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:to="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets Held-for-use</label>
    <label xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment losses on long-lived assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, useful life</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Estimated Useful Lives</label>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, useful life</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</label>
    <label xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software and Software Development Costs [Member]</label>
    <label xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Computer equipment and software [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</label>
    <label xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Laboratory equipment [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <label xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_EarningsPerShareDilutedAntiDilutiveImpactAbstract" xlink:label="loc_fhtx_EarningsPerShareDilutedAntiDilutiveImpactAbstract" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_EarningsPerShareDilutedAntiDilutiveImpactAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share Diluted Anti Dilutive Impact [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_EarningsPerShareDilutedAntiDilutiveImpactAbstract" xlink:to="lab_fhtx_EarningsPerShareDilutedAntiDilutiveImpactAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</label>
    <label xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_WarrentsToPurchaseCommonStockMember" xlink:label="loc_fhtx_WarrentsToPurchaseCommonStockMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_WarrentsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrents to Purchase Common Stock [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_WarrentsToPurchaseCommonStockMember" xlink:to="lab_fhtx_WarrentsToPurchaseCommonStockMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_WarrentsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrents to purchase common stock.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <label xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Type [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryNotesSecuritiesMember" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_USTreasuryNotesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury Notes Securities [Member]</label>
    <label xlink:label="lab_us-gaap_USTreasuryNotesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. treasury notes (due within one year) [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryNotesSecuritiesMember" xlink:to="lab_us-gaap_USTreasuryNotesSecuritiesMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</label>
    <label xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</label>
    <label xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale</label>
    <label xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Estimated Fair Value</label>
    <label xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</label>
    <label xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasis[Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</label>
    <label xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</label>
    <label xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury Securities [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_PreferredStockWarrantLiabilityMember" xlink:label="loc_fhtx_PreferredStockWarrantLiabilityMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_PreferredStockWarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock Warrant Liability [Member]</label>
    <label xlink:label="lab_fhtx_PreferredStockWarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock Warrant Liability [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_PreferredStockWarrantLiabilityMember" xlink:to="lab_fhtx_PreferredStockWarrantLiabilityMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_PreferredStockWarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Preferred Stock Warrant Liability</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</label>
    <label xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</label>
    <label xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</label>
    <label xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock warrant liability</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</label>
    <label xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <label xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <label xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <label xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_WarrantIssuePrice" xlink:label="loc_fhtx_WarrantIssuePrice" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_WarrantIssuePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Issue Price</label>
    <label xlink:label="lab_fhtx_WarrantIssuePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant issue price</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_WarrantIssuePrice" xlink:to="lab_fhtx_WarrantIssuePrice" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_WarrantIssuePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Issue Price</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_BeforeIPOMember" xlink:label="loc_fhtx_BeforeIPOMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_BeforeIPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Before I P O [Member]</label>
    <label xlink:label="lab_fhtx_BeforeIPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Before IPO [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_BeforeIPOMember" xlink:to="lab_fhtx_BeforeIPOMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_BeforeIPOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Before IPO.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_SeriesAOnePreferredStockMember" xlink:label="loc_fhtx_SeriesAOnePreferredStockMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_SeriesAOnePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A one Preferred Stock [Member]</label>
    <label xlink:label="lab_fhtx_SeriesAOnePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A-1 Preferred Stock [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_SeriesAOnePreferredStockMember" xlink:to="lab_fhtx_SeriesAOnePreferredStockMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_SeriesAOnePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series A one preferred stock.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leaseholds and Leasehold Improvements [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ComputerEquipmentAndSoftwareMember" xlink:label="loc_fhtx_ComputerEquipmentAndSoftwareMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer equipment and software [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ComputerEquipmentAndSoftwareMember" xlink:to="lab_fhtx_ComputerEquipmentAndSoftwareMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Computer equipment and software</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_AssetsNotYetPlacedInServiceMember" xlink:label="loc_fhtx_AssetsNotYetPlacedInServiceMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_AssetsNotYetPlacedInServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets Not Yet Placed In service [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_AssetsNotYetPlacedInServiceMember" xlink:to="lab_fhtx_AssetsNotYetPlacedInServiceMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_AssetsNotYetPlacedInServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets Not Yet Placed In service[Member].</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <label xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Accumulated depreciation and amortization</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</label>
    <label xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization expense</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_AccruedResearchAndDevelopmentExpenses" xlink:label="loc_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Research And Development Expenses</label>
    <label xlink:label="lab_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued external research and development expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:to="lab_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for expenses related to research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionPayableCurrent" xlink:label="loc_us-gaap_ConstructionPayableCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ConstructionPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction Payable, Current</label>
    <label xlink:label="lab_us-gaap_ConstructionPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued construction in progress</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionPayableCurrent" xlink:to="lab_us-gaap_ConstructionPayableCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</label>
    <label xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</label>
    <label xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued employee compensation and benefits</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</label>
    <label xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional fees</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments" xlink:label="loc_fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long Term Debt Noncurrent Before Debt Discount And Accrued Payments</label>
    <label xlink:label="lab_fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, net of current portion</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments" xlink:to="lab_fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt, excluding current portion. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Debt discount, net of accretion</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Gross</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Principal amount of long-term debt</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Gross</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument loan amount</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Final payment fee</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year One</label>
    <label xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</label>
    <label xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</label>
    <label xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</label>
    <label xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</label>
    <label xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Short-term Debt [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_TermLoanAMember" xlink:label="loc_fhtx_TermLoanAMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan A [Member]</label>
    <label xlink:label="lab_fhtx_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Term Loan A [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TermLoanAMember" xlink:to="lab_fhtx_TermLoanAMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_TermLoanBMember" xlink:label="loc_fhtx_TermLoanBMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan B [Member]</label>
    <label xlink:label="lab_fhtx_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term Loan B [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TermLoanBMember" xlink:to="lab_fhtx_TermLoanBMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_TermLoanAAndBMember" xlink:label="loc_fhtx_TermLoanAAndBMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_TermLoanAAndBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan A and B [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TermLoanAAndBMember" xlink:to="lab_fhtx_TermLoanAAndBMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_TermLoanAAndBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan A and B.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term Debt [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, description of variable rate basis</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, basis spread on variable rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, interest rate, stated percentage</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, interest rate, effective percentage</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:label="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, over Time</label>
    <label xlink:label="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt, weighted average interest rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:to="lab_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage" xlink:label="loc_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid Percentage</label>
    <label xlink:label="lab_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt, final payment fee percentage</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage" xlink:to="lab_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt, as a percentage of the amounts drawn under the Term Loan.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_InterestRateOutstandingBorrowingsLoan" xlink:label="loc_fhtx_InterestRateOutstandingBorrowingsLoan" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_InterestRateOutstandingBorrowingsLoan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest rate outstanding borrowings Loan</label>
    <label xlink:label="lab_fhtx_InterestRateOutstandingBorrowingsLoan" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest rate outstanding borrowings loan</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_InterestRateOutstandingBorrowingsLoan" xlink:to="lab_fhtx_InterestRateOutstandingBorrowingsLoan" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_InterestRateOutstandingBorrowingsLoan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The interest rate applicable to outstanding borrowings under the Loan.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="loc_us-gaap_DebtInstrumentInterestRateTerms" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentInterestRateTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate Terms</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentInterestRateTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument interest terms</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateTerms" xlink:to="lab_us-gaap_DebtInstrumentInterestRateTerms" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="loc_us-gaap_DebtInstrumentPaymentTerms" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Payment Terms</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instruments payment terms</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPaymentTerms" xlink:to="lab_us-gaap_DebtInstrumentPaymentTerms" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Maturity Date</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument maturity date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Frequency of Periodic Payment</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument frequency of payment terms</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRestrictiveCovenants" xlink:label="loc_us-gaap_DebtInstrumentRestrictiveCovenants" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentRestrictiveCovenants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Restrictive Covenants</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentRestrictiveCovenants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, restrictive covenants</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRestrictiveCovenants" xlink:to="lab_us-gaap_DebtInstrumentRestrictiveCovenants" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_WarrantsIssuePricePerShare" xlink:label="loc_fhtx_WarrantsIssuePricePerShare" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_WarrantsIssuePricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Issue Price Per Share</label>
    <label xlink:label="lab_fhtx_WarrantsIssuePricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants Issue price per share</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_WarrantsIssuePricePerShare" xlink:to="lab_fhtx_WarrantsIssuePricePerShare" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_WarrantsIssuePricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Per unit amount of warrant issued.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Term</label>
    <label xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants exercisable term</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Not Settleable in Cash, Fair Value Disclosure</label>
    <label xlink:label="lab_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants not settleable in cash, fair value disclosure</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="lab_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_DebtInstrumentPrePaymentTerms" xlink:label="loc_fhtx_DebtInstrumentPrePaymentTerms" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_DebtInstrumentPrePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Pre Payment Terms</label>
    <label xlink:label="lab_fhtx_DebtInstrumentPrePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument terms</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_DebtInstrumentPrePaymentTerms" xlink:to="lab_fhtx_DebtInstrumentPrePaymentTerms" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_DebtInstrumentPrePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of the terms for debt prepayment, including, but not limited to prepayment fees and applicable periods.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Debt</label>
    <label xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of debt</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Debt Issuance Costs</label>
    <label xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments of debt issuance costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_PercentageOfPrepaymentFee" xlink:label="loc_fhtx_PercentageOfPrepaymentFee" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_PercentageOfPrepaymentFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of prepayment fee</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_PercentageOfPrepaymentFee" xlink:to="lab_fhtx_PercentageOfPrepaymentFee" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_PercentageOfPrepaymentFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The fee for prepayment of a loan, as a percentage of the principal amount being prepaid.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Term</label>
    <label xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Term of loan</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term Debt, Type [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term Debt, Type [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_AdditionalRateInEventOfDefaultMember" xlink:label="loc_fhtx_AdditionalRateInEventOfDefaultMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_AdditionalRateInEventOfDefaultMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Rate In Event Of Default [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_AdditionalRateInEventOfDefaultMember" xlink:to="lab_fhtx_AdditionalRateInEventOfDefaultMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_AdditionalOverBaseRateMember" xlink:label="loc_fhtx_AdditionalOverBaseRateMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_AdditionalOverBaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Over Base Rate [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_AdditionalOverBaseRateMember" xlink:to="lab_fhtx_AdditionalOverBaseRateMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis" xlink:type="locator"/>
    <label xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember" xlink:type="locator"/>
    <label xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember" xlink:type="locator"/>
    <label xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember" xlink:type="locator"/>
    <label xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</label>
    <label xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</label>
    <label xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_OxfordFinanceLlcMember" xlink:label="loc_fhtx_OxfordFinanceLlcMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_OxfordFinanceLlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Oxford Finance LLC [Member]</label>
    <label xlink:label="lab_fhtx_OxfordFinanceLlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Oxford Finance LLC [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_OxfordFinanceLlcMember" xlink:to="lab_fhtx_OxfordFinanceLlcMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_OxfordFinanceLlcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Oxford finance llc.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Base Rate [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentPeriodAxis" xlink:label="loc_fhtx_PrepaymentPeriodAxis" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_PrepaymentPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepayment Period [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_PrepaymentPeriodAxis" xlink:to="lab_fhtx_PrepaymentPeriodAxis" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentPeriodDomain" xlink:label="loc_fhtx_PrepaymentPeriodDomain" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_PrepaymentPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepayment Period [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_PrepaymentPeriodDomain" xlink:to="lab_fhtx_PrepaymentPeriodDomain" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentWithInFirstTwelveMonthsMember" xlink:label="loc_fhtx_PrepaymentWithInFirstTwelveMonthsMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_PrepaymentWithInFirstTwelveMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepayment with in First Twelve Months [Member]</label>
    <label xlink:label="lab_fhtx_PrepaymentWithInFirstTwelveMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayment within First Twelve Months [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_PrepaymentWithInFirstTwelveMonthsMember" xlink:to="lab_fhtx_PrepaymentWithInFirstTwelveMonthsMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember" xlink:label="loc_fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepayment After 12 months but prior to 24 months [Member]</label>
    <label xlink:label="lab_fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayment After 12 months but prior to 24 months [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember" xlink:to="lab_fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentAfter24MonthsMember" xlink:label="loc_fhtx_PrepaymentAfter24MonthsMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_PrepaymentAfter24MonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepayment After 24 Months [Member]</label>
    <label xlink:label="lab_fhtx_PrepaymentAfter24MonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayment After 24 Months [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_PrepaymentAfter24MonthsMember" xlink:to="lab_fhtx_PrepaymentAfter24MonthsMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Price Per Share</label>
    <label xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par or stated value per share</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</label>
    <label xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of convertible preferred stock</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:label="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity Stock Issued During Period Share New Issues</label>
    <label xlink:label="lab_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of preferred stock</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:to="lab_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shares of new stock classified as temporary equity issued during the period.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <label xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant exercise price</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auction Market Preferred Securities, Stock Series [Axis]</label>
    <label xlink:label="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auction Market Preferred Securities, Stock Series [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auction Market Preferred Securities, Stock Series, Title [Domain]</label>
    <label xlink:label="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auction Market Preferred Securities, Stock Series, Title [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="lab_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBMember" xlink:label="loc_us-gaap_SeriesBMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SeriesBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series B [Member]</label>
    <label xlink:label="lab_us-gaap_SeriesBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series B [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBMember" xlink:to="lab_us-gaap_SeriesBMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_IssuanceOfNotesPayableMember" xlink:label="loc_fhtx_IssuanceOfNotesPayableMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_IssuanceOfNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Notes Payable [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_IssuanceOfNotesPayableMember" xlink:to="lab_fhtx_IssuanceOfNotesPayableMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_IssuanceOfNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issuance of Notes Payable.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</label>
    <label xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</label>
    <label xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaap_PreferredStockValueOutstanding" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Outstanding</label>
    <label xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying Value</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValueOutstanding" xlink:to="lab_us-gaap_PreferredStockValueOutstanding" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Liquidation Preference, Value</label>
    <label xlink:label="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liquidation Preference</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="lab_us-gaap_PreferredStockLiquidationPreferenceValue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</label>
    <label xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock Issuable Upon Conversion</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_SeriesATwoPreferredStockMember" xlink:label="loc_fhtx_SeriesATwoPreferredStockMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_SeriesATwoPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A Two Preferred Stock [Member]</label>
    <label xlink:label="lab_fhtx_SeriesATwoPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A-2 Preferred Stock [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_SeriesATwoPreferredStockMember" xlink:to="lab_fhtx_SeriesATwoPreferredStockMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_SeriesATwoPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series A two preferred stock.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series B Preferred Stock [Member]</label>
    <label xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series B Preferred Stock [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaap_CommonStockVotingRights" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_CommonStockVotingRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Voting Rights</label>
    <label xlink:label="lab_us-gaap_CommonStockVotingRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock voting rights</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockVotingRights" xlink:to="lab_us-gaap_CommonStockVotingRights" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Twenty Equity Incentive Plan [Member]</label>
    <label xlink:label="lab_fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020 Incentive Plan [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:to="lab_fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:label="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Twenty Employee Stock Purchase Plan [Member]</label>
    <label xlink:label="lab_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020 Employee Stock Purchase Plan [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:to="lab_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember" xlink:label="loc_fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Twenty And Sixteen Stock Incentive Plan [Member]</label>
    <label xlink:label="lab_fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020 and 2016 Incentive Plans [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember" xlink:to="lab_fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand Twenty and Sixteen Stock Incentive Plan.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</label>
    <label xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares authorized</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock shares available for grant</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</label>
    <label xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation costs related to unvested options and unvested restricted stock</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</label>
    <label xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average period of unrecognized compensation costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate fair value of restricted stock that vested</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value,Exercised</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair value,granted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</label>
    <label xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of restricted common stock to scientific founders</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</label>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock option expiry period</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of additional shares authorized</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Maximum Future Increase Shares</label>
    <label xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum aggregate number of shares added to plan</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:to="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum aggregate number of shares that may be added to the plan in future years.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Automatic Increase Percentage</label>
    <label xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of automatic annual increase in number of shares</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage" xlink:to="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of shares authorized to be automatically increased on the first day of the fiscal year, under a share based payment arrangement, as a percentage of common stock outstanding on the last day of the previous fiscal year.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_InitialAmountMember" xlink:label="loc_fhtx_InitialAmountMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_InitialAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Initial Amount [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_InitialAmountMember" xlink:to="lab_fhtx_InitialAmountMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember" xlink:label="loc_fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Initial Aggregate From Two Thousand Sixteen And Two Thousand Twenty Plans [Member]</label>
    <label xlink:label="lab_fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial Aggregate From 2016 And 2020 Plans [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember" xlink:to="lab_fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_InitialAggregateMember" xlink:label="loc_fhtx_InitialAggregateMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_InitialAggregateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Initial Aggregate [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_InitialAggregateMember" xlink:to="lab_fhtx_InitialAggregateMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_InitialAggregateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Initial aggregate.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember" xlink:label="loc_fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousands Twenty To Two Thousands Thirty [Member]</label>
    <label xlink:label="lab_fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021 to 2030 [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember" xlink:to="lab_fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousands Twenty To Two Thousands Thirty.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ServiceBasedVestingMember" xlink:label="loc_fhtx_ServiceBasedVestingMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ServiceBasedVestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service Based Vesting [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ServiceBasedVestingMember" xlink:to="lab_fhtx_ServiceBasedVestingMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ServiceBasedVestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Service based vesting.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (in years)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares, Granted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Number of shares, Forfeited</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares, Vested</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares, Exercisable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price, Beginning balance</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price, Ending Balance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price, Granted</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price, Exercised</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price, Forfeited</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Contractual Term, Ending Balance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</label>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Contractual Term, Vested</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price, Vested</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price, Exercisable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value, Vested</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Contractual Term, Exercisable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value, Ending Balance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <label xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted common stock as of December&#xA0;31, 2019</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</label>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Vested</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</label>
    <label xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Expenses [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <label xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and Administrative Expenses [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_CollaborationAgreementAbstract" xlink:label="loc_fhtx_CollaborationAgreementAbstract" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_CollaborationAgreementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaboration Agreement [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_CollaborationAgreementAbstract" xlink:to="lab_fhtx_CollaborationAgreementAbstract" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_CollaborationAgreementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaboration Agreement</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</label>
    <label xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_MilestoneReceivableUponAchievement" xlink:label="loc_fhtx_MilestoneReceivableUponAchievement" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_MilestoneReceivableUponAchievement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone Receivable Upon Achievement</label>
    <label xlink:label="lab_fhtx_MilestoneReceivableUponAchievement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount receivable for achievement of milestones</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_MilestoneReceivableUponAchievement" xlink:to="lab_fhtx_MilestoneReceivableUponAchievement" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_MilestoneReceivableUponAchievement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of consideration to be received upon achievement of specified milestones.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</label>
    <label xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsatisfied portion of the performance obligation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_MerckCollaborationAgreementMember" xlink:label="loc_fhtx_MerckCollaborationAgreementMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_MerckCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Merck Collaboration Agreement [Member]</label>
    <label xlink:label="lab_fhtx_MerckCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Merck Collaboration Agreement [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_MerckCollaborationAgreementMember" xlink:to="lab_fhtx_MerckCollaborationAgreementMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_MerckCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Merck collaboration agreement.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:label="loc_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Development And Regulatory [Member]</label>
    <label xlink:label="lab_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Development And Regulatory [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:to="lab_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research development and regulatory.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales [Member]</label>
    <label xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales based [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ExpirableMember" xlink:label="loc_fhtx_ExpirableMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ExpirableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expirable [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ExpirableMember" xlink:to="lab_fhtx_ExpirableMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ExpirableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expirable.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_NonExpirableMember" xlink:label="loc_fhtx_NonExpirableMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_NonExpirableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non Expirable [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_NonExpirableMember" xlink:to="lab_fhtx_NonExpirableMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_NonExpirableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non Expirable.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Authority [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</label>
    <label xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carry forward</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</label>
    <label xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carry forward</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:label="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Limitations on Use</label>
    <label xlink:label="lab_us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of the limitations on the use of all operating loss carryforwards and tax credit carry forward</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:to="lab_us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</label>
    <label xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in valuation allowance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</label>
    <label xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_TaxCreditCarryForwardsExpirationStartYear" xlink:label="loc_fhtx_TaxCreditCarryForwardsExpirationStartYear" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_TaxCreditCarryForwardsExpirationStartYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carry forwards Expiration Start Year</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TaxCreditCarryForwardsExpirationStartYear" xlink:to="lab_fhtx_TaxCreditCarryForwardsExpirationStartYear" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_TaxCreditCarryForwardsExpirationStartYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The year in which tax credit carryforwards begin to expire.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_OperatingLossCarryForwardsExpirationStartYear" xlink:label="loc_fhtx_OperatingLossCarryForwardsExpirationStartYear" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_OperatingLossCarryForwardsExpirationStartYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carry forwards Expiration Start Year</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_OperatingLossCarryForwardsExpirationStartYear" xlink:to="lab_fhtx_OperatingLossCarryForwardsExpirationStartYear" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_OperatingLossCarryForwardsExpirationStartYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The year in which operating loss carryforwards begin to expire.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_OperatingLossCarryforwardLimitPercentage" xlink:label="loc_fhtx_OperatingLossCarryforwardLimitPercentage" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_OperatingLossCarryforwardLimitPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforward Limit Percentage</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_OperatingLossCarryforwardLimitPercentage" xlink:to="lab_fhtx_OperatingLossCarryforwardLimitPercentage" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_OperatingLossCarryforwardLimitPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The limit that may be applied to operating loss carryforwards, as a percentage of annual taxable income.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember" xlink:label="loc_us-gaap_ResearchMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Tax Credit Carryforward [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Federal statutory income tax rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</label>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State taxes, net of federal benefit</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</label>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in deferred tax asset valuation allowance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</label>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal and state research and development tax credits</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent</label>
    <label xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</label>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:label="loc_fhtx_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Operating Lease Liabilities</label>
    <label xlink:label="lab_fhtx_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="lab_fhtx_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating lease liabilities.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</label>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</label>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development tax credit carryforwards</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</label>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxAssetsCapitalizedStartUpCosts" xlink:label="loc_fhtx_DeferredTaxAssetsCapitalizedStartUpCosts" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_DeferredTaxAssetsCapitalizedStartUpCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Capitalized Start Up Costs</label>
    <label xlink:label="lab_fhtx_DeferredTaxAssetsCapitalizedStartUpCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized&#xA0;start-up&#xA0;costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_DeferredTaxAssetsCapitalizedStartUpCosts" xlink:to="lab_fhtx_DeferredTaxAssetsCapitalizedStartUpCosts" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_DeferredTaxAssetsCapitalizedStartUpCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capitalized start-up costs.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</label>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</label>
    <label xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities:</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:label="loc_fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities Operating Lease Right Of Use Assets</label>
    <label xlink:label="lab_fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Operating lease&#xA0;right-of-use&#xA0;assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:to="lab_fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of deferred tax liability attributable to taxable temporary differences from operating lease right-of-use assets.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</label>
    <label xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <label xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_fhtx_DeferredTaxLiabilitiesDepreciation" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_DeferredTaxLiabilitiesDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities Depreciation</label>
    <label xlink:label="lab_fhtx_DeferredTaxLiabilitiesDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_DeferredTaxLiabilitiesDepreciation" xlink:to="lab_fhtx_DeferredTaxLiabilitiesDepreciation" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_DeferredTaxLiabilitiesDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of deferred tax liability attributable to taxable temporary differences from depreciation.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</label>
    <label xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Contractual Term [Axis]</label>
    <label xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Contractual Term [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Contractual Term [Domain]</label>
    <label xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Contractual Term [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_NewLeaseAgreementMember" xlink:label="loc_fhtx_NewLeaseAgreementMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_NewLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Lease Agreement [Member]</label>
    <label xlink:label="lab_fhtx_NewLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Lease Agreement [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_NewLeaseAgreementMember" xlink:to="lab_fhtx_NewLeaseAgreementMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_NewLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New lease agreement [Member].</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ModifiedNewLeaseAgreementMember" xlink:label="loc_fhtx_ModifiedNewLeaseAgreementMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ModifiedNewLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Modified New Lease Agreement [Member]</label>
    <label xlink:label="lab_fhtx_ModifiedNewLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Modified New Lease Agreement [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ModifiedNewLeaseAgreementMember" xlink:to="lab_fhtx_ModifiedNewLeaseAgreementMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ModifiedNewLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Modified new lease agreement [Member].</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_PropertyUnderOperatingLeaseSubleasedMember" xlink:label="loc_fhtx_PropertyUnderOperatingLeaseSubleasedMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_PropertyUnderOperatingLeaseSubleasedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Under Operating Lease Subleased [Member]</label>
    <label xlink:label="lab_fhtx_PropertyUnderOperatingLeaseSubleasedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property Under Operating Lease Subleased [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_PropertyUnderOperatingLeaseSubleasedMember" xlink:to="lab_fhtx_PropertyUnderOperatingLeaseSubleasedMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_PropertyUnderOperatingLeaseSubleasedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Property under operating lease subleased [Member].</label>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis" xlink:type="locator"/>
    <label xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</label>
    <label xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:type="locator"/>
    <label xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</label>
    <label xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc"/>
    <loc xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MA" xlink:label="loc_stpr_MA" xlink:type="locator"/>
    <label xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MASSACHUSETTS</label>
    <label xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Massachusetts [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MA" xlink:to="lab_stpr_MA" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</label>
    <label xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Subject to or Available for Operating Lease [Domain]</label>
    <label xlink:label="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property Subject to or Available for Operating Lease [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:to="lab_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficeBuildingMember" xlink:label="loc_srt_OfficeBuildingMember" xlink:type="locator"/>
    <label xlink:label="lab_srt_OfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office Building [Member]</label>
    <label xlink:label="lab_srt_OfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Office Building [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OfficeBuildingMember" xlink:to="lab_srt_OfficeBuildingMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</label>
    <label xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Area of Real Estate Property</label>
    <label xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of leased property</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty" xlink:to="lab_us-gaap_AreaOfRealEstateProperty" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease term lessee gross</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease term extension</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Expense</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease rent payments</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_LeaseholdImprovementsLandlordAllowance" xlink:label="loc_fhtx_LeaseholdImprovementsLandlordAllowance" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_LeaseholdImprovementsLandlordAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements Landlord Allowance</label>
    <label xlink:label="lab_fhtx_LeaseholdImprovementsLandlordAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements landlord allowance</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_LeaseholdImprovementsLandlordAllowance" xlink:to="lab_fhtx_LeaseholdImprovementsLandlordAllowance" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_LeaseholdImprovementsLandlordAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The monetary allowance granted by the landlord to a tenant to entice tenant to move into landlord's building which will enable the tenant to prepare the leased premises for tenant's occupancy.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_TermOfPropertySubleasedUnderOperatingLease" xlink:label="loc_fhtx_TermOfPropertySubleasedUnderOperatingLease" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_TermOfPropertySubleasedUnderOperatingLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Of Property Subleased Under Operating Lease</label>
    <label xlink:label="lab_fhtx_TermOfPropertySubleasedUnderOperatingLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of property subleased under operating lease</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TermOfPropertySubleasedUnderOperatingLease" xlink:to="lab_fhtx_TermOfPropertySubleasedUnderOperatingLease" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_TermOfPropertySubleasedUnderOperatingLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term of property subleased under operating lease.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_LeaseTermCommencementDate" xlink:label="loc_fhtx_LeaseTermCommencementDate" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_LeaseTermCommencementDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Term Commencement Date</label>
    <label xlink:label="lab_fhtx_LeaseTermCommencementDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease term commencement date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_LeaseTermCommencementDate" xlink:to="lab_fhtx_LeaseTermCommencementDate" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_LeaseTermCommencementDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease term commencement date.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaap_OtherIncome" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income</label>
    <label xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublease income recorded as other income</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid" xlink:label="loc_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements Landlord Allowance To Be Repaid</label>
    <label xlink:label="lab_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements landlord allowance to be repaid</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid" xlink:to="lab_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">An additional monetary allowance granted by the landlord to a tenant to entice tenant to move into landlord's building which will enable the tenant to prepare the leased premises for tenant's occupancy. This additional amount will result in additional rent payments to the landlord.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:label="loc_us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Tenant Allowance</label>
    <label xlink:label="lab_us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Reimbursements from lessor</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:to="lab_us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" xlink:label="loc_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change In Operating Lease Liability Right Of Use Asset Remeasurement</label>
    <label xlink:label="lab_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in operating lease liabilities and&#xA0;right-of-use&#xA0;assets due to lease remeasurement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" xlink:to="lab_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The increase (decrease) in the operating lease liability and right of use asset as the result of a lease remeasurement.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals" xlink:label="loc_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases Future Minimum Payments Receivable Sublease Rentals</label>
    <label xlink:label="lab_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease sublease rental income</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals" xlink:to="lab_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of remaining base rent payments receivable from the sub-lessee over the sublease term.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LeaseExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Expiration Date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseExpirationDate1" xlink:to="lab_us-gaap_LeaseExpirationDate1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis" xlink:type="locator"/>
    <label xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:type="locator"/>
    <label xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember" xlink:type="locator"/>
    <label xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</label>
    <label xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</label>
    <label xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease cost</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term Lease, Cost</label>
    <label xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term lease cost</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</label>
    <label xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for amounts included in the measurement of operating lease liabilities</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</label>
    <label xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities arising from obtaining right-of-use assets</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract" xlink:label="loc_fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Weighted Average Remaining Lease Term And Discount Rate [Abstract]</label>
    <label xlink:label="lab_fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of WeightedAverage Remaining Lease Term And Discount Rate [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract" xlink:to="lab_fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of weighted-average remaining lease term and discount rate [Abstract].</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term&#x2014;operating leases</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate&#x2014;operating leases</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future minimum lease payments</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" xlink:label="loc_fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Operating Lease Liability Estimated Lease Incentives</label>
    <label xlink:label="lab_fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: estimated lease incentives</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" xlink:to="lab_fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of estimated lease incentives used by lessee to determine present value of operating lease payments.</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</label>
    <label xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability [Abstract]</label>
    <label xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability [Abstract]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_NonRefundableLicenseFee" xlink:label="loc_fhtx_NonRefundableLicenseFee" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_NonRefundableLicenseFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non Refundable License Fee</label>
    <label xlink:label="lab_fhtx_NonRefundableLicenseFee" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-refundable&#xA0;license fee</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_NonRefundableLicenseFee" xlink:to="lab_fhtx_NonRefundableLicenseFee" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_NonRefundableLicenseFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-refundable&#xA0;license fee</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ReimbursedPatentCosts" xlink:label="loc_fhtx_ReimbursedPatentCosts" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ReimbursedPatentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reimbursed Patent Costs</label>
    <label xlink:label="lab_fhtx_ReimbursedPatentCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reimbursed patent costs</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ReimbursedPatentCosts" xlink:to="lab_fhtx_ReimbursedPatentCosts" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ReimbursedPatentCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount paid by the Company to reimburse the licensor for costs incurred related to patented technology.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_MilestonesPayableUponEvent" xlink:label="loc_fhtx_MilestonesPayableUponEvent" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_MilestonesPayableUponEvent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestones Payable Upon Event</label>
    <label xlink:label="lab_fhtx_MilestonesPayableUponEvent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestones payable upon event</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_MilestonesPayableUponEvent" xlink:to="lab_fhtx_MilestonesPayableUponEvent" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_MilestonesPayableUponEvent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount the Company will pay for regulatory milestones on each licensed product upon the occurrence of specific events as outlined in the license agreement.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_AnnualLicenseMaintenanceFees" xlink:label="loc_fhtx_AnnualLicenseMaintenanceFees" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_AnnualLicenseMaintenanceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Annual License Maintenance Fees</label>
    <label xlink:label="lab_fhtx_AnnualLicenseMaintenanceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual license maintenance fees</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_AnnualLicenseMaintenanceFees" xlink:to="lab_fhtx_AnnualLicenseMaintenanceFees" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_AnnualLicenseMaintenanceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Annual license maintenance fees.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_StanfordLicenseAgreementMember" xlink:label="loc_fhtx_StanfordLicenseAgreementMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_StanfordLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stanford License Agreement [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_StanfordLicenseAgreementMember" xlink:to="lab_fhtx_StanfordLicenseAgreementMember" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc"/>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:type="locator"/>
    <label xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc"/>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ServiceAgreementTerm" xlink:label="loc_fhtx_ServiceAgreementTerm" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ServiceAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service agreement term</label>
    <label xlink:label="lab_fhtx_ServiceAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service agreement term</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ServiceAgreementTerm" xlink:to="lab_fhtx_ServiceAgreementTerm" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ServiceAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The term of a service agreement in 'PnYnMnDTnHnMnS' format.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_CashPaymentsRelatedParty" xlink:label="loc_fhtx_CashPaymentsRelatedParty" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_CashPaymentsRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Payments Related Party</label>
    <label xlink:label="lab_fhtx_CashPaymentsRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments made to related party under service agreement</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_CashPaymentsRelatedParty" xlink:to="lab_fhtx_CashPaymentsRelatedParty" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_CashPaymentsRelatedParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash payments made during the period to related parties as part of a service or consulting agreement.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ServiceAgreementExpirationYear" xlink:label="loc_fhtx_ServiceAgreementExpirationYear" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ServiceAgreementExpirationYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service Agreement Expiration Year</label>
    <label xlink:label="lab_fhtx_ServiceAgreementExpirationYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service agreement expiration year</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ServiceAgreementExpirationYear" xlink:to="lab_fhtx_ServiceAgreementExpirationYear" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ServiceAgreementExpirationYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The year in which a service agreement expires.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ServiceAgreementExtendedDate" xlink:label="loc_fhtx_ServiceAgreementExtendedDate" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ServiceAgreementExtendedDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service Agreement Extended Date</label>
    <label xlink:label="lab_fhtx_ServiceAgreementExtendedDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service agreement extended date</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ServiceAgreementExtendedDate" xlink:to="lab_fhtx_ServiceAgreementExtendedDate" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ServiceAgreementExtendedDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The revised date of expiration for a service agreement upon extension.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_AgreementsAxis" xlink:label="loc_fhtx_AgreementsAxis" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_AgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Agreements [Axis]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_AgreementsAxis" xlink:to="lab_fhtx_AgreementsAxis" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_AgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Agreements.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_AgreementsDomain" xlink:label="loc_fhtx_AgreementsDomain" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_AgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Agreements [Domain]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_AgreementsDomain" xlink:to="lab_fhtx_AgreementsDomain" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_AgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Agreements.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_FlagshipPioneeringMember" xlink:label="loc_fhtx_FlagshipPioneeringMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_FlagshipPioneeringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Flagship Pioneering [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_FlagshipPioneeringMember" xlink:to="lab_fhtx_FlagshipPioneeringMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_FlagshipPioneeringMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Flagship Pioneering.</label>
    <loc xlink:href="fhtx-20201231.xsd#fhtx_ScientificFounderMember" xlink:label="loc_fhtx_ScientificFounderMember" xlink:type="locator"/>
    <label xlink:label="lab_fhtx_ScientificFounderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scientific Founder [Member]</label>
    <labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ScientificFounderMember" xlink:to="lab_fhtx_ScientificFounderMember" xlink:type="arc"/>
    <label xlink:label="lab_fhtx_ScientificFounderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Scientific Founder.</label>
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>fhtx-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 18-March-2021 [12:26:36] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CoverPage" roleURI="http://www.foghorntx.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedBalanceSheets" roleURI="http://www.foghorntx.com/role/ConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.foghorntx.com/role/ConsolidatedBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfOperationsAndComprehensiveLoss" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConsolidatedStatementsOfCashFlowsParenthetical" roleURI="http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NatureOfBusinessAndBasisOfPresentation" roleURI="http://www.foghorntx.com/role/NatureOfBusinessAndBasisOfPresentation" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#MarketableSecuritiesAndFairValueMeasurements" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurements" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#PropertyAndEquipmentNet" roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNet" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#AccruedExpenses" roleURI="http://www.foghorntx.com/role/AccruedExpenses" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NotesPayable" roleURI="http://www.foghorntx.com/role/NotesPayable" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConvertiblePreferredStockAndPreferredStockWarrants" roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrants" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CommonStock" roleURI="http://www.foghorntx.com/role/CommonStock" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensation" roleURI="http://www.foghorntx.com/role/StockBasedCompensation" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CollaborationAgreement" roleURI="http://www.foghorntx.com/role/CollaborationAgreement" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#IncomeTaxes" roleURI="http://www.foghorntx.com/role/IncomeTaxes" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#Leases" roleURI="http://www.foghorntx.com/role/Leases" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CommitmentsAndContingencies" roleURI="http://www.foghorntx.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#DefinedContributionPlan" roleURI="http://www.foghorntx.com/role/DefinedContributionPlan" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#RelatedParties" roleURI="http://www.foghorntx.com/role/RelatedParties" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#MarketableSecuritiesAndFairValueMeasurementsTables" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#PropertyAndEquipmentNetTables" roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNetTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#AccruedExpensesTable" roleURI="http://www.foghorntx.com/role/AccruedExpensesTable" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NotesPayableTables" roleURI="http://www.foghorntx.com/role/NotesPayableTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConvertiblePreferredStockAndPreferredStockWarrantsTables" roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationTables" roleURI="http://www.foghorntx.com/role/StockBasedCompensationTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#IncomeTaxesTables" roleURI="http://www.foghorntx.com/role/IncomeTaxesTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesTables" roleURI="http://www.foghorntx.com/role/LeasesTables" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NatureOfBusinessAndBasisOfPresentationAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/NatureOfBusinessAndBasisOfPresentationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfPropertyAndEquipmentAreStatedAtCostLessAccumulatedDepreciationAndAmortizationDetail" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfPropertyAndEquipmentAreStatedAtCostLessAccumulatedDepreciationAndAmortizationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareDilutedAntiDilutiveImpactDetail" roleURI="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareDilutedAntiDilutiveImpactDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#MarketableSecuritiesAndFairValueMeasurementsSummaryOfAvailableForSaleMarkatableSecurtiesBySecurityTypeDetail" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfAvailableForSaleMarkatableSecurtiesBySecurityTypeDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#MarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail" roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetParentheticalDetail" roleURI="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#AccruedExpensesDetail" roleURI="http://www.foghorntx.com/role/AccruedExpensesDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NotesPayableSummaryOfLongTermDebtDetail" roleURI="http://www.foghorntx.com/role/NotesPayableSummaryOfLongTermDebtDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NotesPayableSummaryOfFuturePrincipalPaymentsDueDetail" roleURI="http://www.foghorntx.com/role/NotesPayableSummaryOfFuturePrincipalPaymentsDueDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#NotesPayableAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/NotesPayableAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConvertiblePreferredStockAndPreferredStockWarrantsAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#ConvertiblePreferredStockAndPreferredStockWarrantsScheduleOfStockByClassDetail" roleURI="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsScheduleOfStockByClassDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CommonStockAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/CommonStockAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsAndRestrictedStockAwardsUsingBlackScholesOptionPricingModelDetail" roleURI="http://www.foghorntx.com/role/StockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsAndRestrictedStockAwardsUsingBlackScholesOptionPricingModelDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationScheduleOfShareOptionActivityDetail" roleURI="http://www.foghorntx.com/role/StockBasedCompensationScheduleOfShareOptionActivityDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationSummaryOfRestrictedCommonStockDetail" roleURI="http://www.foghorntx.com/role/StockBasedCompensationSummaryOfRestrictedCommonStockDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" roleURI="http://www.foghorntx.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CollaborationAgreementAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/CollaborationAgreementAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#IncomeTaxesAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/IncomeTaxesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#IncomeTaxesSummaryOfReconciliationOfTheUSFederalStatutoryIncomeTaxRateToTheCompanySEffectiveIncomeTaxRateDetail" roleURI="http://www.foghorntx.com/role/IncomeTaxesSummaryOfReconciliationOfTheUSFederalStatutoryIncomeTaxRateToTheCompanySEffectiveIncomeTaxRateDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail" roleURI="http://www.foghorntx.com/role/IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/LeasesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfLeaseCostDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfLeaseCostDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfSupplementalCashFlowInformationRelatedToLeasesDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfSupplementalCashFlowInformationRelatedToLeasesDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateLeasesDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateLeasesDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfMinimumLeasePaymentDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfMinimumLeasePaymentDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#LeasesSummaryOfOperatingLeaseLiabilitiesDetail" roleURI="http://www.foghorntx.com/role/LeasesSummaryOfOperatingLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="fhtx-20201231.xsd#RelatedPartiesAdditionalInformationDetail" roleURI="http://www.foghorntx.com/role/RelatedPartiesAdditionalInformationDetail" />
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/CoverPage">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_775508" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_775510" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_DocumentType_775510" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_775511" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_AmendmentFlag_775511" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_775512" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_DocumentPeriodEndDate_775512" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_775513" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_DocumentFiscalYearFocus_775513" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_775515" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_DocumentFiscalPeriodFocus_775515" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_775516" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityRegistrantName_775516" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_775517" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityCentralIndexKey_775517" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_775518" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_CurrentFiscalYearEndDate_775518" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_844855" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_DocumentAnnualReport_844855" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_775520" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_DocumentTransitionReport_775520" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_775521" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityIncorporationStateCountryCode_775521" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_775527" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityAddressStateOrProvince_775527" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_775531" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityFilerCategory_775531" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_775532" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntitySmallBusiness_775532" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_775533" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityEmergingGrowthCompany_775533" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_776660" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityExTransitionPeriod_776660" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_775534" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityCurrentReportingStatus_775534" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_775535" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityInteractiveDataCurrent_775535" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_846153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityVoluntaryFilers_846153" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_846154" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_846154" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_846155" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityPublicFloat_846155" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_775536" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityShellCompany_775536" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_775538" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_TradingSymbol_775538" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_775539" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_Security12bTitle_775539" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_775540" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_SecurityExchangeName_775540" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_775541" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_775541" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_846183" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_775508" xlink:to="loc_dei_IcfrAuditorAttestationFlag_846183" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_775117" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_775072" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_775117" xlink:to="loc_us-gaap_AssetsAbstract_775072" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_775073" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_775072" xlink:to="loc_us-gaap_AssetsCurrentAbstract_775073" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_775109" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_775073" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_775109" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="loc_us-gaap_MarketableSecurities_843115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_775073" xlink:to="loc_us-gaap_MarketableSecurities_843115" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_775110" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_775073" xlink:to="loc_us-gaap_RestrictedCashCurrent_775110" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_775111" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_775073" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_775111" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_775112" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_775073" xlink:to="loc_us-gaap_AssetsCurrent_775112" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_775123" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_775072" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_775123" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_775125" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_775072" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_775125" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_775128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_775072" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_775128" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_775131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_775072" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_775131" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_775132" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_775072" xlink:to="loc_us-gaap_Assets_775132" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_775117" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_775134" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_775134" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_775135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_775134" xlink:to="loc_us-gaap_AccountsPayableCurrent_775135" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_775136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_775134" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_775136" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_775137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_775134" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_775137" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_775138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_775134" xlink:to="loc_us-gaap_LongTermDebtCurrent_775138" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_776064" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_775134" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_776064" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_775143" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_775134" xlink:to="loc_us-gaap_LiabilitiesCurrent_775143" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_775146" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_775146" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_775147" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_775147" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_776065" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_776065" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PreferredStockWarrantsLiability" xlink:label="loc_fhtx_PreferredStockWarrantsLiability_775150" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" xlink:to="loc_fhtx_PreferredStockWarrantsLiability_775150" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_775151" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" xlink:to="loc_us-gaap_Liabilities_775151" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_775153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" xlink:to="loc_us-gaap_CommitmentsAndContingencies_775153" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_775154" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_775154" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_775156" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" xlink:to="loc_us-gaap_StockholdersEquityAbstract_775156" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_844926" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_775156" xlink:to="loc_us-gaap_PreferredStockValue_844926" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_775157" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_775156" xlink:to="loc_us-gaap_CommonStockValue_775157" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_775159" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_775156" xlink:to="loc_us-gaap_AdditionalPaidInCapital_775159" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_843137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_775156" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_843137" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_775161" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_775156" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_775161" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_775162" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_775156" xlink:to="loc_us-gaap_StockholdersEquity_775162" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_775171" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_775133" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_775171" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_775199" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_775201" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_775199" xlink:to="loc_us-gaap_StatementTable_775201" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_845102" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775201" xlink:to="loc_us-gaap_StatementClassOfStockAxis_845102" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_845114" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_845102" xlink:to="loc_us-gaap_ClassOfStockDomain_845114" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_776884" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_845114" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_776884" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_845124" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775201" xlink:to="loc_us-gaap_StatementLineItems_845124" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_775213" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_775213" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_775215" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_775215" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_775216" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_775216" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_775217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_775217" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_775229" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_775229" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_775230" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_775230" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_775232" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_CommonStockSharesIssued_775232" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_775234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_775234" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_845054" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_845054" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_845057" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_845057" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_845066" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_PreferredStockSharesIssued_845066" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_845063" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845124" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_845063" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_775089" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_776066" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_775089" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_776066" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_775069" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_775089" xlink:to="loc_us-gaap_OperatingExpensesAbstract_775069" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_775070" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_775069" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_775070" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_775071" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_775069" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_775071" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_775074" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_775069" xlink:to="loc_us-gaap_OperatingExpenses_775074" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_775076" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_775089" xlink:to="loc_us-gaap_OperatingIncomeLoss_775076" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_775081" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_775089" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_775081" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_775092" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_775081" xlink:to="loc_us-gaap_InterestExpense_775092" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_InterestIncomeAndOtherIncomeExpense" xlink:label="loc_fhtx_InterestIncomeAndOtherIncomeExpense_775094" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_775081" xlink:to="loc_fhtx_InterestIncomeAndOtherIncomeExpense_775094" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_775095" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_775081" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_775095" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_843205" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_775081" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_843205" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_775096" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_775081" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_775096" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_775097" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_775089" xlink:to="loc_us-gaap_NetIncomeLoss_775097" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_775099" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_775089" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_775099" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_775100" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_775089" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_775100" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_843220" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_775089" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_843220" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_843225" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_843220" xlink:to="loc_us-gaap_NetIncomeLoss_843225" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_843234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_775089" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_843234" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_843236" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_843234" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_843236" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_843238" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_843234" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_843238" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_843252" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_843234" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_843252" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_775164" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_775166" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_775164" xlink:to="loc_us-gaap_StatementTable_775166" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_775167" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775166" xlink:to="loc_us-gaap_StatementClassOfStockAxis_775167" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_775168" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_775167" xlink:to="loc_us-gaap_ClassOfStockDomain_775168" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_775364" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_775168" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_775364" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_775174" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775166" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_775174" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_775175" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_775174" xlink:to="loc_us-gaap_EquityComponentDomain_775175" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_775176" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_775175" xlink:to="loc_us-gaap_CommonStockMember_775176" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_775177" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_775175" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_775177" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_845714" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_775175" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_845714" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_775178" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_775175" xlink:to="loc_us-gaap_RetainedEarningsMember_775178" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_844251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775166" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_844251" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844252" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_844251" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844252" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_844253" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844252" xlink:to="loc_us-gaap_IPOMember_844253" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_775169" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775166" xlink:to="loc_us-gaap_StatementLineItems_775169" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_775179" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_775179" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_775181" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_775181" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_775185" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockholdersEquity_775185" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_775187" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_775187" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_775183" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_775183" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_775184" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_775184" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_855041" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_855041" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_855040" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_855040" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_855046" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_855046" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_855047" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_855047" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_844255" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_844255" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_844256" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_844256" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_844260" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_844260" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:label="loc_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants_844261" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants_844261" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_775190" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_775190" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_775273" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_775273" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_844262" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_844262" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_775282" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_775282" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_775192" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_775192" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_844263" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_844263" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_775195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_NetIncomeLoss_775195" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_775180" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_775180" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_775182" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_775182" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_775186" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_StockholdersEquity_775186" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_775188" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775169" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_775188" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_775310" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_775312" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_775310" xlink:to="loc_us-gaap_StatementTable_775312" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_775313" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775312" xlink:to="loc_us-gaap_StatementClassOfStockAxis_775313" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_775314" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_775313" xlink:to="loc_us-gaap_ClassOfStockDomain_775314" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="loc_fhtx_SeriesBRedeemableConvertiblePreferredStockMember_775319" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_775314" xlink:to="loc_fhtx_SeriesBRedeemableConvertiblePreferredStockMember_775319" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_775315" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775312" xlink:to="loc_us-gaap_StatementLineItems_775315" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_StockIssuanceCosts" xlink:label="loc_fhtx_StockIssuanceCosts_778683" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775315" xlink:to="loc_fhtx_StockIssuanceCosts_778683" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_775077" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_844302" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_775077" xlink:to="loc_us-gaap_StatementTable_844302" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_844303" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_844302" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_844303" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_844304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_844303" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_844304" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ConversionOfRedeemableConvertibleStockMember" xlink:label="loc_fhtx_ConversionOfRedeemableConvertibleStockMember_844313" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_844304" xlink:to="loc_fhtx_ConversionOfRedeemableConvertibleStockMember_844313" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ConversionOfWarrantLiabilityToEquityMember" xlink:label="loc_fhtx_ConversionOfWarrantLiabilityToEquityMember_844319" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_844304" xlink:to="loc_fhtx_ConversionOfWarrantLiabilityToEquityMember_844319" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ConversionOfNotesPayableInToWarrantsMember" xlink:label="loc_fhtx_ConversionOfNotesPayableInToWarrantsMember_844323" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_844304" xlink:to="loc_fhtx_ConversionOfNotesPayableInToWarrantsMember_844323" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_845240" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_844302" xlink:to="loc_us-gaap_StatementLineItems_845240" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_775084" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" xlink:to="loc_us-gaap_ProfitLoss_775084" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_775098" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_ShareBasedCompensation_775098" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_775087" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_775087" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_775088" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_775088" use="optional" order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_844283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_844283" use="optional" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_775090" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_775090" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:label="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_775091" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_775091" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="loc_us-gaap_PaidInKindInterest_775093" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_PaidInKindInterest_775093" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_844284" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775085" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_844284" use="optional" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_775102" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_775102" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_775103" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_775103" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_775105" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_775105" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="loc_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities_775107" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" xlink:to="loc_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities_775107" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_776067" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_775101" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_776067" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_775113" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_775083" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_775113" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_775115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_775115" use="optional" order="27" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_776068" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_776068" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_844287" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_844287" use="optional" order="29" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_775116" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_775114" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_775116" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_844290" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_844290" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_775119" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_775119" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_775120" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_775120" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_844293" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_844293" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_776069" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_776069" use="optional" order="36" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_775122" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_775118" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_775122" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_775139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_775139" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_775140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_775140" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_775142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_775142" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_775144" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_775144" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_775145" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_775144" xlink:to="loc_us-gaap_InterestPaidNet_775145" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_775148" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845240" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_775148" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_775149" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_775148" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_775149" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_844295" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_775148" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_844295" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_844296" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_775148" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_844296" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlowsParenthetical">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_776762" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_776763" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_776762" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_776763" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_776764" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_776762" xlink:to="loc_us-gaap_RestrictedCash_776764" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_776765" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_776762" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_776765" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/NatureOfBusinessAndBasisOfPresentation">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_775193" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_775194" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775193" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_775194" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_775214" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_775219" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775214" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_775219" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurements">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_775197" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:label="loc_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock_861237" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_775197" xlink:to="loc_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock_861237" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/PropertyAndEquipmentNet">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_843711" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_843712" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_843711" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_843712" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/AccruedExpenses">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_775389" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_776917" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_775389" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_776917" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/NotesPayable">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_775380" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_775382" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_775380" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_775382" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrants">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_775403" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="loc_us-gaap_PreferredStockTextBlock_775410" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_775403" xlink:to="loc_us-gaap_PreferredStockTextBlock_775410" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/CommonStock">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_844197" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_CommonStockTextBlock" xlink:label="loc_fhtx_CommonStockTextBlock_844199" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_844197" xlink:to="loc_fhtx_CommonStockTextBlock_844199" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/StockBasedCompensation">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_775355" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_775356" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_775355" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_775356" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/CollaborationAgreement">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureTextBlockAbstract" xlink:label="loc_us-gaap_DisclosureTextBlockAbstract_775383" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_775384" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureTextBlockAbstract_775383" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_775384" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/IncomeTaxes">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_843519" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_843520" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843519" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_843520" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/Leases">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_775434" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_775436" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775434" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_775436" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/CommitmentsAndContingencies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_775437" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_775438" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_775437" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_775438" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/DefinedContributionPlan">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_775376" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_775377" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_775376" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_775377" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/RelatedParties">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_775306" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_775307" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_775306" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_775307" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_775226" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_784217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_784217" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_775227" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_UseOfEstimates_775227" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_775244" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_775244" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_843515" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_843515" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_843522" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_843522" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_843524" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_843524" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_775259" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_775259" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_843529" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_843529" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_775262" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_775262" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_775265" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_775265" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:label="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_843530" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_843530" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_843531" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_843531" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizationOfInternalCostsPolicy" xlink:label="loc_us-gaap_CapitalizationOfInternalCostsPolicy_843532" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_CapitalizationOfInternalCostsPolicy_843532" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_843536" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_843536" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_843538" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_843538" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_775267" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_775267" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_843540" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_843540" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_843544" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_843544" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_843558" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_843558" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_775268" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775226" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_775268" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_775279" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:label="loc_fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_845729" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775279" xlink:to="loc_fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_845729" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_775283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775279" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_775283" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_775207" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_843736" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_775207" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_843736" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_775208" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_775207" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_775208" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/PropertyAndEquipmentNetTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_843715" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_843716" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_843715" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_843716" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/AccruedExpensesTable">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_775392" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_775399" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_775392" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_775399" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/NotesPayableTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="loc_us-gaap_LongTermDebtAbstract_775412" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_775414" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_775412" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_775414" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_775416" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_775412" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_775416" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_844086" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_844088" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_844086" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_844088" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/StockBasedCompensationTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_775360" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_843820" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_775360" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_843820" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_843821" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_775360" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_843821" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_843823" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_775360" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_843823" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_775361" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_775360" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_775361" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/IncomeTaxesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_843539" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_843541" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843539" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_843541" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_843542" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843539" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_843542" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_775445" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_775446" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775445" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_775446" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="loc_fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_775465" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775445" xlink:to="loc_fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_775465" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:label="loc_fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock_775471" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775445" xlink:to="loc_fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock_775471" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_775478" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775445" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_775478" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OperatingLeaseLiabilityTableTextBlock" xlink:label="loc_fhtx_OperatingLeaseLiabilityTableTextBlock_775492" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775445" xlink:to="loc_fhtx_OperatingLeaseLiabilityTableTextBlock_775492" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/NatureOfBusinessAndBasisOfPresentationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_776153" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_776159" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_776153" xlink:to="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_776159" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_776162" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_776159" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_776162" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_776163" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_776162" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_776163" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_776164" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_776163" xlink:to="loc_us-gaap_IPOMember_776164" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_783843" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_776163" xlink:to="loc_us-gaap_OverAllotmentOptionMember_783843" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_780547" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_776159" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_780547" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_780548" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_780547" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_780548" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_863435" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_776159" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_863435" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_863436" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_863435" xlink:to="loc_us-gaap_EquityComponentDomain_863436" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_863437" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_863436" xlink:to="loc_us-gaap_CommonStockMember_863437" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_776159" xlink:to="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_776165" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_776165" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_776166" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_776166" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_776167" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_776167" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_776168" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_NetIncomeLoss_776168" use="optional" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_776169" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_776169" use="optional" order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ProceedsFromUpfrontPayment" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment_781960" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_fhtx_ProceedsFromUpfrontPayment_781960" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_843451" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_776161" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_843451" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_775316" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_843638" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_775316" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_843638" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_843639" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_843638" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_843639" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843640" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_843639" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843640" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_843641" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843640" xlink:to="loc_us-gaap_IPOMember_843641" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_845287" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_843638" xlink:to="loc_us-gaap_StatementLineItems_845287" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_843642" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845287" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_843642" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_843643" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_845287" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_843643" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfPropertyAndEquipmentAreStatedAtCostLessAccumulatedDepreciationAndAmortizationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_775295" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_775296" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_775295" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_775296" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_776587" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_775296" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_776587" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_776587" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_776616" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" xlink:to="loc_us-gaap_EquipmentMember_776616" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_776590" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_776590" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_776612" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_776612" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_776625" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_776588" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_776625" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_775297" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_775296" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_775297" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_775329" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_775297" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_775329" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_776576" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_775297" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_776576" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareDilutedAntiDilutiveImpactDetail">
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_EarningsPerShareDilutedAntiDilutiveImpactAbstract" xlink:label="loc_fhtx_EarningsPerShareDilutedAntiDilutiveImpactAbstract_775334" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_778746" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_EarningsPerShareDilutedAntiDilutiveImpactAbstract_775334" xlink:to="loc_us-gaap_StatementTable_778746" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_778747" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_778746" xlink:to="loc_us-gaap_StatementClassOfStockAxis_778747" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_778748" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_778747" xlink:to="loc_us-gaap_ClassOfStockDomain_778748" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_778755" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_778748" xlink:to="loc_us-gaap_EmployeeStockOptionMember_778755" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_WarrentsToPurchaseCommonStockMember" xlink:label="loc_fhtx_WarrentsToPurchaseCommonStockMember_843600" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_778748" xlink:to="loc_fhtx_WarrentsToPurchaseCommonStockMember_843600" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_778750" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_778748" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_778750" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_778753" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_778748" xlink:to="loc_us-gaap_RestrictedStockMember_778753" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_778751" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_778748" xlink:to="loc_us-gaap_WarrantMember_778751" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_778749" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_778746" xlink:to="loc_us-gaap_StatementLineItems_778749" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_776181" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_778749" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_776181" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfAvailableForSaleMarkatableSecurtiesBySecurityTypeDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_843745" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_855070" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_843745" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_855070" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_855076" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_855070" xlink:to="loc_us-gaap_InvestmentTypeAxis_855076" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_855077" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_855076" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_855077" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryNotesSecuritiesMember" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember_855079" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_855077" xlink:to="loc_us-gaap_USTreasuryNotesSecuritiesMember_855079" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_855072" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_855070" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_855072" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_843746" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_855072" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_843746" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_843747" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_855072" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_843747" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_843749" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_855072" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_843749" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_775235" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_775235" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_776645" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_776645" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_776645" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_776647" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_776647" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_776648" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_776648" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_776649" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776646" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_776649" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_776650" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_776650" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_776651" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_776650" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_776651" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_776652" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_776651" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_776652" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_776653" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_776653" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_776654" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_776653" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_776654" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_776655" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_776654" xlink:to="loc_us-gaap_MoneyMarketFundsMember_776655" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_843779" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_776654" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_843779" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_776657" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" xlink:to="loc_us-gaap_FinancialInstrumentAxis_776657" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776658" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_776657" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776658" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PreferredStockWarrantLiabilityMember" xlink:label="loc_fhtx_PreferredStockWarrantLiabilityMember_776659" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776658" xlink:to="loc_fhtx_PreferredStockWarrantLiabilityMember_776659" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_775247" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_775263" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_775263" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_775269" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_775269" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_845474" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_845474" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_843773" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_775250" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_843773" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_775285" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_775287" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_775285" xlink:to="loc_us-gaap_StatementTable_775287" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_776620" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775287" xlink:to="loc_us-gaap_FinancialInstrumentAxis_776620" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776622" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_776620" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776622" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PreferredStockWarrantLiabilityMember" xlink:label="loc_fhtx_PreferredStockWarrantLiabilityMember_776623" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_776622" xlink:to="loc_fhtx_PreferredStockWarrantLiabilityMember_776623" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_844306" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775287" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_844306" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844307" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_844306" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844307" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_844308" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844307" xlink:to="loc_us-gaap_IPOMember_844308" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_BeforeIPOMember" xlink:label="loc_fhtx_BeforeIPOMember_855212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_844307" xlink:to="loc_fhtx_BeforeIPOMember_855212" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_844312" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775287" xlink:to="loc_us-gaap_StatementClassOfStockAxis_844312" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_844316" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_844312" xlink:to="loc_us-gaap_ClassOfStockDomain_844316" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_SeriesAOnePreferredStockMember" xlink:label="loc_fhtx_SeriesAOnePreferredStockMember_844320" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_844316" xlink:to="loc_fhtx_SeriesAOnePreferredStockMember_844320" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_855113" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775287" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_855113" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_855114" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_855113" xlink:to="loc_us-gaap_EquityComponentDomain_855114" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_855115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_855114" xlink:to="loc_us-gaap_CommonStockMember_855115" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_775290" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_775287" xlink:to="loc_us-gaap_StatementLineItems_775290" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_776624" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775290" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_776624" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_WarrantIssuePrice" xlink:label="loc_fhtx_WarrantIssuePrice_775293" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775290" xlink:to="loc_fhtx_WarrantIssuePrice_775293" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="loc_us-gaap_MarketableSecurities_844322" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775290" xlink:to="loc_us-gaap_MarketableSecurities_844322" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_843739" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843740" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_843739" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843740" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_843741" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843740" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_843741" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_843741" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_843743" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" xlink:to="loc_us-gaap_EquipmentMember_843743" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_843744" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_843744" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ComputerEquipmentAndSoftwareMember" xlink:label="loc_fhtx_ComputerEquipmentAndSoftwareMember_843751" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" xlink:to="loc_fhtx_ComputerEquipmentAndSoftwareMember_843751" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_843753" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_843753" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AssetsNotYetPlacedInServiceMember" xlink:label="loc_fhtx_AssetsNotYetPlacedInServiceMember_843755" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_843742" xlink:to="loc_fhtx_AssetsNotYetPlacedInServiceMember_843755" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843758" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843740" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843758" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_843763" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843758" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_843763" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_843765" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843758" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_843765" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_843766" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843758" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_843766" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetParentheticalDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_843781" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843783" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_843781" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843783" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843784" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_843783" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843784" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_843785" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_843784" xlink:to="loc_us-gaap_DepreciationAndAmortization_843785" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/AccruedExpensesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_775404" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_775406" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_775404" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_775406" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionPayableCurrent" xlink:label="loc_us-gaap_ConstructionPayableCurrent_775407" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_775404" xlink:to="loc_us-gaap_ConstructionPayableCurrent_775407" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AccruedResearchAndDevelopmentExpenses" xlink:label="loc_fhtx_AccruedResearchAndDevelopmentExpenses_775411" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_775404" xlink:to="loc_fhtx_AccruedResearchAndDevelopmentExpenses_775411" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_776906" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_775404" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_776906" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_861268" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_775404" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_861268" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_776594" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_775404" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_776594" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/NotesPayableSummaryOfLongTermDebtDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAbstract" xlink:label="loc_us-gaap_LongTermDebtAbstract_775420" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_776911" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_775420" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_776911" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_775422" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_775420" xlink:to="loc_us-gaap_LongTermDebtCurrent_775422" use="optional" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments" xlink:label="loc_fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments_776910" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_775420" xlink:to="loc_fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments_776910" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_775424" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_775420" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_775424" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_776919" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_775420" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_776919" use="optional" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_776920" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_775420" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_776920" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/NotesPayableSummaryOfFuturePrincipalPaymentsDueDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_776665" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_776668" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_776665" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_776668" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_776675" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_776665" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_776675" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_776677" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_776665" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_776677" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_843861" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_776665" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_843861" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_843863" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_776665" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_843863" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_776680" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_776665" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_776680" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/NotesPayableAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_775435" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_775435" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_776694" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_us-gaap_DebtInstrumentAxis_776694" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_776695" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_776694" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_776695" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TermLoanAMember" xlink:label="loc_fhtx_TermLoanAMember_776696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_776695" xlink:to="loc_fhtx_TermLoanAMember_776696" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TermLoanBMember" xlink:label="loc_fhtx_TermLoanBMember_776698" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_776695" xlink:to="loc_fhtx_TermLoanBMember_776698" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TermLoanAAndBMember" xlink:label="loc_fhtx_TermLoanAAndBMember_855245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_776695" xlink:to="loc_fhtx_TermLoanAAndBMember_855245" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_779131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_779131" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_779132" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_779131" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_779132" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AdditionalRateInEventOfDefaultMember" xlink:label="loc_fhtx_AdditionalRateInEventOfDefaultMember_779133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_779132" xlink:to="loc_fhtx_AdditionalRateInEventOfDefaultMember_779133" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AdditionalOverBaseRateMember" xlink:label="loc_fhtx_AdditionalOverBaseRateMember_779134" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_779132" xlink:to="loc_fhtx_AdditionalOverBaseRateMember_779134" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_779136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_srt_RangeAxis_779136" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_779137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_779136" xlink:to="loc_srt_RangeMember_779137" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_779138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_779137" xlink:to="loc_srt_MaximumMember_779138" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_779139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_779137" xlink:to="loc_srt_MinimumMember_779139" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_780553" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_780553" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_780554" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_780553" xlink:to="loc_us-gaap_RelatedPartyDomain_780554" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OxfordFinanceLlcMember" xlink:label="loc_fhtx_OxfordFinanceLlcMember_780555" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_780554" xlink:to="loc_fhtx_OxfordFinanceLlcMember_780555" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_780556" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_780556" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_780557" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_780556" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_780557" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_855272" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_us-gaap_VariableRateAxis_855272" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_855274" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_855272" xlink:to="loc_us-gaap_VariableRateDomain_855274" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_855275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_855274" xlink:to="loc_us-gaap_BaseRateMember_855275" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentPeriodAxis" xlink:label="loc_fhtx_PrepaymentPeriodAxis_861282" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_fhtx_PrepaymentPeriodAxis_861282" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentPeriodDomain" xlink:label="loc_fhtx_PrepaymentPeriodDomain_861284" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_PrepaymentPeriodAxis_861282" xlink:to="loc_fhtx_PrepaymentPeriodDomain_861284" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentWithInFirstTwelveMonthsMember" xlink:label="loc_fhtx_PrepaymentWithInFirstTwelveMonthsMember_861285" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_PrepaymentPeriodDomain_861284" xlink:to="loc_fhtx_PrepaymentWithInFirstTwelveMonthsMember_861285" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember" xlink:label="loc_fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember_861287" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_PrepaymentPeriodDomain_861284" xlink:to="loc_fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember_861287" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PrepaymentAfter24MonthsMember" xlink:label="loc_fhtx_PrepaymentAfter24MonthsMember_861289" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_PrepaymentPeriodDomain_861284" xlink:to="loc_fhtx_PrepaymentAfter24MonthsMember_861289" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaap_ShortTermDebtLineItems_776699" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_776693" xlink:to="loc_us-gaap_ShortTermDebtLineItems_776699" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_775439" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_775439" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_776702" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_776702" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_776703" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_776703" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_776704" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_776704" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_776706" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_776706" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_776707" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_776707" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_InterestRateOutstandingBorrowingsLoan" xlink:label="loc_fhtx_InterestRateOutstandingBorrowingsLoan_779032" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_fhtx_InterestRateOutstandingBorrowingsLoan_779032" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtWeightedAverageInterestRateOverTime" xlink:label="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_780183" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime_780183" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage" xlink:label="loc_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage_780184" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage_780184" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="loc_us-gaap_DebtInstrumentInterestRateTerms_843899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentInterestRateTerms_843899" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_843913" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_843913" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="loc_us-gaap_DebtInstrumentPaymentTerms_843909" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentPaymentTerms_843909" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_843922" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_843922" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRestrictiveCovenants" xlink:label="loc_us-gaap_DebtInstrumentRestrictiveCovenants_843916" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentRestrictiveCovenants_843916" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_843935" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_843935" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_WarrantsIssuePricePerShare" xlink:label="loc_fhtx_WarrantsIssuePricePerShare_843940" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_fhtx_WarrantsIssuePricePerShare_843940" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_843942" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_843942" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_843994" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_843994" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DebtInstrumentPrePaymentTerms" xlink:label="loc_fhtx_DebtInstrumentPrePaymentTerms_844013" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_fhtx_DebtInstrumentPrePaymentTerms_844013" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_844021" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_844021" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_844062" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_844062" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_844716" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_844716" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PercentageOfPrepaymentFee" xlink:label="loc_fhtx_PercentageOfPrepaymentFee_861281" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_fhtx_PercentageOfPrepaymentFee_861281" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_861311" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_776699" xlink:to="loc_us-gaap_DebtInstrumentTerm_861311" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_775401" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_779120" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_775401" xlink:to="loc_us-gaap_StatementTable_779120" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_779121" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_779120" xlink:to="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_779121" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:label="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_779122" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_779121" xlink:to="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_779122" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBMember" xlink:label="loc_us-gaap_SeriesBMember_779128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_779122" xlink:to="loc_us-gaap_SeriesBMember_779128" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_844212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_779120" xlink:to="loc_us-gaap_StatementClassOfStockAxis_844212" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_844213" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_844212" xlink:to="loc_us-gaap_ClassOfStockDomain_844213" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_SeriesAOnePreferredStockMember" xlink:label="loc_fhtx_SeriesAOnePreferredStockMember_844217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_844213" xlink:to="loc_fhtx_SeriesAOnePreferredStockMember_844217" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_855278" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_779120" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_855278" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_855279" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_855278" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_855279" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_855280" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_855279" xlink:to="loc_us-gaap_IPOMember_855280" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_IssuanceOfNotesPayableMember" xlink:label="loc_fhtx_IssuanceOfNotesPayableMember_861373" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_855279" xlink:to="loc_fhtx_IssuanceOfNotesPayableMember_861373" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_861374" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_779120" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_861374" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_861375" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_861374" xlink:to="loc_us-gaap_EquityComponentDomain_861375" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_861377" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_861375" xlink:to="loc_us-gaap_CommonStockMember_861377" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_779123" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_779120" xlink:to="loc_us-gaap_StatementLineItems_779123" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues" xlink:label="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues_855283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues_855283" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_776233" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_776233" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_776235" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_776235" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_780185" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_780185" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_861372" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_861372" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_861379" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_861379" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants" xlink:label="loc_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants_861380" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_779123" xlink:to="loc_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants_861380" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsScheduleOfStockByClassDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_844094" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_844121" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_844094" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_844121" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_844122" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_844121" xlink:to="loc_us-gaap_StatementClassOfStockAxis_844122" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_844123" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_844122" xlink:to="loc_us-gaap_ClassOfStockDomain_844123" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_SeriesAOnePreferredStockMember" xlink:label="loc_fhtx_SeriesAOnePreferredStockMember_844126" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_844123" xlink:to="loc_fhtx_SeriesAOnePreferredStockMember_844126" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_SeriesATwoPreferredStockMember" xlink:label="loc_fhtx_SeriesATwoPreferredStockMember_844127" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_844123" xlink:to="loc_fhtx_SeriesATwoPreferredStockMember_844127" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_844128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_844123" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_844128" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_844125" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_844121" xlink:to="loc_us-gaap_ClassOfStockLineItems_844125" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_844130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_844125" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_844130" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_844141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_844125" xlink:to="loc_us-gaap_PreferredStockSharesIssued_844141" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_844143" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_844125" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_844143" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="loc_us-gaap_PreferredStockLiquidationPreferenceValue_844144" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_844125" xlink:to="loc_us-gaap_PreferredStockLiquidationPreferenceValue_844144" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_844146" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_844125" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_844146" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/CommonStockAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_844201" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_844202" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_844201" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_844202" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_861458" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_844202" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_861458" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_861460" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_861458" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_861460" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_861462" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_844202" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_861462" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_861463" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_861462" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_861463" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_861464" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_861463" xlink:to="loc_us-gaap_IPOMember_861464" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_861471" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_861463" xlink:to="loc_us-gaap_OverAllotmentOptionMember_861471" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_863334" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_844202" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_863334" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_863335" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_863334" xlink:to="loc_us-gaap_EquityComponentDomain_863335" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_863336" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_863335" xlink:to="loc_us-gaap_CommonStockMember_863336" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_844203" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_844202" xlink:to="loc_us-gaap_ClassOfStockLineItems_844203" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaap_CommonStockVotingRights_855294" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_844203" xlink:to="loc_us-gaap_CommonStockVotingRights_855294" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_861466" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_844203" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_861466" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_861467" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_844203" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_861467" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_861468" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_844203" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_861468" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_775368" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_775368" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_780208" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_PlanNameAxis_780208" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_780209" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_780208" xlink:to="loc_us-gaap_PlanNameDomain_780209" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember_843900" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_780209" xlink:to="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember_843900" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:label="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember_843901" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_780209" xlink:to="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember_843901" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember" xlink:label="loc_fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember_863354" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_780209" xlink:to="loc_fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember_863354" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_843918" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_843918" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_843918" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_InitialAmountMember" xlink:label="loc_fhtx_InitialAmountMember_843931" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" xlink:to="loc_fhtx_InitialAmountMember_843931" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember" xlink:label="loc_fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember_843933" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" xlink:to="loc_fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember_843933" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_InitialAggregateMember" xlink:label="loc_fhtx_InitialAggregateMember_860554" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" xlink:to="loc_fhtx_InitialAggregateMember_860554" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember" xlink:label="loc_fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember_863350" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_843919" xlink:to="loc_fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember_863350" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_844044" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_srt_RangeAxis_844044" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_844045" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_844044" xlink:to="loc_srt_RangeMember_844045" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_844046" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_844045" xlink:to="loc_srt_MaximumMember_844046" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_844049" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_DebtInstrumentAxis_844049" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_844051" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_844049" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_844051" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_844057" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_844057" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_844058" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_844057" xlink:to="loc_us-gaap_RelatedPartyDomain_844058" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_855295" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_855295" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_855296" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_855295" xlink:to="loc_us-gaap_EquityComponentDomain_855296" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_855297" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_855296" xlink:to="loc_us-gaap_CommonStockMember_855297" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_860545" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_AwardTypeAxis_860545" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_860546" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_860545" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_860546" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ServiceBasedVestingMember" xlink:label="loc_fhtx_ServiceBasedVestingMember_860547" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_860546" xlink:to="loc_fhtx_ServiceBasedVestingMember_860547" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_780207" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_778990" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_778990" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_778991" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_778991" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_778992" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_778992" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_778993" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_778993" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_845973" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_845973" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_845974" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_845974" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_845975" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_845975" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_845978" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_845978" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_855389" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_855389" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_860548" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_860548" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_860552" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_860552" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares_860556" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares_860556" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage_863340" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_780211" xlink:to="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage_863340" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/StockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsAndRestrictedStockAwardsUsingBlackScholesOptionPricingModelDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_844083" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_844084" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_844083" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_844084" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_844085" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_844083" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_844085" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_844087" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_844083" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_844087" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_844089" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_844083" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_844089" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/StockBasedCompensationScheduleOfShareOptionActivityDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_844102" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844103" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_844102" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844103" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844103" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_844106" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_844106" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_844107" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_844107" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_844110" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_844110" use="optional" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_844112" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_844112" use="optional" order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_844114" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_844114" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_844116" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_844116" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_844118" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_844118" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_844129" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_844129" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_844131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_844131" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_844133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_844133" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_844134" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_844134" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_844135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_844135" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_844136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_844136" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_844137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_844137" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_844138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_844138" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_844140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_844140" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_844145" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_844145" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_844147" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_844147" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_844148" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_844148" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_844150" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844104" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_844150" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/StockBasedCompensationSummaryOfRestrictedCommonStockDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_844163" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844164" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_844163" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844164" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_844165" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844164" xlink:to="loc_us-gaap_AwardTypeAxis_844165" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_844166" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_844165" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_844166" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_844167" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_844166" xlink:to="loc_us-gaap_RestrictedStockMember_844167" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844168" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_844164" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844168" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_844169" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_844169" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_844170" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_844168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_844170" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_775363" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_776670" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_775363" xlink:to="loc_us-gaap_StatementTable_776670" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_776679" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776670" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_776679" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_776681" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_776679" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_776681" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_776682" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_776681" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_776682" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_776683" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_776681" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_776683" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_776673" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776670" xlink:to="loc_us-gaap_StatementLineItems_776673" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_776676" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_776673" xlink:to="loc_us-gaap_ShareBasedCompensation_776676" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/CollaborationAgreementAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_CollaborationAgreementAbstract" xlink:label="loc_fhtx_CollaborationAgreementAbstract_775393" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_776635" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_CollaborationAgreementAbstract_775393" xlink:to="loc_us-gaap_StatementTable_776635" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776639" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776635" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776639" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776640" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776639" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776640" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:label="loc_fhtx_ResearchDevelopmentAndRegulatoryMember_776641" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776640" xlink:to="loc_fhtx_ResearchDevelopmentAndRegulatoryMember_776641" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_MerckCollaborationAgreementMember" xlink:label="loc_fhtx_MerckCollaborationAgreementMember_781734" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776640" xlink:to="loc_fhtx_MerckCollaborationAgreementMember_781734" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_780191" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776635" xlink:to="loc_srt_RangeAxis_780191" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_780192" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_780191" xlink:to="loc_srt_RangeMember_780192" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_780193" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_780192" xlink:to="loc_srt_MaximumMember_780193" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_780194" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776635" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_780194" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_780195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_780194" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_780195" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaap_SalesMember_780196" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_780195" xlink:to="loc_us-gaap_SalesMember_780196" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_776638" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776635" xlink:to="loc_us-gaap_StatementLineItems_776638" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ProceedsFromUpfrontPayment" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment_776859" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_776638" xlink:to="loc_fhtx_ProceedsFromUpfrontPayment_776859" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_MilestoneReceivableUponAchievement" xlink:label="loc_fhtx_MilestoneReceivableUponAchievement_776860" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_776638" xlink:to="loc_fhtx_MilestoneReceivableUponAchievement_776860" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaap_ContractWithCustomerLiability_775398" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_776638" xlink:to="loc_us-gaap_ContractWithCustomerLiability_775398" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_776633" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_776638" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_776633" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_780571" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_776638" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_780571" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/IncomeTaxesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_843569" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_843570" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843569" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_843570" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_843588" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_843570" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_843588" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_843590" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_843588" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_843590" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_843591" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_843590" xlink:to="loc_us-gaap_DomesticCountryMember_843591" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_843592" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_843590" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_843592" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_843593" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_843570" xlink:to="loc_us-gaap_TaxPeriodAxis_843593" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_843594" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_843593" xlink:to="loc_us-gaap_TaxPeriodDomain_843594" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ExpirableMember" xlink:label="loc_fhtx_ExpirableMember_855303" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_843594" xlink:to="loc_fhtx_ExpirableMember_855303" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_NonExpirableMember" xlink:label="loc_fhtx_NonExpirableMember_855307" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_843594" xlink:to="loc_fhtx_NonExpirableMember_855307" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_843648" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_843570" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_843648" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_843649" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_843648" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_843649" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember" xlink:label="loc_us-gaap_ResearchMember_843652" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_843649" xlink:to="loc_us-gaap_ResearchMember_843652" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_855326" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_843570" xlink:to="loc_srt_RangeAxis_855326" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_855328" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_855326" xlink:to="loc_srt_RangeMember_855328" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_843653" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_843570" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_843653" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_843656" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_OperatingLossCarryforwards_843656" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_843657" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_843657" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLimitationsOnUse" xlink:label="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse_843658" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_TaxCreditCarryforwardLimitationsOnUse_843658" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_843659" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_843659" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_843660" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_843660" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TaxCreditCarryForwardsExpirationStartYear" xlink:label="loc_fhtx_TaxCreditCarryForwardsExpirationStartYear_855298" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_fhtx_TaxCreditCarryForwardsExpirationStartYear_855298" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OperatingLossCarryForwardsExpirationStartYear" xlink:label="loc_fhtx_OperatingLossCarryForwardsExpirationStartYear_855300" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_fhtx_OperatingLossCarryForwardsExpirationStartYear_855300" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OperatingLossCarryforwardLimitPercentage" xlink:label="loc_fhtx_OperatingLossCarryforwardLimitPercentage_855308" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_fhtx_OperatingLossCarryforwardLimitPercentage_855308" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_855320" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_843653" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_855320" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/IncomeTaxesSummaryOfReconciliationOfTheUSFederalStatutoryIncomeTaxRateToTheCompanySEffectiveIncomeTaxRateDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_843676" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_843677" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843676" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_843677" use="optional" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_843678" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843676" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_843678" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_843679" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843676" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_843679" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_843680" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843676" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_843680" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_843681" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843676" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_843681" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_843682" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843676" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_843682" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_843689" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_843694" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843689" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_843694" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_843695" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_843694" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_843695" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_843696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_843694" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_843696" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxAssetsCapitalizedStartUpCosts" xlink:label="loc_fhtx_DeferredTaxAssetsCapitalizedStartUpCosts_843698" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_843694" xlink:to="loc_fhtx_DeferredTaxAssetsCapitalizedStartUpCosts_843698" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_843699" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_843694" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_843699" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_861447" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_843694" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_861447" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:label="loc_fhtx_DeferredTaxAssetsOperatingLeaseLiabilities_843700" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_843694" xlink:to="loc_fhtx_DeferredTaxAssetsOperatingLeaseLiabilities_843700" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_843701" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_843694" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_843701" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_843702" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_843689" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_843702" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_fhtx_DeferredTaxLiabilitiesDepreciation_843703" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_843702" xlink:to="loc_fhtx_DeferredTaxLiabilitiesDepreciation_843703" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:label="loc_fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_843704" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_843702" xlink:to="loc_fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_843704" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_843705" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_843702" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_843705" use="optional" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_843706" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_843702" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_843706" use="optional" order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_843707" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_843702" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_843707" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_776123" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_776124" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_776123" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_776124" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="loc_us-gaap_LeaseContractualTermAxis_776125" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_us-gaap_LeaseContractualTermAxis_776125" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="loc_us-gaap_LeaseContractualTermDomain_776126" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_776125" xlink:to="loc_us-gaap_LeaseContractualTermDomain_776126" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_NewLeaseAgreementMember" xlink:label="loc_fhtx_NewLeaseAgreementMember_776127" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_776126" xlink:to="loc_fhtx_NewLeaseAgreementMember_776127" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ModifiedNewLeaseAgreementMember" xlink:label="loc_fhtx_ModifiedNewLeaseAgreementMember_776134" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_776126" xlink:to="loc_fhtx_ModifiedNewLeaseAgreementMember_776134" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_PropertyUnderOperatingLeaseSubleasedMember" xlink:label="loc_fhtx_PropertyUnderOperatingLeaseSubleasedMember_776135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_776126" xlink:to="loc_fhtx_PropertyUnderOperatingLeaseSubleasedMember_776135" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_776128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_srt_StatementGeographicalAxis_776128" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_776129" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_776128" xlink:to="loc_srt_SegmentGeographicalDomain_776129" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd#stpr_MA" xlink:label="loc_stpr_MA_776130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_776129" xlink:to="loc_stpr_MA_776130" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_776131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_776131" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain" xlink:label="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_776132" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_776131" xlink:to="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_776132" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficeBuildingMember" xlink:label="loc_srt_OfficeBuildingMember_776133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain_776132" xlink:to="loc_srt_OfficeBuildingMember_776133" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_778973" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_srt_StatementScenarioAxis_778973" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_778974" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_778973" xlink:to="loc_srt_ScenarioUnspecifiedDomain_778974" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srt_ScenarioForecastMember_778975" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_778974" xlink:to="loc_srt_ScenarioForecastMember_778975" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_778981" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_srt_RangeAxis_778981" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_778982" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_778981" xlink:to="loc_srt_RangeMember_778982" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_778983" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_778982" xlink:to="loc_srt_MaximumMember_778983" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_860575" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_860575" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_860576" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_860575" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_860576" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_860577" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_860576" xlink:to="loc_us-gaap_LetterOfCreditMember_860577" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_776124" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_776137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_776137" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_776138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_776138" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_776139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_776139" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaap_OperatingLeaseExpense_776141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_OperatingLeaseExpense_776141" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_LeaseholdImprovementsLandlordAllowance" xlink:label="loc_fhtx_LeaseholdImprovementsLandlordAllowance_776142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_LeaseholdImprovementsLandlordAllowance_776142" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid" xlink:label="loc_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid_776843" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid_776843" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromTenantAllowance" xlink:label="loc_us-gaap_PaymentsForProceedsFromTenantAllowance_776844" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_PaymentsForProceedsFromTenantAllowance_776844" use="optional" order="29" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_776145" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_776145" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" xlink:label="loc_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement_778986" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement_778986" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_776146" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_OperatingLeaseLiability_776146" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_TermOfPropertySubleasedUnderOperatingLease" xlink:label="loc_fhtx_TermOfPropertySubleasedUnderOperatingLease_776148" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_TermOfPropertySubleasedUnderOperatingLease_776148" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals" xlink:label="loc_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals_776150" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals_776150" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaap_OtherIncome_779097" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_OtherIncome_779097" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_LeaseTermCommencementDate" xlink:label="loc_fhtx_LeaseTermCommencementDate_780204" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_fhtx_LeaseTermCommencementDate_780204" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_855361" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_LeaseExpirationDate1_855361" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_863363" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_776136" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_863363" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesSummaryOfLeaseCostDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_775450" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_775451" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775450" xlink:to="loc_us-gaap_OperatingLeaseCost_775451" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost_775456" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775450" xlink:to="loc_us-gaap_ShortTermLeaseCost_775456" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_775454" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775450" xlink:to="loc_us-gaap_VariableLeaseCost_775454" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_775453" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775450" xlink:to="loc_us-gaap_LeaseCost_775453" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesSummaryOfSupplementalCashFlowInformationRelatedToLeasesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_775467" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_775468" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775467" xlink:to="loc_us-gaap_OperatingLeasePayments_775468" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_780223" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775467" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_780223" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement" xlink:label="loc_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement_775470" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775467" xlink:to="loc_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement_775470" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateLeasesDetail">
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract" xlink:label="loc_fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract_775475" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_775476" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract_775475" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_775476" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_775477" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract_775475" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_775477" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesSummaryOfMinimumLeasePaymentDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_775480" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_775482" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775480" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_775482" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_775483" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775480" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_775483" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_775484" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775480" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_775484" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_775485" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775480" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_775485" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_845702" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775480" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_845702" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_845703" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775480" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_845703" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_775487" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775480" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_775487" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_775488" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775480" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_775488" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives" xlink:label="loc_fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives_776902" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775480" xlink:to="loc_fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives_776902" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_775491" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_775480" xlink:to="loc_us-gaap_OperatingLeaseLiability_775491" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/LeasesSummaryOfOperatingLeaseLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract_775494" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_775495" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_775494" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_775495" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_775496" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_775494" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_775496" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_775497" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_775494" xlink:to="loc_us-gaap_OperatingLeaseLiability_775497" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_776561" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_776563" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_776561" xlink:to="loc_us-gaap_StatementTable_776563" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_776564" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776563" xlink:to="loc_us-gaap_StatementClassOfStockAxis_776564" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_776565" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_776564" xlink:to="loc_us-gaap_ClassOfStockDomain_776565" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776568" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776563" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776568" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776569" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_776568" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776569" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_StanfordLicenseAgreementMember" xlink:label="loc_fhtx_StanfordLicenseAgreementMember_776570" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_776569" xlink:to="loc_fhtx_StanfordLicenseAgreementMember_776570" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_776571" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776563" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_776571" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_776572" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_776571" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_776572" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_776573" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_776572" xlink:to="loc_srt_MaximumMember_776573" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_776566" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_776563" xlink:to="loc_us-gaap_StatementLineItems_776566" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_NonRefundableLicenseFee" xlink:label="loc_fhtx_NonRefundableLicenseFee_776596" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_776566" xlink:to="loc_fhtx_NonRefundableLicenseFee_776596" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ReimbursedPatentCosts" xlink:label="loc_fhtx_ReimbursedPatentCosts_776598" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_776566" xlink:to="loc_fhtx_ReimbursedPatentCosts_776598" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_776599" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_776566" xlink:to="loc_us-gaap_CommonStockSharesIssued_776599" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AnnualLicenseMaintenanceFees" xlink:label="loc_fhtx_AnnualLicenseMaintenanceFees_776600" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_776566" xlink:to="loc_fhtx_AnnualLicenseMaintenanceFees_776600" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_MilestonesPayableUponEvent" xlink:label="loc_fhtx_MilestonesPayableUponEvent_776601" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_776566" xlink:to="loc_fhtx_MilestonesPayableUponEvent_776601" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.foghorntx.com/role/RelatedPartiesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_775322" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_778953" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_775322" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_778953" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AgreementsAxis" xlink:label="loc_fhtx_AgreementsAxis_778955" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_778953" xlink:to="loc_fhtx_AgreementsAxis_778955" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_AgreementsDomain" xlink:label="loc_fhtx_AgreementsDomain_778956" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_AgreementsAxis_778955" xlink:to="loc_fhtx_AgreementsDomain_778956" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_FlagshipPioneeringMember" xlink:label="loc_fhtx_FlagshipPioneeringMember_778957" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_AgreementsDomain_778956" xlink:to="loc_fhtx_FlagshipPioneeringMember_778957" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ScientificFounderMember" xlink:label="loc_fhtx_ScientificFounderMember_778958" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_AgreementsDomain_778956" xlink:to="loc_fhtx_ScientificFounderMember_778958" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_779091" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_778953" xlink:to="loc_srt_RangeAxis_779091" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_779092" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_779091" xlink:to="loc_srt_RangeMember_779092" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_779093" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_779092" xlink:to="loc_srt_MaximumMember_779093" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_778954" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_778953" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_778954" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_775333" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_778954" xlink:to="loc_us-gaap_AccountsPayableCurrent_775333" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ServiceAgreementTerm" xlink:label="loc_fhtx_ServiceAgreementTerm_778949" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_778954" xlink:to="loc_fhtx_ServiceAgreementTerm_778949" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_CashPaymentsRelatedParty" xlink:label="loc_fhtx_CashPaymentsRelatedParty_775325" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_778954" xlink:to="loc_fhtx_CashPaymentsRelatedParty_775325" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ServiceAgreementExpirationYear" xlink:label="loc_fhtx_ServiceAgreementExpirationYear_861436" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_778954" xlink:to="loc_fhtx_ServiceAgreementExpirationYear_861436" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="fhtx-20201231.xsd#fhtx_ServiceAgreementExtendedDate" xlink:label="loc_fhtx_ServiceAgreementExtendedDate_861439" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_778954" xlink:to="loc_fhtx_ServiceAgreementExtendedDate_861439" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g105868g00g23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g00g23.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[22V4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ))J^DW X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%?QRL         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@             !10   E<
M 0                         !              )7   !10
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !10    !29VAT
M;&]N9P   E<    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M C_P        .$))3001       ! 0 X0DE-!!0       0    %.$))300,
M     !IH     0   *    !7   !X   HR   !I, !@  ?_8_^(,6$E#0U]0
M4D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M86-S<$U31E0     245#('-21T(               $  /;6  $     TRU(
M4" @
M       18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP
M=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     4
M9&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0
M   D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M!#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M    $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV
M-BTR+C$
M             %A96B        #S40 !     1;,6%E:(
M      !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:
M6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W
M=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
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M"58 4    %<?YVUE87,          0                        */
M G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M
M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H
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M9^EH/VB6:.QI0P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MH19"L<'1X? D4@H7,_$E-$-B<H(8)I*B_\0 ' $!  (# 0$!
M  $" P0%!@<(_\0 21$  0,"! 0$!0,$ 0,# @ / 0(1(0 Q P1!404287&!
MD:'P!A,BL<$RT>$'%$+Q(Q4S4B1B<C2"""4U0[)$%U-48W.2D\+2_]H # ,!
M  (1 Q$ /P#[^-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32
ME-*4TI32E=/5Y;5.AS)SZ@&VFNLY[)*1R3P>,<XX)YQSVRY?"5BXZ$)NHL"]
MHDR0!;\D[:^;QA@Y=:U62#XOI8[=(MUU$W\W]N7:+95V\;2HKMS[AW1=#=L[
M<VXQ0+HN9%4K<EN?/3^8TJR:74KB-.9I%*J3C\AJ+.9CN(B*=\M!"49>((&#
MCA"1^E*0WU2PT+D&\P Y-]<7"E_/P2HL05K-P"75JX21WDLSZBL<6EXI[BW7
MEKKEH7EM585FT).UT2HT?<JEUEN[;LD;CTBA2UOPJ@NXZ7)M542K5AVTZ?2:
MC;51G5&XJ/-ITJH4R0M::;KK!"BQ!D$&1!DL-&TZ^O32 D ,I2G?8?2?I9B4
MDEWL6EG>.WMK>/>RD7''AWQ<VW=<H\_?]S9J+^7V75K7F1J=&@W/)<J+D]^]
M*HTJ?(72(RHS BX0A;X)4L!0K8S-]A$Z^'5S;I8<@ <?^X %Q;8D@EA_X@/'
M;"]R>/B[:!6]Y:7(H$:+)I]9KEE;+4*-9%QW)5KMK]&N@VNY,5_8N[:]=]<9
M;;$BX*E2VK"LN4W2X4P4.L5EQ"ZDP.D>A+V8W-F.D54I2578-J6F9  ;9@+
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M96.,E22#ZY!X./N<]L<:OEBK$45$I "@Q9C/2!)WEB!K6'$PR.5(?L6\-'!
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MI!Z\<=R#CTY QVX_X<:U,L,S$ SZ,XASU?M J2/+0V?OVW('>PJ>'E!*2!W
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MTZE$T*G5B7\0R"A\Q/A700YQS^.)&'G% AR&:&EAU)!(B6<[W/4^%WQLHER
M#SEQ?E))_P#&0"07<C8 AJQ[:NXUL[P7)2[UVOVW\/*+7V]>V_7_ &PW :%'
MKPJNZ5*HUSN2+*F0Z4@4M,)-R--,1IBG)-SW#\73'7Z+(1\2.87-]A=SVOYZ
M>%=[%'(M27);67,"[ZD&>Y:*JFZ_7KRF)LG?#;78>_++N#Q$';A5$9L*KNAV
MHPX-SS5W+4XUS5JN4AVKI72U*9<<,LXER2Q-E@I>4UZ>_=JQ= 9V@EO,>;^)
MUUYN3Q34BS+\OI%F;$;6V]48.X,>P;&JSFV5YU.YJJ;1K51M*H5>GL6O%A2K
MO51F&Q\+0K6DTN=0F)@'Q$UI?67N:RI2"EW-YD ,_P"!.OAKL_X6]P$[G[DH
MNV1;%/M.IO[8U.G5JG4ZES: B76:7NE=4.I5>5;M42*W;U0JDA!F3*+<"WZY
M3WUEFI/O2>I15"@0+DA[G2+%P^O;SKT 4Z/,4 V5#.,G/<=\=R>,9YQWUC4P
M5(#,.NMS#:-O/E4/H2/MT!VU_B30ND. ^2#@#MP<8Y&.0<#&,8]>_J+."6DO
M-FW%F%[B2=:EK@&!)>/1R^GI4"W$%7S-D$D''T]/3_3U^NL9(>P!L!Y1N^^Y
MVJ0-'!@D0#.K-)Z/=K1!;B.H=2.V.<8[\#..<>W'V(]:NEV:VL #?QW;QU99
MIB\RTG29'74]'&D?B$\4E=VAOI-J4^V*75HQID&H_$2I,EI\?%(4E22&T.("
M4$820<J&23WU\X^(?C97!>.+X6 @@8.!BR]\5/,7;!5U=U^K-]D_I_\ TNQO
MC#AAXF,?%P\-6/BX)&$G!)_XE@$OB8^&9U 0=A-9XVNO>3N38UKW:_#CPI%6
MCF0[%C+4XTV"L@!"W4H43@'(P<*SWSKU7!N+?]0PD+6EOFATA)AK/&&DV#RW
M=J^<?&?P^KX?XYF>&A:\3^WQ"@J6$!1+"" M22SAB"0>U7O6Y40/10N,V^2A
M:0%NAHCIP%!*3C)SG)]?KWULY_$R^'F.5: X2DGZB!(+6!':9NS!ZULGSX>&
M4*64ORD?2\Z6!!Z &+WBJFG"*]";5\$&$=:QT(6%C@D=04!Z^WIGM@DZM@8^
M3Y!]#!S_ )*9_!)(M=_&*+7B_,/+C/ N&ZVCKI+%]SV(8AEAWI9_AE2<CI)^
M;W/()P??C/J=9/E8..M6+AI)2R4BXL^I(?0RY]:UU*Q#BCG6.9K] ^@&MK6(
MWJDF2&J=#>=9CMY\Q(PKY23VR<@@Y[CMG'?'>N9Q1D\(JY6/VZF#VV>LN%AG
M$Q$@K(!22R8FS:$3H':6Z4M-FIJR)27HG24IP>ET *2!P#CI([CYCD:ULIB?
MWV&<127!4I+@M^D[)Y='L!HY:S,$Y=24)7"0"'#_ *G-R'TD=XKMJ=$B,K(9
M9*5!(41U!6/3.<D=P>YX]^<:Z>%DDX;*"2#)8FVQ_4XZ?DR-+%S)62.:#<L1
M(T@&="7V?IV20VLG+6".,'.<?89]>Q]L$'6=6#S$DIEFDB_9]+:5A"N8.YF+
M P_@W35QH]<)0T5*!: ]CSZ#]3^O?&?0ZJ,N \.^Y/21]721VZU);?NPOY !
M_$CKN3Y06,(]2..<'.1QCG)^I^NI&&G#8 ,9)N9-RY=NSM-7',4%E1UAQXW[
MAV:^TD!OS_\ TSRH]NQXYQCU^X[^F = 052!]C!MT<V:T;BLA!"!)!(>6VN[
MG2[[U,'E!:<M\]:L'^F,_;GGWY&I)#M-X<']FC>L2A^DOH)<"8GQU:US4PJ0
ME9 1QV) ((S]/O\ 0?34.SL+-T&N\ 1<?S42-6-QZO(!TZM+DUPL-J(*VLJ]
M#]/0X![9R?;/KG0L6?U$>9'F'TV>@%B"S2+">XA[7EM-#RH-$I'E@@@ #';W
M)_Q.?\M"1=GUCT/6=K3XB"Q<R"29@;1%R_7I(J2^&NM&6NK 3@D X!/8$@XX
M.<#D^G;6);!8 !=A+1W!T8783 H 7!9[Z1M(8 -)W,0+U./3T\-=2#@@#U/H
M/]M;&&T,/W&N\$--[-4EVE4B6%KQM+EWOT-1+2DI^9H\<=)!&1Z<C.1Z?Y>I
MG$@[V\-^T3_NJI)T+.6TO]QW:H.M#:4!*.Y) ]AGG&?Z8]O7OJCP_CX?C??H
M]#>3H!U>T@R;$RT-(@5P9)"<AODJ[=LG[%/W]3]<:GF8$D;Q&K3[-]];IP^<
M_JL+&XZ$Z7LT6ZUR)!(X0$Y],=^<*!],Y'8=OIG.H.(.O7[W($2'<29(M4C"
MUYAJSEB-!#GO?^8POJ0"6_4@>V .<\8'T.21GGC&KB020[F?_)_4 'Q>W:BA
MRF"^OK%[D=A4+3@RX/)5P/;WXXS]O;)]/0:EX(8,.XZSJ=6#L)-@]018DWU_
M@;"X]2]<I<0KNCD@9 'I[D<_7^IX'&L99[:"7[L2 ;WT+=W-"(@Q/MX<. -@
M2-Z)+:@2$<#/(QGUSP.??/Z#VU$.7$]K 6))[>?8FI(+.Y.DV+=[G:'=]14M
MH-!U1+6,G)SR03D?ICDGG@>I U?#( M=3EBXCJ+FT6D6J"[W+:&SL-/L._6I
MP6$JPEHXZ2<>GUQQDDX)]1Z^IU<F=39V%I,/.A8[[W%&<&1!-R9M[L_X@\T$
MD):/?&,$XY([CMWSW'H!GC!V9P2S%R[B'-X>T"P>7FG0J\K!GF-V[R#,U$"5
MK!\LG&>P*?7G@^GL",9S@>T:_AB6 L3#V8:/#F"*6$&[:C:S ^IL(O>M'('&
M..WM]-9 ^ND=^O\ NJUSJ:4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E=<^M#3JU84I1&5!2G5)!4EMM"4=7\%KJP!TYP25+(RIS-4X2<3$,
MEV^H?6UA,$.&$@3]C1>*I Y6 $2  202SJ:[J8%1:T, WFWN#XM[ZHNYMW4(
M)HENVO:U1509D.0_3*I6V'&S(*;@P">A#J0EQ$90RVVI#;B2ZA:C]&X-\'X6
M;R^%C JQ3BX:<3# 1B)3B A)">9.+]/,"P=(C0S7E\_Q?'PU+2D!'*H@I*L-
M1$D.'0[C</>3 K36A?BD7C5:Y.H$.BN,R:'4FX$2==#D*@TZ[6\(#;7YE)ID
MB!3:I4@KXBG-B0OSXCL9]7075)'J\S_3+*)P3BJQ&Q.4*7AI&.0D@ !(Y,U+
M] [A]VY*/B#,!2?J+'5\,O+DNK#DN3H#L-_2C9[Q2&YK7D5;=.B1K J;2G'_
M ,K3,-=;CTHN*;CR*C.I400D+D. O(4AMO#3C86?,"\_/N*?"V)DCS99L3#)
M(47*&(;](6M947)YIC;;L9?XB3^G,?0H $%G)*HGE0EKCE  B3!K-3^]UG-4
MZ/4*:M^M-2%H0MRF!V0E@.X65N%U 4AI(5PGNA.!A( &N$.&8Q++  V@[ZA0
M ;N_2MC&^),FA+NZ@!S,%) '1L(\Q.D2[O5M+\0-O2)\*-1A^:-NOR#/<00D
MQ4QTJ04J2$ A:5)Z58&,I)Y.I/#,0,68O)!#GN2L" Q,$-9A%<X_%V4"P$.I
MR2H+2I)[!L(R$I=W'>:O.+N[9,AVFLSJE%IJJH\S&@F6XI(?FK.$LM!3:>I>
M1T#DX//KDZV+E5X3BY#: !F_^1 ;O,P&KK9'XARF;4@(7R\Z3(YB^_\ @[$N
M'(C6 :RL% NH2#D)'&<\_*2%<\<YX('/H<#6".50-S^\BW3?U>NO=8.@;[;[
M%_%[S4]'\H_USZGU_P"'WYU6LM1:4II2FE*:4II2N""<>V>?M^XX[_KCC5%@
MEF'IY.?'[TKI*]4V*/39<V4L)98:<=.<X 2DD J SR0>_P!LZVLK@JQL1&&'
M<D ]!8G6P]9L:T\]F$Y? 7BKLE)+:DZ0);[V-:3/U9ZMUB74Y!ZE27UN-\J5
MECK4&!W!!#8'MV'<:]]P_"^2"A@GE$#7\SN 1XM/R#BN.,QFE8LGFF'9PWZ7
M:UW(MH:S"[6+#LW:Z9N??<:F"F;7TVZ;Q<JT]B,M^CQ*;39LFJ2H3TH%N,^]
M CKC(>2X@/NEJ&I65@:\5QX'^_)D$$$2[0/$.6+*&H  >/J/PR'X;AI$!3@Z
M?Y78WO)!!:'=-><5R>*3PY4VU=G]T;3\.NSD^=5*??%7<5=]Z42UJK:]2VZN
M*(U5[;M>LTK;B_VKOO69<M:";7I[J[615J^\RRW6XJZCD<\WT?E$V> -'TZ
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MXAQ Y#,>5G!8@ RWO6QBZPQ[@%VU<P_8=MP"Y'"G$I60$D?,>P R1@]7N><
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MSBX6.58J0P),!W!$$!P/\AMII!K1Q<WF<;&2MBA..@%"0>8*2 $I+)2"Y
M8%R =0<$[Y;@UJTXL.%$>?8N-3:76I4*GJA,27&B$.^;DX0@$*!QP2%$:@(P
MV=@7+R79^HAIC5KVK@<3S>8P74_*I";\H2>8D:$7#%R")<$.:RUX6+ADWE?-
M/_\ ,7\JJ49BFP*U2//6A]%*K?G" GRE*'2772@N<8Z%N%(Y!SSN)X _MU8J
M !,7TMT NT,;0"#7HOZ>9U>;XD/[I:EHY2E(423S$I:  _,!]0D!@2]>PC80
M".D8[]LX)YR0/8GD ]OUQKQ7,2MB(>_@7\X+_P U^C0&T9V)\0_5NVE3]7J:
M:4II2FE*:4II2FE*UHWTN92?(MN*\D..%+M02 .IM@@+;Y(_O)Y[GU],:]+P
M'+)Q%\Y <E@2\.VQAY&I+" 9'@_C'.KP<'Y224INLEF,,!9R)$B7=W 8X'I"
M@0",K2/E0L'CI"CP#W![?MP>->M2@(S&*BS(PR\ZI!&Y#Q<:/I7SC Q%8F7P
M\12@25XDP"67<L!,%R)F\UF^MP;"G[(7$YNA%^+V_HL.1=-S1%"5\._3[0F_
MVI7\8B,.B9'2JCH6NER%*9FJ:;C/-J3,"%?/N.A\^IR2'<-9@1 -COO8%FC[
M/\,$_P#3L()8&4S+L3_D&:X &SEM]"[QWJ\&ELT&G;A57;04N-OG:>Y":W;E
MT7=:&W283=":MVWKZM^/0[LO"A6TF^WA"IKJ:50HS%:F36%SF7F:NXX])YRF
M<N!8!O ,))DP2'VZ5Z3#!Y6'^*C)!+EU$F&<!X^[$"KAN=?ATN&4J';6U6_-
MPNQ*%>M1NYNV]RZ_:4B39\9YQ=R1+H:J>XM+J%STZIA,EU=">CR'76U^28I3
M*Z%+:'_>H]Z:U9E 2I,,QY1)Z %-GZ@[5=FZ.[WA4IRD5ZN;97)6&;3B;1KI
MJZO\+:UF2X\]FMLV>R^NZJ[1[>?I]!0_46ZC-K[#=,8F+8 D2GFXJP]O[]SK
M4@8C'F4 _-,E0>TO$Z/T<U?7A8K&UUQ;D,7!M!0UVY9U<VMJ=512$5"#5:?&
MJ\S=&ZW*T:)/I-1JM$E4-RH><NENT&:Y151E)-/2ADA(AWV9M/;?S6NM^:5<
MT"?P=CTK?U?1YRRKG!Y.![ ]/!]/;&?L=85MSD:L&AVZV\WZ5(#X;M )ON"?
MQ(T?QJ0X&75J0>X 5T\E#G*$I+F?5#B<(Y ]03G4 @.\M)'^)$ $FSO:^C41
MBE) =H!! #@2[%C=YWKQ9\0WX*>P/B'WDOS>*Z]T=VZ1<%]U154J5,HLBUVH
M,1QQ2%N-TXSK9J%3\M:T@JS+=2"<M!"  /-9WX:P\_Q-?$%%0*T8:2HEP A(
M3 3B Z$2D=+U]5X'_5?B7!^!X7P[@X6$<OA_.4E*?EI6^,I2U$%>7+"26YU"
M--?6#:_;NE;7;>V1MW1IE1F4BR*'!M^GRJBI#LZ3"IS*66'IKC,6 R9"T#J=
M+<9"0HD '(UZ/+Y9&4PP'*N0,+PVC%SX'MUKYCQ3%Q.(9_$S*H5C8AQ% %#%
M1DRE3>+]@+'Y@/QH=C_!KN-XN6:SOF_XBFKP.WMM15#:VJV!&MS\I9:>3!+\
M>[K=J3R*@' <J9EJZU84A+?(UYKBOQBCA6?/#5$I_P"/#Q+:X@<?_JZC!?\
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M+Q$>8BJ46(A5GRVVD(.2@Z]WETH2%(#!04GFY .="OI4EQ/U,$EBSI(T(YO
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MBJ;BJ\E4)AI3C:UKR.M2G%=1YZ1R=9N#8V2RW!Q@X6(M2#F,51.)A#FYC/\
MB5-+D,H/L]Y_JCQ?XDS_ !CA.*<OE\/$1@*0D93&P\5+*@NK,8&7=)%P<,@'
M]):1W7B6OC;*S=E*Y7[KDWD: U7[;CR'*%3*=(K:I+\AQ+(\IYV+%5%40H2N
MN4CI3V .=;F?1E,7AF,I:E<A YE)026(^DA+@N"?_)[.*XOP-POXMSOQMD,/
M+8&$K-*R^(<OAXV)E482FP_K=2'9@1=):Z16M_AIWJV0N2D[KFUG=S51:-2:
M,JK?G=%MF*M E3_*I_Y2W&KTQI2%.8 5YR7,\J0GD:\G\-)X=E\AQU6'B8JF
MPDE95A<H .*0 D#$6?U!BY:3VKWW]1/A[XJPL;X8P.*Y7)8.8Q.+9DX6'A9P
MXA5RY=U?,7AX2,-* DD@ %3P2;5MOM'=5BWS7*O;U">N=$F7;LA955H5/;92
MVTXAMPGR7Y""^%)/ =.3_-T\#7?^$\#)<6XWQW+X:EDG@^3!*T-R\V,4N X\
M3S Z_2)/SWXGR_%N!X7!,QF\'+)PT<0Q58:<'%6HJ4G!)(6HL0EF8)1=W)#5
MG&G6!1[7%2K JM4?2Q39J'DB/!"DAQ!+G0<#)2 .@'(QW/KKTG#O@W+\.S6<
MS0Q5$?V\$A3LY)#',+!=I^A[08KPH^(LSQ-2<J<-"BK,N H@ 'G+?IPDN0'9
MU,3<15JV_<5K.U!UF(NN+>,":294> EHM)C*+W0!+9^; /\ ]/E6?FQR/,<!
MS>45Q//Y9*UE03B@CD4P'S""0HD"S0[CJ:[6/PK/)P1F,3!P$X7.@A?S5.Y4
M&^D(6T-:'(#ZU;EL5:SUW#2!$>N(OOU!/PR'V8:&E*#:P1Q4E]+>>K&$D@IX
M3K#PM>3R_$<;#&(OF^?B+(Y5,RE$ACS*DW80&=JV,YEL[B</5BXF%@##'.DJ
M^:0IT,/J0G!8I +PYB-*R5$7;RZPRRB15$R53EA*3'@EOS?-45Y)>?\ 0@$E
M9XP2A! &O5(_L\?,X8&(HJYTLR%-<  !Q'773KRFS*,JML+ ^6<-3@XF(L_I
ME0;##'6P8L[:Y:%MPU2A)#KP<\YM1X:3E6!P0V D\8YX5[\\Z]<G@R/[E..E
M3CD0]P;:LMQ)T':O**S)4@I*06YM2VL2'(^QUO7?OH;2I8\UWK( ;!&,!LC.
M,=QR.3R>>#Z=7,H2G (#P '>3IJ?*WE6O@K/.  &EQINP=VOJ=;B*UEO2PJ#
M4KGJD]^M52$[)<+CC3#$1Q@N):1U8+PZRK 'RY !(QZZ^5\4X7@YGC"\5:E!
M10@$,6AV@8J6+W/*]M)KWG"N.9K)<+3@(P\,HYUDNME J8$@'!6D  #E!6!=
MZRFBWZ7\/!:,B87(\.$A*O+;3UI0R@(64M'H)4G!5CG.1R,$^NR7"< X2'4H
ME*4@$A3-R_\ S(Z!YWD1YO%XYF$XF(E*$LM:UP1#J+A14A1+[ A+DL 'JXGZ
M=!2IA)?F93' ^4*[<]QR21ZC'KD'/;IJX;EN4/B+_2!_E L!"O$:!X=ZU\/-
M+QN=?)A@J42WU VDD@ #5R&?9A5O5^W:;/,%R1*GI2S'<0CRV(KN>O/*E/I\
MS/8 9Z>/<<\G-<)RJV/.IF.BB-=?F#6X9MH@;6#C8@YP$88^OZ?K4W_Z*HA[
MC1Q:KAH<>)2Z3!A)>D.);\WRU.M--K(4!_,EI(;R/0]SV^IZW"4X.1R?]LDN
M%8JUDD$-S ,0Y4P@75O:U:><"UXZEJ _2A(+E5B3=@0YNP@:UU=S6K#N9F$X
MN3)8;CK= *&PLE3@Z2>_'T';W]M<WB?!_P#J(Y@6!*KAQ.L8B+"S&!VK9RG$
M%912R4I)5RD-#CZF^DH41W8.;&E LN)0J8] 3+E/)D2F5^8M*6U#RU*4E& >
M.^,Y.0>Q'&K<,X/_ -.R9RY+OC*Q"68?6S_J6J8>5:AA%1F>(*S6,,8(2G_B
M((*@YY8@A*1/5(,&:[I=-89A.H+KQ;*PLE0!()<4#DX]AD9[?; .7$P E*F!
M?L&))+&_1]"1<&M?YI*TL (;R2-&L7O9B[BU01VH##$D];R_Y.I1/J!VQP,
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M$]SVR#GD>F=*#'U&PG1VO/06(>B22XY>@U)8WW$=G%'$M@@%WN 1Z9(/; '
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MP.H/WY!)]R._ID>GW!]CG6UACZ@;"(ZQ.@)+%]1:\5QD?KF&)Z,'!D$@C80
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M22.1V/\ 3'OQEA<*S. ?EI6F5 L!+D6E?3J^XK6SN>_N,V,7#!^4$I2 Q+
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MF,#_ *]PU1PEJ;$P70D?6H<I8(YBE)F [0'>M2O#[$I$?<*(Y!O"T*ZY^5U
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MKQ#B!*T*4S)G_P#,8LM+#E=Y!:,T>'S;J[K+VNH]!N*EM0ZHS5*M(?CIEMK
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M3XPWJ*@2@]0QG'6>_<D8'KV]3]OKG"28.A#;/9HN6L?]V/E'H00+,-@3NU@
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MKI>')=]W'H<4!3JSD=S@=QGC..!Q^^.<<:PK'UGJ$O+-?6^AC5QUJ! !;5G
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M9G&X$V@0SUQ/B3(X2^'+"<'#*R.4J5AH4HI 826(4P2RG@ O%?)5>5/W1O6
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M,5?2;AE$: 79[5T"&C:-_P FU5&LU132E-*4TI765>:W3X+\IPD!MM>,''<
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M*#'_ ,==RQLPOX"IS+:_(<..DE8&#D]N<@GOGOZ#OK8R6'A#+%SS)(/,7+L
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MA^D#?4SU;7]I,;:7/+4, 'J[>N1CWX'ISDZD R#N?$'L^IT;2J8I3S.)=(M
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MM.UP'/'(IP^'*#' *TJ!(!3\Q:ER[E_J.IEC9@+GI=SP7VQ494F"J-6VJ?\
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M%I\-B''\Z2ZMZ0YY3"$(\QQU:E*44]1).2<YU@5B<1Q\R5YK&.,@CE*E2OE
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M!S]^YXXSCMZZOAW#^ (VB(#.)M>PJ"""QZ>_)OS-4LI2@TX %E7E.%/0,CL
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M5QP>.WMV[]\<$XY';G@Z3)[F[/\ =O3=Q(J-!/4!VU )?O'KN*EO%86.D <
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ML'8,-)<#[CSO5<I:RTYU%) 4G'][@GW^Q]?0^AQKJ8B0I!#/ TZBPN/QZ55
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M)8D@^=M2WG5%)#AGLPF.TEX?MMJ:X2XLJ4.G[>W'UQG/H?4#WXU#D.28.C2
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MW V+I>TE]R-R)2H:X4.E7)4[C<J,2=(4W3HJ&OC8P4EYT.*&>@9.-8\<J"B
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MHUYK&,X&#QDC/('<>@S]_;6;!+*/5O??;\7K7QP6<$0"&-I8'Q8_S6/I@P2
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M[:@EO&  23S_ )C YX[:RX,(@/)V$]>I[=ZHL2\P-&TM/Y#VJ!;JNG(&!U<
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M4II2FE*:4II2H5)"DJ2<<@CGZ@C2H(?_ $]8VJ[!CR'&>/EPK.2!\P2H9_\
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MHR8MNQ%.GI\X7)/9GNT^;'6TW!BE$MW*9!6N]T%R6'KMX:-O+Z403B98+*F
MYF+C32P+6L'"G:!&PGAUK-%N*]+"N&W[3AV-2JUX<:)4&+3I_E*C413U_72E
MZ$EQH!#RFW$*\Q\=1=7U+ZB3G6)0<,[=^X]^-:FI\/SZ=]7K=A)'G*PA*LJ5
MR3CN1[GWX'T'KQK&&.(Q .[W=B\7$SXZ5E)9 '-+6UTVZ='+"=X9#B4=74E
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MZ@G) '.!C.QA?%>,O/)P@A@R8Y47)((=I;ST!K7QN#(P,N5 E0.&%D JLH/
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MDW)!4Q;E_70FU*9"E*CSE1*C#J!<;4]45+;<9,;K.8X\SIP.-O,IYEDRQ"3
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MM:D**"H821K&6A^_D1+]/5ZU'EO>O[5N6%I#RLHZB%8&.<^N._)3Z>VL2?\
MN0\R_FT-#OXS K*I(^6% ]"#OKO$S%VBH)!0IQ0Z$]*4!16HXPOKP$D<C!'(
M],^FF,0$%QU\1;U/\5&#B$%P2+NUV(+SX1OKM6N]U^&?9^[Z_4;CK]M?&U.H
MO%Z?)$Z0VIU[*2"&TDX Z0.#\PY/ICR&9^%^$<1XDO/YG""\PKD0HDA_^,<J
M6=)-@-2_E7N.&_'?Q'P[(HX9DLR,/*HYRA')]/UDJQ"?K0')4\,WC6;*11X%
M IM-I-)C^13J?':C1F@5+\IEI(2V@K/S*   YR<]^=>FR^2PLEAI3@)8('*
M\A/0L V\/X/7C,_FLSGLXK&S!YL3&Q"M98 %99RSEPQ.]6;=M]2*#5?@V84=
MYM,8/];CBDJ)Z<J'2...,=^/?7FN*\=5DN)'**8$(PU!V!^L.._IVL:[&3X.
MK,Y9..7+J4EP[#D-H,MV^U7E0JLY5Z9#FO,):<DM!TH0HE !&4D$C)R,\>FN
MQD,Y_=)06#K#7%B=N_A>M''RPR^(M 5^@MULYZMIKXUB;=S8+;#=R;3ZMN!;
MXJSM'A.L0_\ JW8Q2V\X.O/E#D!1"DE1."#_ "]]5XKP/AW$0,7-807BI3R)
M)@<HLXY9(?H2W6NUP;XSXY\/9#.9+AN/\O!S"_FXSI)4HP((4DI,;0]Q704[
M8;:NU[7IUL4JW2U16ZA4)C$43'EA+[C0<>=+ARLJ5V.#CC&<<:TL3X5X.G)X
MB1@?2G#);F+: F$]WTD-%=/.?&'Q%Q3$S^:Q\S\S&7D,I@K*4,5X:&"$#ZW#
M27=C?45?UH;?V?2Z7/B4NDMQ8TN5&>E(#RW$NK:;RST%6"E6,Y QCC]-7@W!
M>'9?AY1A8:4X?S\4D.-3($2YEV@BO/9KBW$L=>'B9I:U8PPB@)48Y6"27YB8
M'6=KU<+EO42' EI334):DELO-%Q1/4,@$GDY3@$>WIK<Q,CDT)+(3)!+$"[Q
M9CVL^UZP9?,YQ>,DE1!'2XM/F+'20:Z9RU+6N:E5&B5.D]4%TLJ<:+JDJ>#0
MRGI4""".>Q^YY.:KR?#,WE3DL1">8J)TL6:2#)#P[>M;/]]Q/(9_^Z0L_2A(
M0HNR2TAG>+>MJQY<>U]A6#:=SW!2: T5-T=U#T9V3(4B2RIQO#/6"1DY^?&%
M# '?!UQN+?#/">%<-S&:3@@<J%."JX,_^.C7LX#&]=W)?%'%^+9S*93$QE*)
MQL-N5 ("@X"I43O$$B]JPOL77;>J5_Q6(MJ0*0Z_3JD1*9FR'WL-! 4UY2^H
MH2<\G.%9![Z\1\$\2R&9X@H86&E*4KQ$D\Q/,RM"W?0%W=R*]G\99/B63X,D
M9G,+Q%*Q,-24'#3AA(*3()423:]M+UO0PU%2Z5!EM Z58Z21U#[$#YO4\8]O
M8?:,9.3YD,E+L9$!VZA[1%K.QGXGA_W"RLJ)@MJ7<P222S_;2N&Q&4>@-H((
M.5$DGIYX3GL<<'M[=L:LI>64$X10! U!%KF '-@;SV%948>/@\TD?4Y@EWT<
M][F#.AGH$6A;@F":W3_XZ'5N)!=5_.KDJP21R2<''?C([:YV+P?)8BN888))
M\=0_Z8^\R:Z2N(YW#PN7YL%,D):&D$O^"WC5*;.H*YCCR(GDR'7"I"RZL@.]
M:5J!2 4I!QD<@Y.M7!X%DQFQB## + N#J&;0_;RJJ.,Y@X 0I84D$A25)#L7
M#\VI -C_ +\W+R_!9_#WOR^;DW'NO9YZ=>5SU^=<U9JC=Q51H/5B;*^*?F(;
M;<"&U*>(<*4@!.<#@DGU(Q,+*H8!"4 6(N!Y]1^*YZL96*L!HB#K9V(9H>T#
MPK?3\S@VA'C6O28$<4NW*5 HU,;4ZXMQFG4Z,Q"B,JZCE1:8:0CJ/)P#W)UX
M[/\ &\LKB*\!D0A -I?I!#: !]:[66R9.73B$EE*)9(#/([,1XFVQ.033:74
M6FICT7*W8[+A5U*2.4 ])[=LY)]SSKM86#D\P@+Y1*4]K6,=_)I)K27FL3+.
MGF'*%J 20"9D3VT9XW+53SXM.2^TA4-#@3&P"IQ0^4!6  "!@9P>/KC'.N;F
M<ME4YQ*.0?\ ;3+BSJAV/6IP,;,XJ%8B%%BLA@ Q+;@WGH7%Y-=JW#IRX\4?
M"IP&E]*?,)">D$ 9/[G^G!UVL/(Y1>&ETB0P(/K:.K:-<L:UEXF92I0YF<@*
M#&^D]&O?J3>7+HM(E(B"3%!2VA90HK4.DG&0%9)Y'(_<9U@S'#LI\@DH  )9
MA<E^FXGUUJ</-8N&%I4H @B%#7[6ZU7P:?3X<%#49L-L)4M0&3D%1PI9.<9/
MKQS[:V\DG!PLLD88"4)'U6N(_P!#<UAQ,RM2RHD$, PZ:>/3H+U6^8T606FT
MK3U*2"3Z\9X_7O\ XZLC%P\5*E(#)"E)(  D7LUZP$\R@5%Y#'8/IM[/6J1T
MMK862P,%2?E"B .3CGL3C.<#]\:UL9N4GE<Q[G][M,5LH$I=6FW4_L34I"VV
M$25AE(!*<_-G/IW[]OTQK&E?(E9" !S#6T:_Q;Q-76"5I^JR6=FW<,?OIOO-
M8>2Z76PR@8 7@'GG&3]Q].,$YX[V3B/S!IO!;3OYA_';&01+G8G1Y!!>8#R)
M\ZGQBG^("TGY4^IR3P?KC[#_ &ULX*B4$M+F.8&QL\D>DO:JJ%F46YK@'H_N
MT3<5&A0]64>P(43QR23Z<<?7'VUD!#0+O 9GV/??M10/_D1(+$/#=;6&]0J?
M2WU$,("DI6H8()P$9P >/0\_?C5,;,#!PE%GU&D.WD6OL1T%4Y>;&2DDN0')
MT<V=Q,,S"1>K0@72Z_4&8JHS8#KRF^HK^<%)SPGU2,G_ '[#A9?BQ7C!+ _4
MSF_ZI9Q=MV9]!77S&22C"Y@LCZ0P=W<7VWMI>]7TIU"G,='8])(]P.#QP1W'
M/OKT2EA3%C8/$/!_(;6N*D%E .))MJ\AV=[-V[&I1< </R'/5Q@8[<=OISG&
M.^JO>#< /U(>;@>ENU6#,>S:@!S9]Q>QDAK5V*#E(/\ P:SHMX_@5CJ/5Z4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI7F%^,5L)NEXH/P[O$1L
M7LW;XN;<6^85CQ[=HBIC$1$_\EW&LZY9JG)+ZD,Q68\6COO/+>5TEME0Y"P-
M/?OWYU9) +F8.][?;PKR.VK\"6^2?%#X,]RMF? G1_ S3]A*[4*]OIN72+[I
M]8K.[-K+H,.+/VVBT2 \\F9'N^?3Q#E/R/*13_BO-: Z.K4'W[<=O'9ZSC$2
MD*22%)(4) +.2 T [%G+]B:L)?X+'C"WZ\+?BFO3=G?>Z=N-[O$WN=N7XA+H
M\.E.IEJUJUY^XMO7'4ZCLU2I-[. UB/'CQZ=0E0$Q76ORV#45P4$(0[U&._L
MVN]ND/>KC'PP0 E+,)Y1]-BW;=W,WAZV;3^'YN[XO/&7X,-[?&WL/3*Q9%I_
MAU4S;'>^F52N=4:G^(BGWY7)S\>&W1Y4:4ZW4/S&15(Z@Z8C<9YEMT%QKB1U
M/OR]Z 5AQ,8<J@D02[@,99DIMLS'>6KZ!MH]I[ V0V]M_:_;&W8UJV/:T=Z)
M0J'&=E2&HC#\EZ8\?.FOR9+JWY4A^2XIUY>5NJZ>E.$B2SQ[]_STK72[222Y
MO=P2#/6]9)2.D >VHJU<Z4II2FE*:4II2I+[*'VEMK Z5I*3V[$8[ZLE12H*
M%P7%54D*!! D-^WD0#X5@FXXBH<EYAP\)62!CLE6%MD'MDI( ![ ^QUZ3 QD
MXF$"+D,2^MC(>WXN[UY+B&"K#6HJ "02S)N)?R&FP'A8DK^_C'/!SS@ 8'8#
MGW YSS[:WLO^A())^H^9.LD:L>E<#$8I$.7+:NT=F=CYW#U:4[ *AC@@8 X(
MX(//H< $]L9SKI8:01 M)@:-:QM9C?S'*Q@ 20 &TMIZ7,]2YL^A/CBV6W-W
MHL2WZ?M5+H?]I;?N*5.%,N&;*@4>7&J5O5.@B>Y(C%*A6+==JJZS3$A70KR$
M(6,ZP8^77B$L2'8,YL))#:]O0R-C)YO#P$@K2EW5]3!W=P'8D!HW:K1\&?AC
MKOAOC7Y3JD[0TP:])M<TBFTIR2\B0BWJ!$HM1NF<IY72*[79C#U3G-)2$F2^
MK (P=9\CE%X9<\P^H&5*L-1+;Z#K)C0XIQ##QP1])4$EH2J3S,P:T,Q?I<FM
M_:0GI*$DJX)3UN*RMPY(\QPC^5:_YU#N"<:WE #.8Q CDPQ%[3?LWD+6YN 2
MK*81_P#=B,3<'F(#@Z]/L\9TF;8V_N_M.Y8UUO5B-1YU1C5#XRW:DJDUF+4:
M/5XU4ILF!44-OKBRHTZ P\A894E2,!0.2=?.^/@'/&X8M%W($#QWUL1%?8/A
MQQPW#V8V,R6(,[L1LX.E6K3/!?L%3(%59DVJJXY=33&<DW)<TANM7'#EQ*W(
MN0U*E5J1%^*I=277ILRKR)5.#"I4J0ZI7 2!H*8G6-";-;OXZUUT A99E.0Y
MW8  $^ UUZ5J7=&\_A=8M6]_#]<^TCE8LNR4[A6A$8E5>@3JE6)MF56/:]PI
M*>I%3I)=D51LQZW4>E*HCCCX6$).H'3M^*Z)1B%'-SL" X8CZ=Y)(9]#(9YJ
MTK?N_P '-V[A;?Q+RLJX6YM5NVI6];E.N"Y(5Z[7VS4;)M6/<3B(;L<R*"_3
M9T"J(,^$TIV,S68(:D):DQFTZF?"==A-:[+ +$EH,DD]_N\&:V(\)U?VONC<
M=RN[/T.?;5DS=O[@^&HD^.(?Y?4F]V;M;JK4"$C#$&EJFH<<IT.,D1F8RT)9
M2$8&HJ%.P=G! <;-KU[SYUZ%J*2X2$DGJSD=OJ,CN?\ #]=8%?J.S#[;>_04
M288NQ&L@%X;1KDOMTHKI*NDH/S+1G(] !C]CR/U/MF"2;N>\^[?:@#.0Q8$'
M70SY;QXNUJ5.X6XDQYH1NHLJ0%*]5$XY4/IR!SZ9/?&N1FL\,',*PPD#EY22
M0 3S!Y-]B+&MS"R*L3"&*"?J"@P>&,@[QO::N)AQM]#3A;*5.)2>GJ^4!7],
M$#/^^-;^7Q#C!)<EPY<GS,[WOVK67AG#))5^EP'F;-?KV'76T;CM.DU6HJF3
M6WBH,(9"FU=*<%. #ZY[_P"FN3G>&JQL^<7Y84#AX8"BA*G:+J<Q8OYUO9;.
MX^%@C#0E2@%%08JW)+@%BT2?WKO(#$2EPH\..E8:90D(#GS*P.0">1@>@X[<
M#76P<)6#A)2G"#@ E@$E]78:;"_DVOC8F-CXBE'"42= 1 \3!U\;U@[>/>0[
M=SZ/!-$=J;-5BOK5B0&4)\M>#P.<#USWXXQG/B/C#XLS/ LSPO+HX9F<T<;&
MQ%+Q,)>&E 2,.$LN202\PQ%M/7?"_P (Y;XAR/$\7%XI@9#'RZ</EP,=&(M2
MTE8',Z 4A+O(EQUK!5^>*3^S=KVY<J;46\JLU>JTQ$9,\J;0FFI9<*B,?*5H
M=!61^O!QKB<3^/LWA<&X1F?^AYQ\QG\[A*PQB8*2V&E+"&"DD& JTQK7O/A/
M^D^7SW%N,Y7%^(LJ@9?AN2Q$8IP\=>&KYREAF48*6 <!Y TKL[ \4INJT*[<
M";51"72:K#@B(B85><J9'6XA0)23U (X&,C.1SQK#A?U$QL/AI4>&KRROFJ?
M"Q?DE0!(8GE=^:6D-K>N?Q?^FR.$<</#$<4&<!RR,=.9PL-900LDE(^;(Y2.
M5K'1Q63K=WG7=%)J\MVB^0BFKA*<;$K_ -13ZE93GI&"D#Y@!@]CCMK>R?QO
MC9O*8B_[5#I +%*'97AH_F[.[5YK._# R><P,).8+J*P%<I = >0"QL6!87>
M7J76]UQ0K;K=Q_DRWQ2T0P&4RRD.?&O*:2WD)&%I)SGD^N!C4\*^(LRK+\8S
MYX9F,=*,! "T+PP@%.(Q" ?TD/)#$B-*V4_"*,_QK@F47Q7"RPS69^6>?#5]
M/*A2W4E)*%%0 Y07D36O&X?BR2YM;NQ6)%GNJCVI8\JO.PQ4%-"4U%D1HY:2
MX >E:BK"U)3D'!SWU?)_%>-QC%^(,NO@N;4C X-@+3AKQ,%86I2B@I2[\JS#
M$39[BO7<!_IM@(^+OA_ 3\090?W'&1@<Z,'%(05)Q3SJPR E:1RN4B'8BM,/
M CXTJ'O)O_3;'A[:/VU+DV]<LQNK_P!H%SU-MTZ,Q(<:<96TG!?#GR'N ,@X
M[^0^%,=66Q5H_P"G8F26,7&Q3AXRD*Q %*!!< PJ&#Q-C ]]_5WX!QN$?#6'
MGE<:'$</_J'RDXF'@G"P^9R.0?5S%@0&9DAB!7MPFX&PU(=^&=466)+GE=8&
M?+96KI5R2"KI[YP..W&OK.-Q].!E^;Y *DH^HJ2@L !N(\.M]/S/F^&@C 0G
M&22I8PW3S!140 'U+/:7@F*QK1MWQ4:I&IZ:-T?%."*E?G)P"6R<CG^;"<^_
M)[Z\]P;XH&>^(TY-6$ ,3#2D""$DB" T,VQ^]>DS?PBK*8"<16:5].!AXA*@
MHW +%Y,EGUFU=W&W)2NIM4]--(ZIO0'B^C"BETH*4^H*>GL,CG[G5.'_ !2K
M$S>'EU(41_UG-X!8@'D1B*2!HX(%F83T%<\_#;)7B',$CY;L02)#A@YWG<Z,
M[6S&WH6BN_E1HRD-_FIA"0I].59=4CJP3R>?KW(QC&M7*?&A1Q/'R9PP>7,X
M@!4UOF*2 'V#6-F;:NCB?"B/[ 9CYT'#YFY0EB$A3@L\[.27V)?854AIT!26
MUE64%65 @!0'&![?[CL-?2_[S^XR_,G"<$ ,>55Q<.X=]8WKPO\ 8LOG^80Y
M4SE0?E)-K-KZ6JT9]I4NH3WY#S3H=>4E16E92GJ&,#'KVY!]>,$:\Z>$)Q\T
M<=2"%D@2!(%N@L">XVKJX.;Q,OE1AA2>0%9(6"I1)V)=A##0>,W<(S,9IB.0
MLEII#8P<Y2D8!//.,8]?\,^APLFG#PP-@ VS/I]_O7&Q%G&Q%1<DAWEP'F3H
M!]M:ZRH"+\0 IEPE+&<I4,#.?E&<GG/;M@^V-<_,9H8&8 ^6E;)"N8I22'>
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ML"LI+@%S))8-:\V-W@=)>\?#C7=O:Y?MMJVNKLFY;-HNPC%'IU6D0Y469*7
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M#3(")$YHS')'F2(Z"MMM8SZ<).3W)&N)G_@+ S&"A Q.;Y2"E(2"[DN7(()
M,D[;:8\#^M_'\/.9O,HR.4YLYC#%Q/F8.&H.A 0GE2""B!( 8@.P-0WIX!+=
MNRAVY3/_ # K+!MUFJHCOQJ;"6Z^U5)?Q3A6VI24 MJ!"5!/;GN3K4RO].<
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MZZIHK)!().3@$8 ],CL,>N!K=PT?0EEK8DP"7CH]P0.H;4S6KBJ5\Q3I2E@
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M6.I/_'IS<P_(&V[[FN)QC+\V"K%2D.  3%@>VQ-:U2U=77T]LD)'N@9""/\
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M7H.#YA>%BJ/R7"DCF3R)8_5<  !V\QO5):].8;I<U"*G&<2948*<1U].0@@
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MH.3[9]!QCC[X'.I9)%@SR[2Q;5_#<]S60D@@%Q!#M:(?N]ZX1'\QUY7FCI2
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MWOKKYU/\A:6L%25?,H\@=C]SGM@>_IQG6?#PSAIY2;%1V(=FZ=WB=:J5A2W
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M_P!.1]/?&H(+_J8&+!_=STTH))9[>[!NT1<"*.ME72"4$< ]21G'';UX^_\
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M0)%K]8G 2H'Y,#N%*QWSWSZ^WTU8OW[[]_XJR"PU\B?)A[+U*>;)Z<]&2
M1Q[\9Y./3[ZJ027Z><ENS'4>&M721+E4$W 8..MQT+1?2H5MC(ZBC(2,'J'
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M3CO]O4_7.IT9AV]^Q58*@;3>]SU_;P-276U!H=([$]BD9Y'H?ZYSZ?3-6+
M:[F'?6_Y]:V$*2%,2T;'H=+QV[[2UH'PSF0"0I/]Y /[GMZ_U([Z@X16GE(E
MP]C9[G75O /O'.V*X)8!M=GM[\;&4AD]+W8CJ0?YT\@?S#/88]LC_$ZU5X'R
M0HI$N()$"[GU:>FDY<3$YN3H% %B),ANS2>^MZAEL]+F4IQR/YADX_\ QP,G
MMG]-9\%16@DL3S$/T%O*XT>M<']()+DZ!_X9F=C482L)4$I25=(XZN/?Z^_T
M^@UF]^_9J2;2SEK7/E]F%266WO,)6T@?PEC[Y/';UY(S]<ZP*!YB[2FUW8=9
MT-S_ #*E!F<MS1+->"'9JY9:4E:2ML<(4GA:<<]@ >1@#N?\-52#8BR2;N W
M4S=HD,(-%$L9.EWO&GIK^*@;9PXC^& 1GNH9(). 0G ]._?U[#0 \XCQ<!SH
M\%V_=M*$CE$V$G7II>3#:^ J&PI+A&$@95P59[COW'^'IV['6V@%^U].KB]R
MSMH2YJJB.6YEFB_>WK^*FGJ+B?Y/YE<]0^GI_P .F(#S.-A!Z$^7K5 2Q$LP
M>SA[M:_BPFBDJ4X2<=@/E)Q^I'MS_35&^[^_"/VH&ES$D C]X=FL\'2I#R7"
MYA* I( Y4H C]#^GU]P-0I(/?Q^]AX@UF0IAL2]@.KWO+:L9+UPMI>1E&>.?
MF3CG/U]/TT(+:C9B/R+L;=F- H&Q=P07!>6ZVZ]XM4#K!5G#?]T)R%H'^I^O
M;G'&IY=@3ZVO?H6,ZOJ7@+$!V\"->VX[Z;"IX;4E#:0  $_]R<\CWX]/;COQ
M[S4<P<](,%AIH&_?K1QI2F\ #([)&%9]N4\8]\8_IC52&+]KZ"7-QH?;U0D<
MSC9C<=.[V^^CURVE:60GCJ*B2 H#VQP>_/'L>?T2W5]9L;_M;IO4%4N-?]>H
M[%FZO,4E19QV)).>H''IZ#CCOK*FP)L'([Q'IYF[U!,F^@G47<_A]-F%<^6?
M+Y&<\=1(/?GL?3WS]^/06(+$EFA@>P<#<EIZ '4""02W6^F^Y^_G4"6L)X.#
MU'MP".!W['/W]\9]:*$EH<6,Q+ ^?=MM)YG@P&F'TVVA[1N-"$*^<9] .#Z\
MY_3GCMSD^O-0+Z:1[N&\ S5, @J_VP9SJ^LR($Z1-MJRKZMI.<]S\V3^N #_
M (#61 /*2\C3IH3.@]0[U4D.-@=-MI +ZN^IKE"%$XR2>GWXY.>>_OV]=0(F
M(WF=P(]8ZNU#NS2S,?\ 46CRJ!""%$$]\Y[=^>W^G/)]0,:A0=78,X?J&T/3
M6QL9,V&M@1.AT;N[GH&:*B2@A1[C(.>>,'/MZ_KQZ=LZJ'9M@ #^6=OSZ5+A
M@8+$-U8!_?0/H\ "TN  Y1D@DJ2",^OS9.!]\>G&I8[Q!\P9@2[@^M06;69:
M6)-[,(BVOH4I/6<* ^;/\Z.KL..G(SSQ_IHX>_>=>QMKM^T &&(),6, ZVUG
MJQ\J]!RGL1R>_K]?\OTUF1^GQ_:JGW[]^=1ZO2FE*:4II2M>_$])NAC9V[56
M>[5F:JVS2C-=H"5JKC-N/5RG,W0[20E#A_,4VZJJ*AJ;0X\E]*%M-J<0G"HU
M9^K=O?N:Z+PJRJG(L6Z2](K$FTF=R;F8VRD7$9;E5>L!N+1S"4Y(GE4^7$%>
M5<**7+F*5(D4M$)Q;CP(?=J4J)=,#QOUCKXU'TZ\KZV_-;/$#&2$G SPD'WP
M?7^G)/KJ&7_Y>GI:WYTBI9.P-M >WA6B?B$9W;INZDZ?M]7[@D.2_"KO_+MZ
M@1V656_!O^C5[:W^RU26V63\17IR:M.@TR.^ZI"VV7W6V@VS*)DJQ! \Q;1[
MEH=@3T;2H",O/S"RI(<@?2;"TAX(U9SO7?\ A*D39#&Y3=)G774]N8]Q6RS9
MDB]GY[U=35'+-H;E\,ARII$TQF*TXN1)9<6MEBNOUF/#*83,=ML%X@)<>C[6
M?L#Z VJ>3 Y4_+43))EY2.6PW+A^YK9R\)JZ3;]<J#$MZ*J)19TM$J/3_P U
ME1U,QP1,CP MLS%1P"M,4+2'UJ(4I(&=3\T(?F+%R2#LY!<:NTR\%KU?"P\
ML5R[D?5RQRL""QU(.FH%X\OMX]WZ_>ECVU3*W7Y=&N*K5*\*/:=0MJN2Z#08
M+WY%1VH-^WY.IC<AZC5*@"J2Y--M& [5D5&4ZZRZAU3:D-1_=(+E(!>"&<DI
MGH+V9C $L]0O"2[86@ !=V>7+#:06ML&J\]F:AN8C?RW(E9N>]KAN-=X[P1=
MPG93<N-8\_9>E6W3AM)=4&G+;%,8E2:J+(;IKE*=#]0J-3W#%4(73UQHLA86
MY 9BP8,(D[O)9^E4"5H'UDDJ=4N[6%^Q]O7I\UV5SSUKXR3CG('/(*DX61R
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M'! WN&=K& T2UB[&TU19+F8Y07DL^Y]#L;!@:F^2YYH40D<GG /N003Z]_\
MG:S$6B7&GFWF^_::O DFQUAH(5T/L;R VZEX# .5D@^@ ^O[@?MGVB7#DDZ]
M3^&B;6L;Y04\A>>I$MU+?ASZBI*3YA'(R>>G@'C@^W/V^FI+OJT0-W^PUT\J
M@$$#;<W\3T]O%<+2L*2 .K@<GGCT^GZ'/I^@O[9G>=C Z^MP*=[&18]Y]7_=
MH7DK*T< G _8]^/7M[9]3GOH1$/9F MLQ<-X]N\I(GH2#VU&K]&WZ1PX%]21
MTY'&<>^,C@ ^G![_ &]G, .4L2SOJ>W=K7FH<> )A_ U*E-.DMX23\JP2, >
MXS@=P.V1]O76KC!2OTDL7D$B/;Q$VVJ4$.2""VYUZ/VN ?5ZF-M+2PVK#@(P
M%)"B/7/IWXX /IQ@>ELOE?F@+5B8B7CE"U!P-0-W.M_-\6)BE"E<J>;<L#N8
M)VZ!YJFG%/E(R5I/7C)<2D$9[ GG.??&K9O$P,NAU8@!#L"H$L-'+6B6(Z35
MLMBK*G^6% W^D%QH9)(\=+C4(@)C+"7%D>;\IZNK!X)!(!''8C[>FM?*Y@9C
M#*\-7,.=20R@0"&+02 P(U[UL8Y!Q$GE"?H&@!AP'&KQT9J[! 4 O). O Y/
M;I2!@=LX//\ P#H8>CG=W;3^0XN8FM92@\AWZ6#GIZ5 0Z$K .1CC!)Y],^W
M/;TQ^FK8EW;33V!I>K!H<I=XF! =MAVTG6C*%]*LD]7ECNHXQDCM]<YSW)YU
MC OU),Z@[OY>%JE9#B(YFTZL1'\WEZFMH4 KDD% &03VYQCWY ]N3ZXT]M$$
MO?O^#>L:B>;M(UGKM[:]1)2K'!(.,9///T^@&- QD>VJ"P-A80+6U8@'UCUD
M--K\U2U*)R,=SC@GD#COG'O^VKAAADF2YF_6[;=!:&J3"0" [ENF_?M:;5&%
M$N$@G&?0G';C//'[\=L^NM;#6"MI)%W/^WMJ-JNWTLT6WL)T<W!T?[0*1DE0
M25GL!R<#!(&.PY/KZ8ULYC_MEA,AQ!D;B=F[U"3RJ 40 SNT=1I#Z-;M5F*@
MSES7%>6HI\U!SD_R]7(R>W P "?ZXUYW &-\^3B%/,7=2FNTW ;5P)ECKT5G
M"^4X"7Y0S) )W8M,7Z.(O61D#"$C&,) QC&./;7ITLP;8>=<DR3W-1:FHII2
MJ1]Q2%IZ"1RCKP O(ZB @I*@4A>3_$3P@CJ4,#!5!Z%O*/\ ?X-C7EO:7CIK
MOYY6ZE>[=M3K#H%W[\6[=+=JQ;BDUNQ:9MA=%Y4.@5:KREP6Z7/%P+MZ#1E,
M093CS=4KM+6T%I2Z0_/?WYT[:D'O[%FK/ \<.U01!ZZ7?#JO@KMD5- MR7(5
M1U6=(MR!-BU13:4A4JHR;OH#$ QD.M2YT^+!;/Q$AM.E+;Z1)OU\NP%IJLK7
MC,VOMJL4N@7#2;TH=<>;1/K5'EVU,5+MV#.N)JW:/.K++)6MJ/5ZO-;?IKT<
M/"73HTZ<4)C,.J;.1N/Y]CTJ&!N!=@;V\(_>._4CQI6_/K%CT&V;%O2HS;TN
M^UZ3#558(IS+]NW)<5RVZY<M.DK(;ETRD5B@26^I*?XL)45W*FGT+4=_O4@,
M[=!V8>9\:OC<SQ-V;8=6N2DJI5>K<JTDH@RZC"@N+H@NV3;G]I*+:4RJ%!::
MK%6@/4QYJ.$CJ-3IK945SF&W&D>#V]Q/A56<O! LX?1CTW9M2_0V[&\55-M/
M:'8N]]T*%4:=<.[=E6S<+E+M^!)FQZ9.J=J4ZY:S&1,6RB.13?S)4=*5J:D3
M>@I;;#_6VEM[;9[]M>U69K!KP/Q( >YZ^=2JYXU-KJ#6J[;<RFW0_4Z#.BTV
M/&C41^8Y7I$G<RU]HE&F-QTNET1+YO&WZ8E 4EV4Q/;JL5M5/"W$0R3^H C6
M ?O4-$6-G=IOV'E-4T7QN[;3VV$-6ON!&JT^MLVY1:0NV)/QU6K:MQ)VULN#
M":!+4AFFWK2*A3)TWJ2PE*&I++ACR&EK  ?XM,0 XU/FXU>]3,L6MN[ZAMB.
MH]:LUOQY6$BNW339],J+,=BKP[:MRF(@+<NJ9<5)A7XO<.CUNE/%E$)RQJM:
M$JCK\U];51G&-!:4I^80F7O!# >/4?MH?"DF7?9]M!K <F&)CK6;MK_$[MWN
MK>TBR;2<KC[@HD:YXU5F4YZ!#G4Z;0[;KZ#&^,2S)3\/2KGHKDI186W\>].A
MH4E452$*2&[=/QKOI%A6T.E332E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-
M*4TI32E-*4TI4*L %6 2 ?OCU&?\M02WO>EXOT[U@O>BUD52D-5J&T%3*82%
M)"4@F,X,N'@ _*GMSQKT' LURYA.$HPHNB?\O_%WO$ '>"\^4^*,@G%RBL<)
M<H20H-H'G])( UB&8-6M-,_N]&0!GI!]AD>N/3D=CC'.O;9V0\$\J=6,@O&N
MI^U?+\ -@X8!CG6P$_Y7NP/?J];B[8X-IPACYO.F<D9_^NH]^3V)].,Y^NOG
M'$O_ *O$\/M7V'@'_P"3<%H&W8-;?KWKSH\8^[NZ5@^(:TJ=:5X7)2:%'LG;
MJK0[4I%;MR!2[HK%5W6JE)NMJ;0JG29M:NZ5'M!EIP4J@U*D/Q&BU+>><0YT
MGGH) &C/([EY&GCOX^FP<-*L+FU),E)C2"S!P+Z$%]JQ'</B'\3U?C7G3W:)
MN):#&\5TT"L[%280M^AU5BSHUS_DU3HM)ES&ZNS1JK-MW\KNJ=-N6&EB/,J<
MB(RTM#&-3[U/GM[[5CQ.7#+  $ I@N;"#>UC+BLHUFM[M6?NBJT[JW:W.DT^
M/M=US;;H-STE_<&BH@6RNX:Q>4\IVPDVQ<DANI1W:;&JM&JC+;?Q+4$T20\D
MN"?V]ZW\/Q1("D62"_1BT&'<$@L[,?"LX^&>BWK1+ZM5O<&[[BO>Z:GL)!KT
M^LW2F"FLMLUJ_P"YI\*ERC3H%,CN"F1'68J'508SSA0HNM)7D!6%3<Q9KM%O
ML*WI4"I[ ! 2M1)/\O?Z$'Z??6%<J[-;SGSJ! >TD,S^K-,OY2#4)=0%_P#K
M)))2GH"T Y&<@)))/')_IK&[/]7A$6#:6/:\[U.G?0Z"SO82&H[U=8Z4J((3
MD@C'8>W&2>^.PXYYU)#Z./#JY+["WVV7M_BY@'<F\QLXW=JY=*LCY%'MG!)
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M.JN-5%#%9:JD]50>:=;DS;C=N:Z9=R3Y2'34*U/3.2A,UE+JWCYB_P#-2'Z
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M':N6C!M]F(TZQ0Y]*C[C0$7F9#C,9"ZU.3TOS*@VS%#4QLVFCD]7-K1NXH(
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MA9;DJ))N[W@@FY?JUX/2>I2RR%)'8D<]P3P,#&?UX]\=]9B L.+V\1O>U8B
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MN)>$:Z'F(+Z8=-VXK-PQ&14E($?KJ5#ITR$VGYT@H5))9Y2ZKJ23JK7=I_\
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MK0W+<VBKVX]V,WJBIP:28\/;6N2:>B?4E-HB,?G3-.>I2E'SD>8H2"$*5A6
M,:,-AY"IGM:WVM;W%9)O3=BR]O+NH=DWUNW$M2O7%2G:O045J U 8JC#$UF
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M6VR&TH"0TVM:E(; Z$J4I20"22I4L4FE , 4RG@1B%1@(48".I/D]*F!Y?\
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MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI7!
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MU0U3J(Q':54]N:C2JT952IR*M$ERG EUNYW]^WUH_9@/?Y?:O6F$$".CH04
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M3GFJ<Y!JS;]6VBW6IZK<Z3-3,0RY!E4^0/(75T.MRHZ9\'\O.2!Y>5&OU]Z
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M54I\)JI5*"$L+Q*@P7HL]N1*C.>6\RPJFU)M]2?+7%(/*H/CX-HVY'C7CO\
MA^TRZJ#XA]U*#5KEW-K41FEW_-JO]LJ;,M^U+BJDW<>GU"F7585N&RJ!3V77
MJ;)DMW>TTW BQKBD.B#$#7ENN*$1MII/2QCPBO:=!R.V,$C^;KS@]PK).,Y&
M#@@@C& -*FN<#).!D@ G') S@$]R!DX]LGWTI3 Y.!D\$X[@=@??&3^^E*YP
M!G  R<GZGW/N>!I2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:
M4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2
MFE*:4II2FE*:4J%2$*QU(2K&".I(.",X(R#VR<?<^YTI4*&FFNKRVFV^I2EJ
MZ$)1U+5RI:ND#*E'E2CR?4G2E>5OXJEWQ;4VPL=J3N37MNV*W<DV!)50;,HE
MTRZA'1"9=$^/-K%TVJFVWZ')\E[XV',=GS6)DIEB.Z8H7'5  !AI["WAUU_-
M>@VRDUJH[1[<36:N_7VI%G4%Q%;E4]-+?JH^ 9!G.T]+T@1E/D%909#Y5GK4
M\\5EQ:IK*&E*:4K@@$Y(!([$@9'ZZ4KA2$+24+2E23W2I(4DX.1E)!!P0#V[
MC.E*BTI32E-*53ON>6A:U ^6V.M12@K7TA)45('RY4C&0$!Y:OY4H*B$E4&?
M?VV->5U-I.QES^-BRMQK.7<MQ[B_F]Y,5)UC82E61&HT=%M.TVI5>XMT9FP-
M!NFY&6DH$.!3INY,^$Z\I#D4?P](?0MH=_/1_44,@_<?Z/I6ZQ\+_A]>O:/N
M=(VBLAZ^X%?;N>%<[M&:F56'765%;-7BK6N0AJI()ZVIC"$2&E*ZFBA7.E0Y
MZ==6(=X%WB'<5Y\;Y[@[CVQ^(58U'L^B7HY:%RQ=O:-=M5HNX$N-94U:G:@9
M#=XTZ-3':%;,ZDPEXIU N:M4BMWNI_S;=#R(;R##C>WI^WOK4MNQEY ZMY6>
MO85DJ+:>K@]L=*D$ <<H4I:D\Y(25' P-303[]WO4W2III2FE*:4II2FE*:4
MII2FE*M2\J+_ &CMZN4#JI:E5FD3J<W&K4=R92I+DMA;*?S"'&>@SY,=LJRM
MJ%4HKJTDI#B%%*@]^_6H?JWY]Q;_ 'I?X4O"UNGL1<]UW!N9N58N[LZLQ':9
M;M;;LR_J9=UE6PU*C2*-MY1:S=NZ=^0H]BTL1%/)@4BB4N=)F"(Y/?DM4^ (
MKV:&S] SZ'R!OX^-;[-**DE1#B02"D.!(/24)(Z1@.!.21A]*7@H*ZT@=.E3
M4W2E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E>''XI6_5A;9[BT"S-Z:=N7=5AW'M:_6+&M6P+J>MZE0MRX-P
MRV(-W7A#8JE!576:0L4YVFTV3-J5-46'_B::L/+#D-WUUC_?45GPPDH=@5.7
MYD@N!H[N+ANK]SZU["5:I5[9?;&M5B6J?4ZG9= ES)JVHS#DMYV R2^ZQ"CQ
M8C+BQ@K;CL(:2<A.>YFL) !+;FLN:5%-*4TI32E-*4TI32E<%*2<D D=B0"1
M@Y'/T//WTI4/EM@)2$("4JZDIZ4X2K)/4D8P%9).1@Y)/<Z4J4Z!U(;''F%1
M2<\-J0DJ"@V<I5D]P<#//)TJ#H^\=#)>O F76/#=>/XA46A;1[7U^V?$C1]W
MZ#4+^W-NUZBU.V:Y:M&0IBXH=,I[OY]/;JDF"\&*(MJ+1'82RMQ%8B ]!>8E
MXG7J??K6="1\LE0"@Q_Q#N]W?T;::]\XCG6AQ/2$EEYQ@I3_ "@MA('2K@K'
M20>I24JSD$' 4J3]Y]3^U8:J]12FE*:4II2FE*:4II2FE*:4II2N,#/5@=6"
M,X&<$@D9[X) )';(&E* !(P  .3@  9)))P/<DD^Y).E*YTI32E-*4TI32E-
<*4TI32E-*4TI32E-*4TI32E-*4TI32E-*5__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g105868g02s39.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g02s39.jpg
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MUR$Y455XF+>2E-,D(B4Q-$$C<W:R)C(V-SAA<7>TM;;_Q  < 0$! 0 " P$
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M R?44=:MI@B4:-!SX>1AA&LI5RK$LR4155;5E)515L2U4G+;K(BKORM4G<W
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MS0*YMSW,G^IP3T8,==,7HI.4KA5_2;HD*Z.7N76]47:_Y;D7Z223-V/W)%<
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MN4YSEZBF\H[E97M\RWAS#FV@!,0.(F\XVOJFX9(</R%I'U,?;E-U,ZB65Y2
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MLYHJ6ZD196[;>M"R>(O^[XWV?T;;GO\ "4XH2C^<H_KL_P R'B*;_P#ET/\
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M'B*;_P#ET/\ W*7_ ,EM=OV=2?0G\#I<W\MKZS7\5/M5,B@% * 4 H!0"@%
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M":<RYH:6Z7#]$(AF:O)$^=\FV%34MO59+7]NR19-""@% * 4 H!0"@% * 4
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M?W3EQH[<G;/\+LZ?A, _4"FBZ-]^A7O'O@QI8@/<(O[IRXT=N3MG^%V=/PF
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MY _5*FB^K_>HOB'/@!I6K'W2#89]_,!VW^[3[C[?_E'('ZI4T7U?[U%\0Y\
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MK0*3>J]:K<Q)'.BC?1R*?)<[M6Z*>>LJV32Y.WE.4L%2Q4MEZY3_  +)H04
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MD7_!G([5'?K\?''ASB+R!5S#JG=*8V(\832%7"^%P,,X(=JCOU^/CCPYQ%Y
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M7Z4%]#I!VBO)D.><F@*FI;>JR6O[=DBR:$% * 4 H!0"@% * 4 H!0"@% *
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MTVR!(\Q" NC'/3R,SYES0LOTF,Z'2#M5>3?\[Y- 5-2V]5DM?V[)%DT(* 4
MH!0"@% * 4 H!0"@% * 4!6V8(_UJQK+8]U!"91Z4'IH=0)&=ZLA)-ZKUJMS
M$@=Z,,]&HI\GSNU?HQWZRK9-+D].4Y2P5+%2V7KE/\"R:$% * 4 H!0"@% *
M 4!U,8TW!9YG6Z;=)C9Y+LGZ1'"V[?&>,8JM%<8XL-8]88[-XBQ5F&5"\IF7
M8MG-6"CRR3R:*"9:&)M>@DB$4=OD#+YN^O(CRM,HC+"I*;3"JLU77-4L]FHS
MX'BF8TE;RR/QC'DE*SI:S*3Q6 *GH^(EL7:X5A3F=Y-!9*!&+V)O'>0X\.4C
M@5K$3@K4=(9!,8\[ 2HA KB<]'!\$J:UDEELEE\99)+K37;9*5MIR07$[QU.
M): !1?&64K\?2V;[:\<LLRH*0:T>++;O\2 LI8..:Q-Z==26X:_;R@""/+.0
M2W5TT0;JO!Y 2D_7;"+1JB3FBJB*LK?V5DU_V7:4[M"XG9V;[?<5N\W0E[=F
M8QMOVHYJ(R)Q(<<1"&3QGN7G\GQ0R/L]$C%FL;M#S*&G7[N'# YV:EH[>*2A
M<4DTP()P^T:;HI-+DZD::9E:JIDHB_BBZU5$GK5"S1W%7QU(1V(GT6P[E NZ
MRP!Q@8'1]S< #R59YD_/I_;E:"B IX_UUG1+'<SC!6499M'KL+8)C!4/,WW+
MWE;0Z S\&LUFTB2G;LL9ROQ35UK8<IIQ5L0OA,++MH),DV.6XW )WB F_="&
M8$YCK(>?!NW<?.\@&M5E4,6  <L/1B2R=4NB5O'PF5 W#'0I+NEX8(#X-;;4
MLGE:[)).2==DY2UJGK0Y@_B?014;A(R:Q-.8V/S/),9QMHV('82[D@G3+^?2
M6W2!RA*)B3;\Z]@9":,69U:<$VL<C3Z%R&/OX@0ELC>.HJQ#X-?C6SE/9U,Y
M2ZY2DGV^K5/'1?B7L\EY/P#CO&V+%7R^5,ZR_#LX8R&6B@TSQ<\B&"\L9A+
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MK/;JU63UF QC/L\91X:)F3#\WR>+9Q*9<SA XSFJ\5&SIR.J"-[60<3Q @\
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MR<S7<-'L$S/"$4BJ1G.>XG;VYE,9R^7F*C.;X%QL!RYJ30"%<10FUW%9+#I
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M+V8F4TDK5LU6K9_J:^U>M3$D=J6UXN3EQHMMPP05+3\$(B\Z(D\1P%^\F4;
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K$[VEB:ZR3K12U@YUUN;VV>III?Z]HK,YI)9>O7L-AJ$% * 4 H!0"@/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g105868g03r21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g03r21.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1+,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $K"^1X0X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%?=D8         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              E0   EL
M 0                         !              );    E0
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    E0    !29VAT
M;&]N9P   EL    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                         /_A/UAH='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N
M8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY-:6-R;W-O
M9G3"KB!7;W)D(&9O<B!-:6-R;W-O9G0@,S8U/"]P9&8Z4')O9'5C97(^"B @
M(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"\B/@H@(" @(" @(" \>&UP.D-R96%T;W)4
M;V]L/DUI8W)O<V]F=,*N(%=O<F0@9F]R($UI8W)O<V]F=" S-C4\+WAM<#I#
M<F5A=&]R5&]O;#X*(" @(" @(" @/'AM<#I#<F5A=&5$871E/C(P,C$M,#,M
M,394,#DZ,C$Z,#@K,#4Z,S \+WAM<#I#<F5A=&5$871E/@H@(" @(" @(" \
M>&UP.DUO9&EF>41A=&4^,C R,2TP,RTQ-E0Q,3HP,CHU,2LP-3HS,#PO>&UP
M.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z365T861A=&%$871E/C(P,C$M
M,#,M,394,3$Z,#(Z-3$K,#4Z,S \+WAM<#I-971A9&%T841A=&4^"B @(" @
M(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D
M9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W1%
M=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C
M945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B/@H@(" @(" @
M(" \>&UP34TZ1&]C=6UE;G1)1#YU=6ED.C<V.48U-31"+3-#,#8M-$8Y12U!
M-3$S+45$-T)!.3$W1#)$.#PO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @
M/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HY-$(U.$4U0C$X.#9%0C$Q038R
M,T(Y,T4S,T1&1C8U,#PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM
M<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C<V.48U-31"+3-#,#8M-$8Y
M12U!-3$S+45$-T)!.3$W1#)$.#PO>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$
M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI3
M97$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D
M/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T
M86YC94E$/GAM<"YI:60Z.3)"-3A%-4(Q.#@V14(Q,4$V,C-".3-%,S-$1D8V
M-3 \+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IW:&5N/C(P,C$M,#,M,394,3$Z,#(Z-#,K,#4Z,S \+W-T179T.G=H96X^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC
M:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HY
M,T(U.$4U0C$X.#9%0C$Q038R,T(Y,T4S,T1&1C8U,#PO<W1%=G0Z:6YS=&%N
M8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,2TP,RTQ
M-E0Q,3HP,CHU,2LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H
M5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]V;F0N
M861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E
M<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYD97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F-O;G9E<G1E9"!F
M<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O
M97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D
M/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T
M86YC94E$/GAM<"YI:60Z.31"-3A%-4(Q.#@V14(Q,4$V,C-".3-%,S-$1D8V
M-3 \+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IW:&5N/C(P,C$M,#,M,394,3$Z,#(Z-3$K,#4Z,S \+W-T179T.G=H96X^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC
M:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @
M(#QX;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z.3-"-3A%
M-4(Q.#@V14(Q,4$V,C-".3-%,S-$1D8V-3 \+W-T4F5F.FEN<W1A;F-E240^
M"B @(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/G5U:60Z-S8Y1C4U-$(M
M,T,P-BTT1CE%+4$U,3,M140W0D$Y,3=$,D0X/"]S=%)E9CID;V-U;65N=$E$
M/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z
M-S8Y1C4U-$(M,T,P-BTT1CE%+4$U,3,M140W0D$Y,3=$,D0X/"]S=%)E9CIO
M<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R
M;VT^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T
M<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/@H@(" @(" @(" \9&,Z
M8W)E871O<CX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D^1V5N83PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^
M"B @(" @(" @(#PO9&,Z8W)E871O<CX*(" @(" @(" @/&1C.F9O<FUA=#YI
M;6%G92]E<'-F/"]D8SIF;W)M870^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N
M/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @
M(" @("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z+R]N<RYA9&]B92YC;VTO<&AO
M=&]S:&]P+S$N,"\B/@H@(" @(" @(" \<&AO=&]S:&]P.D-O;&]R36]D93XT
M/"]P:&]T;W-H;W Z0V]L;W)-;V1E/@H@(" @(" \+W)D9CI$97-C<FEP=&EO
M;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,  0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$(
M )8"7@,!$0 "$0$#$0'_Q  >  $  @$% 0$             !P@& 0(#! D%
M"O_$ %00  $$ 0,# @0"!@<$! <1  $" P0%!@ '$0@2(1,Q%!4B00E1%A@C
M,F%Q%U*!D:&Q\"0S1]%"P=?A)28G-U-BDB@T-38X1DA46&9V=X>8LK6W_\0
M' $! 0 " P$!              $"! ,%!@<(_\0 .A$  0($ P8%! $#! ,
M P   0 1 @,A,01!41)A<8&1\ 6AL<'1!A,BX?$'%#(5(T)2,V)R))*B_]H
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M5N!\VSZ*S_1 E]'2/T^(E+0[*;VSQ]N2ZVD(0[(;96AYY"$DA"77$J<2@'A
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MD!1/<2 !P2K[D^Y/W]]%0MVB)HB:(FB)HB:(FB)HB:(FB)HB\J_Q/H&2+P?
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MPD[Q:87PT,44,+DC_&]##_D 7;:M5A16D;8;<<Y]1M7W"FUI61Y\$D'@$?\
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MN^G9ST0N9"7X:$+*E.=QT)LC$1 F7$ YI"[,W_MY"F:[SP7$^'X2?"<9!'L
M':C@@VS":$ !ZT#4-'%JJOWX76VG7-TB]'V%MWL:EZE,1R5:LUB0*K(I\7<2
MII)C2%LP*E%RI=;:-,(96M-6'8\HK4>%**QJP08N&6!%L$@EWC<YL;6:A 7>
M^)XOZ7Q8$4N/%?>V3"_]N882[#,W!(8FPHS$J[5Y^)GLMB-!'=OJ_)<>R[Y_
M&J+7"LS1&Q.UJI4R?Z9?M+"Z#45B!"]9L/2HPDQV&0DJ</"CKBCQ44L-,VLB
M0&LYM8\MVKKJ_#O Y/B$TC#1RS!$X'W08""!0D/0/G3-U:C8KJ<V\WUP.-G%
M3?P*UI^9D%2(SUM7R6'55M@ME<N-8,*;@S(I2UW1);"^Q]DH4!R3K<D3X(Y<
M,3WK^5"VT:4I8,M3Q3PC$8/&SL+LP1?;,$)BEQ/!67 7_(DAS$";F[6"G^)D
MM).[1"R:KEE7<4AB=#<)"E<I'"7B20"!X Y/MKF$<!M$*VRUUX+K3AY\!(B@
M-QD/8\&-5C><;G8+MQ"C3L\SBIQ2+8/KCP9%Q(;B-27VF%27&6"ODN.)CMK?
M[4@\-I4L\!)XXXL3)@B,,5#5G$3:T-C0@4M1VJMC#^&X_%&(8>3,G;+;7VX-
MIMIV)(! _P 3?0\LDH\@J<EJJR]HKV/;4UI'$R!8PEM/1Y<5YD!I]EU)[%)[
MPH@@^#RD^01K,38(@\(+%B*%FS#[LZY%MVO/PN(P\V*3.@C@FPD@PF$NX%+
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MMAY+QV)PDF*,S),6&B@B_P 8(8S#'"(83M&*$@L7&IU "\,,2WF_$8J_Q/\
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M9099D)0\W("V^UUM+K)94".Q37EM86/"BL%)Y\\#C6<'^Y)CAA_Q9LB_$9T
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M!$B1Z_$<?9>AMJ99??KV9[Z&RHJ3V3)XDR0M(XY6M:UJ(Y6HG79"3)A80PT
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M&&Y@41SRHD\ZXL+A9^&EQP@O%$8B(@0P<O8TH;\=RV_%_&Y?B6+@GB5##+#
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MB1"*$PP@,]*&N^JXJZMAU<>)#B->G&B($)(]9R0&DI(0VV%K4I:R$+0D D^
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MB3*>:82M(1#94I/8.$\*!U,,9@<12XA^1,.TVVQ+ 1"S!A77HL/J6'PH&"/
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M<0  - (B\3-$7<O3^%W7B?U!%C,-.E2I,$N9/,N*=%MQ$S3+@,$+B*4(86A
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MWX:K<7VOZX(]^001_?SHJ[73UVO/U>W^O]?R.BCBF_TUX)\0U_6'^'V]_O\
M;1'&HI[)\0U_6_R_YZ(X-C?OO?1<9FQDK6VIT(*$I4I:P4M\J]0A </""X$M
MJ6IL*[TME"U )6DDCCA:AO7+BN3XAG[+21^8((_OT3:%0XIO"?$-?UO\O^>B
M @V/STNGQ#7];_7]^B.-1I?/1;?BF02"L)X_K?3R .XJ!/@I2#]2AX2?!\Z(
MXU[9_1;OB&_/:2O@<\(25D\D#P$@^>#W<?U?J]@=$<=][PN5*@H<CV_CX/\
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M:IQY+;_/,92 70WW!)<_COFROD&SIRW-G0J>T=$>1I2D#K7ZQ^  !W93LX5
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M^JH=^5V%3U]N:]-ZR.]$KH4:0L./QXK#+KB4]@6XVVE*UA(6L)"U J"4J*4
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MB)HB:(FB)HB:(FB)HB:(N(D%12>24_M![<<<<=O/Y'R"./(/OHL2X?@2#HP
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MV$JB>GBZ^4B,^S\*BM<N8C=M*JVV&XTBT3\Q<=5+<>6NC+>6L,B*9TKFX_\
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GU%DOO:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g105868g05d92.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g05d92.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1NH4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &XR^<%(X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>9U<         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@             !5    :\
M 0                         !              &O   !5
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !5     !29VAT
M;&]N9P   :\    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M2W9?F[*\C+NN]:SU?T7V>XRGZWNQK*W7U,O^W$LNAA_4X):STO3+&_I-K/\
M"7>C_H[54JZ#]:[<5EEG5'TY1:6NK+R1MC(J:Q_I-:SUWU?L[U<BO^9R?MEV
M-_.(COJ[]87,K+NIBRRIK7UMLW.8VW;979[O;<]K&MQ/1NW^OO\ MN0_]+D)
M)0,/^,"IV$;BRXN/ZPQ@J#?;]HNM9<_8=K[F5XU&)D5;*??^LT^I^F4G8OU]
M%%KV9%3;W-8X,:6N!>1C,OV^NS95Z;*\CT6,V4;W_I$2GZN?6"KIUU;>I#[?
M==18<F7ZMI;72YESM++=U=7OV^CZ_P#A+/TCTS^@?6A[LE[NJ3O?8^BEK[:V
M /LQWFHV-+KJ:W8].337L=9]A^U>IC?S:2E.Z;];LBKJ;<C*].[(^SLQ7U6>
MFQK69%UF2_';6WU<=MF#916_U'VY3[/4_3?S"+B8OUSL9<,W*KJG'N;3Z>S=
M]H<&-JL>_P!'^8JL]:S$V?I/L_H?;?7R/50[/J]]9;;+2[K#F5N<'-%;G@F&
MV[/^);3ZE-'I5^S+^S_;,C]9NL4JNA_6AE>:Q_5@77XU=..[WG;96&M?<=^[
MT7W_ *1EEM'_ (8_GDE(*\+Z^TTM]'*8YUEE;[!>66.8)M%K&N;76UU3OU=]
M[/\ C?L7HJWF#ZYC-R_LAJ?BNL:,7<6-+6NIL8XQZ;W.;5E^A<_>_P!2S^:K
MK0+?J_\ 6>VRPCJOH5.J:VNNNRTEKV4OKK/JVEUCOUM]=ES_ /M975^GKWJ-
MWU>^MCY%?6#4?UKW@O,NM!^S7.8[<QGI_P W]FJ_18WI^OC?I=Z2DIP_KH\M
MKLRZA6XLL<]NT/8_[0SU*:_3KK:_
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 /_A/UAH='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_
M(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@
M>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#
M;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @
M(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S
M+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F
M/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D
M9CI0<F]D=6-E<CY-:6-R;W-O9G3"KB!7;W)D(&9O<B!-:6-R;W-O9G0@,S8U
M/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @
M(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X
M;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B/@H@(" @
M(" @(" \>&UP.D-R96%T;W)4;V]L/DUI8W)O<V]F=,*N(%=O<F0@9F]R($UI
M8W)O<V]F=" S-C4\+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @(" @/'AM<#I#
M<F5A=&5$871E/C(P,C$M,#,M,394,#DZ,C$Z,#@K,#4Z,S \+WAM<#I#<F5A
M=&5$871E/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R,2TP,RTQ-E0Q
M,3HP.#HU-BLP-3HS,#PO>&UP.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z
M365T861A=&%$871E/C(P,C$M,#,M,394,3$Z,#@Z-38K,#4Z,S \+WAM<#I-
M971A9&%T841A=&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \
M<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN
M<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @
M(" @(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P
M+S$N,"]S5'EP92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z
M<W12968](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O
M=7)C95)E9B,B/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YU=6ED.C<V
M.48U-31"+3-#,#8M-$8Y12U!-3$S+45$-T)!.3$W1#)$.#PO>&UP34TZ1&]C
M=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HU
M-D9%1#%%-C$Y.#9%0C$Q038R,T(Y,T4S,T1&1C8U,#PO>&UP34TZ26YS=&%N
M8V5)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED
M.C<V.48U-31"+3-#,#8M-$8Y12U!-3$S+45$-T)!.3$W1#)$.#PO>&UP34TZ
M3W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*
M(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z.3A"-3A%-4(Q.#@V
M14(Q,4$V,C-".3-%,S-$1D8V-3 \+W-T179T.FEN<W1A;F-E240^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C$M,#,M,394,3$Z,#@Z-3(K
M,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS
M;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S
M=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V
M960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN
M<W1A;F-E240^>&UP+FEI9#HU-49%1#%%-C$Y.#9%0C$Q038R,T(Y,T4S,T1&
M1C8U,#PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.G=H96X^,C R,2TP,RTQ-E0Q,3HP.#HU-BLP-3HS,#PO<W1%=G0Z=VAE
M;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O
M8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E
M;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T
M.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\+W-T179T.F%C
M=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^9G)O
M;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P
M<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYD97)I=F5D
M/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A
M;65T97)S/F-O;G9E<G1E9"!F<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP
M:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z-39&140Q138Q.3@V
M14(Q,4$V,C-".3-%,S-$1D8V-3 \+W-T179T.FEN<W1A;F-E240^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C$M,#,M,394,3$Z,#@Z-38K
M,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS
M;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S
M=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-
M.DAI<W1O<GD^"B @(" @(" @(#QX;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=%)E9CII;G-T86YC
M94E$/GAM<"YI:60Z-35&140Q138Q.3@V14(Q,4$V,C-".3-%,S-$1D8V-3 \
M+W-T4F5F.FEN<W1A;F-E240^"B @(" @(" @(" @(#QS=%)E9CID;V-U;65N
M=$E$/G5U:60Z-S8Y1C4U-$(M,T,P-BTT1CE%+4$U,3,M140W0D$Y,3=$,D0X
M/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN
M86Q$;V-U;65N=$E$/G5U:60Z-S8Y1C4U-$(M,T,P-BTT1CE%+4$U,3,M140W
M0D$Y,3=$,D0X/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @
M(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N
M/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @
M(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N
M,2\B/@H@(" @(" @(" \9&,Z8W)E871O<CX*(" @(" @(" @(" @/')D9CI3
M97$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^1V5N83PO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO9&,Z8W)E871O<CX*(" @
M(" @(" @/&1C.F9O<FUA=#YI;6%G92]E<'-F/"]D8SIF;W)M870^"B @(" @
M(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D
M9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z
M+R]N<RYA9&]B92YC;VTO<&AO=&]S:&]P+S$N,"\B/@H@(" @(" @(" \<&AO
M=&]S:&]P.D-O;&]R36]D93XT/"]P:&]T;W-H;W Z0V]L;W)-;V1E/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T
M(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_  !$( 5H!M@,!$0 "$0$#$0'_Q  >  $  @(" P$
M            !P@&"0$% @0* __$ &(0   & @( ! ,#! H+"0L- 0$" P0%
M!@ '"!$2$R$Q"11!%2)1%F%QD1<C,CA3=X&AT? 8)"4U4E:3E;&VTR8G*#,T
M0F*2M0H9-T1&55=GEL'A*38Y0T5'5'-U@H>EIO'_Q  = 0$!  (# 0$!
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M9O+W?!?4^F[,AZ]>OF, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , >GI_-_\ # & /0?P'^? Z'YK+)MTE5UC@FB@F=550W[DB:9!.<YOP I
M$1_,& 1IJ?=&K=YUY_:]2W6&O5>B[!,560E81555JUL, Y%G,12IE4D3 Z8.
M0%%<H%$H'#[IC!ZXE/)R.JCDS\MP[MU3Q_IYK_N2[PNOJ:25BX4]@GE546 2
MLV[(QBF0G126/Y[UVHF@B'@Z$Y@[$ ]<2N(,=W?QNTWR/2UJ7;U1:6Y/4VS*
MON&@?,JK)!![ IZQW-=L"'DF+XUV"JACID4[(;O[Q1],C4^LN?7@QT?!VUUO
MQ1.H  >@!UZ '\@>@90<X P!@# & /\ 3]/S8 P!@# 'OW^K & , 8 P!@#
M(INN\-3ZZNVO=<W:\PE<N^UW<BPUW6Y%95.1M;N)0*YD4(LA$CD4.T0.514%
M%$^BF#KO)*F)O^_T$Q^S?P/UU5NG5F[XB8GM476&O$1 6*5J<R_A5554(^QP
MC@S65B7 JI)&*Z9."&26*!1*!B_=,8/7*/"/6?CF2C@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & ?+!\5KEASGT_R[NT=6;OMVE\7J9J.
M!L=9LW&^ K%ZE:?<10<N[!/[RK+H%9Q6LH*))&;LT!9I'B$SKIN"'7$P8U-I
M/A9IJ)64*\:IZZJ;05).'-Y:2=N=N'!6OG,22[=_B3WS25X^'MRGL.ZD]D<)
M>3''>YUG84NG76]8B2;NJ-1/=(BXIL%#*FKCZV%B9"#"",\42;/RO&Z0J@0I
ML3'=X-0O%)J?!-=;9LG%:I^^.-ISZ/JB!J+R;^(AM6@?#I4>\A)'6EBY];XW
MV^7DD:Q$R*U,TTRKP2^OHB(CWJ'D&<HQ#0C]FX7 YB.)85CF/Y1<7?=:\>$7
MFU[Z3/SADVFGH_%N+SI"\\E>\:-/B>\U=.\<.5&JYC:#"^[:UCSJK7$&C[]M
M4$R35@*];Y(C-6XV-@D!&#E[&$5,9L9?PI%\/J(> HABJHE.T6E+PRTX\-(+
M9NW.STCGP\HUXEKJIM/G'IKE_*< YGE<[Y!.MX<7;=MS7>TU(.&:W#5%_K[0
MCANFK]F%.T<5Z;<G*E'(/">B!P.03G$1PI[T2JHL^%+^L>.:RN1I1;\*G3UI
M;)=><3\;OB3<J^7FQ.''&*MVYS7-H:Y-M>2YXRK:+:@JNTU*Z>Q2<,X342,6
M.3NBJ"9VZA2)"L(F!/\ = .92VTLM7R7"_A(B,E\I9'&KN9NSHK@:Q0B-W.M
M,;&V;SZW%JZ#9Z@U-%V?9M]AXVR/B!6:! HK,(UG8W!4T%7-B>E6Z*4Q5BF%
M7L(FVKN[EJ%>VBT>3Z6&NOT_=O6WCG2KD'RIY$[\^&]S4UAR&LUGMTCQUYP\
M:*E4I>_Q,5$[$1@['/LI4\3<DH;^T5)-BNT P>6(F1^8.@8?N]!%DVYLZ;O@
MW3GGDDIO:?$.+1JO#-_'EXL^OWGS==TZ\X:;KM_'A>*;;CB*6@>E+2SE@U*5
MTXD8QI(_99Y0Q8]2R#"+R7Y+MW0BDXL'V<B)3"< '.I-)QI.5[S\.-C'2E<;
M>Y^)HQX4?$;N[*B\VJ[N?E#L^G7S4.FD=BQ-;Y3:E9-;MJ-5=J6.7M1Y&(69
M-;_ N+"]9EBHA%NU+YBC%$%U?FE39$^JA9-7:A7\YXS\,FGDHE\]6[]'\\[R
M0/Q\Y^<T*OR.0H<YN?=&PM?[8X7;HW9"2^[]>0-)=#;JA 2$C W#7$0Q5</6
M-257;@=DWDE5#N$Q %/1,HY*:I:C+\4MZQE$>&BLR-0[*]IUM[]'G,\6=I3.
M9GQ"=?\ PSDN?5SY+J7BU;ME*MJ&@5-_48IO5]5K3-X=5H=B2*B291E98C Z
M:ZPN3%; LD!QZ\(!B7"J<1*RG*Z<KX<RQ'&\9N?V+?;"WMR^^'SI#D1L>W<S
M*3RQ=Q6A(?8%)H5HB8I#955MTVFS!2R'3AU2I.J$U5?&521<-S?M"21C*#][
MNN;KO+)\%'-M:J5?]U(2RM/OC3ZP1G3^2W-SBWMS@3,;,Y6L^4-1YXMU&%LH
M1Z_!LAUU+2]:/8(Z>HZ\3XG"$'!'.1E($7$Q#K)^!0Q0'P9%*B7.G765>ZXM
M\+798SM?7]2DLES@^)8AQ;JO,F/Y9N".B<Y['QKB=9/:7!.:M(59U=1@&\A9
M%?*!W).V)7B!&B8J%32;MA\/[8<# =4J92AK)39N%*MG/S@:^&?R^I;>H\]>
M2NF]<_%<U%NGEDBWG>*&Q]/U/57(&Q:_:6*U)K;?;)O7$$RJ4:LQ0FYA<ZH1
ME7;F5(1BY/\ ,#XDTA+EEIU)W2EIV3CHO"/U@EE$7F,I2XSRX6L[<9)G^%%R
MQY3V3GQOWB?NN];>O.OX7CK3-VT\^_JI!5;:41+RUE8PCLRS*$,<C*!F&SY1
MRQCG1S+HE004,("<?$3;;419/FI=2Y6LO%BRB+>[Y9V\NA,/,G=G)G<GQ*J9
M\/W37(!QQ7IL3QDE>0EBV)$Q$4_LESGAM*%=BZZP<3(>0C$Q::HOI)%#M14B
M3D3]> ABF[PN$YK/A#3ZET<WY1Z^'ZPYR+Y1;ZJFA^*VIU.<#>V;QOUBN4/-
M3O%'6T?==A;B95AP_:M@KI',@$-6%H<6Y$;6_4!5$[U!UX4B>#K(ZHB[NXLI
MNIG/2?5R>L_7+UG0FE_$PY]VCB!K@K7;[N%VX7XA+7C&O=[#6X=:=>4IYX6Y
M$K7&-R&CW4Q'BJ*C@R0 59RB!#&\ F'";O+3_%":6?DH7JXRTR3]T6XW^19>
M:YW<R^$VP?B8:GV!MYQR1<\?^.]1W;JZR6>NQT8^AK#<7*C)=FX:Q:9$%(.-
M4[73:"44TR)E 1Z\66:IJM9)Q\K+C'R15%H>=[S;SOE<DBL<E>8_%?C1LKDC
ML3F1KSDNZG^()]]UO3DM#Q+.]5>\2$*E,IOH)&(6 RM"B#NP;/&[A X@1N8P
MJ$$G027#FJ]W96CE*OYWM'%NBU4\_=G%M;^17SA%SHY_/=IZ-?7&R[JVMKGD
M-J>[V?8CO96N*U3JSKVS(P!INL3^H9!A)JO9:IM7)OLZ0(=L8H$!)50J8G*4
MI2YEN'DW"SCW\/=FX50E;26XO.<*7+_2$[HOY\#FX\QN3.CJKS(Y)<EY+8=>
MOT)?:77]1HUV,BX>)=U?8SJ+:W%_(MDRN7TXHE$R\><IO"D#!PR+X?$W[&TM
MN'-HNM9X^O(9:>L\O?/G-HP'?^\^6?)CXDW)3A_J/D\EQ#U]Q/X\TS:;.;;P
MT.\?[#NEM8'ES2EB=S =_D) HJMVTJW:=>4DW46!4BC@XE2VVE*A<%=O+/A&
M4ZZ:K9N_*^FJB\N7Y%2N3WQ .9$SO71?%.G[OLCU6'XKI;DO6XN(NOHBZNMM
MWTSHT6SD8QE+2"36/H3)5H9Q82LW!P3=+.$"@0A2>"-M+5S_ &DD]>&7!:W#
M7'R^OKDUQQ"/WMO7D1O[X'-^Y(5Y: VTEM7D/6[ HJT8L!L"%;9J1479!8QS
MATS9K34>V;O7C5%8Q4':BR0  %ZS*ENSUMFO%QUMRMD&LUEH5QU'NOF!J7C)
M/-^-#VU-ZC/<[N11-NH:D&OO-X+0B%BD3LS4B(G2J [;)+E!1X9HW66,!%$Q
M+UUDOI935-IF\+];JW G*_[<7ZD^BKX/'*B1Y.<?[<>S;CM&W;KKB^OJK8C7
M^A):_P!@U(11!=G7;A&H+*(R$FV3(?QRR9$/FA PB@0 +EI<K7Q4%?EZ]0;<
M<H& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & :\^2?PP>*7*3
M8<AM384->8.\3]92I5PF=<W^P44UYJ279"5ZXMX9<C>=C@;G5:>4Y3[^5641
M,8Q!  D*_/\ 7ZL%1?B$_#"N?*C3FB.#>GX?3^L>&-(DZ)+6.0<$DS[)J2=)
M=23,T70&:396.,>7KCY1HO)/7!5SN7;T7(F!0%,)1991SF>5\HZ7!LF=\0-(
M2#[C1*/*XJ#_ (F$<?L,BQ=F8LX%1Y64:F[,NR1)Y+Q-6(0(D5(_A*FH'F%]
M<J]>G)&L^? BI;X:7$![6.0U/E]:A.U_E!>EMD[88S$FY>?/W13H4YR%7Z(O
M!/&B@ JS59* HV4#LA^NRC(2F+2Y?-ES]1R]>9^O%/X;_%OAS99^[ZCK-C>7
MNQ1J,(]N^P+;+WNU-X!L;Q-X"-F)Q59Q'PZ(] 1DV$B?A I1[* !A)*6EG=\
MQX^O7I&;:EX-\:](;BW5OC7%"1@ME\@3%-LF<*Y.J61Z* *D8-C$!.,(Y.'G
M.BH#^WK=J'[$1Q"EN+O,$#6#X1W"NP:OA-3JTNSQ<'6-N6'>-6FX&Y2L/<:U
ML6TN%7,Y,0EE9>4^8IO3K*%,V3'P%()0*("4I@0N4++BN-^?@+O5Z>XZA'X.
M/!AO0]GZU3H=H&I;AN% OU^8KW:9>.)JX:V4%:N3RC]X9P\!^=P=1Q*K'64-
M(KJG.IX \)2NZFH?+K;]K@OUN'3NOM\ZPMNG]H01+%0[K$FAIR+,NLU6.W*H
MDNV<LWK8Z;EE(,';=N^8/4#E6;.VZ*Q![( #20K<LO@4EU]\)CA?0:[N. 5I
M%COZN^:>E0-DV79]QF;S;9>EM3%4CJXWGYA51XPC8Q9-!RQ2;"7R7+9!;L3)
M% )&?.W[>95:(>67K+0QW7WP=>%6N+#!VV&@-BR=GKM)M>MXR<L^RK%87Z5$
MN$*M 2=5\<DHL0D,WC5CI1K-N1!-FITL4#J=B))++/CJ_7JX+$P_ _C+$<6!
MX9C04Y;0/V<[C"U.:>K2"Z:3IXI("X2DS@1RB^;O5#.&CM+P+-U  2#Z=#?7
MF"(M&?"AX5Z"9;$:5O7<G;UMHU0U$M\GM"S2FP)9W2A*)"U=H_G5%E8^&2)X
M2I-6HIE3!-,"B $#)"X<A\G*]_U_8]'C_P#"3X5\;-B(;0U[1[(^M,1&R<13
MSW6Z3EQCM?QDNF=%^SHL;,K+-:XDLFH8@"S(!DR]> P" &Q"F8O]7/S'KUZ\
MY,A4^%UQ 4TO&Z!-29H=:Q.Z%M_,HK\I'GS2>REYE*>4E3/O+\TS49)%-4&/
M0) 4!)WT/>(41%O+F#F^?"YX<[*0Y+H7'7S^5_LLIVDVC;ZQY]ZDN\L>NDDT
MJ?-P"R8%/ 2$/Y1%$5V@F$R@")^RB)1-*\K.[SGZ^05H7!0CMN.OPW.,?%W;
M+O>>L8N[J;4E=>AK2Q7&WWN<MTK9JT270FD0GEYA5=1\_:N6K1%HY\:96S)J
MBV21*!1,:QGSS'!:+UZZ'9<M/AV\8^:,U4;5N2MV%"ZT=D^B:_>J':I6CW%O
M!29P4D*^O/0BB3MU"NE.U%&"QC) H<YB]>,P#'2GGGQU71YH$;6OX27".ST'
M3.NVNNYBEQ>A#20ZUF:!:Y>IVV)).*K.)]-S98U0DD_+/.'+EQ+&74%1VLX6
M4,<!..(5N67P''B?C5?A&\):778^I5VAV%E78K=<9R"CHLUNE'*+39T2BFBV
MF$SN057% X)%.Y:**G*X5$RAS^(PCB$M%ZUZ\Q^WAP)ZD^#G&^=VON'<L]1P
MG;COC74=JO9I99ZH]A)^E18+ TC!B%">0@8GGG$SA,WF&-T;T$.\G=4S?GP?
M7U (5T-\)OA#QV6O:]'U<YEU=AU)_K^:-?+!)W7Y*AR0*%=TV!"946"%KJI%
M#)#'L_"GY0%3[\(=#8M'P^*^(/'0OPH>'?'&XN+QKRKW%:83KL[4ZVA;+[8;
M1$46N60JA)B(H\5)N%&E=:.DU3I"1JF(D3Z*40$I3 A>Z.GZY7Y(=?/7Q+5\
M9^->J.)&G*UHC2<.\@=<U)Q..H2+?2"LHY;K6*;?V"4,=ZN4JBH+2<D[5* E
M $RG!,/0H822R0F?AY6*X<JOA@\2.8E^C]H[;J=D:;!:5K\BY&V4&X3-&F+/
M3/,<*?DK:G4(JD:=A.W3@GR;T#E\E44#"9(J9"6 =+MCX3W"K;5<U/6W>NY6
MB):5IW['E E]5VB6U_88VB'2(DYJ;N:@U4GDE#//"95VW>'5%=PLNN<XJ+',
M,A0E%EU#GCZF_F2!$?#IXIP#SC4^A*([C%>)BTXYTP5M./Q3AGEC1\B;>2OG
M&64FG<@(G6<+NU/&9=1101[,(822CD3]>7T\&1=-?"-X5S%*"E)TRU01$-CV
M7:\5:*U=YN!NL%=+<Y6=SK^&LL:H@]9MWBSA419_?1*4P@'J(B*.OF(CHE$?
MJ68XM\0M&<.Z;+TG2%:=P[.R3:UEM4U-2SRPVFUV!P0"+2]BL$B8[Z4>F)]T
M%5C?=*(@4 [RY*/5^>9=9S=EY*$6<P!@# & , 8 P!@# & , 8 P!@# & ,
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M5"AT4Q0.0ANA#H!+V'J 9+RL[2WPAS\U&2T\#YQI&<S/+E/FYL7YRE& , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MYY<CSP48 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M<%\:"R2Q!'H#I*%4*(] /H8HB'L(#[^V!GYWOZ\C]<%& , 8 P!@# & , 8
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M"'N(94H2\IXPEZ\3*A?C?"%;+6U^KRF9Z0X+V5XAUOL,P^@?D-;N@^@"6 D
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M]E/Q'T]O=N'??UZ'\V1U):STN.].;BVB>:=N7PG)Z *S9!'TKTY[B =Q+X
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M0#H?"(CUWT/YP]?K]?7KV'Z==,_#W/3U]1FW'.(6:<RDGF\X\;PE'!C=B B
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MV\025<0;(@(_NW8E* ^,>]1MM3P=X[KQ4I6-5M&QU<$L3">-354_[V"J*?\
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M>3]?3XH-3F6VX9_O1^,G\0VJ/]2(7(IB]GK>?70%E<H& , 8 P!@# & , 8
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MY@X=-N5%/[WN\^FGW_M/W_?N^-LI;[FU;RVW&4V;6)M&(^<6:X3X'8./^3.
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MGSOS*LOWUGB[?I:(@V%92+I'(8*, 8 P!@# & , 8 P!@# & , 8 P!@# &
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MD A#!X@ !Z'+#B=/W^C)WUP?.V76Y^:B]/0!67/'1Y5)%,J3AX6'(+ETD("
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M6O7\T&[P1Y/3PGW&=<,_WH_&3^(;5'^I$+D5EKXYE+*Y0, 8 P!@# & , 8
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MU_[$0N 65P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MO7K^B#=#AC(SKAG^]'XR?Q#:I_U)A<BF%.>H+*Y0, 8 P!@# & , 8 P!@#
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M[YJ)C)]?&TN?V-B'#,!#B/QE ?<-#ZI#_P#Q,+_4<BR71&197*!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , @#DZU,KIRPOB=>9 2%:L20B/0E/#V*,= <!^@D HF[^@ (CZ .:S>ZG8
M,6O/V56%C<_XO%HJMSMGDLV=]^S/%[O;'=V!_9WA@;SW=7*F:=LW;M6%$:RV
ME&N1.,8N#J.8.2F Y5V;94#%'L# HB0X& ?K[_3T'O-C0^]32\YI3GC*3.D;
M11[/:,?#:AX>-BT1$1W:ZJ8C2(B#WLR/B5*L/[\F@?Q06;_MA'-'B?U@V;_N
M_&_WB]>!ZQL'^9O?W^V&Z_\ V2LMKF\/)S$[Y)FAJ3;I<IO":,K<T_*;OKPF
M:1SA<H]^G70D <^.T5^RP,;$<_@PL2JV?X:6Y7-0;3<>S+;-];IV1KO+:=Y;
M%@.F&Y6+M.'0U"NY561A/'R,/$Z2U>S4#I0]-AY!0!]P4EVY98WB_P"D)GPB
M;\_><?=E/<W?L:B)V?#KA?\ VE/?]_>E\S>_:#M-.U]M^U.+0YHIWUMVSTO3
MN[)BO9*8Y1@*.4$Q9SCIPP!@&.6BH5>[1@0]M@(BQQ97*#U-A-1[62:)O6IO
M&U=D;NTE4@<-C_?15\'B3-ZE$, JMJKA;5M//+FYJ>V=T&;WF5<34S'R=D@7
MC<K]R\!T8[98:NF_!)% "QK5!=VNBUC0^6;D3_=X^GI^OJ1KUEURC/XW*\\M
M>-6NM*</N9EDJ!YY9U8]+['1;-)F2(_8UB+D_M2S2<'6D@;(*,HE_8GKB8<(
M.%7:GS:G9%B)%*F 9*6U;6/6?QTT+?<- ZXD<90_#0VJ?]2(7(E"2F>92RF4
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8!&^X8@)[5.Q8GPB8[NF6($2@'8BY1BW+AKT'U'YA%+K\^<7
M;J'7L6UTI2WL^-W4W"=2PZG3+T_$D=C['[8]@[5=G=KE)8.^=W.MNR6'5M6%
MAXK?+V==1QIZ7).:OHDH13S?FJQ#F.<?<52LD2J@/7U!0#!DV&MXFR;/6VIJ
MP<-N,E5W;];^ [7[)5L/:??VRU4]WV6]-L5*B%W7C5NEKDTU!).<LZX5+L/[
M\F@A_P"J&S?S3"/].:/$_K#LW_=^-U_G%Z?@>L;!_F;W_P#[8;K_ /9*RVF;
MP\G(*Y,2"D=HG9AD%/+=O:P^B677[I1W+@6,;I$Z]1.HJZ*0H?43?AWFNWO7
M51NW;'1>MX-5%"F.]57^%4SSF#O'V:X%./VZ[,K$I[^%@;TP-LQDXA8.QM[5
MBUU-V2HHPG4WR)<KL4E!U^"A4.O)AX:+BTN@Z#RH]B@T3]/I]Q$OZ/;.=AT+
M#PZ,-94444):10E2H\$=2WAM5>W;?MNW8G\YMFU[3M5>OX]HQJ\:J^MZV=SF
M9Q!@# & , IA\1/]XYRE_B6O7_8;O_3@&=<,Q_X(_&7\ T-JCU'\U(A0_'Z=
M9%E=\;VRFSM;(%D_&3_"+_U@_IREA\'Y,>,G^$7_ *P?TX$/@_)@3% !,(@!
M2@)A,(@  4 $1'L?3H.O41$ #U]?3!/7KU?WG61L["S/S'V1+1LI\JJ*+G[/
M>MG?RZP>Z2WD**>6H'U(?HWYL [7 & ?B9R@19)N=9(CA<#F10,H0%52IE R
MADTQ'Q' @#V<2@(%^HX)*^7EZSR!W#=-5%!19)-=QXP01.H0JJPID$Z@)$$?
M$IX" )C^ !\)0$1Z#UP)]^7K.VIZ#B=A&D@VB'4O&MI1Z F9QR[ULD^=%#OL
M6[4ZA5E@#H>Q3(;VQPYN/(2O7/([7!1@# & /;WP#JV,W#2;AVTCI:-?NF!@
M(];LWK9RNT./8 5RDBH<Z)A$!#I0I1[#K!)3CG<]EW(,6!2G?/&K,A_,\!G3
MA) I_*2475\(JF*!O*0256/T(^%)-10W1"&, IY&=M2*MT#N$2+.P4,U1,J0
M%7)4BE.H9 @F R@)D,4Z@D ? !@$W78=B3QMPEJ6>:3A!<5@0626%NJ9!<$E
M"G%%<I2F,BJ!1'RU2E.4QB&Z, &*(AT(8*?M@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8!^:R2:Z2J*Q"J(K)G253.'93IJ%$AR& ?02F*(E$!]P
M$<C2::=TU#7%,RIJJHJIKH;IJHJ55-2<.FJERFGHTTFGQ*Y\6UU4=:N:TN(>
M?1[?;::H CV<"04TZ9H&-ZCT!T4RG)]!*8!#T],U>YW&R584MO9]HQ]G;>OL
M<2JC6[_+F\ST/[4,.FOM+A[RPVWA;\W/NC?-+C^UM^Q86-B4\^[74Z7-TY6A
M9#-J>=%2["'_  R*"/\ ZH;*'U_\\(_U'^?TS18G]8=F_P"[L?\ WE/CZOH>
ML;!_F<W]_MANO2?^B8C],MIF]/)RM?(A<)%?3]% GF_EIM^ED=)^O1XJJR1+
MG+I'Z]!37CJ^Y04 P^$2J"40$3=#J=Z5TNK8-F=4/:-OV>W^E3@5?><2G+*K
M#P:D[JS;S@]'^SS#6ST]K]^.KN?P+V.WV\&JTK:]Z[-5N39*J7FJJ-HWAAXE
M,15-*<J&63 .O3Z '0?F_-^'IZ=?U[VQYOZ7KY\SG!1@# & , IA\1,>N#G*
M7^):]!__ $;O([IQGU@CR>EF='J;[>#X<^K@K R?Y0_V*E(^QOL45PE?M$-;
MQOROV>+4/F/F_.\ H>5^V>9UX/7.%O+VJW=MOL>_[;[KC>R]DG[3O^SJ[O<5
M/XN].7=OJCM/8C^#WVP[-+>OW;^#?X:W<]N^^^S^Z?=OO-'M5M'M?XOV3I35
M?M/P1GJ?.+_\H'T >+EB AUZ &TNN_7U[\(A^GU'H/?ZY^7U_E#?]GM3=-WI
MWFLE+E6CE;\7]G@?UH[O^#Y?\/V2NS>?99=;2FHZ<U-SGKX@7^'RQ]^_;: =
MCZ_]$ 'O]68S]H=GW>U2_P#P;S?G9M>H)W?\'O\ T/LFA\^RS:_\4KY]#Z6Z
MY$W:>X-)PE@0V*[O<QH=_&22$,Y!IM!69?U9PU6")7GG+("6P#JB=@$D[:^9
M(%235<(F/YA?TWN3[S_ ^[/OGM?O2V+9_O'M>][7VJPZ>_[3O35WISF[>>J/
MY4?:9_!7^4#M<MR?<OX)>_MX_</X.]E]P^[>WK]G]T>#_$>Q[OY/9?Q<7I<(
MU-:)2W)JF)VI9M4ZM/45=:ZQK=EF=FK:#V9QG;W..ITZZDK3KJ_ZTV:,G6+=
MLI]6OM1REL*DV%\JJ])'LWKQNU63\6TODUED^/N7QGW,Z-90YSYJ%T;O#_9<
M+ O=A<\KI6ZSMRM6'8$!&S5.8;@A-<0FMZ[.M'3.T[$2:1&L+1(*5Y^_5>PM
M%.5Z_P#L&39R8^8+PSLR1/&-TG->?KY^9'>=&LIFZMP:X\>$Z(_>$V%SQM=\
MG*]%3.TX.[R:FU$[+6+-I-*)TUK"(A&CAWK*7H6QWM710N4C95T&+!PS/9;2
M9V,B['Y"(,Q\TKP]?'W>)>.?F].K^D\\WB%QVWSAG&<5O%?5^S:@K,5K:#6M
M4V-TPUM^P]3%@:Y'U\TDZ8G9&?G?6BWIS\Q%1Y7#X9FKM8)TRB7YWAX]5Y_&
M.L3YY"SY-\\XO;](XJ[E]QQDFN4>Q]\Z9EMO06W)>N:WW9N^/KU[O="F:JZD
MM;SG'EDI7Y:=44UUJ]BLQ6O#^>AH>1=4N!.NNBW9@DY6(BZ<EDGZ^+^(3O$S
MP7"%YOF[WZ,P+E)1+7'\N[U:HG2MWVY.VB[Z2=UJ$L6E-G.)-%K6C5PA)OCS
MRXUP_EZMI^)C'3=[(W2H[$A8)C\\VF7DY)+0=D2.FU5N?.R<Q>SUF&HFR%H=
MX?#^\VE-H:Y<<^?%NW_\00E_W66AQ.^'*1Z%RQ;U^%LFAWB59HUVIDJF.A/R
M9%KKQ-I/*ST6@\7C5T]JW]I>8]1"0"/K;EZSBTHWR>:7OSYKU:++2KY1+G/-
M1G:^<))M:DPR%IYNT*W6&K+7?>5]ME?I+%UJ%@31]=D-<;<6D-9OIZ=F-GWB
M#K$/%4N>@=C*'JT?7V4_ NR1\; D5AY<U@<S+6OO722:SGCRNE'SLKS:.'#N
MF^>7)9SSLK)MF*5N_P#.:XNXFGU&[<@OR.GKGKN/L&W-@\>HZCWFI/96#G'.
MQ(*"KLY28F+>5."D6S!%E:Y"NNVK)TL1B:7F/NN'$NU9Q.3CWWY]? LK73.\
M>L^:.@;;$^(71:,UE[59MY7%U<:))GEEXK0<*\EM:S,1?EX2/D(N%A:M\Z9W
M*5=).0DP?Q=M6$JX2<1556X"@6Y>&<VZSZ\A9Y/WRO*2S^B;#ROVKPWY 1-G
M_+ICN5M+;)K&IY^_5IU1;7/5\8QFI4IM5):F:[ ZKLSAX@QE4*?7@.8B0G:)
M*IF5,N$UHV_-_O[V0%5S1E1H4A-<0N)&[JGR=H?'FTLYVP6[6=QUO7Y:]IQ$
M>0\1>WMF:Q;3>-VEK*W6DH&3ASVX3*)N9-*808/ *Z!Q*SF>$YVX.%Q\RM&X
M$N8V\=-+-)NN;KV(UKUDW*C3;!+:RM5;O#Q*Q<,-W1#YC(Q)=8ZK=.HUM?Y2
M!@Z])!0HQ)2?F0K[60G'S1%P.+UE6AI1#;RORY>^\(LI0YRSO;E//QR?,V3<
MBK%+ZPW;P.V3+4S:]@IE.JVZH>[K:XUGL'9KV#DK!0:,S@4YZ"H$#891H5V]
M8OT$'+YB1 CANL3S2*=E-<LLDLDO*-/ +]O=GQUX?6"9V1YD6F^[(CM8O]DZ
M9I<M9N4^PXZR0.EXI*4LAZS2-&/=,QTD2XU%X3YFS2TM;F1S/&03LZ2(D8=!
M9%W%F48G,6E9NZ<O.T.'G\((G-_@U&2X2OG,GXPFZ^?LGR(UNPGJS=X"MR;K
M5!#U1IK>;7H,Y2YJALY#9-DM5E+KR10K-E@K8K(M$VDCL^JJ1BK-G%FJDN+U
M.06)O)J.=G/DVUGD.C>;SE7LX5HC.]WP@W7Y2C & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8!6_792U;>.WZ@)029V1."V%"D*802Z?M/LZ;(0H@ "J
M:5:+.UA*(^CD@CZCFJV5>QWAMV#,4XRPMJPZ8BE=].C$AQ=O$IJJ:4Q/"(]$
M[0M[T[$=C]\)NO&W<]O[.[;5$O\ D^-]YV&JJJ7^'[IC48-"<7PJDIAM60S:
MGG94FPB/]F500^G[$%E^H?\ G='V]._U^^:/$_K!LW_=^-_O%Z_<]8W?_F<W
M_P#[8;K_ /8Z_GZ@MMF\/)RN,V@G;N2=/9 4%6NKJ3.65WV<HD2F[:X0A(4X
M$#O]N2CVT[XO%X3@FX()?03".JQ$L;>VSTV:V/9L3&J34_QF._9855.BJIII
MQ9UBI:-GHFPXE6Z?LVWQC6IQ.U&_-AW9@U*G\56Q;HPZ]OVVGO3>BO:<78'9
M-=[#:=X+'9M3SL8 P!@$?;)V77M55]*RV9G:WT<M*,(@B-/IMGO$H#N25%%N
MHI#U.*EY-)D4X=NI!1J5DS)^V.ETB?>P"F''G:.V;=NV\%<;?3VQI^$AI)*R
M3;JG56CU*M; 6E4U8&FZW79,F]GFR1%?,*-T>626L*#:9[00?-G!OD4$\6K=
M-<I>K;\LD8ZVG6;RI^6D1?/)6*5[@W3M>U<:^?E9W#8I:P/7NF-M7'7L3 /-
M66&@16OXF>E:8W0B9*D5R)L36>15(S"5CKA9+,Y,L=^9%=D=BJT++JT3PT=^
M,19<=.&KL=>&K]\N)OSRNF;+>,EHC*1P?T+;IOY@(FM<<-<3,E\FB"[GY..H
M$2Y<?+(&.F"JWEI&\M,3E\9^@$P=]YC753AT55U?EII=55F[)2[:O/QXG'VO
M:L+8MEQ]KQN\\+9L'$QL3N)55.C#I==7=I;2JJA63:ZI2RHI/C4\-CE P([9
M 1#Q 7\BX[L0]_\ &;KOKZ"/??T^N:I;]W>THKQ;I-?Q55T[SD[:? \R_P L
M792_\3O:VGW79YX9?>P/QJ>&P (BCMKT]^J5'?S]V8!#\_Y_3\^'OS8$F^]B
MVE_S5>23<\-.MUS'^6+LI;^)WO?_ -%V?_\ V6\39;5MHT^U:SB]NMY 8JCR
M=6)<_M.=(G'?9\ ,>:36>R8"LJDS*V9E.LY$53E2*0_9S==YM<.NG$PZ,2FU
M%=*JIE19W4K0])W?MV#O+8MEV_9E5[#;,##Q\)8E/=Q%3B4JJE5JEU*EI1,.
MI<XB:G*\K>'_ "'C9.@WIE*NZ>]A9"[QZ>X-3W2L4F_5^DB29D)^I/+?7F4;
M:&\&#=&2,W;>)_Y/D.D&2J"J:A\K/@]>/B<SKTM^GQL60UCO#4>RW<E7=<61
MA*#68NL.C-FC5=@S"(L<(C,UY6*!R@V3=-%8<Z2O@:%-\F0 17(B<O@"^,]
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MJ-C6QW6E<:,L=FT/.Q@# & >)B%.4Q3E Q3 (&*8/$40$.A 0'L.A#T'T]<
MKY7N)O&FI24Q+UG1VLX&3L"JB\V]BZC#LEY5=5]]I*+/E$&I#.53O_[;,=43
M&,O^V"(F]<!6Y]2O/.75VNJ%PQYESE*I-:J\O<]27F2M,C!P[&.=SS\L$]Z=
M2:[9%,[I;LYC"=43")S&./WC"(QY.\<^'/UX$:LU.D2W\62#Q[J(W[@5I2E
M]^SAM7&/7T"#_P KY@&@R>NXIH#@4!.F"OE"KXQ)XR>/KP^(H#V&-=*Q<.NB
M85=%5,Q,*I1,<IX^*S.'O'9/O^P[7L??]E]ZV?&P/:=WO]QXM#H[W=FGO=V9
MA-3EWD:D@^ U(@!>^1"(^$ #O\A.O8 ]0ZL/H/IWWZ]=_FSKE/9U4JFG[U79
M)?DHO&OY<_$\,?V)8S<_XP8,N9_X.Q(NY;C[Y?E=<=87 _ ;DA*8O]D,EZ]C
MW^0A1'OH0[[&Q?G['T'L?P^E?9Z4U][KEJ'^"F(\%-LE?))NYA_D2VE76_\
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MU#KNNSK QBG,REH>J13"0:F.01*8R#I!5(3%$0$2B(>F"DZ8 P!@# & , 8
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M0@6B]W&53=NY2Y13QTG$/)!60,@^AV[)9,J2J*I#QJZ:\9;]RR+Q]UOC?X&
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MUWKV1T_LBWTZ1J+^>WILZ_54@1E;=PK"5KL%4K17&*4%*%=1C<S9Y%M6J2(
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# A<.?CQ& , 8 P!@#
2& , 8 P!@# & , 8 P!@'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g105868g05j33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g05j33.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1\ 4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'N2^>0@X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>I=P         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              C    *D
M 0                         !              "I    C
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    C     !29VAT
M;&]N9P   *D    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M1BD%A@_TBAO\5M+!^N9PATJG[3Z?JG+Q1B[P"[U/7J_F9_PGI>I]%)3L8F(
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$  @,! 0               04"! 8#!__$ $D1  $# P$%!04% PD%"0
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MV@_T-+MF^/9_#PMT[UV!>H/_ .#'87Y\?^09/^/X^Y'\_P#7^G-G5/ZOJO\
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M]GSZ^W)H8$KN[:,*EK"K6PGK-;%*!KX*JN#8^<MX&KI+.U,B@8YT,5U%,_\
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MC-G'LGND$IW<V #"TEP'^(=.]<[M?NO0]:WH%-4]'=J]G0&UK+"2ZPH^:EK
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MWV.Q:Q7/[![1LL/49VU#ZTWNSEOF*Z>KRP5>2?1K]K"3[;:,L\2.)_OF4?\
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?&D((^)C'3.:OE.% %O+ \%=KA2G")PB<(G")PB__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g105868g08g84.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g08g84.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1\"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'N:^>1 X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>")L         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@             !:P   6L
M 0                         !              %K   !:P
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !:P    !29VAT
M;&]N9P   6L    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MKP):WZA*STA*[Y&/-0D_WYU()W+29(;2OS\O?JA;^]JWUE/M)+%G-1/#%IU
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MD:9C2R(L.1E9*6W)"4KBK8@O:^]'>R&6+['8U[O0_P"S3O&R=9O"OJ]JUK7
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M5XR@ K&/.1:X5A31"A(" E*70E"1W9*$+A#EQMVDI /()?@='?G?ZT) 4V@
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M5##@0_1"ZL$;EV>#5)X)QN=OEG(;^O9\_&>E9S$$/E<C<@'O<+,"N4AS^8N
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M;\@L2.9A")M2I(3^8'EQV&"Q(SRY;MGI1@J^Q5Y&8F S=$!<Z2H;BV-S%N&
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MPUP25* 2H+VE8%QSC\F\C&WUJ$8E$OH3CN6>JC?8JLU22H],G:I/3<.7E*?
M7-1XJU)VPT0PY)W1H0+N E)B(&XAU>\JB,DB1DP;2/KS6*U B^-"PU5:9E92
MV[SFI>45$EXU1AP*6F44N&HI5%@(%8C3$1&"0$P(BRD80KGK0(8!$.8<;0CZ
MB36=8U+5JN0"@(/J2!ZL8=;-V=>E+OBA4VY*%-1(U+GD*)\S:)N7BI<&!&A#
M 62&+\?PE^,ZCI\1 (Y7'U)/8EURZ3HT\+Q:@?&@A^X@M.R (P AT:.+?$)X
MBK'\.ECQ+UO&8FURRYQ--I=.IH1$J=5J6Q:ONDO#FBB7\V+Y>Q.Y<.&@K!7$
M0/4GR.!\-Q/B.)_I\,/5 E ,D  %IRQ.#%>P_IO]/?%?J+X[A?!_#@?]S4-!
MU$@ '7XAPT^+PF2=))_<%X3B_/\ 1]L/HL8JFTWU2V0$*\QH=N$QE)2HD)/[
M;)=@S>D/W8>GM!\A^,\))&@E0M6B.<:RQYKJ:]\XG]&_GYXWAX?%T^$$>+]O
MPB*+;U_,05I4D@%6!E;,^'#QY:8>)>N3]JVS*U^VKBI\NJ;--N.!31,S$"!&
M$*8B2Z9*JQA$4@K2DND)0?X5$A*NN^*^"X_PVJ5X<D@$7$?MU,<[P=YKU;]2
M?H3YK^G>&=7'D:9U_P#V]6K2 <:>%\1QXA,G]I(\3!8VJO[4NC:>24O,U9$S
M.1YM8ARDA()0N:C_ .T0HH2GY)4A (+J2 3UX^G0=1@*_;E/W^M>I?#?#:OB
M8TE6$HZCV\0Q)+\IK "O%S:T*HQ),6=>42<43L*DT?8D,QXKBQQSM03C )#'
MR!\)Q=2 %_\ UY6D8O."YKS=?RCC!>"Z 47WU?\ <LS(*V:+K,VGVKM#U$,S
M!D(%0ID[*PQ$7)U!4-*E(+@D$#<7)8 ##."&?K@^(T?]/J\/$(!U<F0I_P!I
M(#'-& )KP_B/A.)\&0.,O%MXA)6#IU:@#<EHWJVZZ:Z6-X>]/*SJ9?\ 5)F2
MMVB)@P?+E88CS]5G9R+!3*P*; 6?QHQ$.93Y14-P"U!3I2>M_#?"\;XWB:>%
M\/.H@F/# 8#>LZ=(D@2;%[&GPWP?%^+U#3P0225< "0 'J0)/BTK<>(_[17-
MNVOMG/#O6[FIM&J5HZD6U*5ZI)IT.MU.5H*Z;3BK:E$>J0I:M*G96$#^94-*
ML< LW7LW'_2'S/@< \;5_IK3I\>H'5PWN@1Q=;@A#PRCB_<\?]/<?X<'5J+_
M &Q_:"29#7&U#3/BE2!^VZ'7BG56#5)&3GI*<AQY2>DH,]+3""=D6#-)!EE)
M+DA*DJ!&<X=R">O3@.)HXVKA<0DD?^H(+M 'JZZ'BZ!P]6K3JTD'3JU#4/$5
M'?5'*(-/JU7EJ%3)BI3\=2H<M"4I<."05+6 2 D*+A?L'2'=WX'+P]&K7J&F
M6>0@.Y5SWY5Q #!4NY4SN?OZUCZAZG4Z;$)$>EU2G2TY,B# F)J+"CI6J,MD
MJ4(82N&DN" 'P6R>M\;AZN&-H0U()M!_N-]S$)# !%OK*WL!'F><EUE!,P@D
MPA%]3E/F;CZ<#U!_26_,YQSQWX]N@]^^U:/"UC1X@=4@D C!8"),=\J*PAKG
MKI:/AST[K^IVHU5BP+>HJ8'F2\&4WS<_,SLRJ!*2-+*(A$>=F-R F& 7+*2P
M=/6F"&0 @B0YP(R22#V. 0.X_37Z:^:?J7YCPO@/@]6G5KXGBU'Q'A:1HTZ=
M6D#5J&KC<./W:0 2#J+\,@@8.\)GCLTI\7<O7I;3Y=R46N6M&2FL4*[:9#DJ
MXB44Z(=1@2T.((423C+<"*4D98 $ =9TD$9+&8R)W/,($;6-=[^K_P!#?-/T
MNM7Q'@T<,ZAH\0/#?B()\/A'Q/'+(1&IEJP\0!W?@K*T)\V, I(_$R4G<'/Y
M=V'#8"B07'(ZI&UF5(-O?^:]%X>K]I&HO6%XC91+$X%P@^;%3QE0U0C^(H>G
M<"%J2XX'JP,_4'I+Y]/M5@ALZG<N "G:!OZ6ILNM'D0P(J0P+Y!5R7#DD/GV
M)ZE $P':,@VF#!+*1"$G>O$ZG,; OE2%A*EVE6TE08':9".",EWVJ(=@4AV(
M/3\'<XY4<#)"1!39F^ZYN^:OEKI MJWV6AOV)2C^;R^9& 3Z4@ 9[_Q?F.2>
MFW0#>P6:R=))) 8)W'\>\F]>CYW9(+D. > IVX&0"P(/<LY!)549)1 9$F[=
MN5C;-Z8 0-KEF(=R&<D$L7/T.4A\$G/2H/\ RW<FP;+A.]Y*(BQ4\ER<8/(/
M&&SD'D_Y@]*.6#Y I V(3#S>]E>F#^DI?/P![GDDMV8@ ^W2J</-R-[@6+')
M8%U0<502LE2%D>4J*5I+E0EXD-0AABY*P5[7)8 A+;B"]Y\_?E5115R7M8C(
MLU:",ELUSUA^"BIT"F6A%TWU5C6Y?EF:M^)/4"D734;6DKDI46@>)Z_[DO&]
M[%JMNQ(\E)3TA)3]4EURU0@5"!4I"I6S2YM:MDY,0XQ<_?+KV[57:#*C;<VP
MYQ:TUM]I%IK1M+M)+'TJID:9GJ19-HTJR9>=FEK,Y49.D4P4_P"_QXJ$PA#G
M*C#3][FC )7!F8\6#YRUPG"1!]^U[=0$$DCZW NP;*X,"42W0VBU%IM*L&1I
MTE!B0924J5:3!AQ)N9CJ 759I:@8TQ'B1XAW*)_$B*4. H  =5GEW1^MKU))
M.XV:*W1N&#$BTF!JEX__  JUWQ(63;<O9LY3I*Y[1J<6J22*OYOW&=@1H1@Q
MI>+$$5*4[WP5$K!RG;SUZS^I/E'%^:<+AZ^&1_VM.K3J! (\)(/_ "T&-AUP
MCZ'^O_TMQ/U1\GXGPO UZ=/'TG5X/&=8"U)"->C]Q(8)/=Q6//L_?"'=?AWI
M]TUV^HU-5<MP(@RJ:91COILG(PR2B"@*C+AJ7$4?-,=4,1UE++BJ&#P?ICY9
MQ?E_"(XFK3<H +PG'^XIX=[E372_TD_07Q'Z-T?$ZOCN-H/'X\:1I.M:-%Y.
MGB\4,@1DC9D5TVA2R4PBF)^',18?FJ(<,LC:Y 44!T)2 D>EP^PG/7MNG6)T
M>(8)%S^ GN#-[U]<XAX>GXGB<31.DZ@6S("&5JN K$O>M-=8]![DKMW1;EMH
MRDU*5&'*HG9>:CQ(46$J&I:C$A1!%$11BF.?,AK.Q 0@I2-RG_"7_P!07_T^
M_-OUY^HN%\S^5C3_ *?_ '/'XP-7]YT:EJU:_F?PNL!A_M#!T@#)KV/X'YEP
M^'PP=1\)#LRPT"(,;R&#RG-&ANFL?3^AS\*M*@1JA6)L3,9$#,* (0B!((0K
M;N(6 I3!2MJ2HJ5D?>_Z%_TRT_TU_3OQ/PVK4/\ J/CS\/K^( \>E:OA]/$
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M;8:R<5V(^S<\%-8\(>F%P4R]JQ3:]?%\UZ'7J]%I$1<:DTY4K+JEI25D(NV
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M2=17^SB\-V:)U NRFMJM"]2YG5C3^E73,RT&4G8J8D*>EH"M\LB:@K"%(@N
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M0,U@\+22=1?B?BG62 29,$^?V%$H@PV4>^W8X40D@C("0 !@%OY=9KEU:B-
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MY( _JP_D>W_/I6SWQSM+Y+>_(H4T." 0S@\')8,&^1EW[GI4$N+#:2$4@(Y
MLQUH6,XBR38]48 ]W\I;G^@5\GYZ>_?OZU'(D9,0/]^<>R**RH9[,X(Y=()
M#]R, '(/Z]*#R(R2+ K(YJV-PJ10(!8$%F&0,%P[=BW^7TZ560RCRON(P9._
M) AT.?3,00^?(B.^0P/&<\_^&ZN#U'WHB?"8:O\ =(B(GZ0001D<DEB&]QG)
MX8,>>V1U*D':UP$$8*_*;"*%G,S%+9/MV41O;N &)^A]^54-P0F.;@YG9',$
MQ42\3*3C\BA\AQS_ $./U[GI0AD\E<18QR5WN9!BI",G?R!@GL"2!ENY;]'^
M.E/_ !%B%R#GU!/(PK&D;<X?/&/@>_NV1CVSTI=@[DIQ._? -W"J )(F8I.W
M_!0.'X/<\?'UX]Q<#N_>WW=07-S \)SG8&27!%F2(HE@')<D'O[$OG'.&//;
MJ4=R/W=FDT;E"Y[8!JD@ER 'W'#8=C^HPHCY/P>E (,D;D@7D&\PL&'UH6 6
MCS 9W!/Q@_&&+_\ #I6@BC>,W73,P=^<42E0(4[@< %^W^6?CZ^W2IMS8#ZP
M>S"+9:RQ1=B2'XPK#\C!QV ?W;XZ5EN\1=6(1<;DE$2'%Q0LD$F%P/\ &B'Y
M#J(8]B&'Z=4]%[^]ZH* =F=I[7@V7<47N+D#/J]L@DX<'L6Y[.#U*$&S;3;#
M)YG90HWF"PK(,0\@() [8 <GV([Y_P QTH[F23B#X0<)_43#4TDJ1Y"%,P('
M'.7+D?10)_RZIN5O6@2AJ.1:,F%:)-RYEU20Z4E_X>& &6R7XR>>1U*R@SMJ
M&-YG,W"2+(P:J.2(2GP6"0Y8\9/T=LCH+C-4@:HS=@;- VE8*512^8$(.<H+
M@<X4<XY;GGZ]NJ;G[UD$3   5Y)MB)#E;D&O&ZD &P+W''_12O@GNR*5,1$A
M^PW,_!+,>I6M+CFW9,$3U?7DA%7NUHJA;-N@)<?L*D%\\JI\N3Q\D]*J)MJ0
M9A YGUKT)/+EAZF)[!U D>^0#\ CL_2LE@R&'!/>X:,-!@N]Y3;APQ8#W )
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M@?GMU*!' ,+JG(:+P;*#(LISN!(4S@YSCCG/+^_T=NE5D2;!X2V02Z"^Y1U
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M1)  &"3^8#)[%/( )UI_N'?M%34E<[C DO-[XMFB"IEQ 2$_DRQ+^DGAB/\
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M2N C# $\WDI)1ZA$0 P?.[CDG/L06Y</U0'Y3GW]KU"08L$%?IW08;&TH$'
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M  RP(P6.T\#/5%B._<?Y^UR%< @(VS<L).+7R2\$$M3@<;GP3N( <AP [\\
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MFPOG// Q]ZL,F I:((<S@[)[@9%%$,[I+=F)X&?5EG?AR,/G!ZE"5@ E DR
M\>3)L.9=(^ =C\_E# <N^2/U?GI4880%HO8V ODG%HQ DDQ@DA(+QE/@L?40
MY/!8$,<_+GJG[#MN.4OZY=-,C;DS)D]!;$\Q:C5*?(RR@&SC.7(.T]B'XYSU
M*I*)8F2,0AVQY Q@PJ(!C!DDF&1DJ#D)<C)8.22W\0))+9*LF0#;[ E^(9.
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M9.,]N_0W-KXMVY5!9[0)M^T<NQV9,)U(2-KCABSY<N0P+<>W&2_TE"4%XC"
M 8-@=XNI!2W=0QE?@J4IPQ0Q.",D]_ET#WQWZ518DJ5W42BDASS!M4R3N0D#
M@0PZC_FW)_(>.7'2D%,A@E[=.LCRI X+C"<CX!8?J"Q+9_W]*D%HY!;3[).S
MB\7F@YPO"8.?Q88(&']3#]?D'+GJB_8_0^_2LFQ6P>-K"Z,8%@CBC2&2#V&U
MW<DLGX..W;OV[2MAV,*8-DN20//!NBZ!<D;B6&0!R"/<Y)Y ]G?MTI<$ D.
MS@;6-NMI-"3N(08.RDI .7 4027^ISD@N>#U=,D(J\]JR3TW(_\ QASLCS!Y
M"BR#O7R'"/=B&5G Y<, YR.,]2MG_=BP8W3WV-XALPZ0'(P^<DL[@\D?S!RW
M&,.%0P .H$&Y:(D]=QN&C%'X03^7S48X(!([#+?Y_KU1]C[[T1>X<<R#; AG
M/*40"%L-Q+_E=OH??Z\@_P ^I0IEBZ&6TK9O<9P35)+IRVUB5$8PP(+?S'Z=
M*F40(*M#)?FA #1,JU"QO\>1&""N(WZPE/\ # <?&.K@WQTSY';O4)L]KF[(
M/H"CRBB5,%%7^KS]3C^C!WX8_/4JW!%@@0,ER;WRE'HF'(8%P4G+?#L6#GZC
M&!\,JF[8Z!%%$,N,#;;J.1_>)<.P\J(0'<X2Q^6/Z_S/5P>H^_YH S!/]J!7
M/$W&T+ 5$A][C*0 2[N6'('Z @<#''4K(0DA*,&^X6V;P0<"E269\OM[=^!^
MA)#'XSSTJA$I-DMB1'8;[^=1++3(!X,-O8@'<Y_H0#]1VZ5HLN#8JRD#S[@_
MB;X2#V !/('\0XSCOW?E\*P2!(,)+D9\BX2,[@MAQW +'#_#C.1GMS\]*<MP
M.P!+$+( ]!0X;[S%3ES 03QQEASR#\YY[YN.Y^@_'^<5R3$Z6/\ )'7"B;02
MY3VY8ACC <;N2'/PWT?$I!=PS8@)PU8$P=BMYISC 4& SGW *CCVVDN>V![]
M*LE7$ERUZE<H31B*%@XCQP3C:HD]AZAGYP7_ %Z51D"!@[X-]K3:*(RX;+8V
MG+N'?YP!D]F;WZ5D,0F06# "+4NQ< <^=4[!@!@ET\ $X9_?N''2A,RK*"H?
MFKC4&5)ZBR;>22S_ (J\'D'<IF(/\\=75?L/H*!H7!!M-B>>W=9NJ,R03D!R
M".Q8'.0"Q.",.>.W4JK(!4FX;@,3>YS/,T,IOQ S$PSM/8 I&0W#@DJ^2!V'
M2DB^ZC-I.-@+%$T^6 ,NDC#I'/#AB,'Y]ST-S4TM%LP!?<8B((=]\4\9 ..V
M$X(Q]#[/THU)YL@-G!9C)7^ &3!)AESSR!Q[,#D=\]OZ=/?^*6$6DGQ3AR(*
M8N0]HBDE@T"&/S."S%F!)8=PY.?TR.J;GJ: L(%'PC!^O3ZP37BM2R$V#?3%
MRFTJ\K+N?,ID>&2_##D.^?C/4]^7OO6AB\'*,OS<P0EF6*OMK;!;-NC):ATH
M.&SMD8 ?/<LY^7Z5DC2R].JYL_S5_P#XRPW!_4[8<##GD!N!D9'?*J4R2N]S
M@)Q=[B64G2%TG:DI(=@&_*"2_'/#>['OGI4$R>9@A,;/I=J S@5PK#GD!QW'
M 'N<^WUZ4&YL2&<9#/<3)")$N:2=S.<@,6''ZY8'W/T/2C@H&;,IG?K:!G^W
M-(^UR-OI#X'(4S9/ _E_F>E4(J<PR[/G!4N1(6 ->]>/$QIEX>8FG\K?D]-0
MZEJ9?%JV%:%,D)=4U-3]9NBXZ-;,LM;-#E:?)3U<D%3TW,Q(2$)CPTPO,B'9
MT[>^]22^X4A3N(9N;NUJS]YJ8J2M'KA^4J(Z"-RDB'^'M2<J$4*64J3Z2$)S
MGI5,;H6B6T$X*'YFL>:3%7[GP@&&RKUL,LLK:*G-%!4 X#I98'L>S ]06'(*
MQ'H:I DM;Y_FRA]I+R)'<HC90_DEV5CGDX^O6A<9FLVTGEF1<VW$+D><TZ#N
M5!@D[!Z$C!R<8?TL<C]<]^AN>M$/VEJ.<]X(OY*$*=%4I$-2E;6 X!(!4??&
M'/<9XQUDZAI#)0@/J4*NG220 4#S!G>1E,>FU81U>U@D=.)61@Q9/]H5&J12
MB7DT+B /"AKC.HI2HIALEE*VX=R!U\8_J]_5WA_TM^7_  _QFCY?POF?&XVL
M:/\ 1XG%XW"T:3JUZ- >K@\+BZC/$!*TP'M79_"?+]/Q(/CXNK2&2 -(.HHD
M-- 7N3A5?M*]2)#4>CQZG @*DXTC$@RLY++4HB''5!"R$*)!6ARH!1 !8A@0
M1UW_ /3#^HGPO]2/D ^<<'@:/A>-HU:-/Q'PW#U\3B:.$>(-1T+7Q.'PSJ?@
MU6TXJ?,?EX^!_P!)<4<33Q1K() !'@\+TY7]PD9!-92;<D;5)4GE_P#>^7;L
M_P#/CKZ376A9(!#:@R1<PR-QF_,.=Q"#JAAXD,!B7PI\L,G]1U=-WL#]%GF>
M=0I01*)B[1DPLP3;T,2"WH4EPSC.W\N'+. 3E@,#YZE6,FZ8U%$?2<,G&:K\
MI)&P$85E3#ANQRY(^A^O2B1 ?/=E)F7SVQU#GMWD^LPQZH:7)5@LIR"P8EQG
MWY]NM:;CV]QY/O4U(B^)F;Y0.2"N44802I>U22#LP27!VD#C#'!#<L>LU2IL
M"PCT#[$3)%B+U12Y!)0_=S[L[>G+_I_7I42<W P83R6B%$Q,10T=DI0RD[3$
MA@9+_G^ '; S]<]4?8_2*MC<$O"FS)!?.UGB:**@5L%)*B 0"6PX.<'D@X[_
M  PZE#+9 $98:.X&X/9\PT)6"0"@G:[$G!8@<#\H' [N>E0 *5S$2+-@V<S8
M@)*AXP)F)/=LPM;@$O\ X2PXP &8_P#EU=^7K0R !8C=" 5$FX?:YH@A67*,
M[0[J'L?;^+W/\^I5 $%BQ=DUM$ .(0[TNU1W%T/S@EOU_P!Y;@?R4(4 RK95
MX,EQ80C;<4A0F8!&PM!B,7)_7@$9+?/&.KCN/O3-Q8O$F]V,!WB5(HL%3.2@
MAV=SWPH9!?.0./T'4H4DTP5S D,@-*^9-S-( 4D!T #:1DDG)<Y#!TCM_$/I
MTI+OI)L1L(8\]^PN#"LK^\I V.88 ))< N^&SD%@YPWOTH;SD69N$IM)(D(#
M>[G4#@;DL!P2Q&/C],]OE^E0F R!D+I#C&T-X5-+MM*D$E)2/ZMV9V^<=*$+
M3B]B2A-HOW#\J&VM'B@E.8"'<EV^" 06R,-@OCJX[GI"_-:EXM9?38%3=&BM
MIX!3Z6?U$'!<N6+]N?;D9ZE0A22;R0N:N)0)Y\DE14DMZD9!W$GMM<A.,8+]
MO]W2I@@X:DDY!=QR^Z1H6 E0CQBZ#ACEOXB"0&;+#/![^W3'G]JMF-KW@%EH
M3ME@<I)6U7?8>SDD%_; [XQV[=*@6ZO8(VA90%B@Q<,FDVJ! =+%P')))(^G
M(Y&?H.E6,$7>[D_FX$).('D]X@D IQ$6[J.'6K<' ?Z<9ZIOV%N@ZVS]J@""
M?^XC,O>5@[A8)HG)?U)4,X+Y/)X' ;#>WOU*I!F0!+DE/K$N\&?.!:5;HFY0
M 3!( !/\08L/9V&>'!'.%!<[@AWL-WYCS)*9?+@F"@ H("(?!)&"Y[#D[CC+
ML,-T-S_CTQ0,AO!?:Q,,L 7Q@M4Y(7M271M^I#@/@XY_R+MTHF64"8"9DB\$
MBWI)5,C@F&Q5## D>HA_<<-_,_UZ"X]_FFJ1?T(]"[+J!(V-2P @H!4CA@ <
M%G(!^G+>V<XZIN>IO?O4"0_D;"X', F;<S7B]3$C^SR^B'(-J5D )!+-3YE^
M>S@_0?IU*T 0N[)FY"G,1$.KU:P"[:M]0*DO1:9C 9I*"."K''2L^-$A.3G<
MO:O0L">"64X/L2KA\ A)<G&. Z@>E#!*(!18EW)\SG82(IH!.U]I(!+CG#A)
M#$NDC'#X[' 5(#4HH/U!@/.3ME&@7+A((Y)<J=^S!V]V8GXY96NK":GG!DF\
MCF&&DZ"2-QPV<-NS[M@!N>QY<#+J@!NCA =+<AN2(0DTB=RCE0#C@#D#@D/C
ME^!VSVZ4Y8!B^2US:N8C%SKGXG-(*KK-85!MVA3E/D*A1M6="K_F)NI1(L.
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M22  Q]7#@E]O( !^7 ;JFYZ[OUS60(+4E!Q;EAR"7ZW\7J8?_5_?0+.+2K1
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MZ^+7D-/9&QE^)*6IJJE1HLI^^E6LZWJ-*3,A!2I*ZF4Q8R%SZ)6+!/ED)30
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M6B+"B1XR (DT(:@F'&)/J]21_%R_+\??OZ5_-_F'S3Y%PM7S#Q?ZRTD$^&Q
M86G#-B^=?+/US\%\M^!^;<;A_ <,:>%< :B9>J2PV3!/(@[UL3"$01%!2TD%
M&!M^4D$Y]B1CY<GKZ;JU/BG3X2%I_N<%$!+>:]'TZ=8 .K4/"X" 13>7#Z=0
MJJ>4!!\WD)4"7'8J*0,\-[=RYZWI3#MS]_6*I8&1&\W&1C&X0LT3 '63W.Q3
M#G\I&URSA\M@,2XYZE:(B66AB+LYGSF!BHU("AM(!"F?<>SN<\!R P9OZ=*S
MOLR"))Y"Q#9;DS!BL$:GZ"6IJ/4Y:N3\Q/4ZHP_)EXTQ(K2@Q9=]NPN#ZB"
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M$C!&Y@2Y=GR_?@DX^>_'4J"V4(!6ZV?(@PRD2#2N'=W(+I=FX[NWZ>Q=NE2
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M.!"CD]QL(.,'@=W+_4?K$>7F/S4!A@& F!]=]U"0%JHS3)(\J-C!=!2V';)
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MC^&:OBLQNK.=Q*$V1Q=23]X!<F%&;@LE0!)[9!"7!X'/TZ+F/,=L_P"*@)
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MNTM-$K50I4C.5>CHB_>$TZIQY6%$GI),P I$5$M,*BP0N$N)#44>F(6+*R2
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MDK(.\(<()\T.A3?Q,XP.X)+9RX!SI^&XG#U^(:SJT()\366+V.E;B]T*X?\
MJM+\.K2 BB=6G3!/75B23YO$L!$01HA4HQ$%'H:,M84ZDAW"68 8+>_+'KF-
MUGG>N;7Q.&>'I\/A;E:=(-CD$D@[6[ I9U)^[E92OTJ0=OF$ #>?9#]QS_K?
MF=/6M+<)\Q'?MM7CZM42#/,@M-%C#C%NE%EMRB<NE!;S2V00&8.#\NRN<%NL
MU23+&18Y3(Z>;MT78%)8E0'+IBJ<$8Y8!^Q!/';)Z5'8W:\WAZ1LS:>:K!^I
M.@MC:E5.3K5=EHTO4Y6)#2J/)J3NF82"61%*T)<D84SALC=@](]QUW\_2M/%
MCS1R +$;_BTY/MBU:59]%D+?HL%,K3*=#*84,1"E42*M3J7%(0 2L.Y');TN
M'Z>_?OZT<S<#',J'&U_M7HG(PI)"0"Y$12L .224@]F&0'+<\*RQS*+1*D-I
M!=5<3>XL5A&E1M)*HD0,(JS@(6%.Z0^. 2"[X]+BBQ[#U];6[XIXI#'/F$WC
M)YFQ!BBA^7*5)]0(&]3J4.!D.WT=V=B.I5<L F(]< 7%N]ZI0<%1]B?S$IP&
MXV@9;C'M@]*C'I_R&18GJ8>SZB[@)F 4I2'A+ X'&26? _7)Y /5P>H^Z^[[
M5;)W&DE^B,<]XE[DP$JPI(<NW(QD9+':_8OGV#AY4)E_MO<(G%B[AY&*8 %[
M@W#@'S%.Q=F]/N_N007?@JI3OJDF[%QB&2(0Z*HMI3, M_V;N8BF #C:P0S
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M[<CIM0W*'V9@\D3).0@>1R'';9'&"\$E@';U</W'=V^O07'VOVH!!).%.!S
MS.[+Q3X.(4-*=Q_#1[* !_B [D=W(;Z]#)- 8&ZL8! ])8-L*)J8,HGW#E."
MDCD9?);AF8 L07Z5D@@FZF\LIAC?8](;J":2505=F4E9!2SDD@.SA1!*0P8@
MI=^.J"B/=XW'UJB0NEHF2QVL1I9$8=4M10B"'.Y2221N/^&D*[D$8)Y'/(':
M&-.K5C2&?XQ]* #QZ=-_&3ITI(("YY;B8W-!Q9H04;SO(B!2 D,761^98W8
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ME$6)""U*:&I1&U1VK/Y=H&.ON7Z!_4''_4'R;A?&<?B\'B<35HT^(Z=>K4V
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MB9-XRX_M/,+MYS4JCM8, [$!V#EP>&/ZD,Y;OA4O+D S ,.X<#LV[!5&O"2
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MCP.'(!)PV.I4$P.<Y(NG#)<@F 1ET\8VAW()"G!R27QCA\OPX#$.Q4&.Q$!
M W8<P 7;.]1K;[RCL2@D=W(W ./8!\X]G'(52V4C:#@1#M.QOMO(HJ&<D!@I
MV960DA@,%R_TXQTJ($@/=7RS_P @^HZ%&J+#< ?<YQM!'Z=^0YPV.E"C$26P
MBVR6F8$ J#M0H)$S%(+?W>'V;(/N3G] <>W/5_VCJ?H/?N#_ '0B]/;WR)Y.
MB22R5.[,X9R']G (<8<\OEP'ZE%C=-!Y*&P29NT9W:,$A20W<N&8!E$8<X[<
ME^26/2A<&T;")8AQ9,@6\H8!_O$<<_/\3 L,_/=R'(?MU<=S[^CZC8U1;+1Y
M&YZVQ$$8!H@8( PD.22S@ 8Y!)['M[_/4J/<%GLSM.;@78)"7[0H"CP0X?N7
M([/P2#@C(;WZ4 !V3E$1##41(A._.AY3=Y(?_P"=$'QM*R,C(^G/U?JF_8?0
M=/I0(:9R2PB4KC>PZYQ4*8N[S-Z4LF,M"21C!(?)#GA^?ICH81'7G?\ B('=
M5>$/]0Z_$8TDVLK7+0\K<@@9R94"ORVAI"8:%10"G8J(!#"E$$D("QY94 P<
MOA*B"AQ'.>4*<R\;"N,_ZFOB?Z7"9GP@AFSV/(-"96]!R\5<:$@))7L#KA(+
MK)3Z=ZP^TA8&Y)222D#< 20=!;!6F"IFXQ!3:YFIQ^#\3H\&GB>(G2M,,B+B
M1*Q^55YR89*22/*9#.S 8)!R!V#<=9$D P/>?I7/J(' 6E62".^(ROYJ-$8F
M6*&8I2T0EDGOEU* SV(!XXX/0_ME@<W;D3$BL@ <+1J)_N *)$7!>9NLA@W-
M2P(Z# 2(92M<, $!0<AR^$XP.2"!_+K&G7IUA@O<9'6FA:CID7-@&B;7,3<8
MVSY#451_L\O>(4E(_=2X" . 5TV8AI9)YR"^>% OEAJMD+5X1(&]\$'J]Q*)
MJ]VM&(MBW0"EDT*DHR%.Z)"72KCMN!;NS/GI[]JN,@,SIN;H'UTGS<WK2OQ-
M_9L^$SQ=W]*ZCZ[Z=3%W71(V[(6K)SL&Z;CHJ)>A4VHS55@P!*4FH2LNJ-%G
M9V,%S!A^9Y6Q*E$) "M$D>=YM)P#( ^_*H_#=]FKX1_"5?4QJ1H5IS'M"[9B
MAS-N1)Z-<M=K28U*FXLM,J@*@56>F82%A4M#AB,E'F%()W EBJ W,[[@;R)B
M(S<?M,;\!*2G(;+ )/;' +<OV^/GI3)(@VD1%PP>1GL[)0H.>,<#V+N' ^G/
MZ$A^E+,[V;*PB7:9!,$% T)-S<&4,/>I6Z,ORX<-("E18@AKBJ1#26]0A0XB
MV!!*$*9R0"J7<! $LMOF[R,[3((IQG(+@%;;B$@$I +Q$0DD*=GB*B)5!!4\
M3=Z05#:%1%@*'DDH<Y6QZ)NGF-"4!M5PL^HNWI1%=1[LD@I))!)26XR^U;[7
M8?1E)=91RP8-8YTFBI59TNP4":E6B"V%!-3F@P9B >WO_7I,/;W[FLD)O.H;
M!0YN.L,Y;K(D;_!C;1D0R&8,[NP/O[_Y%NJ((.Q% &"BV V9?3I;ZT^&_E0G
M00R$NS<_7C]?GOU*0+A0,G<6EQMA8=2.H,X4<I;;V<%R??TL /<M\]*)!B)S
M9@_1W,%"TU''*C!4""2"D$@ .ZBE^6P,_!9OA51#04VW\H M/+]U(O=MA;07
M0C+L 24@ <GN&;L[#VZB)U:)6E_NY@^W<4/]L71,LKH>11>;R9J/;$ *E(+@
ME@.Z<.Y<9/U_7E]ZB"1X0HEH2R[/'GRIPC!&OII(<%6DC:WYH&<1&2"I$-&S
MS4%*E**E0\C*4\.>.3@8QUQ:^'I\.GP</1JU ZCJ\02R$1?H".\5!Q..-6I<
M0Z=.H(%G^VTA#<9.,4<(,5:2(H*FV@9&UB,D!G'.?@X[=<FG7J$'3I'/2T?.
M=[GN:R= U']Q8)LHL<D"R,2CMA($/RHBV@I&X!E  %QG8>6![A^2 .H5=!^X
MZ<JWX>'I'['XLM" Y&=6\P5>G3BOP2^0E2#Q\L&^7(XX;''6M-QO*ZHJLD1+
M(>PO#+9/(X?:B%!E*40?7L2D !^"[]WP1W9_;K-:,\@@9LV8,I#('G9LB%(2
MH,4  $X=AN#%F)R6/<@ GZ* Y> B0YE@6V+5XS?C)K[68DIK->!BU(S<)4RE
M"XJ(1B^6@)Q"@C 4M.$J (V]^&Z5H6C(RL_0],UOEX1J-,TO3;]HS42(L7!4
M9BH0$+P(:4'R  AU!(*3NV]F+@G/3?U][=(?.IJ/V*Z$/R%W]C6U@PM@"$E.
M"0^/4>7P' (!['Y/2H '>S 683E"%( \Z@F4@1Y178+B8'?\-9Q]3S]!U=^4
M_;[\_K4U$!$/?8(O9%]_O4[AA@@'#D[07Y)R"P(_F7^#*!Y>R[; (%&QB#U#
M?,!=*0DL"".22W()P';#_P#DJI2D6<R07*19#]B\121,027<05Y#>E_COS[,
M/?JX/4?>H?VF[@MY^FPS*W,S@J8<@  Y'<9+MG(R!VY/OU*(!GJ"7=]3.QD<
MILH=WRSA(&,Y22H=VPQ^>E68**O'=!'ZK9(342U-,)R0?+QWYW>D@\<$G].E
M4R\X6T7$R9&V5)EY=U-N(Y+X&?\ 5 /\6#V_ITK(+5HFQBQ9+N$A"E6*#=Z7
M60_#'><EAD%WPWM[OTISP9LP)05I#43A0#4*5#[Q%5M( @H9^,?+EL<#LWQU
M<"<F':V/.EM21(-RIV928=W>;Q1(4D9"PK(#OR'  !SSW?VY;F5"B<Y)!_N:
MDG "F+['"$D;@0>"'/R'.W)!X+OW2#TJV9#$B8NU) 0W-W!.Q%@$)C3!) +,
M2<ER<DX<A\_1N>K@7ST[>GLT$F(>U[0") -RQL;%T6%.2X+;07/))!+#('Z8
M!QU*F+A,]W'-03%[E'#4J;;Z21E.0 WRS%QSS@9_56C,XA$.>19NP+38/8>2
M4?+."?QEL6QZE%W/^]F#?SI^H?3WCDJFDQTN V3OSAQOV0ZF3N4,)1'7$6.X
M<@D@>_+\MP,-TOY>68][URZ3IX.C42P=7[@I@HA_S;-F.=7VE>LNHNB7AFN2
M[--HTS2[DJ-6D*+&N:#",Q%M6BST[YDU45( *4B*EX<&(H?@&+#.&<.(3I 0
M)08(DA^5E 6)6/H?](ODWP/S?]4< _--/#XGPW"UZ=1X?%&C4-7_ ' 3^S6Q
MK !! (3U@FU:,_9&>)/7+4Z^]2+%U#N>KWM:U(H\E7J97:Q$3-1J%/*2F75)
MIG4#9,"=2HQD05'\(!08$GK'#U'5<.4,-+R!9S?D :^I_P!=/TO\C^1_"_#?
M%? Z.!P=?%_L_P!#1PM/CX>O5JTD:QPT&#I\8!\1%G*KOY++7Y(<*90"H0)<
MA.0=Y)PYY ZY-5SC[6B(C_-?F+@:2= U:O[$YFP@S[G 5:]>(S5Z<TFM>5F*
M7(PYNK5:.J#*+CD^3!+#*@'!2$NWOQUT/S[YMP?E/PHXO&/$TC6P#P]'C,<F
M.\QLK=7\Y^:\'Y=P1KU>(#45I T^+EDA7YX6Y\=X9];JSJDFKT^K0(,.JT>%
M"F#'ET&' F9>*H@$)XAQ 24&'G *W#@===^GOG.CYJ3JX)U'3I%]>GP'G#.]
MOQ7C_)/F>KYEIU:M,@+PZM0\+F00R>AGM6QFI*@=.KU40$@VG6""6223(Q]V
M/@CCY''7MOK<>85>PZM,D.=)%DHD8.]_0JK]:B(8MBW@H)?]BTPEG(S)P2,C
M'!'3 DF!)O:I^W/A!9NG?[WJ_A]Q!<$J+-W2&;/ZN1PS>W2LH,WDKS'K,1B\
M52V_1N6#<#^0(&#]1GLH,O-A(+G*#(99DYN)0D)!!#D\$/EP[C]1SAVSCE10
M-P&(]DA;%Z28< 4$C/I8D.[@?S^/?)]QTI8Q %@S/9WD$!!N:XM>/JKF6U0U
M8->KMTTBKV]X94W+X;(-)J5:E(,UK')W',*B3=(D*9'@RU9N.3G46S+0:?/"
M8@1Y&?G("X"D15=*UIL>OV%N6UHK-_CHAU>]O#/2Z_9]\W;(5;3W6'0B7N6D
MV5.+D9BLUF!JMIS*7!;U>FY)"9E$G3I:IS<6?EY4B7\M48J4N#NZ=398N6$M
MM^MN=R8O?98P/*>92KI"B+&13EE,%4:*F3,:&G<A C+,LN)#@J42X!6Z#%B,
M3B(<*?JYB)BH!O,!_P#]UMKQRA"L8Z'S-6F=/J?,U&EPY&>CU"M*F)/[U"CI
M@%-4F4)2B)#4I"DJAI0OTGDD%B#U LOR_P 5&K!N7 P)-N^S&X%96C+CJ@QG
M@)'X9'IB);GZAC[_ /+K03")OMY9+FA)EB +.[S;"ZCO%2RHWD(*X#NE/_:H
M(XX9_P!?^0ZF[,O\OWSK)@Q$002&+CR'F7DNIPN)D_=\)9FBI8,?K_D^0.D;
M^G+\QZ\JJC&&'(!;=G!$DQ*(BA)E<8RL1I=F&[TQ &2 0^3DN<#AR"3WZ"XS
M,<_/_(O0E^(""F22[&1!.YCTJ2"J(4I*I;)0A0 BI(V'?WW<X?Z_J.AYWE]?
MHO:LX7&0V"@Y6()RK$W<5,%Q2[2^&?,1+X9WS[8/^0ZE4D+860,W,JW,8'-"
M@YI43RDO+@?BPR&B!OS#D*."6;V'=NJ.5_K[]<.A((M"5_[2"1*O>.ZS1H6L
M%0\A1<H=XB6X[%_C!P"V3WZE4N6$9(+V'):K=;VQ32N)R)?@N28@X?OGMV_3
M(ZL;^W^)J,-7Y@P3N;I@?N[MP@Y]<40#_=P 5(8B*,>I/RWLXY<]%(4]8^_W
MH;%W R28:ZLF;*S#HP*BN'@;G1#VO&0<L<#+\OG]?CJ>_?OSH7L /# ,"5!,
M>7*PO38L6-#AQ5F76K #0UI6LA9"'"0<MN*BS\/]54 "3%IYC#).(N&'&W'?
MQ!6_,6GJ1<5+FJ?,3$O59N+5)&IQPE6]$TDKBH06) A!P"6"2 V>IM(_/3V:
MV/>:W^\*WW^'HU0$3<G'A#[Q4?NR9M318D S"?+B!SN1"4G<I!+ CV)ZM0VL
MQUSB.JSV.=C"J($%I=1;=M'F(9R"222K# X^@ZJYCU_%<8(U0MC?8 6@6DVA
MI4'&,7SY,F7+!45CYP)+(7A@IB0"""1V=_3E"/0<IOWLK+,(52UI!@EA"^/(
M;AVB!8MXH_\ AP 1@JB L[Y(<Y+>V.W2-_3S_C?E4)L2&Q&;M#!RC=PY-*I<
M4I+04*40<A8#G+=P/<9_R?J;^G.JR$%;S  G=]0F00J%>,9F7_NZG,%0W><G
M+9+AVY]V?CMU<'J,#GF_L[T4ABXZ<HD0 N<VV+*HC!H)8.3^(D9SPQY9@WL.
M,=(W\A^53!@;72G(ZS>V=T4N,S_=P2EMOXJ0<)/.>7 PWZN1U*I (! 68*5R
M;H1*V.$Z$*HPFT@P&9(!'FI/N01G)+A^<\>W503?IUR]AM4,7TWPRRAR:3NY
M#=Z+*HA+B68I9@8@ ^ 0%9(/_'/1!7G9'Z^_JC.S%S+)Z@V,2#L@6J12YD@C
M[K#(//XB06;EC\<'Z>[!&Z/3T;^U7Q:L:8?OH;O;-C0R3$3,Q_[N<P$<Q4D9
M/U_FWZ]#8;>C_(=^P@5 63=F#R0D[)H9]:)>.X!@0PY<NH99R_..,-P#R<]2
MM,"85WU*/4B'DE4Y2XA)> 69T$Q4\,Y2<M\[>0.7=NE1@_[9O<79&"3#@V<P
M*'A*B^?,_@)=0=RI)8NQ?/QP,@MAGZT;">@\V>GUY)#()+<"Y,@D+U0-EL[S
M.5+'_P /V&3%3R&^6?ZYR1[]0]7[YU06$1C* L\2<=  :I2XI()E\L,>8D-C
M#,6_\AQU._UGT^JI/_&,[GO#]<P6*&E%1?)6?())BQ/^U2"2%'_:#,_S[?'5
M):Z+I_F_>@M:Y[ES8CD!@&[ FFHC+4F*%2X9,<H(W@G;N.#G('=B <@'GI$)
MC\[CO[P+PGQ?'IUD !@<IR).?/N:\?>EIVW?%#JEH770I"MV_5Y5<E4:74H2
M)J2FX$PE,52IF$K<5^6H%$$)=4-W QU;YF3N,E(SSS=$5Y7R[YK\7\F^,T_$
M?!<35P>+PM0.CB:3*(_<#<$:@1I(_P#$$$7&.])-$]--%Z9.4S3&R*):**O'
M$U/II4NB$(JX:4H0F8BJW1(T-:<PPY$)LA/'5TK4L'3R3 4O?K!CG7:?J;]7
M?-_U,>!I^8?%\3XD<'2='#&H#3ITO42O!X1=@.PDQ6<DI6A _ *?+@E(2(@(
M20&;\WOW?Y^D,ZB6YBX)Y"+^PZZ2.'\,@@?#9.5,VN0]TPZT<\;BYO\ <6@)
M$A$B(74V5/I3O$FGT#;$4'* 2V>/GKTG]<<+7\1\'PN'HT_[B2IR'$=[2S,U
MZ5^J>#KXOP7!TC2P=;&HLQ  .1D[M#IX?P+&<@1;S@"3\^6,O+1(=2;8T=)"
M5RN]3%0(];C#'G'7@?HKX37\+PM>HZ;WY#.4Q?M<NM_I7X?7\/\ #Z@=/^TS
M#!<GNFCRAEC>[4>)%7IU>A,N$PS:=9/J4G<ZI"8)P[_FS\ \/U]#"-CO[Z\J
M]O&HE$A, KJ1=0.3$HVM7IK54#;-O%.U(_8M,P7!!^YP0KG_ &GZ) *8'TH=
M+)/A'<D6BRJ_$@;L@ $[GYRGM[N2GOSCI4*.KZ*9>\64S$@$88P(+DO^7]"[
M," 3SCX(+MTHTH(0:"O-X%P[3!C-4-N!N=^'<*8'@ !G&0?\AGI223F"U%Q
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M(6"2[E6"V0?H 1\D]4?8_3WUMSK)+!M8=0 <Q<F?KBC" 6]PPPPSM8\L#CL
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M5(G<  0,%B2X=A@Y3P.P(([NS=*R9-VRP.ZW :2!Y@B:I:622%*8 EW?#,P
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MVC0X']XBIY/DH]7+98#LQ?LQYRPZN!U/VJ9> ',N#YHE HP/,HDI892YPS*
M(<E@SD'VP?;J4%PFAVO FQ(V*!+NR:HX=0R2,,6!R-H<#U$.R>'3@ NY4!A
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M6C$ <G8;T+/R\O\ =XA$&&"%(SM42Q5DI^I# C#'H R'F_UH2-(A#:]Y;Z.
M=NU&?=I=3;X2%#:@CT_ 2"?E]V/;]6,[FJ4"X!6T\T"0(%\J(BD^ZRW_ ,J$
M[%BRF'N#GGV[XZC._N_UFI @@&RBZ'[>H@LV#5G4$:4ERE+0H9:)"?TJ&7=@
MW+_KTJD#D.8$&X-N3;LN]3&4E0O,*'A+GT$A)(9W?+_/;HSO0@0%="QW)RMI
M-\G%/^Z2[J3Y<(.'_+ELL"'8AW^>JSN?.LH<@C< N(+V-MY>]!QY26\Z3 AP
MF*UH#I(=H2W9CABP ?N0.F"^2_C;Z<CC4!#>2#TN;[3$7C)9E98<0H8 &00Q
M +@_R9ASWQP\J'3 M9("Y#C<<R48QA/NTN7!AHXSW^0#[CX'.?TK)N2>]$CL
MVI#4XB^&D0!B13*2HCPCY,)1,%8 "2=S8) &?J.XQVZ;G\<_QC[U>\)RQE $
M]#U! -[DB7E$AONZ$GVVD/V #]\CG#9]NC.Y\Z(38F\LJ99G;MS<U]VER2/(
M2E1(2'8@$<%O8$,W\0^'9XC9F*B!P//F@CS<YW9(<*Y26^\(_#A/M;;L/ !)
M97'/<Y!S[]2K#$%?=)(\@7$@B&JG^[2KAH"5'E@?</[@8R!_X:L[GSH]+#%H
ME>67BQB6A>C+2Y!/W='!).#SV8<M\/\ /1G<^= -*,;1Z0T1+NB9Y4.)27^\
M1&APO\%#)VGMR>0/Z9X/21:/X_S[5#)(?9*2>;WDJ&%!-$&5EPPV )PX=FRQ
M?N?S=CR_1G<^=3PBR'5V@E3D+N+IU1EI9#[9=)(!(9@X<.Q)PVXD=@&]QT9W
M-/VM(A@"6Y)-NMSORJ"#*RIC1R8<(D,X"3@%B"Q[8;CC/!Z,_=YR+TA1;PF+
MS> 4"G=NIONLL<^2EB6)W8'R'/+_ -'_ $,[GV_R:+3_ .N\LJY=XV.^-U^Z
MRX=X2#C VJR7[=SC^I[]1G>A4KP]4%*65Z696XTI*R_DG\.$"8RSD%G"CR#E
M_KC ZI84V 7</[T !#,8+!)@@ #M#DOG19DY=F\H$DNSL['/)(9CQRP#9'1G
M<_X]^<T*Q:241#CKVMO%H52DL3&(APVV!SM+L$ER_N2SGE@.>C.YF"9]:@46
M@E"20>0%VF2TSC,$&1@;$J\I#;0YV$@DL&';') XY?V$G[8W>,;>E KSNY *
M>Q,D[HHP ;EF7EAA,NGCD>G^3GVX]W;HSN?.M?M5FETDJ\,.Y2O6K/B<U6J&
MDMM24Y;\I*Q:G69DR<"+.0E18$H4E(W!*<?QODL3AP>O5OU5\UXWRWX/1KX8
M9),W+!',8.7]:ZGYO\?K^ X/CX;)(.# 9$2!N,0A7E/"]K17-3854I=SRLG$
MGJ03&@SLM!5#3'A*=]R"2$$*)9)RP?@N?&_2GSWC_-.#JT\4& W$HE! EI#G
M?FO!^0_-N+\TUZ]'%$@G4-1NB40O$0NI]*V7U 1 _LWO):8*=JK4N!?J(208
ME-FBD,>"5':,'TC/;KW'2  A #^Y]3]:]GUZ1HUG2 &-1TL%Y#LH;Z&,UZ*U
M5(-KVX2I*?\ 0-(&T9V[:?+I9_<,Q^>E9(!+.DGN/S5_5N=3'@*+#D@]\C&
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MK*46I\$'RH?=X8;<X.$\\-G'; RXZ&Y_S4"AAL"P8N5S=W=DF(F0=E,X+@@
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MX(,J+7@6J&+@ I&XB+#9/8Y9P X8/P /KTK6&4# ;#@YW/[;S. '11(R '+
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MX P #,;OLA! )F]ZE.[VR E2E%(+D9(#=P!\AP XP2J6Y1'-GM&Q)M(#,0S
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MI0(()6V",!B"H$'=DL/ECR'W ]*@;]&R5!NH)&Q4V$NG*R!M<@*]3%MV,Y?
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MK7"?W9MUU!Q0J0#N$-W%/EPQW,<,V1_/GH+#$5C5J+,D2K[5Z%1 "G=09B,
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ME.[4&U4=I2HDI ;;C_\ M'!!?N^[V;I3O+D9/9BT2\,$ "H$J'WA8*DE)A)
M&X)&X<I]/+#L "/;L+@=3]!4)1[774N27,W#(\YBLL05 L0['!'<*<AF &?3
MSCGJ58PWSQ^X"+W=YD9+I^Y#%94,Y8D!PE@X2>Y4D .20&8@\*A$@"0 FG!D
M6[X'-@T/!(\^9R,DAE$,3V!X/ .""6+8 8W _CWY_0UH6OCF!&42.@(4MU,"
M&8@%)+>S-DN7V,/A@_('4J&#F<!)387!=O1VI04?4@8<A^6?< ,#Y.&9AR5(
M9)U)Y##BV1$%RW%#2BD^00 DO'B#L!^?DY<X[G]>'-+<OO?O0?VQOAXGMO\
M231*E %]Q"222Q9F 8OZL/\ 0%W. >I2X)L8$H%^CA)Y'>HE,512[$PCNRX6
M" D.6# L'4$X!#%/2J#GFIN(#4&7=F3$DU4LL&722IO2EANR& </D\_ &<
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MT!,&,3$4$>6Q48> HJ  *@.3@9)R1C(Z6(?\>C^]5W$OH6T3 \DUU*-/@SD
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MV;0*5@&!;L/9W_U0#D<AL\/WZ5"!(8EGR<%L7N29G:F[@[%8(8'ECM!+G.2
M<'L"/=G5=EN2XO$%$!GN>:)IS)*6Y)]1 /8.?I_XSTJ$)%RS+WLSB%]I(JD-
M@D 9V@<X+,,\D''=@0Q;I5!#AE]$Q()V:]"PZ0 .0"%, &!R&4 Q/_>"QVX/
MSTK. ]H%S+%KR,0W_<$ %!2<!27"2D\.R20&'+'(]L%G(Z4!()Z/?$FY[=I
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ME;%@[YZYIVX!1=0?ALA@'4"QP3G#8P[G Z5@RPY)V@ 'PCKRP]DZH%20S@@
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M_P#NIJ7IW%IP@W;<7[L32(J;IB2M2E).0IT./-4N!4JG)ST"$K0'7N_H?O\
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MCTNVKMNB'J;^S],(5?$S=L.&I=O)B21^?JA-I5WRJ[V][]0H^M:R^'C1F_\
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M4X;& R5V4)B'@U18\<\DNE_@?PGZ< 9YQTJ;$#(L (O ER&9*Y,I2,.Y(8
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M2F5APH<M*R\G*@#;*2Q7N4$[4T]L?3V^=0VU89SNQY"RL0)#J\3!V0E*&U0
M9E. I*F\S:4@LHH/X8 8J9(YZE1M@#!QVM=J+^AC5SQ"^&6U/$#)6Q-3U;NN
MQ;VM"<F9BWM0-.JN;9O.6IE8296X+?%>$/SX5!N6149:J2,)XL%81-2JDS4"
M$L*V/X)Q![#>4$K(BLJZ5Z>V7I1:U%L"QJ1#HMO4&6*9>728DQ'CS40_WVH5
M2?CI1'GJG/S)7%FIV<5$JM3C+5-S9*2#TH;?XGE/\=:R?$W!$4HW/M41M =V
M?TN" HA@3M();!'2L61624#(0.(""/.5N]']6/!E:.K>HZ-0H=T79I\F[J%
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MI29!)'(E[3W5K4]@5-PI*?S<MAB4\LY=QW#OD=*6DF&9#9VF!:Q'07-*DNV
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MK,"+QAIDX.QV!%A3J!<AB<L<,_8?!+YP>PZ5#, M'%^4Y*@7LR1BAEF[$DI
M?)X)'.<?3D\]*KLU=IR,7*&^[L @Z>Q'/=_JK()!8'L#_,!^E0MS:)=D%#%Y
M)W@J4::ZW=0X!)XXRP!!<'V<9+%ATHY"EV$,.Y9!:M<61:*5/J=LNQYX2=PP
MWLQ _3CI3]UI"@"]FB<*0[R,4TAPD\@,Q/+.6[$,1C(Y'R#THY. &T<]ISN'
M*DD%0#Z2DA^W+%).2Y9SS@<=N_2A$G97):,D;E$J\%6)5(0S;L$GD^_M_M>_
M_-^E"04G=H# )EE+9PK2%4,RIH2U'<A(04E8*89"'=:@I18$)!4" IBQ 40W
M2J"2P"\S^ZXLV,X*.7BN=WB:^TM\/_A$U H&G6KE*U<AU>[JI;5#M:H6YI==
M5ST*Z;INCSY:B6Q1ZY3).-)3]>GXLB8:)" I*_-B0SL)W!3L_1#?V_N*F02!
M!(G(7T=F.<5G;1[Q3:>ZV3E>IE#D+ZM.;M6W[)NFMP=1;2J=AS,K*:A2U6G:
M"G9<2))17 AT6H2DY!V':K9E) 5TY^_3IUH @ ;E^Q,&<,7K.\>X:%+4]$_&
MKM)ATR*?*EYXU65A2<:*5.8D*.N+Y$8PB0I284RHE*2-N.E.O7FA9N=Y,/,J
MB#6*0(42.FL211"@&?C1(D] 0F%(+2QF20I0$O% *X2U[$$$%*R^5"'ZPI)M
MGE;SL%47[Q494Y+21J\BF:FH*5RDNJ?E(1G8,>'YD!4O+1(HCSBEPO4B++@P
MSW5THEZY>TO5TZ6?+4[Q>>.;1[P6T*FW/K#3M2(ELSE-JE8F+ALNP+DO>FT*
MET54HFH1[@CT.3F(=(AHAS15YTR"D0T+B!*BENE!(:3&+^[+Z"O<^'/Q.6#X
MG+(F]1;'EKLHMOPYF!#@(O\ MVJ6;5HDI'@2U7EJR:96(4K'%"CR4Q ,A4%(
M$";6)F!Y@5!/5!#M@;RWOGR6U#I*NS@GD00\1S#,S>LWHNJV_O,O A5VEPU3
M'W>!)P%3\HB+&F)F3AS<G)(@+CJF5QTR41,ZZ(14F!-0U>I.TF7Z_6@">)\@
MAOZWFKG"J]/5.?LN'4Y(5."$Q(U-1/P!-PH14 %Q919,X4Q"24K\I*,LX'2A
M1;, ;68SDORB9%7S<VT'(+G#@_0^WS@9#_/2LX-E#2-B22.2WW3A4XEF 8I8
MER> ,L6;D]NQZ4$HC)<ME&#+ \+WFW*D?><!AR2.6.!M'R0[]GSTHHE=+AN3
M"F4 -H.*4@A( !&W! R2#GTX)+.!Q@$C&>E4%\PBG)8WQ; ,LDPTK$8/^R!D
M.HLIPY'NY!;+8]@J(2181O92GRR;*%=GR'P0.S%_=F+C+D-_1NE429SRN;JY
M!"L\(B[IY 9@<GY<8^,.3V&,\$#I60(V"OU."RG8["X--)3Z<D@,#C)9AV_E
M\<?55@ZN@%YYFZ*N)LP>B@84< J9(;ER'8_(#9?W/2C,\I(N(-PE+!V![$TC
M$]\)4IR<%W]_<I+ ,'(=\]*2AD%V;E;<[MEN"F5? ) 2IWSE]Q(^K$/_ $/U
M4.3OS&&1(L4 8"B=Z4L5#<  0,G@ERP<<L&S_P ,J7 N+A &V6'U<DR(9"0D
M9 ! <G@Y]VQ]7;W]^E6[V!N)\Y!A:9Y.0Z3&YE/G(Q_,_IQPQ?'2H;F&;$^4
MR39.X,%I.J4G+I_BX26P0Y!YXQV'8=^E 8&0#@+( "B["G)%F#01$5DL"2<.
MW?VV'GGGI3]N1/4#T.H$=,6J5B7<!W+$9+$_1\@ %LGLW/2FK*67S5RL$.9D
M2E3"'SNVN6.4X+D<_P"L>X!)?#MTJ<DPB0)EJTLAA] 3T;R0<D#U.,A78 \,
MWN<GV//2J0V2[ *YW+20[@] A3B!@YP06#$CWPP8!\EC_FZA%U9 @20<;F<"
MW(, A$I 5DY!=D[G(8D C &7R7=R,%F59(SZ79.UPK0$VJ: X?<6!( 4_?'8
M@@J./XB"S ''2HY1E  IX(7,X'5PBZD;" ';X#!BDN2"[/VQ@EGSTJ*38MF8
M@YD"3&X$NFD@*8.R?20&;/P2_/\ LL>QX=5!4DON8NA:_<7,;KG#;3@D Y__
M "]PPPS?4CI1.'S*W[;L)BPATCD\!0]AV!)8G#8 ?AQD]^E$"3<, ^S,1)(Y
MM&59SE3$@[@X..Q'('+D\YR,X4"EX2, '"DAVGN!AJ GOR,.H>Y#L2,;WP'R
MY8!B K-WL4P.0^FY4&S4HQV^D<#!/IP<D,S'#9)Y*ORGI6G,D3<3;M@R;H Y
M=-8!U%6.Y*2""><$\=V!+'#'I3E@E"08P4&7 4$*^YI@[N"[9/\ %^B22</R
M W2C <3,!P+V(S ,<Z5;X+L0<) <J#AN[]VSA^P/2@_<PKJ9BT +!Z, />JP
M.2% A((;)4 QVXR",GD@<<CI0HE)(X[0"98)M F5<5D !(47R,L6?EG;N'&"
M'P!G:J),E&UK(L8P(\D"ZI3$@DDN!P"[''J2V0_'!<G!;I5%CRR<EMC#1R9C
M%( 5.H.,N%%@& 8,D,P]B_S\=*).(4^9C-X<E#L0O(&"IN2,DN,,7(;^7P.7
M5G?$L..MN84(;RJBB,J&M 20_!!4X)+ ^Y(8$$'VX#]*VRY.2]K+:P(-R+.3
M7+S[2C1K4K5ZI_9\36G5GU6[4Z8_:*^&75C4"+3Q!"+:TYM2HU^:NBYYM"XD
M-29*BPX\I,ST9(,2' 1N0514A"GVGZCZD>E5Y.VT'F,D7S:;37/CQL>$_P 1
MFJ>IGVCE7I%F:R5&P-0__02J.E4[IE&I54A7!-Z=T.[YC4N8D[$N*YK>IVI%
MNRM9J5&F;@LBGUBC3%?4N;E518LS-0_-5;?S?E/MPY%:2W3X-?&'=G@HT:M>
MX- M3[?G+#UTU:J-HT&Q+2HES4JLV+<--I$.WKKU;\/=<U@C)M_]JU65GH4A
M(VI>$23M"% B5&1D(,:MR:0Y_2;_ )Y75"0(S@>^G:LL:B:'>.VW;:U%E9#P
MQ:F7#6]?O 'IOI!0*;IQ684>@:9ZG6FN!^W)&XIFX[P_:-*B1H:%*5%F:G5J
MO%*42T";F(:0E4GF?+\!/+AE TCE?U_,5Y:_?!'XXJEXC[.J%4M#5J*F<M7P
MS_V;:AVA;-+NN)I2FR*)19.^Z).7;-:VZ<2%@)@5&!/?M>0C6E6(EPR\6(N/
M&G\ IC._3TRA:K7?;[2#3"^]8? +XEM--.Z'4KYU!O+1^XZ!;]#IB967G:Y7
MIVD196!*2.Z85+&/,S24HB?Z0FDPXNT0U1&2#<9)Z>9*\[+H)K+(*4;OHN;<
M8[UQ9\>NGVIULZQ>#;1G26YXM)O?QS^'ZQ?!3XA[0I5PS";CT^M"D3=E76C5
MB1MR#YT2! H5G4S6&WZS5(2)6>CS4]+RDK,J6MNANK/#V(NI@BWF#%4);K8?
M3S0GE6 M6M [RO\ \67C_P!*-"] =5KSU3MO7[P?VUX>-=+1NZ;D[#\,BK1T
MPT:K-Y3=P*K5U4V%0)6>M6F32ZD44>J3%RK(I,&',*,.765PCFQ[DQB^U!AD
M"S-9TT$\&'CAH'VBT*^-1Z?JA*SE/\1NIU^U+6NE6I+SUCW/I#6852%M6_4=
M2ZCK&8T]2)B!/2TE3M,I'25"[?CRZJFF;@08!VO>)]]J8MCOTC[&OJT8<%)V
MN21[GX#;<^R2#WSTK$(';FP S#O/=; &D*6X &7 "<@,"RN>?D?#CI5,1@6!
M2DGFTHY71PH](90 "OG/R[X8#."XRP]E9,BZ4I)$ R5DK)CG%, "2^6PD$.^
MY08]U/@..0S,[@E5)+#\C"!+'+:9((+L*<006=( ).Y0R>6R0 HL?< %3#CI
M1C:X:%DK0=X,$%,C9?<$N<$Y+%ASE)&1EG()</@]*BN6@'!$HMB^"8'/HTY/
M);_5+,/;+I!?L,-[<=*(Z@\ W9B>>S9+LI@TH/J4"_8,YX]V<EW=F^<MGI5(
M5H".9,ASV%I+2NE*<$ ,"00EN#[ECD=V&<8?(Z4,DWV(E08P4PR"N8D&D.$@
M*8ARY.0"%.Q+.RB.6;X(('2CF+ SR$CH-R-P]TK*!! ;LV"   '=BHJ+!BQQ
M@@'I2"QE,$,F7,1D,"#]&/@$$$CG=RS8VAR!SR_8Y;I208@%"P)!*W15I.X@
MMTJ4\.%,.00$N3WPK^8R7_3I4@*).Y,#8-62GI() IB&+/R&9V'!8ARW=@Q<
M?7I5LTN4BXY0!9DD0BKA4$L!M*78Y4"'8D,QR !AW+YQWZ4)&49&059GT)C<
M,;)O2<A\MRA^WN>?_#8Z5A#<^7\U#'4H14 $@$.0"0'&]BWO@9YP.E;/]NO_
M -ON/R:HNY<D^D'))R1$?GZ?Y^Y=602/#_[$?3\^T*2$I3*R<* 9\,2QQQ^K
M/\]*IOI_]'Z'\>V:J*I24$A2@?5PI0&"P8.PQ\9[]*H,Z1U__B#]S]+4B24H
M!"E/C)43RI#\D^Y^G;I5U#]I.6?_ .7OK&PIP)!&2Q2AP<@O$C.X+@_J/ITK
MC-AU([1%1;UB* %J;RDJ;<?S*"5*//=1)^. PQTK>J-,;D=@3'H.\Y-$Q P)
M#@J2'+ESGZ_^7;I66O%RU !S_P M_K?S-1 D(20I0*@22%$=Q\X_3I7(!^X_
M^* Y,4^,I2"=JE!@D\D_YD_\^E<>DL@&1;LC#O4<5:DJB%*B#N2,'L2GD<$Y
M.3D=CQTK8#(&/"_/G?M:VU2$E@=RGVQ?XE?P&)M)#L2.Y/+ ER!TK)C5X<,1
MU3][12A18!RWEJ/S@J;/.&&'9L<$]*"9,LH]'I'W]H4Q3DARHN(G\2NS-A\#
MW P>[]49Y#[BKI))G<"PLB?0@+;&:;O7M?<7*>Q;@?'4K++U%S/U ^E.6H@0
MT@X6L;@PRX<L>1_^%F[=*V;F\ D2<#21ZFJW*"81"E.H$GU'/YNQ+?TZ5G5%
MLE>FD_6YN<TPK4$J(4H/$AIP2/2I+$ # PD,0Q#8(<]*"W322.H)][&':GDJ
M91W*<;@/4K^'S&[_ .R']VR_2M(1 MIQ$F8M--0M12C)#@.WI)=G)(8O\\CM
MTH@ 2+CQ+DF/IYW,U1)"CDG:%D.2IB!C\SX^#CXZ5G3(+F=([$S].V*4K4"6
M41Z%*P6SM!?_ ,? X ZN!U/V_-:TR=3Q PKV7UO2+ 5N4I*2H0 -Q2"2E2AN
M2HLZDE@Z5.DG+/GJ5, S) ,F0S'O[U&I"$KAK"$!<:*M4580D+B*"8" I:@-
MRE!$&"@*)?;"A)=H: %-$MDE+)Y\Z5)))))RD+.<%3I&XC@J;NS]*N-4F#J4
MG%ISWJ/8A!,5"$)B+"0M:4I2I8"2 %* !( P < 89L=4QY ^G\U1?_\ +Z@1
MMVJ0P((2R84-(B!.\)0E._9^3<P#E+G:3D.6;J5QLLC \48@%1:*>A"%%*U)
M2I:]L-:B 2N&6/EK)RI'^RIT\XR>E:9=_P#<1V8_-[\ZQO&TGTNC:NRNKD;3
MFQXNJLK;42WI74J):U$7?DO0%+C[J' NU4D:]!HZOO<T54R'/IDE&9F"J 3&
MB;K8 Y9] %5,^,&P 7D_K5_H]DV;0*[=%QT*TK9HMPW7'D9NZ:]2:#2J=6;E
MFZ?*P*?(3-P523E(,[69B1D)>7DI.-4H\S$E92!!EX"H<*%#0FD1I.[]#6-)
M)<F 3<WBO3[$!*B$(!"4@$(2" E]J7 ?:ESM2^U+G:!UFC)!+V':??GN:<%*
M"4Y.0Y[Y)+G/2M)Z_#C9G:J*CN=R[)//!(+D>S_'2@_MT\]2.QG:V![=.BDI
M)8_QJ.<_P@ME\.../CI4!)+-XFV0,<B?8%,4M04!N."59SD1"D.3D^D ,<8=
MGSTK6H  (;_0GZ^U3%+6$(]2O4$OD_Q0W4/@$@$@,'RS]*(>(# #[OWZ[FI0
MI022Y?> [EV"00'Y9SQQV9NE33@;Z2>[3\A4D,!2'.24E1R1G]&_EQ\=*R26
M9-]]HI"2$H()<<$G=R#[O^GMVZ5N[>X';QD?0#VZA4M;ON4[>Y_VC_F ?TZ5
MG3-]_OI_)\ZGB$I) *@"I3^H]PD]S@.HX&,MP  K+._*H4J4?+=:SN2E_4K+
M[G[]V''MTK9_VC?47V(': HIY)0I822!N)8DD8/R_MU3CF/N:FF1JY".S_SU
MFF%:R4C<IB23D_7_ ,-VQQT,$]33&HY TH[,8JE**8:B"Q#,6!;DX=V..1GJ
M5H2NO;^S:U2N1Y9!(W14 Y.00DE_=^YY(QQTK(^F@GNS^34'GQ0XW\*4,A)_
-B/<A^E<GA'/S/YK_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g105868g14e02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g14e02.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[13F4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %,J^4R(X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>#R$         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              ^P   8$
M 0                         !              &!    ^P
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    ^P    !29VAT
M;&]N9P   8$    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M539T9>+RLX3#TW4
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $
M 8D# 1$  A$! Q$!_\0 '@   P " @,!              $"" D&!P,$!0K_
MQ !A$  ! 08$! ,%! 8$"08&$P !$0(#! 4A,0 &05$'$F%Q"(&1$Q0BH;$5
M,L'1"1880E+P(R3A\1<E)B@T-CABDC-$:'*"HB=&57:8TC4W0T5'2%169&=T
M=7=XA*6RM,+_Q  = 0$!  $% 0$              0(#! 4&!P@)_\0 9A$
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M]2J_EH*G")!J2*TJ%Z60*$["ZU-L(0B$5%*A+6%Z>5 **=SA%_'WK\'W@!%
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MA$T!44!45"@?BO0BJ[81EST7H!X4#[C4(7LBJA HBI7^(("NW;"(RNQ&KT9
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M2#M7"!"5;WLK>99HI5H*@[V1 MZKIW5<()[WT_%/10E!2NU5-42ZDK6V@P@
MOOVPO"0FC2Z6 _O72@PBLQ!#&AV3VI(6P$)5"FJ%+5"IW'D1YVP@ "S"KV^8
MK79PQ,4+* #L@1/4X1#5"W-^5!HWRA"Y*7J!O92!H4*7J3A!/?H"Z(S;/1(
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M,C<,99D+.D! <(<W<1H6$B74P@XR F4-#,062I1,YP(\2XLYEGKY66_9NO\
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MP\F,@E<._A)=*HB(9>"(;A82'B8AVX99>,M,!\VT&BT2UA%7[W"A7+J@?8.
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M(FJG74J?CU._,(0*MD[$JJK<BOKA#;GJ*"AM9SXD62#_ '/4_GA%3_!F]_\
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MT M1%5"$6H&FM,(H.].?PUI #4LUT N@0=U0W^IPA:S*?2OP6KBM4*!:4*J
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M9+U[LD?)47PL:"5OQ2DPTJJ2!05 !4+]5/94]-\( J#55#"MRU=] %)=A%W
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M>AT^9INF$5Z'>P 86(Z@DL*V6 74T(5>IJ1042BKK3"(?$4%"?GRE:NSNF]
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M@!"FB^9U[_5%%<(A6HY,Z(/A8[$J46"X0)8H.BKY% #6Y-=<(O.A+\J-8H]
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M05M=2VE'N4 74,KP@!=:FP-U(I];[UZ81;W0'5 EPAUTJEC6 $A$0A=!5%5
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M_P 8Q9Y)I,/,9G*SX,ZA,223A^3PIS* 20F)ASR%0'E+$%8[QVBXKD,WV4[
M9#+9F3%S?".$\9R_$<&66<397%S/:CC6=P))YC*)9CB93,X&,/JYIY0,1"1,
M#*.!9K\-_&V.^T683(4R?^VRE/H!T6(R3(U%Q;H,PT/\<Q"-O#8E614--,E#
MC+/8.+B_7"3#,W>X?F\*7]$KB3R)+*Y<SG4 ,Z/&'9GB>0R,O#QFLS+@_4]K
M.!<0Q.]+B))D\KBDX^.>[(5&$""90LY!^S*2&^_(?#UQDA))*H:(R/,73]Q
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MY2:I!3>Z*@ @$3L2/5,;E0BJ$CA)I"E#< M5;DFY_ .ORG7B?X%OF7C3K/\
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MK'$,MU9;J 3FR 6F\VFJ'2]?/''9;]'$#C]_X=4+G-8JMI2M8[7V@3O81O\
MM6SZU3N_FCAMKW3D=6[(@B1FC,!/PDRK+E!44>SX4I1>QM2F.;D*YO,HA_<,
MK6CS9A%9:>58\]SK=F^ J@_A/M#2W[CP,-4-LK@BB1R$K5MG<7I]!:P0*NN-
MT%=7?P$=<W%!T<(M]QX[1\%VTN98XJ*R>""U*#WJ*("$4([)K9,;64)G<3?
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MO,J-C5HXGQ14RR6LE%$>Q="0KQQ7K_;4XX_CJ?58)=?K!_I2?*.S?1J?W_Q
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MZ>1+F%:?B(>.73;;#LAG",@%!8L68IS1:U:BD!*Q\/,/B,X-Y2G68LN9CSK
MR:;Y6DLTS#.(:80\=#,N91)(%J:3:*AXAY#,P\;]GP#+47$NH-Z_>.G++3;3
M)#+2(G=*!!JQ?;E8/J58(F#_ .D0SYE?B3X.<MYOR;,?M7+\S\1WA2,%'!Q$
M0[+\.O$GPR8;:88B7;IX6"T*-<B%*&F$9R?S@4![H9K3 JU"X]7MM,'Q 4JC
M(%]1<CU(3<*N$:=%%/,AZ"@-JTJ'JZ@%*@'>E[H.H"#J;X0U"(?.E-JE:*@
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M$.72E6*(@??;NA6A4*U^$(/3YU (6ETJ<(<JEUIZ( E]"*HP-JB@&Z$!2%]
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MD(;X12M_%;ZJO+9$.AAHE 2HUL-@HJH1!0&HTPB+4E$I<IR=5J7*%XE"239
MI*5H$Z $WO3>F$7R5DN5)IT8D+R<PQ?5JRTTT4:GJ.^$"V@:B[E7ZD(ZNKHH
MAK=++1;@!$*DK?=+*!A$7QM\:ZZ4TN#7*5*)J1NI"=::]\(+2JBX*-X>>C)"
MJB$BRUV!"*/5<(+][^/C["-"0D@ HM2*D(:T(T.M154NF$5;^=S\M16ET84@
MD+70G3I;:YMA$K9 KD"^E?)14[1QZ>Y3RWF9ATZG\E@)HPZ):<B,<,O&G;30
M+)+#SX7C*AHT#5Z@&F(0"QC/O&5P7)<_! 2.2$:6,8ZYX\*F2IZXCGN6HF)R
M['Q#IKV3GF,3+&&VV"S\3MMDOW3MI5)9:>(11E3B3#O2S2_TI2/$)&ME\4X6
M-A8DP)&%B2SE*GN3@E-5  =.=QB%G#PI\5I!(Y2X@("#S(ZD\=EI\_:E$2R\
M?MPTLC81Y$O7<*_#F(;Y'<,T\Y&79::#3+#()4#98N7Q/R;*X,KS86+DC,0@
M'=P<3#,\UJ2RDBA8 :1V7)\7RIXQQW/8LTV#A<1R':3#P)9I3-,,7B64S<N6
MP9NYWD)Q,:3#)),LI))(E"C&.=PD5!0>98>,AWT*_=YXR^&W+]VVZ>LD3?+@
MJRVRRU4BXH@2M<;7%;"S9/\ QCEEO7,90H49@H>]WCL&0,IXEV>0J!V,XXB$
M%#^9^T2WJJ%&+H101,F ]PR"O_R1XO8P;NOX6(^6&5; X4E3AH6I^YBOOX1A
MQE^(=O/\ID;_ /6XC^6G-(Z@\0Z^QC@!\/ZCSJIU'OD.B?C^&.O]L F'C:?F
MK,CPQ)=_;/6/4_H#_C<G5/VZ\(-1_>>,RL?01BIGK_7#+RK_ .U9,PIHO^3D
MZK=0NF//N,!.)9,A'[/YHM_D.:]T'6/IKL<?[&.T-?\ ?*X?Y\?X0/@^U(Q8
MFQ3-.1BB_P"(\OH %(/O$4"?,>EQCSW&7\X\%6V3R0\,3%$?2?!U_:_VN-1^
M>>,HUC@9=/=VC]%'Z%)3X<>(/_XMS!=U&5\MBA1!444HH48]G^B/]0Y_^M<7
M_5\O'P!^S;/_ ,Y'9UO_ #0RR43]:\2.GR\(W&J?X_FU^6/58^-.\-/]'_PQ
MK2\:O SB)Q)SA/H_)L\X 0T!GKP[YFX(S*#XT9JG67X^3L9AGL5,WV9,NP\L
MRMF-W&\H,&R]=OGLO:;B(!P"]_HV&V'(_@=E5WC*1@KHI%"59""BBA\>3\^\
M+W#WB;+N*F=N(G$*<<#7HC.%/"[AG*Y)P7S=/,UNG3K(4QSI&&<3UY.,KY:,
M&^CW69'$)".7#J* =R]MDO0&6&1 KNNR!/8^-KV8A*&]20CZ&KD'9!2,\P-J
M4LA3_P#S7=5*]L6-.JWY)][!+(U[1)(J0>4BE&0"?(FO8VUPBUWYJ2P)JE"/
M$P!34E2-V01?]U$*Z7\CA$.B)UO9:AEVO&N3]*8U_FNRF@KXCO"<HU4>)'AA
MI0VOJ+4.%MV^*_",\.LR?T?]J6E5:F^T;' J"U@M; >FHUZA1A&G"*V% J%$
M523=.VG8811O\Z;<NGJ&50DD]S:G2B$[%0>IPAY[5JNG1:%:)!1#\)HI (*'
MJ=/F2!A"IV/*@= WE<P $G]T4N+IH17YWPA;;VNE%IN>KJ5HEQK4"Q!TJ?JF
M$2!%NM#0TJ=T30^25KA"#6R=454KHJ5WJ=*X0]^GOI$*B 4*U7N;T!IU0C8X
M1E7P'D =;@'P<"S07 35:%D'>BUT"H-D.$%;6J:\_)27+(2A@(6H!-:G4I9*
MBG9#3?"%%'( 6%3?0L]B;/#OK1$0C5/4J%L3K73",8=52M@NHUII>RVTIA"
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M+7#(J#4A4$%+TO\ *P/6A.$1:<_914)\(= *T4Z*J][DGRVKA#X!U]].::B
MH5(0]1Y4[[=4\T2GR@L$!.G?I4432Q6HJ3A"! 1N%]%V/F"I4&_7"$([&YHJ
M +V[[<P.H"81>37O7[G(+I<P?(A2B5-#>I!76YZ@X114>9T>S!$7DL(!:$VJ
MBU VNH&A">>$12'U2UP_)?)##Y0EJZT%;H"A14(J2J6.R"U3I5@"R&ONBI#
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M WY[&ROX\V,#*76NY-Z;EG3HO73"(5_"E]&=SZ-%IMK14L-M_HE:BF$2%8V
M%-+42I5-@/,)KA")0DH":!3I4U2Z5]!N<(H9R%TZ/\O2Z@*UH22*JAMU%/)
M>ML(O6A45\=7:A8 LL'Q4":]$IW%%W)5=L(C.OES75[AFISAE 5(NE0%3U^5
M!YX0KT%-179NMN44.B?,*=5"#>NQTIA$A4[;T&H4A:Z!22H/6B(0$'R2Z*;V
M*50]-:T&$4%/$'WN+*U>1D$_$*]!<^I%NXUI6Z"-[:E45:E+L>0$WJ$U5-Z(
M"B61!A%Y5755:M:U(JY8M H-41* 52OH O4U%QA!#0<UW4 :KH$N2A18H$ 4
M7N2#^*6T%4%1;",8$)2J (:[7"V^M$JJJ$("GWD%-[BO0'Z*/,H@/?MH1L0:
M"A! )!!Z5 KL1IA%TU5$H=G]H1ND"(J'N23IL1KTKVW0%@FI^?I5D?H:@5-$
MT6U/]Z]U("WIA"UO.Z@GTH#M0P[= ;"J];&FJ =Q;"(7^/OVZPP.RI<=AT'7
MM3L$(DW3E6BU*6]:];U"X11K1$]I[$'[JU N@-ZI4HOSMA"X#.!T4?>M*^<B
MZ("M+$I>H)-NJJMAA!?G\'&R,-^D6+(&@2-*)^?FJK=<(7<&O7SJ;GX0 ($K
MUJ?---JBMTJ,(A*^)/C *%*]#07!T\MKJ4 PA >Y";U%P3U2VJ '1"B$3>A*
M(=2M39*#RJNXPB[U9-*55//4:%89%QYV:14K:Z]REDP@$5;+M\>8MK1("$ )
M *42MNBFXV(]$P@.:(_I7P";IK#!O1-+GET1"*#I1?GA$@IMJ@N-"@%!1+(M
M3J:X0A;H JI6I-KE=]#6UL(1Q7-62<JYSA'4'F>1P4YAG#QI["B*=<SR$?/&
M>5M]"OF2R^AFVV?A;;=-L%H$,M*+0RRS&4S2RDRE920%E-T-0H8H0M(U\/,8
MV')B8<F+/))C=T8LDLTTLN)+*5 Q &G[I*RB94(\=7'CE\*4HDG#7-?$K)41
M,@)1EV(E[S*X=/H]EIS'13EIY%0S]GVL8?8@<Q=MEID,JT7C+(0=7[59(XO#
M<[FY#/-B862Q,*7"ED[W?&)B2$EOM+*%8 J!SCVSZ$.TWY%VKX#P#%P<&7+Y
M_M)D\]B9S$QOJS@S9;+8^'+AI,F'W9R0#--,""TO>6-+^? 1G'+P(0_X+)FH
M(0@_J[.U"4:![@%=R#CR_C'ZSR;N.S^9"&B_D&9HH0;@I\(^QNQJ'LOV@<(?
MI*X>]0GY^X.A:HT-%I&*\W(&:,CJA21Y?-O_ *1%'4L^N//,<?PEP5U7)Y$_
M]K$NZ\Z1])<'_D_VN8?KKC5D;ZC+A/2W./T4_H43S>'#B"NG%N8#I7*^7+VT
MH#OICV;Z(RO ,\=>*XA_]WR\? '[-L)])'9T:=D,O_WIQ.-R>/5H^,XUK>+=
MO,N2^-F4^)N1LV\9\KYFB>&<1DF-;X:\$LO<7)-$R1C,\1.G;,Q>3YEXS*)D
MS&/"6&'+ +^'Y6VFD 9,(*,4.J*&VO\ ARC5E[I"%P'#H^S4K>Q6/<\'/V]F
MKBMQ5XFYRS;Q?S1FZ99(R!E!Z\XF<',O\(X2&D67YOG2:2]F2PTA9=.IL_:C
M,P3+W]Z_=AIP[$&P&F@TC(#5"=0$TW.D0D(0 PWU?=S0(J.6C8P:DW (7S[+
MJE-3>V+&*% G0C0U'3P"E2L'(R:\K+5.5>4 H;U()/73H<(*;G?4'FA2NKIR
M @#M@+\#(4<J@  A" H T%*J!A$4VM]S<@:!-TC7+^E+999\+DJ  9'[1_A-
M0! $'B0X8V 0"JJ@&$9R$N_\T?Z4K>"IHO.-C;)H +H"F]-#1 454N5W&!J8
MP3WX.45K<]PD,J HH4J2 I_NHH2MAA 53WY*O2 -74 &EU"^9&F$4C1P%6Z;
M^TH"441)4:HNR5[$)YFGGA"[)=D*AM%/J4.D4!6I1$!U!72M==2;T3"):EO!
M"?;(*LKA@T"ZHG<Z4VIWUP@GDNMK^^L(@$!5%1>YM0ZFYV2NV$''M>?O3: (
M:E213HJ%0-*]=Q7"%-.>OOI<:B"VB: 4)I8BA*CO3"*%=]R;:(=5:Q)/6$"@
M-?/4G_JW7<DUOA!"44>12[+X,-2  8%)W)5%!0&FP4!-4'4'"(0BAJ:>S?>R
M@(U U*T6HJ$ZD;#6OYX0.S^/G9>6D2JG86/U^I0[:U(1!$=O$'W\=PL4M>BD
M(>P0#2O7?K5#Y6?Q=F_"\39HHAN:$_, E>R8113KZK10@75617:!2JE1I8TZ
MZ4!T*_CA!J64(%<] KFBA-](H4522:7H #T-._I>Z(;>%C2OOP:)H.7_ +1I
M44VL@H4ZX1=>FWC;FMW6L5J*(H/D4!\[81BE=O?OYI!0CN$5 "U:R]B/[L(4
M]^L04%0B)O?N"I2B(;5JN$9!U7;954^.A\NZJ4K0(U":(GJE -/K?"#%:JNB
MG_2J;M4\H0V1*^19ZFJ^H%1A WOOO4C9ULK$:Q0).H-37Z BE:]J=CA&/W??
MYPBJ@A42IIHI6VE]C;"+U]^#Z>=(%J@!*("=-*G10AT6E\((RM[VJ>C>:2M"
M@W)%:$E*[KLJ;LTPB@4Z59554;>J&SAA!<_NH+$JBIH%339"BIIA#H=*[A00
M'O0E;*T7;>G5!VL!R]17"(WL6;<NE02@>\($UN"1>X04HO4KK36JX0TH1M7S
M?JB0*4HE*GS3^TE5)2B*,()\J%>7/YC=$M BWJ40V))%ZIWI;""/;8579O5E
M>\'S)0A J5WK0:T-;:X0":AKT47&]6<-5+,ZDDH-['ZC:H ]5PAI2C^V>K*Y
MV2"A()!JI%1^*&EZ6N,(KT%FI4\DOT5'"P4LG:R&FY!&U3KA$>OB>>J._G#*
M"]:D]12R^@N#;2F$2 !0A*Z714)"T.]*W080]Z^^70P( ;CST30(11#:V$4'
M95;<J5\=#]R>%^X<Q;E[#Q##J(AWK#3MZY?.V7CMMAL$-,ML-JRT""000B:8
MA (((!!8@A01H0:QE+-/AS":0F2>4@RS2E)I9I;@AP>2.A%H_-+X_P#A2\X=
M>)!]%RN2/Y;DZ>Y$S"^DT2RY#N7MQ;&7YPW,86&:8 88]D]>LM%WRLH7A+*J
M4\=[896?"[02XDN#-)@3\(S\F'/+*!(9I<CF.]+*0C@S H74UC[Y^@KC6#G_
M *,,3+8F>ES/%,'MEP'&SF'/B&?,228W'>%C GQ!,\PGDPR 1WB!*Y8+JFFW
M^M.1T2LCD&E/](BC:A3T/T/D^/\ K+@O^1Y*R4Q,4?!(^S^#G^Q[M;4?PSQH
ME7_N.7ZZQ^BG]"D0/#CQ!HH_PN3"MU!ROERRFZG2]=CCV;Z(_P!0Y_\ K7%_
MU?+Q\ _LVG^D?LY3^1^6T'_"G$_>GE&Y#G9W^1_+'JL?&:'0^!C4%^D,SS*Y
M!Q#?N,T<0^(&1G>5?#EFO/O""&R<\SBX@IUQOA9]',R-W,QE:!BW,R>N74GE
MT(YE\V+N$:A9I%LM?#$-$1EWT7S3XQJ2L.1>[(MB=;44M4QWIX%YUPVS;#9I
MSC+N+V9.,?&/,4IRM%\49S/I?F>3PDE9+J/:E4@R[)YU*I9+I5))=$/)HPX@
MY5[4EY[1_%-%X^9;:R9&(*UV16^>XB3+LEKJ?-2=[*M3&P70(@WYDKU&M!L5
MK3<R)76K(*>!LC<JH$#)1 @(!N "ME%5KO5;81'&HYDZU0 &_*M28:JI&H4$
MI^Z= =*BN]<()1M @-55Z&_-0B6)UQ_I2Z>%V5#_ *1_A/7N/$CPQKY@U[86
M\/C[ZQG)_._Q13_&E8M6OP9(V-LV9\D*&Q[FJ-$7_/","UFT*-RW(N0%W(!A
MKRTU -*I5"O4"O73KA! 3YMULK$LVI9D$"%31FH52/F5H%K1+WIA#YLFMPSE
M%8JX8(K)%*,Z:J*UNHLBV^A546P4,UCY&^[: , 0P;!"*J0!2A)-]:?).R(0
M_P 5V%6UNRJ"MX9  (K9!J:_W+ZX1*F@\O4^&[*IA*50J4(5+ G\$HFJDG"#
M.FAJG-:UY4 NL"D! -JC0T)!793?\SA CEZ<O&R*-+0$A 2G8#74V[%"BT7;
M",J? EV-$'J951TL8 BD%="230T4 J+(O\IA$IU#L&"D%$*52E>2JM E&B4H
MJ?CH0B;J,(&J$*RK?<V4A'!"LD4BG9-$6[*#H4J-L(B\SOU>RK1V/1(5"0*F
MBIH2@-5%FJ7U[X17Y64DM7=B-'*6J2BH\N6O5**>GF*U-!A#ENFP=49PFPN@
M6E*->E1H3=#H$1-$'?"&B)<<Q9G4JK.Y%DA4))+7RJEMA==CW3"*] '&X8N4
MJ694)JI(H@+WH#1;49*)06OMKL2B'D5/S&ZU9U=MI2^M2HIM4DIL32M2!UPB
M*B5U>M&Y:W%*I#)5H@$@H@VW4_3\]$$U\?)EKJ?@\)0$4 @U*50E>X0!?0G"
M#VT1=AO5Z490%>%]Z@I4D[:>I%-/SPC+=:,Q(-]1<W77D!3I^)!6Q*Z[% O;
M"!&N]=M""J:@,*/-#6YZ!5'D@715)]-\(FBM</2A5>5 YUL(:)4+0H0-4I;J
M4/8G")["_-J>"C<PE11<"A*T1 H06-"EJGKA#?U<KI8&RUUU$"'F(!(_M4CR
M4)K5=SA%9']5T!T?;0!6#HU/^\=#H$ZJE5.Z#15PB@ 79RHK5D3I4HINB"@&
M305IJMZ5L*G4@A=1A$<*H(>S5!H?%&*6(6$ETOS4&EBE#W\KB@*HM;HH!6ZA
M+CQ2ZA71"I(74$4V)K1*$*/^$KA$IX@WZ.H&J$.62I0*:4HB^8+->C(4FX'6
MF$$U^ 35D#+T50'*P+MJB<JT(H:=BG4(N$$^]4!=PY-;_,059!I2HKK8#\2E
M*:[HJC>Q:VM"!H_1!0"CEL/X55#\AYD5\ZX1#6K(J6I8NXH"@=@B 0K;-#0T
M4>MDOT0G=$5[JQ?R5=:#<J%)970&IH0 =B42I6AUZ#7")9@;Z4W92-RUN;I1
MDBZ'HH _+T3<X1'J#MI?V10Z49*&5H45/,+3HM#;5KIA%3D&T(K<W3DKBY+J
MU:*$ V%+TO2HV\J(,P%U(*I5D<H-]43<A^(IUZ,UKI<A$NMJBV$4H!;<*2S;
M(%4N$JQK&.?BMX;0W$S@1Q+D;$NAHV>#*$]>9>?O'++41#3)B >-NQ#O>1MZ
MZ]J6 PV'9'M&3RD- H.(X[EORKA/$<.7#EGQILEF9<(F4&83384P24H2.]1
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MHTN<(NKE K,+7 .I2GR#+*"A-":VT'7HG7ZHC$)1@@!5U-6-%5*\R88) L@
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M!6J55*K0'H=@GR 73",6;E3:G0FJ\RE%H 7N0M]34&GYZ$81/(;>_>L0@H;
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)^ >H_+"$?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g105868g17c48.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g17c48.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1AZ4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &%Z^8C@X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>3$$         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@             !%P   7(
M 0                         !              %R   !%P
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !%P    !29VAT
M;&]N9P   7(    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M+)>!8"0(9^<]LKG*JZA]>[K';@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$!_\  $0@!' %Y P$1  (1 0,1 ?_$ !X  0 !! ,! 0
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M,A],O)1<T1*(M5_5_P#\L[I8_P#9/U!?^^XZK;U]/+ZK7HZ]?D6GOT7U7?\
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M[/#X$"FY@.]NN.X-YQS,Q&DG\8[_ &%M202$I^)VC25=R?C7P >]*NT:_P!
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M&R"#O[#?TK=T<0'4]YQO)(R YBYGG&9@KJ>TJ)HXG#T:+!NU:#JIEI+MYKH
M:1 #2)!$'0R"O9?>IV^8W8+I>9MAARQ;HJY"@PX&_"3KN*5.DZ&]D;_UUMZF
M/<QY:-TB^?'3(@6["Y#9.R6X[>%;?81>6VL,Q!!SX^<*^&>HN-Z+3DRR2&.^
M%\:?14E]STU+'I@-A6M^E\RAO?N1O6JW#<;3%-U6I[K1P(L2;3)'TOP6TQF
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M][.CYU7//PKS6WX/]F0(F,YSW1<\9&65EYEB,12;M#:M-I!8:F+<T@M(/O.
M(N&F9&5N<*Q\ZX[SV5&QQ$7%;L^6<JLTIQ*8AVAAOXH.+.U?PI*TCW^OGWU6
MPJX:L:EFO-Y$AQL),@1UO$>B[%L+:=*E7PP+VM#=@8QI)<T;KBQL,<?: !Q.
MAO<65]JP',DN$#';P%;4H_XD5%.T^04]QU_=H>1Y\UO:6'J"G$&9.A&4C@,P
M8Z\EUW%XJD_%X&H=W=;@ZLD%I )<8!)) /(G3(JQ.2>.,[GX-E,*)BUWDRI%
MJ>99:3 6%*6H@: [P->23X((^OFMC6PM0/R=SLXQG_V;1$99KDMC;5HTZQ$M
M%B!=@!L=/:";Q?UF5=RL"S3X!MO]F;V%")LI^!=<<(2Q)8#20PE3I2&T(6$A
M)VX2I7RG0RQ&$KU,%493#B]VY AY,-<"38&1 )D"W*(7&^*,6RO4#L.0:OM*
M1]P@D .!<#N$F(!D 1Q/#"S@[A;EZS\P3KK=,!RB-!5B-DB":Y:9[3'Q4;#<
M?2IDNO1V]-IDQW(R$J<3_P 2TWW**3W\&_ XH5@2QX&[1S]I?<I4FD_IU+20
M9!O[U['ZI_$WQGX8VG^'/AW9VS:V"J8^C5Q#ZXH5,$YX#\?[1K'BEB'U@YK#
MN'?: ',>&^[NA9/<=<89]!M&3IN&)WY+CO)7)=UC*=86%&WW7+ITR$KM"@E3
M8BJ24!25:1[$J^8=@PV&J"@X .#C$6=RF+3KE;CEE\[[=Q^"Q/\ 5HI.IDT_
MS'M #3/ZFTBTG=<9&\TQ( S(-B!:N=<9<DKE\A?E^)Y$OXW%\4C0Y$9E]GO>
M8R>XOR6VE(<24N)BNH4K2O*=>"-@[+%8?$&H#NOR.\1[0RXD\N@XVSR7</!.
MT]E8)O@88MU _DMJ;=K8UM3\O(I5]_V'M/:.;[N1'M"UL$;I*DCC"Q\R6:-D
M:?RW,X*E93>)<5*R^M"8Q<4J(D(6F0OT%#2EH]-?</X2GP1OL!0Q#',<XOW1
MH=^.AT]3EU*Z'M:M@JF'PC9I@MVIM"I4+32GV%2M4<P$S.[#A&][DD$2KLO?
M+_4-A5PF*C\8WG.88N6*V^,VF#<(K[<6Y+";W<77'&F65MPT_,RI*&DMG7J^
MIOQN:SZ[77!(TF8!\@(G2]A?DM^<!L?$X)IIUJ5-Y#G>Y4HA[MUHL(!$"Q<(
M,Y6S&6EAS>ZSI#,:X87D5F+J@IU]V('HK*2T%CUGFRD)TM1"CVD#7ML[&ZHU
M'N82\&6@F[B0+3D8O.>1^)/4*F&HL%0MKTRYH)#0YLN(=>(U(F )O-]%]JY\
M@8E9;E$M%UR&TP;G<4R7;?"DR4LR);,9!6\IEM9^=36B% $=P!"?F\'+VPY7
MF+W@#0:]#$\@%M6,=4_2)N!QSUM-EX[IR1A=JBFX3LHL46(TM"%N/W)I'EV4
MU$8T-DGO><"=>=DC7C9&1K, DD1<D"=[='#2>,VRR*S.!Q(:7"C5(:TOF"0(
M$G)I,Y#*_&+KYTCE_ 8<V-;Y>6XZU+D(C+1'_,XX=<3)-P0VIM*UI'SN0' G
MN( [5=Q *"K1..PP-W[HF)<6CXSRDZ +>8+8NUL<)H8.M4]V?<I53/$#W3).
M8 DV(N8"M1'4;PQ-43%Y+Q%P(1(<*?SZV;48@<<DI\3.W_%VVG%.I.M!!)4
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M;Y)CO-W)V:U*0RZMDMD$AO%H]Z9O?B9GN3:>80\OW/>=LM25^BQ (2D%2ED
M?,H *5^I"4I )_1('Z5K"P["+Y-YQ^SY%;;E9[[ 8NUJNT9<.X6^<GUXDB,X
MDI+:F%_NTD [2XA*7DJ"5AP*2DBHH=5TQ<%JQI.(*P&'^0H>:DI83=;^U/\
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M)FH "#<-@S[H.4Y'.RJ8B-QUN.(4XI3@2#ZBN[03O02= _SV3NH0"]U3_.<
M#PME;]U02*;:<RUKG.$DDR[.3P&EK+U55%U/,I>1V*4M(V#MM10HZ!&MCSH[
M\ZU]/-4&)L#((,\#FL7M#Q!+A>?=,'77A=>(VN.5+5WO@N A6G  2225'Y-E
M1W\RB25:'=NL&M#'%PS+=TR!E?ES.<B;Q-UFXESJ3RYTT0P,$F(89$S),Y&X
MD67H3$;0E* ITA" @;<.]   G6AW>/?7N2=5G.5A8S.OFH_WWOJ&Q?O;P%F^
M\9,"\1H9D<5UJ@,K4A16]MLI(_>>"4G8WL$^_P!B*FLZ^O/6?WU5833((T8:
M<'*"(D@1+K9KO^'0'2Z%.!1!!'>>WS^A]B/<:(\^^ZH," !$@Y#3(=.2P+9+
M22?=! @Q8F3.I/,GEDJ4Q6TE1*G5]P((6LE.C^@ _OW4< Z) M<0([[Y(QOL
MW;S7/F9NXF#Q$ZJI<=MSM"^Y24I*>PGY3L:VH?Z0]P1H@^:H, BT'.1.7?<E
M1S X@F; B-+S>#K?/HNAJWQVEJ<3W]RU!2B>P;TCL VE"5:"=:\[! \Z\'%[
M6OB6MMJ )X:RLPZH+&M6>!,-?4+FB220&FP$F;:W7I]%&E)^8!20@Z41]%#N
M\$?,0HDJ]]@*_B&ZHM$:9:^LY^<SJIK,G3,SEESGY^BX+#:N[N!/< "223I/
ML//N/KH[\DGZU" <Q*REUX<1-[&(_P"[_HSK$2J5QD+;6WWN)[T]I6A>EZW[
MC8*02/!^71'N-Z-9-.Z00!;0BWHL'MWVEI<X B)!N.,2#<\;QI"H3"8 1M/>
MMOPAU:6RZ /8!80#H>X^N_K6+@'&2 .EATULM1CWTV&FVH_=(@@N,'F0(!/,
MA5B.E(/[Q[R0=EU1T0=^ =IUX\C6B/!!%  &EH $B)B3$1F9^2TBT"^\^U_U
M'ZV\LBK5O^ XADLB//O5AMUQN$%F2S!G/QFE2HC4MLMOH8>2E*T!Q)()"N])
M)*5)/FM/V-,D3/6UO0+7IUGTO?9!M,.$@VD2/W6O'J8PHXAC=]A(CI-JGJL;
MUJEJ9:6TTW'R:QO2&'%OM.*+RE2'66RA2=I#7CNV7.'Q52K1>:0#2U\ NATP
MX1O-@@3!)F" ;P05W7P]69M!KF8FG19 <T^S9$@B<ZA?:'&;7-A:ZQZY 91_
MA>Q;Y6P2UB30<0TPE;:?S?-==I2V-*^;^(@D=B=$$;5UO:%:K1<"V3NDNAQ=
M>(,&"#!B(%KPO8/!U#"MV1M/%MP]!U7![1K8"F'4J9::3</3>*CH;O>U#JIA
M['L;80R02<$<&0%RGVNYP[5G/D*5W()MEZ*RG9\>ILA14%;!T-5UW\Q5+G.+
MC(WR!+HL"0"-[0\[=5]"8C!X&CL3PQBV8'!>VVN[9GYF<-1W:?MGTR\T-UH>
MP\/:.J&YF97Q>0BE5[XX]1#;BAP0CM*T@E)$!2SKR$GOV4J[DJVGV((!KCJV
M(K/Q="D7O#:NS<3BG$.=(J402T-]X@,,>\""XZ."Y'PK@L <;XVI.V?@7,P?
MCO9U*EO82B3N@-<-\%MS<V8&-Y3)&^_H&2A'2EPN$H2D+Q^2Z4A*4 *3/DZ
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M?]TY\PN4\)_WC^(&=_'VS[Q_V6>6N4Y@\EORZ"/^2GPK_P VY?\ _(2:]/\
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M#KT/)[@112<^1_F?*_HJ&LU<=_+2<5RMI,]E;KH<LLU*[>I!4 W-3Z7[I:M
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M/N?Y^?FI)U%_AG\P.4*MS-G&FYR_V4RQTPKBS;T(:LDU2IR7'FVE3X8](>I
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MA+M0XOP)L+#;T/I;>V?[2GK3<]XJ%D%LRW?%ITSF8P,SK-,M5>\6]3CN^L_
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M\0Q&6"PB0\H(0ULD!!^VHRF>D_92915:@?QI>8<BX;Z3<=N=JYBO? &+99U
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M9]>^.5\7JG<VY-;\F7!Q=R]HOZH\"4U;XTR-JX^LZEEI],9 >4E+(T#1%M3
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MT_MSQ*B?<KI$N*LHR0V2!!+JK7=+@CC[+4/M7MM&AZ$>T2)LN.I:@!/CQ?\
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MA8&Z1LC&SK(SY1I.?FOOK^C16;A?P^VD PN=C/$^SF-<"!N&!3)<#,R?>M!
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M[@ OB62H>^])B*&CY]R?(U_6O'_%_P#RAPN@_J?&^5^,?=?>7]',1X!J"/\
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M/3C'>QR,_P Y<5M2,P=6QBL=><X\E[(7FI)AN-6=LSPN>XB4"PI$<+4ET%!
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2$2B)1$HB41*(E$2B)1$HB__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g105868g23f27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g23f27.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1@04&AO=&]S:&]P(#,N,  X0DE-! 0
M    %_2^83(X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O
M;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U
M8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M                0FQD(%5N=$8C4FQT                4G-L=%5N=$8C
M4'AL0%>6$<         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@             !'0   =P
M 0                         !              '<   !'0
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !'0    !29VAT
M;&]N9P   =P    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M64:6G:X-!AK]GJD
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                      #_X3]8:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E
M4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE
M=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V
M-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z4D1&
M('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M
M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T
M/2(B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]P9&8O,2XS+R(^"B @(" @(" @(#QP9&8Z4')O9'5C97(^36EC<F]S;V9T
MPJX@5V]R9"!F;W(@36EC<F]S;V9T(#,V-3PO<&1F.E!R;V1U8V5R/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O(CX*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O
M;#Y-:6-R;W-O9G3"KB!7;W)D(&9O<B!-:6-R;W-O9G0@,S8U/"]X;7 Z0W)E
M871O<E1O;VP^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#(Q+3 S+3$V
M5# Y.C(Q.C X*S U.C,P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM
M<#I-;V1I9GE$871E/C(P,C$M,#,M,394,3$Z,C4Z,C K,#4Z,S \+WAM<#I-
M;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T93XR,#(Q+3 S
M+3$V5#$Q.C(U.C(P*S U.C,P/"]X;7 Z365T861A=&%$871E/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T179T
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%
M=F5N=",B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(CX*(" @(" @(" @
M/'AM<$U-.D1O8W5M96YT240^=75I9#HW-CE&-34T0BTS0S V+31&.44M034Q
M,RU%1#="03DQ-T0R1#@\+WAM<$U-.D1O8W5M96YT240^"B @(" @(" @(#QX
M;7!-33I);G-T86YC94E$/GAM<"YI:60Z,S<Y-#<T13(Q0C@V14(Q,4$V,C-"
M.3-%,S-$1D8V-3 \+WAM<$U-.DEN<W1A;F-E240^"B @(" @(" @(#QX;7!-
M33I/<FEG:6YA;$1O8W5M96YT240^=75I9#HW-CE&-34T0BTS0S V+31&.44M
M034Q,RU%1#="03DQ-T0R1#@\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*
M(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO
M<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N
M8V5)1#YX;7 N:6ED.C,U.30W-$4R,4(X-D5",3%!-C(S0CDS13,S1$9&-C4P
M/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M=VAE;CXR,#(Q+3 S+3$V5#$Q.C(U.C$T*S U.C,P/"]S=$5V=#IW:&5N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0
M:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA
M;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z,S8Y
M-#<T13(Q0C@V14(Q,4$V,C-".3-%,S-$1D8V-3 \+W-T179T.FEN<W1A;F-E
M240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C$M,#,M,394
M,3$Z,C4Z,C K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I
M;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA
M8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO=FYD+F%D
M;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC;VYV97)T960@9G)O
M;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P
M<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO
M<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N
M8V5)1#YX;7 N:6ED.C,W.30W-$4R,4(X-D5",3%!-C(S0CDS13,S1$9&-C4P
M/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M=VAE;CXR,#(Q+3 S+3$V5#$Q.C(U.C(P*S U.C,P/"]S=$5V=#IW:&5N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0
M:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA
M;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO
M<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" @(" \
M>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.C,V.30W-$4R
M,4(X-D5",3%!-C(S0CDS13,S1$9&-C4P/"]S=%)E9CII;G-T86YC94E$/@H@
M(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YU=6ED.C<V.48U-31"+3-#
M,#8M-$8Y12U!-3$S+45$-T)!.3$W1#)$.#PO<W12968Z9&]C=6UE;G1)1#X*
M(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C<V
M.48U-31"+3-#,#8M-$8Y12U!-3$S+45$-T)!.3$W1#)$.#PO<W12968Z;W)I
M9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M
M/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP
M=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z
M+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F-R
M96%T;W(^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \
M<F1F.FQI/D=E;F$\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@
M(" @(" @(" \+V1C.F-R96%T;W(^"B @(" @(" @(#QD8SIF;W)M870^:6UA
M9V4O97!S9CPO9&,Z9F]R;6%T/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*
M(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @
M(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M+W!H;W1O
M<VAO<"\Q+C O(CX*(" @(" @(" @/'!H;W1O<VAO<#I#;VQO<DUO9&4^-#PO
M<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^
M"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $B
M >0# 1$  A$! Q$!_\0 '@ !  $$ P$!              $" P0(!0<)!@K_
MQ !,$  ! P,# P(#!04& P4&!@,! @,$!081  <2""$Q$T$4(E$)%3)A<18C
M0H'P&"12D:&Q,\'1%R5BX?$F.$-R=I(H-#56@K5E9J+_Q  < 0$!  (# 0$
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M*5ELY0H93C16[/:E&L0Y=_1:^;5'/51U3'D5 VATY8R03@TS= Y)&!DYR<
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M^KV'?VP=%7&O;\.-&SLK JETJ<BAVVO2]9MU4D)K$-88>2HAF/V'S(>2 LN
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M?@Y4EUMMHGDX2C\(_0:ZWX\_4W9OAS 0SX9D)BB <F;(H^8?$2Z#/*QS79_
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M_CV_NA@D8F1 3&&RCB8NU"RXJN43K O^G3XE?NG:S;&+58,F(BD4./6:U76
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M _3/ F49<6U]LQO"T1CVM</6IPP>F5>+KA8_U+VC\3>@V;LR2=YQ\+9,HL2
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M>%,LU^+ ) F[] S;V_N[E79C$+N%?BXF"$2YIAGB$-!69,B@A #@[Q&Z*C=
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M LB283 23 ;PG^D\X;'R4HCL-_@9:1VQ\J$@8_0#\M9N7=R^KEUCNP[NX !
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MB74<$C';P21W/D^3YT1.">W;P<CN?)[?71$X)''M^'/'N>V?/OW_ )Z*,!Y
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M DE4@)4H =L9 T5K7APY\AZTS.:I5>D%M4Q"J9<ZU0U\2I-L5KTY/( YC*$
ME:$Y[$@*QW.3X>?"EU'HY(XU#<'HX%F^M54;RA OG[LN?#$5$H@6Q6SZO- 4
M(\<_=_[Q\9PM"L$+RE)[:=]_GV5\FSY*I-X1%I;*J;<C7J1$S!_[.5KD@*!(
MC.#X!83([$*;)"P>V!Y-#:M4BH/G0'O5T=V]PQ'>5O)=?[A;I6_:UK3+LJ[%
M>@1:339]5!FVY6D-LNPXSCK33Y3""PN0ZE#;2 %E96/D..W#;=VK*V/@,3/G
M3&AGR)F'D@011 SC#%%"(C!+F10.PK'NR_\ <ZY/9&QX]MX_#8>3##%%)G2Y
MTPF9# ?@B(0S##\29+AC8$G=@$R.CB%G(Z(Z7:;)H5IS]P[JIM>:O7=JXDW3
M70BWJXZB)2GV@Y1*:UF"4QX<:"\A1PTVMY]YXR/54TDIZA^ENQ9F P.U9N+
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M%-/I=S2BO'+3\EM;D=0\"\H2W"VFF7*G%/5/*U6S6^/89,,9@#^^GPVT>RE
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M26D(XXY?+G')2E?H"5$D@?PC^'P,:*K5S;%(3U3=4*4@!*;.Z=DI [  0MU
M ![ # _3'TT4-CR*VGT531$T1-$31$T1-$31$T1-$7&2<ID!1< "P A!3DE2
M4Y/?Z]L]_'Y^-8S(IGPS\*,0Q2WBC!A$6]"30![<ZZ+7NP_%'Q 8H8VA@#D
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M2F*V?1[-A32S@@D^HKY@2=%7%_,D-9^&N2.6W55FHK3=593\7\.N-Q1&)B!
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M<Z4N6O5BB2#=M8#C\EN0A:41OW3:.PCH'HDAM1.5 Y)('<:(:T.=@QU!KJW
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MD_Z?3]=$(Y]#IK7/O)0I'+'S*&/\)Q_N#_U[:(0[^SD#/35ZJ<$D$_PG(P2
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MIL./KYC 2$E)\9! SW((."#G'^^M4Z1!-,J**I@,5*9D/0@W R927,B@,VC
MF%BQL <WO46U7G1U=]6=V[ 7K:MG6G;=,GBI4D7#5JE6Q+1&DQ%3YD9^%378
MLZ GXR$U%#[OK?$!*9K&&TE1Y>)?JS^J&(\&8_9V#P\#F;)F38G@,6\/]*E,
M=AJ $7A+15!-E[=^DGZ58?QML_:&,Q$Z("1/ER1N3886^683O/@,54M1XH:"
MP<$YTGJ.N[>^BT:T^GVC.IN"N4>ERKRO>H!Z+:6UQJT*-,>A!]A2%U6X$(DE
M*8,1U(:<PB1Q6VM)^S%^+=L>-=@;/P?AF7,D;5VA#_X_%"'$2H,-+,,+GXF$
MGXF? !""&F0Q AX@2"XXW"^#]B^"MN8[%^+IL,W9FSITS^!P4$4J.9C(H9D<
M,LQ2\1+DR_A3-Z&*8)<0B&\!-$L@PG8#9K:&C[6T'X2/(DU:NU60Y/NJZI*0
MFIW!5GUJ7(=+O *]!IQ7IQXJU*]%H)0LK4.1[IX4\+[.\"X""",'&[5Q>]'B
M<9%\'$SYDPDQ&&&=')PT_P"$\9$(B<MF[E=+\7>+=H>.]H?$A P6R,(TO"8&
M6(Y$F3+AA$%)<$R;*,X[@CCB);>J  T(V)@__ET_-R^97<G)SG'?'8'Z@  >
MP&NWRX9D,($PO&28BYB) B.]"#O5I"0&R:E%UDQ2XJRQNP#Y0& <PT)^4D%R
MY>YN:K,UFHFB)HB:(FB)HB:(FB)HBL/%8*2G) !)2D_,O'?B@=AR/?!40/KK
M")S%" 6%7O;F.QUH-./)6T24$D*<0KYPG*0GY"K.&EA+KA2MO ]12@E/S# &
M%$;&-*$4>NFM@&.5[<D8MQY&VK/;JKS?+*^7+ 5A/+/<#W&?8Y]L^.^M<.\#
M$"7;=:^8+W3OOOC97"0D$DX !))_K_EW_P!\U"[AF;/\+"?DI;+3;CC3;CRB
MAILNMI<6HC*%)2M:.0&%%03R)Q@>^FYO W:&I(!IS(!9^+!\T#E]0'-"U2>>
MA-6?@B'#S^4DCMY*AX)"@I) \$'!R1CZ^=:/G@C;^TAQ4G@7LYJ/3K>C=]YK
M+225J^@S^GG']?KK>B+4H<0D$Y/=6$E* !DE65H./;Y<G/MC1%"%ASYD*2ML
MCLI)2H%0.#\R5D'].(Q[GVT4%>Q]#VX5S158TIP-H0LI4H)<2?E"L )"E$J*
M4K(R 4H&/G=4VWE)6"-<R'?W!_\ ,A/#.Y- *WU:R+S>L;KBJUU=1"MJ'+/A
M1+?J-QUBV:=*7,?:N*GR::R\XF;4X+@6E]+BXZT/P&6HSL$NL!<ATN#79,1L
M6&5@1B 8S'N0Q1$_T$&$F("'=!%<S$3FRI8V#<:U]?3U7I!'4>Z5)X^R04%*
MCV!4I2 5>D"3\B%**BD9SG('7(*.,P:U]OKZZ"=]_FJRM9HFB)HB:(FB)HB:
M(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(N(<J1:?4AST@A"UM$
MA+ZU*)0'&EI*6R%*P'$O,-I=+2 )"WD(24$H30M]6>V0X]U4&JI=*##+,EM;
M?)+J%/J:><<>1'CMMK:8=PVMY:C(DH#[<)+?]X0 XE:78K^_=4!=OMY-;V\E
MK;M<!_:GZI'._P"\M#IU6<X['X#=)..Q(QA(/E0R>Q(P=$-GS#GJQ'=>J^EW
M^ZAK=V"M1NXZY3YM4D5"HR*51:5"1AZH3(S ?>2IU9"&4(02>2L\^P&/(Z7X
MX\9X/P)LD;4VE*FSH9T\2</+PL$$P_-+,<)FB;.PX# ?-NQFX J5WGP!X&VA
M^H6UIVR]ESI,B+"R(I^)FXHS(81##,A@(E_"E3HB[T)@%:U#KF-H-[J!O194
M"]+7BS6(<IQ^+(8J$=++L:?$46Y49($D^N6W 4MD%'J@9PG.ON\,>(I7BK8>
MS=N8&*1)P^/@EQ_"Q1^'.@$3;T(AE3)\(B&0WXLC7+A_%7A_$^$]O[2\/XZ&
M9/Q.SIL<N*;AH3%)F"%VBA,V&5&UG^0:7*[6-244@H3A>!E+C82<X[CCZ^1W
M]LJQ[GWUVJ*$0N\,<0!H8/F!Y'= +ZT'LNNP[T8A(FX>#> +38B(H>$0A)8C
M,/2M:*VFI23G]TVLI/S); *@/\1!D8 ^O?/OKYH\1*A+&7/#"KPP]:F("CYM
MFK#+FQ$CX^"M<1S"'X_*_H.:NM55A:%DOQ,MY#N'@"VH#)2MO*NX[ @.'O\
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M9E9K*/22&T@<02<C."3W)R !D^YQYSGOK="(@/FB,1<U))+:.<A8#(*@ 4
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MJ.C6T2A(.X>ZPY) <"KOG\BGW;"O4*FT9[\4G!."<ZXH[8BB,1CP6"F&(O\
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M<JJ./\1YGIGWP0='%J)((W&W5R%AWO=TXCU1_P#$QZGXOI_ST.VB;X'!G_\
M3-M+VX6X(X_Q'K]U)Z.+4*BL[B;IE:LY)NR<4DJ_$5(*^*E'"2"02C'RD9.H
M-LD%Q@<&[$5EDT.5Z-Y:B[G&@\XONJ3T;6EQ*/\ M$W4+9R%I5=TY16DXY)6
MLKYJ2<?*"<(RKB!R.LOYW$P'\#@J$G_EG-N/#MD<?XCS-O/U]%5_8YM3 2-Q
M=TP $)&+MG!0:;)+;/(.9]-.3E.<+[<@<#0[;B(8X'!,X-)35#UH;U].:.-!
MYG[J1T<VJ"HC<;=7N"D9N^>>"3^)*/WGR(/^%. /;6'\X-?_  6$J7/RQ5.M
M^\W"=!9L_.]U!Z-K0( .X6ZF  .UX5 $ =P$D.91WSG'G.#D#6'\T#D_P6%K
M_MB^_'IDR/1F]_NV:D='%II4E:=Q=U0I/X3^U\["<>"!SQS'^/'+ZDZVC;)
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MZ9G)IR@FX@7G"G*1,"FP,\OA2<:@\_-O=*:L;5(=NK\U7]W7B!+ N"A#FH&
M?V8DGX% 0$J2HFY,R2H@GEAC&<8( T5).5=&(].>?*RDTZ[_ -]BO4$!4=*6
M0+9E_)+*0')+X_:;$A)7E:& &?3&$^NLCD2Q 9Z'INWUR;AE4T%E/W==F&D.
M5VA.MB*E#P<MV;S=J R?BVU"XL,L<L$0^#A !'Q/?(>G??FJ P+DUU(<#(\*
M\\N2M-4R\08_KW!;KW%*Q4 FUYK7QBL'X=38-S.B+Z).5!0DEW'8M]B'MD-*
MU;FGRC,5NY%;WX?9E4BGWF/ARY<= 6ZB0\N44VU.0A^(H ,QV6C<RS%>:)65
MRBM\.A20&&^.57[]]GTJ\YQ#+JW(ZV9N+J'*;>2VW$MW%06E_%I=8=%L3%J;
MACTB8KA-S)+SRBASE+!:!2X@>@2V5+/P'?>5LF1G#5B&KA\Z/2S^K6HJG:;>
M2U3E-W'0D>JIDTT*M>4LT]*$I2^EP_M(CXTOD**3_=?2Y@87Q&IY>OWMZ\5:
MY0G05A %>\C[JEVEW<I4DM7!0FDEIH0 ;9E.&%) (?D.']I4?%(=!.&>+!;)
MSZKGC5?OO1G4K1A8TJ*=*W#CADRK33KO2L$U^@^D(WIAL6U-0LS,DF471<RL
MM$D8B< <@DOG.!%6S.AH2*MR;*^5GLC<"\4JCJ7<-!6$-+1*0FVYB$27RHEI
MUH&XU_#)0CBE3.7O44"OU$9"03Y11PV0<>?GY='-I%-O)*8_JW%;SKH=<,Q:
MK7EI^*C*.6H[2/VE/PY:&075&2%GN&T=P248U#&]1PT;@JA3;RP#^T- #HEI
M7R3;$P(-."LJ@EHW(K]ZH  3 H!/?$8Y #6W"_F:U]!PS3Y<R#E4BO!_75VJ
MCE-O-7Q9;N&WT*<>8^$S;$U2(T1!47H[R!<J?BG7/W?I2 J.&.*\,.!TA+3O
MO+R3Y7?>KE4-^;GCH54]3[R6[(+-PT!II4=M,1"[9FON1I20L.2'73<S?Q#:
M^?[M@-L^E@@NN9'$E,JVMNT:WMQLI-,NP+*D5VA(:,-25-&W)O(U11*C/+J+
ME3F,HG*Z<4?, !\8/.G?;>N:@X_+?.Y+9.;95;AI2FF7?ZC"EW!05-HBJ1*9
M%M329$U6.$II;ERK^$9;(RB&$N]R?[QXP5>H:O44K?NS,&=5(@7BE4;U;AH#
MB4>H)6+:FM.2 <>D&W!<JOARV0>9XO>H#@>G[NZ?DGW3G09NU>>C45K[NO3B
MV?VCMWU$R5+6HVO.+;D,@YC!K]J!P?R1F7S4, I^'P3HGRW!TSI:S6L/LH72
M[S4)!:N.WD.*>1\*LVO,6F-# 'JQ5(%SH]9QU0RF3R:],$I]%0[Z5^_&_&];
M_=*#,"[6I6K=>=E4Y2[P*):(]PT!@+:0FG*%M37%07 M!=6\57*!,2ZD.)"
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6)HB:(FB)HB:(FB)HB:(FB)HB:(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g105868g28m19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g28m19.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1LV4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &QJ^:3@X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>&5D         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              Q@   ;
M 0                         !              &P    Q@
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    Q@    !29VAT
M;&]N9P   ;     &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
M       !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!
M46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%
MPJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V
M-T=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3
M!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%
M539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G
M=X>7I[?'_]H # ,!  (1 Q$ /P#U5))))2DD#,R68U#['/#"&DM+@7"1W<UG
MNVJO7U;'./9;:X,=4P/(F=S3]"ZO_@K/S$:)Z*:WUDSCAX]#P^QK7V;7BF X
MM#7.W;_S6LA83^I=5L_6JLEC:',%C:/4:V[^5?[_ %&L^B][M_Z+9^B6<_JE
ME^59EY9:<II<=C0?8S</3JL_TE.0P;?2;;]#](IU_8[KRXFNMI:[T7,;[WF/
MTM#VN_K?S;E;AB$8ZUYTP3GKU>IP^HY3:MD_;BT^^[VMY&[;[8KW:^QB,>IO
M+BVLL<>[)AS1&O\ 67)X/4V=.<UN3664EIML>+V/<YI]K6Y-3_H_F;/0^A_A
M%KV9]%M;:\)OK67-<\@ MV _1+OY+_IJ*< #LL.65;U3IT]6+@UE1%]IT:R=
MKB1'J-)/M]JU0N.Z'D59>63CDQ4YI=:1(WD>_P#2_1?L_<78J*0'1EPRE('B
M7222365222IYV>W&+&AS=[GANQP/NG_!L?\ 09:__!^HD!:FXN;Z[U=V%U-M
M6^TMV,+65D-9N>YS-EAW-_G&_P#;*M]8ZWZ'2++\,@Y3@655F"X6#Z;':_SE
M:Y&C-Q_<7O:\7&+K '%CG0W=9M]CO4I>WT_6]_J,4^'$3<B/"EF25!U:<KJ[
M;FLNSV-8YY9ZM+F'TQ$BNRJP.]3Z+_3_ ,,MZGJESF-+J@:B/Y[<(/\ +_E-
M7'"NEV/86EHR2YLTT%K09_FKO5?[&.VO_G=RNX'6<6DG$RF"EH<**F,L;=5N
M ]SF;OUAKW-_,>I,F,5=#3PIA]PC9Z%_5'[-QL8:VD;[6<Z'7]&K&+U!V1:U
ME0%C?\*\&-NFYCH/TMZY_J.?26/<V?LE+@+<D':"/:QT3[/INV;U=^K#O68V
M]@-;'MC:YNTEH^BW:?\ /WJ @4J&21F!=BW_T/54EF=;ZE7A4"MS/4=>U[0#
MQH(]VW;^]^\L#]M_96;Q8]K;(8T!VYP</H5[7%VZQS_\+_H%)'$9"]F*>81E
M57W=*QCLSJ+V
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                 /_A/UAH='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY4
M8WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B
M('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@
M,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI21$8@>&UL
M;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT
M87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D
M9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY-:6-R;W-O9G3"KB!7
M;W)D(&9O<B!-:6-R;W-O9G0@,S8U/"]P9&8Z4')O9'5C97(^"B @(" @(#PO
M<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"\B/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/DUI
M8W)O<V]F=,*N(%=O<F0@9F]R($UI8W)O<V]F=" S-C4\+WAM<#I#<F5A=&]R
M5&]O;#X*(" @(" @(" @/'AM<#I#<F5A=&5$871E/C(P,C$M,#,M,394,#DZ
M,C$Z,#@K,#4Z,S \+WAM<#I#<F5A=&5$871E/@H@(" @(" @(" \>&UP.DUO
M9&EF>41A=&4^,C R,2TP,RTQ-E0Q,#HT,#HS-RLP-3HS,#PO>&UP.DUO9&EF
M>41A=&4^"B @(" @(" @(#QX;7 Z365T861A=&%$871E/C(P,C$M,#,M,394
M,3 Z-# Z,S<K,#4Z,S \+WAM<#I-971A9&%T841A=&4^"B @(" @(#PO<F1F
M.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U
M=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT
M(R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B/@H@(" @(" @(" \>&UP
M34TZ1&]C=6UE;G1)1#YU=6ED.C<V.48U-31"+3-#,#8M-$8Y12U!-3$S+45$
M-T)!.3$W1#)$.#PO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-
M.DEN<W1A;F-E240^>&UP+FEI9#HP1$%$041"-C$U.#9%0C$Q038R,T(Y,T4S
M,T1&1C8U,#PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D]R
M:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C<V.48U-31"+3-#,#8M-$8Y12U!-3$S
M+45$-T)!.3$W1#)$.#PO>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@(" @
M(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI397$^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V
M=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$
M/GAM<"YI:60Z,$)!1$%$0C8Q-3@V14(Q,4$V,C-".3-%,S-$1D8V-3 \+W-T
M179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N
M/C(P,C$M,#,M,394,3 Z-# Z,S$K,#4Z,S \+W-T179T.G=H96X^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O
M<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HP0T%$041"
M-C$U.#9%0C$Q038R,T(Y,T4S,T1&1C8U,#PO<W1%=G0Z:6YS=&%N8V5)1#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,2TP,RTQ-E0Q,#HT
M,#HS-RLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W
M<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO
M;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G!A<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N
M<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.F%C=&EO;CYD97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F-O;G9E<G1E9"!F<F]M(&%P
M<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO
M<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V
M=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$
M/GAM<"YI:60Z,$1!1$%$0C8Q-3@V14(Q,4$V,C-".3-%,S-$1D8V-3 \+W-T
M179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N
M/C(P,C$M,#,M,394,3 Z-# Z,S<K,#4Z,S \+W-T179T.G=H96X^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O
M<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @(#QX;7!-
M33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z,$-!1$%$0C8Q-3@V
M14(Q,4$V,C-".3-%,S-$1D8V-3 \+W-T4F5F.FEN<W1A;F-E240^"B @(" @
M(" @(" @(#QS=%)E9CID;V-U;65N=$E$/G5U:60Z-S8Y1C4U-$(M,T,P-BTT
M1CE%+4$U,3,M140W0D$Y,3=$,D0X/"]S=%)E9CID;V-U;65N=$E$/@H@(" @
M(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z-S8Y1C4U
M-$(M,T,P-BTT1CE%+4$U,3,M140W0D$Y,3=$,D0X/"]S=%)E9CIO<FEG:6YA
M;$1O8W5M96YT240^"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @
M(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U
M<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/@H@(" @(" @(" \9&,Z8W)E871O
M<CX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D^1V5N83PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @
M(" @(#PO9&,Z8W)E871O<CX*(" @(" @(" @/&1C.F9O<FUA=#YI;6%G92]E
M<'-F/"]D8SIF;W)M870^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @
M(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X
M;6QN<SIP:&]T;W-H;W ](FAT=' Z+R]N<RYA9&]B92YC;VTO<&AO=&]S:&]P
M+S$N,"\B/@H@(" @(" @(" \<&AO=&]S:&]P.D-O;&]R36]D93XT/"]P:&]T
M;W-H;W Z0V]L;W)-;V1E/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @
M/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( ,H!N0,!
M$0 "$0$#$0'_Q  >   !! (# 0              !@<("04* @,$ ?_$ $80
M  (" 0,# P,"! ('!@0& P$" P0%!A$2  <A"!,Q%")!"5$5(S)A%G$D,U*!
MD:'P"A="L<'1)4-BX31$DJ+2XO%3D__$ !P!  $$ P$                #
M! 4& 0('"/_$ $ 1  $# P,"! 0$!0,# P0#  $"$2$  S$$$D$%41,B87$&
M,H&1H;'!\!0C0E+1!^'Q%3-B)'*2%D."HE-C@__:  P# 0 "$0,1 #\ W^.B
MBCHHHZ**.BBCHHHZ**.BBCHHHZ**.BBCHHHZ**9+O?WDTSV2TG<U7J B:5I8
M:^*QD=D5KF5OL-VJ5F?=2!"%=R 0-]F!^0^Z/T;_ *CKR$+%M5_:FXL@DI"4
M[$D K +]@ Q2Y)+"FFKUR-,AB[@0)\Q^; 0< Y)<NP@&J]<7ZT>Y^1U52&0Q
M^"QVE\U:#XX0HF0JX>I(=JL&5NHJB2R\91I 6/M2$Q^>._70;GP?9M, 5J4$
MLI1!"ED"2 +Z0"HX(3M(,#O5+W7"+K!7E)A)\P$@ E[>UGA@YY#364[C>I//
M:)R\&KM:ZYJ:8Q2TK7\&Q\4*PUKHC)!DLQE1_*GV$E<^2R,&V_ =Z7X8T^I1
M_#Z:TE9W 7%++G<<@J7=#E,A@6!Y!ICJNMZA-TE+A  *=FQWG -MP?7AX#-3
M4T/7I7[C8N"30NI;\>J,.UF_D:,?\V7+XZJQ9SC("""K1@D$  _/XVZ<W/@%
M6C)N7$(\,LE.XD@DY2M)U*D@' )^P@T@.MZHLIU[@Y8E 4E@&(/A%3EV,'@/
M)I6Z+_5'[6'#Y";5NIVHY.E8]D:>R.FKRWED0B/W)+E93%RF=655WW3@6\;]
M1&I^#%7?YMBT$(#I4H71N!#NR57""$N&,-#EPU2FFZ\OP6O !6]7E4E)=REB
MXMI/"@0)[B15AG8[O5@N\NG3J+&+!6BL'G!"TDK2R59(XC':*2 2!)"S($XJ
MNZ'8D\CU2.J]'N:%3*25 J(WEH4 _P#2M6>_#&"2U3O3^IHU2E#RI( ( YD
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M.C1I# S>"NY)(+N"0"=]C^Q\@TX6Q( ;EFX>0#W/J1$M4=<URNGIN"6OK\4
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M&F?P=B@'*W&UW!*<ER1+#(^@,:=%^)KR]8=/YCXEVV@)'_\ HY#()&T.3,
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M::?_ +3][\?W%UQE*NN(]/ZH%:.KHV7(R5VLU)/I?X@]FVB3GW2UGZPHLNW
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M[[#>$+&6 V ']A_??Y03DC[&)<!QW=_S& U5GK-DVD@INA965!21NW):>0D
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MC#G]@?MR?]A38Z[U=H.#!6J>H\MCWI9BM8I1U9+,/^E;J0Y3DVS%0.:MO]I
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M@Z1LY+)8.S7PN#HWLI=H0W,G92K5'U4:QH9[,H*0UT?VWEF8.L0C$A4E.C6
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M)9]1>UB(LJ,E&_M/+=:: 1M"S1M,CMQDB1G9=BI78 $1Z-6FQ;V+*=ML+*W
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M_584E [;6# YPS 2P<>X[-418UME5Q1W)3=\00I0 VP20"ISN,"0P$NTVO\
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M;L%&=GAFE>O%,D44%3:2?ZR2%HZ_#WBI$9V;'J]I-RW96L)-U8M@%264I1
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M>GV=5<UB%&\GQ4"S_+";:OE26*P%-D@L8>)K47;96JVE&W:Z1C+3!(+"<O\
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M"TVE[5['1WYAR]QQ6@GL)*\(9 R\491[GMGR0-DE:6]XME2-VTK/BI*R!L(
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M+ULN5<_0^_$>%F0[%5+$^%\R][XAMW%@V+K("]IVD@ @L1"O?'T9R[/_ *&
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M@I0&U#?%N=X_9,C^[&%C/,L@XJ>2]->JWUF_;7;M@VTBV"RB%+)N%*D[0'+
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M $\]\+FLL19[2:RCQU:=B^+Q&8OS1QO@(Y!5]Q6,@_\ PLAIU=Y!]V\"[/\
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MMH8N#_=#R#]PYSU[X M=:LI0B\M:K1*B0HD@G:IB3M#;5-'I,YM>]W_ZH_\
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M'F>0<MX('CIE:M:F[<&ZXI20P9@9)@0V7[R<YA$V$H>'EQ." 03#RT$ 0)?
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M,$JQ[/EF@[HHZD;MYC-'8[)2TK-F*G=IM=D]M:]RLDL]H%R-T5IHQQ;<;C8
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M%R.KL5,VJ\(:L-/-X^PYRB12 .D4EB*7F5V8[^X7\_O^*IU._H46U)LVDIW
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M4LD8$H).QX\N._X_ ;ZK4(TH)B'P3E_8N0V2WE<^M(6^GJ7Q)_NX#@-\Y #
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M^!8U%NZ1LT[&VA:2H/XA7AP3M46.X!V96Q:N^%>_BKGB'PU%((0D$A)\KH)
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M6ZMB&Q0R,J PPBU*\#OLQBD<[MR/J6EU?\,5BX]XDNLHM.7$G:5A#0( Y,-
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MRR<XR6+!QQ'M!B1$BILHVVD$@@AL@C)<3+AS+\M P],+5]92D@Y"(! _IF
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M1%%N\)AFAEC'NAD<QLP 1^KWT>Q>T]JT@"$[QA!^:XI0,J40Q)&6 X;,;?\
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MW;)8@YSB#&:LR_3(["^G3U!=E>XG;76^EL-9UY4R=;(5-5U(OHM6UL3;J/\
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M+0S>4#))?TD2<AY%)>&@EU"9=N8D.XX/HT4G]<:SNZ4TY<R5>+ZNRK%:=:%
MSM+LA::1@-XHW 1!*IY;H03X'6A"F5;7\I<LT^K$$D,7CZ]Z2\&V+@@P"7!(
M,D@@D0' @SRU9K0/>Z[/B)8]187'X[+:Q%/'C)>TUN^,='$4>"I9+'Z=)I0J
M32*%EDVXNS(  P.@L&X%D+##Y0LMN))W.9+@8D=P&IZ;:$(\D'())S#@"1DE
ML=QWK-9[*YS,114[$TQEQT!J5ZWU;_R:\3\0A50GMC8;A/.PW8'STX?3V=/<
ML@>:X7 \SEPSDMAW/><"FBE*-P*)&Y(8*#-DD@O!9^>8J1?I_P"_][L[EYSD
M&FR^F;]%:6?T1DA6R&D]15I)%-FA>Q>26:DENU"#%!>]H30DDK(N_5=ZA\*:
M76:9=Y*%)U"TK4A87<)02#M4$A6U27'RD88=Z7&FMZQ#7W4';YMKOWVER>TP
M>QK:)_3WC]-VM.W>>[F=A] 2:$3462&/U-BY8)*\E/)5 TL]&E(I^GDQT4KM
M].U/C"5&Q&^W7FCXCTO4]#U!6GZA=3<"-W\,1;MH4+9(W!10I6YR$D$LTB9J
M3Z7TG1Z)-[P+:T>,4&X]U:@2G<S)4H[6"F/)P8%6(K!&JE0#L6YG=B3OL!\D
MD[>/CXWW_<]0!),FII "/E>23)>3EG=O^>]=H  V ^ !_P /WZQ6:^]%%'11
M1T45\(!^>M5)"F?@N**-AMM^/C_TZR P8<5@I!S^_P!Y]VKHLP1SQ/'(I=7'
M%E&WE3R4C8D#RKL#^X_R'6P)2002",$9K5:$W$E*AN2H,1W&#^!/O5+GJ:_2
MCQ7<77EON-VYU;6TU9GR,F3DTYDL6MS%>[:26:[*C0RPS+-)82-8U+-$J2R%
MHRP0BZ=&^)KFD";5P@ LE1"$D9 &0X#22\<Q5&ZK\)Z51N7]+:*;B@1-RX26
M#LE)44RT$]P'YJD+U&5]1]FH]38+4^$NU/X7(^/L5K%":*I,B3F,W**2(PEJ
MV K.'+'VU("]7VWUC3ZD)-M8\50!<$GRAW(3L:0TCMS7+-1T766-9ON).W<0
M80#N)>3N)</@AO5Z8SM]G*&K;="C6H#'Z=]RM#:LABJPQ3;>Z_!2/@'?<#Q^
MX\=+ZBXM=E1!"B09'#"7P28P9XGE3J238T;6@RVD0J6?"@PCTAF[T\O=73\N
MG<IHU,9)'])1LJV-MPO+'(*TB@-*9MPS-.K>VP8[D.1OL>N>:RY=.IVJQ,,(
M;&/?@D ?2N/7E+7K+O\ $ *!W###)(! Q,Y]VITV<Z@P^+K1V[$%Z58WO6XI
M&"HJ3H%+,I\JP 0GS\GD3YZ2,^O[[<>T0T#EM=%I).U)#PD.2)8QV#NQ.".P
MK-4<!CUI24LK-#EF69E+A!&\4"INBN8P"_)U16)W8\O).Y'64N5)!9@\,[N_
MX SS].6:KQ02M'E8AGD)<.>'((8"" 2[L"!VR5Z,2PXJA#5CY$_2PH C*^P8
ML.(&VP#.Q_.Q!Z4VH,-\I'!SW]6?]?4[6]0L'>Z26D[4DD /@CT PQ)8C)$2
MM?\ I\JZLUH,MD\R]*>-Q)8 L21I;BY<O8+QN./$_=R!!)&WYZQ_#Z=:@+@)
M27?S$.&R^<LX_&IH=9U1TES3)4G:L ,$("I4'PEY:3'#EYKWVO3Q@17HRXW(
M69A(TQF6>:5X9/9!"B$O(=CX&S#8GP23TJ/"M>6PX2'9R29B2KF0)'L16VHZ
M[JT:(:6^L&TE@$A*$DC+.$O,N'X<DP]:?JR]-F8Q\B:JK(*M3$12Y*:&W,Q^
MM%0-*4@5SQ,KA=D<#D/QX ZF^EZ6ZO46+@#E-Q)#@,",%G:2Q8^P>NF_Z;=?
M78U%E-D.FY< N%6U3@EH"T$I(9A//<UB_3A@-+ZMSNC9LE!+B_X5#!D;<3SE
M5LY:M91ZK+)N'CC,B#>-/M<$+Q\]=C_AUCIKW&!VF6 .'@ R2SD/Q):O3OP=
MU#2#K5K4%#W1<$[G2Y(43MV;<MC@P*LPU;A<1F=.6<,U*'Z:6,1SQ!!M*"O"
M.6,@;QR@$,LJ;,'XL&!ZJ6CUE_2WU7;2@DVE*6'2%,QRQ!'JV"Q#2*]%=7/3
M.NZ2WI=;:-U%RVFR4HN+MG8M+%B@)+N1R.3WJ*MO0-+MIE,AEZ4,\N#N(BV)
M(^;&L[; LX\E@@^>6^Z#\^3U>ND]:NZO;XJTJ)SY$HW<\)#23_5[M@<5^*O@
MK3Z07%=+M7$)#E(5=7<8!\>)<)@'M]HKW1Y&CEYX(J;$RF)C" ."F(@AF \!
M6*DG?8;GR?QU:"I2D[K98L^)"F<CAP.TAX9G)YC<L6=(;B=6DBZ I*?.1YV.
MTLDJ#DCEW#O24R&-JVC))?@2PU28Q$3V!#-[3> ??4K*8QONR\MCY!W\;[Z=
M5ZX";K.)8)"<&"0(.8Y?%,002-L@\ERW$8(+#LV>T9[&UJ5"Y#CZ$,4=>: ,
M&38UF)'SS8[ON3OY)'_';IOJDW$L4"))!8YPSF"W+C$/%/+=K3D;E)(+00HN
M" Y?T? ,'\2K8JL^.1PDM9I)/+! H9/V .VR[$_^';_A\L=J'P>)!+\S$$Y<
MN8?EQ2.P,2R2/UP(,#/;GM(;367=?5&E=48/$8''0YF2]7E@FCDEE@A5Y !(
M2Z%5 )\#X(_'SMUD6D-#M(R<=Y>2&)]"[U@I#.1B"W,,Y XF&!;'K3X8SN;9
MS-'%?P:M2Q<VD<?3QK0T$+&I8G^Z7(RN 38ND_\ YR4M, "0X(VZT3:3;=@5
M!1.X*)((, !)#,PP^3B7*!MY!YVD,68N8<')) <,PS$%/UYL@F6.:>5BF[,]
M@2OR]QY/>+CSX82>58#DNYV(ZQ<T]J\2%))$@R0""SA@8/W!;)K(MA@%2X #
M'+B1V9LAV#59WZ:O4QV6U&FD>U/J3T3:[HX<S5<=@M2V*U>WJO2UJ7*I#5J8
MC*\&SEO#3SR;/7GLN8(BR0J(U"]<L^+OAD]%L+O]'4=/OWW%H6I5]%T7 2K>
M+JSM4#\I2S?D\7I;75[EI74;8NFV$H04?R5)2D!(8VV"B!\SY::VQ](Z;T_I
M_3&&P>FJ46,T_1QE:#&4($:%:M,QK)%'MX97 ;^82>7+?EYWW\]+-\ZBY=6M
M*EE2G\B0"7F!!8\E+G\K.FVA-A-A(*4( 2&479, ;GW8]?5GI7 !0%'P  /S
MX V'GK-; , .P:OO16:.BBCHHK@RCQN? &WGR3_G^2/\O/SY ZP2 S\T4F=1
MZ/TWJ_&SXC4^&HYK'3?<]3(5H[$!/SX60'C_ ' /[_'2MK47+2@;:U)W20"0
M#!R.??@L0_#>_IK.H1MNVTJ $.)'X'L/TK5E_4)]'NB>U_=BW=T1FL?A\IJK
M^(9NAAL(\4-S'01AB8IZL?\ 0I;?A(RJW#8 [ ==7^%]8K4VT[@J()(R4@"#
M,>IYG)KD_P 2Z:WH+JVV *.'P%%\EB, ,^)DFH4]@,[JFOEM3Z+U-5L7\35@
M8Y#(3H_$'=@EH-^9XT'$RC[BNZ;[>.M^K6P]PCA2O7+$Y[!_;)!&.7]=TMI=
MG>G;NN#=EV=Q.<GT?L0PIQ:>G8\-J/*Y+ M]?@+1@$?LN@2"=6#,RQD_8 Y.
MR;> 0"%V\4_P@+A@L6QZ&6.'CV/&*YZ-&I9"0!DN0-IG#LV8]<F'8.;EJE.]
M6QEB[E(,<'E9YK32<%>9MV19VBWX2<O$H!WY$[[;=9*V.UR6)!,\1W8#+QWX
MFEU]/N *4$D^G+L-T$CB!DM.1&9H3TK..4*^*S-FHS5[T=>3[C'"#''(DCD;
M!B%8,#]V_G^^"N(X;\7(C+&>P(=IRPN].N!G208.Z7+Y<!R>!VDQ2-RMG&XV
MM;RN<GG@A67VHJCD25XX'($<<(7=05_VU.Y\_P"?2R5C:'[" Y?$X'XULFPI
M+)VD%(;)!#9=I?C#^LTG:3U:MJ3)07)30M\X3%64E9*\B*1RVW]LG[AR'G]O
MQUG>'Q!^C&?IV]JSX<$%(@ #NX/OVC]":1&JZ.J-06H\+#<KXS1D]23^(<=S
M8G="_L@S#>1#L>/V[ _GYZM_PCHO^J:X:<C<$;3(,.Y$ O\ TO,XPYI?365:
M:_;U1"G4H*!8D$.S D%,%AB 29FJ\<WZ>[J:PMZ7P$,+7M769KN,NR))8/N1
M6&"RV[<@)KE7C(2,'BR>V=O/GNB-+_TY*-.P06#I9@HB']C)#D,/:N[])^+K
M-KI"1=7"$)!=204AA!=\<LX!ACBIO]JNV>K>S^DL3A,SD8\LJ6+'U5N:?W$6
M6U?M791&KD<%CDL/$@ \!!M^ 'UM.Q&V"1N(& /,XSSG#]F:N:=9U]OJ.NU.
MIM&+J@1ARR &AWP'<9!P7=QLU6JC(XW*PTTM0K!,MF2.175MY&5N:L=FX#=
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M:5@,2Y9G#O\ +S AW:8>+26437/:?%'6U-L9>6+W,5//R1[,:$QJGNMYC19
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MV8+9,44%VC7E%BU7 ALR,TH4[O[DD/ ;J#R*@#STX2K2+L*NJWAK94Y6 "H
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M _;Q\_'0SAT,#W9Q['%!+!_RKF-]AO\ .PW_ ,_SUM6:^]%%'111T44=%%?
M-AMN3_GM_P"@'0<']_E6 &^LGWKIFKQ3C:1 ?QRV7D ?QR() _'C]^LH4M'/
MXEC[A\S&6^U:KMH6&4D'U8/[/FL?<PV-R=66AD:-:Y3EC:&6O9A2>&6%QQ:-
MXYE=)%==P>:ML"=B/'6EN[?0HJ2I0)43_4,G,,?M[9K6Y9M7$[%(24L Q .
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M+F?L/HSTJIV_J$EBPD $XP7*H9\?4.AA?XKC:%-+I$EV&NL%F<LI5W5 N^Q
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MV]R/'7;W\'IXJ.<;^U'+8<.%XB29R.1[?TW_ %5N(TJ=)K+0MOM N6;-P )
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M'/8L@8.88X)/%X'HE_3R[=>E6OC]:-8S.:[LY'3Z5<]F+UN"?&8N>Z$;(X[
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ME#AL@D._(=ZD3ANXNE-2X7)21;SUM.9&ICKXAA%J'ZIJU>623WA$GNQ2>Z)
MRJO$.4.Y4MUU3I74_P"-MH22_P J3R [Q_W%&3,P'@$37.M=I%:>X0P&XD@.
MRBEF+N$@Q+DLHL\%JR,V9Q,V,EL:?@)D=TJ&=8/;6.W9DLB-YE()>.)8XBO
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M8M+31W3J/X@%MMM%Q@1AB0!\Q#,##,[@D<*T9.6SCP4G2(Q(BSE9 -S&-RL
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M_K>W[XFDZB*]/7RTN4HYF6S(AKXJ\EH>[]"(BR"5&X%ER,S,OQVQSW^HDA<
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M'111T44=%%'111T44=%%'111T44=%%'111T44=%%?&8*K,?A06/D#P!N?)(
M\?DD#]ST45I@_P#:4<'VCU-ZV_T_\#W^U5E=&]F,M@;^.[D:HPMT4<IA-,2:
MBSSW\G1LKC\NE>Y"&0Q-)C[T;; &K84F)\=O3_C]_C6!'JW_ #/;V[-57'JP
M[>_I<>F9NT?=S]*_U?\ =CO;ZM,#W3TNNEM!:EQU+N-@<E7;( 7+$%NOVGTS
M2P-Y)#4KI"9K5J]]0R5Q7D16(T3AN?S-9G[OC]&X/T]JLF_52[)0^LS]1_\
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8Z*P"3N<D^8YGM3G=%;4=%%'111T45__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g105868g33c86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g33c86.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MKAKX:%??<UE!2.(1KC0-:(R28FPP'1EKP4Y86NTCFNX2L=?KVN1Z3X7NM7C
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MX9>'=4\/6^HKJ=K]G,S(4&]6S@'T)HQ-15&K"P%&=)-2/0*Y#T1,<T +0 4
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M(_*:7>W*^F,X[>E7SR<>7H9JE!3Y[:B7^B:?J=W975Y;^9-9/YD#;V&QN.<
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MOA%G9SHX!)SQ/(!^ #<5M]9JKJ<\L'0D[N/XLUY_#FCW.DKI4NGPFQ086$#
M7W&.0??K6:G)/F3U-94H2CR-:&99_#WPK8W<5U;Z2JS0MN0M-(V#V."Q%6Z]
<1JS9E'"48NZC^9T^,5CL=04 % !0 4 % '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g105868g41v33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g41v33.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1D84&AO=&]S:&]P(#,N,  X0DE-! 0
M    &/R^8Y8X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>;1T         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@             !(    EH
M 0                         !              ):   !(
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !(     !29VAT
M;&]N9P   EH    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
M       !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!
M46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%
MPJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V
M-T=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3
M!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%
M539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G
M=X>7I[?'_]H # ,!  (1 Q$ /P#U#)O;CX]N0X2VECK"!X-&Y8M/UOHMM94,
M#,:7N:W<:QM&[^4U[MRVAE8QR#BBYAR&C<ZD.&\-_>-<[]J*DIR<+*ZCU.C[
M9AY-=5#WO:VJ_%>+6&M[J+:KIRJ_?7=58W^;5?/Z7U8A^0W)W6.(WC%8^IQ
M:6_]S6M?[?\ IJW]7OZ!;_X=S_\ V\RUIH\1\/LBIYS%Z3UFQ[O5R'X[:]FS
M>;+&O@[_ .;9G.^AMV6;_98KU]'UA%V.]O4,9E+7_IV_9G>]KH:ROW9+_P _
M\[?7_P!=6JA9'\V/Z]?_ %;$1(^'^+%5)4DE"QQ96YS1N+1,$Q_!R:IFDDDD
MI22222E))))*4DDDDI22222E))))*?_0[6JVZOZP]5JQVML<S&9?72&MGUG
MMU?8ZKW6[&,_GJZMBF,KZWBZEKL/&=4X,-K@XMB0/5;_ #K]OI_1WM;=_P!>
M3XKF.^MF96&-_1X];S8'V[]SS&QU;G_9MFQN[]'7_P!_6XDIR?JP;3TIQN:U
MEIR\XV,8XO:'?;,K>UECF5.L9N_/]*O^HM99GU>_H%O_ (=S_P#V\RUII*4A
M9'\V/Z]?_5L15G?6!]S.CY/V;;]I<S9CBP.<TVN(90US*_>[]*6_124Z*K9[
M!9CFLS[B(@8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $E F0# 1$
M A$! Q$!_\0 'P !  (" @,! 0            @)!PH%!@$#! (+_\0 51
M  8" 0,"! ($!PL(!PD  0(#! 4&  <("1$2$Q05%B$Q"B(7(T%1&#(Y57&5
MTQDD,S5987:!D;/!)39"4Y.7H=<I0T96L='A-%)F=7>2M?#Q_\0 ' $!  (#
M 0$!              $"! 4& P<(_\0 4!$  @$# @0"!P4$!0D&! <   $"
M P01(3$%$D%18? &$R)Q@9&A%#*QP=$'%>'Q%B-"4I0D,U568H*3T]0T4W)S
MDK(E0V/5-394=8/"Q/_:  P# 0 "$0,1 #\ W^, 8 P!@# & , 8 P!@# &
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M*+;2:;CI))IM-ZI-=,K74^K*DC & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M8?9<$XAQVYY8WEBG1T7VBH_L]3']YT\/G>/[/)#+U<]2[W/D!U8P!@# & ,
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M$ET3 'B<O?2MMMMO+>K;W;[LRSF\ 8 P!@# & , 8 P!@# & , 8 P!@# &
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M)ITZ^A7*>$M3:N#IDR".J\;'!#O&,<U%VU0>2,@HF[5.LJ4@E_+1?KGWO/\
M(D+@@8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M3]_^?&B?V]__ %NU?_[V_9_3WP6?W(^^?X_+]=S9&P5& , 8 P!@# & , 8
MP!@# (]Z">:V=O-Z!KJ]WF\+M=[6EIL!*ZR-UD4Z9L).MT\\O2JA\Y-6Q&5.
MC(M2$D(UA5#.JD@[EI$8UT9P=ZDB&,?)/X-O7XO/CWZ$A, 8 P!@# & 1&Y;
MQ4D2(U7?203ZUUG56UH"]76M1S<'CYU76+*39K2K-@)@^(NH%R];R1&(!^N(
MDH;R+Z7UZ7T:J4W5XE9.M"VN.)<-KV=I7J2Y(*XG.G.-*<__ )<:\82I\_\
M9;7<\*Z>(3QS1IS4Y1_V<-92ZN.<I&)[]MFD<G+;HBL:0"4M,G5-O5#9%BN9
M*_,Q$50ZS5S+NIQF[DIA@P!66GFZR<4WBF@.D'A55#+'%-$HYL[/A=YZ/6O&
M+CB_J[:G=<,NK"WM?7TJM6\KW"C&C.%.C.?]51:=2563BXZ<JRSSE4A7E25+
M,N6I&HY<K2BHYRFVEJTVL=2Q$/M]^_\ G_?_ )\X<RQ@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , T_N6EZHE6ZE7,TVU^?'+KATNY=:F1K$?Q0JSUE6;G7VNLZ\1-[>I%
MO4YH)FYQ3L[J..Z.*HDC$F)".O3\6K8626-$MVWE]?#587AWR;+G"N6@9SC#
MJ*5K.W-C[W@WE6:JQVV-MI*([$NJ B8"R]H3581:A9%;L/J =BW'L ?JPQ^>
MNN?SV]Q5[O\ +;X$.^JY'PD9KF V-L7E'MC26LZFVG6K;5^E9J1K%^W?M"69
M+-J'7XB7K[E"Q/UFTJ=JHG"-"*M#F*+AWX)^0'$K/1)Z=<:>.NGS*Y^4LEU*
M:+TI-'6ZV[I=:XGZ[&U*4W2[?-G3O>%D3E+S%-ZC47MM1?-TXM4(%R4UPD2,
MU9.07(5D*B!16*(LN7F[KZ=WIAOW+ZL^3GILO=>P-];YI</OG;6I8/B+TM(S
MESKU/7-TE*BA/[D=2*C9&9NA8]9$+/%QJ,44@Q\@*J @\<%,4"K'\GN(26Z6
M[Y<M=-,+PSGIKIH1;W9RJY.;VK/(3D*??FU-2V7B+P"XA[\UO5:):7U7J,[M
M39<1!72[6:UUMH=*/M3*?(J[JY8R50=1Z,<_]-%$JX$.$+5+W+SU)22?364D
MWC7&R7AGPQW\"WOE1U7MY\;)K3T!3>GAO'DXTV-H#7.X):\:SG!B:_7Y^YJ3
MJ$A15VIZ38S?$X8D*VDUE#/TS"TG&*9FJ8IBJM+TZ9\5C\VG]"%%/.9)8;6J
M\/'&^Q7QT%-P3^_.H[U@=OVG5UCTM8+W+Z#FY35]M<^\L=-<JNMM)&B9=S\/
MBO6=I@D"AC?#FG<IR_J@[=QA=?AH^_G&S[]<DR22CAY7M:XQUVZK3WOQU-KS
M)*# & , 8 P!@# & , 8 P!@&,=;*[*57V)^D:M4RN()[%F$]?*4]\Z>JV#7
MI8J#&(L%M*Z23!G;G<H,VVD&;85&J;!G&'(<3J*  :=/+,G8 P!@# & , Q)
MN=PNXJ2-/8JG2DMD3,=0VQT1$KA%C-'.:S/VQP^I5XBIMIV82,';L=@'U+W\
M@V?"4HW7VJ:3IV%*=[)-9BYT<?9X27]VK<RHTGX3/.H_9Y5C,WR+7&C^\UUT
MCE_ XO1D<PC8F\MX]FU9H(;/NC5%-L@DB4C=L\0201 $RA^K1(4")D^Q"@ !
M]LOQ><YSLI3G*;?#K:3<FVW*7.VWEO5]7U%-)*:6W/+\OP,WYJ3T& , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M3):,X33<)QFEHW&2DD^SPV<MGD6& , 8 P!@# & , 8 P!@# & , 8 P!@#
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MV;(^"HP!@# & , 8 P!@# & , 8!!VY\N(SCLMM1SR1K9JA!U^4LEUKUCU[
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MNHFRU"?(B1P>'L,+((MWK)8Z"B;EFX,C[21:*)O&*R[=0B@B&FM&3&P0, 8
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MMS;418H;8C#3=7F[-:(*DS\)*3($@VJCEQ'@0K[T&KQ4$S)I^\412 _T,<
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M16'TP.)_I@$>=S<X>/&C;GQTHEQN\>><Y0V]U4M6GBUTGT6]%A%*RKV:D)=
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M?WWC1/\ X*[5#_X?3_4&.OR[>?'XEG]V/^]^)LC8*C & , 8 P!@# & , 8
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MTAIG7U9L#=RP?%91<2Z9S-G3C'14UFK.Q'<1;9JLHDF=ZG!>X*4[86RROO\
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M\\[/+C?M#C)O=]S"Y05;9T3M&+WWL#J"-=G:*V#2.&%VW'L9WJ@)V(?:ZM]
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M?04 1!F+ & ?DY1.0Y2G,F)BF*"A/ 3IB(" '("A3D$Q1'R+YD.3N >13!W
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M-)K.&DUE-/#UU32:?@TFNJ/IRI(P!@# & , 8 P!@# & , 8 P!@# & , 8
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M\K333J8[MO4>WW'::XF7B)=UD)FI1]TV7SN4/76:J1-7<=]WU;CGO9")0/\
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M_P!^BYNX:_N4Y,P+W^ME;VJU]?54JBT?]12S.?-VC/"AG7+DD29
M.P 'T  #[  ?L ,YXSQ@# & 1:U (7O=&[]L''UXV)D6.EJ:OW[D^%4([A:U
MJ)!]2B*M[D; F5PG]'#-!J'D8J91SHN*+[%PKA'#=54JTY\6NX[8J7JBK9/K
MI94Z+<7]V;EW,2CBI7KUMTFJ%-]HT_O^&M5RPT]5C/0E+G.F6, 8 P!@# &
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M\+1',VK.$$&WZU[*L2J@F0QQ*&.F5G.,:[_+!SCKJEZ2:=.]/J1*5:ZCI]1
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M?\AU -], ^=EL&A24G'0L==Z@_F9B/"6B8EE989U)RD6("(24<P0>J.GL>(
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MN3_IQHG_ 'FU?O\ ZP'(6[^&7^7P_,L_NP_WO_=^2P;(V25& , 8 P!@# &
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M'U+G[H^U63=6RN/U:/Q;V3"!?M?5Q>:.^F'&Q*RY1KKM4(R0;H'4;IG?))F
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MJ?TJ4TR)$(DD0B:29"IIIIE A$R$ "D(0A0 I2%* %*4H !0     ,L>9^\
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MGW;HG2NYSPY:\?;NI=<;// $>#(D@SWZG0UK-#ED!;M!?%C!EA9%>"T:BZ!
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M]5XE>5[RLHQG6EE0A]VG!)1A3CUQ"*44WOCX&13@J<%%:XZ]V=_S"+C & ,
M8 P",.TQ#9NUZ)IE'NM7J\5MM79A2]S(+LXQX9"DUIT)1],Y92=25EWC4YDW
M"2,7%NTP,DMW'H>'+]W\,O.+-\M>NY<-X?IJI5(*5Y<1SJO5T&J4)).+E5J0
M>&C N/Z^XI6J^Y#EN*^SRE+^JIM/3VIIR:W7+&2)/9SQGC & >!$"@)C" %
M!$1$0    [B(B/T  #ZB(_0 QC.,?+OX BCQS+^DR;OO)Y^7UFVT'#6L:?\
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MF*8I3%,!BF #%,40$IBB'<#%$.X" @(" @/80^H8(-;KI6_3K(]<K_3C1/\
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M?1]M9;$VEMAG/4MA(M-B;IB$X+9EL;./(R4M:HM']4VD').QA*F)B"3Q$IA
M>^"KW9+W *K.JBVM5_I>@.,M6BY86O*G?M0U9L*S1$4X>_+NK6@GLEX))O6[
M98L9&SD3''AE7+A5L0WNA226*J8 $2NK[+/Y+ZM%3O4;K43QVY.<J6+W6EK/
MK7>_2?-Q5XP1=,U[9[?".MHPUA>H,]:, K</*MJZ_?QSR*!HO)F8I.46YC'<
M&*@H<C\_X[^>I9?=6JTEG#]RP^_1Z+QT(;;QUUL?1%,Y.:)V[K?8UBV[R=Z<
M'"S47'Y*(H5GN*<]LFE1->JMIUZRGX:+D8N(FZM8"FL#\DL_C44V$<>0*N=8
MS=)>-??^NOO\.K]W>5AXPUA2<L:+3.=,]\:Z=<M:%XG*'IZ]0'>4IIF9T9U*
M=@\38*E\?-:ZWM^NZM S,Y'3VPZR:;7L=[6?,+E7DCO)AO*1D0J51DJL*, W
M5,Z.50B2,^?Q\/."BPEAK/QQ]$BOSH*:VV/J#J.=8'6NW=M2F]=D5*7T'%VS
M;4TT78REWE$W>W#J3+QJY?RCA%90AR)F(K(.C!Z8#Z@]^P//G\/@6D\QAIA>
MTEOT:^';Q[]#:]P4& , 8 P!@%6G6JV5MW4O3'Y5W?1DXXK6R&=2KT5%3L=(
M$C)R.B[)>JO7;0K779U$CEGU*Q*2Z$8#10LD"ROJ1/>4(S 1:&.9965G7Y?K
M]=],G\\7HUV[?_\ =->*KC4RMDLED=[8C#VUJ)WLHV-1GI7;#84Q.)K^Y1(@
MPJ[^7<%D'@$%*0,U!%8KM9 #U6N/<F^O1::_/&KZMZX?M-)0>F-,YT\,>[W8
M>F,Z;?UA<L8XP!@# & 5D6EUR5W%MW;.I(5S :_>TR3,NSV'2K]M&-8QFOK!
M&-%:,29JD=88J(?;1?/PL;J6=>@K$A!L8E-,PK(*(G['A*L>%\-H<3XK1I75
M.ZNJD;.Q^QV56I7C0]6J]2K<W%"K4A03?(H4Y1?,\K#DY+%JJ52I*G3T<8+F
MFY37+S9<4E&<4V]<OMUT2.[:*B;5^FJQZ[W4]E).SZ]@(*W5%N>X72UU2R-I
M)Q*1WS\BVN<[-KL)Q@ FA!9-_09L%CO56Q53JE<%].,U;;]TV]]PF$*=O?5Z
MUM=25K:6UQ;RIQI5%92E:4:*G1FTZJG+FG.,8\SBDXBDI*K*%3[T8QE'5M-/
M*<US-X:^Z\:>+W=@.<490P!@# & , 8!T38LS;X"MK2M+CJI(R#-<JT@%SL*
M]7@V<,DW<JO9!>60CY+TCMCIM_RK()H>B==51=/T@ V;84K6O<*G=U+FG3DL
M0^R4(W%:=5RBH0C2E.GGF3ELV\I)+7*\JTJD*;E2C3E):OULW3@HX;<G)1EC
M&G3;.I7'6>1-OY?7&"TTRC]4GI[2]V5[M=[0=G?.CQ&J:IMSZ)C6SE)K#MD$
M(_8-IB&$E!G.Y[2=<CWAE2^U>I^OWMQP*T]%K2MQ:=3B:NI6=O#AD+[A_P!C
MC*YXG:PJSE%RJRE*=C;5:E.LE%>KN)PY7S0?+I(7M7B-6%K%6WJU6F[AT:_K
M6J=O5<8II122K5(*4,M<T$WL];5$TR)$(DD0J::9"IIID*!2$(0 *0A"@  4
MI2@!2E       .V?-FVVVVVV\MO5MO=M]6SH#]Y & 5Z\@>J/PTXP[(?ZGW!
ML=_ 7>,8,9)[&-:S,RB:#61!8S41=,VYT!.<J!S"0IA$H>(F[>09V_ _V=^E
M7I#8PXEPNPA6M*DYTX5)7-&FY2IXYERSDFM9))O";-9<\7L+.JZ->MR5%%2<
M>63PGG&J6,Z;;G$\&N1>I^9EYWWR&U[/K6!"#FH73]2:O(YVP6K5!B&?QWW9
M4G:1 3?WZT.Y67DC-Q$ZL-!4YF_\745Z:?IZ8<"XEZ*VG!N!WU%476I5>*7,
MHSA-5[ZK+U/*W%MN%E;1I4Z7-HJE>ZE3S&JVXX==4;^=Q=TI<R4HT()IIPIQ
M7-UZU)MR>,>RH)ZHL@SA#:# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & =&V=L6K:@UOL#;%X>*QU+UE2[1?[
M<_00.Z695JGPCVP3CM%LF('<*MXR/=*IH$$#*F(!"B F[X'YM+YO!59MK6_4
MFY*29MK<3>:FAM;\;]MTVKV/758N_&.,NMNCZW9ZM'.CNI"PO9-%P[7?F=K2
M"":J13,DW";;N(H^0B5CJM<]'O[]-]O*UG=PTX\.^*G&K56A9&YN]@R>OZ\G
M&REO=-08!,R:RRKM^Y:1Q3J!'1XNEU08, 44!HV!-'S-X]\!O+SC&23V"#UG
M115,F=1)-0Z)O-$QTRG,D?MV\TS& 1(;L(AY%$![#V[]L ]3ADS=BD9TT;.3
M('!5 SA!)845 ^RB0J$,*9P_8<GB8/V#@!9DS<*H+N&C9=9L;S;++()*JMS_
M $_.@H<ACI&^@?F3$H_0/K@'TX!K<]*T/_3(]<H?WWC1/^SU=J_\>_\ MR-<
MOMIC\RS^[%?^+\4;(V25& , 8 P#&&WMPT31U+?7K8$HJQBFRJ#)@PCVBTI8
M+'-O3"G&5RL0;4#/9N?E5^R#&/:$$QA\UUSH-$7#A(//R(W473=UWI;H/>?*
M"'2CD8!V:6TMQW4<(R4#JT%D5FZ5POJB(G86W;[^/<*H+N.RT'2&+MW UTBJ
M[B8F)8,_7?\ ->[\>QG/77&S0.H[%.V[6.G]?42T6=51:?GJS68V*E)514XJ
M*F=O&R!%3^H<1,< ,4IA'N(#@&;< 8 P#$6Q=\ZDU,^81NP[FRK#Z41.XCFS
MME+N#O4DS 506YF$>[34,0QB@9,#^H7N B4 $!S9V/!N)\2A.I8VD[B%-XJ2
MA.E'D;U65.<6L]'C&^NAYSJTZ;2G))M-I:Y>/<CK43RATM9V3IQ2;86ZOF[A
M%DC!UZ.DU)=[(.0-[=DV;/6;(OF82B"RZJB;5F @=XN@02F'WJ^CW%K:<8WE
MJ[2$DYNM7G35*$(XYIRE"<]%E-**<I?V(RP\0JU.2?++F:TPDTV^BU2U?R[E
M>%)F;K3-E[]VWH1A/3]EF-B3L!MO5-MA[@^@@MD+'QLFW1K]MEUF"BZ\:UET
MDFIH! E2[OU&4<)00>G5Z"REP7B'#Z'";RM.G0L[B3M^(^LA3K0J5W!W"5O*
M,E]EG+EE%N4IY@Y-[*/C-583=2"3E..M-+*:BLQS):N6K3Q[NA,_CI6[9-7:
M][BVB=?](=@BX2N-XEO$+Q5>JE68JO73>$@U73A=U)F6>F5>R+Q?P,94R/8G
MF94Y];QVO:TK2RX7PY1^PT:E:O*HZJJU[FYDH1=:LHQC&GB&(4X13PN;7&$6
MHQFY2J5/OM**6,*,?O87@VUGQ6>J)A9RYDC & , 8 P!@$..7\Q78XNA(^_R
MC6.U;8-WQ<9?D'CM-JTDVZ=/M\E6FDP4RA#KUY.V,8=W)E(!DT73>,<//!@D
M[5)U7HO2N*CXU.QIRGQ*AP>K4LG&+E.G)W5K3N)T7AI7'V:=6-/.,QE44?;<
M4];Q&4%]DC6:5O.ZBJR;2C)*G4E!3ZNGZR,7+&S46\1R:W/');8!.N%LD-,F
M6-6%-Y[6)<301@/6AUZ+R:$_OC,_)D,<+LL<:.\1\3NO0%'N7S$/OW'OL+_8
M[8?O7E5RN#\-=HJVEQ]OY:6.6,O;]9R^L53*TCG.,HX6Q=;^EE?[+ETG=W'K
M7'6'J4Y]?NN.<./TZFX;GY7/I@P!@'\__KERD9)]0_9IXY^T?IM:]4V+H[-P
MDY30>MVCKUVJQD3'*1PB!R JB8?-,3 !R@;OV_:?['Z4Z?H/8JI"4'.O<U(*
M<7%R@W!QE'.'RRP\-;I9VW^:>D<HOBE7#3Q3@GAIX>9:%T?X:,HAHGD>;L(%
M-L^I% W80*(EK3\1 !^P^(& 1[=^WD'?]F?*OV^__C' EI_V"ZZY?_:*>K]^
MNNF<&_\ 1+_LMU_YT/\ V,V7<^ G6# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & 1>YO46T[1X8\M-:4>+6G+
MIL+C5O&DU*%;F*5Q+V6TZSLT'!1B!CB4A57TF^:M4Q.(% ZH"80#N.2M/D_J
MFAU7A*+^4D4\:"Z)-H;:.T^WM_-_F?0[6AK2D)62DPVP4&\349U*N1Q)2MQB
M!2&*BQA'H+1S1,IA B#<A0$0 ,@MS/.=.^R>O3?MYTT+S-$:H'1^IJ7JPUVM
MVQ1IT0C%#<[T^"2M<]Z0B/O9EZ  #AV?OV.< #OV#!#>7DRY@@8 P!@# -;K
MI6_RR/7)_P!.-$_[S:N0MW\'],?EX%G]V/OE^)LBY)48 P#P(@4!,80 "@(B
M(_8  .XB/^8 ^N :6G-'\5#>M+\JKYJ31FB*/;M8:GN\M1Y^P6^6FV\_;92M
MR"D58CQI&!TFT6T;2+5XT8&.1158Z'K*F,B<@95RP\8S\>G5]M-M6M3T5-M)
M]UG;.F=_.#84X$3$7S2UQJ[J!7R4;VR6V-#2LEJ*G)(JA3M'PS::DZW*QD$Q
M=";XA>CR4*]:6:Z.BF=K+("QAQ:12#<AK%'H\=F]]_Y=OGUP6<8(/R4Y#"8I
M3E,8@]C@4P")1[=^Q@ >Y1[" ]A[#V''Y[ Z[;K=7*)7I*U6N5;0T%$H^N]?
M.C^)" (@5-),H=SJKK*"5)!%,#**J&*4H?<0][:VKWE>G;VU*56M4>(0BM7U
M;?11BLN3>B2R5E*,$Y2:26[9A&E\K-27:PL*RV=6* D9@1"!/;JW)5ME/B'U
M D0]D$R(.U#E_.1(#%.9,0. =A#-O=^C?$[2A.XE&WKTZ6/7_9;BG<3H9_[V
M%-N4%G1O&$].C/.->$I<NL6V^7F37-KT;6ID^=VI1H!?V2\VC(2AC"1*(@R*
M3,FJJ'_J2MF!5@(KW^G@N=$>_P!^V:^CPZ\K1YXT90II9=6LU2II?WN:;CE;
M:Q3W7<NYQ6F<OLM7]"%/SS2V_*V2G]X1@5:/E]?,F>IS; 1019(G:R*AI[TF
M;GU4(^4>)K(=S+@54Z*?I@8>X=NL^QW<O1NG1X14^TU*5].7$OL,I.34J:]3
MF<6G4IQ:;]G1.6<8,?GCZ]NHN5<B]7SK31^TUE:/W_#8[)IE>A6CEILRU:E2
MB7-+C]:14/9I6%10+#N+\YG$UDACP3(0@.RP;=9%\Y:E*18I2(J"(D[CC\55
M];^C5A;<3E4C=3XA4JV]*M)NM&RC0<7ZS+;Y?723A&6JW6A-/EE<3E3PX*GB
M36,.;DMO'">7U)6Z['9HK[ _20QI[% -@RP:]&HB]%1[KL(N$^#OK3[U10"V
MI63^-)2!6O@T!JBP%(A>YLXTRC)& , 8 P!@# ,5[FVQ#:3H4IL*P1LK*1$.
MHU(\;PR .7_B[7(V2,@V#NHY.991-)-N@11PNJHFDBF=0Y2CLN$\,J\7O:=C
M0J4Z=6JIN$JKY8>PN9J4MHKE3;E)J,4FY-)&/=7$+6C*M.,I1BUE169:O&BZ
M^Y:MZ)-E?]4ZM>BKOL![J.MT7:KG;#=RE&-->/JRM&V.0FG;55RRCDFK@O=(
M#%(FK(.U>R,4Q4-(.P!NBIV[>Z_9CQFSL:?%+B]X8N&2BZDKZ%PJEO3I0DHS
MJ2E'?JH16M2:Y(^TS34O2.TK5I6U.C<.YBU%4'!QFYM-QAKME8;;TBGS/1,D
M<?2FS;4@;8UR6H,UMJ5#VK*M7./?3^M];U%Z@N+VL5V-9JE%[.KJ"S+-VAQY
MK29DET4O29%;ICH?WOPZVDK"S5]1X92]J=Q:5(4.(<0NH-<ES<5)IJ%&/MNC
M;1TIY3>9.1G?9:]1>OJ^IE<RT4*JE.C0I23S3@D]9O3GJ/[SREA81PW''C?L
M#1,U,*D2T8G$6JY7.VV9[5JA.1=K6);9V4GTH9G)N7:I!CH59\A'1Z;H3E+'
M-$RB7U0 <]>/<?L>,T:2;XPZEK9VEK;0N;JC4MHNUHTJ$JTZ<8K^LK*$JDW%
M)^LD^C(LK&K:2EC[*HU*M6K4=.E*-1JI*4E!2;V@VHK/]E=UK-_./-H5S\D^
MJCP]XG[0>Z?W+;[+#W=A$1,VY91=1DIAH6/FD5%V"A7K4P)&.HFF<3IA^9,0
M !^HAG=\ _9QZ4>DO#H<4X5;6]6TJ5:M&,JEU3I3YZ32GF$EE)-K7J:J[XS8
M659T*]2<:BBI-1IN2Q+;5>XX;5G-.L=0!"6J_$:=G6-,AEVS+:^V92&6A9"L
M-9!(ZS>O5&.?")W5EG6B:P-Y0P&;1"!%G)B&6*GV]>)>B5QZ$NG<>D]*A.[J
MJ4N&\,I556A<S@TI5[JI#"C;T)-<U/[U67+'/*V*'$*?$E*%E*2A'"K5G%Q<
M$TVHP3WG)=?[*UP2]B.,^A(>+819-3T62*P;E0^(3E;B9J8?'\C*+/).6D6C
MA](/G:ZBKATZ<K'46754.(@ @4.7J\?XS5J3JOB5Y3<Y.7)1KU*-*"V4*=*G
M*,*<(I*,8Q2227O,R-I;127J*;Y5CFE",I/NY2:RV\MMMZF2ZK1Z91FKEC3*
MK7JHS>+E<NVM>AV$.@Y<%)Z95UTF""!%52IAX%44 Q@+^4! /IFON;R[O)1G
M=W->YG%<L95ZLZKC'?$7.4N5>"PCVA3IT\JG"$$WEJ$5%-[:I)':<QRXP!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & :W/2M_ED>N5^_P">-$_[/5VKV_XA_F^V._GI^F/Y
M8Q9_=AVS+YY6?/7H;(V"IQ,W/P59CUI>QS43 13?MZ\E-2+2+8(]^_8%7;Y9
M!N03=A\0,H F[#V < X!QLC7S6K.+NO=ZH6G-4SJN+.6?C%8),B8")N\FDY.
MT,<.W8$RJF4,;\I2B80# (GN=X[@Y!^K$<7:XG7*,X,HU><BMCQB[>OBEY"1
M9?6M-<$2D[TN!0/[63<ECZT=0/ \D!R]A!Z?+.>WY+W,U2^8?X?/CG:N3TY:
M*]S/=P45;+,M8-O,Y>BR=EDXBTSCTTG:W[>7@2JPD>,O)NGL@5A*N&*42#@&
MQ55$D?4'>6WHWQ>ZH1N*-JU3J1<Z:J3ITIUH_P!ZE3FXSJ9QA.*>6\=BGVNG
M#V&TW'L\XT2U:SMCJ_?U-P_BOIK4_&CC=J/3&GWC4^K-=5!I$5F5,\152E4'
M#AS*24XN[!04#.9V:?R4N[$IQ(5T]6(4>Q<T\Z-6E4E1G3G"K3DX3I2BU.,H
MZ.+CC*:]Q;*:YLY3USGITU.@<I=V-(2H0E2HEWCHNSWR_4ZB/9Z/<)NUJA7[
M))"TE[-ZA .U3]HD5-FFJHL0J:[](_D @&=-Z.\)E6NJUU>6<ZEM965U>QH5
M(N*NZUO#FI6^&U)\\FY-)-M0:P>%:JE%1C-)SDH<RUY4WK)8TRDUC71M&,=M
M:K:\:Z]6-J:ON=S5M#&VU.'DH6QVR0G&&QF<]*-HY[%*,WZJJ:<@X!P+QLZ:
MD\D"HB(%]-, '/X9Q&7'Z]QPWB-I:*VJ6]S5IUJ%M"C/A\Z-*52%2,H8;IQ<
M>249MN3EOEL\YT_414Z<I<RE%.,I-JIF6,-=-\Y7XX.W<C8?<=EI]3LDS5*Y
M)5FEWJL76PTRM/)68GI:&C%%3.@5;.(]NS='C07!X+)!5P"XI#W*8"B&8W J
MO"[>ZN:%*YN*=Q=V=S9T+NO"E2HTJU1)0<91J2G!5,<G/+EQS8TSDM65244Y
M1BXQG&4HIMR<5OX/KHGCKDZ+NC9E(Y,Q%%UEJR$F[!95;C6YEV[4@).'0HL-
M%N/.66D)%9!L,>L+<3- :H*%,I]A[%\!S,X3P^[]'JMYQ'B-6C0MXVE>E&*K
MTZKO*M18I1ITXR?K%S>US26G37)6K.-90IT\N7-%YPURQ6<O+QTTWU+ H"J5
MRKMBMH&%C8LO@4BJC-FBBNX$H 'FY<%**[@YNW<3KJJ'$?N8<XJO<U[F7-7K
M5*KSHIS<E'PC%OEBO"*2\#+45'9)>Y8^?<^"RZ^H]R516M=3@;"JW3,D@I+Q
MK9\=%,P]S$2,NF<4P,/W\1#OEZ%[=VJ:MKFO04GF2I5)03:V;46DWXD2C&7W
MHQE[TGCW9V/HK5)J-.(X3JE;AJ\F[],7)(A@W8D7%(!!,52MR$ XD 1 HF 1
M !'ZY6O=W5TXNYN*U=QSRNK4E4Y<[XYF\9QT"C&/W8QC[DE^!B#0"FL%'F]O
MT:2-PD%R;YM1-BEMJ\^NFPV,%:IHS+"JA.D*1&IHQ0P:C!&$\H0C]:3%L<7)
MG8%QRW\//Z]>Y(? & , "(  B(]@#ZB(_8 _>. 0_OO/+BQK*VQ=.N^TXJ">
MS$JM!LY9T@["L#,-_$'$8K8@2^%IO&XF*5=+UQ](P@4X@/< ZFR]"_23B%K4
MN[/AM6O"E25>5*$H.X]3+[M54,^L<):\KQKC*6,9UE7B_#Z%6-*K<1A*4G!2
MDGZOF6\>?'+GNLZ=<&:K=O#5-(9-7D_=H1,9%%!:+8L71924E2NDR*,RQT='
M^Y=NCO"J)^U B7BOZA/ P@/?-1:\'XE>3E"A9UGZMM59S@Z=*ERMJ3J5)\L8
MJ&'S:YCAY1EU;JWI).=6*YL<J3YI2SMB,<MYZ::D/M];=GY-/5NRY?4ELA=)
MZMVC$7FXO[C[.)FK'%IP=A@8]2(H"ZQK$]6J\[.1-]01>,4A>?+"7PP%GPH$
MSJ>"\*H4WQ'A]+BEM5XOQ+AM6TM*=HYU:-O4=:A7J*M?)*A"-S1H5+*3A-\G
MVENIB&377=Q4DZ%>5M.%K;W$:M257$9SCR3@N6B\SS3G*-9)I-^K3CJ4#Z0K
M,YOSK8.]LZIEN^OXO<7Z0%[N0R[&-D:LUK22;J(9*KD1,^=69(CRO^P2 QS)
M+OE5B @U7$/MW&+FCP7]D,>%\3I?Y?4X6[*-HU&=2G<2N6X59I94(6[Y:_.^
MJ@EF4HLXRTISO/2MW-NWZB-QZYUDY1C*G&E%-)O&?6:TW'']IO:.3</S\K'T
MP8!C78VW:#JMBDZN$ZBU=O#@C$P+)-22L<Z[/]$F4+!LRJR$@Z7-^1)-%$2F
M-^7S <V%APN]XE-QM:+E&*S5K3:IV]&*WG6K2Q"$8[MMYQT/*K6IT5F<L/I%
M:RD^T8K+;^!IG=7/CARSY*\R;!M6B\6MQFJ\I1Z1'Q2Q:Z>0770CF3E,'#H(
M\RY8]VL50#+13HQ'[$1 CM),X]L_5'[,^.^C7 /16APZ\](N%_:*=W=U*B]>
MHQ4ISB^6//RN<$UB-2*<)ZN+:1P7'+2]N[^5:E:5W"5.FHODU>,[X>CUV>JZ
MHM>_#X:&W+HK6/(V-W'K6W:W?3][I3V$:6R(<1*THS9P$L@Z<-".  5DT%E4
MTU3E_BG.4!^^?./VW<9X5QGB' :G"K^VOXT+*\A6E;58U52E*O2<8RY=N9)N
M*[)FZ]&+:XMJ-U&O2G2<JL'%3CC*4,97N-AW/AQU P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8!K<]*WO_ '9'KD]__?C1/^SU=J]O_#(>>;;HM<KITV_-X]^2S^['
MWR_'S[S8\>O6<<U7>OW3=DS;)F5<.G2R:""*9"B8YU%53%(0I2@(B)C '8,D
MJ:'WXHWE_+;DEM,ZST5?9>U:&K,?..=EOZ>G*C2GNR!E56S2+D9]HFG$SAF$
M2BD)60.72+)X*WD0C@#AGI.WKJ@KATYJC.;I1J.+4)323<5)K#:3RTGGPU1Z
M4W%R<<^WA-+.N'IEK&<:[]5H=$_#&*J6J\[6K6^8ZWWK2M9@HNP:HI4PG:;'
M3T=CA)"G*NHJE-3N(:;<I0X)J"@^C7K1HN!7:*";T/5#*M.&7=W1JUZ,(*A1
MG&%6M4JPI4X3G]U2G4<(IM:[XW^-:\X0E%-^TTVTLRD\;MI+.^G;.S-YEU=K
MO+QCEG2]5SK-N9DLU8REJ=1E08M ]N=)N88ETN-A0(B'@8A"PP$(4H$_+V#M
MD0LK.C.#NN(T'RRBY4K6%2ZFTFLJ-2*5N\K*_P ]GP/)RDU[,'[Y-1P_<\OZ
M$&..7)OC11-+VFJWVVU5E;J]8KW%[(3<"E(?-]B;3LJ2069./35+/>8?WH#<
M@J*MSHG(HBD)_P W8<>]'^/WO%K>XLK:XG:U[>SJ</:S#[+;NA2<%4BVG1QK
M/F>%)/23QIA4+FWC2DG..8RFIX>5*2E)2U>CQC#73JEJ9*X4Z[HE^T7 WQR9
M:QURQV>^2=&C0L\H[@(:I_.$PS90HQD?)$AW"S)TS>I/$GB+PS=P!VX^F=,Y
M P/2R_O;+B]:RCBA<4;>RA>U';TXUZMS]DI2G5]94@ZL5.,H.+@X)Q:>JPST
MMHTZE)5$U.,I3Y5&3<%%3E'"2?*\--8U^>A+>\T?4ZNOIVKW"'K$)09-!)M+
M("DQK\:D)UB S7*NV*T3:NT78I'9N"&*H1P!/$1\A*;F;.[XDKZC<6M6YK7M
M-N5*2<Z]1^R^=-2YW*+CS*:::<6\F1.-/DE&2C&#WSB*6=%KHD]DG[B,]+U#
MQUB[;69-]NJ7V.\@)!L-&KMQV+'3<;%2)S%1CEF<<BFV/(RJ)E038N71EU2F
M4**9!4\#!T%WQ3CL[6YIPX32L(5X25[<6MA4HU*E/>I&=23DJ=-I>W&*BGC5
MK4QX*VYE_7*;B](RJQEAMI+"6,O.$M]\=2<RRZ#=,5%UDD$@$ %190B28"/V
M 3G$I0$?V!W^N<>DY:13D]\)-Z=]#,REN\''-G<$FH8&CF)(LX. G!LLS*HN
MH/T 3 D8#*G'[ (^1AR\HU6O:C4:BM.92Q%?'9?0C*[K7Q1RV>9)Q\G+1D*T
M4?R\@SC&2("95T^<I-6Y  .XB958Y"!V#Z_?+TZ52K)0I4YU)O:,(N4G\(IL
MK*48+,I**[R:2^I[6+]E)M47T<[;/F;@A5$'319-P@J0Y0,4Z:J1C$,4Q3 (
M" C]! ?VY$X3IR<*D90G%M2C).,DT\--/7<E24DG%II[-/*,#J[97U-$7ZS\
MF[EJ77E70V!*M]>33>R.FC,^O"Q,0M#GMSB?:1J3.W?$2SYI-K'&=QB#$C Z
M3U4QE1+EV'#>(<4K_9N'6=Q>UVLJE;4I59M:+/+!-[M)=6]%D\Z]Q0MX>LKU
M848+&9U)**3USJWC&C>??G8RW3;M4-AUV.MM%LL+;:Q+)"O&3U?D&TI%OD@.
M8@J-GC511%4H'*8HB4WT$!#/*ZM+JQKU+6\MZUK<4GBI1KTY4ZD'VE"237R)
MI5:=:$:E&I"I3E]V<)*47[FM#GWCQM'M'+YZLFW:,VZSITNJ8")HMVZ9E5E3
MF'L %33(8QA'[  YXPA*<HPA%RG.2C&*U<I2>$EXMO!=M13;>$EEM]$BD7FC
MU.]S<6(32FW&VKJ=+:IW'/V5K"5R1EI-"]'J]>2B7"4[(.$F8Q<2^F&\G[AK
M$%]^+<A$R/'**JAR)?7_ $2_9UPKTDJ\7X8^)75/B7"J-O*M<4Z5-V2N*[JQ
M=&$92];5A2E3Q.K["DV^2+23?*\5X_<\/C:7"MZ4K>ZG-1@YR57DAA\\GA1B
MY)Y4<Z+&7VF?7N5LUR*THG<-$ZINSF+NM%>O&]XN1F>OZC6U'\2X36?C)SRR
M$C.-XA<RBOO:S&RZ!_;>H"A2"!\Y*OZ-4N!<6=KQGB5G&I:7L(2LK7FOKNXY
M*L6J;I48NG0E5CA<MS4I-<V,-Z&TAQ"=[:JI9V]62K49.-6IBC3AS1QS<TVG
M-1;;S34MM&:S'5"Y%:/V_I'C'1=:V^H.[3JR4L]:V%"PTNR<MXJP$$Z#^8&1
M1,#5Y&S,@*L@2634,@8[A1-4Y%TEDR?H/]G7 ^+\+XSZ17O$+:YC;<1I6]>Q
MK5:<HRJ4-'3H\C]J%2C32INDUE**:RI)OA_2"YH7-KPZWH2@ZU"<X5H0EE1E
MC'/S;.,GF7.NN4]5@V<.GIJ*H4+BOHN4;)U6S6^0UW$.)?8<2NA87<R+L%E4
MVS:U*J/7+EA&ME$HI-!F\".)[,Q6R14^W?\ /7ISQ2YO?23C--NYM[6%_5C2
ML:L70C2Y&DY2MDH1C4J24JKE.'K'SYDVSNN#VM.A86F53G5]3!SK1Q)R;64E
M-Y;45B.CQIH=JYN\J-1\0-,!M;=57D[?35;3"UH8B*B(N;<FDY4'2C)P9E+J
MHM!21]HH8RHF%1,1*) $1'MB^B7HYQ/TGXK^[>$W%.VNE;5;CUM2K4I+U=-P
M4XJ=-.67SK31,]^(7=O96[KW,'4I\\8<JBIOFEG#Q+33#U*[>.765X-[SW?K
MG4>OM0VFLW.^3X0=?GI*D4V'81KU1D\<"X=23)\9TT1]NW63,JB4QOS^ AXF
M'.YX[^ROTPX1PB^XG?<3MKBTLZ'KZU"G=W=6=2"G&.(TYPY9RYG'1XVSEZ8U
M5IQSAMS<TJ%&WE"K4ERPFZ5.*3:;?M)Y6BU.*ZVO."0TMQUJS?CAOJ+J^X@W
M/6VDTRJDE!2=B)33U&^'DRNF#UK)$3C_ (PA!^LN"!3D<%;D!0 .8IO3]DGH
MC#BO';F7'>#5+CA:X37E2G<TZM.A]K^TV7J^6494\U/4NMRK.&N;3*0](.(N
MWM(_9;E0N%7@FH.+ER.G5SE-/3FY<Z=BCOI_=0'GQO?F-HK4<WRCM!8F\6>3
MBI$9>N5>98E:HU:>D%#GCF\;#JN%B@S\V8A((D0> V<K$<HHJ-5OKWIMZ%^A
MG!_1;C/$Z7H[:^LM+>G5@J->O2FY?:*$-*CG5Y4W+VLP;<.:*<9-27.<,XIQ
M*XOK:C.\FXU)N+3A"6BA-KV<1;QC^\LO'30W0-;:$HVN7[BRA\4N6P)$H_%]
MBW9X6;M;TRGU63:*BDA'5]BH;Z_#*W'Q+ 0\15054#U!_*=_QJ\OX1M_ZNTL
M:;_JK"TCZFV@ELYK+J5YI?\ S+B=6?9I:'?TK>G2?-K.HU[56>LWG?'2*_V8
MI+'<S9FH/<8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8!7#U:N35SX@< =^[]UTL^
M:7NF1=;"JOF+=BZ]E+REO@8U%9\C),)-H,4HFX5:28G9G4!DY6%LJU=>BZ1V
M7"O41N95KBWI7=&VMKJO*VK2J1A6DJ,X44W2G3J8A7G3JR49Q?)3EEM93I4B
MYI04Y4W.45SQ2;BDU*6DDUK%..SWZ;K^>'Q1ZP7./67*B7VG"7F'DK=R#N58
MC]G@2GTV(7NCI:=%*(^*RT=4GTH\"/<RKE%(SU*7>(QSR0:1QFKIVF\1R[+B
M/K[JC0N;'AUS0K35O"B[>-LJ4JW-2A5C7M?5W4W1G.-1*K4KJ:ARM2<\GI5H
M)4Y.-2K3<?:;3YGA>VUR5&X>WAKV>7&=.RW:7?&CJ8\ERLY[><CIYJS>$1>M
MJ1>[%**:LA4E"IK(>UT_K<]@B+PH("119+;]RN; 5TP591,,)CMPWU"AZ \/
M;=[>\9XW5B_\U86D;*U>NL95+RI3N,1:QS1AKV><K5RJ<5J/%&VM[>+7WKFM
MSS6^O)1A4BWL\<T>S>Z.-O&EN2''2XJS.XX2C\L]7V36X(W".6T,+K54.I .
MUTH>@?)T*VNJC-))B@DZ@IIS5(^O,E%OA[T6QCMS*=+2J>B/I1PI<,LK?]Q5
M+:]C&UMJW$:$[BM"I"//>*5S&VH2Q)N-6A&M4K24>>FFE+&&ZE_85G4N6KFG
M.FY.K1H5%&G..<4I1A*K4]K>-3E44WB6-#V<8:GO_D[L@;93]?7+I_:CHU.<
M1NM'^O\ 55#JL3(.9&2#XO$1U.M]9,W.R=%*1\XE4JRR2=F*!&ZI0*81OQ:E
MZ,^AW"8<-A/A7I3>7%VJE]9RN[AQHJ-/^KK.K85:4(3B_9C3564HYS-/0I1K
M7O%*TJE.-UP^C"'L7$J,%*K)O6,:=:,I<N->=QQ+IHD62I:%Y6Q#5Q[3FU)S
M9B(+"0+AHBA2'J""9NQ53UN8J =C#V QDR$[!W$"_LSB7QGT:JRCS^B4**RD
M_LO&KVFTLZM?:*5U\,Y-@K6_BGCB7-IIZRTIOY\E2GG/NR:XG4'O&DGW ?55
M6U58*@?:-;Y5;#C]VL*Z1I$6]S:S&VH%BF;!$I+GF AIR139NX]5RL]C?0!D
MQ3>+KL# G]]]!K+BT/3;B=SQ*A=?NVX]&["IP>I<.56U5LOW;ZBE0JRBJ7KJ
M%-RA448PFI<\W"*GKP_'*U#]T6]*A4C]HAQ"JKN,)<E1S:N.><X)N?)/1QRW
M%)J*DVBV+I1L>3AN /']QK^?TH%15:;!/!QUJA+B2:;(%VI>$W:;^0BGAV:Y
MU)4C]=%1!@F!6BJ!#>JH0ZA_F/[2Y^CS]-^.*]H\6^TJ5BJT[:M:NC)_NVSY
M'3IU8*<?ZKD3YJC7,I-))I+H^ 1X@N$67)*UY.6KA5(U5-+U]7/,XO#:>WLK
M3?59>3N:<%M>R:DA*SRM-H-'CI.;ATO';1DJY/7=A*(0JVR*^9F18LS",HUM
M$/ILD7&SKT\RV/'Q#QZ^(<GMQ53U_HE6X90XG7N/1K]]/CM'A7%JG#H7%"SJ
M4Y5HV%;FY?4UISE5A1];4HQ]5)3JPA!IYP\CB4;J=O&%[]E5I.YM8UY4ZE52
MC3=:.<\T(14)2Y8SES>S&3>F,K7=YG5>&H'6!AX'3%+IS-E7=M\8E*!3HL&5
M5J"L@6N:P=1;$KF*8+MHAG)R"A?>RC9@[5*+IP_.W?+&.FM]V]$[BK??LKJU
MN+7=W.=?A?I$KV[J<]S=QA]IXC&I-QJSC*K.E!-0I.I!-1C!2A'#7$\2AZCT
MGC"SI02A7L?54H)0I-NE1>'RIX3>7*7++5N6KU-@;E27D/O*L:YTYR*TQ5M/
M:FOFXZ/#VK8E Y #/OV9$TY>09PY6GR;5I)-&R/&2,)[I-8ID%7R( 453IAG
MPWT<_<7![B_XKP/BMSQ7B5CPJ\K6UA?<#5&$VW2A*JY?:[FFW0C-UN5K50>R
M3.UO97EQ"C;W=M&UH5KBE"I7I7:E*":D^5+DIR3DUR<R;PVL;Z4#;]ASZ*ZJ
M\%KW4$;95:W3]F4=O6:$SN$N)9'LFV[LCR$]++I&.\.8RBRTDY% 3"8QQ(3[
M?;N!U%QG]FM>_P"*U+97%U87DJ][*THIP2<ES<M&G%I16D8TX\R6$LO!QMW*
M=EZ1QH6JJNE&M2BJ"JS?.W%/&:DVLO.6Y/Y:&U78MY<LHTAA@.$5EL9P+W*0
MN[]&Q8'-V_B@9_=4P#L/T[F[ /WS\VT.#^C-1KU_I?;VZURWP?C%7'_HM'O]
M#Z!.ZX@ON<,G+P=U;1^O.ROK:%RE]XK<K8WE1J4VHMA4KC@>?U'I"X;'I6RH
MI5B9M9"S^T(J/J<S,U@UA:.R1<>U>&(I,1*!G"R(H@<JQ>XX;:4N#_T9J>C?
M$UQ2RN^/*AQ3B]K87?#ZG.W0]1PVK.ZI4KCU$H>MG*.E*K+$7G'*]1<U)W7[
MPC?6_J*M*S<[:WJ585HO27/648.4'-/E2>'**;:[JKCHN\E]W4%SM2EP:=FN
MU(9PT6^902U7WULB'J,BZD@*JZC:_IK6>T7,,:33!0'*\@QA(];V_<'JBP"0
M?H_[6_1_@]['AMY6=O9WDZM6$JT;C@MA5NJ<:>5&K7XK?\.57U;QR1A4JS3E
M]U+4Y_T4O;R$;FE!2JT81ARQE&ZJ1I2DWK&-"C7<>;5RRHKV5KT)BK;FX^2X
M=4*!ME\07WA/<9]J66DP.P5]P1(P<A9=4WR/V#7=2PG(*"J\_!.'CB(IRTM!
MU&(:13MNFU)"H*_"[$DSX#A? .(64O0NOPNWNI\(EZ967[VJTJUG><U:G>\+
MG:5+RKPNXNZ'V6G1E7]1SU7&E4E6<W&56G*6\N[JE./%H74J2NGPFO\ 9(M5
M(9@Z-QZV--5X0DJKER<_*LS@J?+E1EB'/1*V;8HTF_J2MM??%/J#,:!.(5_2
M&H++N*:5GIH;4S<OP;PVK=L,*BDNTAFJ3QW)0C,DJ"384ES%C7"B/??M?X?;
MU)<$O(\-X-=7<U?495^+\4M^%451H_9I0BY5N(\.G=-3JSY(4ZTO5Y>8^W'.
MA]$JE;%[3=>ZI4%ZF2C;495Y>LESJ36*->-)84>9\BYFDLMQP7KRT9&6&.D#
M_H,YT;O.HQ> =S;[ROJ*.73,W4$XOZM:]BZ)KCE$0_,=J\K2O< $B;83#X&^
M,TZM6A4II<8]#N$)3@DK2SCQ.I'$ECDN+:PXQ733VE"X3Z\V#L71A.+<J/$K
MG*>?65I44\YWINK:TVNK3IXQC31&GORFZ@=XY!ZDU)H6_P!1:-'7'6PW=A!6
M=M(>H_F(:0&/BH^)G&( X;DD(5O#)(KRC*2=I2)CB8J*8$!57]2>C7H99<"X
MIQ3C5E<U)KCM"SG6MY07JZ-6FJE6=2C-N,G"M*JY1I3IP=-+',\X7S[B5Y6O
MJ-M:58QC&RG54*B>92C+$8PE#'+F"CK/F?,]<+<VM.$2O)MSTZ-+%K,'HB%J
M*V@1782$A9[U+6)\P5A9$QW4C!-J/$QK"37+YB=LWL4H@13Q_OU4.XA^;?2]
M>CZ]/.+NYK<9JW:XTE*%.WLZ=O"HJM/$8597E2I.G%XQ)T*;:S[$3N^%QNH\
M(M(4XV\::M=&YU)3:Y7JX^K44WNTI/ME[FB1<VDA\W6LKA!0R_S'.>N*2"P(
MF5^)NA5%$IRB8$A/W%,#CY@7MY"/;/V':R@K:V<9)+U-'"DUE+U<>52QA-]'
MRK&=MT?.ZB?K*B:R^>><:ZY>?'H;^O /4VW)WACQQ=)\C[E4H=QK.&48PM2I
M% ;.8QJ8[CP:_$[3#6P72B?8?[X58)^7?ZH!VS\6^FO$N&4?2KCL'P&UN:L>
M(U>>M<WE[*-27LMR]7;5;913VY5-X74^F\.HUI6-JU=5(Q=&.%&G3REC;,XS
MR^N<? C]U;.$'('<O%=.JZHOF]>1ET#8M6D@I5JD=/L(U*+:I2A7LL1&N:_U
MR0ZS'UDB)>M)JB!5S=T5A_,7>?LT]+N"<*](Y7/$;+@W ;3[!<4_M=M#BDZC
MJ2E2Y*?-<7U^_;PV^6"VW2R8G&^'W-Q9<E&I<753UM-JG)T5'"YLO$:=/;*Q
MF3QUZ%(_ OI0\S*9S T'9][<7))+4,+>$W=\/:7%'G*\6#",DDS!,0Y9R1"2
M8J.5&Q%6AF+I-4#>*J)T_+O]:],OVD^BMWZ,<:M^#^D5-\3JV<HV7V>-Y1KN
MMZR#7JJKHP]7-+F<9\\&MTU+!SO#>"W].^MIW%FU0C4S5YW3E%1Y99YES/*S
MA8P\]C;#Y-<!N.G*C3\-HRZ5MU2=?05SB[U'QNI4Z_13DFX>'G81F0Q$*\_C
M_8@RL3_U$"1Z:@J@W,1<A$SD4_-OH_Z:<=]'.*5N,6E>-W>U[2I9U)\3=>\3
MHU:M&M)Y=>%3GYZ$,2=1I)R]EMIKM;OAUK>4%;U(.%*-2-1*CRP?-&,HK/LM
M8Q-],YZD6./_ $3^&_&S<5%WCKI_N)2Z:\DW4K )V&YP,C"F=.XN0B%0?L6M
M,CEW"7M))P)"IO6Y@5!,XG$I1(;I.-_M:]*>/\*O.#WU/A2M+ZFJ==T+2M3K
M**J0JIPG*[J1B^:G'+<):96.V%;>C]A:5Z=Q2]?ZRDW*/-43CEQ<=4H1;T?=
M:[EO&?,#># & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# *H>675DUKQ5V]:]8.-*[?
MVO$:>I-2V5R1V+KX*@%<T71+M94JO!2TJPG[%%3EMDC.U0D'\#6&+E\Q@P/+
MJ&.T0>':B<?5X6^K[>_;&<)YW)I\AM5:BY6Z%M^D]BV$2ZVW%68I*3<PDG M
M)*2K3B0CIUJK&J6&,FXX6DJ5@D@HLO$.@49+."MQ0<^FX0S+"\^P75.Z^SVU
MVH0KPE;7D:D[:M3KT*EO4C5C1JT*CCR59-<E6#4E%YPFGYU(.I!Q4YTWF+4Z
M;BIQ<9*:QSQG'5QPTXM.+:\33TZ<'2:X/V+J=\Z=;.7^RHR&X.; U8^T[*.=
MA4]^23>3<M:GWKRJ$M1'#.0*Q3J[5J0W=9PG[U9ZT<,9!-B[;95IQ*WLKC[5
M1X9:U:W)5C&%W4N:]O1E5A*"J4*4*M"HJE+FYJ3KU[B,9)2<)-+$U8SJTU%U
MIP3:;=-0C-J+C[+<HRCRRQB7+&+:>$TC=X1GZVBBDB2?AQ(BF1(HFE6 F$J9
M0( F$%@ 1[ '<0  [C] #[9J6\MO3+>=/'+T^I8]GS)7?Y^A?ZT8_P!O@'GY
MCKW\_0OV[_XT8_;]_P#A_M@'CYCKO;_'T+V__-&/;_?Y&5ME9!U-W":D?.T7
M[Z(UR\?MU55V[UVPK+AVBNL/=99%RLD=9-54?JJH0Y3J#]3"(YE0OKR$'"%Y
M<P@THN$+BK&#BLXBXJ:326<)K"UP><J5*34I4Z<I)Y3E"+:;W:;64WX'9&DQ
M4V#=-HPE*ZS:(@8$6S1[&MVZ0'.90P)HHJD3(!CF.<P%*'D<QC#W$1',>=24
MY.=2;G-_>E.3E)M86LI-MX6%J]-$7226$DDMDEA?)'"VMGK"]PCJL7AK0[E6
MWQVYWM>M:%>L4(\.T73=-3NHF7(\8.#MG*23AN99N<45TTU4Q*H0I@]K:[N;
M.M&XL[FO:UX)\M>VK5*%:"DFI<M6E*,XJ46T\264VGH1.$*D7"I"-2#WA.*E
M%X>5F,DT\/75;F%*[QBX95*P&M==TCQ\B[(#Z.DVTVA3*,>2C7L2*0Q+B%<K
MLE5(,8PR" QQ8<6*;(R*(M2)"D02[>OZ5>DEU0^RU^/<6JV_+4IRHN_N53J1
MJ\WK8UHQJ)5G4YI>L=7G<^:7,WEF)3X=84JCJT[.VA4;3YXT:?,G'&.5\OLX
MPM(XQ@RCLBI:=V_6%:;LME4+C6%7C.2-$2\@U4;DD8\XJQ[]$Z+M%=L]9*F%
M5F[;K)+MU>RJ*A%"E,&ML.)7O"[A7?#[JI:W"A."JTFE)TYK%2#33C*$EI*,
MDXM:-&16H4KB#I5J<:E-ZN,EE96S\&NC6J>JU(PUG@=P>K&R%=O$HT+9-D&?
M,9%I;;[L:V; E8IS&@!8\\4M<K9- S,S*!2-URE,Y32*1$%_1333+T5QZ>>E
M%SP]<+?%/L_#^2=.=K96ME8TJD:FM155:6]'FY]Y+*BWEN.6V8%+@W#J5=W*
MMU.NVFJE:=2M*/+]WE=64L8Z/?HVUC$V_F.O??X]#=OOW^*,?M^__#YR&5W7
MS1M"!G)K@#P\Y;W^)V;N,TN]M\) !66$A6MG2-53)#@LJN+=1O$/T4U1,HNH
M!SG 1.4W@;N7Z9V?H_Z>^D/HQ95>'\*KVD+:M7^T3A<6="X?K>5)24JL6UHD
MTOB:R]X197]2-6YA.4X1Y(N-24,1;SLGCP]QSO%#A%Q+X725PE]$ ZAWU[9Q
MS&Q+3VPG5F!RVBUE7#,J!91ZH5J)%%5!,9$"B</H;Z!GEZ2^F_'O2RG:TN-7
M%O6A92G4H*C;4K=Q=1*,G+U:7,FDDLK3H6L.%V?#?6?9*<H>LQSYG*6>7.'K
ML]7JM^I6MS-Z25KY\;^L^[]M<F=9ZI^%(-]?:QK^NZJ^MRCK5L&Y?3,#,W:3
ML%VK7M;TZF;-8FLJP@V:\$E',H99J]4<.'B2/7>@W[57Z&<%J\(7!H\152^K
MWOKWQ#[,H^NHV]-TO5JTKYY?L_-S<ZSS8Y5RY>!Q7@$.)W$;B5PZ35&%)P]6
MII\DZDD\N2_OK3&C3?72473.Z<M2Z=#S<SMMR"CMLFV\WH*"H.:[&U 83Y&4
MN*H'*<EOL8R(R7S:;R 0:>U]B40%?UQ]+6?M _:'+TZCPJ,N%QX8N%RO9+%X
M[KUWVQ6JUS;V_)ZO[*L/VN;G>V-?;A'"%PIW&*[K>O5)8<.3D]7ZS']J6<J>
M.F.7X*UH]AK:I#IJ3D(<BA#$.0THQ$IB& 2F*(>O]0$!$!_S=\^;IX::>&FL
M/QW7Q-T0A=]/CIROG3EZ]XU\>W+MXX7=.G"T'"G57<.5#++K*&%QW,HJH<RA
MS#_&,81'[YU\/V@>FD(QA#TFXK&,8J,8QNI848I1BDNB222\%@U[X3PV3;=E
M;MMMMNG%MMO+?Q;R_$ES2X[66NZI!46C%J56I]7CD(>OUR'=Q[2*AXQL E08
ML6I%_!%ND B!$P^@=Q#.8N[RYO[FM>7E>I<W5S4E5KUZLN>I6J2UE.<GK)OJ
MS-ITX4H1ITH1A3@N6$(K$8Q6R2Z)=CG1E:?^V2K??_.\B_O_ -IGCZR6OMR\
M?:??KKW7S1;"[+Y(^DMBK9"@4LY"$*4.Q2EDV!2@ ?L  7   /W &5SE[Y?O
MRR3S\R5W^?H7]_\ C1C]NW?O_A_W?7^C 'S)7?Y^A?ZT8_V^1GQ7;X^>@'S)
M7?Y^A?ZT8_V^2!\R5WMW^/0O;]_Q1CV_V^OD97= ?,E=_GZ%_K1C_;Y(//S'
M7OY^AOZT8_V^1E=U\P>/F2N_S]"_UHQ_M\G*[@?,E=_GZ%_K1C_;XRN_A\>P
M//S'7OY^A?ZT8_V^1E=U\^^WS!X^9*[_ #]"_P!:,?[?)RNX'S)7?Y^A?ZT8
M_P!OD97=:;Z@?,E=_GZ%_K1C_;Y.5W\^4P/F2N_S]"_UHQ_M\97<#YDKO\_0
MO]:,?[?&5W!Y^8Z]_/T-_6C'^WQE+=X!X^9*[V[_ !Z%[?O^*,>W^_P!\R5W
M^?H7^M&/[N__ %_[OK_1]<C*[KY@?,E=_GZ%_K1C_;Y('S)7?Y^A?ZT8_P!O
M@')-G;5ZD"[-RW=H&$P%6;+)KI&$HB4P HD8Y!$H@(& #=P$! ?K@'T8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# -9;
MJ#</.8TOO;G/%:.T.YV_2>H;HO4VKV6Q&ESJ-?B=+VJH3I8N?=WR.L,@TFUJ
MX2I.74XR=5=G,NG,@V^'BP(LHB96.N?<M-_'31:?J732Y7G6+SUU3[-/ICPW
M]Y,?E5T,>(7-&P:INN]I3:3BX:LT50-#Q[RG7-Q6HU]6Z"O//F+QS'$0=%-(
M.9"RRRJZXJF,*)FR(B/HB8\E5*26,_#?\376X.=$?ASO_J&]3/C3>76U":\X
MJ675\5K,\/=W$?.JMK8>\EE!L4F5J<TLIVK[ 6QCII^CW6$ $% [//\ $]'*
M7+%YWRO_ $O&F_Y:Y7<DIRX_#'T"%VYQ18\4(#9]DU/,WR=;\J)*R;68DDZ[
M14PK?P-W70DQ9NC/%A5L(*A&HO%NS=#U$R_J_-A?PUZ8P_?]="%4:3R^GLZ)
MK.O3X]4U\3/O)O\ "_<28C0>TI+C6WW1/[W9U=POK"'GMJ 6'D+.#AL#="0&
M01:,@;F0%P8WN'**7D4O<P#V 8QYR_.?'<A3EE-O*ZII;>=M3T<6_P +_P 4
M)CCWJ>3Y/-MS5_?SVJ-5]J0U>VJ!H6.M0KN0=-HXT:D[8BV*@#<Q?;.5TO(1
M['$>X8QWU]_GQ?X;!S>='I[D82XT_ACM<2V_>4$;R1@=H06AX>SQJ/&27@=K
M,C3$_63MDQD7%@+'F=O2N$W J 3XBV9J  %\""&/U\^>OQ8<Y:8>N-=%^F[6
M_?YGCD[^&/US$;]XCQW&B!VC/:(FK^LVY7S$_M5D$Q7:$#^"*B\K@2)FCXST
MS%2;.;X8W>K"=%+ND ^ &8_EG3SV7X$J;PTVWIIX/O\ CT>_SSARB_"_\3HC
MC[MN3XR-]S3V_F-)FG&J(:P;4 L+)W--L8T.TDQD46C(&JKD"E4%RY01 !'S
M.4.XY)"F\K+TSKHC]\8/POO$J7X]Z@D^2Z&YX#?SZC0CC;<+7]J=X6-NYV__
M "RTC!CT7C(6:2WT2]JZ71[?4B@_4<!S>='ITT6WR_$P1Q2_#(:^F-T<MF'*
M:!V?7M.0NV)1EQ0E:[M5D:5L>JDYB;3BY&RA&B\=EDE(=.%55"309N?666[H
ME-YE*)E/;#Z:Z==/KXI+.C/;R"_#':WC.3W%V(T# [0F>-$Q(SQ>3D_,[59!
M/P$>FR?&@SP /C-I$RBST&)5OA[1X;P,IZ@ '?M#6F/SQ\OR6B7P(4WAY>NF
M-/.R[F9N5OX8#BO#<=MLRG%EKN2P\@V53<+:IA+'M0I8.1M)7+8K=O)&D46;
M(&YFXN3&]RZ12\BE[G >P"Q[_F_U"F\K+TSKHMCGN/'X7OAS)Z1UC(<@4]U0
MVZG=3CE]E14)M4PQ+"UG*?XBW8&8H.6@MTS>($%!PLG]_$XADXZ]0YO+P\)O
M31+3IG"Q_$CEPU_#'T&<O7*%OS!@-G5>D1.RX]KQE>5;:S$SRP:X,2>!^_L(
M11WRQ7Y#)0?IA(IM%Q!=;]2/YP)"7NQKA>_W[Y^FJ)=1XBD]D\Z+=^<_$C1S
M$Z*/$'1W4KZ>O%*EOML#J_DT%_'8WQ.].GDZ UIQ7TX\863%L08[N63<>MV2
M4]0? ?IXY*6<^Y_AYSX$Q;<9O/W4FM%US\.G8GIS#_#!\:8/C5M:5XB,MPV;
MD<RA8]35D#9]J)%@9&9/8H=*12D1E$F+ $B5]286)[EVB3UDDO$PJ>!3"JF\
MK+TZZ(R)H[\+QPF?Z5T^_P!V?INBMS/=6Z_=[;BHG:9ABHS9SFIQ*U^CXP6;
M9PT-'L[4>6;LQ;.%VPMTDA0653\#F!SEEX>G31;?(C+PM_#':[G97D*3F3 [
M/J\7&;>EF/']2J[59F5F=2$;H#%24W\),_,$FHX%<J@/@;.O$"B= OT$82U?
MCX_#\,>4B93VY7TUT6_RT^'S/5N'\,AK]CS3X]0.HH#9\EPUDZK*+<@+3);5
M8A:8:T$?3)8MO"E=F1EC-U&2<.=063%RF!U5?,X#Y@5C^7G3OT_ <[Y7K[65
MC3IU\/Q?NZY(YI?AAN/4#QTOLIPVCMO6CD*W;L_D2$M.U4BP;M<SH@/ >FEB
ML6( 5KZAB"NZ3#S[=N_VQRKLO/NQ\<8R0IO.NJZZ+I[L?CX[F:-4_A=>"KS6
ME#=;24WG';'<52#6O+".VHJ+!I:3L$3339F9LT50%LD_%8B/HK*)^ !X','8
M<87X[O/TRU_ <\M=<+MC3ZY?UR15X6?ACM<3TER*+S*@=H5:.C-Q3C'CVI5-
MJLS*36H$Y&9)"2<W\*,_,646CR1!U@?%:NP.LKYH@83@6?/G^)+F],/HLZ?C
MW^7;X>-@?AC]=MN=NAZ[0H+9[S@W(TF[.-YV][M5D%PA[HWK%F6I;6'(N*<P
M+1W9$:VW="RCG"0(.''K*)I>H<D8^7G&/KKOL1SO#UUTQHMLZ]O/0[?SL_#$
MZ.KW&2^2W!V*VS;>2K9[3BT2!M^U6Y(!XS7N4$A;SO33(1T?Y-:>I..FOK.T
MA%VBCZ('5\$S3Y84WG5MKLL>>Y(C7'X73@4ZU_27.Q%MZ,+\XJD O=&3':BP
MLF=J5BVIYYLT%!HJ@+="3%RDCZ2BB7ID+Z9S%[&%CSYVWW(YY=_P_0B5P4_#
M':WL-:W*KSA@=H5&QL=TV)AI]"H;69G0D]-I1<,I7Y24&'&0($JM*J3*:X.S
MH.P322$Z!"^!C,>_S\=?B6<WE.+PL+.>^S6N<K'CX80MOX8_7"'.C7E=J<#M
M%QPA=:VEG>PK:YVJS^;F6QR+E"*8L2JF)+^P40[BH*,<JW\@[&5*/8,C"T\/
MU3_(<[Y=_:Z:=/#3"^O7N8=ZQ/0LX8<'>%=@WYI>0V]\\Q>P-?UIM\SWYU,Q
M7PZRRJK21\V)FR("OZ*9?15\P%,W<>PX22V1"F\K.,>Y=>NWGZD_-6_AENGI
M==+ZZNKQ[O4UDMVL*A:G14-G.D6@SD]5(Z77*BB+(2I-C/W1@33,8032$"^7
M8.^,)?CN_KKK\2.>7?Z+]",_!+\,=K:Q4_:B_.."VA4K<SV_:&.KFU1VJR,V
MD-2(^A\L2<A\&-(I%DG'=?W!7)TG0>)?41)].['\-7]==?*)<WIA]-??UZ'B
M;_#':W)U :C6H:"VBKP)6T<M(6NY*[69?.;;=@2-N*C%-TSB6:&(%@A4SB*4
M:HS]1TY$7 #ZI4V->F-??EOR_EV"J/$EU;6N%MH_CKX?@<AU ?PQNJ:UQVDI
M/@3";3N7(,EJKB,="W+:K0L(I5U5'?S$X4--FC6/N$$RM?;^3D%>YA!,AOKX
MSY\[A3:>NJU[?!]-F3"9_A<.G<:#;*/7F^2SAHI$[I$FU'7H%E!:%%5,@@R$
MOI%=B8I1 PAX@'8PE ,86?S^?ZLCGEW\=4OKO\FV0KX ?AC]=674EB><](':
M%-VLE?9]M78VF[69*1JU#25+\!=KC"FDFWO%DA,*X*+$6[_QTRCD8^+[_/;M
MN\>!+F\Y3_7/ZY/1(?AC]?EY^P5;80&SS\#5=62+R<N)]KLOG%+9Y6:1H^/1
M3$P37PY1V*I%#$CC-O$ \E@#ZX22V2_CTU^9/.^7IGOA;:_#/CC/8YOG;^&+
MU-7=10S[@Y#;4MVV3WZI-I>,N&UFI(Q*AK2:)+6\2&8^'-1>MHT55&P%6.N*
M@!Z21S]@QA:Z+7?\]L;D1F\^T].NG\B6S?\ "Y=/D:FBLNYWP%I&NIJK-@VF
MX]N%@&-*=1$!]F*?HA(^28?G%/T_^EX]C8PO/A_)$<\N_P!%^A$7@+^&,U58
M](R<ASOA-J4_=2>Q[8TC(JG;6:&B5==((Q U1\J:%&1:>^<JJ2Y7(&<%7\4T
M_52('@)I\_H6E4;>CT]RW>^^?Y['#H?AD*"/4'<5E>O[.#@&72!GZ%S#:S(;
MJ;=02"12Q1D_(9KX2+#U#B(Q@,_, [. ,(!CRQSOE_VL[X6VO9>[SMR'/G\,
M;K*N:JH3S@C![1N.T'&Z*6PO4;<MJLB1S333B,LY[E*,AFAC6WQ1I)(UI-J5
M%55V*;AQZ2"A04$D=<_/+Z>>V,]R%-IZZKPPFGTZ?F2CO/X8SIXUC5EPM*;W
M>Q+#7J!/V A5-H.E6Q9F(KKR1(11,K+Q5;E?(=C$ ?$Z?< -V'ODD*<EU_#\
MM=>I(C\-0W]GTOJ<S*JLLDRW%O5D@==4RROHL]ESS=(#'-]1$$TR^0_3N/<0
M^@AA><^?QU[DU%B3]R]^RW[9WQXE_F"@P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , @AQZO_3YGN1.^$^-L]I![R2M
M:S:0WVYH2;)*ZVY2J/W\:A(6&41;I%M*4!(RC]DH]8NY)"/=/CHK*I*+E SS
M^73\1KA;XR\9SC+>N_<G?@# & , 8 P!@# & , 8!UBZ76I:ZJL[>+W8HFIU
M"LQSB6G[%.O48^)B8UH05'#QZ[7,5-%%(@"(B(]Q^@% 3" "!!9ON;IK<B54
M.7PW+0VPWO%E)\LUW++$:A-:=1FD4GKE1L^F6C28A$YM)BBJT.W;@67,W3(P
M%TH %&$T\XZ/'Q)Q+;77IW_EGX$L]*;[TWR-I@;"T=L.N;*IWQ-["JS=;='7
M1:R\?Z8O8M^V<)-WT?(-R+(*J-'S5NOZ*Z"Y4Q162.>2-FT^AEW & , 8 P!
M@# & , 8 P"+.]C<2=S6&&XD<@DM9;"L%VBG.Q8C2]Y9MIL\Q$TI8JR]H-$.
M4%FB2$(JL"I'+LZ!RB<3H ?L(@'\L^\]VE>4_%'9UGE](Z-V[KNT6?5T>6'D
M*'5) HKUZ+KPHPWM&+8446SIC#BDC'J#$JO$&7IE24,GX" !A]B4& , 8 P!
M@# & , 8 P!@$8=\\L.*FCY2&USR!W%KZC2FQF*S&-JUMD/%::B9-4898[YJ
MD@Y(QAGJS@T<:0EA9QJJAE$/<B8J@%$X;V39C2F;;Z?_ !"L54XF4.X:4TC.
MV=Z,_5M0UPS."0=R-Y=K2R;\K5@A\+8O;4[75?-??.6J\LHN55L5?UDQ.&KU
MU?=[[:?3'T)TX(& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M*^22R)@* =WS\^?T+2VD\IIM8>VB?NWQTWWR;C62>8P!@# & , 8 P!@# &
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M#UBO14Y.G!2;F8V%C6,M,' PG \K(M6R3R0.!A$P&=K+"!A$0'N(C@'8< 8
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M$C'4U&I_F_(PE%VJCYF3\QORMUTR_F-]/J. =CP!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M'C!HF@E&NE4I-J\;ISY\?CY?O$WF3URM,:YZ+S_##+Y\%1@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8!#KE=P7T1S35UZVWZ2_V&IZ]F0F
MR:XAMB6>KZXNSI.0BI1JCLBHPCUI'W1K'OX9FXC228>K'G%S[19('2WFW)3:
MSC&OAJO<]U\/B3!22202300331113(DBBD0J:22290(FFFF0 (FFF0 *0A0
MI2@!2@   8(/9@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
I& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g105868g46u77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g46u77.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2(D4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (@B^AQ(X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>T_@         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              Q    E<
M 0                         !              )7    Q
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    Q     !29VAT
M;&]N9P   E<    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M C_P        .$))3001       ! 0 X0DE-!!0       0    #.$))300,
M     !?5     0   *     T   !X   88   !>Y !@  ?_8_^(,6$E#0U]0
M4D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M86-S<$U31E0     245#('-21T(               $  /;6  $     TRU(
M4" @
M       18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP
M=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     4
M9&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0
M   D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M!#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M    $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV
M-BTR+C$
M             %A96B        #S40 !     1;,6%E:(
M      !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:
M6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W
M=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
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M"58 4    %<?YVUE87,          0                        */
M G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M
M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H
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M-4TUAS7"-?TV-S9R-JXVZ3<D-V WG#?7.!0X4#B,.,@Y!3E".7\YO#D
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                          #_X3]8:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60]
M(E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS
M.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U
M+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @
M("(^"B @(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I
M<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @(" @(" @(#QP9&8Z4')O
M9'5C97(^36EC<F]S;V9TPJX@5V]R9"!F;W(@36EC<F]S;V9T(#,V-3PO<&1F
M.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D
M9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z
M>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(CX*(" @(" @(" @
M/'AM<#I#<F5A=&]R5&]O;#Y-:6-R;W-O9G3"KB!7;W)D(&9O<B!-:6-R;W-O
M9G0@,S8U/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX;7 Z0W)E871E
M1&%T93XR,#(Q+3 S+3$V5# Y.C(Q.C X*S U.C,P/"]X;7 Z0W)E871E1&%T
M93X*(" @(" @(" @/'AM<#I-;V1I9GE$871E/C(P,C$M,#,M,394,3$Z,3DZ
M,S(K,#4Z,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE=&%D
M871A1&%T93XR,#(Q+3 S+3$V5#$Q.C$Y.C,R*S U.C,P/"]X;7 Z365T861A
M=&%$871E/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP
M34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @
M(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @(" @('AM;&YS.G-T4F5F
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52
M968C(CX*(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^=75I9#HW-CE&-34T
M0BTS0S V+31&.44M034Q,RU%1#="03DQ-T0R1#@\+WAM<$U-.D1O8W5M96YT
M240^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z,38Y.3A#
M,C4Q0C@V14(Q,4$V,C-".3-%,S-$1D8V-3 \+WAM<$U-.DEN<W1A;F-E240^
M"B @(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^=75I9#HW-CE&
M-34T0BTS0S V+31&.44M034Q,RU%1#="03DQ-T0R1#@\+WAM<$U-.D]R:6=I
M;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @
M(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C$T.3DX0S(U,4(X-D5",3%!
M-C(S0CDS13,S1$9&-C4P/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z=VAE;CXR,#(Q+3 S+3$V5#$Q.C$Y.C(Y*S U.C,P
M/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A
M<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z
M<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG
M960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S
M=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC
M94E$/GAM<"YI:60Z,34Y.3A#,C4Q0C@V14(Q,4$V,C-".3-%,S-$1D8V-3 \
M+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW
M:&5N/C(P,C$M,#,M,394,3$Z,3DZ,S(K,#4Z,S \+W-T179T.G=H96X^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H
M;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N
M9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P
M;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S
M=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%
M=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R
M<SYC;VYV97)T960@9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S
M:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C$V.3DX0S(U,4(X-D5",3%!
M-C(S0CDS13,S1$9&-C4P/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z=VAE;CXR,#(Q+3 S+3$V5#$Q.C$Y.C,R*S U.C,P
M/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A
M<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z
M<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG
M960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T
M;W)Y/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX
M;7 N:6ED.C$U.3DX0S(U,4(X-D5",3%!-C(S0CDS13,S1$9&-C4P/"]S=%)E
M9CII;G-T86YC94E$/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YU
M=6ED.C<V.48U-31"+3-#,#8M-$8Y12U!-3$S+45$-T)!.3$W1#)$.#PO<W12
M968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C
M=6UE;G1)1#YU=6ED.C<V.48U-31"+3-#,#8M-$8Y12U!-3$S+45$-T)!.3$W
M1#)$.#PO<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \+WAM
M<$U-.D1E<FEV961&<F]M/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @
M(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @
M>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(CX*
M(" @(" @(" @/&1C.F-R96%T;W(^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@
M(" @(" @(" @(" @(" \<F1F.FQI/D=E;F$\+W)D9CIL:3X*(" @(" @(" @
M(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T;W(^"B @(" @(" @
M(#QD8SIF;W)M870^:6UA9V4O97!S9CPO9&,Z9F]R;6%T/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N
M861O8F4N8V]M+W!H;W1O<VAO<"\Q+C O(CX*(" @(" @(" @/'!H;W1O<VAO
M<#I#;VQO<DUO9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @/"]R
M9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0]
M(G<B/S[_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0'_P  1" #& EX# 1$  A$! Q$!_\0 '@   @ ' 0$
M      $" P0%!@<("0K_Q !K$  ! P," P,%!PP($0D' P4! @,$!081!R$
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M38J(Y=R7*2^/?5O\-ZE\T6E^!QG[0_X8/7;@8LOB*R^\<?\ 53'C)$+W9/\
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M96'&E@GQ&W'P':/L;#[5),?2>TH:BNCQ''4(_P!>C/CU"-\Y$]GX,50]I.G
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M UC@)6>$IF02IH#*XS69:OAV%$-@!^8 M E4(J!*:RD9!0;QY8=I'5>X=/\
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M@3;:)\MU[9=F=N=H:7'@N1M&T9QQ]\!\N.QU=%Y[SY"YF0Y-Z2*&1CF61UW
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M]5K*Y^]?;9__ *9H)_VZ7_6Q_1'-63G]I]E^@_6M3SX^'OCMO_-OP^VNTO\
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M+$29MHA *O%5OONNG-H Z5[HD2*"Y@9*AYRP0>@/CZ3OG;Q&_3U\-7$ )+Q
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M3P'94.\.Y2=ENL&\^>][IH5T,)?W0O5+O)CY#M0W_:_I\/#[4C?1_2[V?[O
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MV3.:EHCV6=11D*F6ZDCJ/+91P<^E,/!^;Y^AXSU$OA&-0;E\,N!F$%6ACA9
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MLQI.GWZ5'XCY.#K!E\16D(S^PD'\;=./'^[GP/"Q"K9=OOWE/FJRXL]YT_\
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M4G3ZCM.I%PU>B4!J-3:W<\YE;_?(AOW2Q<-/IJ!'#3]-@0:FETHGM@52]*F
MI6:2!%1>=][&ZCD)2MEQ"@"%H*<'/B.NQ!VZ[$';8@\4.T*R,CODDEGM0*U$
MR!B6\:KMN^N3=2-96'*A,9CV]JA=5*BH:FRTI,=**6ZA02'L)[L(*4H',,.*
M5G/7DTQXN:/%>=D19(R&L=SJB]%NW4V'-8GPAVN82DI][SQ!:W,5NJO--/-U
M.I*0\@%L^72P"20E7]?P !D@GQ&/^MP0S%>AV@3?21,J$Y*D]J-V0]&UKEI
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M:L)^!5Q@*(&U*E^/I^I#PZ^/IZ<4:/WA($**!+Q>H++8(KZ_,?+%&EIT0OU
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M8-E7'@';%*F?/@=V?9G'&PBG<KF=V"9_)MVM_%0I0?(4Y*-C'Q1ZC_@3<?\
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M+%_!BZ^F?M.F?[2^CT^'#6P_%R>]&NJB>'^8>K,=KBQ=_P!K%V=,[0Z8?_\
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M?VCICVC:%I$4$JZ'" "E8CCJ+9.)4H5H:JWTW8?8\![M/0C'<<CPGHUAZ 7
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MEA(,2&0C!251D*4"-P02-L* 4-NHWXUOPW7T) )$E.$_FV94W\9_-IPID$
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M=<>?*AN18TN)$B&DU>@4FH4^I/3HS'D%895<=-F)I<Q+#[D-Q+OFEQH+$@2
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MJEB4W-C08EO7?<+<J-&E0VUU)B:W9->B1'J?W[#LF') >(C. Y6@0)+),"H
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M7"56U/177"'34K4@4ESNXT;/Z]VKK#L_6#2?1&OHJ35>U7TYN6_[?K_=(30
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M7<H25?JQM21?<SK3@-1J3!U0N2-:CKT.77+?]Z*:\[49M+8N*)29$6L..B3
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M)F-K8\H0"MLG">[(<YAWA1S#E)'*.4DG.P!STX!TGBE^*8<<&-JJPM9[<O\
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M]#J2HY0LR4B*4I,(05"@D@+A(L:)N,ELA*%!Q*\K0%%'U)20P6BD!I(4A'<
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M,9]7IQOPL/8CGZ,:V5!\LQED!0Y4Y&R$I"@KS22X.[ *L!(4G[+9)!W&QUU
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..8X,8X,8X,8X,8X,;_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g105868g48e61.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g48e61.jpg
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M 0 "$0,1 #\ ZE^=\#\KPX . #@ X . #@ X . #@ X . #@ X . #@ X .
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MP < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P <
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M&!P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P
M< ' !P < ' #_1\]F?T ^B)1?N*+^SYQAX[XNZQ57M;G>/T8Z-, =4:'V%ON
M#V9_0#Z(E%^XHO[/CQWQ=UBJO:W.\.C3 '5&A]A;[@]F?T ^B)1?N*+^SX\=
M\7=8JKVMSO#HTP!U1H?86^X/9G] /HB47[BB_L^/'?%W6*J]K<[PZ-, =4:'
MV%ON#V9_0#Z(E%^XHO[/CQWQ=UBJO:W.\.C3 '5&A]A;[@]F?T ^B)1?N*+^
MSX\=\7=8JKVMSO#HTP!U1H?86^X/9G] /HB47[BB_L^/'?%W6*J]K<[PZ-,
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M\.C3 '5&A]A;[@]F?T ^B)1?N*+^SX\=\7=8JKVMSO#HTP!U1H?86^X/9G]
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MSX\=\7=8JKVMSO#HTP!U1H?86^X/9G] /HB47[BB_L^/'?%W6*J]K<[PZ-,
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M\.C3 '5&A]A;[@]F?T ^B)1?N*+^SX\=\7=8JKVMSO#HTP!U1H?86^X/9G]
M/HB47[BB_L^/'?%W6*J]K<[PZ-, =4:'V%ON#V9_0#Z(E%^XHO[/CQWQ=UBJ
MO:W.\.C3 '5&A]A;[AO)S%AG < ' !P < ' !P < ' !P < ' !P < ' !P
M< ' !P < ' !P < ' !P < ' !P < ' #\[;Z:8QG?;77&=M=<9VVQKC.VV?
M%KKC.<X\>VV<XQKC'Y<YSXL8\? #]< ' !P < ' !P < ' !P < ' !P < '
M !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P
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M.PXX74:M<36HB  )6HNP^Z]65R[>I'<]?ZR+AFT"ZGB[@F,W*"K'N:)&V4K
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M.Y^^T=LG)%(< ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P
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M>9:(9SOMYQRJNLH BMY3WGO/_CR"YN!(< ' !P < ' !P < ' !P < ' !P
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M\T'RX?JO_K7\I'5'P9_UV_VW_/AZ,K8_G"DO_$,_^F,N:#'5 KO@ X . #@
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M$LTH<)Y*57-*T$X24:6BLE),U(;61D9+;0LE(*[.6HO0X . #@ X . #@ X
M. #@ X . #@!T*?A%G^XC#O^9. ?]A6KS;/(U^E<K_!)?[Y3QH?X1'Z"P_\
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MQQM2758\)UH(FNO#F]-)0B@20E;=+6O=@RNY!2J,'P<!(W!@SZ031P%:6K*
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M(MFEF=\K9%MONL>?ERRS&OE66AW]HX=#J[>";DLF2UZSKZ7V ,E-)63.M+H
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MHDEE1#+P,49' I%NHGLFX9% AP:--A"K)9N1#F1S J-=-7[-LX2"!]8A#XM
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MM(_LRR\A^YEZ?U!?"'VB>=--3NU1U<O(_)D&"=KNY>YA1R0A*%Z:2K:AZPT
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M1\2B<?!MBNC+LTZD/9*U*LED[ZO>9EI5\B];1K<,XE+-Z6MD(,-UPX"M7:
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M^D;,<" X ="GX19_N(P[_F3@'_85J\VSR-?I7*_P27^^4\:'^$1^@L/_ #)
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M?[B,._YDX!_V%:O-L\C7Z5RO\$E_OE/&A_A$?H+#_P R0/W"JCQ%<Z?'$X<
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M < ' !P < ' !P < ' !P Z=97W4LGKY-^T.+)E$.D8]1]VMD%(#I&U>Q-!
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MG=$'OZ:43 (K$Q>!T.SB/$I)O%'<L/OCM436:)6K% !"X(O+)!"JX/A&0F0
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MBEJKNOJDGA=31--1;&FN%5$TL[[))[J8QY>VB>RJNR>FV<ZZ94WSKC&=]O&
M%44E]-DEDDUD]LZYV35TU4TVSIMC?7.VF^,ZYSKOKC?7.<?DVQC;'BSC&> '
MXRU;9RKMENAG9?.<K[913SE;.4M4,Y5SG7QJ9RAKJCGR_'XTM=4__P!,8Q@
MTHK9==[WW[-MGBRKMM%:#ZU,XNW<J;KH1MI)S=QNY*U )*[;IAVTA=1R/.3B
M [5ND6< @RS_ %<*"V.R 3N+SG]A=Y_6-WN! < ' !P < ' !P < ' !P <
M' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P
M < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < '
$ #__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g105868g52h11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g52h11.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2!:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (#Z^@E0X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>6$<         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              J@   *D
M 0                         !              "I    J@
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    J@    !29VAT
M;&]N9P   *D    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M>J]0;EY%&!C5W-PJVV9+K;?3)WASVU8X#+/?L9_.7^E3_P""+1Q<AF5C59+
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M2P["[J>:PY#K S9MI+FD-ENY\-:-_P!+]Y:"S<'&H9U?J-[& 0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L
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M%B)1%Q@C)#(S@9'P-38W0E-4<723TB8G-$-65V%B=J&QL[71U/_$ !P! 0$
M P$! 0$            !! 4& P('"/_$ $P1  $# @0#! @# P8,!P$   $
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M_7N3R5GT5A^&6#71*F4=H&RO G8$AS$%('X_PP7.'W3R[\(HGZ X4:)IB#Z
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M57%$\_:6J6X[A^"TT A:WU3#+AU3/,Z3-<.#PUMK&]U\-7BF#6^^'[/S;,]
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D-4(AC; +>'3[<QX V[D5@.5$X1.$3A$X1.$3A$X1.$3A%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g105868g53c77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g53c77.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1B 4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &&2^8D0X0DE-! 0      " < 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  $1V5N83A"24T$)0      $.')"A7;Y_SV*:I=Z)!5H1(X0DE-!#H
M .4    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
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M;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L
M  !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG
M3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^            !"<F14
M56YT1B-2;'0               !";&0@56YT1B-2;'0               !2
M<VQT56YT1B-0>&Q 5J&J          IV96-T;W)$871A8F]O; $     4&=0
M<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M     %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M        $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O
M;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T
M4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M    $ .__C4  @ " [_^-0 "  (X0DE-!"8       X             /X
M #A"24T#\@      "@  ________   X0DE-! T       0   !X.$))3009
M       $    'CA"24T#\P      "0           0 X0DE-)Q        H
M 0         !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ !
M *&9F@ &       ! #(    ! %H    &       ! #4    ! "T    &
M   !.$))30/X      !P  #_____________________________ ^@
M_____________________________P/H     /______________________
M______\#Z     #_____________________________ ^@  #A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@             !/@   C8          0
M       !              (V   !/@                     !
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M;&]N9P   3X     4F=H=&QO;F<   (V     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
M  =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L
M;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U
M='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT
M3W5T<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M       ! 0 X0DE-!!0       0    #.$))300,      X3     0   *
M  !:   !X   J,    WW !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" !: * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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MNFD,]*UU;8)U#=ON25;=:[<T.$B1,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! ?_  !$( 5$"6 ,!$0 "$0$#$0'_Q  >  $  0,% 0
M        " $"!P,$!08)"O_$ &T0  $# P($ @8$!P<)$0T'!0$" P0%!A$
M!P@2(3$300D4(E%A<14R@9$6(S.AL<'P%Q@D.$)RT28T-5)4D[+2\24G*$9'
M5E=B='5V@K.TMM/A&38W0T1C<W>#AI:DPT5F9Y*4H\)3A(>BU/_$ !L! 0$!
M  ,! 0             ! @0%!@,'_\0 3!$  0(#!08$!0,# 00( PD  0 1
M B$Q P1!46$%$G&!D?"AL<'1!A,BX?$4,D(C4G(5%B0T8B4S-4-C@K+"!U.3
M)C9$5&1S=)*B_]H # ,!  (1 Q$ /P#[^-$31$T1-$31$T1-$31$T1-$31$T
M1-$31$T1-$6*][[CJ=G;1[DW;1GT1JM;=D7+6::^XTEUMF? I<B1$=6E05S)
M;>;2HIP0K&"#G1,1D\^"^..H>G1XK&N$^HTY-VMHXDHV\$.<BL(MVA>N+V9>
MMFJ2FY::>8BH35.D7?3!27*AX8EM4AU2PM$UP+US]W9AO9'S+W^B_2Q$1[ME
M^H_6?Z>8H;,C]GR/]3:SBB WOTCQ#^K,>U-W_P#A[_M)'9"__$Y^$_\ 9RVM
M+.]F[7#_ %O_ &J'P5';V-VCL=PW7_18O_B!N7"TM81^J_V8,5Y$0OX$:G'$
MXP^/7>YGCE58._=#VP1PLQZ%=E%4NQJ3715J,[:,"J2[?D*>#9;<=FO.+,[\
M8O"N7DP"1P._'L>:\7(29I#R?6IGX5*P;O)QO>D/V.X5>#/="[.*R-)K'%_N
M; IM0N&D[04:IS=N[8;BS%OQ*/;T8J=N&3*>:;4HY8<"0$)/M9U)UQ\/OX'"
M2CAN!8TQ!/*0U'!>^_HX+OW+W!V,<O+<K>JM;XSZI<%213[FN';-&UE4AQ&%
MI0::Y;:7'5(:8="_#>4XH+"NF ,:O9[P0LY($C0YASH)<APDO0C1$T1-$31$
MT1-$31$T1-$31$T1-$31$T1-$31$T1-$7G#Z5#<SB8VGX2KFNKA/8B2-UC<-
MMTQ>'J>;CC6E-FJ%SR['@51Q,*IW?'@H"Z3#6AUQP^+X;2UA/*[[[ZJ3!# '
M1GGY4>N++PZVQ])]Q [>\-W$$RSOW<&[.YU-O*P[,V^@[^[?)L;>#:^;?4F/
M#FU2]:>VRBC5FDTUYQQ=(>;5R.A',XE*>5 F3>,\\,J!O1)FI$I%@QH#4,'X
M/EQD,K=#CHX6.)SAYX8-WN*^=OC1^.S;R[J/;5Y&VZ+2+GV4W630O7Z)<]OL
MP IF;:E*F28CDF/,(8DQ6WQE"^5:+R)PEKW-)RH!,4!D \P&DSB;S9W *ZQP
M(<;G'-Q4\0%4VDKFXMA3U\)%I772-RJ=;50I(=XD[ZIEQU^WJ-5ECU-*Z)2E
M_1;+LQZG*<;"0W*_\L]G[VMA%8V=VM3'9Q0WJSCM8(8(Q%'!#!;VM@8;:%AN
M1F*R,<,)?>LXH(_Y,.YVCL2\[,V;L#:5M>=GV]E\17&^;0NME=+T+>]W2RN>
MV-H;%M;':E@(88KC>K2\;,MKS86$<444=QM[K>@1#;PPCB)7I+.,S;CA>](3
MN/N@JC4_>':W>2S]K]N:'$;@5*@;??AO454QA^!(;AQO7(U-COM/J745R2J:
MV%./*0L(1\[0V1$'RH;0$0 6OS(X8A%:O%O16>Y!"8(-TP@01;\0B$1,;$ <
M2^1;.C%R_P!/L;Y8Q0W*SAVC^MO-A>8;;:(M;3YUM<OD72Z&[7**RBN\-G=K
M>*]6]G:0VT<5[M(;2""R]'_1?[Y<0MVW;Q3<.W$;?4/=>Z.&^\K5I%*W.:A1
MZ=4+FI-W6_\ 3*6:K$B8BHE4V0A]E) +OA*0'"2 =8[Y>O%<&*&4W&\SZ%@9
MB@P!:3R"]>DXP"!@8 [8/3H,Z*\:]NKM$31$T1-$31$T1-$31$T1-$31$T1-
M$31$T1-$31$T145T!_IQ^WZ^VBD5#R\U4=AGOYZ*IHB:(FB)HB:(FB)HB:(F
MB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB*A('4D >\G'Q\_AUT1='W$M.
MG;B6+=MD39RXL*[+>JUO2I45:5.QV*I$=B.NM]2DN-H=)1S=.;IHH3W]^SD"
MO#*7Z 3ATD2*K+5?=RIJE6V&=V0$OU>,!&B/7FB[47(%A']F&V@]2V%'!$9]
MQ*5$9U)X-SSUE1NNBKB;[QW@1+@?$])<%+[;7T9NW>VC/%?%I]\5^>KBLMV%
M;MS"5X*31&(5!C41N33T@!2I"VHP><&% .*)&,#%4))I.4LJ 2>CC$8OSTK@
M]&3MW7[2X(+4FWC6Y$#@FO*'=]M(F,QI*;P>:0^A4.L-/)4CP@72$)Y .0:=
M]_= 78LQJSSIN^1GE(:+T\IU/I].;+%-A0X$<%1\"$PS&9"R05GP6$(;"E'J
MI24^T>I/71!S]*G-IY\ER&1G&1GW9&?N[Z*JNB)HB:(FB)HB:(FB)HB:(FB)
MHB:(FB)HB:(FB*A('<@9[9.,Z(HI\8?#'9?%QM*]M'=]R7'9[BJY1[HMV[+,
MJZZ3==N7';[ZI5,J=*=:4E;P2I;C4F.<H=CN+"OJC5 =^^)/?WR30.SRU)<$
M-AAB"H+6=Z'?89FV]ZHN\U]7WOA?6_,.CP+IW'NF1#:KU*;ML(_!TT5$)M C
M2Z2MI+J)2@7%*.5GSU%26%)Z%^\Z9Z+2VZ]$18MH5VMWW>?$+NYNKN,SMA<F
MU&UU\7C4HTFH;/6Y<U/72)T^S, B%7VJ<ZY'CU)*DO,Y0X%<R4J!"0-"S3+5
M]VU-<"R[YL[Z)KAVX?;]V&W.V?JUT6E>6S%LS;7JM9@S&2YNQ3ZD])E3I&X3
MC2 :Q4')DQ^0F2X5*3EM&3X8)(XPH69SIFS^!*[E<OHTM@[NL_BKLFX)5R5*
MD<5MS4^ZKT\9QLO4&NTK\=2Y]ME;>&E0Y*6I )R,MCJG).AF&!(=L1WSPGQ4
MF\VD#+-R&.)8]7S=ED7@EX'K-X,:'?4>DWC=6Y%[;F7#'N2_MP[TD(D5ZXYT
M*+ZA3FWB@<B68$- 9:"5*)RI1P21IDW?!L&5=ZU?4]92E^9J= (/8@_+KHJF
MB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(J'..GO'EG\P_;Y:+,5*
M^CZ.3+N1HJZ+2:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)
MHB:(FB)HB\=_34[W;I[/\->W5)VNOJ9M4[O!OQM_M7>&Z%/;:,VR[.N%V9]+
MS(LI])8IK\I++;**@XMGU=*5A+R/$)U"^'8]A4]@O5AXX:F@KP*\Q>*6PI'!
M;L9Q)T[A_P#2![G[FUR79-FUV/LU=E[+N^XK2J\^?#6N[(5ZMOJJ=*IU7=<*
M'::Q(:;1'?Y0V0D'1Y_;UHQPY\HQ,W(F9$Y9N\39>ZQ=Q#<?W%W6=@*GL;N#
M%I.UN[&SVX/ Q<,6_=J[IK*5W38F[E49CRJ1=$V6_*?=JLB+X$B4AMU+3Y=E
MAY"@&R+H15\Q@2\APR&JO @,Q-#/?$.N (9B3)C@H\19G&%O5Q-<1+FQUR\7
M%T;PV9Q7(I5L7!2MPU0]@[0L2G3HHG4FO4"6V[&=!A@\S/,E">99*5$ZDIY3
MX^&/CU2$E@"3,!G(9V%7K3$<Y,O4:V_3&[[6UQ<?N#;V;;[?V195!J53M-R=
M/769-6ON=;-F2*],JMJWE394JW7;CJ,RGOQXMMRH450,AM(/B9.J[/KWXZJ-
M,5=Y4&%2^ #ZR<R"Q[M7Z>K=FK4"[]Q;WX?J"]M_,L"ZKTV]BVI*K356HS](
MK7T13*1>%3J$F2U,]>*VI$J93X;:&SXB.9K!"3DGSQ_+BF3(PJ'I24G<B6;'
M37-3,X'_ $C'$OO3Q.VGPZ<06V^T- -[["N;ZT>X-M*_/J<B#3)KH53*)58T
MJ5,;;ELQ5!,EY"FR7_JIQD!GWZ^ZDWTXC@<'\6U7N P1G&%9P4I)43S(3T2L
MYQU4.OG\,=-%1CWWTZU6ZT531$T1-$31$T1-$31$T1-$31$T1-$31$T1<94W
M5LMEQM(*VFGGFTJ *776VU*0R/,*6H !23D9T[]UDM(EVQRYC[.[:+Y([.M>
MV>)]/%+Q;<2''QNAPZ;Q[.\4BK%V\%(O-^D4#:NU[<N*G1*/0&MM$.-_A.W>
MJ79$60\Y"?$A"W7>5Q+3Q 3>A!>LZ<M']66S*CCG@6DU"#UE( K:6UQU<7VP
MO$AQQ[B6W<-K;L[)63Q ;=V=6XVX%0K'TFJEW8_'IS4BQX,=R/ H#CP5ZX_$
M5&2VDK"$M@@@#4O*9TY?99A!(9W8!SBVZ'8OK,L9TE6%N\V_F^-[QZ31W[UW
MXO2E7?Z2=5K3=M[ W%DVE=ESV9/MQ4]FQ*!<:2XFE4I'BAH(#>?'#+I;5R]7
M''@"VC49U8@06!(($GG2%SE.3FA+%FPF#9_$GZ2'T>O#U7*I7;$N 6KN/O5<
M\C;2E;X7-'W6W%VIVQIS4=<1NJLM3:54J_&D>VT_*'.N PTJ0AE(409IWHU.
MP51,\ZDEIXDL)XZ8NLH[L^G-WW=@[/4G9"V-I+HNF;M!/W:W+G*I]PR:-='T
M4Y+9?M.RH]1DT]%*D/*BAJH3Y50D*A2)3?A,*8;<<3N& &R-H;2S$4-I#!\K
MZ_F$10QQ&TA^@V9@@,(@C>TACWHX1#!%#O1#FBYV1V=:W_\ U"YPVT%\L+H-
MEQF]_P"HVUE;6%XMHK_9B&ZFXBXW>.P@N]L;2_0WOY]XN_RKI;6)M;:Q[3O!
MZ9SBO:B;D[D;4[:;-VEMQLE;^Q_X:6/NI59J]Q:K<6[-*@U6HLVZ['FL-3HM
MN*>D042&&%M34AI]&<N<OS#G0>LWPP.3/5S1<$R!Q+AI-*4Y4D7,B:R 9?29
MM+=DB_-MK$O67&1#EW;:%O7))B,K)8C2*S3(T]UAE)RH-MK>4A!42HI R<ZT
MH'\,R?3[K(NBJ:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB*U8R.V<'
M./V_5HLQTPKCS[G+-7#L-%I-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$
M31%0J"1DG [==$6BN5&;)2N0PA0[I6ZVDCY@J!T16^NP_P"ZXW]_:_Q]$3UV
M'_=<;^_M?X^B)Z[#_NN-_?VO\?1$]=A_W7&_O[7^/HB>NP_[KC?W]K_'T18B
MWQVBVIX@MNZUM;NS;=(O6R[@2WZ]2)RHZPAZ,2Y&F17E$F)-C+]J-);Y7&U$
M\JAG10]_C%J^4U#BQO1;\$EAVA>=G4S;E-0A[AMP&KMJEPUQRM5^?!IDA$B#
M3?I>6M<AJ'&<:;+<5M7AI"$C'33OO@CSIQ+,*:2_!T7?+P]'WPC7Y4*U5+FV
M^@SI==1MDU5'#40T)C>SSZ)%@!20<E5&=;0E!.2M (("3IWWQ2F%3C.0^H<@
M: K-6SNP.SVQ50W!J6VMOP[>E[JW3+O.]'VYB'OI.X)R$IDRW$DCP@H) Y$^
MR>XZG)9T]^^2D\BS@!JCB\FUR+'%1ZE>C@X/I6\[6_<^P(U7ON)7W+MC,U.J
M&;;[-S/,.17:U'HDDKC-3E1G'6^=( RO)'D2NG-VY$#[S#R*X:P_1D\&>VLV
M]I%K[=1A"O>CU2@5:C5.J&H4:)1*R\J34*?1*:[S,04.R%^,DLI!:6!R]4Z)
M/I@U<17263UQ"Q)P[>B]V[X7N-2-Q$[0UKZ)V[3LY-VZ=L^KU=ZKU-%1E2Q(
M;D,S)BE+:I[* $M16U!#7*$A.,Z@#9\RZIF7XB089^E?LO7)N=%4/:?C)P!U
M\=H?9CFR,?=VU5!B^9^WAXK5]=A_W7&_O[7^/HJGKL/^ZXW]_:_Q]'%'GDB>
MNP_[KC?W]K_'T1/78?\ =<;^_M?X^B*Y$F,Z2&Y#+A R0VZA9 'GA*B=$6N"
M#V(/R^/;[]$31$T1-$5"0D9) 'O/QT1:!F1$DI5*CA0[@OM CY@JR-$5/78?
M]UQO[^U_CZ(GKL/^ZXW]_:_Q]$3UV'_=<;^_M?X^B)Z[#_NN-_?VO\?1%M9,
MB(LMD2(J\$@Y?:RD$?6 *L9![GN!VT[ZR4+R9JA^N'!0$W!]&WP6[G;O)WJO
M/:>B52[TS(-8GLMRDQ[;KU=IT@O0JM6[=9*854J,5PI=:ER6U+"D@@Y!T8>?
MY[FFC9,:GQZFM'?!=NJO GPKUY6ZCE5V^I2OW8[MH5[7]';EM)CUFXK<?3)H
M\]#:>C!C/)2H) Z8P<#LKY]]4#N&D X,JT:5,/"4EQ5)]'MPB4&O6]<E,V\I
ML>KVONBSO%1)'T@E9C7^Q#1":JX2?-+"$(QT'LYSUT4<FHF,\7R(,M:LZR9Q
M(\*^Q/%51:31-Y;?1<,2A//.TQR'5U4Z;$]:2$2FFI$=P+,>2D<CK2AR+02"
M,$Z("9N]3AAI*N%>&L?[K]%YP.WM;FWEK53:.DTRC;6PG*;:8H51%'J**<\Z
M7Y4"HS(7*[/A2W25OL/**'EE7,#S:$>_'!NY8:*O66+8%G:=:<9S>2Q5QJ^B
M5X;.*>U*FNW:73]O-SI5/LVDT^[Z?*+<)%+LUZ&FFQZC2F"&)C[%/AHAQY$A
M"G&DDI!2%'3OT0%\&[X,U:8-P'IUMI;\6P[$LVRE5&-+5:5J4&W53@XTVF8J
MD4Z/"4^$\P \0L%> .G-@Z(.#'OPR\%WOUV'_=<;^_M?X^BJ>NP_[KC?W]K_
M !]$3UV'_=<;^_M?X^B)Z[#_ +KC?W]K_'T1/78?]UQO[^U_CZ(M1#[#@);>
M:<">Y;<2O&>V>4G&B+5T1-$31$T1-$31$T1-$31$T1-$31%0G'89^'[=M%F*
MA^WJ0JZ+2:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB+2>&4I]HI <0
M20GF)"3DIQ@_6 Y3@9 )/8'10X<?0GT7FU8.Q%N[U[G\0E=O:[MRB[2-T:A1
M:3!H]X3J-3*;3F(4-U#,6&RVM"4E;JU%6<$$= 029*3S-6+/QRTDM$LU1(5I
M.4IO,DX--9A7P1;28'-=.[N">A_=&J9R>ONCGMDX_8:H#2"SO.\R6;N?-:8X
M(=H3T%T;O9_]8M4__P";&BJN1P0;1G(3=&[I[9!W%J@Z9_W.._F-%"6Q9Y=L
MM7]Y!M/G/X3[NY_]8U3Z=<YZ,#KG48=SXU>N.:F^/[CXX4Z*G[Q_:;K_ %3[
MN]3D_P">-4N__P"GU0&DF_#GX'V51P0;3 Y%S[N@]?\ 5%J?GCI_6_;H-1AP
MX$C/W]TWP:GP/MHG[R#:;O\ A-NYT.1_GC5/_J/T_P!&KWWBF_#GX'V5J^"/
M:5)!5=&[H)( _P \:I^1\AZOCSZ].H^W4WOET8.&=@3*@G-V"T#O2!):>/KG
MXGDJ?O(]I".871NX<X('[H]2P?\ ]C&3D]OL\M5WGG-'%)/7O 5E+@JIX)-I
M%GI<^[BL =/W1:I@>7DP#D8P>N/?U'08M_Z2QW3D!Z4'<D+AC.>383Q./;51
M? ]M(OK^$V[J?YNXU4Z_86#]PQHW?AY*.U7R!+3Z4\%I_O&MI3_IIW@'_P#D
M>I_KCZ*;\.?@>_RKT\#NTJ3D7/N]]NXU3/V]8YZZC5UY'J&HF_#PY%^')%<#
MNTJSDW/N\#W.-QJF,_/^#G\V-&YY/AWU3>&#G@#RZX(G@=VE0<BY]WB<8Z[C
M5,X^(_@_?1AB)YX]0F^!B1UEHM0<$.TXZ"Y]W .O^J+4^Y\^K!_H^&C/5^I'
MDP3?AS\#[*P\$.TO,D&Z-W>;/,!^Z-4^N 1U'J^".I[]SY^6C92QDWLKO AZ
M@2?)N/L5CBA;/439GB@VPIUG7)?\RDW):%U+K--N.ZI5<ITA41 5'?,>4V@H
M<95@I*!USCIJI%, '$B7&O"GW7H-'5SEPA*D)!",*'UR ,.)5DY0H8Y1GWY
M/<CS;1^\M7'"A6YT531$T1<+7GG(]+J$AI90Y'IT]Y"@.8)6W&<6A?+_ "BA
M200.GS]SJ.'=>25(!$C6;2QY:A>9O#+PT6ANSM#1K]OJ]-V:A<M?JUR29\QJ
M^:C3VE<E=G-,LL1&4.MLQV&FT(:0,*2GV22, $[[Y3]UG\<#VT2\A-T;O].I
MQN-5!Y_&/V^ Z?#10D"JK^\;VD_UT;P=L?\ A'J?WX]7[_9J-TRS[JIOC(ZR
MID[9\U<C@<VF1DBZ=WSG!]K<>I],=L?P<$?+\VC!W[^]$WH<_ ^TU5S@BVDP
M NZ-W1WQC<6I_#W1S\!U_IT  ]=>]&H%=X&CEO#JC?!#M+UY+HW=^/\ GBU/
M]<?R_P NA -9MY\F0Q;M2S\9]%J_O(MIC@FY=VSCJ,[BU3I]S(T;4GC/O[!0
M1/1RV4O-O#V5G[Q_:88Q<V[HQ_\ B-4_UL'1@>C<E3$!(EL<>JTG.!_:12T<
MUS[OE1S@)W&J7D.Y_@_0#X=!\AT'*=*X=^'5!$"Y$VK^*].2J."#:5LY%S[O
M*/N.XU2.#]D?I]G0$=,>==IT9:,>\PE+*HY.KD<$NTBBH)N?=TG^5_GC5/[O
MR'7Y]^_7.D5I\VI'TRD .N? Y462-R9<;WC[8T;$*B^"':08Y[HW='? _=%J
M?EC/:.?( ?\ ;IV^*"(&DV[\?15;X(=I.I1=&[QZ^>XM3Z'&.QCC]N^H0_>4
MT,0%2W>G917 [M*H@FZ-W^F>VX]4ZY.>H$?]'EHPG(3JIO@M-\. U?":JG@>
MVE1U3<^[V<YZ[C5,_#'5C&/GG1@>K]LF\,_ \\$7P/;3+(*KHW>Z#'3<:I@=
M\Y.(_?R^7WZ,,)=OB^,^*;X.)/7O\(C@>VE3U%S[O>1P=QJGW'SCY_;W:-)G
M(U$CV4WQGY\O!6KX(-I3R W/NZ"DK4DC<:I#F*@D%*B8^.H2  <#OUR=5'!9
MC(&=7TR+=1XKK_#_ &)#VOW^WILBAUZ[:M;[5#M"I1:?<]<D5WU-^7%6XZ83
M\D)+"5*5E:!U41U/0Z2[[[=5R!-F<GA3G,>,@IRMD=4\P4KJ3[/+T]Q\CCMG
M1!C[O^. 6KHJFB)HB:(FB)HB:(FB)HB:(FB*A['O]@S^;ST68J'"D\IA5'0#
M1:31$T1-$31$T1-$31$T1-$3(]^B*F1C.1C&<_#OHBKHB:(FB)HB:(FB)HBB
M1PUX-[\2&/\ 9?J@./[808(/V]OUZ@QXG%^\F0J6H&!@]0#TR/V^/7_)JK,-
M*-X<^VRHJX'N'W:+2K@#L -$31$T1-$31%MY(]A*A_(5G&.X/0C/ET\]0P".
M*%RS%^(:84,6[#$=.\ACC[J&] XFU5CBDO;A[^B&FH=J4.'4XU805*<D3'&6
M'7HJ@24X;#WD,Y!UW(V>/T,%X:($@3BE"Q)!W:#3@#-=%'M'_?X[L"&A,FG$
MX&.,B*<N$Q(JN?)'0!""1U^LL<V>OO\ =Y=O+73Q0;D<64P-:8=S\.[@CWX8
M7'U,#1JX9&9XC@5O-%M-$31$T1-$31%8K\HCY+^WH.GZ]%DAR.!J'QAP43K]
MS^^PV8Z=/P+O49^;8Z?+'PT6N^BE<SG"LX\L>_M_1C[<Z)WWWZ+6T1-$31%P
M]PC_ #!K/0'_ #+G]_\ <KNH:'@:TYJ?S@#F9-.^BB]P/ 'ARL[S_AUS=QV_
MJAJ0Q]GOU10>E.2JES@#L -$31$T1" >X!^>B)@#L,:(FB)HBXRJRVX41^2Z
MH-MQXTF2\[G'(Q&96\Z0?+V4?9WU];*#?B$.),,,(SBC.Z'K(5/FOA;VALX2
M1+Z8HB<A #%PTY]8F\*O$PYQ%T>\ZP_1%4)VUKUK-KHBDG,N#3W_  HU0())
MQ)00O(Z'RR#KLK_<!=8+*1$-I"YW@9$3>>#N,%U-QVC%>HXRP.Y%N_3B)@4R
M;0D'*LO&!A;G3'4>6.A]_N^ QKH+&'=M+4$D_5)_?'#&6N'H(B\,!S'LMS@'
MN,ZY"PF .PQHB:(FB)HB:(M-W\FK[/TC19/\O\1_[E%*QACBFWJ)&/ZF+,ZC
MN?X&H_F/[>>G7#ACX]Y).6;4+_\ *_>O%2N; Y$G SC1 ^]%E+RP]5?HM)HB
M:(FB)HB:(FB)HB:(FB)HBL7V^W19B=I5[/=7IBKQV'GT[^_1:31$T1-$31$T
M1-$31$T1-$6-]V:ON#0[$KM2VLMVCW;?L6*IZWK;KM3^AX%8E-^TJ$JID%$1
MUY *67'2EH.$%Q24@G298 A]<L4EB_+#60)Z37G!0/2R;06;=5-VMXN[3N+A
M8W5F.IB,4FYUPKJM>H2,E"W:9<UHOU=E<59!<;7)CL)0T<O+20=0/C73OUS9
MU2!AXGU]V.87I_:UW6W>U&I-SVE7J9<UN5V"W4*-7:'.C5"D5.&[GD?ARXRW
M69#84%(*D+YFW$K;=2AQ"DBK-)4E+-I=],UVC154R, @Y!. 1U'YL]/>>P\]
M$3(&<],=23D#[^WY]$3(QG(Q[\C'W]M$3(]_?H,],_+/?[-$0D9 )&>I SU.
M.^!YX!ZZ*&HX^A41^&<$7IQ*9!!.\]74 >Y3]'T\!0'N)!P1WQJ#'B:M3#EQ
MHM'"E!3ACKFI<ZJB:(FB)HB:(FB)HBVT@X+6?J\Q"AG&<C ^?7KCOT]V=?./
M]]E-OK.('\2U<RRT \%H,=T-(G&=,&],67D)8;?JW&%4[ZRGUBY;_N&UG7"0
M4J8@-M-I 7C"^K6,<Q (Q@:_1[Y!##L*QLF#PV,,1%"Q#C!QYG@OSJYVD<6W
M;:T)_=;1 .<-Y@14=!0XU7KXSR@G ]M0RH^1""4IQY]OA]N,:_//NVCY=\5^
M@@-@*"F>.%#V%N-%I-$31$T1-$31%8?KI^2_L^KV]W]&1YZ+,4F.N8#\2<-%
M$Z_/XUVS&?\ 67>GP_\ %#.B0T'#\>"E<Q@HR//KD=B.PP>Q\^Q.#[M%0[G*
M3:YK5YD]>HZ'!Z^?N^>BJISI *BH!(R23T QWR3T'VXT15*DC&5)'-]7) S\
MO?\ 9HBX>XB/H&M#S^BI_3/7^M7=%EGBAJSD.QX=YJ+_  .$'AQLT@@@S;E.
M001G\(:EGJGH=%<^,N@4N=%4T1-$31$T1-$31%CO=R4N#M=N)-;6&WHMD72^
MTHG&%MT68I.#Y$J"0/B??C7+N >^W4,_]>SE_P"8>55P[^6NEX(E_1CG)Q(Y
MZ$KSXX#HB:!<MU49I'@M5BTK1NM;..4"75H7C2' ,#)6K!*NN<9R=>N^*&-W
ML8F$HC#)F?4:.'Q>:\C\,/\ J+6HEB7'+CE@^2]16B.98\^A^S UX."L4A7U
M.GG3)>[.'#U*UM;431$T1-$31$T1:;OY-7V?X0T6?Y:[H\R_HHI6.".*7>K)
MSFV+,('N_@:NFK@>(]5(Z<O6%2N;^HGKGH/\GV=OTZBL./')L!-7Z+2:(FB)
MHB:(FB)HB:(FB)HB:(J*[=\'R_H_R:+,5#WX8R?SP51V&>_GHM)HB:(FB)HB
M:(FB)HB:(FB*'?'Y=D"R.$7>RY:C-N:"S M)\-.6A/72J\],DOL1H46+56QS
MTYJ1*=:1+F)*2U&\0A220=#VW83$4QKFV>&/K)W\I[$L/;/A7M;A1OJI<.^U
MEZQ-_)M#MW=:OW!7T;A;DT"X;Y]69HLJ@U:XW*K/FP%+FJ55HL13,9D%9Y4I
M2""5<8T!P<M.5=.;+VQV&V0L+AYL=&V6VL%ZEVG3ZO6ZO ICK[C[<!VX*G)J
MTN-!#BE"- ;DR7?5HC7*S';4&VT)2D#12IQ>>/G.;X>A69) 44>RKD(/16,D
M9]P['/QU0SS#Z40NTJ\O62\G/287!NY8=(L.L[/;YW=8.X^Y=T4/:7;&P:(R
MW(IU;N^MS>>57*BV<$P:52\N35G"62J.2H<V3.O;#I^4#D3U!HW-\2)@>K!1
M$N[>WBVM^D;O;L/;W3'4<*-V618-9M)N,W]%;CI]7CN774ZQ%R%-2ZBL/ML
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M(FB)HB:(FB+@[D>3'H59?40 S2*J[E1  \.!(5Y_+KH02(H0'BB&[##C$20
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M/?$4/S+O=K,!XX[W=P &,1 M 8C"#5@'-6&3SUN(CDB;L\.=3QU1<U4ADGL
MY"0D9)P ,DX]Y'3MC7(V(QV;MF Q#Z[,EL_I>0S!:DZ+A[<$7^I;'BW2T$9W
MJL/K !)8MC^)J8$/ 0M(.<*)^623CMW^W]>O)V $-E##0@Q/"S1#ZL0^LBP<
M+UT9)M#$7G##/O&6$JK>:^JB:(FB)HB:(FB+3=_)J^S_  AHLG^7^/O[**5C
MY_?2;U9_UL6;CY>J*QJX'B/7[K)_:*ONCSA?OBI7H^HG^:-1:A_D_P#<:\E=
MHM)HB:(FB)HB:(FB)HB:(FB)HBHKM^W7X8R,_+19BIPGPP>AH[^JJ.PT6DT1
M-$31$T1-$31$T1-$31%';BNOF5MKP_[F7O"NZBV%*MVVIE19O&X83E2I-"<:
MY B3(IS(4_.4XM2668K*%NO.K2E"22!HH9RF,7&B\1V4[T[D7CP@S>*?B+I+
M6UVY=ZT>^-O';5VPJEMO7#6*0]'FT*AUJKR&VW+;^EG2SX#<PL&6VM;:0H%2
M3.L^/86G8N)M*C!ZAVX YKZ.&U+6\HE"DI 4D XR"%*&21T*58!2.X'?560[
MD$ZCA]NWPK(!*4A.>8J&"!D].I&.V#VSY:(>Z<%\_O'MPZ7XYQ;W-O6WM]NI
MNC:.XG#NK;&R(6V4U<1RS-VZ=6'I%'EUY3;Z'6Z3^,CS'W5(]6=;"VU%77#U
M_'*B!CR^G 8N\I4($Z-R6%(FP_%G9M@;D<-%U[.5R^+YXD*W8-RIW:IZ(SMM
MV\F-'88KB;DFA:A$D41E7,E#2TJ?>944=2"6$UHSG@ W7.CG#KQ5K'"YQ&W'
M85O\#'[E%>A5/;K=G=;<.7O9,9;C6'6+6J5I2(EL/T^H%0D2*K<%54S39D5P
MAQIE84^2E"P(^0><YT_'JCN)RH .IPK6NAS#\3>7#]Q*<0EL6#3:=L+<%D3>
M%S:2C6[6HUQ1X\&%N#=-JS4.+HUKM-*)GTR<U#+L91"FU!YL*&3T3\J>/?AG
M'\<OLO3#@FMO="^]WM_N(2XMN;AV4IU^;=;6;:6W1;G@M,5I57LAFN/U:N-P
M6U!**<V_56HT8.!)<0TWA6 0&+Z=ZXJQ&0#B1D:N\VRGW-9^X/*17:)7>(F!
M<=R.735$;P5=;M4<AIADI7#AE#7AI6L'D&!G/EWT% ^2BF_JHFB)HB:(FB)H
MB:(L$<3;_JVPNZ;H/*1:%4;!Z=W4);Q]O-CSUW/PX'^(MB#._0 \-R-<':1:
MX7L_^$?_ %0GR4?[IAYX*Z$Q@_B+6MV1VZ@MJ0L\WN'4GOT&NPV2#_M<)C_M
M&\]-^(^##W!756PW?A^$_P#@01>+]X\%+7;!U+]E6Q(!!+M IA/7/5,5E/YR
M#U\_CW/GKX7OM]+-_O=XEPM8@NYN,6]<KL7<&S!#?XPCG19"UQURDT1-$31$
MT1-$5BOKH^2_T#13$<#YPJ)E_A1XL-E0 "E-G7DXHCZXY6\CR^J>Q'GHA;'&
M75>2''-PU;HO<5^[.Z%+VXW+O^%N_LM;MK;-U?;RHKB1;,W9MVJLNP9=X)2Z
M$MT=HJ:DN&0CP'&$OH())P9\NVQ[\$SBF*.XR?"N-1DV*Z!.X>N)AFUKLX.Z
MSM!6ZE6MP-_*3O =](3;"K88H<EM<ZINU.J<WB-5&GRY"X;3*%94AE/* " #
M/]CY\JY9R=:W@#O-+A,/EPX<EQ5U\,?$/O%MO;?!Q$VLO.U:UM3>.\-[5#=N
MKI8CVE<U.JEM5V+;,*E5-#@=>E71,JL:*X%J_$!)\8<H)3*NQ^Q[P029I TR
M\*UFV:V]_;&\2'%%#L>\:7L+>.W3O#AM!MI:\ZVKF9C17K[N2TJBY(KU)H:$
M*2)S4=I7/$>6%-.GJD]@;WVZ$L7/^7)_+(KT8X2;3W"O:\>*+?"\+&N[::W]
MQ*#;UL6O1:XANFU]T6U1 BIU-<=HJ+23);,>,^L?C&24@]P"/09<L2T^>C><
MI^!&,B'PS6#&:=DOH9<N)'C3'?'D.%-PU$<SCO3F4>I\]'=N$M17U49B<WGH
M:-X>*F%HB:(FB)HB:(FB)HBA5Q5MF;?O#-2QDB5N]2G2,9'\&:=7S'KT R.I
MZ#(]YUZ'8[?H=KDG]MW'B>^O(^>VN3^OV0!C>(\6EN&=:!UN>*8AJO;(SN7E
M,6_T1LGM^/;;3T/Q\L9&?AD:FQ3_ $K]#_X1/AXT?3+%-MRM;D9D_,  YO4_
MGBZE["4"%  C(23GW@ ?=U\OU=?.;N[;VHU!J]>].&7H8"38V1-&,(Y<>?VH
MM_K:)HB:(FB)HB:(M-W\FK[/\(:+)K$,3"/_ '**5C_QI=Z<YP+7LT=\?^2*
MQTZ]ACKY@_<[[Z)0"@E4S9F!Q'?!2N;^HG/N_P GYM$AK%C.KU+##MJ8*_1:
M31$T1-$31$T1-$31$T1-$31%0C(Z''QT68OVGEYJNBT*#'7--$31$T1-$31$
MT1-$31$T11/XY*3M76^%+>J!O15YU V[5:$I^M5JE,M2:Q378SS+U-DT>(^4
MM3*F*BB,B+$<(1(6LM+*4*4H#K[(*C,3''N@7CA;\3=BH3N"VC\5^\UPUKAK
MN*X:#6-KT4S9RCVA+E5BB>K#;FC[PW!'J4@T"7+48;D)%&9#<U]O#ZTDITKB
M&+84U=N%'IFCB<0!WABQ!+S+3(TI#,\5]&[6>=2E*/,L84WC"4E!P" 22"4D
M9(R%8R,=M%F$N2[.,/.>LN0#S6XT6D  [ #)R<>9]_ST1-$31$T1-$]5$GAK
M.;VXD",=-X*JD@'."(,'O[B<YQ[NNF/?/I+JBEMHB:(FB)HB:(FB)HBC7Q=R
M1&X>]QE*4E*7J4U&45*"1B1-C- 9/3)*@ .N2< 9.N[^&9?$>Q8C*&"^;T41
M_;"/DVH>(R$(<B9EG)UUNUXA#LZ\NTX(89ZQPKJ%^4\1.$R7#P1ZK8M/<",#
MFRB.TX.GEC))Z=OEG7-V1:0P_%<$444,+W^WC))#!XXV/ R:LSB%PKW!N_#[
M"@NP:(N!$P>50]:+-6R#ID;7V-)\GK9IIZ>?*WRCKY]!C[\>>N@OKB^WT$$$
MWR\Q3D2(K6(@Z@B8.+OBNPV5$8MEW)Z_+Z8,W(<WS66=<9<]-$31$T1-$31%
M8K\HW\E_;T'^719,B.!P?&'!PHGW[_&OV8_X&7I_R8T6E*UD^R1D=^V#D9'G
M[^W3'D/L!05-9MES8#QS*UB >A&1[CHJF![OV';[M$31%PUQ?V K?^]4_P#Y
MJ[I145'$>:B_P.?Q<;-Z'^O;E[^?]4-2[=3^KY:"@61CQ[P]\W4N=%4T1-$3
M1$T1,CWZA(%2BLYDDA/?SSCI\NH[GX==59+N,JGDYG@U.:AMQ N"5OSPO4OH
MH"\JC4U)!]H)APBH+..R0<]>WO\ CZ/90$&R-MVI+?T[*!VEO1$B$.9 EZ8L
MO.[4._MC8UF)_P!2VB,.+0@$Q;IFP 8EI3*W'%OA-"VZJH.#3MQ*'[0/LI\6
M4AOJ1T!P?,]P//6=@0B..]V4XHS8'Z0 8FW8B[-A(\&.2UM\B&"ZVN\T(M0!
M$[0NX F,7HY9QF%+.G*#C27!CVFF3D8(/.VE><CWY!^6#KS9E>+>1 WB!D=T
MM+AX+T%G_P!38N07@$1; Q $^/@U1,\CK:TFB)HB:(FB)HBTW>J"!U)Q@>9Z
MC19_EQ$NI=CYCV44K'/^BDWJ';^IBS.G;($,X)'G\]7 \1Z_92(/+2O,:9!2
MN;^HGY#45'\O\O0*_1:31$T1-$31$T1-$31$T1-$31%17;Y=?L\_V(/RT68J
M85QZ>OW!8JH[#Y:+2:(FB)HB:(FB)HB:(FB)HB\^?2/[J</UI</=Q[<;[5BK
MH8W@@R[4M2VK2@2*O>]?KJ?"D0W+:ID1#C[C].EMQWE2%I3&;44H=6 O1!63
M_?1>-?"75*]O?N[LILQQ+<0FZ\&WMO*M N#:K9K<S;^3:,G<)VUDF1;IGW X
MA$"=+I3<9AXPDN*DN>$%)1J9>3]:G#3@*L:7:8KI-WTF=2=<G7U&Q'T2</!*
MT\Z$K0'$E)Y%YP0%=1GMRGJ,$8U5D O4--LYL9CUXK>Z*IHB:(FB)HBH>X^?
MZCHIEQ]#W-1'X9QB].)3WG>>KG[/H^GC[1D'KHJI<Z(FB)HB:(FB)HB:(HF\
M;3H1P\7>VH@"7.MN(<]L/W!3DG\PUW.P0#M*Q>@AC/\ _EO%V\%T^W21LVV;
M$P##-\=0/2:Y[=*&1P\7+'2DD,V#G 'DQ! ';'<#/[=?G=&'Q(#416Q+O)R3
M(S[,\EF]$Q?#H=ANV !G-MUWQQ\.)"[/PZ/>L;+[=/=#S6Q"&<Y^IS)_/C\V
MOCM@-M:^<898B0KJN1L<_P#1EU!>4)X&>'"G-9MUP%V2:(FB)HB:(FB*P_71
M\EY_-^O10EB":,1U;V43K]'^BPV8/_W+O08Q_P";'G^K152N9[$>[&,X\QG_
M ">X?;HC5U6MHB:(FB+AKB_L!6_]ZI__ #5W19/[H?\ S>2B_P #G\7&S.I.
M9MRGKY?U0U+IHKB94+> _"ESHJFB)HB:(FB+2=.,8\^;K[NF?U:^<0F#P&M2
M^LI=46W'U^^1D_>1C'ZOLU]$[X*&.[Z_'XK>'&(GJ&(UTRR!UP$Q" M7N2",
M%7E\\Y]#<_\ [N;;>GS;C,Z6N'/#.N"\Q>Q_]HMC%S*[W[7^ PU>N"Y;B[!&
MU]&D8)$:_+7=/?"0JH)&21V'3OT\QJ_"_P!.U[V,?TMJQEA8C Y]15ECXG#[
M(N[U-ZL0?_K??52MH2@JF05Y!+D&$LX^,5KS]V,8\^ORUT%H28XWPM+05E*,
MT[GX+TEC*&$?^'9OQ$$([^ZYC6%]DT1-$31$T1-$5"0.I( !ZD_:/TD:+)=Q
MH[\Z>(43[)_C3[T_\%;+';IGU-73/OQ]_P!FG=./LJX&(ZJ5S?U$_+12'^7'
MT'7G/.;J_1:31$T1-$31$T1-$31$T1-$31%8OM]OW:+,1 $WKAW,9A7Z+0H/
M2G)-$31$T1-$31$T1-$31$T1>,?'C5YFP?%SPX<85[;<W5N+L=8UD77M_=;]
MG4)=U53:ROUFI1*E#O)^@!"G'HBV J,NI0N24SR+05<H2'!ZL_- 7#--YG .
M!+74B=,Y8NW,XI=O_2+;G<.NW?"Q9=_7)4["W7H&XEV[V5^Q:E:=&VPMR@N"
M748\6JU1IJ5*J5>;;52':4RVEMUE]9RMQ* )73/N=>>-,!(A=R[TP +X2$^<
ML9+WG2%*65K24D*6E/M#'*E6$JP.IYQE77. <$:J@+X5F^8Z5T6HI24XYE!.
M2 ,G&2>P^W154\5LJ4GG3S(&5#/U1VZ^[11Z:JI6A(!4M(![$D '[3T_IT55
MI=;2"2M( 3S$YZ<N0,Y'3 )&?=G11QWP?R52ZV,Y6D8]Y ^[/?[,Z*H'$$I
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MEWJU 4*C.I5TT@+D0I,6*%<_J<YP(C 97X.5>_15@XB):<(RS&%2W.>84A^
MR1'F<,=@3HA*HTYRX9;2E!:%E#MP5%2>9MSVVU=3S(."GH-.Y],?-27?+[>"
MF+HB:(FB)HB:(M)?UT8[X7Y?[7I^OIKY1?\ 609,?.%_17^$? >N*VX4 A(
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MB)HB:(FB)HB:(H?<>VX%'VRX1]\+SK5E4K<2!1;1=\:T*_SBWJFY-DQH4<7
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MB  $1!^DFL.8H*K*7$7",W9:_4);6H_0LA9"4E7*(ZT.<Q&20!@GM@#L?+7
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M13:-2(R5%*I$VH29"6V&&^=9"%JY0D*(*%RX\Q^7F,A(AC)8QK_%KP]VKN=
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MUM2SB/\ W5C$Q>0BF93&8K3D\RT%(0D9 P,8)&<CN,?#_+KS^\"6>;^/DO4
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M.M**(Y:=8;0VI(U-9^/E5#.1+X.92\^KXKZF6\<ZN7'*!RC \@<#K\P<9ZD
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M*"I.?IVQX+6T531$T1<-<7]@*W_O5/\ ^:NZ+)_=#S\E&#@=_BXV9_NRY/\
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MF4D.GQ(SM=>"W:L\EQ.0I;;KI0,=4D8)Z9UW5J?TVS3#%^^WWK0C]I 9V(&
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M6IVY;LE3;TK\QX8=<EU@JG\BE*ZE+27 V,], 8 U]=NV]E# 1\P"&RLC#4
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M/FW1=O=X19W>SLP-W<#;K,&8,>QG-<MJ+ZKBZS!BU2FS:7-92_$J,25"DLK
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M;A[V2KAMRG;BV!;UA4,3[B17515W)6Z^S$@)=MBI6B@RY45Y00$+BEL<JB%
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M3NPM&NZAV+4MU+1C71<<>%*H\+Z3C*]:9J00:<#(0I3#:YP<1ZHVXM*G^8!
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MSKD65WCMW$ $6!^H AWXR\:-5<>VMX;(_42!.;.*#3MU@3]_APN E2MT:4"
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M(0PI,M7+C<]4$1D>)(6AM ^L5E* D $Y42<)'OR>GO!UQ;>^6-U&]>+6&SA
MF8L-9#SPS7VAL;2U806<5H29"$.>BQ==6\.WE$!:FUQB3+:4HBFTO^'3W%@'
MV?#8YN3)'UE*0">F3G7 /Q-LJ$1_IKW9WFVA'U65F^]"")$[T+,2PK7 LN:-
M@[2MA9Q6UVM+"PBB&[:1@"$D.X !WG +T$J3=8TF[I7[>S7T=MS9-4I_K "4
M5^Y6#%BQ4$X#[;045NE.0L(6.N.NO,WS:^V=HVQL;O<;:"QBEOG=:$$D.&;
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MYR3TUYF]?"1O)A-WM3=XQ$8HHH=X;P-'$)U?US[NR^)K2P AMX+.\0@M"+8
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M2.AP$C^:E"<<J1V QCMUU[RPL!=[(0 ONAAA.G;28.%Y:*,VD;F=)G'-ZR
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M<UW65(>E6Y+K=?FE<F7#I[LF04P\(:4'U\P*N52:)=UECW1.\2*@T<R<. 7
M<RJLI[U\'.R^_5X4R_;YHM33=%+M&OV(NKT"JOT655K4N'E,^BULQ4CZ6@M+
M1ST]N65B(I;A;QSXU&]>,\E'(PP8LXRG5IY'E(3Z6KT?/#<J[Z3?";3J/X2T
M?9VJ;$PYZZU-Y&=O*S3GJ9.B^K\Y;-5,.0^TU4BDO-^(H)Y>F-2QY4K[5=E
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M^H$W;"@/75=XMGA*G/[@;T7?<-\WK;J+YOZ;7Z1!M^N/1(7T8N+&;;=\!M2
MATJ0I*ACIA/?4GGGKC)_+,B;@TT2^5!-\@W2A60APL4?) W8W1*DI"BG\(Y/
M-C!*?9\7.5 $@?RL=M#CPZ*//\^+4\%5GA5I+Q*F]UMTST2HI-Q2@!S#(Z>)
MTZ=Q\=&,IT&4S+B16=/5'?OPG/N:U_WI]-_V5-TO_B.3^IW51#PH4TIQ^ZIN
MB#[Q<<G/_*]_CJ,<^H_$O',E$'"A31G_ #T]T3\[DD]/_P!W1CF^<O:GBB'A
M1IWENEN@?_>.2/\ ZVC>;G5';\$^2H.%&G'_ %4MT4]O],<GS^;O[?#1M3X#
MR 4!T[RKWF9%:3O"K2F0D*W5W3"G5<C:A<4I10X1D+ \7^1C)SE.,Y&C$FLJ
M@,)-WD])JNV#/*3S>4Y_;/!8Y'"C<:-S4NN;O[CC;]RV6F&6A<;WK;UQ!]1>
M>5A>?"+!23@X!SV'<SC C#G0L>^K*&( U(ER.<V\-6F5DA'"E2UI0$;J[I<J
M,C_ODD]?G^-SW['M]NC$&>3:U-</"KTHJ#WY=5?^].IO^RKNE_\ $DK_ *W5
MY_;OO)$_>H4Y/;=/=%7SN23_ -;YZC%W<\)-WEB,RH2V!Y E5_>HTX]]TMT1
M_P"\<D__ %3^C5Y\I>S^*H+_ '!'FJ'A2IP[;H[HJ_\ >.3G_E=9$+4)9W:7
ML_BCM^"?):;G"K2TD>)NINBV/(_A))P3VY2?%QD^0^.J7P+<G4<3.6<I<*SI
MR*M/"K2>_P"ZONG_ #1<<HGOC&/$/Z<_FTGGU$_,>2.)S&?*O355/"G2<E)W
M6W2(21SI_"25U)! &?%\L]<:3:LVJWBW?-5=7MWAAJ%G;^6%N92[NNFXJ+0[
M;N"C5./<M7<F^"]4$!$=R,AQ2B%<P'B8Z'J<],ZJCBCS[.'XXT3C:V<NS>?;
MS;ZE;>TNFU.Y:!OEM;>4UZ86D*C6_;%PB?6E-2""H*:9Y5)82H>(>GEC5^WV
M[ZH"&S U)8NYU/J_!>:.^'!5Q%W5>>]VR-N[?PZQL[Q [X6YO!(W.-:]51:\
M-ADFK4R7$_+*F-O*4&4C(4D I.,9G?;+>]3B2=79P9:>*ZI7> WB=W0LJWN$
M2OV+3;:VNVFN'<RZ;=W?772XBZE5NVZW3;4IQ@IRX@N3:NW]*!0(2RPHJR,@
MED&A'CQR(DMI=_![QA<0D:V[KO?:VB;>W'P_[:6%9MA41ZM-RD;C5NS9BWI[
MJ^0%$:FSFB/4EK  4?J@C.E<,)^2/UY"<S)FIZ9+T-X-]K-\7+TW_P![MZK&
M@[:U[=&FT*V;?LEJ?Z]+C0;>IB8[L^>\@%I"9<L#U;!4HM'/EC3P5)$L\7YG
MQG3";N[=DV-X-)MJ[<4VD73N'N%2JLU4:],?IU*N"0W3XB:A5I4MMIAM"D )
M2VZD@ 9]KY:A#MS>7)JN'T_,66V^%FCN%Q*-U=T%*:P%@7%*Z9&1_P"-ZY^!
M[ZC&@) ;3P-1VRC@5("-\*U)?YO#W5W1/(I2%8N.4,*2<%)_&]_=\.NJ TE5
MJ_O3Z;_LJ;I?_$<G_K=&+?N+YL._%5QD/'W0\)U-)!_=5W2Z#&!<DG![]2/%
M[]>_P&A!P+<ON/%^DE$_>H4Y/;=/=%6>O6Y)/3X#\;H.O?GP9">P"?=4_>H4
MY1.=TMTDX]UQR<'/_M?+1C@? =]U0$9=01[*X<*%-'^JINB?G<<G_K="'J99
M=)=M5%;^]4I#3[+CFZ6Z"L*"B@W)*"'$I(44K_&]$].I\A\^IGKH1H1WYX(L
M<;9\)UR-4:KB_-VMRWJBY<M:D4M;%R2/9H+LI1IK2L+3S*0UW./OZ:3S\.]<
MT?.>&.@ EQ'X61QPH4TG(W5W2.,?Z8Y6/^5^_0OFW>J>/=54\)U-)_\ "KND
M.F.ER2?O_*]])O67#URY/JBJ.%"FC_54W1/SN.4?_JZ-G-BX[#(J_O4:;_LI
M[H?_ !'*_P"MT:N#]XN$5#PHTX8QNEN@<_\ WCE#_P"KHVI/3T 4)T/*;>O@
M58>%2F!02K=+=!).<?U1R2#@9)SXO0?$_'W:$ MI0Y(XUEF"']=,_!6JX5Z4
MD*)W4W0PDX4?PCDX&.G?QO?Y:-J?#V1YMCWWX58$GA7I2RCEW3W0.,E!_"*3
M["U <CA!=R?<D'H3UTW6ZDYU&#?=4%P\Q)LC(X^C-@5L]D=A:CM+NYNC=2KB
MK=QV_=],MR-3Y5>J*JC+$JF,K;E("UE1:2%JZ)YLJ  (Z'59J]\6H=%FH,FX
MT.LL&QFQG-E+QM]HE+84.<@  XYE8!R<9SA/8GW]/@"KM(\FR X=NRUTJ2H9
M201UZ@Y'3H=%571$T1-$5",XZD8_/^W](\]%"'Q([G]LB$P>O4]<?9COCY_F
MT1CF:Y#D,^,Y\TP<@Y[#M[S[S_1HHQ_N/A7E(\""J<I_MC\/UY]_P]VB&$O*
M(@&H]C@J@$'ZQ/O!_-\OC[]%6.9UQZ.[,J $9]H_#X?M^;K\]% ""^\3H>\O
M&>BJ0<]%8^& =$8X1>'/O!I)C QGR[G].B"0F29U],571:31$T1-$31$T1-$
M31$T1-$31$T1-$31$T1-$5"0.Y SG \S@9.!W.!UZ:(9+%&Y^]FU&S\>C/[F
MWU;UE_A#+-.M\5^:89JM15RI;A0\)5XC[CBVT)22D96!GKHD\/'+W[Q7B4WQ
MW<0%D;L;FW3O)5MSK.VW9K.XU(V9M*J[36A'VQOR;0;:J$ZV(,[<1+YNN$JL
M2&H\N!(:8=:F\ACJ<:\4D1P7 KW5VIB*TS0 ?RF1)P2)8D"<)?5O(+KER<:W
M&+LI1=NIU[[@VKN-+XF=GJ!?-CI5:U#H3&TUXW!5&(;<!I-.C(5<= @175+2
M_5 7'I"4A8&5 WOOU3= F'$R*DG!Y$XDN!@2R[#4N*CC"M3>F)P<S]U[=J^X
MNX%P[5KH.]ILNBPY-LVY>\*H3;CA(MAECZ%J,ZFHA%NC2)C2T.>(2[RD\R'%
MGT['DA  !F:XS#,7F3DS B1GBO1[@5WKW$W/HF[]C;M52)<VX6PV\%Y;2UJ\
MX%-AT:)=S5M3RS!K@I, )B0GY<5;:I#3"$MAT*Y!C&F)&54E44(=JMSJ2S5^
MYGCHB:(FB)HB:(MG-+3;?CN)6H,)=<RV5!P)2TI:PC'F4(/<C) 2#[6GIGW[
MK,3.!5WPPQ.G7D5X867Q>\1-4N2R-]JK>L.1L_N#Q(U;8^#L\;-I,>11J$W5
M)=+@5E5R--_2PGI<A*<?0ZHMK2X.IS@'\=#V.:K,>$GG/"4V8L")GJO=".D!
MQ[MD<@&%?R?:*<M#HW@$)_VV"<]QJ]>_?MT ; -@<6R[.K+=ZBJ:(FB)HBZK
M>EQTRS[;JET5A$URFT.,Y/F)IT)RI3RRR,K$2"TE3DA['5*$ JZ= >VBA>0!
MY,_-M&J9+QE5Z4NL;W[!\1%>X>=M-P6=VMM:S+H=ITO\$%SI%3CHGBG)K#$>
MK-II\BHM<R7U4B0DE(20I) .I]I]].:K5+38UDY ,GP,^5)R"Q?9W&=Q 7.N
MR>'&F[R7;2N(F]MV8]JWS4=U]I+)MFX]JK78M%=P^M4.@4-4JW[F:N:0A]JF
M3YCGCQ6(R_88=7E0>-3W3S,A/,U)8&3DX5,G+URG,EEIV7Q?\6F]MUU_86VM
MT:185X;*4?<FK7QN<W8]$K$N^UV1.?AT>(S0:@S]&P&:EX075E0DI6R2?!/E
MH2PQE,J,!@\F$R&&-*Z/C.2X&V>/#BDWMV]W&WPL:\:!8-M<,]A;>UZ\+'1:
M5+JXW3NBKUXPKHD*J,ML3+?IKE'8EKI\."I(1.=R"4)2M%Y?;OIX*M-YNWA7
MVP7T%657TW/;%OW &C'-;H=,JO@$GV#.B-2"D)42H!!648)..4C.,:* ,3R$
MW?O%QB2\UVI:TH25*.!U[ DG )P .YP#HA('.G?/V4'>*3BKMRR+1W:LG:&Y
MZ3=/$U:EGJJMO[7TD-U.[42)+[+;,T45]L-2FVV5N/!M2U!7("I/+G1_'OOD
MC!W/"K,^(%9F3R>CNO+RS>-/B6D1+$V#J^Y%XT7B:W9W)L&TW7MV=J++M5.V
MUN727G)=S6S3J$95/NUA"F%P(S=50E]+ZP5-\Z20)?\  &>7?1:$,CGA]3TZ
MB4W8DTY\Y0>*SC'O3<V5P?Q=TK;H.Y>WMR;O?A3OA'M*@5!RYJ'8CI5:T==H
MRF4TBF5&HI06ZR64 L-+#C04M&%N^^YH "-[*8KBU"YPSI(5,NKP^-?C*W=M
M7<BZ++OVT-O)/#EMK^%%TP&[9HU;B;I793*PF+-9E29[1-OT:;!"UMBFHYD2
M1R8"5<R9.7CW]NE%&$Y#*9+L:XS=@"Y<9KWDV:O1>Y.UNW.XC\)--EWS8EJW
M3-I[;@<9AS*U1XLZ7'84 0XTS(>=;;>YN9QI+:E)"CJJ-/+.C'[].:R?HJFB
M)HB:(FB*)7'%O/7.'KABW4WAM=AF1<UH4-A5!$IM3L-FK5:HQ*- ESVAT?AP
MY$],IZ.X"T^&?#<24JP69R4:89^ 9B=>,ABV 49>#[>[?0[]W9P^;V7W#W5=
M.T^WN[UNWG&M:D6F]3S>5';J%6MEVG45I$1Z!3)2RQ3);V)<B. Z\AM2O#3'
M))IK3R%'ST,L53"P#2(XT<C%]9-*4JKU%C*YN8^TGJH<BL^1'M YP1Y?T:J@
M=IZY9RI+BMUHJFB)HB:(HB<9W%;:7"!M#6-TKHHUPUY<:%,-)I=#I$RJ-3)4
M4QU+8J;L1)%-BJ1)24RW#A2DE &1@E#JS-Y:Z>%77F]O_P =N]VX=M\/]V\-
M%#WCMVQ[PM^JW/NI6K6VDMR[JS2(4&*VZ(+-,O5UJ,AE&''43&76E2&4E2"5
M #4>D_!LGD0_L^;%5@',]"21(!P]!1V&+/B7Z._QO;];JTS<_<+8S>>(-M^&
MC:2P+RFHK>W]N_2N\=R56LPV+F@W07&^>SGJ7!?F0%0J"MQM-1C-)0IQ+WK#
M=![Y:COC1N@UXU(HYDQTQSH9+J,WTAO$FW:;7%BU<T!O:5K>9_;AS9!RT*6V
MG\'Q"_%U=RXUH-<=JOKBO$4TE:6E)'LJ]HH$IG-@V ]M56<8 ;I+XF;,3+&G
M%2#X=N*WB(G[L\,U;W-OJFW7MYQ<U?<VDT.R8MI4VAN;=IMB+/GVVY%K$1I$
M^>I]N%X4],_G4I2LA8"N9#QS[T";OD*OE*LS,82=RO;2(H*2X,J.'%_60$=0
M2%82,CEYLX/<C!Z:JR,F9NQ/'MUN]%4T1-$31$T1-$31$T1-$31%:K&.N>_?
MW?/X:+,5!FX;CKQHKM%I-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1::TE7
M+@=03[6<%&005#X]>FB+&.X6T>W>Z:*4WN%8]OWF*!*5-HYN&GLS?HZ9D<LR
M%XJ3X,A!2E27$X4%)2H'H-%)X>/"39SU&*@.CT:U&JVY*JGN%NQ?FX6R$*L5
MZZK7V*KTU;UNT"[:]39]->GLRSB2J% CSW7:7&+Q3'DM1R$@(T[]UK+,8Z2E
MP&5)KJUL^BFLYJ%==.W%W2O?<B(BQT[:;/&LN\LC:.SHTWZ1I,2@N(""Y*IT
MI+13)<YUE#83SD$C3MN^YH]-//MNBJ?1:TR9:%7DUO>B_:MOZ]7+6K5L;[N.
MI1<=JNV(VZBU8D-H)#!AQ6'G&9+:FB) 6>;F(&IWGP,\?5"0"\V!=L9U9NDA
M13;X7N'.B\-MCS;8AU>HW9<]R5VIWAN#?=:/-6+SO.NO>M5>MS%#V4JD/*PA
MM(2E"$@!(U?/%9Q+4DPRK+R4E]%4R/>-$3(]^B)HB:*$@56REE92@MA2@E67
M$I&2I!Z%'*< A6<*]PSC'?1":3S;!Y&NB\WK<]'9;5 WI&X35_W9)VWIE]3]
MSK?V9>= MJE7Y47B]*J[2B.=3(=6\XPR5E*"OZH.@$YF1X%M:/R^R.&+3/;<
MM:+T@C-NA^0ZZE(\3EP0D E(^H">A)1[0/S'7H-%!*3 4)R)TZ?:;K?:+2:(
MFB)HBV\EL.(P4A8((*"D*"LXP"E0*2G^V!!R,]#IEWU[^\+X-6;Y>ZB5?G"%
MMU=6UU];:6PBI;:F^*VY=4JX[1E.0JQ$NE4CUI%68D-J2O D86Y'SX2T@I*"
M.FAI(\_S+NJ F9(X82SS?CB)XJ(G_<M(U0H%Q7/7]Z[WJG%!4[WHM[0.(AQ:
M45ZERK>ILNB4>F0H*4IC"E1:54)C+K)8_'.O!U0):21,&Q:OY]2J#]3LPH6Q
MQ:E,Z F39;FL>BRH[5K6DU8&\M]6'N;!9KT&^MT*<X%UR_J9=KBGKIAU5*TJ
M:2*B\M;C:DH26>;"2D 9IZ?GVD@J7I@,M3GX>86[N;T5MAOSZ' L&_KKV\VZ
MGVK9UG[Q6#0W\4_=ND6'.:JU#<K#IRIF<_4&BN>\TII3[;SC:E*"B":?;<<^
MZ.J]939@TL*4G@'K@]5ZF4:G,TF'&ID6.F/"IT6/#A-I[-1H[26VF4YZ^PA*
M02>YSHLAZFI[KC-SS7).IYL HYDD%*L'!'-@9'V9ZC.-$.''$/@?7AQ48-X^
M$K:;=N)>E0=MZ):VX5Y4EFDR=T;9:33[YB(AN!Z XS6VN6241W4)*F5+Y7$%
M2% CN3'E[^(=]=<(9_\ <N8U=MVOU/<;>V^KVWX>E6U(L7>Z8X&J_8*+,E>O
M6U'I+3:4-);8ECQ)BE(4N0%K!Y@HZ9C-5S+0B1#.V<M?0E;65Z*>CQ+)M@VK
MO)>UM[\0[ANZY;NWVB.<]QWA,W <"KQBU-M84T(<]'.U&:#83&0L\@2HYU"[
M-BU:<U7+EQ)S)\V.6=:46K>GHG-OZC$H%&L#<2\=O+>GVG#L+>"E4F0M3>Z]
MKM34U*4U6'%E2F)TR8"IV8T6U\B@DK]D 7SS67,^&L^G,8F=,_4RS;6I=E6[
M1;5H,3Z/H%M46CV[0:>%%:8-'HE.C4RGQ4K42M7A1HK2%*42I:@5J)4HG1*D
MFFC,V,NIF*RRGVK15-$31$T1-$<9K#^^VSMI[_;67MM!?$=^1:E^4&70ZOZJ
M^IB3&\3D=ASXRT*2I,F#-:CRV#G!<92#D$C26.B:C$9X:83=1SX3.#%/#C5[
MHO2Z=QKCW=W%N2ET&TT7;<@0B33+'M&((%LV[&9:2AM*8,,!IY_D"WU %:U8
M!!#$] :."22'/EGG,Z*="!@DA)2",X/;)[_:<#/W]<]"@'>(TX##[3U-%4T1
M-$31%U&];,MR_P"WJI:=VTB/7+=KD-5/JM-E-I<9E175I6MM84,I * 24D*Z
M@9\M%"^E.>HX&3^640^(?@ZJ&ZK5FO;4[L7AL/5+2HK]J*<LUT(I]5M"8VF/
M+H\N"4J86OU;G:8D<GBH"OKC&=.^W5!D7$BX;R)SS4;ZGZ)FP(WX-4?;C<6\
M]N;"D6Q0[/WELZE/!<7=^DT*NM7*B167'.9;%1GU9L*F2&5-%Q@):)(!3IWK
MI/JJ^$Z2YUTH#ZNZYYST75D2-T9%;7?=S#9&1<SE].;#J4%6PB]G(GJKE58=
MQXJ&.H=;C!P-I6D$(&!HCG=8]1X2RS&<W7<MA_1YTG9/=N!N/)W(NJ^K?LJ7
M<\O:"PJZM"Z3MR[>H?:N!Z HCF<<\"0XW$*E*\%..7!&BA-)9T<BKMGCSRJ_
MI#%;4VE16D)6M9*\'(4>HYA_.&"1T&>WGIWWP[P4 8<R]9X//.JW.BJ:(FB)
MHB:(FB)HB:(FB)HBM5V[$]>P^1[_  ]^BS%3S=O4CEJV"N'8>731:[[HFB)H
MB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(L;;M;N;=[&V)7-S
M-U+F@6A8]N,(D5BO5'QE1XB'74,-#PHS+\AU;CKB&T(::6HJ4!CKIWZ*%I.'
M=^4G,S20XY+!.SW'CPH[\W<;!VSW>H%:O=4!54BVM,CU6AUBHTQ/*I4VEL5N
MGP$U)D)6ESEAN/.AL^(6PCVM%!",!2IKHQF_IS64-N>(_8_=EB^I.W6X]LW4
MC;*IS:-?R*7,+DBU:E3T..2XM7CK;;?CJ:0TXKG"%-J"3RK/3144D,3R.-'
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MJ:25F0L>"0K)UB)F#F<Y$#^WWGC,<%J;U:$@!^)+O3@0P!ZO _APW XD-O\
M8W:JR*5N*]MK/7PA7?<5H2KP0EE%*I\F]ZNU;3KTZ1%7*IZ'*(J*S3U*4$L-
MJ:7RCE!U\@XQF'F#KA^>JTTAB["4R)!R6<G68+Z$A=3JM\5Z\.%7C/V!W&W
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MRJA-8HCU2:J%-:N2I5-AIT-JFSJI/=<0^D)4EH^%T2G4GWWV?#3!FD"2[OD
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MOT=.VFX^YJ-Q[FN*XENHV"K7#\]28Q0VQ)MVM4A-(<JZ) =YVJBPTD/-I#9
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g105868g54l66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g54l66.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2184&AO=&]S:&]P(#,N,  X0DE-! 0
M    )#R^DG8X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%=[WP         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              M    3D
M 0                         !              $Y    M
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    M     !29VAT
M;&]N9P   3D    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M C_P        .$))3001       ! 0 X0DE-!!0       0    #.$))300,
M     !H)     0   *    !<   !X   K(   !GM !@  ?_8_^(,6$E#0U]0
M4D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M86-S<$U31E0     245#('-21T(               $  /;6  $     TRU(
M4" @
M       18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP
M=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     4
M9&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0
M   D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M!#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M    $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV
M-BTR+C$
M             %A96B        #S40 !     1;,6%E:(
M      !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:
M6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W
M=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
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M"58 4    %<?YVUE87,          0                        */
M G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M
M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H
MGP"D *D K@"R +< O #! ,8 RP#0 -4 VP#@ .4 ZP#P /8 ^P$! 0<!#0$3
M 1D!'P$E 2L!,@$X 3X!10%, 5(!60%@ 6<!;@%U 7P!@P&+ 9(!F@&A :D!
ML0&Y <$!R0'1 =D!X0'I ?(!^@(# @P"% (= B8"+P(X D$"2P)4 ET"9P)Q
M GH"A *. I@"H@*L K8"P0++ M4"X +K O4#  ,+ Q8#(0,M S@#0P-/ UH#
M9@-R WX#B@.6 Z(#K@.Z \<#TP/@ ^P#^00&!!,$( 0M!#L$2 15!&,$<01^
M!(P$F@2H!+8$Q 33!.$$\ 3^!0T%' 4K!3H%2058!6<%=P6&!98%I@6U!<4%
MU07E!?8&!@86!B<&-P9(!ED&:@9[!HP&G0:O!L &T0;C!O4'!P<9!RL'/0=/
M!V$'= >&!YD'K >_!]('Y0?X" L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)
M$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W KS
M"PL+(@LY"U$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0T-
M)@U #5H-= V.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@]Z
M#Y8/LP_/#^P0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2
M)A)%$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P
M%1(5-!56%7@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8
M&QA &&48BABO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC
M&XH;LAO:' (<*AQ2''L<HQS,'/4='AU''7 =F1W#'>P>%AY 'FH>E!Z^'ND?
M$Q\^'VD?E!^_'^H@%2!!(&P@F"#$(/ A'"%((74AH2'.(?LB)R)5(H(BKR+=
M(PHC."-F(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G
M&"=))WHGJR?<* TH/RAQ**(HU"D&*3@I:RF=*= J BHU*F@JFRK/*P(K-BMI
M*YTKT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP
M-3!L,*0PVS$2,4HQ@C&Z,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43
M-4TUAS7"-?TV-S9R-JXVZ3<D-V WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z
M=#JR.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/> ^(#Y@/J ^X#\A/V$_HC_B
M0"- 9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519I%
MWD8B1F=&JT;P1S5'>T? 2 5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB
M3"I,<DRZ30)-2DV33=Q.)4YN3K=/ $])3Y-/W5 G4'%0NU$&45!1FU'F4C%2
M?%+'4Q-37U.J4_940E2/5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:
M66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8 5@
M5V"J8/QA3V$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "X 4 # 1$
M A$! Q$!_\0 '@ !  (" P$! 0            @)!@<$!0H# @'_Q !.$
M!@(! P, ! D%"PP#   ! @,$!08 !P@)$1(3%"$5(C%!%C1156%YE*'6%R-Q
M@;<D)S)$1E=TD;'!\24I,S4Y0D=29G+1\'>FX?_$ !P! 0$  @,! 0
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M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# *S.I1^-< OCO\
M\X;J3^R#?OS^GM]N1^'AU^7D_/M^OAX@LSR@8 P!@# & , 8 P!@# & , 8
MP!@# .C;V>MNYEW7&M@A7-@8)%7>P:$HQ6EV:)NWBJYC4US/$$Q\B]CJHE+]
M8OS\AW[I8]\:HWRIMC1-\L+I5S54VO"-C2A)_)-]GY,XJ47)Q4HN2ZN*:<DO
M-K?=?<[S.DY# & , 8 P!@# & , 8 P!@# & 1:Y1\J:]Q0@JM<+IKO:MPI,
MU*/HZR6?6=,D;JWUZW:M47"$Q;H^((O*-8AZ*BJ"3ULT<)I*-U1<>F0 ,,;V
M_%+\6#M^/O+GC=RGA GM";@I.QVY"&,\8P,RU6FHM1(2E7;RT*90DG'.6QS
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M)7SLLG&2E#91AO+9M]VVDT]D^BW99%F@GJ# & , 8 P!@# & , 8 P!@# &
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M';=[RDVY3F_.<GO*3^KZ=ELNAM#/..T8 P!@# & , 8 P!@# & , 8 P!@#
M& >;+JD<CZEKKDM4]8[%YW:LTO:G%G"Z:CC=A\):KN]II*J&UI"(RQG%JL:!
MG+E6\VB+DY&-LM?0E9!HY<#5'I&+.+]<(]NGC^S_ *[=?H/M_O\ 0L,Z57(*
MS<AM,[(G[#R'+R@0J>WYVE0.VF&BXG0M:F8F(A8)04JI7(IPJ6:A$'SEV"<^
M]08O57(N6"C-(K$@FN^_Z[^9/RZ=NGK\]BT'!1@# & 5F=2C\:X!?K#=2?=W
M_P#"#?O^K^G\O;[N^/+UX/MZ[;@LSP!@# & , 8 P!@# & /L^W (L6_D')6
M"9D]><=8-GLJ]QZYF,[9G:JZ.KJ N!O!8]BL#;Q^G95L/D 5FMK+O/7**,F]
MB0*(FV3%T.NBFO.UZ^6GX<XJ=&-!1EJ6='NE11+?W%<EU_B,B*ARO>N%N^QB
MRR'.3KQHJV:>TIM[50__ %)/>33V^&'7S:\>ZUYQZC86=2V+LZ<>;7VVJGW/
M:K"0GT17!4*'J1U JY ^B*E%)CW(06:!Y9T3Z\E)O5A,<>C.URRVEX&G4QTS
M2T^F-1)NW(V[69V2W[W*M?CS-5+HH5PBDERKH49>\ME[V[_ODND?E7'M"/RZ
MMOJY-MMR-   .P   'V 'P ?U9X1D# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# *D^I-83ZPVCPZW#/ZVE[1IFH7W8!MU6:C:AC]L7V.;.:*O'T2 &.^CI"
M::U&>EWTH,V[BDA60=1T64YDTU#>0C^B?;]?V[F:]+*S;,MFF=FS%S87AM0G
M.]+^KH-]LRFLJ'?IC3SA=JY@GECK3-FP,Q41D5I1C&@[:(O#Q#5B9<!,/D(O
MIEF^ , 8 P"LSJ4?C7 +]8;J3[^W?^]!OWO_ $_'<>WWB&1^'U_#O_;[@LSR
M@8 P!@# & , 8 P#"K]L6F:PKSFT7B=9P40W,1(AUQ,HZ?.UA\&T=%L$"J/9
M.2=*"";9BQ07<K''ZJ?B!C!EX6#EZC?'&PZ9WVRW>T=E&$5UE99.34*ZXKK*
M<Y1BO%[['79;"J+G9)1BOQ;\HI=9-^"2;(TDB]N<E3JJ64)W2ND3K$%G6F3@
M6.R]D1IB=Q4L\B@?U:C7WJ9O((.-$DJX24\9"0$@F;%V!V:7P_LL9T:QJ_+\
M>1.//I^GV>,<>N6RRLB#Z.ZS>J+C_EPZ\SQX^^R=W-3QZ6ND-]KK-^_.UOR1
MVW6R^)[[M]"4E0IE6H4$QK5/@HZOPD<D5%JPC6R;=(I0^1.<2% RRIS")U%E
M3'44.(F.81$1S7,K+R<VZ>1E767W6/>4[).3?R6_1)=DELDNB1E0A"N*C"*C
M%>"27WZ>/S,GS'.0P!@# & , 8 P!@# ( \F^HSHWC+'BK/-+;99=*U'JKJ(
MC:[.1:3=RT563DW))J6B48EXFS!!0R1&#AS[WZHH*>D8%LW;AW@/6>([.7'E
MC45/&63&VR^FQRC-)UQ=55CL@Y\RW<U'E\5OT/-S-4Q\))V*<FYN#BHR6VW=
M[N.S7DT]GY]22^G]]ZZWC&$DJ(\F%P"+CY5PA*UNP09FZ$DGYH%*O+1K-H[.
M @8I_9+N #MY=_ 2F'7]4T7/T>QUYL*H_P"995&5>11<I.M[-\M5DYQ3[ISC
M'R[[HS*<BN^*E6Y-.*EM*$HM)]OYDEO]&RHKG7SLY!Z;Y=S6D==W(:A48'CH
M.VT/HG1[G<4Q-60DF[:A&ODV)R.HB*42;D*9T!R@43&$H@8N>2=Q%VY=7'=A
M0XZ25BV_0-%UG8'$J<W?=K)%ZBDMJQI;M#VYM7"1*R"*;IU5HQ1)0QY$\DLW
M1C7PG:+.2"0HX'K^GY?F?,O6 Y943:7 0N[JI1Z;J_<NK9F]<AU B"(*Q4)+
M[/C=7ZVO<6\,\>J047,K6NEV%XP%VLDFVE%DS*)D "ISQ[K;]]]G^R^H)>]*
MSJ7W'DY0]^WGEG9=9ZL1B=]P=8TPSDGL/3 =Z^V+J^F[7U]$+J2CMJ,S95:W
M<HU5?Q\WBICB!D@$.V4$*-"=6_E+;IS3UAMMOK4A"[%Y<V70<Y3G^E7U=H\-
M3F-NME=CIMEN=JLFP-8S)0<>#2.< J1_(O5&)@*HGY")YI-;_CM]B3*'5?O"
M_4E7TZ6>U:'$]/<<EQB*!GD6&P0VQ&TYC-*V<%BOAD5*RI8TIFN( 5@#(RR*
M0^Y.8Q>X>6WU^WCW_NOR,LX3<W=Z<CN0%WJEOW-'Q4=4MZ;)HK;5\7H"45CY
M.ITN14;-!7VVFP&(9R+EN '5\WQ5RJ%],2>1P 12]? & >9OJO<N^IAJW;6U
M*'1:K;=)\38FEH/:1R0U3K&4VQ<K=9E:2PE5H62.@H1*A@A<5I""^D447($C
MV2#PY?47,!7KU^)'MX[??\B??1@?4JP<+ZK=H+>=SWU?;TX8V;=]CO=H=V*>
MK^VGE;@T[)45FSPB9ZZ2'(BT(6#(F0B!CF<"'FX/@OKU]2VG & , _"JJ2":
MBRRB:**1#**JJG*FFFF0!,=110X@4A"% 3&,80*4 $1$ # *S>I&HFLOT_U4
ME"*I*]0K49TU$SE.FH0VGM^F*<ARB)3E,'82F*(@(#W 1#(_#Z_L_7U!9KE
MP!@# & , 8 P" V]N?FMM3[A@>., P=V_=UO4B6%?ADU$VE>:2<^Y]I%I3LR
M(J S()_-99(J8K FGX@ &.4<W71N"=0U/2;]?NLABZ/B*V=]KWED2KICS6.B
MGISOLD]]MVN_4\_(U&FG(AB).>1;RJ$.T=Y/9<T^R?3?9KKVWW-OZ_T&Z/9$
M=I;LFD=B[/#^=B4#HF"EZ\(H!O\ D^DPRXG(BLF0P)N9QR4T@]4 RO=+N&>7
MFZU%8\M.TBIX&G-<MLE+_F\_9[\^9:MFXM]8T1?NX+IU.ZO'?-[Z^2MN_P!/
M3X*UY5Q[)KQGMS/IY$FLUXRA@# & , 8 P!@# & , 8!A]RU]1]AQJ,/>JI
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M_7[ZH<?'8P%+9.E&-IWJ]:>O&"= XIO8;7;10"_3\L7L*:TOW3BF CW!=98
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M#D-P@6W9O2E\AJAOW9FC-BTW7<[K%%]1(FDS+>2K%AD0DI!)VUN<#.MB.!5
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JT=[DQ!$? 51+]V"KU]_H;0P!@# & , 8 P!@# & , 8 P!@# & , __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g105868g59b86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g59b86.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2584&AO=&]S:&]P(#,N,  X0DE-! 0
M    )3R^E3(X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>BZ,         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              @0   +H
M 0                         !              "Z    @0
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    @0    !29VAT
M;&]N9P   +H    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M C_P        .$))3001       ! 0 X0DE-!!0       0    #.$))300,
M     !L)     0   *    !O   !X   T"   !KM !@  ?_8_^(,6$E#0U]0
M4D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M86-S<$U31E0     245#('-21T(               $  /;6  $     TRU(
M4" @
M       18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP
M=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     4
M9&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0
M   D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M!#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M    $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV
M-BTR+C$
M             %A96B        #S40 !     1;,6%E:(
M      !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:
M6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W
M=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
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M"58 4    %<?YVUE87,          0                        */
M G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M
M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H
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M=P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M @(# 0             '" 8) @0! P4*_\0 .A    8" 0,"!0($! 4%
M 0(#! 4&  <1"!(A$Q0)%2(Q0191(V&1\#)"<8$7)5*AT3,T5V;A_\0 ' $!
M 0 # 0$! 0            $"!08'! ,(_\0 .!$  0,# @0$! 4#!0 #
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M/X]DQK11N*H)%"NUP?#7-)VWHJ>J3D>WG["!1Y /' \#^0[@, #_ "SL2/\
M/7V(7\T@G((@X,<P")$\N^)'=>[(JO'/GC^7/_?C^_\ \PI(!CM/Z_MY+SA5
M,(F$3")A$PB81,(F$3")A$PB81,(M)&_M=7NRW[J<F;-I;J9M]^-,OV_37==
M;R:S&FU.$8ZWK*50<QC-K)-8]P\'886"0G36!E(@N*OI"F1F5,@OYY^4>6W+
MJIGGT&>^9CSQRZ0MO^LS60^O*.>Y-A96U2J5]2SM![>6L^>*:&ET![1,0!2?
M"N00(82 (#VCQCW[A!C'3Z?,#G]CL0LXPJHNW5!,++JJ^0<G:YFD,9&M2J"]
MHK\JRA9B(+[14WN6,I(-7C1FL @!/57;*D #"';R.(GE//\ RH8Y_+KSCUVQ
MN/15J^&_'MV71CHU)%ZXE"M8&<:I23M=-RZ?I(6^P)$>N7"1$T7#AT4@+K+I
MID(HH<QR$*4Q0 9( \6,X@=^WTR"(PH""7$,#9=..6!CR&-U=>0CFLF@9J\3
M*LW4 Q%D%"E.DL0Q1*9-4A@$IR&*80,4P"4P<@/C&,RT.D$9$[[_ #&/59!S
MV.8]CRQS7!S7#^X.&0X$;$$2#C/HHCN&E-=3U4D:>: BH2.E!!P@O"1[2*<1
MDNU[5(Z98+,DD!0E(]<A'#9R4?5(<G <D$X#\M2QMZM"I1;3;2#CXO%2 :YA
M,R]I_N!!(@C;'9=%IG%>N:9JUKJS-0N;FZI-=;EEW6JW-*YM:@_W[*NRJ]PJ
M6]=H<*E$X<"2(\,B+M3[+M%2GU-*;;?(?K"-9F=5*XNR>WC]F5IMVI_,VZG(
M)(66*%5%&S0_(*)*G+(-@.R=)F#\;6L*!%E=U *K ?Z=[B)N*3/[GN)C\XD
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M([@R"#//E"B[:.L*ILFLKUNPQJCA$YB+,I)HL9"7@Y) 0593$0_ P.&4DS7
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M7@/I > X\@'/G[_U_.;R,9Z1^^Z\P7/CD.!X$/\ 3QEVV0B<%<1(4P !BE,
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MVI#$.5NB4Z8"4AP(4#% >>0*;CD \C^?R/[X5\(Z#W^GFO*K1JN("NW16$/
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4   R+( #9<\*IA$PB81,(F$7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g105868g60p32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g60p32.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1(^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $B*^1D(X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%?GK@         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/T       2 #4    ! "T
M   &       !.$))30/W       <  #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      ,U    !@              >    EP          0
M                       !              )<    >
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG    >     !29VAT;&]N
M9P   EP    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   '@     4F=H=&QO;F<   )<     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3001       ! 0 X0DE-!!0       0    !.$))300,
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M/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
M   !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                _^$_6&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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M'Z 9;6:-;$XG@VIO3:6ZESO&J#(8M[LZRNK&O H>TH<'*$6HY%L@Y4$JS@A
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MS(\6C887)4XUBS!"U+TTN/NT]!4?=Q-C5I>@QFT-[6_:-%UQ-7YQMBYTV%M
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MY96J8I<QNNE;=L_*V,TQKU.8A6+G2BUPNS^RP=\AFSJ?8Q%@3W!7U5H&1>S
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MO$!(W]Y,AD5$U3VU8QC&,J9YP>J7&<,MEO-:J:<3V;(-]6S.R4U(_;E,J+]
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M,R]L5CD$VG(S9*174S.22BK^5D%?$3N7KM11=PH)E%#B8PY.S&,8QC&,\"(
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M?V2'=(CY?+,JBJL)"^*19WIIIHID22(1))(A2)ID*!2$(4  I2E   I2@
M    !GOC&,9T\_88"J1#ZPVB<AZW 1:(N).<GY-E#1$<W P%%=])2*S=DT1
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M6[/*CK"L1--A)"UH3$_9Y%G"*)0*3^PSIHUL>6EG2Z8+/I$Z"0.?,[P"$;B
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M\0*GX*&'P.4P\@W^O@!!$LU^T334+_J"8[\54U52>73/\A@(B?R*;HQ#>)3
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FQC&,8QC&,8QC&,8QG@WZ#_,/_+/.>B?^P'\YO[0Y[XQC&,8S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g105868g62s71.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g62s71.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1Y$4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'BB^=R X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%=^,H         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              BP   *8
M 0                         !              "F    BP
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    BP    !29VAT
M;&]N9P   *8    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MMW1^A&YVWW>KL]/^6M19WUCO;1T'/L<U[QZ%C=M;'6.ES2P>RL.=M;N][O\
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M2>GZWZ+]+6NF24NL[ZPL>_H74&LL=4?L]IWM#28#7$M_2-L9[_HK10
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$!_\  $0@ C@"J P$1  (1 0,1 ?_$ !X  0 !! ,! 0
M   (!08'"0$#! H"_\0 /1   00" @$# P,!!08$!P  ! $" P4&!P 1$@@3
M(0D4,14B05$6%R-A@3)QD:&QP1DD,_ W0I>WT>'Q_\0 &P$! 0 # 0$!
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MCX[5?G^O#@7(&[2+7<:78>NK#G'ZY80XC&N]S8\]*:<P&(<D:AQ$R#AY'_\
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MTA0&DFPC1FZ:TDJ]-LAP*R&*Q.ICA"FS3K,$@T+%FE,?'&Q?)JM79C%['5*
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M %'K&;#\(P^TM:2\L<9I#+?&WGR4-C/6BO*J7V@S1+!X,JQ>4#BQ6-@G5O\
MMQHC5^.90>H&_P"D4R75VNIYBIYL)QJ28V_@RHR1]0&KB<C&"2N'N9E6+]]A
M""B"QD+^]L*(Q%\4ZXU?KK[P:W#=3VWQ@;1.OO3QB>SM^B:E@"BR+];PL'8V
M-#@I#3XQ84^)" 48%2-(-' /'+3LBG(:*KXW$/>Y7*Y5Y&%3O^S=<X D[F!(
M%*^)?G$CKG"\1R&$0>\QNEM( ;$*V$B,KA9F#V5;.TD V)KHE1A A#&302)^
MYDC4<B]IRPUT;U-K_N=(IEQK+7E_+9D7>&8W9SW-*[';:8RI#FD/HG3*0ZI*
M<Z)5E!695D6!W;%?\JG?$6(=3Y)Z/<-W(_;01X%9EN.3;&T7="5-/(VI&LLD
M/U9L'/[R\#8*U&LITH\(EMLFD11 (+%L;Y5:2BJ\O;S/WM&)WL7!+4?<"S;V
MH^]]\3<ML3Q7)*DNGN:"FMJ:U&]@P$NO%G$,&D\7^W-$Z)6R1NZ:[I4Z7I.1
MJOP:*].=KZ\K<](IMI@6!&R"6-KBF/DRTU=9 !%$58LCZ^KL1HX+06%WM=QC
M%##11DL;\2,B8B]](G*P-Q#5G(H_K]'L=X:(.7F4^B$C+=39O 724=ABEO:N
MQL^FHW @(E+&1C4@N0.05B0U8\SI!*Y"D9&\E42+OR15,_F"_+Z>'*);>P%7
MU_-WYCPE]K//M9;FQHG(L'0*TIXCYZ<U"*EH<\131!3%A($(A9*QA-?8!F0/
M5/&84J*1JJCE1##RM[0(>] U0SWXVIRX[B*\_!-=TV/"5S\6QP+&\8EBO @T
MJA6@U4U.6MW"?!"V%?;D"-B6PC>QJO;.SW&HKN*5MO.GC&5^3 -R9AZ,=_)W
M@?L?,/0AL'%:<6U)HZFMS"*LVU79134#P"71CY[%MYBD6#16R"%YGD6JR[.>
MMG:PJ[CI3&JSS\6NCW:Y<;VN'K:U(A]:6+/J1N=@>7")$X;ZF/3YF>08YAN.
MVL!-[>I*($#/02C/%L!''0K3VKY1T;7W#_TH^2( A4FDC&DE:GCXJMZ?7T@W
M[=>OVC(^946G\(P3-;3+,<QJMP=8;+(,S;+2P3!EM?XDV)QHL \DA4LSHFR2
M*C'N>YJ*J=(J\1C0#4@T\#I6@#7MYQ%W.=E>BZW R>AM1J6,G(<<Q]Y)U1BZ
MK9641-;'#CP=.5$.JE7U;6W<;AP8E4D(<WRZ1KE5)9VXG4^GT$9%J.^G#ENK
MP\](N_#_ %4^FO!\1Q[":',3#*K"\.P^BHO"M/,+M1AZ[%JFJJ07MB1;+(HA
M\@QI;"NB3[D=]I"^5K4]SPL'WV]FWE]?#C6))4&S\"R:BI<DILFK"Z?(*FNO
M*DI"&1H36VP<)X)'MR*U[/>%(BD\'M:]OEXN1%14Y6/#S'WB9N"CX1?O)%ZT
M<>7A#B%C?0;R>>X6W!S#B'5>=.KV>,![XT%3;VK<?"L<AN,9)QXVUG&L*=@\
MLLP=]3ET%W7S1$_X:,-JCB8&3M7W!I7-G8UZL\5=>\*'<6IZA_&D5JLTW4@9
M5K_+IK4PRSUQC^58M1=P001OHLE_1HXPRU8KGS+4BT88XDJN[D[EED:CGJG(
MUNGO3U>  :CF_.]:TUC,7+%ZZZTAQ$ZZ&GI:,;XOK*EQ3/-CY^ 02^SV63CI
M5R,]L;11Y<<I8*09PJ,1'*X@>!LI#I.W.F<Y>^N(HIZ^I>,D<0AQ$-=;=5^V
MX\HAWG?HTP?-[[*,@=D=[2EYMD>1GY3&!$(Z"SQ/-L.P#"\WPEC)$:@H>1U^
MML;(?:1HXX,J,E\+7I.O0U@*7M;74TU/#[Q,"*)L,44+/AD4;(F(OY1L;4:W
MO_1$XBV8> C]JB.16N1'-<BHYJHBHJ*G2HJ+\*BI\*B_"IQ#Z1"'*_0IK?+"
M4<5D.1AUIAEN1D%4&@K(+P>RN4OQPGR*WS"CK[1K)HGCHKI8V^T]&HOEQUSO
M]XC W#\XSKHO2E5H[%K#'*^\L\DGM;=EO87%M&/"5,X:FJ,>KAFPC?X,<051
M2 0(J*KIIDG(?XK-X,0  \WY<MWY,9H>QDC'1R,:]CVN8]CVHYCV.16N:YKD
M5'-<U5:YJHJ*BJBHJ+Q!_%_'VZWQ 2_^GOK*_!J*>;*\K%HZZA!K"JP50VI9
M6M$/GPN+9!).YBO')H8MC7W0D+5'.?#6.F5B".;,;Z>E1 <?#RNVFHBY->^B
M3$< SNGS^'-LHMK,6_ES&_&,A!B$R7,W-NXH+XA(D5X#!Q;\X9*X=7P/8T=S
MI/.-5<A75O+ZO](EWE6/!9;C608O8JJ Y#365*6YK6O?&/9AS!RR1M>BM]R-
MDSGQJY.D>UJ\0+4IJ-U-U_I6(5V/H)P<LP(P+.,JK74:4UCB\4< ,\='EE37
M5%2_)T23Q4Z0ZOI H)JZ96#,ZE>Q_D_X1>O3[UBE#?3VP:ME FJ,_P N EH#
M <AQ5WVX!"4><0KA"6>6/1_A^H27#,!I6D5<RQB#^_9+"_LIBPN5(@%*L?#T
MXQ(S#_3AK?#L2Q?$1!3S1<6QVDQP8PLQ5++'HZP6LA)*6-K6*1/&*V696-:S
MW'N\41.DX@_/R/T$9[XB"CZGAPWO8LP+DFF^'$6FGXZJ_%^<.(L.(/U](<1"
M^E?'JEK5K2'$-;Z$>-+Z<J>D.(4-:TTW,^@WU!WZ0XAOZJVM:Z4/VB+WJJ]3
M%7Z8,/QC*;.BBO5RO-*3"@8S,DH<3JPC;LF,>$VUOLC,!K  H72(LDDLWDO7
M36JJHG$/'RZ?P>,#67U)]+X97YE_>C88Q@U_BVIJ[:]93R[!PVU@S<"T)RX4
M6HPRV!M7A79_N8HZ.5XSU'9-8BPK)[C96L=<_>%_1_%Z'3BU>5H_6,^OY;PH
MS(3=)Y?7:?K]S:XT3:[,9?XB6RDS/:*Z\!Q<ZUQAEPS(&8T[(MGXMC]A;!AF
M. G,=8DC15 IIPZUZ?B\-6 J*6M>@%R:,P^D9QWAZF)=*W=#&3K#*\GPJP.P
MBLML^J;#&QJ<*US_ "],-IJ6H#LK<2UR:[",?#;7=;2A%2@41$1O<LBK E;R
MW^E?$?O$S VJ= VM7X&FZ^^L1';]6G33:O,+ O$[RNEQ^[HL?K8#\@PT:(BV
MR$^ZKPJS)S7WWV>"VL"T!QI];DTP)8U>X6;VGO(9$LBO5F\?+C3DU;Q)8[U@
MTD&K=,;.$Q(LP'<64@8V(+!D&-EBTD9+2I"[DB[K;(VGL*P2 .8ALM864^>/
MQ1C$D5S&HO7G&-,_^IGZ=L5"P2SQ@ZSV!79;LW#\ MB:85U=_92HR\2W/@V#
M81WB5TA^' AT5I.19533&2(&2R#W)()&M1CHPTUT<-S;DU#5K/\ NO\ J%XA
M?;VL]-8]@&2VE?4;UP[0YF>H?304A%]F&'YED4=S5"R&+8'U-/=8)D>'VKF0
M,(AO*XE(X9!HUFXKX>O5W\(M-;UH:\#RT\SQC8C^>(@YW=A]7O:O!VW,XC*'
M$.O-NN-(<1.-'8[M+[V%GNU-8<0&]Z-P(\[TWG]G$&&X>_KKSAQ"S#A[$/PK
MRWLT.(5X=<?Q#B+#B(U&]Z^>^'$8W/\ VB+Z@ CPH_/0M#B,MP-=6-KCAQW5
MX5=Q"M.J_;WX-5Q%;KV\M(P[MW26'[I3!8<R9(2#@F;TV=!UKAJ\P"TL*69L
MXX5J+8BEPS@2O8B3,:QDBI_LR-7YXA&/,P](FILTL-L'V-8/ FU]75.J#!!J
M:@^TQBDJ&Y2@YN+Q35DK:^P>_*S99?AXZRC"O;"U6O5[[-PY\]/S&.9LPJ:@
ML]* D>QTO0O>,.4/T^<8JCRZNPW#LN[U+8;6PG=%IIP@3"0\;N<[UX-A"XI-
M<7P>,QY@71@7>O,5R2:ACO!@SK.M9":LU7*0!.BE@330G?8N;\2X_$5R_P#0
MEB,VR-=YK@.?Y+K+%M:BSLH=24E)B=UKR*VL[<VRR+*QZ_)JFT,K\OOA37TT
MV1AEQV596,6*EFKGDG/*===&(]2PJ&'"MO+]KQCD/Z86K VUT[=@YNZVQ"3'
MWZRMTJ<'B(PAV,VEQ;U4Y,$6--%S0]A-[8QSV.51'ERC21QM?%)'[SIKUZ[_
M *10Q8[Z]>=K"+IV3Z3#*G66C]>:_M [8+ MK1Y9E!^96TE#87@MS^HID1H$
MF/8I<5P]L^6RE( K6U -7VUL+B1V]R+8$L.M'._<+[X\N2_36TMEJXU'=Y%F
MI(>-XCCF&1!,(IXX3JO&L;RS&1)"W)5K(A4P>7G3SR0NC9]R.(Z.-C&R,D#1
MR^_C]O6!L7K<V'MKY^,6,ST#AZLS;T]3ZIN&V-=CVV=;YGLJVSV_GCO[6'6>
M,[9BFN:D.FQ(H:]S#.,EVG;7>2SVMMCX$<WN3AN<KD#<+L&I\P?R4?HWC '7
MA3D2D>;D'AI:NTSB,=Y%6)H;4;=K2AOH8<1D/2P\*?M:'$+>?N8<18<1C0$G
1Z;DDWX@W-?HXBMS\S]#'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g105868g66l79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g66l79.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1NP4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &Y2^<& X0DE-!"4      !                      .$))300Z
M  $9    $     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!
M     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y"
M:71B;V]L      MP<FEN=&5R3F%M951%6%0    ; $( <@!O '0 : !E '(
M( !- $8 0P M $P ,@ W #4 , !$ %< ( !S &4 <@!I &4 <P      #W!R
M:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M    "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O
M9@    EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN
M=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M    4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L
M<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M     $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M            1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M     $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
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M8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P
M.$))30/M       0 [_^-0 "  $#O_XU  (  3A"24T$)@      #@
M       _@   .$))300-       $    'CA"24T$&0      !    !XX0DE-
M _,       D           $ .$))32<0       *  $          3A"24T#
M]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R
M     0!:    !@       0 U     0 M    !@       3A"24T#^
M<   _____________________________P/H     /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H   X0DE-! @      !     !   "0
M D      .$))300>       $     #A"24T$&@     #-0    8
M     VL   <G          $                          0
M   ')P   VL                      0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   VL     4F=H=&QO;F<   <G    !G-L:6-E<U9L3',    !3V)J
M8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R
M;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@
M  UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   -K     %)G
M:'1L;VYG   ')P    -U<FQ415A4     0       &YU;&Q415A4     0
M     $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L
M;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R
M>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV
M97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M"V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M  QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
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M?X(&*1/P:O6:>HVNJ=A"TAH>'BJ]M!EQ8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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M5FDTNQ"X$><78<DSP=OARZP6BM84\//QGQ,I#4YI;";+;7# LL$K  $D1L0
MRAU)P.PJ0P\HYBJF:($*9$!.< L 3AMIQS\3<CY#RK8+F&LM.*59S^Q*%&:O
MCTBYUAAG5R%.;)==.#FVZ$VFN1+@I=O6J1A-=2FJ3X-DRHKF+C .9&*?_8GV
MWE6V.=@"M^4_L?(^'X13P?\ "\(%>6?"!';5=R^$=P\#U?,>#X(;PO)X)!Y^
M(YJJ5^T5RV1'I]8."C\&/(3$>F")T<A&:DJAQ""6%OQG'&\.J@SX4M*>^[51
MY<=[':AU"LP59<;@1D9&01RR1X_?!'YJD$'L.?%5=Y%33BE.*4XI7&\\S&9=
MD2'6V6&&G'GWG5I0TTRTG*W'7%JSA*&VT)4M:U9PE*<9SG.,8XI6!:)U6],>
MT&L/:WZ@],7QM1X!5L*J.R:C8>VR6M,U=8!]@LM*5Y4L21I'(.%V>'*X@3?$
M4/\ BK_@\SVUQ&2'@E0A68[HV7P5]4>8')<C=Y,C-8EFA?U,J-S \%@>;>I'
M(]IQR\M9^YAK+3BE6ZY;JJS;(=#=L@)N[D*\1ML&HK*PDV675A!$6'*6..$R
M_@B\#'EC0@;,*(CYA1YY.#$=>2_):0JVUMI?:=@8*6P=H8@D+GLR0"<=N 34
M9&=N1N()QGG@$ G'D!(&??JXN5J:<4IQ2K*V%LC7VI:F2OFT;M5M>4D.X/9*
MVVZ'1M;KHYXL1BB!;4TP7DQ($9PB5G0AL)#SZ%2ITN/%9PMYYM"KHCR,$C1G
M<YPJ LQP"3@#)Y $GR 9JKNJ*6=E11C+,0 ,G YGES) 'OU1*'N[3FTL"<ZT
MVIKW8&#P$C:0N:;< -EP5K8<YBL%CH_(B?+Q*%"['G $A.9[^/",?[VR7&YF
M,L\EX98\\2-TVL%.Y2N&*[@IR!@E?" \8Y]E0LB/C8ZMD$C:0<@':3R\AY'W
MZRAS'5Z<4K'.O]P:GVPNRMZOV70]BKIAIRN6Y%(MH*T*K)YKPF' YY(6=-R*
M(IRR]CQ2;AE[.67L)1G+3G>W>*2/;Q(W3<-R[U*[E\HR!D>^*JKH^[8ZMM.&
MVL#@^0X)P?>K(W*5:G%*<4K$VUM]:1T5&"S=T[<UQJ>'8Y,R)7Y6Q+D I\<U
M*',M2)\<8\>GP6YKL&.^R_+1'4YF.TZVX]A"%ISG)'#+-GA1O)MP6V*S8!["
M< XSXLU1Y(X\<1U3.<;B!G';C/D\=7?6+S2[JHPFG6RN6K-?EC(!S-=-#C*1
M,TU6PEQ#Q2"ATB0F(^4J=EKMF'MO90J8!."2T?#D$A%?=JR.F-RLNX$KN!&0
M&*DC/: RLI\A!':#4AE;.U@V" <$'!(##./*"#\!!JZN5JU4BP6 #4P1BSVD
MT*KE;KXV88/'SI"()"A1(YAR5/)E2<YUB$/'PHS3DB7,E/-1X[+:W77$(3G.
M)52Q"J"S,0  ,DD\@ !S))J"0H))  &23R  [235-I5XIFR:N(N^O;97+Q3;
M!'7*!VJIF1]@KQ>,V^[%=>&EQ4B5 F-M2F'XSJF'UX:D,O,.=ZZTM"9=&1BC
MJR,O(JP*L/'S!P1RY_!165@&4A@>P@@@_G%73RM33BE.*5Q/L,R6'HTEIM^/
M(:<8?9>0EQIYEU&6W6G6UXRE;;B%*0M"L92I.<XSC.,YX[.RGPUTS:UZ9^YR
M;'EE6-=]54?:$:E:_%:AJ]?KNX]067.F=:V':%"+ :8!F5VJXML\)+NM.I]5
MK+FSS=\DB8RO8W6IPU9!25]H]Q?1XWP&,N[2,6CE7BR"-U9R&;:&".S-PPF2
M-S XK@K%:MG;+O"H$4!T.Q&="%!"Y*EE4+O+8[!C-9FL'<\NG*J/UUV9N?;U
M").;!JT71<U5ZH$.5K0R/O5JVX!UMJ9FPT A$+0)]Q)F#V0UTB7ZP3X(B&$0
M2S6A*!*<2WL[;L11.-C&8;'(D&Q8R\N'!!"@#*E "2<;F)JYMHEVYD=3N B\
M)? .68*@*X/,DX8,>7D  D8O<PNET@7;&0-A;1G$*+3S=()!DV^@F2@K&QM.
M['U<=*E9DZA$+2")VZL[7M5Q>"02H>F3+A)AVZ-44YS):FR=0N ,E(P'<.#M
M< [)$D  #A2%,:IG!<*-NZG5(2<!F\$%2-RDC<CJ<G:6&1(QP"%R<[:[+:X#
MAUBO JT/7(<'UX,+!P7):T.2EPQ,)B!&7)<::9;<D*9CH4\MMEI"G,J4AIM.
M<(QP&8LS,>UB6..S).37* P !X@!\55GD5-.*4XI3BE:Z=6VG#_4#TZ;2TW5
MR\ ">O@6"*'&"4J;!ACG(YT23=DKF#H!.;&>1'@O>*/1X$E2)>6%*1A&%+3G
MMI1#/'*P)"$D@=IRI'C('C\OU5BGC,L3HI + 8)[!@@^0^3R5J#=>YK@YMS'
MG:-<3,)YW7G5-),[$O=IL=SV>WU&;K!:+JFM=UPG9"&1LDCK&O:G=9&9:F G
M <B)77P41<YV>3B<E;Y@N'52 ]OB-%5(S!$9FDB('BD:7)R&SX63CD<+6H+9
M5B,I+EBQ+\1Q&%D'+&5">48Y8&>==>W4KT$]456TT^ J-%!;!EW ;O"LU_1.
MJ+#>"&I=3VV^Z-UIK6I;A!6&ROU<S#V$[;:9;+A)?,U\?2A4G:UZ>*V/RLT^
M9OO-M[RW:7+.4"&)C-(J"614F>1HF5=R[-KJO)BYX:$#').-+;S+'M502PD4
M1QE]D;-&JK("<'<"I;)  WMSSS;9C;7<TMTV;6=]K^O[)J$3?=E;DWWLBQ7$
MU,,LFF(MNDV"3H>2.M$K7-V("R6J5V$JZZ.KPL"4'3S1$A2=BA'%%467CQ7\
M2R(TBRE(XH455QC*A>,"H= 1)M'JBRD##1MRVYGM9"I"E S22.2<Y\+/#PQ5
MB"F3V 'GE6'/,[![F7M.'MK.V6[C1HQYS=,?:STV-:]@XF94QUL1=X(<\%@$
MU!<,L=/4^YZFCO*:0TW(M1JMHD-U8Z7*.P;Z,IL*N5X/"P53MZKP<]I..,%D
MQY &]4 *CJKAM^Y<\3?G+9&)^(!V=O#+)_\ J(Y@DUVFU77ID9N/;6T#<P;)
M:N 36U,I\6&J2N6+J-%AV(L^@KX>*PTR0(72]6V1X*$],C+%,!GG7T2U2(L;
M@,X,4<8SX)D=LXP6<J.7/L"(O,X.21C !/,"D.[G'A!57WE7)Y^0EF/9RP >
MW-=9MFZ!.HV;8=<2@%XU1%#4SJ=V?OK,C,\T.LPN%?>N)GJ.D0A!=W6ED)+E
M']0YEZZL(NNF-<MI-2YL,S8[Y2YZQL;G+>0!9 R29>WCAQ@%24M.!DCB*,++
M^44L).0!"HXS7$-M+X.&0!96DSS#8:?BX'@D^$G@D K@YR6!Q6L>UN@?=FM@
MO3;0*'KR+LT[*$#0M]MU?FGV@%$V))WWKZX63<D,Z_,#RI1DYJZOYU[8G[4.
M#8:HH4<%#3+#$CO4@ER([R)S.[N8QN8HAVY>/@NJ1%0#@+(=Z[2<NQ9L'##$
M]NZ\-54-D ,PSA7XBL7!RN257:=V,* ,D>"<UT'N86W*S8@]GN=RI.U2M5ZI
M];;MCYNML(R!%X%5,CN;RQ>#(6#IJ#)JNY7A>U!2D2Y9[9RC[M#KP0C>A &!
M7VJWB>_B9654>,-;R0G:HRI81;4!XOA1?DSR CQN+;&8MNR+:N""S*^V5'YG
MDP4OEN2 K)X>>U\E0-RCL[P^=37/IQ2G%*<4IQ2G%*Z+=]=RLVSMG<^\MC"-
MB:^&UG<&UX>U)=7)2++A<PSK^H:IJVFY1A<:MRF6)%7Q]/N9/9B*F,^,'Z+)
M8>E/-3\!>VAU&.**)"CEHHS&#X. '>1I0/"'JOR(&>S:_9GGP)+1WD=PRA7<
M.1SSE518SG:<;?RAY<N:GM&15G^YM=0.9=SG/7K5UBBSKQ7K&;J1JT;/8K_5
MA%%[PL.T'"74I(2%*9JQ\=4S(VA!8]7$[%&.1J]#21=75_)50KT=>A\$!'7P
M& 95CW6Q,(C M\%=REAO;<4//(\++,-K(2QW*?"5L$MB;$A?,O+"D A1M#=G
M;M\$6A7^YC=4(B#J\(_L'2_DRA:=O.L7Y0DI:A\R7"NND-[:^E5V0_+UH4M)
MRL)V#LRJWG#<Z^0 :(X)Q;U!G6X7#M9>YO[<F0A)?#E23!"D#;+$^X 2! VQ
M&7DA;)_L@4[1 M)0J+NC\&-DR,C(:-U(/@EBNY@WJL>#ZDMAJIVS^YP;<JCA
M[<L4=3]DW:K5S;3VOV:>\:F[,K5X)5#I7<T58:*T7 BQDZ35]KZ%/M6D01L=
M5&Q==W\V5BG9,Q1.OR+1W\3%8\LB,8@^\ 1LH:X$P?#$@-',I4A6)D0 @ !J
MA[:0%I %=@)-F,EPQ$7#VY ]2\>"-R@*Q.>T'N*Z:M:EM1Z+UO1++*20N(\#
MY6OQ)#JWFR>QK9-EVW89)EUQQU:XT^ZG#LJ+WSKF41766\+RE&.=7/()9G=1
MA"<(/)&H"1@^^$50:YL2%(U4\V RQ\K'FQ^,G\U9RYAK)3BE.*4XI6KG5?JO
M9.TJCK;.IVZ/*N.M=YZNV]%%[#L1ZJ5DW$H)9\C,#2+!6ZA>R@R1/0ZEN-);
MK!%I"\9RZC&.SMY%M)'&TG$W[9(9(B45692XP" S(#CQ^$.7*L,R.X39MW)(
MCX8E00N<@D*Q\?DKKO-=S7W67%V&1*N.OU%KFBYVLW605F)U^FAKU?>I^T;]
M(@!42V:>VM5K10 @JQI (;O6LC,>UEXKIB?3@+S\)X5S1?Q J C@)M56*AG*
M);K""=LD3*Y*D^!(NP' =L'/&-JYR2R^$&)4$A0S3&3 RC*R@''A(=QYE1VB
MNO\ <_>I">NX9)[)U.NVW'IX@:P&;R$3=JUJ_P"H#47IX9U#.I6L*;7I@VMH
MU6<O47Z:4R=/L4,E *F3KHFGQ+*U5[36H%[ -N(Y BSF0PD1LD@,W$#R.PW<
M0)^3P%(("@OMW*TFVE(8%TW-%LX@WAD/#";44$#86\,DG.<X ."L1_<X-L."
MJ;'1=:#K@27W&?>VQJ:A&+L7UT#Z6+/(U98[#H?5I4V&$DY*S-ZT]"/R)I6O
M5<7"C;:VW %0X3<V+B>-]%EO!=RL0X4CA!(;A1(HFD + 863;@,Q/"B)/(X=
M5D\'PE0%SO12Q40ML)C3(':T><D*,.^ ,BK>K_<P=HO7*V2]C["!7NGVCJ3J
M&T;- *VXG(A[,UZ&V#M6X$85VI\/50/O+>FOWH'KU$8Q?-@BSM4#R LHT$JS
M%>J@:6U",*O#0HRP/&,(,QNR1J"C\0^#E"_*.,ACG!;<Q@6C9;>P8&57.6/A
MJ&=L,NT<\-MP78$#&0N%&T701HRZZOF;YLES@6$,#([!GZYT)6[3'8AFJUTY
M4.S7*RT8;)@1B1./$;19MDW<>&6ER/(FTD-3'YD1AU"6T<>\F600JI#$())B
MO,-.ZHKG.!D[8T+>1RX!Q6:WC9#(6R 6VQ@]HC4DJ".>/"9@.?-0N0#78ISA
M5R:<4IQ2NKOJ_P"@(SU5;:('RYFLLZSL8;I@K]C%O%#XRVX@:8V9O2Y6V4%E
M# LJ/ +OC=H@ETL@V29>CGQ4R1+6+;BPI4OGVUX+>, !N(IN"IP"N94@5<@D
M9 ,3;QCL(QGGCB3VW&?)V[#P002<D1M*QQRY'\H,'/:/%X]9ZYW.3JYK>O+5
M0"-XT'L8CMS2O4]H_:>Q+88O R?!8Z@]\W#9R=FA*4.UN0&VJRP0-F1(G5.?
M9J:+:MR'&(=CD"F6I[W):^MF=7"3((I;>:-%"8)AA6/AEC)E5+#DP5B4_:@\
MJQ"UF"LI:)R\<L3LQ8<I)&?>%"88X897*C.<'%;!]0O07NK:-[T4;#=1%IL=
M0U@8)*4$M)>I44Y1(,@YJPD&L6N3U6TE;)!NT5P90[ 'CR[1Y+N9"-<R49>U
M8 .2>!6#!!>0QI,# JM(!S4.ZL=L@*NK3+A6+@G;E1M&(]VUERR6\C-&1(2J
MYR"0I7FA#(5C;++M(&[#>$?# R#AQSN:F\0T2SM5>U:B?:V*Z^[M0.?)6$@/
MOKF.I7<.U1,N8W9M=7JLM%PFNKQ2ZR/*&Z):41'*S.K0R +B) 7(3DZ]"2NY
M91P_['M '#_(11D#;(C8+H[$*ZYR&))W(:=6D&=I3PN;@DG<>*[Y\)&&=K
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MEBJ^_$G\*&_RCCJ-YZP?]7]=.^FG>RT^.3ZJ>6*K[\2?PH;_ "CCJ-YZP?\
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M@U=M< 0)&AQXC62H8 ,,4F$1L98*8$$V3H\#%(R@<:!,(EFH8Z+(E-6%I.2
M$4Y .1)$0 5# L0Y"@J003C.<#)Y5!N(@"22 .7-'&3DJ0 5&2"#D#F/'5V6
M3J?U!5_8G)FGYQ 9=:@.NE<E5JK72W3BP8Z.*'*])@!:K6C)&0R6KU<MIW"U
M-M/0QM:(RI,9,=MYZ/5;>5MV% *,48,R+@@X;)9@!@E5\A+  YY5)F08)/)@
M"" S9!R1R4$\P"?S'/95DR.M/3,>/<)*IQ9MBL3\I&3)(&Q,B+J"AR:F/L%@
MJ1ML(^)*LULI:/)9L>U+R0$2AK[YQH0-<\?:MU67P>0RPYC<N4/AD*XSD9"Y
M!QS!Y9/*HXZ>%VC:?&#@CD"00"" 3@\^1'/ YU2I?75I<=!I4PHU<ACUG5(C
M6 00HUU'G-<S!P&);#*KR,(5N&Z$$!JGY9LLHW*4S%F!0SA,(@L.D9F1YZG*
M2X&T[1E3O4B0$E5V$,<LS84*.8)P<'MCK">#G<,Y!!5@5( )W CD ,G/C R,
MC)&8:?U#ZLO5HBTFN$K,];GV"DF;72>NMB5XM7&!#<!Z0Y<XE@JHMRD^-L%1
M<@*FVX#+L,8E!D DD69+;F<30R(N]@ O(!@Z,&SG&PJQ#]ASMSMP=V,5D61&
M. 3GGD%6!&.W=E1M[1@'&001D$5F[F*KTXI7C?[ICW.;KJVWW07=6]M&ZQE3
M:X5.ZU-4>ZB]HZVJ1=@C5]94(5DH.;*WD)8PT\580DK$.6J+"E-R(C4Z&O+>
M8\A7TKT&Z6=&K'H?I>F:G>*LJ17T5S;265Y/&R3WUX_#?9;20R))#*NY=S*0
MQ5AG(KXT[IW07ICJ7="UO6='TYW@DGTR:SO(M1T^UE62VTS3X^+&);V&XADB
MGA;8^U'#('0XVL=.:]W-7NNM22VFJ578-92R6D'F45[J3UV%2T<EEZV?EF6L
M#=LQL-EI)ZFU W((I[)CQ>JULDX\J:#&/1=EFZ6= K@DW$MG.3&(29M'NI28
MECFA6([[!LQK%<W$03U(CN)D VRN&TRWZ"=U&T %K;ZA;!96G46_2"QA"SM-
M;7#3#AZHN)6N+*SG:0>&9K2VE)+P1,EQ#>@3NT(8$?JPA.XQ58M8YD1:*X-Z
MK:;! V05&K,"E1AA\1%W$T/,#V*:*%U-B$1CR8S59&P *&T"X<>*WA?I)W.Y
M)8IY%TV2>W<R03/H4[2PR-.]R7BD;3R\;FYDDN"R,K&=WE)XC,QY$70_NMP6
M]Q:0MK$-K=QK#=6T72>UCM[F);:.R6*XA35A'-&MG%%:*DBLHMHXX !$BH,*
M_6<>Z+_G 1_L?3:TI\7_ +Q>SXL]ON>YSL_1]T3]M#\QU'\)73>E9T[]HQ])
MZ1^/I]9Q[HO^<!'_ !M:3^+_ -XN/Y//]MZ/NB?MH?F.H_A*>E9T[]I!])Z1
M^/I]9Q[HO\'^/Z/SVM)_M;%]/SSQZ/NB?MH?F.H_A*>E9T[]HQ])Z1^/IGN.
M/=%_S@&,_P#S:TIZ_3GS[%^[QZ/NB?MH?F.H_A*>E9T[]HQ])Z1^/\_>I]9Q
M[HM^< Q]O;6D_P",7/[/W./1]T3]M#\QU'\)3TK.G?M&/I/1_P ?3ZSCW1?\
MX"/^-K2G\8O'H^Z)^VA^8ZC^$IZ5G3OVD'TGI'C_ /\ /I]9Q[HMYO\ B 8_
M&UI//[.Q<8_7X]'W1/VT/S'4?PE/2LZ=>T@^D](_'T^LX]T6_. C_C:TI_&+
MC['V^/1]T3]M#\QU'\)3TK.G?M&/I/2/Q]/K./=%_/\ \0$?\;6E//\ _P"Q
M?V>/1]T3]M#\QU'\)3TK.G7M(/I/2/Q]/K./=%_1]("/^-K2?\8O;QZ/NB?M
MH?F.H_A*>E9T[]HQ])Z1^/I]9Q[HO^< Q]CZ;6D_7]C8OW?B[.SM]&'H^Z)^
MVA^8ZC^$IZ5G3OVD'TGI'X^GUG'NB_P?V/7_ %VM)^Y_A%]?^WLX]'W1/VT/
MS'4?PE/2LZ=^T@^D](_'TSW''NB_YP#'9CM[.W;6E/1^,7U\>C[HG[:'YCJ/
MX2GI6=.O:0?2>D?CZ?6<>Z+=O_D C_9^FUI3^,7MX]'W1/VT/S'4?PE/2LZ=
M^T8^D](_'T^LX]T6_. 8]7]=K2?Q=O\ 7&]7V^WL^QQZ/NB?MH?F.H_A*>E9
MTZ]I!])Z1^/I]9Q[HO\ G 1_7_7:TIY__P#8O^KX^/1]T3]M#\QU'\)3TK.G
M1_\ Y(/I/2/Q]/K./=%_S@(_XVM*?QB\>C[HG[:'YCJ/X2GI6]._:,?#WST?
M_B&?/R9I]9Q[HOZ/I ,=G^%K2GVOZXN?V/N<>C[HG[:'YCJ/X2GI6=._:,?2
M>D?CZA]9Q[HO\']C\;6D_=]7_&-]OS]G'H^Z)^VA^8ZC^$IZ5G3KVD'TGI'X
M^GUG'NB_YP$?\;6E/XQ>/1]T3]M#\QU'\)3TK.G?M&/I/2/Q]=P?<R.Y#S--
MG(N]>J^OB).R0TY3FO-8*(![,'ILJ(]V,W*PSA$LF!,V7OT8?K<&%-GCJ^C+
M1AYYVPYAMU[0^F/3M=0B;3-#ED%I(N+N]VR0R7"L.=O"LBI+'#@XF9E1Y3F,
M 1;C+Z?W/NY@^F3+K/26")KZ%\V.G&2*XBMF4\KNX>)Y()9^6;>-'D2$8E8F
M?8(/09SRRO<*<4IQ2G%#YGR>_3BE.*>?EIQ2G%*<4S3BE.*>?GY*<5'E\?\
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M\,$S[>9"HV['('''USCKV^$[L7_Q@_WGYS/0=T9]IK3XI/O*Z_TP.F?NAO\
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M $HONJA]<WZ]O1]4YL7_ ,83M_\ ^/\ /[7'H.Z,^TUI\4GWE/3 Z9^Z&_\
MTHONJC]<XZ]OA.[$]7_WP?J_^#_=]WU\>@[HS[36GQ2?>4],#IG[H;_]*+[J
MH?7..O;X3NQ?_&#_ 'GX]!W1GVFM/BD^\IZ8'3/W0W_Z47W51^N<=>WPG=B_
M^,'\7_J?XOGVYX]!W1GVFM/BD^\IZ8'3/W0W_P"E%]U3ZYOU[>GZIW8G_C!_
M9]'D?]G['JX]!W1GVFM/BD^\IZ8/3/W0W_QQ?=5#ZYQU[?"=V+[G_+!_O/\
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MWI?B2?'%_P ][]S_ )7/-NDUGKMCJLEOTCFFGU,0PM))/=B]D,3+F$&<229
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M$=^.ZZTAU"%N(QDNI:<TL4"W]DT\ZJ\,*W4!EF1@2K11B0O(K $JR @@$@D
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M ;*#5 U62UH&. )=K@6;RS/EE0X(S@?-DA0E7;IEE6N,[*L9%N^B@4.K8LL
MB(;RBQG9<H Y!<,%.0I7 P2,C);>OB4;"2VT@U0W,8.#D9"L,C!(;)R <<@
MI/C\(#&>59/;ZQ-2R#K%?A0-@SYA"6'0!D1*.66-LH:P#-F%P]N D7/!19E0
MGC]/;%F1SCJX[#D$ T32C(H[79Q?'U:7:6\# !W#>,J5,8*D?X0,J# SS;':
M& MQT)P-Q)P1A3S!WX(\H.QR#Y!GL()L-_N@&F"E%,V[7D*U;#("Y,\;BO!!
M>7,12B<52/7\68X.48&5@793%]I(B/+D9F%1<@W-R8 PU5&ZM5V_4I0ZJY5
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M8C(LB)(F.B3J/!9M*)]. 9>IM -;0/1X&R]8EI+-'K4R_P "QFX+ NX3'2Z
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M]Q:30VUR]I.Z@17$80M$P96R Z2*00"I!0\B<8/,:LE]3]7,O))H=U% X:9
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MB.Y"_P!D@_J<3?\ !/FZ>EQW1/\ &^F8_OZ\X]-[N1?Y/^#DWX2GUXCN0O\
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M[YLWV*>RVI_W/X.7\EQU#4/?^6'VJ=]])][YN?L4]EM3_N?P<OY+CJ&H>_\
M+#[5.^^D^]\W;[%/9;4_[G\'+^2XZAJ'O_+#[5.^^D^]\W;[%/9;4_[G\'+^
M2XZAJ'O_ "P^U3OOI/O?-F^Q3V6U/^Y_!R_DN.H:A[_RP^U3OOI/O?-V\?\
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M4F34I!.P2W2-#(%WF/?C>^YF*RNJL!A54@PCES).03A\4+2L[!-VT/M'@KM
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MS*L25!+XC&Z0$ 2*H#$L1M:/+,VT$%O!(VD"VZX!')F\'PN28R4)) P,D-@
M;N>#D<P:M>NE.OX+:#Y08Q?R];+/;(NXR#?@%$48-M 9M\J=8 V.$*%LB:G+
M*T^D:F,5X%2Y],;DVJ^E[$2KYUA^UCZY<BR*J#L##AH2K. N=C,R\\L SR L
MX<[4"Y7"EJ@W )(#D$NV&"Y."0 V!@':JD!2OA,3@\P.T^F"3X*K Q-JM4R[
MV.% :;-VJ<-"AWS1)>5.RI*!5>'BQ(^(EUQ3 ^)'B9=8@-1FYLLC.Q)(2NN8
M@L2JA5)Y*"3@>(98DD^4Y[>S Y5S%!  8[CCF< 9/P  8\GO=N3SJYN5J:\
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M,U5N8*Y=.*4XI3BE.*4XI3BE.*5Y^/HD/\P[JO\ QK:/_HAWGSUWN+_LIO\
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M9!KZB@GANH8KBVECG@G1989HG5XY8W&Y'1U)5E8$$$'G56YCK)Y?%\7Q^/\
MCIQ4TXI3BE.*4XI3BE.*>?GG-.*4XI3BGG_+Y_\ /L<4IQ2G%*<4IQ2G%//S
MYTXIY^?DIQ2G%*<4\_/X*<4\_/\ Y4XI3BGGCS\_@IQ2G%*<4IQ2G%//ZJ<4
MIQ3_ )>?YZ<4K.-&_I>C_P!_E?Y97-7U3^W)/W,?^P*WG0_[G1?NY?YQJN_G
M7UV].*4XI3BE.*4XI3BE.*5Y^/HD/\P[JO\ QK:/_HBWGSUWN+_LIO\ ]X+K
M^D=*KP#]4;^PG2O]*;+^B=;KQ/<^FZ^+JS[TPZSI.W=VU"C;)/6*KT*>S92=
MKL58#$S1$.)K=5-V)<J3@17K9+"!%/BV(UAMZZQ8(-*!OS[83#D!P>5&<ZG7
M+VYT_3+BZLHH9[M#!';PSR)&DDD]Q% %'$FMUEEQ(6AMQ/"UU*$MTD1Y58=[
MT:TVRU;6K.QU&>XM;"07,EW<6T,LTD,-M:SW)=N#;W;P0;HE6YO#:W$=C TE
MY+#)% Z'=>\]S:RU!V1?ZQLVG:_UB!! 2NN%[4V-1K$YLV:1UD9V/*B5'85'
M5!J1X)-8KI,74;!)#5@L<+2H HK2ZY*BGEB-9M>FF6LK.XL;F[OYI98[T6%E
M=0]15+Z*R5KBSNM]Q#*K3I)<0K+<1Q1J\D=U.K0B3<KWN=$1ZE?VVI6>GZ9;
MP02Z<=5U*QN#J;2:;-J+I::C8[+2XA=;:6*TG:&UFGE>**:RM76XX-P; [E8
M8B%U-4+<.O(&+/?ZE1M6TG9=GAB[O<,GC^K:02(IE1($& Z\-M^RDR$BAXN1
M+S5 18H[G$ML;$,8;3I[$T>;O3KQ^!:7%U?W5E TEM;"&*_ND0JSLX#VUCC>
M\@7K$T<8RI=H^3J'<OF20=0U?3TZUJ%G8Z79:E=)%>WAN9]*LI)-RQQQL8[S
M4PPCBB9^J6\\K>&L23436'<]M97F,:7%W_FW3XFX-,ZQ!1 E(O%#@F5[)A;G
M<-M3"EYIC\H60"OZ?,OP20\'8J_(AQ'XC\M)R<D8+R7_ $POK0Q;M(ZNK:;J
M=]*TMU:W;1]2;3!$5CM;D*Z2KJ40='EAF5F5@G"4O)Q],Z Z9?K<%-?ZV\>K
MZ+ID"0V-]8I/WR36C<!Y;ZS+0R0-H\YCD2"XMV5&1G$\@CBL^M]S8N)YBA&9
M.V]>@JALNN&K[3K061/CQ2^N*;IX%M385N:8=4UAING%;,'UE,A2I,=#]V0<
M0Y/A"J\3GM<F;II;0F[B&GW<MQ8S16ES!&49H[VYU&6PL[<D Y-S'!+?*R@D
M6O"(1WF1:XEMW.KR<6$S:K806FI6TU_9W4PD5)M/LM'@U74;L XP+*6ZATQT
M<J&OA."\<-O+(+LZ;.YLS=SW3J<I4RQDK?\ 2?>QKO7ERTLN%:J1;=PV2'8B
M%"F%RZAQ#O=9R8U7DMV:;&2/)"))L*U(F0W?#,.X-:Z:)IEMH=RL*6W?$=<O
M+;4PT%U;Z="T*7:QQ[TS?*TX,"-O2012E488(YG1ON<R:U>=)K)KB2\[T$Z=
MI]YHQ2ZL;O6+A;A[!Y9C')_[8ZVCBY=!')$T\ 9T.5;*%4[G7HDWI?4MS+6K
M9(JW7"!TQO6C ^WUD^J >WYN9G7K]<E:SA:J0<U\$;K,"V%J]LNVWTE7W[2"
MC5-\3+*%X,1W@7'3'58]4U"UBM[*2WMGUP0;[>>+=%I.F&\$ZWS:@8KR0SO;
MQS65O:),()6N!(L<;N.RM>Y]H4^C:1>R76HQW=ZG1HW7#O+:?ASZ]K(T\VSZ
M8FE"?3X1:QW<UOJ=WJ$MNUU EHT+33Q1G&MXZ*]#BJP< @SNV1>RP/3A;>I6
M1<["9JQK6"@-1WM;]4RZ@1JPBBB;2'GS U;9)#K(S;#;<VQ2F0J*PA$UEYCG
M6O2757N(I9HM/DL9=:M]$%M#%/%?"6XTJWOUN4GDNI()4628I) ;>(I"IE,Y
M*$-UM[T.T**UF@@FU:+4X.CMYTC:\N)K6;2S!9Z[>:4UG):PV,5U \D-LLD=
MT+N</<NL M<2*RWK7.A#I=;L%]58MG7@M0Z]K?HWM=:M)"ZU#2C)F;U+UB6;
M,DB#I_6>T4CX(]QAN16JLJ(DIF*M<,M8G)2%24\6?I5KIAM!#8VL=W->]([>
M:W2UN-3,2Z).(HT00WMB7=P2)YPQCW#='#M(%<VUZ#]&!<:B;G4[V:PMM.Z'
MW5M=/>VFB"9^DMH;B:64W&FZKPTC(W6UKLXNP[)K@LI<=8^^-;?2;W9MO4Z7
M2K[6M]CW.DQI1N'''EYD*MV @)A32,*))EQ8LN;$BLRGV8TJ1'0M[.&75M]Z
MK.\:5>]\M,T_4,1@WME;73+$Q>-6GA21E1V"LRJS%064$@<P#RKS;7-.[SZU
MJVE RL--U*]L5:9%CF=+6XDA1Y$1G17=$5F579020K$8-8GYSZZJO>%W C^I
MTTW_  F;3_SAQSY3[K7[,KG_ #&P_F:^ZNX+_>[LOWRU3_>:[IN>9U[-6'=]
M;!-:QUB8M%:A-D+,X6IU7KD5T$5M+6#=XN0"F0)SU8!$1!JQQA#Q[!F8#$EA
M9 I#'R(<4E ==3+9RPH)) K'"X=F.X+R1&<C<P*J3MP"00"1R/95)&**2.9)
M"KR)YL0!R!!(&<D9&0.VM;JQU3;3@E7:'=M4I+W594*/!G(ZHNI0%@Q;4[',
M5WRE5;):MBFZ)(@4S5UIM]EB%["7GQ0. 3T> JQ6%JGCLS6\9&]),)AB0?RC
M+LX8;#*J!P6D55(4 G/[4;SB$S [67+9 !'@ [MQ&02Q7 0LV2?!((YG:+-K
M'=#(IZQ!H:M07657;F2H,NJ%J\,L%C=%TNZA]9QE&KS* UXO6J\4@WR]&J\F
M),/P@+\&BV:4BRJ(M!QAV[614'\HFY ^X%E7+(7.$#%68%$#9"EO#7P0,E:B
MYYKE&VN5VD G 8+S8@$ [F(P2!A2<DX!RYI?JVB;3*B1\JH$A8<O1K!>X-R4
MN/'@38%<K.G;8<C,UUN87*,HKK&Z055*3W9RU2+> /QH@Y$7P*VL<ML8P3N!
M(=4*>,%FE4<\ <^$S#EZ@J2<\JO'-O(&T@%2P;Q8 1CRY]G$"DY/A @>*L)O
M]T2>@766%FZ4NL\5)J=+M *%4X)"\GV8!8=#M%DEV>91X5G$5^=%JVP]*1Q=
M?--AAS=GM)5@E=TUY00_+RBRRH(E0'<ZDL0@)!*J%#E21N28DC)VJ"$SD53K
M)#$<-B-JL, L>8RV2NX9 :/ ( R3X6"#636>MP=*+1X<?61C DF* W(39)EL
MJ\09]+.P5O<UMCW@^VI]R96T1:_I0P4G@Y;#Y&%%ME(:E*9)$BXT%CZJ0,\0
M9!*,H5B=X:)=B_X7.4 'D#M?'( M?CC.-IQC=DD8VXD.X]N.49.#XBOC) L*
M=U_RS5,M<JCZD-PKU7BL:M2Q=_>D5D=7CEIGZYKM$43%6*+4;38'YUGVD#AE
MJ\&@PUY8KMO2$L)-S-,<N.066&7?*I1@6RGA$A=[/@KO50%C)#-V;DW*/#VT
MZSD-M0AARPW+!;:%R.1.2PR!X@V"?!+9'T[UI1=V&:H#JVH=A"Y-O?66@/7(
M:5I3$+7C0('87[C/;M($3,ER6(EFKD7(FL1;(*D$++7\0+5,%RYI8;CEM>$K
M,TJ$* #L(?\ *$L-G@L0.:GFY5L!O R,&Z3[RH","V2-W@^" #NYCGV@8&1D
MC!(R1N]SB5GIQ2OS^>["R0D+NJ_4),LHR6;KD2TZ<DGPP\BD1/+!6-.ZN=*#
M(15<0@@9+GP4/Q8Y!4":F$\ZB3F))PWX%?USW.5E;H%HZP.L4S0:DL,KIQ$C
ME.I7XC=H]R<14?#,F]=X!7<N<CX$[K[0IW4^D+W,;S6ZW6CM/#')P9)85T?2
MS+&DI201.Z!E60QOL8AMC8VF4L?=02QYU-F@:*UY5-A@J%MG6U$("%/6*BUZ
MK[-)ZJCMQ2>O=F,7T8>0#H5*N=%P(\;'565!O$>1%K@M )V&9M#T&CB!@?5;
MRXLYKO3[V[20+!=S3V,=^24O+%K1XN+=W-K=\3:]PK6I5II.*'BQW/=,FN"+
MF/0M.L]0@L-5TVQDAW7%C;VNI2Z4@673]26_CN.!I]E>V BWQVC1WR.MM$+=
MHY[HN/=+-9;,I6P]>W_0=]<JNPITLA,A4K<M<J4@7$F6+5Q=-&#O/Z;/P!6N
M P/26K:770(X3%GB*Y6LMMEG),I3R,%MT)O;*ZL[RTU:T%Q9JJ*UUILUPLC)
M#?1];D U*)Y+V274[^YFE>1DDGF!,85<'D7G=&TS4K/4;#4-!OS:Z@[R.EEK
M-O9M$KW&E2BQA+:/<1PZ;#!H>E65M;QQ+)#;6V!,78M6$%=?A0[87K!?=>M7
M&,[U+&>IM%%FVF?]+MJQAZD;&:?J"*])AS)&*?2[18S)BX1DD4$-A@Y2PDN:
M'(/2+ YVGH3CBA$-I>&V8:+'H9NU@3KA@DN(I-1N#,K*#<W,$,<=LQ0I9RKQ
M561 (1TOH[EFN#/?:>MY&>DDW27J#W4@TX7,-K-'H]H+=D=NIV5S<3RW:"02
M:C;N;=Y(9&:X-&MG6]BY;U =0<[6 \/=@NB#>KD1P-E,/BF+U+J-QH]?V:-=
MMWLLL"':T&L0B=%$F3IR<^?K[<]5@;9DHB1,EOT8ZMI4NCK?O+:R:K%?9E@C
M$C6BW%O=2V,@M^KPXGEAD5I8HHE$,Q3@DJ6;#=]-#>:W!K[Z9'#>PZ'/I@6"
MYF:%;Y[.[L;?4XC=];N UM#<0R)#-/.[7%NLAN K!$V D=TXIYFQ2C=KZ?9A
MYA%IDV01$SL,4T_$@M[LJNUQ5+FS9FNB>9537 UKK$#8V(K(\D>GAK<?S/AR
M;^:9:ZD="+F*%8K?5UB;@+ []3D(9SI=QI\ERJK>IMN-][?2PEBZ0I);0[&6
MSB)[UNZ3:S7+3W6@-.HNGN8D.HQ@I'WZM=5BLG=].DWVG#TS2[>X55CEN)(+
MNXXJ-J$ZBVQ_='@2:&3KI_45NLUHF:#'Z1''2.YS":Z%QBDW.MGC\.D,UU(6
M1@I8KC.O,&*1Q-FU\VW"R)+,+$#)+.9^ADINTGAU"W@@75WU1XDTR+C2'K5M
M/%"UT9C*NR&V6U=DVK-$6XD9$CJ<"=T.'J$MM/I-W<W3Z FAQSR:U/U:$=1O
M;:>X6Q6W$+&6XO'OD27B-;W 0Q2JT4;B_3'=5JZ>)&R)WIT8L3M@W5/V<5<L
M5Z'FWYP5_8 >] P\K!6A3X,BR42( "T2CV=4'P >D!X0%09\7-L(XYQ8^@4T
M21I%K+0B+3$L8Q#:O$$D%G):2R*8[M7$-VTLMU=0!\R74KS"02+"\7/F[J-O
M<2SR3]'EN#<:W)JDQN+Z.<O"VH0W\$+"6P>-KFQ2W@L+*Z,96&QA2W,#0R7,
M<_7WU-;^E=0USJEB7#L,(=2]7T?689%MLS-PLTMBKPI$@P<.6*.$KK! E9K8
M6L=DDJ0(CJ947\7>=FR&G9TG;=$TA='MKB$-"SW5]=7TIMX#;0*UPX$<44)E
MF*)!;QPP+F0Y$>0$!"+H7237GZ07EK<%;A([+3++381=W*W=RZVR,TT\]PL-
MNLDES=S7-RQ$*D&;:S2,&D?L[[C[U\;5U7L^I]+Q</9]H:JV(<2/K@0/'>+6
M#69N<XX_+/ VNWOLTQ7:\1N IQUJ(*CM2K./5'D-%HIK4>GG1BROK*?64DAL
M[ZTBWRRR$)%>1H %BE/LCL2W< LY*POE2C1[WW+^F>I:9J-MT?>*XU#3=0G$
M<,$2F6>PFD)+3P#V-VO=QDA$4-<)AED6;V \\&KZDIQ2G%*<4IQ2G%*<4'G_
M ,_,4XIR/OTXI3BHS_%S/P<_JIQ4TXI3BH\Q[_G]?(4XJ:<4IQ2G%*<4\_/S
M_DIQ4>3M_C_CQ_73BI\__-.*4XI3BE.*4XI3BE.*4XI3BE.*C/BSS'E'\?BS
M^:G%33BE9QHW]+T?^_RO\LKFKZI_;DG[F/\ V!6\Z'_<Z+]W+_.-6&.L(?L$
MMTV[2&:K]D?L_GBA$6N9J4L[ L&)#UF"(EY@3JR_%L$/&!N9N9DD1)CSF(.)
M3C+S2D]^GF=&WLX];L)-0X'4TDE:;K"Q/#@6\I0.DX:%LR; JR*4+[0P(Y5U
MW3./49NC&K1:3UGOA)#"EMU-[B.XW-=0!^'):LEPGY(OO>%UD6/<58$9K4YN
MI[,T3>P_TQ8&^;AK*5KNRJ!0]"VO?NWVFMS%RL@5-]E2K-:+5L6*B10VZZU0
M9)N<UJNM6!%P+DG QR8*).=KJ46F=*-&O["VN;33KNZF2">ZN6T[0+Z'2Q"'
MCETZ[T^*SAAGAO#-)<O;8U&:,6L2B:!98CJ,=MJG1S4;8ZG%KU]I9TZY>W30
M;KI#K<??N:5XI%O1=W5[J*HVGBW&GM<.-)M;GKL\A@N)(938IJ3U(L;#"G[M
MK_>AS9GLLT3+U?7A-IVE'U.+UPY4J<C98ZVFM+S1^J,;&&;"7=Y5^=W$PFKV
M"K,B8%1<DCUL,IY.CVFF66@VVFMK>G7Z6NF7]KJVL7=GI46L:GJ<$DZ6M\MK
M>1M=)!=V:VSP)HX#P7<DSRI&1@<&ZDZ2]](KJ]TS7I-3:]T&72;.WN]7&C0:
M6UG9C5(+NXT1X])[Y0ZB;YM0;6U%K<6BQ)9EHR@%-H];ZY"=;T4,O!V^"0LG
M46[XUAE4B-;!VUQDMV]ZL7 :O96ZE"5>>OLRF-VV-K^=D? )0%N%9(/*)B&G
M&NW9^B37NIB$V$;MJ>F<&2_,$NED"SU$ V\=E&EPMB+PVO7@&DCV%#.&0$'K
ME7NA1Z7HCW":K.J:+K768-)ZS!KF3J.CY6[FU*9[1]5.G"_.EY$,AD$JVS)(
MRLM-V9K'J/<VB&J.C@.][%H&+>:[)8 ;.WIO;7;A6SQ=%]0I2\)5MN',L6X
MNMI1]S2$83BQ2%U6;M5J6+%^)P'R+^(L[S18[*:;5I]'BUCJUPC3Z=I6CZ@B
M0'5]'BM"M@1#I<]ZL2ZJSM;CCC32DKEVX8-]1T[I)+J5M;='[;I%<='>N6<R
M6NL:YTBTJ62Z[P=(I[]7U8-<:Y::<9WT%42[_6[:RKVZ")&F86(P&Z_!&MKU
M: )3=US=(:BT]3#-#M$:P +B+,EXAEXS<];R2+KAB9<M4G%1JQ>LL%)SVQ:C
MC-JQ-('X8EPSRS+T/DOK.":/2K8)J6I745W T,UL\4;Q"*UOE0<);74(0UQ:
M;HU%E<?K<HD32\+A"#N@PZ7J%W;2Z[>-+HVBV,VGW2W-O>PSS1S--?:8TK-,
MU[I-SMM+_9*[:E:9N^)+<I%Q^]6!"9'0X\&.N2XS&;PTVN9,ED)2DI[>S+\V
M<](ER7//YW9#SCF?-VJSV8YY,[EV9V"@L<D(BHOYD0*JCW@ *]\CC6*-8U+E
M4&T%W>1R!_A.Y9V/OLQ)\M3?*U>O/Q]$A_F'=5_XUM'_ -$.\^>N]Q?]E-_^
M\%U_2.E5X!^J-_83I7^E-E_1.MUXGO5ZOL^?MQ^U^SSZ;KXNJXJE;[70K&)N
M%'LIZGVL#)\<"66L%IX(Z)E^#<9S('%AC\:=#>4RZZRM;#[>5LNN-+[YMQ:5
M8;BWM[N&2VNH(KFWE7;+!/&DL4BY!P\;AD8 @$ @X(!',"N1:7=U87$5Y97,
M]G=6[[X+FVED@GA?!&Z.6)E=&*D@E6&5)!Y$BLGRNIOJ-FR+W+F;XV_*E;1&
M1 NQWW]C6UUV]!QX^2)@"K8M992CHZ$*F2Q<2$2\8CQALN3!9;1%D/-+X*Z'
MHRK:*NE:<JV$C2V0%G;@6DK.)&DM\1_DG:15D9DVEG57)+*".S;I)TB=K]VU
MW5V;5(EAU)FU&[+7\,:-$D5X3+FXB2)WB1)=R+&[1J C,IEY?4?U!3P1JKS-
MW[8DUNQG!MG/ 7M@6E8@Q8PWD?R2>(C\E/%99<;FNU]4(@\TN5&6##K:=2L;
M#4S9=&TA)8IUTO3UFABD@AE%G;B2.&7B"2)'X>Y8Y!-,'0$*PED!!#MFC=(M
M?>":U;6M5:VN)XKF> ZA=<&:XAX/!GECXNQY8NKV_#D8%D,$!4@Q1[:U(ZL^
MJ*67,GY?41NJ4<L3%9C'BTG9=P?(&(]+G3"=08)2G2ZGIC58)$2) "A]2TBI
MQ"?+A89?F27'<0Z/Z$L<4*Z/IBQ0F=HHQ8VP2,W2JER441X4SHB),1CB(BJV
M550,S=*>DSRSSOT@UIY[D6JW$SZG>-).MC(\MF)7,Q9Q:RR226X8D1222.FU
MG8FS .[=QU>;1"5;VGL$ 0U=!+B];S0]O/#95#&V"20F'A]1?B3V7*_"-2BQ
M205B"U1F"+I&:J6V]F2]W_)ETS3ITNTGL+.9+]HWO4DMHG6[>)46)[@,A$S1
M+'&(VDW% B[2-HQPX-9U>U>QEMM4U""33$EBTYX;RXC:QCG>22>.T9) ;>.9
MYI6E2(JLAED+AM[9X9&Y-MRYN24K9E\DD%;"3MK,^1:S;TY6T$>#PC8BI;DU
M3ZKHC#3>$67*\ET=XGO)>.SDKINGJNQ;&T5.IG3]@MX@G43G-GM"[>K')S!C
MAG)RM0VKZJ[\1]2OVD-_WU,C7<Y<ZGR_]P+ERQO1@8NB>,,<GJKL=0F]HIJ1
M8XVXMEL'I8<=7I1AFZ6!LC(!"+,Q=!0=Z6F?AYT:,M\:/:!\-:LL0C[+1:,V
MU.0E[&,Z1I31B%M-L3$LCS+&;6$HLLD!MI) NS =[<F!V'A-"3&24Y5E77M;
M69KA=7U(3O#';M,+VX$C017*WL4)<2!C'%>(EU&A.U+A5F4!P&KG.]1N_P"S
MT/.KK%NO:1O6V7LR%4(I>[)-J"WLEWK!W[M>?)+%NY\NRI!K&'(JL8+/.$<8
MQ+SEWD1:-I,%WU^'3+"*]Q@7:6D"W('#$/*8()!^2 B)#9,8"'P>56GZ0Z]<
MV'>NXUK5)]-SNZA+?W3V9/&:XR;=I3"?R[M.,J?RI,GJ\-4U3^IKJ*U[-E$J
M)O/:]/(3J_5:G,G5J^V8-+E5BC0<C*97Y#\ BPZZ'J@[.8-='K5F,'B?SB T
MPUV)Y6YT/1KQ52[TO3[E%FN+A4GM()56>Z??<S!70@27#^%,^-TC<W)-7L^D
MG2'3Y'EL-;U6SDDM[6U=[:_N87>UL8Q%9V[-'(I,-K$!';QGP(D&V,*O*L/&
M#!:PEB9X\3(&CAJ?+*F#!:9((E"I,A(<E3B)&?+<>E39TV4Z[(E2I+KC\A]Q
M;KJUK5E6>QCCCAC2*)$BBB18XXXU"1QQH J(B* JHJ@*JJ %    %=1+++<2
MR3SR233SR/+-+*[22RRR,7>21V)=W=R6=F)9F))))S5.Y>L>?/\ JKWA=P(_
MJ=%-_P )FT_\X<<^4^ZU^S*Y_P QL/YFONKN"_WN[+]\M4_WFNZ;GF=>S5)3
M1HXEXIY1@0I_B$U@E!\=BL2O$B,7O_%I\3P[;GBTV/X1SP$IGO'V>_7X-Q/?
M*[9!(["1D8./&/)\%, ]HSX_S^6K?L5 H=O@%!5LI-1M LY*'SC0VQ5L,;@%
MYHG#"14PI#)0I,<A*&8BQL#Y$MMYV%B.QB,MO#3?>RKNI!5V4C(!5B" >T @
MC&?'CMJI56!#*K X)! ()'82".>/%Y*I;VI=522K!V1K/7SYR*1)&(QEZF5Q
MTK'+&1D$(7*,$5C53&2)4,,&B"4YMY,F<,'P8$IUV+$8:;GBR ;1(^T@ C>V
M, D@8SC )) \1)(YDTV)G.Q<Y)SM&<D8)SC.2  ?*!BKA%5*J <P\@ZS7@V1
M\8G"@9%!1H[,&&:FQB9B)#S#C,YC1BQ*%#($V&>\:GS8D:7*0Z^PTXB"S-G<
MS-G!.23D@$ G)YX!('D!..VI  [ !C., #MQGX\#/EP*LT9HW2@5H9'#:?U:
M(8"615R"LB]?U,>T(MZHL>"JU"VX@EE(^R*A1(D/)V)ADIF+%CQ\RO!,M(38
MS2G),LA)78<NQRF<[3SYKDD[3RR>RJB.,<A&@ .X *HPW9NY#MP ,]O*K:U?
MTV:AU(W9<UFKQIDZW$R!,^9L;<0Z;(K)PD#IL>64EQ?&9C4V&A>"\F:N24LD
MV41,6@@;-E")*5:2XEEV[V.%   Y 8.1R'+D>P=B@ *   (2)$SM'-CDD\SV
M =O;XN>>9)))))-7!!T/HX6FN)&Z9U0.33B:S513!UW4(B:L9<<%NK+5S$<.
MW@&36Z$"N+GC/%92G! M>7<J'Q,LU,TQW9ED.\8?,C'<.?)N?A#F>1R.9\IJ
M>'&,81!M.5\%>1[<CER.0#D>2KGK.O*!2L(33J-3JDEMTR\VFLUD*!PV]8Y(
M^;8748%0HN$.G9@@5+,N)[%%)(P>_.R^["C+:JSN_JW9NP>$Q;DH(4<R?4@D
M#R G';5@JCL4#M[ !VX)[/*0"?+@9J\.5J:<4KP ]UZ>K<?NL.^I%RB$)]08
MN6E7K7!$NH8*S:VUJ+5:SD08^XMM#)"2+3*9A.K<;0W)6VM2TX3E6/K?N=B=
MN@&DBV9$N#;:F+=Y 3&LYU&_$32  DHLFTL "2H( KX'[KC6Z]U77FO$DDM%
MN]&-U'$0)7MQI&EF=(V) 61HMRH21AB#D8S5+@;*[GZ[.W(]90Z)C9BIG*KK
M&'5M)M54.,;*!KYFK%I;TZS6PZY9:,6+TQ$JTCW:87LN*O%R;S969)Y\]D>R
MZ7!=-$$A4QW$5Q?-/J9N)7,<MIUB-0L%O$(+J..Y*P.+J.#CMPA 1"L7'34>
M@9DUAKB+>)K2>UTQ+;15M88A+;W_ %65C)<W4YN;&>:R#72-9S7/54,[7*O<
M&?YL6]>A4ZJQ$P.HZS2K AJXR:BJ3JB1::I' 2MLW.8&HI2J1[M6TE;/+U;%
MH<.+L"46C304RP7%F(3@RP]7E0D.E=*HN"DNH3W4)-LMQMU!8+@S+I]LLMTE
MPUM-PX%OVNV:T6-DE6&V+1LLDZM%SKG0BXZQ+!I-M97&V\>TW:6US:I ^K7K
MPV$EJM[;B6Z?2TL$34'F5X'N+Q5EC>"TDCD[!N_H*$4H4YK[2D:9=@^K(8P,
MS=JKD_ C[ +3=%03I.TH;)A&;<\"C@]Y6P+@Q/*Q7BEC A\DF:K-33:A>'2^
MEDERXO-3*6LE^SRM:S\%VLXUU5XD@RDIMQ*9=+MY>&L;!(99.&9TZS<4N-:Z
M#0V<)T_1A)>P:4L<*WUJ+B,:C+)H23R78$D NS"L&NW<'%DE0RW5O#O%HPLK
M/6[J]N/3M<K92Y73G7?8X!'4U(ZS0X];C5P4HZR:*8AK$H5C)^>RNO\ DF1/
M?MLRQ6&(7D$!;UUN,*#"-O\ =='K;6+:WN5UF;CRO<EX&,S32<$Q1[N(<F)3
MQN(%%NL,+1JCBUMF=XAKW2R\Z/WEW9-T>M^K6\=D(KE!;K;Q<=9YMAB'.XD4
MVW!:1KM[FY69I(FO+Q(XYFU(^?S[?G[G-@K5*<4IZNS_ &\4J^=:ZTO.X+S6
M];:VK9&VW:VDFA8($+;PN1*D.8RMQUUQ:D1X4"%'0]-)DYST<>,'QY,^?)CQ
M(SSR.-=W=M86TUW=S)!;P(7EE<X"@<@ !DLS$A4107=R%4%B >786%YJ=Y;V
M%A;R7-W<R"*&&(99V.2222%1%4%I)&*QQQJSNRHK,/;/W.WN=E%Z):/Y4)8'
MVS?%M&L-WN]):RY'%QUY1(53:9F0A+T*NPW\(S-G>#8GV::PW/(H9BQQ0L7\
M[=*^E=STBN=B;H-,@<FVMLX9SV=8N,<FE8>I7)2%243+-(\GUKT%Z"VG1&TX
MLO#NM:N4 O+P E8E)#=4M-PRL*G&^3"O<.H=PJ+'''V4<U&O0*<4IQ3S\^7U
MTXI3BE.*4XI3BE.*4XI3BE.*4XJ.WW_)Y^?*G%33BE.*CLY#Q8^*G%33BH\_
M?Y?!_)BG%/,^?B/,?53BIIQ3S\M.*>?GY_U4XI3BE.*4XIY^?G\5.*4XI3BG
MGY_'_'3BE.*4XI6<:-_2]'_O\K_+*YJ^J?VY)^YC_P!@5O.A_P!SHOW<O\XU
M7?SKZ[>L<[(U\[L$>,B1[=:*9*%RBTIDG52DL=+<43JQ^NLID(8D-1I:!DTS
M#L<%F>S+CH, AKBF%(PYV\VRO!9O(S6UO=+(L:F.XC5U&R>&8E<@LI=(W@8J
M5/#F<9SBNMU/3CJ,<2+>7=D\33.LMI*\3DRVEQ;#<%95<1/.ES&)%=1-!$2I
M&:P3$Z8KC&DNR%=2FWW5)R15#=R0_P!TH<)5\4"R]/RY,>@S7!;XUT\&9CCQ
MT".8GRL$(144_,%R^V;7;5E"]Y-.') XV^"0DTDN$PH=0X=8I2SR.T:+L>.0
M+(O0)T6O4=G]$VLG^RE#Q/"!EMXH-TA+F-S$T9N( L4<:SNW$CFB9XGF$],U
MIC%(1>'U#[:>EQ8R8CC)PM**#9+8^N @026L;$)B(B2K<H(LU82&4+S8YIDP
MA; YN1'S%KW\@:-XVT;3U5V+@PQI&ZEYII95$C1R-PRLO"A3(X"Q1$%RIW3Z
M%KI98YH^D>L%XT",L\SRQ.([:W@@=HDEA3C!X#/<R8/67GG!6(.NRN?4]%VW
M@\AC<FQU.#R V>19F'[$]".*AU(15Y.)3$2RCWH^7Y0Z7:XZ(LIN%&LY)R?(
M@D&VLL/XN_$9$BMIMD Z.B%(85:+=<23@JS0.#A76W)92QMT"*Z$Y'(]#DP:
M%EUG4B8Y(I)1)<7+)/LLX;1PRI=1LFYHGNU".(UNI3(T<BKM;-=$K<ZGU !6
M25B(6N:&@)A/V$KC."!/*''%(>D]^_*=RIMM:(Z%/RI<E;3*%RI4F0IU]SJ[
MN=+FYFGCA2W25RZPQ^HCSC(7 4<SDG"JN2=JJ, =Y86TEG9V]K+<R7<D$81K
MF48DE()(9LLYY A1N=V( +N[98W;SCUS*<4KHE^B$:!>]C=&.L@FO:5;;V:B
M]3U,*RA%-KABSE(PMC5.Z8CY)^ $ASI;,!F7.A179CC28[<B9%84YAV0RE?J
MO<@N[6SZ2WTMY<V]K$VAW,:R7,T<",YO],8('E95+E59@H.2%8@8!QX7^J!L
M+[4>AVF0Z?97=],G2:SE>*SMIKJ58AI>L(9&C@1W6,.Z*7("AG52<L ?'3]2
MQU._!RWQ^*'8/\'N?1W?W1/;G2OI&T^^KY ]"_2;W.Z[]$:A^'I]2SU._!QW
MQ^*'8/\ ![]CL\W'?W1/;G2OI&T^^IZ%^DWN=UWZ(U#\/3ZEGJ=^#EOC\4.P
M?/\ 9_X/?/S<=_=$]N=*^D;3[ZGH7Z3>YW7?HC4/P]/J6>IWX..^/Q0[!_@]
MQW]T3VYTKZ1M/OJ>A?I-[G==^B-0_#T^I9ZG?@Y;X_%#L'^#W'?W1/;G2OI&
MT^^IZ%^DWN=UWZ(U#^NWI]2SU._!RWQ^*'8/\'N._NB>W.E?2-I]]3T+])O<
M[KOT1J'X>GU+'4[\'+?'XH=@_P 'N._NB>W.E?2-I]]3T+])O<[KOT1J'X>G
MU+'4[YOZ'+?'Q_\ %#L'/_\ #WS]?9QW]T3VYTKZ1M/OJ>A?I-[G==^B-0_#
MT^I8ZG?@Y;X_%#L'^#W'?W1/;G2OI&T^^IZ%^DWN=UWZ(U#\/3ZEGJ=^#EOC
M\4.P?5_W>^UQW]T3VYTKZ1M/OJ>A?I-[G==^B-0_#T^I9ZG?@Y;X_%#L'L_S
M>^?Q>?M=_=$]N=*^D;3[ZGH7Z3>YW7?HC4/P]/J6.IWX.6^/M:AV#V_KU[_7
MV<=_=$]N=*^D;3[ZGH7Z3>YW7?HC4/P]>V_N&E,N%"Z :C7;S5+)3+ SL;9D
MEX':P12NF&HTH]AR+(<&&(L.:VQ);_GC#JV,(>1_--J4GS\^8>ZG<V]WTNN)
MK6XAN839V*B6"6.:,LL/A /&S*2IY$9R#R-?:W<0L[NPZ V=O?6MS9W"ZCJ;
M-!=P2V\P5KC*L8IE1PK#FI*X(YC(KN!YYU7KM.*4XI3BE.*4XI3BE.*4XI3B
ME.*5X/.[!Z WQ<^Z-]2=EI^D]N6NMDR&M5#;!6M;W$Z$(IBZ:UW"DJ@E18:5
M EICS(TF(_EB0YAF4P_'<[UUIQ"?JWN<ZMI5MT,T6"XU/3[>9$O=\,][;12I
MNU*\9=\<DBNN596&0,J01R(-?"O=>T#7;SNB])+FST75KJWEDTTQ7%MIUY/#
M)MT;3D8QRQ0LC[75D;:QPRLIP00.M+ZEGJ=^#EOCS>C_ (H=@_'G_P##WN\W
M;O[HGMSI7TC:??5YMZ%^DWN=UWZ(U#\/3ZEGJ=^#EOC\4&P?X/<=_=$]N=*^
MD;3[ZGH7Z3>YW7?HC4/P]/J6.IWX.6^/Q0[!_@]QW]T3VYTKZ1M/OJ>A?I-[
MG==^B-0_#T^I8ZG,9_,Y;XS_ /*'8/KQ_P#E[U?L\=_=$]N=*^D;3[ZGH7Z3
M>YW7?HC4/P]/J6>IWX.6^/3^=!L'U?9KWHX[^Z)[<Z5](VGWU/0OTF]SNN_1
M&H?AZ?4L]3OP<M\?9^E#L'^#W'?W1/;G2OI&T^^IZ%^DWN=UWZ(U#\/5=K'1
MKU97"Q!:L#Z;]W.%SY***')GZRN >!B3,=2RTN<7+"(0L7";RKPDL@2F18$*
M.AR3*D,L-N.)Q3=(] MXI)Y=:TL1Q(SN5OK9VVJ,D*B2,[L>Q4169F(5020*
MS6_1#I5=3Q6\/1S6VEFD6.,/IEY$FYC@;Y984BC0=K22.J(H+.RJ"1[&NYV=
MS:K'1)1?*1(<BV;XMPUA%]O:!TA<<7'7EN2JE4M4B.E^%6H4A#:ITW*&)]I(
M1VR1)MB+'#B _@?2OIDW2*YV),L&F0.3;6QE0&0C(ZQ<88AIF!.U<E($)1"6
M,DDGU+T%[G:]$K/BRVSW.M74:B\O!!(5B4X8VEH60%(%8#B/@/<NHD<*BQ11
M=D_DPE[W3OO21\GS4./!Z]%\HGUUO_5;GV-/^:&3[/BIY,)>]T[[TD?)\<>#
MUZ+Y1/KIU6Y]CS_(R?9IY,)>]T[[TD?)\<>#UZ+Y1/KIU6Y]CS_(R?9IY,)>
M]T[[TD?)\<>#UZ+Y1/KIU6Y]CS_(R?9IY,)>]T[[TD?)\<>#UZ+Y1/KIU6Y]
MCS_(R?9\_P"5Y,)>]T[[TD?)\<>#UZ+Y1/KIU6Y]CS_(R?9IY,)>]T[[TD?)
M\<>#UZ+Y1/KIU6Y]CS_)2?9IY,)>]T[[TD?)\<>#UZ+Y1/KIU6Y]CS_)2?9I
MY,)>]T[[TD?)\<>#UZ+Y1/KIU6Y]CS_(R?9IY,)>]T[[TD?)\<>#UZ+Y1/KJ
M.JW7L>?Y&3^M?C_JIY,)>]T[[TD?)\<>#UZ+Y1/KJ>JW/L:?Y&3[-/)A+WNG
M?>DCY/CCP>O1?*)]=.JW/L>?Y&3[-/)A+WNG?>DCY/CCP>O1?*)]=.JW/L>?
MY*3[-/)A+WNG?>DCY/CCP>O1?*)]=.JW//\ 6\_R4GV??\7_ (>3"7O=.^])
M'R?''@]>B^43ZZ=5N?8\_P C)[_^+3R82][IWWI(^3XX\'KT7RB?73JMS['G
M^1D^SY_'3R82][IWWI(^3XX\'KT7RB?73JMS['G^1D^S_P":>3"7O=.^])'R
M?''@]>B^43ZZ=5N?8\_R4GV:>3"7O=.^])'R?''@]>B^43ZZ=5N?8\_R,GV:
M>3"7O=.^])'R?''@]>B^43ZZ=5N?8\_R4GV:>3"7O=.^])'R?''@]>B^43ZZ
M=5N?8\_R,GV:>3"7O=.^])'R?''@]>B^43ZZ=5N?8\_R,GV:>3"7O=.^])'R
M?''@]>B^43ZZ=5N?8\_R,GV:>3"7O=.^])'R?''@]>B^43ZZ=5N?8\_R,GV:
M>3"7O=.^])'R?''@]>B^43ZZ=5N?8\_R,GV:>3"7O=.^])'R?''@]>B^43ZZ
M=5N?8\_R,GV:>3"7O=.^])'R?''@]>B^43ZZ=5N?8T_R,GV:>3"7O=.^])'R
M?''@]>B^43ZZ=5N?8\_R,GV:>3"7O=.^])'R?''@]>B^43ZZ=5N?8\_R4GV:
M>3"7O=.^])'R?''@]>B^43ZZCJMR/_CS_(R=@\0&WR?^/%3R82][IWWI(^3X
MX\'KT7RB?74]5N?8\_R4GV:>3"7O=.^])'R?''@]>B^43ZZ=5N?8\_R4GV:>
M3"7O=.^])'R?''@]>B^43ZZ=5N?8\_R,GV:S/2V76 ,=M]IQES#TG.4.H4VO
M&,O*SC.4KQA6,9QY\9[//CT<UO4F5KMV5@P*I@J00<*,\QD5NFBHZ6$:NK(P
M>7*NI5AF1L<F //M'+F.8JZ^<"NUIQ2G%*<4IQ2G%*<4IQ2M#^Z&=<P7N?\
MI>L;D.Z\*;+B67: 7638(38(E;DQ))FJ76TH++G3!A5IUAAJF/0U1$QT...3
MVWL/)2PIMS:^A_1:7I=J<^FPWD=DT%C+?&62%IE98[BU@,857C()-R&W9( 0
MC',$:)W0>G$'0'1K76)]/EU)+G4X=-$$-PELR--:WET)2[Q2@JHLRFP*"3(#
MN 4@].'MF777P3+K^-4%_ SGH_I(WON@M?F$OXFO'_\ U*Z=[E+WZ5@_!T]L
MR:Z^";=>S_"J"_@9QZ2-[[H+7YA+^)I_ZE=.]RE[]*P?@Z>V9==?!,NOXU07
M\#./21O?=!:_,)?Q-/\ U*Z=[E+WZ5@_!T]LR:Z^";=?QJ@OX&?/T<>DC>^Z
M"U^82_B:?^I73O<I>_2D'X.GMF37/P3;K^-4%_ SS?/S\>DC>^Z"U^82_B:?
M^I73O<I>_2L'X.GMF377P3;K^-4%_ SCTD;WW06OS"7\33_U*Z=[E+WZ5@_!
MT]LRZZ^"9=?QJ@OX&<>DC>^Z"U^82_B:?^I73O<I>_2L'X.GMF377P3+KZ_Z
MZH+^!G'I(WON@M?F$OXFG_J5T[W*7OTK!^#I[9EUU\$RZ_C5!?P,X])&]]T%
MK\PE_$T_]2NG>Y2]^E8/P=/;,FN?@FW7\:H+^!G'I(WON@M?F$OXFG_J5T[W
M*7OTI!^#I[9DUU\$RZ_%_P :H+^!G'I(WON@M?F$OXFG_J5T[W*7OTK!^#I[
M9DUU\$RZ_C5!?P,_V<>DC>^Z"U^82_B:?^I73O<I>_2L'X.N[SH7ZNQ76_T_
M"-]AJ20U]!+6.S5U%;)FHQ^6PY6I^(#DI1&(/&,K1+5GPB&L14J:3_,J6O/G
MYYATJZ/2=%]7DTF6Z2\>.&"8S1Q-"IXZ;PNQG<Y4<B=W/R"O;.@_2V+IMH$.
MO0V4FGQS7%S;BVEF6X=3;2<,L9$CB!#GF!MY>,FMP^:Y6WTXI3BE.*4XI3BE
M.*4XI3BE.*4XI70QUB=W3I72'U'[*Z=BO3O:+N0UQ(K3$BT#]@B0L,KFR4RN
M7%M3(R36"#\7Q5JPMP5X<EO>%<BK?3E"'4MH]7Z.=RNZZ1:+9:S'K%O:I>B<
MK ]I)*T?!N9K8Y=9T#;C"7&%& P'/&3X3TP[N-ET1Z1ZET>EZ/75[)IS6RM=
M1ZA%"DO6;*VO 5B:VD9=@N!&<N<E2W(' UG]LR:Y^";=?QJ@OX&<[OTD;WW0
M6OS"7\36M?\ J5T[W*7OTK!^#I[9DUS\$VZ_C4!>G])GZ_ZW'I(WON@M?F$O
MXFG_ *E=.]RE[]*0?@ZWJZ(>[0Z-ZS;85US["RVI-DM-*G5FJV:S#BS5W&1X
M^7B*JZ7C#1K+QD5A#LB;7W8R)RQ:<E1ZI\:(7P*UOI'W,-4Z/P)=]<BOK0G;
M--#;NAMG)PG%C:1R(WR LH.T.=C[2R;]OZ(]VW1.E5U)IYTZ;2[_  6MK>XN
MXI5O$5=T@@E6&,&:, LT!7>8P9(RZI+P^TOZ8\?WJ>^^D?(\TOO,_KZ_)G[5
M>C^B./V*_P JOV*?3'C^]3WWTCY'CO,_KZ_)G[5/1''[%?Y5?L4^F/']ZGOO
MI'R/'>9_7U^3/VJ>B./V*_RJ_8I],>/[U/??2/D>.\S^OK\F?M4]$D?L5_E5
M^Q3Z8\?WJ>^^D?(\=YG]?7Y,_:IZ(X_8K_*K]BGTQX_O4]]](^1X[S/Z^OR9
M^U3T1Q^Q7^57[%/ICQ_>I[[Z1\CQWF?U]?DS]JGHDC]BO\JOV*?3'C^]3WWT
MCY'CO,_KZ_)G[5/1)'[%?Y5?L4^F/']ZGOOI'R/'>9_7U^3/VJ>B2/V*_P J
MOV*?3'C^]3WWTCY'CO,_KZ_)G[5/1)'[%?Y5?L4^F/']ZGOOI'R/'>9_7U^3
M/VJ>B2/V*_RJ_8I],>/[U/??2/D>.\S^OK\F?M4]$<?L5_E5^Q3Z8\?WJ>^^
MD?(\=YG]?7Y,_:IZ(X_8K_*K]BGTQX_O4]]](^1X[S/Z^OR9^U3T1Q^Q7^57
M[%/ICQ_>I[[Z1\CQWF?U]?DS]JGHCC]BO\JOV*?3'C^]3WWTCY'CO,_KZ_)G
M[5/1)'[%?Y5?L>?+RT^F/']ZGOOI'R/'>9_7U^3/VJ>B./V*_P JOV*?3'C^
M]3WWTCY'CO,_KZ_)G[5/1''[%?Y5?L4^F/']ZGOOI'R/'>9_7U^3/VJ>B2/V
M(_RJ_8I],>/[U/??2/D>.\S^OK\F?M4]$<?L5_E5^Q3Z8\?WJ>^^D?(\=YG]
M?7Y,_:IZ(X_8K_*K]BGTQX_O4]]](^1X[S/Z^OR9^U3T1Q^Q7^57[%/ICQ_>
MI[[Z1\CQWF?U]?DS]JGHDC]BO\JOV*?3'C^]3WWTCY'CO,_KZ_)G[5/1)'[%
M?Y5?L4^F/']ZGOOI'R/'>9_7U^3/VJ>B./V*_P JOV*?3'C^]3WWTCY'CO,_
MKZ_)G[5/1''[%?Y5?L4^F/']ZGOOI'R/'>9_7U^3/VJ>B./V*_RJ_8I],>/[
MU/??2/D>.\S^OK\F?M4]$<?L5_E5^Q3Z8\?WJ>^^D?(\=YG]?7Y,_:IZ)(_8
MK_*K]BGTQX_O4]]](^1X[S/Z^OR9^U3T1Q^Q7^57[%/ICQ_>I[[Z1\CQWF?U
M]?DS]JGHCC]BO\JOV*?3'C^]3WWTCY'CO,_KZ_)G[5/1''[%?Y5?L4^F/']Z
MGOOI'R/'>9_7U^3/VJ>B2/V*_P JOV*?3'C^]3WWTCY'CO,_KZ_)G[5/1''[
M%?Y5?L4^F/']ZGOOI'R/'>9_7U^3/VJ>B./V*_RJ_8I],>/[U/??2/D>.\S^
MOK\F?M4]$D?L1_E5^Q3Z8\?WJ>^^D?(\=YG]?7Y,_:IZ(X_8K_*K]BGTQX_O
M4]]](^1X[S/Z^OR9^U3T1Q^Q7^57[%7H%*H,P&YZ&5,)<6ZCP:EX7G&6UY1G
M/?82G&>WL[?1CL]'.LN8#;3-$6#E0IW 8SN /9D]F?+7=65T+RW6<(8PS,-I
M;<1M8KG( [<>2JMS!7+IQ2G%*<4IQ2G%*<4IQ2O/Q]$A_F'=5_XUM'_T1;SY
MZ[W%_P!E-_\ O!=?TCI5> ?JC?V$Z5_I39?T3K=>)[GTW7Q=6Q^F>D_=N_@C
MA_6(.LE8>;A$U\.CFMC:ZIA:Q7D@&DGA]2J@6Y6@"4M5@GBX<B1#&@(A"3)6
MWX!I"I"DMYZ;4M?TS2)1%?2SQMU=[QVBLKRYC@M8Y%B>YN);:"6."%'959Y6
M0#.3RYUL6C]%=:UZ$SZ9!;2IUM+"-9M1T^SFN+Z2%YX[2TAO+J"6ZN)(D9DB
MMTD9B-H&X@58D#1>[2JZVT+T]M,DY<F)<JH('Z^MDU5KC0&(\J=)K6(PEW)V
M/#BRXLF4^*\;:CL2H[SJD-OM+5RGU73(Q.9-1L$%L56Y+WENHMV<E46?=(.$
M69651)M+%2!D@UP(]$UF4VPBTC4Y3>J[V8CL+IS=I&JN[6P6(F=41T9VBWA5
M96) 8$W?;>D_J9HKDANTZ&VP,\2I8/89-[%%L4Z*&IEC$R#8H^=F#H$N*$AN
M#81!Z9@J]#?%O#"L(HU#FBB$>-Q[?7]$N@#;ZMI\FZYELT'6H5:2ZAD6*2&)
M7=6E<.Z!>&&#B2-HRRR(6Y=UT6Z261876A:K%P[*#493U&X=8;*YA:>&XG9(
MV6!#$DC/Q2AB,4R2A)(942TX6A]XDI 6&.TSM>?+LE<S<*[%A:[M\J0?J27X
M<95I"L,!W'2M=Q)(CH^3<%+XS#\^&UF3X24PE?(?5M+02L^I:>BP3]6F9[RW
M40W.&;J\I,@$<^U';A/B3",=N%..,FA:W(T"1Z/JLCW-MURV5-/NV:XM-R+U
MJ!5A)EMMTD:\>,-%N=!NRR@H>B-W3RE="0]/;0D%K<#=M%6'(H-JS,L5780A
MR19PC'DKPA.N16G$/2CL)+PJ.RK#S\I#?\UPVJZ6B32MJ5@L=O*(+AS=V^V&
M=N2P2GB8CF8C"Q-B1CR"DU":'K4DMO"FD:FTMW;F[M8Q871>YM5&YKJ!>%F6
MV5?":= T2KS9P.=5$GT[;R'7'9="9U9=C]FTZ?,5G9D6F@"%VAT\N!DEHI-D
MP7J;!D2Q&9<!&%MD/'50)489-EQ9+T6,Z\FB:QI;VUE=F_M88-1ABGLFN9DM
M6N(YEC:,QQW!BD+$2Q@IMWJSJK*&8"LDG1_6X[S4K :7>SW.CW$UMJ:6=O)>
MK9RP-,DHFEM!-"JJ;><B3B<-UB=T=D4L)&+H+>TYF!(@Z5VU,CE:V]<A;\77
M%QD,DJA'CP);]K'N,AUHF5MF(6%2GCD93@QN.2@/KE8:F1UN6;5M*0N'U/3U
M,<XMI U[;*4N2SH+=P9 5G+QR*(FQ(61U"Y5@*)H6MR"-H]&U5UEMC>Q,FG7
M;"2S58W:[C(A(>V5)8G,ZYB"RQL7PZD\(S1F[30H">#:=VF6"6AW#%9,C->V
MV>*L;W@2LGP0(C%$.PR[OBX(T_X,>[(5ED.5=[.\'RU-2^JZ9%)+#)J5A'+
M,SQ/>6Z20@&,$RHT@:,9EB&7"C,L8[77-8]$UF:*">'2-4E@NCMM9H["ZDBN
M#B5L02+"4F.V"<XC+'$,IQB-]O/G0.]\2!T/.E-MXEF"QH")BYUO<<2"ARMI
M*KL04<QD-X2<6 (!'%FAT5+LP6@,55.98P.F99COOI6UV[YZ?MBCBED;KMMM
MCBF,8AD<\7"1RF6(1.Q"R&2/83O7-N\.N;HT.C:MNFEG@B7O=>;I9[82FXAC
M7@Y>6#@3\>-<O$(92ZKPWQ;=SUGLC7*X"-A:^N]#65620+1<ZH>JZB*PTOQ
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M>I7((W,.1[#TW= Z0WO1/H3TGZ2:;9#4+[1='N[^UM'#M')+"F5>98RLC6\
M)N+A49':"*0*Z$AAT;Z-TWKSKFT'<^M;J,Z;]Q[ WC#4:?C$J'>G:H+VLQ4%
M.P@F-9UU-P&9",UV+ 8 $&FH"6Y1(5-F@WK =E31K.[WUY/H=_#HVG:A9V]D
M=@*3P<5[0RG<_69."X=I"Q=26)".H?AQA6/R1T1Z*Z'W7>ANJ=U7IUT%Z4:U
MTN3K3I<:1J[Z=;](TTS=#9]X;%=3MS:1V44$=G,J0A9)[>66T:]O))81E/IP
M[H7U#[/[GCUQ[I.B!878G3/JG9IW6UY;"Y=$%R]>U?9;4%AEAI/,B"7,U$@'
M&J.+4E#!2&6&8G06Y#DAZ7T?2O2+32;FW%K(2MS"\LD3$,8F5@-ZXP1%+D[%
M.<%' 8C 7US]3EW3NDO=)Z/:X_22R2.70=2M["TU*&*2)+Z&:!Y#;3[RRR7^
MG".,74R;.+'=VS20K)O>7K$V1W8KNEM;!4MB<(JM EZVUUOBC[FMT^A 9H[:
M^_JGHW:&^*+9:%$G1W&Q]-CZL@Z7N\^,VP(3+(;">'J@O"DQE-ZKGX,8[?Z_
M@^+L/:.=?1=9UV]W2/KQUD3KK VYV]M]'3]4]LOPMD:FZ77@Z[7;.HBOZE&.
M[<L6LMDE0&O]&.0"Z(Q&Y K8FWUZ3-@D#P@='P^XW/\ S[:5L87ZV^L2P]'&
M[.NT/O[5=.S7+/>Z57>D<5JVLFCE"GU'<;6M8HRVWZSV1-BG;(\E1';.<'RZ
MZ/KV!Q=E4,5!C)CE$*5V2]SNZ@=F=3.KME[/VP4%";<WO;9M&DZ.@AXXTMTX
M1J$:57H&J[O/RRDC9;\Y C1;A8K"\[D-.;LP[%68;!M1Y,V <_&1\5*W_P"3
M2O/Q]$A_F'=5_P"-;1_]$.\^>N]Q?]E-_P#O!=?TCI5> ?JC?V$Z5_I39?T3
MK=>)[GTW7Q=3Y_8XI6T_208!![KLU1*;$%GB73?U#AJ"3G2V(+$2YD]56..Q
M':ER%MM-D3=?S8:V%;PKP\HV9'0X>,S)$?G0]((Y9+:QX:L\2:UHTEVBJSEK
M9-0@))5024BFX,\O+"Q1.[>"IK9NBTMO#>:EQ76.>3H[TAAL)6=8U6\ETJY5
M5#N5 DGMS<6T SN>>:)$\-EK?FU;]Z JU%,V/6U2UK8K261O2VUX+9>G 5(#
MTXS;J5TZ#-6THD*L $C73K%2L=.VP18SAF75H$RPDWFV7&+!*60U.WTGI;.T
M4-[<7L,$?>FVFEAUJ027$5O=:R^H7220RI-$UQ!<Z>AYK.ZPQC(,(";U=:[T
M$MDFN=,MM.N+N4:[>6\%UT=B:&SGN['HY%I5C+%<026\ZVEU9:K*/!>UC>XE
M(#+<N9,JA^J[N?E/1M"/KZ'5JG5;==34)^JQM"2,6:RUW/7E1=T@2N+]@>\2
MA:V@].M4#52)J6:ZS"BV&M.N-A(\N4U+)]?+H'2ZY-B;QKBXGM[:)A<-JR<"
M";T*7>F2Q]4WA&O7UFXDN&U!!N:&<?E2JE8^UBZ4] K0:HMA':VMK=WL\9M5
MT$FYN;8]/;#6H)NOA&D334Z.6D-HFDN0BW%L2(%=P\N)W-\=S_(-ZUF3ZM3A
MQH)9;NJ3D=I0,?KRWCE%VS!J5]VF)-:Y&6JSM578Q76EB(TIO9&SJE;A$4HV
MFBU)(:%7B_8#2>ER&]5)[EXI8+7;OU.6&8"*[T][BTL)([V2W@-Q91WL*7)L
MK&>VE9#UNYXK31]5W\Z!OWM=[6TCE@N;W=P]&@N+?=/8ZM':7^J0S:=%=7*V
MFHRZ9<R60U+4[2\A24=0M. EM-4J]U+]'F*S'I5D*:Z)&0USWE9*9;)G2[XS
MI6K&KXGI?1[(&= 35'1&!UE!Z\VQ6PD)J%)57"9$38?8W54RXC("DVB=(^.U
MU#'>)%);:5!<VZ:Z5U.XBM>_IX1U=1%)O@EO-/GE8NHF1)(>/<;6,N2WZ1]$
M1;BSN9-/DGBO==N;.[?HR'T6TFOAT7 N%T!S-#PKJ#3M6MH$"-U:26"X-M:[
MU%O+CM\]S3?]B;L_5XX'7 6^3%B@505K8*8/S]<DMA[.) 6-HE+#12!R="I]
M7.TA;@JO[DM0"UP0<2HD]5M8'R#Q.SZ3TU'6 E\\LTNDQ0O<27LL<*7L=E8Q
MS&Q2&ZCB5KF>*Z'$FTV"6W>5KF._.\1(CUSN<-U0R:8D%K!KTUREK#IT$UQ)
MILFI:G+;KJDMQ8RSR)96D]ENBM]:NK>\2!+2720(VGEN4%U1]#E73N,A3QM$
MIMM,U7<E:\N!=%8ER=D,WSI&<U15$ZX+Q:?4TZ.2SMLC;3E^@5ZIT&O6.!9V
MD1P:0\=L4(P2Z%TIG[VI<O=75O'/ILW"EU7:MD;7I#U^XZ[&UQ<=]<Z>EO%:
M/-<7<T+P',O$8R/R(>D_0FV[\R6D=C9W4UKK%MQH="#MJ2W_ $1.DVHTZ5;2
MT&AA=6DO+C4([>TL+>YCN@%@X2+%#UP=;1D ?ZEKZ2K\Z 4[1&LX-I*C'V)<
M(MLP3JFD"=M%6YT52XQ%PGM"#;YTDDPXZR2E/OSVG742,.*W/HQ'+%HEHDJ/
M'^4OG@CD4JT=E)?W4FGQE" 4"6+VZK&0#&H"$ KBO.^F<UO/TCOI+=TD_(Z:
MEU+&RLDVIPZ590ZM,'4E9#+JB7DC2J2)&=G!(;-:I<[^M7IQ2O>%W C^IT4W
M_"9M/_.''/E/NM?LRN?\QL/YDU]U=P7^]W9?OEJG^\UW3<\SKV:G%*<4K0;J
MHZ?-W;EM\)^D&@<*MPAU-)AIQ;:.P*PJK6^B$;K;(JTZ\KM;)U2X,V6X_2M<
M(&K&43)"C*O)=&B7B$$:J5S+>:*)2'#;B7! C1MRN$7U98,I5>)@*.9;F<$B
MN/+&[MRQC"D'>PVLI8^I VMD[>9/+'(<JMT!TP[]B7@Z2GWI#%1CV]@_71JM
MS;9.+-0:]1]OUVL!SPW ZO1158>-V?5]@+UM,NS3U2:I81LVUGZP]6J\(LUQ
M!L $?A%=K'AQ+C<\;,5.6);:LBAO!&'4A58,S0(I-Q);ENR!O<YPK@ CD ,L
MI(YDD$$E=H%A0= =6A:[ Q%@/9'# 5$IXEFQCMZ[66-K.(4'5 F*>B>)5"MQ
M]J["@%=:[0L1,99HX,,KZ:0)PS+*L)>C.7,UL%)49+.Y*F&/+9,AQ@LW"3;)
M&H(R<QM@<A5.%,6 )Y!0 >(_@^H&>0&Y@4<X/++C)QRKFI_2!U%@:^#JS=V&
MUEEN%78=@L5:W5MAV6\#L5- UO<-1"US->$"!TF;=RFS=WUW9")B+:]<)=4
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MN[2[O6]4+>W2:%)%C(_LUSMPJG9$3*28O8;5-;Q:+6@=.IU,]C55K0R(&
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MZU;>R(/EH_M4ZC>^P[KYO+]BGD(W[T$_O&5\EQUJV]D0?+1_:IU&]]AW7O\
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M/E%SFT05*DSNG]$:$TH6UE7>F.!L2LZJ[MQC5<VQESU[R8&U<?'".4JQW0T
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M(N3*%Y%0"!5F,[M<L;_50;L*)=NKZFBH%((ZLJ7:K9$X\)K,0,XR'+ D'E;
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M3:$&U> $MU%J2/5FVX)D/A2%FYU"&=!:@7^JGJ9D,._5]4<N9&WMUHO=L;X
M\HQ>]8$2^!$$3P:E':9%=$2 B[5M?$.58U6EQYK=NXV2Z2:F%1LQ8Y]F]-GH
ME<\&K*L4Z(29J*7^]E)!XE)2]BP:,2"46FG;EAX !TS3C'L!SN,1M3$TV?\
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MXSWD60 L-VT\*KE%C",RGXE4^-,@'1KMIVJB/8C?L@(.1=T[?@SX\_PCKO@
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MNY5VHA[5EB^+)D2#!6B6#!V12!MN"B!D;)U\LH*V_/9@(2,@CM(';SQ@G'+
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M/F6>S[B]@4-E[7NA+]?CJR98$PPR?J(8/(*JPDF?DH,9##EVDDD>('D%SVG
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M+L1,I%B23D4$O=V+*)A&X(J6[Y*I=DN;\)FDY!V$U&PX)) Q[_O9Q\/9R\I
M'CQ'#8!B2HVC)!)R"%W%3D#F!CEY2!ZK(%K[GZ[6]66G?E1$4(Y>S>K*[)D
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M_#4<,X!R"Q9%"@\\N-PSRV]A7F&(&[F1X\>C.Z,AFMEGJ5:M/;3$8P?K59
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M-6X)Y@E2>8 !..3!.TC!R=QQRY*?)6P6WNK"+JO5=7V8=IQRK*+7VPUXQ6;
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M&P8NUH+BPM5V%2"ZHF: BTSX ,(3I]L VR1'4%!,NAR,4M"<CLK:G;)S!S@
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M'9FLB%9BB+I+%$;5;=7-LQV9Y0%$CP8*OR.221G.>?9XN>3@'M'+G[_.A$F
M22< 'U1/BSRY^%A7SD#D&\6:^K!L_HL(:;W!O0-K6D['KM7P$V+<(4'22L6.
MYVPO6X]CU\4P*L-+A$K =M(R[0EUJW2(TJ*W'M$B6LQ&ANE'6XVN"!G!.0/"
MY  D'F#R P<C^(T"N&5<E3ZD>%@  X;QXP".8^+&:G)=^Z+<OG!MZU[KL5?I
M8NE"[Q1Y^CBQBV$6Q@XQ8*T+C"7-:M6#85=J+.L+"0%%0X8F# Q:#+)I4*:"
M=]&8?Q$XYX.[ [?+G SGR]IH!(0""<9)!##&>0SD' )!'CR<@<ZL ];>@R]B
M;EJ8A715  0K3)U6?8"ZI?IXZW5JI3=3B+*-R9"T]WQ32RCKVMM;V8]*DURN
M/R@8:O9*M"V ;TF<2<CG/+(\+.#S]_U6,D#F>9Y9S4@29##))&[MY@MN(SSS
MO]4P',\R2#SK/5KV3TF[3H+1B[#:ALK7XJ^2Z "C6;5!:Z#B=]805K<\-0*\
M3IQ.3;Y[$5NP"9DJCC#,9H=$L+#\I,&"6PQ4!@>60<9Y''+WSG 'PGMQ[U5
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MZVMIT*YK^IK$NM.56?1%MN#E"<PUMKI!4I35H4SE*JJ2GU[.,B)DB&Y&YO\
M"/QGRY_EY_#SJ-S?X1^,^7=_* ?AY]M6O!Z9M(CK+"L437U78BB-?6;6%?IL
M>NUZ%0*[3KR2C%+\.$4^")BB&\WN1 &MVIR6S+P2ACVH*4,19)%J=.YO*<Y!
M)R<DCLY^]XL?U"FYB#DG)(8G))) PN2>W;S(]\Y[<8O EIK4!EJ4R7U3K8JS
M-3)3,:)4:KSFI:9A(":EIE-RA;J'TRC%5K!:3AW"\/DJX!GN]]*#CW8\9/E/
MQGR8_D)'P&@9AV$CX"?%D#X@2/SGRU*Q]&:2B>&\4T[JR+XP :JDCQ?7U29\
M/5V 2:LQ6WO!B$^% ,UE"*XT'7WPYL$A(A$9(].(^&3Y3VY[3VYSGX<\_AIN
M8_MF[<]I[<YS\.3G/E]_-5)W4NJGZ^&J;^L]?/5:N1YT2O5IVF5QRO@8I.-(
MA$HP8,L;D<+CD(<N5$G,P8S#<N-)D,/I<:><0ID\^9Y]O,\_A\M-S9)W')[3
MDY/PGQUS*U;K)<N9/7KFB*G$"$(M/FJJ%?5+G%1MG<NPXG,DY'Y>DD(%R>=M
ML*8\M<F+9W7#S#C95:I>63Y3Y.WQ'D1\7*F2.0)'YSV$8/QCE\'+LY508V@]
M%0WURHFEM3193H8?77),;7-/8?<KXF$(&BP2WF@R7%AAHZO@8 \6I684.$$$
M18[#; V&VRR?*?C-3N;_  F[<]I[222>WM)).>W)/E-3GTE=-^4H9GZ4NLO+
M \R>L< K[ ZKY2@V&TOIDV<[#G>2O&HQFQR4(D'BC+J)Q=]"72#\AQ.%89/E
M/B\9\79\7B\E1N/^$<$ =IY@=@^ #L\E4FS]/>C;B-6+/ZFU]*9]@\W6D66S
M4@4(L)H!$,0KLNG@34*"P5 5]P$5)B$# TR#&CP)\N-';:;?<QEN8>,]N>T\
MSVY/E.:;F\3$<PW:>T$')'83D#GV^2N<IHK59_94?;%BIH.R7(;6JS5Z]+L(
ML8:C5.'53=E/CI]4C$(;_L?-OS[/*\H%QSC,N5''!6,+;2.1W[<0, D#)/(X
MSG';\5-Q"[03C)/PY &#Y1RY9\9/EJNHU/JQN73Y[>M-?HG:\&("T":BFUU,
MNC!VXZ8B!-/DX&X>K(Q$1"(J( 5<**F.A+.&L-IPG#)YC)P>T9//X?+3)Y\S
MSYGF>9[<GRG/C-45G0>BHWB&(^EM31\"@N*V+PSKFGM>3:ZF:Z22!@>##)\3
M"I(OOS\"X_@X.)KSLK#'AW%N9;F_PCY>T]OEIN;GX3<_?/;V9^$CE\%7D!I-
M,JS[LJL5&L5R2^/C"7I $ *$/O"H1,T:AC'7A\2.XX/B&;)8BT:$M68S!,^:
MGM-HE%)SK[)/:2?/_D/BH23VDGQ\SX\ 9^( ?  /$*U\ZFJ[=SWL)]AVD]1;
MB\4]DGE'Z:CXAGV.^'\@>)^0?*IX)WWE?P,KRIX#QKL\F#O"^![6_"]QI$UM
M%UCK&I7^G[N%LZB)#QL<7=Q>'#+_ &/*[,[?5OC//&NZ];WD_5.J:+I6K[./
MQ.^;0CJ^[@[>!Q9X<\7:W%V[L<*/.WEG<3<S E=QU2_*A6%XLPY=\"9H_#6:
M]!:=#P,$D6+*T9=2_+;3'0$\$M&,O-3?"85C">S4-",@CU *T(C,=OQ%?/&8
MB8[##CEM4[N+GQ%,5Z#TJ$1ETAFCN&F6:\X3QXZO&IMQQ1<9Y[G 7@X(YK)G
M/*J+SMJU[M\_SY^#S[*<5-.*4XI3BGGY_P#/ZJ<4IQ3E\7\5.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BGG\?U?'3BE.*4XI3BH[//XNW^/W^>.9IQ3GY^/^.G
M%33BGGY_\JD28V"9&D Y2,W-&%8,L:1AO=]X*7!G1W(LN,[WN4J\&_'=<:7W
MJDJ[U>>S.,^?CLI6I.>@GI<=9#M3J"5+O 2 ^<+)&]A;&,FHK RK5.EPP:39
M.URBJJPW7:/5X:JTN9D(X\,Q/7"R0ESI4F^]N?/D1C&!CM)\G(Y).1SJ_$<9
M\(C(QR"@<R3GL[<D\_?Q5'U'T0T;7UPE7JSE/9B9@E0\VB#A^+J JM!BA%[6
MD1XX<$>V->W%.RYNY[M-FQ6B4&IQY7D&4 J &:#C2UBY(P.0/;V9/9X\#ER'
MO^4FC.6&!RSVG RV=N<D*/$@\6[M!8YY<@CN>/28 #2@(379@4-(-&HA1$#9
M&S(LDR)L8"C5D_7S<YFW)F&:X:#ZVI;!4"3?E"R#P;,N5%=EDBST]Q'\O9V<
MARQG!'+'C(^#X!4F60G);)Y$<EY$$D$<N1!8\^WG5_U;H]Z>:7;<W>L4+(FP
MXN12_,OL66UJA1+28&; $D", 2Z;<%P4O1=HWA28L2&S$8DF&9+#+3P<&L;&
MYL8SRQCL'8"",_!@?%[YS4NQ',Y!4+V#U(VD#./\4>9.4#H_T .H=^UNQ3B+
MU7VC8 %IOR"%SNQ0U:#U7=K[P0@5LQ&PRK%)>C+JX7QKORF4E\1Y'EK!%1(G
MF8WMD'/,9 Y#QYSXO?\ JIO;(;/-0=N  !G.<# '[8^+EXL8&+?@]"O2\/J"
MZ&QK=2ZJY%G0E#)-LN<K/BY'4<O1LE*9LBP.$&W,:T)%PC#[<I,B+-.'+%&=
M:L9<@5D-[9SGG\ \N[R>4#\PQV<JGB/G.>?+'( <FW>(?X6#X^P<L 5D1KIP
MU.W1BNO5BC\NOG-@#]IF'R%XNI"QDK\)M 2XC;',MLT^_9GY,(_7 <B/&<*J
M'MPQD02F)@2TF%QN.<\NS'8,8QCL[.8)J-QSGD#C;R  P05Q@#'82.S^.L=V
M;H7Z8[>JH.'M?S)3M$KY&M5AYFZWF$\/'%GK1*(.J<AV-A4LK+G7.QDGS<S+
MY=TG.9(N3531@I^"#L,X/;V\AS[/>][^7RFI$CKG#8W')Y+S/+WNSD!CLY<^
MTYK9GHXZ>;!(C/%J1+E,QK4"NN!F+A=& ;]CJXNCA*W/E@8]@:#R\@!6N:B/
M#MOPEH'0Q\N)%PU%-G&23>P\?8".P=ASGGC////RU =AV'Q$>+."22,XS@EB
M3SYGX!BH"ND_20:/$AP05DQ!%L6R(!'2]B[#(C:M#NE<FU$W"J(XC:)4*JQ,
M5XF2&C&*^P.0&;(37A>(LB0X]EN;.<\^63@<\$$9Y<^8';V^.A=CVD'LR<+D
MX.03@<SGR_U"L8U7H&T2'%60=8X!RV*/V.V&(G?VN[!AE8&G#5=>!"ZN$A6Q
MV "(5NI4;7]*<LXU,4R=%59S$QQB$>+BGY+L2#\'DYX[<G&>9)./%GWA5C(W
MBP.0!Y#GC/:<<\EF.#RY^\#5Y2NBKIRF+><?I13.9;4S!-MN]WYF,:G2S^Q+
M6V=/1&;,W$.6499MK[ /@[&58EF@IBPK(C)L:4.$.CXWL/'_ ! ^(#^,  ^\
M,57>WE_B'+DHY'&<$*H(SCE\.;]C=.VH(=;L%1C53P-=M%LH%U.#6S!Q+<X[
MK"%KX;2<Y<P1\.R+#C]74F#D&PZT&GPQ+L<C!EM$RJ9K<<@YY@$#D.PYS_*?
MCJ-S<N>,!@.0Y!BQ/B[<L3GM!/+L%8M#="/3)729,Y7:2>KYXO8W+3-L +9>
MS0UAR5?A6T9+Q'/C;?%,0X$\?>;1$GC(DUF#,03R[(8<DQ8;\>=[=F1@#&,#
M&!@XQCGV#M_K-29'( )R .P@$>(]F,$Y \7BJYI/2!H*8649E5$H_*>M5HN$
MUE=XO6!I4I<MA"MKV"$:$HL:1IJMRMBA8%L8JA6++K< AB6S %QAY$A#E1N;
MR^+'8/$-OD\G+/;\0IO;L!_:@=B^(;0>S.<9&<Y([35SD.G+4Q'7VOM8J"&!
M]5U9+'D*%D%<;C7[#72 X&8K2"$6W!#L"TNSY@*Q'QI69*+OR"S)DBL@Y(?D
M*=Y 8@D\N?;D @\\]A&.T>2HW');.2V<Y (()!QC&,9 QRY8%8[B=#?3/"A5
M@9&HA) NH'JW9P8K-\V X*8L%.%4L'4R\@:Y9U09Q"MA]>T\6'F3&'I,(:'2
M.:=Q FD8TN=[>7^(>_[WOGXZDNQ))//!!.%R0V21V$\]S?G)/;@U\VGHMTP7
M$BFZV/+5&ST_6076NN[#'M%T(P*K&I8:[C=<&"557:H86YD:-/V!8CPZ19$R
M2,LO*3/DD\$8T"=#!SX^8)R1@<\XSXN60 .79Y*;SXR""Q8C"C.2I;L'+(4#
MEV#\^9,-T']-(JLC:O)IA4Y#@U:32Y$@W>;X1EDZO-UJK4DBNS7Y5F>=576:
M*[($" +;B!E?7*ED D> 3ERIKPNQ.<^//8.W.?)Y?+4[VR3G!SGD!R.=V1RY
M<_C[#D5>H_I/TD+59I$0'9<%[B'+A+-9GMB[#D6\Q%/E@ADR_+MKUH78LD2+
M]8J\&21021+<K]8KU8R[[' \ 4RWL<=G+LY+XNSEC&/>[.9/CJ-S<N8P#D !
M0,CLY8QRR<#LR2<9)-93UEK*DZ>I0C7FNPB*]40;A9\:*;E39N&9!TR0L)=]
M4DC)ERW7)QDJ0GN^$?4AMR2IIA#,=#3+<$DG).2?'4$ECDDDG'/X  /X@/ZZ
MOSD5%.*CQ^^/^6?A'/XZ<5-.*>?GYBG%*<4\O+_GY]E.*>?G\5.*4XIYY^&G
M%//XJ<4IQ3S'GY\J<4IQ3R>]_P"*<4IQ2G%*<4IQ2G%*<4\_Y//\XIQ3\_;X
MJ<4IQ2G%*<4K1OK/KU1/?2V]E6E=L;@\4]F/B'TL'B3/L=\/[%O&O+GD\05[
M[ROX&/Y,\-X#L\F$/!^%[5^#V+09;B+K? U&PT_=P-_70AXV.-MX6^1/['EM
M^,^K3..6=0Z506DW4.M:1JNJ[>M</O89!U?=U?=Q^'#-_9<+P\[?[')C//'9
MAL*F6RTG:%- V:,(!@R9E5O"2XTEYL\-)"'(\"1%<COMH23"DFF'(S,IO,9^
M+.GJS(8>89;D><Z=>P6:W?%MVFEEBC6WD5U4Q.DJLX;*MX$B9#%?"#*G(@DK
M['K&F76I2:?P+M;>"WGE>[A=&<3QR0LD;+M=1Q(9,%0W@E9)#N4J V.DZ[V_
MY*8RN;K;RWFR][);2JT9%8I_@<?SYA[,;$M5E\8[<>+.,I%^![%>-]_G*<=J
M=8T_><0WO"X/@DM!OZQGL(]3P<8\('?GEMQSKHAT<U;A#-SIW&ZQA@$N>$+3
M'J@Q.\W&[]H5$>/_ ,F:F)FNMJX]EGD^=KY7>+@^P;QSV1H\8;S)Q@EFV> 9
M<\46F'WRH. _CJ5R>Q,C+;7:OE5UFQ_(;X+OF'ZUM>$[3M_)\#(&X;O5\39A
M>:Y/*K/T<U3]=<.ZL#@IU'?'<#<-WY3K6UCL(3)3@\0%N38'.IC&NME>4&<*
M(4;R7[%\*D+PD_Y0Q=/ *RIAEO*/%\U?QGO,8E+=26\!WRLP_"8PG,=^;+:<
M076_CX4;XMO5L]I.,\?;SV@<//+=CG4^AO4>(N;JRX75LL>'/Q.N;?4JN[;U
M;=^W+<7;GP :E8FN]L9;J?CT[7B7ERY^+UB)FRK;CP<2VL"U5/+S#:I<M<#P
MRIZ#&(3+<O#2(ZW6<J7B6UFPS/L@N\!4ZKN>$%GVG?Q\ [5#8V&/>2N20#@5
M5>CFJXM=]SIX)=^N[4N2%3>.&;7)'$<QY+B7A@/@*67)'"_KO<&!A+,:;K;)
MG%@RD0A]5H2,75>]7V/$G6XZI35@[[P>,QXK+H[O<KSXUVX3C,C6=/WIF&\X
M?"_*$-!O$_+D@/@F+M\)B'[/!J&Z.:OPY-ESIW&X^(@R7/#-K@^%(0=RSYQX
M"JT>,^'V5/3M=;.Q-M&!L^AK')A1\TM4[%@;FOD<IC>-)M"&&W&(L)*\R_%U
MBG)CZDIC>$;1E3O>576;+;!O@N@Y8]9VO"5">%MX!(!9O4Y$@4#PL$X&;OT<
MU+?<\.ZL3&$7J9>.X#M)X.\7(5BJ)G?M,1D8X7(&3CZC:ZV5D@"Q,(49(M0'
M*K,N,@^H@U9_ R>QH$VZA$:0!\8Q$QF00=C$/ YDJ\6[]+25&UFSV2[8+KB<
M7\@&>+88,CG*0-RR[=W@H&3( W8)(+T<U+B0;[JR$1@)N2L<YD6YVMA8 6"M
M!NV>'(5DQN.S( -/BZ[V_F'7LS9NMDSU&5)MB8JK.N&S7O#L=XY7EO1T/23.
M8V9.5,$FXL'#^&$XD9;4XI-VUG3]TVV&]*<,<#<T 8RX.1, "%CSMPR%FQGP
M<@9HO1S5]EOON=.#F8BZ"I<E%M]RX-N207FV[\K($3=M&[&37)+UWMO$2RY@
MS=<JG)+MIIZ9>;,B(\!\8=\*Y95LL./1B^(G@<MLBT2X>9&74J?PUA"E0NLZ
M?NAW07FWAGK&UH2PEVC A! #1[LY+E6VX\'.11^CFK;+G9<Z<7$H%F'2Y"-!
MN.3<D$E)=FW"Q!TW9!;&"9N3KK9F"1O$2?1<B$UY2JXN2D^DD[:_ Q>\9-M-
M-KC,5[P^9N%28+L@EX%,56(O?K=2BJZS9;(]T%UQ.-^6"O$4$&6R8R0&:;&S
MP6"IDMX6 ,W;HYJ7$FVW5B81;DVY:.<2-=;4PLRABJV^[B9=&>3:$\ DMB$+
M76S<RJM@C/HB8*XLK-U5"38%RF)V$O>))JR'VVV9<52_%_&EEEPWDIR]X)"\
MI1WQM9LML^R"Z+!EZMN>(*R\MW'(!*MV[1&'!Y9(YT3HYJ1>UXEU8A"K=<V1
MSLZN-VP6H9E#J3MW&4QE?"P&Y53V]=[B\E0<NS=:8.9/Y22;;5:<BDU;O$]C
MT%Y4;$QP_P"%[_&8\AAL=WG>Y\:[[.<8N=9T[>V(;WA\'P"6@WF?)Y, -HAQ
MCP@2^<^#BL8Z.:OPDW7.F\;CXD 2ZX0M<#PD8G>9\Y\!E$>,>'G-3<S76U,(
MMOB$[7ZG$/CO8)B9[(T(D1LRE8+9MN66G%0WT0N]4.2&Q.;<E=\B2IIK&%YJ
MNLV.;??!=X(?K6UH25;;^3ZOD#<"_)^)L(7FN3RJ[]'-4Q=\.YL"0T?4=\=P
M RE_RO6]I)C8)SC$/$#/R8J.=<RM=;,\HJPB?1?)/L9RI"U)/X(YN7B_:EA3
M>&\QL5GQO^9S*P[DKXO_ #>(?A?YCD#6;+9S@NN)Q\8#Q;.K9[<[=W'V_M<<
M//[;%2>CFI;R!=6/"ZMD'AW DZYM]3@-MZMO_;AN+MY[,\JX8FNMIY14O'YV
MOTK6\0]G?BGLC6B/'Q)Q@5FI9>:1F8\N'WRB"3&(*&Y/8B,IUKM7R6UFQ_7&
MR"[( 3JNYX1N.W\IUC .T!O4</>2OJL'E54Z.:I^M.)=6 ),G7MD=P=J[APN
MJ;F&\E/[()N& W)21SJ4=UWN+R3*RQ-UID[BQY3";=5:<"55+P*N]>E/(C9F
M)L?C'>XS&986,\#WRL2_"=B<V&LZ=Q%S#>\+@Y8AH.)UC/,*#X/!V_MBV_/+
M;CG53T<U?A.1<Z;Q^L80%+H1&TVGPG8$N+C=CP ICVY\/-5";KK9N)5IP.GT
M14)$6+FDJFIL")3\W*6?'4VE##;C42*E7C'BJQ*YKJDX9\*A&5+[VBZS9;8-
M\%T&+-UD*\14+SV\ D LWJ=PD"CMP>0SD?HYJ6ZZX=U8E J=2+QW 9GY<070
M5B$4>%L,1D)P"P&2!%K76S/* ;#T^BX%*K2%6!;23^2#5P\7DY<9#-K;Q&?K
M6)>(:429KL<IF.J2I43#J&D+'6;+9)B"ZXG&(A!>+8;?<N#(<;A-MW9504W;
M1NP20'1S4N)#FZL>%U8&X(BN.(+O:V5A4N%:V#[,.[+*5W'A@@ RD37>V\Q:
MUF=-UTF<HL[BXIB9LRXK +QEK#+E:6\PAZ46S$\.IUDHB)#Q)PTE#^6LK6FS
M:S8;IML%YMX8ZON:$,9<'(F !"Q[L8*%FQG*YP*JG1S5=MMON=/#F4];")<E
M5@W#:;8D@O+LW9641INQAL9KXE:[V]B"?S"FZW432;[VK(E*LZ8+M<\*[VN'
MW&8ZY$<WX#P&? #FY4'PN7<>,80E"E%UG3]\6Z&\$?"_+[6@+B; Y1 @!HLY
M\)RK8QX.3RANCFK[+C9<Z=Q>-^M0Z7(C-ODY,Y4[EFQ@[8PZ9)&[ !JH2==;
M*P0/8AD*.H6D%A587)2?20=LW@8_:T>;:0N-'!>,9EXQ('NR2&64QU9C86IU
M**C6;+9%N@NA)Q?RX#Q%!#EN<1*AFEV[>3A4SN\+&,W;HYJ6^?9=6)C$&;8M
M'.':YVKX,ZABJP;M_A1L\FW;X&<U\P]=;,S/J^"$^BI&*@/9NBX:; N>P4\'
M(\ BKMOMMQY4#+V(F'G"KD.1AO,C*&U*2WA1M9LML^V"Z+AQU;<\04ID9XY
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*<4IQ2G%*<4K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g105868g72z06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g72z06.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1C:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &+Z^8S0X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>:A<         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              @0   +@
M 0                         !              "X    @0
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    @0    !29VAT
M;&]N9P   +@    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
M       !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!
M46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%
MPJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V
M-T=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3
M!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%
M539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G
M=X>7I[?'_]H # ,!  (1 Q$ /P#U5),G24Y-V+U9_5W757AF(ZHL;.H8XM?[
MO0^C;;Z_I/\ ?_@E'H=W4QEY^#U#*;FNQ#467"H4F+&;W-<QCGM^DMA87012
M.M]=]&DT--U6\.8:]S]A]2]L_P XVUW^&_PJ2G=22224I))))2DDDDE+%)!S
MK7U8=]M8FRNM[F <R&DM6?\ 5G.R<_IGKY3M]GJ.:'Z"0(CZ,-0L72TS D(=
M2#+['722217*22224I))))2DDDDE/__0ZCJMF<WJ.2UUF4W.=8QO2756EF$
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M+&CC_KC+%++/K=0P\<:MKWY-G]@>E0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                    _^$_3&AT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-2XS+6,P,3$@-C8N,30U-C8Q+" R,#$R+S R+S V+3$T.C4V.C(W
M(" @(" @(" B/@H@(" \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N
M=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/@H@(" @(" \<F1F
M.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP
M9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO<&1F+S$N,R\B/@H@(" @(" @(" \
M<&1F.E!R;V1U8V5R/DUI8W)O<V]F=,*N(%=O<F0@9F]R($UI8W)O<V]F=" S
M-C4\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(^"B @
M(" @(" @(#QX;7 Z0W)E871O<E1O;VP^36EC<F]S;V9TPJX@5V]R9"!F;W(@
M36EC<F]S;V9T(#,V-3PO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP
M.D-R96%T941A=&4^,C R,2TP,RTQ-E0P.3HR,3HP."LP-3HS,#PO>&UP.D-R
M96%T941A=&4^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR,#(Q+3 S+3$V
M5#$P.C4Q*S U.C,P/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @/'AM<#I-
M971A9&%T841A=&4^,C R,2TP,RTQ-E0Q,#HU,2LP-3HS,#PO>&UP.DUE=&%D
M871A1&%T93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM
M<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @
M(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP
M+W-4>7!E+U)E<V]U<F-E179E;G0C(@H@(" @(" @(" @("!X;6QN<SIS=%)E
M9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E
M4F5F(R(^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/G5U:60Z-S8Y1C4U
M-$(M,T,P-BTT1CE%+4$U,3,M140W0D$Y,3=$,D0X/"]X;7!-33I$;V-U;65N
M=$E$/@H@(" @(" @(" \>&UP34TZ26YS=&%N8V5)1#YX;7 N:6ED.D(R.#-!
M,C$Q,3<X-D5",3%!-C(S0CDS13,S1$9&-C4P/"]X;7!-33I);G-T86YC94E$
M/@H@(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z-S8Y
M1C4U-$(M,T,P-BTT1CE%+4$U,3,M140W0D$Y,3=$,D0X/"]X;7!-33I/<FEG
M:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @
M(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I",#@S03(Q,3$W.#9%0C$Q
M038R,T(Y,T4S,T1&1C8U,#PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @
M(" @(" @(" @/'-T179T.G=H96X^,C R,2TP,RTQ-E0Q,#HU,#HU-2LP-3HS
M,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W
M87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T
M.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N
M9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO
M<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N
M8V5)1#YX;7 N:6ED.D(Q.#-!,C$Q,3<X-D5",3%!-C(S0CDS13,S1$9&-C4P
M/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M=VAE;CXR,#(Q+3 S+3$V5#$P.C4Q*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T
M;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @
M(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E
M9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E9#PO<W1%=G0Z86-T:6]N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYF<F]M(&%P<&QI
M8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%
M=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F1E<FEV960\+W-T179T
M.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^
M8V]N=F5R=&5D(&9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO
M<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA
M8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I",C@S03(Q,3$W.#9%0C$Q038R
M,T(Y,T4S,T1&1C8U,#PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @
M(" @(" @/'-T179T.G=H96X^,C R,2TP,RTQ-E0Q,#HU,2LP-3HS,#PO<W1%
M=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E
M;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W
M87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\
M+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*
M(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI
M9#I",3@S03(Q,3$W.#9%0C$Q038R,T(Y,T4S,T1&1C8U,#PO<W12968Z:6YS
M=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^=75I9#HW
M-CE&-34T0BTS0S V+31&.44M034Q,RU%1#="03DQ-T0R1#@\+W-T4F5F.F1O
M8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT
M240^=75I9#HW-CE&-34T0BTS0S V+31&.44M034Q,RU%1#="03DQ-T0R1#@\
M+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/"]X;7!-33I$
M97)I=F5D1G)O;3X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS
M.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^"B @(" @
M(" @(#QD8SIC<F5A=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @
M(" @(" @(" @/')D9CIL:3Y'96YA/"]R9&8Z;&D^"B @(" @(" @(" @(#PO
M<F1F.E-E<3X*(" @(" @(" @/"]D8SIC<F5A=&]R/@H@(" @(" @(" \9&,Z
M9F]R;6%T/FEM86=E+V5P<V8\+V1C.F9O<FUA=#X*(" @(" @/"]R9&8Z1&5S
M8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B
M"B @(" @(" @(" @('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]P:&]T;W-H;W O,2XP+R(^"B @(" @(" @(#QP:&]T;W-H;W Z0V]L
M;W)-;V1E/C0\+W!H;W1O<VAO<#I#;VQO<DUO9&4^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^
M_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$!_\  $0@ @P"[ P$1  (1 0,1 ?_$ !X  0 " @(# 0             &
M" <)! 4! @,*_\0 01    8" 0," P4& P4) 0   0(#! 4&  <1"!(A$S$4
M%4$)%B)181<C)C)QD20W@25VL;71,S4X0D-%4G6A\/_$ !L! 0$  P$! 0
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MQBI@<YS@0 [CF'D1*B=^_."1[>RDN%4PB81,(F$3")A%ZF.!>.0-Y'CD"B/
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MH_JFDNIM+BUKFF'07 $WD$\QY 6"SWKHTPB81,(F$3")A$PB81,(J27OJ3W
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M[$33(":9 X   "$*!0#@/ >V;+3H(%N4>_L+<M5TS6AH:T6 $-&D-   B!H
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M5_P^WQ!^O\2XK.FX]U#%_!?AZV.^(?B'XKPTT7U8<6"E ;!X(TO=;KTRB "
MB''/!1#@1X#]>/\ CSG<#V_E?O $ #EV%],*JB&]MN:YT1U)ZLME\MD36(RZ
MT2X4N7/(.%$NTC-_"3<+*N")%.86Z#IN\C$E>SDKJ733 >%!$-1BL5A\'F.#
M=6K4Z)Q#*M%OQ" 'D#C&MB0 1T#H@K@?$&=Y5X=\2Y7C,QQ^&P=/'Y9C,%5%
M9S@]WP\1AZ^'K$M:8;3<VM3!)!)JQR5XHT[95@T59J JU603705 XJ%437#U
M2G!01,)@,!^0'N'P/'(AYS; @B1H;CRV7> M(EI:X$E_&T_L=Q$N+FG3A=)(
MBP! L%S<JR3")A$PB81,(F$3"+2%]ISKJP$VGKG9- :VU*1/3;3$WFSL[1ON
M2@H*!+:M9L3-$J#IJ^U9<L@I$O)"T/'0-G#N9C:@LS0;NWQ6Y<6[/D._/WQ$
MP1&Q@0;6O< ;WMZ6TV<]*!'"?3;I(CRKA2W1=:5$'-5!HZCP@5PAVI58H&#Y
M9R^: S. H^@\76<I]HE74,H!ARG;:P_/SF4$$F\C733;Z6O&FEU8,2E'W* \
M<\<A^8^??\^/]<BL"\"-C%N]=1]E1C[1V$L\ST@;=2JMT=TE5C#(2,JLRB(6
M5^>1"$DR%Y +DF6+U-HC(@(%4>,@0?H]O*#A,1$1)&U]C,_D_*XF-;JUFK/&
MLM>!^5'JG_(F'T^G],(-/G[J>853")A$PB]3" <>. 'P(AQX\>/U']./RPL7
M&+^FO8]X^:J/NU^ML^X5S04*Y5*R=_#6G:+DG=_A:DR= HQA#G+^$BMC>) D
MJF<>XS!%8IB"18.=7BW5*U>E@J),/!?7>"#P4VD#@-Y_U(@6/$ 8-Y7*YX]^
M:8[#>'J#BVF0W&YO4:1^S!,<#3PX<+<>)J"'-F?A@G=6>B8B.CVC9FS:)-6\
M>BBT:)(%[2(MD4B)I)$ H% $RD(!2E  * !QQFR8UK&AC!#&V VMK\Y \EU%
M-C:3&TVM:QK6,IAK0 /ALM3$ #:.?S7=@  ' !P&9"P Y+Z?=><(M>/6OT,M
M^J^2JMB"[/*K)4R*F6D>W2CD)!L^</E63Q!1QZITU4?1<L$RE]$_)TU3@/ \
M9S>?>'J6=U,'5J8A]$X-SW,# "'AX'&TSL0W47]%^:^._P#'F'\:5<'BJF-J
M86M@*-:G28VDU[:HK%CB'3#FDN8 ")B9V"L1H78[BY5@E=FV):_L"A+)56_5
M?U YBI2/;$!!XQ[Q]1U"3C4Z,G#2 $*DZ9K%(H*;IJY03W6#K,JTOAN_;5H@
M->PP3Q?@B'M/(S)-AUV28\XO#&A58*&.R\LP./PKG$&E492:YF(HB&\="M2-
M-[:@#FRYS"0YC@+"$$1*41]Q* _W#G]<]0MU\UO-5[81,(F$3")A$PB81:.?
MM.*+#FV3KVPU373"WRDH1Y([>&J1U)LFQR0C)[4X&%D)&#N,HS285%I6U+:Y
M^=(II)A-P\,T>K"P.[*:=]Z=/.X6-SS&FP!OUZ7@7-[F=-I_3$M*..G[3J\X
MUK[*86UU5%)%K5EDG%>0=FB6QEDH== RB"L>0YA!L=$YDC)]HIF$O Y3[Z?3
M[:(V;SSL.G2VG\VF5G?"R6O#[4IIKA?HPVT\V/,)0[2$BT9NOBK93UKYC98Y
MXW<1L8DJ1ZS"36>&(<B<4H*Y'9O!D#\>,7/%-KGD2&-+B.< F%\:]44:56J0
M2*5-]5P! EM-I<;D'7ACUO91;HEZ_M:]0,'#TY".<T>0KE*K";<UDF(Q,)I5
M)BS9G3CTP.B8ZA#%]0R8 8P)B'(9H,M\1X',L1B,/3)94H&'A\,Z?MDW ,F(
MG5?G_A3_ "1D_BS%X_"46NR^I@B+XNK3#:Y-0THI7%PX"T;V)DK9>W5*LF14
MBA3D,(=IR&[BG 0YY 0$0$! 0X\\![YT,M/^TR".D]^W)?HC22!)!Y$7!'I;
M\_-<D?\ 7Z>W_P#?WPLEQE'3=$P%55(F(\@4#F !,(?ER/U^G(^?KP/')?-U
M1K2 2!RD@<Q(]9!WZ%?<IBG*!BF Q3  E, \@("'(" A^GY8WC?EO[+,&0"-
M#H>G._\ /-0?9%UB==TZ<N,TJ9-E",'#KTR"'J.W(% &;% GNJZ>NA1:-D@
M1466(0 Y$,^&)KMPU%]=P+A3'^V8XB2 !M,F "+W,;KQYAC*.7X/$8NNX-IT
M:;G&8!<Z(93;S<]T-:+RX@ &0L3=/%'EX^'F+_=RD7OVRG:=BGC&3X-%M5B
M,576XFX,1I#L3)-2DX 3G(90W)S&Y\^ HOITW5JDC$8@_$J7GA&K&"= WE,3
M>>6G\.X&O3HULQQX#LRS-_ZC$R"?A,(BEAFD@13I4X!;H7 NBYFR)2E('!0
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M@"-@-(*YGQ)X;SAF48FGX0S+&8''NX/A8>IBW-PT![2_X;JK7FC^SBX> BX
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M>.*Z^/'P"SV/5=3ZH#\6T1E?2<$25.)2/$RD, F1*.<R[%>(,3G='#5\&QN
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MSSZ+)DR8M4P$$F;!FT8-$T6;5!$A) U(L/74#T'U]%- ,41$ $!$/< 'D0\
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;[\Y^J 6\B?E('RLK Y%4PB81,(F$3")A%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g105868g73f73.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g73f73.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1,:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $OZ^2&(X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>_*P         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              S@   E@
M 0                         !              )8    S@
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    S@    !29VAT
M;&]N9P   E@    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
M       !
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MVMOU)\]W@+[X]]>M5"!/J+)DKGDYH&4OE"1_T[\)AWWX7=7NW_O9_</B+X>
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MG:TT>Q:7MZI![D.;#OY_$#WX,\O(?:H)WM_BU7?4X1'H2)H-%I7^IP=V+O\
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MS"7,F#W2!L:" IB5 ,;-N22D@ M<"[<N]B[NRDAH%D@SLBB3<!RBA<"'0.C
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MRQ[<$B.<TK$@'?Q$CF\02U@1<E3$D;L7:VRM)6;!"@]+K:24H +S(8$@GE4
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M)6$3EDM.U^4%E)ON7)(8.VS@]2[;_<YMA5LF8!RYDD*%$6Z0!*22[\VX</\
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M"'(/3S(+@V8N6PH"I74Q!:,SZ'), A *K%O"Y4.IY5.2X&S))Y6NX8.#92+
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M4O9,#F+>G! +?GS?<;=[DMB.04(VCY*D6);DFZ@;MB!*0R6*9I$O8CTQ??\
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M#W8_RF#&YN')V.%(.1X("):<C'@;4Q J88"?2X;_ $*#8.]P%#^PZX4BYYS
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M<Q+37/ B*A\J26YB$V =T[%Q]6SW/?%L;6P?6@G2&2SD7N[^"/E7VX><(D"
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M017J;$23$FDH0OE4D[,DAP"!L2&!Z-OB^1]^!JW01F39B8.UP7GRKM)JT@H
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M-QA4R6M,CJ!UV@<G,157^J[G8BQV]]P 6'O-L*$K.X.;-WY(D6@VH904I0L
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M&Q)[#%%QF:A,2%LVI8F.N,BSC@5"K9M"F94N[.BP!!(OUW'WGN7$C 6]_O\
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MR.FQ(2PX.QN* 3R@[AG!/W ;"XW_ &,,*H,!V9!'FS<[3.]XH42"$V)=V#L
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M'0G"H AL '>\3(!*:Z"< "%(AK)"X,-0+AE .;$-<;D6/3OA0C<&%:0I.,#
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M;^'S!VS<,3+'.I4ZCN7?8E@ 0-AN2X('F1Y$J>"B#SORW: D8A4W!9+D,S$
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M#2D.+,;V,3=J.L/9<@=^5:2EH.6=_,[,O>!%>QR_F"GYCI$I6I!2E2TQ#5$
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M$D$#"BBS*C+_ "AF6#.V4+&CE2-T@[] DAR  X)<W;=B0"X4'*H#)7)EX!3
M#Y&7F#E\J6 Y02.@# CH#S'9B&!.XL" V%4'[%[+QQI+@29$1/H@ZK#WLD.
M P^H6 8 @$6NS,,* B9"DALD%\U>_)R: E(Y;,&<DL227+%KN '20_4 .^%
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M=F4FR #R."0G<*][5]5H18D)4  $D\H#'8#S #= .XQ*EKY0ALGF01OU-U3
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M7OA5& ,^!3O"0NHR$02:O8.Y9P02"3?8ERY VV21TPJ6$%&P"")S <^-]J"
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M^)Z-A4 %LA1UW/=<B#ROFH-7ISM[4D Q/^F2WA#M_P!@6ZC?WDOA[]S[VVJ
M0_H?1$VE H-P:9J].%C59%P2&];EG(-@X]#:["P;S5MBP_?E?ZT46$A7ZF/R
MSOML*9J].N?:DC9_],E[D;\WYDD,S#N$CSQ.2^_2B#<2]EB;23%SDJD*O3K'
MVI(O9_TR7N[W)$ >786OM=[]SG/I3NCPY0;V@6\7XHABL4T$CVG([])J I1)
M-AR)A E]@ 7+L"Y!PH19@21SL\IVW.^&^3VG3^L]!.S,E0:X+V[]68=Q;%4K
M/4?.U90$X_\ 28(Y+H)DLHBH74Y#E61/0>8)402%@A02;\RC;WGPC<!\4 L
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M+1M:\"3BZM4E*0=T]24@)?<,D=N@8NURYZ*!QTW*)G/@SFVE .J"4WLGF+6
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M)J'3\KU"?BT:@YRJ4*%+97J=3A+4(4.!.KK<&I)3-KAKEY*+$A"%/K7RQ5*
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M1>$&0*\+C]H_M'$.MQI T F3!)"DDR3L5L02=;] 4A?$[QZ)58#4[0\O<O\
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M7P;(\ALZMF??F"07Y?,OY [WLZDB8!ZV[R@Y"DK8F;N@P(2UP2;$D))^KS?
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MVBZ+M<FFU@X9QL0.:P?H" Q:^[W]RES,W'BPP+&WA*DMR''0]"72+;[;CO\
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MW2[?[_CA3#Q9%D1./8(5K# 6Y00'8%W)][]W&S&_7"G.[+>W5R@$4X3M-5<
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M+$D-?H"S;A@W0NY\FON^%#8_Q$;\@V1@@B+YM84!B'4!LIWZGM[@&[.;C"D
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M?:P[$=[D!B=C^.%#DF=LJX)P"B8%P["U6"6V+;&SN_;J.O\ YO(X50S!((U
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M]8&;L2#2 8$DW'BW# $ 'E(#"UG;K\0I<LYA'EJV;OAX(PBB4@V)2IWZL0;
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MI7U()6IEO[IH)"QO(HZBX<+VLYZ!STPHAAB-MC$*XL,JV]'JE49_:J!T8R2
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M-(:1<66_Y7"2&W.BM%;JW_.4@OM]Q?KA^)IM^%+$RK_+Z/I5'#[+GMO;#_\
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MN7EY#+(C0YE49,2(J=BPHD/\PB)$MK$^'A[-"4%W6L9^L1!YEVK9=@@D;@%
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MP#^+V#@</A_S:M/:^%K('^+N 26H8Z*:X/G-Q-M_%SIUOTS]/W!W#?-I_O\
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M/Q-O;3730D@.?I%G&;=C^YLGR'1B+N'Q.Y\.SQ>)'^C7:$>DO^M/Q?VC!/\
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M< EF(<<VGA]A&E'4;$$GO:2;,@$&4DV"RQ6>+QOB1U#\@/YD$=)P@"1@EL
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M0J)&V .[K8"PNSLJS%GB'/S/WK(TZ>9_ZCFR1DB284)9JO59<DLA1V<&)$8
MJ8,QYKAR.@=WN^"Z^9V6]7N:5+G^;O&;WDB-G,J8IF5@$L$$ #_M(P-B>O.
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8#AO"Y%W8;#Q=QA4)4 ^!#7GEW07RK__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g105868g74u24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g74u24.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[11.4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %#*^47 X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O
M;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U
M8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M                0FQD(%5N=$8C4FQT                4G-L=%5N=$8C
M4'AL0%?QRL         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              J0   ET
M 0                         !              )=    J0
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    J0    !29VAT
M;&]N9P   ET    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
M       !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!
M46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%
MPJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V
M-T=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ J0)> P$1  (1 0,1 ?_$ !X
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MXBWJ/\:PB\^>^G73N;-WCW3P/;W)+AZTA6>6XEC^&180A08[V+6 @"U^=*Y
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MDG53:=/9&N<P0TQ(EQN2 ,EQ]+><E5@DN%[\UH<@07PYZT.,[ZZ0'?48;67
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MS@\X')0Z&S)P8]Y6H'D<^W/M_+5>$7W1%T2YU;'DAA]YAMYY1;0TI2@5GD>
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MB$BFIZ2@/-.."' I1///W).MWW+O\[-3X >(-XN&[I:,@%SZ=5SG38N) Q
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MB=;$WD&+WQ:W(8PYH_#>2; F0;&!,XS Z P;S8+[3Y9&8R9,QZDES:NJG,E
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M.XJ?=(U$C3(O%SU B]I7N"Z*<HV+G;*XM@6Q><U>;TFV=358M83:TI+S%FQ
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M:.)P <21^HC$M'$7"2V#>V"JF_A]L-'9G%]-[^"DYSV-J/I\;B'%O"[\R0!
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M5A:N]#2+F.YQ P)O)[IFPP3K:-:RR^)BF[<A5)!JK2V@T+<9E^X6@U[BIZ7
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M]U:V@PJ,GP$I( '@G6(WYM-.A)B2(N"3UDB'&P$'0F#BRQ]7:2TXF 8BQO$
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MNP]H5SR"5>#R0;NS5#L[VO;$@R"6\Y$"+B0;G4^46-KIC:*3FGBAS0TD.@P
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M%*X\\<\?;D=I[,;V92:UI-@&@#O7UN!3,GPO'B5HM+M0[8:KF.!L2;R((D6
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MV%YN ;VVI=T+?'9[T!YY_.ET3DIV+(R;F18QV7W5K9:HVRH_+U-M]J43/^\
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MR&P&PE(Y^]W$YSO^3BXWFY))BPM>RWT#A$?\0 +$&T@ F\QYQDW5?@< #VX
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M@Q.MY(M$=W7I]%4-CU@'.GH  [YQ)OH"5VSMU"2Q*$-<J2Z^XA*0J.9ROB2
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MYU:8 H@5 ;D.H01'=SL>FL-!,VFRMT>V%9S WX,5 [O.#@6N8!9PFFX<1-G
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MW"M7J !8\K.J?_$/XD;2*;6[.2\8#7[DXR3.8;%M( ^Z#M)OFO\ "I4J3OB
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M^>.;>YGC>"6@BQKG,(ZY..R+28FLJY2675&U1\T65(:6T@MJ3X04J)4H*3V
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M%S_</L>/^/\ U_AJ1D?>RI=CTT!UY%<> VZVR/57W]Q[D>WA)\@'C[_KY/\
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M7%82VJ98/F5,<5VCN4J2I"5/$DG]J>"YR5D_5P)]W,_5!H?3%ATC^?V[H#@
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M)2&Y-4*UD>H]+L8Z&(SW<L)6MQ7"./.M6#N,!_\ S =__(3RZ]/LNF-$  G
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MT/);HRHVHT/;<. <"(@APD$1:/"RY6JU6FB)HB:(J9S&0_%QFY=C0)=F_P#
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MPA3J5>X4I#:E@\J1W'C71-R[,U[6F<#D;1_W6MX$1"^9^W=:K2K.#18O,&0
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M;AW5[?/(T45[42JW=1BR=IJBRDRH#;3J[*,'9,2R#O:M5<Z2>Z3Z/ 4O_O%
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M*@9$_BEMGLJL[944&U%8%AQQ]WN=:4P%%Q;A[U$*=6>Y1KYW^GA[RD_6/O\
M3W*DUT^]'F<N.8VG=FCI,:K<#FQ(TBDB);G+OU4\5+H%7Z7+/RF4ZL^JEOE+
MC2N$!7G@!/J)/G%_L?JA/N->46.H^Y"I3J3Z9M[;K=7#9^$X7CM;M*E5CAB,
M+Q.=85%#"@/V#JSD]Q C1J!BN=>G)J;*2&YKHM%U:E^HX'DN+1).FF=-"; 3
MUCS3 OY_4PI-[;]"..5K[5WN/9-W5TW%7!1'Q]A=17MP5(]-#"4./RG$);0
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M.=/N.GO7P1;>'=#V\6:[E2[*EF5S\W.:A%DF#F%3;_DH(IJI7R9"3P?ZC*^
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M&U*AQ2I*%$Q6./23[ . !MA#&L\8 DZYR9.L P%L&ZMVG8G&.$-X*0@3<M8
MXB7$@EPXG B9?)))*DN2&T%7\![_ *\?<_J3R3]OY: $F LZXP"?3WT6L'D
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%31%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g105868g75b52.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g75b52.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1JN4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &I*^: (X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>%'L         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              D@   +\
M 0                         !              "_    D@
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    D@    !29VAT
M;&]N9P   +\    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M$);[/W/Q"FDDIAOL_<_$);[/W/Q"FDDIAOL_<_$);P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                _^$_6&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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M  (1 0,1 ?_$ !X  0 !! ,! 0             ' 0(&" 0%"0,*_\0 1Q
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MA!; 6=93CE0K;,;-R\%Q)&$G#17?W+.DOAZ9RG>F5V94=X*=#O989F#QL_\
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M_4LZV"@$;Z_D%QL']"XC_>3M$Y>S6'VLT5]="_XR+\@?[0U\E:FP/S_)<0M
M_5:5(_,DCA!^8OD.N5_+O-/7P>W[[$[I"A^\L]TE'F!0]_=);]X([%'N_+WX
M18"?!^TR)\D=I#/SVV/S_/<;'SW'Z\(6S\7^L:^3IL7EQSCAVC,EC]E>;1;J
M[3RG6U,5V9US916SWB'.AI%LP17N*/=R7Y15HCC2IZOT':>54 !.';2E%-4,
M&3)Q64"*:<HY U2&DDEMZ8SFPC=J=(Q[96=3_NQ+9C?JJ=S\\_")ZMZJE) N
MKX29_G MN2PL"Q8[">N@]OWR+WUK]X9[[ZM:]_??0K6OGI5KX.MU%PXRC2?I
MGRBWZA ^?71-:*M^I9UH("R?S_ 0I*R?@)4E7P0>%].N@\0MK?E[9\\HT*JX
M',CEUS7YP\W5<Q\7Y@4ANX,;).76/B(FW@8BR]+3&ER8T=S?[4XI7N0H\9+@
M4];U\:QCN.>J=BM,;/,F457A^'T)HYM'-W%F36SE*[*94$HW@@J9/85"][>:
MTJ8I*A\N]O8 ?/O;S@A@G4!G];\3Q?,;SU614EU6P;:MM(4J!918\V'(;DLE
M#T>2WYK+B2%_"T;('SM*A\I.M;7+7*6J7,24K0HI4E08@@D$-R(:.1_2.>;"
M !OUL36M[]0SK6@=_G^-$'_ @_'&$(&?!!T9L0'OV,EG?;6^W7]MC?Z;'Z\(
M0]?!)UZV)OMV$AG?YNCXZ_NOV?YO;\\(G'*W5^N</7P=;];$UK>_4LZUTK7O
M?7\="%K_ ,J%GX22$6!GP "3-B #8),ED $!"B">O0TEQLG] X@GLI.T(J9\
M$'1F1 =ZT9#.]]11K77\]8*/\P*?D$<(13U\#_C8GV/^TL_!!4#^?[I!4/[@
M3\#A"'KX/?\ ?8G8$G]Y9[ #J)/O[ )]Q_N[_'"(_,/T/>'KX.M^MB:WK?J&
M=;!2DC\_R%*2-?8J2/DC:+'U;DQWE*0S(9=6D=2D-.MN*2"HI"E)2HD#J2I.
MSH=25#Y!TB9Y$'VZ^^1C[<(L>2WCA\,V#VW,&E\2M[SY@XO.Q+)L2,+ N9U<
M_GG*^5?X[6O6D*GC44-$S(L:3:5,&;;WL;&$1!8QVI5O9I6PEYXQ*NS4X8[V
M\[YW04%CH$@DW=E =T"-].[DP #:'M L%O\ Z*B$N&.Z6O'J9C$UNRQRCL&7
MJR0U-J:^2T_3!::EU#T9M8<K0YMQ,)85N*E9ZDL] 5WWQ69[$7N^=K7Y^7<(
M@=@^;!V_G+Q\XU0SOP+\E,^YD6/-:P&4U>939XO8=C1Y'95GT7*# 9JW<FJD
M17VTQK9ZN83$6ZD='2MUP)\QU:E8@,&_[%3\"<P,[%W-\[QD22_-(2>82V[Y
M,,FX%Q'=N\EN6^#<P/#TS2XQ7&=0HS:ABWDUE,N\=KCB=K.>9DV;_7*?]1.>
M=EO>8XKK?<4L]^,R7\@/(,/:,<LG-_<W/AUK&SGT2HU_9T313T=F4]T>46>D
M_J/*4IO_ "$CB1>NO6!HZ=0*36Q"DE1(\E&B5>3U'6OD^G9V?^Z1^@X1&&>O
M'KORBX4U4._H(N]I5ORDCW)><D _'R'GG71^BUJ/WX08<!Y#@WM%/HE1L'Z=
M$VE(0/P4]D!KR D=NP#/X>O]SMPBP^B5/<?3HFB2K^I3^8].R>WS[$]_[A^G
M=$;1K=:>;Z99Z8'S+Y=UN883>T<2*Q#L78JY51,9:2EZ);0UB; ?:5V*5B6T
M@E6_N2>/%V@PP8OA-91@[LY4OM*:8&WI53*(F2)B2<BF8E-X]O9[%/T;&*.N
M("Y*9AE54I5T3J2>.RJ):TZI5*47&40]R+Y[8;S<N[? TXK;5V78551SE;T^
MJ\FI-O#>%;9,0I6@A13/?><CH*4%R.XMQ">E!)U;8_;VAVHK*O!$TE=(Q3"*
M9'ZFJ?3*ETOQ4M:9%1+DS; J[8[Z PWI9WAE?:]L_P"GE?LK0T6-KJ\/J,*Q
MFH6<+3(J4KJ_A9J%3Z:9.DLZ1V("%D%03, 2221&S?T*G((-=$(*>@CR4Z*2
MRE@C6O@LH2UKXZ$I'VX^A_8 >$?.F'#K/WO$:X?R)Y98+DN9Y9CV/ICW.?6
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MY W]-LM;+JV>Y])H#S&U#9( 1TN$^6M"U7GIQ:WG$) UOPU\HH+VM/\ '+^
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@SE14$(6-($ Z>.O'/.)GX18<(0X0APA#A"'"$.$(_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>g105868g77c24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g77c24.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1I:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &CZ^9Q@X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>_*P         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@             !%    E@
M 0                         !              )8   !%
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !%     !29VAT
M;&]N9P   E@    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MI^+FX1-E>:_TZ7!KCW>USW>T;&L])WO?[%/,NRK,JC#QF
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M0T1667:&LL72_\0 ' $! 0$! 0$! 0$           $" P0%!@<(_\0 0!$
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MMP2$RN5BPIR+#EI1:)@HT 6#,S]CEL#8.KQEJQ>=G0RHZ.W3J7==\25".D5
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M[L^7+@#QOMPA >V3VSY<8VP<Y;T.&.4(&V=SD#O]P!Z[DYW&7'"'GE/+0_;
MP S><-EF^C_RX0B)Z1AM^P SZXSYW;#\(#Q?GQZ0%L,<##$G]W/;L"S^>W"-
M!?WR;W=[AR0H;KF&M15TLRRRPL*B(4'PH)/2$D]P' \DYX1I41"C.&+ -DY"
M;](A^692E10B(%'J<(2@0_ '0D+4!WZHCGR<\52B*=K:Q 970!,B@3JY*V=N
MT15+*6H*4F&P44JZ$PR@H;"BF(B(7'<!27W?A9%;**"%)0K8%UM5"0;91S?!
MZ_\ TB4*2>D=/0"DA&4J (*DOL020&<;\2',&V0L,TS%>H3K'P(5L4B5J=2K
M<G2:; K%7$%-2J<*3@P9JH0I9!1+P*A&EX<.).PX"5+1#3,*B)2"E3%2$L@9
MK'-U14R1$T15S98^XB$H(1U!!7U E3!*4K+IB14 !+*B#YND?PE12Y#DH&8:
MJ.BFA.A#Q%,L$D+$.$%!1 *D=?1"<CX4,8*>L#XBB2IUK6[ACPAS2NQR2K-J
M@#6Z1*) 6H*+ $K *70H*A,/XC$A1 "DA3! 2%)"0HNQ#SSI#F'@&36M1$ZH
MJ_-K%!D:_)3%,K-/IM5ILVB%!G*?/RJ9B3G($*(I:(4>!$ZX,2%\ZPN!'AQX
M*]U("5% 63YS3QD.L!, ;IDF00.O5U[O''2;<I%O2$&E4"C4BCTR6ZDRE-ID
MC IU.ET!1Z1"DI:'#A)*H*_AQ"DH1U04%*$I(2BK3P[?QF=8<P)N+K85"H,U
M0^[1]<08A0897GI"5*4F'$^*P2D+C H2Y4E+LDI; 8LYG3W_ # S!%"UR#M=
M:V!3\1SPTJ3#Z5%VP&"4_+V 2   !@ AVW).>$8**$ZKG>GQ$FPY QZ*!#>N
M26]F^W""]S7U!;KXL&0$MXRS -YSW^F?3A%J2.@WT16LBTHI @ !)&VQP00?
M7;]MLX'?A$+:5T;N<B#V)*PB,DYZGQL'VV<EQZ/C9APAGE\H0!0.*FQ>L/&Y
M\[@]_! )^@#_ $X0^-$9Z:=E)H3!\JB&+%R=LGW(V[^_"#H=P^RY[=$2\!8X
MV #^,E]\8W[L?0\(4\VZOTWK$OW]_3;&-R#]M_") ._OG?\ KZ=_Z-PCIAWZ
M?,(;8QN^<!A@^VV-F([<(S_C_P"WQ[]=(1\L[=6.S.1]_/9@? X1/VTZ5I^!
M18PSKY,ZC2NFU4CZ97'9UF5^'-2$2H7G?$-<Q0;3M:%&^+<UQ*E#&@2LW/4R
MDHCQI&!4XAI7QQ\6H0XTM#7!B/'\SC4M6)+;7&M2AO0=M.%]\]/,Q;VF]HFD
MUA%<C5BY->%4#4F@Z50KAN74.R]+H4@JRKJE]/("9.2IEJ79-19I%;KLK)2*
MH4M"I<Q3Y.3AS,5<P_?SRD=$6OY0W=_;N&C(9YU]<ZK0+@UQI-9L=&FVE4YH
MG2+SL>DTN6JZ;ZGM4I.@KKLY3KECQUU.0AT29N&5_2X,G%EH$14I,0%R\8CJ
MX W[>?F"#NU]:]S7W2,HZ'<U>L,[7-&-0-3:_;DWI5S$6QJ5<UOVW3;>7+53
M36G6- -8EH<_5X$>8CUV-&IG]S/+5 ,0S"?[I));@6104*HGE%'\*L&=*ABJ
M_.Y=^H$9EM?\3WDAO&]K>T^M_6V6CW9=5<@VS0J1.6C?%)1/7!'B*A0J3!J%
M7MN1IJYR)$!$.$B<6(A'R*(X1D@E1;6B,:#4)9LR6OLF,E:DI^<%9*4@@.>E
M'6H'I5@$$-U,7PP[HR0@"LF]3>AR<*$116.78$,X=MV;9MG'N7?SPB)1,O1'
M.=UI2C"&[>&R#O\ [(R&/J^?#/N.$1/BH2IJ<@B/KU@W#MG&Q9WP,[NQS].Q
MX036OHCG,]1;JB9PS,3N,!L[;/N06\8'JA<^]:[&I>Z*U%AC9]G=B6=LE\#S
MVSY&.$$S;SWO71J0#?#;@MW3@/\ 0C#;#'T0;J/+>^6P4< 8W;J<^OKWRP]>
M$$7++?I7T]88.0",LV.S9/TR&]7X0V/GS4].J)6X!)SCLW]._D;'R.$![/LF
MSIV='$(ER&8AMRS@.SYR??;Z\(H<4+DT6J&P9Z(Q%50L%_?N!W)SD %Q]P/Y
M<(,Q;VR92$/J<R:P> W46=W)P^1C=O=OY<(4)VR TNI"A+/?. %S@?+[=R-F
MP/NX&[\(&CE]54H0B*XW9:(RPRG!<.VS=_N"<>'([-PB+E?-KJE41;A+PR62
MX?TQ]7;9L/MMXX00DOU=]M_581]>^!TG?&1ZY'KNW"&S[LEETM>M:"&X<G_9
M  ^K]AXS_APB)YIY3KU0?<[A\!A@?\<?N,YX14^'<?L]7ME2!]V\ERYW.!L?
M4$^!ZMP@G[?.5'W+#1.<[DL"[[^@[$ ]6 &PV_""!G'G6^J5L'ADO@#SN/9C
MEPV_OP@EU3M==:Z=T$(X#$C!+C^%_P"3M[9^G"+7,L'K4Y ER[$U*M K8%NW
MC '@NP]G!SMYX00 FZ9^K!2VX(O<0F8 =\N >E_=PY_EVX0+WZU5 ]"4H%"N
MJDHB2!#,.HXVV[^1D']O/""9H*YG1E8I1BN2M"&Y.6) R<G=F+C;ON1MYX0/
MJ!HB7V<E,U"(P(%#<EB<8RP_??ZGVX03(* O<M6YI1M"',G ZF'?MD$G_#OX
M'")Y46]NL(=O)=V8/OOCMM[\(&^G72H]Z>T!.1C+D9RSMD_5@/3W#()J.F7G
M[HA0W)<,&(WR P?T9_KD';A!-?QWSNGRT& S@EG;8[)<@EMMQ]#]$$7)_P V
M%>B4M2$21NV7]P"78D@ANW\N$4!6!6Y8IZ*?0=('#L S$]MR.PQA^_TSP@]?
MFQN>I[JM""$CU&2",GW&2!W[?0\(E*I1M>P+UJFK*(8((#NW89.WTS[9'GA%
M((+$+55 +]6!S:J*A?7'SDV77(FJ'*A>\G>MTR,G3^8BQ*2+2I4W&E;>J2JS
M.3")NI5^4DT(BU2'+R\,PDHGXT26E2L14PC$ 4$=: KD5JHT4]74:-%"M6:S
MIK=7,1?HY<KZILEJSIE4=0JYJ'>]>OR"J^+QNV;M*:@4O22QK9FJF)NITZ4B
M('YQ<60-*D0?@4Z15.%,VF9;]J_#?F H-AY:,@<J59JMJ7-7%<L-,DM2X4?D
MXT^NR[+3FKHF9:WJSS$S4S3HZ)6Y*Y!$_#M^[ZK\>YA<<:8E(TU!5 B?FI?X
MT/IXL-38LA--?$$6?TAYK.:BH<PE@Z'<Q?+=96ELIJ%:UXW#;=R6MJ;%N^,N
M)9DK FYV!-RL2E4U,LB.B/"^ $*CA?S))0D!103*VFGMLGO&R^"3\&&5!(6$
M(*TI_A2HCY@ER6 R '\,2_ U*4M'$U_/B;&EVCD<>-SNP]"'^^'SWX00]K7%
M;>I2EX.KN0VWW+N_T8[?OP@AWV4_&;9+H\ 9SX< ;,_H.Q_FYX1//+>&%OL6
M=]RXV W]R![O[<(N_IYYHJP@S#!!.'SG(R-CEW]G&W"!RZV;\',5-U,22"S%
MF&&8?OOGO]CP@2+5[)ML$&CHK&$2^'V<%RQ/D,P'L?\ OX1:)KE[@JJ@N0T1
MP-@S,06!QW.Q^_U![%!%R53FY4%*]$0%T15(D2Z??8.,MY=L>6R.$ 'NEV-\
MD5R*+^#  0-NQ.^Y/U 9OMY?A G.JJ=+H%!N3HM0:PB&8A(QN1V(&.[MW+_S
MX1'+>Y&9-[J=ZPPH%G8-[OMAMO8CT]N$,Z]E#5=;9BV2P*8@G;;=\.V_T.PQ
MD\( .F:T"]NUC#!&6VW9W))#GOG';R#XX0\LF5?,[PG/<9';#'!8C<[AL'<_
M3A!.V?5-,[IZB$5$$/ZN/ .1V[#^7KE!*^]-^EJ52A8L[YV;?O@/AMQL<X?;
MA!.^2+H^6E]FA'J('JSI^YW.VW^/JBA :T+&S=UJZ+V*A@ER&R0YW^C.1CM_
M+&>$"&JWR46CV5$IJT)BX<.?!<AO+D_MGSW'"*K$*4S#.+HET%4-E8F >0Q[
M9()?. <._G/=G;A$3-:&@R1FHA=$%E16;GNIO!]?!# XVV9LD/P@FF?[$.1T
M!4D$*E CU?.02>^P^^S^YX0]%5"G>ELT5'".81.S."SXV=G /DD=_P"?9$T.
MVHM>U*IDRQ)W& X;O]<'=S@?=^$.N8\/7;6%U$L[-OYP'<>I&-O?A!!KVO;H
M=4S>D-+]^V'[EB<G_/GA'22_3I5,O9(6X;N[;#!Z<N/9QZ;=N$9_QO\ W9@G
MNC/WZP@.SAG#X9\/]'&^VWE^$0IJHV.C[:C1F)P5S&:"6US*Z9SFE-WUNZ:'
M;E2J]%JE4BVE6(]%GY]-"G!4):F3DS /7,4F8G(4"+/R"_[F<1 APXX7"ZD*
M192A7?(%"%IV1]E-,#3/(S;LW2[4@1-5=5D7%9=*N>VZ#>\K<B)"YY:T+O@T
MV#7+-^-)RT&25;T9%)D?RTN93XDI'1&F(<3JB8>>?O\ A-\P4^%79,VSR2L0
M@?A]Z+4V:HD&A1[KH]HTN!97ZEI](UZ81:-U3U@(0FUI^Y9"(%FISE.C0H,V
MN-%6\[$EI>''"TPDM$'GSG$,P4-UN'2MK&JV(%8]GICR<Z>:77M)7;2JE<]5
MD+:E*_3[#L^NUB-4;6L22NB*8U?@6Y2H_5!D8506HPA"ACH@RQ$ !2>+%Y@:
M>/GJ'VR,5,_$IMRC4>L\CDU3J+2*?,KYTM*T)CR-,I\K&Z(JYPQ(9B2\M"*D
M@AP5@DG+@L>!?]OF+8J=Z-T?Y[JNV>!#*%J  ^'E( _B?#Q5DY*U/TEF &>$
M9F.M0W1"I6IR7LY,=OV?< @[,&=A]1G_ !RC&^2@ZJ:D7KZ+1D<%M\#ZA\@^
M^PWV #N>$ ZV1QH;)NZT%2GVPCDD@[-AVQL_C=F]@X\H9*CJY!]Q6]B0S@T>
M79MV(?L0&+^?0^Q[\(==&2^3J=5<!C>$Y.220^P \9]>Y ]'/;A!$W2YKT(&
M2NH1JI$@7(.')V&& &7/?<%O.VW"!9GZJG0)O7TA,&# >K^2,9WW(V\ON.$%
M.?8-JR99HR@P,3G._8[#N?5ML;@!L<(%F*,+\W:MZ]72@3$CJ&,EF=^_?W&W
MD^O"#. ;(K.XUS=26#(T'4S%]SEQ^SYQ[9'U;A%1<D 0. BZ*TRV-:$LI>0Z
M@-\Y'8^,L_H^? X1"!=2C5HE;*G1!F;+&P)8N2<G]OZD%MWQA"QHKI3J EWH
M#N+&0(;)=LA\'&<!^$'Z%B>MRE:&V=X#E.,X[ CV^S,,.6'GA$1#2]T&5BKN
M-O8<@YSG P_=F'[$^K=N$$H!4Y7WR3\E42(]200"2%!B0Q)9R6+#&X)?[/PC
M25<783.P2]@_2YAENI@,.'[.02-NX\L-QPB*:J%0I5=U'R::0V;&2"<^YP7]
M"X8;]^W")L*=>NMU9$WA#*L-M@>"&.?3J[C?;;A%W[IFRA:J,T*N+P>H&P#.
M,DDG9NV3CVX0<LM=5I<H=,DK1("V^3\NS,PQ_B<Y#;;<((4.]:J7.5=*N]6"
MQ#@>A#=^S=\''JW@/P@145J5SWL6*Z+52A >G?/9@<#R3OD.!C]R>$$71 "X
M=EH[LIZ(PB.&?&,])<X)Q]=O<-]46MT%RQ*A3FMB="HB;$93G=\N/.WD[;EO
M7?A$:A4=@:H7-@^05:(!")RS D@OEVP_T +EG_H>$74%$0W '1"JBZ!1FZ/;
MN.[ =V#Y.S[%_?LW")W:Y5G1+M4)5ES$(.Q=F\'Y<]_8D?S'9^$#N>KM\A?E
M@CM\OCT&SA6P<['!/O[\(FC[FQ#',Y"UE%("S.Q#@'&_<X/HSD^@X0>F]6[J
MAS2CEG6$1G)?R,LQP3]F?V?8<(-8=TM9]^K,\'@Y8$DCN"XQ]W/MV?A"BYTJ
MV[=+U[!C'@'8'L00[.?7/[=^$#Z'0!.@.6R](ZZH\-">I2@$="E=98 H274L
M$D#I0DA2R2 $N2[#A&N4]+!0Z(EG"*C'6\84M?F7T#O6ZYVQK5U8LJO773JO
M-V_-42FUJ4CSJ:Y(2L*=GJ7+A"_ASLY*R<:%,1X,E$F5)A+"\@**47E-4 I<
MN-;A&L-HSD"=ATL0X<;C^;D9R_",G55!="X==JJ&0 YJ(^3.4>0J<27_ %&1
ME)U,E/HJ,FJ9A)CJE)R"Y@S,L%!X$>$ZOAQ4?,"2Q?A'3F#6WJ:-DI7-F)98
M\3+:1:;R==%RR5AVC+5X34::_68=!ID.I+C1D%"IB+.0Y5,Q%C**UDQ%Q3%*
MR5*6K8H<R5TH**.XH2CG6P^[;MF4"U%U 6Y;]%H2:E-"=G8M)D9247.S(?KB
MS(A04&*J,F)$ 4LJ,(E:DYB%D3FE<%:W50U<Q?6*;:PH'_+VY04E*05:?:_)
M0M(1U!1H%,(3\R3\K.-V<^K%%!49T2M5;5B')&L7X3VZF<  X9^EWVQ_NDM[
M;<(YDWUT8EZ]3D[U4!NYP^2#C9@2._IOY/""(*:%5!L:*^G<B!W!)/D$ ;'/
M\A_E^$1'1#Z!1I7H5*Y0A_#@ !G]7#AQZ[9_KP@ZI0T1]&-T[T2B0P01G&VP
MR';9O)#^?VX176JUN707(.6J!7-8"<!3>,;[.<'U&_H.$ "X<,5]@"XN=7M6
M%\I;!'4_=@#W;WV]FX1'2UM[$:#.RNJPG (! +'<=QV)\_0^X+<(U09$A'RZ
MTHZ@@5! +&,EG#D Y##;< EC@#Z^O")>J-9]ZD7<)<J#2&SAQ]B7P.SMCT=Q
M]SP@+!/0[6*G5]'0"%A\>X.>SECZ./4^O"*02A/5U)4VJ!45(#L KL'!^7.?
M5]G]W=_#,S\(B$(^72N9&3#1T+0,Q!(\@@;!L?7N?;V+H.[NQ52]_P!G!=E#
M"!R0&+.1G[# ]WWW8^>$1/067Y&5T2BHJPNGQN1N<.""[>V//"*NP#T<UW3V
M!K80R,CR07]PD-]BQ]^$/-2"7N"<J=GAY[$$AW!&X\/X?(]"'X0[@5!LN?LJ
M$H5:P1+CL.P]CG!&&( SMOMPB)JMR0%[FHNK9%"T+!;*MBX[N0-M_P"+A&D(
M=$V!]4"?:CM6QAY &00'&?1]@^=L OZ-V1%Z,"2%4JCJZ%[!W565._89& <C
M?<;=+9<O_CPBH<R<R&(5$<*JC?(&&Y<!F&R</]7[CSN&[=^$$"/N1W9E N "
M 5<&T!QTDALY('C]L^SCMMPB U2_=ZC,NB5&<('."'4VP?'=W);U&=NV#PBE
M-6<@E*:(*J *($17 8!#Y<EB6SC)_<;>I^O"(GA0.VIZN@J+B!B'W;.VV-GV
MRXR?8=^$&+MUKK4N -C=6,,;!B"S@OML6)\;-]6VX1+FH]$S9E0[4H+-)]W
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MR'/\N$,NH=CH YH0P) I<K$BIA\Q8C);]Q]M_IOPB)E=:LK:YFE]D6.%:\*
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M;4FVZU8%UT#02?IETWC/6';-<MNF2*JBNNF5DY>I4<3]7N.H099,U6/TU"H
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MQZCT[C]D Q56.:J1TN,Q<5HH<'8@-]@ ?E[[@/\ OEN$ FFNY(0HMEHF8J2
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M.I&J2%>ILK4*;:\"65-*N60E9N:EI>2CQ8DQ38=0B*A0^N66.(FS^F_5XT2
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M@D$-W &? QYX0%'UU#@$4+%0G?(PR<89_&2?48S]>$1'TL2&T56?YA9+/]G
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M , /ER7_ &X0S0M=%0;KIXSRVV&""<>.YW\=+ -WVX1.I"(%KLXH*T)L@*0
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M A!V^A'UVR XR[ES_7A" NS#& !G^1P7'OGQPA -@[D^N-G9_P#)\\('Q(1
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M+;V89RY?!(<8VV/^##?=^$%2EQ\IWJJLA(3,]7=RQ<@?ON!Z?MPAI[:+WO\
MD!1!EL$$C"<C \;;G;U^F4+E;N6SNR9J/W@Q[';#!MGW+$^2,^V.$'^7>Q<]
MB0#;,+"V<.,#)8$G/J=M@7]N$7+JCL+C\Y."66 MG&,99B/9T_U+>G"(/87I
M=RZ,O=D*F)#MA_7[D,7/J,G]CPB0. 2&QY( #Y!=V?Z;Y[<(0%QME^VX&#A]
M\EL[#<^.$(,-V/;/?V?!)(<[_P N$(;#8^QSD_;T^P\#A"$,,!W&-MV[G.6
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MRJ*3CA T.QR^?EHVP0MU9[J\AW; R,^'<@\(Q-278:I2K%1LG5HY&[G [O\
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M(HE)V52(J).%,BGPRJ$$3L&34\(?6P>"P\0.3S$%W45>I&1"RGN\5!0_D:%
MBHU[7#1^@JA_B64^^H,K,:0\K_,-J%"GUKAR\W+P])Z-2X41#E/Y\+U!F*Q3
MOB @PD3,@A<4%H2HA8G,WT?'DD,YY99:\W/*)2 _,3-B2%79@]4+1VEPI2!]
MS,XE*AM"6W#NE(]##YK>:VMJF?TWDYF[:$.(F4$>\+QN>H5&3C103!C+H5K:
M83Z2B("%A[QE(('RHF2IHI\,_#8\M,3"0@D']3!,LW*4*$8C@$9ER6"1?T9"
MB3.Z*78OF*%24!(18PMKCJAST5C1O5^#*HM73V++Z;WOTSEMZ!ZD7/<-.FXM
ML5N+*3U*JD[KM1C$FH<MT2\U-&T*[&I\^D32:<E:$@=,/!YP!-,%*2/-*!,6
M $OW!E1$)5;D"/3_ ,7#$LLR\R@3"J?<IJ$!T("D$M'YE/\ P>'375.\^:W6
M"WM3[PUSHFFU4TZN2YKJH$I<FI-LP[]O:7K-FS*:G==6I,W08TS_ .+IF&$H
MC3L*M7$%18LK-0I9,S(PNN)PIPPJ&H2Q<HBB:9%L4.9 "QY<1)%$H1'5%I4A
M0J%J%3=#'[A=.],-&]*9.!):=Z<4&Q855EXLY,3E(MJ#1IY41)$687<5> 34
M(U1F(AZYF%4YV-.&*5_&6I:2KCQG#,ZH.:Z2JKLR9%1FRI'"6;GF+N2A1:KD
MP%"4LF=,'Z^:M4:M2%HVO0KVB6E)7!=D*G7'>85-RD6SI65I]37+E570\E*3
M,[-)5!AIFIH3$)9"IA,,'CZO!\'^F<2?$P^?DPUPY)9__P I*DJIY@0 %YBE
M0!,4$>B;]#""XA1+_>]$4 ,=(T+?BY:WZO<J6B-3U2Y;+[U!J][6=J!;ED0.
M82WJTFH524MBY:34*A4K5O2/"@U.GW=#I=7A08U!F>H2E,FHT>%$B2ZI^>1/
M]N)X26? _6GP_P!'$F']@,Y$H>BS-DDP!"HT>0<3)C8LV'(#R@D J3U'VA?6
MX%8NG^%5?G-=SM\F&G^J.ONJ=YVE1:A4*K39N#9,A4*+J%J4F6J(EOUBH:AU
M.-/S]"M2H0PHII^GE+H,R 8B8E9,,!/'P991*4%%JJE5:K(-^MXW-]H5F<&H
MR9'^=(W':=:8Z7Z/TVJTC3RS8-L0U@56L3,K*SD_6ZY-QE 1*G5Z]6(D>H7+
M5(ZP53$S5YR>FEK/6N(M6!LJK.226#K6K^A.L8!)()^T&6AH>A3-E!ZI&3A6
M##B"%'1.0T&05/JCF"3+P82$]?1'F8D&"E$12<E,5$-CU)1A()S'02RS(%#$
M!"K.E:ZH%9\HU_7)J7JA>"M7+\LS6&DV=:&FL^J5E+0F:1;-8%6-+A0)F;F(
M]9G92'-T@U<+BRDK!1&F4_$02E1*@@?=PL'A_P!'A%P)IYL>28S8H!/*DY'W
M2@CF E )1Y0%M":?!D,TO, 9%!"3.H^TZ*3U.Z1:*UM>[$J%MV[4:U6(E!J=
M2IU.B3,I792=HRX<W-2T**J"(D_3J;+1$A2_EBP!^77#*%H6I!"S\[&X6:3$
MG ($B_:7+&C$DZ*2J[QS,\I>5"5U5$L;=-;K&1_[64&?DZI.TJ;5/2],6E4Q
M'I714H2XD:!#4B/ 7+B8^.J %!2C ^)+0R/[]8(5T<)<.8S2R 2DS$ <Q,J%
M244H'U4D%!'7"D!FE)! *3%5*I9C_E39T6-:-JZJV)9NOU_795KJK,*6_(2L
MN*^+4T>E9FZ:I1YNXDW#0)^MVY0C6;LE9)*J/&HL*E774*W&G8,6FS,J($K^
M7A?2/ SC"!$LLIF"D338C2D*"IE!$P*?:<-KK0_9EP\'$D 0$S5 FQ.6X",*
ME*"42@DBCYM_MJ=1)Q5RWC*U*=M6B(A5FC:94R%#CTR6,C$34:=6M5[SB3G]
MG/U. L0INA63'JL"E42HPY>H1YB9GX<C$HGSL4'#Q)I05 0$@  DR@DH@0$T
M*#F 4J7C&-Q7 <)A'AI2F/(LV+.?URO,.:422"0X<I,LX'-S3_V@3@G^WOP]
M8=5=3HTG1]+*9(P8,] F8L>Y2B+.TBF($>*(D*8N2HTZ3DIN;@J3$@1Z=0:#
M=-)CSB(OY:MTN!\.3E,":842B^B#,94!-'41^/\ J$_&8Q$G"I*I0'[/[40@
M\[\J.1]Q( Z^1K^@,]4J#+775:U>VI^KD:I(EK=GZQ=U9L63LZ8ILW/3:9^@
M0(%%N&!;5,D(M/,0SII<>'5H\?\ *Q%0X$S @)[8'%8DDYPK4F"2NM0\I!",
MI.81 ^>&DQY,##'$S\V*XF4"54F)!'Z9,O++*@$P14*RB98RGH)8E9M6DW+-
MZHT*!5[SJ=7I\"HW/.U\WK5+O3+0I:"B95+S-JV]3925@KG8Z@NAR*)52$F+
M,1?S!BJ7OC.(Q)9 5(E$K8<OV@*4#2H @  EF#"S1]/"K45JRY4=50NH]A&9
MYZQM.9V)4%3VG]!F(E/3 $28-KRRXJTQ8,-<-,.-"_OHZH:%I2KH<PF"5 ,0
M/+@XT\^%+B*?N,S,"TQL95#.>JQ[.3[05J2$F94T0KW]XKMJ59=Q:;W?3K]T
M,MN754YJUA2:U0YBVZA4*$BF+J$>9@5&$L5JEPJ54)*8BQHJY6#UB>2PBH5$
M4W'LP)^<\DQ64S#_ "$JD9( 35"&9PX)CA-ARO9&J<W&2->JZ1F+0ZBP+&LZ
MDT2<-:CUNYIRM7/49J)28U/>>FIE$S/(3+ S4*2EA$BI3+0HTP%188*D=3+(
MG'XIQ>(,QY6DDE'*1,$EE0*0 %0.'2I+Q)9#(.66BKLJD("?E#D8S/!KTM&1
M+S!EZE#A3DS$E$_%E8\,PUPE?#!7#0@F$A2@>F)$Z4*'S=3$/XP^0:]^]/+O
M&G#N5R1;H0B ZAVT!C@77H*>LF7FRA%1_25G\K,K4F*2D=:>B"LKA'J'Q(Z
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M7(W8 .!V<^/N'X1:(>OK?3;;844)0M:RF&A"5*4M1"4I2D=2E*46"4@!U$D
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M_P"H/'<OU/A?H>-B_3N(F,^'Q XKZ9AX<\DJ S8<F+Q>%CSR@@H3A2@D$ S
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MJ9%FH$C'7*Q(*9B(@Q $OQZ(YR4Z^;C?:T::]%:;9]#U%T=T5UFU+U_T:I%
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M!%$%9AS<"67'E(WP(P@STJB/)Q3#4(<=391@@VERHP*%BU\W8/J*Q:PQ$?\
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MSIZ4ND@ @A<X1D9;N>$*\U=G5$UN:HG=1&U) <GW4-VR2EG'=S]M^$0_VR[
MIF '>S&.;<8(<> [!^WNSC^F_",4(6AS-3J6+ H=5JB0E88XW;)  )[$>K_7
M'" -MM\E!<L:  U.4+KAGJ/4D!!)6H_+T[G<MMN7PW"*A!H50-540/F#EW:/
MC5>ITZ4IE1G)NHRDC*2$+XD].1X\&# I\!*8<6),342.I,*'!@P5",OXI2A2
M <L>*A;6GG2-23223&?%3].64F?G_M(0L2% ,RL7(6\4VF-4-0M>IN8M_E_)
MMBP$Q)F7K&NM2E@969E8"HT"<E-*Z5-E,2M5(3"^I%S3R44BGQA"^'#CH0D*
M D4H6T/3.GI&9_TL8_\ 9*_^)K-HO*+,$"#J8J)JORZ?ADVGJY8,76_3JV;K
MULH!EJA2KGO>4J=8NBX*A$,C\*JU6HKF_P O59B8F($,IB3:/R<L8*):4EH$
MO#Z>/5P_TW%QYABX<BRNDX,H%P5$VR(U$"HWU.'^D_4\;"$V%),<(D\TWW!B
M7#%Z%DJ@L8O]/ZM1;FEHE&TDH$S><S+(C2L:X5I_3K7I:Y2/,2,Q#7/1 DS<
M]*+EH<66D9-"EQ$E" LI5QX\+AI<'BC^HLDIF G=2 4)ERL :("5I';"X;&X
M3%E/%_: 0JU-S<LQE*J#8VC5=RI\I6M-J<U]6U'U:DJW-VQ%GJW.BH3TDN)1
MZI4YN$F)+1HDLN(J'+PY%1$."N*A4=4=$)*CT$\?J?J?U62;@C@8<R@B0 2U
M$O,"$ 3);(A!6I_5\;]:^F'Z+Q7#+)^M/)A  \K\N+)-<*A2W9'C>+.52ETF
M4B34Y/2<M#@LI4Q&CPX$,0X2"7B+4R1#"?E^ @$,0P+\?E\,_J&A?/,]:TKF
M%C^>XW$X7+_VN50P"_:,DI6Y)!-(UB:X\V.J],O]<'1F71>-BV_T)O>LR]!1
M&E+<)6$J@IG(DS#3$A,M*H\40E&'"*U)!4D#CVR?3^=Z*.RY#\[ZC\CQ'&_5
M!Q\DL@F/"F9)YIL/^T&4DI,9G"H[5LJ1F.G6G>^M]+EIRX)N)/T^K2?5"*Q,
M4NT9"#,0.F(:33Y<B<K\[#"^I,6IQH4EU@/!4.GCB<$</.]92R,EWO\ N65D
M^MARSXH!G!<E+([H7?-697A61I/K#%JUAV-><E(PM-]/*W+5"C52GRL*!6*B
M*.J.NG&I)5$,& B(5 1!+O&6&W)+^_\ YL@P.(EE)_4Q\/\ 2FYI@?M)!*!C
M_BSD/2/IX?#2 "<S#_M_<!1S1E>_6-@"$])".@@A"1ULX*$  !VPIOL>/DQL
MN"2FB&X4H4*>U;$QR@$$@$=/?;.V/L?;[\(S0.Q4D5;9[$([[P$^'. V^[@.
M?9AALOZ\(HU0.Z)0L@S52%5@'H(9<$$9P1Y8YS^V3Z%^$9T37\,!=6W"(ZH,
M-M\LXRK+_9@P/ESPBG5\T+#HSAR$;)@8>#ML4EO=SYVWQ[GTX1-\\U;1&W?)
M$0P%R01AW?PPP[=_3Z=N$**WH ^IK:@1=(14X!V8@_7.XW;8^QP_"*X7J#H%
M JRNWO#&[,[$AL;*R,_1B_GZ<(,SHJ%<D8_LF5$>$2^V/(?U(;QDG)[;[MPB
MBQLZ$C(>B($#*X5%A!V+;.[N7\!Q^Y89 \CA! *UNH#%B44)H'95#&!R=A[M
MER7W?^6P]#@(41PRKHB)D5UJ48$5DP91V&&+XP_;P_;+]APB$T6MZLJ%:A\Z
M.JDU@9B #\VY)V(RS_=O+?3A!:K0LFK*B(F=.\(.YV#L7W8DM]>['OC88"!R
M\* $J&R"NVI4P'*0Q'KY<[OZ$L/'T;A%%672E+)4+75;JH,GR'P[?<NX/[?7
MA&<Z7?/\>#2([)R[Y5]>WU_P/CA%<GTWV9'*,14A8'R,-TNXV#$_OVVW.WJ@
MC,:^/0"ZFPH2\2.#N "WN^WI@8)]N$0+DO>]M%<#?LG)!;/5L_8.Q)^^&[;[
M<(K O;HI&J+0#<EJK&O;\1&ZZS:>AE"C4^IWC0J+7=6[)MW4"L:?R]0CW73]
M/)E52F;BBTQ=,@S,[(QEBGTZ4,S*H"DKC$$_,_#UIIOYZ6CH%H4!LE&R[T6S
M1J&Y;]0)*8UPTRJ]M7CS(W-J?/<TU;LR%,WI)79!HE2Y7Z?(W) ME%Q0)V5@
MT51ET2=)CIGXTO"J,S,*ZEQ"5'AYYO&C0TI>/T_A^D$DY"7+>0#WR #X._;A
M'(^CLP2UA4C,,%W$W+.3@,Q'^UZ-V]?KVX1$"[YVHZEC=-$=8Z?PR2 Q <."
M2&'4X45C*AG )V+;<(V"+G4APA<FZV*@LO:.4(4@*$-"0E945*8/\V72D .Y
M)P0YP<D\/-]WB*R,IJ5 (2A0*J:'='BB&KQ;GWY.\Y_L!KX'9G_\G:9V[/X^
MG%L-S\?B-(JY$!#5P3[-%]$ X!+,$N.[C#'V;;U'$CF6S>]&(:BAWZ!&B3YS
MV&? W!^Y ;NW"(F72KZE6:A1.T+#%CZ)[%W=L[MACV<\(O0-6A'R :[LT'KN
M.G=VR63N?8G(\OPB7<7R&Z ,#750B:]-12I:BQ)2M3'W.X_=_3[<8,X!1"S=
MNL>G!F/+,"6'Q6E13LMXI_S=4NE4^V:3J548T21@V+.+_69F7GXM.B3-K5A"
M9.H0ES$N4+B+I]732:U#ADJ^'"IT8I!^*L'Z7 #GQ9<-0LPF,JRJ>8!0*-+,
M/6QC]!_3'!R<5]1ED(^Z:8"5@5(/,00A !"@$WK:*P:?TZJZRZ=S%<T^EIF_
M:+#M.?M^F&KU^%#EI^]JG2#3JK<BXM37$BF+28:Q2)2$A"4]$.9BI#S/4-<6
M)</&Q9".4B:8( R E!I:CJ@>A^YQ>#A?2/J7'&8_IF?B,5!* ADE) $U$E*+
MN $K&R/3X5V#:5%A7'1Q19Z2E)60C22)N%401+P(<$K5%AD(2%*AD@I?!#8W
M\)<S#4:"MTU-3^!'X7ZAB+Q<^+*5E)4<H'JF5S5[6R%"8PDD @!(9/4_2#L7
M[[9QWWXR:YQY^8S+,?\ )261:J%"#504"(B-'(!L-SX&[-W)P,;,_@\2!S2C
M]5HH17)N+%W60"@Q8N"V[8PP]G_SW",YNJA=%?U1*H5[$#@N^2S@]MB=_'C<
M OP@R: %+YH=B;A H<4,![!PQ)+_ '..[[D^"0-L<(:HC)6_LA6Y>4$E2\(Y
M8NS9/EE$GZL&V'?A 72E-&HJJ,ZDZ *##[EMLD]PX=_9QC/GVX0T)R3;=;&Q
M0 BH<%Y. &(#9[#8EQN2P[=CP@P]\CU#A,M]P&SX\AR1L0^/J0[_ ->$2F8<
MMD4>O374,8B4@.7W)#;.'V<^.Y_[^$6IID]73=%)9^RP,"3OOMV.[X]6.7_E
MP@+(1NP2P=%W34JY18 !)))(;#, <[?\>S<(7*V47#D%%8=505)J5;/D98D]
MQW!P[A_/\O**HH4HE1DCIT1[D<P"@'8*()9VR[#R?7U],YQP@M0&6H1U)% H
MID[D@,XB=CN 6/EW]VP';U)R<CA!U3)0H5MD-T#:% QB?D,Y( ?L=W)]B[]_
MVX1"77(J%0(&0"NB,@V6$"7&  >^^SDMX=S[ \($U#M^P1LD&Z:L!\N2X(?V
M<C/[G/H>$"A1J@][)06 8*2"'N.GL,C(^H!#_P!7.P/"#YUJ%<OE7N%>B F)
M)#/XQZ$8&#^W"-R7Z;7H+9IZ"*5<_6J]\Z+:!R5^Z=RU2J%QP-:.7^W_ -'H
MXE/U:OTB[=9[*M>N4"G?GDF4$U6*15IR00J.N"A*(JE&,@@!2(',UP2<T7]Q
M?H#%4M'[ L:#K#:=PP?PYM5;"N"9N6=G3J)==TRM?I%M3<>#,":N*<E)N]*Q
M AS$0K4J572:<C\O$C!,$P2OI+SP)^8W122WMFX_F-N,O#B(CF+U+^&4*08:
M^H=#*ZH9AA4(*)*%'XW7%40L  $N>'GY]?2,$@BM]+JFM$5 OK'?9NDC?.YW
M V<^&RS;8W X1E56]* 5-@H-VJM2A>(MOGI9B!EL]P[EQY;'8\(J*[D."5!0
M5T1157*E1FHI(07((+!W<.X;ZL,[ OMY0%:7U!0J"P9 3FK%\M5'XG1>I<C!
M'S#_ ):NE7EL?G.Q)]C]3YX*#0QN4,0XKZY$ #9%]HVII4D.5*"7) +L,].[
MM_G8'A @E BE]US #7VHX,2^*@$@*2%.$,^7/8#[;Y+N^<(AE.12H.:,I! 5
MSF R6"]>9FI:! 7&CS,*!!AI,146*M"$( (=2UQ"$( ?*U$!)R6[YGGEPY>:
M>82RA 9IB@"E IL[0EEFF*2A2051"P='1!5%9$<@-4K4WF5MV8E[BL?1J1K.
MKNJ$*2G)"3I=CP4S],H58CP(L*5C7/<LTJ%;5(EI>,H1(WYZ;"8B$&##!B+0
M#B3'P<1L/%DF44EF!;IY0QU.#B2IS23  $H00^>M^YJL?EW_  K>7O\ % N;
MGDU!_P"7/,ZHU/E^D).XJUJQ3=0+LCJL:]+C@P)F%9DO1)*'44TN<ITI65R,
MW,4FGO0I^WH2EST*/(JBPE^H8>+)RSS8<XEF)Y3,"!-9 41"A-5^!X8<0/TL
M199203,50<IYW(!/^- %F!17$?JJBZF4L2RK?T<MM=T1:5)QJ; BR/Y>D6#2
M)B7"I:5@3E7$"5DDPY% 1!A2=/\ BF'+I3"@2[!$2'F88DF)+AXDIEE!=0A$
MI<D]\R' SBX.#@<+-*3Q&'S @\@F!GJJD(!*BIHA8H^F'F7Y8=2M;=<;_P!6
MUS,&[*1IG-4*GWK^ES'PZ1*PZ7(P:G6:#;AGNF>C"1A_WDW,!*8:B%E.<<?M
M^ QN"PN P\&4B7B,<8@P,,_=.3*AF$Q 24S2S+*)B"9IN4N#'ZO!_J?!X/@,
M67#DPR,.24+RR$EP"6F"S*22P<T!C<$G7NP+<L"4GK#I-8O1,C3)<RU)LVB3
M55A0)A,DN8$K&B24$2\E#2@*3-U&*LPT1%!2B5J2!^4FX3&EQYACR3A25FF%
M25(F=&5$2J@46/Q_$_59^-GFFD!)F)))J>;,@D,C"5 $0 UBMXO+6B/+67=]
M'U.I-9G]8ZG IDSI])2$NM=EI,G4)R*NB1E11TPZ4B3@2=>BS*28D]$1&AH4
M0B&KMQF$LDXDPII9,$2B?%0(5( ,Y?\ N)OTK'AQ.$Q<:2<2<7R8D\H27FFY
MF()0$34"JP<D.\6$IO+Y<M67#G+WNDU:9@E*TPHZYRL J*>MD2TPFGTR&IS\
M-ET^.A)RF(I02H?-P^7#(']VK54@DEK4*-9J].#X*7 *XV+-B$@J9IE"W43!
M!<M0*6CR-4Y=M6:'$O\ H.G-<M&!9FH6:G^O2L;]>D%S,M#E)Q4BJ2E$2G0(
M"HAAPXJ@$Q&4"X''NEXK#26:8S">2B H<U *$439VCWSR\+-(<,22_<$$W+*
MH=RH'-HSU6+BVG0H=L6[1*"@1%PJ12Y*1$;IBA*A)P42Z5Y2P5$4E2XC@$N%
M,PX\>-BG$GF)H2=:NY>X9VI' 84DC!" C"@NR)F*@Y41/4!4,*00KJ)+AB[
M=S@;'!SQR) 8E"6 +/E&QS$&4#[2V7__ %["D<OQD!QU!F(8.?KNV3ZGQZ\(
MG),J\I8JN>B(,M'*Z"/QH:&)6ENH!WP[J#>Y8MX;UX1E"TI%40 O0%7LS!EM
M0&)E:$E^M+#.^$@]R3Z @N[-YX1.68JQ7>IHX5]*#=A'RDW%05SZJ8BLTM52
M#DTU,]++G4I'PRM2I1,0QPR8J"HF&.E*P26+CI^CB\O/^G/R5YN4\J(2JTI*
M>T8FFEE/*9I0:(6*J@U<D !GJ*Q]?K27 (?#L<C ;&",@MZCP>.<: -EHHV*
MW==D=Q6K!< YQ@]V!W/HPV\;9X0N7KT"CN#U)!!<J8"%$-X#8/;S[%MCX]^$
M% =^P[=,PAV4$!9A@#.<M]'^I!.PRW;A#92S..G7(!]5$!+ O\SD.=NP(^X&
MXX1/0@6W(WZ.=A0#$X_A'8MW_F 6\[#A&BH#E"FJJMW*$A;!5*Q(#=ADE]]\
M^1_+?A$-M&HI5+@GHM&&20O]H@,[9+#?SNY\'P>$#0*2F2E=+(,PS@Z1$L[%
MV+9?+CSDCW\#]T4EK%LBE2UCJ%J5*J( W<.!E\_<#P&SM]6#H$Y%,J"C5%_8
M9 E)#+ .!EW\9^7W(SZ#.>$3,O0)[+56(MLU(&[L"-P/<X[; ?R] R)Z9H]-
MD%?CK'W.[@G.X.''LVWDOPBO:R'379]19!2&,C.2Q#MEF[;/DC?U'"(>@V/J
M<VR8:4A@ -@]P3VQW/C9QP@5-UR#FMAYWAL._?.>VY.<,'X0<ZI3XZ_ 2PB)
M&X&&P2_9GS[G<CA%!I6OJKI1"B9]&3&>H>H-I:7T!5S7O44TFW_STA39FJ1Y
M:-&E9&--1?AP8U2B0H,9$M)?$0OXDW$3\.&(A4I20.KA'1 51%1%4+U"$(1?
M*T4IK//+)P^8NBZ.6S9LA=% J57H--E+AIE<AS%9J:ZY255!5PVU1($.)+3]
MLTM!3 J%0$T@0(B(R5H2H901'78FVM_1%N[QLA2X0GN>Y=(!QWR7?P&_8'A'
M.E; 6*UL@0/=7-W(A[]+N^X&P]@P?Q_0\(>&Y5+J=_D6A' 8L2[Y<>_OWR2'
M\;<(H"GW"!$)6ZIL 4N0Z!!(8.0-BV"S[??U=O'"#"H0MO8B@T"T(6Y<T,UA
MSS\\GF<?V$U]/<#_ .3M-;ZG^G"-2T"#)Z_Y%>GYB^I(!5D#^+[LG^H^_P!>
M$<THVI]>J(BHEF<&$ VY"N_D;MOW)RP\\(NX3T-%< 4%:+D6AD9#,6\[DX[_
M % &WC(X1.E<F0/0,+%:C4&  EP6 P=AMGMMN'(]3P@UG_G94J*KM2.HI?2(
MS)<DJ8D9?UV)?8-W]N" V7)E]P?WC9'* 5+A:D [ (V6P"15CFRT5@:]Z(7=
M8<Y5YZA*FU0*S GI=2E 35*A=4O+Q@E0>3F$H>/"V*BY!+\>OA<;]#&DQ&:4
MRE$8*JJ&+A[@$5C]!_2?&G@_JN#BS@\LT\LI4@ 2DA9@II*@46=!6,;<@NA*
M-#M#J;)0ZO.W!&N>:_M3-QIE"X<K*S,[#*84"G0E'Y9>%+)2E:1_^\.2.HX<
M3B2XV-//S,22O_D">J4!&8RI'M_K#ZC)Q7U'B#PY$XEQIY292"J()S, :,P-
M6JJ1>M/6M( 0I:5PR2KI9E$8QV.VP]\<>4H"4*CW\SZB/ROVSX*332RSD4+$
M^_FS]N"@IA0PHD=* .P/W?#]W^_$C@ @ -4 -6W;VR[S?W)'<'9_&2#^P..$
M;0V89$(J+6CMF4<J"@AL0Y V!#GOZLSOZDD;]N$*H^2#(="FB  ED=1#(ZCX
M;J'N2 !^V?IPB4&;!K(OP<C>Q40@78.VP##N^[,,%_39CZH=K_QG9JL[$$P\
M#P2 1GN.[>P<#U?P>$'KZT3OT).RD$Q$.X)<#?R[/OZL^=V'"&8;T ^*9*9;
MAA#!8OC(=G[EO.!_@!]4$471=\\@^0=%5*E#'4 ^QP2^S@=(/C??VX0M9QFE
M/0EQ1]%< <G9P#T[^_\ 3<;EAZ\('K1:#2KJYNV@>#&7WQN2"&# G;<MML^3
MX0=G[4*EPEE=&=!]L#D]F=0![C&/5LMVSZ\(J)=6*9H03HHLNI8-"."2&\C(
MQ_([..EF]^$$-'NR%5S=07J55*)2&'9P ?3OZN<%_8>.W"(RHI]AH$I5SS'-
M7>$-W!<^N[>2XR0/!&WOPA9"HNA710,G5*@W<"&"0VX&27'=CZ>CM]'/9 WH
M70(;+6K*M2NJ%S++]B0/IY 'J<.?'"#)UHRZJ; .C75(CV+!SG^3'WR2S^"!
MMPB>9ZA;%&4"C,JB'G ;P^V<!_ML1W!'8CA!G_&Z7N^:(V<-/=ML ?0#S_G'
M".DEZ6^:F_[]O-73:U!N^FRU+N2C2%;ITM6:+6H4E4)<S,&%5:#49>K42H0D
M *Z9BG5F4DIZ#%__ &1@&(=LO/%B2IRG4E5.BY=#U*Q]V"E8!!'2.E+I3A/Q
M23$B=#DJ ^8)9F=)]^*2OY)7;M$* ,<K?_)68$.B=#'.>^=GVR7<''U+$.VW
M$C$,;8;ZDG!\^Y=_ZMPBFJ5^<DZ(D17TI<E0 QDG8E0 /=@<#P[#A% ,S)1,
MF%\O%UC@7TKA.E84%L04G! 4S@]P_L-]QQ"%!&<:"@N"CFA948(M$_BD:H_Q
M.IV2AU?DDES.2B(]/YQM+ZI.P5S$%$24IT(S8BST="U)5"E894GXD98$-+CJ
M5GBRRT \W[QH*57;+N%*=WC9%=^H-B630YFY+RNRW;>H$G#5,S%3K-5I\E(H
M@H B*BF--3$.& $_,%)*CATOQUP\'%QI^3#DFGG1>664DH- "?V!CIA@\P1
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MC/\ 57#<!"UIZXHA0(<:(HA"%J+.I+[GJ+I(W< 9;C^(V37I^_F<?<(52E@
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M0P2?3LD,/V)V_P X[<(#5<R];N*G2C.M3'$(T,**3$3U%)7_ ! GH2KH).^
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M>R_-]H_+A_X07R2\X&L/-7I+J)I9<<XNP+YFK.TKM"BJOM%LPJ?J%.)B_ 7
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M4-1\)4FI$%L;$^.%T\\:*.= 6I==*VR[V5(E_K+?P_\ <\WF@C?_ !,M\?\
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M_01HEVT9TJ;_ .'UJ#TV_L_Z8SVX0YI<_?X@_P!!&B7;1G2IQ_\ D]M3N_\
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MVSPBJ#0FA# _BN44SY_^46W=6>4;6[3[1G0_3>>U/N.@4&6M.%2[8LBV)_\
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M9\ASV=R6[#/".,#=_&&;';8=LC#._DX9"$KL_J3W&V<."?3L [MPA"<,Y4$
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M>%/242$E29N J(_B-D*":T2AR9:E/@JL9P^+"!3U188ZP5H'6'6EX8ZDEP5
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M%I</7\K3(V+ I)7@%CO]\ ?4G?L>$!J_?U8L!6^41)?J+D8'[C8>^#[>G"-
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M'#<(I,PW4E .@[A?=+PA$ANE/4DA14WS)(/3OTYSTN.K=GSOPB=+;9DJ$S!
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MBN<^HT4 "@Z&[7@4I(R2$@@%R0"-_."2,;]O3A!"C@W6M+&A1"O<I=#J06R
M[I&0'5D=(\J "L9;/GA#[D7,K3K:BM3*R0@H* ^<9#@@@@@$LI)!SM]1GA"G
M<MDM >BW.1%814D))$1)"=PZ6#$ OG&=W[XWX0<JST)?5=D:F5P4@*QN%#J?
M9Q\K#.YP^_;[9X14M_!-; $H U:AA02&P+Y)]'(;/22[XV;</PB$)U"W3T1
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MC)2'DEPKR=L>.V^QSZ!O/"% XTSH'%6<@]P51(1)=0!<9[=R68?YV<@8X10
M="!V9060)ZJ@)>(@.Y?T[X#'[X'G(?N1PBD)2N:JX1JNYN Y6@B1<*QOW]2
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M<M=GR6,P6!JCIUJ49]=A7C0[M%(CH@5(T2H09Y4A&B?'1TS AGJ1+Q8DNO\
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M%MV2J=F3<A.25.2F];0L"-,3\?XO3"E:;=-Y42GQED]2.F92W7"4!///*]A
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MJDU*3A3!(F5Q9:=DHTDB=*TIZ9CX*8"STQ2WU,'CI9N'FX?'$TV',92.100
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MF]YV!=]KR5NPJ/;U/LVT)M$U$CFL4^:T[H:9N>GDJ ,M&E:Y/U61^##=H<D
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M+A'5T8@"TJ<=2201\J5#N'8A^K/<,_@<(42E:H<__P"JM8HBJ82HB(8ZB0,
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M,'%QN0"0D@@2@E2,?%#*'("V(0@>7 QAB8LP$AE^V8S$S$I_ZF4 J]#47C]
M=$GJM.TB4FJM28M$J4>72J)3(\U(SJ96*"5"&9R0)@$$ I*TCI#EFX_ED>XJ
MM X"$HURJH:.FF\:B-3:1J=J1SSZIVG)VOJO?5EVM0-*YR FT->YO2>A6>JN
M2$K.S\[,T*1G:?%N"">E:HL-49:8N4+@Q.L $/Y\[Q0F@74/Z_Q2,5WOKES5
MVWI9SORUJ69'KEHV5JU<%OT;4^JZJ2],KECTN4F*%!C2,I;$2AU2;F44P1EI
M_-F:49\QBLK3U E"J)^?8_F/#T*JUFE<N&JW,K UNU/EM;K(U?JDE:%OJU+F
MZG1;G-.F+8@2%G3%A3\6-3)B%5D3LU(#X=&$X@1_BR*X,<)6%CGEE1U3<IGG
M%NED5?C2WK%@>:'7K5C5"X-$],M-K4U%LHUZ?O0WM"NZ?K>@=.K<_;%HSU9E
M9"F7G-VS4KCBRAGI9<])PK?@?^,UP(<JN*B#$60-6RO6WI7TB 9@?S56'7.*
MQ6US :FWKI_J)JS3]2]2*1>VAIT*MK2FUK@K])C0[CF:Y<MQ4N[5W-(R<M3*
M7J+%K\[((I,A7DR4.4B4Z1@U"GQ(,_/1XJ:JBM+/F?R:](4+"JJ<OY2,U\MF
MJ&LU"YE]*[=O>>U!J%2U%J_,-+ZS5BJ7A0+HT=J=,M2>KM3L2I:;4VG5ROSM
M!I]"$O3;?KDW#539>4FEQJ/<J%UF/34@"]TNFGE<E=XA 2F?KFE5I<JD7<YZ
M*]:="M"SIJY=0K_I<6IUV<I=D:6Z55A5 O+6^_IZB3LO;%J4FMT94*LTJ7DJ
MA%EJM$JB)B%3*8B33.7%$_0H4X%Q4N59.X(3WZ+ /D5"E*7!KHPN4(CRMS:D
M\P6@?++RP4N>J-FZ@:Y7M?NCVCMU5^N19B=M\U._4U-$_7YHT"+*KN.:H?Z6
M94IIT])4VYI\S<8S4H(_YB%:[_ 9_P";/416=% 5;U52FC$%,V5"#55?XA',
M?:= MFX[VM;2.>EKYJVN6GMN0K;-WRT&C7QHSK99^D2KUN.>FZG-0Q:%=C71
M4KAG:7#EYA5)@44TX7!-1HJ$Q(JVJ]$VJXKZ/$Y11V2]&+V*M=<@RIPZC\SF
MNVH"-7]#I^X;*IE]:/5&\;GG;QT6JE2DJ;4K(LSEVHVH$.#,R]8*Y^7J2]1-
M0;'IL(4LD3]&DYV5BE,"8C.C1#9KF!GZI\7,=S0KGNUIU#M;2ZT*/(699MXW
M36ZG:L-6L:ZW^L6W3K(LNE5Z<J.HLO F912JYJ;^H2M5M:1@187P+?7-3RS$
M,!0502WR<M?EB^L0@#W)W"(B.B.JBF4;&N4'6RMZ]Z&V=J-=D&T92Z*[#JJ:
MA3[3GXU0HP52JM.TU%2D(DY4)B<_2XJY8+3!6B(J&M3]3)=,Z>>L0!*644V.
M8N58)9D$:S[!Y@+ZT7@P^8&_[UNFX]-IO4?F$THKUNU.;_485/J](K4W5=,Y
M2G0 DF5FJE-09RWH*L@2ZI!)/!PFZU]O!WBD*"+HBHK;FNKK&S_E;DKKI.CU
ML?Z0[AG:WJ!=DK'OFX9:=G4SL_1IFYHT2KPJ1!ER2920H\G,2\E+)(2YA+0S
MXXOX4V[5Z;Y!8A=#4*R(V9H1I^YC1Y2-2M:;:O&+JA-SNHDE08?-=<=CU*_D
MZZ4^MTB<M.<N%5+@V] T*JX$ST*5$13UU:DI$S1DO&A%DELG1!GG9^FH-HUI
M6VUW\%8^[2M3M?9RV9+2VG:H7BNZ^;&E&A:;W"BJ?FINTJK:VI5P6[<]3ILZ
M4_\ -)F%0)B4J*)=E='Y()/<\%J:O_-\UR_,8Y,$+"F1:D7VY -3]1=:[RO2
MXKIKE:C4?2"R[4T,GZ?-Q#"EZIJM;M0K4+42OS<B$A)F8L.E468,TX<U<JR^
M+$F_M.V?7]DZ1M42 WUW#CMCQV/H,\(Y$J?#YXYK'','I@1B '"%EBX=@?\
M=^;P' <]LD'C,XYI)I<Y9A>X(L_9XWA '%D!H9@#2A+U:F;11_F/U@UTL33&
M]J_8NC\:9GJ5"C)H]2F*Y3*M 7+"=1\:H)H].>I(^'"08Z8,TS] 0H#)X]OT
MKAL+%FDPL6<23&8$23%.8N4YC,%JA ()1B"4C]1_3GT_ XKZWP_#XL\LTAQ)
M@YY1.#,B$<TO]TLQ( F!H-L0\E_,%S+:H:8*KFH>DDQ4JI+U"8A0*S+S=,M3
M\]+?#I6!0YTB<BIE^M8,Q!>-$3#/PD%1!'JX_A<#AL0RRX@$W(?^V HH2#S&
M<H2Q1;LK+]?^O?H_"_2L;A)>%FE$V(,.;%PY9^<RRS8F.><+/B<@)YE'V@MR
M@$$S;,)1<2+)PHTS*KEIB/!A1IB3B+,Y^6B] 49<J 62K)!4$D$Y2ERP^6M/
M2SM^*]8_!$5:R5*U8+EF IT++H)YGM3M:(&N&H5&HE^U-%F43FVM-54M.!.U
M21GZS:]L\GDUJ8FSZ1-6Y6Z34*%#J=PT.:J%:EIN0FH52JB95"I:.F(J$O))
MZ*%<(&0*I_#'OI!EXM1DM\^R94F^>KF,M^A4"3AVQI9?=PZ@:;V=JI9,*TIB
MK1X]JT.O5I-&G+:K='G+A1.7O<E.E"J?HTE)U>E3=QF#,(@28F(28?%5-=/>
MXZQEBI5'0EJ@BM:(V^9C!5;YO-7;HU5L75*>U LR4I.GNE%<G9JT(-+U@HE)
M7J;$U"B6!,0*Q;4M E:Q4:[+ICRXEK=K%/J4DJ82B6DE_.*D'GGF\5.EV:,B
MVM^(+S.W?6[GL"AVEI;3+QLV/JE,URL730[NH<G-4K3ZT).\($O3;*FJY&J]
M)J503%53XDM,1YF%#"A.+G$&"9544T?.GH3>Z::N2.OG3+I6\2K'/KK11Y_3
ME6I5IV=/BM2=D:ETF2L"KW/((E:+<5+GYJ<HD],+3$_65R<S 0D+"3"GNLP_
M@D((X%:ATJ&"_A*Q0!2F53^_O&/;KYZ.8_3S5ZV[EJ<:Q[QB:I:-6.JR+,LD
M757*':\]J#?M*E:;'NN@",N?K5<H\K,_"CQ:3/4),^E$:3^ .EE46S@@2S>V
M6U:L.T72KO,QJ9=7)'KQJ-<]/G-,]1;(D[RM>F5"D4J9E%Q*E(2,&'(5RG4>
M<K$6J4,3BIL/)5F(9BF_#,4@J0P9J<W_ #3K$ ()R\OH-*(,XI;I+=FKM7U#
MIG+3K#?-[6'1ZAJ;1ZI7Y"FZI_VNGZ#0XNBUP7'1I"FZLA*:U/INV]*!&G8U
M/BK":(F3ARO5TU/,5T1D!7-?AOP'A2@Z! %\\*"/O:><[_-=(61<,I;TMII=
M5!T<G[(H"KCO\70;JU!H]_:YZAZ36K/Q:C25(HI1 H5L4JO(JD-1-R!0B)Z.
MI2S0O1%^*&I<V409=?#_ #FP-HR?4>>GF*@U'5>PTR6AE#OKE^M[6*]+PNBN
MIN6G6)?M*L!5EU&B4*T*2JLIK5(JE9@W8]U5I2;F3;JH<!*(1564&&6EG;.G
M5::(Z) #MD?'WJ:J6C"&MO.=J_;UW:5<S-!I=R5^VD7-1=/XNG-NS]1-HS\]
M)\H>H&LUX7#5DA)ZK%M2X;OI/]J*^'B?^0R$!)*>DBR9*-K+^-TK 7L?6K9L
M>ES5HLQ4>=?60W(NJTN8T2JEC4#F3T$Y=JM+"+<']H+OCZF4.PJK6M2+,0*T
ME'Z)$3>L:!:5"BPXRHD&BJN.+$6%&&F<P%=+*F11 Y1"#?O%1D&KJQ.6@<4I
MG01<7G:NRKT#E@O:Z;(KTY3JG*5&P$4^M4.:"YY$&>U&M6E55*(F06I50J84
M I12H!P&(&DJ=%RNC>#T?(9LR0;J$4+D=+J2ZK%'Z5?FJT6ZI/D=E[WN!.I,
M+7F#>$2\E3Y578G+&(,/5*%545,)(1$FYR>H&F:P4N'JH)<#B=?,_?:+N!1_
MD9)UBXG/+7H],Y6KPFK<N:J4:),W#IG0U7%;E;-,J,K2JSJ3;-(JJI.LTQ1B
M4^,BF3D\%3!^9)<J4_ DG?\ :Y?*[:6A*FV;4TL*DY*"N]%[XU=JW*)JY%M'
M1W5&M7_;5XZ66]4X]#U)N&N:I0K0ORK7,BFTB8I,>3ASEXUJ8K]/3/J5;T*L
MKA152 ")RAI4(R8KHENWLJH;'7.#W9U8UR7T:.[:GXE>I%,M>:K.IE@T5$%-
M\ZCZ,4JH4Z4K%(75-5[?G)*!94G.4&/%FYFDTRY8L]"A1_BS4S%@K@Q4?&64
M%2K!/<&Z?C7=RK1\2BZHZH4NNTO6J[KMO*<U21S/C2ZY=([;G:E7K9_L:)9,
M"H4VFZ?TXF.:A)RYBS,G/1/FBF&F(I74IN [[-N*_P 12+:5[(QK^T9/N.K6
M]S&\TU8A71?.MFC=ET;E\@712Z/-W%=FC50I=>E[E,")6IJCS<S*R,TF#+ Q
M>NM4><E8@2Y,1!#JKX?,CIVR 0*!247/4IW2@!11%;I?\1?7:P-*I*8I\>V-
M0CI_;T[4KGGJO;5YUNX;JMA-]UVV;8KU<N:C0;;LRS)ROT*C0XE(GU357%>C
M)CSXH4),P8Y#/W'P1%Y1_!1NB;Q9:O<X54U)CZEZ07M=DGH&K2^6OV?U_P!2
M:+,Q(,2RK1ILY3(FGZK3F*JN/ 55K]I%PR:BN4*YT(A529I,2*F1A*#SY7XM
M36(X1 2^;A57PFIK2+)<C<.[5V-J!<-4F[T78-TZ@3%:T8MO4&K3=;ON@V%
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M,I1[YBP)N[Y&%:5&3 KBX$X9Z5,T""/S$G4 FH0HOPUI3&0D@%6!&R'G[-M
M*0H*Y997<I6RQV);EHY?H5#%HIT<T^308=.3;JJ1_9>D&0@TF8FA6A3("!
M3(FH*74##" 4SI3$2S$D4_"Q:A0:TJ'IG33K6.Y:W+7H+8QC&S-([!MM"I6K
MR,8T6UJ7(1HL"L22*;6H<U'A!*IF!4Y%"):9A*AJ,6$@I665DV6>;*;?@K$0
MT4JQH,\LR^R#K]E&ANDXGZ-4_P#1O9:I^CRLC*T69C6]38TQ292D0E0Z7*4Z
M.I ,E*RL-:A\"$DH5#68;CA%?2A[V\]H\!(\H7+!38%?AR6A.E\K!O9'Y&Z(
M<*S*,$W'!5-KG42]4 @DQ)>5J+SD%)62F($E(PQN=TOI3U41%*AW(H14]"43
MPFV3:)H[II:UCQ-,Z!85KTC3R/+SD":M*6H=-_LU'EYTJ_4):>I))A3?ZB5J
M5&B&"IR?G(R.)T\S\MJ\5TRJ3< #L2M?$/@4<I?+?!LV<TX@Z(Z=(LB?K$K7
M)VV4VK2DTJ+6I<C]/JA@/T?&D$)^'#482XG22$ )4I*KVUZ>Q*6SB(<SZ99-
M15U2[1ZV3T1TGE)"+3(>G-FR\E&I]L469E)>@TY,HNEV5.1)^U9+I$&&I4I:
M\Y/SQH,+X*!*=25! Z4DSR^=/8Y00V;< HU557U7M%8.9?D&TUYEX4DN+5T6
ME3YB)<$:O2-+L/3VOHK\Y=M/I%+J]SRZ[IMV.:+>2Z128<(5^%#C1B%L82U)
M8U'?)>X44S]%, ;#-*DC,JJ$I7)F*Q9&VM"M)[*MBS+:I5D6Y"I&GZ*G4+7_
M #5-1-S,A'G:3$H5?K2(A*6K%<H=4K,":F E(/ZG$!A]/5"X):ZH%LI*N.BL
M[6$%1S0^K!&M='9UK%1JU^&QI-<&L]J:KBHPZ;0+(N*RK@MK3^F6'IY)"@3V
MF*E0[5HM(N\4&-7I>RX%<AKKRK>! ^+\HBPRLH1$0OX"_P ME#FJEE71.D7,
MMW1;3JV=.I729%O4ZIV9!FHTVBAUF5AS]/B3T>K*N2*I4,A('772:L"I!"8A
MZ3U*  4SZE8JOXH*+M1?:/NIL&Q$7DK4"':UOP;ZA44VD+J13(?Z]^AKG/U$
MT--42E,9-*5/@1# *""0#\H"2+F<M@@8 ^4JL9(=$#FCO0FXIJF@S\A+<O\
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MGZ3:-%EZ/)S54APT2\&:7!E@F"A8@)" E" F&EX:%]&[5,_!LNL'*A5HQLS
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K @FA;*+%2_08?5#'2A:U*2ES@$YP26=0462>D/CA%&OY_$<_"+!PA'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>g105868g77m50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g77m50.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1)\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $F"^1P0X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>!P0         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              D    DX
M 0                         !              ).    D
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    D     !29VAT
M;&]N9P   DX    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M C_P        .$))3001       ! 0 X0DE-!!0       0    #.$))300,
M      @N     0   *     G   !X   22    @2 !@  ?_8_^T #$%D;V)E
M7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,
M#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,
M# P,# P,# P,# P,# P,# P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0'_P  1" "3 EH# 1$  A$! Q$!_\0 '@ !  $$ P$!
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MHQ&BK@WTQC1=?++^+(\P_B%=F:V?JG!]9&=&O[%U]91 [(>V#U.OBZZTUMW
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MDK&O]&T>L>O7D2?Z6[N[UMN_-9T5W?D^M:FPI^L@>QZFYZZ/T!0Y(Y.@$HI
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M#@#@#@$&J3_I%-I_3_ZK%5_L3_\ $.I_\5_\N 3EX X X X X X X X X X
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M&OT)]Z6Q8YE<;&"Z)8FA0M0%IP\C$'@A24V;IO)JBSU164-)6>8WD +6T],
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M\7*F&<FEL1+*&&9>P:IR12RB2RL8]6IZHQSD<J??T7T^PNJT>G#1_$V"\$'
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MOZKRG_WS?(+_ (B%_P#+[_\ A_9P";/ ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' (D>9'6%]V_UK78L##R[BC32U.DO
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M<6-@*=8SCG&SDZR[C803'(^$6<86)6P5X,8X$GN . . . . . . . . . .
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MC 92B8_KNVV=+J"\W.V.YW=9/NJBBZ=&I(B%G(/UD6.#U!-L+&]]7)>P ,=
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MA@AC8GHV.**-&LC8U/LUK6HB)]D3@AW\ < A-X5?U7E/_9_^<WR"_P"(A?\
MX_\ 9P";/ ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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MRQ/:^.5C9(WM7U:]CVHYCVK_ &M<U45%_M1> ?? ' ' ' ' ' ' ' ' ' '
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M> . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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M3Z_7^&5XTPN6O'CU]:<>.AF7]DC7?ZW?E!_.M9_@W)KU^GG_ !\AGP7'//\
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M8.C9(8H[$@N?W333O(=)+(KA>N%A-I_(D=P0< < < < < < < < < < < <
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M,JCS1RK/'+ JQJL4C)U69CX_:YLJK(U4>ONX!4. . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . >=X@LD\9,@P[R845L1#X8W
M3Q-7[JD<KFK(Q%5$54:Y$7T^_ +0U'7&*V< HNCH8#A1;ROT7TT))]:.=:U9
M0YH<ES#5%!17X:%""RDU-VVPJ3E'A:<"2R-C4#APT\M/L7=&&)#,21"*-%.:
ML:F3QP1,F+6)BQQ*3*UJ/G6*-5CC65SU8Q5:WT;]N <S""$P(*0,/.,CH7(/
M-#'+ CAI8YAW)$]KHT=!-%%+"OM]8I8XY&>US&J@86FG#AX>1U)6UR3$$( $
MA!;X)"IT%@^8F05&M&>1+\?OF>,UC$@=(YSH48U(U:C4] /2Z*)SE>Z.-SW-
M:QSG,:KE8URO:Q7*GJK6O57-:J^B.57(GJJKP#R35580XE\]<!,\QD49;Y@Q
MY'%,A^\+"7/C<L[(E^\395<D?_41.!A=/'X]3L97@1JJQA",545JJP:%JJU5
M>JM56L3U15DD547[>LCU_P"L[U YD!!EGA*E#%D)'651R)!X7SP*1'\,ZPRN
M8LD2S1*L4JL<WY(U]C_<W[<?CAX$PNBUU>G/J?:##(^.1!X$?$JK$](HT?&J
MQ) JQN]OJQ5A1(55JHJQ(D?^8GIQQX^N/[OYLN$N"QR^'3Z([^ . . . . .
7 . . . . . . . . . . . . . ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>g105868g78v37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g78v37.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1*F4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $HJ^1T8X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>,>P         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              F@   E,
M 0                         !              )3    F@
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    F@    !29VAT
M;&]N9P   E,    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M C_P        .$))3001       ! 0 X0DE-!!0       0    #.$))300,
M      A8     0   *     I   !X   3.    @\ !@  ?_8_^T #$%D;V)E
M7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,
M#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,
M# P,# P,# P,# P,# P,# P,# S_P  1"  I * # 2(  A$! Q$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M0D4>?=%31%:\;,<4FW;V,Q\CH95_&%'G:2-;0)-LTVG*DY)KVW%>C]JHJEW
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M\013A.E^.7#DN34C-I'H)%_3Q[N8P+T:IEVD)BVD"I$9.1ZTGFYKH]AM(2L
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M1!;U[Y:YJMHJFB)HB:(FB)HB:(FB*"_7EBK65;*5389%48S*QS/\?R:LL;V
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MMP[6RFR*RU<>K8$-F:W":6/#>JG&W2[5B$H 9JG/*J/DN>OQ]EQ-H)(>X$Z
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MQ"]LZZQQ;+LG_*"([$;K65Q+'[&_DTR^H7J_'R&:\VV505$C,>[QRJ$K2#Z
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M6[M1N%".5!PN/C[V 7,I/AYTFMEQYE11@$6JE*I.Q[JSC2X;#9(\@)YK$V'
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MOO$RZM8]"ENQX[H-)):Y4%,5UP-J?BX3P0XAM#NTK&5)OYD7J%]!\#&P>)[
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MC?#@YVTM!/\ K[@W2'!S@ZI!,88-;0%*/9_[7O%\PW0Z5L2L<9;QO*<FAX]
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MP_#C;>5C3$V_F9)+8"XR1N-][SOB?O"4K/WP01W)@2WVGHC2-Q):&C<B.XT
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M17YV/P:3'8>/+!K9)-=Z19C<19#[2JJ*X\:*J\ZY7.M9$Y4@=!QKQ775%K:
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M2K;>*_\ =5=5C*MJ:\SK)(?QU@#;JN).L,R6':*^R3LVMKHC,H'&4]/3O/\
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M;VTGVSJ6HM28%#CC%%\)(J;(F(LF ^!O/.PIE*+$A]PY4EDI)J\O(&S   @
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MV;F$LHE<NY\*YCO1(U=>#698W,#.8BJ$ZYGQSF0@8KX]=4-0E8A3YK+K0CG
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M\<PNQ\)\!\&QO#\3$:S"\0/]T<+'<7X^ =GV;=+CB.!<T8YP@1+& %\T<#O
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M1<#Z2,X)W'H$@X$J>,S=S;9E&FI#=?9H*@JH2EZ/*(GS>/*<3;<5^$P.PH!
M)@C>DBE9B\V'W ';^$^%G;G%N,2&DF"!! X":P,RT@KU^BC[4W+NN+9E_=/:
M?I9S>5+;RR;BRP)N64%1C$5R%$KY:R9V2389V;8DDPF'!C8Q*4#!41%5/&O8
M<?%QW'YL0+P T"UX!)S-[<I6_P 6\'9L#</Y>+!>/I^8)<8DF@( : --Z;Z+
M+NY^+=>^]^#9?C[66[*;%P;O&KFL2IQJAN=P\R(["*XT$1<XR";68[6\BXC9
M6,?!%D-N<26&HRH+3>W;QM&$S>P7!M)DM:[D/JF3H9%LZ3PO!\?PPXQPO$<!
MV+NOW7$8V)ABCMTF,,4F;;SHN"0M5'V:OV,^[73[FN[5WU#9M*R"'D_W5-HV
M7K6ISVO^.>L7SDR;"ORC'YM3)L27M)Z<D!LR?4G1;;(^$XFP8FVXSW#'>"T5
M #&-GA+01%]#2^:]%XIB?#.#@L=L>R.&(9!#MIVMX%#,M<YL?5NQSRD%;7-X
MND+(,AL=NIE2UB&YU3B+631I6([HU-'!HE6]&I!JPAQ\3H*D7)]<-8ZK!/>H
MH^NYP2*Z?=CMGA[-LQ/]5@Q TNAKZ $S%HF!!$UD&L+E>!?%NT^#X.+A[#M&
M)L0Q0QIQ-F: _P"6QP<UI?B;[P)):ZL.:8,P"LP; ],F.X#M9B6+YI2U.0Y%
M2049D//G*L:J$ZCKCGH4<6R>>"OAQT)&X[3#;2  (B"GA$SV78O[/##,&6-!
MB/\ -H;I#B3'/CP75?$?CNT^+;<=L?BA^*0TG$.%A-<7 220QH:3-S634U4@
M<CVHV]SC%7\2RW$Z>YQV>V 3:B5$;^#D(T2$T3C(( D3:B)-DOS J(HJBZY^
MX'X89B &0)$9_8^JZ79?$]MV3&_N<'&W<<U+RQCS6XA[7"N8SA-N=H=N=I:,
ML<V[Q:MQ:F.4]-.%6-JT!RWT$79!DJD9.J( "&I*HB(B*HB)J86!A8((PV[L
M\23YDE7;/$]NV]_S-JQSB. @?1AL;_[6-:VN=*YJU<^Z:-B-TKV%DVX>U^)9
MA?U\=J)#MKZJCV$UF.PY(=991]\2<)MMR5((!,B05=/C]9=8'9-G.,<<X8.*
MX@EQ+B"0-T?3.[;@N3L7Q#XSX=A8F!L6V' PL0RYH9ADS %"6$M@4 ! $F+E
M9E&NBBPS&%OL88 6F6@50!MH!00; 15$$  1$13P(B@HB(G&N3T&5@!80%U8
MQL4/=B;WUO.\YT R9)FHB3)),"222K,SG:O;[<NL8ILZQ:JR:LC2VY[$.UCC
M)9:F-$!-2 $T7M<;-MLP)/(D JGMKCXFRX&*\XCV$N,2=YP_Q;NB@(%J6R7.
MV#Q;;_#,5V-L6/\ *>X;I)P\-X@$F-U[7-%2; 75QUF-4]+7PZNHAM5T"O:1
MB'&C"@-,-H*"@@*>$\(GGW1?/.JW9\%L0R(B*NI%HKJN+M6U[1MFT.VG:,4X
MN.XEQ<X 7-MT -W<HB(HL P^CSIX@[DCNY'VXJF\_"ZD9$-Z$B<!)=R@="19
M_!C(2#\6\CSJNO+'[S-PG"5255UH/ANQNVC^Z.$3C"*E[RWZ;?07;NF62[MW
MQ=\0.V >&?WC?[3=+-T;-LS7AAB1\T88Q3:GUVD6*DD,..*"B OR)P*J1*J)
M]$YY]D^B?37-(!:6FQXD>1O^<UYQQ<]_S'F7G,4'D($]/O./LHV<VMS:X@7^
M7X)C.2W-8@#7V-W51+&5#1LB-M&')3;BMH!D9#Q^JI%QQRNL68;,-NZUHB2X
MS]1).I=)Z6X+F?W^V#9';#\_$_M7/.(<&?HWR "X9@D  D$6&@7NW6"8ED?P
MGWY15MLD%Q'HB6$1F9\.XA=W<WZXGV\^!)$\$ B"\BB(F<#0>0]-$V?;]LV3
M#?A;/M.+A8>("U[6G_($%IDD$FA,5I,B%<L2(Q"9&/'!&V@X0 'P("(B @*>
MP@ "( *<"(B@HB(FGET 'LN$!!<:DN<7DG-SC)/Z79T531$T1-$31$T1-$31
M$T1-$31$T1-$31$T1-$6(]]\FKL1VCSVYL[.IJ&6\<M(K$Z\C.3JMN;.AO18
M83(++4AZ8P\^Z#3D9J-))P")"8<;0TT3OR6O?[+MZF=K=VTQT6&ZD[+%Y*C+
MCU;5W(M'*^P"TGQW:S%\55W$9,H"'%Q?9LAB1FI,9B:'#C:E*R)@WK%O4WZ6
MXA;9-%4T10UP[E.O???]O2ITNJGG\-SNJM/;5/\ QY?<K%MO+_XM4RM19)HB
M:(FB)HB:(FB)HB:(FB)[Z(J7H-=XGV_,*<)Y7C^*<\+_ !U  +3U4(#CO&9_
M<V[HJ?PC/S)P2(9]Y(ADG))QQSPO*IXY[5^7GGQYT(!B<C-*91EW-5DXEX <
M9 $#*@,W$$UU79U5$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T
M1-$5$([3:"((J (H -\KV  @#8@(^R (@BH*>$)2+W)=%([\OP%]]$%[N451
M)%%0554.%7G]7VT2+<.^_*Q(55$X3A/9/":*K ^3=06!XKN%6[;6TZ;'OK*5
M50DDA7F[30)]YW_<]9967>*1)MJC9% 0F";<'E2)>-%*^?F*=0>[J%^Z]3M)
MNEUR8YB&YD?!,KPRQZ4,_;MJ?)9U184LF4WNKMNZVS(9DNDPX2"V0HRI 9@K
MCH!RVFL<3#:\ &"(FHST,??ADMVS;?M6 XMPY: =T$!M+P1<B]^:F)M;AG3Y
MLEBXXEM+5;;;?8T4HK'[@Q-ZDI:I)[JMD[+6"Q*;%'C)L.\S'U5[.#]E36.'
MAMPY AH.@/G3/N5GM>W;3CQ\QSWEH(!<!(:001) B10W'DLE-Y5@Z'ZIY)C9
M.*2GR5Y5KPXJ]RE_Z:J+Y5>..>/I]-;GN+F[A@M @4RB%PFX 81B$$.=]4U@
M$UO0&.S"KIE^%"VC8Y1CRBB\KW7U87/:2FA%S,Y4NY>>Y?K[^$U@T##_ ,8%
M^-[WZGU6PCYL-)WJ@YFMQ2N>H_*ZOY6XJHB 93CP,DXH"JWE81+Y;_L!*6HN
M*+J(T:?[7?W(JJOG,N!@P"2))!H3)O&>=Q>ME@UC\)V[7=:2!4Q$ 4G2M(D&
M\&J[89AAHHJ)E.."*KY'[]JD5%Y\^TU./KX3QSX_'6*V%Q=&]4QF*=3'O6PT
M78'-\.043\J<<\(B?\>57X>/>9S[?WZ*3W!/K"I_EOBBJ1IE>-H'/:G?=U78
M/CD2(DF(7<XORB//'/TT2O=LIZUIR\^?Y:XHJ*J95C"*B^1*\K4-/V*/Q?A5
M3VY7]O[-$KS[O?\ /7+[^6^(=O\ ZTXYSSQS]^5?;_\ S%7CCZ^VBJ+G&'IQ
M_P *<<X\\_Z<JOPY3C^N?Y_?HBZ[^<XLB#Z.4XTO/**JW=6JB7*^GX26OR.$
MGIJ7GA>>%\*J%*S;GQM$6XWTR51K.<1($)S*L9557G]'=UB(*?020IG*&B>_
MLG//":))RBU)D?;GZ6E5/RXP_P#Z4XYQ^R\JE7]OM,]N/Y_S)7A'6U.%Y[O!
M<WP_Z95CG_7E4OE?9/$S^_1 33\'[Q^M3943SK%.\ ;R?&W",V40$NZQ31OO
M_K+IHDO@0::7U$7GRJ*B\HNGVGO\Z)7VMZR=!<6T7NUUM76S1/5EA!L6FS4#
M>KY+$MCN3RH(ZPXZ"&@D!**DA<$!*B"8JI.N>E(%",[\Y'0KTT7E.4]E\IH@
M,B1FFBJ:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB+&&[VU=%O)A4O",AFVU=!
MDS(5@W.I)[];9Q)E>XKL9Z+,CFVZT0FJ\]I)W"JBJ*BKHH3 )T6-NGSIEP[I
MY&W3%LBS#(7+F%6ULA_+<@F7KL>%3.378$2&4UUTH[+#EC,7M;X1?57NYX3@
MH"";@G(P1?G^=:465=V<W/;;;7-L];C,S#Q+'+.]&(^X33<I:Z,Y(^'5P4(A
M)WL[!5!+YE3PNBR6O[9WK]R/<;(JFMN,&@4L9FZJ,;R:L9>?DY.MID;^X*5\
MNCJV7Y /5E;'P)J18G\1/4VLB:$G8DF";128O;W-:=W4K;.)F*<KCI7FL=XK
MUI;:1^MC>;)"PW>HX%ITX=.-(S&#:O(';:'(JMP.IR:^Y+KV45Z-7O#8,#&F
M/(7KRQEQP5!8\4FW*W7]^JEK "H&9I8=;?=2T_IV[3\_^I.^W'_[.Y5SSSQ_
MS7[%_NT67??HOG].[:9?;"=]^/K_ *G,K_A_\'\=$KEWV)3^G;M/SQ^1.^_/
MGPFSF5_M_P#E?N_GHI]64>9X<.?HN)==VTX@1+A.^J<"J\KL[E0BGX*I*S[)
M[JOTT5URXJVL6^T7V-S"M"YQN@WGO*HI5E""QK]ILF>B.R:6RE4UNT#@1^%>
M@VL.7!<:1>?685/KHI7VF3^K^717-_3MVH5>!PG?;^.SF5__ $>/;_O_ &:)
MSCO\_JMUR_IV[3_]"=]_/"I_J=RKV7A$Y_1?CHKKP1>NS:=.57"=]D1$Y55V
M=RI$1$YY55]+PB>_/T3G13,"1.?Y[^U;>R'[1'8_$ZF5>Y)CF]--51'(+$F5
M-VFR9MIJ18SF*V"P!JPB..RYDEAEH47E2-$3A51-$K2-:GE?\+WAZ[]IE3N_
M(G?91)$(>-G,KY[5]N?T.B"3!U />?/I&:Y)UV[4?7"-]^/I_J<ROZ^WNSIT
M]O*_ZXJU_/-??Z=FT_\ T)WW_!/]3N5>_M_S7XZ* SIW!]C]\X'Q.N[:?QSA
M.^WUYXV=ROZ>?^9_#W_EIT]O._[X*JUYWVBNR,'):O$9&/[S,Y'=4UY=5-,>
MTV2I-L*S&;*@KLDLF6O04E:ISR6D)U$^4_O !5.4'12IFVFO\<B+ZA72G79M
M.J)_P)WV\\)_['<J\^_/'Z']BZ(3 K'.#[5X9HG79M/_ -"-]_/MQLYE7M^W
M]%HKWWW1?/Z=NTZ^V$[[^_'_ +',K_BG]E_X:*5G*.=?9/Z=NTR\HF$[[\^?
M"[.97_\ 1_DGG17O\JW:3[0[93(YEU$IL>WGFN4%L./V[<?:;)7'*R\1B),?
MK9PI'7T)3-;:U5FK1>?A)#9JJ(2\E/+\"OX]ZE3OB2$E1(LH4)!DQV) H39M
M$B/-"XB$TY^D;+@O+9_."_*7S(NBJ[&B)HB:(FB)HB:(FB)HB:(FB)HB:(FB
M)HB:(FB)HBBYF737C^:[EQ,]GWUBS7.S<<M<BQ-F/&6!?V>'B^WCLQ^>9)80
MT@@^X+D:,HI(1/)(G&G8I[]E8R:#7,&+7.=#E6:Y*)MM]GMTUS>J.ERTL'Q1
M[%VMG,KH+/$BR*W^]G<FM\PQN[A7*P2O$LY# 0:RP#AGM9;<,34>WG@MHQGM
M$ -LVNZ,M9%(O6M3%0I+KT%=)1JIN[-4INFJDX:W.5JIF7DR5?OY/)%RJ^$Y
M5>>-#4R5F['Q'7W?_8VG*E(7Q>@CI&)./S,4B?M2YRI%3^/W][ZQ#0#O5)))
MJ217AET_$:<4G&;NO)(B*&+<OXX+KKT$=(X\%^9FE444T<[[S*D[0'N3O\WR
M(J)QSY^B\_CJN <(,BLT\HY7XSZ:683<([S-XF<W$Q<$]SRD*-&UG07TY-[M
M=0MA:8WA^3T%YF>*W&WN+P,PO[.7A]#4X'B^.7$237Q<D-^H67FE-=371?;
MR!3=5/4(UUB,-L9Z7M;^/V0N2[&>6P=VQ$[L2*W,3O0 32XM-5)MKH)Z1R;
MBV8HU(A125+C*^%)?*JG^G_95YXTW&\5AS53^@1TC?\ X+TG_7.5_P#]]K(
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M>HDXO(>BL>D@K5'2[8=M9.8<6-.CC%EL(;<U2T2-(M I49"N@J3S\]C;:(@
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M3L:;NIB7-^['&#$72#'?K>/+DJ"+=F9,B-:J8'2IMYD>UVRU'A^4(3=C&O\
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M55%>$\<<\E51.*VZVK;JDZ)(J&A]GSB0D)":" H2$!J!<I^JB<<+RJICOJI
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M*<U^8Y)=:DNBXZ7>7*F@_6G)(XGT\[?K@LPXYCM1B5'5XU01!@4E)"C5M5
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..$T1-$31$T1-$31%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>g105868g79y27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g79y27.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1EN4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &5*^9((X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>+5X         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              U    E0
M 0                         !              )4    U
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    U     !29VAT
M;&]N9P   E0    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M\?SGH>DJ
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MB#V@* *RH)2KE*E=A(44I5PH@<<\@$%/"@2D@E2JB0 22  "22>  /)))\
M>23[:4H"@H<I/(/L1[$>_(/L1^XY&E'>O=*4:4KX2%^FVI7D?21W))!3R/!
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M 2E4ZWK82%R#$0N7-CQT*E^?\JE;SB$F2>#VL ^JK@]J#I1_S[?YJ\5.A(]
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MW-<H;O')S=?,N:>%C\Y%O(D3V/32XZVZJ!]1[\^TQ]1]'K=-P>GG??([/??
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MF&4)GNQVR(<$?N''Z_I^/.">WIPS "!W)_,,/D[>=1V<;;=.^V4G:7&K'/\
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MMUD<IL5KK;KW:&742&6UK4TKN"5I2KJW1_ASI_\ )C5Z@ P@&\LG: 2D _\
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M W1[3CW(!JCJ5E%BZM*2HI02 "QQ4"M=UM[\[S,WF?83>RU0J%I]-?B,.I7
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MT^775NLGGL(UZT2;?3+XN(2 H@)W,-S!X!@L 2Y[-Z-I"^J:_J.DN6KBU%*
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M.SMP;'!MNMQMCZBWN:AF-GK3#SU;F#+-8Q>X<:Z0X(T!3:U$O..-27DPUS&
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MF,^HU(:@1FV5LJK_ %VH386D1I*X[[G+;2TZ[CTKX5TNA4A6VVEGW6U)MA3
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M5=N/E%549:(D:-,9GMS:=F:Z?";."J:&F7H,L %B4RI3"^3VN>% 9'7=)NE
M_E-/=NV@K<56QO8X*" -P(R8C'I7@7-I#J ?@G[R QQ#'V,/3LX\F*N,P\T\
MTJ.\AM;+R7 IIU+Q!:4VXI7UAWO24$$A86DI)"ASK&U2%*04*24N"""""'W
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M!/']9U2^FYJ+-T!"Q=6$!0*24$PH)*RR3#$&7.6JSL]2M]0Z1=UA2+FS4+M
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M_P#(5H3LW*=!/E)=,>8R)V@@F')YKUM5RWKK>N:X^E6G4,4E(>VH*(W;@X
M8!8*MK OMIYNW&19+OC06(S;#L@1+P%URN1?5DM<=FWERG55\X1X[Z4B0[7]
MP$UE"EEE7"'BTI0"N;WM*K2&?*8<$$.0'8#:&P6RWK-5[*3\1V@JXAPE"R%
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M,1V:6X996Y7Q8LFQ]/T6'BG":Q2]1=1HO.A-R[905)4H )"DC: +B5!(+;@
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MT+47&P0DDJ\45:K4ZJT?!6A*5)21XB%;A)W,%*5G^G< S^CUE=!KQ?4%*"E
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M9M0F4E:7'GFDNLK2IQ+R.QU*05ME2N[CCQY\JM)<TQ4I0*"@G<RB[AG$^9,
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M+;:8C5X3A5+&HL=H&E1:^#%8#04IYQ4J5,?X2A;DJ=*?=E2W5=RW7W%K)!/
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MJL/D8KU@TXQ7WS<.0]Q94,U#+-;.HEN1UO5OR:WWVFVEM375/!7'U)\#]/\
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MO^?YQWKK-LK))4V.';@]F)]OOQ5WKS56C2E&E*-*5\BH!!*4\CDC@CGG_O\
MZ:I+/A!P'Y]99F9N]0EE^@,%_P ^U:Y?W+5)53IS;;"Y#,9UV+&>?;C-R)++
M3CC+"G'"D-)<<"4E9]^3^!J[T=A>M4A&U9"C+)*BD$@$LQ, \.V>]6NLU-G1
M6U+6I"<L"I*02 2!*@ [&'!_<1PX/\0.DE2[BNW$IV<4M:J9(B38L$O3RQ+#
MSC;<:)Z2^;(NK!"'HP<1[*5]'!/2-7_#N^G2V;ECS;K*%J1<D*"DI)8&SY2
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M,)(+^<G@EQN=L&MGZ:-M-SL3Q:0A5+91G[VR198_ :4ZS(@(FI($"8XI*%.
M\D.M*\H5WH(Y!XCI>E1;TBC<6A+[E D,0&EXXR8:(&:K]2U&@U-G8E22&8@E
M!?EV<&>PDGU=WP8PYN/EAETF<X]$N7**.*BK??"0BO=2"TQ%B-M@OS'B3Z:&
MD)45J^E"3[:!K.Y*=H2"250!/F+D ,&$G(#2FM*NIMVUA-DG8&9(Y?LQ[F (
M/(<&MXPTQ:-MZK:9=Q7,4R550F)8:,"35O(6BT@W<)P)?B\DH])QQ""WSRH
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M-%,@NE+DB?5-LN&0P/7D3%S&_3!27E*2$M]Q.(L7%  FYNW6R!N/F!4 Q)@
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MBS92A]QI)L$0U*K&HY8>((3,9>*$<IX6A1([DZSVHM6]=IU^*D J"@!< !)
MB5')_P "L+<2+9<$-Y26?U'/,<9<YK'8WN%98UG4_;=V4)-<V^P[!+KO:J"R
M^ZS-@1VB@]B%LPK"1&2%$!+A4A0!Y ^;OB[I2[?4$>%:N+2+P(-M"B  =V4@
M@#(]B (BK'4:,7K-^ZE!)%JZ7VN[(47@%P8<=P0#()DE3+<3:8KB-<VRM4]Z
M/+DSY0#X2OL0HQ7'?(1WI\*!4"$DGC@\C KLJ2X6E22SL4D&>&(!A_[SSHRQ
M<2/D6F-K%!$ NX#/W#@<20U+UCR(>$VE[*L29,EA+*8CL5'DNOJ2A4916"I+
M*%+"4JY[0..#[:IK2+2%+4-H2E2G5#[>SC/;%8^Y8M7B$J4ERI(9TN2_;DG#
M2Y9FAND_H/Q&5CFQM).GMJ;G9&X_?%"V>QYEJ4Z4LM*6!R>&T?U*3^XXTWJ.
MJ5J"DDF7AS(#B0?W.>U?2_\ #KIJ-!T>V?"%LW05LJWM(/R@LT/EF>GNK="
M$+#A)\]P05 >?R/'Y_\ ]C6, <.&]B0#Q+%NX_ :W]2PDL0?5@3^W^JN=17N
MC2E&E*\*DCW4D?U(TJ''<?<5JF4914XI0V-[<2H\&MKVG'Y,E]?8TTVGGN<6
MI2DC@<CD\CDGV!U<:/2W-??MV+2-ZUJ"0#^W/T&8BK/J.LM=,TMS4W5!"+:2
MLF/>/T+X]6J&/>WJD@;SY/0XC DW.*"@R2?*?G0;1+34F# 966A8H6I*7(5@
MTM+C:$DK;!3W<$<:[;\.?"PZ9;\>ZDJ4I =*T)9!8@A)"0P)/Z.QEOFCXQ_B
M!J.HWQIM*^U"U#=:-U94C=Y2M*205!G=H!(?NR*PSK;.FS#+2NAI;5_%E"TH
MYS<R1ZMI:+;*WF'EJ44.*:DE:4=I(!3]/((UOFGU=S4GP%!24H/AED1M2"D9
M!!# #UCWKFVIU 4GQ#94%W 5J)0M)*E,5'<>ZCN//(Y%>[6;JX]9HR[>K*[.
M3AV2NT7^$&\<AF1ZL6%*=2U$GQFRL.?,RVREQP(;"TJY44\<C7C7=%L7]@\,
M,KS+4HI.S:H* (4EY4 SEBS2::36:M*U*M:LVU)BV LI)< $I4% ADN^7()>
M32U1LWFPV,4AMT[&;0()#L)K(JR:W-6F$VEQMUF=W)<,F4A2E((/>XON4 2%
M:QG6NC)T^A0NVM"%&TB$K0WR)[2&@-PY]QL'P=JM3J.KW;=^Z;@1?4 HJC;X
MB_ZOZMR@5;B<L].GW&Q*LO,/P1JK@2,$F?I[!$ZDDAFSIHBHJ?EH<Y#Y;<G1
M79'=Y=4X[VDN*)/U:YSHS<%^ZE5PJ 4Y<@)6H*DI+$;@#, / KZHL(%O16U"
M&0(#$@%/)!&#]@X;M\.GBEQ+')-BW+IU5F9NRW&X=E)*I O @GLE*+I6(S<H
M@J(;44#O)3XU/5U7E*9*Q<ML0L<I@8*<D<@^]7U@I\!(4"^T%YESDRY&/\M3
M@,J5O+&>LLADIK$XQ%JWC-P%I:IRKB,0$NKC(!*V6G6@#Z:>>25>?MK7-+:T
M]RZE"E%U+VIN&0E9<RHB%"0)[ &J@2Q<, #W8,,]LR9Y R#36,[V1V_S&!&W
M!M,(F1,=<;C3<KQ:NNWJ?]'K8*XTEYV.S#4)PD_+(0KY8 J<<*AV^2-;$CJU
MW1VSH4*4I=LE%B^BP;A42[DD.A0220[&(JA>Z<C4@KW@!0\R3<2&+@!NSAV!
M.9<<Q<?%'L=G=L*G;W<7:]PY';7GZIC5Y)MK1R4_5A@*EHF3FI#A5)?C-J:8
M:><'<&4,!7OYZ!\&W^HZM2[>L)TR4J2;:[G_  (6A0<N;@V_,YQR1C'/OB'X
M80MU(N;P0HD)4A1B [)>!$EP0#D5"!F/6&_ A-.QX05/5'CJ$BK"HDEME,&.
MQ([W(Z1ZJG9"7'$H<YX"DM_[NNC]5OZ?3:>WITZJS>N6TNHHO6[I4"4D'R$^
M;;!  +<$16#TGPS>1I+8=85N4X44@ JN+?*1COV+\ TZS ,BR;<#&\*G5^76
M$=$6 BPD0[22S7+B-SD>NTZ%MAM;CC3Q>(#BN[A8YX).J_2[J%:<G8E16"(#
MNG@D23N;L1]!6-U6@U%EP3<2  Q=I$Y9@6#@B08+DUMU1O'E&)Y&](@V;TR.
MQ* 4%+;5W*AO%QBP94MHE<A///?RHA7GD<\:N!HTWD$W$9WI4% B/E( (W!)
M$$0X$N:M[5E=M(22=X+@EU9<^9F'H/T&:QV4YO13XDNTK';M687LU^386MA+
M]:/(2XL+=X20GM5P2D\?@?CS/\FD$ E 0 R1 ( &,@;0V6!PYKT L?.D.#VR
M2[%V>>7,^KO2:9'/H$U-,S>5 R#YJP=DR4-KDF:W$CQEK6U'>BE$EDO*)![G
M2UY'"1R>;A)\&V4))D*4R0X#@.0!$L1A@\Y+^%7;R5,@,D%*N6=RX(2'+9;/
MW:FT=0NW=3&KJ3-\<@3X>)93'B+9@V'IR)%!(B!3?RB%H[' A1_CMI?[GU..
MO?4H)^G%ZI&\.KD@EWR/J[XX8.)%9/IMZY<4$$*!2P?:H0H@]AD.G^P:L/MP
MF9M^;&NJ7WK.OL,=<<=G?0S%!E]J%H*E*+:WXWSJG?I45 $CP4'63Z-M"5Z5
M?_QW+BKP, ;BE"2"20,)$$.1D-5;JA"M7;.=FGMI4^8N7B X_P#RX9C,P:RN
M4N/[0P:'*L?M5R'7I(B297J(*K190AM#CJVR0YZ##3S'<22$=B>>"-<D_B/T
MTIU*%::RM06SFV@KV@I>2A)Y&"P=XQ5E>TZ;B5 !*@_ =W<^L,Q# 9ESE[NT
MF50Y6"6.;/\ :^[WA4>!W@Q_2DQT+;0EL?SJ2M9Y'!*3XX)!US&YH[MA5I(L
MW65;WJ.Q0"5$EP3M#*'_ *NX'Z:AU+3JM7DI"% % 47203)'8!X AX@=Z<KC
M-&_,QO'[Z>]&4J1*,EZ$AI*&T,.+"/*CQ_%0@_<G@<\\#5PJQ_QN$*+ ?TP^
M6,?Y] .,%=2I1(60@0"%$#)]>.#]>[F6[X<U!_CO>6;<Q&)#=%@M.]'<<=;[
MVERWNV-&927$GM6DK<=!3Y"&U$ZU;J>K-E)M#^L+! )< $# ]"!).3AWKHW\
M,^A:?5ZZ_KO*LZ.]9 *0A>TW+=Z"6<!6T 8,/!#U/@T&V">T+'*OH2$$E" /
M3 ^_@E"E#@^.>=:KO*E'NY=W'+."8(ALOR6$U]&J6$HMI"2R$[?*">27Q#!@
M>[/VK(I/(!'/! XY]_[\_?GW_P!/MJ:\@N >X>JM*FC2E&E*MY"DI"2M02GD
M@J40$CD'ZE<D#A/N?/@<G7A2B"@!*E;EA/E!+/ <#CWH^T$NT=P,$'DC@8J%
M7XCO4-9WE)D6R6+4E)D>.2(U&Y?7Z91>=CV-59-W!A1@RI3;<AK]-]0DD+1V
MK2>"1KKOP7\*)O"UK]4+MJYN*D6ELE)00 E6U0<AU @X^4PX-:KUC6%15;04
M*2P=3^8*!/(YX82>>:B<8M<-SG':659,U$:SQ_U'6ID]P1&UQ:^0I4F*I1"5
MR7%-S%J!'/"&G5*\I)'7=.M5FXJQ9\12=@)0$$A!#6TJ2T#L0TD@M+5K*U*M
MH2K:Y"MI;YC\RB_W$%OH])#E&'[6;\6#TC JN&U;8QB##%W'@60>78Y- G.N
MS;)EQ9#;+3T1QA((5]?8"DD(64WMF[J-*%G4W"M-S4*-K=:*#;MK2-EN -VT
M@LIG.Z6BHWJ60 A2?*'S+*G/<'F1[F$8JH4N+DE582[:765=98L0'US77&DU
MI9"F'V@XDH+CBNT]K@) */J))U=:A7\W9%H()5O2MDB?([9!DN['!+ BH(2<
MS!9F)E6>[">*VW=!G;%FVQRMPG+9%K.L(P>O@M;CZ5+5*4ZZV?YBDK0%!!/C
MC@_@Z\:2W=0BYXUD6MJR$)SO3MDJ<%E$\8COD0E(3M(+ S$$X "1.>0"/4EZ
MR^2;][=XC!K[?#9=O6Y/!:9JDTC;K;T*QA( 8DI>9!]1+8)4LD#E(Y/X(M6*
M[PMK*5I):!\H?F2($.[AGKPNR;B-H"DRDQ+[3(+/#9P,L 13]>@GXF3^VST3
M:_<#&(&+X+;R["SJ)3B)$$Q)5B]W*G,#T@I;,UQ(_C.I]-0)<2L]O.M2^//X
M?:#7:=/4M/<W:K:A*[:#;6%I#E*56PE2G=14Z6E^X>E<^,ST9 LJ4A2 0"DJ
MVJ$)!;S1$!WG R]EUV=:.7Q]]*B949!%M\'K,+CWE?C\ -/.1JZQN/E[*3+E
MMN>LE]T4X4W'6D..I0&PDA1"KK^'_P *6--TS4*U-@VUND?_ !;5@NH)4 0%
MG:T,[$]W;2>H_$5_KVL)2I2=/<6I*/$4K8!;05A.[Y!O(=X=X!)IEF].^N,[
MIXC1W:ILY^VAU]?)KH28B(IQW)HBK&KF.5#K?"!6V3<5JS?C$J0$NL1U#OBD
M)W/I73=*=5=0NVA";:U%*[B2-UHD*#[LK263#N E0S7JQHM1=A-T^9+*"5)9
MP)8L[8D-@@,U-VJ>I>'5X[=5F48XR[;2H:(SPB--Q57#J'VBB:"T XF0H('J
M.)Y]1*EH)*5'6=U73=NOT2;%T*TMP7#= 4-KA"B-^T$00  ^6(BL;J>CZH7&
M3<)![^8,S$,SD!R>"00/6D"D=3Q:>MFA20JYEF3&9AU:FD2G'@3V$A1"EE8)
M!\ D*"2?)UXOHM65%-NXA2G("4K2M;S_ $R<3]2P?&6T/0ED#=<4% R2I*08
MXB &+]_1BUKM#U#WF7YU:4<^PO,?2PU.;AR4E;K!95R/E3\TDHC K*>4M\%(
M'L..=8U%PC4I0JV4G<PW!0*H+ 88AN.>7%7.LZ8K2VO$\4+ #[2M),&8 W%Q
MWESDB XN9<9GAM12)EY0Y/F39GS23!F-O&$4NE;BE-_6A*'FO#A3P.3P#Y\Y
M-=LW22$J!.1)>2.S$<QQZUC0/$W (44I! .TM/H 6.&]36XN;PLYE"I\9SYR
MS57U$IVRCFODI8KI$]\%,MYYAM #C[D<=OJ>Y_XN1R;1?2D%164IW  $C:"0
MDNEW3\H<]H/<QYVJ&UE$.J0H$,X?!.<-Z@8&$TK<@A3[F1*G.O(Q]OYH*CS"
M7FGJV.%J>8E-'GO8>82XAU!'"T$H (.LCI=*+:%%)&Z0&*8*@T%(!YXD.7]*
MQ "=L/EVER3W)@%F[F126,X=B^Y&.WE-7X]:TN8,-3,JKGH\EPU5BREQSYJF
M3#FCT&6V8:2]&0PD.!WM]$=Y /K6W%I1<"=VQ2"D^7R@GRE3R2[R\-VDFXTQ
M5:NV5$A6VX@Y+L%IVN78,H98\Q@AD5/B:(]Q;6Q>7$MZ6>?3K@D+6\8Z^_\
MD!4KO^C@)[0? \'SJSZ9I[8#E0!"=K%20P=QGF#W;V K8]5K+BT*2$ECRQ=X
M+/EH8M^M2-X#=X_E%>^C(%SW;^'6,U:JAZ6C]'E42%_/&023ZK%ZTZLF/)00
M4)'I@\>-4>K=.3<W!)24E!2P&XAQ)B &<F'=BTUK6KL)N6U7-H!2%7 0 %%8
M0<020>WJ<5UM_#6ZB,/RS;>EV=*95/>;;XI7M/.6\@!JRB*6V\U+C2) 0B2
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M$@N&D!C^OX<E2R?!]_QX]_/'M_KJD0_I^8^M90$%_3_?^*]U-31I2J1R0>X
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M5N7=LAW-<ALZ(Z.Z;Q2$LY2S2%%PY#S]026X:M!L+51B1G)#B&7YTAEQQP(
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M$WUQ#%?QZD2N-45CM:L13 C%P)"5M^APMODD.=W*E#@GK'PIU0)%NT;BKBF
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MI>5*E3I+B)DF4EL)CLL(3PI]):$MQ?K 'M;[".5C5_J[XNOY0H$@@>T APX
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M:>4*Y!(/<E7C@GGG^FN>D*#A3@B&/O(D^V'K>[8TZK;VU)*5 $;6VG=@@@F
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M=]R5,5&.S_>NI?!%BZ=*%7;5U-M=O=;*T*2A3DD*2%0Y!!<?J&%3,-)],-H
M/L?'L!Y^X//]?!\\#\<ZU51<DUT1"=B0,=^P_P!?6O03PODGGN3P>/?R> /
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M];U86O9;VE6[85(4I2P6"=J4_*7*B H!P&!8,LH^GS>/>'**C)MRDIP_$?\
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MV(&K!Y(4XM8>Y2IM0"5!1.KO171=*2<1[L#^$Y8 LT5])]*^(+%[06TDGS)
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M<":F)!B7D_&,<7$<4@.W#$YA)EMQ97\93B%(Y03VJ(^@]A/D'M(.MQ_E4Z9
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MGS#+.[1)&"^[2)&+T-7CTZ9)E5+$C_S2)4LQ_F2_,@J3RM^2.2CU$J:0ID^
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M<U^*RB]=4HD/X9'),$L1B1VPQ#02:T#KJ[NJOV$(3+':/E+A4F0D'.=S%B6
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M7T'_  MLV5:.Y< V+7>4BX5.02FVDI(+LD +  R')[5I'70M.H! W;4$I)@
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MRRI?:4$=KGT@\(\]Q\#@D<U-.H6[5U90I!MH4Q5!A+L!)'J",GEA5JO2E!"
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MSO)ZIAZ6F5$"7)ZJZ([";KY[-=&<?4EI4P@*64H*DI:_B]@/'T=^K'J"R;3
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M&_TBP;5]3F_=_F =J&*;B4I#A%ZX,H+'<F#YD@R:>LM#PBZ7VA2D_, 1 _\
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MR22 Q+01QG+XE@!\[=>_A]:Z;U#4VT(!MJN+7;&XDE*U;4A9\1RO:Q(+,3
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M<0-JB21(+$0(B'R<P'K&R(R'#'L7ZV-.MFDQ?1EQV%)B);6>Y3C*0>?2425
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MW#*:VQW(7%,)R]V&N9D& +E1U1$V-)(0H"/"EQE.-7K82IQZ(A@IX[#KG?\
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MR #V/VI [M]BHK+"UF]TB(VWW)C CDE*#R #XY(  /\ IYUMZK U*#?MJ_\
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M0NY<6A)\J%+4I"<_*DD@%GP._P!8  P /8"LNE* E(2D)2GCM2D !(]^  .
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M$$^/'/G@>"?&CM<*2_RNW'VX/O\ WJ6A_5J'$!2D'@$@@'D<@#N!_'Y ^_\
MS\Z\K!"DJ26+@<]YQEXR\#BHB09'TSQ]/SBL1:XWCE\J&;VBI;I5?)^=K_U:
MK@V)@S$]H3+A_.,/&-)0$)2F0SV.I2 D*  XNK>HO6=PLW[MK>D)4+=Q=O>D
M$D!00H;@"26+AR3DFO!0DY ,NQ (&0&<</\ M67#2>5?2CM5X4GCPH<=O"D\
M<'@ #SSX\#@#C5L$KW[BKEV!/]QW_3FO8@1[Q^C&JD(".>  2>3Q]P  .?Z
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M"0E(+#:2_P H !]_KFLZ$I!!"0"!V@@ $)YYX!_'/GCVYUZI0>/N0.?SQ_\
M.H) R:5[J:4:4HTI1I2C2E&E*-*4:4KPI2KCN2%<$$<@'@CV(Y]B/L?<:5!
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M+8>O1)(8DD=B7%9*'6UU+%CUU170JRNCI+<>)!C1X$&& D>FEF-&;::2VI7
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MVUR2^T"^VCG?>A?%U[3%-C6W[JM.$*\QN7EH7$)7:%S:2\@B"1@<R/0D'T(
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M!4%(5"@".Q#C[&L'&Q^AJY4^S@5-=$GV;C;L^7'A1F)$UQH#TER'FFD./K:
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M(S?35A75#6Y7;QHT"DOL)SAS+$0**O,F4P^O.(\#&!;(QUE$CYV/->$-R0Y
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>BBE*BCGM*DA9!4 =*FOII2C2E&E*-*4:4HTI7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>g105868g80r02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g80r02.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1T44&AO=&]S:&]P(#,N,  X0DE-! 0
M    '/B^=!8X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>FFH         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              D@   +L
M 0                         !              "[    D@
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    D@    !29VAT
M;&]N9P   +L    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M])<W]:*<?[?3;N%MEK?1NI-U57LEKVL
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M=VL2OD9%-LH=A82DRD8_C]PB')<:"21$00TAT&.\&F#OPN@GA$F>$D@ @H1
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MP+N">/R67S<0-Z2Z&W,O <MZ_P"7NPLJY;<4EI2MDOLEP@SL1Z^7W]P5J;Z
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MKJ E:92^.QIT W3;BV?IMX^]?58^E6;\0TFT\$@L:.&8#AD.GC!QPB:G!!)
M Y&/F9.T#U5@HVJ&FTM7"-G^&.K&P*$9-3%0)]@ 9@)_V'6K-G=MWM;@?^S4
M_P#RI#FG ()Z @J,J_47/9NN%C0-L86]HTC&HTFNRB->P7;61D"D15.Q2AN<
MOD2\Y+8\H,! CL,OI=\Q:DGV5+6T9IK*O%<MU+XQ:^@ZDX4FT>_#Y+1RX/\
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MX-V4<"5$DMB0H26MFU<9J_92C4U!G:/1*=M8=I+>F^FVX--K:.HT'EKJEGJ
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M"RU7LJ%O VDB30X=.3Q @] .Z())#0),F<DQTA2#+2"0"TC.8!(=D@9XC@
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M9),DDR3SD]8 \O+&Q5W/@-'R"O@U3R!!W^'1-]T[E)!\KW25*(]]BH[;$G=
MZ*8^W58_-^A!*A25&ZDE"C\-A;E!1Y123Y&Y26SY92204?)MQ[=%$>)]3CR'
MU\UL:&C/O351^92O\/B?:4MMU2OU/NIQII9/N5MMJ/="2"1Y^I_?WOU*P*"B
M 2D4M4 GCQ KH@X\"\4%.S/8I,A\I([I+SI&Q<62]^_4I&V^/$^\\^L#H%@X
M_0%/$TE04A/ )^&P]@GRT,\0/)V"?*:::V';RVVT?90D D3U]3]UL:&C*E+-
M-5%:E%2EFNAE2E%T/%2E%G<J+P#I).Y= <^V-^B #Q^O+IT'E@^2_->/4"T+
M;725"VUH+:T*K8BDK0IM;10H%D[H+;CC9201P6M.VRE U<UKVN:YH<UX+7-<
M)#FD00X<P08(.")!PK-<YCFO87->UP+7 D.:YIEK@1EI! (<(S!F57S#*NIT
MQSJ1I=<5T)>,9,J9<Z9V$N)&<0T%;KN,,6ZM"B7*WY'JU#JN3M<XTTD+4V0G
MBM)<>SNJGLY6)_RV^^)==GZCORTP)==:5)YVQ(J6[7$EU%[6MES2%VVL,;VD
MTEO:.@&G4K$4K7M%1:T\5289:ZL #$7('P[@@#AKM+B UP)L*:"A5OO2U*M^
MY*JZ(K?N#[ED_P"9*3MO[I!]P.NWP?$+B%M\"I I*Q3504C;@H5\0%/%16GB
M?)W'%:E+3M[*)4-B2>B0M?S?H>_U)4;$;;?#8>VWE^201Y.VQ:^B/XM_1GY>
MW11&_P!R,>I_:3ZK;X%2<BL4]4%J/(J%?$Y%7-ISD3Y.Y5YC#+FYW/-EI7NV
MDB/>WH?E]$ CKZGY[E1)J+I%4651&M\%H<>H\XQ2P>R3&'XM5 @1+&<M+GQ6
MBN1&CMI?J\IBN/PK!;J5J8EN1+=(5+KV3UL+6\+'OIW+ZE6TN*;:%PPDO<VF
MV!2J4YDA]N0UU,"98'4A#'N"B (@;''SQG?'7P\EZ? ;3$<^Q6MR*!1UK D-
MNQ;"ND5D-$NGM89^'VU+/:+(4S,K9,5<"6TH#8QP@;MI1UY[FW=:UWT'P>&"
MU[<LJ4W %E1A_P!S'L+7 Q^5PV4CQ),8R3C&WI]9.Z]F:&B*O,--4E8//F:Z
M&5!17YG/EY.^Y6.?+?<K'+?<;]8/?W2!C?'B?N@H*)._&FJD[[;[5\0;[<MO
M9G[N2MOPY';W/13'WZI\ HMB/@M3L4\2/AT/NGCQXGZ'NGC\NQ[<>WMVZ)Z^
MI]_SG=8^ 41 !I:D@$D UT,[$E.Y&[)VWX()V]^"=^Z1M$#H/3WT'HHB>H^9
M^L'TZ3A9-#1DA1IJHJ2I*DGX=#W2I"U.(4#Y6X*'%K<2000M2E#YE$F8'3V-
MO1/7?KYYWVSM\H7+BP($ +$&%$AAP-I<$6,S'"PRCRV0ORD(Y!IL!ML*WX('
M%.R>W1 (_N?T/UZ[\\?-SQ0^#S4WQ#^(C$;TW&'46AR</@4F;2:Y4"%J+/EU
MKF86L2+.KIN 7]=GE?690_@E_BT',,G5AV.2JW();F W-Y,J[NN@ =Z9,Q B
M6X&"1($@@@EW%W7<+0#+E))Q $@$3)S)&#@XC,#AR)<2.ZK[::X<C3W L1P=
MM=2XUBE!643+E%C]?BM2MFLBMQ&E0L=J0*RH94AI)$&O0U#9/R1F66@AI%B9
M^G7ER$DP(Y2?-0!$XWS..O,XGT 7N"0.Y.P_$]0I4 :X$?&]">X_\:<?_P#T
MU_\ Z_=_I_K]Q(I_Z(G1$Z(G1$Z(G1$Z(H^U+P:/GN,2*P.*A74-UJVQFX9)
M1*IL@@*\ZNFL.CYD(\U(9E('RO1G76U \@1I-?TANLZ>^W#O@W=%[;G3[IL"
MI:7M \="LQT$@<8#:@V=3<X%;O0-8?HNHT[DM^-:56NMM1M'9IW=A7'!<4'M
MF"2P\5,G\E1K7#91YHSKWCNI=A<8(^J1#U,P:.AC.*5R*ZW%CS&'DPGY5?-^
M:-*BR7BAYI+:TK;0^&U)^0JZT?93MKI_:&XO-&+GT]?T5HIZS:&D]M.E6:X4
MW/HU8-.I3J.AXAW$T/ (P2M]VM[$:AV<M[+6FM95[.ZVXU-$O168ZI5HO::K
M*=>C(JTZM-DL<7,X7%A<#W@%83KMUPR=$3HB?U_\?A_7^O4>_IX''GX>(15Q
MS*8C1/,)NI&RF=-,N*#J*RPVMQ&/9)'CICUN9,QV4$HC6\9EFIO^ )7,CU<T
M(4])G.JV]LTZE099"77M Q9$EH^-1<Z7VQ<XB74W$U*,F>$U&;"F%6""<B-R
M#R^O/;H(&-RO?:3:O8;K3C"\MPA^P>J&[&76+58P507Q)AN<'.+96\VXTH<5
MMNM/.)*5;*\MP*0GS:AI]SIEP;:Z#&U>!K^X\/'"\2,@;[R"!!Y$&5(((D$$
M3@B=OGGY\Q!YJ4.O$I3HB=$3HB=$3HB=$7S%\7.DOC$SO6'';_2^])TBK,:?
MJ+#%,=SBUPZYFM/Y%A%KDCDQEA42):7MU35N04&/R';*+&KHLA;?J*QR;*FO
M5 $N+Y(QP@9Q+9!&QS).#( !PCMFAN_>XI P2'#!SC+8P"#)'(C\J;#/$5B4
M?PIUN57M%#Q*)JU)-IBV7MW69:CUZYGYQOXA .>)RMR%(9IZ=0B62)<2[DR'
MP@L6_E-\56Z9)/" XQ D3) ](.,;B=HW+B,-+B6C8@8QUWF9WGIO]+.%UN/T
MJKV[;CT,O?W.^Q^(_AQV[=B"3N" "E:^7=[G]*JMN)V_0)>_+R]@3]9?9\WY
MB -RW\@(5\_1/?OWGP6?+NONE5?N3W@2_L\VRD=K$=PV'4E7L5EM7$)2I*WO
MW[SX1F,XY^//G_;E]4\NZV3^E59(*>7Z!+ ]W>?'ZQ.Q*2R$[D[%+I/(.(#3
MW[^_+H4S.PCW^T_IXEY=WQ_O55RX]SZ"7QY>6V-]OB6_'S@ZKCRW\M3:.7)"
MG%O+W^B9S@>'*?/?81[V%NZY'C)JPC<\08,LJ"?,! *A8@$^3NDD) \S98'$
M%LD^6,1'O$($76XWE59&R=]H,L'EQ7R(/Q$]BK@4C;<)"P22H*23/A^GW]?H
ML!N\XG>55%6QV(@2PG?B./8V6_V^1/S#=) !!!)*<_I_/\*ABM1[&NURSO*<
M=P"\H(^&"/3:FV#^.S6*C+J%V2RAK(ZT)D-IEVM&XXF20TXX]+K&G]W E)0K
MXQ_U VCVPUG4+'L_JMFS2?AVG:&O4M>"WU6R<]@9?6KFL JU[-SFO.7.?;M<
M"<8^TCLZZMV-T73[_M#I5]4UCXMYV<MZ5V*EUI-\QCR_3[H.<32MKYK7,$AK
M:=RYD-."KU0)DVTB0[*OLJ:973H[,J+*CQ)+C<F.^/,;>9<38E!0XRIM2#L=
MCN3N"$I^QT:U*XI4Z]&HRK2JL;4IU*9#F/8]H<US2)!#FD$>!7QJM1JV]6I0
MKTW4JU&H^E5IO:6OIO82U['-.0YK@01C*Y/EWFW]ZJM]NWZ!+V!\LC<_66Y'
MG;*V'<M_)N%?2=9%B]_?[?-;!%SR.\FLX[_*!!E<N/-H[$_$-B?+#R=P "M;
M2M@EM:'7G\O>9^BG/OWCEG/DL<+K8?I57ONGD?02]MN3W+8?$?<I+ &Y/$H=
M)!#B V]_K_'H>N(Y^'OY8C^W/J[NB?R.GLJ&Z32V%5;P)5=8PWZ^6IF3%EQO
M(>;4!9!20I2W2%)4'$I+?!:'4>:JU.I4HU*=6D[@J4WM>QX)!:YI!:1OL03!
MQMTR(D$?M/7>=P>GU5;= ,4BZ(SKK1"*B'6K^(6.68Y82VITA.64EA)YK<CK
M78):9L*0$5LZ"V"4H9CSN/E2D@[G5KBMJ?P]3<[C[E.WK,#0/@56-Y@;LJ_Z
MC'F3)<TGNH     !&W3PG,]))GDK3I1<]^4JL([;<8,H;>^^Y-B=_NVV VV/
MON-M(ISR_6/V*QPN^_Z55[\3Q_0)?97'L3]8]QR[[#8E/8'?OT49GP]^$?5/
M+NMO[U5@]^_H)>WNG;8?$>W;G^/<I.WRD*(9\OU]^_)PNMQ^DU>VXW'H9>Y2
M%JY;'XCL"6R@)W! 6%J(4DA"2>QS]=O1<J,F:D+]8[%=)#?E^FCO, $( =Y^
M;)D<@IS<MA/#@C9*BM7S=%/OW[^07*Z(G1$Z(H!UO&]WH3^[6B@/_P"&OA__
M 'HGOW[PI^Z(G1$Z(G1$Z(G1$Z(G1%QWHD:0V^R]':=:E-K9D(6VE27VW$*0
MM#H((6E2"4D*!!!V^_;JCV,>U[7L#FO:6O! /&UP@@CF""1!5VO>QS'L<YKZ
M;FN8X$@L<TAS7-/(@@$$;$2J\XM+DZ-90C3^Z4I6 Y).?7IS<+42BGL9"UR'
ML+GJ5N&T.K6X[0.E26U'G  YF.GKB=.JU>S&H-T6ZG_);ZJ\Z'=.D_A:[YJ/
MTJLXX >XN=9.)S#J)R61VVH4F=J=/?KEJ/\ SEA2IC7K1HS=V[ *;-8HC)+F
M@-9?-B1W:TD"H5ZC2K6NAU:L\[JZ:CR:G=P.]%%8.Y!5KKV9[Q5*;#]:M14'
MVN41Q1!V6&7(SQ 2^@=>[LWVNL^TUQK-M:V6HVCM%O/P==U];.H,KOFH..W<
M2148#3/CPN8[9X7B[3=D+SLQ;:)<7=]IMXW7+$WU!EA<MN'V].*9^'<M 'PW
MD56P,@N;49NPS,W75KDTZ(G1%'6I.#G,Z=A5=*^%9502DW&*7B!]+76T=)XM
MN*20MR!.;*HEA&WX/1G%;CFE"D^JTN!;U#QMXZ-5IIUZ7_.F[>.0>TPYCMVN
M Y2#!GEOYP//Q73XKJO43<:N[#+'&\:O,)CN)SJIEDI<J'8J%%R<TE(*Y%9-
M0CU$"2RE:7FG$)!\S=/5Z]D]M:FRA-:G<$?AJC1BH''#3, 5&GNO:=G#Q"$@
M DF(^GCS7KL&SO%=2,<AY7AELS=44XN)CSF$O-A2VB XVMM]MIYMQ!4GDE:$
MD;C\>L-S;5[2L^A<4S3JL_,TP8Z9!((/4% 00",CKU\?FO7]8%*=$3HB=$3H
MBICXA?%VK0/,*G%W]-IN7-WC50S7RJK)H$:>FRO;NMQVN=L*94"4_6XRFWMX
M,*9DDR0TTB2XMF)"FK9>\NH,N+3C$@G;E()SF"8$9@^:DB T[R2"-B(!S!W$
M@"<1(*CV[\3>%ZC3_#/%GP[7%LRO=85N.XLJNNKV+!=Q1K(*>[:5E-93_ 74
M,S$[1O/D0I,QM0=8B*0E1%L0"#((!!CJJ\RTQ+3!$\P <=8D?=7S&24Y( D/
M_,4@?5]E[K*@GOZ38;E"O?;;;OMN-RF1M.>BP,FICOM(D=DE9^KK/[(;\X[?
MH?<^7W"1NHGY "OY>BB0.8WCYK8Y'4#;=^1W4I/:NLCW2XTT?:)[>8\V ?8@
ME0)0AQ20SU]"/U21C.^WBL#)*<[;/R/FX;?5UEO\Y?"=P8>XW,9[??;;B"=@
MXWS)(ZCKR]5@Y-3!(49$C8H"P?AMF=TEEJ0#L(>^_E/-JX[<@2I!'F(<2DDC
MJ/?]EL<CJ$K+9??"DDI(^'V.VX>#'VO2<2/-(2""01\X)1\W12L#)*=1 $B1
MN0DCZNLAV4E:Q[Q.WRMK)W[@@).RE)!;[)(ZK'YS4W'GZB1Q^;O\.L]_E0%G
MMZ/E]E0/MWWV&Y!'11(/,>X^ZRK)*A.X+\@$;_\ IUD1]I*?<0SO\RA[?<=_
M8$@D@[$;@+R^9P\1SG'YN-W:9$B+/;'E%$*S:?C2DK48DN+)1$"XLJ-);2ZR
M^"E32T)7V203K]5TRVU:QKV%VSCI5F8(/"^G4$.IU:;QECV. <UPR"%L=*U2
MYTB^H7]G4#*M%V0X!U.I3=W:E&JPRU]*HV6/8X$.!\E7'0S5[-JFYR'!=;JE
MK'7F;$Q< RI<!]@9U7QU20E4Q]ICRGK]4%,)\,%MJ5-4N3Y;2W6U)/ =D-=U
M^TOKO0^V-E1T^M^(?2T+41PANM6]-U1H-6HP_#-Z:3:+N$BFZJ34+0XC/T'M
MAV?[/W5C9Z]V+OJNHT?PK:O:#327%^AW%5M,\-&B\?$_ "J:S?B--1E$"GQN
M:'!6U&2TQ44"0^5)44$?#[$G=+C+1V/I-E?/(:&XW!"E*WXMN%'T]?+<?/;Z
M3'U3\Y:?8'U$COQV^K;/?YU2$)[>CW&ZHSPW/MQ23L'&BLDCJ/5/SEIN/+U$
MC;8J_P -L_9+3;Q[>CWW\MU!VVW))0 5I4D$D=1UWY=5L<CJ.7EE^1R*BC;X
M=9;<@YY1'+TG';F=M]]MOG!X?-TYQU21$SCJH6U0QJIR JRG'76&LI@0'84R
M+8UE@:?*Z%]*O58[?(,,)7&D(0KTTH[KA.D. \%%*O?9W?P?Z-7C- O#@YA(
MJ4*H_+6I'_DTY+00'@$'*@QO,XP)W&>7C\US='LZTT=Q:/28I6LX@NF;4FPP
MQBOE,OTKQW+JDQF8ZO.B/+2HQ9S:5-2DI'%16%($7]&Z;7-:O5=<"KWF7$\8
MJM$9#CEK@,/8[+3R&"@((!VY0<1&(^1,8QT4L.Y31QVE/OS'&64A2E.NP;!M
M"$H\ODI:E10$I3YJ"5*(3L2=]DJX^( D@ $DF !DSY!6G,<^BPSE=#(;:=CS
M5OLOA!9>9@V#K3J7'%M(6AUN*I"FU+;4 X%< D!94$*2HB""00008(((((Z@
MY42.H790;.'9!PPW'' T&BOS(TF/L'V_-;V$EEDJW002$\B@_*OBKMU"E<_H
MB=$4&YCX;=$M0,LL,XS# JN\RFSJ(-#.MY;LWU#]36OMS*^$0W)0VEJ',;;F
M1^"$J;EH3(!\U(6(@9/6)\2-B1M(\E!S'AMCE.1XSGRQT"\1GF#XGI\UX><5
MPZC@T5#4ZR4C<"!$0HH8#U3D+KQ\QU3CRW'W5J<><==6MUQ14LD]3T\!'D!L
M$..6YR9R23ZGF3X>$Q:C8?@/^.BE9Z*('0)T4IT1.B)L#[@'HB=$6-A^ _XZ
M) Z+/1$Z(O+9AAM!G-+(H\AA"3$=4AUEYM1:F09;1Y1Y\"4WL]$F17-G&7VE
M)6A2?<I)!UVIZ59:O:OM+ZD*M-T.8X$MJT*K9+*U"HV'TJK#EKVD$$#EA;'2
M]5O='NV7EC5-*JT%CVD<=*O2?BI1KTC+*M&H"0]CP6D&=\J'&\DS;1W]#SIJ
MPSG!4<4U^=5D-4B_HHR>*$,9?7,#E+9:&Q5=PQR4D;R6%.$JZYK_ ##5NS)^
M%J[:^K:.W%+6+>DZI>6E,<M4HL_U&-$?]U2$D#OL<XRNG=I^D=J?ZNC&WTC6
MG$?%T2XJBG97E0\4OTJXJ$BD]Y@"RJF 3_3>UHA=OH7X@<(U_JLAN,+38M1\
M<OGJ*6BSCIC.NK#3<F/*92%J)9DL.!Q(.RDJY(5NI)ZOV,[<:/VYM;^[T?XX
MIZ=?OL:S;BG\-Y<&-J,J-;/^G48X%LY!#FD2)6+MIV&UKL)>6%EK0M_BZCI]
M._HFWJ?$:&.>ZF^D\D"*E)[2'#:"#B0IUZ[-<8G1%Y_*L>CY7CMSC<J3+A1[
MNODUSTN Z6)L=N0V4*=CO)(4VZC?=*@1^'L>LE&J:%6G6:UKG4GM>&O$M):9
M <.8,94<L>6.7+Z?1070^'"GPS%J:NP_);R!EN.&0JKS.<^9MA+0^I*U5UXT
ML\+*I64A/HWBKR@I2F5H4=^ME5U>K<5ZSZ]*F^A7+34MFCA8TC''2.]-\?[F
MC/\ ND*.$8\-I]_VY1E1UKAFF7OZ39UI]F&/.UN96M#+@8_?5DN3#Q;)):T!
M#)BVZ ':>:XH<E0)9 W/$/A&P&LU1VJV&G76K=E+>AJVJ6E)U6TTRY/ ]U=H
MEM.JV#\1AQ#F028$2MSH%OI-UK.GV^N756QTJK<,;?7=%@?4H4'$\;V XX@"
M<G F>:F3PSTMUCVAFG-/D3!C74&C\N>RJQ-JM+JYDET%4U2U\RM"T.%I*U(C
ME7IT$H;3UK-*O]:U33[6_P"T5E1T[6KJF*NH65O(I4*TEI:T'+9:&N<WDYQ$
MG=6[0V^D6FM:C;:#=U+_ $BC7++&[K-#:E:B&M(+@,&'%S0[_<T!V)4Z];!:
M9.B)T1<:9,B5\5^;/E1X4.,VIZ3+EO-QXT=I/=3CS[RD---I^]:U)2/O/1/[
M_+JH UAG0+2PT#GUTV+/@R=9,?=BS(3[4J+(;-/?!+C$AA:VG4'OLM"U)/X]
M$5B.B)T1.B)T1.B)T1.B)T1.B)T1.B+!"5 I4 I)!"DD @@CN"#N-B/<'L?]
M^H,&08((R#G!ZCH4F(CUZ>*@V1X?, B//V&$L6&FMT\\Y)=M<(F*JS+?=4\M
M1L("P_7S6^;[BN+D=*T[A+;J$)2D<B[L3HM&H^OI#*V@73WNJ/N-(J?AC5>X
MDN^/1(?1K ESB0ZF'9 :YK1![!O;?6ZP91UA]'M#:4Z;:++;6:8NA2IM#0!;
MUP67%!P#&@%M0MQ)8XDE==:M:[8956LZ/D>%9G75L"9+\^]KY=#:M,1(CSQ=
MD.5ZGH+Q9#86ZXHH+B03Q!/6"Y;VPTNVN*S+_2=4HVU"M5X[VC5LJX;3I%TO
M=1+J+N&.)Q)$@';EEMW=CM4N+:C4L-7TJO<5J-(ML:]*^MW/J56LAC:X96;Q
MAT-: Z'$9ZP7X<?$]J7J!@\B^RS3RSRDQ[RS@?'L%CL/1 S%>XI8=JDN.3!(
M82=N: 4OM\'1\RR.N-[ ?XA]H->T5]]JFAUM0++VYM_QFC,8^EPTJA 8ZV!-
M4/8,$@0\0X;F.W_Q#_PX[/=GM;98:7KU#3VOL;6X_!:V]].MQ5J8+JC;HL;1
M+'DSPD@L(+3M*FG,-?H];BE],IL5S2+DD>JE/5$&]PV\B1G;%+14PT^[Z?B$
M%?N=P%;#OWZZ[4^V=.WTV\J6FG:LS4&6U5UK0O-+O*=-UPUI^&Q[_AEH:78)
MG/D97(:7V(J7&IV=&[U+1W:<^YI"[KV>K656HRW<\"H]C?B27!LD#<1X0O'Z
M,^)ZHN<%JI6KMG68KF[JG_B-:W#L&([;:5)#"R%QU!IU8*N;04H(V'?<]:KL
MK_B#;W6C6M7M16H:;K+@[\3;,HUVTV">X<TR XB26@D!;3M7_AW<VFM7='LK
M0N=5T5G#^&NW5;=U1\CO"&U 2T8@D G:)4ISM;=#K.&_%M,RQB5 >;*9+%BE
M3D5;:AL0\B1'+13M^V.W8CVWZZJGVU[-![33UNV;4&6\+JC7 CH> $'V5RSN
MQ/:IHSHEY&-@P^(B*D\MEUFFW]COYR.O:8Y>AY<J \X[B]3=R)6/N-*6E:K!
MJL?#B8[K:B A<5UIE(61Y6WMN+?M3IVM5#:6^H6=[<4P:DL@W36- !EW"UQ9
MWA/%)G*UU_H&LZ92%?4-.NK2B7BF*E9G"SC,D-F29(!CD8/@I_']?=U[5J$Z
M(G1%"7B)TXN=6=(<IP3'WZQBWM7\;F1&[M4A%+8?F]E5+D;]-;JBL29'PR[C
M5+U3."([Z51IK@<9=:*T%S'."#'7WO\ ).1P3((Q_<;Q'7/FJYZ<^#6Y@8YI
M0G,-5<UQBPTXL+W((^"Z6W-?"TYC75Q839D$1F[K&9%F^QCD6:[75828#"8Z
MU!</LDB2<-&>ZT-).YB<G)DGS58/$3M))#1^4#$#8;<E8*5H[D[K93&UTU8B
MN$R"E9F8T_Q\P)]."E6.H"O3D'?O]-R[E.PWA29Y;<YF?ETY_1:1-&LJ:FA^
M5KQJQ*A_-R@IE8TP=BF2$@24X\M?REV.K?RQOZ8C;9Y7 F>L?+T_GKX+NUZ4
M6)2L(U>U;2I22$J-WCJ@A1&P5Q.+ ';W(W .W1.]U'I_/S\=I"X3>D5ZF+7-
M.:UZLN2HPC"?*%ECB!8%IKA)4(XQI28GJG?I0$+=\@?(GF-U$F>1&_,;#W'U
M^7"DZ.92ZET1]=M5XREFP+:C*QI[R@_%4U !"L>1YGH))3*7N4^J"2PORTJY
M@F?#U._IM[C"C'4'2_42UQNQ5IKXK<HQ^YJ,AQQ5E8WTK%;6IKZF%E,69E-3
M/$>F0N-86.++DTU<\Z$&)9>EFN((6M"!(B=AU_G;F$'%D$B9]!Y8/7[J6(NG
MPGA#4+6[4N4^N&S-2(N2XO(*HL@K0Q,0VWC2BJ*^XVL-._JW"A24+)2=HZGU
MSMS^29QGEZGK[ZH=(,@,6,U_;;JR)+3C:I$KXAC>TEM*B7&PQ^;?%CS$D)"T
MK64<=P%;D=2G7Q]^^JT_L?R/S'U#7'5G@N0MQE!G8W]#'4@A,;G^;GTI0OY_
M.*4J(' H'OT0S&-\?S[^JC'/](-4)=+=4&!^*C,L>U"L:Z2YBRLA.+SXT:4$
MQ?+D2JMFF;FS(;/E2E.>2@J(E [ ,#F^>V_@/'V$SO/@!'/S]X4IP--)<EE;
M*=:=4)DR%Y46Q5%R#&UAB<([3KK;K:,8*F%K2ZA]++O%Q+3K:B.*@23/7KR]
M/3ZK3^R#(?1(8_MOU8]8F6V\N;Z_&^*XJ9XD+B>F_-P)27(.\#SPX5(4?5AL
MK'E$G>\)Z<M^OEX?QLYI#?J?4M&MFK+;)FM/ACXCC:BF&B)Y+D'S?S;!)=E?
MIGJN'- _1PV4_2=$@XR?VVZ?M(Z[[QCJ!HAJG98Q>T6&>*#.*3-;;';EC%W<
MACXM8UHM33P8<>=/K&Z9,F=61+0/3I\=A"^3-FF&2 RVMZK@UP<QS6N:YI:Y
MK@"'-.' M,@@B000008*EI<"'-<6N8X.:YI+7-(RTR,M<#D$$'"]'I[HO6T=
M Q1T6KF9ID5H;:OFL5M\2BP!>EI"[-]4*+BZC$7(E%;WDN[.I2M(5[ ]>6SL
M;+3Z'X>PM;>TM^-S_@VU)E*GQU#+W\+ !Q.))<=RO7>W]]J5<W%_=W%Y<!K*
M9JW56I6J!C&AK&<51Q(:UH :)@=-UZEC2#(&X:F7M;M67Y9=4M,P6&-MA+1=
M"DM>G&-J2KBT"T5ES=1/F; @#KUQ[DGZ;>_%>.#U]^]OK.5^<K1J\?=4IO6K
M55IHOQ'/)<FXS( 89Y^J8Y+QI)/J]T[.$ L<-TI7OV%K3N >L@']?!6#G-/=
M<1Y$@_3WY\H:U;\.LW*L&R?%7O$CFU%+G4\EMZ992\2CM1T2O4M179BF:6/*
MC1"\]&;4ZTM*W?3J2@\GU!"B*5&JRLVA;N>QP+2^C3>.(3$M<TM/4 SY+(*]
MP)BO6&)$5'MP-\@[9R>4^O;:1>'^NTRP+3?#9VN&:S,IB8I4U\BU@W^+L?G'
M;M5\==Y84B96-.6"ZN98JD2H,;SGS&A/1XY40A.\/;2?<5+DT;=E>H27OI4*
M5(G$'#&M@0,Q@P24J7%S58&U+BM48""&OJ5'LD8V<\CG@Q.1F58C"L-LL3^)
MFQSK+LT5/DER/^<[]8ZBLC)6M3,>&FNK8&Z@E?!]]Y3BG^#:@VT4GE;V%A$\
MS_/.?#H!R\<+W?12G1$Z(G1$Z(G1$Z(G1%JH;A0W]Q_N-]^_M]WW>_M[?B4<
M_/\ 7R_>>07R:A>![6NLQ3-,4C6.DTF)D8TD8EN/7F4L(S=[2/42+F;N2YS$
M;PIUMW(=2J]Z;39=]+;HB)JZ<*F7\>1);A5:.&FQI[_ !W2,.(I-ID[X,\3\
M#\T#))<+.(>][P SCD=TSP\3W/\ &8!# .+8D\@#9'PV>%ZXT4RQC+[:PI),
MZ=HQANGMY'J)]Y+C-76,Y-E=N$U#5I&BQH^.PZR\@UM<(\6ND/+BO/2J]I:P
MZY,YY[,;L<EH+>([Y< "<GGLHQO$$N<[!P XB&C; SR5UNI1.B*A6IGAJU/O
M?$E UPQ.;@<B%7OX9:1$Y#;7U7D->]AM/E5?(QN$]78U<L,X_F#^01EWLAJ4
MAUIJN055=D[Y7E&R'$\B'"1N0X$01(_+,M()VY84D]V!S(F?]H#@[&_YHX2(
MYR#TGS1;1QO26\UKGQ5116ZHZI*U$@1F9UK8RHAF89B5#8MV,BU+CWJ7K:AG
M2FF6)#\./!>B,Q_(0V(S 8:&B8#G1/0P>I,S.^8A0229.\#;F1,D#RZ*>>B)
MT15XU#T@LKS673C6K&6Z1W(L"PO4'$U1KVWO(+$YG+9.*RZUEA$*):08;##]
M+8N64Y-<;!T/06AZIIA*(T $/)GNN86.$ _[FD.$XEHXH&)) )C($B(Y@\0S
MMW3(/3B/#)W !B=C%7A.\-N<:'6V5V686&(.BTHZ/'V$XC*MI2\CE5$F;+DY
MSE2K.FI_+RJX]:F'-2TJV/IH,52[9]1+;1O=:&\\'&PX6M: /.)]=T=WG<4
M @R.I+B[./&/DKN=2B=$5#/$)X3+O4O-K3.\-7B*YUI'P+XS19G99!\&RHX5
MF=9D?P>X2S67\:%3RZZ++A^7"K)#:WWPJ5!=0I:Q42 YN.$N:X-S@M;483Y@
MN#F[@$<L$V+AP@!LN#7MGS>UW)PD$-+73G//91=7>#+6!=UH._<7FG:8NE,3
M2JN?NH=ODLR^JH.G.>XAG]DSA[4K%X[33.8-U-Q@MG&D6=<E.+M5,A]V9ZF9
M3P[L(:23WCP4VR<Y8Q[#ON'EP<Z3N,R0"<;^\  WA/&\X)V>]CA_\.$AN/F
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AI11 _OGWLO=CN ?Q Z(TR >L[>:ST4IT1.B)T1.B+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>g105868g83b78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g83b78.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1=@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %T2^658X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>9+          *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              N    E4
M 0                         !              )5    N
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    N     !29VAT
M;&]N9P   E4    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M2'U:@O=2QUGTRT%VD0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@ NP)? P$1  (1 0,1 ?_$ !X  0 !! ,! 0             (!@<)"@,$
M!0$"_\0 1Q   00!! $# P(#! @$! 4% 0(#! 4&  <1$B$($S$4(D$)%2-1
M818R<8$7)$*1H;'!\#-2T?$8)8+A&28T8I(H0U-RQ?_$ !X! 0  !P$! 0
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M?^U1K]ZGI32E-*4TI32E-*4TI32E-*4TI7$X4@*45=>$GSQSP?@*/] 2#R?
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M[14V5I2E3"%-=5GTWX?L'/\ 0="<#BD$:=8J4D)04*0;=L@$$22$D J!Y$@
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M,MNH<DM,$E0<*> HA(Y5Y)!!(D_DF>>#.1ZOQG=TX_ _7"O>(]3+2GF5[[<
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M1K%#2V0%K82-@!42F1@ YDJD0,@#O@9BL=<^*5*<2E=T I*@$)*1ZE$P /\
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MM(;[*<ZA7"D@K63_ %%&XT_R05.I*4\G)/N9A1X]C(K*VOC#^:4&+6Y\UY2
M6D)24JDJVS):2E)Y$$G@]*F7L3:;AW>%1I^XU4*F]3*E)8B(]I+WT@<6VER1
M[:E()64]D$$DH*%>00=:G=A ?<#9E 4G;R)]"=V")PJ1)/0P!78=!5>NZ;;*
MOD+3<E*RM*RC=!=<VR4>DRWY9'4")S-7WU:UL%-*4TI32E>:VZRRA20KW5*>
M4DI22%!?SP>.>OCR.>/ Y'.K)"4V22DDK4\ZI21ZA)5)@$E7'?'3%3*F1(C
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M*FCPR#N.FRQG=141JUM*:;N%5YM>K5"G9G)COK7-3):;!*''99,AIE8007
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ME "$_P!QI/4#J>#V'QSYUH^K;@X!$)G.#@]<R>3D5Z>\#H:;TY"9 =CU),S
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M_O\ WZUQ/ ^E=2K]:C2FE*:4II2FE*:4KA<>90A3CJTMMHY*UK(0E 'R5*)
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M" %"(P (J]M7F&.U=3(Q!BG^FF7D)I0JG*WO"E3H,\/P5!E20I*GF9*FC)
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MS'!@2)Z#K%_TW9+A-UD^?8]N;$DLP[2HEIJFFVPEB=8MR4*CQI"B0CB4DDN
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MOR-R9*6)2TBQI&:]R49U<EM02M<?SVXX)= ''*CKEGBCPOYA<O0@^9;H6_\
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MGY]T@YGGM56Y9N,U3)Q?,W[_ /M%9S.E,TE"&82V'4-!M,9A//\ %2CH$I>
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M.--I>2KEQ*)16T"H]BI)'][QJJED@"01P"#$ ]1QG\/>>UL+%&Q#@*25I"C
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MAQSKI7A;PTM3C;R]P"05( !&8!)*O*X' 3',=:X[XR\;(82Y;,R224K65(,
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MG*,\ESUDS*NIR)5'<X)QP;L0JR4F#A\+'L1;H\0MKN-6U36-Q516K5U#\O\
MM!%4XT&53)C@"9,M,A<R+(<6EYIMX*2,[>:A*20HDJP95/'"1!Q !@#W)DG-
MFZP7.G'!'OS)S/&3F>1,5@KO?4S.R/<'(]M,PQ"QP2[K[54E*'I@8@R*MA#C
M:$2D2RW*<<FA'U">6PMT+[A/)UOG@_75>4VS/R-AL F1@=9<Y[8$CIBM+O\
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MA2VT>X0V%$;&T^18"YLRHJ2A"F]H5N3E*2 $%*@1GJ#@''-6]TVI;;C:A&X
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M28BY;6R J0K)X M+J,D../,&)$L@8<<%]XO,KBE<LH 6ION"!T!#VU&3Z=H
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MI%E*EK$IU]Q;JBZN5,!4@.NJ*E+5W'9:B1SK8&W_ #&T+Y*TI7'3U $S)/\
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MJR>9B)=2M*W9+M6Y)DNO]@IL.$HU$-.72!ISUVXS; % <\Q\I"22$C<AMX)
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MBTK<<=9(7"BAQU)4"<?U),#"2!)SF,D'TG;>*M.U%II/\[9A]200D7%OY@(
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ML"7)*/!W\<_\3S?PH\'+\"Z1?LCQ;XAMELLH8NEIO].:<!:W/"UUFQO;$DJ
M"A;/ DI*0?D/:/A!\,G/$VILOW^GW*&-WF(6]:*#9""8A3UE<!0) C:1,8R:
MV1H\6+61V(,&,W$B166H\:.RVEIIEIE"4-H::0A*$-\)\! "2""GE'!/YY]0
M&H7M_=ZGJMVX_K=R\M^Z7>7#SK[P6K<Y*W]UVZ2,$NK,]59%>]+!0\+VC.C6
MMN?+2G!2S@ C83Z#;@0?_P#% $R<P?*R2^@8QCM[D-FZS&K:6%*L)+LAQ# :
M,9I;KBBXX4I;:?:064J40E:U=!SSR,OX<TA_Q%J^GV-G9//OW=PPG^3M;=3C
MPEQ.!;M(?5 $J(\LA,R>:M-0U2TT31];U+5+JUTU#J2NV<OWF[-#Q#!'^RM]
M;272%&"&W"02,R8JU/Z;GHAJ/4R[E&[&]&-RGZ-S.+;+F'/I)D&?;65Z]&D1
ML?7/E-)8$>MIHU7'E^RKWVW$^P2T0>/T*>';"W\!?"+PCIELE+6I.6%H+BR:
M*$7#*VK@[E/,-HM74%28 *Q!22H^D$#Y=FT<\;>+]7N]02Z;!NY>+-TM"EM/
M)4H[0T\\+IEQ/]0V&1SM43 V?]MMO\2VOPRBP;"*9%#C&/0Q J:A'=3<)A#K
MKBVTK=_B.!4AQYWW%_\ B%?<<)4G5"XO'K]U5V_O\QZ%*#@(6( 2 H*4M0(2
MD#*E8')YKH]EI]OIMLU96R4!EE,)V["#N)6HRA*4R5*45 )3"B04I((&)C]5
M[TOR,\VPO]UJ;*LD;E8G&I$KQ14LG%E5SSS=5/DN0D@.ID-QG ^ZYSRAH*<(
MX"E)W/PAJ08NDM+ $E2MP/7>DY3(Y"^2H#TQT%<_\=:"+FV5<-22 A)2$] D
M@0I*%DQL B#A0S ,ZP=SBF;MV^)/5+M3C-5424.Y0S :0I5O&36*AKAOAL'N
MXJ8I,E+2OO*1WXZ@D]@<2U?M""",$#<DF(D?\H(Q@^WTKA]O=/:,\X"%@C<F
M2%""!  &YHR>< G(S5M,BQO,1+=SF5F7[K68]/8EHJ$4T!IM%9&GB5)8C /#
MN5P@8Y(![*^WY\:P^K#:V1/" !C$ 01CITS^%565G4[9\."-V],F1))5!SYF
M)ZGOQWEAN/B-SO$_0IQ^UKL9PQVBCIR!+;)7+N8DM++K=,PS%\PG9#15UF)X
M4@ D'@$ZT1T^LD< GH<F!P9G@1[8R,5R*^>1H]^X4Y5N.TR!P<_+L)Q B8.*
MBMGNQ<^P9E.8DBMAQ\;>=<JA("7Y3KL9OVD_N<I^2IQV:WTZPGFC[8X'N^?&
MHMNB3C F),' R)W#KP.O-7>C>.7+:Y&]:@/,G*E=XP/YE(3Q!$3$=<5?KTK>
MH+<W&JRJQO?"ZO6S4603AE[*EM?2PZQ(Y7736&EH;6"\G[@>?=))'//;5^VL
M%()@1.)G$=IX[]8YBO1?A?XE-^2D><D@)&-X,* .8-X. 1[C&,8O_P"H_?G;
M>%0.9KNS96KT*[B3:^IO<-9LS)9EJ+@CN"!!C.*?#"R>P;[=2DI[>#JYU%P%
M%HD%("6T1SMR#@B2<G@XC)Z374'M5L;IIM[SD*+[:'3"VB?]Q(5F'#!)4 1)
MYSN.:UB]R-U\HRBZS^LQ[,\COL=F6[KU=.N)$RN[4+,]SV9;M9&0IF0]*B>T
MMU=DMB2IQPB0VA[ND;38VI=T],?\#D<''_V_H<$$\D&J5NI+JI;A0F/3$#'M
M,G)_">(JY6RL>/%DOQF+M%E1WA97^S2H:V4JF*C]E$E)+4<I4HH4E*U)204I
M40D<]0\,V2$,6I4I)_V63MA,I5M@@^D9F#$3SU-6E^HA2TA)!"E2<RK(,P (
M($QT/T-2&KX4^KKV*]4"'$F?6-+8$93SCK:$K]P,)4CE;BD-_('D@=O@:W.Z
M 2U"<X@# !Q/3Z&#V@=":LK9\H5!D01')C$"9(YC/',^U2,9R6ILVJFQJ;)^
MTL*I$55K'D%EV&;>,OV6HC:DA3JH8;)4X5?W5IY7P.!K"*0HB2  J((GY?KR
M#S$3T')Q(I)4\M<84I2NO4SGD?GB>I%1=W']-,G(,KG9.U=15UMV7)TEA27'
MY;$F0M3CK$=@=EAMM1*4)Z^$@$ #C5DZR"<B?3$<B,=\_P#CBLC;KVQF(/3!
MDCCD<&,UWX6R]548;?5[:_K)J5-_2SFH:TN-+"4$(6L-]D#MP% \< >?'S?*
M8LTVUNIR I0SAH*Y(B,$0!R3,G.,U3<,K6D29/<*.0.<\Y^W/!JY.VV*9]6T
MT>3+JYMAA]0S'DY194#<N8JJ2EYYIN;;O1VW(];"D(=CPQ)EJ997)X9"BZ0D
MV^LZC86NG$%QL%22E*2IH$P-T"5I)( )P#"<P )K6=5LG'$J(3/20"8DQT0K
M' F<F9YD9XOTYM@-Z&=TO3]NWEF'Y7D>S^0V'U>W,[$+R$W#PZSI95I6S;7,
MT-!0CQX[L.3!D092VBXZD-E)<44GS/XCU9FX<NT-J$24F0""2#T#AW G&"03
MN3((-6_A[0G6[YJY+:@E:@0I.#*5QA8:A*@1U.X#)@0:VW8J.B4 #@!'W>#Y
M<4>SOGXY]SMS^!\ <<:Y>J"I1'4X^@P!^']Z[6V-J$B(A(D>YR?S)KN:A4]-
M*5\X\\_TX_'_ +_\?^FE*ZTE@NI/0E*R4_<D#GJ/GR0H<\?'(_R.H@Q^?[X/
M,=O\U3<1N&)GVG(ZCM^GWK6D_5K]+F1TU]4[IJRJUS2FR.UDQY6.7R(IAU+2
MT*?;8COO.MMI92IGJRWU'!)X))&NK?#.Z0Z_J6ENK2&G;);PWE( )=:;(.XE
M()"B"?+43P3!BN(?%#2'%H;NT)*DE(3(2K!!G)""),QR#'L":Q]^BB JLW@W
MECFIAT<9&$[9+:B0VX[+#B#:Y@MQ]?TZE-+<#LI#3KG8+3_!2KCEOGYK?^IX
MI5G<> +:W)*2M3B?+)(40UJ8@!&U)!0!@)R "3 BO47\*CSEKIP01P$I/S3S
MD\CI/;(QBKP^K^XJL;K]C+"\@NJ@G?C&*>:TY'+J7!=8UF]0MN3'4G[&F/J5
MK<6M/4=R%'D<:X#_  2MAOXGZB$D2]X'O75P1\ZM5T(F8 (()/,D=2:W[^*Y
MM%Y\'-:?4 =E^$=R4_R5XLY(5\P@'U B 1P*A?G.UV2;B9K<SK>QBTVW-):5
MEFF!5J?9OS/:IQRJLDQB&X4="3%CSVI!2E'M%*0EU2]?8U[_ /M5@9XU.VG(
M*L)<R(P8)S/8_?XUZ=JO^FVCY$E7\PL\P /+1RG>@S"3!!Q($\BHBYUMKN'5
MH;W!PMUN';TB$JK'JR3+=<;>,AQ#$VO1+[D/%"&Q9F4/;7T46^5$ZNU?.2!D
M>TS!/L>!)(ZDYQBN@:!XZVH:=6X?]HH3)40  A!.#<\ X$&!QB!&0WTO>JO<
M6VHZE_=R[F0-PZ. 8$E=DVMC'[6&THM1'&8SA:2UV0E(?"QRX]W=;_A+2=9.
MW="  3STZCKF3^8X))F1-=_\*?$=G44HM7'DA),3YB((F(]5XKOCT]*I7U3;
MQ[48M07TO-LMM\+S:_B2YU#.Q>)8.07Y7L+6B0M<1IR.VTIO^$5+4$D'GD#C
M5R;^+IAH9#B2"(F3)!P5=9P2"3&.M="O+NRMU,I:<;5_,H\PPXTH$S_\5CD<
M?,8@3R*UP\GWESW.DF#.SBVLJ!J\8=F6-G)=?C-179'L1VDQ4H0^DJ0ONXA(
M\?:5<$@'.,V"G+IEQ0,;@<@_:24'@=?V*)MPM)<29$3B.#U.U)[G@D#/2I'[
M85AEXK*H;1YC*F(!D"D2KF,N$R^\ZXV[' ")(9<6E1*W1P"D!"B ==UT:&+!
MM 4">23 ,9@0(..(C,3 )@6#\+5&SY1&TY ^AVR.IXZ_A>N@LY5'/QN2PXS6
M.PG4HGNL+*WX,"$@V#[ZVUDKD/.OPXK<8\<]R4)/*^#>/)W@XDD$\ ]_J(G,
M?YQCW$'C'/3!&.3(!SB()G$"KZ2WZJULY@J)T>TIKV)*H1:/->P^TB<V@_N*
M%)X ?;65\K))0>.".Q&K=-N2VX%B#M!@&09!F93!@R1'7GH:E:665D\@]C)
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MHD$]RKI!JL8^/Q7OJVK"P'U+C_ON1J](;?=;6HJ)6DGE9//W%*>A/)\#C5H
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MBI1"@$J'^XO:8*1$IB21)&8BIP-)"4< *3RMQ9"B207%J<5Y/X[+/ ^ .
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M<-Z&W'L)2%EI*1*CQ.%,-J"_=]M21R$D]@3SQX(X U>)*5!2D$*&[E)! @R
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MH<VG.PT1K>ZAS+!;C"XN1?3NI#< MKX;2KW'%*'4DDL*\?:H#K6GL(M[!.T
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M,21CMSB<MMHOQ[.IA6;ST:"M*P^^VA"T*02#I7BW1FTMKN0^RA]MA]AMUQT
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M6X[U 5W+8)3P23^=8@:EYYV).4^D"21 $"/5V';N(JRO_AYJ^GE27+=85)4
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MQ*AR.SJ$29JVGTO2)A0I0]MQUIIMM+*'.1RZH\'61T-"KU\A:H#2_+&XQ*0
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M>6?,0EUHI(0202D$DD\#].HO+&X<A*2E6.X5.1)!) ^Y'UC%;=D179 *NH<
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M7&7!PI#2D):<ZI0>2I(  U!,QP3!/8$>PXG]>09$5W33-40^E*09)XZ8Q Z
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MM0W[4.OK&2A ;#BW '75@O/+[+5RIU2E<<)!X XIW5T[>W#MT^LN.O*WN+(
M*E0!) QTJ!R>W:) [0>_?]><W''_ %/_  .J%*:4II2FE*:4II2N%91[9)Y"
M>23P#\\_R'G_ ':@3 F)[^P[]:#'&/U_&K4;G;0[>[S4"<8S^@8O:1N<U.5$
ME)>"%2F' MI77G@@*2"2/Z<?R-:VO7;=1\LE,X@C!S](.2:M;RT:U!ORWQN2
M!&9!@#@?+4(/7QL3M:OTJ9XN#A-8Q)P3'TR\4>I:A*9U?81TB(E#"HB/JB7H
MX#3RU$J6%*6I16"3LFAZ@ZJ^2%N2%$E841$ >DI$<@D".QSS(U/Q-HK%OI9<
M::*5H2/)*$P3Q.Z"2J1)$@928)D@Z<;&V.1]\FQC%<G=H6;SZ#(X&.SVV&I=
M,JQ4([Z6$2.'DK<2RH.!8+@ZGW.%=M=8#FY@$'<2,%)W=^W(/TCM@UJ_A;4%
MMW!;<.P)40-WH  $\E/'7DDS/2*O%$&X$QO',:J*J7*R6P?^A]]?+BILV+6Q
M9KG"6>>P=>?5_<!25>$\D<"LXM+;*%E29V"9(&2!W'.,XD1760Z"E) D%(((
M((,\'$\B.,0)F*R/;;?IF^I[<G**27<5K^W]/"QEB9+E3Y'LT%Y(?D^ZRE;:
M#W]Y\GORI)/)43YUI][XEMV%+2EY*R%E.U!\Q0(PH;4H4< ^P Q[5/O/_$R<
MF3$2,YXZF?\ R*R.^D3]-3*-N]UT;B;RIQV7$QP/M8O4P'S+0Y+_ +HGR$*1
MU+*@72PCD$%0/X\ZSJ?B=RY84RTLRH1.< \F2@$&($3//!P)@>I'V/?/7K^X
M-9M8S;;+#33+?M--H"&VP.H0A/A*0!X  XX \ >-:;NW$R9)DF9^\S0F<FOV
M"DJ4!\_GP0/_ '\^?^SJ4*224"9&""#]1GZ<9Q[8I7T!*>2!Q_/CG_O_ .WG
MXTA* 2!&,Q_BDD\F:)(*01\?CQQ^?^__ %.HI4%I"AP>)$=8I7ZU-2FE*:4I
MI2FE*:4II2FE*:4KYP.0?SQX_P /^SJ6/4%3P(C\?\U"<QG\,?C^_P!*L3N_
MZ=MI][9N,3MQL:CWSN)S5SJH/*(;0ZYUY1(;(*9#"E))+*N 25'GSJ\M]0>M
M)2VJ 2"1$YB.QZ<=JLKG36+Q0+B)P1UQ&9&0.OVFL4_ZM_I]VBJ=A$Y?68A
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MR9+ZOND/.$]W'E<*<65+/)4=<ON;MRY67'"%*,\"!GD]9X'6NB<)">-N /\
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M[)*3^?\ UYU*I(4DI/!Y_'[5$&#(Z5QAI 4.0>1R1\@?CGQSY/Y_/_/1(*8
M. "(CH?>I2D$R1_;]*Y"D%0)/Q\?X^>/^>H%$J"IR#(_?_:H\8[X_O\ VK]:
MGI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI0 #GC\GG_/3FG'ZU^
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MF)*0"?21R36;UODQX_D\E#?/D\_)\\_T_.O;UP8#1X_WFI]Q/]^:X<S\@_\
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M,&.TUZ\^%B66M'M;A025AMH F/\ C$9Q@C),P<C.:D3Z$3__ %9;C^?M_P!
MV(^!SQQ_;[.?Q_\ 4H__ %'QY.O0?\"2$M^'_&2$_*C6T!/L/Y&U/WR29Z8%
M<\^.*MZT+3@./;DQB 0,<]\=?PS6;%H\1H_(_#?/QX/*@/Z?U_IKWA<@PV.O
MG-#\\?3]BN",_(/_ +#7BJ4EN3*;<7[:7GU.]B>#R@= !_0@GG_?_35DIY#
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M=C(6AN/ J*R,N=8S)"U^$1VH\1SNL\)0CW%'P#J9QU+!NKJZ*$6UJTIQ*UB
M$!K<ZHG,[8)DQ!%54-^8MMD$DJ(3 )'J)P1'UR)R)$YK7>F9A=;Q[B9!OWE<
M:77V&:(H6L&J+(K5,Q#;6M45X_1R([G(BVMX7;7-LK90E"HTVX,!T$04=?D-
M_%-\5;[XB^*7-%TEQ0TG1U7-OY*5>D.%LH*G"VL!1:,)A22%$)SZ17K+X<>#
MT6.F-ZDM/KVI62I/$$&<C@D[8DD3QB!WD'J?!)2G@ 'Y2CC@('CR$?W ?R$\
M\Z\M6JT6.H-/-P6KH*0)R-S:,G=B?5/&1/>9Z@P^G4'5+2$P8  & 0((^\3S
MR?K74IL,=WFW+P79""%*:R:?'R#-70#UK<$Q>QB6-FY(/P&\@?=8H8R5<I=2
M;,<$-* ]:_PH_#)KQ-X^7K%TT5VFF%%W)"@@J6#*1@HW)V()' 2H0,UR'XFZ
MPNQ8=MD*@J0I*1(^8\  &<1 [=HFMB^K-=45#,:(U]/ KHR(S*4\D-QH;0;:
M2D)220EMM*4H0D\!/  YU]<+5:+AE*VL-I):2#R T=D1VQUSU->4WWCYJUK,
MDY(B!'<"3,YX&.OO:^3Z@]M(LB1&E6]BS(C/.,.-IHKPI"VSP>JDP%)4"?\
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M%'L7"6TH64VF N2)MLTPR@"53&R9>Y=C12C@?\0'P\O?&^A!NP\U+J&G$*+
M>WJA*R0"T%*.Y*MO68'0FMY\(ZZUI[FQT2E2DE)5L@04[A!,B=N3R5$@QQ4&
M*ZP@VL.-:0)#$J#/BQ;"!+:4"9,68.IX!/VK3\+3_>2KGM]P(U\:=<T5[2-0
M>T.W#G\RU=.VZB0HNE:%DPKTATE,3M(F)%>P+>Y9NV6A:K"-S39)9(2/4E)_
MH.">AQ [@&NZH%L*'' '8I)!Y\\_D\_X\?CSYY.J!N%:9;'2;MD-W3DJ\Y"
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M396P2H$\R!,P.>!BN?\ QL26RTT9_P!IP(SS("R?OG/TK->U_P#IXW_^C?\
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M_P#ZC_%"RR?EIH\_/+:?_33<K_DK\3_FFQ'_  3_ /J/\5]*4@=0E(!!'X2
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MD) 2>Q)5X X^XDD^/)))\G2E$I2GMU2E/8]E=0!V5P$]E< <GJE*>3YX2!\
M:4HE*4@!*4I ! "0  ">2!P/ ) )X^2.3I2!VH$( ("$@'@D!( )  !( \\!
M*0.?@  > -*5]X'GP//SX^?QY_R\:4K[I2OG5/(5U3V (!X'(!^0#\@'\C2E
M?.B.".J>#\CJ.#R>3R..#R?/^/G2E?/;;X4/;1POGN.B>%\@ ]AQ]W( !YYY
M  ^ -*5^B 000"% A0(!!!'!!!\$$>#S^/&E*<#DJX'8@ G@<D D@$_/ ))
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%*:4K_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>g105868g85n13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g85n13.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1VD4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '8B^=6 X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%=N8          *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              K0   +X
M 0                         !              "^    K0
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    K0    !29VAT
M;&]N9P   +X    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MY&%=D!T
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M=S3XA"4Q(;57S;:<S'I8MEQ$]>Z5!>LW LJ?",;Y(#==UT@$9D"-8S@3QXJ
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MEWY^'(*ST/IG]?IIQA5-PV/]1M3[^U>\?;CZ#Y\\#YG@_($ZI$<1Y3^%)_\
MJ[V_*&X;!X]#:_CZ!XC^M\KGG]I^W]0U^4(">^D=1[_C^?:;.>AY</&>S[JJ
M;AM0Y$&U'V"O@UT@'LPX_P!/!3]\ALMA/OYRFVCPI8TCJ.'N)_@]4GH>/+AE
MS[UTS5#<-C_4;7W([5[Y]BV.>P/;\H"#\PAPCLA7".H]_P >?\Y)/0^W'Q/J
MJ_&&^ ?0VO<@?]'O\]U%/<<<\ I)/;LDA7LH$HZCL]?7PZI/0^WY[\C 7#9
M/H;4<\=C7O\ (Y"CWX! ^[P>_8E(/<Z1EJ/#.?I_"3T/M^?Y5#<-C_4;4_9*
MN!7O<]D(7Q[?>4'.E(]RM*T^Z3J=\OKDD]#[?G@N1MD!03Z&TY)(Y$!TI'#X
MC\DCMP5'S ?;R07?N#G5CJ.S'\^&:D]#YQEQY\!^-5Q^,-\ ^AM>X!X^'O\
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M,=HSCEU09[MO6(FP=QJ6Q157"$*%>J7'ARX(;E(C(<GQ@8<MR;!GH2YZN(V
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M8#3:8\:SL$)D*B.1W<9@NF2-TN:!^[>WF-(' RW/0QN@?]I%B8T&;6G>'RD
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M')P,E8 _,0T9:G423Q!TY>F2V0T-]59-4PKRCFLV%98-)?BR65<I4A7NE:2
MMIYH\H>9<2EUIQ*D+2E0(&G5*;Z+W4ZC2Q[20YIU$?4'(@C(@@@P5GWW_"]C
M]WS_ .?'/_/]NL$31$T1-$31$T1-$31$T1-$31%JV_E!_"]NEO=&8R"!NK1N
M;94TK!I=MLIG%DG$L+MUX]ED"WN5JR6($/.VV752)&,-_%9D"#6L35O,+6ZH
MC6(.Z9<-[,1Z 0!.I=+IZ1!"&2W=;\ORD.(_[?-,GP'RQH?-;%]NVF&,$Q!B
M-3P\?CLX[4M,4=?8LW$"I9;A,H;KX=K&<>CV$:(D!EF6TZXB0V@.)6H*YUF=
M3XG77S4&@\%"C=_^3^QC=+>+(=YXNX%SBN0WZ:B6XS&IH5HB-=T-.FFJIJ7)
MDI"7J]I@*>D5#L<LR7R%EY'2.<6@M=O C>#MYI(TRB#SUD:05F7DMW<H+=TG
M61K/('F0,^@78S3PVX?A,+PU*DV5W>7^![QP##NC-?JH\Z5N#FR[K))$RCA/
M?#EAV9/=3!0M+OP]I*0PH**E&N.\YN0B !.9@ @YGGED/H%@&Q,',F3/B!D/
M!3F&/UP4%#U/(6EP$R7NRDNNO#MU>W6\OD$<%/"3V &DS_H?93='7PD^'TR[
M$?,8W6C@?G79 ;',M[[H83&_2]_*2._OU<K^]WT5CJ>/N9^OXTF>2L=K5J4H
MB2"HJ4>)3P[J4E1[=7;ND=OD.WS.BA$\2-8TRRRTY</JB<=K4?=]3_=]Y3Q^
MZLK'][](]_J.WMHJ!UGOAXJ#>\.%;^QM]\?S#;ZBKI& 8EC#\N>\J8&[3(6P
MW-5:XN\\IY+ZC/1Y":_\F41IGER^HAE0UX[M5:;>C;;#<6P2TLWX%A6'U*U8
MRQMS?95'7.&N<7!W^8-IFA(W650*A(#87LNREWL =A<3P?'+R]9CV+8C2HT&
M!KW6UB&NIBUQ)L-W1\%SJGQX=O5*,THWG B96/)QO*J.MR*FDO2ZRYBLV,1]
M$MXA3<A4:04J 4"AQEV.EMUH\*;<0\TL E8UZO8WEMB%I0O+1XJV]U2;6IU!
M!!#Q):>3FF6O:<VN!:Z' A>2WUE<8?>7%E=TW4;BUK/HUJ9G)S"6R.;7B'M<
M)#FEI$@A>R,<K4I"0)1 (/\ :GN24J?4.Y7]9#@/R/V?T1KEKB1KF9YY3PZ:
M9"<E3^;E:!QQ*(Z0GCU3Q[>6EK]+WZ4CO]>3\]$,QESGQYC(?:5U&L+QUF1)
MELP4M2I@XER6SY<B4.$@"0\@)6\ $@#S%*X[ZR+W$!I<XM;^UI)(;X Y#RA(
M]N_;@L%9+B3FT-S(S?&XL^?@-G*,G.<6B.ON.4KKSWG/9=1L-DK*67$H5<5S
M22E^+UOM)#C1Z^RI.9?TFVU4AEU3 ;:UW$#XC01_QJI,:Y_#>3\I^4_*9 \9
M&69.?3EUS^NI7>VDW?VQWDO<YH,+>M92\#EQJZPF.KD(A3FY3=C 9E5[ZN$O
M,."+*"%I)*N&WQ]E2%:QOL(N\,I6E6Z#6B[8ZI3;,O;$%P>/^K@*C<CH9&HR
M@<'$@&8R/+OVR(YSG,8W6CGM)[J4K^U/>ZBT3Q]KZLM\?^;](ZZU4B>?#0QS
M_)ZH,<K0%#B2>H@GF4]VX6IP<?:[<*4?W<#VT2.I]?K/^T..5O 3Q) !Y'$I
MX'D)4GWZOHL_OX/RT2,]3H/;CY\516-5BQP1*^Z4\B6\#P6VVB>>KWZ6T]_T
M@3\SHD9DR<^'#R7(X[7%SS.)/7SSR)3W']J$SVZN./. [<<='V/N]M$@>\^<
M1WZZJ@QRM3P )/L$_P!J>/(2TMH<GJ_0<5R?FKA1[@:)'4Y^WK_,<(S08W6#
MV$GWY_M3WOP ?[WS"1S^WOHD:YGOOW/-55CE:H*!$G[1)/$I[W*TN'C[7;[2
M0.!_=Y3[$Z)'4GV^D+N0JR+ 4I4?S05-I;/F/..CI2M;@/VR>%=3BN3[D<#V
M T2(YYR?IV/#U]'15:M_%7X<=]_$%O8G%*9MW%]D;2BI9=[E;][67E!8WM"Q
M-G5ZK' Y\MN<FTBVR8-1%5 C_#S7RG[N69DR$S#U T$$NU:Z6"!F2 TN#LRT
MN:ZH#K :(&\Z59@#J-TF8^7>+@($3!#2.9)!)#1.Q+;;%$8+@&&X:W%@P6\8
MQRIHT0ZR1*EU\9-;#:BAF%)G-,S'XR/+X:<DM-O*3P5H2>PR)DD\R3S6+00
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MYQ+U?,2V\ORWE(<<=CE]CS.%ATD@ZUJO:7%N ZHPFF?VU:9^)2<.&Z]LC,:
MP8X+,1R&O37\CHKY8ATTEM+L:/7/LD=*'6&X[K9"0ILA*VPI)Z05MG@GC[23
M\QKCD%I((((U!!!S\>GMXI \?'/L+["LKASQ ACGW_-VN_L._P!CO[#_ '#4
M2!$1EWWT5#5UI]X$0^_^KM?,A1_N_-0!_$ _(:*K[LQ(L8DQX[+!*0@EII#9
M*02H)/2!R I2E<'YDGW)T4  T 78T531$T14) [D@ #DDG@#\?D!^TG1./\
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MG5V)M6%*F8^\JPL<72XVVS&R9 (+I()R:-V&-W-V'9&3OC>!EQAT#= 61+7
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FQ^!_]4ZG$^ ^KD5=5$T4;H/ ?1-%4T1-$31$T1-$31$T1-$7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>g105868g86q07.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g86q07.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1EL4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &5"^9( X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>:A<         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              @    +P
M 0                         !              "\    @
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    @     !29VAT
M;&]N9P   +P    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M C_P        .$))3001       ! 0 X0DE-!!0       0    #.$))300,
M      \>     0   *    !M   !X   S&    \" !@  ?_8_^T #$%D;V)E
M7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,
M#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,
M# P,# P,# P,# P,# P,# P,# S_P  1" !M * # 2(  A$! Q$!_]T !  *
M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M?IN%K/0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M_\0 %@$! 0$                   $"_\0 *A$  @$# P,$ P$! 0$
M  $1(3%!46'P<8&1H;'!T0+A\1)"(C+_V@ , P$  A$#$0 _ /?QP!P"-VRJ
M78X]UZIS7'+;-)N"T6.9['S+"Z2PJ(U#8S3 J"X]+EU\MT$]G;F,R;%@.E62
MP(:,56CAO,608_[T^>GB;&;RZ6HYS5XJMZV[D6M;:UZJ[7,-W!C;/V-JP&4Y
M"V^Q[.,\KJO83J@A+>0=^)X3@=QLS,\*CXDVE(!K+$%)B%I&EC<%T*0S^IQ\
M?))EJ(G,)-M)PZTI3J=Q]#FQMI[%USGZ;=R^)GF4X)NG/]=#RJ)C57B26]3C
M+JO[?)/14RNKXDOM-*TRQW*TG9KE1%3CG.=2_B[UE0HF]:U_1-/@T. . . .
M . . :*J)\JJ(GRJJJ]NR)\JO_9/E?\ 7@-Q<VT>=#EN(V+*CR'"7L1H#B,K
M/GMW<@GO\45>Z)Y=NZHJ?V7@D[>:>?&)P;K@HX X X X X X X X X X X X
M)"T1@,J94%QJ_9D$W[;1OJ+!EQ8?<C4ZP:QT4J3I26T<\4];[$;W"?7!DQRQ
M?'WF&&YB/0&M$KK"\KI+C<KK]*\&'1=(;7CZ_N?U#A@NI?;C<?N_U+-S'[E!
M]VC5LC]3V-A:S;GN]7M^KD6$HB^/@I51B(C3:B"O^7;GN69\%' ' ' ' ' '
M ,!E9BQ\8R$X(L::8-):%'#FE:&'*>.$=[8\LKU1HXQG-09WN5&M$Y[E^$7@
MCM_/FG,7/,U_L\V\LPVQM#U!*K*=7ZPP,='N:1/@3,)C"AV+VRK.QK78^+VY
M1TLL8KFUC9D*8%C8XK";)<BJ^<B-DR_[L_G-0U9Z3,Z1_-,GJ$_^^4HX X X
M X X X X X X!6KL3J+WV6VZD<KU]D>B\2P/I=LY=5>8EL2!=RLOS@]+A%!G
M=I.E7,+)JF+AU/>1;Y*G#SK3V+I1XOW0Q)P3_;Q6,XEKQ[77T85*).9E;2KU
M=8B'5*L;$_,"RE,XPO%LP2NEU'ZEHJRZ^USFJR97K8Q!2EB26*B*PP%+[9$5
M$7NWY1/PD-*[K:%'K,763EW!3#Y#+AU]%<3K&*:= AULR3-A1H;["1*B@ \A
MXX8 V$),*437,9%8Q[CN<@VM57=N 5X>F#<T>0Z?W!<8Y5RZ2DG]36W)%;4S
MZ<V/38,92434#)I3C":O(CFN58Y!,5J.1W;]WR(IK.TO5Q#A%D_!1P!P!P!P
M!P!P"'76QGMO0:F%KG#RJFQ=[7]?J/"6"5WO1I.4/^GN;A[6KYMBTE']=.E'
M3]HF(UZJB)P2;THL^.^;VIXB3>=,.GO3RNM1[\T7@M-A&*T9Z_7'4,7'ZT$*
M1EN$Y/\ 15[LUR/Z0;%LK3'LD'!R"38RD(?V5G,\T:9_%B2W,K&T9I9?,JLU
MEVZ@D!E!#( 490G$,XB#>U["",QI!D8]JJUS'L<US'-56N:J*BJBIP5426WL
M?;@HX X X X X X X X!Y\NKB9-R[>>WBVF$T5-E>L;:]RBMRF3K)N0J+6V"
M:UQ:3@ 'F*QT#-+S;FU\QCT,6',#+-3TF(VT0#(J#20\95E-769G-6M-M)I>
MA>CK"POK;7N&6N45@:7(;+&J:==5$=/$-9928 "S((F]D\1QCN>)C?[-:B<?
M2\Q7U*E$TBK]Z>G0YTKFHJ-5R(J_A%7MWX*8VWESHU78GIX8;2V!"DEKZTLI
M(@YLT87OCQ32E&7Z49RHT;CJ(GMM=Y^#NW91&U%&O?KG%WI<\W/0MUC9S6=8
MEMTQ9+L[4."ES[<&Z<RR'41A,O,RA7$&31"%15^3L6&,SKF.B383G0@D5H2,
M&-W97*(U2<TA^S?FKRIZ'I91?A/^G^G\?S_^<%E:KF.NQKP4< < < < < @#
MB8W;VZT<MS<BOD8'TQU)=>XPQS4+!F[4R&,V1E=N!_91ND4-.=:-RHJO&21_
M\%X)URY4XS%+Q!,_/L*I=BX7D^#9#&'+I<II;"EL $8U[7 GQR <Y&O141XU
M>A!N_+'M:Y.RHG BD7Z^E8QT>Y%OHJRZY'AN4Z%S>:6;L/ILR!-:V4R6]5EY
M!A#([9FL<L=Y_P!0_P!UQ%T6NFRW(J&NZ6V7R<Y%[ KNT8UW\/B)I\%' ' '
M ' ' ' ' ' /-KUTUV(S^J#-!8)K#=,'9DJ90,R',<K_ %'=:0RM1T]:^.F/
M8="M03K!T>'[,25/QX">$^,=G@IVD<YTYQT(ISQY_?NST-X"TS,,QAAQL$5E
M'5L>,89,<;'-A!16LCRU64!K53L@Y"J9G^4BJY%X"25LMWNVF^<9U#MK"<UL
M]G:?SK%I5Z>LP^1E"Y/CT*X6%56<.95,2"Z37N5HITYTL?L1B$=XQT=Y=D[J
MO'.:$R^BCUM1Z+6N+$5\?U#U6NV#LZYQG*GZRF7I[23$RS)F1LVJ+ 4S+I%I
M4Q8>-',^/$?78T2/4D*@Q(!X5&B$_P _'7]%:3NN<^RD+ID]..IW#UM7>]=F
MZESO*LBH=I;>QW+NH? KT&$5XLZCR*3].9' JH<A),(U)#(8*^P)6>9&^3"(
MJ\$E0H<62S$VGMK3J7U2,8ZS]!!.3$,IJNIK7<&.4OV/.2 Q_;E=# U[D!5Y
M*%@*?() A(GMON%9(.]B-[>3T57/2SXO>6+13LIS%4M7.'%:D ?1_P#4@S+K
M,ZB^M+5V=VVQVR=0Y/YX?BV<XU14?Z?Q9MD*IEP94BJ7WY%] O6S8[F&3VBT
MY($AB^XA%5S[]>:6T8FD;Q3VC>AZ!N"C@#@#@'2?41M:+IC3F<[ <K"6-33E
MCX[#[>9++*+/M QVO$-%1Q7R;61&1S&]U]I"._#5X(^T5F>0<=Z4M42M0:0P
M_';LA)69VH9.7Y_9F5'RK3-LK,ZXOY,HG;N4@9$EL!CE^4!#$U/AO _RIG2B
MT7@D=P4K+ZPL\J^C7:6)=:EG!N2:OF5*ZEZA1X[7DLI@Z*RDME:\S,E<#Q?)
M+B^5^%6>0KO\-2Y':%>J,9W:YSG;7$7Q#<-JTO&M8CY)P:4VWCN]M8XCMG$(
MEW$Q;.*D%[C[<BJC4UI(J)?DZ#/)7R%4HHUA'0<V$]R_UXAPF3X>B(-+*TYY
M\=(@[4X*. . . . . . . 4V[LT%N#(LQZH[";TLY%M[(\^O+%VD-MU^[,)Q
M86!43-;8S0XC'J*6XS*GM:(F.YE!NKZ8\56Y\Z3.*=RRAE02*SV[_P CE*YA
M**6TS,*J2N^F+HM8UC!R>MU[A<'-7M)ET3&J:/DKVG9*:Z[#  .Q<D@:J,RN
MDM(JE&JL?W\FJK53@JRZ]^6TBG>3G7!3#9$"!)H;F-:S2UM9(K)P9]@&5]$6
M##)&(R1+',5%2*2.)7%9(5.P7-0B_P"7@C2=\.>Y7;Z75?0U>F=NU^+WDK)<
M?B]3.W!U5[.M6W<NSB^Y1N;)/:M1J3GJYSF^^C4[HU&]OV\$_P"GV?=IKO1+
M7)9,<?O"(+R<SW!O9Y-7LYODU6^35[+V5O?NB]E[+V7LOXX*U-.=?>-:HJ6M
M/38KM&9IG74_TO9AF/\ [BK3)K#.Y]?F=S!/B6P6V#(0\FP:YCU=/6E'"R.I
MJH$"MFR"2EIK.OK;)C'N;,^J+SHHWMXIVI#J3\JT=GF:+.M;?NY8)H7>.+[]
MP*+F6/!FU5A&E2J/,,1N1)$R3!\PJRNC7F*Y% 5RDB6-;)8J-<J*";$)&GQ"
M%BR0D<+,7:S6W3Y\:G=7!2/N_.J#3'3+"Q6QW)E+L6AYK=LQS'#_ &Z;/987
M97 :"N;]&$OMR9+I VQAO\5.[S0:.5CNS$]?2/LDJ8Z=YGZ-SGG4WH?6U9'L
M,TV=C%&LZ..1#K23QR+R4AF(080TL3W[)\A[51K0+'1ZO7Q^%X#<RDU/MUXX
MI0\X68]6^V>H[UI-&:'K\=W6;I5%#J]A/H,FKFT6.WEY2QW_ &S,V4EK7Q)X
M<7@RBE:YL@YGSY+AR!#8UJ(@B271VUMASI;2IZM41$1$1.R?Q_'!KFIKP"N+
MU:-12]Z] '41JVON\JH;#*<0=$@2\-QR=E=Y*FCDA-$J64E:(TZ3!MY QUUD
M2,-2QH,@YVJBC[\$=UI7SA[Y\S@C[Z'&2WV.=%F"=-^U)6;Q=V:-KEC9-4;(
M@V%3D,C$LCLI]IA]O30;=@K(N*PHI#XG&,5G:+98[-B(J!2,XC]\[2)KC2EY
M3;C64KKPKES_  4< < < < < < < I,]1+J0#C.X8>!4NWY-9)QG4EY:GP7$
MMK8UJW(,9V#;34-B6=9*;(AK^K:0-:!K 8G7.F3/]^<F/W3;2$L4Z-3/%,O:
M,:Q8RX=>LMS:DJM%;W9;AJ:PM+76F#65Y8);W,[%:*5:6C8AJ]MC/-6QWR9K
M8,A@CQ$DE5Y?8*(1!^7BYB*B\%6>O%.VE8VL=A\%,%DTBEAX[>2<C .501ZF
M>6YC&AK8"D5@XI7S@E@M&99C"1FD:^,@B*=%4:,<KO%0MS5T*Z_2SL<,MM)[
M9L=>5T>JPN7U+[<+CU?$I7X[&BUZEHT:(-*^-#?7,0C2+].Z*%455=X?N1>"
M*[[<YJ]YLQX*%3OP1I.Y4QU^Y1:] F/[&]1'6%6&YJ,>HZ\74;J-UBRFK=G4
M0CQJ7',QII#PFBUNR<7E38<)9S@>.28RKZ><Y\B#4% TYQVY,R)33B&Y7JE;
M$1"^E'#.C_U4,_ZZ-$XAL_IZZ4,[O+K)Y%S#M9>068L6U9ALNMM)=<L2?L*\
MAP0Y)/C,"*190,,KKZ1"<58[V*1G[E-(77]?<K-254)_DVZ0H4_/GW(B^JKZ
M>W7IUKXQHI]IL ]G-Q#:,3)IV :(DU^%X]AU$U\!TZQDY9F.745MEF6!$+PQ
MR?&JZP-<8<LB1P+(:4CG.=35?:'271VFDT<TM"R78:*Z2=#Z7J*2;C6KZ6/F
M@ZJO':YGDWN9?G\R:.()DDUCF60R[JZ+((5KW&0%G]-YJ[V6^"IW?KGJPIK,
M7HMM^O-%S>5TX:-F[7B;REZTQL^W((!Q8>?$#)6_CQ@M5@XXI'U*":!K57L+
MV?!5_<K5=\\"%IMXMLNIW;P4< T5J.^%3NB+W^?Y3@$'.K?6N34$S&.K#3%/
M)LMQZ/BS?O6+UJD0^X-,32-F9[K&0!B^,VW04864X&1[7&AY=2PH87BA7%FP
MUG6=+XT,PEW>:UUC7H2MUML3$=LX)BFQ\#N(]]B.945;D%#:QG(X<JOLXPY(
M5=V_W<@7FH)<=_8L64(T8S6&$]C85/$6\1,4CTE*?4YOP4< < < < < < J[
MZ\>L:[Z6<_UM6TV X!('FE!>'-FV?K>PA7%G##:I28%C$W'L=NSRKEUL"OE6
M468_ZD42YK745/=RI,S[>Y]DVK&4HS2U83C$:]+%, OIN48;C626=++QNQO:
M2LM9U!/1$FTTJ;""<U;)1&L7WXCWJ$G=C.[F+^U/QP%GZW=)S&UCERN:CD:J
M_*_A.R_Z]NW?_EW[\"5RO:+[VL8RZES(539S*ZN+<6$2%)D0ZF.>)'/9R@A>
M0$$4B<8$..265K ,-*.$ W/1YB#&CG(,_E57BNM'?-M]:6*]_3-M;R\U1N6V
MR3&9F&WL[J>VX:SQ>PL*JUF4LA7T35AGL:.9854LC6-8_P!V%,D![/1J$545
M$4QOS[-*:[>M.998[P4< ZBWOI' >H[4V;Z3VC E6FO]ATQJ#*JV#-)6RIU6
M<@B%C"GA:X\7W5"UA""[/42O8BHCE5!'./X[3B:3Z''.F+IEU+TA:;QG0VD:
M:90:WQ EH2AJ;"R/<2HBW%E*MIR/L)2)(D(2;-D%12^3T0BHY[U[N4(ERU6(
M^UHU73]2 X+'[WZC@#@#@#@#@&BM1R=G(BHJ*BHJ?RG;_153_OP2)O;G3Q7#
MFA03U2=<NL?1AW15XUL&JR3(= =6F1W.8:SQ;#"X\Z?J79J6]6#9D5T#(+N@
MB5VL<FFY#!S0$F-),RFR.;E '160I4)HDXS3-=W;FNI)M*:77C=0]*V<OM?)
M36\*]K(=K72 2H<Z.&4 \<X9 7B.-I1JPT<A1$3P>W]XWN8[\M<YJHJB)RWM
MM&6GUZK<R?!H< < < < < I<]038$B\V9CN.8R#,,#R' J>RM;W9FN<^TI1[
M<I,9&2)8 FTE;F?5MINF#B5DKYCXY-F87G]8^QK9Q3X.*.D.=8HK5TC%=<3T
MI1F;S3.8O2LPZJV52F9MPUW9!N<%Q*VC6,^WC66/U,V/:6IZ259SPR(02,ES
MY&-E+CYI<AKD*<E,4E:XCG.B/(%6/<"K+43:8I[Z1G2;0HE[5P'=DKJ3QC/,
M8A99:8;4P<>D#/3YU$IZ*OKZP.1IE6,V.'SLAJXMQ;Y1+F4QJ^S/4SHK&1O:
MEVM6V&)I'2L[_=ER VE>BRU272M*W>^*X.K]>ZEZMZ3+MVV6(Y.+"96:7S;Z
MGR+>[";@I@RY%S(DRZC$L5PG:>-MK\8#3D "$L\N/64&Q&0+8$^"K"J(_P D
MFJMIV[.%N\Y?>AFO3,C97#U-N2+G-M27N7 ZG-N,O[?&Z:9CU'/L$=0^Y(K*
M2?<Y!,K8SF^*-C2+FP*Q4572'=T1K7GC'BA566K..ML[]6RQW@T. . . . .
M . . . . . 0BZPO3QZ5^NV1K63U+8'*SEVI;.PM\'$+(KNCCUL^T)7$G%D@
MIYD0=F,ZU4)KXEBV3$>P3AO"K"D1SG.?!/F:[XGMG;=&+F] ^!XF_P"X=-&Q
M-H=*5JU/)M9J7(EEZND%;\L^KTGFH<GU;%"1_P RW8QC6,V4EJ_-HQ41>-=_
M'WZX)55;4)5ISVMN5T0=M^MQJCKSD8UG6G*'J/Z**#%!?4YCJ:EUW@F19.CH
M0GMO:RKS/:(IC,U#-4P[+%UN!54D(B%J1C:2*P];Y_E+U2])%,NJO5TUS;=T
ML6K:]ZV^G;/\@!@Y\OF:TV<9%3_TIW106^I=B/*SX*RLH,WBU*9.$3N[5L<1
MEY!4E5JNCSS#5KW0L^/,](EDB<8S?#\U'8&P_*<=RD-38'JK4N/7=9=#K;.,
MO:173WULF2V)/ OP:(=6&&OP]K5^."+\DW'/OT.4\&AP!P#SY^I] Q:VW2._
MPS,M2TF6X]K]E;F<: 71$?:ECD +8*0J>[F;<I9Y$AQ*.WJ+S&Q1[&NBM%59
M &>YQ9]-X"3ZN*IYI7K\J5K>/J,EJ766"$O70WW+\3H76;Z^2R9 ?-6LC?4/
MB2AM:.1'<3NHC#3VR-[.9V:J<4=M%SGH%G68=4[/#6*YKZ'8O!3#Y!%C3:*X
MAR[*53195;-CR+:#.?5S*T!HY!EG1;$;QO@2(S'.,*6TC'1R,:9'-5G=!':D
M;:=7&D>Q7?Z7]76TNG-OU=1DEKF%;"ZFMN!AY+=Y 7*K:X"A*-R2YV0'*<MH
M9SG.:LEYR.5K&L\NS$3@*9>E(M36S>URRC@HX X X X X X X X X X X X
M[(OY3OP2%HO!U!NK1.K.H+!KO7VUL.HLNH+JOFPE'<5<*P-7%EQB1V65666
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MJ321!0/=I$:T%3,BPI4%GN>YV":(!Z*JN]M&N15!.K4:-]]=^D]2R[@HX X
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>g105868g87w79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g87w79.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1(>4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $@*^1A X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>K.D         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              C@   DD
M 0                         !              ))    C@
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    C@    !29VAT
M;&]N9P   DD    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M C_P        .$))3001       ! 0 X0DE-!!0       0    #.$))300,
M      ?0     0   *     G   !X   22    >T !@  ?_8_^T #$%D;V)E
M7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,
M#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M 0T+"PT.#1 .#A 4#@X.
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MBC)^-<_*6*!J^XT94G$!@.2#\?80A5;SORUZ)WO?<WJX(, 8 P!@# & , 8
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M24VE>D;W]=ZP"J8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M8&1< 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M:Q/37*+C P8$Y5H=^#$D0)J U+^I +[S^TOL.;^'[TK]%)^OIK!/4EK@# &
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M (W']=F2GR82/G1&3&'(^*^6%':22QIIIUU7Q]H6UMM'LWI6]A:^_73V)H8
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M;B=[UO7JE6_3>MZWZ;UO6 2F@?Y#AOZICO\ 0V<BV7H"JY0, 8 P!@# & ,
M8 P!@'%:T-I4M:DH0A*EK6M6DI0A.M[4I2M[UI*4ZUO:E;WK6M:WO>_3 /#'
M2T5,-./Q,G'RC+3NV77HXT8UIM[24KVTXX,XZA#ND+0K;:MZ5I*DJ]/16M[
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M+$6ROOS,H8 P"&'CCO\ A^\S]>GX=(H?U_;_ &DI_P"; )GX P!@# & , 8
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M\O0QMXWK0OOOF>I"M+3^<BB:TI.TJ3O^TE/TTI/KZ^GZ_K], FC@# & , 8
MP!@# & 6#U+HE>Y+SNY=*M1;04!38$Z;/?><^$A6AF_08;3F]*TEPTQ8X3.]
MZWKXQ#>M_3> 84\/>?SM0Y"U:KP,Z/T[M$[*=CZ.DI'L.#F[I\$B'KA:=[7M
MIZGU$>O5<D=#BATR,4>2/I.BU:V!*G & , 8!Q6A#FO:M"5I]?7VK3I6O77X
M;]-ZWKUU@63W5S G+_%CQTXI=^C])Y/QNAT&]]<E$S/2+16X,<"5MDBAYXE+
M\B\CU2A&BB""OE@T#"_-$/D[8^.\XXH&V]&[KH]3*EUI56Z-59ND7:&&L%5L
M8GR$W#&+?0-("?%;?^ \L5Y@A*?BLMK]6GFU>Y&OTO3UUL#%#GBUP-VTJNBN
M=@:LBFXMO9S<M8V6/6&$4!'/:BVIE$2DMD-6QG#4@Z,*:TE);[_L1[0/%OQ+
M\??B3"T<_P#@-6%C8]A %M5V$B)]O48S#LJG84:R-1,P\'&L-B1Q,B$23&(V
MZJ/=&<??6XWMY.Z]1_@R-R[D?.N+UQRI<RK3%5KKA[DEN,'.E9!I!3@XHG[R
M[,'R)(XK0H8S P##S8(C36D"C,Z4OW 9'P!@# & , 8 P!@# & , 8 P# ?D
MUNJL<9MTI<^4/]E@8$5,\73Q)>CUPMK45[R56 :S]!MU%K]9<@6DNG*G_P I
MXT^-:2Z\&YM7OU@?GOD89\*+_P 1O$'=5\0YY"TB)%E(URP',]?XKV&T669(
MC65:+M%@Y%U[M)+CX(_L !=N5M1+K#9;0* P"EI.A6K/^K;>R\_>Y*7I?2JI
MR2GR-ZNK\H-78IT%DU^'K\Y93&UR)K  N_NRO1\E(? V20TE\M0Z1 V][?+?
M892IS0EK_P"4ON84LGF1Q.K3S]<DC+6]([E'*U"[C:;.R ELO#$>-+&<^JA0
MXRFIBY@Q9HIY<0WMM#0SR5Z*7M*TH%MZ?-$=_/WRAX= ?9\]?ZG:KN/4:;<J
MI.TR%.LD?*QQ"K@J6*K3E9+"T$\2)*,S\:?%.?%1H-1(RG&"WA7&2'>.I5A2
M47-R_=)1BHPG.3;Y*,(REYMVLEJVD;>#P.)QTZL<-&DW0IRK595L3AL+3A3A
M:[=7%5:-*[;2C!3<YMI1C)Z$M>+>1'#>Q<LJG1^:]5I%LI4K6-2P<\#.AL#_
M ';$C-MRAI8YZPS8YB/VC:S5R HNAF5-ONZ0PZTXNPJ1J14XMV=]XR@TTW%W
MC-1E&S3_ -R3TV,,7A:^"Q%3#8A4XUJ:@Y*E6H8BFU4IQJPE"MAJE6A4C*G.
M,E*G4E&SM>Z:5[[Z]R9-GEZ0KJ'.]7.OQ#U@GJCNZUK5GA($=Y([\W+P&Y/[
MUC8A@A:&'I(T1D)MY26EO)6K2=YFL7(Y;*JSM27;-7VE(^\]KTY,QR-HU"2(
M4/,[5I1.MI^Z9:2CHN3]?3Y"1/""*^$24PTX']?7;Y\CXJWU-&]:79ZZG>WR
MQM:5-1J=[) F45TX?6MDZWM\*P.(@BVO[H-,K1&/)0:K3&P/BK?4T[<2JT5U
M.V7=L/:5-1NMM/:EE0.V7-;)UM#NIU*H7;:O1>I9*H[>OG-;9P"BA]3YC(R4
MA"Q_1J&?,1+NF96)#M]?*DHQY16@=,R #$BLH)W9JDAZ;)::7LI6A]:^-O2,
M KB;;5%[:TBS5Y6WFVWF=)FHU6W6G2E!-.M:T3OXC;AB5"-K3ZI64E0Z=[=U
MM&@(P]Z\[_%KQJF^95WK?5ZW 2_8)EN!Y^(U*19CD](.2"8K6ATH/2KY=$@O
MY1TM*5CLD)4RZXAW7LS@K5U1<$Z=>IQR45\&C.JHWYS<$U"/64K)<V=IEV4U
M<RAB9T\7EF&6%INK-9AF.&P,JD4F^'#QQ$X/$5':T:5+BJ2;246=_1?.GQ6Y
MM,?DF=UN%NG0%DM L<OY )+=GZ<X>23L(01^A\N M=CB=%&IV&V;.@Q46@C2
MD$',Z0XI'.=99]'ZO1?-Z7VTO?5=3'"N_P#E!UQ&V>0<CYYPB )6$RQT'RBZ
M+7Y:U)U*%$ Q1D/P/C$U:7)1N3+$+&#CKMV;E4ZHD4@5R)24R\.V&B=F[^G\
M_P )^Q%[RK^R\YYY^\VAZ!Y>>9G4>CF!V>LW."&YL3R_EW/H.5)^]H^/>JE
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M<CW+[1KL]#/$9T]LAM;5:\>;1=&"?AOJ41H%%M@M)>VI:2F7-^_6Q\?&U/\
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M3*5G-;X685Y9I1Q&&P]&6+I.EAJ-)WE5A>U5/CJS<MMN>A/C8P!@# & , 8
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M>P/\APW]51W^B,X6B2Z JN , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MC_UC*K.;2\DTBX,S-88 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MZI_EMSK_ %M__,#W^_?>SV/O[HWNW]##JO\ EKSK_6^"#?D;W;^AAU3?X_\
MCKSK_6WZ\%LNO7D^OYW/G[H[NW]"_JG^6W.O];8"2YNWLRC\+\O+UWB"YO=:
M_P"+O2X?GG2X^'FXNY2UEI/RH%?FF$$C2YT:/)+D?AH86AQP9II1'U]-)WO
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MW>K12&U_,C/I3I2$:6H"0F , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@& _(V]D4:B1R!:Y6;01=+G4>?(CKH[MFHHU;YD>*678%?(R6E@"I>VZH=
M0;VB5)2UI/JK6\#OZ%U\6OSO3^8U2[D13$*5+C'L&QHCRB0!SH27D($Y464M
MD=94.07%O%0Y2QV%DQCPCZF6E.;;2'J91P!@# +>MIAL=6)V0CEP398,668A
MVSE/@UYIL9I3Q+LR8,,8^-'M#(><)>0*][&T[4I&TZ5O0&+?'&SVFY<DK-DM
M%1JU'W*(+?KU>I[QJH@:I_-O)K;Z1CXB#?C23(K0Q9,7N/:T"Z\H?7NTCUV#
M5M/GZ\_J9SP!@# ,>=8MLY1.<W"XUR#&LDS7(,Z6"A3)!,4,>X&TI[;+QZD.
M_+HVE*M[7IMQ7T]$H5O>M8!%#FOEU5K!W7FO!X2 K$$5=N5%=-L_RYP\<8U>
M)B K5X<AH2%:%:<F4KB9\^8GYTCX"ENK#VW\X0N2V&*U:_D[???IM]?G/+!!
M@# +1OUC>J%)M-H'^Y]/0$'(2K:[#*M0<"TH,=;WQIF8>TIN-C&-)V\<7M#B
MF1T.*;;<<TE"@]=N9#KE_D/=)P[ELC(<IJD,SV6]VNOS-OACB!=3 %7$6BL6
M80<^'CIJ88F8UAO8;\FRTVP!MKY-]X=2,#OU[_G3F3SP!@# & , 8 P!@# &
M , 8 P!@# & , 8 P#%-.XISBA6^RWFK03L?8K6AUJ4(7+S!@;(Y)NI(L6)B
MS3B(V%$+D=?/D#18HK*R=[6E"=*4G8B5M#*V"C .AXH4?:$D$L,*<]?AI>>;
M:VOTWK6_9I:D[5Z;WK6_;Z^F]Z_;K ._ +;JU1KU*CC(JM1Z8T&0L=LMAC.G
MR25$3]WL\M<+-(./%O/O[5(V"<DC$L_$T.$T\V""R, ,*,R!76"A2?=\L2P1
M[/3W_ >;=]OKZ^GN^&I7M]?3?IZ^GKZ;], [M[UK\=ZU^KZ[]/K^S //\Z'\
M;Y?YL;YCU]/@?':^-ZZ]=[U\+W^_U]-;^GM]?IO /!8(")M,))UV=$2?#S C
MH,D$IQYI)(C^O:ZRIT=QIY&EZ^FU-.(7K]2M8!8,!P[D%6NR.C5WG=2A[XBM
MIJ;EKCX<,>>(@M+%7\J=(MMZ*.>7H$5M9YKCY[K#"1UE*8]6]A[O3ERU,K8!
M\]=>OIZZ]?3>_3U^OIKTUO?I^/IK>]>N_P##K /N 8KZGQB@=E%JXE]CY4Y%
M,LK-PK+L39;'62HJR#QDG#CRK)5<E(M]PD>/F))D?;ZW4CK)V^RELA#;J [^
M1=<12ZW!3LY9HR/VQ.V46%#G))91A#\BQ7@U 1&G]$D.MZ6**I36W6T(<?WO
M:R%.N;]^ 73@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8!0+-5:Q=
M(<BOV^O0MH@BU-+)A[!&!2\8^MAQ+K#CH1[+XZW&'4I=9<VW[VG$I6VI*M:W
M@%1BXN,A(X&'AHX&(B(L0<",BXP1@".C@16DLBA@A"MM#""C,H0TP.PTVTRV
ME*&T)2G6M!L>[ & =.B1]N[8T^SM]/XLZ=1MW7T]?JWI7OU]/K]=?A]< ZCP
M 94$V,DPA)&-D1" )"//'9,!/!,96.6$:(0AP<H0H=QQ@@=]MQE]EQ;3J%(4
MI.P.;+(H(S0X[0X88C*&F6&6VQQAF&DZ0VTTVC2&F66D)TE"$)2A"=:2G6M:
MUK .;3[+Z?>P\T\C6_3:FG$.)UO]GN1O>O7_  >N =OKK7IZ[UKU_#_#_P 6
M >?18FW?@:*'V]Z^WX.GF]N^[]GP]*]_K_@]/7 !8@IXSX1PPYH932V"1"V6
MR!B&7$[2XR^P\E;3S3B=[2MMQ"D*3O>E:WK> >!F @1WHIX>%B&"($!<7".L
MQP33T+&/-CLN1T4XAE*XX!UH,5I8@FV1UMBCH4WM+#>D@5? &]ZUZ>N]:]=^
MFO7]>_V:_;OZ;P!@%+FH.%LD4=!6*(BY^#E&%"R<--1XDK%2(J]ZVL8Z..9?
M#+85M*=J9(9<;5O6M[3OTU@%!@N=<^JX<9'5FB4VNQ\*6^?#@058A(@.).*U
MM))L8+'@CL %D:WO3Y(J&GGM;WIQ:M;W@%Y8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# ->/E7RL^X]QHEKD_&B6\C*='<"['31!HQ7)].5/I%EN?)
MI.JRC!/3+W2GZZ<Y$5ZR:%MU:>>D8;3;B=$"N%,Z>%Y/7IIUW^Q#!ZQ?:(<!
M#5;>B&W69J_*N3UP>9#-G^22\'V3IU&MWCO'1M2HTP5(1EQ,LOD%41.X5VFQ
MA-9",UTBYUD&;GCY/[H"$+?R^O-/>]M/KJ1K:U^77376^][+=Z:)];DS/&Z!
M\Q:QWB6B.V3-QO/.V^9C-&W61<YI TK\X $-RL1+=5KT ]*VZP"6*:UU&<$F
MC44-VLI2=7K)6)T4BASS2V_?WMR5]%]P^5O?Z[\NBLM]^J(Q\6\.^]>/_&N&
M66-<G(R\ET'C]&[USWQTJ7*>>W!N%K5 N9<O)'REMN5@IW2.JHZ;+UB/L-_?
MF8]4I!1Q3@HWW>Z?MX+*[LK+DF]MDE>VBLG<],)3/M#IVV4AKJ'YTY*/CK7S
MBRW8RL6#C=2KP+D,='#2$5!  S<L?<ZX:R;(R,T4@NFR3( +XAE;EI!8+F.^
M^7L'Y)?7IUUVTY==R2W9?&<T_N=Y[%S3E-,#NC_#@ :CTH&L\U3:@>M.7>;=
M.F@#K"&\0U9VZL:SZV"1&<'?%V@!XLC2%!Z!OK=VTMJU;I;^.1&Z?KGVDD-:
M[)'QTKU6RU95@?BF#8\CAJ/;0WV!]P4]&'FS<1('6@$W1/Y0Q+$+!NGLO-(;
MFHQD=;ZQ=/+WN^7E;2_G?\T*#YC]HO)ZD)0RP]HJ5AFX04N8*:L7"-,$3$+7
M[!'0@ \:\9;H^)W\ZJ))DF8_W!F$N_$+ECVD.N:$;2TWTO>S^72^^WRZ7<74
M_M*8SJTC$@VJ^G\XBK/'LT&=VUQ"55,5=R/BB;<]T1\F8K)(Q3D@1)"UEZ.@
M#'QQ6"?9&K(;BTOB7TOKYZ/Z<_HN>FYF+QWYIY65OOM5L'9;%TZU4D3C<E#N
M2<W8N:D1C5^L$;RZ5FAYZ&JB(DA\86<@K>U!'!Q!"8\PA0K)OW*8QK8KMR]]
M_/17]GUOHWR-EF , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# -/?0>-=S;N/9YWF?CU:6^T$^0QW2^>=[9M?):W$F\ZC*E".:IA$Z
M7>3+F6%<-1DG1 *Q8:!(UB&F9D6SRP0H40W(I=]V^WS+MYNWM>[6U^2U>W5=
M"VZW=//VM66NTZUSUG%D>H=435*=%V]CBY%EB^>II/,[=8>B-C59PY\B+J\]
M$]7I9Y\L"'MJ3N5 ==KT>$XRA+[7O?1_?UVV^A';EKH^<ES:\NE^>_G8RO4Z
M=YE73QZ\DN>]4!N4Y;)J.%C>;SE[)Y+&%3[Y+(6I9MNI<]D]14'&L$((^;9D
M.A3 TOZ/?=!\> 0..T[ZC2]^3M_V]'O9V]EU\RB+\<O)3A(0Q/*IR;.U=8Q1
M-AK/C_3^7\UJE7O4)50HJEJ+IO4+E;P6*O)2NGRNA2]6G'9:8>227\F/O86E
M![7UYOEIM;O7D4JB5CS^F.M\\+ZJOJSU1KEXKD[:#XN9X?6JZZMWT"E81NJ0
MYLW,3E-":6])*F&K9\Z0UIMARLL2/\4.N_DM_MK]_0RWVCQNMK'4NQ]7XGS6
MN1%\/XDD3G%YBHCG;<T+UEVQA;>E@$65IX1JP(@M$[^^9N/6"ZTC0SQ#WKH=
M5\].G+[?GKYDTVMY\[7O??UY(Q!;8W[2& N_0 H$_IMNJ0\ZU%0,@&]X_"CE
M<^?35Q1K3!GF#A2[EXC756"6F8<RJ-(EDL2L6 /#H+JA[4W[_M?=&2LK=+^;
M>OJWMRO[Z%M\]YW]HM-6T<VYVSME.:L,;J+M<PS)^.^F1XBGI\SE4Y@&&UJ[
MQ\-,R[\GXSNV Z'%.(DOO(ADZ;<9B9!V'?XV([7M;SY^6G*_UY[V/3)P'VHD
M7)5Z/%LU[E85V- D4SC0_CY*2[/19*@<")-C+?'Z74PU\RBKU^>]I34,L.14
M*F1%;F_AKYX0M;;R?)WWOYZ\[>VMK"Z?)IMWV=DK+:_U5_R9#@.<><:NB>/,
M[?+CU6?J\?;J+<>J1H<OQ2.$A)-^"\F*[98=(4"!#E2]1#9G.)ZE(O3\^M;3
M:)N)<?L ,J8*Y=W_ )Y]VTFBTU>]G^[KSY6LG:]WJC:[@HP!@# & , 8 P!@
/# & , 8 P!@# & , __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>g105868g88t46.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g88t46.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2,D4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (PB^B6@X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O
M;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U
M8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M                0FQD(%5N=$8C4FQT                4G-L=%5N=$8C
M4'AL0%?)1\         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              U    ED
M 0                         !              )9    U
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    U     !29VAT
M;&]N9P   ED    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M C_P        .$))3001       ! 0 X0DE-!!0       0    #.$))300,
M     !C6     0   *     X   !X   :0   !BZ !@  ?_8_^(,6$E#0U]0
M4D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M86-S<$U31E0     245#('-21T(               $  /;6  $     TRU(
M4" @
M       18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP
M=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     4
M9&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0
M   D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M!#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M    $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV
M-BTR+C$
M             %A96B        #S40 !     1;,6%E:(
M      !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:
M6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W
M=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
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M"58 4    %<?YVUE87,          0                        */
M G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M
M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H
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MWD8B1F=&JT;P1S5'>T? 2 5(2TB12-=)'4EC2:E)\$HW2@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
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M(+=?]$?R'IP$Z-R2,;$WU? /<D@YKI]1Y'MCMP0$MZ/A)XNYOD^=$G^B1Y$
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M_B?TX01GY@'</>>8%%QQ_5^%@;S8L6%Z#R^S&S2YK:BI_P"$?I']?_5:UEO
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M% ]BDB@;@X."/3/;A_IGU/\ EX'_ /=A3]=X'_S-_);.M-U;5S)Z7!25_-O
M#LE2M/KZ 7ZA"4V^HJ(\Y"0/?/ _AGU #^;P-?\ G88W^SK)^N\ LPQV9\,&
MH($G-C%]%$372#I%K3K#HQJ4[=-UT>-I.SJ+%J=$&D]\21<L:_K+J-I)*Y+M
M%93'<IB*@N4PH,S M2>@MM ]1#\,^I+_ +_ # $ ^-AF[!JGTYJ#Z[P:MC8U
M(PB##USC/C1<S*-\/BS:/ @3!S"734;TTV?TQINAM9G<O=WNT2V;.TOONK7]
M2Z#>]#_"MO7E,JE0KDF+5JHW4:05QHL141B,]\Q9?Z7]3_GX _\ YL/P>QSU
M^N\%J>)2V$^KCFNEO)!%L+E/TDN33NMWW=%_5NY-6-0M5:M78&C=]6Q $O4.
MJ,U65$@T5%*GQZ? @2$.L1V&YSJ@TD+*4]7#_3/J';S>!2OYV%MLWX*_KO :
MF/4>6F\B/@J8G_"7TJ/44RKM4$JZ>I.GM\J3OV65"@$(;400E;G0DE*AG;A_
MIGU,?N\"?_G8.7\)^N\"8\2*_LZUH3 UX*A?,UI2A+BC(O$AKK#G3IQ?J@E2
M$A10%IMTMN*Z5)(^4M8^H;@]L8OH/&PXO*<7@O%/%PFM*3T7;P_'\/Q<'GP>
M9G:<)!< $C*XO5.];%TTF[J+#K]&,U5/G(*V/Q]-G4J6 .X=A5)B+*:."#A;
M0&^,Y"@/)XGAXO"Q'!B9Q_B01WNW)BM^<:\EL&=E>#GOW\X&WOC'\>,*?YWD
M4BYN1WFDW((!QCQC?&XP?0_X8/G@L0\^S/P!!&C:;GKW.<8_P!]._;T/!,J
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M6IV_[3;;BS:A\T4R')6:OTQY54#+JH##Q2[(#:D)2'0E"BSY#DS&Y?VIPJ>
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M]R-AT^A'!%M:FDN12A?2DJ03D]>%=]TG)S^G\>'?+NB9]]_:J;>5 7\]XA_
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M8 O35Z@5H4I[X&VY.<^<9/V'^X^."GJ&:F=&OW$NE';.2 ,9]\8W'G!P?O\
MEC@F5[:<#H^SYBJ;'/YD9WSX!WQ]@/\ )*Y7IT=Z/&MZL4$8S@=CX[[X((SV
M)[''WQP2.<MP8Q0-40(NJN^-^X.^/((P<?X=N"D#61%8O(CC6X9(-R2-@3W.
M<GUP/0_Y] 0Y%GOZ;QR.1J5)P,@;$9[>.Y!\#8[>^?S*M-9!-[V(S+B>%*A
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M!,L^AL=0D-1T43\1\MM*0IMD/J<2HDA:0E)!)5D#?/#IO]BHOIC^&+KOK;S
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M$?*:N=0*@\>CU*/<'<8./ & 1_(;[Y.,X[\%/2E:UJ2[.Y,@ ATI&Y(&Y/\
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M4F#$BMM1NII">L]#3:.M24_+Z<I)( QG'$) =[7W2;-J^7SZKKCRBE1TI'S
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M%B*F*W< .]#[RA..H^N/'8> 02.X]O?[$RT$?+B*F,V:M53[@]\CT]1C^/\
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MJ5A.D%MH"2 5=$+\L$01G;'GU&V.!:S\2_L%9D<B^(": CS/-,Q$2MH8YB:
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M,O$&=C_EH;YV"#8^?"O^43[[9P/?&3Z^A#]LA&3U@/Q$.R.K!^D9'I]6?XC
M^W!0C/VDMOUN)J0ZC8DY]CG;<=P,#)_0?GX(;6CU)(=Z5&=:O"7R,8[C[]/G
M(^^W;;VWX*=\?XWZP>W?'?()&<@C??'\<9R>W!$G5G;O[]P,]_ V SW[=L$<
M%6[Y?SDUWA&,]]^_;.P!/MOOC[X[;;E$$9W\_GVP3@XWWSOVVV&_<B4X[9/I
MOOO_ "R?&?.^-]R(R2>V !N<^#_O&,_IZ\$2;G/L3ZX/KW[8\> ?UX*QSKI-
M1WG2"D.<[;^^^1Z D8V/Z#[8X)8V]S.=P_"E2"@]QD]NX)\X\;Y./7)]LC@K
MGE('ML[;F79W2Y&-QG\O/DG.<'\R?/!0[_ O\P!H'1L>Q3CW!]?3('MG\N"K
MYN7V]:UEFUU00/OX/<@#V .1[ ;8SP4K[9G>QO-79DIZ3D8QGSC&<;G_ 'YX
M('K6W,$-RHDS]QD'?)[^VZACU/CU\<%?G0Q09.8@&LD@70# (&YQGQV/D>>W
M\1MP4J7SWMG3<D9OHJP<C_H/\N"Z8*'?V"7@MHX(C@BC9KGRB\NG,O)MV;KQ
MI+:FITVTFZNS;4JX&):7*+'K4FGNU!J$[%F-/-&6BFP1*2E?R)JHH,ED)4E"
M'?JI>-:TL*;"/9U?HW*CR]6[3Y5)H.C5@4:D2M-4:.NTB!0XS%-=TP;<J\I%
MF/TUM**>]1/QM=JCYISC2HY=FN/]?S0""2VPW?J)B=X-4WM+^'YR>42];<U#
MI7+QIJU>%I,V]%MRNRJ.)L^CLVK3(M'MQR,[/<G@OV_38%/@T92D)<A1H4=#
M;X^4G#OKWF@>^M&[U'!SFY%@\L>B&EVH]ZZK6#I39=L:AZA+6]=UYTNE-(K%
M9>D/N2I#BW77E.01(G+<G5-BGN,-560\)$I3C[8Z"3!Z4%ZU]YLN?O.?!J+N
MJTAN"4E0@TIY?SL):PF$EI82MUQ0.',X0'%J ]0.!KR].XID@I>"1UNWKQNH
M:_LVY"?I99(SW2A/3YW!SC'H?;[$0DB8;7^-_NJMTLV)66JDRN4EIIL8!*$#
M(\;XSW[[?GMP#M)<]]V1.==XE",V65H4H)&.M"@I0./4;G'8@^G<]ES]K;;W
ME##/'N_=H3:@5M0R&T@'ME!!V/D$YW'^T<" :]]WS4<&A!65HD:I*J#2GFT[
MJ 42#Y/MMZ#??T'CAH(X1[)QUW'PFRYP](YNKFF)M>*(LEXN%Q46<RT[&4DM
MD'IZ\ #/<$@YS@;@E[]\^[15P]J7PV*FF4I]%KT'YBU'YJH\=I+><=/T!*_(
MQU8!&<GTQ=T6Z:0_#[N"U;]H-=C6]0&E0JO%F...1V?GH;:4WDM!;B<+'2<#
M()[^A)%]!M;A24V(Y&.4E%(9AN/.M'Y?S6V$M]*4I!'0D )"@, )&=^)V.CV
MSY^@S&UYNUWTA09D:9U!:G2C]GN!9)!^6T,Y.^2L]0(/G?MG]W'%1>2#I--3
M+;?=A4P.%QL?.2A'6LA>4C*%$?2, $*& C<@Y'!%T#I-/<A6<U3PM#3B:?\
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M%'Z7W[S1Q;$6&MG H!:+!WK!61P<D X/C;&01YP-CY&?R X+&_J[6B9MRJR
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M0K_H]OU>HU"4IUXITW8NJ;9D&ELI4C\- D4ZIOLX)#A4>E%:K:N16!H:6?\
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MIV>8USR[;5;%[2[6I]R29\)B+)?DLPZ/6ZM\Q!8F1W"E*@HEP-I2I0<"./\
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M2K9*L9P 22<=\'OD#/@G<[?EP5%0XT'I\L8_<7>%X>E*UI60DH"0%$G*0<;
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MESYM*'1(KE!FRY;$]^W)JD]41],9;KB%#Y:% #CS_7_A^'Z;%C\OB8<>$ D
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M.* V[<4TRZG-*3):9C(K=5Y9X@"1>[N2]NR0ZM(MRAT1U:Z32*;2TRW$ORA
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MGBVE)"E/]-^N_P"GQS2<&G^ZE9X60_4>$SCQ S&E:/<')F:[J>@UVTG1A/\
M2Z,.HJ4A(I=<RI)6VE1 _9F2?F/HZL X"NHX2"0_T[ZW_I\?/!_[ED_4^%;'
MA(K3$^KY9T5LZ^:3G=-VQG ,DE-.K7TE(ZBE8_9F4+"2%%*@E72I*L84,P_0
M?6"OT^,?]ORMX?%P8P\8F+.*/5I8WH5O]LW;;]WTTU:WJ@W4*>)"XID(:D,C
MY[;;+JT=$EEAW(;?:43T8^K )(('FQ^'C\/%Y<>$X<3.Q:F<.++H,6&Q W(V
MS.3-7->6_$1G;(N]J;&7,AN6W6FY45IY,=R3'73Y*7VFY!4A,9QQM2DID+6E
M+"B'5D)0>,54$'%+R,X#W=J:47$WX:3UR7KJ%;-TW'J99MXV];VD$FAZ4V11
MH]1C7#IQ:-<D6]+D4FX*P:%2Z;=]4@1*-1Z _5E2'UO-($FGNB-^(+]$=T.:
MT;Y5T:X-3R$+N<_%2\@!UILJ;="F,)#G0KI+:7?K&R_E+6TX4E)++CB,]*L&
M+/F#/N=6D<P&K6DE8UR@TXLS(YI4)3502HU".&F2S,6[D.F2TILH=6ZCH2Z\
MH$J'0H84R#P0D1(LSQ&;M%"X_@W&*9&:>#RJ?%0]';#$9U$:.%M1D*6$!M\(
M#H :Z4J9!"$ X1D$\$)<,"YC0U8&S$&H]%!+FR(_X3GP_3X_K>U"&?<6 LX_
M(#/Y_J2V(;@"U3.3N6&HY="<G?TW)V'\<G._Y'';V++"-6XQ0,&K>0]2*$&.
MG<#!R>Y'Y8QDX]=\8[[#@I.9/!X>*FXM#P&+DI,]L8SG;VV^G&>G;VW'W[<%
MILW:'M$@DLY?.A,B@++U8SY5@9.WI[=\9/Y>=N"C.SP \35YK.0AY(:252!G
M&X[^>^=^Y[X/C'V[Y/!-\LG!I(#L6Y-(+ !5DXZL^!E1&2<X'8?;..^XWQY*
M,(J:L*0'[)AK:6%.-J2M"%I4M*?J0E04H*4G("D_44*(&4]0&=P =^"H!=SA
M]!L]!O<-P/'#XS?/Q>WP_.5@ZF:1Q:;6=5*G=E"I-,H4J%'J_P" H4YF8FJ5
MFJ4UH&4BD19,>"U*FN(0RDN);2\-^EWU&A6P(%B);@1UE.I\,2^;MYIN7#2?
MG*UEA23JCJA0JK)IE+J%-33(=BVRBX:A3(<"V(&/[%%7BT^-4ZC50VV_5&)[
M39$>*VW%:)BH1GSRXFC#F5U!5CH42/I"=@#N0,X[^3X\[X[\0E@3D'7,%B,W
MFH$MJ.(8<0O.EU& DC /KCS@]\'N#Y.Q/$&($@ %S;A[K9!=R6%V?T<\=N*K
M4X@H=RL ALJ.5=) ()R1G*0< 9P.QZ<XXTH 006H0>4VK>AG(0$S>M^I]'T=
MTVO"^ZFXM0H%$G3(4!IM+\N=.9A.O1H\2/U!^2Y(>0AI#<8*<4M24I'6=OH_
MA7X6/Q'Z_P"G\+R@_F8\(\3&:8, Q '.6<@&NU>?U'C8L.'$"10,"!.H+/I$
MC1X@%RD\U^L/-LJOV[+I]!L>/'IE'N"3<=M-39C@I==4^EBEMNNO*8@7#&CQ
MB9:'#U1WE@E&V./T?X_^!?2?A'AX/$P>)B\3'B!PX,.(T())(DD@4:0(< %<
M? \?'C+>4:F3\-68EH==);1L*B69#<C4B"A$F0I3DZJO+5+J=2=ZBHR)DQ[+
MSCJR<J0I2FTG9M*!@C\=B\0XS))'^)C3?8E>[L=\UN@0>R"/IZ2"O*@5'][I
M3GZ2!YR #G? XQ&NGWCX4EOL9X5'78F%[L8.=\X[YV[>20._Y_EMP7+J,F+P
M] "::D$\2Z '!))[[D9S@=\YQV]L_GX(^U(<!@Y% Q$YEG!>+G4"D$*VP2"<
M'.Q';/C_ *>"H!<P#FS@0QEPS&K#A"C=K92KRETFC_@H]4J5!9N5MRYJ;:KZ
M8M:J5NN(*FXT=:G60E<>8?FOD.I4IGZ4DDXX]_T?B>'AQ8IPC&<)\AQX7 +,
M]#+6#4>HCL"W=-C'=0O9HC O.#;<O^D+50C4I=Q/*MFFW Z)%<IMM#*H\><\
MEQU*GA+)>ZOF+(CE*224XXS]9XGAXO$< >;R/C. -A.,@!VT#ZSJLG+NSY1V
MQ=BU//=9UWZ@Z#ILZQHP=K=;U3T3BR&G6Z@_!_H^WJC:S]QFL(IDV#,=I1H,
M:I)D_A9+;BF5+3TGK"%>/"/->S]]\% TPT3NU(T 9NDJ-CFAW,#86J5$M[2B
MIV=:-#IO+IJ!_2AV#;%;>L:HW34+\MZI4B);U,DUEZ92K@-%9?0Q.?F22$0I
M*5%*E(2N4^UY<TKP2@>32M103$-+\<U#71NQ;[3:BXTFQM3W.;!B\N49[3FY
MYT2OHB4:C4K1'EU@W?*JU;>>30VZ XY0-1F[V:?5+EN51-06Q&D.K96MG/?>
M^RKM;E):6[WE2(UUI_-'7N86RKJN.Q$4MVDTS2-O3*T[8GU:[*/-KBM9:]$O
M^7)NV&S2(5K55K3YVVZW-54(+K,BFP'Z&\Y+AJ$8N^CH]SIF_$9N;:)AFK$U
M8-"M^<;?OU=#H5O:&N\P-LW+!N230]1==HCNN$74*/4W(4O]LN1&$U&SZU4J
MA0?Q-'<GPK%0REY+#@@OOQFNZ;];=]E3YLB?K+/Y"JYIQ/=N)[F2M'0.F0:\
MEOYR*XS=%;LQV?$8I=0=*67:^(2Q#2XF2IEN>$%U]*E'#/M^;(6A[D-O8_=-
M-;='K"M!^8^R*' U.MFS+WF06M-4QZ'5*M7J33(EM6*SJ%*IL"I2&)2XJKB5
M<D]A+KS+SI-1_!-N?V =(USE-)&KVXK8],&-:+8Y9S:^G-+J-JU!C6FGVQ:]
MVQK6,.IU>P*G<71<%X.6I5_GKI3ZZ>M^0TJ>0H+"9"&4-J#!=]>PH68D,>KD
M2!]DP]PZS\YFFS5C.:B7O<T"T+M<;;OB]5670&JG9DFGUJ^*?$:HT.0EEIUZ
ML4RBT"1.'25%$GY["2F2Z4&;/KKWRT5BVXRG+OU6DQ+UYNM2[8T5YD+2I-RU
MRN-L1Z76G)5-73795H0H 3<5S1K;:4W3)595)_$2*) D-!M^0U]2@A25*(/Y
MO/K]F3YZ.\W%_2M=Z);VH=YW"]19\*^7+GM%=H4[\#08E*?I<2S9+,VF(D25
M3JF_,ZYL50!5(^<A81\C'!"'[L[D<5G>=[335[4#5^C4JS:+4*K;]5&BD>6J
M:BJKLQT,:HJ7=#5;8I<N"Z\TFBD.3TL.,K_![=1X9^D=\RCN)AJML]IO92QY
M?-.ZKH1;E:TCJ-R0JG>EPFZ;[MNF42G5=FS+/H[YB4V%;E 759-1DQZ=!J"D
MRRS/FO/J7+DEOI2!P'-WX=^KJ.]B&(%A!,S?@[PQRY9:A,W91:90[9H&G6M4
M#F;J=PW^=6=1FZ7<;UN5NA.S*T'Z2:XS*DP9$:LV\:9_1>GP8A$93,9#SC"P
MK!:4ON2ZTTT;4*RY6G%FWO95@1.7FDT_5UNZ*;6Z72KAU9<7:#41V#'KTDR7
MJI3$MW8[4I$>*U%/XL*0M_J ,Y]][G@H##YTM!IG[<%UB9Z@TCK&%]*>KMNK
MI'4?I"1WSV2!Z #;BJ8:'<\-'OF6ARKG!:1P1'!$<$1P1'!$<$6I5R@4&IK,
MFM4JFU QOF*2N73X\Y:4!LN?*:3)9>47%-I)Z6""3LD9...F'QL> >4%A2AW
MM6]C>ZX8O!PXL1)PDF9>)I!-C$D"=ES%H7.UHU>AY@&M*N7&\[ZJV@EWVY9S
ME*CVE2Z+,O*?<K9?:GTIBN1HO[-M>+'2])EUVIAM"F62Z&4I(5Q?U)((.(F@
M&^9<-T8)^E'^(S,Y6C^326F3/+!JCI5S2:2475RV=-H]N1)U4KM'D4BN4>CO
MSJ;6+;GNTZI1FYT)MR)/BHELK0U*BK<8?0 I!(WXP?J_J@2,.+%Y9:7#-#?Q
M%4_38!4!S,FAL-!NQOHI'BP[.#)/]$;;#>"M38HL!74HY40,,G)R2#V.<@>.
M+^K^K'_F8F:D^KL-BGZ?PRT 9L];R].\@("5OFQTHMGF/IN@-Z<OM;LVD5FH
MU^F6SJQ7:7;#-KUNK6S;IN:L.P*0M'[710X].2MI=Q/)_ B2AQCIZD[ZP_5^
M+7'B(Q7#ES4R:D'^H 4.\Z_3X6C"XL(+;,6?[[K>^4WF*T(YPJ?JA<&GVGT2
MFT73/46H:>M52MT:F,(N21!;9?\ V]2DK@LJ9IM0#R50@\E3LAE34AO^S=3B
MCZO&S#&7!,N0-!9FLYX*'Z8#^QW:(C.Y;@#UF=;$9B.RTRRRAAAD80S&3AM*
M0,!M"0 D(2/IZ1TC(.  <<><^+B.,O\ N.=)9C3)JL*2X6\/@X1APLP9R6+"
M]G)/++A!?G#YL*5RBT^%=-0T0O+4>VVJ56KLO2XK7CT6%1K(M:@.P3-J-3J%
M44/Q=8=>FM-T:W8"4SJHI<E4<J<04GOA\;&P'FQ",S!8A]YF\"0(6\'TX(,B
M##0\C6CF-R FITD^(CI!J[S53^5RW--+BAU=F#7S3[AJZ:-':D2[8LVVKXEL
MS;;"7:W0J+,H]UTX4BO34EB=/:, ,A!:6K&/ZKZD8R,&+&<)-7:N$/.I<&*E
MX%,8_IQAQ%Y$7$49AEU72QFB0?E)"J?!*D]25*_!1D%72HI!6DM'"L =6#T=
M1)0 @@<3]3]4?[L8C,PT  4RI%<IS^3@AQR.9=[S0D6*Y_\ .]SQZ=<EE8T:
MMNX-/'[YN;6BJ7<Q;-,I=9MBUTQ(5CP:#+J\V?5;B7$IK<=$JX:2V6%R67'
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M=L9QG /8>AX(QHUA5N6Q(AI#@O58RK5ZCT2!,J%7J<&EP8#1D29D^2W%BLM
M+45N/O*0V$ ))40H].-\$CB C$0 7)+ 7)V3REZ$4#@T@<8NVSL%&*3J+?\
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M/YFL9<V.3V"<R.I#;+;?3U%)^7D8/UY)Z?.X[8SM@[['AWUF,UKOLU;18VJ
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M&RL#8\:PR0:,'S;E4/ENM 87;(&*\WU,<[A<J^:V^KDGZ^:5W'0]/KIKEO\
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M23^%?D0'77&,G<%I:U((.X*3Z<6QW'NI<;'_ /'NZZ%8'U9VWW]-E'^)QO\
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MIS^R0''F+UN=M#.^567NY?\ F;UXN[F*NGE[U\T;LW3"X*#I?#U1@5*RK_\
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M--IC4 7O*U>YJXFW*%5ZQ^SJO6S2XSDLTFBQA+J=1<#:EMPH;14E#CKBTAM
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M_<@9X*WV UM=XH##P6 H4HR1YSG8[;>N""#CUQ@>@[\$IM6\Y00>#C6X2#!
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MSJRWE K>CC:D=T"8B&/$=/N ^94R0M&2D.)ZDX*T#!("U%(R,]BI"T@[Y*5
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MH0WO\?.J0XSL1D$  X&" ?S/?MX/G@G?"J4;8SWQ[Y[9/KG?MZ9P/3@B/O\
MIGU[9/GL<C![]CP1&/3;V&-LG<[^OZ#QG@B.X(R#_L.?Y;]O3QP1(,CL<]@-
M\C._;&3M^7\L%27YOKWV&E(0!W)/_)]<_?&WL,_EG@J)@=@P-ZERSY)?OW&!
M@D;YWWV_3.?L.";/.0HW&K5TO)5.? R/1)V]_"L_;/V'!*[YV811J-:L.S5J
MW] 2?T./&"<Y'?MP4XLW9+@%Q83K2$8.3O[[9 S_ "/YY/VQC@J_'=H$TE^1
M'$%(#G)QW[X!R/T&3ZG<?EP5R&6H(.LE@)B*3*/0'.3OYR"<[X'V]=O3QP4U
MC+=F K-QE =WD*.VV/;;WWR!MGT_Z>"AK?7?N9 -M54!C/N2?UX+I@H=_8)>
M"VC@B."+BC\2[FGYC=&-?>73270BI7!26M2M,M>[VN)-GZ+5'7.[IK^F]2T^
M31HK5OTNLT>92J',:NBJ_CZM'F27( $52H*%)0C@328$GBX/0 OPS4S.K7H
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M@C/Z$$CSMC@JUF;/3)P6G5P,KA*<#8C.2/\ '<D ;^N_Y\%/CXKID=FT3]T
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M0^9<59NG^FNJ,6?7$:DPXJ(LNPH[]'_K3K5$NZJS57+%T^BWQ=LNF5*W:/\
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M]T&W;</>@48XPL9I4$X)ZCD98[_2<G[;\%/, QEC3.*^S<5ZFH4*G$F!!A1
JXD)7^'CM1P0@Y2DI9;0" 5*.^3D^@'"W?>W'BQ'RG=[/P9Q&LDWHO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>g105868g95v85.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g95v85.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1U<4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '4"^=(@X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%>1FP         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@             !/    =$
M 0                         !              '1   !/
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !/     !29VAT
M;&]N9P   =$    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MG(Q+F68PW-+BZ^MT $@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(U%A%C)Q%T*!D:'!\"0SL>'1&#128D-3DO_$ !T! 0 !!0$! 0
M   ! @,$!08'" G_Q !!$0 ! P,# @,&! 8! P,$ P$!  (1 R$Q!!)!!5$B
M87$&$X&1H? 4,K'!!R-"T>'Q4A4S8B1#<@@6@I(E-%/"_]H # ,!  (1 Q$
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M+T]1FB(60W-S*<8>N52GRY%D2)R>C;"D?=)3T=2E3COX7W'/ U['!HT0UA+
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M',K<4SW;G+K2BFXMN%#IZ6PO$5]E)K+7YU!34D=HZT-O=FE21Z3P "E7/O\
M!\NZA0&EH/HU*;75AO<:CF34=)P7$!\"8$Q _+%EP?3^G:K36<ZJUNYQ@.>!
M$YB "#:<COS.5RWN:!BJJ:[#U5=I86R&6 Q/LDI^IC1T)'"^ZUAGL.20 .Q4
M>>?W\_VO]^XNW  G$QGMC$BW-N+]14JT&TJ;&LW.=9WO()!P 0[\M[W(7?M5
M9BX].L41/X._'96Y)CUCR4H#L-E;JTH6R4%YLA0/8@@_WX.KM=S0X06P6MQ
MO)^1M%^>+JTQCW::HYDT]CWV80T$M:-QAIC'(Q X*Q:YIO)=Y?7VM>W+L6ZY
MZRD)>,IY3B%-1I2TA#;;BBD*'0GD)!)/Y' U0".W>> <]N;D#C$+GZSJA<0Y
M]1P!%B\F\P+%QO$#..1"B;N1NU$VUD#^(Y *Y&554UFD8EH2E4F4TUT2EH\'
ME7=!"2GV./R. -86HUM*A5;3<&EQ9N$AI(&]PB29$1Z+.Z?TQVKKMJ!H+6#:
MX08DF;P"((\Y[9OP?"K=C<:_S*Y3D=0]D%;#DQ#7Q(I4J64DI)63[[%*5?(
MHDCGWQVX$LK"L+1:#C,CU/?"O=4TXT=>F&C9, AMCD8AHG]H-CD^E#QWWEQ'
M;Z'8,R)4UE%U8Q$,T<AAMIR+,>"4K:9;;("QV/*G"GL5 @G\$:_J>F;48T$
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M3].0ZFTEPV![ZC0\M9(\1OXS,[W.@ R1KZFE+=::@=O!:V\N,-8U@OP)BQQ
M\S,!\!V$S?-)>9Y'NU!B3\7EPY4Z!4TMI76,R6RM]PKL_IPVEV,S'YY;AI4'
M'6DA+G91*CL#6 BFX@.<YK6EX):20##G1MDXL2 3W!:MP2U]$6)ALN:=I(BU
MFDR1:\@>IF386'L!M3CFZB;+"MY[NHCUKC=DN@B19$*L5<A!<C,6M>Z]\*78
MZ@&%NMH)64DC@>AI^H]!=JR_4"G[OP[=K8<PELB1MI.%\_J K3],'Z<N#!4F
MS7'+8%Q^7X7)Q+2,JM[OS&R3%,HC8YEC&>LV,%+[:+*OBMQ*V1%4M"6K&%+9
M*'5-EL=Q]_<?O^>!Y1UOIK=$YQ@@W(M?-Q.UHC_:TIZ::SSM)R0#$Y'8-<.^
M,XA2JM?U(6<.Q2LPVNRV]R6RR:M#,1##2W[& Q+:#3AF2'5J]M<J[N=RY^22
M/6N.?6+G3?@>4">Y^5[3/"N5>GG2474B+_FO.'2(C:V<6G.!)!BN=OX=7:8O
M OE90W+D3X4V:U3B2F4N7(2$2$)=+RU?2K==<4AQ3?5 ZGCD]M4^],VM'IB?
M_EGN#.ZQE<Q5I#>Z0!?L?(' 'G .3;*AIY1;3Y;Y%6F/IGNV.#2\86MZM<IX
MC$Q,-"D-(1PE8^G"7%!:UN#AQ2EDDCJ#K#U&B=JJC*K20&M]WS)@N?\ \3G=
MR1(G@+?='U3-,]U-S0XO(=P!$;;P6S>.(B\F5-#Q0Q^;LK<5-:N=_B&6BMA,
M3[%V.W$ERK!U"1V=0V!V7\'P$D<^B4_D:R*5$T0!F,DS?SN.,>>"8LM5[0ZG
M?J6N$ R,3CU!_P"5P+9!GE9C]G&Z#(=Y,*_CI:3)5*^5FK0TVXVZ^(TE:7I"
M"D@E!)*2M)(4D+XYX(LZ\[F@PTPTB,7D?6>[N,8 V_LFPU.MZ /<[W;MVZ"8
M/AEH@"(/AC[C.1#0E$9EH>BAIL<$@^@D < \\ #@?@<:XU_YW1_R/Z^2^GJ3
M VDP?^#1DS8"/,<=ES/Z_P#G_;^W]_\ XU2KJ:(FB)HB:(FB)HB:(FB)HB:(
MFB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB^=4E044@J ("N
M!V /'(!_(!X'(!X/ Y_&B+0\MMIMQYU2$(90MQ3BR$I;0A)4M:E$$)2E()4K
M@@ $D'1%CEE_J>>*\2X6&Y6ZTK;J+D3F*3-_*O8K=J=XZ5^1M3OX<["F;R1<
M3:PQEAFR5]#.NV;*90PYI^DEV;#Y+6D^7Z<^LX])^B@WM]V^1^PLA$6PBSFH
ML^/)COQ)+,=V*^RM+L>8F2@.MN0I2'DL2D*3P4*;;42."GV>!-H\_OR_0]NR
MB\_#]>QF+0,B;>:W2^PEUM3JFF>[J4H2XMA!6^\.C!;4I:'2\\A);#1'=8*D
M%)X]PE^/.?0X-S-HCYP@?BE*^KB5-A:F%K"VU1P$N&(I+RRZ65J$AI452%'Z
MH.(+!0"A1U,'-LV]>P@3SZ?1+6MZX-CS)M!C)O$V5J=W]Z<$V7Q2IS#-YDUF
MFN\YPK;J&JKBFTF?XIW RFNQ;'XBTP7U?&PFXL(\>9_G2AM/QK#B0$+?#[YG
ME2;\^A@&9O;@BUQG]3=ELQU!"D!OA:"\GTTEQ0<X4N0!W "%D!3@+8)< 4L%
M0]1Y_?U_=#Y_YL<Y%AS;^R?,V>%,NM*2KUT;4PI2W.Y25*<4Z$%'/I:$@.]D
MGA7(ZDHF.,GN,GM-H.<\X4:=T_#OQBWLS&'G^Z.S6&YEF#,>%%=O)[5C'-G!
MKW2["@WYKWXU?E%?$<[+BU61Q[&$TI2@A@!2B1&?EV/RR%/($D'TM@FQ(@J3
M42%$@Q(T&#&CPH4-AF+$B1&&HT:-&CH2W'CQV&4(9889;2E#+32$-M(2E#:4
MI &H(GDCT,*1]_W^*AAO?Y40]N9%Y04V)9#D.009+=86($9#MA)<GH+K:JV&
M!U4VVG@&0Z2"D)41[YUT.@Z'6JLI5S+J+PVH-IJ0<S+A3+#!S!$002;K$?5&
MXB/$)$D $"Y%B;Y'QCSC&3F6>;7[YW-'A4&!?8?O+#;F/?PV<EEB#<3+I?U[
ML9T1RF*Y.KEK6U)3P?A<2XA!" #KO=!2JZ;>_5[*VE;38[94:XOHAC(<1O:1
M4:=NX@!KFFTPH)8X0!XKB8$$F,R;$7OY_$U7M)Y,0?&G+9.WV85]!'G1T)-G
M;P'URI\UWMPIF5(#84VD.'E+'REEL (;"4A)UB]:Z.SJ#&5Z#/!4;NI -<T!
MK@2#L;1,>0O$Y6/1U+:=:LUQ@!Q!@@@P8MX@ !$X[VPJ0_46\E,;W'QC;:B;
MJDRZ6VB6&0R),E\P%QT.*3$08BI*W8DL-+8<4VZ4<<GD <ZW7L!T#4Z76U*F
MZHQQ<UAV.>+ ;ANBD#N(=,%T$8!$+4]=US?<[6.."1<7.#'B(F!:TWE>9*NR
MQ>S'^T')\9>FKCS+6=&B2P&W+6.9$A?#JY,%*/Y:0KA98*&RD?C]M>U:C3L$
M^]:QU0?G<Y@+G$ "2YP!GDD^*_*YW3D$,? #G7+AR;B9 ];?WE5AL]EE[E,>
MXL[._P#K+I"5S&)[;CJEM!U!=X1RHK9<"2E*PE045@D_<235I:;&N;#&1/#6
MB.,F+6X^MEB=2)<T ^*^'7'U$0)F2!V)E<F@RBZ%G/DQ)K\20MPS&)SZG4/*
M<KUNH==!)[H47)!_!!4/?)Y*AL:E.GN)%-D@F0&MMYQQW)%OHN<=IW2:@LPR
M0,"!V ; 'K-[]PI"X3 W"W4J[ZKKH<6[L*ZJ<GSKAR##1/=-%&2LQXUFI/\
M$'V4L,H2ZV'BD+2M(24I UKZSJ=$A[W"F'.%,&X!?4=#1 &W<YUI< 9R6R2J
MQ492@.8QQNYVYK3+0"9\1D "^T?FBTQ:EL*R.]5);=RAR2YCT!AT/Q?K)E:_
M'38<M.(:=^1'U#+<DNE3:26PL%' /K658Z=N9.Z2V9_,3?F0( /;N(6)JFLK
M@U*#6M+Q VB#X8!_('";1X2?.\J^M[B=%CNWC^48AN9'M),5MH-XJTD*<#KS
MA4E#KJU]GFT@]9'8%!6"%?OK!H&LW4['4Z^QHD5'.#J=H'!,.N;$ B9L%@TM
M-5D.J5'G<0"QQJ"1S9S0"#?'F!E8D,RR[Z#,)EK;5S\.P>M7TN-0Q':;>6XZ
M [(8#77CJ>3R!RD\D<?C6T.J#*HHDRR&^'(OS!=$?"(\EU&DTP?IP )XN 8G
MO+2;DB<3R5)3*MLT9-@-!N&NUJ':J-#E1[!,EI$BXIWNJ%0W7FNJG9D:<P'O
MD*NZ6EH2I?"@-8FKT_3M07"MT[1U1G=5TM"H'$B#=S2!!(R;DR)"Y;44*]#7
MAK:E5H-5HVM<]K1,_P!(  :8Q!$V/ 4$<B:FG+L6RC;M;^0X!7/2(MS'8+#\
MB.&R$34KB+;7-4LN_(IL_(&_A4TVV $:\F]J?9C\1JSJ.G::G0H-T].F:>DH
M^ZI>\:ZH7'91H.9O(+0YQ,D1-@)Z#4,I[FTZM-A>:5-P+F-<8+;DEPD@YL 3
M)/(4P\(\C,,G,1*&L:?QN330W(\7Y:I54_.?CJ^1F"\'C\LEJ2Y(<"DJ5].[
MU(#9*3KSVKI*ND>14:\AO#@XB>WB:WOFQ]+KF^I]'=5\5"FQI)_]MNTB+7VT
MS$6@9 ^"G&U<EC;B):MR1-<MFX;DF1)2A8B+?6GY64 E75ME0*$!)"0!T'VI
M T+R2"QFU@ !VC:W<+F0)&Z(D^0[+DCHM9I7%KWU@XR6N+JNX-)P)8T@;@3
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M+HU/3Z3:\,:#8N(:P&UHD!I)C%["W"YO6MJ521)/E+K9-H\S)R?@ K1P<31
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MV-_>-P%J=9D(?=6OO*D=D+<=C#T2M2E!04E0X]#@<<;S0:*EJ WWU&F]W8W
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M9+CV0PKBIN<0-ID<_'+>^=LYS#<%S")-I'--CRU<3;5Z$FTBH=BV2"'Q_O\
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MMVF]^+?2T# [6,<%4/E3K]=BBHUU$@JR-FM1]3)(2\N!*4D%Q#+R@>G'(_\
M;Z@'D #6QK5PYSB+-)F(B.\<WXY_>W[O=)B"1:>;&('^NZBS*7*GMTORO-!2
M9#AERPVE3JHG*T!/8H)'"1QW!"SQ_G]>M>^I'IP+>GUX_P *!3!D@#']HYS(
M\LWS)PE><?BU6OY#)RO9NN^JR=J8_=Y0W'><BN&"4O+?*5EWY$]@E+BB@I[*
M)5^YYIT0U#M6YXG87=VV-K#F9!MWF;+)+*+J+6D . .=W<D$W@' S^BC)A\W
M(X]/B#+=X_2S:9IFV2]:*7([$DR)$%P)[?*VY(6XL)6"5)4"/1]^F]/J564V
MAQQ?Q$8M;!%X)-CS-UH-5TYE0F!R9&#%\R[N1,G(MY5)G._6Z]G/I5QXE)?T
MM:^OZ^+40UH<D-*<X<3)^9M7QI*24?RR@=0%>N=5'6:W\:YM$N-,"G !%P6-
M)@$<.F1B28(6H_Z&'U'2  XV)@@18R=Q.!!QP>Z[BSR_)LKKHG\(I7\:@,.-
M*DM1@E(9:(2HI*NI*PL$J/<JXYX'XUNJU;J#*(< 1X9 EOU)'!O*H_Z&< 1$
M0;7&!_7\3VYY7$5FR''H]+2XM897D3J51&I;KO\ (BK5]O(82 E*A^2M2>21
MR5#6MI5=1J"'U6ESW.(RTV&#,-D<>6+JL=(--G VS'$GL "8()L;1'DN]R?<
M"=B^(S&K.*W79=50PQ&KI44+?6J4/M*2I"OL0.>BB#P.??' .;5U/X6F73<
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MX=;J4.RI*U.6=>E]U25M(<4IQDI(06^O!ZD 95#7:JGMIA_\MH#&@L8#M;8
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MK^2I#<=AF+!<<4W%AJ 22PAGD-CXW 4K4 /E)Y63R-<ET_15M/6JL<28D%I
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M=34AU0DWVG;@\2 ;S;E5/MOD3LR&_BMA'<=E5881.9GCL%)"4MM(94L\H#?
M2H@GL$D_[Q.M([<RA2<(!?2IN,B<L!OBW,<GF %SCZU32L8_4[33+0X"FT-,
M$=SGSY!MG-ZFT)H5N18-2J,):PF2ZT W'Y"ON4D-A7*2HDA1)*@ =8S*U5[H
M(&2+ 6/^!,Q X[(Q]#J!:*#'-<8@N<'8O@#MVGL1-EN3*R4J0F0DQ'V1V>D0
M^X"W$*^Y*DJ<2.H4.#P!^_[GG61XP?,_FD @\1G_ %D]QANZ=J6U7M<?"UY
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M2IT600YH8&L@@RW:(CB2.;?LM;['_P -NH]5UVIH]7I5*.FI5'!CJM.I3#F
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MY6ZY"0M!:^1X(425GORK]APDD$)!'/L :3>18^6/DJF$TR"&BI>_O1O'%X)
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MVJA;IL;.9#+VQGWF6X7D[&3Q\>S7#+J%N&,6MZBNM\5NJS(H=I;4EG6SZU;
MARER8S+@>AF 8^1@S;D1/I':#ZB)BV>Q@S?GTS@7MWL/^HGDTSP5VB\H/(/9
MK+\:RW<#&]G86.8S02L!==WNW"W9J<>=J&]J:R/N)=JH,<L[2YDO5K6XUQ3V
M57CD)RUR%]EJ*_)>3S\?L)&/+'RCU5PH/ZD&$U^WWD-EVX^T^Y>W.3^,<;&[
M/<W;"S=PNYR\8_F$>JF8OD&/S<>RNTPVXB74.T[,1&<I$QJ3#DQ'4APMJ(7$
MW](O]8'U0SY8MZ_/_4&5VVVWGE(W"RZVV\M_&[>K;+-I6ULK=W;:CS%[:^4]
MNEAS2OB1)QZ=0[BV-#46*5K9^HJ\MN:-Z/\ ,D2%M!#A!3]X^_G_ '4</''S
M>WBWS\)-Y]Z-W< W'V8DX3'W46QN)B7^S"9)L(&+9-=54=G#:$Y?F[<?(L?B
MP68M@J_:543Y[,A^GG28BD=(O^F/KQ8?$GS3[^_O]5?K=GS>3XY;+[:;C6VV
M.X&Z&'6^V-1FN0;C2LTV7PXQZAG'JFP=_C#649CB3EON!8MS9$C_  UB-/-@
MO28<M'\3AA;*%RG[JEU>1-UN!YM^"R, R^Z3LEOOXI[][J+H$,MP:^X<:8V<
MML"M[2+*9=D+F555D-NF/U=0TV[.>*DK0>NDW ^/[7[3\,*.\1(^$6^.)^L+
M*-HI31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31%QGN$@K'KH4@ 'UQS[Y
M2#Q_\:>2H=:#V)^N3ZV^JM;O1MTK=C:_,=ODVCE2<LHYM3]>T@%;");#C2U-
MJ /!X7[[!7KT!R=9/3]1^$U#*IOL)%LB8,Y&/@%B]0TPU>DJ48!W#DV/K(-H
MM(%IO:5YN][OTW]Q=B=N<ES>3D&.WL/&;!V56.!Z6W+C-V"4PX*G#*9>"4F:
M\RAQL.J!0I:T\'@)]7Z%[14-15I:9[B70#XAG$B7/(G@"('F9"\9U7LGJ^G:
MVMU!X;^&?5#FAKBZ&"#^7W30 ?%R8Q;G'5BF/[<;CP9\R]H4T67UD^-3VD5<
MMYU;TWX6>DZ*%GEZ++:#,E20"$J>4VGA*4I'H>IU.GH4 ]I:+6C: /7O'K@!
M=QT/K.F:&4&N;(  ;+9W1!(VU ;018#L. IO>+WBSF&;;V[9W^,8:Y*HL(OV
M#DLV=#,2J72GA2D24/(2Y-^1 4XTIA:"$J2#SP>>-]HNL:"IT?::K65R:@@%
MCGDS %GN<+ #Q"+9 NNZ94-9@?,R)[>7)QB)/(/*]8,"$F+'C1V$I9C1VFV8
MS+0Z,LL-("&FVTI  ;2A*4I222  "?Z> OI5G:IU1U5Y!=NV[SS>XVP"/OLJ
MY&V(OP8 _2Y^/*[$)(Y">.">3^Q]GGCD#G_B??O\G64=TP/@?U)X^GH)5*W-
M5^J)HB:(FB)HB:(FB)HB:(OA/L#^O/\ TX_^]%!-P.\_0+;=6I('4<GV5#_^
M@X"B%<@)*>P7[YY2E0 Y((IVESKNAIM:?T N3]F$)@$]OOY=UAP\]_U'Z?9B
MKW'VVQ'%IF27=;03X.07DQA]K'ZQV?"=:7 :*4EZ?,0V^4NAE2$L/(225I5Q
MKOO9CV7J:S5:>N]KVL#Z=1@ <)+2' G^601:8F#8=XTU3J#=U:F2(8(D]SZN
MXF)L9X@@+S1UT9C+<1.8QUPJZQR-#T[_  ^Z74329JBM<F.74H!0C[BEE06K
MCU^3KZ89.CTK*)8=K&-::A@ ';9I!VF1S [FYE<GK33+O>$B 3VD]^2+!W<7
ME<[!X.5T"U5V/6=@7IS:Q-:JVT_,\ WVZ/*66@PI/*0 3V4> !QP=7F/T]:F
MW<UI+#(G;\\FT3?D\W6HK]0I,#0YS0)$>( X,_UB;#Z25'!G!=Q\;RFWS+-\
M8MX-6YDS$>'823]2Y*5(>2ZQ]0V''G8R/B5\Q/V<E(X/4E)S*3=(?"-LQ,-#
M1:1)!R0#8_<45M?3<QP:180!;D3$EQN1<3'![S)W<3(X661V\WF53*<EHZ:,
M(+U"6JIM2*IY*&US6$QI"Y:S\:/:BAU2O:70.4JKI4*-!NUCB\%[G/\ >$O=
MM<?RM=N&ULFP@M L1=:32=2'XVI[R US-C8@-L1!(+C> 03B=HBQ"[OQYQ;.
M<^W.-TF:F%&;J7+"^L'UH9^M%@8ST9IQ;KCBW'H[C#3;:4L(_E+>['OT4G4]
M6I430( :     )  , &#8@1Q-@.%SWMLYU?3!U(DR"XF3(@WL 3))'<1>  L
MDV*[S;I;>OP,3A(CY;"M9T6JC5:E*6V])F.$.,ME*D<(;:;<Y*B4I_!YY&O(
M>JZ!CGN<&BSMU@ 18@SX>,^L',KA^D:K5T!LJ5*@H/<&;'%VTNX$.ALVX$R+
M0+J?5^P*[&&TY0FFJXDMIMEANOBI+D!^0CLM#BU_(5K95V2M;?7@\?N1KF:K
MO=$@2"!'^L'L1(CX+I]=1;5T^VH&;7")+6%S7&#)EI/ F'673XK'?Q"M4[5*
MBY1%D)+C[SR4L-LM=2I/11ZDD#GN%=B>.!QQK'#]QW$QWP,_$WCSO=7=%0IZ
M/1%[6L> X"[0 9G((:?C(D3=1+WFW:K;2@L:I%+5M252T_%(KWTKD-+3*ZN@
M!*RHE*>>?7 YY5R!U-NI4(BYQ_CGZ_I(6@USF59:UE,'=,L$. M:9(@\"_P4
M+4Y=64TBT=EPW''FH*W8ZTN!'17'+BW_ )0I*E*;[)/0)!Y '!_-AM8,>"XB
M!(,6XS,B.(F#FQ6#3Z?6K" T^(S8'@W_ *2.(QYWRNP\6-X,/W4S9VIB.-Q)
MU5;!EUHOB/\ ,\@J+2F7B3U4A:$N!22#RG@?<1K--5M1AV&9M(N/OSQSPMI4
MTYT;:9J0#@!UH,@028@7@DV]2(7I7\2;^3$PZPQRY#YD5%K(1"G39,=Q5A&D
M.+<;*5M_$'5-I6E"%*2M?0=5'MR1R/5-.X.]X)@$S8FYP<6&1V,CF9][]A>I
M43T_\/9KVEH@EMS=I A_B,C=N$R).%,IEX.I[<=?8 Y(]DCGU_P_KK2D1G[_
M +KT-C]PF.WUQR<_3E;VH5:^'G@\?G@\<_CG]N>"#_R(_P!=$^_N5"+?SQ-K
M]^?(;QJW7R1.+6^'[)/;BOW.'Y)4(N$9#(R_#+?&:^3$:?4Y%;772[%$A2Y#
M+BT);)0OL "5-K\'O:\9XBUP;6\I7,\K/$R)O?X]R=G-MK*GVNMZ?*L)S[;^
MTBTB)%'1Y9MUEU7G.-+F4<1ZO9E5CEU4QXUG&:>C/R:MQ^.S)8>4W(;&_'P]
M%.)R3^OZ"?K "M1LYXK[S7V[>\_D)Y-Y7MW8;B;E['4_CC1T6T5;=Q,1Q7;J
MLM<LO9\I4O)+"TL;J^NKW)WGWA*Z0ZMJ''990XMR8X^2. .V?OB +^MX4=Y'
MZ=>]>>>#N)^'&\&9;09%6>/LS:#_ & WS6&9(_5Y;!V:BIJZ)&]&,6N3V$6X
MK<AQE1QZ_JZ=%8VU,=<O&"F0RPE#(,]OG<6OQ'^TYM'<B?F8]?F29[JJ\'_3
MTO(?C=Y"[/LX#XK;%97O-$QVN:F>/NW5SCM8]#HI-;(3)RMR??2Y%L\9<"6J
MN:CF+_#67@V?E'(#[^_OM\',P3C!]>)'WZ*6[GC-;'R0V=WK.1P45>WNPUMM
M!8TXB/.2K6PLIL24;.*\ZI;4)@)C$J ;+ZG..7".02'$9.+C,7QB\=Q^RC)M
MKX3;[8CL'Y">*]MN%MC.VJS:'N@=J;R%C%Y$S>DLMS,GLLB>_P 8_+D#U18P
MZU5I+::8JJNL7+*4//.$]BIZS@_/A0?+R^DX'<9%H-L\6^W<_3FW>R?<7"\M
MQ3--G[F-"\6Z#QPE*W8PFVRB3M[-JJR' L=P-J6XF0PFF[FY9B.(M:ZT2MAU
MN)#[NJ D?(^\R?OU^MU(/':WEY#U].>UE(#9KPDRG;K/O!W-+?-::T__ $H^
M+>6^/MPS'K9J7LJL,@K]NJR#>UZE3%M5T!J'A<U2V)*'WNTIA"7B$+Y0>8GG
MCX7O9)FXYQ/^K @9\\3G)7HI31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$3
M1%M+:"TK220%D$\<?]Q_Y_\ )4N&X1,7E?4M!*4IY)"1P.>/^P]?\.-1%R>_
MR4@0 .PA6VW,VVQW=/%+O"<MAFPQV\;8:FP@M;?R(87\S7"T<*!0\$.I^[TI
M"?[ZS=%JGZ+4-U--TU!AKIVB,WS<#O;A874=,W7:1^C>P-801O:"'WR9-I%P
M"+$$S/.*)'Z7M5C?D5C.7XPS5O[81Y[5Q.KK0_/.CN1H[*5U[B0@&;&<E-..
M-+65.--.(:[]4#75:CVRUVHH>Y=1T[1$;VNJ;I@-Y>6@C.(GA<3H_8JCH=7^
M)IZW6OD@AE0TBP";_D8'0+C,V$R25F+I,?JZ6.&:V#$KVNH;#4*-'BH#;7+;
M:"&&T=TA ' 7V(YXYUQ==U6K6?4=6J.W$.#7.W-!V@$^9<9))[QA>@4AMIM9
M  ;($<B;8\N./2%W_'K@>OV''[:H(D1)'F/W5Q? ./W)_P!= "!!)/F<HONI
M1-$31$T1-$31$T1==:VD&E@2+*SE,0H,5LNR)<E8;89;2.2IQ9("1^W//YU(
M:7&&B2>$D#)A4'6[HX_=_$_22X-M#<<+7>+,9+PX("70WV5W:7R2" #P/^.L
MQVAJM82X&=H<+';@VF,R(_8J;18@W.#\!;/!5PDO_(MKJI [)^0 $D]%)!Y/
M'KU^.?P.>3QK &\%^]H :8!$WS,^8@6'=1 -[RWM$7[\W@C'Q4<_)3R)QCQY
MP^'DN30K.8NWGRZBH8K&"\?K6ZJ=.5)DN'^4Q'9C1G5+4Z?N40$^TG6[]GNE
M5.M:IM!CQ2$M+RYI(+=X,")-XS:(,K#U>I_#M,MD$$?$S,&?*,9/D5Y",Q\B
M7MY+[/K"?<-7%I*M[6;?05_$>DQQ\J+2&>/IUMK9+/8A!6% @*  U]0=*Z1I
M^E4J(IMF&-:-P:-NUH @@";#-C@Q,+C*LOJ/?N()=ND?$Q'%YF9O,'M3\G$W
M+>KH,N@VM4':28R[)Q_Y%(F1("&5_&X& 0CJ7%=$H"0V3_G!UMZKW:ACJ#FN
M#3XS4;R8C;+I)/-^)"T74=0]K3$3)&3VR1R./57UOMT,9S"JH[3%=O8N*RH<
M9I602H#;K;EO:1DI:,Q8<4X4NK+25!#71DJ)*T%/.L33Z.KI=X.HJUVO?X=S
M6 L:;[98&EQ'<@VM(@SQ747NK.HAI]W%3QEIC(CS\(S>YY$P59:?O/:7=O<U
M%DPS*B7=A7?-6OPF5/-R849$%MSEM 2ETM(+Q3'"0I78E//&MM1TC&!M0%\@
M. ON@..YT2,D]Y@D0LUNG_\ 3[G5JA,;B"0!($6\X@$^40KPSJ+$:BM=M)58
MSA3D9B!'R:PGH=>@-QHL6380FTQ5!;DI-W\07*:CE+K#K30[MI[)5;94J;W
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M#S4FO>0^$.AWY@$N-R6I#*V2C\%AT'T4ZY[K?1C1V_AJ3CN)+B!(@M=V$R"
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MF"?/-C8W<6WI]I$N+JVYJK.3,?6TI]I/SQU-A3O\N,PIQ2FT(:2P%!1)2O\
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M_P!"X&G79"7&I@M/K@E)D+#T53X1V"D>AKT5U34ZJ@VJ:/X?;+G,>]E9[VD
M^%S12%/:; .:3XC@RL*DVD=PIU?>$0+-<S:?,.)W Q)(M BV5-;,/&_;C=C"
M<$J9[F*%C'$5Z,6RRJ@,OV3,UAI:T2Y!6^VN;V?2R_)CKEEMY: %*;  /-C6
M5=/7=#'.+G3!J 7@ AHAPX_+>3>Y588'$3 %X-C8@P>(SY_4DVO&-8/M'D>7
MXYG=ECF=1;NF789#+OH34F?+^5#$=YM,1D/0ZYM;<9E,)MT+4T$NA*WSV4-M
MMK]7I4:K :)T[H<TAKP15MN<7%A:&^ZBP>7;IEO.<P4].RH214#P#AS(#07$
M<R7%T RV!\% +S%H?'G>_;6?&V_P?'*:9BL^.@RHC/\ "<HKX"DI4AZC37/M
MHG-J7$^.=]2P@I0J,ME:>7.W5^SKZVDU#&U*PJV .UH:W/FPOQ8>(\@@DB.*
MZUK")-.A$$S_ # #'%B",P<$6/.<63CN)X2NGF6U#2L3H,)2(#5V\)S[[["5
M@NV"ES'725MJ9=3RA@-J4I(*N/7LVGKTW:9LORT $!TBP[--[6OY P(7 5OQ
M&NJAK7^Z;3=)/\MP>'1 _HB]LF9DXONP=RI&8TC%3A5=B\!\6ID3F,:+*94I
M042^N9)4E3L=KCVTA1=3W"O9]ZQ2VFZK^8B;<W@Q@N@Y\S](RQI7TZ<OJ@P)
MDL;8\7!W3GRF3$W7+F6\JOFIAR;!Y^4T4N*$U96RMY2@H1@&U+#@:]<*44I5
MUYZ).MC^%<ZFWQ\FQ: 9F(DN]>_?R6&UPIO>6LW%S8S'_P"6#$]K><RJDM\E
MS+(* XX\[Q5!YJQ^)###3 =2DL_(RX@_*I8:=6GHH\<$GGE/&K)TC=^]SP'[
M2R=EPV?RP'0+CX$6Q*J+P1$;03C=/BYFPOQ^YD*A5Y6:1F51 O2ESV5M?0(4
MHEE2T_$AYXI/*&G&5N +*>J5E*/95VU/X<&S:A-\;;S_ /L(\\R.XQ4W3,JN
MO4+=L'\I)-X(@$$2;\7R;A4FW%8-G'GO1X\*MI8HBMM,ND%YXI*_B;D\MJ*W
M%)+I0&SU""2KA/!S6U#3;MVR>'%PG'8@_P"X />X:#:4P=YYD$7$XDF8L .Q
M)&!'1Y!>X/E,2NCWV.S+*="E]'I0'\V(SV/5#+RFWOJ8_'MU?V%*TM@\\\ZQ
MZFC;K"&EXH@>,$-]X#%MI$MB";D3V,3>!6<QQ(IBXB=X,]Y$&+Q$F+&]U<.@
MC2,FMV%XB(E?!I( :8;>0Q$F2&T_$A3+*2PY\SZNP*4@??P0%)X U=;2_"-C
M<:A)O +1,<D3 %KF+V,Y6.XFH"70!BX!Y-H,7$6B3$QBU.;CO1J.(VJZ@J1;
M*GIY?CQ%-VZ6$?<ZEPI"0E#@/"C]Q( X!_&L=VH+WV8 ,?GL>\2V.T"1 .;"
M,FF06A@)%I) D2#^6 /GZ>JT4-% RN*,@HR\$1V%AI;L@E]Z6A!X8>9X!2DK
M^WN2K@>PD^@;PJOVD;<VL1@7!QQY$#O,*T]L.C>0?_C:W/PX\\@775Y3E;>W
M>)6.6Y5&G&,JS:AR5PF KX%+ 92AE:E(2\KNL?:0WV_<C6#J]95TU*I7]W[U
MM,&6;Q3#I@?F =M@P8O.#F%D:?:U[7;PX@8VF<8&8SVSS.8[85E6_%GOE6Y]
M*Q[*9>S+TD6./HFUS+C$"M<KFXBUR!&4Z\$MN-+DM=4DK??2VL-I27E> ]5%
M36=6=5-/W7CLW<U]XGG: 1DV$@XG&AZO5H0YI.UYW B2+3(&)(DS-I[A2ZCU
M.3U^\\M5'"5(C[E7E#;4M+"AK<7-C3*]]4QGM(BI2)#3K?J+\C:Y+J@TE;:U
M)YR7:XZ=U*BZC8M(]Z:GY2UD@[ UTRZ&Q/AD&X6FI:2AJ@*,[]Y #(>)(((
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MBX6T'BV5/NURG0B1\+DLN+27F5(2D#OSW(_W==!IJ]-S1%.!%H<#8$>6#Q>
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MVS\S#;:G$.EN0H-]T.**62A*BH?@*2G\\\ZRF:RC4I^]:Z 9\(D@$"3P ;@
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MC=,;I[F%:<VG(+&%I ($Q,'.+1 $?.V%=K10FB)HB:(FB)HBQR_JSX;+SO\
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M%OK?O-E/QC'E\/\ "W)]Q64D(.Y!,A0XS;W1V;(>;^()>_\ :6^Q);^E45*
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MI@FS3D6N8^,CL:5 57N+*E)\"8#I<!.;3<7&!?(DE=1GFR>18GE]Q8X@^_\
MPRG+3]97.(4^EQ"B4.?))0CN0IDJ2&RCIW*2%'@$[+I?4',<"\N<+ AL_JYV
M9^%\\+$U6C?!$LO.)BX&9;Y^D]A"Y_TU?;QV9\M7TTIRN<B284AUM$F,TLI4
M_P!F0I0"2^A'50)^W@$#L!KN-+U"CJ@&4VU&N8W>34# " 8RUQ-Y%L9NM+5H
M.9=T&3P#8$C@BX[W$KB7O\,D5M763&$/TKZ(U<RA+C3:&E(2ZM,IQ:UI2@AQ
MM+84DE75Y0/'XUDEX$"#,189OZ_6,W\UANJ;7;2#(=!@8OGB9@G]96W5U]3$
MB6L>M3 =M871<AM,H++:FVUK8)>7U[(+25C[>4!92">.#J*M0"F"9<)%A)-Y
MOD6@Q!/97FTR0"( CF;9\-A,R)O,F8E5)'>;ZJEO2 H-_$'F6P"E$GXDJ2VM
MPA(4E25\_9VY*??XYU:#BZ/"1G(L2+3%R?,C-[X@YA%BX#S!/<3%ACX\Q:RI
M3.<.7EE0S ,H!A3GUO\ ZA1*9*V^5(COI21RT.3U!5Q^Y_H8KTGU*1;+&@P2
M]P< UO+@0)#C:#8 @*:(:ZIMD"QS$6$\R/T/& J.V?W9Q^KOEX'EN+09V%(F
M-QK)FHMHM/D"I5=V<CKQS*FH4FRI2[(2V_:P&&TIL6VC"5(0AU3B>)ZSH-'K
MVU-/3HBIJ6M+&O?2IU=/6<,5M2T-W5:K/_:J3+"&P5M*!V.!FV8!@B\\P ./
M2!YK*AC>ZU*-JY-CEN[.Y6Z.15,+%7++;.-(7CM+D^%0FGXF)8CA>31,3C6F
M.9%A-DP[=9'.^M4WD%7($#ZOM(7\7B=?^'7M!JNM4M.VIIV:1YJE[ZQU8>\4
MV%[7:A_X<L>X%H:PP8)VVRMP-=0;3(+7N<(@M#9(Q ,GSGR62#]-[Q0:\D*5
MV]W RI_+<)Q>QVEK;2UIZJPHZ++*'"J5K):[9J9 G5L.4U8[?YI78Q;RMR*^
M5'N;Z*U]#*?4F6]&5H>OT&],8=!5VFNP.9_++=AVN#=X/A<&Q<#;)ELAL.63
M3>VJS<V(R"XP;Q8QD@V)OS%KKTZPV Q\0ZIY"'&PH=_8"@>W!/5*G.O=[JGV
ML@<J">QXA@-,AAONG&+$F2)$6)F!GXJ8,&\[?K-OC]F%V.KZA-$31$T1-$6E
M2NJ5*X)ZI*N![)X!/ ']3QP/[Z*0)(%A)B3@>ODJ;O,CB4T*1.F!<:+$0M^5
M)=ZH8CL--+>6^\OMREE 0?D(2I7H@)5K U>K-"D7^XKD-J;7O:P;:5(!WO-5
M4.X;--2 +JE4V:VY"-&^J*+2-SH@SX9)L)S)]+"^ 5@Z\1]Z*SQ2F;]8#(BR
M[W$\AWUWBWBIW&N8:-M\3RR]5?L5N4(4$LQWK.5.DR:L5R["*ZQV6]):5P@<
M#KO:L:2J[W-+4:P-JC:W1Q5-6BTD?B*0]\TOTY(_[@@7 ,25NM1T34Z:FRH^
MIIWBI$!AJ$B1/-,"<S!(F(\IU+\GFMQ*R')QH*J(\V.AWY)KBHKS:GD%<9*5
MK<$8(DI(6VXIT(6E2>B^5 'P'^)'\8M3IM>S1T-/U#2GW@!+V&F,@1(US3Y@
M0( ,C 70=$]G*FHI^]!IV:#!#W$ @?TLHN<2)'!/E%E)/9[+)V38RB1;%IRR
MBO*B2$1GOG64H5P@K6%J0%+2.W4$#\D_CD^Y?PEZ_J.N]%][JJS7OVM<V7N<
MZ#>#NJ5)(!R";<]])[1:$],U'NRTN#KC8+3S&YK#;D$#]A>AM[Y"1T6GC]U#
M@?Z?G7JP?/\ 0\>K8GT[CS7/ @X^_O\ TM[5:E-$31$T1-$31$T1-$31$T1-
M$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31%P9,5,CE#B2I!]A1Y5U4.>
M.$%)2I*TK6EWDCD   D]DVV.J4W2T&.?S<=@(SWG@6LJ*E-M5FUPP9%A]3>W
M&,$W6,_S"_3XQ/>;$9SFV%9CN'YH9\JTD.F.8D.^=L>$/M6,F-&==C\/?(^V
MXVPLE2U )!)&NRZ/[4:O2,]Q5JN]V7[@27SNYD"JVSH8)C+<7)/&=4]E=+7+
MJM&E3:8 +0UD1-B)HN-G R ;AW)QA&W$\&]V_%"AIIV80H%VS=/6$%#F,?Q*
M]BH;C-MREM6!<K8Q9*Q(7\+[P"5I:4DE(;05=YTOVBTNM,/JM)!\;70V)%O^
M[5)XL0(L.;+SGK7LSJ]."6T3!N"R7@GM_+HV$&XF;]B5C:O,WA8]EMA25]$:
M5Z1:,K7)F(EQ*V4RI)4I2''V4CXVR.RB&2WRH<+/L#JJ572ZA[32+'0TB&FD
M3.8\)/''YO2%RPT>JTU)[:P>TD[@"*@,0&P X-,=HM@Y-KSVE4_7X K*:6>Q
M=3)$^/<N/U<UN6VTY$=3\<1YQGGX4M]0EU#O177VA*P.3Y][84C3K!S 0)!L
M+C$V [^GI>_GO7&O+G&"!!F0X7/TS.?.5>JASN1EE M^-/AU-W-891+: ,MM
MQR0T"^0I396T$_$!U"#SVY/''KG!6?6IT]Q,L;M$R8YM)/EVQCD\72IN+G[F
MD!K@!).!(Q>_8R9O?!7,K<7K5-+C9%+C63@"?A5'<^F<0VX%&0@-J2CYB\L-
M_'^P"2"03[1B>QQGSYD?'CT5\LC @'C-X@1X23 /K$8L5R9U7&<8:KFG!51'
M2605Q7G$1(S*0E#BW"A(3\H=5\I;*PH(3SR.NKC.?U^?WCU6+J!5:^DZF'';
MO+B Z)AI'Y0 +D@2>X%I5DH>TV%8Q<6.3.06)M@LR$(L(49E:WT.E/8N-N_%
M\@=^WX>0#Z</KGDUR1Y^7J+_ -49\\"%N:74M0VCLEX$8\<2 >S[7DGC':55
MEAC.(2HRYTV*Q!KGZQKZR2RPML(;9#J^CK;;0<$A04>1%1(221V6D<$7J8W-
M><F&@9!\N/7TQ"PQ5U5?5Z4-<\15O!J &;D0TF0"+R.<D76*/R-VAK[FVILF
MQ*F>:Q.%-ES/XE%@ 6C[H"4= V\67.A([%3SB$!)YY_(UZ1[&/#">\FTP9M@
M$@8[X,\+ZQ]A.EZVKHFDU'SM#9W53: 0"13=<$1<]U67C1*W7A9),AQ:J5+V
MXBQ7FY,IMMP,_P 3>2'$)9#?=#DA+1X=42EM*N4I6H\<[WJ545JY;/Y22,=Q
M%MSC<VL!\A?U'IFGKZ2M5]\YQ::8:-[GS.Z9\;6CCC )LIT3JZ)?T3LJ*W,8
MMV6$%=8A0:FO?&L!27T\*;^#J2K[G>3P/0_>S1J>[(!($_ 3Z C)^ [+/JM-
M0&; R6\#F+P8'^\*SF=;9XQD,FLN8<5&.7[+*6'F_B0J)*C);/S/SELN.%$=
M,E+*5J2TM7R%L!'!)'0=,ZBVA6<7.;#J9;<@?U Q>H!)B;S\C(U]?1RTWN+@
M3)D0?^)CY^I[1VW H<ZQUV+7MT%3:5,N#('Q24M!$X\@H>@E"B^&4=2I+JD-
MK#G1L(X62GJF:ZD]N\N:2)FXBP%OS&1>YS/ 6E?HOYAALWC&;Q!(;VR2(GLJ
M#3BUA4[<2LAMY58'7*9^Y@PVI42#8OM*>7'%1+[2$ON+;6%'JT'5%*$%*E<E
M(L4NIT*E<TBYI :YT%[#!! :1_,/$C= @D]R5DU-(YFG#FB3N $3BYC\O.T"
M#Q>QLJEP5R)D5''E%F3'9F&(\J'8)1&<A.(80U\;*7'09#:N%+[D\D#D ^QK
M:4]7IB!XF"<>*F"9L1^8WXN/FM74I5"+!V)$AQB^<6CB]_DJVE8;D-_(-7CG
MU,@2VGX,9R)],X7)*FRI$>.AUYI3C[@2I+8;"G"00D$^M5:FOIG:=P]ZRG:[
MFO8(O_X;G $P3X0!><2K=)E3W@)N(=,@@3Q=T2>USV NHO8=M96X_83K>:AZ
MHL8UJ\)RIS)^QUN2MEUL-R0769T@MO<\M!#?QN<N!P)0O5]*TNF_$O>Y].L;
MD OI/$QG\@FTWYX,*^Y[P;;B/*2?U\C $9OY2,I9*:Z;%E"-*9K(2EN(^J<D
M269$EQ##JY<20JQ8 2U],A8B*BAN0DN,E38<*]9^H=HSJA1;2I"NYCR'MIT6
M& V8W-!>"6^$D-)B([HRK5=4:W:\,(,SN@$#F3%[F.2++V0_I9;L[#0?$B$]
MC]RQBK%'?V$K<>9F%W J(B<MM@U(G6T9RSM$(CTCY=8K:V.4!0+,9*6TKX!^
M3_;GI/4'==KEM&H]M7<: I4:SG.#2"YI<UA:7 $OF6L#"9@B3O\ 2ZIH8&N<
M(;&Z2T1.")>)!L( F<3A97Z+(:+)JV%<8]:0+FHL&?JJZTJI<:PKIL<\#YHL
MV$Z_&<1V7U(#H7V2L%/VJXX*M0?1JEE9CJ=5A(+7-+7 X((< >Q!%B"""96Q
M:\.$M,@_49XFUN5W>J%4FB)HB:(FB+XH<I4 .200!SQSR/QSP>/]>#Q_0Z@B
M01)$@B18B>0>".$4+_)?=:,Q@^6X'BEO$;W$?B0HH@R*HV0@M/+$I]V8RN3!
M^=#T5"TL--O(4\X4M*5'2ZIYKR+VS_B=T?H52K[.N<']2U5=_3*S7FB7T.G:
MIC]+5USFNUM"LQK2_>S5&@^@T@N<QS@&K>]+Z-6U51FI%-QI@!\AKH!$&6_R
MWV;)GQ6%P>5AD=J(2)41NJE2\<BUC;-Q)<N8%K-DXM;1DH=R%>YSLK+9(R*I
MNJV<%8_7*BV42E6@I*%M-H+OES/:[1^S^HIU]>]FHHU:S-!TX5'T:@JZ"L]N
MW4_S=32;4#=I'OZ!-( V8X@A=J[0U=4UE,,+BPCASN]CX7<$B?4S@*OMM(4Z
M5?VK+UK9S*!:W7*6^MZMJLL;=!6%J?<D,R95+,ITA0:J8W6*\B,4<MM+2$CY
ML_CA[0Z*OU@5.FM81[Z?Y+:+K6YH5C:1Y7/I/=="T'X2E#V$6X:/4_TM(,W)
MV\ 'F9@8SY)46PCT>@G 6S]U-:*H$-#+*XKG^5J0XI<ML_3_ !CDJZ+7SP$H
M/)([#^$G\4M;T32465O>"GNIES7BH YK7#<)?KZ5MLS,"<V6B]J/9_3]1J"I
M!:X"Q$3_ /&!3>"01VD' !!G(KMWNMC.X]>BRH9GRQ^R4N N,!QM2D!S^8A$
ME[A/!">03]QX( X)^T/9C^(G1_:;:W3%P>X@ ;M+DB22*>LK':+@F,V\UY5U
M+HU;IQ(>TXD.+7-$2!%V-&Z^", W,6NNH%0X!(/KV#P?^@_?7?N!<T;21,&0
M8,>HE:4$ \$C@_N%JU6B:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)
MHB:(FB)HB:(FB)HB:(FB+;4A2E@A1Z@#E!Z]5'DD\@H)_I["O^'(]TD.W @V
M Q,"9\KS]+71=384E=9L/,3ZZ#.9?X^6-*89>8<Y'106EUI:5#H3R"G[B.I/
M"B=7Z>IU%(@LJ%I:"T$/>" 9D @V!-XCZW6/4TNGK2*M-K@3N(+6N!($"01>
M/6RP0?JV[2;.4=;ADYC .<QRUTTXET*8E545]/&*ODES&$A+:'S\:&FU,L*4
MYPHN*&O1O8O5:NL*[Z]=KF4ZK& OJO-22W<8#B6[;CM))GS\P]O-+H](_2OH
MT:C2ZB\N;2I4]I J9(:ULNS$R0-L<E83MKL*G81FUKCJ+:.O!<GC&0C&/D1+
M<>G*0I#BV_B;Y;'5*2I3JFT%7)' UTWM!H':M@J-J4( $A]0;C!O #76O$$Y
MC"\.ZGHW:YKGT:%0D2"7TCQ)PUCYF2!:.X)5Y=OMDLKM<TGL;9T=C>QUH4Y+
MK(<.6^Y"=:61VX^ H4RD+4%K9<6 HI2!R1KSZN:6F<VG()ATED$&#W\/?D<K
ME]!T#J/4M2_2Z;3N-0&"7TZH;DR993>; &9:(S"OUFVT.0X35PK[/-M<LHT.
MI+;,Z77.L]Y,=!4?AZ.K0VA\\=%2OIRLI20D +ZX_P")9P3VN 8MSXK6](LL
M[JGL9USI# _546.8]P#?<-U#YNT D.T[&D9,XN8$JU5_?!BB:FMXYD*XLBQ3
M4,/N(=<CR2EAEZ4(JUE$:08S;T<2$L.N%I2@ESJ%(*[U+4-@D-J.F =C [X$
M!QCR,Y%O+3NZ?5TS:;M50J17#C2 I/)&RS]WO&- _,RS,B9 @*D\@GS7'H4E
M=Q74>/1((>EI_AR5OI*"!#1*Y;[@MK#XD*9^<H#B>W/8#60UY>8#*@N3=A'Q
M@3_A4-TDBU"J9-OY9 $6.&QYB+?$E45F6XV)8?6Q\BR[**"FIU-_(5/2Q)8F
MH6D_&N(EEE;3*W__ /6HH=_(<;;ZIYS&,--CBX$;P(MB"<S@^4;LVLKFGZ3K
MM7J],W1TQ3=1J!]0Z@5*0<V1&PL8=T'_ )&P((<K08QN'LSO65UN/;CX[9R6
M@_&D44-;:9K,-]10X%I>2RVX'AU3V0>S752TCW[ZSV=ZA3TA(J!\DV+&AV9,
MDE[2(&9D3E?8'L&ZMH] RE6##4VM!(+G"0T"9.TFTYN1=7:Q7&9&VD-G$*FH
M2*EI;LIAR$ZEQMY+RBXVA;SG0NCJ?N<X*DJ 0 4@JUT=2K-5U=T[*L-8  3C
MD$PWYD&_)7;R]]1SG%NTW #BXS,DP9 %Y!MCBX-F<@BYLW:7%G"J+!QJ9)^,
M%F9\#R%E7*4)2WR"PH@)5[3P/N 5QQJ^]A;3%26[0)B3<&V(BUN8_?(8Y@,$
M;I@7VF(Q SS_ 'NHS5/DQ&9R2YP;*XL*OGIL7J85<\*9=:DI5PA#4X)<+K3Q
M_F%#I:!X*^>4 '15.J--5M&E[UM1KY+B(:6BT2U\DFV1CG 51<PC!$S@ 7'!
MOZ@DB;&"  I$3JF/N)1XQ);L:ZFFT2ELR'7F.2B'$EL2'D-.DE#S+X;0R">H
M6IQ*3U2HG75Z;6U10))=.TQ+G<M  ,NG,GX3<RL)] .<UP#0)$BPQ)/'U)]3
MPHUW> 8/E5Y;,YC7Q)>354]<%FN:ENQHU9$CN%Z+-#,5:TI1(;?;<*OB/W%0
M(6/SIJ.KKU-<\-J!A]TX[GU',; <VP.[S-N\JZ]C'LVD7D$6; SZQ\K>1(BX
M&UFWUG=S\A*5Q_\ #M5&>C0')"43"B8A"6HR8SC_ ,#RD K5U^P*(YX3SP-;
M>IK:^FIFH_4TBT"2&5B3 M:7-G(@#RO<K%?HZ9NUHGN0+7N+-/?,F9$K-E^G
M5^GR_F>?8UG&[&W%HO"L9KW;.LM)LF345E[? A<,+@@)?DPP5*7W ;)+83V"
M5$G@O:OVWJMZ>_3=-U-6GK75:<.#R *0)-2"RL29! NS:;@@JVS0L#P:@8YH
M$P0.8C#/CP1;,%7:\SOT.J#*X4C)?&=Y*<HLLTF9!:XQF-_,:I8M=;_4R;*/
MC;J8LTQ"JT=1)^&67$)C_,TVZCL!K7^QW\3AT[5MI=9.LJ4@W:7TMU8[A NR
MKJ& ,V@S!)F &Q$VM3T\02P,OP !.8-FY!YMZY)\^N]>WF5;+9MDVTF<0HL+
M(,(LHT*[K6)3$M,91B191^C6VM*W0N)+C/-J6VUV#R @*<"FQ]#=+ZATOVB9
M1ZET^KM+VN#'5_=TO"?"Z2TO>,$7-H.Z&RM)4I/T[MSB7-$>$&3<P"! !B;0
M1':Q5'87D&4Y$F5BM W?V$>SDM%K'ZJ9.LG[>8PM#D!E=&(Q29!=9:4VW(8+
M96@?S4\?(EU/I_1M+1?7U[:%5X!+O=LTM8@09#?>!OBR )B" >QML;5J/!9(
M%A<N:<^G<R9S@<+V\_IE;79)M3X?;1467MW,:_M(=SDLZKN0XU,I5W-]<SH=
M=(84&_IWV:N3#0["2@QX[J%!I;H0EQ7R)[8:K2ZGKU<Z)FS3,J/;3LQKG2QK
MCN:PEDM<YPD$F!< @A=/HPX4@'SN(DVM8EOJ) !C$S$860?7.K+31$T1-$31
M%P;"4F)!F25-*<#$:2Y\94EL.?$RXYT*U'A <Z=$K/H%0)'&L37ZNGH-%J];
M5GW>DTNHU50-(W;-/2?5=&YS0#M88)<T3EPR*J;#5>RF(!J/;3$S$N<&WVAQ
MB3PUQC )LO-EY->2>9Y#F>41GHG\(ESK*&PLP'&T3$0:Q:X;+;<Z.VI8<4H)
M*EK6$A)6LDGE)^$?;^DSVEZW4]H-+J&C65 S2/%6HUC1H6O<Y]5I9[VJ=6 6
M[9J.I$@^%O'NGL[IM-H>GMT^HH.=7VEI<RFUS"2V)#G!I(+I,;0 +Y  L#@F
MX&4UER]D=[*=?-FZVFZ=GK;G?Q!IL-1V69#+X^-QIB*TC[UH5SQPIM0 &N,Z
MF[5ZC04J6MJO<_I6G]QTUS*CZDT:3-U.I7-22RL7[I]P&-V@%H"S]$[2:;4$
MZACG![P&;*;';27 -G=M  @3G!/"D4K+,TRR9=O43L-K'8M*EZ--J$MB2'&V
M%*>:D!T)CQFD%*0A,:/RKJ  @^QYF>FOZAJ:=?J3W5SO)>/^\-LR(%=C]QN"
M9,#C$KIG&D1_*MRW -HR&VCM$^I"B4[?64S*UW^06ZY$F,F.VW]22"68X 4>
M>G3Y% <<#\^N#_3U+I_2>C_AFC2TW,=[O:2^CIV 6@F6,MZ]K&;@\]K'5&U
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M13W3-HC,V-Y7E5W*CW=5<OS)BW)CS$QV09"5DEYML NPY++@"T26G0I4EA7
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MQ$YNN']JM>=C@V27>"00-LBT]KC/P/,YY&V3'2$CH&TI8:;:0 D(0V2% ?T
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M;L;5X1DLUF1"RF\KJ-9:2\W @S+.0B.RS+6RE2W62MT(4&@H)<*%NE+"'%#
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-\/W1<G60B:(FB+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>g105868g97b09.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g105868g97b09.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2&J4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (8Z^A9 X0DE-! 0      !@< 5H  QLE1QP"   "   < E  !$=E;F$X
M0DE-!"4      !"ZEVQ$]2R5(VA#VC^P4=%J.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0%@&%(         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@              R@   E\
M 0                         !              )?    R@
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    R@    !29VAT
M;&]N9P   E\    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M C_P        .$))3001       ! 0 X0DE-!!0       0    #.$))300,
M     !=<     0   *     U   !X   8V   !=  !@  ?_8_^(,6$E#0U]0
M4D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M86-S<$U31E0     245#('-21T(               $  /;6  $     TRU(
M4" @
M       18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP
M=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     4
M9&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0
M   D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M!#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M    $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV
M-BTR+C$
M             %A96B        #S40 !     1;,6%E:(
M      !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:
M6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W
M=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
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M"58 4    %<?YVUE87,          0                        */
M G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M
M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H
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M-3!L,*0PVS$2,4HQ@C&Z,?(R*C)C,ILRU
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ R@)> P$1  (1 0,1 ?_$ !\
M 0 !! ,! 0$            !!08'" ($"0,*"__$ '40   % P(# @@%!Q(.
M#@8+  $#! 4& @<1 "$(,4%180D2$Q07&G&!%188D:$*(B8G5['!(R0H,C0U
M-C<X1$=56&9TE-'P)3-"0T9(5%9D=X:6QN$9.4524V)G<X23E]/6\6-R@H.F
MMF6%AXB2I*>RM,+2_\0 ' $!  (# 0$!              $# @0&!0<(_\0
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MG^0,%U(_N71:A_\ L/'ZR(=^.UOTHV@X?W8Q#VA_'#Y=O&[L'RQ.*7?EF_\
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M-_F$! =F=F_H_@N[^2Z'S/(#N_'SV+OQVM^E&T'VSB'M$3\NWC<_=B<4F?\
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MQ]0/IZQXH@.?3<=PVSD>G7EMSR'> \I?J/O[^;L>(D=^@[B&VXB&VXX'8.8
M _-RU%[::7/$[O*Y+<;/Q1&P8V[^8A@/O\\  ]<;!U&3?W],(GKSQ@!VWR&1
M#&.0CW!CH%/7.H\>I%_,; =7BN;-#L[>S[^R&V,;X[!P&>P<C_,!Y;!NWZ;K
MGU-Y_+QA$8Q@-^FV,9'(=FVP=_/?(YTUOY/=K/H?<PB<[>+G&=@P&0QG'MST
MR.P^T<Z6OU&_DW^:$.0XP(=,  [A_JQSVW'.,9R-_)Y/'<;]P(U!?2'OI^[R
MQ ]O4.W8-@R&,;".^W+;G3IZ_+PZF#!^UVZT3[,#G80$,"'?C;H&=L9P&P8T
M Z]6T]1X< ?1:'O[]L  1Z!CIOCL[ YAD>F $1][SD<+'KUW'U:F'OK  QOL
M.P=NW7/,<9WR(9[@'(AH[O;CV'=[@^<7A#EG<=L@..F^ 'ISW$0#/3.^G[WW
M'T]7!]VA$(]]_J<[/RV[HAR .%>;;>V[5C_Y,#CF(9QOKY=\+7Y.477C=-_^
M!B7OQ/BC[-\!OY68C_\ QVK_ /\ 2PB/6V[W@#.&N\=V+GW=?;P7R:WNZEPY
MK<AY;6A7 :6IO=IQ)7.4.")LI60A6LI;DBQT.(14JE2E2"8LL#U!QOCF5<+0
M?"AC&'T-%02L/PQ<NAI*:CE+F)JN44BFDHDI4LIJ4ISJ2@%65*0Y+ !@/I6)
M_ U@.*8EB&)SL4Q>7.Q&NJZ^:B4JCY.7,JZB94+1+S4JEA"%S"$9E*5E <DN
M3CL?J<3A5''V[N(+;KYY;C/_ ,@^WMY[Y$,ZVN=S'/!V%?5K-&_[UQN\:/,7
ML[X7QKZU#['#U<3A5#E>WB"#N\]MSCGV?$$/?^ -M3SN8WX-PKZM7ZZK?OAS
M%[.^%\:^M0^QP]7$X5ONW<06=]_/;<]0$/[P>89Y\^0:<[F-^#<*^K5^U0YB
M]G?"^-?6H?8X>KB<*V #TW<07?A;;C??.WV [>[4<[>-N_Q;A3\<M7V?X5#F
M+V=\+XU]:A]CAZN)PJ_=NX@L8#(>>VXW$-L[P#L^D '?&I/PN8WX-PKZM9[5
MKU[H<Q>SOA?&OK4/B_B</5Q.%7[MW$%[16VX'MY_8!OM@/9D.0B&G.YC?@W"
MOJU?M4.8O9WPOC7UJ'V.(]7#X5?NW<07O6VY' 9R !F _P \\M1SN8Y;\'85
M8_S:N^O^5>YW0YB]G/"^-?6H=?T/S>>)]7$X5=L7MX@@Q_AMN?\ P#GZ>[3G
M;QSP=A3\<M9Z.ZM+GTZWAS%[.>%\:;_.H?3W'ZH!]3B<*H;^FWB#[OQ[;G;V
M?8!_/?H.-3SN8WX-PKZM7?\ VJ',7L[X7QKZU#['$>KB<*N,>F[B"#_IEN/?
M_8#]_ISSL(.=S'/!N%?5J_:A]T.8O9WPOC7UJ'V.)]7$X5N7INX@>H[++<;#
MW?8#T^][L.=S'/!N%?5J_:H<Q>SOA?&OK4/5_D?5$!]3B<*H?LW<073]>VYY
M@/,/L!R'7D/,1]FHYW,<U^+<*^K5^/\ C79Y-8<Q>SN[%\:^M0^+^)Q/JXG"
MJ Y]-O$#[UEN/P0$ ^CNTYW,<\'85]6L\?\ &ON%K6AS%[.^%\:^M0^QP]7%
MX5ONW<07;CSVW.PYY_H!S[LXW'IMH?A<QSP=A0;_ !:OSCNJ_NQAS%[.^%\:
M\2J$?\G#U<3A6QCTW<07N66X#?M'$ Y]G+D ZGG<QSP;A7U:SVJ',7L[X7QK
MZU#['#U<3A5^[=Q!!VX6VXY;?O V'(9R'+3G<QOP;A7U:SVJ',7L[X7QKZU#
M['#U<3A5^[;Q ]F 66XY<^L 'K_,-.=S&_!N%>2L]JAS%[.^%\:^M0^R0]7$
MX5ONW<06>@^>VYV_^ >S8>WY\N=S'/!N%?5J[\?XUO\ 3#F+V=\+XU]:A]C;
MMB/5Q.%;&/3=Q!#[5MN1_P! <=_W]1SMXWX-PH=B:O>7/\:W_K\3F+V=\+XU
M]:A]CB?5Q.%;;[=W$%R_NVW.^1R/]@(?R]^A^%O'#_)N%=A35G_FN+'U\',7
MLYX7QKZU#['V^^KU<3A6ZWNX@A]JVW/=^\+?<,[Y^;;3G<QOP;A6_P#-J_:7
MMU-#F+V=T^-\:L_YU#O_ -$AZN+PK<O3=Q!8V_7EN=\=OV _/ISMXWX-PI]W
M1J[=G\*\O'L80YB]G?"^-?6H?8X>KB\*P_LW<07N6VY#_0'<.H=@]VVG.WCG
M@["C9CT:R_\ M5NP>-XGF+V<\+XWO_.H=/T/R\8>KB<*WW;N(+WK;<CV_O![
M_P  YWS/.YC?@W"OJU?M41S%[.^%\:^M0^QP]7$X5>E[>('^.6YZ=X0$!SMW
M!W:CG<QSP;A/C15]?^5>]^-G,7LYX7QOZU#['V^XN'ZG$X5A_9NX@NOZ\MSU
M[_B#G/3GC&V-.=S'-^&X4?\ PU>OZ5#F+V=O^%\:^M0>Q^AHCU<3A6^[?Q!!
M[%EN ^] ?Y^X-.=O&_!N$NUCEK"?+W5#F+V=\+XU]:A]CAZN)PK8QZ;N(+ X
MV\\MST_R!ST#K[-3SN8YX-PKZM9[5Y]WI<Q>SOA?&OK4/L?OU;I]7$X50  "
M]W$%L.?S;;D0^;X@[?\ D//3G<QSP;A/U:SQ?QK]_5$\Q>SGA;&MWYU#X_XF
MU_=XCU<3A6SGTW<07\<MSW?O!WY<AR'=H?A<QL_R;A7C35G_ )J(YB]G?"^-
M?6H?8XD/J<3A6^[=Q!=X>>VY]_\ 8#C?KM[-1SN8YX.PGZE9[7&0^ S9T/\
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M7:W5#F,V=\+XV_\ GT/G_@=[P]7%X5LY]-W$#_'+<\^W] //4\[F.>#<*?\
MS:OVJ)YC=GG)^-\:\:J'U48_<3Q,/5Q>%;;[=W$%M_AEN>7^87NSS[]1SMXW
MX-PI]YRU@_YKU^:!^ W9WPOC7UJ%]^_N3K[6L^KQZN)PJ_=MX@>O-9;GK_D#
MO[\ZGG<QSP;A3;AEJ_:OU1',9L[;\+8U9_SJ'?\ Z'NW.3>)#ZG%X5@_9NX@
MMLX_'EN WY?W@_0&-1SN8YX-PGJZ-98_I7ZHGF-V=8#XWQJW^-0\&_P.Q]=R
M"8>KB<*NX>FWB!W_ ,,MS^" ].FIYW,<\&X4W^;6>GNKWUB.8S9V_P"%L:OK
MTJ'V-W'%_$]X>KB<*OW;>('V LMQ^& #C^?;ISN8Y;\&X5]6L]J]+P/P%[.W
M_"V-:VZ5#;_8XCU<3A6^[=Q!#N CE;;D<X[?L!_G@-1SN8YNP["?J5GM8@/@
M+V<U.+8V?_%0W[?X&8>KB<*V<^F[B"]GGEN<8[,?$'ETTYW,<\'85VY:OVK7
MS=4.8S9WPOC6E^E0W/'\3;Q>N\/5Q.%;[MW$%TYK+<CRSCG >_V>[.IYW,<\
M&X5]6K]J[3XX<Q>SOA?&O+0'_DXD?J<7A6'G>[B!YY_-EN0W#V0+.G.YCG@W
M"OJUGM41S%[.^%\:^M0^QQ'JXG"M]V[B"]OGEN<[8_>#RVY<NSIH/A<QSP;A
M7U:L?\U[]>L.8O9WPOC7UJ#T]QP]7$X5?NW<07( _-EN>0#G'Z OY]-1SN8Y
MX.PKQ)J_:C^KM:',7L[X7QKZU#['#U<3A6W^W=Q [_X7;C_P#UV^;4\[F.>#
M<*T_FUGM7W]<.8O9WPOC7UJ'V.)'ZG$X51_9NX@OX[;G'+H'Q!V[>NX!J.=S
M'/!V%=9RU=_]J_=NAS%[.W_"^-?6H?/_  .\/5Q>%;D%[N($/^F6Y_\  7SC
MS[^6IYW,<\&X5]6LZO\ *O5]\\QFSK-\;XW]:A;R=Q^]_$]7%X5L8"]W$$'/
MDLMP 8'N^(/S#J.=O&]^&X4?_#5V[/X46]][DQS%[.[L7QKQJH#_ ,G#U<3A
M6QCTW<0.-L_CRW.^.W[ ?G'GISMXYX.PK>W1J[/I_&KMUQ/,7LY;\+8UN_.H
M/8OU^.'JXG"IOF]O$%N/]VVY[_W@;CN(9_#OJ>=S'/!N%?5J^K_*NJ(YB]G?
M"^-?6H?8XCU<3A5ZWNX@QZ#^/;<Y]GZ >77D.^G.YC?@W"OJU?M4.8O9WPOC
M7UJ'V.)]7$X5@_9OX@OX[;C/7G]@.^X]0]F-0?A;QL_R;A/C35F_Z5#F+V=\
M+XU]:A]CAZN)PK?=NX@OXY;GO_>#USN//OYY<[>.>#L*.^Z:OVH;[^:PAS%[
M.^%\:ZNE0^/^)P]7$X5M_MW<06_:LMQVB/\ >#@>8\PTYV\;M^#<*8;@FK]J
M][[C#F+V=\+XU]:A]CAZN)PJXQZ;>(+ ?X;;G<>_[ -^FVWWL3SN8WX-PKZM
M6^__ "KKM]\.8O9WPOC7UJ'V.(]7#X5>M[>(+K^O;<[COS^P'.V>W?J.G.YC
M?@W"OJU?M4.8O9WPOC7UJ'V.)#ZG$X50Q]NWB"Z?KVW/3/[P>S80^]ISN8WX
M-PKZM7[5#F+V=\+XU]:A]CAZN)PJ[?;MX@MN?X]MR(#[OB#@,[\NT=.=S&_!
MN%?5J_:>H>2',7L[X7QKZU#['#U<3A6Y>F[B"_CEN.O^0/M^<0Y;:<[F.>#<
M*^K6/Y>ZH<Q>SOA?&OK4/L</5Q.%7[MW$%UQ^/;<8 !SMCX@<N7S?,YW,;\&
MX5]6K]=3[N8<Q>SOA?&OK4/L</5Q>%7[MO$%_';<]_9 >>,!GGMISN8WX-PJ
MW^+6>U7AS%[.^%L:^M0^R>N)'ZG%X5ONW<07,!_-MN>G^0/+N^^.^HYV\;\&
MX5]6L['_ !IWZW>',7L[X7QKZU#[''$/J<3A6 <^F[B"_CEN/I^P'?\ G@0T
M/PN8X?Y-PK?^;5G_ )J',7L[X7QKZU#['$C]3B<*N_V[>((,CG\V6X^8?L W
M#GS[NS=SMXWX-PKA\VKZO\IMINMU0YB]G?"^-?6H?8X>KB<*OW;>(+&=@\]M
MSCW_ & Y'8?Y<AMJ>=S'/!N%?5J_:H<Q>SOA?&OK4/L</5Q.%7[MW$%W?CVW
M/_@'GRY8 ,;!RPYW,<\&X5]6KT_2H<Q>SOA?&M/YU#['Y/7#U<3A5^[=Q!<_
M[MMR ]^X0$,Y^CH :<[F.>#<*^K5^U?KAS%[.^%\:^M0^QW@/U.)PJC^S;Q!
M?QVW.<=F1@';W9Y=0SISN8WX-PK?^;6;_P#2NWR]KN8O9WPOC7UJ'V.-RN!W
MP35E>!"[$AN[;BXMT9<^2.WCM;A4VS91$S6DAI=Y+$I.<M34,48958.!2R((
M4Y-1BHQ,"92K"I/4:)1A7/;2;<XCM-0RJ"LI**1+DU<NL"Z83Q,5,ER9\@)5
MRLZ8G*4SU$LD%TI8@.#U.R/P;X5L?B4_$Z&NQ"JG3Z&90*EU9IC+$N;/IJ@K
M3R,B4K.%4J$AU%.52G22Q'JEKB8^BPTA#2$-(0TA'5*7(CU*I$0L2G+$/D16
MI"E!)BE&"F@3$XJB**Q-3^<%@)A/EJ*/*T -9?C4AG1CJUCH>+:P<<8[6D(:
M0CY^6* T"!-+\O474:!/CT^5$JBJFBLP"\^.)=-==%-58!XM-5=-(B U  H0
M\L4)M1(&EB=112;65X]/E:"ZQJIH,J+SXU-%55%=--8@%-0TU  B-(X0CX(U
MZ%Q*J/;UJ1<30::GK.1J"5)5!Y-7B'$U&$5UT4FE5?6FEB(5EU?6U4@.VI((
MU!';:$=O40AI"&D(XUUT%45F&5TEET4C77774%%%%%(9JJKJJ$*:::0 1&H1
M   ,B.-(1327ME44C4G=VL^FD:@JJ)<$AM(#076=4 C0=4 #2248;5G\J677
M6.*:*A"<JAJ"/$?U0CNT*4QE0T4*"*ZZ2BU%5-!I=50$&^-Y(X:0J$0*,\2O
MR9@AXE?BU>+4/BCB&/#>WOU]4'''K\7&.N0ZMBDJHY,Y(%!-)M!%1I"Q.:52
M<;4%)9-1A9E5 &F554TT%B(5UU5 %("(@&I((U!#W#@BW&(<<1'?U$3#2$<#
M#2RJ0J-,H+I&JFD*C*Z:*1JK$*::0&H0#QJJA *0SFH1   1TA'/2$-(0TA#
M2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(
M0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#
M2$-(0TA#2$-(0TA#2$-(0TA#2$-(1 YP. R.!P&<9'&P9Z9[>G/2$?FZ=8E>
MGAI'B@XB*[2.EBG55'I7*XM(YDYVA>;MR:_UP[\1:?.=@+67(MD^C(.(6V5S
MTC4[ML.(O-;YLGL4%9&XM%C"DYKPB:/:"Y<\R) F)F K0E24B8F6)2)2D"=,
MEK"A*FH*G5R:E(6Q4H!@5>?D7*Y29E,LD*('14I4Q2\V1)209B5,PY1*5#H@
M6) VR>+>^$C>%3.Z#.YPT/)Z&SDD6MT=D$ 3PAJF5U+]J9!=:-&)EY9CP[0C
MAPLLWMT/1E&4$&3JM:>X$IWMU6+*4VMFHT@@)20\U()"BO++E-++A@%3IA*G
M?HLU@ ]K5!(+D6EDCH  J6ZQN<2T6TZ76;1;3(V>%!(9)W*B$=RE4SCZ2-/Z
MR%S286<3QJY-QF>_+6^K8U9VM@<EY43M*MLD@>8DX'2TUC<W2M^9EBAN,D38
M[JPS)H<R$]#(2H9TIF9D(,IGF9F*I@F$*&4* (4Q8@1B.Z %$9W#%E974H+=
MD7(",@(.9B7!U#GHW4MCX0UA<'5VC;=)[@SA5!+;0<ZYL-<[6L[^6\R!PNC=
M*[)D;J?7V&R%-;%!+D-H;8-4?*E\2<$L=*HDHU.RIM<ZEL2UTBLN;*A.=:LB
M@ILJ>3ER\V4*Z9'*3"<B@22D]$C+*DSP[.HLD!26&4DJ4MG(*DDY$@9DL Y<
MCI9PM/:7B520'B<GEWH.]SV\<VL58RTK4T$3J(PJ1W"&!V>/<IJK8I4W [L$
M+7O%TKE3UL1*'!,C1BYLA*\ZDEI,1+ZZYDR0%R$RUI3+ES9LPJ*%+2@*F#+F
M20%* 0A)(!)8L+N^2$3,LQ2TYEF6A 8A!7E22HN"0DE:E7(&G\UC&E\7LCQN
MV;L')H;P[6&F5OEK_.2$D<D[*%A;97>=X= [9*RH:JO-"X)<\FUE;DX3-0,?
M7SB"26/R60M[8A=YA%WE,90V+]A4RFFS4JG3D+ 0Y23-7*"E+ 6):E2\[91F
MR*24AR$J!N*4HG2Y9$M"ATNB60E92$]'.D'*[VS WMG#!HV.>H7X0DEI^.4@
MD%]I#4[W>01:36YM7*;*Q^0MUF8_:1E1TRN$'2%6U,38^7!O:QT.,C7JY$8Z
MQR%OCR2P,K<)RJFND&DS94B4EI1*5S!-4DS#,-E,%$Y)1Z(:Z@'7818U18DK
M/3RJ2,B3D"!TDDEAF6'N7"5$:Q\9:U>$F:9Z[&Q$N[S_ %QEO:ZXLK>998FN
MV<CM\W6+\1V9I&D;ACKL]7ZD-[SE1'PX7$XW%$2-,TNB)S;6"EP;U6230F6G
M-R8<D* 3-Y1*S-LH$N.13* +9BHDD%S ]TA1;.IB&/R824\F'<NGI%;WR@#=
MJT4EAMYX2V!N_P .42Z[ES"XPID0DQV0SFTR9!-4[)PL):"\&U-XE(3I_P 1
M;D6E8*W,A0FBJ.*JG$]"@3O2A:XBNB4,N64A\O22F82DF??4]((D@NV7-FU)
M $0!4"[K402SJ2RAR0X !)*S:Q8I+:O%XQVWW''*> _B:M[<<B8/5X[EOT@A
MEKT$Q<(.,E8+>2Z*0N/&OR]<V361LWC('9;,Y)6WJ94J/( FI&@;F]-6A8DN
M"ETR:N2N64B6@!2BD+ *TK60/F)(<! !" .)-U'++.,B8E045*Z*0<K@%*0_
MSB"RG+9G:S!FC %Y_!RW9C*%#;FR47C+HRE6@N)&S)_"K=V6LW69*KIJH+:-
M.<Y,D5&/?#KG"K5O-U9.ID;TF6K%@*3$"90H<%1:13=+K):CGFJ(/*).1:IL
MWHH"YA *RK*%K"$L-" 19XP73J'0EBV10S!*$,5%*4_- !R@J-P2P8 []HX#
MP_\ $A:^+\><C-4O]SKE2:(1BUW#RXNA-MXP[2>'6ZMHOJBM"-#%:V&+QQO^
M.LZDC430Z SKC@9@<'"D"34AYFNN=)F*I4L):$J5,FL5J2E4Q8<WS*4<J$DL
MXOVQFE$P)GN"I1"42\V6Z4IL6S96S*4- >T,8UI0^"VG5IF2SK="WFMQ<U3M
M:$+G*K.P^WEF6AA9>'N+R6=15T6(*G%S.G-R9==1#&&9?/G<]S=#/.J5XTLR
M.A:JUL&N3,4LJ #"8)9FJ7,*C.(0H.PRH3+<A#!-F)<B,.YB@)"#_-SE"4IM
M+!4G>25%8#J))#V!&81=+$V^%-"96H*>$MT4;7%;2)DD]=T;]961-DIDBBR\
MH>C@*;G&:1HA5-2;HK6.$F [,BIN-/CZ63$SUC;'186OQ)H<DQN3*E3'0")H
M(3R@#/D+)R J<*=B04J+$9#ND&6X661T[H()R$ZYATL[!F((W@11R(UX5-3;
MBVC7Y]=9I7&3":T2=W*=;6/$Y4"6BCY$$DKRT.US$">+0Y:L^,*]WAI5Q[@"
MA<2$Y=5)L<6EMJ<%4.>8HB7\U+).?)O*DI(1TE , K(DESOZ9A7=.5(&8',7
M4,I)L&)!7T07+I=3$#=:-^.(ZP<RNS=#@V=ZJI*]-UL;H(I?<A4@E:I@@A)<
M78E#VB=WB!%/B5ODJ]UEC<WM;/2H:GXQB)<CS212% 8KIU9,Y,N74@,"M!2A
MT@KZ19@MG2 DDJ8A][V$73$*6J2;]%693%DA@]P]W4 !JVKVC>W6K%\-(0TA
M#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-
M(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA
M#2$-(0TA#2$-(0TA#2$-(0TA#2$-(1K[Q67K6<.7#I=Z^+>PI9.MME#'*5)H
M^M6FMR5V-0>3\5&>N((4FI2S/'')I9!M5.-J!UZF"8<G%L6H,-5-,E-;4(D&
M:E(6986_2"24A3-H2.V/%VCQ96!X'B>+HDIJ%X?2KJ$R5**$S"@@92H E(+Z
M@&/S7C]4FW ,P%7"O"ZJ<YQ5<9ZJ#-.! 0 8S^6 <8$ ]G+(_7^:"F&F-S^K
M^!2_V]A'P;GXK_H]2?IT[]C'(?JDZX6_Y%F&[9_9'?/<&\;#?/8 YVY:CFAI
M;?AN??3^!(O_ ._Z6WPY^*_Z/4GZ=._80]9.N%TX68:(=OI'? VWW',9]F^_
M7ED-3S04WAN?^AR_V\2/AWKOH]2^*MG'_@\(>LG7"Q^I:A@[X_3'>P[-]XWO
MV<^OSN:"F\-S_P!"E_MXCGXKOH]2?IT[]A$>LGW##'Y%F&\QS]L9\Z>V-=F?
M9UTYH*;PW/\ T.7^WZVAS\5WT>I/TZ=^PAZR?<+&?DLPT>GZ8[W].(V(_1J.
M:"E=OCR>_P#W*7^W][\##GXK_H]2?IT[]A#UD^X><?):AG+/Z8[X'^C7W\;9
MS@-]3S04S/\ '<_]#EGT3_1#GXKOH]2?IT[]A$^LG7"V_(M0S?D'I'>Q'/\
MFV'7KC'?R'3F@IC_ "W/\=%+_;^_;#GXK_H]2?IT[]A$>LG7"_<M0SGUN.]A
MM@1S^AL>F,#RW^:.:"F&N-S_ -"1^W^_J:'/Q7_1ZD_3IW[")'ZI/N$']JU#
M>>,^D=[V_P#AO.<8]O,.Z>:"F\-S_P!#E_MQ]T.?BN^CU)^G3OV$1ZR=<+?\
MBU#-@^Z.]XWV#<(V/7LS\^HYH*;PW/\ T.7P_I_%N\D.?BN^CU)^G3OV$2'U
M2=<(1'\BU#<!U]([WV=\:VQUY\^0:<T-+X<GZ/\ B<O]O#GXKOH]2?IT[]C
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M8W%JZ<$F)4BRHM+7@G:BA0F6:D390FU4REEKER:F;*2I"PA(FS%2)29<U14
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M4@&,?R9TC(MIQO<%+GK42[_K:.?/W=H#S]_M^GGI&&GCZQH_5V>;2..>F $
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MB87'SCQ5*%X4PV@9!42>F A(0-*!>H2/ BW!6JFFH0J8H)RI)#A0+LK(2&U
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M!<2K954N;4TM3,31+37T\Z74TZ<1-(4S:9-!+R3DR/EB9=;-+,LR9:% 'R=
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MES;P"E2"J@U&0>GR$V><R4DDC,HG*DJ2+%;*()"20ZDADD;F)$%2Y0RJ&X)
M&95RS ,[$M9RY'$,(R[++,6?76A(MF_LE2:VL+0(ES>G;WA]0K8V3%:*UJ)R
M;7QL7%/Z9<VEEG&4J4ZVI4=14>2:!Q9YI9E29BQ,SA734X)(3TGU#, W$,P8
M$,SG)2$%(&B0-"X-M&(+AK7)=MYBUXQPV6 .2,[VR1Y<XE&J(;(V]>Y2J:.*
MY4=#FE6V19:L.>GLYR4"C1N2E146NJJ\Z<#:7):4<O**.HS5.FG,"IK*#!*1
M\XNH6%@2!I<,PMI 0@,<O\TW)<E((!#N-^I!O<E[Q:+KP;6Y:[43ZUMIE=5O
M0N+$&VW3[(7LR1W%7(H,@I7I"F9E2OLO1U-JQO0NSB5'%H*SDK,M/+7'-;F!
M )J\DU,SE$3)@"\BE+"0$H=1:Y*4N02!F_G,1F=S&/)#*I"3E*DA(+E=M&&8
MD"Q4P=@3H=(RXFL):I-;NW=K/@/[#K8*(VMB+:F<W!O%&YQ1(>C9EYQS>M3'
MKCT]1YJNH%=:B@QP M:;08J3DFT5F;,*UKS,N8%!18%PHAP!UONNUC:T9!"<
MH38!+9027L+7T!UN\6;1PA</Q2%G;T<25HRX^W6U:&4U!+I6F6M:"TKLYOL&
M2IEA;T"FGX-='IV6*ZZZZS7DY<<8\5K3*2:RLN7FDJ.9\W*%0RI8F8D)66RM
M<)&ZP%FO&(E(##*P2$LQ(^824/TK@%3L-SZB/M;&QM@K4S>0(X,TK$TK-BR:
ME0A=9%,),BC<)>WM[4$L<93R1U=6.+,"]])>51S#'P0TF&%T5J$WFI+?27"Y
MLU:4E9Z(46("4NI(#E12 5$)(8J<@$LQ*GE*)85T00I@3F42P)40 ]@"06 (
M&HT:,:,'"3PCJ5LQM^RMCXN?(NEM\A=TYMRKEN#W;]"PEO,@MVUQ=U7R<]1#
MD3:@E;L:WML:4H$U;:[5DKR#R#PIJS-14=%1+!6<@Y$!*W8+*F2 LG* 5*>Z
M0Q! C 2Y27"1IE!Z1)2Q)2 RB4742P(!?4B,HE\*5B: *#XK+3:Z'**NA2A3
M,9>L6&.,*A[C!HTH-7+'\]8JK;6%V< I ]0;YR[**GY6![W26NHPY:;IFLR@
MP2@ !2DJ(   NH C@ 0"$EHLY.6"" K4$NHN<H*1H7T)L=YS&]X^2;A+X?$9
MK 81"PI^+".'-K*4,FD_D4B* Q>3Q"(HP)^&O$.)9F2922@@LX#!K7N5;N<)
MKJ0E5E.7FE^E=165=%(^>4J420+J4I"2=&8 %M61!(8,!E:YT2%  AS89B&)
M )N1H12"N"WAK")J8.L@U;S&E!=ODZIO?I5*GBLY!:^NL80V&J'!Z/4T-+/2
M:>GJ:Z#:$#BD5*T;D0K3*CRZY-3.S\IG93K+A*4L9EEFP N-^H9P7C#DD,4L
MXZ-BI2@<OS0"26 L"S@AP7TC(378.T[+<YPO T,JUOFCH%)KA4BE,D(CJE>+
M0WQX7@^(%O%,4,=S&1I;VRITK9Q5 0F\>DRD\Y2<=B9BS+$LD91H"E!4 Y4P
M4V8!R26+;C8!LP@9LSL3KTE,69SE<I)8  Y02 SQFH! 0 0$!"K&X#D, '0=
M\\AY8Y[8U7]UO3Y(R=[LS.6W7/WCCH >$ Y[;=N:1W]XXW]N?OZ1)TO?@RA;
MQ![=C>B CCEW\_K0^D.?^O/32 #Z^;I'S'3[FWQQZ^WF Y#'(.G;D<9#KG2,
MMW9H0Q?4[^#!V.YH@=^@C@1W$1SSW'Y^8B'WATB?&+@.  0[6''30 ^D14F>
MMS+<T-;,)X.@*2@1>;A54?Y81^MIIII 1J"O(T&454B6:6-=)E(T55!4+,7T
MWQB;\;N0UKDL6]W38W:V\;4+B+<B%WI3T.8IRQ6TI:AJ(I/Q]>!8U>[Q@ :J
M0K\8**ZZ IKJUSJ6TW18'8.7.\^_OU14-(F&D(:0AI"&D(:0AI"-#O"?_P"U
M_<5_/]*&0\N?-/KIMC/RIP+^L)/KCCOA!_(K:3^K)WI1'\[00#',.N<@.P9Q
MG;&!V  #D.,!US^L'ZNSKT\=M]K#<[B/Q! -@Y8[1 0Y#G ACKT# ?-MB==#
MXM#X^&HW=KBQ>Y[(#MXH@. ]^.T<8W$!QG?NW[%B3^KA][^?>#" \L#@>?+F
M(=NP#OD-_=GM !KQ.N]M+<>SAYH>_EW>]K]L1@-NNWMQS'Q<9R(]_O#&,@^_
MMLP<?N9^K5KJ3Z8!GIG A[]@Q@!#F(!RR'0=L@.I]7Z_=QY8>_GW>_& ;[CO
M@.8#N 9 0ZAV9QSZCORC1FM??OZAX].RUH1. P(]=\=VW: !L&V^P  AT'<3
M8;[C]9+&[ZL+F)W;]?%;Q=?'Q7A@ $!^8,=0Z@/(>G: CG ;XT[7W^FVGN-Y
MB/?]7E@ B&,=P@ 9 =M]AY[#V#G/UW40&?'OX\=V_4;N!:%_3O\ +[[XO297
M$G5P?BZ$VE;W**8G'4$3BY3RO.6$,$;;/'%$RM)!@B0A0$UFFFB2G++ TXTP
M\T33C*ZQU::DI:3ENYI$N3R\Y=1.Y-&4S)RR<TR8?G+4<H%W8!@ E@-NIK:J
MLY'NJHG5'<TE%/3B;,4L2:>6^23+!+2T))4K*D!U$J-R2;+[LXQL.P8$,  =
M<@&,;]_/6RWE[?)PL'/BW$QJ>]NKL], WY .! <X$.8@'\\#C<>P,:$MV>4D
M"Y\FN_RM#W,1W#L'/?/,0#81WZ<A'<-.IQ;0/HQ\5GU':(>7J\O[_'$\N[F(
MXSN'0>@AN..6.N, &H9[O=RVEN.XC=V[B8=?'K]/WPW#< $.HY#D'=D=^N>0
M[CC&^IMZCHSEA?>YMU-" <Q$-\;[@'4=QYX#J.^!# ;XR&ATOIX^P"Q??U@^
M2$<L#C<1Q@ ^C B.>@<]]QZY#&HLYT=SH^G61IU\2_&)'7NX:\2UMV^..W9D
M0]F-Q[=QR'0-QZ!G<1E_%OX&WJT\MQ!SQ/CZK\?'VPW# 8[0S@1VZYQGJ.<;
MAOVAIK>]KC1CV'[QUV-U^'7IP]7'=$[XZ!CGD,?E=^@\MPZX^?&H9K7OON>U
MPQ&EMY.^]XB&1\;& Y]N^,^WW\N6>F=3N?T-?6P/HT,2'>S^+6/T#_4ZOZJZ
MZ.>?H?4=G20-F/;MGETW'.0U\K^%G^XE#_W\?[I;Q]H^ _\ *2O_ *L5_OD1
MB[P_X_D^S>?Z2]O ZB'YKE/3D'//7EV<M[X+/R7']8U=_%)MYO/'G_#/^61T
M_N71=OSZFVK>:/$CF 5 &PCN&=NNX[=H\]\  <M\?1M[=7N_D_7U_)QU!QOU
M\[>]HV=X0KTPVPEZVBXLZC*F3LB)DDK310WHOA!U8W1Z:CV]ME3.C&1PXQ4Z
M1]492O1%)99&E0F%AYN^-]>#J?&Q[#:C%,.F4E+/$B89LF8<RLLN:B7,"UR)
MJC*J&1.2Z5%4B<ECTI2Q:/>V:Q2DP?%95;5TZJB4F5/E@(1RDR3,FRU(EU,I
M'+TI5-D*(6A*:F0IPZ9R" 1OLEX]K&/A%Q(PKBTM8SKF7)BS\U3-'#X0TI(,
MV,_Q=0NQ0(G*43&0$(KF>8'K;F5$350I)!&E4$*9$O4K5>N65LMB4M5+.3.I
MY@HZ2?*F4YGU$Q=2N9RJI?21(II151A:4T;R$@YE IEI"1'82]K\)FIKJ=5/
M4H575U/.E5:::D0FCERQ(1-2$3*BKG!%>):EU[52U=%*@:B85+C+LF\(3PRQ
MF[2I925=2X'Q8D,L5QRX;;'(D@H1-+NZ(3J+?Q])&[D0UX=;>"B3**DR^J61
MD:%:JKSR'.:&I2D5:$C93&IU"$O0TIGR*=,VD7/J%9IDM"GJIRIE)42T5>92
M73R$YTCHST*"5)].HVSP"3B6=/QC6<A/J52:U%/3R\LN9-04T<E,BNI9RZ+(
MDD+[JIV*W523$.E6%E?A%K4^45-+5 )0E@YZ.0*BXP;%X$>V%RM?<,J6,C\>
MT&NQJ%6H9FRDYO+.-,!2494*9'6G(,%05Z*=DJ_HS)E7(54A4I)G<O5!9D)I
M3(FRPL("D\HL!;!+$!U!QECRCMMAX>5+HIZ:4IG*33FGHU2Q4+KNZ9,Y4M4P
MI494L% 43F#Y4*2.D*W*/"'<.3E/W28%VFFTF^&J[9'.9DA;&PNA4KAS^YN:
MY4@9Y3<BZB]I!&D6IZV9O4S-];52]$44"6.M@%)"*I.R>+(I44YKZ>0)8JPD
M253' GRD2TA2Y%)0IF9U(4)BDT\I24*)S3EN3?.VTP-5=.JAAM54\M\7E9GR
MTC,JFG39BS+E55=B2Y02E8,I!JYTM2D 99$L)2GIJ/"/VS9UB<V-L]RWMVI7
MV_*D5SI)&8 SSNXD?8'M>ODC=)D#4_NZ)+YTTJRV!$G*?'2AS0E#0YJTA $I
MBLALA63!\M,HI2,E6)5')FU4RFI)TV4E,A<A<R5+6K+,29JE&6@H4>@%EU'
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M5L0';70==]VMM "_J+ETZ_3W;9'<.8[]>6D-=^[S==V%CH+;M8C(B \]A[!
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M(#]0LP ZO7XN$9)UC$PTA#2$-(0TA#2$-(0TA#2$422"-+$Z54U#34"0P0J
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ME\A1K^+Y*9ID\JI1I$F>#-9&5*95R^:UZUX#M%W9M!2R-J\6FHP?*BCGF?7
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M04E<Q"0IS+6X ).7HDENF&8_-ZE<V53S9LHI2J4@S?E$*4%)0A2BADS);9B
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MS^"&U6H;V%5B<.5,* E:98F"2!F*EYES91FGYLL!( 2JQ!NP)(S*3:,5$HS
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M\/36C,?,IV=^%] VMVX-ZQ&XANBW$=N[7SZ;]=T55,.W41\6D-^0;" !OD,
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M<W HIUJR3LEBP-:I573JY>8B892JJ=R-8@3Q---5B7A\J;+EI1\DF89M8HI
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M">DT4J(@Y6I L:O()235!OBE%UUA(2I7S4E3:L"6NV[KMVQ!(&I [2!H'.O
M7[(K8" AD!R [@(<A#MU$3#2$-(0TA#2$-(0TA#2$?G3\)WX(7B(XUN)NN]-
ML9Y9J.QJJWT4B?P?.GN:H'SX08E#R:K/\@P0*0H?,S*'$D$]7PB)U55)OE""
MO%H&OZQL;M[A6SN###:RDQ"=.[KGS\]-+IERLLT2PD S:F4K,,A?H-HQ.[X=
M\('P98YM7CYQ7#ZS"Y%.:.GI\E9-JD3N4DF:5%I-'/04'E!E/* V+I%G\\ ^
MIS.,O;-V>&@>W[*+H8'D/(;3#C?<?:.NKYV]G_!^,/QY&B<_[<(XCF-VIO\
MA+ ;_P"48AZ\.AZN9QEY#[;/#1@.GQHNA^&TP_R]_74\[> >#\8_U5%[= ?
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MTA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA%#DOYP.O\
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M6H+ &^H[6>[\= 1P$9/OOQ*WLLPCM"B)@\74R.60!WD<Q.4)*%4;^/3'3$"
MMC'%+A<6'+B720*) ]'LBEKHN')CD<:55MEO9#48I,1:Z9$J;G)6H!*F1=CE
M.8YU,E5@P=\B;L5BT;?*%&4L]AN<!0'S?G /J00YZCNH+AQ3W^:#R5#LTVU:
M&"4NMP$;6^.$*FI:&US-!>(^+67,DMPE7Q_H)DS<?%9$JFRFI!5!$:$MG-..
M<J6<Y2X(,1(E*=C,) 0?G(&<JE*64IZ-CF 2E\SO8$L]@FKN2P!?5)&7II2Z
MB%78%SII8QCNW/&1>EN$J.G.5O[FO:)>TKR8JGCTM*N)<IGN'Q"7SAZB1P94
M=+ZTS3"+>PR%,<D2ISXW+#/BN742XOR(DU$[U1,II1)5TT N,SH"$%,J6H!?
M1#J6I12X*>E=BY$92YJTD ,IMQS%2LRE.H'0   D78 W8-%<=.,.^9K4U.C&
MW6^FRY.A0.Z:21&/W!;X,0^R"T=RY*XVYD;'3-G)8Y2*W;Y&F)/)*53NA.S)
M6LHR.QE\3%U#BFFE.0HK0+@A2Y944IF(&=)RV"P24]$V264I+D6\LLZ%)(#]
M$*(S%*B4E.8.4D :C71VCMSOB@XD83+%="UWM64,=9)^PGM[C"WN.Q65O#'<
MFSJ B5ME3Y<U.+:J0PV:._FS4]SUNC(J6YS<7Z7,;,;6XQ^$4\E2199S*0IP
MM)4E*D32$ED%^FD72@J(8 $ZR9JPY)2&2JS$!124W#J86)U4UKD"XVB07\?5
M_#_(+J#2F>)-1;QN<VB!L,;,8Y6$N<_AIK;TH$JIK+6I01+'E(F"( E=5#,!
M!)BPF6R=H7I'<K7,H"<F6Q *VS*4Z2FQ_FI(R@])P_\ BI(:+<[H*M>C8 ,7
MOUD,2S%VWN1>-06_BFXAK-0EGA,^9E1L^B<O);I4ONDUQQYFDNB4A9C'EC>&
M!/%[LQN"+W12_IY(T%-#/.W^1I&)F;_,(<]N!XI*-@R),Q16E3(4ETB63E0H
M$ A6:6I8#%+E2 ').<"\5<JM"0%!E)(!*VS$$;@%L22Y "B0D?-)BL/''/>9
ML&;HPB,14'L\V)9DK\BC19D6AD;-D#FUDJIRK?KXQ0XE\6)TS>74W38;*J$J
MM4<N:4$I8BBW T*66<I=0!0[%?26<N8Y&DJL/\7E>T%P!G+&:R;%@<H( =KO
M-3<[LQ1Q (O'W/XW+X%*U:11%+>-JQ3;5=)V5 >S/"TI&[((XL>@=Y>L+N,B
M?F2,.E26@QK/3PE="3J%!;;Z8ZW' U1W-+#%U$9P"<X'1)9D_)E.8;W4%#7D
MV-G+3"6 0^5P&)W&YZ0+.&L"DFP6\95?N*FXZ3AFBMXFINB!4E<9,<S/=3\Q
MI43#6B2.:M,<ICB.B\@0M<<L((*):5)U^/@%R555 W/*]?46QZP33H,]4LE8
M2$DAG*G9QF>6%#B1R68#<!>,C-6):5#+F*F+@#?=ARA%A_CWM&O5Q>-"]LL(
MDT-@29!'SWB$O/F;I\071LE\2=TMM6J;4NM2<J\*R2ET+%:T]G0DN$#CB(LP
M0,9I@_JT1]%5B*:6DI4HYF6+!8*2,Y0W]J"2S N%DWN@",%3EEPFPROIE4#E
MS-\_,YTNA('$FT=U9Q3\1%2*605L*CT*5010D;53^_,2M_>XXV1V8,L=4.\P
MK77GDTD<$,U9S%#RB<I2VP1P2)EZ8XARE'FRIQ/GN>2,JR2L+<@)5E"BI)4
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M[!5@0V ,YR XY@Y3F!5=1!5T@D[VU9[/8=;B^2-3>[!@0Y+G3Q7>PN2#%2(
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M@8-(@.B9:U?FD!B7((!"=6+7(ZH%:1O!+@$ BSZ/PT.K1WJ[M6KH;%[W7<N
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MR,<$3ZA9YA&5MS8C'8I<)F:HI/(W9VTJZU+%+HZ*\%<O<U;&3<Z1QV/W$F2
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M ,U>_7\Z*!1T@TI:8=DB4/\ ]8? [3^U;=MN'XQ3<^W^E:=T3_[_ #O]8O\
M^43W)2_X-3_ZF7_\8D&EJ <@V-X#ON"), [\]P*Z]=.Z)_\ ?YW^L7_\HGN6
MF&E/(OK\C+O_ /UCE\&-NP_!Z'(<A\T3[>S\3VU'+3O[]-X_VQ>O'6)[FIQI
M3R1_Y4O_ .,<@;F\.2%&'L3$!_\ TTY:=_?9MM/E%6\\.YY TD21_P"6C_XQ
MR!"B#.$:4,\\)R0S[<4;ZCE9O]\F?75^N)Y&3_>97^K1OUW1R\S2!R2IP_\
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82$-(0TA#2$-(0TA#2$-(0TA#2$-(1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737975282248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Oct. 23, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Foghorn Therapeutics Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001822462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 291.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FHTX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,816,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972180360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 92,795<span></span>
</td>
<td class="nump">$ 14,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">92,975<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,917<span></span>
</td>
<td class="nump">1,363<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">190,687<span></span>
</td>
<td class="nump">16,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">19,528<span></span>
</td>
<td class="nump">2,683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,733<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">842<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease&#160;right-of-use&#160;assets</a></td>
<td class="nump">42,804<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">255,594<span></span>
</td>
<td class="nump">22,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,680<span></span>
</td>
<td class="nump">3,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">9,161<span></span>
</td>
<td class="nump">3,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">3,981<span></span>
</td>
<td class="nump">1,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Notes payable, net of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">2,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">18,846<span></span>
</td>
<td class="nump">12,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Notes payable, net of discount and current portion</a></td>
<td class="nump">19,654<span></span>
</td>
<td class="nump">10,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">58,361<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">12,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_PreferredStockWarrantsLiability', window );">Preferred stock warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">109,407<span></span>
</td>
<td class="nump">23,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock (Series A-1, A-2 and B), $0.0001 par value; no shares and 28,629,622 shares authorized at December 31, 2020 and 2019, respectively; no shares and 28,615,546 shares issued and outstanding at December 31, 2020 and 2019, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 25,000,000 shares authorized as of December&#160;31, 2020; no shares issued or outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 175,000,000 and 46,600,000 shares authorized at December 31, 2020 and 2019, respectively; 36,790,946 shares issued and outstanding at December 31, 2020 and 5,762,745 shares issued and 4,870,851 shares outstanding at December 31, 2019</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional&#160;paid-in&#160;capital</a></td>
<td class="nump">309,126<span></span>
</td>
<td class="nump">6,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(162,936)<span></span>
</td>
<td class="num">(94,136)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">146,187<span></span>
</td>
<td class="num">(88,016)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, convertible preferred stock and stockholders' equity (deficit)</a></td>
<td class="nump">$ 255,594<span></span>
</td>
<td class="nump">$ 22,342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_PreferredStockWarrantsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of obligations related to preferred stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_PreferredStockWarrantsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737975229064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">175,000,000<span></span>
</td>
<td class="nump">46,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">36,790,946<span></span>
</td>
<td class="nump">5,762,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">36,790,946<span></span>
</td>
<td class="nump">4,870,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock Authorized</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">28,629,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares, Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,615,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Proferred Stock, Shares, Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,615,546<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible Preferred Stock, Par Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible Preferred Stock, Shares Authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,629,622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,615,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,615,546<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737975109768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Of Operations And Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration revenue</a></td>
<td class="nump">$ 430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">57,715<span></span>
</td>
<td class="nump">$ 44,362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">11,246<span></span>
</td>
<td class="nump">6,722<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">68,961<span></span>
</td>
<td class="nump">51,084<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(68,531)<span></span>
</td>
<td class="num">(51,084)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(979)<span></span>
</td>
<td class="num">(540)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_InterestIncomeAndOtherIncomeExpense', window );">Interest income and other income (expense), net</a></td>
<td class="nump">1,001<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of preferred stock warrant liability</a></td>
<td class="num">(69)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Condensed Consolidated Statements Of Operations And Comprehensive Loss</a></td>
<td class="num">(222)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(269)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (68,800)<span></span>
</td>
<td class="num">$ (51,128)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to common stockholders&#8212;basic and diluted</a></td>
<td class="num">$ (6.23)<span></span>
</td>
<td class="num">$ (12.20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares outstanding&#8212;basic and diluted</a></td>
<td class="nump">11,046,802<span></span>
</td>
<td class="nump">4,191,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (68,800)<span></span>
</td>
<td class="num">$ (51,128)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized losses on marketable securities</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (68,807)<span></span>
</td>
<td class="num">$ (51,128)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_InterestIncomeAndOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income and income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_InterestIncomeAndOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737969555960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>IPO [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th">
<div>Common Stock [Member] </div>
<div>IPO [Member]</div>
</th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th">
<div>Additional Paid-in Capital [Member] </div>
<div>IPO [Member]</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss [member]</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Convertible Preferred Stock [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,250<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (Shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,575,544<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="num">$ (39,273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (43,008)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (Shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,475,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series B convertible preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series B convertible preferred stock, net of issuance costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,040,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options , shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">891,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(51,128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,544<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (Shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,615,546<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="num">$ (88,016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94,136)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (Shares) at Dec. 31, 2019</a></td>
<td class="nump">4,870,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,870,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series B convertible preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series B convertible preferred stock, net of issuance costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,007,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of preferred stock to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (176,405)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock</a></td>
<td class="nump">$ 176,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of preferred stock to common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,623,413)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,958,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock upon initial public offering net of underwriting discounts, commissions and offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon initial public offering net of underwriting discounts, commissions and offering costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,451,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Conversion of warrant liability to equity upon closing of initial public offering</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants', window );">Issuance of common stock in connection with the cashless exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">$ 1,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options , shares</a></td>
<td class="nump">611,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">611,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Issuance of warrants in connection with notes payable</a></td>
<td class="nump">$ 188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">891,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized loss on marketable securities</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(68,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (Shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 146,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 309,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (162,936)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (Shares) at Dec. 31, 2020</a></td>
<td class="nump">36,790,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,790,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period in connection with a cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972904200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=fhtx_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_StockIssuanceCosts', window );">Stock Issuance Costs</a></td>
<td class="nump">$ 198<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_StockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred directly with the issuance of an equity or temporary equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_StockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=fhtx_SeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=fhtx_SeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737975461384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (68,800)<span></span>
</td>
<td class="num">$ (51,128)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2,961<span></span>
</td>
<td class="nump">1,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">(Gain) loss&#160;on disposal of property and equipment</a></td>
<td class="num">(206)<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of preferred stock warrant liability</a></td>
<td class="nump">69<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset', window );">Noncash lease expense</a></td>
<td class="nump">4,201<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Noncash interest expense</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion of discount on marketable securities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(4,670)<span></span>
</td>
<td class="num">(991)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">474<span></span>
</td>
<td class="nump">1,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">3,194<span></span>
</td>
<td class="nump">2,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">15,135<span></span>
</td>
<td class="num">(1,160)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">14,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(31,286)<span></span>
</td>
<td class="num">(46,335)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(16,183)<span></span>
</td>
<td class="num">(968)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(92,981)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(108,914)<span></span>
</td>
<td class="num">(964)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from initial public offering, net of underwriting discounts, commissions and offering costs</a></td>
<td class="nump">122,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock, net of issuance costs</a></td>
<td class="nump">89,861<span></span>
</td>
<td class="nump">15,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock upon exercise of stock options</a></td>
<td class="nump">1,221<span></span>
</td>
<td class="nump">691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance&#160;of notes payable, net of&#160;issuance costs</a></td>
<td class="nump">19,800<span></span>
</td>
<td class="nump">7,984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of notes payable</a></td>
<td class="num">(15,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">217,473<span></span>
</td>
<td class="nump">23,969<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">77,273<span></span>
</td>
<td class="num">(23,330)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">17,255<span></span>
</td>
<td class="nump">40,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">94,528<span></span>
</td>
<td class="nump">17,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment included in accounts payable and accrued expenses</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="nump">$ 367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Issuance of warrants in connection with notes payable</a></td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=fhtx_ConversionOfRedeemableConvertibleStockMember', window );">Conversion of Redeemable Convertible stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of redeemable convertible preferred stock to common stock</a></td>
<td class="nump">176,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=fhtx_ConversionOfWarrantLiabilityToEquityMember', window );">Conversion of Warrant Liability to Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of redeemable convertible preferred stock to common stock</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=fhtx_ConversionOfNotesPayableInToWarrantsMember', window );">Conversion of Notes Payable in to Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Issuance of warrants in connection with notes payable</a></td>
<td class="nump">$ 188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in operating lease liabilities during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right-of-use assets under an operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=fhtx_ConversionOfRedeemableConvertibleStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=fhtx_ConversionOfRedeemableConvertibleStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=fhtx_ConversionOfWarrantLiabilityToEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=fhtx_ConversionOfWarrantLiabilityToEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=fhtx_ConversionOfNotesPayableInToWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=fhtx_ConversionOfNotesPayableInToWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139738060623128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 92,795<span></span>
</td>
<td class="nump">$ 14,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash (current and&#160;non-current)</a></td>
<td class="nump">1,733<span></span>
</td>
<td class="nump">2,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">$ 94,528<span></span>
</td>
<td class="nump">$ 17,255<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972001704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Nature of Business and Basis of Presentation</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1. Nature of Business and Basis of Presentation</div></div></div><br/></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Foghorn Therapeutics&#160;Inc. (the &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company discovering and developing a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. The Company uses its proprietary Gene Traffic Control platform to identify, validate and potentially drug targets within the system. The Company was founded in </div>October 2015<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> as a Delaware corporation. The Company is headquartered in Cambridge, Massachusetts.</div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company is subject to risks similar to those of other early-stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and the need to obtain adequate additional financing to fund the development of its products. There can be no assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#8217;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In March 2020, the World Health Organization declared the global novel coronavirus disease 2019 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(&#8220;COVID-19&#8221;)&#160;outbreak</div> a pandemic. The Company&#8217;s operations have not been significantly impacted by <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;COVID-19&#160;pandemic.</div> However, the Company cannot at this time predict the specific extent, duration, or full impact that <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;COVID-19&#160;pandemic</div> will have on its financial condition and operations, including ongoing and planned clinical trials. The impact of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;COVID-19&#160;outbreak</div> on the Company&#8217;s financial performance will depend on future developments, including the duration and spread of the pandemic and related governmental advisories and restrictions. These developments and the impact <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of&#160;COVID-19&#160;on</div> the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company&#8217;s results may be materially adversely affected. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October&#160;</div>27<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, </div>2020<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, the Company completed its initial public offering (&#8220;IPO&#8221;) pursuant to which it issued and sold </div>7,500,000<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of its common stock at a public offering price of $</div>16.00<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> per share, resulting in net proceeds of $</div>107.9<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million, after deducting underwriting discounts and commissions and other offering expenses. On November&#160;</div>19<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, </div>2020<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, the Company issued and sold an additional </div>951,837<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of common stock at the IPO price of $</div>16.00<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> per share pursuant to the underwriters&#8217; partial exercise of their option to purchase additional shares of common stock, resulting in additional net proceeds of $</div>14.2<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million after deducting underwriting discounts and commissions. Upon the closing of the IPO, all of the Company&#8217;s outstanding convertible preferred stock automatically converted into shares of </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">common stock and the Company&#8217;s outstanding </div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> warrants to purchase Series&#160;A Preferred Stock automatically became warrants to purchase an aggregate of </div>7,608<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;">shares of common stock (see Note 7).&#160;</div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. Since inception, the Company has funded its operations primarily with proceeds from sales of preferred stock, debt financing and an upfront payment of $15.0&#160;million the Company received in July 2020 under a collaboration agreement with Merck Sharp&#160;&amp; </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dohme Corp. (see Note 10), and most recently, </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">with proceeds from the sale of common stock in the IPO completed in October 2020. The Company has incurred recurring losses, including net losses of $68.8&#160;million and $51.1&#160;million for the years ended December&#160;31, 2020 and 2019, respectively. As of December&#160;31, 2020, the Company had an accumulated deficit of $162.9&#160;million. The Company expects to continue to generate operating losses in the foreseeable future. As of the issuance date of these&#160;consolidated financial statements the Company expects that&#160;its cash<div style="letter-spacing: 0px; top: 0px;;display:inline;">,</div>&#160;cash equivalents <div style="letter-spacing: 0px; top: 0px;;display:inline;">and marketable securities<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>will be sufficient to fund its operating expenses and capital expenditure requirements for at least 12 months. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will need to obtain additional funding through public or private equity offerings, debt financings, collaborations, strategic alliances and/or licensing arrangements. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborative or strategic alliances or licensing arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company&#8217;s stockholders. Arrangements with collaborators or others may require the Company to relinquish rights to certain of its technologies or programs. If the Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate some or all of its research and development programs, pipeline expansion or commercialization efforts, which could adversely affect its business prospects. Although management will continue to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations when needed or at all.</div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px;;font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Basis of presentation</div></div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972037016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="margin-block: 0em; margin-bottom: 0px; margin-top: 18pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2. Summary of Significant Accounting Policies </div></div></div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of estimates </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, revenue recognition, the valuation of stock-based awards and the accrual of research and development expenses. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentrations of credit risk and of significant suppliers </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. As of December&#160;31, 2020, the Company maintained cash, cash equivalents and marketable securities at financial institutions in excess of federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company relies, and expects to continue to rely, on a small number of vendors to provide services, supplies and materials for certain activities related to its programs. These programs could be adversely affected by a significant interruption in these services or the availability of materials. </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Cash equivalents </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all highly liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Marketable Securities </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s marketable securities are classified as available-for-sale and are carried at fair value with the unrealized gains and losses reported as a component of accumulated other comprehensive loss in stockholders&#8217; equity (deficit). Realized gains and losses and declines in value judged to be other than temporary are included as a component of interest income and other income (expense), net based on the specific identification method. The Company classifies its marketable securities with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities are available for current operations.&#160;</div> </div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Restricted cash </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Amounts included in restricted cash represent amounts pledged as collateral for letters of credit required for security deposits on the Company&#8217;s leased facilities and credit cards. These amounts are classified as restricted cash (current and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current)</div> in the Company&#8217;s consolidated balance sheets. </div>  <div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Property and equipment </div></div></div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense is recognized using the straight-line method over the estimated useful life of each asset as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 90%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;; width: 51%;"></td><td style="font-family: &quot;times new roman&quot;; width: 2%;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; width: 47%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt; width: 51%;;vertical-align:bottom;"></td><td style="padding-bottom: 0.75pt; width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; border-bottom: 0.75pt solid black; width: 47%;;text-align:center;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; display: table-cell; line-height: normal;;text-align:center;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated&#160;Useful&#160;Life</div></div></div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Laboratory equipment</td><td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">5 years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt; width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Furniture and fixtures</td><td style="padding-bottom: 0.75pt; width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">5 years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Computer equipment and software</td><td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">3 years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Leasehold improvements</td><td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">Shorter&#160;of&#160;useful&#160;life&#160;or&#160;remaining&#160;term&#160;of&#160;lease</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Costs for capital assets not yet placed into service are depreciated once placed into service. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is included in loss from operations. Expenditures for repairs and maintenance are charged to expense as incurred.</div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Impairment of long-lived assets </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company evaluates its long-lived assets, which consist primarily of property and equipment and operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. The Company did not record any impairment losses on long-lived assets during the years ended December&#160;31, 2020 or 2019. </div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Fair value measurements </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:2%;">&#8226;</td><td style="vertical-align:top;;width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;1&#8212;Quoted prices in active markets for identical assets or liabilities. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:2%;">&#8226;</td><td style="vertical-align:top;;width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;2&#8212;Observable inputs (other than Level&#160;1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:2%;">&#8226;</td><td style="vertical-align:top;;width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s cash equivalents and marketable securities are carried at fair value, determined according to the fair value hierarchy described above (see Note&#160;3). The carrying values of the Company&#8217;s accounts payable and accrued expenses approximate their fair values due to the short-term nature of these liabilities. The carrying value of the Company&#8217;s long-term debt approximates its fair value (a level 2 measurement) due to its variable interest rate. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Revenue recognition </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its one collaboration arrangement, entered into in July 2020, under ASC Topic&#160;606,<div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#160;Revenue From Contracts With Customers</div>&#160;(ASC 606). For additional information on the Company&#8217;s collaboration agreement, see Note 10,&#160;Collaboration&#160;Agreement, to these consolidated financial statements. Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements within the scope of ASC 606, the entity performs the following five steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price, including variable consideration, if any; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company assesses the goods or services promised within each contract and determines those that are performance obligations. The promised goods or services in the Company&#8217;s arrangements would likely consist of licenses, rights to the Company&#8217;s intellectual property, research and development services and related supporting activities. Arrangements that include rights to additional goods or services that are exercisable at a customer&#8217;s discretion are generally considered options. The Company assesses if these options provide a material right to the customer and if so, they are considered performance obligations. </div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i)&#160;the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii)&#160;the entity&#8217;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the research, development, manufacturing and commercialization capabilities of the customer and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The transaction price is then determined and allocated to the identified performance obligations in proportion to their standalone selling prices (&#8220;SSP&#8221;) on a relative SSP basis. SSP is determined at contract inception and is not updated to reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In developing the SSP for a performance obligation, the Company considers applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs. The Company validates the SSP for performance obligations by evaluating whether changes in the key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance obligations. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">If the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The Company includes the unconstrained amount of estimated variable consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Company&#160;re-evaluates&#160;the</div> estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cumulative&#160;catch-up&#160;basis</div> in the period of adjustment. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#8217;s control such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For arrangements with licenses of intellectual property that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestones at the later of (i)&#160;when the related sales occur, or (ii)&#160;when the performance obligation to which the royalty has been allocated has been satisfied. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded for deferred revenue. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between the transfer of the promised goods or services to the customer and the payment by the customer will be one year or less. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time, and if over time, recognition is based on the use of an output or input method. </div></div>   <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Classification of convertible preferred stock </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company classified its convertible preferred stock outstanding prior to the IPO outside of stockholders&#8217; equity (deficit) on the consolidated balance sheet because the holders of such shares had redemption rights in the event of a deemed liquidation that, in certain situations, is not solely within the control of the Company. </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Research and development costs </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses consist of costs incurred in performing research and development activities, including salaries and bonuses, stock-based compensation, employee benefits, facilities costs, laboratory supplies, depreciation, and external costs of vendors engaged to conduct research, preclinical and clinical development activities as well as the cost of licensing technology.</div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upfront payments and milestone payments made for the licensing of technology are expensed as research and development over the period to which they relate. Costs for research and development activities are expensed in the period in which they are incurred. Payments for such activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred, and are reflected in the consolidated financial statements as prepaid expense or accrued research and development expense. Determining the prepaid and accrued balances at the end of any reporting period incorporate certain judgments and estimates by management that are based on information available to the Company including information provided by vendors regarding the progress to completion of specific tasks or costs incurred. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Patent costs </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Leases </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In accordance with ASC 842, <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Leases,</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>the Company accounts for a contract as a lease when it has the right to control the asset for a period of time while obtaining substantially all of the asset&#8217;s economic benefits. The Company determines if an arrangement is a lease or contains an embedded lease at inception. For arrangements that meet the definition of a lease, the Company determines the initial classification and measurement of its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset and lease liability at the lease commencement date and thereafter if modified. The lease term includes any renewal options that the Company is reasonably assured to exercise. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, the Company uses its estimated secured incremental borrowing rate for that lease term. The Company&#8217;s policy is to not record leases with an original term of twelve months or less on its consolidated balance sheets and recognizes those lease payments in the income statement on a straight-line basis over the lease term. The Company&#8217;s existing leases are for office and laboratory space and an equipment lease. </div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In addition to rent, the leases may require the Company to pay additional costs, such as utilities, maintenance and other operating costs, which are generally referred to as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. The Company has&#160;elected to not separate lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. Only the fixed costs for lease components and their associated <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components are accounted for as a single lease component and recognized as part of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset and liability. Rent expense for operating leases is recognized on a straight-line basis over the reasonably assured lease term based on the total lease payments and is included in operating expense in the consolidated statements of operations and comprehensive loss. </div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Stock-based compensation </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company measures stock options with service-based vesting or performance-based vesting granted to employees, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> and directors based on the fair value on the date of grant using the Black-Scholes option-pricing model. The Company measures restricted common stock awards using the difference between the purchase price per share of the award, if any, and the fair value of the Company&#8217;s common stock at the date of grant. Compensation expense for the awards is recognized over the requisite service period for employees and directors and as services are delivered for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees,</div> both of which are generally the vesting period of the respective award. The Company uses the straight-line method to record the expense of awards with only service-based vesting conditions. The Company uses the graded-vesting method to record the expense of awards with both service-based and performance-based vesting conditions, commencing once achievement of the performance condition becomes probable. The Company&#160;accounts for forfeitures of share-based awards as they occur. </div><div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company classifies stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient&#8217;s payroll costs are classified or in which the award recipient&#8217;s service payments are classified. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Net loss per share </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In October 2020, upon the closing of the IPO, all outstanding shares of the Company&#8217;s convertible preferred stock automatically converted into 21,958,588 shares of the Company&#8217;s common stock. Prior to this conversion,&#160;the Company followed <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;two-class&#160;method</div> when computing net income (loss) per share as the Company had issued shares that meet the definition of participating securities. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">The&#160;two-class&#160;method</div> determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">The&#160;two-class&#160;method</div> requires income (loss) available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to share in the earnings as if all income (loss) for the period had been distributed. </div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic net income (loss) per share attributable to common stockholders is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) per share attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common shares. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s participating securities contractually entitled the holders of such shares to participate in dividends but did not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reported a net loss, such losses were not allocated to such participating securities. In periods in which the Company reported a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company reported a net loss attributable to common stockholders for the years ended December&#160;31, 2020 and 2019. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following common stock equivalents presented based on amounts outstanding at each period end, have been excluded from the calculation of diluted net loss per share because including them would have had an anti-dilutive impact: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 69%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 3%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Stock options to purchase common stock</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,016,460</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,886,489</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants to purchase common stock</div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">18,445</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Convertible preferred stock (as converted to common stock)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">15,467,863</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested restricted common stock</div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">891,894</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Warrants to purchase convertible preferred stock (as converted to common stock)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7,608</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; padding: 0px; width: 69%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; padding: 0px; width: 69%;;vertical-align:top;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5,034,905</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">20,253,854</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; padding: 0px; width: 69%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Segments </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating segments are defined as components of an entity for which separate discrete financial information is made available and that is regularly evaluated by the chief operating decision maker (&#8220;CODM&#8221;) in making decisions regarding resource allocation and assessing performance. The Company&#8217;s CODM is its chief executive officer and the Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company is focused on pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. </div></div><div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Comprehensive loss </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Comprehensive loss includes net loss as well as other changes in stockholders&#8217; equity (deficit) that result from transactions and economic events other than those with stockholders. For the year ended December&#160;31, 2020, the Company&#8217;s only element of other comprehensive loss was unrealized losses on available for sale debt securities. For the year ended December&#160;31, 2019, there was no difference between net loss and comprehensive loss. </div></div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Income taxes </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#8217;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to the provision for income taxes. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-step</div> process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. Any resulting unrecognized tax benefits are recorded within the provision for income taxes. </div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Recently issued accounting pronouncements </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to &#8220;opt out&#8221; of the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i)&#160;irrevocably elects to &#8220;opt out&#8221; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2016-13,</div> <div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Financial Instruments &#8211; Credit Losses (Topic 326)</div>.&#160;The new standard adjusts the accounting for assets held at amortized costs basis, including marketable securities accounted for as available for sale.&#160;The standard eliminates the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses.&#160;The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For public entities, the guidance was effective for annual reporting periods beginning after December&#160;15, 2019 and for interim periods within those fiscal years. For nonpublic entities and emerging growth companies that choose to take advantage of the extended transition period, the guidance is effective for annual reporting periods beginning after December&#160;15, 2020. Early adoption is permitted for all entities. In November 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2019-10,</div> which deferred the effective date for nonpublic entities to annual reporting periods beginning after December&#160;15, 2022, including interim periods within those fiscal years. The Company is evaluating when to adopt this standard and the effect the adoption will have on its consolidated financial statements. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972883160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock', window );">Marketable Securities and&#160;Fair Value Measurements</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">3.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-weight:bold;display:inline;">Marketable Securities and Fair Value Measurements </div></div></td></tr></table>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, available for sale marketable securities by security type consisted of (in thousands): </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 56%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:5%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:5%;"></td><td style="width:0%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:4%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td></tr><tr><td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Gross</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Gross</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Estimated</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr><tr><td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Amortized</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Unrealized</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Unrealized</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Fair</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr><tr><td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cost </div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Gains</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Losses</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Value</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 56%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">S<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div> treasury notes (due within one year)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">92,982</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:5%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(7</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">92,975</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 56%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:5%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 56%; background-color: rgb(255, 255, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">92,982</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(7</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">)&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">92,975</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 56%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:5%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company had no marketable securities as of December&#160;31, 2019. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables present the Company&#8217;s fair value hierarchy for its assets and liabilities, which are measured at fair value on a recurring basis (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 61%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td style="width:4%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Fair Value Measurements at<br/> December&#160;31, 2020 Using:</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Assets:</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash equivalents:</div></div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Money market funds</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">48,770</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">48,770</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U<div style="letter-spacing: 0px; top: 0px;;display:inline;">.S<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div> treasury notes</div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; text-align: right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212; &#160;</div></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">42,997</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; text-align: right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212; &#160;</div></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">42,997</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Marketable securities:</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div>S<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div>&#160;treasury notes</div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:4%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">92,975</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">92,975</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Total</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">48,770</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">135,972</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">184,742</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;width:;;height:16;">&#160;</td><td colspan="16" style="font-family: &quot;times new roman&quot;;;width:;;height:16;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Fair Value Measurements at<br/> December&#160;31, 2019 Using:</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Assets:</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash equivalents:</div></div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Money market funds</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">14,951</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">14,951</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Preferred stock warrant liability</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">45</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">45</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The preferred stock warrant liability as of December&#160;31, 2019 consisted of the fair value of warrants to purchase 14,076 shares of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;A-1</div> convertible preferred stock at $1.00 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">per share and was based on significant inputs not observable in the market, which represented a Level&#160;3 measurement within the fair value hierarchy. The Company&#8217;s valuation of the preferred stock warrants utilized the Black-Scholes option-pricing model, which incorporated assumptions and estimates to value the preferred stock warrants. The Company assessed these assumptions and estimates at the end of each reporting period. Changes in the fair value of the preferred stock warrants were recognized within other income (expense) in the consolidated statements of operations and comprehensive loss and were not material during the years ended December&#160;31, 2020 and 2019.</div></div> </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In October 2020, upon closing of the IPO, the warrants to purchase 14,076 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> convertible preferred stock automatically became warrants to purchase an aggregate of 7,608 <div style="letter-spacing: 0px; top: 0px;;display:inline;">shares of common stock. The Company remeasured the warrants as of the IPO date and reclassified the carrying value of the warrants from a non-current liability to additional paid-in capital in its consolidated balance sheet. During the year ended December 31, 2020, these warrants were exercised in full.&#160;</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for marketable securities and fair value measurements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737971917736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4. Property and Equipment, Net </div></div></div></div>   <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 74%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 6%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Laboratory equipment</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,740</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,202</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">815</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">337</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Computer equipment and software</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">100</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">81</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,961</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">75</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Assets not yet placed in service</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">15</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">280</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:top;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">21,631</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">3,975</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Less: Accumulated depreciation and amortization</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,103</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,292</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:top;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">19,528</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,683</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation and amortization expense was $1.3&#160;million and $0.7&#160;million for the years ended December&#160;31, 2020 and 2019, respectively. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737979476568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5. Accrued Expenses </div></div></div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 76%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 78%;"></td><td style="width: 5%;;vertical-align:bottom;"></td><td style="width: 5%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Accrued <div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">employee compensation and benefits</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">3,513</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">1,867</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued <div style="letter-spacing: 0px; top: 0px;;display:inline;">construction in progress</div></div></div></td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">2,385</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">119</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Accrued external research and development expenses</div></div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">2,146</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">1,384</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr><td style="background-color: rgb(255, 255, 255); width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Accrued professional fee<div style="letter-spacing: 0px; top: 0px;;display:inline;">s</div></div></div></td><td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;">&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">979</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;">&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">274</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 78%; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other</div></div></td><td style="width: 5%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">138</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">57</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 78%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 5%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; background-color: rgb(255, 255, 255); width: 78%;;vertical-align:top;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">9,161</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">3,701</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 78%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 5%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737979441576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6. Notes Payable </div></div></div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 74%;"></td><td style="width: 5%;;vertical-align:bottom;"></td><td style="width: 5%;"></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Principal amount of long-term debt</div></div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">15,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Current portion of long-term debt</div></div></td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(4,152</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="width: 5%;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Long-term debt, net of current portion</div></div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10,848</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Final payment fee</div></div></td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">530</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Debt discount, net of accretion</div></div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,346</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(418</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="width: 5%;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt, net of discount and current portion</div></div></td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; width: 5%;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">19,654</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,960</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="width: 5%;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Loan and Security Agreements </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2019, the Company had outstanding loans under its amended loan and security agreement with Comerica Bank (the &#8220;Loan&#8221;) of<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>$7.0&#160;million (&#8220;Term Loan A&#8221;) and $8.0&#160;million (&#8220;Term Loan B&#8221;). Borrowings under both Term Loan A and Term Loan B were repayable in monthly payments of interest-only through February 2020, to be followed by monthly payments of equal principal plus interest until the loan maturity date of February&#160;1, 2023. In April 2020, the Company amended the Loan to extend the interest only period through May&#160;31, 2020 and in June 2020 the Loan was further amended to extend the interest-only period through August&#160;31, 2020. Interest for Term Loan A was the greater of 1) Comerica&#8217;s Prime Rate or 2) LIBOR plus 2.5%, and for Term Loan B, 1.0% plus the greater of 1) Comerica&#8217;s Prime Rate or 2) LIBOR plus 2.5%. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A final payment fee of 3.0% of the aggregate amounts drawn under Term Loan A and 4.0% under Term Loan B was due upon the earlier of the maturity date, the repayment date if paid early, whether voluntary or upon acceleration due to default, the sale of substantially all of the Company&#8217;s assets, or the Company&#8217;s IPO. The Company may repay the Loan at any time by paying the outstanding principal balance in full, along with any unpaid accrued interest and the final payment fee. The final payment fee of $0.5&#160;million was being amortized to interest expense over the term of the debt using the effective interest method. Upon closing of the Company&#8217;s IPO in October 2020, the final payment fee became due. In November 2020, the Company used a portion of the proceeds from its new loan and security agreement described below to repay the outstanding principal balance under Term Loan A and Term Loan B plus unpaid accrued interest and the final payment fee. <div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;The Company recorded a loss&#160;</div> on debt extinguishment of $0.2&#160;million related to this repayment. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On November&#160;19, 2020, the Company entered into a new loan and security agreement, or the Oxford Loan, with Oxford Finance LLC, or Oxford, for an aggregate principal amount of $20.0&#160;million (Oxford Term Loan A) and up to an additional $5.0&#160;million (Oxford Term Loan B). <div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">On November&#160;19, 2020, the Company borrowed $20.0&#160;million under the Oxford Term Loan A.</div> The Term Loan bears interest at a floating per annum rate equal to the greater of (i) 8.0% and (ii)&#160;the sum of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(a)&#160;thirty-day</div> LIBOR rate plus (b) 7.84%. In addition, upon loan maturity or prepayment, the Company is reqired to make a final payment fee equal to 5.0% of the aggregate principal amount borrowed which is being amortized to interest expense over the term of the debt using the effective interest method. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is required to make monthly interest only payments under the Oxford Loan each month beginning on January&#160;1, 2021. Beginning on December&#160;1, 2023, the Company is required to make consecutive equal monthly payments of principal, together with applicable interest, in arrears, based upon a repayment schedule equal to 24 months, with a final maturity date of November&#160;1, 2025 (the &#8220;Maturity Date&#8221;).&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At the Company&#8217;s option, the Company may elect to prepay the loans subject to a prepayment fee equal to the following percentage of the principal amount being prepaid:&#160;2% if an advance is prepaid during the first 12 months following the applicable advance date,&#160;1% if an advance is prepaid after 12 months but prior to 24 months following the applicable advance date, and&#160;0.5% if an advance is prepaid any time after 24 months following the applicable advance date but prior to the Maturity Date. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s obligations under the Oxford Loan Agreement are secured by a security interest in all of its assets, other than its intellectual property. The Company is also subject to certain affirmative and negative covenants<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">including&#160;</div></div>limitations on dispositions, mergers or acquisitions; encumbering its intellectual property; incurring indebtedness or liens; paying dividends; making certain investments; and engaging in certain other business transactions. The obligations under the Loan are subject to acceleration upon the occurrence of specified events of default, including a material adverse change in the Company&#8217;s business, operations or financial or other condition. Upon the occurrence of an event of default and until such event of default is no longer continuing, the annual interest rate will be 5.0% above the otherwise applicable rate. As of December&#160;31, 2020, the Company believes an event of default would be remote. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In <div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">addition, in</div> connection with the Oxford Loan Agreement, the Company granted warrants to purchase 18,445 shares of the Company&#8217;s common stock at $16.26 per share. The issued warrants are exerciseable for 10 years. The Company valued the warrants using the Black-Scholes option pricing model and determined the fair value of the warrants to be $0.2&#160;million. The Company determined the warrants met the criteria for equity classification, and, as such, the fair value of the warrants were recorded as additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital and as a discount to the <div style="letter-spacing: 0px; top: 0px;;display:inline;">debt which is being amortized to interest expense over the term of the Oxford Loan of five years. In addition, the Company incurred debt issuance costs of</div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> $0.2&#160;million.</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2020, the interest rate applicable to outstanding borrowings under the Oxford Loan was&#160;</div>8.0%. During the years ended December&#160;31, 2020 and 2019, the weighted average effective interest rate on outstanding borrowings was approximately 6.4% and 6.9%, respectively. </div></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, future principal payments due are as follows (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;; width: 85%;"></td><td style="font-family: &quot;times new roman&quot;; width: 6%;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2021</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 85%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2023</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">833</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 85%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2025</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9,167</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 85%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; width: 85%;;vertical-align:top;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">20,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 85%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972214792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock and Preferred Stock Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Convertible Preferred Stock&#160;and Preferred Stock Warrants</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="text-align:left;;vertical-align:top;;width:4%;"><div style="font-weight:bold;display:inline;">7.</div></td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-weight:bold;display:inline;">Convertible Preferred Stock and Preferred Stock Warrants </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Convertible Preferred Stock </div></div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">issued&#160;Series&#160;A-1&#160;convertible</div> preferred stock <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(the&#160;&#8220;Series&#160;A-1&#8221;),&#160;Series&#160;A-2&#160;convertible</div></div> preferred stock (the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Series&#160;A-2&#8221;)&#160;and</div> Series&#160;B convertible preferred stock (the &#8220;Series&#160;B&#8221;). <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">The&#160;Series&#160;A-1&#160;and</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;A-2&#160;are</div> collectively referred to as the &#8220;Series A&#8221; and the Series A and Series&#160;B are collectively referred to as the &#8220;Preferred Stock.&#8221; </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In July and August 2020, in two separate closings, the Company sold 5,600,000 shares of Series B preferred stock at a purchase price of $7.50 per share resulting in gross proceeds to the Company of $42.0&#160;million. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In April 2020, in two separate closings, the Company sold 6,407,867 shares of Series B preferred stock at a purchase price of $7.50 per share resulting in gross proceeds to the Company of $48.1&#160;million. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2019,<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>Preferred Stock consisted of the following (in thousands, except share amounts):</div></div><div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:51%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Preferred&#160;Stock<br/> Authorized</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Preferred&#160;Stock<br/> Issued and<br/> Outstanding</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Carrying&#160;Value</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Liquidation<br/> Preference</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Common&#160;Stock<br/> Issuable Upon<br/> Conversion</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">A-1</div> Preferred Stock</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9,707,826</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9,693,750</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9,609</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9,694</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,239,865</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> Preferred Stock</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,804,165</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,804,165</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,179</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,206</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5,840,089</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Series B Preferred Stock</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">8,117,631</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">8,117,631</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">60,756</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">60,882</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">4,387,909</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">28,629,622</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">28,615,546</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">86,544</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">86,782</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15,467,863</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon the closing of the IPO in October 2020, the Company&#8217;s Preferred Stock automatically converted into 21,958,588 shares of common stock. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Warrants to Purchase Preferred Stock</div></div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">I</div>n connection with the issuance of notes payable, the Company issued warrants to purchase 14,076 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> preferred stock at an exercise price of $1.00 per share. In October 2020, upon closing of the IPO, the warrants automatically became warrants to purchase an aggregate of 7,608 shares of common stock and were then cashless exercised in full for 6,728 shares of common stock. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139738061485240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_CommonStockTextBlock', window );">Common Stock</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8. Common Stock </div></div></div></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October&#160;27, 2020, the Company completed its initial public offering (&#8220;IPO&#8221;) pursuant to which it issued and sold 7,500,000 shares of its common stock at a public offering price of $16.00 per share, resulting in net proceeds of $107.9&#160;million, after deducting underwriting discounts and commissions and other offering expenses. On November&#160;19, 2020, the Company issued and sold an additional 951,837 shares of common stock at the IPO price of $16.00 per share pursuant to the underwriters&#8217; partial exercise of their option to purchase additional shares of common stock, resulting in additional net proceeds of $14.2&#160;million after deducting underwriting discounts and commissions. Upon the closing of the IPO, all of the Company&#8217;s outstanding convertible preferred stock automatically converted into shares of common stock (see Note 7). </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are not entitled to receive dividends, unless declared by the board of directors. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_CommonStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for common stock, including, but not limited to voting rights, dividends, and stock splits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_CommonStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139738059332360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-block: 0em; margin-bottom: 0px; margin-top: 0px;">&#160;</div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">9. Stock-Based Compensation </div></div></div></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">2016 Stock incentive plan </div></div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s 2016 Stock Incentive Plan, (the &#8220;2016 Plan&#8221;) provided for the Company to grant incentive stock options or nonqualified stock options and other equity awards to employees, directors and consultants of the Company. Upon the effectiveness of the 2020 Equity Incentive Plan (the &#8220;2020 Plan&#8221;) in October 2020, the Company ceased granting additional awards under the 2016 Plan. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">2020 Equity Incentive Plan </div></div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October&#160;21, 2020, the Company&#8217;s board of directors adopted and its stockholders approved the 2020 Plan, which became effective on October&#160;21, 2020. The 2020 Plan provides for the grant of incentive stock <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">options,&#160;non-qualified&#160;options,</div> stock appreciation rights, restricted </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">stock awards, restricted stock units and other&#160;stock-based awards<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> The number of shares initially reserved for issuance under the 2020 Plan </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">wa</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">s (i) </div>2,200,000<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares (the &#8220;share pool&#8221;), plus (ii)&#160;the number of shares of common stock available for issuance under the 2016 Plan as of the effective date of the 2020 Plan, plus the number of shares of common stock underlying awards under the 2016 Plan that on or after the date of adoption expire or become unexercisable without delivery of shares, are forfeited to, or repurchased for cash, are settled in cash, or otherwise become available again for grant under the 2016 Plan, in each case, in accordance with its terms (up to an aggregate of </div>5,078,295<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares). As of December&#160;31, 2020, </div>2,213,094<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares remained available for future grants under the 2020 Plan.</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The share pool will automatically increase on January&#160;1 of each year from 2021 to 2030 by the lesser of (i)&#160;four percent of the number of shares of our common stock outstanding as of the close of business on the immediately preceding December&#160;31 and (ii)&#160;the number of shares determined by the board of directors on or prior to such date for such year.&#160;The number of shares reserved for issuance under the 2020 Plan was increased </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">by 1,471,576 shares effective January&#160;1, 2021. </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The 2020 Plan and 2016 Plan are administered by the board of directors or, at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors, or its committee if so delegated. Stock options granted with service-based vesting conditions generally vest over </div>four<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> years and expire after </div>ten<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> years. The exercise price for stock options granted is not less than the fair value of common stock on the date of grant. The Company bases fair value of common stock on the quoted market price. Prior to the IPO, the board of directors determined the value the Company&#8217;s common stock, taking into consideration its most recently available valuation of common stock performed by third parties as well as additional relevant factors which may have changed since the date of the most recent contemporaneous valuation through the date of grant.</div></div> <div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">2020 Employee Stock Purchase Plan </div></div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October&#160;21, 2020, the Company&#8217;s board of directors adopted and its stockholders approved the 2020 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;), which became effective on October&#160;21, 2020. The aggregate number of shares of common stock available for purchase pursuant to the exercise of options under the ESPP is 360,000 shares, plus an automatic annual increase, as of January&#160;1 of each year from 2021 to 2030, equal to the lesser of (i)&#160;one percent of the number of shares of common stock outstanding as of the close of business on the immediately preceding December&#160;31 and (ii)&#160;the number of shares determined by the board of directors on or prior to such date for such year (up to a maximum of 3,220,520 shares). The number of shares reserved for issuance under the ESPP was increased by 367,894 shares effective January&#160;1, 2021.</div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, no offering periods have commenced under the ESPP. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Stock option valuation </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of stock option grants is estimated using the Black-Scholes option-pricing model. Prior to the IPO, the Company was a private company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies. The expected term of the Company&#8217;s stock options has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain-vanilla&#8221; options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted in 2020 and 2019: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 71%;"></td><td style="width: 11%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 10%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year&#160;Ended&#160;December&#160;31,</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 71%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk-free interest rate</div></div></td><td style="background-color: rgb(204, 238, 255); width: 11%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.4</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2.2</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 71%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div></td><td style="width: 11%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">78.5</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="width: 10%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">78.2</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 71%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Expected dividend yield</div></div></td><td style="background-color: rgb(204, 238, 255); width: 11%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 71%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (in years)</div></div></td><td style="width: 11%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6.1</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 10%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6.0</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the Company&#8217;s option activity during the year ended December&#160;31, 2020:</div></div></div> <br/> <br/> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 61%;"></td><td style="width: 4%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:4%;"></td><td style="width: 4%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:4%;"></td><td style="width:0%;"></td><td style="width: 4%;;vertical-align:bottom;"></td><td style="width:4%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 4%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/> Shares</div></div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Exercise<br/> Price</div></div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Contractual<br/> Term</div></div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/> Intrinsic<br/> Value</div></div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in years)</div></div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)</div></div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Outstanding as of December&#160;31, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">3,886,489</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">2.39</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,922,377</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8.87</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercised</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">(611,048</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">1.99</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited</div></div></div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(181,358</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2.10</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Outstanding as of December&#160;31, 2020</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">5,016,460</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">4.93</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">8.5</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">76,941</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Vested and expected to vest as of</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>December&#160;31, 2020</div></div></div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5,016,460</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4.93</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8.5</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">76,941</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Options exercisable as of December&#160;31, 2020</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">1,508,122</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">1.91</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">7.4</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">27,683</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:times new roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company&#8217;s common stock for those stock options that had exercise prices lower than the fair value of the Company&#8217;s common stock. The aggregate intrinsic value of stock options exercised during the years ended December&#160;31, 2020 and 2019 was $3.5&#160;million and $1.2&#160;million, respectively. </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:times new roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The weighted average grant-date fair value of stock options granted during the years ended December&#160;31, 2020 and 2019 was $6.01 per share and $2.54 per share, respectively.</div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Restricted common stock </div></div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">During 2015, the Company issued and sold 4,459,459 shares of restricted common stock at par value to the scientific founders of the Company. The shares were subject to vesting over a period of five years and began vesting upon the closing of the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-1</div> Preferred Stock in April 2016&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">and were fully vested as of December&#160;31, 2020.<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the Company&#8217;s restricted common stock activity during the year ended December&#160;31, 2020:</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="width: 87%;"></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Shares</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 87%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Unvested restricted common stock as of December&#160;31, 2019</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">891,894</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 87%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issued</div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 87%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Vested</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(891,894</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 87%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 87%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested restricted common stock as of December&#160;31, 2020</div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 87%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="white-space: nowrap;;vertical-align:bottom;"></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The aggregate fair value of restricted stock that vested during the years ended December 2020 and 2019 was $4.8&#160;million and $3.3&#160;million, respectively. </div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;">&#160;</div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Stock-based compensation </div></div></div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recorded stock-based compensation expense related to common stock options and restricted common stock in the following expense categories of its consolidated statements of operations and comprehensive loss (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 72%;"></td><td style="width: 8%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 8%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year&#160;Ended&#160;December&#160;31,</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Research and development expenses</div></div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,724</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,140</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses</div></div></td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,237</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">554</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%;;vertical-align:bottom;">&#160;</td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255); padding: 0px;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255); text-align: center;;vertical-align:bottom;">$2,961</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255); text-align: center;;vertical-align:bottom;">$1,694</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 8%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);">&#160;</td><td style="width: 8%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>   <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, total unrecognized compensation cost was </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$13.5&#160;million, which is expected to be recognized over a weighted average period of 3.6&#160;years. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737977950744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration Agreement</a></td>
<td class="text"><div style="margin-block: 0em; margin-bottom: 0px; margin-top: 0px;">&#160;</div> <div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10. Collaboration Agreement </div></div></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In July 2020, the Company entered into a research collaboration and license agreement (the &#8220;Collaboration Agreement&#8221;) with Merck Sharp&#160;&amp; Dohme Corp. (&#8220;Merck&#8221;). The Company and Merck will apply Foghorn&#8217;s proprietary Gene Traffic Control platform to discover and develop novel therapeutics. Under the Collaboration Agreement, the Company granted Merck exclusive global rights to develop and commercialize drugs that target dysregulation of a single transcription factor. Under the terms of the Collaboration Agreement, the Company and Merck are each responsible to perform certain research activities in accordance with a mutually agreed upon research plan. Merck may substitute the selected transcription factor during certain stages of the research program, subject to certain limitations. Following completion of the research program, Merck is responsible for the development and commercialization of the compounds developed pursuant to the research program and any product containing such compounds. Pursuant to the Collaboration Agreement, the Company will also participate on a joint steering committee.</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Under the terms of the agreement, Foghorn received a nonrefundable upfront payment of $15.0&#160;million from Merck, and is eligible to receive up to $245.0&#160;million upon&#160;achievement of specified research, development and regulatory milestones by any product candidate generated by the collaboration, and up to $165.0&#160;<div style="display:inline;">million upon achievement of specified sales-based milestones per approved product from the collaboration, if any. The Company will be eligible to receive tiered royalties, calculated on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">product-by-product</div></div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">country-by-country</div></div> basis, on net sales of approved products from the collaboration, if any, at royalty rates ranging from the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-single</div> digits to low tens, depending on whether the products are covered by patent rights it licenses to Merck. </div> </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unless terminated earlier, the Collaboration Agreement will continue in full force and effect until one or more products has received marketing authorization and, thereafter, until expiration of all royalty obligations under the Collaboration Agreement. The Company or Merck may terminate the Collaboration Agreement upon an uncured material breach by the other party or insolvency of the other party. Merck may also terminate the Merck Collaboration Agreement for any reason upon certain notice to the Company. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company determined that the (1)&#160;research, development, manufacture and commercialization licenses, (2)&#160;the research activities performed by the Company and (3)&#160;service on the joint committees represent a single performance obligation under the Collaboration Agreement. The Company determined that Merck cannot benefit from licenses separately from the research activities and participation on the joint steering committee as these services are specialized and rely on the Company&#8217;s expertise such that these activities are highly interrelated and therefore not distinct. Accordingly, the promised goods and services represent one combined performance obligation and the entire transaction price was allocated to that single combined performance obligation. The performance obligation will be satisfied over the research term as the Company performs the research activities and participates in a joint steering committee to oversee research activities.</div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The upfront payment of </div></div>&#160;$15.0&#160;million was initially recorded as deferred revenue and is being recognized as revenue as the performance obligation is satisfied. The Company recognizes revenue <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">using&#160;the&#160;cost-to-cost&#160;method,&#160;which</div></div> it believes best depicts the transfer of control to the customer over time. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Under&#160;the&#160;cost-to-cost&#160;method,&#160;the</div></div> extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs expected upon satisfying the identified performance obligation. Under this method, revenue is recorded as a percentage of the estimated transaction price based on the extent of progress towards completion. As of December&#160;31, 2020, the potential research, development and regulatory milestone payments that the Company is eligible to receive were excluded from the transaction price as they were fully constrained by uncertain events. The Company will reevaluate the transaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur, and if necessary, the Company will adjust its estimate of the transaction price. Any additions to the transaction price would be reflected in the period as a cumulative <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">revenue&#160;catch-up</div> based on the ratio of costs incurred to the total estimated costs expected applied to the revised transaction price.&#160;Sales-based royalties and milestone payments, which predominantly relate to the license, will be recognized if and&#160;when the related sales occur. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of December&#160;31, 2020, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation is $14.6&#160;million, which is expected to be recognized as revenue through 2028. The Company does not expect collaboration revenue to be recognized evenly over this period as it will be recognized on a percentage of completion basis (using <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cost-to-cost</div></div> method) as the Company performs the research activities and participates on the joint steering committee, which will likely vary from period to period. In estimating the total costs to satisfy its single performance obligation pursuant to the Collaboration Agreement, the Company is required to make significant estimates including an estimate of the number of transcription factor substitutions and the expected time and expected costs to fulfill the performance obligation.&#160;The cumulative effect of revisions to the total estimated costs to complete the Company&#8217;s single performance obligation will be recorded in the period in which the changes are identified, and amounts can be reasonably estimated. While such revisions will have no impact on the Company&#8217;s cash flows, a significant change in these assumptions and estimates could have a material impact on the timing and amount of revenue recognized in future periods. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company assessed the Collaboration Agreement to determine whether a significant financing component exists and concluded that a significant financing component does not exist. Through December&#160;31, 2020, the Company had recorded $0.4&#160;million of revenue under the Collaboration Agreement. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737978068504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-block: 0em; margin-bottom: 0px; margin-top: 0px;">&#160;</div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11. Income Taxes </div></div></div></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the years ended December&#160;31, 20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div>&#160;and 2019, the Company recorded no<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">income tax benefits for the net deferred tax assets comprised primarily of net operating losses incurred and research and development tax credits generated in each year, due to its uncertainty of realizing a benefit from these items.</div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All of the Company&#8217;s operating losses since inception have been generated in the United States. </div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;">&#160;</div>  <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 84%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 75%;"></td><td style="width: 10%;;vertical-align:bottom;"></td><td style="width:7%;"></td><td></td><td></td><td style="width: 9%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year&#160;Ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Federal statutory income tax rate</div></div></td><td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(21.0</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)%&#160;</td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(21.0</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State taxes, net of federal benefit</div></div></td><td style="width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(6.4</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(7.1</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Federal and state research and development tax credits</div></div></td><td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(3.7</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2.2</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other</div></div></td><td style="width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(0.5</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.4</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Change in deferred tax asset valuation allowance</div></div></td><td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">31.6</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">29.9</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td><td style="width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:7%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Effective income tax rate</div></div></td><td style="width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.0</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.0</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td><td style="width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:7%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>    <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net deferred tax assets consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 76%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 72%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:3%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Deferred tax assets:</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net operating loss carryforwards</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:3%;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">39,289</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">23,769</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Research and development tax credit carryforwards</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">4,955</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">2,415</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">start-up</div> costs</div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">174</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">190</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Accrued expenses</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">1,010</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">522</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr><td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;">&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">436</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;">&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">74</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities</div></div></td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">17,032</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">414</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred tax assets</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">62,896</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">27,384</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax liabilities:</div></div></td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(2,819</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">)&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(482</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(11,694<div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></div>&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(281</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred tax liabilities</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(14,513</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">)&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(763</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation allowance</div></div></td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(48,383</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">)&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(26,621</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net deferred tax assets</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>   <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div>, the Company had U.S. federal and state net operating loss carryforwards of $147.3&#160;million and $132.3&#160;million, respectively, which may be available to offset future taxable income. The federal net operating loss carryforwards include&#160;$12.5 million&#160;which expire at various dates beginning in&#160;2035&#160;and&#160;$134.8 million&#160;which carryforward indefinitely but in some circumstances may be limited to offset 80% of annual taxable income. The state net operating loss carryforwards expire at various dates beginning in&#160;2036.&#160;As of December&#160;31, 20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div>, the Company also had U.S. federal and state research and development tax credit carryforwards of $3.4&#160;million and $2.0&#160;million, respectively, which may be available to offset future tax liabilities and expire at various dates beginning in 2036 and 2031, respectively. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Utilization of the U.S. federal and state net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Sections&#160;382 and 383 of the Internal Revenue Code of 1986, and corresponding provisions of state law, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income or tax liabilities. In general, an ownership change, as defined by Section&#160;382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section&#160;382, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section&#160;382. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization. Further, until a study is completed by the Company and any limitation is known, no amounts are </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">being recorded as an uncertain tax position.</div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets. Management has considered the Company&#8217;s history of cumulative net losses incurred since inception and its lack of commercialization of any products that would generate revenue from product sales and has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets as of December&#160;31, 20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div> and 2019. Management reevaluates the positive and negative evidence at each reporting period. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The valuation allowance increased by $21.8&#160;million and $15.3&#160;million during the years ended December&#160;31, 20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div> and 2019, respectively, primarily as a result of the increase in net operating loss carryforwards. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div> and 2019, the Company had not </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">recorded any amounts for unrecognized tax benefits. The Company files income tax returns in the U.S. and Massachusetts, as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal and state jurisdictions, where applicable. There are currently no pending tax examinations. Since the Company is in a loss carryforward position, it is generally subject to examination by the U.S. federal, state, and local income tax authorities for all tax years in which a loss carryforward is available.</div></div><div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737978077992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-block: 0em; margin-bottom: 0px; margin-top: 0px;">&#160;</div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12. Leases </div></div></div></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In October 2019, the Company entered into a lease for 81,441 square feet of office and laboratory space in Cambridge, Massachusetts, commencing in January 2020 (the &#8220;New Lease&#8221;). The initial term of the New Lease was eight years with a five-year option to extend at fair-market rent at the time of the extension. The base rent payments escalate annually over the eight-year lease term and totaled approximately $60.3&#160;million. In connection with the New Lease, the landlord agreed to fund up to $3.0&#160;million in tenant improvements to the leased facility as well as up to an additional $16.3&#160;million, which resulted in additional rent payments to the landlord over the lease term. During the year ended December&#160;31, 2020, $15.4&#160;million of leasehold improvements were reimbursed by the landlord, which resulted in an increase to operating lease liabilities. The Company is obligated to pay its portion of real estate taxes and costs related to the premises, including costs of operations and management of the leased premises. The Company is required to maintain a cash balance of $1.7&#160;million to secure a letter of credit associated with the lease. This amount was classified as restricted cash <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(non-current)</div> on the consolidated balance sheet as of December&#160;31, 2020 and 2019. On January&#160;1, 2020, the lease commencement date, the Company recorded an operating lease asset of $38.6&#160;million and corresponding lease liability of $38.3&#160;million. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In June 2020, the Company amended the New Lease to defer payment of a portion of the base rent and operating expenses and to extend the lease term by nine months to September 2028. The amendment was accounted for as a lease modification and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset and lease liability were remeasured at the modification date of June&#160;29, 2020 resulting in an increase of $7.4&#160;million to both the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset and lease liabilities. </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company had a lease for office and laboratory facilities in Cambridge, Massachusetts under a noncancelable operating lease that began in August 2017 and expired in March 2025. In April 2020, this lease was assigned and assumed by a related party which became effective in October 2020.</div></div></div>  <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;">&#160;</div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The components of lease expense were as follows (in thousands):</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 70%;"></td><td style="width: 9%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 9%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year&#160;Ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Operating lease cost</div></div></td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7,032</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,671</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term lease cost</div></div></td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">61</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">60</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Variable lease cost</div></div></td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,217</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">547</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 70%;;vertical-align:bottom;">&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; width: 70%;;vertical-align:top;">&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8,310</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,278</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 70%;;vertical-align:bottom;">&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Supplemental disclosure of cash flow information related to leases was as follows (in thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:81%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 70%;"></td><td style="width: 8%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 8%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year&#160;Ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash paid for amounts included in the measurement of operating lease liabilities</div></div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,086</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,731</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Operating lease liabilities arising from obtaining <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">38,306</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">271</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Increase in operating lease liabilities and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">right-of-use</div></div> assets due to lease remeasurement</div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7,384</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6,513</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>   <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The weighted-average remaining lease term and discount rate were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 83%;"></td><td style="width: 5%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 4%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Weighted-average remaining lease term&#8212;operating leases (in years)</div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7.7</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.1</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Weighted-average discount rate&#8212;operating leases</div></td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5.35</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="width: 4%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7.53</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Future annual minimum lease payments under operating leases as of December&#160;31, 20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div>&#160;were as follows (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 76%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;; width: 77%;"></td><td style="font-family: &quot;times new roman&quot;; width: 15%;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;;width:0%;"></td><td style="font-family: &quot;times new roman&quot;;;width:0%;"></td><td style="font-family: &quot;times new roman&quot;;;width:0%;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 77%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2021</div></div></td><td style="background-color: rgb(204, 238, 255); width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">9,814</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 77%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div></td><td style="width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">10,016</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 77%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2023</div></div></td><td style="background-color: rgb(204, 238, 255); width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">10,107</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 77%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div></td><td style="width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">10,347</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 77%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2025</div></div></td><td style="background-color: rgb(204, 238, 255); width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">10,595</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 77%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div></td><td style="width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">30,500</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 77%;;vertical-align:bottom;">&#160;</td><td style="width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 77%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Total future minimum lease payments</div></div></td><td style="background-color: rgb(204, 238, 255); width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">81,379</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 77%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: imputed interest</div></div></td><td style="width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">(15,104</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 77%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Less: estimated lease incentives</div></div></td><td style="background-color: rgb(204, 238, 255); width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(3,933</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 77%;;vertical-align:bottom;">&#160;</td><td style="width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 77%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></td><td style="width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">62,342</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 77%;;vertical-align:bottom;">&#160;</td><td style="width: 15%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td></tr><tr style="font-size: 0px;"><td style="width: 77%; padding: 0cm;"></td><td style="width: 15%; padding: 0cm;;vertical-align:bottom;"></td><td style="padding:0cm 0cm 0cm 0cm"></td><td style="padding:0cm 0cm 0cm 0cm"></td><td style="padding:0cm 0cm 0cm 0cm"></td></tr><tr><td style="padding:0cm 0cm 0cm 0cm;vertical-align:bottom;;width:;"><div style="margin: 0cm 0cm 0.0001pt; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div><div style="margin: 0cm 0cm 0.0001pt; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; line-height: normal;">&#160;</div></td><td style="padding: 0cm; font-size: 8pt;;vertical-align:bottom;;width:;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td><td colspan="2" style="border-top: none; border-right: none; border-left: none; border-image: initial; padding: 0cm;;vertical-align:bottom;;width:;"><div style="margin: 0cm 0cm 0.0001pt; text-align: center; line-height: normal; font-family: &quot;times new roman&quot;, serif; font-size: 8pt;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="padding: 0cm; border-bottom: 1pt solid white;;vertical-align:bottom;;width:;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td></tr><tr><td style="padding:0cm 0cm 0cm 0cm;vertical-align:bottom;;width:;"><div style="margin: 0cm 0cm 0.0001pt; font-family: calibri, sans-serif; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; line-height: 10pt;;display:inline;"><div style="line-height: 10pt; font-size: 10pt;;font-weight:bold;display:inline;">Included in the consolidated balance sheet (in thousands):</div></div></div></div></div></td><td style="padding: 0cm; font-size: 8pt;;vertical-align:bottom;;width:;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td><td colspan="2" style="border:none; border-bottom:solid black 1.0pt; padding:0cm 0cm 0cm 0cm;vertical-align:bottom;;width:;"><div style="margin:0cm 0cm 0.0001pt; text-align:center; line-height:normal; font-family:calibri,sans-serif"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-size: 8pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">December&#160;31,&#160;2020</div></div></div></div></td><td style="padding: 0cm; border-bottom: 1pt solid white;;vertical-align:bottom;;width:;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td></tr><tr><td style="background: rgb(204, 238, 255); padding: 0cm; font-size: 10pt; width: 77%;;vertical-align:top;"><div style="margin-top:0cm; margin-right:0cm; margin-bottom:.0001pt; margin-left:12.0pt; text-indent:-12.0pt; line-height:normal; font-family:calibri,sans-serif"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Current operating lease liabilities</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0cm; font-size: 10pt; width: 15%;;vertical-align:bottom;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td><td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap; font-size: 10pt;;vertical-align:bottom;"><div style="margin:0cm 0cm 0.0001pt; line-height:normal; font-family:calibri,sans-serif"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap; font-size: 10pt;;vertical-align:bottom;"><div style="margin:0cm 0cm 0.0001pt; text-align:right; line-height:normal; font-family:calibri,sans-serif"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">3,981</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap;;vertical-align:bottom;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td></tr><tr><td style="padding: 0cm; font-size: 10pt; width: 77%;;vertical-align:top;"><div style="margin-top:0cm; margin-right:0cm; margin-bottom:.0001pt; margin-left:12.0pt; text-indent:-12.0pt; line-height:normal; font-family:calibri,sans-serif"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, net of current portion</div></div></div></td><td style="padding: 0cm; font-size: 10pt; width: 15%;;vertical-align:bottom;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td><td style="padding: 0cm; white-space: nowrap; border-bottom: 0.75pt solid black;;vertical-align:bottom;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td><td style="padding: 0cm; white-space: nowrap; font-size: 10pt; border-bottom: 0.75pt solid black;;vertical-align:bottom;"><div style="margin:0cm 0cm 0.0001pt; text-align:right; line-height:normal; font-family:calibri,sans-serif"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">58,361</div></div></div></td><td style="padding: 0cm; white-space: nowrap;;vertical-align:bottom;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td></tr><tr><td style="background: rgb(204, 238, 255); padding: 0cm; font-size: 10pt; width: 77%;;vertical-align:top;"><div style="margin-top:0cm; margin-right:0cm; margin-bottom:.0001pt; margin-left:36.0pt; text-indent:-12.0pt; line-height:normal; font-family:calibri,sans-serif"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0cm; font-size: 10pt; width: 15%;;vertical-align:bottom;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td><td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap; font-size: 10pt;;vertical-align:bottom;"><div style="margin:0cm 0cm 0.0001pt; line-height:normal; font-family:calibri,sans-serif"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap; font-size: 10pt;;vertical-align:bottom;"><div style="margin:0cm 0cm 0.0001pt; text-align:right; line-height:normal; font-family:calibri,sans-serif"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;">62,342</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0cm; white-space: nowrap;;vertical-align:bottom;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td></tr><tr><td style="padding: 0cm; width: 77%;;vertical-align:bottom;">&#160;</td><td style="padding: 0cm; font-size: 1pt; width: 15%;;vertical-align:bottom;"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td><td style="padding:0cm 0cm 0cm 0cm;vertical-align:bottom;"><div style="border-top:double black 2.25pt; padding:0cm 0cm 0cm 0cm"><div style="border: none; margin: 0px 0cm; line-height: normal; padding: 0cm; font-family: calibri, sans-serif;">&#160;</div></div></td><td style="padding:0cm 0cm 0cm 0cm;vertical-align:bottom;"><div style="border-top:double black 2.25pt; padding:0cm 0cm 0cm 0cm"><div style="border: none; margin: 0px 0cm; line-height: normal; padding: 0cm; font-family: calibri, sans-serif;">&#160;</div></div></td><td style="padding:0cm 0cm 0cm 0cm"><div style="margin: 0px 0cm; line-height: normal; font-family: calibri, sans-serif;">&#160;</div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Sublease agreement </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In April 2020, the Company entered into a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-year</div> sublease of approximately 16,843 square feet of office space under the New Lease, as amended, which began in July 2020. As of December&#160;31, 2020, the remaining base rent payments due to the Company under the subleases was $2.5&#160;million. The Company recorded other income of $1.0&#160;million during the year ended December&#160;31, 2020 related to this sublease. </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737977905272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">13. Commitments and Contingencies </div></div></div></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Leases </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s commitments under its leases are described in Note&#160;1<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">License agreements </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Dana-Farber Cancer Institute </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In 2016, the Company entered into a license agreement with the Dana-Farber Cancer Institute, Inc. (&#8220;Dana Farber&#8221;) for an exclusive license for certain biological materials as well as patent rights to methods of identifying compounds to treat prostate cancer. In consideration for the right to develop, manufacture, and commercialize products based on certain of Dana Farber&#8217;s intellectual property, the Company is obligated to reimburse Dana Farber for patent expenses and pay low single-digit sales-based royalties upon the occurrence of specific events as outlined in the license agreement. Unless terminated earlier, in accordance with the provisions of the agreement, the agreement will terminate on the expiration date of the last to expire of the applicable Dana Farber patents. None of the Company&#8217;s product candidates utilize technology covered by this license. </div></div><div style="font-size: 1px; margin-top: 18px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stanford </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In July 2017, the Company entered into a license agreement with the Board of Trustees of the Leland Stanford Junior University (&#8220;Stanford&#8221;) for a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-exclusive</div> license for patent rights to certain diseases associated with chromatin remodeling. In consideration for the right to develop, manufacture, and commercialize products based on certain of Stanford&#8217;s intellectual property, the Company paid a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-time,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-refundable</div> license fee of less than $0.1&#160;million and reimbursed Stanford for $0.1&#160;million of costs incurred related to the patented technology. The Company also issued 42,781 shares of the Company&#8217;s common stock upon execution of a share purchase agreement. In addition to annual license maintenance fees of less than $0.1&#160;million, the Company will reimburse Stanford for patent expenses, pay low single-digit sales-based royalties, and pay up to $1.1&#160;million in regulatory milestones on each licensed product upon the occurrence of specific events as outlined in the license agreement. None of the Company&#8217;s product candidates utilize technology covered by this license. </div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Indemnification agreements </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, contract research organizations, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its board of directors and its executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. The Company has not incurred any material costs as a result of such indemnifications and is not currently aware of any indemnification claims. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Legal Proceedings </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">From time to time, the Company may become involved in litigation or other legal proceedings. The Company is not currently a party to any material litigation or legal proceedings. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737977972776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Defined Contribution Plan</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">14. Defined Contribution Plan </div></div></div></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has a 401(k) defined contribution plan (the &#8220;401(k) Plan&#8221;) for its employees. Eligible employees may make pretax contributions to the 401(k) Plan up to statutory limits. There was no discretionary match made under the 401(k) Plan as of December&#160;31, 20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div>&#160;and 2019. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737978068504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">15. Related Parties </div></div></div></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In October 2015, the Company entered into a five-year service agreement with Flagship Pioneering (&#8220;Flagship&#8221;), </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">an affiliate of one of its stockholders, to provide general and administrative services</div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> to the Company, including certain consulting services and the provision of employee health and dental benefit plans for the Company&#8217;s employees. The Company made cash payments for services received under this agreement of $1.2&#160;million and $0.9&#160;million during the years ended December&#160;31, 2020 and 2019, respectively. As of December&#160;31, 2020 and 2019, the Company had no accounts payable to Flagship for costs related to the service agreement.<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This agreement expired in 2020.</div></div><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In October 2015, the Company entered into a five-year consulting agreement with a scientific founder of the Company who is also a board member and a <div style="letter-spacing: 0px; top: 0px;;display:inline;">shareholder. In October 2020, this agreement was extended to January 1, 2022, with an option to renew. During</div> the years ended December&#160;31, 2020 and 2019, the Company paid the scientific founder $0.2&#160;million and $0.2&#160;million, respectively. As of December&#160;31, 2020 the Company had less than $0.1&#160;million in accounts payable to this scientific founder. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737974942776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;). </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of estimates </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, revenue recognition, the valuation of stock-based awards and the accrual of research and development expenses. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Actual results may differ from those estimates or assumptions. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of credit risk and of significant suppliers</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentrations of credit risk and of significant suppliers </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. As of December&#160;31, 2020, the Company maintained cash, cash equivalents and marketable securities at financial institutions in excess of federally insured limits. The Company does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company relies, and expects to continue to rely, on a small number of vendors to provide services, supplies and materials for certain activities related to its programs. These programs could be adversely affected by a significant interruption in these services or the availability of materials. </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash equivalents</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Cash equivalents </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all highly liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Marketable Securities </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s marketable securities are classified as available-for-sale and are carried at fair value with the unrealized gains and losses reported as a component of accumulated other comprehensive loss in stockholders&#8217; equity (deficit). Realized gains and losses and declines in value judged to be other than temporary are included as a component of interest income and other income (expense), net based on the specific identification method. The Company classifies its marketable securities with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities are available for current operations.&#160;</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted cash</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Restricted cash </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Amounts included in restricted cash represent amounts pledged as collateral for letters of credit required for security deposits on the Company&#8217;s leased facilities and credit cards. These amounts are classified as restricted cash (current and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current)</div> in the Company&#8217;s consolidated balance sheets. </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Property and equipment </div></div></div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense is recognized using the straight-line method over the estimated useful life of each asset as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 90%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;; width: 51%;"></td><td style="font-family: &quot;times new roman&quot;; width: 2%;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; width: 47%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt; width: 51%;;vertical-align:bottom;"></td><td style="padding-bottom: 0.75pt; width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; border-bottom: 0.75pt solid black; width: 47%;;text-align:center;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; display: table-cell; line-height: normal;;text-align:center;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated&#160;Useful&#160;Life</div></div></div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Laboratory equipment</td><td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">5 years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt; width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Furniture and fixtures</td><td style="padding-bottom: 0.75pt; width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">5 years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Computer equipment and software</td><td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">3 years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Leasehold improvements</td><td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">Shorter&#160;of&#160;useful&#160;life&#160;or&#160;remaining&#160;term&#160;of&#160;lease</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Costs for capital assets not yet placed into service are depreciated once placed into service. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation and amortization are removed from the accounts and any resulting gain or loss is included in loss from operations. Expenditures for repairs and maintenance are charged to expense as incurred.</div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Impairment of long-lived assets </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company evaluates its long-lived assets, which consist primarily of property and equipment and operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. The Company did not record any impairment losses on long-lived assets during the years ended December&#160;31, 2020 or 2019. </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value measurements</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Fair value measurements </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:2%;">&#8226;</td><td style="vertical-align:top;;width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;1&#8212;Quoted prices in active markets for identical assets or liabilities. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:2%;">&#8226;</td><td style="vertical-align:top;;width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;2&#8212;Observable inputs (other than Level&#160;1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;;width:2%;">&#8226;</td><td style="vertical-align:top;;width:1%;">&#160;</td><td style="text-align:left;;vertical-align:top;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;;text-align:left;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s cash equivalents and marketable securities are carried at fair value, determined according to the fair value hierarchy described above (see Note&#160;3). The carrying values of the Company&#8217;s accounts payable and accrued expenses approximate their fair values due to the short-term nature of these liabilities. The carrying value of the Company&#8217;s long-term debt approximates its fair value (a level 2 measurement) due to its variable interest rate. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Revenue recognition </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its one collaboration arrangement, entered into in July 2020, under ASC Topic&#160;606,<div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#160;Revenue From Contracts With Customers</div>&#160;(ASC 606). For additional information on the Company&#8217;s collaboration agreement, see Note 10,&#160;Collaboration&#160;Agreement, to these consolidated financial statements. Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements within the scope of ASC 606, the entity performs the following five steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price, including variable consideration, if any; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer. </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company assesses the goods or services promised within each contract and determines those that are performance obligations. The promised goods or services in the Company&#8217;s arrangements would likely consist of licenses, rights to the Company&#8217;s intellectual property, research and development services and related supporting activities. Arrangements that include rights to additional goods or services that are exercisable at a customer&#8217;s discretion are generally considered options. The Company assesses if these options provide a material right to the customer and if so, they are considered performance obligations. </div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i)&#160;the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii)&#160;the entity&#8217;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the research, development, manufacturing and commercialization capabilities of the customer and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The transaction price is then determined and allocated to the identified performance obligations in proportion to their standalone selling prices (&#8220;SSP&#8221;) on a relative SSP basis. SSP is determined at contract inception and is not updated to reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In developing the SSP for a performance obligation, the Company considers applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs. The Company validates the SSP for performance obligations by evaluating whether changes in the key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance obligations. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">If the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The Company includes the unconstrained amount of estimated variable consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Company&#160;re-evaluates&#160;the</div> estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cumulative&#160;catch-up&#160;basis</div> in the period of adjustment. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#8217;s control such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For arrangements with licenses of intellectual property that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestones at the later of (i)&#160;when the related sales occur, or (ii)&#160;when the performance obligation to which the royalty has been allocated has been satisfied. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company records amounts as accounts receivable when the right to consideration is deemed unconditional. When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded for deferred revenue. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between the transfer of the promised goods or services to the customer and the payment by the customer will be one year or less. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time, and if over time, recognition is based on the use of an output or input method. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy', window );">Classification of convertible preferred stock</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Classification of convertible preferred stock </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company classified its convertible preferred stock outstanding prior to the IPO outside of stockholders&#8217; equity (deficit) on the consolidated balance sheet because the holders of such shares had redemption rights in the event of a deemed liquidation that, in certain situations, is not solely within the control of the Company. </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development costs</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Research and development costs </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Research and development expenses consist of costs incurred in performing research and development activities, including salaries and bonuses, stock-based compensation, employee benefits, facilities costs, laboratory supplies, depreciation, and external costs of vendors engaged to conduct research, preclinical and clinical development activities as well as the cost of licensing technology.</div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upfront payments and milestone payments made for the licensing of technology are expensed as research and development over the period to which they relate. Costs for research and development activities are expensed in the period in which they are incurred. Payments for such activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred, and are reflected in the consolidated financial statements as prepaid expense or accrued research and development expense. Determining the prepaid and accrued balances at the end of any reporting period incorporate certain judgments and estimates by management that are based on information available to the Company including information provided by vendors regarding the progress to completion of specific tasks or costs incurred. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizationOfInternalCostsPolicy', window );">Patent costs</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Patent costs </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative expenses. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Leases </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In accordance with ASC 842, <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Leases,</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>the Company accounts for a contract as a lease when it has the right to control the asset for a period of time while obtaining substantially all of the asset&#8217;s economic benefits. The Company determines if an arrangement is a lease or contains an embedded lease at inception. For arrangements that meet the definition of a lease, the Company determines the initial classification and measurement of its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset and lease liability at the lease commencement date and thereafter if modified. The lease term includes any renewal options that the Company is reasonably assured to exercise. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable; otherwise, the Company uses its estimated secured incremental borrowing rate for that lease term. The Company&#8217;s policy is to not record leases with an original term of twelve months or less on its consolidated balance sheets and recognizes those lease payments in the income statement on a straight-line basis over the lease term. The Company&#8217;s existing leases are for office and laboratory space and an equipment lease. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In addition to rent, the leases may require the Company to pay additional costs, such as utilities, maintenance and other operating costs, which are generally referred to as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. The Company has&#160;elected to not separate lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. Only the fixed costs for lease components and their associated <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components are accounted for as a single lease component and recognized as part of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset and liability. Rent expense for operating leases is recognized on a straight-line basis over the reasonably assured lease term based on the total lease payments and is included in operating expense in the consolidated statements of operations and comprehensive loss. </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-based compensation</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Stock-based compensation </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company measures stock options with service-based vesting or performance-based vesting granted to employees, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> and directors based on the fair value on the date of grant using the Black-Scholes option-pricing model. The Company measures restricted common stock awards using the difference between the purchase price per share of the award, if any, and the fair value of the Company&#8217;s common stock at the date of grant. Compensation expense for the awards is recognized over the requisite service period for employees and directors and as services are delivered for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees,</div> both of which are generally the vesting period of the respective award. The Company uses the straight-line method to record the expense of awards with only service-based vesting conditions. The Company uses the graded-vesting method to record the expense of awards with both service-based and performance-based vesting conditions, commencing once achievement of the performance condition becomes probable. The Company&#160;accounts for forfeitures of share-based awards as they occur. </div> <div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company classifies stock-based compensation expense in its consolidated statements of operations and comprehensive loss in the same manner in which the award recipient&#8217;s payroll costs are classified or in which the award recipient&#8217;s service payments are classified. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net loss per share</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Net loss per share </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In October 2020, upon the closing of the IPO, all outstanding shares of the Company&#8217;s convertible preferred stock automatically converted into 21,958,588 shares of the Company&#8217;s common stock. Prior to this conversion,&#160;the Company followed <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;two-class&#160;method</div> when computing net income (loss) per share as the Company had issued shares that meet the definition of participating securities. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">The&#160;two-class&#160;method</div> determines net income (loss) per share for each class of common and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">The&#160;two-class&#160;method</div> requires income (loss) available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to share in the earnings as if all income (loss) for the period had been distributed. </div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic net income (loss) per share attributable to common stockholders is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income (loss) per share attributable to common stockholders is computed by adjusting net income (loss) attributable to common stockholders to reallocate undistributed earnings based on the potential impact of dilutive securities. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the diluted net income (loss) attributable to common stockholders by the weighted average number of common shares outstanding for the period, including potential dilutive common shares. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s participating securities contractually entitled the holders of such shares to participate in dividends but did not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reported a net loss, such losses were not allocated to such participating securities. In periods in which the Company reported a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is the same as basic net loss per share attributable to common stockholders, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company reported a net loss attributable to common stockholders for the years ended December&#160;31, 2020 and 2019. </div></div>  <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following common stock equivalents presented based on amounts outstanding at each period end, have been excluded from the calculation of diluted net loss per share because including them would have had an anti-dilutive impact: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 69%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 3%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Stock options to purchase common stock</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,016,460</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,886,489</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants to purchase common stock</div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">18,445</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Convertible preferred stock (as converted to common stock)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">15,467,863</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested restricted common stock</div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">891,894</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Warrants to purchase convertible preferred stock (as converted to common stock)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7,608</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; padding: 0px; width: 69%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; padding: 0px; width: 69%;;vertical-align:top;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5,034,905</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">20,253,854</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; padding: 0px; width: 69%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Segments </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating segments are defined as components of an entity for which separate discrete financial information is made available and that is regularly evaluated by the chief operating decision maker (&#8220;CODM&#8221;) in making decisions regarding resource allocation and assessing performance. The Company&#8217;s CODM is its chief executive officer and the Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company is focused on pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive loss</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Comprehensive loss </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Comprehensive loss includes net loss as well as other changes in stockholders&#8217; equity (deficit) that result from transactions and economic events other than those with stockholders. For the year ended December&#160;31, 2020, the Company&#8217;s only element of other comprehensive loss was unrealized losses on available for sale debt securities. For the year ended December&#160;31, 2019, there was no difference between net loss and comprehensive loss. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Income taxes </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#8217;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to the provision for income taxes. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. </div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-step</div> process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. Any resulting unrecognized tax benefits are recorded within the provision for income taxes. </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently issued accounting pronouncements</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Recently issued accounting pronouncements </div></div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to &#8220;opt out&#8221; of the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i)&#160;irrevocably elects to &#8220;opt out&#8221; of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company. </div></div></div> <div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2016-13,</div> <div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Financial Instruments &#8211; Credit Losses (Topic 326)</div>.&#160;The new standard adjusts the accounting for assets held at amortized costs basis, including marketable securities accounted for as available for sale.&#160;The standard eliminates the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses.&#160;The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For public entities, the guidance was effective for annual reporting periods beginning after December&#160;15, 2019 and for interim periods within those fiscal years. For nonpublic entities and emerging growth companies that choose to take advantage of the extended transition period, the guidance is effective for annual reporting periods beginning after December&#160;15, 2020. Early adoption is permitted for all entities. In November 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2019-10,</div> which deferred the effective date for nonpublic entities to annual reporting periods beginning after December&#160;15, 2022, including interim periods within those fiscal years. The Company is evaluating when to adopt this standard and the effect the adoption will have on its consolidated financial statements. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizationOfInternalCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for capitalizing internal costs associated with exploration and production activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 360<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015634&amp;loc=d3e516343-122869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398226&amp;loc=d3e511914-122862<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizationOfInternalCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116854557&amp;loc=d3e20905-112640<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737973595592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock', window );">Summary of Property and Equipment are Stated at Cost Less Accumulated Depreciation and Amortization</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization expense is recognized using the straight-line method over the estimated useful life of each asset as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 90%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;; width: 51%;"></td><td style="font-family: &quot;times new roman&quot;; width: 2%;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;; width: 47%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt; width: 51%;;vertical-align:bottom;"></td><td style="padding-bottom: 0.75pt; width: 2%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; border-bottom: 0.75pt solid black; width: 47%;;text-align:center;;vertical-align:bottom;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; display: table-cell; line-height: normal;;text-align:center;"><div style="font-weight:bold;display:inline;width:100%;"><div style="font-family: &quot;times new roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated&#160;Useful&#160;Life</div></div></div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Laboratory equipment</td><td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">5 years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="padding-bottom: 0.75pt; width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Furniture and fixtures</td><td style="padding-bottom: 0.75pt; width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">5 years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Computer equipment and software</td><td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">3 years</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 51%; background-color: rgb(255, 255, 255);;vertical-align:top;">Leasehold improvements</td><td style="width: 2%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 47%;;text-align:center;;vertical-align:top;">Shorter&#160;of&#160;useful&#160;life&#160;or&#160;remaining&#160;term&#160;of&#160;lease</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of Earnings Per Share Diluted Anti Dilutive Impact</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following common stock equivalents presented based on amounts outstanding at each period end, have been excluded from the calculation of diluted net loss per share because including them would have had an anti-dilutive impact: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 69%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 3%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Stock options to purchase common stock</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,016,460</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,886,489</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrants to purchase common stock</div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">18,445</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Convertible preferred stock (as converted to common stock)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">15,467,863</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested restricted common stock</div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">891,894</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 69%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Warrants to purchase convertible preferred stock (as converted to common stock)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7,608</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; padding: 0px; width: 69%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; padding: 0px; width: 69%;;vertical-align:top;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5,034,905</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">20,253,854</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; padding: 0px; width: 69%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the estimated useful lives of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_SummaryOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972015784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Available for Sale Marketable Securities By Security Type</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, available for sale marketable securities by security type consisted of (in thousands): </div></div></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 56%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:5%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:5%;"></td><td style="width:0%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:4%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td></tr><tr><td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Gross</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Gross</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Estimated</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr><tr><td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Amortized</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Unrealized</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Unrealized</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Fair</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr><tr><td style="background-color: rgb(255, 255, 255); width: 56%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0px; margin-bottom: 0px; margin-left: 1em; line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cost </div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Gains</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Losses</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;">&#160;</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;width:100%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Value</div></div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 56%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">S<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div> treasury notes (due within one year)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">92,982</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:5%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(7</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">92,975</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 56%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:5%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 56%; background-color: rgb(255, 255, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">92,982</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:5%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(7</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">)&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">92,975</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 56%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:5%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables present the Company&#8217;s fair value hierarchy for its assets and liabilities, which are measured at fair value on a recurring basis (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 61%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td style="width:4%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Fair Value Measurements at<br/> December&#160;31, 2020 Using:</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Assets:</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash equivalents:</div></div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Money market funds</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">48,770</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">48,770</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U<div style="letter-spacing: 0px; top: 0px;;display:inline;">.S<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div></div> treasury notes</div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; text-align: right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212; &#160;</div></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">42,997</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; text-align: right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212; &#160;</div></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">42,997</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Marketable securities:</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div>S<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div>&#160;treasury notes</div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:4%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">92,975</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">92,975</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Total</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">48,770</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">135,972</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">184,742</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td></tr><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;width:;;height:16;">&#160;</td><td colspan="16" style="font-family: &quot;times new roman&quot;;;width:;;height:16;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="14" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Fair Value Measurements at<br/> December&#160;31, 2019 Using:</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Total</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="font-weight:bold;display:inline;">Assets:</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash equivalents:</div></div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Money market funds</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">14,951</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">14,951</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div></div></td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:4%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Preferred stock warrant liability</div></div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">45</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">45</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:4%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td><td style="width: 3%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:0%;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139738054479144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Sumary of Property and Equipment Net</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 74%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 6%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Laboratory equipment</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,740</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,202</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">815</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">337</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Computer equipment and software</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">100</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">81</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,961</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">75</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Assets not yet placed in service</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">15</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">280</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:top;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">21,631</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">3,975</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Less: Accumulated depreciation and amortization</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2,103</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,292</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:top;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">19,528</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,683</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737978139992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Table)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 76%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 78%;"></td><td style="width: 5%;;vertical-align:bottom;"></td><td style="width: 5%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="vertical-align:bottom;;width:5%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Accrued <div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">employee compensation and benefits</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">3,513</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">1,867</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued <div style="letter-spacing: 0px; top: 0px;;display:inline;">construction in progress</div></div></div></td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">2,385</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">119</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Accrued external research and development expenses</div></div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">2,146</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">1,384</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr><td style="background-color: rgb(255, 255, 255); width: 78%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Accrued professional fee<div style="letter-spacing: 0px; top: 0px;;display:inline;">s</div></div></div></td><td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;">&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">979</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;">&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">274</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 78%; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other</div></div></td><td style="width: 5%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">138</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">57</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 78%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 5%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; background-color: rgb(255, 255, 255); width: 78%;;vertical-align:top;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">9,161</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">3,701</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 78%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 5%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255); width: 5%;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139738051583272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt, Unclassified [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Long Term Debt</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 74%;"></td><td style="width: 5%;;vertical-align:bottom;"></td><td style="width: 5%;"></td><td></td><td></td><td style="vertical-align:bottom;;width:5%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Principal amount of long-term debt</div></div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">15,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Current portion of long-term debt</div></div></td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(4,152</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="width: 5%;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Long-term debt, net of current portion</div></div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">20,000</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10,848</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Final payment fee</div></div></td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">530</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Debt discount, net of accretion</div></div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(1,346</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(418</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="width: 5%;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 74%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt, net of discount and current portion</div></div></td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; width: 5%;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">19,654</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,960</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 74%;;vertical-align:bottom;">&#160;</td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="width: 5%;;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;;width:5%;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Summary of Future Long Term Loan Principal Payments Due</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2020, future principal payments due are as follows (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;; width: 85%;"></td><td style="font-family: &quot;times new roman&quot;; width: 6%;;vertical-align:bottom;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2021</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 85%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2023</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">833</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 85%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 85%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2025</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9,167</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 85%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; width: 85%;;vertical-align:top;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">20,000</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 85%;;vertical-align:bottom;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737977967432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock and Preferred Stock Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Schedule of stock by class</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2019,<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>Preferred Stock consisted of the following (in thousands, except share amounts):</div></div><div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:100%;"><tr style="font-size: 0px;"><td style="width:51%;"></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:3%;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Preferred&#160;Stock<br/> Authorized</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Preferred&#160;Stock<br/> Issued and<br/> Outstanding</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Carrying&#160;Value</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Liquidation<br/> Preference</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">Common&#160;Stock<br/> Issuable Upon<br/> Conversion</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">A-1</div> Preferred Stock</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9,707,826</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9,693,750</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9,609</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9,694</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">5,239,865</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-2</div> Preferred Stock</div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,804,165</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,804,165</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,179</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">16,206</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5,840,089</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Series B Preferred Stock</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">8,117,631</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">8,117,631</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">60,756</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">60,882</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">4,387,909</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:top;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">28,629,622</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">28,615,546</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">86,544</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">86,782</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">15,467,863</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21553-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21488-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21484-112644<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972063768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options and Restricted Stock Awards using Black-Scholes Option Pricing Model</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted in 2020 and 2019: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 71%;"></td><td style="width: 11%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 10%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year&#160;Ended&#160;December&#160;31,</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 71%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Risk-free interest rate</div></div></td><td style="background-color: rgb(204, 238, 255); width: 11%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">0.4</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td><td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">2.2</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 71%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected volatility</div></div></td><td style="width: 11%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">78.5</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="width: 10%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">78.2</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 71%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Expected dividend yield</div></div></td><td style="background-color: rgb(204, 238, 255); width: 11%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 71%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (in years)</div></div></td><td style="width: 11%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6.1</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 10%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">6.0</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share Option Activity</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the Company&#8217;s option activity during the year ended December&#160;31, 2020: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><br/> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px; width: 92%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 61%;"></td><td style="width: 4%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:4%;"></td><td style="width: 4%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:4%;"></td><td style="width:0%;"></td><td style="width: 4%;;vertical-align:bottom;"></td><td style="width:4%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 4%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/> Shares</div></div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Exercise<br/> Price</div></div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Contractual<br/> Term</div></div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/> Intrinsic<br/> Value</div></div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in years)</div></div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td colspan="2" style="text-align:center;;vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in&#160;thousands)</div></div></td><td style="vertical-align:bottom;;width:;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Outstanding as of December&#160;31, 2019</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">3,886,489</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">2.39</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,922,377</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8.87</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Exercised</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">(611,048</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">1.99</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited</div></div></div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(181,358</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2.10</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Outstanding as of December&#160;31, 2020</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">5,016,460</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">4.93</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">8.5</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">76,941</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-size: 1px;"><td style="width: 61%;;vertical-align:bottom;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:4%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td><td style="vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Vested and expected to vest as of</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>December&#160;31, 2020</div></div></div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5,016,460</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4.93</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8.5</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="width: 4%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">76,941</div></td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); font-size: 10pt; width: 61%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Options exercisable as of December&#160;31, 2020</div></div></div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">1,508,122</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">1.91</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:4%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">7.4</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">$</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">27,683</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="background-color: rgb(204, 238, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Summary of Restricted common stock</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="width: 87%;"></td><td style="width: 1%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Shares</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 87%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Unvested restricted common stock as of December&#160;31, 2019</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">891,894</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 87%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issued</div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 87%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Vested</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(891,894</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 87%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 87%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unvested restricted common stock as of December&#160;31, 2020</div></div></td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">&#8212;&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 87%;;vertical-align:bottom;">&#160;</td><td style="width: 1%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recorded stock-based compensation expense related to common stock options and restricted common stock in the following expense categories of its consolidated statements of operations and comprehensive loss (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 72%;"></td><td style="width: 8%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 8%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year&#160;Ended&#160;December&#160;31,</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Research and development expenses</div></div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,724</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,140</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses</div></div></td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">1,237</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">554</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%;;vertical-align:bottom;">&#160;</td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255); padding: 0px;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255); text-align: center;;vertical-align:bottom;">$2,961</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;"></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255); text-align: center;;vertical-align:bottom;">$1,694</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 8%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);">&#160;</td><td style="width: 8%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737971995592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Summary of Reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 84%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 75%;"></td><td style="width: 10%;;vertical-align:bottom;"></td><td style="width:7%;"></td><td></td><td></td><td style="width: 9%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year&#160;Ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Federal statutory income tax rate</div></div></td><td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(21.0</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)%&#160;</td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(21.0</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)%&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State taxes, net of federal benefit</div></div></td><td style="width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(6.4</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(7.1</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Federal and state research and development tax credits</div></div></td><td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(3.7</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(2.2</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other</div></div></td><td style="width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(0.5</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.4</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Change in deferred tax asset valuation allowance</div></div></td><td style="background-color: rgb(204, 238, 255); width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">31.6</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">29.9</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td><td style="width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:7%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 75%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Effective income tax rate</div></div></td><td style="width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:7%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.0</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">0.0</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 75%;;vertical-align:bottom;">&#160;</td><td style="width: 10%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;;width:7%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of Net Deferred Tax Assets</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net deferred tax assets consisted of the following (in thousands): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; width: 76%;;margin : 0px auto;;text-align:left;"><tr style="font-size: 0px;"><td style="width: 72%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:3%;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width: 6%;;vertical-align:bottom;"></td><td style="width:0%;"></td><td style="width:0%;"></td><td style="width:0%;"></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">20<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Deferred tax assets:</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net operating loss carryforwards</div></div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:3%;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">39,289</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">23,769</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Research and development tax credit carryforwards</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">4,955</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">2,415</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Capitalized <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">start-up</div> costs</div></td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">174</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;;width:0%;">190</td><td style="white-space: nowrap;;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Accrued expenses</div></div></td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">1,010</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">522</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr><td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;">&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">436</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;">&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">74</div></div></td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities</div></div></td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">17,032</div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">414</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred tax assets</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">62,896</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">27,384</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax liabilities:</div></div></td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="font-family: &quot;times new roman&quot;; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(2,819</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">)&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(482</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(11,694<div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></div>&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(281</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total deferred tax liabilities</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(14,513</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">)&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(763</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(204, 238, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 72%; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation allowance</div></div></td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:3%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(48,383</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">)&#160;</td><td style="width: 6%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;;width:0%;">(26,621</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;;width:0%;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(255, 255, 255); width: 72%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net deferred tax assets</div></div></td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td><td style="background-color: rgb(255, 255, 255); width: 6%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">$</td><td style="white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;;vertical-align:bottom;;width:0%;">&#8212;&#160;&#160;</td><td style="white-space: nowrap; font-family: &quot;times new roman&quot;; background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 72%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:3%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td><td style="width: 6%; background-color: rgb(255, 255, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;vertical-align:bottom;;width:0%;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="background-color: rgb(255, 255, 255);;width:0%;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972877672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Lease Cost</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;">&#160;</div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The components of lease expense were as follows (in thousands):</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 70%;"></td><td style="width: 9%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 9%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year&#160;Ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Operating lease cost</div></div></td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7,032</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,671</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term lease cost</div></div></td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">61</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">60</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Variable lease cost</div></div></td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,217</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">547</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 70%;;vertical-align:bottom;">&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="font-family: &quot;times new roman&quot;; width: 70%;;vertical-align:top;">&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">8,310</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">2,278</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;; width: 70%;;vertical-align:bottom;">&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td><td style="width: 9%;;vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Summary of Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Supplemental disclosure of cash flow information related to leases was as follows (in thousands): </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width:81%;"></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td><td style="vertical-align:bottom;;width:4%;"></td><td></td><td></td><td></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px; background: none;"></div> <div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 70%;"></td><td style="width: 8%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 8%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="6" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">Year&#160;Ended&#160;December&#160;31,</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Cash paid for amounts included in the measurement of operating lease liabilities</div></div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,086</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1,731</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Operating lease liabilities arising from obtaining <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">38,306</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">271</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 70%;;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Increase in operating lease liabilities and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">right-of-use</div></div> assets due to lease remeasurement</div></td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7,384</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 8%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">6,513</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock', window );">Summary of Weighted-Average Remaining Lease Term and Discount Rate Leases</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The weighted-average remaining lease term and discount rate were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="width: 83%;"></td><td style="width: 5%;;vertical-align:bottom;"></td><td></td><td></td><td></td><td style="width: 4%;;vertical-align:bottom;"></td><td></td><td></td><td></td></tr><tr style="font-family: times new roman; font-size: 8pt; page-break-inside: avoid;"><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2020</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td><td colspan="2" style="border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;;vertical-align:bottom;;width:;"><div style="font-weight:bold;display:inline;">2019</div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;;width:;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Weighted-average remaining lease term&#8212;operating leases (in years)</div></td><td style="background-color: rgb(204, 238, 255); width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">7.7</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="background-color: rgb(204, 238, 255); width: 4%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">1.1</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Weighted-average discount rate&#8212;operating leases</div></td><td style="width: 5%;;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">5.35</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td><td style="width: 4%;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">7.53</td><td style="white-space: nowrap;;vertical-align:bottom;">%&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Minimum Lease Payments</a></td>
<td class="text"><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Future annual minimum lease payments under operating leases as of December&#160;31, 2020 were as follows (in thousands): </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 0px;"><td style="font-family: &quot;times new roman&quot;;;width:77%;"></td><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;;width:15%;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td><td style="font-family: &quot;times new roman&quot;;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2021</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">9,814</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,016</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2023</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10,107</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">10,347</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">2025</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">10,595</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">30,500</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Total future minimum lease payments</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">81,379</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: imputed interest</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">(15,104</td><td style="white-space: nowrap;;vertical-align:bottom;">)&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Less: estimated lease incentives</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">(3,933</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">)&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="vertical-align:top;"><div style="text-indent: -1em; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">$</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">62,342</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;">&#160;</td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_OperatingLeaseLiabilityTableTextBlock', window );">Summary of Operating Lease Liabilities</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:76%;"><tr style="font-size: 1pt;"><td style="font-family: &quot;times new roman&quot;;;height:16;"></td><td colspan="4" style="font-family: &quot;times new roman&quot;;;height:16;"></td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 8pt;"><td style="padding-bottom: 1pt;;vertical-align:bottom;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Included in the consolidated balance sheet (in thousands):</div></div></td><td style="padding-bottom: 1pt;;vertical-align:bottom;">&#160;&#160;</td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;;vertical-align:bottom;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2020</div></td><td style="padding-bottom: 0.7pt;;vertical-align:bottom;">&#160;</td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;times new roman&quot;; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Current operating lease liabilities</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">3,981</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"><td style="vertical-align:top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;times new roman&quot;; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities, net of current portion</div></div></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td><td style="white-space: nowrap;;text-align:right;;vertical-align:bottom;">58,361</td><td style="white-space: nowrap;;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr><tr style="break-inside: avoid; font-family: 'times new roman'; font-size: 10pt;"><td style="background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;times new roman&quot;; line-height: normal;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background-color: rgb(204, 238, 255);;display:inline;">Total operating lease liabilities</div></div></td><td style="background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;&#160;</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">$</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;;vertical-align:bottom;">62,342</td><td style="white-space: nowrap; background-color: rgb(204, 238, 255);;vertical-align:bottom;">&#160;</td></tr><tr style="font-size: 1px;"><td style="font-family: &quot;times new roman&quot;;;vertical-align:bottom;"></td><td style="vertical-align:bottom;">&#160;&#160;</td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td style="vertical-align:bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td><td>&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_OperatingLeaseLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of operating lease liabilities included in the consolidated balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_OperatingLeaseLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental information for the statement of cash flows related to leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average remaining lease term and weighted average discount rate related to leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ScheduleOfWeightedaverageRemainingLeaseTermAndDiscountRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737969645224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business and Basis of Presentation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 19, 2020</div></th>
<th class="th"><div>Oct. 27, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,800<span></span>
</td>
<td class="nump">$ 51,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,936<span></span>
</td>
<td class="nump">$ 94,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ProceedsFromUpfrontPayment', window );">Upfront payment received from Merck</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants granted to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during the period shares new issues shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,451,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock issue price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock consideration received on the transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants granted to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during the period shares new issues shares</a></td>
<td class="nump">951,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock issue price per share</a></td>
<td class="nump">$ 16.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock consideration received on the transaction</a></td>
<td class="nump">$ 14,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization consolidation and presentation of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ProceedsFromUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from upfront payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ProceedsFromUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139738059062168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 27, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment losses on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of preferred stock, common shares issued</a></td>
<td class="nump">21,958,588<span></span>
</td>
<td class="nump">21,958,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737974223736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Property and Equipment are Stated at Cost Less Accumulated Depreciation and Amortization (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Computer equipment and software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, plant and equipment, useful life</a></td>
<td class="text">Shorter of useful life or remaining term of lease<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737975288136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Earnings Per Share Diluted Anti Dilutive Impact (Detail) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">5,034,905<span></span>
</td>
<td class="nump">20,253,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">5,016,460<span></span>
</td>
<td class="nump">3,886,489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=fhtx_WarrentsToPurchaseCommonStockMember', window );">Warrents to Purchase Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">18,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,467,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">891,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,608<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=fhtx_WarrentsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=fhtx_WarrentsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737975149960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements - Summary of Available for Sale Markatable Securties By Security Type (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 92,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">92,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryNotesSecuritiesMember', window );">U.S. treasury notes (due within one year) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">92,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 92,975<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryNotesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryNotesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737974148504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 92,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">184,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=fhtx_PreferredStockWarrantLiabilityMember', window );">Preferred Stock Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Preferred stock warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">48,770<span></span>
</td>
<td class="nump">14,951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">42,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">92,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">48,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Fair Value, Recurring [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">48,770<span></span>
</td>
<td class="nump">14,951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">135,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Fair Value, Recurring [Member] | US Treasury Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">42,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 92,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Fair Value, Recurring [Member] | Preferred Stock Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Preferred stock warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=fhtx_PreferredStockWarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=fhtx_PreferredStockWarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737969406152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 27, 2020</div></th>
<th class="th"><div>Oct. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 92,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number of securities called by warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number of securities called by warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=fhtx_BeforeIPOMember', window );">Before IPO [Member] | Series A one Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number of securities called by warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,076<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=fhtx_PreferredStockWarrantLiabilityMember', window );">Preferred Stock Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number of securities called by warrants or rights</a></td>
<td class="nump">14,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_WarrantIssuePrice', window );">Warrant issue price</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_WarrantIssuePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant Issue Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_WarrantIssuePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=fhtx_BeforeIPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=fhtx_BeforeIPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=fhtx_SeriesAOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=fhtx_SeriesAOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=fhtx_PreferredStockWarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=fhtx_PreferredStockWarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737974248280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net -  Sumary of Property and Equipment Net (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 21,631<span></span>
</td>
<td class="nump">$ 3,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(2,103)<span></span>
</td>
<td class="num">(1,292)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="nump">19,528<span></span>
</td>
<td class="nump">2,683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">3,740<span></span>
</td>
<td class="nump">3,202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">815<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_ComputerEquipmentAndSoftwareMember', window );">Computer equipment and software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember', window );">Leaseholds and Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">16,961<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_AssetsNotYetPlacedInServiceMember', window );">Assets Not Yet Placed In service [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_AssetsNotYetPlacedInServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_AssetsNotYetPlacedInServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139738060969368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net -  Sumary of Property and Equipment Net (Parenthetical) (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139738058204568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee compensation and benefits</a></td>
<td class="nump">$ 3,513<span></span>
</td>
<td class="nump">$ 1,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionPayableCurrent', window );">Accrued construction in progress</a></td>
<td class="nump">2,385<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_AccruedResearchAndDevelopmentExpenses', window );">Accrued external research and development expenses</a></td>
<td class="nump">2,146<span></span>
</td>
<td class="nump">1,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">979<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 9,161<span></span>
</td>
<td class="nump">$ 3,701<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_AccruedResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for expenses related to research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_AccruedResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for the acquisition of merchandise, materials, supplies and services pertaining to construction projects such as a housing development or factory expansion not classified as trade payables. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139738083252360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes Payable - Summary of Long Term Debt (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt, Unclassified [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount of long-term debt</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,152)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments', window );">Long-term debt, net of current portion</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">10,848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Final payment fee</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount, net of accretion</a></td>
<td class="num">(1,346)<span></span>
</td>
<td class="num">(418)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of discount and current portion</a></td>
<td class="nump">$ 19,654<span></span>
</td>
<td class="nump">$ 10,960<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt, excluding current portion. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_LongTermDebtNoncurrentBeforeDebtDiscountAndAccruedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737969556232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes Payable - Summary of Future Principal Payments Due (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">9,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737966418408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 19, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt instrument loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Final payment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">$ 530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (222)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fhtx_OxfordFinanceLlcMember', window );">Oxford Finance LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_InterestRateOutstandingBorrowingsLoan', window );">Interest rate outstanding borrowings loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime', window );">Debt, weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">6.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage', window );">Debt, final payment fee percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateTerms', window );">Debt instrument interest terms</a></td>
<td class="text">The Term Loan bears interest at a floating per annum rate equal to the greater of (i) 8.0% and (ii) the sum of (a) thirty-day LIBOR rate plus (b) 7.84%.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">Nov.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Debt instruments payment terms</a></td>
<td class="text">The Company is required to make monthly interest only payments under the Oxford Loan each month beginning on January 1, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument frequency of payment terms</a></td>
<td class="text">monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRestrictiveCovenants', window );">Debt instrument, restrictive covenants</a></td>
<td class="text">The Company&#8217;s obligations under the Oxford Loan Agreement are secured by a security interest in all of its assets, other than its intellectual property. The Company is also subject to certain affirmative and negative covenants<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number of securities called by warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_WarrantsIssuePricePerShare', window );">Warrants Issue price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrants not settleable in cash, fair value disclosure</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_DebtInstrumentPrePaymentTerms', window );">Debt instrument terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">At the Company&#8217;s option, the Company may elect to prepay the loans subject to a prepayment fee equal to the following percentage of the principal amount being prepaid: 2% if an advance is prepaid during the first 12 months following the applicable advance date, 1% if an advance is prepaid after 12 months but prior to 24 months following the applicable advance date, and 0.5% if an advance is prepaid any time after 24 months following the applicable advance date but prior to the Maturity Date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fhtx_OxfordFinanceLlcMember', window );">Oxford Finance LLC [Member] | Prepayment within First Twelve Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_PercentageOfPrepaymentFee', window );">Percentage of prepayment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fhtx_OxfordFinanceLlcMember', window );">Oxford Finance LLC [Member] | Prepayment After 12 months but prior to 24 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_PercentageOfPrepaymentFee', window );">Percentage of prepayment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fhtx_OxfordFinanceLlcMember', window );">Oxford Finance LLC [Member] | Prepayment After 24 Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_PercentageOfPrepaymentFee', window );">Percentage of prepayment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Oxford Finance LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt instrument, description of variable rate basis</a></td>
<td class="text">LIBOR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">7.84%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=fhtx_AdditionalRateInEventOfDefaultMember', window );">Additional Rate In Event Of Default [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fhtx_TermLoanAMember', window );">Term Loan A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt instrument loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage', window );">Debt, final payment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fhtx_TermLoanAMember', window );">Term Loan A [Member] | Oxford Finance LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt instrument loan amount</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fhtx_TermLoanAMember', window );">Term Loan A [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt instrument, description of variable rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fhtx_TermLoanBMember', window );">Term Loan B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt instrument loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage', window );">Debt, final payment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fhtx_TermLoanBMember', window );">Term Loan B [Member] | Base Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fhtx_TermLoanBMember', window );">Term Loan B [Member] | Maximum [Member] | Oxford Finance LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt instrument loan amount</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fhtx_TermLoanBMember', window );">Term Loan B [Member] | Additional Over Base Rate [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt instrument, description of variable rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fhtx_TermLoanAAndBMember', window );">Term Loan A and B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Final payment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt, as a percentage of the amounts drawn under the Term Loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaidPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_DebtInstrumentPrePaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the terms for debt prepayment, including, but not limited to prepayment fees and applicable periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_DebtInstrumentPrePaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_InterestRateOutstandingBorrowingsLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to outstanding borrowings under the Loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_InterestRateOutstandingBorrowingsLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_PercentageOfPrepaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee for prepayment of a loan, as a percentage of the principal amount being prepaid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_PercentageOfPrepaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_WarrantsIssuePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per unit amount of warrant issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_WarrantsIssuePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRestrictiveCovenants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of covenants that limit or prohibit certain actions or activities without the lender's prior consent within a specified period of time or until certain specified targets are achieved for example, reduction of the debt or an increase in net worth to a specified amount).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRestrictiveCovenants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtWeightedAverageInterestRateOverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated over time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtWeightedAverageInterestRateOverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of warrants not settleable in cash classified as equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsNotSettleableInCashFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fhtx_OxfordFinanceLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=fhtx_OxfordFinanceLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_PrepaymentPeriodAxis=fhtx_PrepaymentWithInFirstTwelveMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_PrepaymentPeriodAxis=fhtx_PrepaymentWithInFirstTwelveMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_PrepaymentPeriodAxis=fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_PrepaymentPeriodAxis=fhtx_PrepaymentAfter12MonthsButPriorTo24MonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_PrepaymentPeriodAxis=fhtx_PrepaymentAfter24MonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_PrepaymentPeriodAxis=fhtx_PrepaymentAfter24MonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=fhtx_AdditionalRateInEventOfDefaultMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=fhtx_AdditionalRateInEventOfDefaultMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fhtx_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fhtx_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fhtx_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fhtx_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=fhtx_AdditionalOverBaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=fhtx_AdditionalOverBaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fhtx_TermLoanAAndBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fhtx_TermLoanAAndBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737969417912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock and Preferred Stock Warrants  - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 27, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants', window );">Issuance of common stock upon exercise of stock options , shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of preferred stock, common shares issued</a></td>
<td class="nump">21,958,588<span></span>
</td>
<td class="nump">21,958,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number of securities called by warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number of securities called by warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants', window );">Issuance of common stock upon exercise of stock options , shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=fhtx_SeriesAOnePreferredStockMember', window );">Series A-1 Preferred Stock [Member] | Issuance of Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number of securities called by warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis=us-gaap_SeriesBMember', window );">Series B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues', window );">Sale of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,407,867<span></span>
</td>
<td class="nump">5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Preferred stock, par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.50<span></span>
</td>
<td class="nump">$ 7.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.1<span></span>
</td>
<td class="nump">$ 42.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period in connection with a cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_StockIssuedDuringPeriodSharesInConnectionWithTheCashlessExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_TemporaryEquityStockIssuedDuringPeriodShareNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=fhtx_SeriesAOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=fhtx_SeriesAOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=fhtx_IssuanceOfNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=fhtx_IssuanceOfNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis=us-gaap_SeriesBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis=us-gaap_SeriesBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737969337288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Preferred Stock and Preferred Stock Warrants  - Schedule of stock by class (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock Authorized</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">28,629,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock Issued and Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,615,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Common Stock Issuable Upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,467,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=fhtx_SeriesAOnePreferredStockMember', window );">Series A-1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,707,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock Issued and Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,693,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Common Stock Issuable Upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,239,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=fhtx_SeriesATwoPreferredStockMember', window );">Series A-2 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,804,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock Issued and Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,804,165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Common Stock Issuable Upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,840,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,117,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock Issued and Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,117,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Common Stock Issuable Upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,387,909<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=fhtx_SeriesAOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=fhtx_SeriesAOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=fhtx_SeriesATwoPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=fhtx_SeriesATwoPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737966331960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 19, 2020</div></th>
<th class="th"><div>Oct. 27, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are not entitled to receive dividends, unless declared by the board of directors.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during the period shares new issues shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="nump">8,451,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock issue price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock consideration received on the transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during the period shares new issues shares</a></td>
<td class="nump">951,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock issue price per share</a></td>
<td class="nump">$ 16.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock consideration received on the transaction</a></td>
<td class="nump">$ 14.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737969910152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2021</div></th>
<th class="th"><div>Oct. 21, 2020</div></th>
<th class="th"><div>Apr. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation costs related to unvested options and unvested restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period of unrecognized compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value,Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair value,granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.01<span></span>
</td>
<td class="nump">$ 2.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Aggregate fair value of restricted stock that vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Sale of restricted common stock to scientific founders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,459,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,213,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized</a></td>
<td class="nump">1,471,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Incentive Plan [Member] | Initial Amount [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Incentive Plan [Member] | Initial Aggregate From 2016 And 2020 Plans [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,078,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Incentive Plan [Member] | 2021 to 2030 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage', window );">Percentage of automatic annual increase in number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember', window );">2020 Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized</a></td>
<td class="nump">367,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares', window );">Maximum aggregate number of shares added to plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,220,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember', window );">2020 Employee Stock Purchase Plan [Member] | Initial Aggregate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember', window );">2020 Employee Stock Purchase Plan [Member] | 2021 to 2030 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage', window );">Percentage of automatic annual increase in number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember', window );">2020 and 2016 Incentive Plans [Member] | Service Based Vesting [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option expiry period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of shares authorized to be automatically increased on the first day of the fiscal year, under a share based payment arrangement, as a percentage of common stock outstanding on the last day of the previous fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticIncreasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum aggregate number of shares that may be added to the plan in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=fhtx_InitialAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=fhtx_InitialAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=fhtx_InitialAggregateFromTwoThousandSixteenAndTwoThousandTwentyPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=fhtx_TwoThousandsTwentyToTwoThousandsThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=fhtx_InitialAggregateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=fhtx_InitialAggregateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyAndSixteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=fhtx_ServiceBasedVestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=fhtx_ServiceBasedVestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737969552648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Weighted Average Assumptions Used to Estimate Fair Value of Stock Options and Restricted Stock Awards using Black-Scholes Option Pricing Model (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">78.50%<span></span>
</td>
<td class="nump">78.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972120520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Share Option  Activity (Detail)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance | shares</a></td>
<td class="nump">3,886,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of shares, Granted | shares</a></td>
<td class="nump">1,922,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of shares, Exercised | shares</a></td>
<td class="num">(611,048)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of shares, Forfeited | shares</a></td>
<td class="num">(181,358)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance | shares</a></td>
<td class="nump">5,016,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of shares, Vested | shares</a></td>
<td class="nump">5,016,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of shares, Exercisable | shares</a></td>
<td class="nump">1,508,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning balance | $ / shares</a></td>
<td class="nump">$ 2.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted | $ / shares</a></td>
<td class="nump">8.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised | $ / shares</a></td>
<td class="nump">1.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited | $ / shares</a></td>
<td class="nump">2.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Ending Balance | $ / shares</a></td>
<td class="nump">4.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Vested | $ / shares</a></td>
<td class="nump">4.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable | $ / shares</a></td>
<td class="nump">$ 1.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Contractual Term, Ending Balance</a></td>
<td class="text">8 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Contractual Term, Vested</a></td>
<td class="text">8 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Contractual Term, Exercisable</a></td>
<td class="text">7 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Ending Balance | $</a></td>
<td class="nump">$ 76,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Vested | $</a></td>
<td class="nump">76,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable | $</a></td>
<td class="nump">$ 27,683<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972026536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Restricted Common Stock (Detail) - Restricted Stock [Member] - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted common stock as of December&#160;31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">891,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
<td class="num">(891,894)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737974984616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock-based compensation expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,961<span></span>
</td>
<td class="nump">$ 1,694<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">1,724<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,237<span></span>
</td>
<td class="nump">$ 554<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737969646232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreement - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ProceedsFromUpfrontPayment', window );">Upfront payment received from Merck</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Unsatisfied portion of the performance obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Sales based [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_MilestoneReceivableUponAchievement', window );">Amount receivable for achievement of milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_ResearchDevelopmentAndRegulatoryMember', window );">Research Development And Regulatory [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_MilestoneReceivableUponAchievement', window );">Amount receivable for achievement of milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_MerckCollaborationAgreementMember', window );">Merck Collaboration Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_MilestoneReceivableUponAchievement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration to be received upon achievement of specified milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_MilestoneReceivableUponAchievement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ProceedsFromUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from upfront payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ProceedsFromUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_ResearchDevelopmentAndRegulatoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_ResearchDevelopmentAndRegulatoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_MerckCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_MerckCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737969303016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLimitationsOnUse', window );">Description of the limitations on the use of all operating loss carryforwards and tax credit carry forward</a></td>
<td class="text">Utilization of the U.S. federal and state net operating loss carryforwards and research and development tax credit carryforwards may be subject to a substantial annual limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, and corresponding provisions of state law, due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that can be utilized annually to offset future taxable income or tax liabilities. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50% over a three-year period.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">$ 21.8<span></span>
</td>
<td class="nump">$ 15.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward</a></td>
<td class="nump">147.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member] | Research Tax Credit Carryforward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry forward</a></td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_TaxCreditCarryForwardsExpirationStartYear', window );">Tax Credit Carry forwards Expiration Start Year</a></td>
<td class="text">2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member] | Expirable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward</a></td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_OperatingLossCarryForwardsExpirationStartYear', window );">Operating Loss Carry forwards Expiration Start Year</a></td>
<td class="text">2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member] | Non Expirable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward</a></td>
<td class="nump">$ 134.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_OperatingLossCarryforwardLimitPercentage', window );">Operating Loss Carryforward Limit Percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward</a></td>
<td class="nump">$ 132.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_OperatingLossCarryForwardsExpirationStartYear', window );">Operating Loss Carry forwards Expiration Start Year</a></td>
<td class="text">2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member] | Research Tax Credit Carryforward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry forward</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_TaxCreditCarryForwardsExpirationStartYear', window );">Tax Credit Carry forwards Expiration Start Year</a></td>
<td class="text">2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_OperatingLossCarryForwardsExpirationStartYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The year in which operating loss carryforwards begin to expire.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_OperatingLossCarryForwardsExpirationStartYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_OperatingLossCarryforwardLimitPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The limit that may be applied to operating loss carryforwards, as a percentage of annual taxable income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_OperatingLossCarryforwardLimitPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_TaxCreditCarryForwardsExpirationStartYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The year in which tax credit carryforwards begin to expire.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_TaxCreditCarryForwardsExpirationStartYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the limitation related to use of the tax credit carryforward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=fhtx_ExpirableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=fhtx_ExpirableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=fhtx_NonExpirableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=fhtx_NonExpirableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972819064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory income tax rate</a></td>
<td class="num">(21.00%)<span></span>
</td>
<td class="num">(21.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="num">(6.40%)<span></span>
</td>
<td class="num">(7.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Federal and state research and development tax credits</a></td>
<td class="num">(3.70%)<span></span>
</td>
<td class="num">(2.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in deferred tax asset valuation allowance</a></td>
<td class="nump">31.60%<span></span>
</td>
<td class="nump">29.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737974149784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Summary of Net Deferred Tax Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 39,289<span></span>
</td>
<td class="nump">$ 23,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards</a></td>
<td class="nump">4,955<span></span>
</td>
<td class="nump">2,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_DeferredTaxAssetsCapitalizedStartUpCosts', window );">Capitalized&#160;start-up&#160;costs</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">1,010<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">436<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">17,032<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">62,896<span></span>
</td>
<td class="nump">27,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_DeferredTaxLiabilitiesDepreciation', window );">Depreciation</a></td>
<td class="num">(2,819)<span></span>
</td>
<td class="num">(482)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets', window );">Operating lease&#160;right-of-use&#160;assets</a></td>
<td class="num">(11,694)<span></span>
</td>
<td class="num">(281)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(14,513)<span></span>
</td>
<td class="num">(763)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(48,383)<span></span>
</td>
<td class="num">(26,621)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_DeferredTaxAssetsCapitalizedStartUpCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capitalized start-up costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_DeferredTaxAssetsCapitalizedStartUpCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_DeferredTaxLiabilitiesDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_DeferredTaxLiabilitiesDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737967053400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">96 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 29, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2027 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease&#160;right-of-use&#160;assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,804<span></span>
</td>
<td class="nump">$ 1,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement', window );">Increase in operating lease liabilities and&#160;right-of-use&#160;assets due to lease remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,384<span></span>
</td>
<td class="nump">6,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Non Current Restricted Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
<td class="nump">$ 1,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=fhtx_NewLeaseAgreementMember', window );">New Lease Agreement [Member] | Massachusetts [Member] | Office Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of leased property | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term lessee gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease term extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromTenantAllowance', window );">Reimbursements from lessor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease&#160;right-of-use&#160;assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_LeaseTermCommencementDate', window );">Lease term commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=fhtx_NewLeaseAgreementMember', window );">New Lease Agreement [Member] | Massachusetts [Member] | Office Building [Member] | Letter of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Non Current Restricted Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=fhtx_NewLeaseAgreementMember', window );">New Lease Agreement [Member] | Massachusetts [Member] | Office Building [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_LeaseholdImprovementsLandlordAllowance', window );">Leasehold improvements landlord allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid', window );">Leasehold improvements landlord allowance to be repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=fhtx_NewLeaseAgreementMember', window );">New Lease Agreement [Member] | Massachusetts [Member] | Office Building [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease rent payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=fhtx_ModifiedNewLeaseAgreementMember', window );">Modified New Lease Agreement [Member] | Massachusetts [Member] | Office Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement', window );">Increase in operating lease liabilities and&#160;right-of-use&#160;assets due to lease remeasurement</a></td>
<td class="nump">$ 7,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease Expiration Date</a></td>
<td class="text">Sep. 30,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=fhtx_PropertyUnderOperatingLeaseSubleasedMember', window );">Property Under Operating Lease Subleased [Member] | Massachusetts [Member] | Office Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of leased property | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_TermOfPropertySubleasedUnderOperatingLease', window );">Term of property subleased under operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals', window );">Operating lease sublease rental income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Sublease income recorded as other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the operating lease liability and right of use asset as the result of a lease remeasurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_LeaseTermCommencementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease term commencement date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_LeaseTermCommencementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_LeaseholdImprovementsLandlordAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The monetary allowance granted by the landlord to a tenant to entice tenant to move into landlord's building which will enable the tenant to prepare the leased premises for tenant's occupancy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_LeaseholdImprovementsLandlordAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An additional monetary allowance granted by the landlord to a tenant to entice tenant to move into landlord's building which will enable the tenant to prepare the leased premises for tenant's occupancy. This additional amount will result in additional rent payments to the landlord.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_LeaseholdImprovementsLandlordAllowanceToBeRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of remaining base rent payments receivable from the sub-lessee over the sublease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_OperatingLeasesFutureMinimumPaymentsReceivableSubleaseRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_TermOfPropertySubleasedUnderOperatingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of property subleased under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_TermOfPropertySubleasedUnderOperatingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromTenantAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net cash outflow or inflow from monetary allowance granted by the landlord to a tenant to entice tenant to move into landlords building which will enable the tenant to prepare the leased premises for tenants occupancy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromTenantAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=fhtx_NewLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=fhtx_NewLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=srt_OfficeBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=srt_OfficeBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=fhtx_ModifiedNewLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=fhtx_ModifiedNewLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=fhtx_PropertyUnderOperatingLeaseSubleasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=fhtx_PropertyUnderOperatingLeaseSubleasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737978164296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of Lease Cost (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 7,032<span></span>
</td>
<td class="nump">$ 1,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">1,217<span></span>
</td>
<td class="nump">547<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total</a></td>
<td class="nump">$ 8,310<span></span>
</td>
<td class="nump">$ 2,278<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737971919416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of Supplemental Cash Flow Information Related to Leases (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities</a></td>
<td class="nump">$ 3,086<span></span>
</td>
<td class="nump">$ 1,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease liabilities arising from obtaining right-of-use assets</a></td>
<td class="nump">38,306<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement', window );">Increase in operating lease liabilities and&#160;right-of-use&#160;assets due to lease remeasurement</a></td>
<td class="nump">$ 7,384<span></span>
</td>
<td class="nump">$ 6,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the operating lease liability and right of use asset as the result of a lease remeasurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ChangeInOperatingLeaseLiabilityRightOfUseAssetRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737979476568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of  Weighted-Average Remaining Lease Term and Discount Rate Leases (Detail)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract', window );"><strong>Schedule Of Weighted Average Remaining Lease Term And Discount Rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term&#8212;operating leases</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate&#8212;operating leases</a></td>
<td class="nump">5.35%<span></span>
</td>
<td class="nump">7.53%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of weighted-average remaining lease term and discount rate [Abstract].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139738054568104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Minimum Lease Payment (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 9,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">10,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">10,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">10,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">10,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">30,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">81,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(15,104)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives', window );">Less: estimated lease incentives</a></td>
<td class="num">(3,933)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 62,342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of estimated lease incentives used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_LesseeOperatingLeaseLiabilityEstimatedLeaseIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737972031000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Operating  Lease Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating Lease, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">$ 3,981<span></span>
</td>
<td class="nump">$ 1,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">58,361<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 62,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737975183464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jul. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,790,946<span></span>
</td>
<td class="nump">5,762,745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_StanfordLicenseAgreementMember', window );">Stanford License Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ReimbursedPatentCosts', window );">Reimbursed patent costs</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued under agreement</a></td>
<td class="nump">42,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_StanfordLicenseAgreementMember', window );">Stanford License Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_NonRefundableLicenseFee', window );">Non-refundable&#160;license fee</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_AnnualLicenseMaintenanceFees', window );">Annual license maintenance fees</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_MilestonesPayableUponEvent', window );">Milestones payable upon event</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_AnnualLicenseMaintenanceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual license maintenance fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_AnnualLicenseMaintenanceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_MilestonesPayableUponEvent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount the Company will pay for regulatory milestones on each licensed product upon the occurrence of specific events as outlined in the license agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_MilestonesPayableUponEvent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_NonRefundableLicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-refundable&#160;license fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_NonRefundableLicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ReimbursedPatentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount paid by the Company to reimburse the licensor for costs incurred related to patented technology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ReimbursedPatentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_StanfordLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_StanfordLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139737975019528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,680<span></span>
</td>
<td class="nump">$ 3,439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_AgreementsAxis=fhtx_FlagshipPioneeringMember', window );">Flagship Pioneering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ServiceAgreementTerm', window );">Service agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_CashPaymentsRelatedParty', window );">Payments made to related party under service agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ServiceAgreementExpirationYear', window );">Service agreement expiration year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_AgreementsAxis=fhtx_ScientificFounderMember', window );">Scientific Founder [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ServiceAgreementTerm', window );">Service agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_CashPaymentsRelatedParty', window );">Payments made to related party under service agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_ServiceAgreementExtendedDate', window );">Service agreement extended date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fhtx_AgreementsAxis=fhtx_ScientificFounderMember', window );">Scientific Founder [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_CashPaymentsRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments made during the period to related parties as part of a service or consulting agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_CashPaymentsRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ServiceAgreementExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The year in which a service agreement expires.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ServiceAgreementExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ServiceAgreementExtendedDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The revised date of expiration for a service agreement upon extension.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ServiceAgreementExtendedDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ServiceAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The term of a service agreement in 'PnYnMnDTnHnMnS' format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ServiceAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_AgreementsAxis=fhtx_FlagshipPioneeringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_AgreementsAxis=fhtx_FlagshipPioneeringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_AgreementsAxis=fhtx_ScientificFounderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_AgreementsAxis=fhtx_ScientificFounderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>118
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;J7HLB" I2J, 0\+08RP;@4>[M\EX2)E24(N,PV7=?-Z"]=IJX2Z$7BX=Y=
M5RE7ZUBLR>^@8"*88NF&B>;<X8)M9'4_\ YJ"%<ONT5:-*I&+%RMK4AIW0+H
M82V@]-O"-FSJ;"$TM\\6Q4>N,;*Z!5#<LRO[,%P57U?6_=D;:B,9KMA"5G<
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M0Z-)4;^S)'9_AO88!IX]\FR['S=H<(/K%D^?I$$'Y1BV:R%AL>NV,N( =M3
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MIHS"+#0&\/M:"'V\,0LT?YHL_@=02P,$%     @ 2(!R4EL1A9'3!@  B"
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M6 7WA*R8BM&0T=\?;'0/ZG=[;I"FZWR=57GV42YIJ?(K5RU]J7OM+05_<"'
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MK[E 0<U)>4.E/FP@:+K6#&#/8&S9:Z,N['?8?&8[=K1[O//$=G@$&%K*L?E
M=ARJ_:V_F.V7ZX)K21<_QB:LR=WR,-ED2!>>EAOQ U9@*XP9-E=@Z(<P[AWN
MW"+7YT.+"/82B,)^GEBV[JA_9!89&*+$M4SCEE_Q8RS3CF"9U(G#*/$2/^R'
MZP#)VH')SJ^9^C?Z#Z2\9HI/,GJE5+U7D8I$6?_L7;^1?%7]P'G)I>1Y=;FD
M1 UP6D!]?\55$V_>Z-],M_]\,/T74$L#!!0    ( $B <E)>N$>J70(  &$%
M   8    >&PO=V]R:W-H965T<R]S:&5E=#8N>&ULC53;;MLP#/T5PBBP%MCJ
M2](K' --TF%]*! TZ_8P[$&QZ5BH+*42G;1_7TEVO*QK@KU8-Y[#0])DNE'Z
MR52(!"^UD&845$2KZS T>84U,Z=JA=*^E$K7C.Q1+T.STL@*#ZI%F$31>5@S
M+H,L]7<SG:6J(<$ESC28IJZ9?AVC4)M1$ ?;BP>^K,A=A%FZ8DN<(SVN9MJ>
MPIZEX#5*PY4$C>4HN(FO)T-G[PU^<-R8G3VX2!9*/;G#73$*(B<(!>;D&)A=
MUCA!(1R1E?'<<0:]2P?<W6_9O_K8;2P+9G"BQ$]>4#4*+@,HL&2-H >U^89=
M/&>.+U?"^"]L.MLH@+PQI.H.;!747+8K>^GRL .(S_< D@Z0O <,]P &'6#@
M VV5^;"FC%B6:K4![:PMF]OXW'BTC89+5\4Y:?O*+8ZRB9)&"5XPP@+F9!=;
M(C*@2K!/:]3$%P)A9I.+6GL;E3\!D]VN4J) ;3[![7/#Z16.IUCRG-,)',^8
MME05$L^9.($O\#B?PO'1"1P!E_"]4HVQ-"8-R<;AU(1YIWG<:D[V:(X3N%>6
MV<"M++#XFR"T">BSD&RS,$X.,DXQ/X5!_!F2*(D^$#3Y;WA\=4#.H"_*P/,-
M]_#-47,T,#Y8@E_W6"]0_S[@;]C[&Q[VYPGOC&F8S-%Z-?1A65J6"\_BQL,Z
MBZ\NTW"]FZE_;<Y[BU9<N/.WUJB7OHD-Y*J1U):LO^WGQ(UOCW?W8SL_VG;_
M0],.GWNFEUP:$%A:RNCTXBP W39T>R"U\CVQ4&0[S&\K.P-1.P/[7BI%VX-S
MT$_5[ U02P,$%     @ 2(!R4A).M;KP!P  ("(  !@   !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6S%6FUOVS@2_BN";W%H@:8V25FV>DF UMF]6V#;"YK;
MZX?%?9 E.N95$KTD%3?[ZW=(R:(M4K0#W-Y^2?0R))]YX3PSE*_W7'R56TI5
M]*TJ:WDSV2JU>S>=RGQ+JTR^Y3M:PYL-%U6FX%8\3N5.T*PP@ZIRBF>S9%IE
MK)[<7IMG]^+VFC>J9#6]%Y%LJBH3SQ]HR?<W$S0Y//C,'K=*/YC>7N^R1_I
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ML4E&EU7+XWAOJ@P;@3D=L,Z[.L?+0/]%W<93II7H(=)/=2A5APOM[S'/LO;
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M-GG^=)28M'^(KI$[V:6+.!C(3[[-(<\+\'WED*7N@14,E_17_P%02P,$%
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M Q()E2.]$B'AY&\*^E)!?]CCTDD2S2D:V>\I J>YQ#.D*K\_ S%/_*XYA#J
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MXC5GFK&,*.JBP'/+F5OO[N2$4K+4'HIW0S?1 /3OD0R-E9ZY%)Z(AFG;[8#
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M?Q_0]9Z>/A2!)/R)B2)92#/6@S<D8#LM=.$G[(CN:M 6K7+XR7ZLJE.3ER2
M.JW7W!T9O9.$,,D&(Y76/-*3@HVPDD$?159""2T,'TPKK";<;#)4"<@#QL@N
M4G8E:O7YF.A@HJVT0J S^3T$9''@1P?+IF3A3"XQ"VR,Q2),PZO#3BODC'O)
M'V4JK5;GCN@^*^,)#ZN>:FWQ\$+0,:A]'DI6[/1:9SD.$*%"9XPG3^A#'DJ@
MR3=IY=_.#+&V;=%U'OIVX'XT-[RBYWVOO=<Q=B>6/Z"& <M"1EGUB&?3#D]K
M55QE>^HQVIQS7\UXU2H0K!\^?N ?4?T-4]B?&8 +1YN,AB^+FLDKMW7"+!>6
M*32&#JGUZP+9YKJ ::B,I#^A3*YN'8(B$R?!;LJ\F!IWDHV<AYQUML';7OKP
M\)&BC(09HIQ980RAP;19Q.-BA^O_G 8>_SEVN))6A#P2AD:X"B&B)P'=$4AC
M(R%U\>3W*,+7VO#2-0.W.-(Q>9@.0D&3;N2^;F=,,%DR]1TG (!9GM7CR%,8
MH,TG<SIA5I?L-!H5<J!D%M<T=\5=J"4UU5#V2<$/8&JR[MQ91X4O?#A\6MB$
M+85"H7(8QHPD2)$1J'+=H+>ZPX02N;>F'TVXC$CLQ4&;HC+11XR@P/8(33LM
MS, P1W>8-W'D3&UL&ECL-$99),-9SV#R='/;I.!MDX+7L5"=0/H83K@*4<$,
MYL3P1,\]:T*DL6D81-H?_ <],>78[$MU'F=UY]=%GG%9I/!RK\?&#C'?*M"F
M\>=N=^P7MP*PM/6LIBB&EYI 2C@W31IY?K9K>8PA6I.DBS-)O9:[2<\G9"21
MZK:1>XCLN.>]BVF2#PS2Y;'G0GL$3:/4I=!N_EHGU!%>2!&WK4V\.!.J9'WA
M[]FS3_D%P>E'>W9#^M;R%V<APMZW6L3(1J\F<DRTLG6HVA,B&$P0(@I@+>R-
MU<A4LR+8I-5/P:O0&C,<L5,&-TK:%HOZ9AS?6Z1#O )N?Q8V%/I9%BH(B><[
M(@\FN1W$\YB>>R$\+<%.B\^(MOKUJ\M<E^33\3H\H/U;J>&&PE8M *%"6DF=
M\!MW%XI=VOM52QPR5*)DF#R9C"3&$>]QZD^?%)V=YK#1W:/ Y7GR5V8$#_TU
M.=CM$8<RB31T)L*':$)+EDPWC2,5!.XEL+F=5$=G/]Z1"=*0+G@M.A<0C!^G
MG_)C4^K'W.$X7]R$V&BT3(D]PNQ=G!@-7:D#%P/ 4E]L4+DFS>@F=EJNJT%\
M;6L)ZMA.+'84< 0G.A-8]TP@H3DSNKT)G$7V5XJW&,T6O6,$5Q#6#V7O<(U&
M!T?:$+/1RN -)?K+^7I)&A]J@'9DJ.:I*+,8*$,H>.!,QA&P,HRR7%[D;U]?
MYZ^OKS^[PX:R-P&)%G:,5FW8W>]U&60RT4CBTF_=&5,HU&%_??:7[PI/EA1W
M*,+-"I#V-*$MN<7.+H<^&/<4VQ#J,J(\'\X6G7TO*+L/]SG0-/_:\B5NF#JB
M 'FAY*)4>$K)FO R#DRPNR/_:6O&ZO_XA)*H_^-'9(L:4CV4'V"Z\1 :ND4'
M=S_+J^(M0<S5(STF,E0X'+0VO<?W+SIQY"F0J8[N\?_+W\GP8B10),L$S.&9
MQ#CWS,Q,)A"3&1/<RPR]F"<2//9\ 1H;8J897Z[%5>'*5J'TFD!.?>BS >OM
MJWEF=Q/F(7'#4'(QW(:>VMVQTA=NCS$; 5*=M$+G)B/7>=*2!*\X1C6N>?W9
M79\C,_E$Y&;6_YG2'%U:P:JE9N_/PR(JH31U1,S&J62T.H5FW,KDJJNE+TVE
ME2_;A8XFZCXD86<!Y+PF^P_1+.J*7,R1^8Z]^[T< UR>7[R5/<>)]Q3B9&I7
M+XYQXJ$&*M[/3S25LH50BT+B0=OG"2',HW9%8OY%/K0<ZE@3>H+?H=@RZCX]
MO]'>#&^!6@MZ7"E-U6Y^>8 $.+[$A3'2@\Z%>Z(32KS.SR_>Y*_>G&=7^?4U
M_77]-ON-<\S^B:<NKO-7KUYG.@V.J=6C,<5)X9-(8L;:TPCBXC4A\45^_>8J
M^\278R6=C)?CTMW#,]=O+_+KMZ^.X?M/X_1%_N;\&A2Z>I6_/7]-=,TO7Q.9
M7K_*;HVFF!]B=._#5W)I*UZQB05BKX5$G>P9F[!ALBA,AIK)Q?(QR[1:'!F3
MTSA ;T.K#/=B0N^RBJ7?M36K)!&I*$KE-]]@ZK&+LS/O/WSW<QR>X=L)]^GJ
M-*4-8W_IU(*^C4*'JI+LX;"KPF[<4$1XSPB:1TY,'U#)I(0X*66/]_61O\LS
M:=POY7ER%":P83YJ&E_^L8>=CNWS4?=)-*N*6YBA<E [T=("8[HQC/": >]5
MH59L[+82^'-_PU2XG !WB'MKDE91.AB"[V0VJ3+(HTU3ALN[H5JS[CA:;](N
MJ=^1ZFP6C/ L#3KP5>R4CX9X+.GI1>MQZN59Q6461[GUI\9P[ UH1894SVW(
M7W&5V$]N5'-K5M+29#/IR@;;?\STYP>S$== (VH3^'#T^O@6R?QX/3W$),WL
MQC+?=N?["&F<\'G\+MXR?F0;MIS@:\$.+_*(C9^1"P<3680C')SVQ:/Q3UQ2
M2%>-TP-ZK3:Y6K;3M"G4).(H62CGA*X('%BL4!2/QZZIQ<Y>F*99#7P1!(\@
M@^?1CU)T49G/XC+ZT62<Y-DU2<G$#_$>^Y(]'3JH\7?/.("8[JAYFJO(G(E&
MIR/;_*1A=_S-/[1=A'!D7V&2:0JF&J,MMUR:$%*EP<\T%$T1"L6[,HXJ\ELP
MR!R,6OP<1NI(A'2#X^5-]R!>8RYC1ZX'2/W^WM1VC4%5?:.)/XA Z$EJ#3$$
M4J/\Z,V=\/J$/)0BT>EH)B_M"6\LB#432<R8^E&3#6<RTJ^.+UK9N,Z$\1HV
M1XA[I4Y<\PT\-!:[H!!,^V-'D5>Y9,&:Y#Q6%RZ;PF=NV?58?A40863]FK.Q
MS@UW:&'+;>9PR*=(_S'FB=*^&&NPAY##AFETH-7Q>,EN2F_:=\6O*PHB)79)
MFOG2BARJ,%RU,B3D'+[3=FU=-%SDYQ*NN;-[4I(:K+2>C()?:K_^$8NPY&FA
MFN^4%%PD(J?8,G_/A+]GX.\9N/2+P;N(,-0MN4PQOM^,CM\XX"90^8(6-Y3!
M%NX<PZ4??X#;/P)5 ['O;V[?C1<U99JYPYV.GI]?NLJ&>>OI' 7%\>R;5>ZT
M9X#J"IL'ONO"G:R4QK]32J[SW5#Q3,,\PJZ[DS*NV\HK@8+5I,@/:T/TJ@3_
M<=BTA&O79Q^&+GL'8X5.QBV^&EJ/UU !,?)QERP)&)<PVEEB%7)A:SH&DJJP
M56P4Z+0^APKB<9(7_G"[A'G)@0%HSI+^P/,0"?D#/<>^F"G":^%XJ* 828[
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M:\&D?5TU_%QMC-7TH?PZ$6K8AQKZ4,/_T]F38&XU9Z9A.2X"VCV#^A&#Y7
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MRA)[>;&BWP5J9T#WI5+V>' !^A_0\B]02P,$%     @ 2(!R4O]FLQ>> @
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MXM= HV4ZK2BF*$#0A! 2?IL\+AQ<.3,,L!RG..&7\#32@%*43*JIG-)+CDQ
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M4O<3(UOW.JZEP9"=6.#/C5!6 ?<W$A^ P\02G'Z7YC\ 4$L#!!0    ( $B
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M<VAE971S+W-H965T,3@N>&ULI5CO;]LX$OU7"%^Q2 ''OY)VBS8)D&RWNWM
M@6*[O?MPV ^T-+*XI4@=2<7Q_?7WAJ1D.;73'.Y+8DGDFYDW,X\C76VM^^IK
MHB >&FW\]:0.H7T[G_NBID;ZF6W)X$EE72,#+MUF[EM'LHR;&CU?+1:OYXU4
M9G)S%>]]<C=7M@M:&?KDA.^:1KK='6F[O9XL)_V-W]6F#GQC?G/5R@U]IO"E
M_>1P-1]02M60\<H:X:BZGMPNW]Y=\OJXX!^*MG[T6W D:VN_\L5OY?5DP0Z1
MIB(P@L2_>_J)M&8@N/'OC#D93/+&\>\>_4.,';&LI:>?K/ZG*D-]/7DS$255
MLM/A=[O]E7(\KQBOL-K'OV*;UEY<3$31^6";O!D>-,JD__(A\S#:\&9Q8L,J
M;UA%OY.AZ.5[&>3-E;-;X7@UT/A'##7NAG/*<%(^!X>G"OO"#:+1<FV=C!S=
M;AP1* ]7\P!P7C(O,M!= EJ= %JNQ$=K0NW%SZ:D\A!@#J\&UU:]:W>K)Q'?
M4S$3%\NI6"U6BR?P+H90+R+>Q2D\Y0MM?>=(_$$/0=QI6WP5_[I=^^!0''\^
M8>)R,'$935S^_VP^"<2M^-:WLJ#K"7K-D[NGR8U8+F;BA GQFQ%_[_0NDC45
MH2:L;%II=@)/R5$IE E62,%PTA6U* Z0I"F%5@7:C80<4,\8Z(>_O5FM%N].
M6(Y/E^]>HG!#+3Z2 ZF?:^E:\8-LVG?BO:T;=L:U,W&6H>*J?N-,_#'REOU(
M(%NEM9!MBZ ^V$UMG>$=RQ_?>=$ZVSI% 3(B?B&#A#I95:H B@D.3=1J&5BQ
M!$(ND7=[3RY"EW0/(6J%P1W--#G94A=4X6?B"PK79>J.AGK(Z\9),-M[2P^%
M[CP41FRT74LM'.N!CPYDFVR_L$V#]4IJ]1\2I>LV6%++(!#+!AI<[KRC3:>3
M95LA85Z9C2:!(C6^<*J-3RI4K'5CGY'DQO..9P>PIUJB)TBB)E <K87BKMF@
M%2VYR&)!+D#@][43Q50%11YEA:O"NE*:@E(12-%TH9,:F8NE5(JNM:/=R(Z9
M9=.-W.%$0 ^JT 6*_B7-QJYC(8NR<R!D<,D'G!U#W'L3SB(_S92Q_P(:1]-O
MT:I1(3*#I'\ 4W8;$4&+II[WXVC)9^4/B )%<7G.<VR<Q[F68URV9#M3^GX+
M8FT[YSL4%#MZS'9$Y*SANNP04(%21S3LN>]B.V?0F?CT".M9U9#:37MD73HT
MA&HE\L'*(/ZRT XP3>0R42 05R?+3^Y-Y-9%/ 6A.Q #>L_@Z(6KDMGKVLHA
M%%C=1>8 \6+Y:K; ::=US+NS32)^&DD ^Z35IJ_1# P<OGJQNASOC76'PE;@
MN4?W+16J4G"EYWCZ3>IR#UKH"Z (Q[!!D:UWAQG 2E4R2QMH$-@%)):D#(\8
M3VYG_Y:OG^^?ES!]SD-'.7:C92UKX073V3L363IB6E7L\Z'&QE2OZ2B-Z&D^
M+)S=2<W]/468NF R<#=60[9XOMZ=[VNQ@^[N^%;^"7_+\ZQ<7PQ<][%"E(DX
M8%W#SO2IZDQ><I4KTQ'+3-7A!IH-,L.$4E5Q8\.<TO ,M>I$8Z%DV2LO:NGW
M=8>9\RNZ&_4KNX"2['L24-$/C+158)\2(#VTRNU5&)83)3MAUZ MR0?6?N?(
M."0>'NY5;^#C2192A:!23-&Y& ;V05+$VD7%S@5G.8+8N=&*,M[J>S+%KF_)
MT8*Q],:&/_0D/3SE#XL=AP+KOB_@7EB-A6[07G5BT(<,E)2,L;K'8P_/SI8O
MC[?B%"Z:CG6?A[;CDIIG%M3IV>KEH7*.#JE\D.T;='P&GEV\%#QBL>] Y,=)
M\0:AXS**<QC+0W\@9\QX[.UKXG\MB<>$)/8A+2 3/6JH4KFY^TCA*]*(;.%X
M';K^6- <VU[+8R6/H_M6SX7D801(/1T^3@91D.+ 4F9QA.4,E<,8)C.T#8I!
M,00?2GV.>:@<.0;0&N,18!0/IP",LL#@L1,K;F,F +,;6K8 9[=QQF#F=TDV
MT.6-8F7<6%NF8 >O]]EB74!\ZTCPB8QELSPH*Y<'+9E>&C%E\E #7J  MHA>
MQO)&6+D,OH.>LGW"<B_$'I<^2GX<5 \2RN61$S,438;SSTQ]GM).YQTAL6%/
M1]%2"$?.Z8XIR(>.#^?!GO-_T1#T%:*ZK15P]B/"T44I D@5-![\%O4Y#LK;
M.$G@!9":-3;W+X'3/%R@DS:L5K+APZ97N&_SUM=5%J3.['ENK1M/9"?R@U'C
MQ?)R]KH_K_N85"KT(H.OV51A-R:UB!\""K6SW:9FY]\\:GN+I'"%)YQ'+V/#
M_L?8?)^;+U6)BL*F;+2IPE!.HPWIQ(:F(&48E#G>T9R+T0(89RF/!^DY>"7S
M4!U/Y9/G5'S/R5(&EB@>-ZR5< 1O9CR-5CAC3-&/VNA,P^&CPWW6=H-7J+(7
MPN_O'7$($.8WL7VB;OIP:EE&AAR;>K&870[3&,CIF7^&BA_[7C ??8G!0;6)
MWYM\FH_21YGA[O!)ZS9]R=DO3]_#/N*%$,>XT%1AZV+VXZM)>J?L+X)MXW>=
MM0W!-O%G31)N\P(\KZP-_04;&#[TW?P74$L#!!0    ( $B <E*6D?B&6P@
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M2'@=OHT]D8<OC)^X6:'6<))8@G78/YOTPGFBN7&Z]%_*%MHY7?B?:\$1 2+
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MDDLEW9XAI#NT,WH&71Q=KB@DH4$BSI+E$]B([2J95PB-1;_RQ70H>QRQP=X
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MBTG@^/#A=.MOKAOM< _VKY7@J&L2P.^EUF[X( /C?V7<_A=02P,$%     @
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M/*J%$F:2$N.#4UKL4/,.E1]!#7-X8$KEX=Z46+X&I)Q7GUR^3VZ>GR3>83&
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MP='HRXEUSL9USN(Z9S]>RM, \_,4GH# 6P-_RF"WZ*@<\_,9A ;AQK:=,'M
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MMD0>')SW"_!W>UO?NZW63?*X*TKW_<FV::JW+U^Z;*MWRIW;2I?PS=K6.]7
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M@\F1?O6#(:T46?(4AD (<,((HTXR72-3.&-B8A..9%/)!@"X3:UVC*W3X7?
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M28Y"BUZ@^((+I7T7NFG0<D5! ^<[.7TM- .'"CKAD)4B#$.-+31Q!V+#D)$
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M\YP7J0]'DT04=A"%<:3C^M4RY4%P/\D@T['T@LP.</_ %U4+!HB61:KX/37
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MM?93C602,5_ASE%!![-QGJ/V"D&TG]H*7[V7>(N6TC2SOX, PXJ]ORX78E/
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M#S+,62WLO=I]P7T] X>7*F&:+^Q:WSYE3&MC5;D/)KWDLCW9R[X/1P'C\).
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MTNT#N7]^2@+)"*A5E]2O1EB4@1]U&21Q K>2@A^M<)_YPQ'I:N!WA\GWQ3K
MLN6EW4JW!T&'G*BT).YDZ,3]C(6RE]ZYS,\;FG3BV.^/7#^QH>VG(V0.:7?B
MQ._%7==_??OX>J09*# 1=D:L[_>9Q7U)1&_ '3[LW<'H6'.$!_=EA6KEO@JL
M!IO:M%?G?G7_X3%O[]LG\_:KY1-7*U%K*D=.KE$PH)Y0[9= .S%R[6[?I31T
ME[MA01]/J*P!O<^E-+N)#;#_')O]!U!+ P04    " !(@')2-=*6.)X$  #
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M(E[0; 11X$+HA_X 7M2[&%F\:-C%?T^72DM4P7\#F.,><VPQQ^]@WK4:!E&
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ME]?8IJ8=4JWA=!.Z<*4=]G18UCC7P7@'/"^U=I^&;^S^GR+_#U!+ P04
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M!0V;"X0I1H7BAJ,&EL5PS;B")R8*A#MDNE!(S3 :SF!:=A#D BY7C N')H/
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MM!W,]Y40>M^PEQGUY=7T?U!+ P04    " !(@')2Z*5>&S,#  "O"@  &0
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MP-%5=U1-K-J4U_]266HFRF%&'25J%T#/5TK9W<0E:'K4\3]02P,$%     @
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MX.M*%<)4"AS4:_%HQ_J8_M.@%>+@] S0CN[3DW!0A^WV-Z'#'0YZC,(P[N>
MMB),V4'(,YF7E0%%H&F+1:WETFPX<G,,':T(T_ 7T-$J*#TLH3]-Q[XDTF!W
M2_08)?0%-EK5I(=E\Q;P]+22V4([L,V4W.2EDFNPP(_;(JWPT>@7<-)*(HU/
MPTF\STDTBG:_Q#UF+WV(::NL]+"T7FH-V/8/TI"_\&B&P%/\'-\41(-:B_2X
M3=+*(AV=GA#62B0+3D)(';9[Z-F3K!X;E@0[=/B=@[:]Y;SGZD$4FF2P1*_@
M/,8MH[87A^W$R-*=O>^EP9.\&Z[PL@7*&N#[I93F:6*/\\WU;?HO4$L#!!0
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M9:G'_+*B*8C:.=#Y2BF[W;@ PUS-?P-02P,$%     @ 2(!R4M_UA#N] @
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M)D"_S[D^FMN).>F[BWWR#U!+ P04    " !(@')26S+8I'@"  "S!@  &0
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MZS=:W;&J\J^6M;+X!O+- M^U3#L#G-\HO%M"QSV$FI?RXB]02P,$%     @
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M.(-#LYT SU=2FJ<+^RV[^OO+[']02P,$%     @ 2(!R4I^8IJOR @  +P@
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M\ T+/5W+%TFAW2\<"MO @VBGC4P+,$60\BS_LK<B#V> L'T!$!: \ .@U;D
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MA#HZ*FM ^RLIS6EB'93_$49_ %!+ P04    " !(@')22<R/HD$$  "@$
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M(&(S>0P@NFU$/$8]A'6J1^9</^S$UQEF '/2QG3'4Z>'LZX"R%P&!CFKK#/
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M5;;FQ76X>)!LGU]!UTRJ"VW>W%$24:X'J/<;QN3S@U90_2DQ_P]02P,$%
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M]T[==;Y?Q;,H(D+W_51>L_J&\;1C/!UEO,4<M2:&&N]1UGA*P\;#_,<"S[K
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M=$8=R-B4EL)^5LL?61W0P-E+E3#^$Y;UW*@#:6FL*NK%B*#@LOJF]W4B7K*
MU O(HP5Q_YD%2;T@\8%6R'Q8%]32\;%62]!N-EIS/WQN_&J,ADM7QENK\2W'
M=79\*5-5,/A"[YF!#W":9=REEPJXE!5)7++?73!+N7B/,^YN+^#=F_?P!KB$
M:RX$OC?'/8M8G,5>6OL]J_R29_S&!*Z5M+F!3S)CV4,#/0RBB82L(SDC08L7
M+.U"$A\ B4BT!=#YBY?'1P$X29/8Q-M+=B86SC%0+F=,IBOXXPKGP:5EA?DS
MX*7?>.E[+_UG49M4\[DODIJ"S1D(7G#KRV8 G[I'I6'N+14"</]KZM" 4,9
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MKJX>JX%5<W][-U'6JL+_S!G%/[1N KZ?*F77 ^>@N0 >_P=02P,$%     @
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MIP,  #D,   9    >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;)67;7.C-A"
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MD82X38B=T(:9DS4GADQ&2JY!V6A$LP-7&Y>-:IBP+BZ,PEV&>6;RA6(--%S
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M5[5W4-LQLG9U?R$-W"*N6<"]S92= ..YE.:]8Z^2[DM@\A=02P,$%     @
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M; #>KZ0TVXUM\W:JI_\ 4$L#!!0    ( $B <E*B!6J*W0(  !D(   9
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M:"4(U]5%5$VLRLO6/%<6&WTY7.'=#=H%X/I"*;N=N&[?_!L8_0502P,$%
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MOJ]*W^$)WQC=<:92B7YG"20M^.MG\*&#P-="U&J$6S6N0B?CQUA=H B_1V&
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MS%^;.X(]MS8TY07CCH@E91)EL-"4P84YD8ORS%X.%"_L*7;.E3X3V\=4WW-
M& /]?L&YV@Z,@_KF-/D!4$L#!!0    ( $B <E(("YH]5@(  %X,   -
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M/W!*:G;3S7HP&^%F]?9W\WK^HDW8_Z.(_P)02P,$%     @ 2(!R4I>*NQS
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M)<U"5GK95-477W:KKC4OM]^?;K^=/?\?4$L#!!0    ( $B <E(>WYE>' (
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M=@*] _4. KT#]0X"O0/U#@*] _4. KT#]0X"O6/RL9) [T"]@T#O0+V#0.]
MO8- [T"]@T#OC'IG KTSZIT)],ZH=R;0.Z/>F4#OC'IG KTSZIT)],Z3GTV^
M4^\Z?AY*O?9\K?'ZWTGU>#ZW7"]_67[MG-SC%YS3;45]_@M02P,$%     @
M2(!R4J5_#G'N 0  D"8  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULS=K+3L,P
M$ 707ZFR18WK)P_1;H ML. '3#*E49/8LETH?X^3 A((*E"1N)M&K>VY$X]T
M5CV_>_84)]NN[>.\6*7DSQB+U8HZ&TOGJ<\K2Q<ZF_+7\,"\K=;V@9B8S0RK
M7)^H3],TU"@6YY>TM)LV3:ZV^>?8N'Y>!&IC,;G8;1RRYH7UOFTJF_(Z>^SK
M3RG3UX0RGQSWQ%7CXU'>4+ O$X:5[P->S]T\4@A-39-;&]*U[?(NMFU93,\M
MQ7)_B2]Z=,ME4U'MJDV7CY31![)U7!&EKBUW18_V)Z=\P[3[Y ?GCV7V!>:=
MM\'YF"<6Z/=Q;R,93D]]+D0A-?M?\3TQES[X_6B8=DWU#[/S]3ZYL![G$=GX
M./R./\[XO?XO^Q @?4B0/A1('QJD#P/2QS%('R<@?9R"],%G*(V@B,I12.4H
MIG(45#F*JAR%58[B*D>!E:/(*E!D%2BR"A19!8JL D56@2*K0)%5H,@J4&05
M*+)*%%DEBJP215:)(JM$D56BR"I19)4HLDH4626*K I%5H4BJT*15:'(JE!D
M52BR*A19%8JL"D56A2*K1I%5H\BJ4635*+)J%%DUBJP:15:-(JM&D56CR&I0
M9#4HLAH460V*K 9%5H,BJ_E/6>^=6_]Q_/@L.]OT;_EL_"/:X@502P$"% ,4
M    " !(@')2!T%-8H$   "Q    $               @ $     9&]C4')O
M<',O87!P+GAM;%!+ 0(4 Q0    ( $B <E((P?!/[@   "L"   1
M      "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $B <E*9
M7)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N
M>&UL4$L! A0#%     @ 2(!R4@R+*!$4!0  @Q0  !@              ("!
M#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $B <E+
MDZ9A>08  &8:   8              " @5<-  !X;"]W;W)K<VAE971S+W-H
M965T,BYX;6Q02P$"% ,4    " !(@')2KC@M:"$#   Y#   &
M    @($&%   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
M2(!R4C"[9@O.!   0!$  !@              ("!71<  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( $B <E);$861TP8  (@@   8
M          " @6$<  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    " !(@')27KA'JET"  !A!0  &               @(%J(P  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ 2(!R4A).M;KP!P  ("(
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M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( $B <E)$"40C" ,  (P&   9
M      " @<1;  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ 2(!R4O]FLQ>> @  HP4  !D              ("! U\  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " !(@')2TPNE* X'  !'$@
M&0              @('880  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( $B <E*J,4.OR0,  #H)   9              " @1UI  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ 2(!R4C]L7PO%
M P  EP@  !D              ("!'6T  'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    " !(@')2UYOZO+,+  "3(@  &0
M@($9<0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( $B
M<E(=F0,YE0<  /03   9              " @0-]  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ 2(!R4I:1^(9;"   1A4  !D
M         ("!SX0  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    " !(@')286P$=A0'  #6$   &0              @(%AC0  >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( $B <E+DW.0@%08  "T.
M   9              " @:R4  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ 2(!R4E"A3))Z @  A@4  !D              ("!^)H
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !(@')2]Y,L
M,),#   /"   &0              @(&IG0  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( $B <E)C3*SRQQT  *-C   9
M  " @7.A  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
M2(!R4GMG8E\R!   ?@D  !D              ("!<;\  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    " !(@')2;Q\1-+X#   _"0  &0
M            @(':PP  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( $B <E(,7F>RX0(  /D%   9              " @<_'  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ 2(!R4H5BKPVB @
MEP4  !D              ("!Y\H  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    " !(@')2L!P )!P#  !/!P  &0              @('
MS0  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( $B <E+N
MTJH=S0(  .$%   9              " @1/1  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ 2(!R4IIO.H$ !0  H@P  !D
M     ("!%]0  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $B <E(]Z9O4_@(  /4)   9              "
M@6CI  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ 2(!R
M4FJT=4@[ P  ] H  !D              ("!G>P  'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    " !(@')2URQ1M-$"  #.!P  &0
M        @($/\   >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( $B <E)?>77@Z ,  ,@2   9              " @1?S  !X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ 2(!R4NBE7ALS P  KPH
M !D              ("!-O<  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    " !(@')21$%^77X#  #*#0  &0              @(&@^@
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( $B <E)76$/R
M7 (  &,%   9              " @57^  !X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ 2(!R4M_UA#N] @  J0<  !D
M ("!Z  ! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " !(
M@')2V5#&4<@"  #D!P  &0              @('< P$ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( $B <E);,MBD> (  +,&   9
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M970T.2YX;6Q02P$"% ,4    " !(@')2HB6N [0%  "+&0  &0
M    @('6'@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M $B <E*?F*:K\@(  "\(   9              " @<$D 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ 2(!R4DG,CZ)!!   H!   !D
M             ("!ZB<! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    " !(@')2J^K2_7<"  #.!0  &0              @(%B+ $ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( $B <E).$&R(EP(
M !P'   9              " @1 O 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ 2(!R4OL#<O@K P  ?0D  !D              ("!
MWC$! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " !(@')2
M54$#UMD%   ,%@  &0              @(% -0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;%!+ 0(4 Q0    ( $B <E+0;<OG& ,  +\)   9
M      " @5 [ 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%
M  @ 2(!R4O>/MF.G P  .0P  !D              ("!GSX! 'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " !(@')28R94'9L%  "1&0
M&0              @(%]0@$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+
M 0(4 Q0    ( $B <E+XZQIVC@(  -8&   9              " @4]( 0!X
M;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ 2(!R4L8B\\7A
M @  ,0<  !D              ("!%$L! 'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6Q02P$"% ,4    " !(@')2-+T\^EH"   0!@  &0
M@($L3@$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( $B
M<E)43V.SRP(  !4(   9              " @;U0 0!X;"]W;W)K<VAE971S
M+W-H965T-C,N>&UL4$L! A0#%     @ 2(!R4E]E )98 @  X04  !D
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M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !(@')2EXJ[',     3 @  "P
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52P4&     $H 2@ ]%   0FH!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>163</ContextCount>
  <ElementCount>424</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>78</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>1001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1004 - Statement - Consolidated Statements Of Operations And Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements Of Operations And Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1005 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit</Role>
      <ShortName>Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1006 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/ConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1008 - Statement - Consolidated Statements of Cash Flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/ConsolidatedStatementsOfCashFlowsParenthetical</Role>
      <ShortName>Consolidated Statements of Cash Flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1009 - Disclosure - Nature of Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/NatureOfBusinessAndBasisOfPresentation</Role>
      <ShortName>Nature of Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>1010 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>1011 - Disclosure - Marketable Securities and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurements</Role>
      <ShortName>Marketable Securities and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>1012 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>1013 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>1014 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.foghorntx.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>1015 - Disclosure - Convertible Preferred Stock and Preferred Stock Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrants</Role>
      <ShortName>Convertible Preferred Stock and Preferred Stock Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>1016 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>1017 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>1018 - Disclosure - Collaboration Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CollaborationAgreement</Role>
      <ShortName>Collaboration Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>1019 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>1020 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>1021 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>1022 - Disclosure - Defined Contribution Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/DefinedContributionPlan</Role>
      <ShortName>Defined Contribution Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>1023 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>1024 - Disclosure - 	 Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>1025 - Disclosure - 	 Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>1026 - Disclosure - Marketable Securities and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsTables</Role>
      <ShortName>Marketable Securities and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>1027 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>1028 - Disclosure - Accrued Expenses (Table)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/AccruedExpensesTable</Role>
      <ShortName>Accrued Expenses (Table)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/AccruedExpenses</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>1029 - Disclosure - Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.foghorntx.com/role/NotesPayableTables</Role>
      <ShortName>Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/NotesPayable</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>1030 - Disclosure - Convertible Preferred Stock and Preferred Stock Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsTables</Role>
      <ShortName>Convertible Preferred Stock and Preferred Stock Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrants</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>1031 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/StockBasedCompensation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>1032 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/IncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>1033 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/Leases</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>1034 - Disclosure - Nature of Business and Basis of Presentation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/NatureOfBusinessAndBasisOfPresentationAdditionalInformationDetail</Role>
      <ShortName>Nature of Business and Basis of Presentation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>1035 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>1036 - Disclosure - Summary of Significant Accounting Policies - Summary of Property and Equipment are Stated at Cost Less Accumulated Depreciation and Amortization (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfPropertyAndEquipmentAreStatedAtCostLessAccumulatedDepreciationAndAmortizationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Property and Equipment are Stated at Cost Less Accumulated Depreciation and Amortization (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>1037 - Disclosure - Summary of Significant Accounting Policies - Summary of Earnings Per Share Diluted Anti Dilutive Impact (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareDilutedAntiDilutiveImpactDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Earnings Per Share Diluted Anti Dilutive Impact (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>1038 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Available for Sale Markatable Securties By Security Type (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfAvailableForSaleMarkatableSecurtiesBySecurityTypeDetail</Role>
      <ShortName>Marketable Securities and Fair Value Measurements - Summary of Available for Sale Markatable Securties By Security Type (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>1039 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail</Role>
      <ShortName>Marketable Securities and Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>1040 - Disclosure - Marketable Securities and Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/MarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Marketable Securities and Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>1041 - Disclosure - Property and Equipment, Net -  Sumary of Property and Equipment Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetDetail</Role>
      <ShortName>Property and Equipment, Net -  Sumary of Property and Equipment Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>1042 - Disclosure - Property and Equipment, Net -  Sumary of Property and Equipment Net (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/PropertyAndEquipmentNetSumaryOfPropertyAndEquipmentNetParentheticalDetail</Role>
      <ShortName>Property and Equipment, Net -  Sumary of Property and Equipment Net (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>1043 - Disclosure - Accrued Expenses (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/AccruedExpensesDetail</Role>
      <ShortName>Accrued Expenses (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/AccruedExpensesTable</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>1044 - Disclosure - Notes Payable - Summary of Long Term Debt (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.foghorntx.com/role/NotesPayableSummaryOfLongTermDebtDetail</Role>
      <ShortName>Notes Payable - Summary of Long Term Debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>1045 - Disclosure - Notes Payable - Summary of Future Principal Payments Due (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.foghorntx.com/role/NotesPayableSummaryOfFuturePrincipalPaymentsDueDetail</Role>
      <ShortName>Notes Payable - Summary of Future Principal Payments Due (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>1046 - Disclosure - Notes Payable - Additional Information (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.foghorntx.com/role/NotesPayableAdditionalInformationDetail</Role>
      <ShortName>Notes Payable - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>1047 - Disclosure - Convertible Preferred Stock and Preferred Stock Warrants  - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsAdditionalInformationDetail</Role>
      <ShortName>Convertible Preferred Stock and Preferred Stock Warrants  - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>1048 - Disclosure - Convertible Preferred Stock and Preferred Stock Warrants  - Schedule of stock by class (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/ConvertiblePreferredStockAndPreferredStockWarrantsScheduleOfStockByClassDetail</Role>
      <ShortName>Convertible Preferred Stock and Preferred Stock Warrants  - Schedule of stock by class (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>1049 - Disclosure - Common Stock - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CommonStockAdditionalInformationDetail</Role>
      <ShortName>Common Stock - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>1050 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>1051 - Disclosure - Stock-Based Compensation - Schedule of Weighted Average Assumptions Used to Estimate Fair Value of Stock Options and Restricted Stock Awards using Black-Scholes Option Pricing Model (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/StockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsAndRestrictedStockAwardsUsingBlackScholesOptionPricingModelDetail</Role>
      <ShortName>Stock-Based Compensation - Schedule of Weighted Average Assumptions Used to Estimate Fair Value of Stock Options and Restricted Stock Awards using Black-Scholes Option Pricing Model (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>1052 - Disclosure - Stock-Based Compensation - Schedule of Share Option  Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/StockBasedCompensationScheduleOfShareOptionActivityDetail</Role>
      <ShortName>Stock-Based Compensation - Schedule of Share Option  Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>1053 - Disclosure - Stock-Based Compensation - Summary of Restricted Common Stock (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/StockBasedCompensationSummaryOfRestrictedCommonStockDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Restricted Common Stock (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>1054 - Disclosure - Stock-Based Compensation - Summary of Stock-based compensation expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock-based compensation expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>1055 - Disclosure - Collaboration Agreement - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CollaborationAgreementAdditionalInformationDetail</Role>
      <ShortName>Collaboration Agreement - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>1056 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>1057 - Disclosure - Income Taxes - Summary of Reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/IncomeTaxesSummaryOfReconciliationOfTheUSFederalStatutoryIncomeTaxRateToTheCompanySEffectiveIncomeTaxRateDetail</Role>
      <ShortName>Income Taxes - Summary of Reconciliation of the U.S. federal statutory income tax rate to the Company's effective income tax rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>1058 - Disclosure - Income Taxes - Summary of Net Deferred Tax Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/IncomeTaxesSummaryOfNetDeferredTaxAssetsDetail</Role>
      <ShortName>Income Taxes - Summary of Net Deferred Tax Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>1059 - Disclosure - Leases - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/LeasesAdditionalInformationDetail</Role>
      <ShortName>Leases - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>1060 - Disclosure - Leases - Summary of Lease Cost (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/LeasesSummaryOfLeaseCostDetail</Role>
      <ShortName>Leases - Summary of Lease Cost (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>1061 - Disclosure - Leases - Summary of Supplemental Cash Flow Information Related to Leases (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/LeasesSummaryOfSupplementalCashFlowInformationRelatedToLeasesDetail</Role>
      <ShortName>Leases - Summary of Supplemental Cash Flow Information Related to Leases (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>1062 - Disclosure - Leases - Summary of  Weighted-Average Remaining Lease Term and Discount Rate Leases (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/LeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateLeasesDetail</Role>
      <ShortName>Leases - Summary of  Weighted-Average Remaining Lease Term and Discount Rate Leases (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>1063 - Disclosure - Leases - Summary of Minimum Lease Payment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/LeasesSummaryOfMinimumLeasePaymentDetail</Role>
      <ShortName>Leases - Summary of Minimum Lease Payment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>1064 - Disclosure - Leases - Summary of Operating  Lease Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/LeasesSummaryOfOperatingLeaseLiabilitiesDetail</Role>
      <ShortName>Leases - Summary of Operating  Lease Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>1065 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CommitmentsAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="fhtx-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>1066 - Disclosure - Related Parties - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/RelatedPartiesAdditionalInformationDetail</Role>
      <ShortName>Related Parties - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>fhtx-20201231.xml</File>
    <File>fhtx-20201231.xsd</File>
    <File>fhtx-20201231_cal.xml</File>
    <File>fhtx-20201231_def.xml</File>
    <File>fhtx-20201231_lab.xml</File>
    <File>fhtx-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/stpr/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>123
<FILENAME>0001193125-21-085777-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-085777-xbrl.zip
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M\5V55WWNS 7,C-K?%'-*^)IX5'4A@NJM!8:.4/',[=^>_G4UI41PH\I+ '/
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MG\Y@\BL(9Y0IB8P%7SV!3*20X3)&AM3>L?LEQZ#WZ]L-$2R5-L-V!FWX:=A
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M/(%I WG<0\+2 IO3 ^ T/*DG6/+P/?,'81?24TBHYPH06U783%IX]P#B*#Y
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M882_+JBE$J*!;H:EQUT,7(9Y[H5&F$KU,5HR A8-Z13P/Y_!Z:LIO(2X)MR
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MM3:XV*%18%548$VCI2U46--HJ>9O)S;3(VM8;K=_!A\=GSD'K]MR['<3_96
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M(_C)K3![%%X'?^X:@UO4#1#8\<7^%8=C8."OP.AJ[,D"#1_^_09L^5?+_H,
MI*HU!><555&,-H.VO%5!>/_L@]SMM]N1DO"=@;\7&H'$Z99V:U'W*WPN*52#
M=M$ZYX?N'\,O@X][($\JY$BSR<Q^?7>_X%E%<RH*.FZY/_I%-]%C?7"]4GB1
MZ,^HAQ_Q_!0\]PV^QLVU)/[%JM9^?+EBU'[$'36<X7=B3:FRF.'6'2ZE'_?<
M@;YV=$/SR]W%\GMP0Q> Y-_@<#]9]_3J6=$-A YPC*+#Q_+>^(Y.<_1W#QTM
M/ /_Y<8-]2!:PF,,18KK0>@[GLQO3UJ?0?QEA &M'F:5\+V/N$^5)'[\W UH
M,?<0 ==HWH&"%<3_2EX$];Q(H@AURF09$!)DY+PMP_]<6F92(6H!#!C4PM&>
MR16EBAO9%JFW'+3C!WL*UEMZ;BF."@XB-HI(.XH8/Z^8LS46SVX?5PUE&VLH
M?3Z!=^J+6:$ HS9E^<W;U3_,$.GC7,W ,MAGQ4;7.?NL?DY2C:PN3,@DMV#C
M!QXR5F1D1Y7G[KX0"LH3G9-%[% Z_K_TT9K-$4*ZB);U\-?"H\5VK@!(,3+/
M[&&-Q5*ZM:8SBYKQ?8\%!!0V9GY_)R:1GJB"=D><<[(,/,YA3RPZY[NB>#D/
M^-9\>'>+%&0*_D4Z@LDCCJVK#&M.O!,4&72($AZL)=^'$Q ')4E3PQI#D!WL
M]WIS)C=B->I,W50CX#(EMJ0MF;OA%.R\\;TL"2RMB?6@"['WJV"6,0RS2%C[
MFT4%$ C(C;$@SQQC0AKWF#'L!\C!)',J>@E27[C08CZ+1&E*.8XBS1UT"C M
M@5-K8E?,?QL/VURX4V-*A$$LY9;=(7R,8((:\YPI*$N:0WEQE@L2LY5IL+49
M3$'1FYFW<.Q_QU+L//4I$I47(%[8#MXK]S*(1_?TT03,.HL0RMN'=_G,5U:<
MUTIXW*"PS'T%]P\=RAP0*&^;-SXW'Y'OLWM[?B#J@ W?M7#X>G<'O9 >8F,5
MD@:QY'#OF.?Z\4RNJ(U2I'];H%PD+,V@+J& @/#715'KO#/=G"'^H<HO5WT
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M=5=@G%9"V,$+Q$WBL3BI+BR;;Q$8@54#BP."--_DI6$ORB2]B( KCC!VR:@
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MGW/3+9Y"'X5GJGF\()8&KR/'5]RCQ'J.0??2EQPXCK*_>GB..5C+"HZA8DW
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MCSQ8>NO=+M&(0","S:YF);+4S:YF%;/4S:Y%(P^-/#3RT,A#(P]K.CIO;07
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MN]2CV.$-U4Y(FRL+> G4K\0A<<<17\*#_H#>M"GB>"%]>B:FI$\R,0F3BDP
M9[S)A(;)!8O$QN7H  \HA_5E1LP6#@KOTE9X: $+6C(,36'!3DT=+ Q6'U)X
MV'2(6 K<3"@&2;)_(\U:+35V9X*U0%%$GUB0YY\6-33I;T0Q[)ET3Z>@ /[#
M;1"&-+#JB5@84\,: [M-X"]Z%136T+-.'8:>!5% X?'[8W:TZ-^$?2%/ 82<
MH<!]LAR;%PU'^*/X"B)B5R/"ANN$HPVV5GG&Y6V#X(* A@0%9%?H.*#)>+DK
M9(': 3Y1;/$;'Y4(BG^S7I(2#S C&EPUP2I!401Q1O].*"NV@* 5O2P(GF"1
MM23-$31HX;)&=>3I=+[$#XMO!%V^ECF?0$YQE;K:G'N\IM#Q7-T&; T;5,N<
M6IXG#/"8Z,QZKK1D4QA&:/N023L,\JGB;)F9*C,@ ^"-_C*W3IQ:PHG ER<.
MC]%"ZC5"'&X&74'@%&(@,XKFV?6(K:7@N^)JF&)L8>)0,+6B/>O,HNCFB&?
MG]&YX1)49=&Y?:/M$GM'E+8FN82.1*,<G("6HOU6 "@B"Y9,(B!KUGS)C=(,
M0F/0#X$EPH?=!3CVEQW1+J2[2?;P;UW#GC:#KWK0^H,/PA<M!BT+GLIIY?D?
MC@'CSY6E< & =,(2 Z<(900_329$@%<U*U=&U'%O2FXHE[Z_WAGN8-)6A)1H
M<'<R243A>[XCUXF@SVRN"IRQ >O5 A;S^#]L3>\>[B-9A85#F8,^$3C%L/+
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MGAL6N7_13FK^,'"4J$1_%ALU?W< $O18A"W 33O+,)2QY478L&R)FPX&<+^
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MJ*SUVK %;?YX_R]:NJ6J3NR!%XWN@8<+\-2*!S>K!U[)/B^9G?*$I='<R-3
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MI2('_Q+CT1H4J9N_O&E'G:ZY"M';H$0T>N8,EKL3^.]GYC.;?GBC39AE">U
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MP8-E3C3,3U]Z(=GH(7S+0-8M';Z71T@6#B((0&K]]M\UYR?(A@&?7<;.,&=
M Y$UG>EYO!Q++2EY#5XMEH;IHAA?S[XZ]N-7L&%3OF?\'V9-OSAN]AK<SBTN
M5O.E8)&!OW1L( G*]O6,.LQ1\SGORO,"-M4SH$Z[N'H[A!2@COZ^O[JYEEL
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M>$+'85B4V@ &5] +]@Y1' !L*!I(4'/D6,PP< !_HH>"YOII;D[ LV!+P\6
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MP@)!R7Q"?B4<OGX"-8ZI/4]8 \6+"JN?:WCGDV+#DW2I(2I/(%?^C>G%L)N
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M'QZ,Z5$_-2-GOF0#-L?&JL189)<)'@+GSI!SVL*9,HM?.@C5@5@ >%@%8OY
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M,*KI>@;%ST5>/:KS5*3ZOQ1, 4:CLG8FDP"8<Q'&'J=1UCLV+ -]R6C<,+K
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MC)$39/3K&Z2;86^!4;<WW!XC@&I;C.[F+LMB4KHSZQ8HZ>WM42*PML;IR<G
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M6-##'E&)>< 4^(6DE\-<!$,"#1R,>1X'"&0^?VR0-!R5V;2$F,%)ZX!< K#
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MB6P#/)M+EFH/Q=(2;E<DW(3Z2?^I\>PP=[6;G99PCR;Z)$[R84< HX7?\\0
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MT6QR):*MT;,YO/N*!+U@%>.*JU [=_2,'P"[!P/3^ 1HA@E,C*\E/Y]<Q]?
M0K[ZY7EQY[L%BZA:KQ<1D,^4&3$+^+<Q<'8/1EKZ 3(:;-T3AP6S5KL-+W[]
M%PM54!>/GUW#!PQ&Q<D>&&"&)5Y97<-UU2RMW!J*Q\_!(>6X&T0M6HE9(&K!
M4O@*S(JBUF@\,<?7YF4&7FO6D5WQ)^J^\=[UK0)0%7?+ @8QJE3%^@HN\8UY
M/1A0&>O".3,EJD%QQ3KP<*%N;6K^@+V7?'C486%)VAVN\F;+MD-2[\5100=
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MU.OL.0V9#)-RZQBZ2J=L"X@8_EU$!<JP8&K@NR+H=^%@%,Z][T])1TD*CO)
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ME()?W?4,IE2+R5!W"O1UG>]8/UNFKF"*#HR"VDS/"'A34W'%B@9$U8 N.=:
MEYDNO?)V(LDB\0>9*B<,AI1GD!0#[QNWZF)Y]7F>Z::L2Y$S5@&10)(]88'Y
MD.MMD<)@,GM!\R F_HF4/)Z(X;K/F6#7I7(&*SC@2!U./)841+<,64^<KSU/
MM0@<\';H$U]]SL?8EJ+" 0E<):M$Q<9C+;JWP,W(=TXW,W.K%%RBT'FX'H"
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MOB+[B5R&8#+9BZ_ZRNG!Y^3:D,U/V8]*#2)1,B+B[40SIKY$I4I<!3B(O'(
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MI.!UQ?!)60EV:/9NKB:]J\FDTBRIF(,EEI*X5$>N(,3PIVQ=(4E2>(G._=D
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MT[6GIQ5.DM'RR9CZ,3;7Z;"K9^^[T+Z>%EB^M:^G_0#3@->^GC.+$Z[EQ>F
M?Z9P$?]@(?9&M;RIP9)&J;[Q %]S3\PZ%\L)[']?+']/_JO6D\\NQ5ZV*B![
M=]^.+I_3/93=WHIRO#CLG7P5;:4%IX>DQ[OPK:*KN]C>-;)JBGJ(->]H2VX5
MFNKHPE;II3JZ,'KSD;K<AZ#@4GTFZCBOHPRU0U-'*Q0"PNQ=#28]<S@\ZO&W
M/%A%7_$.7O&VQ2P<H7*3CEC0E_JL"??I\NWK_J6^W/IRG]09MXUC'WK_P^O>
M>*(S ]99F7Z*4*''3T9NB;;++%@7;&>.)I2GQ%XR4&,0Y0SZ;?VV?COWMD)
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M(#:@LO?+BW%R?P2&\S'5B*$T,BG[B$0XY>:(7VC$USRC(W,-;(;NO&K[*"!
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MUD<- '7\:^PQ!4@2#M:"DX8LKP \I!!P275P0Y9ZW:(,H4> I$!D3]@K7MS
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M&H6W=<V(]M:)V"(3=Q^-.],XHL/MNAT40]."IBT"3<?F5$\+;N8^'[W1I1(
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M?3^X_VDX&(Q^PI]_P@=?B.>CYR4\#]>-JA2^,'Y2YL+__OJ7O_S_4$L#!!0
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M3D;A%Q&&D^]@).CQ!0T@V8P4SB*VU59;21V6*P0Y*RQG99!4"$FD$!"S-V3
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MW6>S6*@$V&FO:'N_.S?<26,$1.Q7Q/BJC#*<0N+6<:QK")4]9R *(OWN!I4
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MB '[.E#]1X 2 >$"DUNP<MLR_C=?;\YO(ICZP_8>X=5BMM237*S*K75"O'G
MM7N!H[&12KFV#0T5]8.^=F#%1VUIKZS46I)RF]G,AM]5XU+1Q3UG&RY>ROH=
M"-66I.3C177CQ8.NGZAUR)M!!-V?P4>88'G+;JZT=OVNE0N#IJJ)U42RZT"$
M>,N@2$&3<(W[<8HR1)F ^@C-C!DEV\&9$4:(]Q!&W+JR'%YPV'5'%^>S*,E%
MPB$1+\[_B_5N9:/:PF#7/' V A?B[85KG.%5V.8^JI$)WP71*&]]F6&'_ PR
M!@FD%G/=6DF_7)CLJLK+FOKF@'@W3T01.KIX;J'DXMZ1J2O( $PKT7:P8(\G
MR.CX95:HEW7W<+R(B-7T&8-<.[BS!&,.H/?AV?\,4$;%> WI,#N?"; YHI-"
M>1'NHO,5S;+M8M "D'T\O<]C@I>$=QZNJ%>N9:]>!.:CVNH7I9(WD" <<Z:(
M"(([@\6_2U^.?YB [ &..,[S\1A&VD"F'2OB8>-0*'U#\"/B1G/R_(E[N8-L
MD#UR4,+QC?ARQW1QS*42OUN.7LRJ9A?3NKE"/,M8I-B[P_V(-X](OJ?(GZ0[
M^'6HQ/=JQ+&'K)T3.T U'B[XF-RYOA&$,17+9'$^\I+9THEQEUK:3KD+UA"/
M,=9LUC$]@J5\VVFV0VD\&?'1J17HY_E[-YOY:ROY-O,[-5>(F:/*P]J TERD
MYAB.1S"&,)57N##O.X0A_G$U.,IR6G"L,\310]-_=).$(_(0#XM6YCRAYE#J
M1\]GD$2(OJQ(3;Y!O>P>D:U &.)94IV-#C*.%"0W^7V"HB$?\$3N=L<>KJAC
MCT@V( WQ$*FL?CG7NB6WJR)[1.4JL!"/ET9P.G=%AV-+YM0B+6=.#6S;1U%?
MU1%?GF)OXHC75O+-$7=JKB!/RJIM,,CFB1<7[X^H3<"H/79N5F&(@X6FZZP?
M5S>#'>8IW#J:2HX-)P-8D]T[KM<0;CG-U5=DM9*6PY78-?%]Y'8-Y)8S:2E#
M4:JZ*%_;H@Y)<:BBI=2Y PTR?]8Z FV^"*>.:JBII<0WQAMDUJXS."4P0K+)
M^.<$2B:RN)^*2TJ_R^\UI-N)MYQI.Y!!YOT2L3PBE&>8G2$ZQ52F3!B.C?ZT
M0:[EA!K0F7.#^?".]S*Z<&,JFX4;-MWN:N@RF5_?8^5-A/4VGZ_L.EF^ ,AS
MHK$B]\S?418OPI:U407KA5M*H0Y2F*G$)H# $VY7,E\$S*C)LU$)M)PP%:P@
M$XSM=5CV5KR81G':Y5QE/CP9L;=1^- E!YJKC&BQG\5=ZQL"4Y2GM(AFDL<A
M&JZ;5MAR V@*VYPAS5.8YA@Q0\:!<J&6LU>&8I_R;!?W*0QOR=YU?MW%XS5F
M42KC-V>S0<^ZPGYSE%:5UJ=D+DJ&&-7_"R!('(+8L%!3-FP2:A0.,8W/+1](
MF$@0;4-"7>&P6:C3V#KXW<.XK7Q'_>Y'<.ZC0D5R]T40^IDVT:)]%3M/_VZI
MV35G].X))H_P"F=LHGV36>,J/7<@-YK7TLLWAAWBA&2+YA\0D+LGO 5S6-;T
M*JQ@B3;$F= )!'_P-H:^4EVOQP *O"%>07.!<8%SLB4+**IZ-090P TQ=Y\3
M"O2XK1&@J.KU\"_AAGC9S!9%?\P@V:(15.I[%990P6Q]O2RD15D_X1@RP.#1
MM^79KL!]RN+Y7KF(E(YXT>+=V$V1JNO;WVZHQASBA4 %".LMVU#"%S>E5(EJ
MNQ?[%/$R6NW/*4.I2.5T682%1!P*']:5P<8-*VLE?9L MK[XMXM9L2[31#^+
ME]%<5US[G!2)O)9SY_P6'4B*0#U>OA1?/9>(^VQ9R3#KCT3MXLKJ":"(^MG^
M++1=:B6.9Q,L=-6=:*ME=OZ6M^)66^4NFQL<ASJ\]DLC56NOA[,'%N(FY;)'
ME3J2&[/6-;2+5VM806:\4K\11(0%665 LJ^B7<3:XPKJ:*]\$_QE/LQ9+M*Q
M(6ZI4_$>Q*7?X&>B$RTXR"@CN=#C%!#R+")A3$LJO=C.%XREEQQ? 38WA_*M
M_&6##S*70[W-ZO7:RVR(U;TLN@'>$&=+)T@6YWJ-JMMO0PC[5,\9B>EHKV&%
MK\ & C[8<\5B.MUK5M_^VT# 9WO.4 QG.\WJ>P4FX':\MPM/?)$)MYP$]QHR
M[I1+GUSQLQ^'7)FU][KV$J*=F,<W;]M<Q&Z2VWE[C_#:)6WHUKRU>T/H1H_=
MTZ62>GU_)L:+)EK!UA%M F3M<'LX-%<F5?$SK&[[$-&_ZJ<Y,;W'VR 8QBOS
MZ@FQ//Q<8@EQ[T&A\S7.HJ;<E67W@+XRG* &L^*E2W=@5AK1I$M8I.CC/Q2[
MV+XV;0LUEEK:I673BVT<(5!JG%+%V@P1R@"!9G5Y7ER925F)"6B&<;L#G1.5
M96?3C;A5R7V@:171M['+>>Q:JF'RZE4"N\^Z5M'CI:=R?>1FRAB3)T!B)S2Z
M6H+H*/5$K>=;<\ 5XA;Q&@#^X93_C=B*\HM7JKM0;*JIS32;L&UW*]@\715:
MG8(I8B!!O\N72Q+V:2JN_MIX&P;Y%E#EB"C$>QAU5E;)CBTLC#S* $29=A<D
MU"E%\?8>T0*3V#[H$-\&9(&NG#^+(SR!&1PC1NL3;!F2(7R=Q^V7-35H@.W>
M0+"=,)S39;O4T ).G3%9WSG8Q8IG/D+-C<Y7R/C:,&G>H=7(['KT/$^G"7Z&
M? *0!TM.,"QD_4:<FJBI#FT6@$+<<!8O56<DC^2I7Q%X:B9/)]0NUG1(MAN;
MIIA6YAHO5C]\QCN#CS#!\LQN,3JI9A1+X790XH(HQ-V XLT[#49TDV [Z+-%
M$V*@UUQ=D:H14BHUNX .D[%2L%W4F=!L%*#5$X^\YS[AC_\'4$L#!!0    (
M $B <E*WFA>>>T,  $\T!  5    9FAT>"TR,#(P,3(S,5]D968N>&UL[7UI
M<^,XD^;WC=C_4%OSN;I\'QW3,R%?/=YU60[;U3UO;&Q4T!1D<9HBU3Q<5F_L
M?U\<.B@))PDH4]5OQ,S;+IL \\D'!!*)1.:__OO[./WP1HHRR;-?/N[_M/?Q
M \GB?)!DK[]\K*OAI[./__YO__V__>O_^/3I5Y*1(JK(X,/+],/5S>W]A_^\
M>+S[<)N5593%Y,-5'M=CDE4?/GT85=7DY\^?OW___M-@F&1EGM85?4'Y4YR/
M/].__R9>^.'Q\*<]^D_ZT_[9IR]1$8\^'>P=['_XW_L'/Q^<_'QX\G\^_-_>
ME__WZ1,3(4VR/UZBDGR@(F?E+Q\;+WE_*=*?\N+U\\'>WN'G^8,?Q9,_OY?)
MRM/?#^?/[G_^SR]W3_&(C*-/R0S'HA7K1M9N__S\_#/_*WVT3'XN>?N[/(XJ
MKD2C7!^43[!_?9H_]HG]ZM/^P:?#_9_>R\%"+OK,H%J\IMG!\6?QQX],746>
MDD<R_, E_;F:3L@O'\MD/$D90OZ[44&&OWP<CJIWIO6]_0/QHG^YS!ECR8!Q
M?1&E3"E/(T*J\B$J*+\C4B5QE'[\P-[P]?%V!?$P?QWE15:]<ZK9$Y]MN_OL
M3^JGBOXO&XME?TA_3\=WE;RDY($V)47!_I['?_0R\=]1G@[H>+S^LTZJZ149
M)G%2M0+GX:V8=-"=;=\BA-).5(YNTOQ[V1WDLJ>.LMY'55V0_O"B+I.,E"75
MTD54)O0=5'LE?1N?;'J#0<+^&Z6WV3 OQOR75Z2*$GO"/+RI(]:G>CR.BFE_
M^)2\9@DE/LJJ7ASG=5;19>B!*CI.2.D#JX<W;07KXJF'(I_0KV9*26$?QH2-
MLUY!^)@;]*K+O*SN&&<Q77KKE/WRBDP*$B>"M&S0&^?TH_LKG++"BKI=;5]'
M149_7SZ0XFE$IYZKA-HM5'CZ-/\Q>2.WXTD45V$UZ2Q&1RU1P^L/VA.=F9](
M7!=T[!,V"]Q$2?%;E-;D"XE*.D7P.6XA9.^-OIJUN<F+IR@EK)-HV0GKXV(Z
MZV_Z3*5QU-EVA8+0X$V245LHB=)>65)KB#Y_ET0O2<I;SUK0#V?123_K/;+>
M"SHV^ R]#8UZ$W*+&O:Q4GA[7T?<LEGUGE24'^6D2__L"+;;2T 0KEB&6X$K
M?6-7*R^O"-T&3=DX\V++V?;7W9)6&O.KO_@]*HK(TS?I^:U;UP%S- SJE-K:
M_-<7T\LT*EUG<=^O[:R%\3C/A !>*+;KKJM=R!41E61 7S@A6>EM-]6BYR!8
M&J0S$[(_X6+$U';DNVL/F*S>$ ;;W#AY)&55)''%_SP?-W[ 6;TB+#KYGZ_?
MV8^NUK2/5W6>*5)JFN>%^"!>"\*-)S^3AG//';'<9O3EY#EZ]^.6L.VNH]1W
MU&;U([!%3Q[6E:02YG5&1R7?*9/,ER.H;?<=43T2[OB@IF3E"8A#CX&\I_T)
M$5^>T.1X4I 1G3:2-W*7E]U=JJ;N/:):.9SH?KRQ)1^P9T?O5G?JS^PQ>U6W
MZ7HK'D3/GL M21U(^BVC<!Q#;IUZG>];3NJ![,R.MF,@J5S9U';244)V")D1
M;AT4R0N/8'B@\[NU<,KV'KU&K5Q#@6SYC@9[9ZGH9US49##;MHAOV%HF>6._
M$CG:=HK66_=;!?1->?T6'.<.65./TBP6FKL\>WTFQ?B*O+@ZYJW[\[(S=-S^
MA=SC^=C(>=**XZA:;>1%@B7S[)_L(+W5=EW=C5\IG^H);<0HB=)Y0$QC.SHS
M;IYST:P;E';O\HOW=Y*\CMCY/)W[HE?:YSA*V/D]?XQ]J'1@7B4E-S$?J3@^
M<'=[IU_\7^B;Q_68_Y;.58R,;N T'?J5?.9;F*FM<;#=37YCMYWG3<KZ Z7=
M899<M BQPMW4S+/P4"1TWIU$Z8RS\JIV=5.W[#UT7*#G2$A%MWYMS;96ID_?
M>!L'N,_W.R[=DI;^9&F<*,4Y'<FIB'OK#Y]'Y.O3#1G0.2-EPZ2N\F*Z:,@F
M[^></L/VMU$V?;H>#DG,0\":C[0_<-B.7 'TR"-0Q):"_D&$)WE0@Z[;,)$N
M7>-60LGE^/48>@E\RKUF$%'>ZC$_D2Z_ELP O"ZKA-J$9!FH)@X]Q;$UVSLL
M3WK%EO5[5 QH8Q;'ED;Q'_155/A2/$\7HYC^X4L^(*[!1_B!;-V_X#C0VK_
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M9I?1)*FBU$B1MIV ">K';4.7'28\)]"/[ )=1@;S^@U&TN0-!+) 6[)P;!G
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M4/K_T%RY8O00C:6@2%R/N\^K?Y"*XHC)X#834;X&AHP-A?"@#NV.!-E#1)/
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M,*F$]Q 5H]#J/;]U::/8S2>%>*#W;AUTJY$?32S,8M'JU14U:I-J:G7$L-Z
MJ^$L3%SP5A9A RPTD2B;<EHZIC>;B*$+'2]B4+PM6VN0T,1T^.<+RQH>@CBO
MT1$>P_%[V8!YW]/_61=).4AB)I;Y,$'?4D!&<,-/\QDISA8L@>$I+4=AD;)*
MXLN\SBI-](3V>8$+U(W6DC ]'#Q!#VS9+L@@J2ZCHI@.\X*G*S'Z N1MN"\E
M4,6!;?D%#,CP1#Y(9;5*QF1H*; &.@QT<2(8J'"@4 (.3_1#:"*Q6"]A&<48
M 3$/A;/.3K!<)DZ.0<T4VZ](=9(DA1.L3I#GJX/,8W 0)@PEZ"HF1Q&L0$V
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M#BYL;7$J>/-QNV2QJ%[F8SIZ8CZ$KJC=I/VL9 U8=:V#/> ;)=V^)"TL!0D
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MP 4\--N40+BZ=3EH=&V$S#^,XU4*S7"N)CE;^,S>]!*5Y-_^/U!+ P04
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MF!#Q<[30<$ D"TX/%5R+AZL"UY$1+M.$/T\P@E+/@8(Y% /60C=P,4>:V-5
M#^<J-E7#W7F"#H3 US\O)ZQ_KNN^:4$G@(L6/]/%)J4WRWE6)HLDW<"C%VU
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M+ '6R"YO#H,J7D?"5NEW9*YN)'S^_OY[LJ0+OD5)N16(R@V'P)8DS9U;DL.
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M$33L;W%UP#,)ZL\97(XRP_UN&U?(W^TU&/8E66OTFW/O#O_#(H35@#U<C.M
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MORW4&/K0CO\Y+>(\60/2;Y8_1WD">]2[J*3BU73MS8!>-PXV"'J$ FP:.HQ
MK*)FA0 O1#!CD:3H3DK[%.(96>R*^E*+FH.HCP.B!MLT:4)/N9$R@6]H#14L
MW*]S&BUNLBYO[[6U<[P+!YHY3B2 5@HFB.2"<+CNJ*6%0KH1SH4R"GTC12/A
MCC9.J8<:(%/JH"Y(0^O?9<:GC18EL')?PJ6Q6\KGBKN'3ZJXO'DG#G10ATP
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M!A=*HB5((&TPQSX6Z:Y2:2,^U*)RRF*L^H]V&V0Z[4BO/A)J@:0LG[.8H2H
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M2U#(B7;F?DX@$R!<'NYD%VV(H,O,@^O3]%>FD*06;I'<>=/;R9>#Y +@S.W
MV;E-@9""WZA()6"^2VCST_> '? G5/AY%9?O"># \F!W=PJ$H?!>Z['P/T53
M\,$M$YX:L+RI*][<ES1/=_5.3N!K&M/T #Z9C)378)-,>7>4DT;M9U G8KWG
M"92D48RTFI'.G3GJUNU=D%8[\SDTF!$<)![(A6_A=W/W.^0RBT.@,M?FMYL+
M@XTX?C:,NB+H?*Z*N&H< H^CU!-8>),$$#XOS'H<(^_:C$8>/Q;R=\>LK4 %
MT)N,D[00G8?EZ/?:%$#UX_CBMHH&?6VB',6I=D]\UX%567"J JS6VIZ*]<A*
M0?<QCVF*E)D4GIIZ%E]T:JHU]WB04LY7N&G2:E-%F]3F]82!5M[7O-S36%11
MU!=LFGO>'@MS+?K$0_BR1[/V8Q:F"8&,&\8_:U&IKET[_S :$]/-N0>$E'.&
ML^0SEIM @\[&(<X55-QKN=U<%31)U: P>1SI2:@;].%)@#1QP$;("PP0(RN.
MO(DYBX?.I>]?HSZ5#J!\V$$6?;^Y "GT(&Y!_KRMM@YBV'A:XV Y\R?CK4V8
M'R,CV 4A6ORZ@6T M&(QBH,F\N#X6:[K4$/P;,C[-__4PTJ""0*5SZ*0J&S-
M/2*E*/3TN4A7Q.S9*7RNR5,]U,S0,J$ ?+]E105YD"8(5C^,@K"Z.0_!),AZ
M)Y(NL2A>IBXF8_"H\[F K!EQ9FJ=\[BS<DW:V*4=ON# K1TV&<"UO5,?L/2I
M-0+=5U&Y)9!L)A)LFK7[$C9GLAJR8MMMS-[6(\1W%UJO9H0=K8L\C33_!!GL
M5]\^5E&:T^13?OT2BYWN42%'DV):#EI%4<V!7/=\7,N$C&.6BE0,$"U5FZP1
MBJO?%<@,#FM\B0R6(BWA+V(#C@F=X;_]?):S7)ON LS,^0"AL];NXRU-ZHS>
M;GZFH 9-5@<NZ8FNY09I=PYFE2<?TS*&67@=573U6*H*^3ANV3X#PYUL'YL6
MC6Z0J2:U(ZUZI-./] Z0<16)U)& DN2;5-/B\J6P-L$XLQ.&<6D77\D;#H'.
MO(R771I'6)S@<CDZJ'"'[[G5\EW48N68VG%,SA I;8G$2G&*E3!'ZDXF\%G3
MZK(ZL$TYB%?,A06(9(QFSP5ACMO.(F;$GTV@_8??O_"/^@__& 0^9XUV+#"I
MC8-LL1UZ"6&@7W\RO*-\3"=3^Y<VY9[&&F'GH/')-_TM:35R1^2%W75!Y)-/
MT6^ P3HXVC!X%M;G*:C8Q5-RX>5C37^B+]7#,\T.] O+J^U\A7U\D\Y*,-H(
M];$OJ:C-V*GUMCV)>Q>ER5OR"XT*<IO;'8T+T6T$PSG8WI^_6J,5Z S*.-J#
M^'+X"^AZ>&8.:#MHR2M;![(NA*1<(R\D1?06Q\T_7R8WA\A"4G(2H!?&1"Y8
M=UP<W99_-O:E70H?02=_C+3M,8Z3?[E@3IX@; DKQU"]+%[>\ %R1,M^4]Y9
MV1=V(:0$E;QQTK:_.$K^<+F4/$'7 D:.47HYA'1 Q" $O!3B>6&;%<NPMRIM
MFJ/7N_;H=;.:>Y[2Y];(0I+OHDCW-9<K<#2Y?HGYHRN17H1EX%Q[[NDX)_$\
MW.QK11JU2*.7.ZXNZOF2<DB@U=^AUEQ=B60=_HVEH=,MEZ'0AKIFD$95>-1(
MO2ZK=">&!G[]*8<5XO1 E24^%C6&J?6X0)PO2FIJ(G4JM7\Y*F53]=%7GY>3
MD7;]:SZAJ:Y__LH\+L$@<V5JVX*/GI&,K/K85>A0#RV4)!)E']MZ'-PA3"AL
MA<,MN7O>.*0"'Z*LIE,)P=++"E2OPR(RX7US%8KWFO(?BO>$G3LBD*$X5\E?
M*&[97UPH_M<+\BMTZ%H2BH]0>CFA^&K#A\TA*R?;\TK-28GGYV<$:GEF*;KK
MF+M0MCP*$)VZ3,). P_)6@V*0Z=>=>II\M MWW206*5L.T >U='KMTP/]]"5
M18=![/H3+"5*C1NSJ\<-TK+- NB?6+ZFFSI/Q+G@-(;K!V\F=U=-'K</@F<:
M= ]U+I <)9)6)+DQW -UI?2!%H_,%M9<[KNB$]R4X,W:#FPF.^ K3)W# 3.W
MEEVHZ<#TN&#2SO9FY.MJHB=W/#C-*SC'K%R=TCYL3SQM<QZ.*G;B2"-/G(BW
M6#E:K"^*<3VU]XW:L4)M7TS3#SLSM9 =RQ8;>W%957%4N[V-XXKM]E'^"JY_
M(15K;K$0_&.%.. J!@96=NJBX,-5T$PL^, U&Z(/\#.-MSG+V!/RXLHO:4;+
MBN6TY'XL3 -?]RR_/FBJ[L^_8<_<^3;=T_<HD[1""4@E0JPYB=VHCG (>_KO
M6_UKT)\J]/?%9@,\,"M[V?':C?T7D[M/:G%Q#1\3P>&"/M49$.&5[(XC!N,4
MQ=N6[N*2');4<=4,H2@_'PO6PTT^;$/:PIAQ,[JEN/*LKC)Y+/XX<W"%G@JZ
MH-+\*L_K*&O=D"\1;./E< $(]TB4WW&3=^PG!9-6W4\+C=3.B>[)!8?:XNON
M2GW$U-#V02)BU^O#9KH/OB8'(V0P2ZO931"NQ@%[39=V*' <O:^BG,\M2=NI
ME62\LDRIQ5N(:@)&[7JH%-#*[;C:20Y<OM3&NLS:<.$*F44%_1#QCQ%\Q[A"
M NCBM^6JKK:L2/_77L5\7['XO[=[^/L='Y+RP^OU"RWBM*1W!>_+&HIR*(JL
M!Y"&+*7F31_WR)?RB!!(A,2@1=]#C.*H/)IGP%PTP\8=4):O#R M-,/F] G%
ML*!E]$.,HSN.F4$F ,>Z\BSK9K7D+BJJUX>"JQC%H"V?#4[^ B&CCD5+VL/Q
M9(E$C_68>!3:BB5"+NFK]!86MD[__$TH%IHLBX9K2(?E8Q^@)N&T:I_3G'ZJ
MZ$[G@YF^BJLN:-BXCW5Y!4K)-Y!.A/C N#0V];#VG=4080K<T>+ 9^PN]H"J
M,<H 4O,L(FS4M.9A&FND'5?'1'$@B_)P"[7%%'PS5=E;2*L;;V9H',OJ:@O-
MC%_'%670Q*6=Y<CN:4[>W.6_Y%_RCP_YC_R?^S>PMKN+D&NL4+GW>.7?D>$J
MXLT];T^^N1;=$U!4*^[=H=F;HRUN'G:@-H*)G=J[**'-GEVC_EY\8FIPB,>P
M"7E1\!Q F(41[1CK8DAPK&WK7_>')JD+R)""[9 ]+5*6# =+E,XMQ8^G9!>[
MK3G<W L-+-Q#&<YBQTL/(3G0]/,Z_=;R#^UTN_X^N<=EV=Y5E2 :__7%=\')
M=Y@>^_$ZW8]0GV0%1G0?9QVLL)]I_'C@/]A@>?@R/V_3>#OYV1;#A-YC&76Q
MHGR>3^#:4G,&C]]QP=]QJV'8V\A573/K67U'S&W[D 2[*M<<&7K6JJ"$YRQN
M'/",+>@A+5O;BR-LQVE4W& Q0>$FHP4T+?ECR(P&V5JIV)/2/(7(6IALQT.>
M0B<GZ,Z/SE9LU@R6._=H4R+WZCMY2X&FW)S1/K<$;+XW1/IP"[H-HK?8-.1F
MMQX\F?0\L+O)HJ=RF^[ON%!*(0#2YX',/6\/P[D6W<-12B1'D>=(^I@U);.P
MDAU.7=@<A]<)VR-=[#B%(^N;-+YA8@UE)G])_SCF&A1M@S[VTJ1 TDH\2Z;2
MC!V9N8ELK\Y8;&_L?1A#NQ\!V_[PF3<D_L/_?8Q*^L_?_1]02P,$%     @
M2(!R4H5PJR/*7P  S4(& !4   !F:'1X+3(P,C Q,C,Q7W!R92YX;6SM?6MS
MZ[BRW?=4Y3],)I_GC-^/4SDW);\FSO6V7+;WS#V52NVB*<ABAB)U^/"V)I7_
M'@"M!R7A28)J@C-5]Y[QM@F0:W4#:#0:W?_MOW].XQ\^2)9':?*/'P__=O#C
M#R0)TU&4O/_CQ[(8_W3QXW__M__\G_[;?_GIIU](0K*@(*,?WN8_W-S=/_[P
M'U?/#S_<)WD1)"'YX28-RRE)BA]^^F%2%+.___SS]^_?_S8:1TF>QF5!7Y#_
M+4RG/].__PHO_.'Y^&\'])_TI\.+G[X$63CYZ>C@Z/"'_W5X]/>CL[\?G_WO
M'_[OX,O_^^DG]@EQE/S^%N3D!_K)2?Z/'RLO^7S+XK^EV?O/1P<'QS\O'_P1
MGOS[9QYM//W]>/GLX<__\>7A)9R0:?!3M,"Q:L6Z$;4[O+R\_)G_E3Z:1W_/
M>?N'- P*3J+VNWZ0/L'^]=/RL9_8KWXZ//KI^/!OG_GH1\9!EL;DF8Q_X*__
M>S&?D7_\F$?36<P^F_]NDI'Q/WX<3XI/1N7!X1&T_J_7*97R4_!.'V2=?'V^
MW_C2<?H^2;.D^.0B8D_\7&GQ<]-W,Q6(1DQYKH*8L?PR(:3(+;Y%VD-;W_84
M9%29)Z2(PB!N_J%;W3G\ZI>"_B\;>/EP/)RQ(<J&VB 97:?3648F),FC#_*0
MYO7HMNF^)53T]U05B^@M)D^T*<DR]O<T_)U^!?_O)(U'=$JY_5<9%?,;,H["
MJ&@,MN9;N\1!<QUV_0EML1/DD[LX_=Y<Q2L]M?VMCJ4CZ;8ABL>@*#,R'%^5
M>920G W\JR"/Z NI#N3T17P^,/YZT^X:?O5+.9T&V7PX?HG>DX@J8I 4@S!,
MRZ2@ELT3Y2^,B+FRF';7\*NI!?0[*0(ZOEY(6&9103NE!-T%4?9K$)?D"PER
MRAX7N/&WVW7:$,%3EM(EHIC3%[!98,9Z?23F<[&T?</OHL+*2C*Z_9S1Y<I"
M\#OMFHZFM"!T@,Z9.,S'S$:CYK.2=!+?_,5O098%-II6I^O&:*;3-.%]6GQF
MI4W3>8;U0B<PPJTAJB-VLZ&L>6-6XCAX2\%4&[QGA(]N"X+$S1M^U3W=5T[)
M:_!I,?XVVC1\_P.=Z"Q>O7S<@89&!9]=N<W,5PRZQ;99?I1]-/P^9J8EA'>:
M16]\F_Y$MRW&WR9MW_"[GDG,+!QJS!0V5&TWVXL=T9(]X<RN,'O=*UM?7&-8
M=KI'R\@21YVNV[&2+#]<TXM;B^G5RF(1-W9H.UE2)6JZ=SO*\IOKOZ 5F\9V
M=E!VXLZ2L/PL04LG5H7E9VPVVLL.?3 :1>R_07R?C--LRG]Y0R>^R-SUX.!-
M>UG)7&!U\*:]8%T])5H.!AGA+J+1H+A.\^*!R2P,RVG)C:0;,LM(&('0DM%@
MFM+IYH_VR&KW4_?+]FV0)?3W^1/)7B9!1FZBN&0?3Y_F/T8?Y'XZ"\*B72:M
M/V./=MCJ(P<?]-6LS5V:O00Q89T$ZTY8'U?S17_S5_HUEISM]Z,P&+R+DH!N
M]X)XD.>$;P(?HN MBGGK10LZ<%:=#)/!,^L]H[K!9^A],.KL(_?(L(N5PMG[
MVME54/E()UWZ9TNPS5Z"@G#C/&0O<(5O=+L?L\0A:>UP1[::!A[2Y/V59-,;
M\F:K7,;]M?'==R4S;I_H;!1&LR"F?^8C]J:T78YJ]NX0DQ-;W[2_O>^C7:!S
M_-:]<\!BED9E3/=BL-&>7\=!;CLIN'ZMN[,<-R(VZZX5;XF3':A]SZU@60O]
M-Q*]3]CV@JI-\$ZHG5=.9SP<Z"MM\YK>YD5$/XBL33S0D^%L&3/T3/(BB\)B
MJ6C?@VQ$&S,+, ["W^FKZ,?G\#R=+$/ZAR_IB-@NV]T'TK*D^&80WCX(Z2Z0
MQ^,XI5#QAG:P+5?2-?.5$>X&G-$KVD4G_O/";G.+TNA5K9Q$NYG>K7MVYW5V
M <"T.W=?7='O,*5V: S^M.'X=4*^OMR1$9T,8^:$*XLTFZ\:/M.)\#6ESS U
M"9+YR^UX3$+N6JH^4A_^?KZK!1[YSA;,)/H'<'LXH$'5K9/3"A?J:]"3DV]=
M[P/9/YEKN-:'RKMQ^Y4OY8PV8E-1$"\C,BO4+,(37E-HU@Q*O7>YQ;ME23V3
M:1 QCS1_C&W;J:UT$^7<@<U&HPO<S=[I%O\7^N9I.>6_76SJFX%3=.CVRQ>Q
M_ O:*J[:9M^O[;:]>"I7N\8ZW3N-=G(!Q*)'_NVSR@GN _W4#1#DLR#)B(R6
M,-@;S*\/\<M;:;C18\RN2Z79)B^LPYSVR"]%Y23\VWOZ\?.(1#\SKM@/G+2?
M#@X75Z+^*_W5-_Z>P1NUV(.P6/9'34,2\[=\VWGFV_GYZ>G!Q0)W>Q^VO _'
M#H\DWU5]A'_6X8% '(-L\Q.#+%SV1W_<D<7FE;+%$S_/N$_ZIW 2Q2LQCK-T
MJB-I\>)4\]%E3C\BG8&._?A#FE&C[1\_'O[XPVSI2'H Z-(/Y5]9D(Q.&NS)
MUL4SH!A&#,=='+Q+Y+/Q#& ][+Z Q%\MEM!1AR6T5+0GDD7IZ)8NZG1&TXRD
MC6<!^U'W):;^>K'DCCV0W!VUPH+XGR3([NAO<HWLMIX&_,?^2$_V_6+YG7@C
M/]!*<PE6G@<.3GV3H0B!6(JG'9;B+35>B_DS>8\8_*1X#*:RZ5/T*" _Z[[L
ME!\O%MM9Y\5V3<G)F+D^(I__3N9*N6T]"]C/?1&<[.O%DCNWE5R\%Z%=EUFV
ML02HS179XP#^HONBTP(02^^BP^-NN00,DJ0,XF<R2S/9?E+TZ+>+DY.+4X^6
M.N''B\5VV<U!M]J)TED_C\#G:2"U[<<Y5T<^[;QE "2[\(,.CSI8 ]@Q2#9;
MG.;Q./!KYKW-YM?I2&VS*%L",1YLV6VP2(3<95\+P!N,1E0".0<VS)ZR]"."
M?$MRZ8J; !7>&#@:$!)Y=MDS [CNHIADUQ34>YJI#=2-)SGP8V\&I?C;)4+K
MLE,&X+Q,@SA>7N!2"FWC20#N@2M-]>T2H779$P-P;J<D>X^2]U^R]'LQ6<0[
M*(4G; %$>.!1,\$@$6;W'3*WGVO[#1Q-:DGN/$XI.#L[\\!>U0*0R-#:.[.?
M[<;"70$[7["\J7;RP"3U3"IN II\XHL8-2 DHK1VUR!L/>@K QXW=A,4P0*F
M9L\A:@)4>.  , (AD6>7'3B Z]<TIGNF( /#33TPMY[]=G%R=GCJS?HH^WJ)
MZ#KJQ $LOY$X_O<D_9Z\D"!/$S*ZS_.29$KI2=H #][,JSH4DG-[:Y_./J7Y
M5+[%47@7IX%Z(JT\!WB]F3U%7RZ1E+5C9I^2>IE0]3/94%0?A$7"FY-!X:=+
MA-5EKPLUHUE>]I?Y]"V-)<+:> ; >G":)/YJB8BZ[&-9)HPX/'I[C8I8YMS<
M?@P@7W9?4-(/E\BJRZZ5)9;;SW 2).]$$1XA>I1#/_%@%Z[\>(G<NN]%J=S,
MXU<1\V%9L (.;!Y1;\85#8$6;US31E D$NYR!,Q].,X&Y2BBO0V*@N0@ D6<
MKKP!-\XN/-C2&4"02+)11,S/VW'_+=T%D)7OL%*DI1Z-@_R-8RKSG]Z#8 ;*
M1.(B7_YF6ZL6O_ZV2IA?25?TE()O4G&'P*8YD_'A*OIJC]@6:9?T*#8?9-][
M<(YTLE.+V,W!HT&%?C'!E6 7#CIC^6X]#X0@380:&:D$*H.!?IVAN5S9G4UV
MR8S^AV6/^@ABPJZ=%==!ELWI$LXS3RCD;-2>CYH#I*V%F2C%XK=#AWY'HKDZ
MB/+(*:0O>IR:"L>'6.'V382M!(-^?Z*Y;"L91:@^R\^8E,_# HBTXVPB734:
M](L5S<7[E)%9$"W3Z]%9:UA,J-5?I4HA;(/60!;2QK2)Z&VPH5_5<&RJF9IH
M0 "R!5Y'N&(4CNYM%&D1Q&CC&?)ZLDHFQ4XM*L5 EC?C]!SY9'\;H4&_YN%Z
M;7Y,D]!R>5XW 5HZ87\9"EF+Q-&%$$P!5Y8<(^D*GP="D,[2:HE6#0/_JH@#
MP6[DFGEF68&&XZ\YX:!5 E:UXPQAA:?7$[01'/QK(Z[,*ZU=!9@[85!9^;I6
MW^WL2@BB#55)_22L#VS@R#3M GA#MJT<N+"M\>+?0G&J)^8N;GDCX 8I^J^V
M(+7Z($.)?Z7%P:P.]6V6V>8-=L_"!L )LO%M(#+)"J#&A'_;Q8F<61&*78K4
MHA:W 6:08A!=2%L#R]75F.[8YTNP<[W4U0V!(Z3KOXU%;X@-_SZ-@Z6]4KI%
M+W3!T\ &\J:[MJ15@/"OUS@XOV8UGRD-OT7%Y+K,BW1*,HM!;M*<W10\..N.
M-6>G %8(7=W:Z98M;V7#<SI/D/=Q]8>['(^K.SRH^_G*;&;D1A4W $ZZ8[<U
MVI^I$;JZ#]1!$\[,CZYK"TQUQY!KH@OF8/%O'K6\]!LIAV$/L#QV9U/?1$5L
M(>/>?]I-4L]^\TU<&&X%0R!QDV:<N5/DT*:&8K;"B7]?RJFU9V;F 7KDHS7W
MOMD5+&>7J1#-/$4!#.5L+FT%['3'J&\V@^MAXM^W:JX$KV3*TA!F<V!G&7(]
MF#(7]: HLNBMY-&ZKRG4.E:HAG5?P&1W]OQ-%*8^>%>7O3#5J-:AKX;KTWYL
M'0U02C3 *Q?AICFDN] B>)HE)KX\0I:Y@;#$4E8!DHC7*W]?Y0*R]K+2UJ/
M'/+>O[9@I6@D]Y"\"JM;%PM["J+1?7(=S*(B$&4<T;0 5I#OGM66L0Z41-1>
MN?<&85A.2UXICH>+LBPY&9F0)%^547U(\_R1%,/Q:_"I/JBWZ8E?[L(^PZVO
M&C7!2E3&*]??,ZL:F)#1;9"QHIMYA8L;,H["2!TXKVO,F3]#]A'45@P+?!)=
M\"IV;Y<G*\,>N$!//5!3U@H\$MG:>_<Z'+_;(&Z7\W3>.S^@&JM$)YH[!Y%3
MN(#?8D****2X>IK/Y?(28W)=?-PK<Q"9H. /LN\].D!?0"V(E4VO0E2.\KG4
MRK'I4*;7<9#GPS&?+P:?D<JW+FU#S<K3PP/TY5,H)HU,I5 <I75!$F\5UDW*
MRM*K/"([#W,6#I$]WWH925PB<CB.DK-@"35-/DA61%2]-_UY7\CT39BBVK E
M.^B_N$ 6MT)LTB@&(U ]R-JR&@K4@B+W]$>C:7KU,"?RJ"O#V6I^WL7@*$L+
MTAC>.H>C-NLPXV!'W'W[1#*>0-/\&%/6 R<8JVBU@1B-CBFUX'J0J64+,N1/
M'90%W?=$?ZRW1GI-V&X))"%'K#75 "DH5\E=NB9Y7G3!6NK0"LA!/Z-T(?$M
M0#W([B*$J<X5;=H4:$(_PW A=Q&J'F1^J1S3UECR#5ISLH[03S@M5< &6!_R
MQ.SD23=:YQ6M.#O'R.'*3<0N!=2'+#$[.+6+NZ0%L-(5!UMM,6^!P:\WW(*(
MS59T7<&$(^S$(<V%+4+4AS0QF[ZF&JNY60>,[@/LX&-K+;#$UH>D,9N0+99U
M=4/@R#>;WA!3'Y+(B*!JUW=Y(\[-F6][=P,\?<@?(X)IMM!K6@)+OGEI34&U
MECIF_Y$F*X[RX7AQPYK^E=^]JD1<LEC+?4>>0)3GZOL,@DTD+7AFR N$^))G
M\D&2DMQ1Q13=3+[]#..2Z17+34G_;Z2._ZW1&UQT1IY[=5(1#\4F:!U%L'R0
M["W%SPNQR.QO4G=*VH:3?8;L1:NG"'I,/2A4]$P%0LEDY7ANJ.+'*4\#OT"L
MG!,4[2 C+K(/32\^V?@W0=:#HD2_D(0R%%.<@]$T2B+&3D&77+WP-2V!).0P
MQ;KB-\76@QB8'8IL)G@@ MF;4E?(<C2N*A8A1O>OP*UO*YD(=OTTD.&E\:9"
MXRJR!5&TCVF2;B)<5E_2FVC:MD M\K1=3^SFV'H0Y'*?T+>3W,!(VWJ2DW")
M?.9E+BJQJ&68FL:S7()@$_+.G!.N4FHMOQ:0+FND;> 6R,^T*8!'7H/K"M0:
M9 ^"5NZ"*./G-H/1_RGS F[1+#.)*0:RLAT0A!R5V'18FR%L'+'2<)0[VG@%
M49(STX3DP^3VDU%61OD$,+.$HZJMEZXMNY!^=."Y-IBC[$-0BY2M.M8<C!5D
MX[VI_/7H^E!&Z9$41ENTC>>  >13[)I6NA"'LP@61$DN<T(LPS&N@CP*F0,Q
MBLM">7RM:0DL>>D^-T76AXB5WPBKS$=&@P\Z:;V3QY)=EQN..>[*,:ZY6M3K
MD%^[/D#VN]?3EH: ^Q#^(L@TM,PR9.#>,6C-C:8C+]7#!ET?PF/JF0:< 633
MWT92)F;"$E,?BB:9)!1[2C,N,4$"69-S>#=OX*QC!TS7/ %PS$ ?JCFI.!E\
M!%',&+A+LY<@)B\D+#/(>;3RQ!CD"'3U"N =>?OJ6H?L-;4697TH,]60^O:F
M1F 9N5X=OF+:,-6'TE@*<Z:>,<[9.44^A-N/'IFPX*R0%G[JO&I LS23CC"1
MX#*Y*EZ&O9KI_ W:0^+,D_V/W 8Y]@ZQ(Y?MF!6//@FLOY+LK;.><4ZZ<B%L
M4TP:F4JA_+F3['$6D&TTO8PDJZ4<SE])]F3YZ$Z/L2L(*\0FLXK,0/4@P'@U
M%!8EDJ@]F";,0#*=L47M(.MR5ZYQ6\W:2CA^9^';@J:=O(7/ Q==R:^FE);D
MS%.)RE$ ,MHTODI'83!Q;ST+'"!;U6KI2/>P$B0]B"26E,'1BE?9#@A"MJKK
MB-H,50_RYAF4N-&K@&D?[.KZ.7;BZUKJ8(VP!P'*VT5NM'H@;@#4(F_$Z@A=
M \=5QCS<"]XOY5L>C:(@F[.C)4,GBJP-*WIXA%WXV<X<UT+I0U!Q!=MC,*4_
MOF9!D@<A Z6USO6-@2OL_'E:24HTP!Q>'S+JW3\-M?/XZAE CIT_QUQ 8@GO
MPNE#HKRF10OXO-B5C+96GI-=#*["AI%VT\KJX=2ZA!PSPC/8QY0:GTE!OS[F
MUR/@!IU*%=R_#"RBKJC2KG:(U:E%'EP%(,](%J7L*#DKD":9EK.J'V+?,&^J
M-7)4K@*/\77 1?'/BZ[X<4WEK,#A*O@87[(M95<^O.C*,;JIM(T0N0K^Q9?[
M]B3&<$-:T9LR8XL>_T)^ _N1?.=_L; HC+H#5K%W%DUG?RNDN!&YDIP49HA@
M4*ATH7YGP$]7CG!UFN  I[-(6-3K:2QN(:<0EHX6;C8OPAG(Z%"Y?&C:?KLX
M/3TX\<TR-(?E*LP5V7&LF/RJ7%1"7-87%W069-U^@>/N%6PQ,#8;0Y:HE5?>
MR9U!!)-HO7EENRTPU95HWMKSBA261 $\\VHJUM(6IA7#CH%CW[8UCC!+],JS
MZ,-F>QPS4Y^?+WCIZC"&)E$&KY(KU-[EV'4 G/FVWEABD^B#M9\3UYA=7Z3-
M7U-)[-<B 9VV"(UU7YS+,]^,UOHP)2JSIVA)B2-$J?844)HDA!\YL_H/KQ-R
M'>23F.3Y[2?)PB@GRM2-CM\ 3/JR06X+O$2-O(J^5*V]_&]#CF]%@VK>L>Z+
MR^O2MWFG/DR)PG@5DZD<1XXT1M$9+S5Y[IO;O@%.R6T[KYRU+$?J>K>W<AS<
M)WF1E3R;#O=4JGPKIEW Y(P="6BK'];H)%KA5TRH:E \$PH]"HMEHH+O03;B
MZ1KNTFQ,HJ+,ZN^/3/KFX^_"-SUR!UNB8%[Y<DTV")R:MX#.N"PTGR0YE_$S
M^5<9Y5%!7DCV$84$:'PF8?J>\%[X8M]P"];DU6!2^*:>>V-%HKU>.:*_!-GO
MA,?[K3VB7Y.,!#$KM<MRDFNR,9IU $N*;P:5)3:)/GCE0*Z=G_L0NQJ#M73%
M$"1"M';\XCKZ^A!J?>';EKU%'B1:63/,]C;!*@/2>J"U;\:*,2J)!M0,Q\73
M "=AUEX>-HEQ2.1:,]P63ZZM!5EW);65J:R-$$FD;NVC%4K=PS20D&-S0HHH
MI'R@Y/$Q2/ZXFXOP^/  8PJMG>7Q^!!Y@910*)LVA=__5SK'C?QZQX==V5=O
MBDDC4RF4/WTZQV/LU#%Z&4F6/CD<K'2.LC (NFZ2_.J9C B9,JVU3]A8JQ_@
M _D.L4),HI"&NA#[E,SQH7;R@>/#KOC%K&;G70Q8N1IU@4Q!$E*5%'NH)$]2
M3!=GW;R5QZE6!1;M@G!5XWU[G"%O(X)\<A>GWW/$#/&K;[!+#+_3C)?O6:4'
M]&"G<'%R<GS0%5>:BE"C?<,2C:-]0Z<N#EW-OR;1OTIR0_(PBS@VS5["M N@
MK2N3Y*8D99X72V2.=AJ=4@B6.TJ_[Y"W G*P$XS;2M)0(00P'6U,G 9I5[];
M:'<;[$QL^N!D8'L13(0E,(QJX43=FA@(?1$$_A %;U$<%?/7%/QFYB)7]P!$
M8&]#FPO<$*6CK4MKXGY,"Y(_!7.FN??):[J\ V N;G4/G(@C_\>W(<JV-D0>
M.1XN3DZ/.I,?P,1V4V!PE'0>R1_\2 JV?7G*TH^(;HVI(9.SD.OAC&14(,G[
M("RB#ZARJ=]DVG<&E6.[8L7O"E>L#0UP.LI5CQN^18&/HT(3@K=^", CV^P-
M9"96 @$^1]GF.W0)EP47)V$4DXUHQ-?4W9S1QNM (,B.;><*URI3/4FCSR):
MKK;CYE6VB; !9^42.;*G57%+K!PU&WW(P7]#Z+>&$0=&?XX)EVHR&DQ9W.L?
M.GTQ:0XD(V>I0= >*V[ZD,1_><-BF-Q$^2S-^1V<X7B0YT09D*YL!PS]^>8>
M,U(:EPRX!+5)R#L[T4-4G)R!)13N[2?CJXSR"9PFL6NP&N51MN7W?;"W5$@*
M9$9,XSH%FTKTBC@%W051QF_]K0E7ID Q:@<+/K)[!D&#S$AQ55; J;N6DI(1
M:KC=$/AOA88']N_GZ'U"P5"&^(0J\]E:=@.<(&? V:.B-.+(52D"3(L'+BG_
M>Y2,EG? 5 Z@G8>!BS_?TJ1@PE49 ^3BE1D8^Q5+GZZY41ZRJX4YW0,\960:
ME=/\/OD@"_)5/J%:'<+ZCNQF1-"NAFPU+JC0"9-:,2LO<BH8^"+-.^$WI0Z0
M5S[G'L8:^%V54\#U&^X"IR-F1F?MFP6&VT_F#B-T*/'"L]HM?KT.@57DP,8:
M2F"J358<-"[0T-%YB4[7?%I>! I8*=%66^ *V9YJ45]D<%V5;D"M "I"FY7T
MRQ?10NI$ZB;-@2_D8[!VU4.&&+<*0\U-NEKRMET %\C'$(VE7QMU'\HP[.*^
M9EE8*%LL/^\UW6C0+46V"B^TFBZ4/5$6SP[.?->=IN#[4''!?(_@)*Z+2P([
M5-OYOJ@&?F<%&E*JY]W2'7 B.(H-5'0&7';EKGG#V$ 3G/THXD"-]65RR_!?
M99012@4=*,7\*0Z2@F[V6 S\C#VB]!V;=@+L=3/6RT3H,H^Q-?[&]1PZL5^F
M.$-"1OD=Y?@EB,EP7$M]S'N!U1XYWL*]_M0@H ^5'';&C2A'JLV\(VH/KG-D
MZ[C]*4<)O7$5AT[,-N8D.K%L0 +(V0&=*TX-_,[J.73/.KZ+DB )'5G'BLZ
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M/-9<2'2H-_5?4$M#-MJR&AIMC?MG!Q[G9T<XUBS]P.W/*I:5KWFN'PUZ;7M
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M,EU?$ZP@2G*M^*03HFLW %>A"/)&</" '"U:6_H&N,0B]RI#DUC'=Z[["\>
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M=TK$6,6_M;AZ8M\M4'N"JV$&DA>KC!/DKFKE(BG5ES0A<SBFN2N3D5Y=Q V
M#F0OJA-YBE5%@[H/]6[7<6.U(NIVX\Q.CL^Q@^E:U @#Y*[*W6+9J<MSV/N$
MLECRS-Z:7:ZX!3#9%2=HVSM;#0>N:M4B*04ODD(_DQ'X0K*/**3D5,[LUZAS
M%K^:B_^DW?>Z? U0C^UZU:B%6)E:H:%QW5S'N1$VKX$O[ITN!^=<G1S!I"T
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M\,TG 3^RC6TC)[D?3(3*[W"<NS)+HJ+,"(N:CC[93_HL#O)&P KRYKBYK T
M8H7I2+; 4&.39&MK)QF]I./B.V5,?1"E;\DQ8V>,JR]46Y1^Q]X\D" GDS0>
M\9LERW_<3V=9^@'W(+3#V[0+8,S[B=T:;L<B>^"2SV-:_),4E(60C.X3"%;5
MC'QM0T",?,#1<.";@_0[2Z24)I.C$'UC8 D[2J_E7=PN6K\#B*1 >46J.OK
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MYX2\D.R#SF#\6W<E&?-OX1D,J"*G[PD+G(0UCD,T/^)V^#Z6.>'H 'G9<*0
MNL/T-FCS^QC^*0X2YB;5N/VJCP'RSARXMR%3L1X)2?#[?'X)2>L'W'P0T",G
M<!"*0RVYK:_'.G.7I8W[GKY.TC(/DM'K=TK (A?:?<(*X%&KAZ%07R S[X'7
M*#Y CJ60B&53AG6!=?%:X"Z,Y>3%-S]E%D[HS%5'SNI^@!3D@[DFTC:$AWJ1
MT%3F@V3T$M'M 0%O5Y/AK>^*N\%/D?V!#21O@; 'I_&.PZCHJ#C\$]II>D8<
M'>#W-0"+L82=G4LK0ZWC2 </ZR!?5F\AB8HHB ?3M$P*39F%W4<YJF,/0F\6
MY OF?A4JK"-YC:S>WS/R'A2$)2>M+%V+%6O %K&M]8RM6[F9=!MU#LQA'_8Z
MT0<W/."& 1CJD9UBK.R?@U-L"\^MI+> H9WMZRWZ'!3N-=WXW23*BKFQ*:_M
M RQ<['L/C21<"VX'C_SSK*C8:?1?VS8:_=6WYR!YESE4-_[.,]%AWPC>IX4N
M1M^M$BOF(I:.\*TG "A2N*28<HE8MK[7U;G['@7S)?B,IN54*9J-9P L4K",
MC/A=\8B_V=6!-])&]H:\%?=)7F0E.\[3^#EV'P8:L#>J" X.!16N2J%T0B.,
M3J9D33@EI\@[8H6D3$0K0..J! J2@!<'^D\!-?<J%F1^-:_^13,5F'<"M"$'
M-V!,$34H<E4QI0.:I9TT=A\&&I"]Y36DIA?_%CY7!5*PG-_M7%QC4>;8%YHP
MCDJ,6'%5^,3O.V^,#.2@>C-QB46M1N6J/ G^_9DZE]X8"=TL<[H0CUBD<B2N
MRH0@B7/P/<A&!BF!-I[C_F(L-POF)"YF0:("WF24$?/%2L*\\RF0&D7K9Q81
MP9R)-1W)R#B^L8W7@2B0EPRQ<DBL@39)D.AC^\Y$>8I^-BXYE%])SJX<:K/S
MBQL 1.Q-9INR$YSHZ-F0"-P7YZ2;^?O!X+:VXS?QU>(0.Q0$81ULBT>)(OL5
M6:B;'F2SPZI.IGG^>^?O^G9^?G%YB7P WI9VU5R*:W,HT6:_LA<Y8N<CB&(V
ML=REV2^LUN >E'K[E2 7Y-G:3]V64BE1<6M/-FY5 B.A/+(<VGE!P(K+7],B
MB*M_9X)Y3(M_DF(MLJ:F2)UW@FRP4S#O5<W;YU*BYU[5.F^-)9 8G1L6OV+/
MJ2I9[_=#0(;(\;D]&0]J@B67/+W*_U5[Q83TE:N"TOE] F1Q7N^3(HN2/ IU
M%4[V\?IO%R>GE^=_J@&Q5UHEP\"KFBQ-">-6XHJMWPC+,$9G&FKF!>^$__&&
MW3,(HJSM$6'Y)2!%Y$!AOP9'788EX\2O/'-UN5O>JE_&G^7#8D*RUTF0+%C]
ME:_-&_--J\.ET0>!3)$/!#T9-6Z(E@P>OS+RJ9(0/E,6LB@L%A6M.'6_9&E>
M.VFCM$/@%#D>;<_*VXPHB?+YE26P[OCE_[,XAP/:5'M=EZ]A,2?'%\A1^)[,
MLBKZ).KK5Q7T58HV-3%O.\O/YRR"#(] BTYW7;P##JK_7#.L<^XD6OOG.AM=
MI^C<YRFI_*UP<_I/Y6S?!YL27=_3R:DLC*DN\,6-PKNR*#-RGX09H4\ =FD$
M5 OO G:Q*T[L15?;YU"BH=8'G_@:6A8IRW0<+H%2FEGFK^!=Y&9HXS4\"\')
MGR+FI%7Z)"K9_(P2,R?W.KIMR[$XH+O7*3A,OM(VK^DMM?6G54?C(H?&PJLR
M2$:BC2UM3'<(5W$0_DY?1;\CA^=9>GP6:)F.2/Q7"O!J!FAVN^WBV"/;<:40
M%95YCO+?[S)"9W>J[50MGBGR-BQ(TW<#J\C'#HX4P['9:$VAHS3A7NZ31&31
M'25AD]ZO*15C%$?%?)_:+GX[" OYP, ??=>0Z"@S>N\T_B;ZB$;4$,'0]^J[
M05!^%WY T'8AA8XRR:/K>AW?H(JL5Y)-M0<1K;P41(-\+-&^=K?+75LY]+NQ
M=^/LP,9J$!9T6!?SOS956_IW>'"$,!5MBJC6K4;S6DH-WP$L(0<N.A*T9*)Q
M3I7?-9-JFQ4/!I=!FW<.+'<FJZ@KG7%LXNW2Y7<EIZ;QDL.RR(L@&47).QR)
MM1C]NO,ND %V<AUWJM1.2*N<-D?;CQG$6Q5!5OBVX19&_>XM@!L$T?4,$-CZ
M*^$,M5#7'F)&J^<]RRL;2M6T[HQ3>8B=(+YU]:O/2].Z8)>@8@FO3C#R=&Z\
M2[,QB5CTP#XF2,';0!S(84F=GR55Q#4M<=8+/<:W5 ^Q-U==UV$Y;8XJKX&E
M>IOXJL-PFV:0C%9^UY3]:I^J;?H)(+J_]F:.V714?0[]Q*@!9PL[C7EY6M?V
MG7>!(+"K8W9=K>6T.:K(Y[/^5@;W5AC@<@?"XO7:O$9N^ 5<:$?8A5*ZKNNV
M9+JJ*.B!UTWJHC>Y;.]L,+C["BY#]&JIZ .B!4)=U6KL]+J@XVTG,0O6B+#Z
M$) A=LG8S@^*>IQVL);E_L>%P+6%-3(L/P7D^*=W^[3%JJL*H)T>';W:31QC
MU]E 'PN.R715:[6GGM&*(P)I=#3[,)#S7U[4O7#LJBRNS\L)_H"QDMI?L3-N
MR715!QA]"-2YX*!=@I\)*V]#?W^=)CP"N@QB=O/A2#<<]OLU(,T_Q1D%$K&N
MJBG[/$RL%UT9K:U<]'+^D5SVV(D].C^H6N#;57UIG\=:MP95;6G^*3;_2,2Z
MJL^-/DS<.$_V5J1 ^DZ0S%\;E*;TN:HB[K-BZY?5P?M[QL-S]Z;XM;\))/NG
MV)Z@TNNJ-COZP'&SHFZRM"?[:.NE7#:G?VTB&O/GJE!]MU),E--ID,U9.L9E
M;C_ZYRG] WO\KQP3VZD'SC 2]WF78^+,^T1\7-"2J<8Y57[GF ! K"C[9Z1*
M%['Q'&#'WIP[EZ188\3(>Y[$0<K8FHUD]!0'R6,P)3<I\S6T$D4E?QU( OF@
M6ZP;KH.>#$APE)@!21VW4A-_(9I+.L+G@8NNNT^:"%FL5VHR^I#TH/'VH_TT
M2&?8WHD]+88.Z6J:*Z'C*VCM GBKRL3MW56T_0:063_N=3'5<ZS;M>ELFF;!
MY\G9LA DRC#8_ 0NMO-^^.(P1H&$S::9&N2Y1CKAFA/_F?GHDYS\Y:*K>F[.
MST^/45QT5!NX:FO];!L/TN\].\.>#QQ1+ID+Q'C]]GC=)W3HDA6TAT5-(XW_
M2]$*>,&VCL2B$LO5!(S?#BX)0JVG2MF.<W.!?)O;1'964M_"YKTGB5 ^)X-D
M=$,^2)S.&-3%:FOB5]*U!IZ0<\N925+J+C+&V /GT2\D(5D04[2#T31*(K;N
M%=$',54)H_9 &/*-]B9*88?2D><&-Y'JDB83'^'.PS#38J<PL%GR%1@<>2$Z
MY8BS=A< &]CW)N5"LMFLK[ X2H*(%/-RG<94?"F4 Q^\9X13LZZ??)^,TVP*
MDYSE/EI205;R1OG&UZ 5WV)=>K:KQ;IU;\.G\995<>O=DSE.;+-5?'++(/_7
M](ED;%3<I1EWO^57<X/@#B?] ]?=VP8?2T_DW<+V>\/<@ O&A'9C[:1_SC7V
ME3JW6N-<,P5L86WI):OL$EP5&2M/_5[&K(^Y=$]FT1JP([MJW$IQ4U/J<(&Z
MG9<HPQ>2A;^+5WRU'F@;?CN_.#S'3J75N@J8T]"]77N>%94%BOYK>W&BO_KV
MS)B2V"\;?Z= #PXOL7-MFM@?XL_NU#;<7#324;KU!.!$<IR*&9=(9>M['6VB
M]RB7+\%G-"VG2LEL/ -8D=Q9,MYWI2/^9D<)[KMU4-7D-)+Q@IU!TF8;9@+&
M41;X;@FYZ6DDXP;Y$H:)[&J=1BZPN<I]CN6<#F*2:\^8*D\!<&0WM)EH)/XW
M 99>Y.IV<&"$GF'+9E968'"58]J50^$I2T-"1OD=1?QU1G$GQ2+02;9YE+=@
M("].N^+%W.5>L 4T (.;]UBV]8_H5%&D"7DF(8D^F$Y^G5&>*3ETJZP2G[XE
M1WZ&':MK)48+4*YR^&).J$O'QV]1,;DN*? IR1ZBX"V*HV*NF%N5[>!PJ"O3
MK$[L=I#ZD&SVF6IR4A(V4XE WWZ&<<DR^PSRG-#_&[T&G\HS!>O>0!)="=PP
M59 F0/N0H'6!?Y73;.$J#9*0#-_BZ%T7\F'4GIFKI^==\1]:JH8AM-;2D.XG
M(@0V)E2[2>XD#,3E[IY^U3H6W^"NA*+5MXN3X]/5=3L,)&R6H<I$DG"NBQZ1
MMN$HL*]'F+"L\D^H</D=4[+"-R@+.LZHI6'D<]QNP-FX0+:X]++2R%@,R>^(
MCEUPAO[&W2:<D<NN#&6QL$PEO(7([^L.% S=,T;A=5I2LU >.:%\'KCHQ+46
MA:#$\E4#<A3P@.4\9K;@(!DQ_VO\/\LLRD=1R+#H'<KJEL!/)^ZP6 O<%)K?
MV24H+7!+6K,F;SP'V#MQ"\5^*18CZ51,1'TI:A?>K2<!/_(9KE@B&NEM?3]6
M[(3$XWS[.8LRIHSJT+*MQ[Y=G)X>'R"/*QG# D>R[/.Q B4DPGCD61!,Y+'[
M)&!"SO5E(1(% K\C&]A$3S\Q*JZ#+)N/TXRG,M,N6N(VC,$S[#S?#18P#2K/
M8QF$ (W2/VI: D'(1ZYZ\5F(78#-50P$\O40XROT:W/\[!1YIV$J(IF#70@(
M+09B'Y'4;&TZZD00DOD\+$;@*O"ALU'5'"C2DBFF7"*6K>]U%<* [5RM:.>#
M0628LAU,+IYNX,V0N0IB0!+[<$;8)9OD_2'-\^IRHI*YO!'0TL&)=E=P8J$;
M0.M#_('8.)PRG[/U/H>W G:0]Z]-!&^"K0\U3X4X'Z)I!-+*A\G77'4Z;M0>
M&.O@OK>1-DA1]J$^)ZLN!!**X_0[B[:Y67PZ.]'(<U)<3YC5<Y]HIPG;KH!'
MY.UR$VVI#;@/%2N_)AD)T_<D^H/#O2()&4>%RGR0M."L8$<X-U$#'2[<,HX2
MI_7F3'>W,'; M\N^]*4(LN*?))#ZLHT[8#NE(^Q0YCKRK0G35?%!5\<3NZ9M
M#6E;=0)' AZ.Z 90797E:T_J56OFB60AD\F[R.2S:@\$^#JZK5%*Q.Q+F-6*
MJ$4^S,5:9>+GV6P![B\/A[@I+HF@&[GU]AY;7BFK&:9)&,41?\UP_#HA7U_N
MR(CE2F6!2"5+LK-J^!P4Y#6ES[!<C$$R?[D=CTG(TJAN/-*C(/5UPLP](A&S
MNBFJ0:&4D@*Q@]Z!F:XX=Q22$P]QEPPT#9&7U_;HF,)MA"56II*&FB;K%@CN
MBOG0BHIIH3N*SL=T!ICPL-I)Y<N3Z(8ZM=LA4-H5CU(KVJ0 [>@&0-?UB">5
M6_TJ>>?6WL)4;ZA1JJXYS1==L7A;T2TC^#THI6#"Q=)SN^W1S7>=O@V5SN)-
M((2N7'!I10?KL-&]A)".5!+VM24=B@M'19K8&V*B3H"ZKER<<:1(2J!M5:C$
MV],_DF)GD/1I2WZ!<&]\A]!?LC0W*ABH;,CQ8%^#,>%;/-P,P3FZ1HXY#>\@
MK14G9=$+D(><^]!0OH;*80"V!SO>'=C"T!&3K:YE3T B<JB=6XTQ!(RZOY4<
ML^U@N0YF41'$+!: 'Q)^G?'*I;)C-M/V0 *RGZR6U.O![,$N4Z3FR]\M#IV8
MBF<?)&?EZL(P*X,XY_^EZ!99TR*EY]75*X!V9+^9\SFE$1,]V%,:<+)1&3T9
M+4.7Q-78V AMIHS6K_MV<79X<H)\ M6V8M9GI:U-K=,5<6T/$@I&/;%9]L"X
M/\<.-'*X*NJ!ME4($7V/;;VW!DJ0?:%NIX9-7(ZR'!0IM;/P15U19CMWBJ A
M4-1Q[Z61.T4%SE$^A;8F]\JGWQ#Z26$D2UYJV!* (U\:-)2->C+7 6R</Z%A
M-(F5<#?7I.?H?5(,QU]S E.6G;C5?0$_R%Y2UPI@"+EQ5H5.!!@M*5C-C7;;
M6%$S8*@[#E)SI;!"US@+PZ;\7[NQZ-<X,3<\]ST_Z(X'M+Y*F(!LG/BA4S/#
M"O$CL?(ET,>!D>[X AR(O8JJM5(8^SFAYLM;EY*9+SY(O]?8?)!EJ3\\0JAR
M_\ *'A#^,3<D#[-H!N%^ZJ3EBE: !-F<DI K'A\F8'IPR,P!+LM?E$'\2K*I
M)M.<K G0@FP=F8A-)G -K!X<%(LP:A/-R1L!-<C&CU9NYN+>0M7%,]Y'\IU_
MN6$];\GC !'9?#&0@&!GJT/4R7+LZ2@:1V1D*3Q-,PX9NQ1[/2&:(D,]^)37
M19R1K)A_I59IMNE1>2GI,L,.R=1R->\!B$!?4NN(N 9(U!/$^JD%5]6E?B'I
M>Q;,)E$8Q(J,D-+G@4[DN!I[ \H,4_<."\V$2]ZW84D-)N7S0 126(N9B 1B
MU:)Q=3!86ZSY4JXY"?_VGG[\G!>SC/9\>,%_^HG]5)4I_=VW+P.1]. O,!LA
M'>.;<;XEIZWO1CVJ<[--6:X==*'X/R0L7M-A-O@(HIA-0G?IUFJBV:U:]P5$
M(I_EU]_&UL?K*I.Z-YJCW?G6Z W81 X'J*\##G1JBX<.EJDW6OB'XW$4DJN2
M$DV1*3-'BQX%_,@!!$WDMFL,*&&ZRMR.9KR_A"0)LB@U,=RKSU(&+B[/D07=
MT&@7XO$PR?L2Q]<DGY&0>QC4QKKL>2 !R;6B%XU E%HDW4H-;R5..E61,,CE
MWC+YPP ?R8%B)ABY,"50NI7MW7&1# 82.ZE O=ET%X.K).W[%I1QF0P.%,G6
M%5,N$<O6][K*H;Y'P7P)/J-I.56*9N,9 (MDE\B(WQ6/^)M=)3-'RFSY,DFS
M@KO)R5OQ2M^F\5$(G_]V<79PBK5T-?=#J#&Y2CK>%0%K70F2%D (\@FZ6E2&
MXMW"XRK/.)* 'TA!=Z+#,5P%U]9G$ST.5""?L>O$)(N-4,!!2RG>9FC;@T&5
M*4U+<(6@!\/4#W\R0^<JMSBFEWB0D8#E(0[BVYQMM)=^,H7P94V %_1(&C/9
MB26OA>8JSSANY!NC:-/CR>9%.LDM(ANT(U_5&+CJY-&]J1I8@'25C[QK"O%,
M$O(= EPLM:'2$EA"SE_A7A5$""5ZX%5BBDV4BRP("ND+G^>,G'32;64J<S4N
MB:1QLSOP+YVD\>A^.LO2#^XOSQ^"9!33[U/=[[)H#0P@G^?6DVP=E!(Y[RE,
MJY&<7],K.DG-@FC43.+K?A@K%R>=/-IS*'L!7HD6>%5+\"F8<[QW:48-VI"0
M47Y'R7TE29 4)I<_S3H SM"#L)O,_)9 )<IA[KKKQ!U0Y55XX^5_JQU,HYUT
MV=8S V3X)#=C<*L(+K-UBQ,7S;>P/-/I,&")4J;B5/U-NX2SC$ZZ@XP6#Q?0
M)6KBU05)"7[C*6+5 @:/EPIABDPB[SWY!F7%1;D/HQ(*!W=/!/=29+. >0_
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M,#(P,3(S,2YX;6Q02P$"% ,4    " !(@')2;K^$4OD4  !6W0  $0
M        @ ',2@$ 9FAT>"TR,#(P,3(S,2YX<V102P$"% ,4    " !(@')2
MR\'M-*L.  !?U@  %0              @ 'T7P$ 9FAT>"TR,#(P,3(S,5]C
M86PN>&UL4$L! A0#%     @ 2(!R4K>:%YY[0P  3S0$ !4
M ( !TFX! &9H='@M,C R,#$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( $B <E(Q
M'6S>]8D  /N0!P 5              "  8"R 0!F:'1X+3(P,C Q,C,Q7VQA
M8BYX;6Q02P$"% ,4    " !(@')2A7"K(\I?  #-0@8 %0
M@ &H/ ( 9FAT>"TR,#(P,3(S,5]P<F4N>&UL4$L%!@     &  8 B@$  *6<
$ @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
